PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Menz, MHM; Dixon, KW; Hobbs, RJ				Menz, Myles H. M.; Dixon, Kingsley W.; Hobbs, Richard J.			Hurdles and Opportunities for Landscape-Scale Restoration	SCIENCE			English	Editorial Material							ECOSYSTEM SERVICES; BIODIVERSITY; CONSERVATION; SCIENCE; NEED		[Menz, Myles H. M.; Dixon, Kingsley W.] Kings Pk & Bot Gardens, Perth, WA 6005, Australia; [Menz, Myles H. M.; Dixon, Kingsley W.; Hobbs, Richard J.] Univ Western Australia, Perth, WA 6009, Australia	University of Western Australia	Menz, MHM (corresponding author), Kings Pk & Bot Gardens, Perth, WA 6005, Australia.	myles.menz@bgpa.wa.gov.au	Hobbs, Richard J/F-5883-2010; Dixon, Kingsley W/A-8133-2016; Menz, Myles/A-2238-2017; Menz, Myles H. M./AAP-6756-2020; Menz, Myles/HHZ-9580-2022; Dixon, Kingsley W/B-1042-2011	Hobbs, Richard J/0000-0003-4047-3147; Dixon, Kingsley W/0000-0001-5989-2929; Menz, Myles/0000-0002-3347-5411; Menz, Myles H. M./0000-0002-3347-5411; Menz, Myles/0000-0002-3347-5411; 				Arlettaz R, 2010, BIOSCIENCE, V60, P835, DOI 10.1525/bio.2010.60.10.10; Aronson J, 2011, LANDSCAPE ECOL, V26, P457, DOI 10.1007/s10980-011-9586-2; Biggs R, 2012, ANNU REV ENV RESOUR, V37, P421, DOI 10.1146/annurev-environ-051211-123836; Birch JC, 2010, P NATL ACAD SCI USA, V107, P21925, DOI 10.1073/pnas.1003369107; Brito L, 2012, SCIENCE, V336, P1396, DOI [10.1126/science.1224531, 10.1126/science.1224006]; Brudvig LA, 2011, AM J BOT, V98, P549, DOI 10.3732/ajb.1000285; Buch A, 2009, SUSTAIN DEV, V17, P129, DOI 10.1002/sd.370; Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cunningham S, 2008, REWEALTH; Dixon KW, 2009, SCIENCE, V325, P571, DOI 10.1126/science.1176295; Harris J, 2009, SCIENCE, V325, P573, DOI 10.1126/science.1172975; Hobbs RJ, 2007, AUST J BOT, V55, P371, DOI 10.1071/BT06088; Hobbs RJ, 2007, RESTOR ECOL, V15, P354, DOI 10.1111/j.1526-100X.2007.00225.x; Hobbs RJ, 2011, BIOSCIENCE, V61, P442, DOI 10.1525/bio.2011.61.6.6; IUCN, REST LOST FOR; Keeneleyside KA., 2012, ECOLOGICAL RESTORATI, DOI [10.25607/OBP-171, DOI 10.25607/OBP-171]; Martinez ML, 2012, FRONT ECOL ENVIRON, V10, P44, DOI 10.1890/100151; MAATHAI W, 2006, GREEN BELT MOVEMENT; Maron M, 2012, BIOL CONSERV, V155, P141, DOI 10.1016/j.biocon.2012.06.003; Menz MHM, 2011, TRENDS PLANT SCI, V16, P4, DOI 10.1016/j.tplants.2010.09.006; Merritt DJ, 2011, SCIENCE, V332, P424, DOI 10.1126/science.1203083; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Richardson CJ, 2005, SCIENCE, V307, P1307, DOI 10.1126/science.1105750; Suding KN, 2011, ANNU REV ECOL EVOL S, V42, P465, DOI 10.1146/annurev-ecolsys-102710-145115; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Tollefson J, 2012, NATURE, V486, P12, DOI 10.1038/486013a; Tongway DJ, 1996, RESTOR ECOL, V4, P388, DOI 10.1111/j.1526-100X.1996.tb00191.x; van Wilgen BW, 2012, BIOL CONSERV, V148, P28, DOI 10.1016/j.biocon.2011.12.035; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Wilson KA, 2011, J APPL ECOL, V48, P715, DOI 10.1111/j.1365-2664.2011.01975.x; Xu JC, 2011, NATURE, V477, P370, DOI 10.1038/477371a	32	250	263	16	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					526	527		10.1126/science.1228334	http://dx.doi.org/10.1126/science.1228334			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372001				2022-12-24	WOS:000314270000042
J	Gammon, K				Gammon, Katharine			DRUGS Blood battles	NATURE			English	Editorial Material							STATIN											Bulbulia R, 2011, LANCET, V378, P2013, DOI 10.1016/S0140-6736(11)61125-2; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; Gutierrez J, 2012, ARCH INTERN MED, V172, P909, DOI 10.1001/archinternmed.2012.2145; Redberg RF, 2012, JAMA-J AM MED ASSOC, V307, P1491, DOI 10.1001/jama.2012.423; Wald DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041297	5	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					S14	S15		10.1038/493S14a	http://dx.doi.org/10.1038/493S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364766				2022-12-24	WOS:000314219600011
J	Srivastava, R				Srivastava, Ranjana			Speaking Up - When Doctors Navigate Medical Hierarchy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Monash Med Ctr, Dept Med Oncol, Melbourne, Vic, Australia	Monash University	Srivastava, R (corresponding author), Monash Med Ctr, Dept Med Oncol, Melbourne, Vic, Australia.								0	41	41	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2013	368	4					302	305		10.1056/NEJMp1212410	http://dx.doi.org/10.1056/NEJMp1212410			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075KX	23343060				2022-12-24	WOS:000313885900003
J	Bolland, MJ; Jackson, R; Gamble, GD; Grey, A				Bolland, Mark J.; Jackson, Rod; Gamble, Greg D.; Grey, Andrew			Discrepancies in predicted fracture risk in elderly people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICIANS SURVIVAL PREDICTIONS; POSTMENOPAUSAL WOMEN; ZOLEDRONIC ACID; OSTEOPOROSIS; PREVENTION; MANAGEMENT; DEATH; AGE		[Bolland, Mark J.; Gamble, Greg D.; Grey, Andrew] Univ Auckland, Dept Med, Auckland 1142, New Zealand; [Jackson, Rod] Univ Auckland, Epidemiol & Biostat Sect, Auckland 1142, New Zealand	University of Auckland; University of Auckland	Bolland, MJ (corresponding author), Univ Auckland, Dept Med, Private Bag 92019, Auckland 1142, New Zealand.	m.bolland@auckland.ac.nz	Bolland, Mark J/A-7554-2008	Bolland, Mark J/0000-0003-0465-2674; Jackson, Rod/0000-0001-5914-6934; Gamble, Greg/0000-0003-0412-3203				Berry SD, 2010, J AM GERIATR SOC, V58, P783, DOI 10.1111/j.1532-5415.2010.02767.x; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Black DM, 2012, NEW ENGL J MED, V366, P2051, DOI 10.1056/NEJMp1202623; Bolland MJ, 2011, J BONE MINER RES, V26, P420, DOI 10.1002/jbmr.215; Bolland MJ, 2010, J CLIN ENDOCR METAB, V95, P1856, DOI 10.1210/jc.2009-2157; Collins GS, 2011, BMJ-BRIT MED J, V342; Compston J, 2009, MATURITAS, V62, P105, DOI 10.1016/j.maturitas.2008.11.022; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Dawson-Hughes B, 2008, J CLIN ENDOCR METAB, V93, P2463, DOI 10.1210/jc.2008-0926; Ensrud KE, 2009, ARCH INTERN MED, V169, P2087, DOI 10.1001/archinternmed.2009.404; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Langsetmo L, 2011, CAN MED ASSOC J, V183, pE107, DOI 10.1503/cmaj.100458; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Melton LJ, 1999, OSTEOPOROSIS INT, V9, P29, DOI 10.1007/s001980050113; Poses RM, 1997, ARCH INTERN MED, V157, P1001, DOI 10.1001/archinte.157.9.1001; Singer BR, 1998, J BONE JOINT SURG BR, V80B, P243, DOI 10.1302/0301-620X.80B2.7762; Siontis GCM, 2011, ARCH INTERN MED, V171, P1721, DOI 10.1001/archinternmed.2011.334; Steurer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019994	19	21	21	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2013	346								e8669	10.1136/bmj.e8669	http://dx.doi.org/10.1136/bmj.e8669			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BA	23338005				2022-12-24	WOS:000314215000003
J	Balbus, JM; Barouki, R; Birnbaum, LS; Etzel, RA; Gluckman, PD; Grandjean, P; Hancock, C; Hanson, MA; Heindel, JJ; Hoffman, K; Jensen, GK; Keeling, A; Neira, M; Rabadan-Diehl, C; Ralston, J; Tang, KC				Balbus, John M.; Barouki, Robert; Birnbaum, Linda S.; Etzel, Ruth A.; Gluckman, Peter D.; Grandjean, Philippe; Hancock, Christine; Hanson, Mark A.; Heindel, Jerrold J.; Hoffman, Kate; Jensen, Genon K.; Keeling, Ann; Neira, Maria; Rabadan-Diehl, Cristina; Ralston, Johanna; Tang, Kwok-Cho			Early-life prevention of non-communicable diseases	LANCET			English	Editorial Material							CHILDHOOD; HEALTH		[Balbus, John M.] NIEHS, NIH, Bethesda, MD 20892 USA; [Barouki, Robert] Univ Paris 05, Paris, France; [Birnbaum, Linda S.] NIEHS, Natl Technol Program, Res Triangle Pk, NC 27709 USA; [Heindel, Jerrold J.] NIEHS, Div Extramural Res & Training, Res Triangle Pk, NC 27709 USA; [Etzel, Ruth A.] Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Madison, WI 53706 USA; [Gluckman, Peter D.] Univ Auckland, Auckland 1, New Zealand; [Grandjean, Philippe] Univ So Denmark, Odense, Denmark; [Hancock, Christine] C3 Collaborating Hlth, London, England; [Hanson, Mark A.] Univ Southampton, Southampton Gen Hosp, Southampton, Hants, England; [Hoffman, Kate] Social & Sci Syst, Durham, NC USA; [Hoffman, Kate] Univ N Carolina, Chapel Hill, NC USA; [Jensen, Genon K.] Hlth & Environm Alliance, Brussels, Belgium; [Keeling, Ann] Int Diabet Federat, Brussels, Belgium; [Neira, Maria; Tang, Kwok-Cho] WHO, CH-1211 Geneva, Switzerland; [Rabadan-Diehl, Cristina] NHLBI, NIH, Bethesda, MD 20892 USA; [Ralston, Johanna] World Heart Federat, Geneva, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Wisconsin System; University of Wisconsin Madison; University of Auckland; University of Southern Denmark; University of Southampton; Social & Scientific Systems; University of North Carolina; University of North Carolina Chapel Hill; World Health Organization; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Balbus, JM (corresponding author), NIEHS, NIH, 31 Ctr Dr,Room B1CO2, Bethesda, MD 20892 USA.	john.balbus@nih.gov	Etzel, Ruth A./N-5700-2019; Hanson, Mark/AAE-8236-2019; Grandjean, Philippe/I-2962-2014	Etzel, Ruth A./0000-0002-5236-3976; Hanson, Mark/0000-0002-6907-613X; hoffman, kate/0000-0001-8029-7710; Birnbaum, Linda/0000-0001-5429-5658; Grandjean, Philippe/0000-0003-4046-9658	NIEHS NIH HHS [R01 ES012199, T32 ES007018] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007018, R01ES012199] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barouki R, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-42; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Gale CR, 2006, ARTERIOSCL THROM VAS, V26, P1877, DOI 10.1161/01.ATV.0000228819.13039.b8; Godfrey KM, 1998, EUR J OBSTET GYN R B, V78, P141, DOI 10.1016/S0301-2115(98)00060-8; Hou LF, 2012, INT J EPIDEMIOL, V41, P79, DOI 10.1093/ije/dyr154; Perera F, 2011, REPROD TOXICOL, V31, P363, DOI 10.1016/j.reprotox.2010.12.055; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Skinner MK, 2011, REPROD TOXICOL, V31, P337, DOI 10.1016/j.reprotox.2010.10.012; UN,, 2012, ARES66288 UN; United Nations, 2011, MILL DEV GOALS REP 2; United Nations, 2011, NCDS MDGS SUCC SYN; WHO, 2010, GLOB STAT REP NONC D	12	108	110	0	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 5	2013	381	9860					3	4		10.1016/S0140-6736(12)61609-2	http://dx.doi.org/10.1016/S0140-6736(12)61609-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	064AW	23290956	Green Accepted, Green Submitted			2022-12-24	WOS:000313044300004
J	Milinkovitch, MC; Manukyan, L; Debry, A; Di-Poi, N; Martin, S; Singh, D; Lambert, D; Zwicker, M				Milinkovitch, Michel C.; Manukyan, Liana; Debry, Adrien; Di-Poi, Nicolas; Martin, Samuel; Singh, Daljit; Lambert, Dominique; Zwicker, Matthias			Crocodile Head Scales Are Not Developmental Units But Emerge from Physical Cracking	SCIENCE			English	Article							SURFACE MECHANICS; PATTERN-FORMATION; ORDER; HAIR	Various lineages of amniotes display keratinized skin appendages (feathers, hairs, and scales) that differentiate in the embryo from genetically controlled developmental units whose spatial organization is patterned by reaction-diffusion mechanisms (RDMs). We show that, contrary to skin appendages in other amniotes (as well as body scales in crocodiles), face and jaws scales of crocodiles are random polygonal domains of highly keratinized skin, rather than genetically controlled elements, and emerge from a physical self-organizing stochastic process distinct from RDMs: cracking of the developing skin in a stress field. We suggest that the rapid growth of the crocodile embryonic facial and jaw skeleton, combined with the development of a very keratinized skin, generates the mechanical stress that causes cracking.	[Milinkovitch, Michel C.; Manukyan, Liana; Debry, Adrien; Di-Poi, Nicolas] Univ Geneva, Lab Artificial & Nat Evolut, Dept Genet & Evolut, CH-1211 Geneva, Switzerland; [Martin, Samuel] La Ferme Crocodiles, Pierrelatte, France; [Singh, Daljit; Zwicker, Matthias] Univ Bern, Comp Graph Grp, CH-3012 Bern, Switzerland; [Lambert, Dominique] Univ Namur, Dept Math, Namur, Belgium; [Lambert, Dominique] Univ Namur, Namur Ctr Complex Syst, Namur, Belgium	University of Geneva; University of Bern; University of Namur; University of Namur	Milinkovitch, MC (corresponding author), Univ Geneva, Lab Artificial & Nat Evolut, Dept Genet & Evolut, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	michel.milinkovitch@unige.ch	Di-Poi, Nicolas/O-6256-2019; Lambert, Dominique Jean-Marie/AAH-6865-2021; Di-Poi, Nicolas/O-2378-2015	Di-Poi, Nicolas/0000-0002-3313-3016; Lambert, Dominique Jean-Marie/0000-0002-6415-3175; Di-Poi, Nicolas/0000-0002-3313-3016; Zwicker, Matthias/0000-0001-8630-5515; Milinkovitch, Michel/0000-0002-2553-0724	University of Geneva; Swiss National Science Foundation; Schmidheiny Foundation	University of Geneva; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Schmidheiny Foundation	This work was supported by the University of Geneva, the Swiss National Science Foundation, and the Schmidheiny Foundation. A. Tzika helped with in situs. H. Li assisted with nonrigid registration. We thank R. Pellet for assistance in mechanics design and A. Roux, M. Gonzalez-Gaitan, B. Chopard, U. Schibler, and anonymous reviewers for useful comments and suggestions.	Alibardi L., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P175; Bohn S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046215; Chang C, 2009, INT J DEV BIOL, V53, P813, DOI 10.1387/ijdb.072556cc; Dhouailly D, 2009, J ANAT, V214, P587, DOI 10.1111/j.1469-7580.2008.01041.x; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Furukawa Y, 2009, INT J COMPUT VISION, V84, P257, DOI 10.1007/s11263-009-0232-2; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Goehring L, 2005, EUROPHYS LETT, V69, P739, DOI 10.1209/epl/i2004-10408-x; Goehring L, 2010, SOFT MATTER, V6, P3562, DOI 10.1039/b922206e; Goehring L, 2009, P NATL ACAD SCI USA, V106, P387, DOI 10.1073/pnas.0805132106; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; Herrmann HJ., 1990, STAT MODELS FRACTURE; Jagla EA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026203; Kazhdan Michael, 2006, P 4 EUR S GEOM PROC, P61, DOI DOI 10.1145/1364901.1364904; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Shorlin KA, 2000, PHYS REV E, V61, P6950, DOI 10.1103/PhysRevE.61.6950; Snavely N, 2006, ACM T GRAPHIC, V25, P835, DOI 10.1145/1141911.1141964; Soares D, 2002, NATURE, V417, P241, DOI 10.1038/417241a; Thompson D.W, 1917, GROWTH FORM; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; WEAIRE D, 1984, CONTEMP PHYS, V25, P59, DOI 10.1080/00107518408210979; Weaire D., 1999, PHYS FOAMS	24	66	65	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					78	81		10.1126/science.1226265	http://dx.doi.org/10.1126/science.1226265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23196908				2022-12-24	WOS:000312985800055
J	Tucker, ME				Tucker, Miriam E.			US drug shortages: a disappearing problem?	BRITISH MEDICAL JOURNAL			English	Editorial Material												miriametucker@aol.com						American Society of Anesthesiologists, 2012, 2012 ASA DRUG SHORT; FDA, IMP AM SHUTD REC DRU; Generic Pharmaceutical Association, DRUG SHORT; Government Accountability Office, 2011, DRUG SHORT FDAS AB R; Silverman E, 2012, PHARMALOT       1211	5	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 21	2012	345								e8551	10.1136/bmj.e8551	http://dx.doi.org/10.1136/bmj.e8551			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059JR	23261759				2022-12-24	WOS:000312701700024
J	Scott, G; Presswood, E				Scott, Gregory; Presswood, Edward			CHRISTMAS 2012: TOMORROW'S WORLD Case report of E.T.-The Extra-Terrestrial	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEN		[Scott, Gregory] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London W12 0HS, England; [Presswood, Edward] Barnet & Chase Farm Hosp NHS Trust, Chase Farm Hosp, Enfield, Middx, England	Imperial College London; University of London; University College London; Royal Free London NHS Foundation Trust	Scott, G (corresponding author), Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London W12 0HS, England.	gregory.scott99@imperial.ac.uk		Presswood, Edward/0000-0002-1429-0729; Berger, Marc Moritz/0000-0001-6771-3193; Scott, Gregory/0000-0001-8063-5871				Bierma, 2005, CHICAGO TRIBUNE; Kershner I., 1980, STAR WARS EPISODE 5; McGhee GR, 2011, VIENNA SER THEOR BIO, P1; Nolan JP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6122; Resuscitation Council, 2010, ADV LIF SUPP RES GUI; Spielberg S, 2005, ET EXTRA TERRESTRIAL; Spielberg Steven, 1982, ET EXTRA TERRESTRIAL; VANPRAAGH R, 1964, AM J CARDIOL, V13, P510, DOI 10.1016/0002-9149(64)90159-6; VanPraagh S, 1996, AM HEART J, V132, P382, DOI 10.1016/S0002-8703(96)90437-8; Wall TL, 1997, ANN INTERN MED, V127, P376, DOI 10.7326/0003-4819-127-5-199709010-00007; Williams SRP, 1997, EUR HEART J, V18, P376; World Health Organization, 2012, CHILD GROWTH STAND W	12	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2012	345								e8127	10.1136/bmj.e8127	http://dx.doi.org/10.1136/bmj.e8127			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IW	23249665				2022-12-24	WOS:000312698900011
J	Zhou, HH; Sun, LT; Yang, XL; Schimmel, P				Zhou, Huihao; Sun, Litao; Yang, Xiang-Lei; Schimmel, Paul			ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase	NATURE			English	Article							HALOFUGINONE; ADENYLATE; ASSAYS	Febrifugine is the active component of the Chinese herb Chang Shan (Dichroa febrifuga Lour.)(1,2), which has been used for treating malaria-induced fever for about 2,000 years. Halofuginone (HF), the halogenated derivative of febrifugine, has been tested in clinical trials for potential therapeutic applications in cancer and fibrotic disease(3-6). Recently, HF was reported to inhibit T(H)17 cell differentiation by activating the amino acid response pathway(7), through inhibiting human prolyl-transfer RNA synthetase (ProRS) to cause intracellular accumulation of uncharged tRNA(8,9). Curiously, inhibition requires the presence of unhydrolysed ATP. Here we report an unusual 2.0 angstrom structure showing that ATP directly locks onto and orients two parts of HF onto human ProRS, so that one part of HF mimics bound proline and the other mimics the 3' end of bound tRNA. Thus, HF is a new type of ATP-dependent inhibitor that simultaneously occupies two different substrate binding sites on ProRS. Moreover, our structure indicates a possible similar mechanism of action for febrifugine in malaria treatment. Finally, the elucidation here of a two-site modular targeting activity of HF raises the possibility that substrate-directed capture of similar inhibitors might be a general mechanism that could be applied to other synthetases.	[Zhou, Huihao; Sun, Litao; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schimmel, P (corresponding author), Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu	ZHOU, HUIHAO/L-6133-2016; Yang, Xiang-Lei/AAR-7107-2020	ZHOU, HUIHAO/0000-0002-9675-5007; SUN, LITAO/0000-0002-8415-989X; Yang, Xiang-Lei/0000-0003-2554-084X	National Institutes of Health [GM15539, GM23562, GM88278]; National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088278, R01GM015539, R37GM015539, R01GM023562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Musier-Forsyth for providing the ProRS gene plasmid and Pro-SA, staff at beamline 7-1 of Stanford Synchrotron Radiation Lightsource for assistance in X-ray diffraction data collection, and M. Guo for comments. This work was supported by National Institutes of Health grants GM15539, GM23562 and GM88278 and by a fellowship from the National Foundation for Cancer Research.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beebe K, 2007, ANAL BIOCHEM, V368, P111, DOI 10.1016/j.ab.2007.05.013; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Coatney G. R., 1950, Journal of the National Malaria Society, V9, P183; de Jonge MJA, 2006, EUR J CANCER, V42, P1768, DOI 10.1016/j.ejca.2005.12.027; Heacock D, 1996, BIOORG CHEM, V24, P273, DOI 10.1006/bioo.1996.0025; Hill JM, 1998, U. S. Patent, Patent No. [5,824,657, 5824657]; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; KOEPFLI JB, 1947, J AM CHEM SOC, V69, P1837, DOI 10.1021/ja01199a513; Koon HB, 2011, JAIDS-J ACQ IMM DEF, V56, P64, DOI 10.1097/QAI.0b013e3181fc0141; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pines A, 2003, BIOL BLOOD MARROW TR, V9, P417, DOI 10.1016/S1083-8791(03)00151-4; Pines M, 1998, GEN PHARMACOL, V30, P445, DOI 10.1016/S0306-3623(97)00307-8; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Schimmel P, 1998, FASEB J, V12, P1599, DOI 10.1096/fasebj.12.15.1599; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Yaremchuk A, 2001, J MOL BIOL, V309, P989, DOI 10.1006/jmbi.2001.4712; Zhu SR, 2009, BIOORGAN MED CHEM, V17, P4496, DOI 10.1016/j.bmc.2009.05.011	21	105	116	0	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					121	124		10.1038/nature11774	http://dx.doi.org/10.1038/nature11774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23263184	Green Accepted			2022-12-24	WOS:000314741200046
J	Kouwer, PHJ; Koepf, M; Le Sage, VAA; Jaspers, M; van Buul, AM; Eksteen-Akeroyd, ZH; Woltinge, T; Schwartz, E; Kitto, HJ; Hoogenboom, R; Picken, SJ; Nolte, RJM; Mendes, E; Rowan, AE				Kouwer, Paul H. J.; Koepf, Matthieu; Le Sage, Vincent A. A.; Jaspers, Maarten; van Buul, Arend M.; Eksteen-Akeroyd, Zaskia H.; Woltinge, Tim; Schwartz, Erik; Kitto, Heather J.; Hoogenboom, Richard; Picken, Stephen J.; Nolte, Roeland J. M.; Mendes, Eduardo; Rowan, Alan E.			Responsive biomimetic networks from polyisocyanopeptide hydrogels	NATURE			English	Article							ELASTICITY; MEDICINE; ACTIN	Mechanical responsiveness is essential to all biological systems down to the level of tissues and cells(1,2). The intra- and extracellular mechanics of such systems are governed by a series of proteins, such as microtubules, actin, intermediate filaments and collagen(3,4). As a general design motif, these proteins self-assemble into helical structures and superstructures that differ in diameter and persistence length to cover the full mechanical spectrum(1). Gels of cytoskeletal proteins display particular mechanical responses (stress stiffening) that until now have been absent in synthetic polymeric and low-molar-mass gels. Here we present synthetic gels that mimic in nearly all aspects gels prepared from intermediate filaments. They are prepared from polyisocyanopeptides(5-7) grafted with oligo(ethylene glycol) side chains. These responsive polymers possess a stiff and helical architecture, and show a tunable thermal transition where the chains bundle together to generate transparent gels at extremely low concentrations. Using characterization techniques operating at different length scales (for example, macroscopic rheology, atomic force microscopy and molecular force spectroscopy) combined with an appropriate theoretical network model(8-10), we establish the hierarchical relationship between the bulk mechanical properties and the single-molecule parameters. Our results show that to develop artificial cytoskeletal or extracellular matrix mimics, the essential design parameters are not only the molecular stiffness, but also the extent of bundling. In contrast to the peptidic materials, our polyisocyanide polymers are readily modified, giving a starting point for functional biomimetic hydrogels with potentially a wide variety of applications(11-14), in particular in the biomedical field.	[Kouwer, Paul H. J.; Koepf, Matthieu; Le Sage, Vincent A. A.; Jaspers, Maarten; van Buul, Arend M.; Eksteen-Akeroyd, Zaskia H.; Woltinge, Tim; Schwartz, Erik; Kitto, Heather J.; Hoogenboom, Richard; Nolte, Roeland J. M.; Rowan, Alan E.] Radboud Univ Nijmegen, Inst Mol & Mat, Dept Mol Mat, NL-6525 AJ Nijmegen, Netherlands; [Picken, Stephen J.; Mendes, Eduardo] Delft Univ Technol, Dept NanoStruct Mat, NL-2628 BL Delft, Netherlands	Radboud University Nijmegen; Delft University of Technology	Kouwer, PHJ (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, Dept Mol Mat, Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	p.kouwer@science.ru.nl; a.rowan@science.ru.nl	Hoogenboom, Richard/B-8977-2008; Rowan, Alan E/F-9702-2015; Kouwer, Paul H. J./B-4847-2008; Mendes, Eduardo/K-7280-2012; Schwartz, Erik/C-7346-2011; Nolte, Roeland/C-9930-2013; Eksteen-Akeroyd, Zaskia H/F-2179-2015; Schwartz, Erik/AAS-9329-2021	Hoogenboom, Richard/0000-0001-7398-2058; Rowan, Alan E/0000-0003-0728-3851; Kouwer, Paul H. J./0000-0002-2760-191X; Mendes, Eduardo/0000-0002-7519-0668; Nolte, Roeland/0000-0002-5612-7815; Eksteen-Akeroyd, Zaskia H/0000-0002-5999-3110; Picken, Stephen/0000-0002-6003-518X	Technology Foundation STW; Council for the Chemical Sciences of the Netherlands Organisation for Scientific Research [NWO-CW-7005644]; NRSCC; Royal Academy for Arts and Sciences; EU [PITN-CT-2007-215851, PITN-CT-2009-238177]	Technology Foundation STW(Technologiestichting STW); Council for the Chemical Sciences of the Netherlands Organisation for Scientific Research; NRSCC; Royal Academy for Arts and Sciences; EU(European Commission)	We thank B. Norder for assistance with rheological experiments, C. Broersz for support with nonlinear rheology, F. MacKintosh for discussions on the interpretation of the semi-flexible polymer network theory and E. Cator for work on the statistical analysis of the AFM images. We acknowledge financial support from Technology Foundation STW, the Council for the Chemical Sciences of the Netherlands Organisation for Scientific Research (NWO-CW-7005644), NRSCC, the Royal Academy for Arts and Sciences and EU projects Hierarchy (PITN-CT-2007-215851) and Superior (PITN-CT-2009-238177).	Bathe M, 2008, BIOPHYS J, V94, P2955, DOI 10.1529/biophysj.107.119743; Broedersz CP, 2011, SOFT MATTER, V7, P3186, DOI 10.1039/c0sm01004a; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cornelissen JJLM, 2001, SCIENCE, V293, P676, DOI 10.1126/science.1062224; Fernandez P, 2006, BIOPHYS J, V90, P3796, DOI 10.1529/biophysj.105.072215; Fernandez-Gonzalez R, 2012, CELL, V149, P965, DOI 10.1016/j.cell.2012.05.006; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Grason GM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.098101; Han S, 2003, MACROMOLECULES, V36, P8312, DOI 10.1021/ma0347971; Hirst AR, 2008, ANGEW CHEM INT EDIT, V47, P8002, DOI 10.1002/anie.200800022; Huisman EM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.208103; Kamm R. D., 2006, CYTOSKELETAL MECH MO, P1; Keereweer B, 2011, FUNCTIONAL SUPRAMOLE, V1, P135; Leterrier JF, 1996, J BIOL CHEM, V271, P15687, DOI 10.1074/jbc.271.26.15687; Lin YC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058101; Lutz JF, 2006, MACROMOLECULES, V39, P893, DOI 10.1021/ma0517042; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Mason TG, 1998, MACROMOLECULES, V31, P3600, DOI 10.1021/ma970564w; Onck PR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178102; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; Rowan A. E, 2011, European Patent, Patent No. [2,287,221, 2287221]; Schwartz E, 2010, CHEM SOC REV, V39, P1576, DOI 10.1039/b922160c; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Tiller JC, 2003, ANGEW CHEM INT EDIT, V42, P3072, DOI 10.1002/anie.200301647; Van Buul A. M, CHEM SCI UNPUB; Wang HM, 2011, SOFT MATTER, V7, P3897, DOI 10.1039/c0sm01405b	28	348	357	33	857	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					651	655		10.1038/nature11839	http://dx.doi.org/10.1038/nature11839			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23354048	Green Published			2022-12-24	WOS:000314219600052
J	Thun, MJ; Carter, BD; Feskanich, D; Freedman, ND; Prentice, R; Lopez, AD; Hartge, P; Gapstur, SM				Thun, Michael J.; Carter, Brian D.; Feskanich, Diane; Freedman, Neal D.; Prentice, Ross; Lopez, Alan D.; Hartge, Patricia; Gapstur, Susan M.			50-Year Trends in Smoking-Related Mortality in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CIGARETTE-SMOKING; TOBACCO USE; HEALTH; CANCER; DESIGN; COHORT	Background The disease risks from cigarette smoking increased in the United States over most of the 20th century, first among male smokers and later among female smokers. Whether these risks have continued to increase during the past 20 years is unclear. Methods We measured temporal trends in mortality across three time periods (1959-1965, 1982-1988, and 2000-2010), comparing absolute and relative risks according to sex and self-reported smoking status in two historical cohort studies and in five pooled contemporary cohort studies, among participants who became 55 years of age or older during follow-up. Results For women who were current smokers, as compared with women who had never smoked, the relative risks of death from lung cancer were 2.73, 12.65, and 25.66 in the 1960s, 1980s, and contemporary cohorts, respectively; corresponding relative risks for male current smokers, as compared with men who had never smoked, were 12.22, 23.81, and 24.97. In the contemporary cohorts, male and female current smokers also had similar relative risks for death from chronic obstructive pulmonary disease (COPD) (25.61 for men and 22.35 for women), ischemic heart disease (2.50 for men and 2.86 for women), any type of stroke (1.92 for men and 2.10 for women), and all causes combined (2.80 for men and 2.76 for women). Mortality from COPD among male smokers continued to increase in the contemporary cohorts in nearly all the age groups represented in the study and within each stratum of duration and intensity of smoking. Among men 55 to 74 years of age and women 60 to 74 years of age, all-cause mortality was at least three times as high among current smokers as among those who had never smoked. Smoking cessation at any age dramatically reduced death rates. Conclusions The risk of death from cigarette smoking continues to increase among women and the increased risks are now nearly identical for men and women, as compared with persons who have never smoked. Among men, the risks associated with smoking have plateaued at the high levels seen in the 1980s, except for a continuing, unexplained increase in mortality from COPD.	[Thun, Michael J.] Amer Canc Soc, Natl Home Off, Dept Epidemiol, Atlanta, GA 30303 USA; [Feskanich, Diane] Harvard Univ, Brigham & Womens Hosp, Channing Div Network Med, Dept Med,Med Sch, Boston, MA 02115 USA; [Freedman, Neal D.; Hartge, Patricia] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Prentice, Ross] Fred Hutchison Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA USA; [Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	American Cancer Society; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fred Hutchinson Cancer Center; University of Queensland	Thun, MJ (corresponding author), Amer Canc Soc, Natl Home Off, Dept Epidemiol, 250 Williams St NW, Atlanta, GA 30303 USA.	michael.thun@cancer.org	Lopez, Alan D/F-1487-2010; Lopez, Alan/AAA-2734-2022; Freedman, Neal David/B-9741-2015	Lopez, Alan D/0000-0001-5818-6512; Freedman, Neal David/0000-0003-0074-1098; Carter, Brian/0000-0003-1166-6521	Intramural Research Program of the National Cancer Institute (NCI), NIH; Intramural Research Programs of the ACS; NCI [P01 CA87969, P01 CA055075]; National Heart, Lung, and Blood Institute [N01WH22110, N01WH24152, N01WH32100-32102, N01WH32105, N01WH32106, N01WH32108, N01WH32109, N01WH32111, N01WH32112, N01WH32113, N01WH32115, N01WH32118, N01WH32119, N01WH32122, N01WH42107-N01WH42126, N01WH42129-N01WH42132, N01WH44221]; NATIONAL CANCER INSTITUTE [ZIACP010196, P01CA087969, U01CA098710, P01CA055075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [N01WH32100, N01WH32118] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH042117, N01WH042107, N01WH042114, N01WH042119, N01WH042129, N01WH042123, N01WH042120, N01WH042113, N01WH032113, N01WH042132, N01WH042109, N01WH032108, N01WH032112, N01WH032118, N01WH032115, N01WH042124, N01WH042131, N01WH022110, N01WH032119, N01WH042118, N01WH032105, N01WH042126, N01WH042115, N01WH032122, N01WH032102, N01WH042122, N01WH042116, N01WH042125, N01WH042112, N01WH032106, N01WH042130, N01WH032101, N01WH032100, N01WH032109, N01WH042108, N01WH042121, N01WH042110, N01WH032111, N01WH042111] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute (NCI), NIH; Intramural Research Programs of the ACS; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support for the National Institutes of Health (NIH)-AARP Diet and Health Study was provided by the Intramural Research Program of the National Cancer Institute (NCI), NIH. Support for all the American Cancer Society (ACS) cohort studies was provided by the Intramural Research Programs of the ACS. Support for the Nurses' Health Study and the Health Professionals Follow-up Study was provided by grants (P01 CA87969 and P01 CA055075, respectively) from the NCI. Support for the Women's Health Initiative program is provided by contracts (N01WH22110, N01WH24152, N01WH32100-32102, N01WH32105, N01WH32106, N01WH32108, N01WH32109, N01WH32111, N01WH32112, N01WH32113, N01WH32115, N01WH32118, N01WH32119, N01WH32122, N01WH42107-N01WH42126, N01WH42129-N01WH42132, and N01WH44221) from the National Heart, Lung, and Blood Institute.	ANDERSON C, 2001, SMOKING TOBACCO CONT, V14; Anderson GL, 2003, ANN EPIDEMIOL, V13, pS5, DOI 10.1016/S1047-2797(03)00043-7; [Anonymous], 2002, SCI BLOG         JUL; [Anonymous], 2003, SMOKING TOBACCO CONT; [Anonymous], CURR POP SURV ANN SO; [Anonymous], AM FAM LIV ARR 2010; [Anonymous], 1964, PHS PUBL, P387; Burns D, 2001, SMOKING TOBACCO CONT, V15, P1; Burns DM, 1997, CIGARETTE SMOKING BE, V8, P13; BURNS DM, 2001, SMOKING TOBACCO CONT, V13, P65; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Centers for Disease Control and Prevention, 2011, HLTH US 2011; Chahine T, 2011, SOC SCI MED, V73, P752, DOI 10.1016/j.socscimed.2011.06.032; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; *DEP HLTH HUM SERV, 1989, DHHS PUBL; Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; Department of Health and Human Services, 2001, WOM SMOK REP SURG GE; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; DOLL R, 1954, BMJ-BRIT MED J, V1, P1451, DOI 10.1136/bmj.1.4877.1451; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dorn H., 1958, P SOC STAT SECT AM S, P34; Garfinkel L, 1985, Natl Cancer Inst Monogr, V67, P49; Green J, 2012, LANCET; HAMMOND E. CUYLER, 1966, NAT CANCER INST MONOGR, V19, P127; HAMMOND EC, 1958, JAMA-J AM MED ASSOC, V166, P1294, DOI 10.1001/jama.1958.02990110030007; HAMMOND EC, 1954, JAMA-J AM MED ASSOC, V155, P1316, DOI 10.1001/jama.1954.03690330020006; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; THUN MJ, 1995, AM J PUBLIC HEALTH, V85, P1223, DOI 10.2105/AJPH.85.9.1223; Thun MJ, 1997, JNCI-J NATL CANCER I, V89, P1580, DOI 10.1093/jnci/89.21.1580; Thun MJ, 2002, ONCOGENE, V21, P7307, DOI 10.1038/sj.onc.1205807; Thun MJ., 1997, CHANGES CIGARETTE RE, V8, P305	36	708	727	1	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2013	368	4					351	364		10.1056/NEJMsa1211127	http://dx.doi.org/10.1056/NEJMsa1211127			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075KX	23343064	Green Accepted			2022-12-24	WOS:000313885900008
J	Sepkowitz, KA				Sepkowitz, Kent A.			Energy Drinks and Caffeine-Related Adverse Effects	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FATALITIES		[Sepkowitz, Kent A.] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10065 USA; [Sepkowitz, Kent A.] Weill Cornell Med Coll, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University	Sepkowitz, KA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, 1275 York Ave, New York, NY 10065 USA.	sepkowik@mskcc.org						BENJAMIN LT, 1991, J HIST BEHAV SCI, V27, P42, DOI 10.1002/1520-6696(199101)27:1<42::AID-JHBS2300270105>3.0.CO;2-1; Holmgren P, 2004, FORENSIC SCI INT, V139, P71, DOI 10.1016/j.forsciint.2003.09.019; Meier B, 2012, NY TIMES; Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001; Thelander G, 2010, CLIN TOXICOL, V48, P354, DOI 10.3109/15563650903586752; Toblin Robin L., 2012, Morbidity and Mortality Weekly Report, V61, P895; Wolk BJ, 2012, CURR OPIN PEDIATR, V24, P243, DOI 10.1097/MOP.0b013e3283506827; YOUNG JH, 1983, J SOUTHERN HIST, V49, P3, DOI 10.2307/2209304	8	80	84	0	76	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2013	309	3					243	244		10.1001/jama.2012.173526	http://dx.doi.org/10.1001/jama.2012.173526			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070XG	23330171				2022-12-24	WOS:000313546800022
J	Riffell, JA; Lei, H; Abrell, L; Hildebrand, JG				Riffell, Jeffrey A.; Lei, Hong; Abrell, Leif; Hildebrand, John G.			Neural Basis of a Pollinator's Buffet: Olfactory Specialization and Learning in Manduca sexta	SCIENCE			English	Article							FLORAL SCENT; MODULATION; HAWKMOTH; MEMORY; EVOLUTION; HONEYBEE; FLOWERS; INSECT; SYSTEM; ODORS	Pollinators exhibit a range of innate and learned behaviors that mediate interactions with flowers, but the olfactory bases of these responses in a naturalistic context remain poorly understood. The hawkmoth Manduca sexta is an important pollinator for many night-blooming flowers but can learn-through olfactory conditioning-to visit other nectar resources. Analysis of the flowers that are innately attractive to moths shows that the scents all have converged on a similar chemical profile that, in turn, is uniquely represented in the moth's antennal (olfactory) lobe. Flexibility in visitation to nonattractive flowers, however, is mediated by octopamine-associated modulation of antennal-lobe neurons during learning. Furthermore, this flexibility does not extinguish the innate preferences. Such processing of stimuli through two olfactory channels, one involving an innate bias and the other a learned association, allows the moths to exist within a dynamic floral environment while maintaining specialized associations.	[Riffell, Jeffrey A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Lei, Hong; Hildebrand, John G.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA; [Abrell, Leif] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA; [Abrell, Leif] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA	University of Washington; University of Washington Seattle; University of Arizona; University of Arizona; University of Arizona	Riffell, JA (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	jriffell@u.washington.edu	Lei, Hong/ABH-1356-2020; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Lei, Hong/0000-0002-5619-3097; Abrell, Leif/0000-0003-2490-1180	NSF [IOS 0822709, CHE 0216226]; NIH [R01-DC-02751]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002751] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank C. Reisenman, R. Alarcon, A. Dacks, G. Davidowitz, and J. Bronstein for advice and assistance; C. Hedgcock and F. van Breugal for images of flowers and moths; and M. Dickinson and H. Bradshaw for manuscript comments. This work was supported by NSF grants IOS 0822709 to J.A.R. and CHE 0216226 to L. A., and NIH grant R01-DC-02751 to J.G.H.	Alarcon R, 2008, ECOL ENTOMOL, V33, P503, DOI 10.1111/j.1365-2311.2008.00996.x; Arenas A, 2009, EUR J NEUROSCI, V30, P1498, DOI 10.1111/j.1460-9568.2009.06940.x; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Dacks AM, 2006, INSECT BIOCHEM MOLEC, V36, P741, DOI 10.1016/j.ibmb.2006.07.002; Dacks AM, 2012, J NEUROPHYSIOL, V108, P539, DOI 10.1152/jn.00159.2012; Daly KC, 2004, P NATL ACAD SCI USA, V101, P10476, DOI 10.1073/pnas.0401902101; Dobson HEM, 2006, BIOLOGY OF FLORAL SCENT, P147; Dudareva N, 2000, PLANT CELL, V12, P949, DOI 10.1105/tpc.12.6.949; Farooqui T, 2003, J NEUROSCI, V23, P5370; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Knudsen JT, 1998, BRITTONIA, V50, P174, DOI 10.2307/2807848; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; Menzel R., 1985, EXPT BEHAV ECOLOGY, V1, P55; Raguso RA, 2003, INT J PLANT SCI, V164, P877, DOI 10.1086/378539; Raguso RA, 1998, OIKOS, V81, P238, DOI 10.2307/3547045; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Riffell JA, 2008, P NATL ACAD SCI USA, V105, P3404, DOI 10.1073/pnas.0709811105; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Schiestl FP, 2003, SCIENCE, V302, P437, DOI 10.1126/science.1087835; Stokl J, 2010, CURR BIOL, V20, P1846, DOI 10.1016/j.cub.2010.09.033; Wright GA, 2009, FUNCT ECOL, V23, P841, DOI 10.1111/j.1365-2435.2009.01627.x; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X	22	102	104	3	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					200	204		10.1126/science.1225483	http://dx.doi.org/10.1126/science.1225483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23223454				2022-12-24	WOS:000313328200043
J	Retallack, GJ				Retallack, Gregory J.			Ediacaran life on land	NATURE			English	Article							COMPACTION; PALEOSOLS; MORAINES; FOSSILS; GROWTH; SOILS	Ediacaran (635-542 million years ago) fossils have been regarded as early animal ancestors of the Cambrian evolutionary explosion of marine invertebrate phyla(1), as giant marine protists(2) and as lichenized fungi(3). Recent documentation of palaeosols in the Ediacara Member of the Rawnsley Quartzite of South Australia(4) confirms past interpretations of lagoonal-aeolian deposition based on synsedimentary ferruginization and loessic texture(5,6). Further evidence for palaeosols comes from non-marine facies, dilation cracks, soil nodules, sand crystals, stable isotopic data and mass balance geochemistry(4). Here I show that the uppermost surfaces of the palaeosols have a variety of fossils in growth position, including Charniodiscus, Dickinsonia, Hallidaya, Parvancorina, Phyllozoon, Praecambridium, Rugoconites, Tribrachidium and 'old-elephant skin' (ichnogenus Rivularites(7)). These fossils were preserved as ferruginous impressions, like plant fossils(8), and biological soil crusts(9,10) of Phanerozoic eon sandy palaeosols. Sand crystals after gypsum(11) and nodules of carbonate(12) are shallow within the palaeosols(4), even after correcting for burial compaction(13). Periglacial involutions and modest geochemical differentiation of the palaeosols are evidence of a dry, cold temperate Ediacaran palaeoclimate in South Australia(4). This new interpretation of some Ediacaran fossils as large sessile organisms of cool, dry soils, is compatible with observations that Ediacaran fossils were similar in appearance and preservation to lichens and other microbial colonies of biological soil crusts(3), rather than marine animals(1), or protists(2).	Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA	University of Oregon	Retallack, GJ (corresponding author), Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA.	gregr@uoregon.edu			PRF fund of the American Chemical Society	PRF fund of the American Chemical Society	K. Lloyd, P. Coulthard, A. Coulthard, K. Anderson and D. Crawford facilitated permission to undertake research in Flinders Ranges National Park. B. Logan and M. Willison aided sampling of drill core at PIRSA, Glenside. T. Palmer and D. Atkins provided mathematical advice. Fieldwork was funded by the PRF fund of the American Chemical Society, and aided by C. Metzger and J. Gehling.	Antcliffe JB, 2008, PALAEONTOLOGY, V51, P11, DOI 10.1111/j.1475-4983.2007.00738.x; Bengtson S, 2007, PALEOBIOLOGY, V33, P351, DOI 10.1666/04040.1; DAN J, 1982, GEODERMA, V28, P173, DOI 10.1016/0016-7061(82)90002-7; DAN J, 1973, ISR J EARTH SCI, V22, P211; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Ewing SA, 2006, GEOCHIM COSMOCHIM AC, V70, P5293, DOI 10.1016/j.gca.2006.08.020; Food & Agriculture Organization, 1978, SOIL MAP WORLD, VVIII; Gehling JG, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P43; GLAESSNER M, 1961, SCI AM, V204, P72, DOI 10.1038/scientificamerican0361-72; Grazhdankin D, 2007, LETHAIA, V40, P201, DOI 10.1111/j.1502-3931.2007.00025.x; Huldtgren T, 2011, SCIENCE, V334, P1696, DOI 10.1126/science.1209537; Jenkins RJF, 2011, GEOL SOC MEM, V36, P693, DOI 10.1144/M36.68; JENKINS RJF, 1983, J GEOL SOC AUST, V30, P101, DOI 10.1080/00167618308729240; Matthews JA, 2005, HOLOCENE, V15, P1, DOI 10.1191/0959683605hl779rp; Mawson D., 1949, T ROY SOC SOUTH AUST, V72, P276; Retallack G.J., 2012, SOC EC PALEONTOLOGIS, V101, P136; Retallack GJ, 2005, GEOLOGY, V33, P333, DOI 10.1130/G21263.1; Retallack GJ, 2007, ALCHERINGA, V31, P215, DOI 10.1080/03115510701484705; Retallack GJ, 2012, SEDIMENTOLOGY, V59, P1208, DOI 10.1111/j.1365-3091.2011.01302.x; Retallack GJ, 2012, PALAEOGEOGR PALAEOCL, V329, P47, DOI 10.1016/j.palaeo.2012.02.017; Retallack GJ, 2010, GEOLOGY, V38, P403, DOI 10.1130/G30514.1; Retallack GJ, 2009, ALCHERINGA, V33, P355, DOI 10.1080/03115510903271066; Seilacher A, 2005, PALAEOGEOGR PALAEOCL, V227, P323, DOI 10.1016/j.palaeo.2005.06.003; Sheldon ND, 2001, GEOLOGY, V29, P247, DOI 10.1130/0091-7613(2001)029<0247:EFCOPD>2.0.CO;2; Simpson WS, 2010, SEDIMENT GEOL, V230, P139, DOI 10.1016/j.sedgeo.2010.07.004; Solomina O, 2003, ARCT ANTARCT ALP RES, V35, P129, DOI 10.1657/1523-0430(2003)035[0129:LAATMI]2.0.CO;2; Sprigg R. C., 1947, Transactions of the Royal Society of South Australia, V71, P212; Vickers-Rich, 2008, RISE ANIMALS EVOLUTI; Yin Z, 2011, PRECAMBR RES; Yuan XL, 2005, SCIENCE, V308, P1017, DOI 10.1126/science.1111347	30	102	107	1	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					89	92		10.1038/nature11777	http://dx.doi.org/10.1038/nature11777			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23235827				2022-12-24	WOS:000312933800036
J	Azzolin, L; Zanconato, F; Bresolin, S; Forcato, M; Basso, G; Bicciato, S; Cordenonsi, M; Piccolo, S				Azzolin, Luca; Zanconato, Francesca; Bresolin, Silvia; Forcato, Mattia; Basso, Giuseppe; Bicciato, Silvio; Cordenonsi, Michelangelo; Piccolo, Stefano			Role of TAZ as Mediator of Wnt Signaling	CELL			English	Article							PATHWAY; INHIBITION; PROTEIN; YAP; DEGRADATION; COMPONENTS; STABILITY; COMPLEX; TARGETS; LATS	Wnt growth factors are fundamental regulators of cell fate, but how the Wnt signal is translated into biological responses is incompletely understood. Here, we report that TAZ, a biologically potent transcriptional coactivator, serves as a downstream element of the Wnt/beta-catenin cascade. This function of TAZ is independent from its well-established role as mediator of Hippo signaling. In the absence of Wnt activity, the components of the beta-catenin destruction complex-APC, Axin, and GSK3-are also required to keep TAZ at low levels. TAZ degradation depends on phosphorylated beta-catenin that bridges TAZ to its ubiquitin ligase beta-TrCP. Upon Wnt signaling, escape of beta-catenin from the destruction complex impairs TAZ degradation and leads to concomitant accumulation of beta-catenin and TAZ. At the genome-wide level, a substantial portion of Wnt transcriptional responses is mediated by TAZ. TAZ activation is a general feature of Wnt signaling and is functionally relevant to mediate Wnt biological effects.	[Azzolin, Luca; Zanconato, Francesca; Cordenonsi, Michelangelo; Piccolo, Stefano] Univ Padua, Sch Med, Dept Biomed Sci, I-35126 Padua, Italy; [Bresolin, Silvia; Basso, Giuseppe] Univ Padua, Dept Woman & Child Hlth, I-35128 Padua, Italy; [Forcato, Mattia; Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, Ctr Genome Res, I-41100 Modena, Italy	University of Padua; University of Padua; Universita di Modena e Reggio Emilia	Cordenonsi, M (corresponding author), Univ Padua, Sch Med, Dept Biomed Sci, Viale Colombo 3, I-35126 Padua, Italy.	michelangelo.cordenonsi@unipd.it; piccolo@bio.unipd.it	Forcato, Mattia/B-7733-2015; Bicciato, Silvio/C-9825-2009; BICCIATO, Silvio/J-4466-2019; Bresolin, Silvia/K-6576-2016; Cordenonsi, Michelangelo/K-7692-2016; Azzolin, Luca/K-8012-2016	Forcato, Mattia/0000-0002-7383-6576; Bicciato, Silvio/0000-0002-1944-7078; BICCIATO, Silvio/0000-0002-1944-7078; Bresolin, Silvia/0000-0001-7677-7084; Cordenonsi, Michelangelo/0000-0002-8253-5724; Azzolin, Luca/0000-0002-2425-6153; PICCOLO, STEFANO/0000-0002-2037-0004; BASSO, GIUSEPPE/0000-0002-2634-9302	Italian Welfare Ministry; AIRC-MFAG; Fondazione Citta della Speranza Grant; AIRC; HSFP; Excellence-IIT; Epigenetics Flagship project CNR-Miur grants	Italian Welfare Ministry; AIRC-MFAG(Fondazione AIRC per la ricerca sul cancro); Fondazione Citta della Speranza Grant; AIRC(Fondazione AIRC per la ricerca sul cancro); HSFP; Excellence-IIT; Epigenetics Flagship project CNR-Miur grants	We thank O. Wessely and S. Dupont for comments; S. Zanotti for ST-2 differentiation protocol; G. Martello, M.C. Faux, A.R. Clarke, H. Miyoshi, and L. Naldini for gifts of reagents; and Tito Panciera for helping with RNA preparations. Plasmids purchased from Addgene were kindly deposited by K. Hochedlinger and W. Harper. This work is supported by "Young Italian Researchers" grants from the Italian Welfare Ministry and AIRC-MFAG to M.C.; from Fondazione Citta della Speranza Grant to G.B.; from AIRC Special Program Molecular Clinical Oncology "5 per mille" to S.P. and S.B.; and from HSFP, Excellence-IIT, and Epigenetics Flagship project CNR-Miur grants to S.P.	Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Ben-Ze'Ev A, 1999, ANN NY ACAD SCI, V886, P37, DOI 10.1111/j.1749-6632.1999.tb09398.x; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Kim NG, 2009, P NATL ACAD SCI USA, V106, P5165, DOI 10.1073/pnas.0810185106; Leucht P, 2008, SEMIN CELL DEV BIOL, V19, P434, DOI 10.1016/j.semcdb.2008.09.002; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	32	346	360	2	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1443	1456		10.1016/j.cell.2012.11.027	http://dx.doi.org/10.1016/j.cell.2012.11.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23245942	Bronze			2022-12-24	WOS:000312890300011
J	Ragusa, MJ; Stanley, RE; Hurley, JH				Ragusa, Michael J.; Stanley, Robin E.; Hurley, James H.			Architecture of the Atg17 Complex as a Scaffold for Autophagosome Biogenesis	CELL			English	Article							SMALL-ANGLE SCATTERING; SACCHAROMYCES-CEREVISIAE; MONITORING AUTOPHAGY; MEMBRANE CURVATURE; PROTEIN-KINASE; EARLY STEPS; YEAST; FIP200; MACROMOLECULES; TUMORIGENESIS	Macroautophagy is a bulk clearance mechanism in which the double-membraned phagophore grows and engulfs cytosolic material. In yeast, the phagophore nucleates from a cluster of 20-30 nm diameter Atg9-containing vesicles located at a multiprotein assembly known as the preautophagosomal structure (PAS). The crystal structure of a 2:2:2 complex of the earliest acting PAS proteins, Atg17, Atg29, and Atg31, was solved at 3.05 angstrom resolution. Atg17 is crescent shaped with a 10 nm radius of curvature. Dimerization of the Atg17-Atg31-Atg29 complex is critical for both PAS formation and autophagy, and each dimer contains two separate and complete crescents. Upon induction of autophagy, Atg17-Atg31-Atg29 assembles with Atg1 and Atg13, which in turn initiates the formation of the phagophore. The C-terminal EAT domain of Atg1 was shown to sense membrane curvature, dimerize, and tether lipid vesicles. These data suggest a structural mechanism for the organization of Atg9 vesicles into the early phagophore.	[Ragusa, Michael J.; Stanley, Robin E.; Hurley, James H.] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	james.hurley@nih.gov	Stanley, Robin/M-3008-2019; Stanley, Robin E/C-7128-2019	Stanley, Robin/0000-0002-2106-3102; Stanley, Robin E/0000-0002-2106-3102	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; U.S. DOE [DE-AC02-06CH11357]; NIH, NIDDK; Damon Runyon Cancer Research Fellowship; Ruth Kirschtein NRSA fellowship [GM099319]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099319] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. DOE(United States Department of Energy (DOE)); NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Damon Runyon Cancer Research Fellowship; Ruth Kirschtein NRSA fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Klionsky and W. Prinz for strains, constructs, and technical advice; X. Zuo for assistance with SAXS; X.-F. Ren and R. Ghirlando for light scattering assistance; B. Canagarajah for assistance with Figure 7; and T.R. Serio for a vector. Crystallographic data were collected at the Southeast Regional Collaborative Access Team 22-ID and 22-BM beamlines at the Advanced Photon Source, Argonne National Laboratory. SAXS data were collected at NCI beamline 12ID-B. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract number W-31-109-Eng-38 and was supported by the U.S. DOE under contract number DE-AC02-06CH11357. This research was supported by the Intramural Program of the NIH, NIDDK (J.H.H.), a Damon Runyon Cancer Research Fellowship (R.E.S.), and a Ruth Kirschtein NRSA fellowship GM099319 (M.J.R.).	Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Choi JD, 2012, ONCOGENE; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan W, 2011, P NATL ACAD SCI USA, V108, P7769, DOI 10.1073/pnas.1016472108; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.e04-08-0669; Kabeya Y, 2007, BIOCHEM BIOPH RES CO, V356, P405, DOI 10.1016/j.bbrc.2007.02.150; Kabeya Y, 2009, BIOCHEM BIOPH RES CO, V389, P612, DOI 10.1016/j.bbrc.2009.09.034; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kawamata T, 2005, BIOCHEM BIOPH RES CO, V338, P1884, DOI 10.1016/j.bbrc.2005.10.163; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Klionsky Daniel J., 2007, V390, P363; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589; Lo SY, 2012, NAT STRUCT MOL BIOL, V19, P40, DOI 10.1038/nsmb.2162; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Sekito T, 2009, GENES CELLS, V14, P525, DOI 10.1111/j.1365-2443.2009.01299.x; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061; Yeh YY, 2011, J BIOL CHEM, V286, P28931, DOI 10.1074/jbc.M111.250324; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	50	170	173	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1501	1512		10.1016/j.cell.2012.11.028	http://dx.doi.org/10.1016/j.cell.2012.11.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23219485	Green Accepted, Bronze			2022-12-24	WOS:000312890300015
J	Gammon, K				Gammon, Katharine			MATHEMATICAL MODELLING Forecasting cancer	NATURE			English	Editorial Material																		Basanta D, 2012, MOL PHARMACEUT, V9, P914, DOI 10.1021/mp200458e; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399	3	8	8	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					S66	S67		10.1038/491S66a	http://dx.doi.org/10.1038/491S66a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040RE	23320294	Bronze			2022-12-24	WOS:000311339800010
J	Agee, CB; Wilson, NV; McCubbin, FM; Ziegler, K; Polyak, VJ; Sharp, ZD; Asmerom, Y; Nunn, MH; Shaheen, R; Thiemens, MH; Steele, A; Fogel, ML; Bowden, R; Glamoclija, M; Zhang, ZS; Elardo, SM				Agee, Carl B.; Wilson, Nicole V.; McCubbin, Francis M.; Ziegler, Karen; Polyak, Victor J.; Sharp, Zachary D.; Asmerom, Yemane; Nunn, Morgan H.; Shaheen, Robina; Thiemens, Mark H.; Steele, Andrew; Fogel, Marilyn L.; Bowden, Roxane; Glamoclija, Mihaela; Zhang, Zhisheng; Elardo, Stephen M.			Unique Meteorite from Early Amazonian Mars: Water-Rich Basaltic Breccia Northwest Africa 7034	SCIENCE			English	Article							OXYGEN-ISOTOPIC COMPOSITION; CHASSIGNY METEORITE; DIFFERENTIATION PROCESSES; MARTIAN METEORITES; UPPER-MANTLE; RB-SR; CONSTRAINTS; PETROGENESIS; SURFACE; ATMOSPHERE	We report data on the martian meteorite Northwest Africa (NWA) 7034, which shares some petrologic and geochemical characteristics with known martian meteorites of the SNC (i.e., shergottite, nakhlite, and chassignite) group, but also has some unique characteristics that would exclude it from that group. NWA 7034 is a geochemically enriched crustal rock compositionally similar to basalts and average martian crust measured by recent Rover and Orbiter missions. It formed 2.089 +/- 0.081 billion years ago, during the early Amazonian epoch in Mars' geologic history. NWA 7034 has an order of magnitude more indigenous water than most SNC meteorites, with up to 6000 parts per million extraterrestrial H2O released during stepped heating. It also has bulk oxygen isotope values of Delta O-17 = 0.58 +/- 0.05 per mil and a heat-released water oxygen isotope average value of Delta O-17 = 0.330 +/- 0.011 per mil, suggesting the existence of multiple oxygen reservoirs on Mars.	[Agee, Carl B.; Wilson, Nicole V.; McCubbin, Francis M.; Ziegler, Karen; Elardo, Stephen M.] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; [Agee, Carl B.; Wilson, Nicole V.; McCubbin, Francis M.; Polyak, Victor J.; Sharp, Zachary D.; Asmerom, Yemane; Elardo, Stephen M.] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Nunn, Morgan H.; Shaheen, Robina; Thiemens, Mark H.; Zhang, Zhisheng] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Steele, Andrew; Fogel, Marilyn L.; Bowden, Roxane; Glamoclija, Mihaela] Carnegie Inst Sci, Geophys Lab, Washington, DC 20005 USA; [Zhang, Zhisheng] Sun Yat Sen Univ, Sch Environm Sci & Engn, Guangzhou 510275, Guangdong, Peoples R China	University of New Mexico; University of New Mexico; University of California System; University of California San Diego; Carnegie Institution for Science; Sun Yat Sen University	Agee, CB (corresponding author), Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA.	agee@unm.edu	Steele, Andrew/A-3573-2013; Glamoclija, Mihaela/GWQ-3360-2022; Zhang, Zhisheng/W-5138-2019; Fogel, Marilyn L/M-2395-2015; McCubbin, Francis/AAG-1095-2020; McCubbin, Francis/D-1698-2009; Elardo, Stephen M/E-5865-2010	Steele, Andrew/0000-0001-9643-2841; Glamoclija, Mihaela/0000-0003-4327-6480; Zhang, Zhisheng/0000-0002-3742-0880; Fogel, Marilyn L/0000-0002-1176-3818; Elardo, Stephen M/0000-0001-5730-8485	NASA Cosmochemistry Program [NNX11AH16G, NNX11AG76G]; New Mexico Space Grant Consortium; NASA Earth and Space Science Fellowship [NNX12AO15H]; NASA [NNX10AI77G]; NSF [ATM0960594]	NASA Cosmochemistry Program(National Aeronautics & Space Administration (NASA)); New Mexico Space Grant Consortium; NASA Earth and Space Science Fellowship; NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We thank J. Piatek for acquiring the NWA 7034 specimen and for his generous donation to the UNM Meteorite Museum, which has enabled this research and sample allocations for future research on NWA 7034. We also thank M. Spilde, V. Atudorei, and J. Connolly at the University of New Mexico for assistance with data collection. Supported by NASA Cosmochemistry Program grants NNX11AH16G (C. B. A.) and NNX11AG76G (F. M. M.). S. M. E. acknowledges support from the New Mexico Space Grant Consortium, NASA Earth and Space Science Fellowship NNX12AO15H, and NASA Cosmochemistry grant NNX10AI77G to Charles K. Shearer. M. H. T. and R. S. acknowledge NSF award ATM0960594, which allowed the development of an analytical technique to measure oxygen triple isotopic composition of small (<1 mu M) sulfate samples.	Aoudjehane HC, 2012, SCIENCE, V338, P785, DOI 10.1126/science.1224514; Borg L, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002402; Borg LE, 1997, GEOCHIM COSMOCHIM AC, V61, P4915, DOI 10.1016/S0016-7037(97)00276-7; Borg LE, 2003, METEORIT PLANET SCI, V38, P1713, DOI 10.1111/j.1945-5100.2003.tb00011.x; Borg LE, 2003, GEOCHIM COSMOCHIM AC, V67, P3519, DOI 10.1016/S0016-7037(03)00094-2; Borg LE, 2002, GEOCHIM COSMOCHIM AC, V66, P2037, DOI 10.1016/S0016-7037(02)00835-9; Boynton WV, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002887; CLAYTON RN, 1983, EARTH PLANET SC LETT, V62, P1, DOI 10.1016/0012-821X(83)90066-3; Day JMD, 2006, METEORIT PLANET SCI, V41, P581, DOI 10.1111/j.1945-5100.2006.tb00484.x; Ehlmann BL, 2011, NATURE, V479, P53, DOI 10.1038/nature10582; Farquhar J, 2000, J GEOPHYS RES-PLANET, V105, P11991, DOI 10.1029/1999JE001194; Farquhar J, 1998, SCIENCE, V280, P1580, DOI 10.1126/science.280.5369.1580; Filiberto J, 2008, GEOCHIM COSMOCHIM AC, V72, P690, DOI 10.1016/j.gca.2007.11.007; Franchi IA, 1999, METEORIT PLANET SCI, V34, P657, DOI 10.1111/j.1945-5100.1999.tb01371.x; Gellert R, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002555; Grady M., 2004, INT J ASTROBIOL, V3, P117, DOI DOI 10.1017/S1473550404002071; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Herd CDK, 2003, METEORIT PLANET SCI, V38, P1793, DOI 10.1111/j.1945-5100.2003.tb00015.x; Herd CDK, 2002, GEOCHIM COSMOCHIM AC, V66, P2025, DOI 10.1016/S0016-7037(02)00828-1; KARLSSON KR, 1992, SCIENCE, V255, P1409, DOI 10.1126/science.11537889; Leshin LA, 1996, GEOCHIM COSMOCHIM AC, V60, P2635, DOI 10.1016/0016-7037(96)00122-6; Lodders K., 1998, PLANETARY SCI COMPAN; McCubbin FM, 2008, AM MINERAL, V93, P676, DOI 10.2138/am.2008.2558; McCubbin FM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051711; McCubbin FM, 2010, EARTH PLANET SC LETT, V292, P132, DOI 10.1016/j.epsl.2010.01.028; McCubbin FM, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003165; McSween HY, 2009, SCIENCE, V324, P736, DOI 10.1126/science.1165871; McSween HY, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002175; MING DW, 2008, J GEOPHYS RES-PLANET, V113, DOI DOI 10.1029/2008JE003195; Mittlefehldt DW, 2008, REV MINERAL GEOCHEM, V68, P399, DOI 10.2138/rmg.2008.68.14; Nekvasil H, 2009, METEORIT PLANET SCI, V44, P853, DOI 10.1111/j.1945-5100.2009.tb00773.x; Nimmo F, 2008, NATURE, V453, P1220, DOI 10.1038/nature07025; Nittler LR, 2011, SCIENCE, V333, P1847, DOI 10.1126/science.1211567; Norman MD, 1999, METEORIT PLANET SCI, V34, P439, DOI 10.1111/j.1945-5100.1999.tb01352.x; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; Papike JJ, 2009, GEOCHIM COSMOCHIM AC, V73, P7443, DOI 10.1016/j.gca.2009.09.008; Reese CC, 2006, ICARUS, V184, P102, DOI 10.1016/j.icarus.2006.04.008; Riner MA, 2010, ICARUS, V209, P301, DOI 10.1016/j.icarus.2010.05.018; Romanek CS, 1998, METEORIT PLANET SCI, V33, P775, DOI 10.1111/j.1945-5100.1998.tb01683.x; Rumble D., 2009, P 40 LUN PLAN SCI C, V40, P2293; Sarbadhikari AB, 2011, GEOCHIM COSMOCHIM AC, V75, P6803, DOI 10.1016/j.gca.2011.09.001; Sarbadhikari AB, 2009, GEOCHIM COSMOCHIM AC, V73, P2190, DOI 10.1016/j.gca.2009.01.012; Sharp ZD, 2001, CHEM GEOL, V178, P197, DOI 10.1016/S0009-2541(01)00262-5; Shearer CK, 2011, AM MINERAL, V96, P1418, DOI 10.2138/am.2011.3860; SNYDER GA, 1992, GEOCHIM COSMOCHIM AC, V56, P3809, DOI 10.1016/0016-7037(92)90172-F; SNYDER GA, 1994, GEOCHIM COSMOCHIM AC, V58, P4795, DOI 10.1016/0016-7037(94)90209-7; Steele A, 2012, SCIENCE, V337, P212, DOI 10.1126/science.1220715; Till CB, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009044; Treiman AH, 2000, PLANET SPACE SCI, V48, P1213, DOI 10.1016/S0032-0633(00)00105-7; Wadwa M., 2004, ANTARCT METEORITE RE, V17, P97; WARREN PH, 1979, REV GEOPHYS, V17, P73, DOI 10.1029/RG017i001p00073; Wright SP, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003785; Young ED, 1999, SCIENCE, V286, P1331, DOI 10.1126/science.286.5443.1331; Yung Y.L., 1999, PHOTOCHEMISTRY PLANE; Zipfel J, 2011, METEORIT PLANET SCI, V46, P1, DOI 10.1111/j.1945-5100.2010.01127.x	55	290	294	7	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					780	785		10.1126/science.1228858	http://dx.doi.org/10.1126/science.1228858			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23287721				2022-12-24	WOS:000314874400038
J	Deindl, S; Hwang, WL; Hota, SK; Blosser, TR; Prasad, P; Bartholomew, B; Zhuang, XW				Deindl, Sebastian; Hwang, William L.; Hota, Swetansu K.; Blosser, Timothy R.; Prasad, Punit; Bartholomew, Blaine; Zhuang, Xiaowei			ISWI Remodelers Slide Nucleosomes with Coordinated Multi-Base-Pair Entry Steps and Single-Base-Pair Exit Steps	CELL			English	Article							VIRUS NS3 HELICASE; DNA TRANSLOCATION; SACCHAROMYCES-CEREVISIAE; ISW2-NUCLEOSOME COMPLEX; HISTONE OCTAMER; ENERGY-TRANSFER; LOOP FORMATION; CORE PARTICLE; PCRA HELICASE; IN-VIVO	ISWI-family enzymes remodel chromatin by sliding nucleosomes along DNA, but the nucleosome translocation mechanism remains unclear. Here we use single-molecule FRET to probe nucleosome translocation by ISWI-family remodelers. Distinct ISWI-family members translocate nucleosomes with a similar stepping pattern maintained by the catalytic subunit of the enzyme. Nucleosome remodeling begins with a 7 bp step of DNA translocation followed by 3 bp subsequent steps toward the exit side of nucleosomes. These multi-bp, compound steps are comprised of 1 bp substeps. DNA movement on the entry side of the nucleosome occurs only after 7 bp of exit-side translocation, and each entry-side step draws in a 3 bp equivalent of DNA that allows three additional base pairs to be moved to the exit side. Our results suggest a remodeling mechanism with well-defined coordination at different nucleosomal sites featuring DNA translocation toward the exit side in 1 bp steps preceding multi-bp steps of DNA movement on the entry side.	[Deindl, Sebastian; Hwang, William L.; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Deindl, Sebastian; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Hwang, William L.; Blosser, Timothy R.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Hwang, William L.] Harvard Univ, Sch Med, Harvard MIT MD PhD Program, Boston, MA 02115 USA; [Hota, Swetansu K.; Prasad, Punit; Bartholomew, Blaine] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University; Harvard University; Harvard Medical School; Southern Illinois University System; Southern Illinois University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	Hota, Swetansu/GRR-2697-2022; Hota, Swetansu/E-6067-2015	Hota, Swetansu/0000-0003-3105-9729; Hota, Swetansu/0000-0003-3105-9729; Prasad, Punit/0000-0002-9132-6078; Deindl, Sebastian/0000-0001-6807-8654	Howard Hughes Medical Institute; National Institutes of Health [GM 70864]; NIH Molecular Biophysics Training Grant; Medical Scientist Training Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM070864, R01GM105637, R01GM096450] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Molecular Biophysics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Widom for providing the plasmid containing the 601 positioning sequence and G. Narlikar for providing histone protein expression plasmids. This work is supported in part by the Howard Hughes Medical Institute (to X.Z.) and the National Institutes of Health GM 70864 (to B.B.). X.Z. is a Howard Hughes Medical Institute investigator. S.D. is a Merck fellow of the Jane Coffin Childs Memorial Fund for Medical Research. W.L.H. is supported by the NIH Molecular Biophysics Training Grant and Medical Scientist Training Program.	Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; Blosser TR, 2009, NATURE, V462, P1022, DOI 10.1038/nature08627; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; Bowman GD, 2010, CURR OPIN STRUC BIOL, V20, P73, DOI 10.1016/j.sbi.2009.12.002; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Cheng W, 2011, SCIENCE, V333, P1746, DOI 10.1126/science.1206023; Chua EYD, 2012, NUCLEIC ACIDS RES, V40, P6338, DOI 10.1093/nar/gks261; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Flaus A, 2003, BIOPOLYMERS, V68, P563, DOI 10.1002/bip.10323; Gangaraju VK, 2007, MUTAT RES-FUND MOL M, V618, P3, DOI 10.1016/j.mrfmmm.2006.08.015; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Hota S.K., 2013, NAT STRUCT MOL BIOL; Hota SK, 2011, BBA-GENE REGUL MECH, V1809, P476, DOI 10.1016/j.bbagrm.2011.05.007; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Kassabov SR, 2002, MOL CELL BIOL, V22, P7524, DOI 10.1128/MCB.22.21.7524-7534.2002; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kulic IM, 2003, BIOPHYS J, V84, P3197, DOI 10.1016/S0006-3495(03)70044-7; Kulic IM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.148103; Langst G, 2004, BBA-GENE STRUCT EXPR, V1677, P58, DOI 10.1016/j.bbaexp.2003.10.011; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; Lorch Y, 2005, P NATL ACAD SCI USA, V102, P1329, DOI 10.1073/pnas.0409413102; Lorch Y, 2010, P NATL ACAD SCI USA, V107, P3458, DOI 10.1073/pnas.1000398107; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; McConnell AD, 2004, MOL CELL BIOL, V24, P2605, DOI 10.1128/MCB.24.7.2605-2613.2004; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Prasad TK, 2007, J MOL BIOL, V369, P940, DOI 10.1016/j.jmb.2007.04.005; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; Sirinakis G, 2011, EMBO J, V30, P2364, DOI 10.1038/emboj.2011.141; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Suto RK, 2003, J MOL BIOL, V326, P371, DOI 10.1016/S0022-2836(02)01407-9; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; van Holde K, 2003, BIOCHEM CELL BIOL, V81, P169, DOI 10.1139/o03-038; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Vary JC, 2003, MOL CELL BIOL, V23, P80, DOI 10.1128/MCB.23.1.80-91.2003; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	65	107	108	2	66	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 31	2013	152	3					442	452		10.1016/j.cell.2012.12.040	http://dx.doi.org/10.1016/j.cell.2012.12.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374341	Bronze, Green Accepted			2022-12-24	WOS:000314362800015
J	Vaduganathan, M; Bonow, RO; Gheorghiade, M				Vaduganathan, Muthiah; Bonow, Robert O.; Gheorghiade, Mihai			Thirty-Day Readmissions The Clock Is Ticking	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEART-FAILURE		[Vaduganathan, Muthiah] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA USA; [Bonow, Robert O.; Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Dept Med, Chicago, IL 60611 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Northwestern University; Feinberg School of Medicine	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Dept Med, 645 N Michigan Ave,Ste 1006, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu						Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; GARNICK DW, 1995, HEALTH SERV RES, V29, P679; Gheorghiade M, 2012, HEART FAIL REV, V17, P485, DOI 10.1007/s10741-011-9280-0; Gorodeski EZ, 2010, NEW ENGL J MED, V363, P297, DOI 10.1056/NEJMc1001882; Joynt KE, 2012, NEW ENGL J MED, V366, P1366, DOI 10.1056/NEJMp1201598; O'Connor CM, 2010, AM HEART J, V159, P841, DOI 10.1016/j.ahj.2010.02.023; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; van Walraven C, 2011, CAN MED ASSOC J, V183, pE1067, DOI 10.1503/cmaj.110400	8	97	97	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					345	346		10.1001/jama.2012.205110	http://dx.doi.org/10.1001/jama.2012.205110			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074FT	23340632				2022-12-24	WOS:000313799000018
J	Gallimore, AM; Godkin, A				Gallimore, Awen M.; Godkin, Andrew			Epithelial Barriers, Microbiota, and Colorectal Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gallimore, Awen M.; Godkin, Andrew] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Godkin, Andrew] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales	Cardiff University; Cardiff University	Gallimore, AM (corresponding author), Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales.			Gallimore, Awen/0000-0001-6675-7004; Godkin, Andrew/0000-0002-1910-7567				Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Magalhaes B, 2012, EUR J CANCER PREV, V21, P15, DOI 10.1097/CEJ.0b013e3283472241; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907	5	33	40	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					282	284		10.1056/NEJMcibr1212341	http://dx.doi.org/10.1056/NEJMcibr1212341			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YG	23323906				2022-12-24	WOS:000313549900016
J	Kourrich, S; Hayashi, T; Chuang, JY; Tsai, SY; Su, TP; Bonci, A				Kourrich, Said; Hayashi, Teruo; Chuang, Jian-Ying; Tsai, Shang-Yi; Su, Tsung-Ping; Bonci, Antonello			Dynamic Interaction between Sigma-1 Receptor and Kv1.2 Shapes Neuronal and Behavioral Responses to Cocaine	CELL			English	Article							NUCLEUS-ACCUMBENS NEURONS; K+ CHANNELS; POTASSIUM CHANNELS; BINDING-SITES; DOPAMINE D-1; KINASE-II; ACTIVATION; REWARD; EXCITABILITY; PLASTICITY	The sigma-1 receptor (Sig-1R), an endoplasmic reticulum (ER) chaperone protein, is an interorganelle signaling modulator that potentially plays a role in drug-seeking behaviors. However, the brain site of action and underlying cellular mechanisms remain unidentified. We found that cocaine exposure triggers a Sig-1R-dependent upregulation of D-type K+ current in the nucleus accumbens (NAc) that results in neuronal hypoactivity and thereby enhances behavioral cocaine response. Combining ex vivo and in vitro studies, we demonstrated that this neuroadaptation is caused by a persistent protein-protein association between Sig-1Rs and Kv1.2 channels, a phenomenon that is associated to a redistribution of both proteins from intracellular compartments to the plasma membrane. In conclusion, the dynamic Sig-1R-Kv1.2 complex represents a mechanism that shapes neuronal and behavioral response to cocaine. Functional consequences of Sig-1R binding to K+ channels may have implications for other chronic diseases where maladaptive intrinsic plasticity and Sig-1Rs are engaged.	[Kourrich, Said; Bonci, Antonello] NIDA, Cellular Neurobiol Branch, Intramural Res Program, Baltimore, MD 21224 USA; [Hayashi, Teruo] NIDA, Cellular Stress Signaling Unit, Intramural Res Program, Baltimore, MD 21224 USA; [Hayashi, Teruo; Chuang, Jian-Ying; Tsai, Shang-Yi; Su, Tsung-Ping] NIDA, Cellular Pathobiol Sect, Intramural Res Program, Baltimore, MD 21224 USA; [Bonci, Antonello] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94608 USA; [Bonci, Antonello] Johns Hopkins Univ, Sch Med, Solomon H Snyder Neurosci Inst, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of California System; University of California San Francisco; Johns Hopkins University	Bonci, A (corresponding author), NIDA, Cellular Neurobiol Branch, Intramural Res Program, Baltimore, MD 21224 USA.	antonello.bonci@nih.gov	Kourrich, Said/M-3916-2014		Intramural Research Program at the National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000581, ZICDA000555, ZIADA000206] Funding Source: NIH RePORTER	Intramural Research Program at the National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Drs. Billy T. Chen, Beate C. Finger, and Roy A. Wise for careful reading of the manuscript. We thank Dhara V. Patel, Stephanie Goddard, Janice Joo, and Keenan Hope for technical help. This work was supported by the Intramural Research Program at the National Institute on Drug Abuse. Viral vectors provided by the NIDA Optogenetics and Transgenic Technology Core facility (Lab head: Brandon K. Harvey).	Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Chen YM, 2007, BIOCHEMISTRY-US, V46, P3532, DOI 10.1021/bi061727o; Crottes D, 2011, J BIOL CHEM, V286, P27947, DOI 10.1074/jbc.M111.226738; Dong LY, 2007, NEUROPHARMACOLOGY, V52, P966, DOI 10.1016/j.neuropharm.2006.10.015; GUNDLACH AL, 1986, J NEUROSCI, V6, P1757; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P726, DOI 10.1124/jpet.103.051292; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; He YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041303; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hopf FW, 2003, J NEUROSCI, V23, P5079; Hu XT, 2004, J NEUROPHYSIOL, V92, P1597, DOI 10.1152/jn.00217.2004; Ikemoto S, 2010, NEUROSCI BIOBEHAV R, V35, P129, DOI 10.1016/j.neubiorev.2010.02.001; Ishikawa M, 2009, J NEUROSCI, V29, P5820, DOI 10.1523/JNEUROSCI.5703-08.2009; KAHOUN JR, 1992, P NATL ACAD SCI USA, V89, P1393, DOI 10.1073/pnas.89.4.1393; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Kinoshita M, 2012, BRAIN RES, V1452, P1, DOI 10.1016/j.brainres.2012.02.070; Kourrich S, 2012, TRENDS NEUROSCI, V35, P762, DOI 10.1016/j.tins.2012.09.007; Kourrich S, 2012, J NEUROSCI, V32, P6578, DOI 10.1523/JNEUROSCI.6391-11.2012; Kourrich S, 2009, J NEUROSCI, V29, P12275, DOI 10.1523/JNEUROSCI.3028-09.2009; Krause M, 2010, J NEUROSCI, V30, P4746, DOI 10.1523/JNEUROSCI.0197-10.2010; Lupardus PJ, 2000, J PHYSIOL-LONDON, V526, P527, DOI 10.1111/j.1469-7793.2000.00527.x; Martina M, 2007, J PHYSIOL-LONDON, V578, P143, DOI 10.1113/jphysiol.2006.116178; MATSUMOTO RR, 1995, EUR J PHARMACOL, V280, P301, DOI 10.1016/0014-2999(95)00208-3; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Mavlyutov TA, 2010, NEUROSCIENCE, V167, P247, DOI 10.1016/j.neuroscience.2010.02.022; Moriguchi S, 2011, J NEUROCHEM, V117, P879, DOI 10.1111/j.1471-4159.2011.07256.x; Mu P, 2010, J NEUROSCI, V30, P3689, DOI 10.1523/JNEUROSCI.4063-09.2010; Navarro G, 2010, P NATL ACAD SCI USA, V107, P18676, DOI 10.1073/pnas.1008911107; NISENBAUM ES, 1994, J NEUROPHYSIOL, V71, P1174, DOI 10.1152/jn.1994.71.3.1174; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perez MF, 2006, J NEUROPHYSIOL, V96, P2217, DOI 10.1152/jn.00254.2006; Reynolds SM, 2002, J NEUROSCI, V22, P7308; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Shen WX, 2004, J NEUROPHYSIOL, V91, P1337, DOI 10.1152/jn.00414.2003; Soriani O, 1998, J PHARMACOL EXP THER, V286, P163; Stewart J, 2004, NEBR SYM MOTIV, V50, P197; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Varga AW, 2004, J NEUROSCI, V24, P3643, DOI 10.1523/JNEUROSCI.0154-04.2004; Varga AW, 2000, LEARN MEMORY, V7, P321, DOI 10.1101/lm.35300; Zhang HL, 2005, J PHARMACOL EXP THER, V313, P1387, DOI 10.1124/jpet.105.084152	44	150	154	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					236	247		10.1016/j.cell.2012.12.004	http://dx.doi.org/10.1016/j.cell.2012.12.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332758	Green Accepted, Bronze			2022-12-24	WOS:000313719800020
J	Grumbine, RE; Pandit, MK				Grumbine, R. Edward; Pandit, Maharaj K.			Threats from India's Himalaya Dams	SCIENCE			English	Editorial Material									[Grumbine, R. Edward] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming 650204, Peoples R China; [Pandit, Maharaj K.] Univ Delhi, Dept Environm Studies, Ctr Interdisciplinary Studies Mt & Hill Environm, Delhi 110007, India	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; University of Delhi	Grumbine, RE (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming 650204, Peoples R China.	ed.grumbine@gmail.com	Pandit, Maharaj K/A-4065-2014	Pandit, Maharaj K/0000-0001-6611-560X				[Anonymous], 2012, BP EN OUTL 2030; Centre for Interdisciplinary Studies of Mountain & Hill Environment, 2007, CARR CAP STUD TEEST; Choudhury Nirmalya, 2010, SUSTAINABLE DAM DEV; Dharmadikhary S., 2008, MOUNTAINS CONCRETE D; DYNESIUS M, 1994, SCIENCE, V266, P753, DOI 10.1126/science.266.5186.753; Ebinger Charles K., 2011, ENERGY SECURITY S AS; Hennig T., 2012, HYDROPOWER PRACTICE, P293; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; Mehta M. C., 2009, ECON POLIT WEEKLY, V2; Ministry of Water Resources Draft National Water Policy, 2012, NAT WAT POL IN PRESS; Nandimath O.V., 2009, OXFORD HDB ENV DECIS; Negi NS, 2011, 103 U BIEL CTR MIGR; Pandit MK, 2007, BIODIVERS CONSERV, V16, P153, DOI 10.1007/s10531-006-9038-5; Pandit MK, 2012, CONSERV BIOL, V26, P1061, DOI 10.1111/j.1523-1739.2012.01918.x; Press Information Bureau Government of India, 2012, 3 M NAT GANG RIV BAS; Rajaram T, 2011, J ENVIRON MANAGE, V92, P140, DOI 10.1016/j.jenvman.2010.08.024; Richter B. D., 2010, WATER ALTERN, V3, P14, DOI DOI 10.1007/S11195-009-9131-2; Sharma T., 2012, MEGA DAMS CAMPAIGNIN; Singh JS, 2006, CURR SCI INDIA, V90, P784; Sreedharan P, 2011, ELECT GRID EVOLUTION; Subramanian A., 2012, CAN INDIAS POWER PRO; Tollefson J, 2011, NATURE, V474, P430, DOI 10.1038/474430a; Wildlife Institute of India, 2012, ASS CUM IMP HYDR PRO; World Wildlife Fund, 2007, CLIM SOL WWFS VIS 20	24	138	142	5	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					36	37		10.1126/science.1227211	http://dx.doi.org/10.1126/science.1227211			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	063HC	23288526				2022-12-24	WOS:000312985800039
J	Kamerow, D				Kamerow, Douglas			Does gay marriage improve health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INSURANCE		RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Buffie WC, 2011, AM J PUBLIC HEALTH, V101, P986, DOI 10.2105/AJPH.2010.300112; Halkitis PN, 2012, AM J PUBLIC HEALTH, V102, P1628, DOI 10.2105/AJPH.2012.300940; Hatzenbuehler ML, 2012, AM J PUBLIC HEALTH, V102, P285, DOI 10.2105/AJPH.2011.300382; Parker-Pope Tara, 2010, NY TIMES MAGAZINE; Ponce NA, 2010, HEALTH AFFAIR, V29, P1539, DOI 10.1377/hlthaff.2009.0583; Wight RG, 2012, AM J PUBLIC HEALTH, V102, P503, DOI 10.2105/AJPH.2011.300384; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685	7	1	1	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 21	2012	345								e8586	10.1136/bmj.e8586	http://dx.doi.org/10.1136/bmj.e8586			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059JR	23262572				2022-12-24	WOS:000312701700003
J	Kharazmi, E; Fallah, M; Sundquist, K; Hemminki, K				Kharazmi, E.; Fallah, M.; Sundquist, K.; Hemminki, K.			Familial risk of early and late onset cancer: nationwide prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DIETARY FACTORS; LIFE-STYLE; UK; FRACTION; DATABASE; DISEASE	Objective To determine whether familial risk of cancer is limited to early onset cases. Design Nationwide prospective cohort study. Setting Nationwide Swedish Family-Cancer Database. Participants All Swedes born after 1931 and their biological parents, totalling >12.2 million individuals, including >1.1 million cases of first primary cancer. Main outcome measures Familial risks of the concordant cancers by age at diagnosis. Results The highest familial risk was seen for offspring whose parents were diagnosed at an early age. Familial risks were significantly increased for colorectal, lung, breast, prostate, and urinary bladder cancer and melanoma, skin squamous cell carcinoma, and non-Hodgkin's lymphoma, even when parents were diagnosed at age 70-79 or 80-89. When parents were diagnosed at more advanced ages (>= 90), the risk of concordant cancer in offspring was still significantly increased for skin squamous cell carcinoma (hazard ratio 1.9, 95% confidence interval 1.4 to 2.7), colorectal (1.6, 1.2 to 2.0), breast (1.3, 1.0 to 1.6), and prostate cancer (1.3, 1.1 to 1.6). For offspring with a cancer diagnosed at ages 60-76 whose parents were affected at age <50, familial risks were not significantly increased for nearly all cancers. Conclusion Though the highest familial risks of cancer are seen in offspring whose parents received a diagnosis of a concordant cancer at earlier ages, increased risks exist even in cancers of advanced ages. Familial cancers might not be early onset in people whose family members were affected at older ages and so familial cancers might have distinct early and late onset components.	[Kharazmi, E.; Fallah, M.; Hemminki, K.] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany; [Sundquist, K.; Hemminki, K.] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden; [Sundquist, K.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; Stanford University	Kharazmi, E (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany.	E.Kharazmi@dkfz.de	Fallah, Mahdi/A-8745-2008	Fallah, Mahdi/0000-0002-6639-065X; Kharazmi, Elham/0000-0003-4919-6641	Swedish Council for Working Life and Social Research; German Cancer Aid (Deutsche Krebshilfe)	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe)	This study was supported by the Swedish Council for Working Life and Social Research and the German Cancer Aid (Deutsche Krebshilfe).	Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Bergstrom A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1053&gt;3.0.CO;2-T; Brandt A, 2008, ANN ONCOL, V19, P2084, DOI 10.1093/annonc/mdn527; Chang ET, 2006, JNCI-J NATL CANCER I, V98, P61, DOI 10.1093/jnci/djj005; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Driver JA, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2467; Engholm G, 2012, NORDCAN CANC INCIDEN; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Hampel H, 2004, J MED GENET, V41, P81, DOI 10.1136/jmg.2003.010918; Hemminki K, 2003, INT J CANCER, V103, P105, DOI 10.1002/ijc.10764; Hemminki K, 2002, INT J CANCER, V98, P316, DOI 10.1002/ijc.10195; Hemminki K, 2009, INT J CANCER, V124, P2250, DOI 10.1002/ijc.24301; Hemminki K, 2001, BRIT J CANCER, V84, P1466, DOI 10.1054/bjoc.2001.1811; Hemminki K, 2001, ACTA ONCOL, V40, P772; Hemminki K, 2005, HERED CANCER CLIN PR, V3, P7, DOI 10.1186/1897-4287-3-1-7; Hopper John L, 2011, Epidemiol Perspect Innov, V8, P2, DOI 10.1186/1742-5573-8-2; Kerber RA, 2005, CANCER-AM CANCER SOC, V103, P1906, DOI 10.1002/cncr.20989; Leu M, 2008, J NATL CANCER I, V100, P1318, DOI 10.1093/jnci/djn290; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Parkin DM, 2011, BRIT J CANCER, V105, pS27, DOI 10.1038/bjc.2011.479; Parkin DM, 2011, BRIT J CANCER, V105, pS24, DOI 10.1038/bjc.2011.478; Parkin DM, 2011, BRIT J CANCER, V105, pS2, DOI 10.1038/bjc.2011.474; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; Pisani P, 1997, CANCER EPIDEM BIOMAR, V6, P387; Sundquist K, 2011, AM HEART J, V162, P317, DOI 10.1016/j.ahj.2011.05.013; The National Board of Health and Welfare, 2007, CANC INC SWED 2006; zur Hausen H, 1999, EUR J CANCER, V35, P1878, DOI 10.1016/S0959-8049(99)00291-9	28	46	48	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 20	2012	345								e8076	10.1136/bmj.e8076	http://dx.doi.org/10.1136/bmj.e8076			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059JI	23257063	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000312700600001
J	Clement, R				Clement, Rhys			CHRISTMAS 2012: LIVES OF DOCTORS Is it time for an evidence based uniform for doctors?	BRITISH MEDICAL JOURNAL			English	Editorial Material							WHITE COATS; FLORA; BARE; INFECTIONS; FACEMASKS; PHYSICIAN; ATTIRE; ELBOWS		Royal Infirm Edinburgh NHS Trust, Edinburgh EH16 4SA, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Clement, R (corresponding author), Royal Infirm Edinburgh NHS Trust, Edinburgh EH16 4SA, Midlothian, Scotland.	rhysclement@googlemail.com						[Anonymous], 2008, Naked Science Forum, Patent No. 5416929; Ardolino A, 2009, J HOSP INFECT, V71, P291, DOI 10.1016/j.jhin.2008.11.008; BARRETT TG, 1994, BRIT MED J, V309, P1710, DOI 10.1136/bmj.309.6970.1710; Baxter J, 2010, ANN R COLL SURG ENGL, V92, P248; Bianchi MT, 2008, J GEN INTERN MED, V23, P641, DOI 10.1007/s11606-008-0546-8; BLUMHAGEN DW, 1979, ANN INTERN MED, V91, P111, DOI 10.7326/0003-4819-91-1-111; Bond L, 2010, J LARYNGOL OTOL, V124, P963, DOI 10.1017/S0022215110001167; Brandt LJ, 2003, ARCH INTERN MED, V163, P1277, DOI 10.1001/archinte.163.11.1277; Braunstein, 1995, US patent, Patent No. [5 416 929, 7560399]; Brewer TL, 2004, AMBUL PEDIATR, V4, P257, DOI 10.1367/A03-097R1.1; Christoforidis JB, 2011, CURR DRUG TARGETS, V12, P221; Church J, 1986, Nursing (Lond), V3, P140; Davis L, 2008, BRIT DENT J, V204, P112, DOI 10.1038/bdj.2008.63; Department of Health Policy, 2010, UN WORKW GUID UN WOR; Department of Health Policy, 2007, UN WORKW EV BAS DEV; HILL J, 1974, LANCET, V2, P1131; Horwitz MD, 2010, BRIT J HOSP MED, V71, P124, DOI 10.12968/hmed.2010.71.3.46971; Jeans AR, 2010, J HOSP INFECT, V74, P16, DOI 10.1016/j.jhin.2009.06.032; K Ota, 2007, CAN J INFECT CONTROL, V22, P65; Lai ACK, 2012, J R SOC INTERFACE, V9, P938, DOI 10.1098/rsif.2011.0537; Li Y, 2008, J MULTIDISCIP HEALTH, V1, P17; Loh W, 2000, J HOSP INFECT, V45, P65, DOI 10.1053/jhin.1999.0702; Loveday H, 2007, J INFECT PREV, V8, P10; Magos A, 2007, BRIT MED J, V335, P684, DOI 10.1136/bmj.39353.427014.BE; Makary MA, 2007, NEW ENGL J MED, V356, P2693, DOI 10.1056/NEJMoa070378; McGovern B, 2010, J HOSP INFECT, V75, P138, DOI 10.1016/j.jhin.2009.12.008; MONTES LF, 1970, ARCH DERMATOL, V101, P145, DOI 10.1001/archderm.101.2.145; Rehman SU, 2005, AM J MED, V118, P1279, DOI 10.1016/j.amjmed.2005.04.026; Rock, 2009, CAN EV CLOTH STOP GE, Patent No. 7 560 399; Schoeffler L E, 1996, J Okla State Med Assoc, V89, P379; Scott Jude, 2010, Nurs Times, V106, P13; Shaposhnikov OK, 1981, VOEN MED ZH, V4, P58; Song J, 2012, ACS APPL MATER INTER, V4, P460, DOI 10.1021/am201563t; Usher B, 1928, ARCH DERMATOL SYPH, V18, P276, DOI 10.1001/archderm.1928.02380140100009; VALDEZ P, 1994, J EXP PSYCHOL GEN, V123, P394, DOI 10.1037/0096-3445.123.4.394; WIlson JA, 2007, J HOSP INFECT, V66, P301, DOI 10.1016/j.jhin.2007.03.026; WONG D, 1991, BRIT MED J, V303, P1602, DOI 10.1136/bmj.303.6817.1602; Yang L, 2011, ISRN NURS; Yoo HS, 2000, TEXT RES J, V70, P542, DOI 10.1177/004051750007000612	39	5	5	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 18	2012	345								e8286	10.1136/bmj.e8286	http://dx.doi.org/10.1136/bmj.e8286			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IW	23249667				2022-12-24	WOS:000312698900013
J	Cote, GM; Sawyer, DB; Chabner, BA				Cote, Gregory M.; Sawyer, Douglas B.; Chabner, Bruce A.			BASIC IMPLICATIONS OF CLINICAL OBSERVATIONS ERBB2 Inhibition and Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							METASTATIC BREAST-CANCER; DILATED CARDIOMYOPATHY; NEUREGULIN RECEPTOR; CARDIAC DEVELOPMENT; TRASTUZUMAB; SURVIVAL; REVEALS; SYSTEMS; PLUS; GENE		[Cote, Gregory M.; Chabner, Bruce A.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Sawyer, Douglas B.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Harvard University; Massachusetts General Hospital; Vanderbilt University	Cote, GM (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.			Cote, Gregory/0000-0003-0181-886X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL101425, R01HL068144] Funding Source: NIH RePORTER; NHLBI NIH HHS [P20 HL101425, R01 HL068144] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Crone SA, 2002, ANN NY ACAD SCI, V971, P547, DOI 10.1111/j.1749-6632.2002.tb04525.x; De Keulenaer GW, 2010, CIRC RES, V106, P35, DOI 10.1161/CIRCRESAHA.109.205906; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Jabbour A, 2011, EUR J HEART FAIL, V13, P83, DOI 10.1093/eurjhf/hfq152; Ky B, 2009, CIRCULATION, V120, P310, DOI 10.1161/CIRCULATIONAHA.109.856310; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Liu FF, 2005, AM J PHYSIOL-HEART C, V289, pH660, DOI 10.1152/ajpheart.00268.2005; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; Pentassuglia L, 2009, EXP CELL RES, V315, P627, DOI 10.1016/j.yexcr.2008.08.015; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261	20	65	67	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2012	367	22					2150	2153		10.1056/NEJMcibr1203156	http://dx.doi.org/10.1056/NEJMcibr1203156			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044MS	23190227				2022-12-24	WOS:000311624400015
J	Peters, SE; Kelly, DC; Fraass, AJ				Peters, Shanan E.; Kelly, Daniel C.; Fraass, Andrew J.			Oceanographic controls on the diversity and extinction of planktonic foraminifera	NATURE			English	Article							GLOBAL DISTRIBUTION; SPECIES-DIVERSITY; ORIGINATION; MACROSTRATIGRAPHY; HISTORY; TRENDS; RECORD	Understanding the links between long-term biological evolution, the ocean-atmosphere system and plate tectonics is a central goal of Earth science. Although environmental perturbations of many different kinds are known to have affected long-term biological evolution, particularly during major mass extinction events(1,2), the relative importance of physical environmental factors versus biological interactions in governing rates of extinction and origination through geological time remains unknown(2). Here we use macrostratigraphic data from the Atlantic Ocean basin to show that changes in global species diversity and rates of extinction among planktonic foraminifera have been linked to tectonically and climatically forced changes in ocean circulation and chemistry from the Jurassic period to the present. Transient environmental perturbations, such as those that occurred after the asteroid impact at the end of the Cretaceous period(1) approximately 66 million years ago, and the Eocene/Oligocene greenhouse-icehouse transition(3,4) approximately 34 million years ago, are superimposed on this general long-term relationship. Rates of species origination, by contrast, are not correlated with corresponding macrostratigraphic quantities, indicating that physiochemical changes in the ocean-atmosphere system affect evolution principally by driving the synchronous extinction of lineages that originated owing to more protracted and complex interactions between biological and environmental factors.	[Peters, Shanan E.; Kelly, Daniel C.; Fraass, Andrew J.] Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Peters, SE (corresponding author), Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA.	peters@geology.wisc.edu	Peters, Shanan E/A-5620-2013	Peters, Shanan E/0000-0002-3346-4317; Fraass, Andrew/0000-0002-2007-3616; Kelly, Clay/0000-0002-3241-1635	National Science Foundation Division of Earth Sciences (NSF EAR) [EAR 0819931]; NSF [EAR 0628719]	National Science Foundation Division of Earth Sciences (NSF EAR); NSF(National Science Foundation (NSF))	We thank M. Foote and B. Wilkinson for feedback on our analyses and this manuscript, and N. A. Heim for help in drafting the maps herein. This work was partially supported by National Science Foundation Division of Earth Sciences (NSF EAR) EAR 0819931 to S.E.P. and NSF EAR 0628719 subcontract to D.C.K.	Adrain JM, 2000, SCIENCE, V289, P110, DOI 10.1126/science.289.5476.110; Be A. W. H., 1971, MICROPALEONTOLOGY OC, P1025; Be A.W.H., 1977, OCEANIC MICROPALEONT, P1; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; BERGGREN WA, 1977, TECTONOPHYSICS, V38, P11, DOI 10.1016/0040-1951(77)90199-8; CIFELLI R, 1969, SYST ZOOL, V18, P154, DOI 10.2307/2412601; CLIMAP Project Members, 1976, Science, V191, P1131; CLIMAP Project Members, 1994, CLIMAP 18K DAT; D'Hondt S, 1998, SCIENCE, V282, P276, DOI 10.1126/science.282.5387.276; D'Hondt S, 1998, PALEOBIOLOGY, V24, P512, DOI 10.1017/S0094837300020133; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Darling KF, 1999, PALEOCEANOGRAPHY, V14, P3, DOI 10.1029/1998PA900002; Foote M, 2005, PALEOBIOLOGY, V31, P6, DOI 10.1666/0094-8373(2005)031<0006:POAEIT>2.0.CO;2; Foote M, 2003, J GEOL, V111, P125, DOI 10.1086/345841; Georgescu MD, 2008, J FORAMIN RES, V38, P157, DOI 10.2113/gsjfr.38.2.157; HALLOCK P, 1991, PALAEOGEOGR PALAEOCL, V83, P49, DOI 10.1016/0031-0182(91)90075-3; Hannisdal B, 2011, SCIENCE, V334, P1121, DOI 10.1126/science.1210695; Hannisdal B, 2010, J GEOL, V118, P111, DOI 10.1086/650180; HAQ BU, 1977, J GEOPHYS RES-OC ATM, V82, P3861, DOI 10.1029/JC082i027p03861; Hemleben C., 1989, MODERN PLANKTONIC FO, DOI [DOI 10.1016/S0016-6995(89)80108-1, DOI 10.1007/978-1-4612-3544-6_2]; HOLLAND SM, 1995, PALEOBIOLOGY, V21, P92, DOI 10.1017/S0094837300013099; Holland SM, 2000, PALEOBIOLOGY, V26, P148, DOI 10.1666/0094-8373(2000)26[148:TQOTFR]2.0.CO;2; Huber B.T., 2006, MESOZOIC PLANKTONIC; Kauffman E.G., 1993, 39 GEOL ASS CAN, P1; KELLER G, 1987, GEOLOGY, V15, P199, DOI 10.1130/0091-7613(1987)15<199:GDOLPH>2.0.CO;2; Kennett J.P., 1983, NEOGENE PLANKTONIC F; LIPPS JH, 1970, EVOLUTION, V24, P1, DOI 10.1111/j.1558-5646.1970.tb01737.x; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Lyle M., 1995, 1995 P OC DRILL PROG, V138, DOI [DOI 10.2973/0DP.PR0C.SR.138.157.1995, 10.2973/odp.proc.sr.138.157.1995]; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Milliman J. D., 1974, RECENT SEDIMENTARY C; Moore Jr T. C., 1978, MICROPALEONTOL SP PU, V3, P113; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; Norris RD, 2001, GEOL SOC SPEC PUBL, V183, P23, DOI 10.1144/GSL.SP.2001.183.01.02; Norris RD, 2000, PALEOBIOLOGY, V26, P236, DOI 10.1666/0094-8373(2000)26[236:PSDBAE]2.0.CO;2; Ogg J.G., 2004, GEOLOGIC TIME SCALE, P344; Olsson R. K., 1999, ATLAS PALEOCENE PLAN; Parket F. L., 1962, Micropaleontology, V8, P219, DOI 10.2307/1484745; Pearson P.N., 2006, CUSHMAN FDN FORAMINI, V41; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Peters SE, 2006, PALEOBIOLOGY, V32, P387, DOI 10.1666/05081.1; Peters SE, 2011, GEOLOGY, V39, P259, DOI 10.1130/G31442.1; Peters SE, 2006, J GEOL, V114, P391, DOI 10.1086/504176; PROTHERO DR, 1980, SYST ZOOL, V29, P119, DOI 10.2307/2412642; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Saito T, 1981, SYSTEMATIC INDEX REC; Schiebel R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001459; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Stewart D. R. M., 2000, PLANKRANGE DATABASE; Sverdrup H.U., 1942, OCEANS THEIR PHYS CH, P1065; Thierstein H. R., 1979, DEEP DRILLING RESULT, P249; Thunell R., 1986, TERMINAL EOCENE EVEN, P363, DOI [10.1016/s0920-5446(08)70140-7, DOI 10.1016/S0920-5446(08)70140-7]; VANANDEL TH, 1975, EARTH PLANET SC LETT, V26, P187, DOI 10.1016/0012-821X(75)90086-2; Vincent E., 1981, OCEAN LITHOSPHERE SE, V7, P1025; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	56	31	32	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					398	U140		10.1038/nature11815	http://dx.doi.org/10.1038/nature11815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23302802				2022-12-24	WOS:000313615900050
J	Metzger, ML; Billett, A; Link, MP				Metzger, Monika L.; Billett, Amy; Link, Michael P.			The Impact of Drug Shortages on Children with Cancer - The Example of Mechlorethamine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		[Metzger, Monika L.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Metzger, Monika L.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Billett, Amy] Dana Farber Canc Inst, Boston, MA 02115 USA; [Billett, Amy] Boston Childrens Hosp, Boston, MA USA; [Link, Michael P.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Link, Michael P.] Lucile Packard Childrens Hosp, Stanford, CA USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Stanford University; Lucile Packard Children's Hospital (LPCH)	Metzger, ML (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.							Chabner BA, 2011, NEW ENGL J MED, V365, P2147, DOI 10.1056/NEJMp1112633; Gatesman ML, 2011, NEW ENGL J MED, V365, P1653, DOI 10.1056/NEJMp1109772; Link MP, 2012, J CLIN ONCOL, V30, P692, DOI 10.1200/JCO.2011.41.0936	3	61	61	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2461	2463		10.1056/NEJMp1212468	http://dx.doi.org/10.1056/NEJMp1212468			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059OG	23268661				2022-12-24	WOS:000312714200001
J	Chamberlain, JS				Chamberlain, Jeffrey S.			A Genetic Intervention Stands a Skip Away from Clinical Tests	SCIENCE			English	Editorial Material							DUCHENNE MUSCULAR-DYSTROPHY; MOLECULAR-BASIS; EXPRESSION		[Chamberlain, Jeffrey S.] Univ Washington, Dept Neurol, Sch Med, Seattle, WA 98195 USA; [Chamberlain, Jeffrey S.] Univ Washington, Dept Med, Sch Med, Seattle, WA 98195 USA; [Chamberlain, Jeffrey S.] Univ Washington, Dept Biochem, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chamberlain, JS (corresponding author), Univ Washington, Dept Neurol, Sch Med, 1959 NE Pacific St, Seattle, WA 98195 USA.	Jsc5@u.washington.edu		Chamberlain, Jeffrey/0000-0001-5299-0059	NIAMS NIH HHS [R37 AR040864] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR040864] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; BEGGS AH, 1991, AM J HUM GENET, V49, P54; BERTORINI TE, 1991, MUSCLE NERVE, V14, P503, DOI 10.1002/mus.880140603; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Kendall GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005054; KOENIG M, 1989, AM J HUM GENET, V45, P498; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005; Nicolas A, 2012, ORPHANET J RARE DIS, V7, DOI [10.1186/1750-1172-7-45, 10.1186/1750-1172-7-42]; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; Schmajuk G, 1999, J BIOL CHEM, V274, P21783, DOI 10.1074/jbc.274.31.21783	15	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1431	1432		10.1126/science.1233074	http://dx.doi.org/10.1126/science.1233074			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239725				2022-12-24	WOS:000312250800036
J	Shaughnessy, AF				Shaughnessy, Allen F.			Monoclonal antibodies: magic bullets with a hefty price tag	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONTROLLED PHASE-3 TRIAL; MULTIPLE-SCLEROSIS; ALEMTUZUMAB		Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts University	Shaughnessy, AF (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.	Allen.Shaughnessy@Tufts.edu						[Anonymous], 2012, LANCET, V380, P1792; Bourgoin AF, WHAT YOU NEED KNOW F; Cohen JA, 2012, LANCET, V380, P1819, DOI 10.1016/S0140-6736(12)61769-3; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; Fanneau de La Horie GC, MAKING BIOL DRUGS MO; Herper M, WORLDS MOST EXPENSIV; Kelley B, 2009, MABS-AUSTIN, V1, P443, DOI 10.4161/mabs.1.5.9448; Staton T, SANOFI PULLS CAMPATH; U.S. Food and Drug Administration, BIOS	9	71	76	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 12	2012	345								e8346	10.1136/bmj.e8346	http://dx.doi.org/10.1136/bmj.e8346			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056MU	23236036				2022-12-24	WOS:000312495100013
J	Kohl, KP; Jones, CD; Sekelsky, J				Kohl, Kathryn P.; Jones, Corbin D.; Sekelsky, Jeff			Evolution of an MCM Complex in Flies That Promotes Meiotic Crossovers by Blocking BLM Helicase	SCIENCE			English	Article							STRAND BREAK REPAIR; GENETIC-ANALYSIS; DROSOPHILA BLM; CROSSING-OVER; MUTS HOMOLOG; RECOMBINATION	Generation of meiotic crossovers in many eukaryotes requires the elimination of anti-crossover activities by using the Msh4-Msh5 heterodimer to block helicases. Msh4 and Msh5 have been lost from the flies Drosophila and Glossina, but we identified a complex of minichromosome maintenance (MCM) proteins that functionally replace Msh4-Msh5. We found that REC, an ortholog of MCM8 that evolved under strong positive selection in flies, interacts with MEI-217 and MEI-218, which arose from a previously undescribed metazoan-specific MCM protein. Meiotic crossovers were reduced in Drosophila rec, mei-217, and mei-218 mutants; however, removal of the Bloom syndrome helicase (BLM) ortholog restored crossovers. Thus, MCMs were co-opted into a novel complex that replaced the meiotic pro-crossover function of Msh4-Msh5 in flies.	[Kohl, Kathryn P.; Sekelsky, Jeff] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Jones, Corbin D.; Sekelsky, Jeff] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Jones, Corbin D.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Sekelsky, Jeff] Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sekelsky, J (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.	sekelsky@unc.edu	Kang, Hojeong/C-7208-2011; Kim, Bong-Soo/L-4779-2013; Chun, Jongsik/R-8458-2017	Kim, Bong-Soo/0000-0003-1243-8280; Chun, Jongsik/0000-0003-3385-5171; Sekelsky, Jeff/0000-0002-4424-677X	NIH [GM061252, 5T32GM007092]; NSF [MCB-0618691]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092, R01GM061252] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. McKim for helpful discussions and for sharing unpublished results, and N. Crown and other members of the Sekelsky laboratory for helpful comments on the manuscript. Supported by NIH grant GM061252 (J.S.), NSF grant MCB-0618691 (J.S., C.D.J., and G. C. Copenhaver), and NIH grant 5T32GM007092 (K. P. K.). Alignments and trees were submitted to TreeBASE (http://purl.org/phylo/treebase/phylows/study/TB2:S13435).	Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Andersen SL, 2010, BIOESSAYS, V32, P1058, DOI 10.1002/bies.201000087; BAKER BS, 1972, GENETICS, V71, P255; Blanton HL, 2005, PLOS GENET, V1, P343, DOI 10.1371/journal.pgen.0010040; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lake CM, 2007, GENETICS, V176, P2151, DOI 10.1534/genetics.107.073551; Liu H, 2000, GENETICS, V154, P1735; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-60; Manheim EA, 2002, MOL BIOL CELL, V13, P84, DOI 10.1091/mbc.01-06-0318; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mcvey M, 2007, GENETICS, V176, P1979, DOI 10.1534/genetics.106.070052; Morgan T. H., 1912, Science New York N S, V36; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040	18	44	48	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1363	1365		10.1126/science.1228190	http://dx.doi.org/10.1126/science.1228190			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224558	Green Accepted, Green Submitted			2022-12-24	WOS:000311991200073
J	Abbott, A				Abbott, Alison			COGNITION The brain's decline	NATURE			English	Editorial Material																			0	12	12	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2012	492	7427					S4	S5		10.1038/492S4a	http://dx.doi.org/10.1038/492S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222672	Bronze			2022-12-24	WOS:000311893400003
J	Rose, J; Parashar, UD				Rose, Johnie; Parashar, Umesh D.			Should India launch a national immunisation programme against rotavirus? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							COST-EFFECTIVENESS; VACCINE; MORTALITY; EFFICACY; DIARRHEA; INFANTS; SAFETY; IMPACT		[Rose, Johnie] Case Western Reserve Univ, Div Res, Dept Family Med & Community Hlth, Cleveland, OH 44106 USA; [Parashar, Umesh D.] Ctr Dis Control & Prevent, Atlanta, GA USA	Case Western Reserve University; Centers for Disease Control & Prevention - USA	Rose, J (corresponding author), Case Western Reserve Univ, Div Res, Dept Family Med & Community Hlth, Cleveland, OH 44106 USA.	johnie.rose@case.edu	/AHA-3700-2022; /AAB-7864-2021	/0000-0001-7458-9303; /0000-0001-7458-9303	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		[Anonymous], 2009, WKLY EPIDEMIOL REC; Babji S, 2012, CURR OPIN VIROL, V2, P443, DOI 10.1016/j.coviro.2012.05.005; Esposito DH, 2011, CLIN INFECT DIS, V52, P171, DOI 10.1093/cid/ciq094; International Institute for Population Sciences Macro International, 2007, NAT FAM HLTH SURV NF, V1, P242; Morris SK, 2012, B WORLD HEALTH ORGAN, V90, P720, DOI 10.2471/BLT.12.101873; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Patel MM, 2012, LANCET INFECT DIS, V12, P561, DOI 10.1016/S1473-3099(12)70029-4; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Rose J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3653; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Steele AD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-213; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Tate JE, 2009, VACCINE, V27, pF18, DOI 10.1016/j.vaccine.2009.08.098; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; WHO - World Health Organization, 2010, STAT ROT ROT VACC IN	15	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 30	2012	345								e7818	10.1136/bmj.e7818	http://dx.doi.org/10.1136/bmj.e7818			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048FS	23203999	Green Accepted			2022-12-24	WOS:000311896500002
J	Dhatariya, K				Dhatariya, Ketan			Should inpatient hyperglycaemia be treated?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTENSIVE INSULIN THERAPY; MYOCARDIAL-INFARCTION; MORTALITY; MANAGEMENT; INFUSION		Norfolk & Norwich Univ Hosp NHS Fdn Trust, Elsie Bertram Diabet Ctr, Norwich NR4 7UY, Norfolk, England	Norfolk & Norwich University Hospitals NHS Foundation Trust	Dhatariya, K (corresponding author), Norfolk & Norwich Univ Hosp NHS Fdn Trust, Elsie Bertram Diabet Ctr, Norwich NR4 7UY, Norfolk, England.	ketan.dhatariya@nnuh.nhs.uk						Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Chaudhuri A, 2012, J CLIN ENDOCR METAB, V97, P3079, DOI 10.1210/jc.2012-1112; Dhatariya K, 2011, MANAGEMENT ADULTS DI; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Evans NR, 2012, CLIN MED, V12, P137, DOI 10.7861/clinmedicine.12-2-137; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Fowler D., 2010, SAFE EFFECTIVE USE I; Frisch A, 2010, DIABETES CARE, V33, P1783, DOI 10.2337/dc10-0304; Gandhi GY, 2008, MAYO CLIN PROC, V83, P418, DOI 10.4065/83.4.418; George JT, 2011, QJM-INT J MED, V104, P761, DOI 10.1093/qjmed/hcr046; Hirsch IB, 2009, JAMA-J AM MED ASSOC, V301, P213, DOI 10.1001/jama.2008.943; Joint British Diabetes Societies for Inpatient Care Group, 2012, MAN HYP HYP STAT HHS; Malmberg K, 2005, EUR HEART J, V26, P650, DOI 10.1093/eurheartj/ehi199; MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K; NHS Information Centre, 2012, NAT DIAB INP AUD; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Sampson MJ, 2007, DIABETES RES CLIN PR, V77, P92, DOI 10.1016/j.diabres.2006.10.004; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Walid M Sami, 2010, J Hosp Med, V5, pE10, DOI 10.1002/jhm.541	24	24	24	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 17	2013	346								f134	10.1136/bmj.f134	http://dx.doi.org/10.1136/bmj.f134			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075FP	23328031				2022-12-24	WOS:000313869500001
J	Paik, RS; Pepples, D; Hutchinson, MR				Paik, Ronald S.; Pepples, Douglas; Hutchinson, Mark R.			EASILY MISSED? Chronic exertional compartment syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXERCISE-INDUCED PAIN; LOWER LEG; ANTERIOR COMPARTMENT; DIAGNOSIS; RELEASE		[Paik, Ronald S.; Pepples, Douglas; Hutchinson, Mark R.] Univ Illinois, Sports Med Serv, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hutchinson, MR (corresponding author), Univ Illinois, Sports Med Serv, Chicago, IL 60612 USA.	mhutch@uic.edu						Aweid O, 2012, CLIN J SPORT MED, V22, P356, DOI 10.1097/JSM.0b013e3182580e1d; CLANTON TO, 1994, CLIN SPORT MED, V13, P743; Edmundsson D, 2011, DIABETIC MED, V28, P81, DOI 10.1111/j.1464-5491.2010.03158.x; Edmundsson D, 2007, ACTA ORTHOP, V78, P136, DOI 10.1080/17453670610013547; Fraipont Michael J, 2003, J Am Acad Orthop Surg, V11, P268; George CA, 2012, CLIN SPORT MED, V31, P307, DOI 10.1016/j.csm.2011.09.013; Glorioso J, 2001, TXB RUNNING MED, P95; Hislop M, 2011, BRIT J SPORT MED, V45, P956, DOI 10.1136/bjsports-2011-090368; Lohrer H, 2007, ARCH ORTHOP TRAUM SU, V127, P827, DOI 10.1007/s00402-006-0269-4; PEDOWITZ RA, 1990, AM J SPORT MED, V18, P35, DOI 10.1177/036354659001800106; Schepsis AA, 2005, AM J SPORT MED, V33, P1040, DOI 10.1177/0363546504271974; Shah Steven N, 2004, Am J Orthop (Belle Mead NJ), V33, P335; STYF J, 1988, AM J SPORT MED, V16, P165, DOI 10.1177/036354658801600214; Tzortziou V, 2006, CLIN J SPORT MED, V16, P209, DOI 10.1097/00042752-200605000-00004; van den Brand JGH, 2005, AM J SPORT MED, V33, P699, DOI 10.1177/0363546504270565; Verleisdonk EJMM, 2004, INT J SPORTS MED, V25, P224, DOI 10.1055/s-2003-45255; Whitesides, 1996, J Am Acad Orthop Surg, V4, P209; Wilder RP, 2010, CLIN SPORT MED, V29, P429, DOI 10.1016/j.csm.2010.03.008; Wittstein J, 2010, AM J SPORT MED, V38, P1661, DOI 10.1177/0363546510363415	19	4	5	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2013	346								f33	10.1136/bmj.f33	http://dx.doi.org/10.1136/bmj.f33			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075ER	23321416				2022-12-24	WOS:000313867100024
J	Thorsteinsdottir, H; Saenz, TW				Thorsteinsdottir, Halla; Saenz, Tirso W.			Tackling Meningitis in Africa	SCIENCE			English	Editorial Material									[Thorsteinsdottir, Halla] Small Globe, Toronto, ON, Canada; [Saenz, Tirso W.] Univ Brasilia, Ctr Sustainable Dev, Brasilia, DF, Brazil	Universidade de Brasilia	Thorsteinsdottir, H (corresponding author), Small Globe, Toronto, ON, Canada.	halla@smallglobe.org			Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Brautigam D., 2009, DRAGONS GIFT; Centers for Disease Control and Prevention, 2012, MULT FUNG MEN OUTBR; Ferrer M, 2004, NAT BIOTECHNOL, V22, pDC8, DOI 10.1038/nbt1204supp-DC8; Grogg P., 2010, CUBA BRAZIL UNITE AF; IRIN, 2007, AFR FIGHT MEN RAC TI; Kapoor A. K., 2012, S S COLLABORATION HL, P233; Love Patrick, 2012, OECD INSIGHTS; Padron F. Sotolongo, 2007, MEDICC REV, V9, P18; Reid-Henry S. M., 2010, CUBAN CURE; Rezaie R, 2008, NAT BIOTECHNOL, V26, P627, DOI 10.1038/nbt0608-627; Saenz T. W., 2012, S S COLLABORATION HL; Thorsteinsdottir H, 2004, NAT BIOTECHNOL, V22, pDC19, DOI 10.1038/nbt1204supp-DC19; Undesa (Departamento de Asuntos Economicos y Sociales de las Naciones Unidas), 2010, DEV COOP MDGS MAX RE	13	4	5	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1546	1547		10.1126/science.1233318	http://dx.doi.org/10.1126/science.1233318			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057AE	23258878				2022-12-24	WOS:000312533100034
J	Kakkar, M				Kakkar, Manish			Dengue fever is massively under-reported in India, hampering our response	BRITISH MEDICAL JOURNAL			English	Editorial Material							THAILAND; BURDEN		Publ Hlth Fdn India, Delhi 110070, India	Public Health Foundation of India	Kakkar, M (corresponding author), Publ Hlth Fdn India, Communicable Dis ISID Campus,4 Inst Area Vasant K, Delhi 110070, India.	manish.kakkar@phfi.org						[Anonymous], DENG CAS DEATHS COUN; Beatty ME, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000890; Central Bureau of Health Intelligence, 2012, NAT HLTH PROF 2011; Chakravarti A, 2012, T ROY SOC TROP MED H, V106, P273, DOI 10.1016/j.trstmh.2011.12.007; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Harris G., 2012, NY TIMES; Ministry of Statistics and Programme Implementation Government of India, 2006, MORB HLTH CAR COND A, P507; National Vector Borne Disease Control Programme, 2012, MAL SIT IND; Organization WH, 2010, SIT UPD DENG SEA REG; Sudarshan MK, 2007, INT J INFECT DIS, V11, P29, DOI 10.1016/j.ijid.2005.10.007; The National Vector Borne Disease Control Programme, DISTR DENG DENG HAEM; Wichmann O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000996; World Health Organization, 2009, DENGUE GUIDELINES DI	14	30	32	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 19	2012	345								e8574	10.1136/bmj.e8574	http://dx.doi.org/10.1136/bmj.e8574			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059JE	23255584				2022-12-24	WOS:000312700100008
J	Ince, C; van Kuijen, AM; Milstein, DMJ; Yuruk, K; Folkow, LP; Fokkens, WJ; Blix, AS				Ince, Can; van Kuijen, Anne-Marije; Milstein, Dan M. J.; Yuruk, Koray; Folkow, Lars P.; Fokkens, Wytske J.; Blix, Arnoldus S.			CHRISTMAS 2012: RESEARCH Why Rudolph's nose is red: observational study	BRITISH MEDICAL JOURNAL			English	Editorial Material							LASER-DOPPLER FLOWMETRY; NASAL HEAT-EXCHANGE; MUCOSAL MICROCIRCULATION; SEPTIC SHOCK; BLOOD-FLOW; REINDEER; RHINOSTEREOMETRY; CONGESTION	Objective To characterise the functional morphology of the nasal microcirculation in humans in comparison with reindeer as a means of testing the hypothesis that the luminous red nose of Rudolph, one of the most well known reindeer pulling Santa Claus's sleigh, is due to the presence of a highly dense and rich nasal microcirculation. Design Observational study. Setting Tromso, Norway (near the North Pole), and Amsterdam, the Netherlands. Participants Five healthy human volunteers, two adult reindeer, and a patient with grade 3 nasal polyposis. Main outcome measures Architecture of the microvasculature of the nasal septal mucosa and head of the inferior turbinates, kinetics of red blood cells, and real time reactivity of the microcirculation to topical medicines. Results Similarities between human and reindeer nasal microcirculation were uncovered. Hairpin-like capillaries in the reindeers' nasal septal mucosa were rich in red blood cells, with a perfused vessel density of 20 (SD 0.7) mm/mm(2). Scattered crypt or gland-like structures surrounded by capillaries containing flowing red blood cells were found in human and reindeer noses. In a healthy volunteer, nasal microvascular reactivity was demonstrated by the application of a local anaesthetic with vasoconstrictor activity, which resulted in direct cessation of capillary blood flow. Abnormal microvasculature was observed in the patient with nasal polyposis. Conclusions The nasal microcirculation of reindeer is richly vascularised, with a vascular density 25% higher than that in humans. These results highlight the intrinsic physiological properties of Rudolph's legendary luminous red nose, which help to protect it from freezing during sleigh rides and to regulate the temperature of the reindeer's brain, factors essential for flying reindeer pulling Santa Claus's sleigh under extreme temperatures.	[Ince, Can] Erasmus Univ, Dept Intens Care Med, Erasmus Med Ctr, NL-3000 CA Rotterdam, Netherlands; [van Kuijen, Anne-Marije; Fokkens, Wytske J.] Univ Amsterdam, Dept Otorhinolaryngol, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Milstein, Dan M. J.; Yuruk, Koray] Univ Amsterdam, Dept Translat Physiol, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Folkow, Lars P.; Blix, Arnoldus S.] Univ Tromso, Dept Arctic & Marine Biol, N-9001 Tromso, Norway	Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; UiT The Arctic University of Tromso	Ince, C (corresponding author), Erasmus Univ, Dept Intens Care Med, Erasmus Med Ctr, S Gravendijkwal 230,POB 2040, NL-3000 CA Rotterdam, Netherlands.	c.ince@erasmusmc.nl	Fokkens, Wytske WJ/ABF-2185-2020; Milstein, Dan M.J./H-2821-2019	Milstein, Dan M.J./0000-0003-1335-5516				Aas-Hansen O, 2000, AM J PHYSIOL-REG I, V279, pR1190; Abrams Don-Carlos, 1997, Rhinology (Utrecht), V35, P22; Bezemer R, 2012, CRIT CARE, V16, DOI 10.1186/cc11236; Blix AS, 2011, J EXP BIOL, V214, P3850, DOI 10.1242/jeb.057455; Blix AS, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-42; BLIX AS, 1983, J PHYSIOL-LONDON, V340, P445, DOI 10.1113/jphysiol.1983.sp014772; Blix AS, 2005, ARCTIC ANIMALS; Boerma EC, 2005, CRIT CARE, V9, pR601, DOI 10.1186/cc3809; Cervin A, 2001, RHINOLOGY, V39, P13; Dobbe JGG, 2008, MED BIOL ENG COMPUT, V46, P659, DOI 10.1007/s11517-008-0349-4; DRUCE HM, 1989, MICROVASC RES, V38, P175, DOI 10.1016/0026-2862(89)90026-5; Goedhart PT, 2007, OPT EXPRESS, V15, P15101, DOI 10.1364/OE.15.015101; Groner W, 1999, NAT MED, V5, P1209, DOI 10.1038/13529; Grudemo H, 1997, ORL-J OTO-RHIN-LARYN, V59, P50, DOI 10.1159/000276905; Grudemo H, 1999, AM J RHINOL, V13, P1, DOI 10.2500/105065899781389911; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; JOHNSEN HK, 1985, AM J PHYSIOL, V249, pR617, DOI 10.1152/ajpregu.1985.249.5.R617; Mathura KR, 2001, LANCET, V358, P1698, DOI 10.1016/S0140-6736(01)06722-8; Meinders AJ, 2009, NEW ENGL J MED, V360, pE9, DOI 10.1056/NEJMicm066261; Milstein DMJ, 2010, ORAL SURG ORAL MED O, V109, P91, DOI 10.1016/j.tripleo.2009.08.041; Philpott CM, 2005, CLIN OTOLARYNGOL, V30, P373, DOI 10.1111/j.1365-2273.2005.00985.x; Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F; Spronk PE, 2002, LANCET, V360, P1395, DOI 10.1016/S0140-6736(02)11393-6	23	8	8	0	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e8311	10.1136/bmj.e8311	http://dx.doi.org/10.1136/bmj.e8311			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059IU	23247980	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000312698700003
J	McCarthy, M				McCarthy, Michael			Containing the opioid overdose epidemic	BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY		LocalHealthGuide Com, Seattle, WA USA		McCarthy, M (corresponding author), LocalHealthGuide Com, Seattle, WA USA.	mxmc@mac.com						Agency Medical Directors Group, 2010, INT GUID OP DOS CHRO; Franklin GM, 2012, AM J IND MED, V55, P325, DOI 10.1002/ajim.21998; Franklin GM, 2005, AM J IND MED, V48, P91, DOI 10.1002/ajim.20191; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487	4	8	8	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 14	2012	345								e8340	10.1136/bmj.e8340	http://dx.doi.org/10.1136/bmj.e8340			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056NE	23241432				2022-12-24	WOS:000312496200001
J	Bhaskaran, K; Armstrong, B; Hajat, S; Haines, A; Wilkinson, P; Smeeth, L				Bhaskaran, Krishnan; Armstrong, Ben; Hajat, Shakoor; Haines, Andy; Wilkinson, Paul; Smeeth, Liam			Heat and risk of myocardial infarction: hourly level case-crossover analysis of MINAP database	BRITISH MEDICAL JOURNAL			English	Article							EASTERN UNITED-STATES; AIR-POLLUTION; TIME-SERIES; AMBIENT-TEMPERATURE; 11 CITIES; MORTALITY; ENGLAND; DEATHS; WALES; ADMISSIONS	Objective To quantify the association between exposure to higher temperatures and the risk of myocardial infarction at an hourly temporal resolution. Design Case-crossover study. Setting England and Wales Myocardial Ischaemia National Audit Project (MINAP) database. Participants 24 861 hospital admissions for myocardial infarction occurring in 11 conurbations during the warmest months (June to August) of the years 2003-09. Main outcome measure Odds ratio of myocardial infarction for a 1 degrees C increase in temperature. Results Strong evidence was found for an effect of heat acting 1-6 hours after exposure to temperatures above an estimated threshold of 20 degrees C (95% confidence interval 16 degrees C to 25 degrees C). For each 1 C increase in temperature above this threshold, the risk of myocardial infarction increased by 1.9% (0.5% to 3.3%, P=0.009). Later reductions in risk seemed to offset early increases in risk: the cumulative effect of a 1 degrees C rise in temperature above the threshold was 0.2% (-2.1% to 2.5%) by the end of the third day after exposure. Conclusions Higher ambient temperatures above a threshold of 20 degrees C seem to be associated with a transiently increased risk of myocardial infarction 1-6 hours after exposure. Reductions in risk at longer lags are consistent with heat triggering myocardial infarctions early in highly vulnerable people who would otherwise have had a myocardial infarction some time later ("short term displacement"). Policies aimed at reducing the health effects of hot weather should include consideration of effects operating at sub-daily timescales.	[Bhaskaran, Krishnan; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Armstrong, Ben; Hajat, Shakoor; Haines, Andy; Wilkinson, Paul] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Bhaskaran, K (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England.	krishnan.bhaskaran@lshtm.ac.uk	; Smeeth, Liam/X-5862-2018	armstrong, benedict/0000-0003-4407-0409; Haines, Andy/0000-0002-8053-4605; Wilkinson, Paul/0000-0001-7456-259X; Bhaskaran, Krishnan/0000-0001-5364-8757; Smeeth, Liam/0000-0002-9168-6022	British Heart Foundation [FS/04/045]; Wellcome Trust [086091/Z/08/Z]; Garfield Weston Foundation; National Institute for Health Research postdoctoral fellowship [NIHR-PDF-2011-04-007]; Wellcome Trust senior research fellowship in clinical science [098504/Z/12/Z]; National Institute for Health Research [PDF-2011-04-007, NF-SI-0510-10090] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Garfield Weston Foundation; National Institute for Health Research postdoctoral fellowship(National Institute for Health Research (NIHR)); Wellcome Trust senior research fellowship in clinical science(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the British Heart Foundation (grant number FS/04/045), the Wellcome Trust (grant number 086091/Z/08/Z), and the Garfield Weston Foundation. KB is supported by a National Institute for Health Research postdoctoral fellowship (grant number NIHR-PDF-2011-04-007). LS is supported by a Wellcome Trust senior research fellowship in clinical science (grant number 098504/Z/12/Z). The British Heart Foundation, the Garfield Weston Foundation, the National Institute for Health Research, and the Wellcome Trust had no role in the design or conduct of this study, or in the preparation, review, approval, or decision to submit the manuscript. All authors carried out this research independently of the funding bodies.	Astrand PO, 2003, TXB WORK PHYSL PHYSL, V4th; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bhaskaran K, 2009, HEART, V95, P1760, DOI 10.1136/hrt.2009.175000; Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018; Bhaskaran K, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5531; Bhaskaran K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3823; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Braga ALF, 2001, EPIDEMIOLOGY, V12, P662; Curriero FC, 2003, AM J EPIDEMIOL, V158, P93, DOI 10.1093/aje/kwg105; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Department for Environment Food and Rural Affairs, 2011, UK AIR DAT ARCH; Department of Health, 2011, HEATW PLAN ENGL PROT; Doherty RM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S8; Gasparrini A, 2012, OCCUP ENVIRON MED, V69, P56, DOI 10.1136/oem.2010.059782; Goldberg MS, 2011, ENVIRON RES, V111, P853, DOI 10.1016/j.envres.2011.05.022; Hajat S, 2007, OCCUP ENVIRON MED, V64, P93, DOI 10.1136/oem.2006.029017; Hajat S, 2005, EPIDEMIOLOGY, V16, P613, DOI 10.1097/01.ede.0000164559.41092.2a; Halonen JI, 2011, ENVIRON RES, V111, P281, DOI 10.1016/j.envres.2010.12.001; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; KEATINGE WR, 1986, AM J MED, V81, P795, DOI 10.1016/0002-9343(86)90348-7; KUNST AE, 1993, AM J EPIDEMIOL, V137, P331, DOI 10.1093/oxfordjournals.aje.a116680; Loughnan ME, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-41; Lumley T, 2000, ENVIRONMETRICS, V11, P689, DOI 10.1002/1099-095X(200011/12)11:6<689::AID-ENV439>3.0.CO;2-N; Messner Torbjorn, 2002, Int J Circumpolar Health, V61, P201; Met Office, 2012, MET OFF INT DAT ARCH; Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314; Nayha Simo, 2005, Int J Circumpolar Health, V64, P451; Schwartz J, 2004, EPIDEMIOLOGY, V15, P755, DOI 10.1097/01.ede.0000134875.15919.0f; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stryhn H, 2003, INT S VET EP EC ISVE; Turner LR, 2012, EPIDEMIOLOGY, V23, P594, DOI 10.1097/EDE.0b013e3182572795; Wolf K, 2009, CIRCULATION, V120, P735, DOI 10.1161/CIRCULATIONAHA.108.815860; WOOLHISER DA, 1979, J APPL METEOROL, V18, P34, DOI 10.1175/1520-0450(1979)018<0034:MLEOFC>2.0.CO;2; Yu WW, 2011, HEART, V97, P1089, DOI 10.1136/hrt.2010.217166	36	70	71	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 13	2012	345								e8050	10.1136/bmj.e8050	http://dx.doi.org/10.1136/bmj.e8050			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MZ	23243290	Green Accepted, Green Submitted, hybrid, Green Published			2022-12-24	WOS:000312495700003
J	Kokkinos, PF; Faselis, C; Myers, J; Panagiotakos, D; Doumas, M				Kokkinos, Peter F.; Faselis, Charles; Myers, Jonathan; Panagiotakos, Demosthenes; Doumas, Michael			Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study	LANCET			English	Article							ALL-CAUSE MORTALITY; 20-YEAR FOLLOW-UP; EXERCISE CAPACITY; PHYSICAL-ACTIVITY; PRIMARY PREVENTION; MEN; CHOLESTEROL; PREDICTORS; AMERICAN; EVENTS	Background Statins are commonly prescribed for management of dyslipidaemia and cardiovascular disease. Increased fitness is also associated with low mortality and is recommended as an essential part of promoting health. However, little information exists about the combined effects of fitness and statin treatment on all-cause mortality. We assessed the combined effects of statin treatment and fitness on all-cause mortality risk. Methods In this prospective cohort study, we included dyslipidaemic veterans from Veterans Affairs Medical Centers in Palo Alto, CA, and Washington DC, USA, who had had an exercise tolerance test between 1986, and 2011. We assigned participants to one of four fitness categories based on peak metabolic equivalents (MET) achieved during exercise test and eight categories based on fitness status and statin treatment. The primary endpoint was all-cause mortality adjusted for age, body-mass index, ethnic origin, sex, history of cardiovascular disease, cardiovascular drugs, and cardiovascular risk factors. We assessed mortality from Veteran's Affairs' records on Dec 31, 2011. We compared groups with Cox proportional hazard model. Findings We assessed 10 043 participants (mean age 58.8 years, SD 10.9 years). During a median follow-up of 10.0 years (IQR 6.0-14.2), 2318 patients died, with an average yearly mortality rate of 22 deaths per 1000 person-years. Mortality risk was 18.5% (935/5046) in people taking statins versus 27.7% (1386/4997) in those not taking statins (p<0.0001). In patients who took statins, mortality risk decreased as fitness increased; for highly fit individuals (>9 MET; n=694), the hazard ratio (HR) was 0.30 (95% CI 0.21-0.41; p<0.0001) compared with least fit (<= 5 METs) patients (HR 1; n=1060). For those not treated with statins, the HR for least fit participants (n=1024) was 1.35 (95% CI 1.17-1.54; p<0.0001) and progressively decreased to 0.53 (95% CI 0.44-0.65; p<0.0001) for those in the highest fitness category (n=1498). Interpretation Statin treatment and increased fitness are independently associated with low mortality among dyslipidaemic individuals. The combination of statin treatment and increased fitness resulted in substantially lower mortality risk than either alone, reinforcing the importance of physical activity for individuals with dyslipidaemia.	[Kokkinos, Peter F.; Faselis, Charles; Panagiotakos, Demosthenes; Doumas, Michael] Vet Affairs Med Ctr, Dept Cardiol, Washington, DC 20422 USA; [Kokkinos, Peter F.] Georgetown Univ, Sch Med, Washington, DC USA; [Kokkinos, Peter F.; Faselis, Charles] George Washington Univ, Sch Med, Washington, DC USA; [Myers, Jonathan] Vet Affairs Palo Alto Hlth Care Syst, Div Cardiol, Palo Alto, CA USA; [Myers, Jonathan] Stanford Univ, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Georgetown University; George Washington University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Kokkinos, PF (corresponding author), Vet Affairs Med Ctr, Div Cardiol, 50 Irving St NW, Washington, DC 20422 USA.	peter.kokkinos@va.gov	Panagiotakos, Demosthenes/K-8294-2019; Panagiotakos, Demosthenes/C-9776-2013; Panagiotakos, Demosthenes/M-9167-2019	Panagiotakos, Demosthenes/0000-0001-8583-153X; Panagiotakos, Demosthenes/0000-0001-8583-153X; Faselis, Charles/0000-0001-9895-0327; Doumas, Michael/0000-0002-7269-8044	RRD VA [IK6 RX002477] Funding Source: Medline; Veterans Affairs [IK6RX002477] Funding Source: NIH RePORTER	RRD VA; Veterans Affairs(US Department of Veterans Affairs)		Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; FOSTER C, 1984, AM HEART J, V107, P1229, DOI 10.1016/0002-8703(84)90282-5; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; Kizer KW, 2000, MED CARE, V38, pS7; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Kokkinos P, 2010, CIRCULATION, V122, P1637, DOI 10.1161/CIRCULATIONAHA.110.948349; Kokkinos P, 2010, CIRCULATION, V122, P790, DOI 10.1161/CIRCULATIONAHA.110.938852; Kokkinos P, 2009, HYPERTENSION, V53, P494, DOI 10.1161/HYPERTENSIONAHA.108.127027; Kokkinos P, 2009, DIABETES CARE, V32, P623, DOI 10.2337/dc08-1876; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Mascitelli L, 2009, INT J CARDIOL, V134, P136, DOI 10.1016/j.ijcard.2007.12.048; McAuley PA, 2007, DIABETES CARE, V30, P1539, DOI 10.2337/dc06-2397; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; MORRIS CK, 1993, J AM COLL CARDIOL, V22, P175, DOI 10.1016/0735-1097(93)90832-L; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; MYERS J, 1991, J AM COLL CARDIOL, V17, P1334, DOI 10.1016/S0735-1097(10)80144-5; Pedersen TR, 1998, CIRCULATION, V97, P1453, DOI 10.1161/01.CIR.97.15.1453; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Sacks FM, 1998, CIRCULATION, V97, P1446; Selim AJ, 2002, MED CARE, V40, P237, DOI 10.1097/00005650-200203000-00007; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6	31	132	134	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2013	381	9864					394	399		10.1016/S0140-6736(12)61426-3	http://dx.doi.org/10.1016/S0140-6736(12)61426-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084ZA	23199849				2022-12-24	WOS:000314578900036
J	Graham-Rowe, D				Graham-Rowe, Duncan			PUBLIC PLANNING Designs fit for purpose	NATURE			English	Editorial Material																		Hanks AS, 2012, J PUBLIC HEALTH-UK, V34, P370, DOI 10.1093/pubmed/fds003; Heath Gregory W, 2006, J Phys Act Health, V3, pS55, DOI 10.1123/jpah.3.s1.s55; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Meyer P, 2010, EUR J CARDIOV PREV R, V17, P569, DOI 10.1097/HJR.0b013e328338a4dd; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; USDA, 2009, ACCESS AFFORDABLE NU; Yang L, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5293	7	1	1	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					S4	S5		10.1038/493S4a	http://dx.doi.org/10.1038/493S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	080CU	23364769				2022-12-24	WOS:000314219600005
J	Ruark, E; Snape, K; Humburg, P; Loveday, C; Bajrami, I; Brough, R; Rodrigues, DN; Renwick, A; Seal, S; Ramsay, E; Duarte, SD; Rivas, MA; Warren-Perry, M; Zachariou, A; Campion-Flora, A; Hanks, S; Murray, A; Pour, NA; Douglas, J; Gregory, L; Rimmer, A; Walker, NM; Yang, TP; Adlard, JW; Barwell, J; Berg, J; Brady, AF; Brewer, C; Brice, G; Chapman, C; Cook, J; Davidson, R; Donaldson, A; Douglas, F; Eccles, D; Evans, DG; Greenhalgh, L; Henderson, A; Izatt, L; Kumar, A; Lalloo, F; Miedzybrodzka, Z; Morrison, PJ; Paterson, J; Porteous, M; Rogers, MT; Shanley, S; Walker, L; Gore, M; Houlston, R; Brown, MA; Caufield, MJ; Deloukas, P; McCarthy, MI; Todd, JA; Turnbull, C; Reis, JS; Ashworth, A; Antoniou, AC; Lord, CJ; Donnelly, P; Rahman, N				Ruark, Elise; Snape, Katie; Humburg, Peter; Loveday, Chey; Bajrami, Ilirjana; Brough, Rachel; Rodrigues, Daniel Nava; Renwick, Anthony; Seal, Sheila; Ramsay, Emma; Duarte, Silvana Del Vecchio; Rivas, Manuel A.; Warren-Perry, Margaret; Zachariou, Anna; Campion-Flora, Adriana; Hanks, Sandra; Murray, Anne; Pour, Naser Ansari; Douglas, Jenny; Gregory, Lorna; Rimmer, Andrew; Walker, Neil M.; Yang, Tsun-Po; Adlard, Julian W.; Barwell, Julian; Berg, Jonathan; Brady, Angela F.; Brewer, Carole; Brice, Glen; Chapman, Cyril; Cook, Jackie; Davidson, Rosemarie; Donaldson, Alan; Douglas, Fiona; Eccles, Diana; Evans, D. Gareth; Greenhalgh, Lynn; Henderson, Alex; Izatt, Louise; Kumar, Ajith; Lalloo, Fiona; Miedzybrodzka, Zosia; Morrison, Patrick J.; Paterson, Joan; Porteous, Mary; Rogers, Mark T.; Shanley, Susan; Walker, Lisa; Gore, Martin; Houlston, Richard; Brown, Matthew A.; Caufield, Mark J.; Deloukas, Panagiotis; McCarthy, Mark I.; Todd, John A.; Turnbull, Clare; Reis-Filho, Jorge S.; Ashworth, Alan; Antoniou, Antonis C.; Lord, Christopher J.; Donnelly, Peter; Rahman, Nazneen		Breast Ovarian Canc Susceptibility; Wellcome Trust Case Control Consor	Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer	NATURE			English	Article							DETECTABLE CLONAL MOSAICISM; CONFER SUSCEPTIBILITY; GERMLINE MUTATIONS; TUMOR-SUPPRESSOR; RARE VARIANTS; WIP1; PHOSPHATASE; PROTEIN; AMPLIFICATION; INHIBITOR	Improved sequencing technologies offer unprecedented opportunities for investigating the role of rare genetic variation in common disease. However, there are considerable challenges with respect to study design, data analysis and replication(1). Using pooled next-generation sequencing of 507 genes implicated in the repair of DNA in 1,150 samples, an analytical strategy focused on protein-truncating variants (PTVs) and a large-scale sequencing case-control replication experiment in 13,642 individuals, here we show that rare PTVs in the p53-inducible protein phosphatase PPM1D are associated with predisposition to breast cancer and ovarian cancer. PPM1D PTV mutations were present in 25 out of 7,781 cases versus 1 out of 5,861 controls (P = 1.12 x 10(-5)), including 18 mutations in 6,912 individuals with breast cancer (P = 2.42 x 10(-4)) and 12 mutations in 1,121 individuals with ovarian cancer (P = 3.10 x 10(-9)). Notably, all of the identified PPM1D PTVs were mosaic in lymphocyte DNA and clustered within a 370-base-pair region in the final exon of the gene, carboxy-terminal to the phosphatase catalytic domain. Functional studies demonstrate that the mutations result in enhanced suppression of p53 in response to ionizing radiation exposure, suggesting that the mutant alleles encode hyperactive PPM1D isoforms. Thus, although the mutations cause premature protein truncation, they do not result in the simple loss-of-function effect typically associated with this class of variant, but instead probably have a gain-of-function effect. Our results have implications for the detection and management of breast and ovarian cancer risk. More generally, these data provide new insights into the role of rare and of mosaic genetic variants in common conditions, and the use of sequencing in their identification.	[Ruark, Elise; Snape, Katie; Loveday, Chey; Renwick, Anthony; Seal, Sheila; Ramsay, Emma; Duarte, Silvana Del Vecchio; Warren-Perry, Margaret; Zachariou, Anna; Hanks, Sandra; Murray, Anne; Pour, Naser Ansari; Douglas, Jenny; Houlston, Richard; Turnbull, Clare; Rahman, Nazneen] Inst Canc Res, Div Genet & Epidemiol, Sutton SM2 5NG, Surrey, England; [Humburg, Peter; Rivas, Manuel A.; Gregory, Lorna; Rimmer, Andrew] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Bajrami, Ilirjana; Brough, Rachel; Rodrigues, Daniel Nava; Campion-Flora, Adriana; Reis-Filho, Jorge S.; Ashworth, Alan; Lord, Christopher J.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Brough, Rachel] Inst Canc Res, Canc Res UK Gene Funct Lab, London SW3 6JB, England; [Rivas, Manuel A.] Univ Oxford, Nuffield Dept Clin Med, Oxford OX3 7LD, England; [Walker, Neil M.; Todd, John A.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge CB2 0XY, England; [Yang, Tsun-Po] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Adlard, Julian W.] Chapel Allerton Hosp, Yorkshire Reg Genet Serv, Leeds LS7 4SA, W Yorkshire, England; [Barwell, Julian] Univ Hosp Leicester NHS Trust, Leicestershire Genet Ctr, Leicester LE1 5WW, Leics, England; [Berg, Jonathan] Univ Dundee, Div Med Sci, Dundee DD1 9SY, Scotland; [Brady, Angela F.] Kennedy Galton Ctr, NW Thames Reg Genet Serv, London HA1 3UJ, England; [Brewer, Carole] Royal Devon & Exeter Hosp, Peninsula Reg Genet Serv, Exeter EX1 2ED, Devon, England; [Brice, Glen] St George Hosp, SW Thames Reg Genet Serv, London SW17 0RE, England; [Chapman, Cyril] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Cook, Jackie] Sheffield Childrens NHS Fdn Trust, Sheffield Reg Genet Serv, Sheffield S10 2TH, S Yorkshire, England; [Davidson, Rosemarie] So Gen Hosp, Lab Med, W Scotland Reg Genet Serv, Glasgow G51 4TF, Lanark, Scotland; [Donaldson, Alan] Univ Hosp Bristol NHS Fdn Trust, SW Reg Genet Serv, Bristol BS2 8EG, Avon, England; [Douglas, Fiona; Henderson, Alex] Newcastle Upon Tyne Hosp NHS Fdn Trust, No Genet Serv, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Eccles, Diana] Univ Southampton, Southampton Univ Hosp NHS Trust, Fac Med, Southampton SO16 5YA, Hants, England; [Evans, D. Gareth] St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Greenhalgh, Lynn] Liverpool Womens NHS Fdn Trust, Merseyside & Cheshire Clin Genet Serv, Liverpool L8 7SS, Merseyside, England; [Izatt, Louise] Guys & St Thomas NHS Fdn Trust, SE Thames Reg Genet Serv, London SE1 9RT, England; [Kumar, Ajith] Great Ormond St Hosp Sick Children, NE Thames Reg Genet Serv, London WC1N 3JH, England; [Lalloo, Fiona] St Marys Hosp, Univ Dept Med Genet & Reg Genet Serv, Manchester M13 9WL, Lancs, England; [Miedzybrodzka, Zosia] Aberdeen Royal Infirm, Aberdeen & N Scotland Clin Genet Serv, Aberdeen AB25 2ZA, Scotland; [Morrison, Patrick J.] Queens Univ Belfast, Dept Med Genet, Belfast HSC Trust, No Ireland Reg Genet Serv, Belfast BT9 7AB, Antrim, North Ireland; [Paterson, Joan] Cambridge Univ Hosp NHS Fdn Trust, E Anglian Reg Genet Serv, Cambridge CB2 0QQ, England; [Porteous, Mary] Western Gen Hosp, SE Scotland Clin Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; [Rogers, Mark T.] Univ Wales Hosp, All Wales Med Genet Serv, Cardiff CF14 4XW, S Glam, Wales; [Shanley, Susan] Royal Marsden NHS Fdn Trust, Dept Canc Genet, Sutton SM2 5PT, Surrey, England; [Walker, Lisa] Oxford Univ Hosp NHS Trust, Oxford Reg Genet Serv, Oxford OX3 7LJ, England; [Gore, Martin] Royal Marsden NHS Fdn, Dept Gynaecol Oncol, London SW3 6JJ, England; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4102, Australia; [Caufield, Mark J.] Queen Mary Univ London, London Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Barts & London Genome Ctr, London EC1M 6BQ, England; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Med, Oxford OX3 7LI, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LI, England; [Antoniou, Antonis C.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England; [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of London; Institute of Cancer Research - UK; University of Oxford; Wellcome Centre for Human Genetics; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Chapel Allerton Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; University of Dundee; University of Exeter; St Georges University London; Birmingham Women's Hospital; Sheffield Children's NHS Foundation Trust; University of Glasgow; University of Bristol; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Manchester; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Manchester; University of Aberdeen; Queens University Belfast; University of Cambridge; University of Edinburgh; Cardiff University; Royal Marsden NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of Queensland; University of London; Queen Mary University London; University of Oxford; University of Cambridge; University of Oxford	Rahman, N (corresponding author), Inst Canc Res, Div Genet & Epidemiol, Sutton SM2 5NG, Surrey, England.	nazneen.rahman@icr.ac.uk	Deloukas, Panos/B-2922-2013; Rivas, Manuel/ABE-8173-2020; Lord, Christopher J/B-3295-2012; Dominiczak, Anna F/P-9390-2017; Breen, Gerome D/A-5540-2010; Humburg, Peter/A-4191-2009; Snape, Katie/AAA-8101-2022; Brown, Matthew A/E-5749-2010; Eccles, Diana/K-6327-2019; eyre, stephen/K-3776-2017; Evans, D Gareth/AAB-4308-2022; Turnbull, Clare/AAA-6596-2019; Lord, Christopher/AAX-7130-2021; Rahman, Nazneen/D-2802-2013; McCarthy, Mark/M-3763-2015; Todd, John/A-3542-2010; Lucassen, Anneke/D-7764-2017; Hemingway, Harry/C-1219-2009	Deloukas, Panos/0000-0001-9251-070X; Rivas, Manuel/0000-0003-1457-9925; Lord, Christopher J/0000-0002-3226-0515; Dominiczak, Anna F/0000-0003-4913-3608; Breen, Gerome D/0000-0003-2053-1792; Humburg, Peter/0000-0002-3331-6496; Brown, Matthew A/0000-0003-0538-8211; Eccles, Diana/0000-0002-9935-3169; eyre, stephen/0000-0002-1251-6974; Evans, D Gareth/0000-0002-8482-5784; Walker, Neil/0000-0001-9796-7688; Yang, Tsun-Po/0000-0002-9077-4434; Harrison, Pille/0000-0003-4117-6910; Ouwehand, Willem/0000-0002-7744-1790; Houlston, Richard/0000-0002-5268-0242; Campbell, James/0000-0001-6756-8766; Rahman, Nazneen/0000-0003-4376-0440; McCarthy, Mark/0000-0002-4393-0510; Newman, William/0000-0002-6382-4678; Todd, John/0000-0003-2740-8148; Mentzer, Alexander/0000-0002-4502-2209; Ansari-Pour, Naser/0000-0003-0908-0484; Forbes, Alastair/0000-0001-7416-9843; Turnbull, Clare/0000-0002-1734-5772; Eeles, Rosalind/0000-0002-3698-6241; Hocking, Lynne J/0000-0002-2414-2826; Weedon, Michael/0000-0002-6174-6135; Lango Allen, Hana/0000-0002-7803-8688; Lucassen, Anneke/0000-0003-3324-4338; Plagnol, Vincent/0000-0002-5597-9215; Hattersley, Andrew/0000-0001-5620-473X; Hemingway, Harry/0000-0003-2279-0624; Donnelly, Peter/0000-0001-9495-3408; Lindgren, Cecilia/0000-0002-4903-9374; Zeggini, Eleftheria/0000-0003-4238-659X; Wain, Louise/0000-0003-4951-1867; Munroe, Patricia/0000-0002-4176-2947; Adlard, Julian/0000-0002-1693-0435	Wellcome Trust [090532/Z/09/Z]; Medical Research Council (MRC) Hub grant [G0900747 91070]; Institute of Cancer Research; Cancer Research UK; RMH-ICR National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Cancer; MRC [G0000934]; Cancer Research UK Senior Cancer Research Fellow [C12292/A11174]; Wolfson-Royal Society Merit Award; Michael and Betty Kadoorie Cancer Genetics Research Programme; MRC [G0800675, G0800759, G9521010, G0700491, G0600329] Funding Source: UKRI; Cancer Research UK [14276, 11174, 15106] Funding Source: researchfish; Medical Research Council [G9521010, MR/K006584/1, G0000934, G0800759, G0600329, G0700491, G0800675] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10219, NF-SI-0508-10275] Funding Source: researchfish; Chief Scientist Office [ETM/137, CZB/4/540, ETM/75] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC) Hub grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Cancer Research; Cancer Research UK(Cancer Research UK); RMH-ICR National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Cancer(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK Senior Cancer Research Fellow; Wolfson-Royal Society Merit Award(Royal Society of London); Michael and Betty Kadoorie Cancer Genetics Research Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	We thank all the subjects and families that participated in the research and D. Dudakia, J. Bull and R. Linger for their assistance in recruitment. We are indebted to M. Stratton for discussions of the data and to A. Strydom for editorial assistance. We thank the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics, Oxford (funded by Wellcome Trust grant reference 090532/Z/09/Z and Medical Research Council (MRC) Hub grant G0900747 91070) for the generation of the phase 1 sequencing data. This work was funded by the Institute of Cancer Research, The Wellcome Trust, Cancer Research UK and Breakthrough Breast Cancer. We acknowledge support by the RMH-ICR National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Cancer. We acknowledge the use of DNA from the British 1958 Birth Cohort collection funded by the MRC grant G0000934 and the Wellcome Trust grant 068545/Z/02. A. C. A. is a Cancer Research UK Senior Cancer Research Fellow (C12292/A11174). P. Do. is supported by a Wolfson-Royal Society Merit Award. K. S. is supported by the Michael and Betty Kadoorie Cancer Genetics Research Programme.	[Anonymous], 2002, IARC Sci Publ, P1; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Barnes DR, 2012, GENET EPIDEMIOL, V36, P274, DOI 10.1002/gepi.21620; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Caruccio N, 2011, METHODS MOL BIOL, V733, P241, DOI 10.1007/978-1-61779-089-8_17; Chuman Y, 2009, J BIOCHEM, V145, P1, DOI 10.1093/jb/mvn135; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Gayther SA, 2010, CURR OPIN GENET DEV, V20, P231, DOI 10.1016/j.gde.2010.03.001; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hayashi R, 2011, BIOCHEMISTRY-US, V50, P4537, DOI 10.1021/bi101949t; Hernandez L, 2012, J PATHOL, V227, P42, DOI 10.1002/path.3990; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loveday C, 2012, NAT GENET, V44, P475, DOI 10.1038/ng.2224; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Lu XB, 2005, CELL CYCLE, V4, P1060; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Natrajan R, 2009, CLIN CANCER RES, V15, P2711, DOI 10.1158/1078-0432.CCR-08-1878; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Rayter S, 2008, ONCOGENE, V27, P1036, DOI 10.1038/sj.onc.1210729; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Rimmer A, 2012, PLATYPUS INTEGRATED; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shreeram S, 2006, J EXP MED, V203, P2793, DOI 10.1084/jem.20061563; Silva AL, 2008, RNA, V14, P563, DOI 10.1261/rna.815108; Snape K, 2012, BREAST CANCER RES TR, V134, P429, DOI 10.1007/s10549-012-2057-x; Tan DSP, 2009, CLIN CANCER RES, V15, P2269, DOI 10.1158/1078-0432.CCR-08-2403; Tavassoli FA, 2003, WHO CLASSIFICATION T; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586	40	186	192	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					406	U152		10.1038/nature11725	http://dx.doi.org/10.1038/nature11725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23242139	Green Submitted, Green Accepted			2022-12-24	WOS:000313615900052
J	Xu, B; Hsu, PK; Stark, KL; Karayiorgou, M; Gogos, JA				Xu, Bin; Hsu, Pei-Ken; Stark, Kimberly L.; Karayiorgou, Maria; Gogos, Joseph A.			Derepression of a Neuronal Inhibitor due to miRNA Dysregulation in a Schizophrenia-Related Microdeletion	CELL			English	Article							MICRORNA BIOGENESIS; MOUSE MODEL; MUTATIONS; PROTEIN; TRANSCRIPTION; TRAFFICKING; MECHANISMS; PATTERNS; DEFICITS; GROWTH	22q11.2 microdeletions result in specific cognitive deficits and schizophrenia. Analysis of Df(16)A(+/-) mice, which model this microdeletion, revealed abnormalities in the formation of neuronal dendrites and spines, as well as altered brain microRNAs. Here, we show a drastic reduction of miR-185, which resides within the 22q11.2 locus, to levels more than expected by a hemizygous deletion, and we demonstrate that this reduction alters dendritic and spine development. miR-185 represses, through an evolutionarily conserved target site, a previously unknown inhibitor of these processes that resides in the Golgi apparatus and shows higher prenatal brain expression. Sustained derepression of this inhibitor after birth represents the most robust transcriptional disturbance in the brains of Df(16)A(+/-) mice and results in structural alterations in the hippocampus. Reduction of miR-185 also has milder age- and region-specific effects on the expression of some Golgi-related genes. Our findings illuminate the contribution of microRNAs in psychiatric disorders and cognitive dysfunction.	[Xu, Bin; Stark, Kimberly L.; Karayiorgou, Maria] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Gogos, Joseph A.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Xu, Bin; Hsu, Pei-Ken; Stark, Kimberly L.; Gogos, Joseph A.] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Hsu, Pei-Ken] Columbia Univ, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Karayiorgou, M (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Psychiat, 1051 Riverside Dr, New York, NY 10032 USA.	mk2758@columbia.edu; jag90@columbia.edu			Simons Foundation; US National Institute of Mental Health [MH67068, MH077235, MH97879]; March of Dimes Foundation; McKnight Endowment Fund for Neuroscience; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award; NARSAD Suzanne and John Golden Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077235, R01MH067068, R01MH097879] Funding Source: NIH RePORTER	Simons Foundation; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); March of Dimes Foundation(March of Dimes); McKnight Endowment Fund for Neuroscience; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award(NARSAD); NARSAD Suzanne and John Golden Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Yan Sun, Merilee Teylan, Xuanyi Zou, and Megan Sribour for support with the maintenance of the mouse colony and technical assistance. We are also grateful to Drs. David Sulzer and Guomei Tang for their kind help with the diolistic assays. We thank Drs. Jun Mukai and Mirna Kvajo for help and insights with the immunocytochemistry assays. We also thank Dr. Mirna Kvajo and Rebbeca Levy for critical reading of the manuscript. This work was supported by a grant from the Simons Foundation (to J.A.G.), US National Institute of Mental Health grants MH67068 (to M.K. and J.A.G.), MH077235, and MH97879 (to J.A.G.), and by grants from the March of Dimes Foundation and the McKnight Endowment Fund for Neuroscience (to M.K.). B.X. was supported in part by a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award. K.L.S. was supported by a NARSAD Suzanne and John Golden Young Investigator Award. B.X., P.-K.H., M.K., and J.A.G. designed the research; B.X. and P.-K.H. performed the experiments and analyzed the data; K.L.S. contributed to the generation of the mouse strains; M.K. and J.A.G. supervised experiments and data analysis; and B.X., P.-K.H., M.K., and J.A.G. wrote the paper.	Ambros V, 2010, CURR BIOL, V20, pR598, DOI 10.1016/j.cub.2010.05.054; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Arguello PA, 2012, TRENDS NEUROSCI, V35, P3, DOI 10.1016/j.tins.2011.11.007; Arguello PA, 2010, SCHIZOPHRENIA BULL, V36, P289, DOI 10.1093/schbul/sbp153; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bearden CE, 2009, CEREB CORTEX, V19, P115, DOI 10.1093/cercor/bhn064; Brenner JL, 2010, CURR BIOL, V20, P1321, DOI 10.1016/j.cub.2010.05.062; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chow EWC, 2002, BIOL PSYCHIAT, V51, P208, DOI 10.1016/S0006-3223(01)01246-X; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Evans SF, 2011, J BIOL CHEM, V286, P29556, DOI 10.1074/jbc.M111.219675; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Gilman SR, 2012, NAT NEUROSCI, V15, P1723, DOI 10.1038/nn.3261; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Junes-Gill KS, 2011, J NEURO-ONCOL, V102, P197, DOI 10.1007/s11060-010-0314-6; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; Moreau MP, 2011, BIOL PSYCHIAT, V69, P188, DOI 10.1016/j.biopsych.2010.09.039; Morrow EM, 2010, J AM ACAD CHILD PSY, V49, P1091, DOI 10.1016/j.jaac.2010.08.009; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rodriguez-Murillo L, 2012, ANNU REV MED, V63, P63, DOI 10.1146/annurev-med-072010-091100; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Xu B, 2010, BRAIN RES, V1338, P78, DOI 10.1016/j.brainres.2010.03.109; Zhang L, 2009, DEVELOPMENT, V136, P3043, DOI 10.1242/dev.039008	43	104	108	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					262	275		10.1016/j.cell.2012.11.052	http://dx.doi.org/10.1016/j.cell.2012.11.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332760	Bronze, Green Accepted			2022-12-24	WOS:000313719800022
J	Han, MS; Jung, DY; Morel, C; Lakhani, SA; Kim, JK; Flavell, RA; Davis, RJ				Han, Myoung Sook; Jung, Dae Young; Morel, Caroline; Lakhani, Saquib A.; Kim, Jason K.; Flavell, Richard A.; Davis, Roger J.			JNK Expression by Macrophages Promotes Obesity-Induced Insulin Resistance and Inflammation	SCIENCE			English	Article							ADIPOSE-TISSUE; ACTIVATION; CELLS; POLARIZATION; SENSITIVITY; DIFFERENTIATION	The cJun NH2-terminal kinase (JNK) signaling pathway contributes to inflammation and plays a key role in the metabolic response to obesity, including insulin resistance. Macrophages are implicated in this process. To test the role of JNK, we established mice with selective JNK deficiency in macrophages. We report that feeding a high-fat diet to control and JNK-deficient mice caused similar obesity, but only mice with JNK-deficient macrophages remained insulin-sensitive. The protection of mice with macrophage-specific JNK deficiency against insulin resistance was associated with reduced tissue infiltration by macrophages. Immunophenotyping demonstrated that JNK was required for pro-inflammatory macrophage polarization. These studies demonstrate that JNK in macrophages is required for the establishment of obesity-induced insulin resistance and inflammation.	[Han, Myoung Sook; Morel, Caroline; Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Han, Myoung Sook; Jung, Dae Young; Morel, Caroline; Kim, Jason K.; Davis, Roger J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Lakhani, Saquib A.; Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT USA; [Lakhani, Saquib A.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Yale University; Yale University; University of Massachusetts System; University of Massachusetts Worcester	Davis, RJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.	roger.davis@umassmed.edu	Lakhani, Sunil R/I-1970-2018	Lakhani, Sunil R/0000-0003-4067-2760; Han, Myoung Sook/0000-0002-7226-2590; Davis, Roger/0000-0002-0130-1652; Lakhani, Saquib/0000-0003-3235-3460; Kim, Jason/0000-0002-7185-042X	National Institutes of Health [DK090963, DK080756, CA065861]; American Diabetes Association [7-10-BETA-02];  [DK093000]; NATIONAL CANCER INSTITUTE [R01CA065861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080756, R24DK090963, P30DK032520, U24DK093000, U2CDK093000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Barrett, V. Benoit, Y. Lee, and J.-H. Liu for technical assistance; S. Vernia for designing Taqman probes; and K. Gemme for administrative assistance. These studies were supported by grants from the National Institutes of Health (DK090963, DK080756, and CA065861). The University of Massachussetts Mouse Metabolic Phenotyping Center is supported by grant DK093000. M. S. H. was supported by a postdoctoral fellowship (7-10-BETA-02) from the American Diabetes Association. R.J.D. and J.K.K. are members of the University of Massachussetts Diabetes and Endocrinology Research Center (DK032520). R.J.D. and R. A. F. are Investigators of the Howard Hughes Medical Institute. Mouse strains described are available to qualified investigators upon completion of a standard institutional materials transfer agreement. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials.	Das M, 2009, CELL, V136, P249, DOI 10.1016/j.cell.2008.11.017; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kitade H, 2012, DIABETES, V61, P1680, DOI 10.2337/db11-1506; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sabio G, 2010, TRENDS BIOCHEM SCI, V35, P490, DOI 10.1016/j.tibs.2010.04.004; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Vallerie SN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003151; WANG J, 1994, CLIN EXP IMMUNOL, V95, P263, DOI 10.1111/j.1440-1681.1994.tb02511.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8	24	458	486	5	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					218	222		10.1126/science.1227568	http://dx.doi.org/10.1126/science.1227568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23223452	Green Accepted			2022-12-24	WOS:000313328200048
J	Downer, NJ; Ali, NJ; Au-Yong, ITH				Downer, Nicola J.; Ali, Nabeel J.; Au-Yong, Iain T. H.			Investigating pleural thickening	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIFFERENTIAL-DIAGNOSIS; THORACOSCOPY; CT; DISEASE; MANAGEMENT		[Downer, Nicola J.; Ali, Nabeel J.] Kings Mill Hosp, Dept Resp Med, Mansfield NG17 4JL, Sutton In Ashfi, England; [Au-Yong, Iain T. H.] Kings Mill Hosp, Dept Radiol, Mansfield NG17 4JL, Sutton In Ashfi, England		Au-Yong, ITH (corresponding author), Kings Mill Hosp, Dept Radiol, Mansfield NG17 4JL, Sutton In Ashfi, England.	iauyong@doctors.org.uk						British Thoracic Society, 2011, PLEUR PLAQ INF HLTH; Duysinx B, 2004, CHEST, V125, P489, DOI 10.1378/chest.125.2.489; Hansell D, 2009, IMAGING DIS CHEST; Hansen M, 1998, RESP MED, V92, P228, DOI 10.1016/S0954-6111(98)90100-7; HARRIS RJ, 1995, CHEST, V107, P845, DOI 10.1378/chest.107.3.845; Hierholzer J, 2000, CHEST, V118, P604, DOI 10.1378/chest.118.3.604; LEUNG AN, 1990, AM J ROENTGENOL, V154, P487, DOI 10.2214/ajr.154.3.2106209; Manhire A, 2003, THORAX, V58, P920, DOI 10.1136/thorax.58.11.920; Maskell NA, 2003, LANCET, V361, P1326, DOI 10.1016/S0140-6736(03)13079-6; MCLOUD TC, 1991, AM J ROENTGENOL, V156, P1145, DOI 10.2214/ajr.156.6.2028857; Miles Susan E, 2008, J Occup Med Toxicol, V3, P20, DOI 10.1186/1745-6673-3-20; Qureshi NR, 2009, THORAX, V64, P139, DOI 10.1136/thx.2008.100545; Rahman NM, 2007, BRIT MED J, V334, P206, DOI 10.1136/bmj.39061.503866.0B; Rahman NM, 2010, THORAX, V65, P54, DOI 10.1136/thx.2010.137018; Rodriguez-Panadero F, 2006, EUR RESPIR J, V28, P409, DOI 10.1183/09031936.06.00013706; Rusch V W, 1995, Chest, V108, P1122; Sharif S, 2011, INTERACT CARDIOV TH, V12, P806, DOI 10.1510/icvts.2010.255901; Treasure T, 2011, LANCET ONCOL, V12, P763, DOI 10.1016/S1470-2045(11)70149-8; Wiggins J, 2007, THORAX, V62, P1, DOI 10.1136/thx.2007.087619	19	9	9	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 3	2013	346								e8376	10.1136/bmj.e8376	http://dx.doi.org/10.1136/bmj.e8376			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066QZ	23287997				2022-12-24	WOS:000313236600004
J	Grenon, SM; Saary, J; Gray, G; Vanderploeg, JM; Hughes-Fulford, M				Grenon, S. Marlene; Saary, Joan; Gray, Gary; Vanderploeg, James M.; Hughes-Fulford, Millie			Can I take a space flight? Considerations for doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SPACEFLIGHT	Commercial investment is bringing space tourism closer to reality. Marlene Grenon and colleagues outline what doctors will need to know Although perhaps unfamiliar with the specific physiological changes associated with commercial air travel, most physicians will have travelled by plane and many will have attended a passenger in need of medical assistance while on a commercial flight. They are, however, unlikely to have experience of space travel. Numerous commercial enterprises exist that will eventually provide competitively priced access to spaceflight experiences for paying customers. With spaceports construction under way, bookings are already taking place. Physicians can in future expect patients to ask questions and request clearance processes (such as fitness to fly certificates) for space travel as they do for commercial airplane flights today. Here, we provide some background to the field of space medicine for non-experts and point to resources for clinicians when a patient presents with requests related to space travel.	[Grenon, S. Marlene] Univ Calif San Francisco, Div Vasc & Endovasc Surg, San Francisco, CA 94121 USA; [Grenon, S. Marlene] San Francisco VA Med Ctr, Dept Surg, San Francisco, CA USA; [Saary, Joan] Univ Toronto, Dept Occupat Med, Toronto, ON, Canada; [Saary, Joan] Canadian Forces Environm Med Estab, Toronto, ON, Canada; [Gray, Gary] Canadian Space Agcy, Montreal, PQ, Canada; [Vanderploeg, James M.] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Aerosp Med Program, Galveston, TX USA; [Hughes-Fulford, Millie] Vet Affairs Med Ctr, Hughes Fulford Lab, San Francisco, CA 94121 USA; [Hughes-Fulford, Millie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of Toronto; Canadian Space Agency; University of Texas System; University of Texas Medical Branch Galveston; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Grenon, SM (corresponding author), Univ Calif San Francisco, Div Vasc & Endovasc Surg, San Francisco, CA 94121 USA.	marlene.grenon@ucsfmedctr.org		Hughes-Fulford, Millie/0000-0002-0756-068X	NCRR NIH HHS [KL2RR024130] Funding Source: Medline; NIA NIH HHS [UH3 AG037628] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [UH3AG037628] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Antunano MJ, 2001, AVIAT SPACE ENVIR MD, V72, P948; BEZDEK RH, 1992, NATURE, V355, P105, DOI 10.1038/355105a0; Blue RS, 2012, AVIAT SPACE ENVIR MD, V83, P929, DOI 10.3357/ASEM.3351.2012; Bogomolov VV, 2007, AVIAT SPACE ENVIR MD, V78, P1162, DOI 10.3357/ASEM.2175.2007; Center of Excellence for Commercial Space Transportation, FLIGHT CREW MED STAN; FAA Office of Commercial Space Transportation, REG; Federal Aviation Administration, 2006, GUID MED SCREEN COMM; Federal Aviation Administration, FOR SUB REUS VEH 10; Gray G, 2008, PRINCIPLES CLIN MED, P59; Hughes-Fulford M, 2011, FASEB J, V25, P2858, DOI 10.1096/fj.11-0902ufm; International Academy of Astronautics, 2009, MED SAF LIAB ISS SHO; Jennings RT, 2006, AVIAT SPACE ENVIR MD, V77, P475; Launius RD, 2003, SPACE POLICY, V19, P163, DOI 10.1016/S0265-9646(03)00039-0; Mader TH, 2011, OPHTHALMOLOGY, V118, P2058, DOI 10.1016/j.ophtha.2011.06.021; Pandya S, 2009, J NEUROSURG, V111, P1141, DOI 10.3171/2009.2.JNS081334; Rayman RB, 2002, AVIAT SPACE ENVIR MD, V73, P1132; Thirsk R, 2009, CAN MED ASSOC J, V180, P1324, DOI 10.1503/cmaj.090815; Thirsk R, 2009, CAN MED ASSOC J, V180, P1216, DOI 10.1503/cmaj.081125; Vanderploeg J, 2011, AVIAT SPACE ENVIR MD, V82, P475, DOI 10.3357/ASEM.3015.2011; Wilhelm M. J., 2001, Journal of Heart and Lung Transplantation, V20, P201, DOI 10.1016/S1053-2498(00)00427-7; Williams D, 2009, CAN MED ASSOC J, V180, P1317, DOI 10.1503/cmaj.090628; Williams D, 2009, CAN MED ASSOC J, V180, P1292, DOI 10.1503/cmaj.090925	22	22	22	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2012	345								e8124	10.1136/bmj.e8124	http://dx.doi.org/10.1136/bmj.e8124			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MZ	23241271	Green Published			2022-12-24	WOS:000312495700005
J	Fujiwara, Y; Dixon, JA; O'Hara, F; Funder, ED; Dixon, DD; Rodriguez, RA; Baxter, RD; Herle, B; Sach, N; Collins, MR; Ishihara, Y; Baran, PS				Fujiwara, Yuta; Dixon, Janice A.; O'Hara, Fionn; Funder, Erik Daa; Dixon, Darryl D.; Rodriguez, Rodrigo A.; Baxter, Ryan D.; Herle, Bart; Sach, Neal; Collins, Michael R.; Ishihara, Yoshihiro; Baran, Phil S.			Practical and innate carbon-hydrogen functionalization of heterocycles	NATURE			English	Article							AROMATIC-COMPOUNDS; TRIFLUOROMETHYLATION; ARYL; STRATEGIES; CHEMISTRY; FLUORINE; REAGENT; ARENES	Nitrogen-rich heterocyclic compounds have had a profound effect on human health because these chemical motifs are found in a large number of drugs used to combat a broad range of diseases and pathophysiological conditions. Advances in transition-metal-mediated cross-coupling have simplified the synthesis of such molecules; however, C-H functionalization of medicinally important heterocycles that does not rely on pre-functionalized starting materials is an underdeveloped area(1-9). Unfortunately, the innate properties of heterocycles that make them so desirable for biological applications-such as aqueous solubility and their ability to act as ligands-render them challenging substrates for direct chemical functionalization. Here we report that zinc sulphinate salts can be used to transfer alkyl radicals to heterocycles, allowing for the mild (moderate temperature, 50 degrees C or less), direct and operationally simple formation of medicinally relevant C-C bonds while reacting in a complementary fashion to other innate C-H functionalization methods(2-6) (Minisci, borono-Minisci, electrophilic aromatic substitution, transition-metal-mediated C-H insertion and C-H deprotonation). We prepared a toolkit of these reagents and studied their reactivity across a wide range of heterocycles (natural products, drugs and building blocks) without recourse to protecting-group chemistry. The reagents can even be used in tandem fashion in a single pot in the presence of water and air.	[Fujiwara, Yuta; Dixon, Janice A.; O'Hara, Fionn; Funder, Erik Daa; Dixon, Darryl D.; Rodriguez, Rodrigo A.; Baxter, Ryan D.; Herle, Bart; Sach, Neal; Collins, Michael R.; Ishihara, Yoshihiro; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Sach, Neal; Collins, Michael R.] Pfizer Inc, La Jolla Labs, Dept Chem, San Diego, CA 92121 USA	Scripps Research Institute; Pfizer	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pbaran@scripps.edu		Dixon, Darryl D./0000-0002-3904-9587	US NIH/NIGMS [GM-073949]; Uehara Memorial Foundation; US-UK Fulbright Commission; Aarhus University; OChem Graduate School; CDNA; CFIN; NABIIT; US NIH; Pfizer Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073949] Funding Source: NIH RePORTER	US NIH/NIGMS; Uehara Memorial Foundation(Uehara Memorial Foundation); US-UK Fulbright Commission; Aarhus University; OChem Graduate School; CDNA; CFIN; NABIIT; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Inc.(Pfizer); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D.-H. Huang and L. Pasternack for NMR spectroscopic assistance, A. Schuyler and W. Uritboonthai for mass spectrometry assistance and D. Cayer for the analysis of the beta-lactamase activity. Financial support for this work was provided by the US NIH/NIGMS (GM-073949), the Uehara Memorial Foundation (postdoctoral fellowship for Y.F.), the US-UK Fulbright Commission (postdoctoral fellowship for F.O.), Aarhus University, OChem Graduate School, CDNA, CFIN and NABIIT (fellowship for E. D. F.), the US NIH (graduate fellowship for R. A. R.) and Pfizer Inc. (postdoctoral fellowship for R.D.B.).	Bruckl T, 2012, ACCOUNTS CHEM RES, V45, P826, DOI 10.1021/ar200194b; Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; Duncton MAJ, 2011, MEDCHEMCOMM, V2, P1135, DOI 10.1039/c1md00134e; Fier PS, 2012, J AM CHEM SOC, V134, P5524, DOI 10.1021/ja301013h; Fujiwara Y, 2012, J AM CHEM SOC, V134, P1494, DOI 10.1021/ja211422g; Fujiwara Y, 2011, J AM CHEM SOC, V133, P3292, DOI 10.1021/ja111152z; Han C, 2009, J AM CHEM SOC, V131, P7532, DOI 10.1021/ja902046m; Hu JB, 2009, CHEM COMMUN, P7465, DOI 10.1039/b916463d; Ji YN, 2011, P NATL ACAD SCI USA, V108, P14411, DOI 10.1073/pnas.1109059108; KAMIGATA N, 1994, J CHEM SOC PERK T 1, P1339, DOI 10.1039/p19940001339; Kino T, 2010, J FLUORINE CHEM, V131, P98, DOI 10.1016/j.jfluchem.2009.09.007; Kirk KL, 2008, ORG PROCESS RES DEV, V12, P305, DOI 10.1021/op700134j; Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5; LANGLOIS BR, 1991, TETRAHEDRON LETT, V32, P7525, DOI 10.1016/0040-4039(91)80524-A; Li Y, 2006, ORG LETT, V8, P1693, DOI 10.1021/ol060322t; Ma JA, 2007, J FLUORINE CHEM, V128, P975, DOI 10.1016/j.jfluchem.2007.04.026; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; MINISCI F, 1989, HETEROCYCLES, V28, P489, DOI 10.3987/REV-88-SR1; Molander GA, 2011, ORG LETT, V13, P1852, DOI 10.1021/ol2003572; Morimoto H, 2011, ANGEW CHEM INT EDIT, V50, P3793, DOI 10.1002/anie.201100633; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Nagib DA, 2011, NATURE, V480, P224, DOI 10.1038/nature10647; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Qi QQ, 2012, J FLUORINE CHEM, V133, P115, DOI 10.1016/j.jfluchem.2011.07.005; Raymond JI, 1971, J PHYS CHEM-US, V75, P3235; RUSSELL GA, 1985, J ORG CHEM, V50, P3423, DOI 10.1021/jo00218a041; Seiple IB, 2010, J AM CHEM SOC, V132, P13194, DOI 10.1021/ja1066459; Wang XS, 2010, J AM CHEM SOC, V132, P3648, DOI 10.1021/ja909522s; Zhao YC, 2012, ANGEW CHEM INT EDIT, V51, P1033, DOI 10.1002/anie.201106742	30	654	657	5	440	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					95	+		10.1038/nature11680	http://dx.doi.org/10.1038/nature11680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23201691	Green Accepted			2022-12-24	WOS:000311893400052
J	Bourzac, K				Bourzac, Katherine			NANOTECHNOLOGY Carrying drugs	NATURE			English	Editorial Material																		Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; von Maltzahn G, 2011, NAT MATER, V10, P545, DOI [10.1038/nmat3049, 10.1038/NMAT3049]	4	153	157	2	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					S58	S60		10.1038/491S58a	http://dx.doi.org/10.1038/491S58a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23320289	Bronze			2022-12-24	WOS:000311339800006
J	Aachoui, Y; Leaf, IA; Hagar, JA; Fontana, MF; Campos, CG; Zak, DE; Tan, MH; Cotter, PA; Vance, RE; Aderem, A; Miao, EA				Aachoui, Youssef; Leaf, Irina A.; Hagar, Jon A.; Fontana, Mary F.; Campos, Cristine G.; Zak, Daniel E.; Tan, Michael H.; Cotter, Peggy A.; Vance, Russell E.; Aderem, Alan; Miao, Edward A.			Caspase-11 Protects Against Bacteria That Escape the Vacuole	SCIENCE			English	Article							INFLAMMASOME ACTIVATION; SALMONELLA; SECRETION; FLAGELLIN; INTERLEUKIN-1-BETA; MAINTAINS; INFECTION; INTEGRITY; DEFENSE	Caspases are either apoptotic or inflammatory. Among inflammatory caspases, caspase-1 and -11 trigger pyroptosis, a form of programmed cell death. Whereas both can be detrimental in inflammatory disease, only caspase-1 has an established protective role during infection. Here, we report that caspase-11 is required for innate immunity to cytosolic, but not vacuolar, bacteria. Although Salmonella typhimurium and Legionella pneumophila normally reside in the vacuole, specific mutants (sifA and sdhA, respectively) aberrantly enter the cytosol. These mutants triggered caspase-11, which enhanced clearance of S. typhimurium sifA in vivo. This response did not require NLRP3, NLRC4, or ASC inflammasome pathways. Burkholderia species that naturally invade the cytosol also triggered caspase-11, which protected mice from lethal challenge with B. thailandensis and B. pseudomallei. Thus, caspase-11 is critical for surviving exposure to ubiquitous environmental pathogens.	[Aachoui, Youssef; Hagar, Jon A.; Campos, Cristine G.; Cotter, Peggy A.; Miao, Edward A.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Aachoui, Youssef; Hagar, Jon A.; Miao, Edward A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Leaf, Irina A.; Zak, Daniel E.; Aderem, Alan] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Fontana, Mary F.; Tan, Michael H.; Vance, Russell E.] Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Center for Infectious Disease Research; University of California System; University of California Berkeley	Miao, EA (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	emiao@med.unc.edu	Pacific-Southwest, RCE/B-6155-2009	Miao, Edward/0000-0001-7295-3490	NIH [AI097518, AI057141, AI065359, AI075039, AI080749, AI063302]; Investigator Awards from the Burroughs Wellcome Fund; Cancer Research Institute; NSF graduate fellowship; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097518, U54AI057141, P01AI063302, U54AI065359, R01AI080749, R01AI075039, U19AI100627] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Investigator Awards from the Burroughs Wellcome Fund; Cancer Research Institute; NSF graduate fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank V. Dixit for sharing mice (a material transfer agreement is on file) and M. Heise for sharing mice and S. Miller, J. Mougous, and H. Schweizer for sharing bacterial strains. We also thank D. Rodriguez and Z. Zhou for managing mouse colonies. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by NIH grants AI097518 (E. A. M.), AI057141 (E. A. M. and A. A.), AI065359 (P. A. C.), AI075039 (R. E. V.), AI080749 (R. E. V.), and AI063302 (R. E. V.); Investigator Awards from the Burroughs Wellcome Fund and Cancer Research Institute (R. E. V.); and an NSF graduate fellowship (M.F.F.).	Akhter A, 2012, IMMUNITY, V37, P35, DOI 10.1016/j.immuni.2012.05.001; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; Creasey EA, 2012, P NATL ACAD SCI USA, V109, P3481, DOI 10.1073/pnas.1121286109; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Ge JN, 2012, P NATL ACAD SCI USA, V109, P6193, DOI 10.1073/pnas.1117490109; Ge JN, 2011, CELL MICROBIOL, V13, P1870, DOI 10.1111/j.1462-5822.2011.01710.x; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Miao EA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00085; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Schroeder N, 2011, TRENDS MICROBIOL, V19, P268, DOI 10.1016/j.tim.2011.01.006; Shoma S, 2008, INFECT IMMUN, V76, P1547, DOI 10.1128/IAI.01269-07; van der Heijden J, 2012, FUTURE MICROBIOL, V7, P685, DOI [10.2217/FMB.12.49, 10.2217/fmb.12.49]; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	26	372	384	7	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2013	339	6122					975	978		10.1126/science.1230751	http://dx.doi.org/10.1126/science.1230751			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23348507	Green Accepted, Green Submitted			2022-12-24	WOS:000315149600054
J	Chatzigeorgiou, M; Bang, S; Hwang, SW; Schafer, WR				Chatzigeorgiou, Marios; Bang, Sangsu; Hwang, Sun Wook; Schafer, William R.			tmc-1 encodes a sodium-sensitive channel required for salt chemosensation in C. elegans	NATURE			English	Article							NUCLEOTIDE-GATED CHANNEL; ASH NEURONS; HEARING-LOSS; GENE FAMILY; HAIR-CELLS; TASTE; AVOIDANCE; ADAPTATION; BEHAVIORS; MUTATIONS	Transmembrane channel-like (TMC) genes encode a broadly conserved family of multipass integral membrane proteins in animals(1,2). Human TMC1 and TMC2 genes are linked to human deafness and required for hair-cell mechanotransduction; however, the molecular functions of these and other TMC proteins have not been determined(3-6). Here we show that the Caenorhabditis elegans tmc-1 gene encodes a sodium sensor that functions specifically in salt taste chemosensation. tmc-1 is expressed in the ASH polymodal avoidance neurons, where it is required for salt-evoked neuronal activity and behavioural avoidance of high concentrations of NaCl. However, tmc-1 has no effect on responses to other stimuli sensed by the ASH neurons including high osmolarity and chemical repellents, indicating a specific role in salt sensation. When expressed in mammalian cell culture, C. elegans TMC-1 generates a predominantly cationic conductance activated by high extracellular sodium but not by other cations or uncharged small molecules. Thus, TMC-1 is both necessary for salt sensation in vivo and sufficient to generate a sodium-sensitive channel in vitro, identifying it as a probable ionotropic sensory receptor.	[Chatzigeorgiou, Marios; Schafer, William R.] MRC Lab Mol Biol, Div Cell Biol, Cambridge CB2 0QH, England; [Bang, Sangsu; Hwang, Sun Wook] Korea Univ, Coll Med, Dept Biomed Sci, Seoul 136705, South Korea	MRC Laboratory Molecular Biology; Korea University; Korea University Medicine (KU Medicine)	Hwang, SW (corresponding author), Korea Univ, Coll Med, Dept Biomed Sci, Seoul 136705, South Korea.	sunhwang@korea.ac.kr; wschafer@mrc-lmb.cam.ac.uk	bang, sangsu/U-4313-2017; Bang, Sangsu/AAN-7238-2020	bang, sangsu/0000-0002-9092-0075; Hwang, Sun Wook/0000-0001-8460-7480; Schafer, William/0000-0002-6676-8034	Medical Research Council; National Research Foundation of Korea [2012000540]; Ministry of Health Welfare [A111373]; MRC [MC_U105185857] Funding Source: UKRI; Medical Research Council [MC_U105185857] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Health Welfare; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the Caenorhabditis Genetics Center and M. de Bono for strains, and A. Patapoutian, J. R. Holt, J. Hao, B. Zhao, D. Miller and R. Branicky for suggestions and comments on the manuscript. This research was supported by the Medical Research Council (W.R.S.) and grants to S.W.H. from the National Research Foundation of Korea (2012000540) and Korea Health technology R&D Project of Ministry of Health & Welfare (A111373).	BARGMANN CI, 1990, COLD SH Q B, V55, P529; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; Geffeney SL, 2011, NEURON, V71, P845, DOI 10.1016/j.neuron.2011.06.038; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; Jang H, 2012, NEURON, V75, P585, DOI 10.1016/j.neuron.2012.06.034; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Keresztes G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-24; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kurima K, 2003, GENOMICS, V82, P300, DOI 10.1016/S0888-7543(03)00154-X; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; Lyall V, 2004, J PHYSIOL-LONDON, V558, P147, DOI 10.1113/jphysiol.2004.065656; Marcotti W, 2006, J PHYSIOL-LONDON, V574, P677, DOI 10.1113/jphysiol.2005.095661; Ohta T, 2008, J BIOL CHEM, V283, P9377, DOI 10.1074/jbc.M709377200; Pocock R, 2010, NAT NEUROSCI, V13, P610, DOI 10.1038/nn.2537; Sambongi Y, 1999, NEUROREPORT, V10, P753, DOI 10.1097/00001756-199903170-00017; Smith CJ, 2010, DEV BIOL, V345, P18, DOI 10.1016/j.ydbio.2010.05.502; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Wakabayashi T, 2009, BBA-GEN SUBJECTS, V1790, P765, DOI 10.1016/j.bbagen.2009.03.032; Zhou Y, 2004, BIOCHEMISTRY-US, V43, P4978, DOI 10.1021/bi049876z	30	93	102	4	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					95	99		10.1038/nature11845	http://dx.doi.org/10.1038/nature11845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23364694	Green Accepted			2022-12-24	WOS:000314741200041
J	Forrest, LR				Forrest, Lucy R.			(Pseudo-)Symmetrical Transport	SCIENCE			English	Editorial Material							FACING CONFORMATION; MECHANISM		Max Planck Inst Biophys, Computat Struct Biol Grp, D-60438 Frankfurt, Germany	Max Planck Society	Forrest, LR (corresponding author), Max Planck Inst Biophys, Computat Struct Biol Grp, Max von Laue Str 3, D-60438 Frankfurt, Germany.	lucy.forrest@biophys.mpg.de	Forrest, Lucy/E-8113-2016	Forrest, Lucy/0000-0003-1855-7985				Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lolkema JS, 2008, J MOL BIOL, V378, P596, DOI 10.1016/j.jmb.2008.03.005; Mancusso R, 2012, NATURE, V491, P622, DOI 10.1038/nature11542; Nasie I, 2010, J BIOL CHEM, V285, P15234, DOI 10.1074/jbc.M110.108746; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Schushan M, 2012, J BIOL CHEM, V287, P18249, DOI 10.1074/jbc.M111.336446; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104	15	42	42	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2013	339	6118					399	401		10.1126/science.1228465	http://dx.doi.org/10.1126/science.1228465			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349276				2022-12-24	WOS:000313960700025
J	Dolan, P; Kavetsos, G				Dolan, Paul; Kavetsos, Georgios			Educational interventions are unlikely to work because obese people aren't unhappy enough to lose weight	BRITISH MEDICAL JOURNAL			English	Editorial Material							VALUING HEALTH; BEHAVIOR		[Dolan, Paul; Kavetsos, Georgios] London Sch Econ, London WC2A 2AE, England	University of London; London School Economics & Political Science	Kavetsos, G (corresponding author), London Sch Econ, London WC2A 2AE, England.	g.kavetsos@lse.ac.uk						Bradford WD, 2010, J HEALTH ECON, V29, P811, DOI 10.1016/j.jhealeco.2010.07.007; Dolan P, 2012, J ECON PSYCHOL, V33, P264, DOI 10.1016/j.joep.2011.10.009; Dolan P, 2008, ECON J, V118, P215, DOI 10.1111/j.1468-0297.2007.02110.x; Dolan P, 2012, MED DECIS MAKING, V32, P578, DOI 10.1177/0272989X11435173; Dolan P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2577; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; Marteau TM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1415; McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Oswald A., 2007, ECON J, DOI DOI 10.1111/J.1468-0297.2007.02077_1.X; Oswald AJ, 2008, J PUBLIC ECON, V92, P1061; [No title captured], DOI DOI 10.1111/J.1468-0297.2008.02150.X	12	3	3	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e8487	10.1136/bmj.e8487	http://dx.doi.org/10.1136/bmj.e8487			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IU	23248082				2022-12-24	WOS:000312698700017
J	Cochella, L; Hobert, O				Cochella, Luisa; Hobert, Oliver			Embryonic Priming of a miRNA Locus Predetermines Postmitotic Neuronal Left/Right Asymmetry in C. elegans	CELL			English	Article							GENES	The mechanisms by which functional left/right asymmetry arises in morphologically symmetric nervous systems are poorly understood. Here, we provide a mechanistic framework for how functional asymmetry in a postmitotic neuron pair is specified in C. elegans. A key feature of this mechanism is a temporally separated, two-step activation of the lsy-6 miRNA locus. The lsy-6 locus is first "primed'' by chromatin decompaction in the precursor for the left neuron, but not the right neuron, several divisions before the neurons are born. lsy-6 expression is then "boosted'' to functionally relevant levels several divisions later in the mother of the left neuron, through the activity of a bilaterally expressed transcription factor that can only activate lsy-6 in the primed neuron. This study shows how cells can become committed during early developmental stages to execute a specific fate much later in development and provides a conceptual framework for understanding the generation of neuronal diversity.	[Cochella, Luisa; Hobert, Oliver] Columbia Univ, Howard Hughes Med Inst, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Cochella, L (corresponding author), Columbia Univ, Howard Hughes Med Inst, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	mlc2155@columbia.edu; or38@columbia.edu	Cochella, Luisa/B-6536-2016; Cochella, Luisa/AHD-8261-2022	Cochella, Luisa/0000-0003-4018-7722; Cochella, Luisa/0000-0003-4018-7722; Hobert, Oliver/0000-0002-7634-2854	Helen Hay Whitney Foundation; National Institutes of Health [R01NS039996-05, R01NS050266-03]; HHMI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050266, R01NS039996] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I. Greenwald, W. Grueber, R. Mann, and members of the Hobert lab for helpful discussions and comments on the manuscript. We thank P. Meister, S. Gasser, and S. Mango for advice and reagents; I. Topalidou for help with the smFISH; the CGC for strains; Q. Chen for assistance with microinjections; and A. Boyanov for help with obtaining integrated transgenes. L.C. was funded by a postdoctoral fellowship from the Helen Hay Whitney Foundation. This work was funded in part by the National Institutes of Health (R01NS039996-05 and R01NS050266-03) and by the HHMI.	Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Didiano D, 2010, RNA, V16, P349, DOI 10.1261/rna.1931510; Dietzel S, 2004, J CELL SCI, V117, P4603, DOI 10.1242/jcs.01330; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Etchberger JF, 2009, DEVELOPMENT, V136, P147, DOI 10.1242/dev.030064; Fakhouri THI, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001060; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Good K, 2004, DEVELOPMENT, V131, P1967, DOI 10.1242/dev.01088; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Hobert O, 2006, COLD SPRING HARB SYM, V71, P181, DOI 10.1101/sqb.2006.71.006; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Johnston R, 2005, ENVIRON PLANN A, V37, P2, DOI 10.1068/a3811; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; O'Meara MM, 2009, GENETICS, V181, P1679, DOI 10.1534/genetics.108.097832; Ortiz CO, 2009, CURR BIOL, V19, P996, DOI 10.1016/j.cub.2009.05.043; Poole RJ, 2006, CURR BIOL, V16, P2279, DOI 10.1016/j.cub.2006.09.041; Poole RJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002109; Priess J R, 2005, NOTCH SIGNALING C EL; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Sarin S, 2007, GENETICS, V176, P2109, DOI 10.1534/genetics.107.075648; Sarin S, 2009, DEVELOPMENT, V136, P2933, DOI 10.1242/dev.040204; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; Yuzyuk T, 2009, DEV CELL, V16, P699, DOI 10.1016/j.devcel.2009.03.008; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	28	55	55	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1229	1242		10.1016/j.cell.2012.10.049	http://dx.doi.org/10.1016/j.cell.2012.10.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23201143	Green Accepted, Bronze			2022-12-24	WOS:000311999900013
J	Bourzac, K				Bourzac, Katherine			ANTI-AGEING Live long and prosper	NATURE			English	Editorial Material							CALORIC RESTRICTION											BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Stein PK, 2012, AGING CELL, V11, P644, DOI 10.1111/j.1474-9726.2012.00825.x	6	6	6	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					S18	S20		10.1038/492S18a	http://dx.doi.org/10.1038/492S18a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222670	Bronze			2022-12-24	WOS:000311893400010
J	Perron, JT; Richardson, PW; Ferrier, KL; Lapotre, M				Perron, J. Taylor; Richardson, Paul W.; Ferrier, Ken L.; Lapotre, Mathieu			The root of branching river networks	NATURE			English	Article							TRIPLE JUNCTION REGION; EROSION RATES; MODEL; LANDSCAPE; BE-10; EVOLUTION; HILLSLOPE; BEDROCK; CREEP; AL-26	Branching river networks are one of the most widespread and recognizable features of Earth's landscapes and have also been discovered elsewhere in the Solar System(1,2). But the mechanisms that create these patterns and control their spatial scales are poorly understood. Theories based on probability(3-5) or optimality(3,6-8) have proven useful(9), but do not explain how river networks develop over time through erosion and sediment transport. Here we show that branching at the uppermost reaches of river networks is rooted in two coupled instabilities: first, valleys widen at the expense of their smaller neighbours, and second, side slopes of the widening valleys become susceptible to channel incision. Each instability occurs at a critical ratio of the characteristic timescales for soil transport and channel incision. Measurements from two field sites demonstrate that our theory correctly predicts the size of the smallest valleys with tributaries. We also show that the dominant control on the scale of landscape dissection in these sites is the strength of channel incision, which correlates with aridity and rock weakness, rather than the strength of soil transport. These results imply that the fine-scale structure of branching river networks is an organized signature of erosional mechanics, not a consequence of random topology.	[Perron, J. Taylor; Richardson, Paul W.; Ferrier, Ken L.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Lapotre, Mathieu] Univ Strasbourg, Ecole & Observ Sci Terre, F-67084 Strasbourg, France	Massachusetts Institute of Technology (MIT); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Perron, JT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	perron@mit.edu	Perron, J. Taylor/D-8983-2012; Lapotre, Mathieu/L-4910-2018	Perron, J. Taylor/0000-0002-0404-8701; Ferrier, Ken/0000-0003-4098-166X; Richardson, Paul/0000-0002-9418-1804; Lapotre, Mathieu/0000-0001-9941-1552	US National Science Foundation Geomorphology and Land Use Dynamics programme [EAR-0951672]; US Department of Defense through a National Defense Science and Engineering Graduate Fellowship; Division Of Earth Sciences [0951672] Funding Source: National Science Foundation	US National Science Foundation Geomorphology and Land Use Dynamics programme; US Department of Defense through a National Defense Science and Engineering Graduate Fellowship; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported by the US National Science Foundation Geomorphology and Land Use Dynamics programme through award EAR-0951672 to J.T.P. and by the US Department of Defense through a National Defense Science and Engineering Graduate Fellowship to P. W. R. J.T.P. is a Scholar in the Canadian Institute for Advanced Research (CIFAR). The authors thank T. Clifton and G. Chmiel for assistance with sample preparation, and the Orradre family of San Ardo, California, and numerous landowners in Greene County, Pennsylvania, for granting access to their land.	[Anonymous], 1983, GEOL SOC AM BULL, V94, P1035; Balco G, 2008, QUAT GEOCHRONOL, V3, P174, DOI 10.1016/j.quageo.2007.12.001; Berg T, 1980, GEOLOGIC MAP PENNSYL; Bonnet S, 2009, NAT GEOSCI, V2, P766, DOI 10.1038/NGEO666; CULLING WEH, 1960, J GEOL, V68, P336, DOI 10.1086/626663; CULLING WEH, 1963, J GEOL, V71, P127, DOI 10.1086/626891; Dietrich W.E., 1993, CHANNEL NETWORK HYDR, P175; Ditchburn R.G, 1994, 3 WORKSH S PAC ENV R, P4; Dunne T., 1980, PROG PHYS GEOG, V4, P211, DOI [10.1177/030913338000400204, DOI 10.1177/030913338000400204, DOI 10.1016/S1546-5098(08)60146-6]; Durham D.L, 1974, PROF PAP US GEOL SUR, V819, P1; Fernandes NF, 1997, WATER RESOUR RES, V33, P1307, DOI 10.1029/97WR00534; Gilbert G. K., 1877, REPORT GEOLOGY HENRY, DOI DOI 10.5962/BHL.TITLE.51652; Gonzalez R.C., 2010, DIGITAL IMAGE PROCES, V2nd; Granger DE, 1996, J GEOL, V104, P249, DOI 10.1086/629823; Hack J.T., 1957, 294B US GEOL SURV, V294-B, P1; HANKS TC, 1984, J GEOPHYS RES, V89, P5771, DOI 10.1029/JB089iB07p05771; HORTON RE, 1945, GEOL SOC AM BULL, V56, P275, DOI 10.1130/0016-7606(1945)56[275:edosat]2.0.co;2; Hovius N, 1996, BASIN RES, V8, P29, DOI 10.1111/j.1365-2117.1996.tb00113.x; HOWARD AD, 1983, GEOL SOC AM BULL, V94, P739, DOI 10.1130/0016-7606(1983)94<739:CCIB>2.0.CO;2; HOWARD AD, 1990, WATER RESOUR RES, V26, P2107, DOI 10.1029/WR026i009p02107; HOWARD AD, 1994, WATER RESOUR RES, V30, P2261, DOI 10.1029/94WR00757; HOWARD AD, 1971, GEOGR ANAL, V3, P29; IZUMI N, 1995, J FLUID MECH, V283, P341, DOI 10.1017/S0022112095002357; JENSON SK, 1988, PHOTOGRAMM ENG REM S, V54, P1593; KIRCHNER JW, 1993, GEOLOGY, V21, P591, DOI 10.1130/0091-7613(1993)021<0591:SIOHSL>2.3.CO;2; KOHL CP, 1992, GEOCHIM COSMOCHIM AC, V56, P3583, DOI 10.1016/0016-7037(92)90401-4; Lashermes B, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031140; Leopold L.B., 1962, 500A US GEOL SURV PR, P1; MCKEAN JA, 1993, GEOLOGY, V21, P343, DOI 10.1130/0091-7613(1993)021<0343:QOSPAD>2.3.CO;2; MITASOVA H, 1993, MATH GEOL, V25, P657, DOI 10.1007/BF00893172; MONAGHAN MC, 1992, EARTH PLANET SC LETT, V111, P483, DOI 10.1016/0012-821X(92)90198-5; MONTGOMERY DR, 1992, SCIENCE, V255, P826, DOI 10.1126/science.255.5046.826; NASH DB, 1980, J GEOL, V88, P353, DOI 10.1086/628513; Passalacqua P, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001254; Peckham S. D, 2011, GEOMORPHOMETRY 2011, P27; Perron JT, 2012, EARTH SURF PROC LAND, V37, P52, DOI 10.1002/esp.2205; Perron JT, 2009, NATURE, V460, P502, DOI 10.1038/nature08174; Perron JT, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000977; RIGON R, 1993, WATER RESOUR RES, V29, P1635, DOI 10.1029/92WR02985; Rodriguez-Iturbe I., 2001, FRACTAL RIVER BASINS; ROSENBLOOM NA, 1994, J GEOPHYS RES-SOL EA, V99, P14013, DOI 10.1029/94JB00048; SCHUMM SA, 1956, GEOL SOC AM BULL, V67, P597, DOI 10.1130/0016-7606(1956)67[597:EODSAS]2.0.CO;2; Seidl M.A., 1992, FUNCTIONAL GEOMORPHO, V23, P101; SEIDL MA, 1994, J GEOL, V102, P457, DOI 10.1086/629686; SHREVE RL, 1967, J GEOL, V75, P178, DOI 10.1086/627245; Small EE, 1999, GEOMORPHOLOGY, V27, P131, DOI 10.1016/S0169-555X(98)00094-4; SMITH TR, 1972, WATER RESOUR RES, V8, P1506, DOI 10.1029/WR008i006p01506; Snyder NP, 2000, GEOL SOC AM BULL, V112, P1250, DOI 10.1130/0016-7606(2000)112<1250:LRTTFD>2.3.CO;2; Snyder NP, 2003, GEOMORPHOLOGY, V53, P97, DOI 10.1016/S0169-555X(02)00349-5; Stock JD, 1999, J GEOPHYS RES-SOL EA, V104, P4983, DOI 10.1029/98JB02139; Strahler A.N., 1957, EOS T AM GEOPHYS UNI, V38, P912, DOI [10.1029/TR038i006p00913, DOI 10.1029/TR038I006P00913]; SUN T, 1994, PHYS REV E, V49, P4865, DOI 10.1103/PhysRevE.49.4865; Tarboton DG, 1997, WATER RESOUR RES, V33, P309, DOI 10.1029/96WR03137; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126; Tucker GE, 1997, WATER RESOUR RES, V33, P2031, DOI 10.1029/97WR00409; Tucker GE, 1996, BASIN RES, V8, P329, DOI 10.1046/j.1365-2117.1996.00238.x; WILLGOOSE G, 1991, EARTH SURF PROC LAND, V16, P237, DOI 10.1002/esp.3290160305	57	88	92	5	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					100	+		10.1038/nature11672	http://dx.doi.org/10.1038/nature11672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222614				2022-12-24	WOS:000311893400053
J	Janes, CR; Corbett, KK; Jones, JH; Trostle, J				Janes, Craig R.; Corbett, Kitty K.; Jones, James H.; Trostle, James			Emerging infectious diseases: the role of social sciences	LANCET			English	Editorial Material							ECOLOGY; EMERGENCE; RESISTANCE; ZOONOSIS; BEHAVIOR		[Janes, Craig R.; Corbett, Kitty K.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Jones, James H.] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [Jones, James H.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Trostle, James] Trinity Coll, Dept Anthropol, Hartford, CT 06106 USA	Simon Fraser University; Stanford University; Stanford University; Trinity College	Janes, CR (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	cjanes@sfu.ca		Trostle, James/0000-0002-6045-9521; Jones, James/0000-0003-1680-6757	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050038] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI050038] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aboud FE, 2012, SOC SCI MED, V75, P589, DOI 10.1016/j.socscimed.2012.04.009; Bharti N, 2010, EPIDEMIOL INFECT, V138, P1308, DOI 10.1017/S0950268809991385; Cohen S, 2004, PSYCHOSOM MED, V66, P553, DOI 10.1097/01.psy.0000126200.05189.d3; Dowd JB, 2009, EPIDEMIOLOGY, V20, P902, DOI 10.1097/EDE.0b013e3181bb5302; Eccles M, 2005, J CLIN EPIDEMIOL, V58, P107, DOI 10.1016/j.jclinepi.2004.09.002; Frost LJ, 2008, ACCESS DO GOOD HLTH; Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837; Kapan DD, 2006, ECOHEALTH, V3, P187, DOI 10.1007/s10393-006-0044-6; Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; LEVINE MM, 1994, P NATL ACAD SCI USA, V91, P2390, DOI 10.1073/pnas.91.7.2390; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Phillipson J, 2009, J APPL ECOL, V46, P261, DOI 10.1111/j.1365-2664.2009.01625.x; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Quine CP, 2011, PHILOS T R SOC B, V366, P2010, DOI 10.1098/rstb.2010.0397; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Trostle JA, 2008, EPIDEMIOLOGY, V19, P384, DOI 10.1097/EDE.0b013e31816a9db0; Woolhouse M, 2011, PHILOS T R SOC B, V366, P2045, DOI 10.1098/rstb.2010.0387	19	56	56	2	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2012	380	9857					1884	1886		10.1016/S0140-6736(12)61725-5	http://dx.doi.org/10.1016/S0140-6736(12)61725-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	046IK	23200487				2022-12-24	WOS:000311758500005
J	Vertefeuille, JF; Dowell, SF; Domercant, JW; Tappero, JW				Vertefeuille, John F.; Dowell, Scott F.; Domercant, Jean W.; Tappero, Jordan W.			Cautious optimism on public health in post-earthquake Haiti	LANCET			English	Editorial Material									[Vertefeuille, John F.; Domercant, Jean W.] US Ctr Dis Control & Prevent, Haiti Off, Tabarre, Port Au Prince, Haiti; [Vertefeuille, John F.; Dowell, Scott F.; Tappero, Jordan W.] US Ctr Dis Control & Prevent, Div Global Dis Detect & Emergency Response, Ctr Global Hlth, Atlanta, GA 30329 USA; [Domercant, Jean W.] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Vertefeuille, JF (corresponding author), US Ctr Dis Control & Prevent, Haiti Off, Tabarre, Port Au Prince, Haiti.	dki4@cdc.gov						Barzilay EJ, 2013, N ENGL J MED; De Rochars MVEB, 2004, AM J TROP MED HYG, V71, P598, DOI 10.4269/ajtmh.2004.71.598; Government of the Republic of Haiti, 2010, ACT PLAN NAT REC DEV; MESI: monitoring evaluation and surveillance interface, MESI MON EV SURV INT; Pan American Health Organization. Technical Advisory Group on Vaccine Preventable Diseases, 2012, 20 M TETCHN ADV GROU; Periago MR, 2012, LANCET, V379, pE12, DOI 10.1016/S0140-6736(12)60031-2; Rainey JJ, 2012, VACCINE, V30, P1746, DOI 10.1016/j.vaccine.2011.12.015; Republique D'Haiti Ministere de la Sante Publique et de la Population, 2012, DECLARATION ENGAGEME; UN Joint Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; United Nations Office of the Haiti Special Envoy, 2012, MON RAIS DISP SUPP O; WHO UNICEF, 2010, PROGR SAN DRINK WAT; World Health Organization, NEGL TROP DIS PCT DA	12	11	11	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 16	2013	381	9866					517	519		10.1016/S0140-6736(13)60051-3	http://dx.doi.org/10.1016/S0140-6736(13)60051-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089RK	23332167				2022-12-24	WOS:000314927500009
J	McCarthy, D; Johnson, MB; Audet, AM				McCarthy, Douglas; Johnson, Marian Bihrle; Audet, Anne-Marie			Recasting Readmissions by Placing the Hospital Role in Community Context	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; BUSINESS; QUALITY		[McCarthy, Douglas; Johnson, Marian Bihrle] Inst Healthcare Improvement, Cambridge, MA 02138 USA; [Audet, Anne-Marie] Commonwealth Fund, New York, NY USA	Institute for Healthcare Improvement; Commonwealth Fund	McCarthy, D (corresponding author), Inst Healthcare Improvement, 20 Univ Rd,7th Floor, Cambridge, MA 02138 USA.	dmccarthy@ihi.org	McCarthy, Douglas/GSJ-0784-2022	McCarthy, Douglas/0000-0002-3295-3522				Asch DA, 2012, NEW ENGL J MED, V367, P888, DOI 10.1056/NEJMp1206862; Boutwell AE, 2011, HEALTH AFFAIR, V30, P1272, DOI 10.1377/hlthaff.2011.0111; Engelberg Center for Health Care Reform at Brookings, IMPR CAR TRANS CAS S; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Johnson MB, VISITING NURSE SERVI; Kangovi S, 2011, JAMA-J AM MED ASSOC, V306, P1796, DOI 10.1001/jama.2011.1562; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; McCarthy D, U CALIFORNIA SAN FRA; Rutherford P, GUIDE IMPROVING TRAN; Siu AL, 2009, HEALTH AFFAIR, V28, P113, DOI 10.1377/hlthaff.28.1.113	10	43	43	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					351	352		10.1001/jama.2013.1	http://dx.doi.org/10.1001/jama.2013.1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	074FT	23340635				2022-12-24	WOS:000313799000021
J	Allen, VG; Mitterni, L; Seah, C; Rebbapragada, A; Martin, IE; Lee, C; Siebert, H; Towns, L; Melano, RG; Low, DE				Allen, Vanessa G.; Mitterni, Leo; Seah, Christine; Rebbapragada, Anuradha; Martin, Irene E.; Lee, Colin; Siebert, Heather; Towns, Lynn; Melano, Roberto G.; Low, Donald E.			Neisseria gonorrhoeae Treatment Failure and Susceptibility to Cefixime in Toronto, Canada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PENICILLIN-BINDING PROTEIN-2; DISEASES-TREATMENT-GUIDELINES; REDUCED SUSCEPTIBILITY; DECREASED SUSCEPTIBILITY; CEFTRIAXONE; MUTATIONS; PENA; TIME; RESISTANCE; EMERGENCE	Importance Although cephalosporins are the cornerstone of treatment of Neisseria gonorrhoeae infections, cefixime is the only oral antimicrobial option. Increased minimum inhibitory concentrations (MICs) to cefixime have been identified worldwide and have been associated with reports of clinical failure. Objective To assess the risk of clinical treatment failure of N gonorrhoeae infections associated with the use of cefixime. Design, Setting, and Population A retrospective cohort study of culture-positive N gonorrhoeae infections at a single sexual health clinic in Toronto, Canada, that routinely performs test of cure. The cohort comprised N gonorrhoeae culture-positive individuals identified between May 1, 2010, and April 30, 2011, treated with cefixime as recommended by Public Health Agency of Canada guidelines. Main Outcome Measures Cefixime treatment failure, defined as the repeat isolation of N gonorrhoeae at the test-of-cure visit identical to the pretreatment isolate by molecular typing and explicit denial of reexposure. Results There were 291 N gonorrhoeae culture-positive individuals identified. Of 133 who returned for test of cure, 13 were culture positive; 9 patients were determined to have experienced cefixime treatment failure, involving urethral (n=4), pharyngeal (n=2), and rectal (n=3) sites. The overall rate of clinical treatment failure among those who had a test of cure was 6.77% (95% CI, 3.14%-12.45%; 9/133). The rate of clinical failure associated with a cefixime MIC of 0.12 mu g/mL or greater was 25.0% (95% CI, 10.69%-44.87%; 7/28) compared with 1.90% (95% CI, 0.23%-6.71%; 2/105) of infections with cefixime MICs less than 0.12 mu g/mL, with a relative risk of 13.13 (95% CI, 2.88-59.72; P < .001). Conclusion and Relevance The rate of clinical failure following treatment of N gonorrhoeae infections with cefixime was relatively high at a Toronto clinic and was associated with elevated MICs. JAMA. 2013; 309(2):163-170	[Allen, Vanessa G.; Seah, Christine; Rebbapragada, Anuradha; Lee, Colin; Siebert, Heather; Towns, Lynn; Melano, Roberto G.] Publ Hlth Ontario, Toronto, ON, Canada; [Allen, Vanessa G.; Rebbapragada, Anuradha; Melano, Roberto G.; Low, Donald E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Lee, Colin] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Mitterni, Leo] Hassle Free Clin, Toronto, ON, Canada; [Martin, Irene E.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Low, Donald E.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; Public Health Agency of Canada; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Allen, VG (corresponding author), Publ Hlth Ontario Labs, 81 Resources Rd, Toronto, ON M9P 3T1, Canada.	vanessa.allen@oahpp.ca	Allen, Vanessa/AAE-2756-2022	Allen, Vanessa/0000-0001-9802-9730				Akasaka S, 2001, J Infect Chemother, V7, P49, DOI 10.1007/s101560170034; Allen VG, 2011, ANTIMICROB AGENTS CH, V55, P703, DOI 10.1128/AAC.00788-10; Ameyama S, 2002, ANTIMICROB AGENTS CH, V46, P3744, DOI 10.1128/AAC.46.12.3744-3749.2002; [Anonymous], SEX TRANSM DIS FIG H; [Anonymous], VOL TYP LAB TEST MET; Bignell C, 2011, INT J STD AIDS, V22, P541, DOI 10.1258/ijsa.2011.011267; Bolan GA, 2012, NEW ENGL J MED, V366, P485, DOI 10.1056/NEJMp1112456; Camara J, 2012, J ANTIMICROB CHEMOTH, V67, P1858, DOI 10.1093/jac/dks162; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P873; Chisholm SA, 2011, J ANTIMICROB CHEMOTH, V66, P2509, DOI 10.1093/jac/dkr332; Chisholm SA, 2010, J ANTIMICROB CHEMOTH, V65, P2141, DOI 10.1093/jac/dkq289; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Deguchi Takashi, 2003, Journal of Infection and Chemotherapy, V9, P35, DOI 10.1007/s10156-002-0204-8; del Rio Carlos, 2012, Morbidity and Mortality Weekly Report, V61, P590; *EUR COMM ANT SUSC, BREAKP TABL INT MICS; Forsyth S, 2011, INT J STD AIDS, V22, P296, DOI 10.1258/ijsa.2009.009191; HANDSFIELD HH, 1992, CLIN INFECT DIS, V15, pS123, DOI 10.1093/clind/15.Supplement_1.S123; Ison CA, 2011, EURO SURVEILL, V16; Kelsey JL., 1996, METHODS OBSERVATIONA; Lee SG, 2010, J ANTIMICROB CHEMOTH, V65, P669, DOI 10.1093/jac/dkp505; Lewis DA, 2010, SEX TRANSM INFECT, V86, P415, DOI 10.1136/sti.2010.042648; Liao MM, 2011, J ANTIMICROB CHEMOTH, V66, P1016, DOI 10.1093/jac/dkr021; Martin IMC, 2004, J INFECT DIS, V189, P1497, DOI 10.1086/383047; Martin I, 2012, SEX TRANSM DIS, V39, P316, DOI 10.1097/OLQ.0b013e3182401b69; Muratani T, 2001, ANTIMICROB AGENTS CH, V45, P3603, DOI 10.1128/AAC.45.12.3603-3606.2001; Olesky M, 2006, J BACTERIOL, V188, P2300, DOI 10.1128/JB.188.7.2300-2308.2006; Osaka Kazuyoshi, 2008, Journal of Infection and Chemotherapy, V14, P195, DOI 10.1007/s10156-008-0610-7; PLOURDE PJ, 1992, J INFECT DIS, V166, P919, DOI 10.1093/infdis/166.4.919; Public Health Agency of Canada, IMP NOT PUBL HLTH IN; Public Health Agency of Canada, CAN GUID SEX TRANSM; Sathia L, 2007, INT J STD AIDS, V18, P647, DOI 10.1258/095646207781568556; Takahata S, 2006, ANTIMICROB AGENTS CH, V50, P3638, DOI 10.1128/AAC.00626-06; Tapsall J, ANTIMICROBIAL RESIST; Unemo M, 2010, EURO SURVEILL, V15; Unemo M, 2011, EURO SURVEILL, V16; Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P1273, DOI 10.1128/AAC.05760-11; Whiley DM, 2010, J ANTIMICROB CHEMOTH, V65, P2543, DOI 10.1093/jac/dkq377; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; World Health Organization, GLOB ACT PLAN CONTR; Yokoi S, 2007, EMERG INFECT DIS, V13, P1275; Zhao SQ, 2009, ANTIMICROB AGENTS CH, V53, P3744, DOI 10.1128/AAC.00304-09	41	149	152	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2013	309	2					163	170		10.1001/jama.2012.176575	http://dx.doi.org/10.1001/jama.2012.176575			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070NW	23299608	Bronze			2022-12-24	WOS:000313517000025
J	Al-Khatib, SM; Hellkamp, A; Bardy, GH; Hammill, S; Hall, WJ; Mark, DB; Anstrom, KJ; Curtis, J; Al-Khalidi, H; Curtis, LH; Heidenreich, P; Peterson, ED; Sanders, G; Clapp-Channing, N; Lee, KL; Moss, AJ				Al-Khatib, Sana M.; Hellkamp, Anne; Bardy, Gust H.; Hammill, Stephen; Hall, W. Jackson; Mark, Daniel B.; Anstrom, Kevin J.; Curtis, Jeptha; Al-Khalidi, Hussein; Curtis, Lesley H.; Heidenreich, Paul; Peterson, Eric D.; Sanders, Gillian; Clapp-Channing, Nancy; Lee, Kerry L.; Moss, Arthur J.			Survival of Patients Receiving a Primary Prevention Implantable Cardioverter-Defibrillator in Clinical Practice vs Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICARE BENEFICIARIES; HEART-FAILURE; GENERALIZABILITY; OUTCOMES; REGISTRY; DISEASE	Importance Randomized clinical trials have shown that implantable cardioverter-defibrillator (ICD) therapy saves lives. Whether the survival of patients who received an ICD in primary prevention clinical trials differs from that of trial-eligible patients receiving a primary prevention ICD in clinical practice is unknown. Objective To determine whether trial-eligible patients who received a primary prevention ICD as documented in a large national registry have a survival rate that differs from the survival rate of similar patients who received an ICD in the 2 largest primary prevention clinical trials, MADIT-II (n = 742) and SCD-HeFT (n = 829). Design, Setting, and Patients Retrospective analysis of data for patients enrolled in the National Cardiovascular Data Registry ICD Registry between January 1, 2006, and December 31, 2007, meeting the MADIT-II criteria (2464 propensity score-matched patients) or the SCD-HeFT criteria (3352 propensity score-matched patients). Mortality data for the registry patients were collected through December 31, 2009. Main Outcome Measures Cox proportional hazards models were used to compare mortality from any cause. Results The median follow-up time in MADIT-II, SCD-HeFT, and the ICD Registry was 19.5, 46.1, and 35.2 months, respectively. Compared with patients enrolled in the clinical trials, patients in the ICD Registry were significantly older and had a higher burden of comorbidities. In the matched cohorts, there was no significant difference in survival between MADIT-II-like patients in the registry and MADIT-II patients randomized to receive an ICD (2-year mortality rates: 13.9% and 15.6%, respectively; adjusted ICD Registry vs trial hazard ratio, 1.06; 95% CI, 0.85-1.31; P = .62). Likewise, the survival among SCD-HeFT-like patients in the registry was not significantly different from survival among patients randomized to receive ICD therapy in SCD-HeFT (3-year mortality rates: 17.3% and 17.4%, respectively; adjusted registry vs trial hazard ratio, 1.16; 95% CI, 0.97-1.38; P = .11). Conclusions and Relevance There was no significant difference in survival between clinical trial patients randomized to receive an ICD and a similar group of clinical registry patients who received a primary prevention ICD. Our findings support the continued use of primary prevention ICDs in similar patients seen in clinical practice.	[Al-Khatib, Sana M.; Hellkamp, Anne; Mark, Daniel B.; Anstrom, Kevin J.; Al-Khalidi, Hussein; Curtis, Lesley H.; Peterson, Eric D.; Sanders, Gillian; Clapp-Channing, Nancy; Lee, Kerry L.] Duke Clin Res Inst, Durham, NC 27715 USA; [Curtis, Lesley H.] Duke Univ, Med Ctr, Dept Med, Ctr Clin & Genet Econ, Durham, NC 27710 USA; [Al-Khatib, Sana M.; Mark, Daniel B.; Peterson, Eric D.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Curtis, Lesley H.] Duke Univ, Med Ctr, Dept Med, Div Gen Internal Med, Durham, NC 27710 USA; [Bardy, Gust H.] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Hammill, Stephen] Mayo Clin, Rochester, MN USA; [Hall, W. Jackson; Moss, Arthur J.] Univ Rochester, Rochester, NY USA; [Curtis, Jeptha] Yale Univ, Sch Med, West Haven, CT 06516 USA; [Heidenreich, Paul] Stanford Univ, Palo Alto Vet Hlth Care Syst, Palo Alto, CA 94304 USA	Duke University; Duke University; Duke University; Duke University; University of Washington; University of Washington Seattle; Mayo Clinic; University of Rochester; Yale University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Al-Khatib, SM (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	alkha001@mc.duke.edu	Heidenreich, Paul/AAU-6864-2021; Peterson, Eric David/ABF-5033-2021	Heidenreich, Paul/0000-0001-7730-8490; Mark, Daniel/0000-0001-6340-8087	Cameron Health; Eli Lilly; Medtronic; AstraZeneca; Gilead Sciences; American College of Cardiology Foundation; Center for Medicare & Medicaid Services; National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI); Johnson Johnson; GlaxoSmithKline; Agency for Healthcare Research and Quality; NHLBI; Boston Scientific; St Jude; Biotronic; National Heart, Lung, and Blood Institute [1R01-HL093071-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093071] Funding Source: NIH RePORTER	Cameron Health; Eli Lilly(Eli Lilly); Medtronic(Medtronic); AstraZeneca(AstraZeneca); Gilead Sciences(Gilead Sciences); American College of Cardiology Foundation(General Electric); Center for Medicare & Medicaid Services; National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); GlaxoSmithKline(GlaxoSmithKline); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston Scientific(Boston Scientific); St Jude(St. Jude Medical); Biotronic; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bardy reported consulting fees, equity, and intellectual property rights in Cameron Health. Dr Mark reported receiving research grants from Eli Lilly, Medtronic, AstraZeneca, and Gilead Sciences. Dr Anstrom reported receiving research support from AstraZeneca, Eli Lilly, and Medtronic; having served as a consultant for Abbott Vascular, AstraZeneca, Bristol Meyer Squibb, and Ikaria; and having served on data monitoring committees for Pfizer and Vertex. Dr J. Curtis reported owning stock in Medtronic and receiving salary support from the American College of Cardiology Foundation, Center for Medicare & Medicaid Services, and National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI). Dr L. Curtis reported receiving research and salary support from Johnson & Johnson, GlaxoSmithKline, Agency for Healthcare Research and Quality, and NHLBI. Dr Curtis has made available online a detailed listing of financial disclosures (http://www.dcri.duke.edu/research/coi.jsp). Dr Heidenreich reported receiving research support from Medtronic. Dr Lee reported receiving modest consulting fees from Medtronic. Dr Moss reported receiving research grants from Boston Scientific and salary support from Boston Scientific, Medtronic, St Jude, and Biotronic. No other disclosures were reported.; This analysis was funded by a grant (1R01-HL093071-01A1) from the National Heart, Lung, and Blood Institute.	Al-Khatib SM, 2005, J AM COLL CARDIOL, V46, P1536, DOI 10.1016/j.jacc.2005.04.063; Al-Khatib SM, 2012, HEART RHYTHM S, V9, pS381; Badano Luigi P, 2003, Ital Heart J, V4, P84; Bahit MC, 2003, AM HEART J, V145, P109, DOI 10.1067/mhj.2003.43; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Cardinal H, 2004, CAN J CARDIOL, V20, P417; Hammill SC, 2009, HEART RHYTHM, V6, P1397, DOI 10.1016/j.hrthm.2009.07.015; Hernandez AF, 2010, CIRC-HEART FAIL, V3, P7, DOI 10.1161/CIRCHEARTFAILURE.109.884395; Hordijk-Trion M, 2006, EUR HEART J, V27, P671, DOI 10.1093/eurheartj/ehi731; Keitner GI, 2003, J CLIN PSYCHIAT, V64, P1091, DOI 10.4088/JCP.v64n0915; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Pedone C, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-24; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Walsh CR, 2000, AM J CARDIOL, V86, P908, DOI 10.1016/S0002-9149(00)01120-6	16	70	71	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2013	309	1					55	62		10.1001/jama.2012.157182	http://dx.doi.org/10.1001/jama.2012.157182			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TB	23280225	Green Accepted			2022-12-24	WOS:000319113000027
J	Hastings, G; de Andrade, M; Moodie, C				Hastings, Gerard; de Andrade, Marisa; Moodie, Crawford			Tobacco harm reduction: the devil is in the deployment	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hastings, Gerard; de Andrade, Marisa; Moodie, Crawford] Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland	University of Stirling	Hastings, G (corresponding author), Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland.	gerard.hastings@stir.ac.uk		Moodie, Crawford/0000-0002-1805-2509	Cancer Research UK [15192] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		[Anonymous], 2012, PRESCR COST AN ENGL; [Anonymous], 2009, NRT SMOK CESS AIDS U; British American Tobacco, 2011, SUST REP 2011; British American Tobacco, 2011, SUST REP 2011 HARM R; Buck D., 2012, IMPLICATIONS POLICY; Committee on Safety of Medicines, REP WORK GROUP NIC R; Davis RM, 2009, NCI TOBACCO CONTROL; Euromonitor, 2009, TOB UK COUNTR MARK I; Medsafe (Regulatory Information), GUID COD CAT EL CIG; MHRA, DRUG SAF UPD NIC REP; MHRA (Medicines Healthcare products Regulatory Agency), 2009, PUBL ASS REP US NIC; National Institute for Health and Clinical Excellence, 2012, TOB HARM RED APPR SM; Nicoventures, 2012, WHAT IS NIC; O'Reilly D, 2009, TOBACCO HARM REDUCTI; Oxfam, POL PRACT MUGG POV Y; Yeaman A, 1963, IMPLICATIONS BATTELL	16	13	13	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e8412	10.1136/bmj.e8412	http://dx.doi.org/10.1136/bmj.e8412			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IU	23248081	Green Submitted			2022-12-24	WOS:000312698700016
J	Prockop, DJ				Prockop, Darwin J.			New Targets for Osteoporosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MESENCHYMAL STEM-CELLS		Scott & White Mem Hosp & Clin, Texas A&M Hlth Sci Ctr, Coll Med, Inst Regenerat Med, Temple, TX USA	Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Prockop, DJ (corresponding author), Scott & White Mem Hosp & Clin, Texas A&M Hlth Sci Ctr, Coll Med, Inst Regenerat Med, Temple, TX USA.							Efimenko A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-10; Fuchs S, 2012, VITAM HORM, V88, P491, DOI 10.1016/B978-0-12-394622-5.00022-5; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Liu YQ, 2012, J CLIN INVEST, V122, P3101, DOI 10.1172/JCI61209; Wilson A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-229	5	4	5	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2353	2354		10.1056/NEJMcibr1210178	http://dx.doi.org/10.1056/NEJMcibr1210178			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HF	23234518				2022-12-24	WOS:000312187700013
J	Borne, RT; Krantz, MJ				Borne, Ryan T.; Krantz, Mori J.			Lixivaptan for Hyponatremia-The Numbers Game	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TOLVAPTAN		[Borne, Ryan T.; Krantz, Mori J.] Denver Hlth Hosp & Author, Dept Internal Med, Denver, CO USA; [Krantz, Mori J.] Div Cardiol, Denver, CO USA	Denver Health Medical Center	Borne, RT (corresponding author), Denver Hlth Med Ctr, 660 Bannock St,MC 4000, Denver, CO 80204 USA.	ryan.borne@dhha.org						FDA, CARD REN DRUGS ADV C; FDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; Wald R, 2010, ARCH INTERN MED, V170, P294, DOI 10.1001/archinternmed.2009.513	6	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2012	308	22					2345	2346		10.1001/jama.2012.54515	http://dx.doi.org/10.1001/jama.2012.54515			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051MW	23232892				2022-12-24	WOS:000312132400023
J	Klose, CSN; Kiss, EA; Schwierzeck, V; Ebert, K; Hoyler, T; d'Hargues, Y; Goppert, N; Croxford, AL; Waisman, A; Tanriver, Y; Diefenbach, A				Klose, Christoph S. N.; Kiss, Elina A.; Schwierzeck, Vera; Ebert, Karolina; Hoyler, Thomas; d'Hargues, Yannick; Goeppert, Nathalie; Croxford, Andrew L.; Waisman, Ari; Tanriver, Yakup; Diefenbach, Andreas			A T-bet gradient controls the fate and function of CCR6(-)ROR gamma t(+) innate lymphoid cells	NATURE			English	Article							ROR-GAMMA-T; NKP46(+) CELLS; IFN-GAMMA; EXPRESSION; DIFFERENTIATION; DEFENSE; HOST	At mucosal surfaces, the immune system should not initiate inflammatory immune responses to the plethora of antigens constantly present in the environment, but should remain poised to unleash a potent assault on intestinal pathogens.. The transcriptional programs and regulatory factors required for immune cells to switch from homeostatic (often tissue-protective) function(1) to potent antimicrobial immunity are poorly defined. Mucosal retinoic-acidreceptor-related orphan receptor-gamma t-positive (ROR gamma t(+)) innate lymphoid cells (ILCs) are emerging as an important innate lymphocyte population required for immunity to intestinal infections(2). Various subsets of ROR gamma t(+) ILCs have been described(3-8) but the transcriptional programs controlling their specification and fate remain largely unknown. Here we provide evidence that the transcription factor T-bet determines the fate of a distinct lineage of CCR6(-)ROR gamma t(+) ILCs. Postnatally emerging CCR6(-)ROR gamma t(+) ILCs upregulated T-bet and this was controlled by cues from the commensal microbiota and interleukin-23 (IL-23). In contrast, CCR6(+)ROR gamma t(+) ILCs, which arise earlier during ontogeny, did not express T-bet. T-bet instructed the expression of T-bet target genes such as interferon-gamma (IFN-gamma) and of the natural cytotoxicity receptor NKp46. Mice genetically lacking T-bet showed normal development of CCR6(-)ROR gamma t(+) ILCs, but they could not differentiate into NKp46-expressing ROR gamma t(+) ILCs (that is, IL-22-producing natural killer (NK-22) cells)(3,9) and failed to produce IFN-gamma. The production of IFN-gamma by T-bet-expressing CCR6(-)ROR gamma t(+) ILCs was essential for the release of mucus-forming glycoproteins required to protect the epithelial barrier during Salmonella enterica infection(10,11). Salmonella infection also causes severe enterocolitis that is at least partly driven by IFN-gamma(12). Mice deficient for T-bet or depleted of ILCs developed only mild enterocolitis. Thus, graded expression of T-bet in CCR6(-)ROR gamma t(+) MCs facilitates the differentiation of IFN-gamma-producing CCR6(-)ROR gamma t(+) ILCs required to protect the epithelial barrier against Salmonella infections. Co-expression of T-bet and ROR gamma t, which is also found in subsets of IL-17-producing T-helper (T(H)17) cells(13), may be an evolutionarily conserved transcriptional program that originally developed as part of the innate defence against infections but that also confers an increased risk of immune-mediated pathology.	[Klose, Christoph S. N.; Kiss, Elina A.; Schwierzeck, Vera; Ebert, Karolina; Hoyler, Thomas; d'Hargues, Yannick; Goeppert, Nathalie; Tanriver, Yakup; Diefenbach, Andreas] Univ Freiburg, IMMH, D-79104 Freiburg, Germany; [Schwierzeck, Vera; Tanriver, Yakup; Diefenbach, Andreas] Univ Med Ctr Freiburg, CCI, D-79106 Freiburg, Germany; [Schwierzeck, Vera; Tanriver, Yakup; Diefenbach, Andreas] Univ Freiburg, D-79106 Freiburg, Germany; [Ebert, Karolina; d'Hargues, Yannick; Tanriver, Yakup] Univ Freiburg, Med Ctr, Div Renal, D-79106 Freiburg, Germany; [Croxford, Andrew L.; Waisman, Ari] Johannes Gutenberg Univ Mainz, Inst Mol Med, D-55131 Mainz, Germany; [Croxford, Andrew L.] Univ Zurich, Inst Expt Immunol, CH-8006 Zurich, Switzerland; [Diefenbach, Andreas] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Johannes Gutenberg University of Mainz; University of Zurich; University of Freiburg	Diefenbach, A (corresponding author), Univ Freiburg, IMMH, Hermann Herder Str 11, D-79104 Freiburg, Germany.	andreas.diefenbach@uniklinik-freiburg.de	Waisman, Ari/C-7383-2015; Diefenbach, Andreas/T-2589-2018; Schwierzeck, Vera/AAL-3028-2020; Tanriver, Yakup/AAU-7064-2020; Klose, Christoph/ABE-6396-2020	Waisman, Ari/0000-0003-4304-8234; Diefenbach, Andreas/0000-0002-9176-9530; Schwierzeck, Vera/0000-0003-4254-3700; Tanriver, Yakup/0000-0002-4806-2548	Deutsche Forschungsgemeinschaft [SFB620/A14, TA436/2-1]; German Federal Ministry of Education and Research [BMBF 01 EO 0803]; EFSD/Lilly grant; European Research Council; CCI Walter-Hitzig-Fellowship; EMBO Long Term Fellowship [ALTF 508-2011]; FP6 Marie Curie Research Train in Network [MRTN-CT-2004-005632]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); EFSD/Lilly grant; European Research Council(European Research Council (ERC)European Commission); CCI Walter-Hitzig-Fellowship; EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); FP6 Marie Curie Research Train in Network	We thank G. Hacker for support, the members of the Diefenbach laboratory for valuable discussions, and C. A. Connor for comments on the manuscript We are grateful to M. Folio, K. Geiger and J. Bodinek-Wersing for cell sorting. The work was supported by the Deutsche Forschungsgemeinschaft (SFB620/A14 to AD. and TA436/2-1 to Y.T.), the German Federal Ministry of Education and Research (BMBF 01 EO 0803 to A.D. and Y.T.), an EFSD/Lilly grant (to Y.T.), a European Research Council Grant (to AD.), a CCI Walter-Hitzig-Fellowship (to VS.), an EMBO Long Term Fellowship (ALTF 508-2011 to A.L.C.) and the FP6 Marie Curie Research Train in Network (grant MRTN-CT-2004-005632 (IMDEMI) to A.W.).	Awoniyi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037311; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bernink J., NATURE IMMU IN PRESS; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2012, CURR OPIN IMMUNOL, V24, P290, DOI 10.1016/j.coi.2012.04.004; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Oestreich KJ, 2012, CURR OPIN IMMUNOL, V24, P191, DOI 10.1016/j.coi.2011.12.004; Rhee SJ, 2005, J IMMUNOL, V175, P1127, DOI 10.4049/jimmunol.175.2.1127; Sanos SL, 2011, IMMUNOLOGY, V132, P453, DOI 10.1111/j.1365-2567.2011.03410.x; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Songhet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022459; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	31	493	508	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					261	265		10.1038/nature11813	http://dx.doi.org/10.1038/nature11813			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23334414				2022-12-24	WOS:000315137700045
J	Ma, L; Tao, YZ; Duran, A; Llado, V; Galvez, A; Barger, JF; Castilla, EA; Chen, J; Yajima, T; Porollo, A; Medvedovic, M; Brill, LM; Plas, DR; Riedl, SJ; Leitges, M; Diaz-Meco, MT; Richardson, AD; Moscat, J				Ma, Li; Tao, Yongzhen; Duran, Angeles; Llado, Victoria; Galvez, Anita; Barger, Jennifer F.; Castilla, Elias A.; Chen, Jing; Yajima, Tomoko; Porollo, Aleksey; Medvedovic, Mario; Brill, Laurence M.; Plas, David R.; Riedl, Stefan J.; Leitges, Michael; Diaz-Meco, Maria T.; Richardson, Adam D.; Moscat, Jorge			Control of Nutrient Stress-Induced Metabolic Reprogramming by PKC zeta in Tumorigenesis	CELL			English	Article							CANCER; PROTEIN; MOUSE; EXPRESSION; GLUTAMINE; PATHWAY	Tumor cells have high-energetic and anabolic needs and are known to adapt their metabolism to be able to survive and keep proliferating under conditions of nutrient stress. We show that PKC zeta deficiency promotes the plasticity necessary for cancer cells to reprogram their metabolism to utilize glutamine through the serine biosynthetic pathway in the absence of glucose. PKC zeta represses the expression of two key enzymes of the pathway, PHGDH and PSAT1, and phosphorylates PHGDH at key residues to inhibit its enzymatic activity. Interestingly, the loss of PKC zeta in mice results in enhanced intestinal tumorigenesis and increased levels of these two metabolic enzymes, whereas patients with low levels of PKC zeta have a poor prognosis. Furthermore, PKC zeta and caspase-3 activities are correlated with PHGDH levels in human intestinal tumors. Taken together, this demonstrates that PKC zeta is a critical metabolic tumor suppressor in mouse and human cancer.	[Ma, Li; Tao, Yongzhen; Duran, Angeles; Llado, Victoria; Yajima, Tomoko; Brill, Laurence M.; Riedl, Stefan J.; Diaz-Meco, Maria T.; Richardson, Adam D.; Moscat, Jorge] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Galvez, Anita; Barger, Jennifer F.; Castilla, Elias A.; Chen, Jing; Porollo, Aleksey; Medvedovic, Mario; Plas, David R.] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, N-0316 Oslo, Norway	Sanford Burnham Prebys Medical Discovery Institute; University System of Ohio; University of Cincinnati; University of Oslo	Moscat, J (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jmoscat@sanfordburnham.org	Leitges, Michael/AAN-1953-2021; Richardson, Adam D/N-7845-2014; Barger, Jennifer/N-1263-2015; Llado, Victoria/AAJ-8454-2020	Richardson, Adam D/0000-0003-3646-2584; Diaz-Meco, Maria/0000-0003-0147-0998; Porollo, Alexey/0000-0002-3202-5099; Chen, Jing/0000-0002-6227-7393; , Yongzhen/0000-0003-1710-5346; Leitges, Michael/0000-0003-4203-6995	NIH [R01CA132847, R01AI072581, R01DK088107, R01CA134530, R21CA147978]; CCSG Pilot Project Grant; NATIONAL CANCER INSTITUTE [R21CA147978, R01CA134530, R01CA132847] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCSG Pilot Project Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH Grants R01CA132847 (to J.M.), R01AI072581 (to J.M.), R01DK088107 (to J.M.), R01CA134530 (to M.T.D.-M.), R21CA147978 (to A.D.R.), and CCSG Pilot Project Grant (to J.M. and A.D.R.) funded this work. We thank Maryellen Daston for editing this manuscript, Diantha LaVine for the artwork, and the technical assistance of Tom Hudson, Jessica Leung, and Nahid Hamidy.	Baltgalvis KA, 2009, CANCER PREV RES, V2, P641, DOI 10.1158/1940-6207.CAPR-09-0017; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Fuchs BC, 2006, J SURG RES, V131, P26, DOI 10.1016/j.jss.2005.07.013; Galvez AS, 2009, MOL CELL BIOL, V29, P104, DOI 10.1128/MCB.01294-08; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Le QT, 2006, CLIN CANCER RES, V12, P1507, DOI 10.1158/1078-0432.CCR-05-2049; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Ma WW, 2009, J CLIN ONCOL, V27, P2697, DOI 10.1200/JCO.2008.18.8383; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Paoni NF, 2003, PHYSIOL GENOMICS, V15, P228, DOI 10.1152/physiolgenomics.00078.2003; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Swinson DEB, 2003, J CLIN ONCOL, V21, P473, DOI 10.1200/JCO.2003.11.132; Tabatabaie L, 2009, HUM MUTAT, V30, P749, DOI 10.1002/humu.20934	21	130	136	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					599	611		10.1016/j.cell.2012.12.028	http://dx.doi.org/10.1016/j.cell.2012.12.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374352	Bronze, Green Accepted			2022-12-24	WOS:000314362800027
J	Cowley, NJ; Owen, A; Bion, JF				Cowley, Nicholas J.; Owen, Andrew; Bion, Julian F.			Interpreting arterial blood gas results	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SEVERE SEPSIS; SEPTIC SHOCK		[Cowley, Nicholas J.; Owen, Andrew] Queen Elizabeth Hosp, Dept Anaesthesia & Crit Care, Birmingham B15 2WB, W Midlands, England; [Bion, Julian F.] Queen Elizabeth Hosp, Univ Dept Anaesthesia & Intens Care Med, Birmingham B15 2TH, W Midlands, England	University of Birmingham; University of Birmingham	Cowley, NJ (corresponding author), Queen Elizabeth Hosp, Dept Anaesthesia & Crit Care, Birmingham B15 2WB, W Midlands, England.	n.j.cowley@bham.ac.uk	Owen, Andrew/B-6302-2014	Owen, Andrew/0000-0002-3192-747X; Bion, Julian/0000-0003-0344-5403	National Institute for Health Research [ACF-2011-09-004] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Carraro P, 2007, CLIN CHEM, V53, P1338, DOI 10.1373/clinchem.2007.088344; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Gehring H, 2002, ACTA ANAESTH SCAND, V46, P980, DOI 10.1034/j.1399-6576.2002.460809.x; Kraut JA, 2007, CLIN J AM SOC NEPHRO, V2, P162, DOI 10.2215/CJN.03020906; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rhee AJ, 2010, CURR OPIN ANESTHESIO, V23, P741, DOI 10.1097/ACO.0b013e32834015bd; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Salvagno GL, 2012, CLIN BIOCHEM, V45, P372, DOI 10.1016/j.clinbiochem.2011.12.005; Schlebusch H, 2001, CLIN CHIM ACTA, V307, P107, DOI 10.1016/S0009-8981(01)00440-5; Shamir MY, 2012, ANESTH ANALG, V114, P972, DOI 10.1213/ANE.0b013e318233041a	10	15	16	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 16	2013	346								f16	10.1136/bmj.f16	http://dx.doi.org/10.1136/bmj.f16			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075FI	23325867				2022-12-24	WOS:000313868800003
J	Powell, T; Hanfling, D; Gostin, LO				Powell, Tia; Hanfling, Dan; Gostin, Lawrence O.			Emergency Preparedness and Public Health The Lessons of Hurricane Sandy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Powell, Tia] Albert Einstein Coll Med, Montefiore Einstein Ctr Bioeth, Bronx, NY 10467 USA; [Hanfling, Dan] Inova Hlth Syst, Falls Church, VA USA; [Hanfling, Dan] Georgetown Univ, Dept Emergency Med, Washington, DC 20001 USA; [Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Yeshiva University; Albert Einstein College of Medicine; Inova Health System; Georgetown University; Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Committee on Guidance for Establishing Crisis Standards of Care for Use in Disaster Situations; Institute of Medicine, 2012, CRIS STAND CAR SYST, DOI DOI 10.17226/13351; Hartocollis A, 2012, NY TIMES; Katz C, 2012, NYC             1027; Kolker Robert, 2021, NEW YORK TIMES MAGAZ; Ofri D, 2012, NEW ENGL J MED, V367, P2265, DOI 10.1056/NEJMp1213843; Shapiro J, BELLEVUE HOSP EVACUA	6	85	86	0	60	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2569	2570		10.1001/jama.2012.108940	http://dx.doi.org/10.1001/jama.2012.108940			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23281545				2022-12-24	WOS:000312916600019
J	Horowitz, HW				Horowitz, Harold W.			Fever of Unknown Origin or Fever of Too Many Origins?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, Sch Med, Div Infect Dis & Immunol, New York, NY USA	New York University	Horowitz, HW (corresponding author), NYU, Sch Med, Div Infect Dis & Immunol, New York, NY USA.							Bleeker-Rovers CP, 2007, MEDICINE, V86, P26, DOI 10.1097/md.0b013e31802fe858; Durack D T, 1991, Curr Clin Top Infect Dis, V11, P35; PETERSDORF R, 1961, MEDICINE, V40, P1, DOI 10.1097/00005792-196102000-00001; Vanderschueren S, 2003, ARCH INTERN MED, V163, P1033, DOI 10.1001/archinte.163.9.1033	4	61	70	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					197	199		10.1056/NEJMp1212725	http://dx.doi.org/10.1056/NEJMp1212725			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070YG	23323894				2022-12-24	WOS:000313549900001
J	Jin, MY; Liu, X; Klionsky, DJ				Jin, Meiyan; Liu, Xu; Klionsky, Daniel J.			SnapShot: Selective Autophagy	CELL			English	Editorial Material									[Jin, Meiyan] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jin, MY (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053396] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cebollero E., 2012, INT J CELL BIOL, V2012, P1, DOI DOI 10.1155/2012/182834; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Mijaljica D, 2012, AUTOPHAGY, V8, P1701, DOI 10.4161/auto.21332; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	10	70	74	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					368	U400		10.1016/j.cell.2013.01.004	http://dx.doi.org/10.1016/j.cell.2013.01.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332767	Bronze, Green Accepted			2022-12-24	WOS:000313719800033
J	Lapi, F; Azoulay, L; Yin, H; Nessim, SJ; Suissa, S				Lapi, Francesco; Azoulay, Laurent; Yin, Hui; Nessim, Sharon J.; Suissa, Samy			Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE-RENAL-FAILURE; PRACTICE RESEARCH DATABASE; EUROPEAN-SOCIETY; EPIDEMIOLOGY; VALIDITY; COMBINATIONS; PRESCRIPTION; DISEASE; DEATH; BIAS	Objectives To assess whether a double therapy combination consisting of diuretics, angiotensin converting enzyme inhibitors, or angiotensin receptor blockers with addition of non-steroidal anti-inflammatory drugs (NSAIDs) and the triple therapy combination of two of the aforementioned antihypertensive drugs to which NSAIDs are added are associated with an increased risk of acute kidney injury. Design Retrospective cohort study using nested case-control analysis. Setting General practices contributing data to the UK Clinical Practice Research Datalink linked to the Hospital Episodes Statistics database. Participants A cohort of 487 372 users of antihypertensive drugs. Main outcome measures Rate ratios with 95% confidence intervals of acute kidney injury associated with current use of double and triple therapy combinations of antihypertensive drugs with NSAIDs. Results During a mean follow-up of 5.9 (SD 3.4) years, 2215 cases of acute kidney injury were identified (incidence rate 7/10 000 person years). Overall, current use of a double therapy combination containing either diuretics or angiotensin converting enzyme inhibitors or angiotensin receptor blockers with NSAIDs was not associated with an increased rate of acute kidney injury. In contrast, current use of a triple therapy combination was associated with an increased rate of acute kidney injury (rate ratio 1.31, 95% confidence interval 1.12 to 1.53). In secondary analyses, the highest risk was observed in the first 30 days of use (rate ratio 1.82, 1.35 to 2.46). Conclusions A triple therapy combination consisting of diuretics with angiotensin converting enzyme inhibitors or angiotensin receptor blockers and NSAIDs was associated with an increased risk of acute kidney injury. The risk was greatest at the start of treatment. Although antihypertensive drugs have cardiovascular benefits, vigilance may be warranted when they are used concurrently with NSAIDs.	[Lapi, Francesco; Azoulay, Laurent; Yin, Hui; Suissa, Samy] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada; [Lapi, Francesco; Suissa, Samy] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; [Lapi, Francesco] Univ Florence, Dept Preclin & Clin Pharmacol, I-50139 Florence, Italy; [Azoulay, Laurent] McGill Univ, Dept Oncol, Montreal, PQ H3G 1A4, Canada; [Nessim, Sharon J.] McGill Univ, Jewish Gen Hosp, Div Nephrol, Dept Med, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University; University of Florence; McGill University; McGill University	Suissa, S (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, 3755 Cote St Catherine, Montreal, PQ H3T 1E2, Canada.	samy.suissa@mcgill.ca	Azoulay, Laurent/Z-4421-2019		Drug Safety and Effectiveness Network (DSEN); Canadian Institute of Health Research (CIHR); Canada Foundation for Innovation	Drug Safety and Effectiveness Network (DSEN); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This study was funded in part by infrastructure grants from the Drug Safety and Effectiveness Network (DSEN), the Canadian Institute of Health Research (CIHR), and the Canada Foundation for Innovation. The funding sources had no role in the design, analysis, or interpretation of the results, and thus the authors were independent from the funding sources. FL is the recipient of an LDI post-doctoral research award, LA is the recipient of a Chercheur-Boursier career award from the Fonds de recherche en sante du Quebec, and SS is the recipient of the James McGill chair award.	Adhiyaman V, 2001, J ROY SOC MED, V94, P512, DOI 10.1177/014107680109401005; Baraldi A, 1998, NEPHROL DIAL TRANSPL, V13, P25, DOI 10.1093/ndt/13.suppl_7.25; Breslow NE, 1996, J AM STAT ASSOC, V91, P14, DOI 10.2307/2291379; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Feenstra H, 2001, ANN INTERN MED, V134, P569, DOI 10.7326/0003-4819-134-7-200104030-00010; Girman CJ, 2012, DIABETIC MED, V29, P614, DOI 10.1111/j.1464-5491.2011.03498.x; Gislason GH, 2007, CIRCULATION, V116, P737, DOI 10.1161/CIRCULATIONAHA.106.669101; Greger R, 2000, AM J MED SCI, V319, P51, DOI 10.1097/00000441-200001000-00005; Han L, 2012, ANN EPIDEMIOL, V22, P9, DOI 10.1016/j.annepidem.2011.10.004; Hernandez-Diaz S, 2001, AM J MED S1, V110, P20, DOI DOI 10.1016/S0002-9343(00)00682-3; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Huerta C, 2005, AM J KIDNEY DIS, V45, P531, DOI 10.1053/j.ajkd.2004.12.005; Ishiguro C, 2008, J EPIDEMIOL, V18, P119, DOI 10.2188/jea.JE2007413; Kellum JA, 2002, CRIT CARE MED, V30, P2156, DOI 10.1097/00003246-200209000-00041; Kellum J, 2007, AM FAM PHYSICIAN, V76, P418; Kerr M, 2012, NEPHROL DIAL TRANSPL, V27, P73, DOI 10.1093/ndt/gfs269; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Knauf H, 2006, EUR J CLIN PHARMACOL, V62, P885, DOI 10.1007/s00228-006-0190-3; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P433, DOI 10.1007/s10654-011-9554-9; LaCivita C, 2009, J AM PHARM ASSOC, V49, pE110, DOI 10.1331/JAPhA.2009.09005; Lafrance JP, 2009, PHARMACOEPIDEM DR S, V18, P923, DOI 10.1002/pds.1798; LaMarr B, 2010, AM J HEALTH-SYST PH, V67, P290, DOI 10.2146/ajhp090009; Liangos O, 2006, CLIN J AM SOC NEPHRO, V1, P43, DOI 10.2215/CJN.00220605; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; Loboz KK, 2005, BRIT J CLIN PHARMACO, V59, P239, DOI 10.1111/j.0306-5251.2004.2188.x; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; MATHEW TH, 1992, MED J AUSTRALIA, V156, P724, DOI 10.5694/j.1326-5377.1992.tb121517.x; Mazzaglia G, 2009, CIRCULATION, V120, P1598, DOI 10.1161/CIRCULATIONAHA.108.830299; Morabito S, 2012, J NEPHROL, V25, P1098, DOI 10.5301/jn.5000101; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; NHS Information Centre for Health and Social Care, 2012, QOF 2009 10 DAT TABL; Olsen MH, 2010, J HYPERTENS, V28, P1593, DOI 10.1097/HJH.0b013e32833b7b08; Perez Gutthann S, 1996, ARCH INTERN MED, V156, P2433; Psaty BM, 2010, JAMA-J AM MED ASSOC, V304, P897, DOI 10.1001/jama.2010.1205; Quartey G, 2011, PHARM STAT, V10, P539, DOI 10.1002/pst.528; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Remuzzi G, 2002, NEW ENGL J MED, V346, P1145, DOI 10.1056/NEJMcp011773; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Schetz M, 2005, CURR OPIN CRIT CARE, V11, P555, DOI 10.1097/01.ccx.0000184300.68383.95; Schneider V, 2006, AM J EPIDEMIOL, V164, P881, DOI 10.1093/aje/kwj331; SHUSTERMAN N, 1987, AM J MED, V83, P65, DOI 10.1016/0002-9343(87)90498-0; Smets HLE, 2008, PHARMACOEPIDEM DR S, V17, P1014, DOI 10.1002/pds.1641; Suissa S, 2008, AM J EPIDEMIOL, V168, P329, DOI 10.1093/aje/kwn135; Suissa S, 2007, NAT CLIN PRACT RHEUM, V3, P725, DOI 10.1038/ncprheum0652; Taber SS, 2008, EXPERT OPIN DRUG SAF, V7, P679, DOI [10.1517/14740330802410462, 10.1517/14740330802410462 ]; Thomas MC, 2000, MED J AUSTRALIA, V172, P184, DOI 10.5694/j.1326-5377.2000.tb125548.x; Thurman JM, 2008, KIDNEY INT, V73, P379, DOI 10.1038/sj.ki.5002739; Vlasschaert MEO, 2011, AM J KIDNEY DIS, V57, P29, DOI 10.1053/j.ajkd.2010.08.031; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073; World Health Organisation (WHO), DAT; Wu TY, 2010, J ROY SOC MED, V103, P239, DOI 10.1258/jrsm.2010.100113; Yood MU, 2007, PHARMACOEPIDEM DR S, V16, P961, DOI 10.1002/pds.1454	55	189	191	0	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2013	346								e8525	10.1136/bmj.e8525	http://dx.doi.org/10.1136/bmj.e8525			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070ZH	23299844	hybrid, Green Published, Green Submitted			2022-12-24	WOS:000313553800001
J	DeWeerdt, S				DeWeerdt, Sarah			PSYCHODERMATOLOGY An emotional response	NATURE			English	Editorial Material							PSORIASIS; STRESS											Evers AWM, 2010, BRIT J DERMATOL, V163, P986, DOI 10.1111/j.1365-2133.2010.09984.x; Fortune DG, 2002, BRIT J DERMATOL, V146, P458, DOI 10.1046/j.1365-2133.2002.04622.x; Heller M M, 2011, Skin Therapy Lett, V16, P1; Kleyn CE, 2008, J INVEST DERMATOL, V128, P1273, DOI 10.1038/sj.jid.5701144; Richards HL, 2005, BRIT J DERMATOL, V153, P1114, DOI 10.1111/j.1365-2133.2005.06817.x; Verhoeven EWM, 2009, BRIT J DERMATOL, V161, P295, DOI 10.1111/j.1365-2133.2009.09194.x	6	8	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					562	563		10.1038/492S62a	http://dx.doi.org/10.1038/492S62a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23254976	Bronze			2022-12-24	WOS:000312488200008
J	Klein, BEK; Howard, KP; Gangnon, RE; Dreyer, JO; Lee, KE; Klein, R				Klein, Barbara E. K.; Howard, Kerri P.; Gangnon, Ronald E.; Dreyer, Jennifer O.; Lee, Kristine E.; Klein, Ronald			Long-term Use of Aspirin and Age-Related Macular Degeneration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BEAVER-DAM EYE; LOW-DOSE ASPIRIN; VISUAL-ACUITY; INTRAOCULAR HEMORRHAGE; MACULOPATHY; POPULATION; ANTICOAGULANTS; PROGRESSION; PHYSICIANS; PERIOD	Context Aspirin is widely used for relief of pain and for cardioprotective effects. Its use is of concern to ophthalmologists when ocular surgery is being considered and also in the presence of age-related macular degeneration (AMD). Objective To examine the association of regular aspirin use with incidence of AMD. Design, Setting, and Participants The Beaver Dam Eye Study, a longitudinal population-based study of age-related eye diseases conducted in Wisconsin. Examinations were performed every 5 years over a 20-year period (1988-1990 through 20082010). Study participants (N=4926) were aged 43 to 86 years at the baseline examination. At subsequent examinations, participants were asked if they had regularly used aspirin at least twice a week for more than 3 months. Main Outcome Measure Incidence of early AMD, late AMD, and 2 subtypes of late AMD (neovascular AMD and pure geographic atrophy), assessed in retinal photographs according to the Wisconsin Age-Related Maculopathy Grading System. Results The median duration of follow-up was 14.8 years. There were 512 incident cases of early AMD (of 6243 person-visits at risk) and 117 incident cases of late AMD (of 8621 person-visits at risk) over the course of the study. Regular aspirin use 10 years prior to retinal examination was associated with late AMD (hazard ratio [HR], 1.63 [95% CI, 1.01-2.63]; P=.05), with estimated incidence of 1.76% (95% CI, 1.17%-2.64%) in regular users and 1.03% (95% CI, 0.70%-1.51%) in nonusers. For subtypes of late AMD, regular aspirin use 10 years prior to retinal examination was significantly associated with neovascular AMD (HR, 2.20 [95% CI, 1.20-4.15]; P=.01) but not pure geographic atrophy (HR, 0.66 [95% CI, 0.25-1.95]; P=.45). Aspirin use 5 years (HR, 0.86 [95% CI, 0.71-1.05]; P=.13) or 10 years (HR, 0.86 [95% CI, 0.65-1.13]; P=.28) prior to retinal examination was not associated with incident early AMD. Conclusions Among an adult cohort, aspirin use 5 years prior to observed incidence was not associated with incident early or late AMD. However, regular aspirin use 10 years prior was associated with a small but statistically significant increase in the risk of incident late and neovascular AMD. JAMA. 2012;308(23):2469-2478 www.jama.com	[Klein, Barbara E. K.; Howard, Kerri P.; Dreyer, Jennifer O.; Lee, Kristine E.; Klein, Ronald] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53726 USA; [Gangnon, Ronald E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI 53726 USA; [Gangnon, Ronald E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI 53726 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Klein, BEK (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, 610 N Walnut St,4th Floor WARF, Madison, WI 53726 USA.	kleinb@epi.ophth.wisc.edu		Klein, Ronald/0000-0002-4428-6237; Gangnon, Ronald/0000-0003-2587-6714	National Institutes of Health (NIH) [EY06594]; National Eye Institute; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [U10EY006594] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Institutes of Health (NIH) grant EY06594 (Drs B. E. K. Klein, R. Klein). The National Eye Institute provided funding for the entire study, including for collection and analyses of data. Additional support was provided by Senior Scientific Investigator Awards from Research to Prevent Blindness (Drs B. E. K. Klein, R. Klein).	Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Christen WG, 2001, ARCH OPHTHALMOL-CHIC, V119, P1143, DOI 10.1001/archopht.119.8.1143; Christen WG, 2009, OPHTHALMOLOGY, V116, P2386, DOI 10.1016/j.ophtha.2009.05.031; de Jong PTVM, 2012, OPHTHALMOLOGY, V119, P112, DOI 10.1016/j.ophtha.2011.06.025; ELBABA F, 1986, OPHTHALMOLOGY, V93, P1581; Goertz O, 2011, BURNS, V37, P656, DOI 10.1016/j.burns.2011.01.004; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Kiernan DF, 2010, RETINA-J RET VIT DIS, V30, P1573, DOI 10.1097/IAE.0b013e3181e2266d; KLEIN BEK, 1990, OPHTHALMOLOGY, V97, P1428; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2001, OPHTHALMOLOGY, V108, P1757, DOI 10.1016/S0161-6420(01)00769-2; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1310; Klein R, 1996, OPHTHALMOLOGY, V103, P1169, DOI 10.1016/S0161-6420(96)30526-5; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein R, 2006, AM J OPHTHALMOL, V142, P539, DOI 10.1016/j.ajo.2006.06.015; RIDKER PM, 1991, AM HEART J, V122, P1588, DOI 10.1016/0002-8703(91)90275-M; Sahakyan K, 2011, DIABETOLOGIA, V54, P1335, DOI 10.1007/s00125-011-2096-6; Scheck A, DAILY ASPIRIN USE AS; Singer JD, 2003, APPL LONGITUDINAL DA, P407; Tilanus MAD, 2000, GRAEF ARCH CLIN EXP, V238, P482, DOI 10.1007/PL00007887; US FOOD and Drug Administration (FDA), ASP QUEST ANSW	22	47	50	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2469	2478		10.1001/jama.2012.65406	http://dx.doi.org/10.1001/jama.2012.65406			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23288416	Green Accepted, Bronze			2022-12-24	WOS:000312441400023
J	Ashdown, HF; D'Souza, N; Karim, D; Stevens, RJ; Huang, A; Harnden, A				Ashdown, Helen F.; D'Souza, Nigel; Karim, Diallah; Stevens, Richard J.; Huang, Andrew; Harnden, Anthony			CHRISTMAS 2012: RESEARCH Pain over speed bumps in diagnosis of acute appendicitis: diagnostic accuracy study	BRITISH MEDICAL JOURNAL			English	Editorial Material							METAANALYSIS	Objective To assess the diagnostic accuracy of pain on travelling over speed bumps for the diagnosis of acute appendicitis. Design Prospective questionnaire based diagnostic accuracy study. Setting Secondary care surgical assessment unit at a district general hospital in the UK. Participants 101 patients aged 17-76 years referred to the on-call surgical team for assessment of possible appendicitis. Main outcome measures Sensitivity, specificity, positive and negative predictive values, and positive and negative likelihood ratios for pain over speed bumps in diagnosing appendicitis, with histological diagnosis of appendicitis as the reference standard. Results The analysis included 64 participants who had travelled over speed bumps on their journey to hospital. Of these, 34 had a confirmed histological diagnosis of appendicitis, 33 of whom reported increased pain over speed bumps. The sensitivity was 97% (95% confidence interval 85% to 100%), and the specificity was 30% (15% to 49%). The positive predictive value was 61% (47% to 74%), and the negative predictive value was 90% (56% to 100%). The likelihood ratios were 1.4 (1.1 to 1.8) for a positive test result and 0.1 (0.0 to 0.7) for a negative result. Speed bumps had a better sensitivity and negative likelihood ratio than did other clinical features assessed, including migration of pain and rebound tenderness. Conclusions Presence of pain while travelling over speed bumps was associated with an increased likelihood of acute appendicitis. As a diagnostic variable, it compared favourably with other features commonly used in clinical assessment. Asking about speed bumps may contribute to clinical assessment and could be useful in telephone assessment of patients.	[Ashdown, Helen F.; Stevens, Richard J.; Harnden, Anthony] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [D'Souza, Nigel; Karim, Diallah; Huang, Andrew] Stoke Mandeville Hosp, Dept Surg, Aylesbury HP21 8AL, Bucks, England	University of Oxford	Ashdown, HF (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	helen.ashdown@phc.ox.ac.uk	D'Souza, Nigel/AAW-8195-2021	Ashdown, Helen/0000-0002-7758-7095; Stevens, Richard/0000-0002-9258-4060	National Institute for Health Research; University of Oxford; National Institute for Health Research [ACF-2010-13-007] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); University of Oxford; National Institute for Health Research(National Institute for Health Research (NIHR))	No formal funding. HFA is an academic clinical fellow, which is a scheme partially funded by the National Institute for Health Research. The University of Oxford acted as study sponsor and had no role in the study design, data collection, analysis or interpretation, writing of the paper, or decision to submit for publication. All authors were independent from funders and sponsors.	Andersson REB, 2004, BRIT J SURG, V91, P28, DOI 10.1002/bjs.4464; Bickell NA, 2006, J AM COLL SURGEONS, V202, P401, DOI 10.1016/j.jamcollsurg.2005.11.016; Bunn F., 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003110, DOI 10.1002/14651858.CD003110]; Department for Transport, 2007, 0107 DEP TRANSP; Golledge J, 1996, ANN ROY COLL SURG, V78, P11; Humes DJ, 2006, BMJ-BRIT MED J, V333, P530, DOI 10.1136/bmj.38940.664363.AE; Lewis SRR, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5976; Towner E, 2001, WHAT WORKS PREVENTIN; Varadhan KK, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2156; WALKER SJ, 1995, ANN ROY COLL SURG, V77, P358	10	16	16	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e8012	10.1136/bmj.e8012	http://dx.doi.org/10.1136/bmj.e8012			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059IU	23247977	Green Published, hybrid			2022-12-24	WOS:000312698700002
J	Taubes, G				Taubes, Gary			Treat obesity as physiology, not physics	NATURE			English	Editorial Material									Nutr Sci Initiat, San Diego, CA USA		Taubes, G (corresponding author), Nutr Sci Initiat, San Diego, CA USA.	taubes@gmail.com							0	18	19	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2012	492	7428					155	155		10.1038/492155a	http://dx.doi.org/10.1038/492155a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053GM	23235840	Bronze			2022-12-24	WOS:000312259300004
J	Prakash, GKS; Jog, PV; Batamack, PTD; Olah, GA				Prakash, G. K. Surya; Jog, Parag V.; Batamack, Patrice T. D.; Olah, George A.			Taming of Fluoroform: Direct Nucleophilic Trifluoromethylation of Si, B, S, and C Centers	SCIENCE			English	Article							CARBONYL-COMPOUNDS; ELECTROGENERATED BASE; EFFICIENT PRECURSOR; ALDEHYDES; REAGENTS; TRIFLUOROMETHYLTRIMETHYLSILANE; COMPLEXES; SULFIDES	Fluoroform (CF3H), a large-volume by-product of the manufacture of Teflon, refrigerants, polyvinylidene fluoride (PVDF), fire-extinguishing agents, and foams, is a potent and stable greenhouse gas that has found little practical use despite the growing importance of trifluoromethyl (CF3) functionality in more structurally elaborate pharmaceuticals, agrochemicals, and materials. Direct nucleophilic trifluoromethylation using CF3H has been a challenge. Here, we report on a direct trifluoromethylation protocol using close to stoichiometric amounts of CF3H in common organic solvents such as tetrahydrofuran (THF), diethyl ether, and toluene. The methodology is widely applicable to a variety of silicon, boron, and sulfur-based electrophiles, as well as carbon-based electrophiles.	[Prakash, G. K. Surya; Jog, Parag V.; Batamack, Patrice T. D.; Olah, George A.] Univ So Calif, Dept Chem, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA	University of Southern California	Prakash, GKS (corresponding author), Univ So Calif, Dept Chem, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA.	gprakash@usc.edu	P, G/HGB-5661-2022; Prakash, Surya/AAF-1756-2022; Jog, Parag/AAJ-3401-2021; Prakash, Surya/AFC-8224-2022		Loker Hydrocarbon Research Institute	Loker Hydrocarbon Research Institute	Support of our work by the Loker Hydrocarbon Research Institute is gratefully acknowledged.	Ball ND, 2010, J AM CHEM SOC, V132, P2878, DOI 10.1021/ja100955x; Banks R. E., 1982, PREPARATION PROPERTI; Barhdadi R, 1998, CHEM COMMUN, P1251, DOI 10.1039/a801406j; Billard T, 2001, EUR J ORG CHEM, V2001, P1467; Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; Dubinina GG, 2008, J AM CHEM SOC, V130, P8600, DOI 10.1021/ja802946s; Folleas B, 1998, TETRAHEDRON LETT, V39, P2973, DOI 10.1016/S0040-4039(98)00391-8; Folleas B, 2000, TETRAHEDRON, V56, P275, DOI 10.1016/S0040-4020(99)00951-5; Forat G., 1996, Eur. Patent, Patent No. [735023, 735023A1]; GROBE J, 1995, SYNLETT, P641; Hagiwara T, 1997, NIPPON KAGAKU KAISHI, P869, DOI 10.1246/nikkashi.1997.869; Han WF, 2012, J FLUORINE CHEM, V140, P7, DOI 10.1016/j.jfluchem.2012.04.012; Hartwig J. F., 2012, [No title captured], Patent No. [US2012/0226041A1, 20120226041]; Khan BA, 2012, CHEM-EUR J, V18, P1577, DOI 10.1002/chem.201102652; Knauber T, 2011, CHEM-EUR J, V17, P2689, DOI 10.1002/chem.201002749; Kolomeitsev AA, 2003, TETRAHEDRON LETT, V44, P8273, DOI 10.1016/j.tetlet.2003.09.072; Langlois B.R., 2005, ACS SYM SER, V911, P57; Langlois BR, 2003, SYNTHESIS-STUTTGART, P185, DOI 10.1055/s-2003-36812; Large S, 2000, J ORG CHEM, V65, P8848, DOI 10.1021/jo000150s; Levin VV, 2011, TETRAHEDRON LETT, V52, P281, DOI 10.1016/j.tetlet.2010.11.025; Molander GA, 2003, ORGANOMETALLICS, V22, P3313, DOI 10.1021/om0302645; Morimoto H, 2011, ANGEW CHEM INT EDIT, V50, P3793, DOI 10.1002/anie.201100633; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Mukhopadhyay S, 2004, ORG PROCESS RES DEV, V8, P660, DOI 10.1021/op040007r; Novak P, 2012, J AM CHEM SOC, V134, P16167, DOI 10.1021/ja307783w; Novak P, 2012, ANGEW CHEM INT EDIT, V51, P7767, DOI 10.1002/anie.201201613; Olah G.A., 2009, SUPERACID CHEM, V2; PAWELKE G, 1989, J FLUORINE CHEM, V42, P429, DOI 10.1016/S0022-1139(00)83934-2; Popov I, 2011, J AM CHEM SOC, V133, P9286, DOI 10.1021/ja2041942; Prakash G. K. S., 2012, PCT Patent Appln., Patent No. [WO 2012/148772 A1, 2012148772, WO 2012/148772]; Prakash G. K. S., 2004, U.S. Patent, Patent No. [6,803,477, 6803477]; Prakash GKS, 1996, SYNLETT, P151; Prakash GKS, 2003, J ORG CHEM, V68, P4457, DOI 10.1021/jo030110z; Prakash GKS, 2001, J FLUORINE CHEM, V112, P123, DOI 10.1016/S0022-1139(01)00477-8; PRAKASH GKS, 1989, J AM CHEM SOC, V111, P393, DOI 10.1021/ja00183a073; Prakash GKS, 1997, CHEM REV, V97, P757, DOI 10.1021/cr9408991; RAMAIAH P, 1995, ORG SYNTH, V72, P232; Rijs NJ, 2012, DALTON T, V41, P3395, DOI 10.1039/c2dt12117d; RUPPERT I, 1984, TETRAHEDRON LETT, V25, P2195, DOI 10.1016/S0040-4039(01)80208-2; SHONO T, 1991, J ORG CHEM, V56, P2, DOI 10.1021/jo00001a002; Stahly G. P., 1989, U.S. Patents, Patent No. [4804774, 4804774A]; STAHLY GP, 1989, J ORG CHEM, V54, P2873, DOI 10.1021/jo00273a020; Wang F, 2011, ANGEW CHEM INT EDIT, V50, P7153, DOI 10.1002/anie.201101691; Ye YD, 2012, J AM CHEM SOC, V134, P9034, DOI 10.1021/ja301553c; Ye YD, 2011, ORG LETT, V13, P5464, DOI 10.1021/ol202174a; Zanardi A, 2011, J AM CHEM SOC, V133, P20901, DOI 10.1021/ja2081026	46	217	220	2	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1324	1327		10.1126/science.1227859	http://dx.doi.org/10.1126/science.1227859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224551				2022-12-24	WOS:000311991200061
J	Wang, WJ; Nossoni, Z; Berbasova, T; Watson, CT; Yapici, I; Lee, KSS; Vasileiou, C; Geiger, JH; Borhan, B				Wang, Wenjing; Nossoni, Zahra; Berbasova, Tetyana; Watson, Camille T.; Yapici, Ipek; Lee, Kin Sing Stephen; Vasileiou, Chrysoula; Geiger, James H.; Borhan, Babak			Tuning the Electronic Absorption of Protein-Embedded All-trans-Retinal	SCIENCE			English	Article							SCHIFF-BASE COUNTERION; BINDING PROTEINS; VISUAL PIGMENTS; RHODOPSIN; COLOR	Protein-chromophore interactions are a central component of a wide variety of critical biological processes such as color vision and photosynthesis. To understand the fundamental elements that contribute to spectral tuning of a chromophore inside the protein cavity, we redesigned human cellular retinol binding protein II (hCRBPII) to fully encapsulate all-trans-retinal and form a covalent bond as a protonated Schiff base. This system, using rational mutagenesis designed to alter the electrostatic environment within the binding pocket of the host protein, enabled regulation of the absorption maximum of the pigment in the range of 425 to 644 nanometers. With only nine point mutations, the hCRBPII mutants induced a systematic shift in the absorption profile of all-trans-retinal of more than 200 nanometers across the visible spectrum.	[Wang, Wenjing; Nossoni, Zahra; Berbasova, Tetyana; Watson, Camille T.; Yapici, Ipek; Lee, Kin Sing Stephen; Vasileiou, Chrysoula; Geiger, James H.; Borhan, Babak] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Michigan State University	Geiger, JH (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.	geiger@chemistry.msu.edu; babak@chemistry.msu.edu	Wang, Wenjing/G-7318-2017; Lee, Kin Sing Stephen/I-9476-2012	Wang, Wenjing/0000-0001-6025-9848; Lee, Kin Sing Stephen/0000-0003-4541-3063; Geiger, James/0000-0002-9443-4488	NIH [R01-GM54082]; U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division [DE-FG02-06ER15822]; DOE Office of Energy Research [W-31-109-ENG-38]; DOE, Office of Science, Basic Energy Sciences [W-31-109-ENG-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054082, R01GM067311] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division; DOE Office of Energy Research; DOE, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant R01-GM54082. We thank the U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division (grant DE-FG02-06ER15822 to J.H.G.) and the beamline staff at LS-CAT 21-ID (supported by the DOE Office of Energy Research under contract W-31-109-ENG-38). The Advanced Photon Source is supported by the DOE, Office of Science, Basic Energy Sciences, under contract W-31-109-ENG-38. PDB accession codes for the crystal structures used in this study: 4EXZ (Q108K:K40L); 4EEJ (Q108K:K40L:T51V:T53C:Y19W:R58W:T29L:Q4R); 4GKC (Q108K:K40L:T51V:T53C:Y19W:R58W:T29L:Q4A); 4EFG (Q108K:K40L:T51V:T53C:Y19W:R58W:T29L); 4EDE (Q108K:K40L:T51V:T53C:Y19W:R58W:T29L:A33W). Michigan State University has applied for a patent titled "Colorimetric and Fluorescent Proteins" (U.S. patent pending, serial no. 13/636,499) related to the design methods and materials presented in this work.	BURGI HB, 1983, ACCOUNTS CHEM RES, V16, P153, DOI 10.1021/ar00089a002; Coto PB, 2006, P NATL ACAD SCI USA, V103, P17154, DOI 10.1073/pnas.0604048103; Dwyer JJ, 2000, BIOPHYS J, V79, P1610, DOI 10.1016/S0006-3495(00)76411-3; Gunasekaran K, 2004, PROTEINS, V54, P179, DOI 10.1002/prot.10520; HONIG B, 1976, BIOCHEMISTRY-US, V15, P4593, DOI 10.1021/bi00666a008; Kochendoerfer GG, 1999, TRENDS BIOCHEM SCI, V24, P300, DOI 10.1016/S0968-0004(99)01432-2; Lee KSS, 2012, CHEMPLUSCHEM, V77, P273, DOI 10.1002/cplu.201100082; Li E, 1996, ANNU REV NUTR, V16, P205, DOI 10.1146/annurev.nu.16.070196.001225; Lin SW, 1998, J BIOL CHEM, V273, P24583, DOI 10.1074/jbc.273.38.24583; Nielsen MB, 2009, CHEM SOC REV, V38, P913, DOI 10.1039/b802068j; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Rajamani R, 2011, J COMPUT CHEM, V32, P854, DOI 10.1002/jcc.21663; Rajput J, 2010, ANGEW CHEM INT EDIT, V49, P1790, DOI 10.1002/anie.200905061; SAKMAR TP, 1991, P NATL ACAD SCI USA, V88, P3079, DOI 10.1073/pnas.88.8.3079; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Vasileiou C, 2007, J AM CHEM SOC, V129, P6140, DOI 10.1021/ja067546r	18	88	88	2	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1340	1343		10.1126/science.1226135	http://dx.doi.org/10.1126/science.1226135			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224553	Green Accepted			2022-12-24	WOS:000311991200066
J	Scully, T				Scully, Tony			TO THE LIMIT	NATURE			English	Editorial Material																			0	39	40	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2012	492	7427					S2	S3		10.1038/492S2a	http://dx.doi.org/10.1038/492S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222671	Bronze			2022-12-24	WOS:000311893400002
J	Di Virgilio, M; Callen, E; Yamane, A; Zhang, WZ; Jankovic, M; Gitlin, AD; Feldhahn, N; Resch, W; Oliveira, TY; Chait, BT; Nussenzweig, A; Casellas, R; Robbiani, DF; Nussenzweig, MC				Di Virgilio, Michela; Callen, Elsa; Yamane, Arito; Zhang, Wenzhu; Jankovic, Mila; Gitlin, Alexander D.; Feldhahn, Niklas; Resch, Wolfgang; Oliveira, Thiago Y.; Chait, Brian T.; Nussenzweig, Andre; Casellas, Rafael; Robbiani, Davide F.; Nussenzweig, Michel C.			Rif1 Prevents Resection of DNA Breaks and Promotes Immunoglobulin Class Switching	SCIENCE			English	Article							53BP1; PROTEIN; REPAIR; DAMAGE; AID; RECOMBINATION; REGULATOR; TELOMERES; SITES; FOCUS	DNA double-strand breaks (DSBs) represent a threat to the genome because they can lead to the loss of genetic information and chromosome rearrangements. The DNA repair protein p53 binding protein 1 (53BP1) protects the genome by limiting nucleolytic processing of DSBs by a mechanism that requires its phosphorylation, but whether 53BP1 does so directly is not known. Here, we identify Rap1-interacting factor 1 (Rif1) as an ATM (ataxia-telangiectasia mutated) phosphorylation-dependent interactor of 53BP1 and show that absence of Rif1 results in 5'-3' DNA-end resection in mice. Consistent with enhanced DNA resection, Rif1 deficiency impairs DNA repair in the G(1) and S phases of the cell cycle, interferes with class switch recombination in B lymphocytes, and leads to accumulation of chromosome DSBs.	[Di Virgilio, Michela; Jankovic, Mila; Gitlin, Alexander D.; Feldhahn, Niklas; Oliveira, Thiago Y.; Robbiani, Davide F.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst HHMI, New York, NY 10065 USA; [Callen, Elsa; Nussenzweig, Andre] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA; [Callen, Elsa; Nussenzweig, Andre] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Yamane, Arito; Resch, Wolfgang; Casellas, Rafael] NCI, Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, NIH, Bethesda, MD 20892 USA; [Zhang, Wenzhu; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA; [Oliveira, Thiago Y.] Univ Sao Paulo, Fac Med, Dept Genet, BR-14049 Ribeirao Preto, Brazil; [Oliveira, Thiago Y.] Natl Inst Sci & Technol Stem Cells & Cell Therapy, BR-14049 Ribeirao Preto, Brazil	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Rockefeller University; Universidade de Sao Paulo	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@rockefeller.edu	Robbiani, Davide F./AAF-7662-2019; Yamane, Arito/A-2959-2013; Oliveira, Thiago Y/HGA-3848-2022; Nussenzweig, Michel/AAE-7292-2019; Oliveira, Thiago Y/ABF-5186-2020; Di Virgilio, Michela/AAE-9298-2022	Robbiani, Davide F./0000-0001-7379-3484; Oliveira, Thiago Y/0000-0002-2654-0879; Oliveira, Thiago Y/0000-0002-2654-0879; Resch, Wolfgang/0000-0001-7594-5963; Gitlin, Alexander/0000-0002-9229-0919; Di Virgilio, Michela/0000-0001-5189-0793	NIH [GM007739, AI037526, RR022220, RR00862, GM103314]; NIAMS at the NIH; NCI at the NIH; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010283, ZIABC010959] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862, U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037526, R37AI037526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103314] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS at the NIH; NCI at the NIH; Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the Nussenzweig laboratory for discussion, D. Bosque and T. Eisenreich for help in managing mouse colonies, A. Gazumyan for assistance with Igh germline and AID transcript levels analysis, and K. Yao for help with genotyping. We thank T. de Lange (The Rockefeller University, New York) for Rif1<SUP>F/F</SUP> mice; S. Buonomo (European Molecular Biology Laboratory Mouse Biology Unit, Monterotondo, Italy) for the anti-mouse Rif1 serum #1240; G. Gutierrez (NIAMS, NIH, Bethesda, MD) for Illumina sequencing; N. Zampieri (Columbia University, New York) for assistance with immunofluorescence image processing, and M. P. Rout, J. LaCava, S. Obado, and L. Hough (The Rockefeller University) for invaluable help, discussions, and protocols for cryolysis and magnetic bead-mediated immunoisolation. The data presented in the manuscript are tabulated in the main text and in the supplementary materials. Sequence data shown in Fig. 4 have been deposited in the Gene Expression Omnibus database (accession number GSE42298) at www.ncbi.nlm.nih.gov/geo/. M. D. V. was a Fellow of the American Italian Cancer Foundation, and A. D. G. was supported by NIH Medical Scientist Training Program grant GM007739. This work was supported in part by NIH grants AI037526 (M. C. N.), RR022220 (B. T. C.), RR00862 (B. T. C.), and GM103314 (B. T. C.); and by the intramural program of NIAMS at the NIH (R. C.); and the intramural research program of NCI at the NIH and Center for Cancer Research (A. N. and E. C.). M. C. N. is an HHMI Investigator.	Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Buonomo SBC, 2009, J CELL BIOL, V187, P385, DOI 10.1083/jcb.200902039; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Hayano M, 2012, GENE DEV, V26, P137, DOI 10.1101/gad.178491.111; Kumar S, 2012, CELL CYCLE, V11, P1183, DOI 10.4161/cc.11.6.19636; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Pavri R, 2011, ADV IMMUNOL, V110, P1, DOI 10.1016/B978-0-12-387663-8.00005-3; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Xu DY, 2010, EMBO J, V29, P3140, DOI 10.1038/emboj.2010.186; Xu LF, 2004, J CELL BIOL, V167, P819, DOI 10.1083/jcb.200408181; Yamane A, 2013, CELL REP, V3, P138, DOI 10.1016/j.celrep.2012.12.006; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180	26	294	297	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120					711	715		10.1126/science.1230624	http://dx.doi.org/10.1126/science.1230624			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23306439	Green Accepted			2022-12-24	WOS:000314585600047
J	Kondo, T; Hayashi, S				Kondo, Takefumi; Hayashi, Shigeo			Mitotic cell rounding accelerates epithelial invagination	NATURE			English	Article							APICAL CONSTRICTION; ADHERENS JUNCTIONS; DROSOPHILA; TRACHEAL; MORPHOGENESIS; SHAPE; INTEGRATION; MIGRATION; TRIBBLES; HOMOLOG	Mitotic cells assume a spherical shape by increasing their surface tension and osmotic pressure by extensively reorganizing their interphase actin cytoskeleton into a cortical meshwork and their microtubules into the mitotic spindle(1,2). Mitotic entry is known to interfere with tissue morphogenetic events that require cell-shape changes controlled by the interphase cytoskeleton, such as apical constriction(3-5). However, here we show that mitosis plays an active role in the epithelial invagination of the Drosophila melanogaster tracheal placode. Invagination begins with a slow phase under the control of epidermal growth factor receptor (EGFR) signalling; in this process, the central apically constricted cells, which are surrounded by intercalating cells(6,7), form a shallow pit. This slow phase is followed by a fast phase, in which the pit is rapidly depressed, accompanied by mitotic entry, which leads to the internalization of all the cells in the placode. We found that mitotic cell rounding, but not cell division, of the central cells in the placode is required to accelerate invagination, in conjunction with EGFR-induced myosin II contractility in the surrounding cells. We propose that mitotic cell rounding causes the epithelium to buckle under pressure and acts as a switch for morphogenetic transition at the appropriate time.	[Kondo, Takefumi; Hayashi, Shigeo] RIKEN Ctr Dev Biol, Lab Morphogenet Signaling, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Hayashi, Shigeo] Kobe Univ, Dept Biol, Grad Sch Sci, Kobe, Hyogo 6578501, Japan	RIKEN; Kobe University	Hayashi, S (corresponding author), RIKEN Ctr Dev Biol, Lab Morphogenet Signaling, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	shayashi@cdb.riken.jp	Hayashi, Shigeo/J-9628-2019; Hayashi, Shigeo/N-5128-2015	Hayashi, Shigeo/0000-0001-7785-1290; Hayashi, Shigeo/0000-0001-7785-1290; Kondo, Takefumi/0000-0001-8127-1141	Ministry of Education, Culture, Sports, Science and Technology, Japan [22111007, 23770624]; RIKEN Special Postdoctoral Researcher Program	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Special Postdoctoral Researcher Program	We thank the Kyoto and Bloomington Drosophila Stock Centers, the Developmental Studies Hybridoma Bank, E. Wieschaus, H. Oda and T. Nishimura for fly stocks and antibodies; K. Kato and H. Wade for assistance with data analysis and experiments; G. Sheng, E. Kuranaga, K. Kato, T. Otani and B. Dong for comments on the manuscript; and members of the Hayashi, Nishimura and Kuranaga laboratories for discussions. This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (22111007 to S.H); Grant-in-Aid for Young Scientists (B) (23770624 to T.K.) from The Ministry of Education, Culture, Sports, Science and Technology, Japan; and the RIKEN Special Postdoctoral Researcher Program (T.K.)	BAKER J, 1993, J CELL SCI, V104, P415; Brodu V, 2006, GENE DEV, V20, P1817, DOI 10.1101/gad.375706; BUNCH TA, 1992, GENETICS, V132, P519; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Corrigall D, 2007, DEV CELL, V13, P730, DOI 10.1016/j.devcel.2007.09.015; Escudero LM, 2007, DEV CELL, V13, P717, DOI 10.1016/j.devcel.2007.09.002; Garner M, 2001, CURR BIOL, V11, P1595, DOI 10.1016/S0960-9822(01)00483-3; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Kato K, 2008, DEV GROWTH DIFFER, V50, P381, DOI [10.1111/j.1440-169x.2008.01029.x, 10.1111/j.1440-169X.2008.01029.x]; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Meyer EJ, 2011, CURR BIOL, V21, P485, DOI 10.1016/j.cub.2011.02.002; Nishimura M, 2007, DEVELOPMENT, V134, P4273, DOI 10.1242/dev.010397; Oda H, 2001, J CELL SCI, V114, P493; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Thery M, 2008, HFSP J, V2, P65, DOI 10.2976/1.2895661; Vincent A, 1997, DEVELOPMENT, V124, P3747; Wang YC, 2012, NATURE, V484, P390, DOI 10.1038/nature10938	27	107	107	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					125	129		10.1038/nature11792	http://dx.doi.org/10.1038/nature11792			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23334416				2022-12-24	WOS:000314741200047
J	King, M; Essick, C; Bearman, P; Ross, JS				King, Marissa; Essick, Connor; Bearman, Peter; Ross, Joseph S.			Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATTITUDES; EXPOSURE; ADOPTION; INDUSTRY	Objective To examine the effect of attending a medical school with an active policy on restricting gifts from representatives of pharmaceutical and device industries on subsequent prescribing behavior. Design Difference-in-differences approach. Setting 14 US medical schools with an active gift restriction policy in place by 2004. Participants Prescribing patterns in 2008 and 2009 of physicians attending one of the schools compared with physicians graduating from the same schools before the implementation of the policy, as well as a set of contemporary matched controls. Main outcome measure Probability that a physician would prescribe a newly marketed medication over existing alternatives of three psychotropic classes: lisdexamfetamine among stimulants, paliperidone among antipsychotics, and desvenlafaxine among antidepressants. None of these medications represented radical breakthroughs in their respective classes. Results For two of the three medications examined, attending a medical school with an active gift restriction policy was associated with reduced prescribing of the newly marketed drug. Physicians who attended a medical school with an active conflict of interest policy were less likely to prescribe lisdexamfetamine over older stimulants (adjusted odds ratio 0.44, 95% confidence interval 0.22 to 0.88; P=0.02) and paliperidone over older antipsychotics (0.25, 0.07 to 0.85; P=0.03). A significant effect was not observed for desvenlafaxine (1.54, 0.79 to 3.03; P=0.20). Among cohorts of students who had a longer exposure to the policy or were exposed to more stringent policies, prescribing rates were further reduced. Conclusion Exposure to a gift restriction policy during medical school was associated with reduced prescribing of two out of three newly introduced psychotropic medications.	[King, Marissa; Essick, Connor] Yale Univ, Sch Management, New Haven, CT USA; [Bearman, Peter] Columbia Univ, Interdisciplinary Ctr Innovat Theories & Empir, New York, NY 10027 USA; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Med, Gen Internal Med Sect, New Haven, CT 06510 USA	Yale University; Columbia University; Yale University	Bearman, P (corresponding author), Columbia Univ, Interdisciplinary Ctr Innovat Theories & Empir, New York, NY 10027 USA.	psb17@columbia.edu		bearman, peter/0000-0002-3745-3164; Ross, Joseph/0000-0002-9218-3320	National Institute of Mental Health; National Institute on Aging [K08 AG032886]; American Federation of Aging Research through the Paul B Beeson Career Development Award Program; NIH, part of the NIH Roadmap for Medical Research [1 DP1 OD003635-01]; Centers of Medicare and Medicaid Services; Medtronic; Pew Charitable Trusts; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003635] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation of Aging Research through the Paul B Beeson Career Development Award Program; NIH, part of the NIH Roadmap for Medical Research; Centers of Medicare and Medicaid Services; Medtronic(Medtronic); Pew Charitable Trusts; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	MK and PB received support from the National Institute of Mental Health. JSR is currently supported by the National Institute on Aging (K08 AG032886) and by the American Federation of Aging Research through the Paul B Beeson Career Development Award Program. PB is currently supported by the NIH director's pioneer award program, part of the NIH Roadmap for Medical Research (grant No 1 DP1 OD003635-01). None of the funders had a role in study design, in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the article for publication.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; JSR receives support from the Centers of Medicare and Medicaid Services to develop and maintain performance measures that are used for public reporting, receives grant support from Medtronic, receives grant support from the Pew Charitable Trusts (which developed and continues to support the AMSA PharmFree scorecard), and is a member of a scientific advisory board for FAIR Health, a not for profit organisation with the mission to achieve fairness and transparency in healthcare reimbursement.	Advanced Medical Technology Association, 2008, COD ETH INT HLTH CAR; American Medical Association, 2008, GIFTS PHYS IND; American Medical Association, 2012, AMA PHYS MAST; American Medical Student Association, EX SUMM 2012; Association of Amercian Medical Colleges, 2008, IND FUND MED ED; Austad KE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001037; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; Fugh-Berman AJ, 2010, J CONTIN EDUC HEALTH, V30, P197, DOI 10.1002/chp.20081; Grande D, 2009, ARCH INTERN MED, V169, P887, DOI 10.1001/archinternmed.2009.64; Greving JP, 2006, SOC SCI MED, V63, P2890, DOI 10.1016/j.socscimed.2006.07.019; IMS National Sales Perspectives, 2008, 2008 US SAL PRESCR I; Institute of Medicine as a Profession, 2012, AC MED CTR CONFL INT; Kao AC, 2011, ACAD MED, V86, P1454, DOI 10.1097/ACM.0b013e3182303895; Manchanda P, 2008, MARKET SCI, V27, P961, DOI 10.1287/mksc.1070.0354; McCormick BB, 2001, JAMA-J AM MED ASSOC, V286, P1994, DOI 10.1001/jama.286.16.1994; Pharmaceutical Research and Manufacturers of America, 2008, COD INT HEALTHC PROF; Sierles FS, 2005, JAMA-J AM MED ASSOC, V294, P1034, DOI 10.1001/jama.294.9.1034; Vermont Attorney General, 2010, PHARM MARK DISCL REP	18	61	61	2	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2013	346								f264	10.1136/bmj.f264	http://dx.doi.org/10.1136/bmj.f264			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084BQ	23372175	Green Published, hybrid			2022-12-24	WOS:000314511500002
J	Moore, S; Evans, CD; Page, SE; Garnett, MH; Jones, TG; Freeman, C; Hooijer, A; Wiltshire, AJ; Limin, SH; Gauci, V				Moore, Sam; Evans, Chris D.; Page, Susan E.; Garnett, Mark H.; Jones, Tim G.; Freeman, Chris; Hooijer, Aljosja; Wiltshire, Andrew J.; Limin, Suwido H.; Gauci, Vincent			Deep instability of deforested tropical peatlands revealed by fluvial organic carbon fluxes	NATURE			English	Article							ENVIRONMENT SIMULATOR JULES; MODEL DESCRIPTION; FOREST; EXPORT; PEAT; KALIMANTAN; INDONESIA; ACCUMULATION; VEGETATION; EMISSIONS	Tropical peatlands contain one of the largest pools of terrestrial organic carbon, amounting to about 89,000 teragrams(1) (1 Tg is a billion kilograms). Approximately 65 per cent of this carbon store is in Indonesia, where extensive anthropogenic degradation in the form of deforestation, drainage and fire are converting it into a globally significant source of atmospheric carbon dioxide(1-3). Here we quantify the annual export of fluvial organic carbon from both intact peat swamp forest and peat swamp forest subject to past anthropogenic disturbance. We find that the total fluvial organic carbon flux from disturbed peat swamp forest is about 50 per cent larger than that from intact peat swamp forest. By carbon-14 dating of dissolved organic carbon (which makes up over 91 per cent of total organic carbon), we find that leaching of dissolved organic carbon from intact peat swamp forest is derived mainly from recent primary production (plant growth). In contrast, dissolved organic carbon from disturbed peat swamp forest consists mostly of much older (centuries to millennia) carbon from deep within the peat column. When we include the fluvial carbon loss term, which is often ignored, in the peatland carbon budget, we find that it increases the estimate of total carbon lost from the disturbed peatlands in our study by 22 per cent. We further estimate that since 1990 peatland disturbance has resulted in a 32 per cent increase in fluvial organic carbon flux from southeast Asia-an increase that is more than half of the entire annual fluvial organic carbon flux from all European peatlands. Our findings emphasize the need to quantify fluvial carbon losses in order to improve estimates of the impact of deforestation and drainage on tropical peatland carbon balances.	[Moore, Sam; Gauci, Vincent] Open Univ, Dept Environm Earth & Ecosyst, CEPSAR, Milton Keynes MK7 6AA, Bucks, England; [Evans, Chris D.] Environm Ctr Wales, Ctr Ecol & Hydrol, Bangor LL57 2UW, Gwynedd, Wales; [Page, Susan E.] Univ Leicester, Dept Geog, Leicester LE1 7RH, Leics, England; [Garnett, Mark H.] Nat Environm Res Council Radiocarbon Facil, E Kilbride G75 0QF, Lanark, Scotland; [Jones, Tim G.; Freeman, Chris] Bangor Univ, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales; [Hooijer, Aljosja] Deltares, NL-2600 MH Delft, Netherlands; [Wiltshire, Andrew J.] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England; [Limin, Suwido H.] Univ Palangka Raya, CIMTROP, Palangka Raya 73112, Central Kaliman, Indonesia	Open University - UK; UK Centre for Ecology & Hydrology (UKCEH); University of Leicester; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; Bangor University; Deltares; Met Office - UK; Hadley Centre; Universitas Palangka Raya (UPR)	Gauci, V (corresponding author), Open Univ, Dept Environm Earth & Ecosyst, CEPSAR, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	v.gauci@open.ac.uk	Wiltshire, Andy/C-2848-2008; Evans, Christopher D/F-2087-2010; Garnett, Mark H/C-2377-2009	Evans, Christopher D/0000-0002-7052-354X; Garnett, Mark H/0000-0001-6486-2126; Page, Susan/0000-0002-3392-9241; Gauci, Vincent/0000-0002-2452-7291	NERC [NE/F008813/1]; Natural Environment Research Council (NERC); Open University (CEPSAR) via the NERC Radiocarbon Facility (Environment) [1323.1008, 15.91]; DECC/Defra Met Office Hadley Centre Programme [GA01101]; Royal Society; British Council; NERC [NRCF010001, earth010003] Funding Source: UKRI; Natural Environment Research Council [earth010003, NRCF010001, ceh010023] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Open University (CEPSAR) via the NERC Radiocarbon Facility (Environment); DECC/Defra Met Office Hadley Centre Programme; Royal Society(Royal Society of London); British Council(The British Council in India); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	S.M. was supported by a NERC PhD studentship (NE/F008813/1). Radiocarbon analyses were supported by the Natural Environment Research Council (NERC) and the Open University (CEPSAR) via the NERC Radiocarbon Facility (Environment), Allocations 1323.1008 and 15.91. A.J.W. was supported by the Joint DECC/Defra Met Office Hadley Centre Programme (GA01101). A. Hoscilo provided land-cover change estimates. We thank I. Mohammed, K. Kusin and L. Graham for field assistance. The Malaysian work was supported by the Royal Society and British Council and we thank P. Kuppan, N. Willis and F. Md. Yussof for field support.	Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Benner R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019251; Best MJ, 2011, GEOSCI MODEL DEV, V4, P677, DOI 10.5194/gmd-4-677-2011; Billett MF, 2010, CLIM RES, V45, P13, DOI 10.3354/cr00903; Boehm H.-D. V., 2001, 22 AS C REM SENS EME, V1, P439; Bruijnzeel L. A, 1990, HYDROLOGY MOIST TROP; Caraco N, 2010, ECOLOGY, V91, P2385, DOI 10.1890/09-0330.1; Clark DB, 2011, GEOSCI MODEL DEV, V4, P701, DOI 10.5194/gmd-4-701-2011; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Evans CD, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029431; FAO/IIASA/ISRIC/ISS-CAS/JRC, 2009, HARM WORLD SOIL DAT; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; HEDIN LO, 1995, ECOLOGY, V76, P493, DOI 10.2307/1941208; Hirano T, 2007, GLOBAL CHANGE BIOL, V13, P412, DOI 10.1111/j.1365-2486.2006.01301.x; Hooijer A, 2010, BIOGEOSCIENCES, V7, P1505, DOI 10.5194/bg-7-1505-2010; HOPE D, 1994, ENVIRON POLLUT, V84, P301, DOI 10.1016/0269-7491(94)90142-2; Hoscilo A, 2011, INT J WILDLAND FIRE, V20, P578, DOI 10.1071/WF10029; Komatsu H, 2012, J HYDROL, V420, P380, DOI 10.1016/j.jhydrol.2011.12.030; Kume T, 2011, AGR FOREST METEOROL, V151, P1183, DOI 10.1016/j.agrformet.2011.04.005; Limpens J, 2008, BIOGEOSCIENCES, V5, P1475, DOI 10.5194/bg-5-1475-2008; Mayorga E, 2005, NATURE, V436, P538, DOI 10.1038/nature03880; MCDOWELL WH, 1988, ECOL MONOGR, V58, P177, DOI 10.2307/2937024; Michalzik B, 2001, BIOGEOCHEMISTRY, V52, P173, DOI 10.1023/A:1006441620810; Miettinen J, 2010, LAND DEGRAD DEV, V21, P285, DOI 10.1002/ldr.976; Montanarella L., 2006, MIRES PEAT, V1, P1; Moore S, 2011, BIOGEOSCIENCES, V8, P901, DOI 10.5194/bg-8-901-2011; MULHOLLAND PJ, 1979, LIMNOL OCEANOGR, V24, P960, DOI 10.4319/lo.1979.24.5.0960; Murdiyarso D, 2010, P NATL ACAD SCI USA, V107, P19655, DOI 10.1073/pnas.0911966107; Nilsson M, 2008, GLOBAL CHANGE BIOL, V14, P2317, DOI 10.1111/j.1365-2486.2008.01654.x; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Page SE, 2004, J QUATERNARY SCI, V19, P625, DOI 10.1002/jqs.884; Page SE, 1999, PHILOS T R SOC B, V354, P1885, DOI 10.1098/rstb.1999.0529; Page S, 2009, ECOSYSTEMS, V12, P888, DOI 10.1007/s10021-008-9216-2; Page SE, 2011, GLOBAL CHANGE BIOL, V17, P798, DOI 10.1111/j.1365-2486.2010.02279.x; Palmer SM, 2001, BIOGEOCHEMISTRY, V52, P321, DOI 10.1023/A:1006447706565; Raymond PA, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002934; Schellekens J, 2000, WATER RESOUR RES, V36, P2183, DOI 10.1029/2000WR900074; Schiff SL, 1997, BIOGEOCHEMISTRY, V36, P43, DOI 10.1023/A:1005744131385; Takahashi H., 2003, P INT S LAND MAN BIO, P311; Vernimmen RRE, 2012, HYDROL EARTH SYST SC, V16, P133, DOI 10.5194/hess-16-133-2012; Wagner F., 2003, IPCC GOOD PRACTICE G; Weedon GP, 2011, J HYDROMETEOROL, V12, P823, DOI 10.1175/2011JHM1369.1	42	204	208	4	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					660	+		10.1038/nature11818	http://dx.doi.org/10.1038/nature11818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364745	Green Accepted			2022-12-24	WOS:000314219600054
J	Weixlbaumer, A; Leon, K; Landick, R; Darst, SA				Weixlbaumer, Albert; Leon, Katherine; Landick, Robert; Darst, Seth A.			Structural Basis of Transcriptional Pausing in Bacteria	CELL			English	Article							RNA-POLYMERASE-II; ELONGATION COMPLEXES; CRYSTAL-STRUCTURE; TRIGGER LOOP; SITE; TERMINATION; INHIBITION; MECHANISM; RHO; HOLOENZYME	Transcriptional pausing by multisubunit RNA polymerases (RNAPs) is a key mechanism for regulating gene expression in both prokaryotes and eukaryotes and is a prerequisite for transcription termination. Pausing and termination states are thought to arise through a common, elemental pause state that is inhibitory for nucleotide addition. We report three crystal structures of Thermus RNAP elemental paused elongation complexes (ePECs). The structures reveal the same relaxed, open-clamp RNAP conformation in the ePEC that may arise by failure to re-establish DNA contacts during translocation. A kinked bridge-helix sterically blocks the RNAP active site, explaining how this conformation inhibits RNAP catalytic activity. Our results provide a framework for understanding how RNA hairpin formation stabilizes the paused state and how the ePEC intermediate facilitates termination.	[Weixlbaumer, Albert; Leon, Katherine; Darst, Seth A.] Rockefeller Univ, New York, NY 10065 USA; [Landick, Robert] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Landick, Robert] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	Rockefeller University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Darst, SA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	darst@rockefeller.edu	Weixlbaumer, Albert/P-3587-2016; Weixlbaumer, Albert/AAI-8474-2021	Weixlbaumer, Albert/0000-0001-9635-3844; Weixlbaumer, Albert/0000-0001-9635-3844	Anderson Cancer Center Postdoctoral Fellowship (The Rockefeller University); Human Frontier Science Program Long-term Postdoctoral Fellowship; U.S. Department of Energy, Office of Basic Energy Sciences; NCRR at the National Institutes of Health (NIH) [RR-15301]; NIH [RO1 GM38660, RO1 GM097458]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097458, R01GM038660] Funding Source: NIH RePORTER	Anderson Cancer Center Postdoctoral Fellowship (The Rockefeller University); Human Frontier Science Program Long-term Postdoctoral Fellowship(Human Frontier Science Program); U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NCRR at the National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Hein for help with transcription assays; S. Leiman for help with Taq RNAP pausing assays; T. Terwilliger for help with Phenix cross-crystal averaging; members of the Darst laboratory for helpful discussions; K.R. Rajashankar, S. Banerjee, F. Murphy, and K. Perry at APS NE-CAT beamline 24ID-E, W. Shi at NSLS beamline X29, and A. Heroux at NSLS beamline X25 for support with synchrotron data collection. A.W. was supported by an Anderson Cancer Center Postdoctoral Fellowship (The Rockefeller University) and a Human Frontier Science Program Long-term Postdoctoral Fellowship. This work was based, in part, on research conducted at the APS and the NSLS, supported by the U.S. Department of Energy, Office of Basic Energy Sciences. The NE-CAT beamlines at the APS are supported by award RR-15301 from the NCRR at the National Institutes of Health (NIH). This work was supported by NIH RO1 GM38660 to R.L. and NIH RO1 GM097458 to S.A.D.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; Chan CL, 1997, J MOL BIOL, V268, P54, DOI 10.1006/jmbi.1997.0935; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Chiba K, 2010, EXP CELL RES, V316, P2723, DOI 10.1016/j.yexcr.2010.05.036; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; DAUBE SS, 1992, SCIENCE, V258, P1320, DOI 10.1126/science.1280856; FARNHAM PJ, 1981, NUCLEIC ACIDS RES, V9, P563, DOI 10.1093/nar/9.3.563; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Hunter CA, 1996, BIOESSAYS, V18, P157, DOI 10.1002/bies.950180212; Ingham CJ, 1999, MOL MICROBIOL, V31, P651, DOI 10.1046/j.1365-2958.1999.01205.x; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Kyzer S, 2007, J BIOL CHEM, V282, P19020, DOI 10.1074/jbc.M701483200; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Landick R, 1996, METHOD ENZYMOL, V274, P334; LANDICK R, 1985, P NATL ACAD SCI USA, V82, P4663, DOI 10.1073/pnas.82.14.4663; Landick R, 2009, P NATL ACAD SCI USA, V106, P8797, DOI 10.1073/pnas.0904373106; Lane WJ, 2010, J MOL BIOL, V395, P686, DOI 10.1016/j.jmb.2009.10.063; LAU LF, 1983, J BIOL CHEM, V258, P9391; LEE DN, 1990, J BIOL CHEM, V265, P15145; LEVIN JR, 1987, J MOL BIOL, V196, P61, DOI 10.1016/0022-2836(87)90511-0; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Pan T, 1999, P NATL ACAD SCI USA, V96, P9545, DOI 10.1073/pnas.96.17.9545; RICHARDSON JP, 1991, CELL, V64, P1047, DOI 10.1016/0092-8674(91)90257-Y; Roberts JW, 1998, COLD SPRING HARB SYM, V63, P319, DOI 10.1101/sqb.1998.63.319; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Sevostyanova A, 2011, MOL CELL, V43, P253, DOI 10.1016/j.molcel.2011.05.026; Sevostyanova A, 2007, J MOL BIOL, V366, P420, DOI 10.1016/j.jmb.2006.11.050; Shaw NN, 2008, BIOCHIMIE, V90, P1026, DOI 10.1016/j.biochi.2008.04.011; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	55	111	111	0	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					431	441		10.1016/j.cell.2012.12.020	http://dx.doi.org/10.1016/j.cell.2012.12.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374340	Green Accepted, Bronze			2022-12-24	WOS:000314362800014
J	Coutsoudis, A; Goga, A; Desmond, C; Barron, P; Black, V; Coovadia, H				Coutsoudis, Anna; Goga, Ameena; Desmond, Chris; Barron, Peter; Black, Vivian; Coovadia, Hoosen			Is Option B plus the best choice?	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; PREGNANCY; OUTCOMES		[Coutsoudis, Anna] Univ KwaZulu Natal, Dept Paediat & Child Hlth, Kwa Zulu, South Africa; [Goga, Ameena] MRC, Pretoria, South Africa; [Desmond, Chris] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Barron, Peter] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Black, Vivian] Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Coovadia, Hoosen] Univ Witwatersrand, ZA-4091 Durban, South Africa	University of Kwazulu Natal; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Coovadia, H (corresponding author), Univ Witwatersrand, ZA-4091 Durban, South Africa.	hcoovadia@match.org.za						AIDS 2012, 2012, AIDS 2012; Chen JY, 2012, J INFECT DIS, V206, P1695, DOI 10.1093/infdis/jis553; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Hargrove JW, 2010, AIDS, V24, pF11, DOI 10.1097/QAD.0b013e328335749d; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Siberry GK, 2012, AIDS, V26, P1151, DOI 10.1097/QAD.0b013e328352d135; Struik GM, 2011, INT J STD AIDS, V22, P457, DOI 10.1258/ijsa.2011.010521; Unge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013613; UNICEF, 2012, BUS CAS OPT B B EL M; Wagner BG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041212; World Health Organization HIV/AIDS Programme, 2012, US ANT DRUGS TREAT P	14	63	62	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 26	2013	381	9863					269	271		10.1016/S0140-6736(12)61807-8	http://dx.doi.org/10.1016/S0140-6736(12)61807-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077IT	23351797				2022-12-24	WOS:000314021800007
J	Granger, AJ; Shi, Y; Lu, W; Cerpas, M; Nicoll, RA				Granger, Adam J.; Shi, Yun; Lu, Wei; Cerpas, Manuel; Nicoll, Roger A.			LTP requires a reserve pool of glutamate receptors independent of subunit type	NATURE			English	Article							AMPA RECEPTOR; SYNAPTIC PLASTICITY; LONG-TERM; SURFACE EXPRESSION; GLUR1 SUBUNIT; TRAFFICKING; PHOSPHORYLATION; CAMKII; SYNAPSES; NEURONS	Long-term potentiation (LTP) of synaptic transmission is thought to be an important cellular mechanism underlying memory formation. A widely accepted model posits that LTP requires the cytoplasmic carboxyl tail (C-tail) of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor subunit GluA1. To find the minimum necessary requirement of the GluA1 C-tail for LTP in mouse CA1 hippocampal pyramidal neurons, we used a single-cell molecular replacement strategy to replace all endogenous AMPA receptors with transfected subunits. In contrast to the prevailing model, we found no requirement of the GluA1 C-tail for LTP. In fact, replacement with the GluA2 subunit showed normal LTP, as did an artificially expressed kainate receptor not normally found at these synapses. The only conditions under which LTP was impaired were those with markedly decreased AMPA receptor surface expression, indicating a requirement for a reserve pool of receptors. These results demonstrate the synapse's remarkable flexibility to potentiate with a variety of glutamate receptor subtypes, requiring a fundamental change in our thinking with regard to the core molecular events underlying synaptic plasticity.	[Granger, Adam J.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; [Shi, Yun; Lu, Wei; Cerpas, Manuel; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	nicoll@cmp.uscf.edu	Shi, Yun/B-5623-2009; Lu, Wei/S-5617-2018; Shi, Yun S/T-8845-2018	Shi, Yun/0000-0002-8842-9818; Lu, Wei/0000-0001-6668-8432; Granger, Adam/0000-0002-3953-6764	National Science Foundation; National Institute of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070957] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Jackson, J. Levy, S. Fischbach, K. Lovero, N. Sheng, S. Shipman and M. Younger for critical discussions and reading of the manuscript; K. Bjorgen for technical help with organotypic slice cultures; and L. Subramanian from the Kriegstein laboratory for technical help with in utero electroporations. We thank P. Seeburg and R. Sprengel for the Gria1-3<SUP>fl/fl</SUP> mice. A. J. G. was supported by the National Science Foundation Graduate Research Fellowship. R. A. N. is supported by the National Institute of Health.	Andrasfalvy BK, 2003, J PHYSIOL-LONDON, V552, P35, DOI 10.1113/jphysiol.2003.045575; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Coleman SK, 2003, J NEUROSCI, V23, P798; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; Copits BA, 2011, J NEUROSCI, V31, P7334, DOI 10.1523/JNEUROSCI.0100-11.2011; Dargan SL, 2009, NEUROPHARMACOLOGY, V56, P121, DOI 10.1016/j.neuropharm.2008.08.016; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; Granger AJ, 2011, J PHYSIOL-LONDON, V589, P4095, DOI 10.1113/jphysiol.2011.213033; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lu W, 2010, P NATL ACAD SCI USA, V107, P22266, DOI 10.1073/pnas.1016289107; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Makino Y, 2011, P NATL ACAD SCI USA, V108, P8450, DOI 10.1073/pnas.1105261108; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Murakoshi H, 2012, TRENDS NEUROSCI, V35, P135, DOI 10.1016/j.tins.2011.12.002; Navarro-Quiroga I, 2007, J NEUROSCI, V27, P5007, DOI 10.1523/JNEUROSCI.0867-07.2007; Opazo P, 2011, MOL CELL NEUROSCI, V46, P1, DOI 10.1016/j.mcn.2010.08.014; Panicker S, 2008, P NATL ACAD SCI USA, V105, P1032, DOI 10.1073/pnas.0711313105; Patterson M, 2011, BRIT J PHARMACOL, V163, P1626, DOI 10.1111/j.1476-5381.2011.01328.x; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Shen L, 2000, J NEUROSCI, V20, P7932; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014	42	221	224	0	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					495	+		10.1038/nature11775	http://dx.doi.org/10.1038/nature11775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23235828	Green Accepted, Green Submitted			2022-12-24	WOS:000313871400030
J	Hersch, J; Jansen, J; Barratt, A; Irwig, L; Houssami, N; Howard, K; Dhillon, H; McCaffery, K				Hersch, Jolyn; Jansen, Jesse; Barratt, Alexandra; Irwig, Les; Houssami, Nehmat; Howard, Kirsten; Dhillon, Haryana; McCaffery, Kirsten			Women's views on overdiagnosis in breast cancer screening: a qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARCINOMA IN-SITU; RANDOMIZED-TRIAL; INFORMED CHOICE; DECISION AIDS; MAMMOGRAPHY; INFORMATION; INVITATIONS; DIAGNOSIS; PROGRAMS	Objective To elicit women's responses to information about the nature and extent of overdiagnosis in mammography screening (detecting disease that would not present clinically during the woman's lifetime) and explore how awareness of overdiagnosis might influence attitudes and intentions about screening. Design Qualitative study using focus groups that included a presentation explaining overdiagnosis, incorporating different published estimates of its rate (1-10%, 30%, 50%) and information on the mortality benefit of screening, with guided group discussions Setting Sydney, Australia Participants Fifty women aged 40-79 years with no personal history of breast cancer and with varying levels of education and participation in screening. Results Prior awareness of breast cancer overdiagnosis was minimal. Women generally reacted with surprise, but most came to understand the issue. Responses to overdiagnosis and the different estimates of its magnitude were diverse. The highest estimate (50%) made some women perceive a need for more careful personal decision making about screening. In contrast, the lower and intermediate estimates (1-10% and 30%) had limited impact on attitudes and intentions, with many women remaining committed to screening. For some women, the information raised concerns, not about whether to screen but whether to treat a screen detected cancer or consider alternative approaches (such as watchful waiting). Information preferences varied: many women considered it important to take overdiagnosis into account and make informed choices about whether to have screening, but many wanted to be encouraged to be screened. Conclusions Women from a range of socioeconomic backgrounds could comprehend the issue of overdiagnosis in mammography screening, and they generally valued information about it. Effects on screening intentions may depend heavily on the rate of overdiagnosis. Overdiagnosis will be new and counterintuitive for many people and may influence screening and treatment decisions in unintended ways, underscoring the need for careful communication.	[Hersch, Jolyn; Jansen, Jesse; Irwig, Les; Houssami, Nehmat; Howard, Kirsten; McCaffery, Kirsten] Univ Sydney, Sch Publ Hlth, STEP, Sydney, NSW 2006, Australia; [Hersch, Jolyn; Jansen, Jesse; Barratt, Alexandra; Dhillon, Haryana; McCaffery, Kirsten] Univ Sydney, Ctr Med Psychol & Evidence Based Decis Making CeM, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	McCaffery, K (corresponding author), Univ Sydney, Sch Publ Hlth, STEP, Level 1,Edward Ford Bldg,A27, Sydney, NSW 2006, Australia.	kirsten.mccaffery@sydney.edu.au	Hersch, Jolyn/H-7153-2013; McCaffery, Kirsten/K-7945-2019; Houssami, Nehmat/ABC-1103-2020; Dhillon, Haryana M/G-8503-2011; Barratt, Alexandra/A-7349-2011	Hersch, Jolyn/0000-0001-5225-6639; McCaffery, Kirsten/0000-0003-2696-5006; Houssami, Nehmat/0000-0002-3641-952X; Dhillon, Haryana M/0000-0003-4039-5169; Barratt, Alexandra/0000-0002-2561-3319; Howard, Kirsten/0000-0002-0918-7540	Informed Medical Decisions Foundation [0189-1]; National Health and Medical Research Council of Australia [633003]	Informed Medical Decisions Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a fellowship grant (No 0189-1) awarded to JH from the Informed Medical Decisions Foundation and a grant (No 633003) awarded to the Screening and Test Evaluation Program from the National Health and Medical Research Council of Australia. The funders had no role in the design or conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation or approval of the manuscript.	Akl EA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006776.pub2; Anderson R. C., 1984, HDB READING RES, P255, DOI DOI 10.1017/CBO9781139524513.007; Australian Institute of Health and Welfare, 2011, AUSTR I HLTH WELF CA; Barratt A, 2005, BMJ-BRIT MED J, V330, P936, DOI 10.1136/bmj.38398.469479.8F; Barratt A, 2004, BMJ-BRIT MED J, V329, P507, DOI 10.1136/bmj.329.7464.507; Bekker HL, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5407; Bell RJ, 2012, MED J AUSTRALIA, V196, P17, DOI 10.5694/mja11.11476; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Collins K, 2010, BRIT J CANCER, V102, P1461, DOI 10.1038/sj.bjc.6605662; de Gelder R, 2011, EPIDEMIOL REV, V33, P111, DOI 10.1093/epirev/mxr009; Degner L F, 1997, Can J Nurs Res, V29, P21; Donella P, 2009, EUR J CANCER, V45, P3166, DOI 10.1016/j.ejca.2009.06.014; Duffy SW, 2006, WOMENS HEALTH, V2, P829, DOI 10.2217/17455057.2.6.829; Elmore JG, 2012, ANN INTERN MED, V156, P536, DOI 10.7326/0003-4819-156-7-201204030-00012; Entwistle VA, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1591; Griffiths F, 2010, HEALTH-LONDON, V14, P653, DOI 10.1177/1363459310361599; Gummersbach E, 2010, EUR J PUBLIC HEALTH, V20, P409, DOI 10.1093/eurpub/ckp174; Heath I, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2529; Hersch J, 2011, PREV MED, V53, P144, DOI 10.1016/j.ypmed.2011.06.013; Jorgensen KJ, 2010, J ROY SOC MED, V103, P14, DOI 10.1258/jrsm.2009.090342; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Jorgensen KJ, 2006, BMJ-BRIT MED J, V332, P538, DOI 10.1136/bmj.332.7540.538; Junod B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-401; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Kuper A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1035; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Mathieu E, 2007, ARCH INTERN MED, V167, P2039, DOI 10.1001/archinte.167.19.2039; Mathieu E, 2010, PATIENT EDUC COUNS, V81, P63, DOI 10.1016/j.pec.2010.01.001; McPherson K, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d791; McPherson K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3106; Morrell S, 2010, CANCER CAUSE CONTROL, V21, P275, DOI 10.1007/s10552-009-9459-z; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; NHS Breast Screening Programme, 2011, ANN REV 2011; Paul C, 2008, HEALTH POLICY, V85, P314, DOI 10.1016/j.healthpol.2007.08.007; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Prinjha S, 2006, J MED SCREEN, V13, P110, DOI 10.1258/096914106778440581; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Saalasti-Koskinen U, 2009, ACAD RADIOL, V16, P546, DOI 10.1016/j.acra.2009.02.002; Schonberg Mara A, 2007, BMC Geriatr, V7, P26, DOI 10.1186/1471-2318-7-26; Schwartz LM, 2000, BMJ-BRIT MED J, V320, P1635, DOI 10.1136/bmj.320.7250.1635; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Thornton H, 2001, Med Sci Monit, V7, P531; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Welch HG, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b1425; Wilkinson S, 1998, WOMEN STUD INT FORUM, V21, P111, DOI 10.1016/S0277-5395(97)00080-0; Willis K, 2003, AUST NZ J PUBL HEAL, V27, P282, DOI 10.1111/j.1467-842X.2003.tb00395.x; Wu DF, 2011, ONCOL REV, V5, P143, DOI 10.1007/s12156-011-0077-0; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63; Zapka JG, 2006, PATIENT EDUC COUNS, V63, P126, DOI 10.1016/j.pec.2005.09.012	52	120	122	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2013	346								f158	10.1136/bmj.f158	http://dx.doi.org/10.1136/bmj.f158			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BX	23344309	Green Published, hybrid			2022-12-24	WOS:000314217300003
J	Powell, KI; Chase, JM; Knight, TM				Powell, Kristin I.; Chase, Jonathan M.; Knight, Tiffany M.			Invasive Plants Have Scale-Dependent Effects on Diversity by Altering Species-Area Relationships	SCIENCE			English	Article							BIOLOGICAL INVASION; LONICERA-MAACKII; RICHNESS; BIODIVERSITY; EXTINCTION; DEMOGRAPHY; PATTERNS; IMPACTS; HERBS	Although invasive plant species often reduce diversity, they rarely cause plant extinctions. We surveyed paired invaded and uninvaded plant communities from three biomes. We reconcile the discrepancy in diversity loss from invaders by showing that invaded communities have lower local richness but steeper species accumulation with area than that of uninvaded communities, leading to proportionately fewer species loss at broader spatial scales. We show that invaders drive scale-dependent biodiversity loss through strong neutral sampling effects on the number of individuals in a community. We also show that nonneutral species extirpations are due to a proportionately larger effect of invaders on common species, suggesting that rare species are buffered against extinction. Our study provides a synthetic perspective on the threat of invasions to biodiversity loss across spatial scales.	[Powell, Kristin I.; Knight, Tiffany M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Powell, KI (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	kipowell@wustl.edu	B, A/AHB-5155-2022		NSF [DGE 1143954, DEB 1110629]; Tyson Research Center at Washington University in St. Louis	NSF(National Science Foundation (NSF)); Tyson Research Center at Washington University in St. Louis	We are grateful to H. Bailey, J. Hidalgo, J. Powell, and M. Schutzenhofer for field assistance. We thank B. Allan, E. Gandy, T. Hingtgen, R. Loh, T. Mohrman, and J. Shaw for support with permits and logistics at each field site. The members of the Chase and Knight labs and three anonymous reviewers provided invaluable feedback and greatly improved the analysis and presentation of the manuscript. J. M. C. is an independent researcher. Funding was provided by NSF DGE 1143954 (to K. I. P.), DEB 1110629, and the Tyson Research Center at Washington University in St. Louis. Original data for species richness and area available on Dryad (doi: 10.5061/dryad.qq08m).	Adler Peter B., 1998, Pacific Science, V52, P69; BIERZYCHUDEK P, 1982, NEW PHYTOL, V90, P757, DOI 10.1111/j.1469-8137.1982.tb03285.x; Chabrerie O, 2010, BIOL INVASIONS, V12, P1891, DOI 10.1007/s10530-009-9599-9; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Collier MH, 2002, AM MIDL NAT, V147, P60, DOI 10.1674/0003-0031(2002)147[0060:DPRAAB]2.0.CO;2; Collins MD, 2009, ENVIRON ECOL STAT, V16, P89, DOI 10.1007/s10651-007-0051-y; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davis MA, 2003, BIOSCIENCE, V53, P481, DOI 10.1641/0006-3568(2003)053[0481:BGDCFI]2.0.CO;2; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Dorning M, 2006, PLANT ECOL, V184, P287, DOI 10.1007/s11258-005-9073-4; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; Green JL, 2003, ECOLOGY, V84, P3090, DOI 10.1890/02-3096; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Gurevitch J, 2011, ECOL LETT, V14, P407, DOI 10.1111/j.1461-0248.2011.01594.x; He FL, 2002, ECOLOGY, V83, P1185, DOI 10.1890/0012-9658(2002)083[1185:SDPDFS]2.0.CO;2; Hutchinson JT, 2011, INVAS PLANT SCI MANA, V4, P349, DOI 10.1614/IPSM-D-10-00076.1; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; MacDougall AS, 2009, J ECOL, V97, P609, DOI 10.1111/j.1365-2745.2009.01514.x; Maskell LC, 2006, J ECOL, V94, P1052, DOI 10.1111/j.1365-2745.2006.01172.x; May R.M., 1975, P81; Meiners SJ, 2002, ECOGRAPHY, V25, P215, DOI 10.1034/j.1600-0587.2002.250209.x; Olszewski TD, 2004, OIKOS, V104, P377, DOI 10.1111/j.0030-1299.2004.12519.x; Powell KI, 2011, AM J BOT, V98, P539, DOI 10.3732/ajb.1000402; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Rooney TP, 2004, CONSERV BIOL, V18, P787, DOI 10.1111/j.1523-1739.2004.00515.x; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; Stohigren TJ, 2008, ECOL LETT, V11, P313, DOI 10.1111/j.1461-0248.2008.01153.x; Stohlgren TJ, 2008, ECOL LETT, V11, P324, DOI 10.1111/j.1461-0248.2008.01161.x; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Valery L, 2008, BIOL INVASIONS, V10, P1345, DOI 10.1007/s10530-007-9209-7; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601	33	199	214	7	370	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2013	339	6117					316	318		10.1126/science.1226817	http://dx.doi.org/10.1126/science.1226817			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329045				2022-12-24	WOS:000313622000043
J	Cianfrocco, MA; Kassavetis, GA; Grob, P; Fang, J; Juven-Gershon, T; Kadonaga, JT; Nogales, E				Cianfrocco, Michael A.; Kassavetis, George A.; Grob, Patricia; Fang, Jie; Juven-Gershon, Tamar; Kadonaga, James T.; Nogales, Eva			Human TFIID Binds to Core Promoter DNA in a Reorganized Structural State	CELL			English	Article							RNA-POLYMERASE-II; ELECTRON-MICROSCOPY; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; TERNARY COMPLEX; NEW-GENERATION; TATA-ELEMENT; MINOR-GROOVE; TBP; RESOLUTION	A mechanistic description of metazoan transcription is essential for understanding the molecular processes that govern cellular decisions. To provide structural insights into the DNA recognition step of transcription initiation, we used single-particle electron microscopy (EM) to visualize human TFIID with promoter DNA. This analysis revealed that TFIID coexists in two predominant and distinct structural states that differ by a 100 angstrom translocation of TFIID's lobe A. The transition between these structural states is modulated by TFIIA, as the presence of TFIIA and promoter DNA facilitates the formation of a rearranged state of TFIID that enables promoter recognition and binding. DNA labeling and footprinting, together with cryo-EM studies, were used to map the locations of TATA, Initiator (Inr), motif ten element (MTE), and downstream core promoter element (DPE) promoter motifs within the TFIID-TFIIA-DNA structure. The existence of two structurally and functionally distinct forms of TFIID suggests that the different conformers may serve as specific targets for the action of regulatory factors.	[Cianfrocco, Michael A.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Grob, Patricia; Fang, Jie; Nogales, Eva] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Nogales, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kassavetis, George A.; Kadonaga, James T.] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Juven-Gershon, Tamar] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Diego; Bar Ilan University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Nogales, E (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	enogales@lbl.gov	Juven-Gershon, Tamar/AAC-7799-2022	Juven-Gershon, Tamar/0000-0003-2607-5476; Grob, Patricia/0000-0002-8330-8961	National Institutes of Health [GM041249, GM63072]; Human Frontier in Science Program [RGP0039/2008]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063072, R01GM041249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier in Science Program(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Nogales laboratory for constant advice and help with EM analysis; R.J. Hall for initial work on this project; A. Leschziner for advice on the implementation of OTR; S. Zheng for providing TAF4 mAb; D. King for providing peptides; and R. Tjian, W.L. Liu, and R. Coleman for critical feedback and helpful discussions. This work was supported by grants from the National Institutes of Health (GM041249 to J.T.K. and GM63072 to E.N.) and the Human Frontier in Science Program (RGP0039/2008 to E.N.). E.N. is a Howard Hughes Medical Institute Investigator.	Andel F, 1999, SCIENCE, V286, P2153, DOI 10.1126/science.286.5447.2153; Bagby S, 2000, FEBS LETT, V468, P149, DOI 10.1016/S0014-5793(00)01213-8; Bhattacharya S, 2007, P NATL ACAD SCI USA, V104, P1189, DOI 10.1073/pnas.0610297104; Brand M, 1999, SCIENCE, V286, P2151, DOI 10.1126/science.286.5447.2151; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Chi TH, 1996, GENE DEV, V10, P2540, DOI 10.1101/gad.10.20.2540; Elmlund H, 2009, STRUCTURE, V17, P1442, DOI 10.1016/j.str.2009.09.007; Emami KH, 1997, GENE DEV, V11, P3007, DOI 10.1101/gad.11.22.3007; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Grob P, 2006, STRUCTURE, V14, P511, DOI 10.1016/j.str.2005.11.020; HERTZBERG RP, 1984, BIOCHEMISTRY-US, V23, P3934, DOI 10.1021/bi00312a022; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Leschziner AE, 2006, J STRUCT BIOL, V153, P284, DOI 10.1016/j.jsb.2005.10.012; Leschziner AE, 2007, ANNU REV BIOPH BIOM, V36, P43, DOI 10.1146/annurev.biophys.36.040306.132742; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; Liu DJ, 1998, CELL, V94, P573, DOI 10.1016/S0092-8674(00)81599-8; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; Liu WL, 2009, GENE DEV, V23, P1510, DOI 10.1101/gad.1790709; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Papai G, 2011, CURR OPIN GENET DEV, V21, P219, DOI 10.1016/j.gde.2011.01.009; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; Papai G, 2009, STRUCTURE, V17, P363, DOI 10.1016/j.str.2009.01.006; PAPAVASSILIOU AG, 1995, BIOCHEM J, V305, P345, DOI 10.1042/bj3050345; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; SUN XQ, 1994, GENE DEV, V8, P2336, DOI 10.1101/gad.8.19.2336; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Theisen JWM, 2010, MOL CELL BIOL, V30, P3471, DOI 10.1128/MCB.00053-10; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; UCHIDA K, 1989, NUCLEIC ACIDS RES, V17, P10259, DOI 10.1093/nar/17.24.10259; VANDYKE MW, 1982, P NATL ACAD SCI-BIOL, V79, P5470; VANDYKE MW, 1988, SCIENCE, V241, P1335, DOI 10.1126/science.3413495; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0	57	89	90	0	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					120	131		10.1016/j.cell.2012.12.005	http://dx.doi.org/10.1016/j.cell.2012.12.005			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332750	Green Accepted, Bronze			2022-12-24	WOS:000313719800011
J	Park, S; Lee, C; Sabharwal, P; Zhang, M; Meyers, CLF; Sockanathan, S				Park, Sungjin; Lee, Changhee; Sabharwal, Priyanka; Zhang, Mei; Meyers, Caren L. Freel; Sockanathan, Shanthini			GDE2 Promotes Neurogenesis by Glycosylphosphatidylinositol-Anchor Cleavage of RECK	SCIENCE			English	Article							VARIANT SURFACE GLYCOPROTEIN; DIFFERENTIATION; PROTEIN; ENZYME; EXPRESSION; DELTA1; GROWTH	The six-transmembrane protein glycerophosphodiester phosphodiesterase 2 (GDE2) induces spinal motor neuron differentiation by inhibiting Notch signaling in adjacent motor neuron progenitors. GDE2 function requires activity of its extracellular domain that shares homology with glycerophosphodiester phosphodiesterases (GDPDs). GDPDs metabolize glycerophosphodiesters into glycerol-3-phosphate and corresponding alcohols, but whether GDE2 inhibits Notch signaling by this mechanism is unclear. Here, we show that GDE2, unlike classical GDPDs, cleaves glycosylphosphatidylinositol (GPI) anchors. GDE2 GDPD activity inactivates the Notch activator RECK (reversion-inducing cysteine-rich protein with kazal motifs) by releasing it from the membrane through GPI-anchor cleavage. RECK release disinhibits ADAM (a disintegrin and metalloproteinase) protease-dependent shedding of the Notch ligand Delta-like 1 (Dll1), leading to Notch inactivation. This study identifies a previously unrecognized mechanism to initiate neurogenesis that involves GDE2-mediated surface cleavage of GPI-anchored targets to inhibit Dll1-Notch signaling.	[Park, Sungjin; Lee, Changhee; Sabharwal, Priyanka; Zhang, Mei; Sockanathan, Shanthini] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Meyers, Caren L. Freel] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Sockanathan, S (corresponding author), Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, PCTB1004,725 N Wolfe St, Baltimore, MD 21205 USA.	ssockan1@jhmi.edu	Sabharwal, Priyanka/AAA-3303-2019	Sabharwal, Priyanka/0000-0002-2099-1994; Lee, ChangHee/0000-0002-9994-3142; Freel Meyers, Caren/0000-0003-1458-0897	National Institute of Neurological Disorders and Stroke [RO1NS046336]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046336] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Englund, M. Goulding, T. M. Jessell, and B. Novitch for antibodies; J. Filmus for Notum plasmids; the Flow Cytometry and Cell Sorting Core Facility, Johns Hopkins Bloomberg School of Public Health; C. Cave III, A. L. Kolodkin, P. F. Worley, and Y. Yan for comments on the manuscript; and lab members for discussions. This work was funded by National Institute of Neurological Disorders and Stroke RO1NS046336.	BANGS JD, 1985, P NATL ACAD SCI USA, V82, P3207, DOI 10.1073/pnas.82.10.3207; Corda D, 2009, J BIOL CHEM, V284, P24848, DOI 10.1074/jbc.M109.035444; D'Souza B, 2010, CURR TOP DEV BIOL, V92, P73, DOI 10.1016/S0070-2153(10)92003-6; Fico A, 2011, CELL MOL LIFE SCI, V68, P923, DOI 10.1007/s00018-007-7471-6; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Hart G. W., 2001, CURR PROTOC PROTEIN; Heinz DW, 1998, J MOL BIOL, V275, P635, DOI 10.1006/jmbi.1997.1490; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Marklund U, 2010, DEVELOPMENT, V137, P437, DOI 10.1242/dev.036806; Muraguchi T, 2007, NAT NEUROSCI, V10, P838, DOI 10.1038/nn1922; Ohshima N, 2008, J BACTERIOL, V190, P1219, DOI 10.1128/JB.01223-07; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Rao M, 2005, SCIENCE, V309, P2212, DOI 10.1126/science.1117156; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee JS, 2002, TRENDS CELL BIOL, V12, P209, DOI 10.1016/S0962-8924(02)02280-8; Sabharwal P, 2011, NEURON, V71, P1058, DOI 10.1016/j.neuron.2011.07.028; Shi L, 2008, PROTEINS, V72, P280, DOI 10.1002/prot.21921; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Traister A, 2008, BIOCHEM J, V410, P503, DOI 10.1042/BJ20070511; Tujioka H, 1998, BIOCHEM BIOPH RES CO, V251, P737, DOI 10.1006/bbrc.1998.9542; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yan D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002493; Yan D, 2009, DEV CELL, V17, P470, DOI 10.1016/j.devcel.2009.09.001; Yan Y, 2009, CELL, V138, P1209, DOI 10.1016/j.cell.2009.06.042; Yanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P1811, DOI 10.1271/bbb.70062; ZAMZE SE, 1988, EUR J BIOCHEM, V176, P527, DOI 10.1111/j.1432-1033.1988.tb14310.x; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100; Zhuang BQ, 2009, NEURON, V61, P359, DOI 10.1016/j.neuron.2008.12.022	28	70	73	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2013	339	6117					324	328		10.1126/science.1231921	http://dx.doi.org/10.1126/science.1231921			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329048	Green Accepted			2022-12-24	WOS:000313622000046
J	Purves, D; Scharlemann, J; Harfoot, M; Newbold, T; Tittensor, DP; Hutton, J; Emmott, S				Purves, Drew; Scharlemann, Jorn; Harfoot, Mike; Newbold, Tim; Tittensor, Derek P.; Hutton, Jon; Emmott, Stephen			Time to model all life on Earth	NATURE			English	Editorial Material									[Purves, Drew] Microsoft Res, Computat Ecol & Environm Sci Grp, Cambridge, England	Microsoft	Purves, D (corresponding author), Microsoft Res, Computat Ecol & Environm Sci Grp, Cambridge, England.	dpurves@microsoft.com	Newbold, Tim/D-1524-2012; Newbold, Tim/R-8958-2019; Tittensor, Derek P./AAV-1117-2021; Scharlemann, Jorn/A-4737-2008	Newbold, Tim/0000-0001-7361-0051; Newbold, Tim/0000-0001-7361-0051; Tittensor, Derek P./0000-0002-9550-3123; Scharlemann, Jorn/0000-0002-2834-6367				Boyd IL, 2012, SCIENCE, V337, P306, DOI 10.1126/science.1225049; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606	5	96	96	2	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					295	297		10.1038/493295a	http://dx.doi.org/10.1038/493295a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TA	23325192	Bronze			2022-12-24	WOS:000313615900013
J	Ma, MM; Guo, L; Anderson, DG; Langer, R				Ma, Mingming; Guo, Liang; Anderson, Daniel G.; Langer, Robert			Bio-Inspired Polymer Composite Actuator and Generator Driven by Water Gradients	SCIENCE			English	Article							SHAPE-MEMORY POLYMERS; BIOMEDICAL APPLICATIONS; ARTIFICIAL MUSCLES; POLYPYRROLE; LIGHT; SYSTEMS; RANGE; GEL; PH	Here we describe the development of a water-responsive polymer film. Combining both a rigid matrix (polypyrrole) and a dynamic network (polyol-borate), strong and flexible polymer films were developed that can exchange water with the environment to induce film expansion and contraction, resulting in rapid and continuous locomotion. The film actuator can generate contractile stress up to 27 megapascals, lift objects 380 times heavier than itself, and transport cargo 10 times heavier than itself. We have assembled a generator by associating this actuator with a piezoelectric element. Driven by water gradients, this generator outputs alternating electricity at similar to 0.3 hertz, with a peak voltage of similar to 1.0 volt. The electrical energy is stored in capacitors that could power micro-and nanoelectronic devices.	[Ma, Mingming; Guo, Liang; Anderson, Daniel G.; Langer, Robert] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Anderson, Daniel G.; Langer, Robert] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Anderson, Daniel G.; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Langer, R (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rlanger@mit.edu	Ma, Mingming/G-1703-2011; Guo, Liang/B-8413-2012	Ma, Mingming/0000-0002-7967-8927; Guo, Liang/0000-0003-4738-4366	National Heart, Lung, and Blood Institute Program of Excellence in Nanotechnology (PEN) Award [HHSN268201000045C]; National Cancer Institute [CA151884]; Armed Forces Institute of Regenerative Medicine [W81XWH-08-2-0034]; NATIONAL CANCER INSTITUTE [U54CA151884] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute Program of Excellence in Nanotechnology (PEN) Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Armed Forces Institute of Regenerative Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	M.M. and R.L. conceived the idea and designed the experiments. M. M. and L. G. performed the experiments. M. M., L. G., D. G. A., and R. L. contributed materials and/or tools, analyzed the data, and wrote the paper. This research was supported in part by a National Heart, Lung, and Blood Institute Program of Excellence in Nanotechnology (PEN) Award, contract no. HHSN268201000045C; National Cancer Institute grant CA151884; and Armed Forces Institute of Regenerative Medicine Award no. W81XWH-08-2-0034. Experimental procedures, additional data for materials characterization, and the device test are presented in the supplementary materials. We thank D. Bong for thoughtful discussion and N. Zhang for help in the preparation of figures.	Baughman RH, 2005, SCIENCE, V308, P63, DOI 10.1126/science.1099010; Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047; Benns JM, 2000, BIOCONJUGATE CHEM, V11, P637, DOI 10.1021/bc0000177; Caldorera-Moore ME, 2011, ACCOUNTS CHEM RES, V44, P1061, DOI 10.1021/ar2001777; Camacho-Lopez M, 2004, NAT MATER, V3, P307, DOI 10.1038/nmat1118; CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0; Fratzl P, 2009, NATURE, V462, P442, DOI 10.1038/nature08603; Hara S, 2004, POLYM J, V36, P151, DOI 10.1295/polymj.36.151; Jager EWH, 2000, SCIENCE, V290, P1540, DOI 10.1126/science.290.5496.1540; Kim J, 2012, SCIENCE, V335, P1201, DOI 10.1126/science.1215309; Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102; Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496; Madden JD, 2002, MATER RES SOC SYMP P, V698, P137; Minko S., 2006, RESPONSIVE POLYM MAT; Okuzaki H, 1998, J POLYM SCI POL PHYS, V36, P2237, DOI 10.1002/(SICI)1099-0488(19980915)36:12<2237::AID-POLB20>3.0.CO;2-#; OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0; Park T, 2006, J AM CHEM SOC, V128, P13986, DOI 10.1021/ja064116s; Qin Y, 2008, NATURE, V451, P809, DOI [10.1038/nature06601, 10.1038/nature066O1]; REN XM, 1993, J PHYS CHEM-US, V97, P5356, DOI 10.1021/j100122a029; SHIBAYAMA M, 1988, POLYMER, V29, P336, DOI 10.1016/0032-3861(88)90343-6; Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516; Smela E, 2003, ADV MATER, V15, P481, DOI 10.1002/adma.200390113; SZAFRAN M, 1994, J MOL STRUCT, V321, P57, DOI 10.1016/0022-2860(93)08206-J; Ushiki T, 2002, ARCH HISTOL CYTOL, V65, P109, DOI 10.1679/aohc.65.109; van Oosten CL, 2009, NAT MATER, V8, P677, DOI [10.1038/NMAT2487, 10.1038/nmat2487]; Yu YL, 2003, NATURE, V425, P145, DOI 10.1038/425145a	26	605	625	42	1285	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					186	189		10.1126/science.1230262	http://dx.doi.org/10.1126/science.1230262			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307738	Green Accepted, Green Submitted			2022-12-24	WOS:000313328200039
J	Lauschke, VM; Tsiairis, CD; Francois, P; Aulehla, A				Lauschke, Volker M.; Tsiairis, Charisios D.; Francois, Paul; Aulehla, Alexander			Scaling of embryonic patterning based on phase-gradient encoding	NATURE			English	Article							SOMITE SEGMENTATION CLOCK; VERTEBRATE SEGMENTATION; MORPHOGEN GRADIENTS; MOUSE EMBRYO; SOMITOGENESIS; DYNAMICS; OSCILLATION; INITIATION; SYSTEMS; NUMBER	A fundamental feature of embryonic patterning is the ability to scale and maintain stable proportions despite changes in overall size, for instance during growth(1-6). A notable example occurs during vertebrate segment formation: after experimental reduction of embryo size, segments form proportionally smaller, and consequently, a normal number of segments is formed(1,7,8). Despite decades of experimental(1,7) and theoretical work(9-11), the underlying mechanism remains unknown. More recently, ultradian oscillations in gene activity have been linked to the temporal control of segmentation(12); however, their implication in scaling remains elusive. Here we show that scaling of gene oscillation dynamics underlies segment scaling. To this end, we develop a new experimental model, an ex vivo primary cell culture assay that recapitulates mouse mesoderm patterning and segment scaling, in a quasi-monolayer of presomitic mesoderm cells (hereafter termed monolayer PSM or mPSM). Combined with real-time imaging of gene activity, this enabled us to quantify the gradual shift in the oscillation phase and thus determine the resulting phase gradient across the mPSM. Crucially, we show that this phase gradient scales by maintaining a fixed amplitude across mPSM of different lengths. We identify the slope of this phase gradient as a single predictive parameter for segment size, which functions in a size-and temperature-independent manner, revealing a hitherto unrecognized mechanism for scaling. Notably, in contrast to molecular gradients, a phase gradient describes the distribution of a dynamical cellular state. Thus, our phase-gradient scaling findings reveal a new level of dynamic information-processing, and provide evidence for the concept of phase-gradient encoding during embryonic patterning and scaling.	[Lauschke, Volker M.; Tsiairis, Charisios D.; Aulehla, Alexander] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Francois, Paul] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada	European Molecular Biology Laboratory (EMBL); McGill University	Aulehla, A (corresponding author), European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany.	aulehla@embl.de	Tsiairis, Charisios/A-9145-2018; Lauschke, Volker/O-3014-2017; Francois, Paul/G-5673-2010	Lauschke, Volker/0000-0002-1140-6204; Francois, Paul/0000-0002-2223-839X; Aulehla, Alexander/0000-0003-3487-9239; Tsiairis, Charisios/0000-0002-9788-9875	Natural Science and Engineering Research Council of Canada (NSERC) [RGPIN 401950-11]; Regroupement Quebecois pour les materiaux de pointe (RQMP); McGill University	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Regroupement Quebecois pour les materiaux de pointe (RQMP); McGill University	We thank members of the Aulehla laboratory for discussion and comments on the manuscript. We thank M. Snaebjornsson for providing Supplementary Video 1. We thank F. Peri, D. Gilmour, T. Hiiragi and F. Spitz for comments on the manuscript and P. Riedinger for artwork. This work was supported by EMBL Imaging and Laboratory animal resource core facilities. The Mesp2-GFP line was provided by Y. Saga. P. F. was supported by Natural Science and Engineering Research Council of Canada (NSERC), Discovery Grant program RGPIN 401950-11, Regroupement Quebecois pour les materiaux de pointe (RQMP) and McGill University.	Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Brown D, 2006, P NATL ACAD SCI USA, V103, P9918, DOI 10.1073/pnas.0603950103; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; COOKE J, 1975, NATURE, V254, P196, DOI 10.1038/254196a0; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; GOODWIN BC, 1969, J THEOR BIOL, V25, P49, DOI 10.1016/S0022-5193(69)80017-2; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Hamaratoglu F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001182; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; KEYNES RJ, 1988, DEVELOPMENT, V103, P413; KOPELL N, 1973, SCIENCE, V180, P1171, DOI 10.1126/science.180.4091.1171; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; MEINHARDT H, 1986, SOMITES DEV EMBRYOS, P179; Meinhardt H., 1982, MODELS BIOL PATTERN; Morelli LG, 2009, HFSP J, V3, P55, DOI 10.2976/1.3027088; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Morimoto M, 2006, DEV BIOL, V300, P687, DOI 10.1016/j.ydbio.2006.08.043; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Restrepo S, 2011, CURR BIOL, V21, pR815, DOI 10.1016/j.cub.2011.08.041; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; Roeling D, 2011, CELL, V145, P800, DOI 10.1016/j.cell.2011.05.007; ROSS J, 1988, SCIENCE, V240, P460, DOI 10.1126/science.240.4851.460; Sarrazin AF, 2012, SCIENCE, V336, P338, DOI 10.1126/science.1218256; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schroter C, 2008, DEV DYNAM, V237, P545, DOI 10.1002/dvdy.21458; TAM PPL, 1981, J EMBRYOL EXP MORPH, V65, P103; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	34	118	118	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					101	+		10.1038/nature11804	http://dx.doi.org/10.1038/nature11804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23254931				2022-12-24	WOS:000312933800039
J	Pan, LP; Blanck, HM; Sherry, B; Dalenius, K; Grummer-Strawn, LM				Pan, Liping; Blanck, Heidi M.; Sherry, Bettylou; Dalenius, Karen; Grummer-Strawn, Laurence M.			Trends in the Prevalence of Extreme Obesity Among US Preschool-Aged Children Living in Low-Income Families, 1998-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							RISK-FACTORS; CHILDHOOD		[Pan, Liping; Blanck, Heidi M.; Sherry, Bettylou; Dalenius, Karen; Grummer-Strawn, Laurence M.] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Pan, LP (corresponding author), Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Atlanta, GA 30329 USA.	lpan@cdc.gov		Pan, Liping/0000-0003-0926-8719	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Flegal KM, 2009, AM J CLIN NUTR, V90, P1314, DOI 10.3945/ajcn.2009.28335; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Polhamus B., PEDIAT NUTR SURVEILL; Sen Y, 2008, EUR J PEDIATR, V167, P1183, DOI 10.1007/s00431-007-0658-x; Sharma A. J., 2009, Morbidity and Mortality Weekly Report, V58, P769; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301	6	107	108	1	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2563	2565		10.1001/jama.2012.108099	http://dx.doi.org/10.1001/jama.2012.108099			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268509	Green Accepted, Bronze			2022-12-24	WOS:000312916600014
J	Yardimci, H; Wang, XD; Loveland, AB; Tappin, I; Rudner, DZ; Hurwitz, J; van Oijen, AM; Walter, JC				Yardimci, Hasan; Wang, Xindan; Loveland, Anna B.; Tappin, Inger; Rudner, David Z.; Hurwitz, Jerard; van Oijen, Antoine M.; Walter, Johannes C.			Bypass of a protein barrier by a replicative DNA helicase	NATURE			English	Article							SIMIAN-VIRUS-40 T-ANTIGEN; LARGE-TUMOR-ANTIGEN; SINGLE-STRANDED-DNA; HEXAMERIC HELICASE; VIRAL ORIGIN; SV40 ORIGIN; IN-VITRO; MECHANISM; FORK; TRANSLOCATION	Replicative DNA helicases generally unwind DNA as a single hexamer that encircles and translocates along one strand of the duplex while excluding the complementary strand (known as steric exclusion). By contrast, large T antigen, the replicative DNA helicase of the simian virus 40 (SV40), is reported to function as a pair of stacked hexamers that pumps double-stranded DNA through its central channel while laterally extruding single-stranded DNA. Here we use single-molecule and ensemble assays to show that large T antigen assembled on the SV40 origin unwinds DNA efficiently as a single hexamer that translocates on single-stranded DNA in the 3'-to-5' direction. Unexpectedly, large T antigen unwinds DNA past a DNA-protein crosslink on the translocation strand, suggesting that the large T antigen ring can open to bypass bulky adducts. Together, our data underscore the profound conservation among replicative helicase mechanisms, and reveal a new level of plasticity in the interactions of replicative helicases with DNA damage.	[van Oijen, Antoine M.] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Yardimci, Hasan; Loveland, Anna B.; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Wang, Xindan; Rudner, David Z.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Tappin, Inger; Hurwitz, Jerard] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	University of Groningen; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center	van Oijen, AM (corresponding author), Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands.	a.m.van.oijen@rug.nl; johannes_walter@hms.harvard.edu	Wang, Xindan/Q-6600-2019; Wang, Xindan/P-3967-2014; van Oijen, Antoine/I-3167-2014; Institute, Zernike/W-7033-2019	Wang, Xindan/0000-0001-6458-180X; van Oijen, Antoine/0000-0002-1794-5161; Walter, Johannes/0000-0002-4186-7570; Loveland, Anna B./0000-0001-9172-7747; Yardimci, Hasan/0000-0001-5009-1391	National Institutes of Health (NIH) [GM62267, HL098316, GM077248, GM5 R01 GM034559, GM086466]; American Cancer Society (ACS) [RSG0823401GMC]; Netherlands Organization for Scientific Research (NWO) [Vici 680-47-607]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086466, R01GM034559, R01GM062267, R01GM077248] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society (ACS)(American Cancer Society); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Richardson for critical reading of the manuscript, and C. Etson for help in the preparation of lambda ori DNA. J.C.W. was supported by grants from the National Institutes of Health (NIH) (GM62267 and HL098316) and American Cancer Society (ACS) (RSG0823401GMC). A.M.v.O. was supported by grants from the NIH (GM077248), ACS (RSG0823401GMC), and the Netherlands Organization for Scientific Research (NWO; Vici 680-47-607). J.H. was funded by NIH grant GM5 R01 GM034559. X.W. was a long-term postdoctoral fellow of the Human Frontier Science Program; D.Z.R. was supported by NIH grant GM086466.	Alexandrov AI, 2002, J BIOL CHEM, V277, P44886, DOI 10.1074/jbc.M207022200; Anand RP, 2012, NUCLEIC ACIDS RES, V40, P1091, DOI 10.1093/nar/gkr836; Barbaro BA, 2000, J VIROL, V74, P8601, DOI 10.1128/JVI.74.18.8601-8613.2000; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; BOROWIEC JA, 1988, P NATL ACAD SCI USA, V85, P64, DOI 10.1073/pnas.85.1.64; BULLOCK PA, 1991, MOL CELL BIOL, V11, P2350, DOI 10.1128/MCB.11.5.2350; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; Cuesta I, 2010, J MOL BIOL, V397, P1276, DOI 10.1016/j.jmb.2010.02.042; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; EKI T, 1992, J BIOL CHEM, V267, P7284; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Fanning E, 2009, VIROLOGY, V384, P352, DOI 10.1016/j.virol.2008.11.038; Fanning Ellen, 2009, P1, DOI 10.1007/978-0-387-68945-6_1; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GOETZ GS, 1988, J BIOL CHEM, V263, P383; Gomez-Lorenzo MG, 2003, EMBO J, V22, P6205, DOI 10.1093/emboj/cdg612; ISHIMI Y, 1988, J BIOL CHEM, V263, P19723; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Kuhn H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn107; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Loparo JJ, 2011, P NATL ACAD SCI USA, V108, P3584, DOI 10.1073/pnas.1018824108; MACMILLAN AM, 1992, J ORG CHEM, V57, P2989, DOI 10.1021/jo00037a006; Morris PD, 2002, BIOCHEMISTRY-US, V41, P2372, DOI 10.1021/bi012058b; MURAKAMI Y, 1993, J BIOL CHEM, V268, P11008; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Sclafani RA, 2004, GENE DEV, V18, P2039, DOI 10.1101/gad.1240604; Seinsoth S, 2003, EMBO REP, V4, P263, DOI 10.1038/sj.embor.embor770; SENGUPTA DJ, 1992, SCIENCE, V256, P1656, DOI 10.1126/science.256.5064.1656; Smelkova NV, 1997, J VIROL, V71, P8766, DOI 10.1128/JVI.71.11.8766-8773.1997; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Tanner NA, 2010, SINGLE MOL TOOLS B, P259; Thomason Lynn C., 2009, V501, P239, DOI 10.1007/978-1-60327-164-6_21; Wang IN, 2006, GENETICS, V172, P17, DOI 10.1534/genetics.105.045922; Weisshart K, 1999, J VIROL, V73, P2201, DOI 10.1128/JVI.73.3.2201-2211.1999; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; WOBBE CR, 1985, P NATL ACAD SCI USA, V82, P5710, DOI 10.1073/pnas.82.17.5710; WOLD MS, 1987, P NATL ACAD SCI USA, V84, P3643, DOI 10.1073/pnas.84.11.3643; Wu CX, 2001, J VIROL, V75, P2839, DOI 10.1128/JVI.75.6.2839-2847.2001; Yardimci H, 2012, METHODS, V57, P179, DOI 10.1016/j.ymeth.2012.03.033; Yardimci H, 2010, MOL CELL, V40, P834, DOI 10.1016/j.molcel.2010.11.027	46	69	69	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					205	+		10.1038/nature11730	http://dx.doi.org/10.1038/nature11730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23201686	Green Published, Green Accepted, Green Submitted			2022-12-24	WOS:000312259300032
J	Campbell-Thompson, M; Wasserfall, C; Montgomery, EL; Atkinson, MA; Kaddis, JS				Campbell-Thompson, Martha; Wasserfall, Clive; Montgomery, Emily L.; Atkinson, Mark A.; Kaddis, John S.			Pancreas Organ Weight in Individuals With Disease-Associated Autoantibodies at Risk for Type 1 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MELLITUS		[Campbell-Thompson, Martha; Wasserfall, Clive; Montgomery, Emily L.; Atkinson, Mark A.] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Kaddis, John S.] City Hope Natl Med Ctr, Dept Informat Sci, Duarte, CA USA	State University System of Florida; University of Florida; City of Hope	Campbell-Thompson, M (corresponding author), Univ Florida, Dept Pathol, Gainesville, FL 32611 USA.	jkaddis@coh.org	wasserfall, clive/J-9078-2012; Wasserfall, Clive/ABF-9385-2020; Campbell-Thompson, Martha/A-7584-2010	wasserfall, clive/0000-0002-3522-8932; Wasserfall, Clive/0000-0002-3522-8932; Kaddis, John/0000-0002-6752-7670; Campbell-Thompson, Martha/0000-0001-6878-1235	NIDDK NIH HHS [DP3 DK101120] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Campbell-Thompson M, 2012, DIABETES-METAB RES, V28, P608, DOI 10.1002/dmrr.2316; FONSECA V, 1985, BRIT MED J, V291, P1240, DOI 10.1136/bmj.291.6504.1240; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Loftin LB, 1991, ADV ED RES SUBSTANTI, V1, P133; MANSFIELD ER, 1982, AM STAT, V36, P158, DOI 10.2307/2683167; Yu LP, 2012, DIABETES CARE, V35, P1213, DOI 10.2337/dc11-2081	6	96	96	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2012	308	22					2337	2339		10.1001/jama.2012.15008	http://dx.doi.org/10.1001/jama.2012.15008			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051MW	23232891	Bronze			2022-12-24	WOS:000312132400020
J	Arai, S; Saijo, S; Suzuki, K; Mizutani, K; Kakinuma, Y; Ishizuka-Katsura, Y; Ohsawa, N; Terada, T; Shirouzu, M; Yokoyama, S; Iwata, S; Yamato, I; Murata, T				Arai, Satoshi; Saijo, Shinya; Suzuki, Kano; Mizutani, Kenji; Kakinuma, Yoshimi; Ishizuka-Katsura, Yoshiko; Ohsawa, Noboru; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki; Iwata, So; Yamato, Ichiro; Murata, Takeshi			Rotation mechanism of Enterococcus hirae V-1-ATPase based on asymmetric crystal structures	NATURE			English	Article							ROTOR RING; V-ATPASE; NA+-ATPASE; F-1-ATPASE; COMPLEX; F-1; VALIDATION; RESOLUTION; F1-ATPASE; BINDING	In various cellular membrane systems, vacuolar ATPases (V-ATPases) function as proton pumps, which are involved in many processes such as bone resorption and cancer metastasis, and these membrane proteins represent attractive drug targets for osteoporosis and cancer(1). The hydrophilic V-1 portion is known as a rotary motor, in which a central axis DF complex rotates inside a hexagonally arranged catalytic A(3)B(3) complex using ATP hydrolysis energy, but the molecular mechanism is not well defined owing to a lack of high-resolution structural information. We previously reported on the in vitro expression, purification and reconstitution of Enterococcus hirae V-1-ATPase from the A(3)B(3) and DF complexes(2,3). Here we report the asymmetric structures of the nucleotide-free (2.8 angstrom) and nucleotide-bound (3.4 angstrom) A(3)B(3) complex that demonstrate conformational changes induced by nucleotide binding, suggesting a binding order in the right-handed rotational orientation in a cooperative manner. The crystal structures of the nucleotide-free (2.2 angstrom) and nucleotide-bound (2.7 angstrom) V-1-ATPase are also reported. The more tightly packed nucleotide-binding site seems to be induced by DF binding, and ATP hydrolysis seems to be stimulated by the approach of a conserved arginine residue. To our knowledge, these asymmetric structures represent the first high-resolution view of the rotational mechanism of V-1-ATPase.	[Arai, Satoshi; Suzuki, Kano; Mizutani, Kenji; Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Chiba 2638522, Japan; [Arai, Satoshi; Saijo, Shinya; Mizutani, Kenji; Yamato, Ichiro] Tokyo Univ Sci, Dept Biol Sci & Technol, Noda, Chiba 2788510, Japan; [Saijo, Shinya] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Mizutani, Kenji; Iwata, So] Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Kakinuma, Yoshimi] Ehime Univ, Fac Agr, Lab Mol Physiol & Genet, Matsuyama, Ehime 7908566, Japan; [Ishizuka-Katsura, Yoshiko; Ohsawa, Noboru; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki; Iwata, So; Murata, Takeshi] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Struct Biol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Murata, Takeshi] JST, PRESTO, Inage Ku, Chiba 2638522, Japan	Chiba University; Tokyo University of Science; RIKEN; Kyoto University; Ehime University; RIKEN; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Murata, T (corresponding author), Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	t.murata@faculty.chiba-u.jp	Shirouzu, Mikako/A-6521-2016; Murata, Takeshi/J-6181-2017; Yokoyama, Shigeyuki/N-6911-2015	Murata, Takeshi/0000-0002-5748-4670; Yokoyama, Shigeyuki/0000-0003-3133-7338; Mizutani, Kenji/0000-0002-7337-2134	Targeted Proteins Research Program [23370047, 23118705]; Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government; Biotechnology and Biological Sciences Research Council [BBS/B/06458] Funding Source: researchfish	Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank J. E. Walker for his suggestions, especially through the structural studies of F1-ATPase. The synchrotron radiation experiments were performed at SPring-8 and Photon Factory (proposals 2008S2-001, 2011S2-005, 2009G660, 2009B1031 and 2012G132). We also thank the beamline staff at BL41XU of SPring-8 (Harima, Japan) and NE3A, NW12A and BL1A of Photon Factory (Tsukuba, Japan) for help during data collection. This work was supported by the Targeted Proteins Research Program, grants-in-aid (23370047, 23118705), Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arai S, 2009, BIOCHEM BIOPH RES CO, V390, P698, DOI 10.1016/j.bbrc.2009.10.032; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; DeLuca M., 1978, Methods in Enzymology, V37, P3; Dittrich M, 2003, BIOPHYS J, V85, P2253, DOI 10.1016/S0006-3495(03)74650-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kabaleeswaran V, 2009, J BIOL CHEM, V284, P10546, DOI 10.1074/jbc.M900544200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; Liu Q, 1997, J BIOL CHEM, V272, P11750, DOI 10.1074/jbc.272.18.11750; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mizutani K, 2011, P NATL ACAD SCI USA, V108, P13474, DOI 10.1073/pnas.1103287108; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Murata T, 2005, J BIOENERG BIOMEMBR, V37, P411, DOI 10.1007/s10863-005-9481-0; Murata T, 2000, J BIOL CHEM, V275, P13415, DOI 10.1074/jbc.275.18.13415; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murata T, 2008, P NATL ACAD SCI USA, V105, P8607, DOI 10.1073/pnas.0800992105; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Shirakihara Y, 1997, STRUCTURE, V5, P825, DOI 10.1016/S0969-2126(97)00236-0; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Walker JE, 1998, ANGEW CHEM INT EDIT, V37, P2309, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2308::AID-ANIE2308>3.0.CO;2-W; Yamamoto M, 2008, J BIOL CHEM, V283, P19422, DOI 10.1074/jbc.M801772200; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Zhou M, 2011, SCIENCE, V334, P380, DOI 10.1126/science.1210148	42	89	89	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					703	+		10.1038/nature11778	http://dx.doi.org/10.1038/nature11778			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23334411				2022-12-24	WOS:000314219600063
J	Perk, J				Perk, Joep			PERSPECTIVE The power of disease prevention	NATURE			English	Editorial Material							RISK		Linnaeus Univ, Kalmar, Sweden	Linnaeus University	Perk, J (corresponding author), Linnaeus Univ, Kalmar, Sweden.	joep.perk@lnu.se						Banegas JR, 2011, EUR HEART J, V32, P2143, DOI 10.1093/eurheartj/ehr080; Chow CK, 2010, CIRCULATION, V121, P750, DOI 10.1161/CIRCULATIONAHA.109.891523; Di Chiara A, 2009, EUR HEART J, V30, P1027, DOI 10.1093/eurheartj/ehp025; Jorgensen T, 2013, EUR J PREV CARDIOL, V20, P409, DOI 10.1177/2047487312441726; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; WHO, 2002, DIET NUTR PREV CHRON; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	7	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					S6	S6		10.1038/493S6a	http://dx.doi.org/10.1038/493S6a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	080CU	23364770				2022-12-24	WOS:000314219600006
J	Oisi, Y; Ota, KG; Kuraku, S; Fujimoto, S; Kuratani, S				Oisi, Yasuhiro; Ota, Kinya G.; Kuraku, Shigehiro; Fujimoto, Satoko; Kuratani, Shigeru			Craniofacial development of hagfishes and the evolution of vertebrates	NATURE			English	Article							LETHENTERON-JAPONICUM; BDELLOSTOMA STOUTI; LAMPETRA-JAPONICA; TRIGEMINAL NERVE; NEURAL CREST; GENES; EXPRESSION; LAMPREYS; ADENOHYPOPHYSIS; ORGANIZATION	Cyclostomes, the living jawless vertebrates including hagfishes and lampreys, represent the most basal lineage of vertebrates. Although the monophyly of cyclostomes has been supported by recent molecular analyses, the phenotypic traits of hagfishes, especially the lack of some vertebrate-defining features and the reported endodermal origin of the adenohypophysis, have been interpreted as hagfishes exhibiting a more ancestral state than those of all other vertebrates. Furthermore, the adult anatomy of hagfishes cannot be compared easily with that of lampreys. Here we describe the craniofacial development of a series of staged hagfish embryos, which shows that their adenohypophysis arises ectodermally, consistent with the molecular phylogenetic data. This finding also allowed us to identify a pan-cyclostome pattern, one not shared by jawed vertebrates. Comparative analyses indicated that many of the hagfish-specific traits can be explained by changes secondarily introduced into the hagfish lineage. We also propose a possibility that the pan-cyclostome pattern may reflect the ancestral programme for the craniofacial development of all living vertebrates.	[Oisi, Yasuhiro] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 6578501, Japan; [Oisi, Yasuhiro; Fujimoto, Satoko; Kuratani, Shigeru] RIKEN Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo 6500047, Japan; [Ota, Kinya G.] Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Yilan 26242, Taiwan; [Kuraku, Shigehiro] RIKEN Ctr Dev Biol, Genome Resource & Anal Unit, Kobe, Hyogo 6500047, Japan	Kobe University; RIKEN; RIKEN	Kuratani, S (corresponding author), RIKEN Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo 6500047, Japan.	saizo@cdb.riken.jp	Kuraku, Shigehiro/B-2801-2009; Kuratani, Shigeru/J-4146-2014	Kuraku, Shigehiro/0000-0003-1464-8388; Kuratani, Shigeru/0000-0001-9717-7221	Grants-in-Aid for Scientific Research [22128003] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adachi N, 2012, EVOL DEV, V14, P234, DOI 10.1111/j.1525-142X.2012.00542.x; BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; BARDACK D, 1991, SCIENCE, V254, P701, DOI 10.1126/science.254.5032.701; Candiani S, 2008, BRAIN RES BULL, V75, P324, DOI 10.1016/j.brainresbull.2007.10.023; Charles MA, 2005, MOL ENDOCRINOL, V19, P1893, DOI 10.1210/me.2005-0052; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Dean B., 1899, EMBRYOLOGY BDELLOSTO, P220; FOREY P, 1993, NATURE, V361, P129, DOI 10.1038/361129a0; Gai ZK, 2011, NATURE, V476, P324, DOI 10.1038/nature10276; Gess RW, 2006, NATURE, V443, P981, DOI 10.1038/nature05150; GORBMAN A, 1983, AM ZOOL, V23, P639; GORBMAN A, 1985, EVOLUTIONARY BIOL PR, P165; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; Horigome N, 1999, DEV BIOL, V207, P287, DOI 10.1006/dbio.1998.9175; Janvier P., 1996, EARLY VERTEBRATES; Janvier P, 2008, ZOOL SCI, V25, P1045, DOI 10.2108/zsj.25.1045; Jean D, 1999, MECH DEVELOP, V84, P31, DOI 10.1016/S0925-4773(99)00068-4; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KOYAMA H, 1987, J COMP NEUROL, V264, P437, DOI 10.1002/cne.902640402; Kuraku S, 1999, J MOL EVOL, V49, P729, DOI 10.1007/PL00006595; Kuraku S, 2008, ZOOL SCI, V25, P960, DOI 10.2108/zsj.25.960; Kuratani S, 2008, J EXP ZOOL PART B, V310B, P294, DOI 10.1002/jez.b.21190; Kuratani S, 2012, EVOL DEV, V14, P76, DOI 10.1111/j.1525-142X.2011.00523.x; Mallat J, 1998, MOL BIOL EVOL, V15, P1706, DOI 10.1093/oxfordjournals.molbev.a025897; Marinelli W., 1956, VERGLEICHENDE ANATOM; Maruoka Y, 1998, MECH DEVELOP, V74, P175, DOI 10.1016/S0925-4773(98)00061-6; NISHIZAWA H, 1988, J COMP NEUROL, V267, P281, DOI 10.1002/cne.902670210; Ogasawara M, 2000, DEV BIOL, V223, P399, DOI 10.1006/dbio.2000.9756; Ota KG, 2007, NATURE, V446, P672, DOI 10.1038/nature05633; Ota KG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1355; Schlosser G, 2005, J EXP ZOOL PART B, V304B, P347, DOI 10.1002/jez.b.21055; SONG J, 1993, ACTA ANAT, V148, P139; Soukup V., 2012, J ANAT; Sower SA, 2009, GEN COMP ENDOCR, V161, P20, DOI 10.1016/j.ygcen.2008.11.023; Steinberg M., 1957, YB CARNEGIE I WASH, V56, P347; Stensio E.A., 1927, SKRIFTER SVALBARD NO, DOI DOI 10.3402/POLAR.V14I1.6649; Stockard CR, 1906, AM J ANAT, V5, P481, DOI 10.1002/aja.1000050405; Stockard CR, 1906, AM J ANAT, V6, P511, DOI 10.1002/aja.1000060114; STRAHAN RONALD, 1958, ACTA ZOOL [STOCKHOLM], V39, P227; Sugahara F, 2011, DEVELOPMENT, V138, P1217, DOI 10.1242/dev.059360; TAHARA Y, 1988, ZOOL SCI, V5, P109; Takezaki N, 2003, MOL BIOL EVOL, V20, P287, DOI 10.1093/molbev/msg040; Takio Y, 2007, DEV BIOL, V308, P606, DOI 10.1016/j.ydbio.2007.05.009; Tiecke E, 2007, DEV GENES EVOL, V217, P691, DOI 10.1007/s00427-007-0181-0; Uchida K, 2003, J EXP ZOOL PART B, V300B, P32, DOI 10.1002/jez.b.00044; Uchida K, 2010, P NATL ACAD SCI USA, V107, P15832, DOI 10.1073/pnas.1002208107; von Kupffer C., 1900, STUDIEN VERGLEICHEND; WICHT H, 1995, PHILOS T ROY SOC B, V349, P119, DOI 10.1098/rstb.1995.0098; Wicht H, 1998, BIOLOGY OF HAGFISHES, P431; YALDEN DW, 1985, ZOOL J LINN SOC-LOND, V84, P291, DOI 10.1111/j.1096-3642.1985.tb01802.x	50	96	99	0	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					175	180		10.1038/nature11794	http://dx.doi.org/10.1038/nature11794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23254938				2022-12-24	WOS:000313259600030
J	Vance, E				Vance, Erik			MEGADATA The odd couple	NATURE			English	Editorial Material																			0	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					S52	S54		10.1038/491S52a	http://dx.doi.org/10.1038/491S52a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040RE	23320285	Bronze			2022-12-24	WOS:000311339800003
J	Bresee, J; Hayden, FG				Bresee, Joseph; Hayden, Frederick G.			Epidemic Influenza - Responding to the Expected but Unpredictable	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VACCINE		[Bresee, Joseph] Ctr Dis Control & Prevent, Epidemiol & Prevent Branch, Influenza Div, Atlanta, GA 30333 USA; [Hayden, Frederick G.] Univ Virginia, Sch Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA	Centers for Disease Control & Prevention - USA; University of Virginia	Bresee, J (corresponding author), Ctr Dis Control & Prevent, Epidemiol & Prevent Branch, Influenza Div, Atlanta, GA 30333 USA.							[Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P32; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; Muthuri SG, 2013, J INFECT DIS; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Vesikari T, 2011, NEW ENGL J MED, V365, P1406, DOI 10.1056/NEJMoa1010331	5	25	30	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					589	592		10.1056/NEJMp1300375	http://dx.doi.org/10.1056/NEJMp1300375			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194VA	23343038				2022-12-24	WOS:000322659600002
J	Czabotar, PE; Westphal, D; Dewson, G; Ma, S; Hockings, C; Fairlie, WD; Lee, EF; Yao, SG; Robin, AY; Smith, BJ; Huang, DCS; Kluck, RM; Adams, JM; Colman, PM				Czabotar, Peter E.; Westphal, Dana; Dewson, Grant; Ma, Stephen; Hockings, Colin; Fairlie, W. Douglas; Lee, Erinna F.; Yao, Shenggen; Robin, Adeline Y.; Smith, Brian J.; Huang, David C. S.; Kluck, Ruth M.; Adams, Jerry M.; Colman, Peter M.			Bax Crystal Structures Reveal How BH3 Domains Activate Bax and Nucleate Its Oligomerization to Induce Apoptosis	CELL			English	Article							BCL-2 PROTEIN FAMILY; MEMBRANE PERMEABILIZATION; PROAPOPTOTIC BAX; PORE FORMATION; X-RAY; MITOCHONDRIA; DIMERIZATION; INTERFACE; BCL-X(L); CYTOSOL	In stressed cells, apoptosis ensues when Bcl-2 family members Bax or Bak oligomerize and permeabilize the mitochondrial outer membrane. Certain BH3-only relatives can directly activate them to mediate this pivotal, poorly understood step. To clarify the conformational changes that induce Bax oligomerization, we determined crystal structures of Bax Delta C21 treated with detergents and BH3 peptides. The peptides bound the Bax canonical surface groove but, unlike their complexes with prosurvival relatives, dissociated Bax into two domains. The structures define the sequence signature of activator BH3 domains and reveal how they can activate Bax via its groove by favoring release of its BH3 domain. Furthermore, Bax helices alpha 2-alpha 5 alone adopted a symmetric homodimer structure, supporting the proposal that two Bax molecules insert their BH3 domain into each other's surface groove to nucleate oligomerization. A planar lipophilic surface on this homodimer may engage the membrane. Our results thus define critical Bax transitions toward apoptosis.	[Czabotar, Peter E.; Westphal, Dana; Dewson, Grant; Ma, Stephen; Hockings, Colin; Fairlie, W. Douglas; Lee, Erinna F.; Yao, Shenggen; Robin, Adeline Y.; Huang, David C. S.; Kluck, Ruth M.; Adams, Jerry M.; Colman, Peter M.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Czabotar, Peter E.; Westphal, Dana; Dewson, Grant; Ma, Stephen; Hockings, Colin; Fairlie, W. Douglas; Lee, Erinna F.; Yao, Shenggen; Robin, Adeline Y.; Huang, David C. S.; Kluck, Ruth M.; Adams, Jerry M.; Colman, Peter M.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3052, Australia; [Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic 3086, Australia	Walter & Eliza Hall Institute; University of Melbourne; La Trobe University	Czabotar, PE (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia.	czabotar@wehi.edu.au; pcolman@wehi.edu.au	Lee, Erinna/N-1523-2015; dewson, grant/C-7646-2013; Smith, Brian J/F-8282-2011; Yao, Shenggen/ABH-9989-2020; Yao, Shenggen/AAE-1602-2019; Adams, Jerry M/E-1199-2013; Fairlie, Walter/M-8401-2015; Huang, David C. S./C-7586-2013; Kluck, Ruth M/C-8413-2013	Lee, Erinna/0000-0003-1255-9808; dewson, grant/0000-0003-4251-8898; Smith, Brian J/0000-0003-0498-1910; Yao, Shenggen/0000-0002-7137-9615; Fairlie, Walter/0000-0002-2498-1160; Huang, David C. S./0000-0002-3101-4873; Kluck, Ruth M/0000-0002-7101-1925; Czabotar, Peter/0000-0002-2594-496X; Hockings, Colin/0000-0002-0248-0517; Adams, Jerry/0000-0002-4360-8628; Robin, Adeline/0000-0002-1199-2135	ARC; DFG (Germany); NHMRC (Australia); ARC (Australia); Australian Cancer Research Foundation; Cancer Council of Victoria; Leukemia and Lymphoma Society (US); Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS	ARC(Australian Research Council); DFG (Germany)(German Research Foundation (DFG)); NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia); ARC (Australia)(Australian Research Council); Australian Cancer Research Foundation; Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukemia and Lymphoma Society (US)(Leukemia and Lymphoma Society); Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia)	We thank Ahmed Wardak, Geoff Thompson, Hong Yang, Eden Whitlock, and Leonie Gibson for technical support; Jacqui Gulbis for comments on the manuscript; and beamline staff at the Australian Synchrotron, where diffraction data were collected. We thank Richard Youle for the full-length Bax construct, Motoshi Suzuki and Nico Tjandra for NMR chemical shift data, and Masato Kawasaki for the pET28a-GFP vector. Crystallization experiments were performed at the Bio21 C3 Collaborative Crystallization Centre. P.E.C. acknowledges an ARC Future Fellowship, and D.W. acknowledges a DFG (Germany) Postdoctoral Fellowship. Our work is supported by NHMRC (Australia), ARC (Australia), the Australian Cancer Research Foundation, the Cancer Council of Victoria, the Leukemia and Lymphoma Society (US), the Victorian State Government Operational Infrastructure Support, and the Australian Government NHMRC IRIISS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; Bennett MJ, 2004, STRUCTURE, V12, P1339, DOI 10.1016/j.str.2004.07.004; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Bogner C, 2010, CURR OPIN CELL BIOL, V22, P845, DOI 10.1016/j.ceb.2010.08.002; Cartron PF, 2002, HUM MOL GENET, V11, P675, DOI 10.1093/hmg/11.6.675; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Czabotar PE, 2011, J BIOL CHEM, V286, P7123, DOI 10.1074/jbc.M110.161281; Dai HM, 2011, J CELL BIOL, V194, P38, DOI 10.1083/jcb.201102027; Dewson G, 2012, CELL DEATH DIFFER, V19, P661, DOI 10.1038/cdd.2011.138; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epand RF, 2003, BIOCHEMISTRY-US, V42, P14576, DOI 10.1021/bi035348w; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Fu NY, 2009, MOL CELL, V33, P15, DOI 10.1016/j.molcel.2008.11.025; Fuhrmans M, 2012, J AM CHEM SOC, V134, P1543, DOI 10.1021/ja207290b; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lee EF, 2009, ANGEW CHEM INT EDIT, V48, P4318, DOI 10.1002/anie.200805761; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai A, 2009, J CELL BIOL, V185, P189, DOI 10.1083/jcb.200903134; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Oh KJ, 2010, J BIOL CHEM, V285, P28924, DOI 10.1074/jbc.M110.135293; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pang YP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00257; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Suzuki N, 2010, ACTA CRYSTALLOGR D, V66, P1059, DOI 10.1107/S0907444910032944; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang Z, 2010, J BIOL CHEM, V285, P17614, DOI 10.1074/jbc.M110.113456	62	399	412	3	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					519	531		10.1016/j.cell.2012.12.031	http://dx.doi.org/10.1016/j.cell.2012.12.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374347	Bronze			2022-12-24	WOS:000314362800021
J	Gwynne, P				Gwynne, Peter			DIAGNOSTICS The new risk predictors	NATURE			English	Editorial Material							ARTERY CALCIUM SCORES; SCREEN											Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Ebell MH, 2012, AM FAM PHYSICIAN, V86, P405; Murrow JR, 2012, AM FAM PHYSICIAN, V86, P398; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Qi L., 2012, THROMB VASC BIOL, V32, P2314; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	7	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					S7	S8		10.1038/493S7a	http://dx.doi.org/10.1038/493S7a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364771				2022-12-24	WOS:000314219600007
J	Willyard, C				Willyard, Cassandra			PATHOLOGY At the heart of the problem	NATURE			English	Editorial Material																		Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Jensen MK, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000232; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Sacks FM, 2000, CIRCULATION, V102, P1886, DOI 10.1161/01.CIR.102.16.1886; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922	6	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					S10	S11		10.1038/493S10a	http://dx.doi.org/10.1038/493S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364764	Bronze			2022-12-24	WOS:000314219600009
J	Goode, J				Goode, Jamie			VITICULTURE Fruity with a hint of drought	NATURE			English	Editorial Material												jamie@wineanorak.com							0	8	8	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					351	353		10.1038/492351a	http://dx.doi.org/10.1038/492351a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23257865	Bronze			2022-12-24	WOS:000312488200063
J	McArdle, C				McArdle, Ciarstan			PERSONAL VIEW Patients with melanoma are avoiding follow-up to get insurance	BRITISH MEDICAL JOURNAL			English	Editorial Material							CUTANEOUS MELANOMA		James Cook Univ Hosp, Dept Plast Surg, Middlesbrough TS4 3BW, Cleveland, England	James Cook University Hospital	McArdle, C (corresponding author), James Cook Univ Hosp, Dept Plast Surg, Middlesbrough TS4 3BW, Cleveland, England.	ciarstanmcardle@gmail.com						American Cancer Society, 2012, LEARN CANC MAL SKIN; Cancer Research UK, 2012, SKIN CANC INC STAT T; DiFronzo LA, 1999, ANN SURG ONCOL, V6, P705, DOI 10.1007/s10434-999-0705-0; Marsden JR, 2010, BRIT J DERMATOL, V163, P238, DOI [10.1111/j.1365-2133.2010.09883.x, 10.1016/j.bjps.2010.07.006]	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 3	2012	345								e7803	10.1136/bmj.e7803	http://dx.doi.org/10.1136/bmj.e7803			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HO	23208251				2022-12-24	WOS:000312188700004
J	Palfrey, JS; Palfrey, S				Palfrey, Judith S.; Palfrey, Sean			Preventing Gun Deaths in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Palfrey, Judith S.] Boston Childrens Hosp, Div Gen Pediat, Boston, MA USA; [Palfrey, Sean] Boston Med Ctr, Dept Pediat, Boston, MA USA	Harvard University; Boston Children's Hospital; Boston Medical Center	Palfrey, JS (corresponding author), Boston Childrens Hosp, Div Gen Pediat, Boston, MA USA.							Barkin SL, 2008, PEDIATRICS, V122, pE15, DOI 10.1542/peds.2007-2611; Gardner HG, 2012, PEDIATRICS, V130, pE1416, DOI 10.1542/peds.2012-2481; Kellermann AL, JAMA; Olson LM, 2010, PED AC SOC ANN M VAN	4	27	27	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2013	368	5					401	403		10.1056/NEJMp1215606	http://dx.doi.org/10.1056/NEJMp1215606			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BE	23272974				2022-12-24	WOS:000314215400003
J	Coffin, PO; Sullivan, SD				Coffin, Phillip O.; Sullivan, Sean D.			Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal	ANNALS OF INTERNAL MEDICINE			English	Article							INJECTION-DRUG USERS; NEW-YORK-CITY; SAN-FRANCISCO; NONFATAL OVERDOSE; OPIOID OVERDOSE; UNITED-STATES; METHADONE-MAINTENANCE; PROSPECTIVE COHORT; HEALTH-CARE; FOLLOW-UP	Background: Opioid overdose is a leading cause of accidental death in the United States. Objective: To estimate the cost-effectiveness of distributing naloxone, an opioid antagonist, to heroin users for use at witnessed overdoses. Design: Integrated Markov and decision analytic model using deterministic and probabilistic analyses and incorporating recurrent overdoses and a secondary analysis assuming heroin users are a net cost to society. Data Sources: Published literature calibrated to epidemiologic data. Target Population: Hypothetical 21-year-old novice U. S. heroin user and more experienced users with scenario analyses. Time Horizon: Lifetime. Perspective: Societal. Intervention: Naloxone distribution for lay administration. Outcome Measures: Overdose deaths prevented and incremental cost-effectiveness ratio (ICER). Results of Base-Case Analysis: In the probabilistic analysis, 6% of overdose deaths were prevented with naloxone distribution; 1 death was prevented for every 227 naloxone kits distributed (95% CI, 71 to 716). Naloxone distribution increased costs by $53 (CI, $3 to $156) and quality-adjusted life-years by 0.119 (CI, 0.017 to 0.378) for an ICER of $438 (CI, $48 to $1706). Results of Sensitivity Analysis: Naloxone distribution was cost-effective in all deterministic and probabilistic sensitivity and scenario analyses, and it was cost-saving if it resulted in fewer overdoses or emergency medical service activations. In a "worst-case scenario" where overdose was rarely witnessed and naloxone was rarely used, minimally effective, and expensive, the ICER was $14 000. If national drug-related expenditures were applied to heroin users, the ICER was $2429. Limitation: Limited sources of controlled data resulted in wide CIs. Conclusion: Naloxone distribution to heroin users is likely to reduce overdose deaths and is cost-effective, even under markedly conservative assumptions. Primary Funding Source: National Institute of Allergy and Infectious Diseases. Ann Intern Med. 2013;158:1-9.	[Coffin, Phillip O.] San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA; Univ Washington, Seattle, WA 98195 USA	San Francisco Department of Public Health; University of Washington; University of Washington Seattle	Coffin, PO (corresponding author), San Francisco Dept Publ Hlth, 25 Van Ness Ave,Suite 500, San Francisco, CA 94102 USA.	pcoffin@gmail.com	Coffin, Phillip O/G-3286-2012	Coffin, Phillip O/0000-0002-3891-6570	National Institute of Allergy and Infectious Diseases; National Institute of Allergy and Infectious Diseases at the National Institutes of Health [5T32AI007140-33]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007140] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institute of Allergy and Infectious Diseases.; Grant Support: By grant 5T32AI007140-33 from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.	Albert S, 2011, PAIN MED, V12, pS77, DOI 10.1111/j.1526-4637.2011.01128.x; Bassett IV, 2010, CLIN INFECT DIS, V50, pS77, DOI 10.1086/651477; Bohnert ASB, 2012, DRUG ALCOHOL DEPEN, V120, P168, DOI 10.1016/j.drugalcdep.2011.07.018; Bohnert ASB, 2009, ANN EMERG MED, V54, P618, DOI 10.1016/j.annemergmed.2009.05.004; Briggs A, 2006, DECISION MODELLING H; Bruneau J, 2004, ADDICTION, V99, P727, DOI 10.1111/j.1360-0443.2004.00713.x; Centers for Disease Control and Prevention, 2005, WEB BAS INJ STAT QUE; Coffin P, 2012, 19 INT AIDS C WASH D; Coffin PO, 2007, ACAD EMERG MED, V14, P616, DOI 10.1111/j.1553-2712.2007.tb01846.x; Coffin PO, 2003, ADDICTION, V98, P739, DOI 10.1046/j.1360-0443.2003.00376.x; Coffin PO, 2011, EPIDEMIOLOGIC TRENDS; Darke S, 1996, ADDICTION, V91, P413, DOI 10.1046/j.1360-0443.1996.91341310.x; Darke S, 1996, ADDICTION, V91, P405, DOI 10.1111/j.1360-0443.1996.tb02289.x; Darke S, 2007, J URBAN HEALTH, V84, P283, DOI 10.1007/s11524-006-9156-0; Darke S, 2011, DRUG ALCOHOL DEPEN, V115, P190, DOI 10.1016/j.drugalcdep.2010.10.021; Davidson PJ, 2003, J URBAN HEALTH, V80, P261, DOI 10.1093/jurban/jtg029; Davidson PJ, 2002, ADDICTION, V97, P1511, DOI 10.1046/j.1360-0443.2002.00210.x; Doe-Simkins M, 2009, AM J PUBLIC HEALTH, V99, P788, DOI 10.2105/AJPH.2008.146647; Enteen L, 2010, J URBAN HEALTH, V87, P931, DOI 10.1007/s11524-010-9495-8; Evans JL, 2012, AM J EPIDEMIOL, V175, P302, DOI 10.1093/aje/kwr318; Evans JL, 2009, DRUG ALCOHOL DEPEN, V101, P152, DOI 10.1016/j.drugalcdep.2008.12.007; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Galea S, 2006, ADDICT BEHAV, V31, P907, DOI 10.1016/j.addbeh.2005.07.020; Gossop M, 1996, BRIT MED J, V313, P402; Green TC, 2008, ADDICTION, V103, P979, DOI 10.1111/j.1360-0443.2008.02182.x; Hakansson A, 2008, DRUG ALCOHOL DEPEN, V94, P48, DOI 10.1016/j.drugalcdep.2007.10.014; Hart A, 2011, ANN REPORT FISCAL YE, P148; Hart A, 2004, ANN REPORT JULY 2002, P30; Havens JR, 2011, DRUG ALCOHOL DEPEN, V115, P107, DOI 10.1016/j.drugalcdep.2010.11.003; Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503; Hser YI, 2002, OAS ANAL SERIES A; Huo DZ, 2006, ADDICTION, V101, P1606, DOI 10.1111/j.1360-0443.2006.01577.x; Jenkins LM, 2011, J URBAN HEALTH, V88, P118, DOI 10.1007/s11524-010-9525-6; Lankenau SE, 2012, J COMMUNITY HLTH; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; Leavitt SB, 2010, PRACT PAIN MANAG, V10; Lee CP, 2009, VALUE HEALTH, V12, P80, DOI 10.1111/j.1524-4733.2008.00401.x; Lenton SR, 2000, MED J AUSTRALIA, V173, P260, DOI 10.5694/j.1326-5377.2000.tb125633.x; Mackesy-Amiti ME, 2011, ADDICTION, V106, P601, DOI 10.1111/j.1360-0443.2010.03251.x; Maxwell S, 2006, J ADDICT DIS, V25, P89, DOI 10.1300/J069v25n03_11; McAuley A, 2012, DRUG-EDUC PREV POLIC, V19, P309, DOI 10.3109/09687637.2012.682232; Milloy MJS, 2008, AM J DRUG ALCOHOL AB, V34, P499, DOI 10.1080/00952990802122457; Nosyk B, 2010, J CLIN EPIDEMIOL, V63, P1132, DOI 10.1016/j.jclinepi.2009.12.003; Ochoa KC, 2005, DRUG ALCOHOL DEPEN, V80, P297, DOI 10.1016/j.drugalcdep.2005.04.012; Office of National Drug Control Policy, 2004, OFF NAT DRUG CONT PO; Paone D, 2010, ILLICIT DRUG USE NEW; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Piper TM, 2008, SUBST USE MISUSE, V43, P858, DOI 10.1080/10826080701801261; Pollini RA, 2006, DRUG ALCOHOL DEPEN, V83, P104, DOI 10.1016/j.drugalcdep.2005.10.015; Pyne JM, 2011, ADDICTION, V106, P507, DOI 10.1111/j.1360-0443.2010.03299.x; Rudolph SS, 2011, RESUSCITATION, V82, P1414, DOI 10.1016/j.resuscitation.2011.06.027; Sporer KA, 1996, ACAD EMERG MED, V3, P660, DOI 10.1111/j.1553-2712.1996.tb03487.x; Sporer KA, 1999, ANN INTERN MED, V130, P584, DOI 10.7326/0003-4819-130-7-199904060-00019; Sporer KA, 2007, ANN EMERG MED, V49, P172, DOI 10.1016/j.annemergmed.2006.05.025; Stoove MA, 2009, DRUG ALCOHOL REV, V28, P347, DOI 10.1111/j.1465-3362.2009.00057.x; Stout NK, 2009, PHARMACOECONOMICS, V27, P533, DOI 10.2165/11314830-000000000-00000; Strang J, 2008, ADDICTION, V103, P1648, DOI 10.1111/j.1360-0443.2008.02314.x; Substance Abuse and Mental Health Services Administration, 2010, NSDUH SER A; Teesson M, 2008, ADDICTION, V103, P80, DOI 10.1111/j.1360-0443.2007.02029.x; Tobin KE, 2009, INT J DRUG POLICY, V20, P131, DOI 10.1016/j.drugpo.2008.03.002; Tracy M, 2005, DRUG ALCOHOL DEPEN, V79, P181, DOI 10.1016/j.drugalcdep.2005.01.010; Vanagas G, 2010, MEDICINA-LITHUANIA, V46, P286, DOI 10.3390/medicina46040040; Vilke GM, 2003, ACAD EMERG MED, V10, P893, DOI 10.1197/aemj.10.8.893; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Vlahov D, 2008, SUBST USE MISUSE, V43, P413, DOI 10.1080/10826080701203013; Wagner KD, 2010, INT J DRUG POLICY, V21, P186, DOI 10.1016/j.drugpo.2009.01.003; Walley AY, 2012, ROL NAL OP OV FAT PR; Wampler DA, 2011, PREHOSP EMERG CARE, V15, P320, DOI 10.3109/10903127.2011.569854; Wheeler Eliza, 2012, Morbidity and Mortality Weekly Report, V61, P101; Wu LT, 2011, SUBST ABUSE REHABIL, V2, P77, DOI 10.2147/SAR.S18969; Yokell Michael A, 2011, Med Health R I, V94, P240; Zador D, 1996, MED J AUSTRALIA, V164, P204, DOI 10.5694/j.1326-5377.1996.tb94136.x; Zaric GS, 2000, AM J PUBLIC HEALTH, V90, P1100, DOI 10.2105/AJPH.90.7.1100	73	209	211	0	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2013	158	1					1	U42		10.7326/0003-4819-158-1-201301010-00003	http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00003			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	065AV	23277895				2022-12-24	WOS:000313119900002
J	Winkelmann, R; Levermann, A; Martin, MA; Frieler, K				Winkelmann, R.; Levermann, A.; Martin, M. A.; Frieler, K.			Increased future ice discharge from Antarctica owing to higher snowfall	NATURE			English	Article							MODEL PISM-PIK; CLIMATE-CHANGE; SHEET; SHELF; BENEATH; FLOW	Anthropogenic climate change is likely to cause continuing global sea level rise(1), but some processes within the Earth system may mitigate the magnitude of the projected effect. Regional and global climate models simulate enhanced snowfall over Antarctica, which would provide a direct offset of the future contribution to global sea level rise from cryospheric mass loss(2,3) and ocean expansion(4). Uncertainties exist in modelled snowfall(5), but even larger uncertainties exist in the potential changes of dynamic ice discharge from Antarctica(1,6) and thus in the ultimate fate of the precipitation-deposited ice mass. Here we show that snowfall and discharge are not independent, but that future ice discharge will increase by up to three times as a result of additional snowfall under global warming. Our results, based on an ice-sheet model(7) forced by climate simulations through to the end of 2500 (ref. 8), show that the enhanced discharge effect exceeds the effect of surface warming as well as that of basal ice-shelf melting, and is due to the difference in surface elevation change caused by snowfall on grounded versus floating ice. Although different underlying forcings drive ice loss from basal melting versus increased snowfall, similar ice dynamical processes are nonetheless at work in both; therefore results are relatively independent of the specific representation of the transition zone. In an ensemble of simulations designed to capture ice-physics uncertainty, the additional dynamic ice loss along the coastline compensates between 30 and 65 per cent of the ice gain due to enhanced snowfall over the entire continent. This results in a dynamic ice loss of up to 1.25 metres in the year 2500 for the strongest warming scenario. The reported effect thus strongly counters a potential negative contribution to global sea level by the Antarctic Ice Sheet.	[Winkelmann, R.; Levermann, A.; Martin, M. A.; Frieler, K.] Potsdam Inst Climate Impact Res PIK, D-14473 Potsdam, Germany; [Winkelmann, R.; Levermann, A.; Martin, M. A.] Univ Potsdam, Inst Phys, D-14476 Potsdam, Germany	Potsdam Institut fur Klimafolgenforschung; University of Potsdam	Winkelmann, R (corresponding author), Potsdam Inst Climate Impact Res PIK, D-14473 Potsdam, Germany.	ricarda.winkelmann@pik-potsdam.de	Levermann, Anders/G-4666-2011	Levermann, Anders/0000-0003-4432-4704; Winkelmann, Ricarda/0000-0003-1248-3217; Frieler, Katja/0000-0003-4869-3013	German Federal Ministry of Education and Research (BMBF) [01LP1171A]; German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU) [11_II_093_Global_A_SIDS, 11_II_093_Global_A_LDCs]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU)	This study was supported by the German Federal Ministry of Education and Research (BMBF, grant 01LP1171A) and the German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU, grant 11_II_093_Global_A_SIDS and LDCs).	Dinniman MS, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004036; Dupont TK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022024; Frieler K, 2012, J CLIMATE, V25, P3117, DOI 10.1175/JCLI-D-11-00199.1; Grosfeld K., 1998, ANTARCT RES SER, V75, P83; Huybrechts P, 1999, J CLIMATE, V12, P2169, DOI 10.1175/1520-0442(1999)012<2169:TDROTG>2.0.CO;2; Huybrechts P, 2011, SURV GEOPHYS, V32, P397, DOI 10.1007/s10712-011-9131-5; Joughin I, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017609; Krinner G, 2007, CLIM DYNAM, V28, P215, DOI 10.1007/s00382-006-0177-x; Larour E, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021693; Le Brocq A. M., 2010, EARTH SYSTEM SCI DAT, V3, P195, DOI [10.5194/essd-2-247-2010, DOI 10.5194/ESSD-2-247-2010, DOI 10.5194/ESSDD-3-195-2010]; Lenaerts JTM, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2010JD015419; Martin MA, 2011, CRYOSPHERE, V5, P727, DOI 10.5194/tc-5-727-2011; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Meinshausen M., 2008, ATMOS CHEM PHYS DISC, V8, P6153, DOI DOI 10.5194/ACPD-8-6153-2008; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Monaghan AJ, 2006, SCIENCE, V313, P827, DOI 10.1126/science.1128243; Olbers D, 2010, OCEAN DYNAM, V60, P141, DOI 10.1007/s10236-009-0252-z; Payne AJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003733; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Schewe J, 2011, EARTH SYST DYNAM, V2, P25, DOI 10.5194/esd-2-25-2011; Schoof C, 2010, Q J MECH APPL MATH, V63, P73, DOI 10.1093/qjmam/hbp025; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Uotila P, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007482; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0157-y, 10.1007/s10584-011-0152-3]; Vizcaino M, 2010, CLIM DYNAM, V34, P301, DOI 10.1007/s00382-009-0591-y; Walker RT, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034947; Williams MJM, 2001, J GEOPHYS RES-OCEANS, V106, P22383, DOI 10.1029/2000JC000236; Winkelmann R, 2011, CRYOSPHERE, V5, P715, DOI 10.5194/tc-5-715-2011; Winkelmann R., 2012, CRYOSPHERE DISCUSS, V6, P673, DOI [10.5194/tcd-6-673-2012, DOI 10.5194/TCD-6-673-2012]	31	59	60	2	133	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					239	+		10.1038/nature11616	http://dx.doi.org/10.1038/nature11616			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235878				2022-12-24	WOS:000312259300039
J	Walker, MJ; Beatson, SA				Walker, Mark J.; Beatson, Scott A.			Outsmarting Outbreaks	SCIENCE			English	Editorial Material							TRANSMISSION; EVOLUTION; MRSA		[Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia	University of Queensland; University of Queensland	Walker, MJ (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia.	mark.walker@uq.edu.au	Walker, Mark J./F-6940-2011; Beatson, Scott/B-6985-2013	Beatson, Scott/0000-0002-1806-3283; Walker, Mark/0000-0001-7423-2769				Ben Zakour NL, 2012, J CLIN MICROBIOL, V50, P2224, DOI 10.1128/JCM.00675-12; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Maamary PG, 2012, FASEB J, V26, P4675, DOI 10.1096/fj.12-212142; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Pallen MJ, 2010, CURR OPIN MICROBIOL, V13, P625, DOI 10.1016/j.mib.2010.08.003; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Tse H, 2012, J INFECT DIS, V206, P341, DOI 10.1093/infdis/jis362	16	11	12	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1161	1162		10.1126/science.1232327	http://dx.doi.org/10.1126/science.1232327			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	045AL	23197523				2022-12-24	WOS:000311666200032
J	Lee, S; Feldstein, SB				Lee, Sukyoung; Feldstein, Steven B.			Detecting Ozone- and Greenhouse Gas-Driven Wind Trends with Observational Data	SCIENCE			English	Article							SOUTHERN ANNULAR MODE; CIRCULATION; VARIABILITY; CONTINUUM; RECOVERY; IMPACT; OCEAN	Modeling studies suggest that Antarctic ozone depletion and, to a lesser degree, greenhouse gas (GHG) increase have caused the observed poleward shift in the westerly jet during the austral summer. Similar studies have not been performed previously with observational data because of difficulties in separating the two contributions. By applying a cluster analysis to daily ERA-Interim data, we found two 7- to 11-day wind clusters, one resembling the models' responses to GHG forcing and the other resembling ozone depletion. The trends in the clusters' frequency of occurrence indicate that the ozone contributed about 50% more than GHG toward the jet shift, supporting the modeling results. Moreover, tropical convection apparently plays an important role for the GHG-driven trend.	[Lee, Sukyoung; Feldstein, Steven B.] Penn State Univ, Dept Meteorol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lee, S (corresponding author), Penn State Univ, Dept Meteorol, 503 Walker Bldg, University Pk, PA 16802 USA.	sxl31@meteo.psu.edu			NSF [AGS-1036858, AGS-1139970]; Directorate For Geosciences [1139970, 1036858] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by NSF grants AGS-1036858 and AGS-1139970. The authors acknowledge N. Johnson for providing the Matlab codes used for the SOM analysis and two anonymous reviewers for their helpful suggestions and comments.	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Arblaster JM, 2006, J CLIMATE, V19, P2896, DOI 10.1175/JCLI3774.1; Black RX, 2007, J ATMOS SCI, V64, P2968, DOI 10.1175/JAS3979.1; Cane MA, 1997, SCIENCE, V275, P957, DOI 10.1126/science.275.5302.957; Chen G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031200; Clement AC, 1996, J CLIMATE, V9, P2190, DOI 10.1175/1520-0442(1996)009<2190:AODT>2.0.CO;2; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Franzke C, 2005, J ATMOS SCI, V62, P3250, DOI 10.1175/JAS3536.1; Gong TT, 2010, J ATMOS SCI, V67, P2854, DOI 10.1175/2010JAS3311.1; Grassi B, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023804; Higgins ME, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011884; Johnson NC, 2008, J CLIMATE, V21, P6354, DOI 10.1175/2008JCLI2380.1; Kang SM, 2011, SCIENCE, V332, P951, DOI 10.1126/science.1202131; Karpechko AY, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014423; Kidson JW, 1999, J CLIMATE, V12, P2808, DOI 10.1175/1520-0442(1999)012<2808:PMOSHL>2.0.CO;2; Kohonen T., 2001, SELF ORG MAPS INFORM; Kushner PJ, 2001, J CLIMATE, V14, P2238, DOI 10.1175/1520-0442(2001)014<0001:SHACRT>2.0.CO;2; L'Heureux ML, 2006, J CLIMATE, V19, P276, DOI 10.1175/JCLI3617.1; Lee S, 2011, J CLIMATE, V24, P4350, DOI 10.1175/2011JCLI4003.1; Limpasuvan V, 1999, GEOPHYS RES LETT, V26, P3133, DOI 10.1029/1999GL010478; Lorenz DJ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008087; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; Polvani LM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014284; Polvani LM, 2011, J CLIMATE, V24, P795, DOI 10.1175/2010JCLI3772.1; Robinson WA, 1997, J CLIMATE, V10, P176, DOI 10.1175/1520-0442(1997)010<0176:DDOTJL>2.0.CO;2; Son SW, 2005, J ATMOS SCI, V62, P3741, DOI 10.1175/JAS3571.1; Tabazadeh A, 2004, ATMOS ENVIRON, V38, P647, DOI 10.1016/j.atmosenv.2003.10.024; Tedesco M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039186; Thompson DWJ, 2000, J CLIMATE, V13, P1018, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Weatherhead EC, 2006, NATURE, V441, P39, DOI 10.1038/nature04746	31	117	120	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					563	567		10.1126/science.1225154	http://dx.doi.org/10.1126/science.1225154			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372010				2022-12-24	WOS:000314270000055
J	Neelakantan, S				Neelakantan, Shailaja			PSYCHOLOGY Mind over myocardium	NATURE			English	Editorial Material							DISEASE											Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Duivis HE, 2013, PSYCHONEUROENDOCRINO, V38, P479, DOI 10.1016/j.psyneuen.2012.07.006; Grenon SM, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002667; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nusair Maen, 2012, Mo Med, V109, P199; Sirri L, 2012, INT J CLIN PRACT, V66, P854, DOI 10.1111/j.1742-1241.2012.02993.x; Virtanen M, 2012, AM J EPIDEMIOL, V176, P586, DOI 10.1093/aje/kws139; Whalley B, 2014, INT J BEHAV MED, V21, P109, DOI 10.1007/s12529-012-9282-x	8	8	13	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					S16	S17		10.1038/493S16a	http://dx.doi.org/10.1038/493S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	080CU	23364767	Bronze			2022-12-24	WOS:000314219600012
J	Thomas, BC; Neal, DE				Thomas, Benjamin C.; Neal, David E.			Androgen deprivation treatment in prostate cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INCREASED SURVIVAL; COST-EFFECTIVENESS; PHASE-III; THERAPY; SUPPRESSION; MEN; MONOTHERAPY; CASTRATION; DEGARELIX; RISK		[Thomas, Benjamin C.] Addenbrookes Hosp, Dept Urol, Cambridge CB2 0QQ, England; [Thomas, Benjamin C.; Neal, David E.] Univ Cambridge, Dept Oncol, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Thomas, BC (corresponding author), Addenbrookes Hosp, Dept Urol, Cambridge CB2 0QQ, England.	bct26@cam.ac.uk	Shah, Syed Imran Ali/D-1324-2012	Shah, Syed Imran Ali/0000-0002-0833-0771; Neal, David/0000-0002-6033-5086	Medical Research Council [G0900871] Funding Source: Medline; MRC [G0900871] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adler A, 2012, ABIRATERONE CASTRATI; [Anonymous], 1997, Br J Urol, V79, P235; Bayoumi AM, 2000, JNCI-J NATL CANCER I, V92, P1731, DOI 10.1093/jnci/92.21.1731; Bolla M, 2010, LANCET ONCOL, V11, P1066, DOI 10.1016/S1470-2045(10)70223-0; Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741; Bubley GJ, 2001, UROLOGY, V58, P5, DOI 10.1016/S0090-4295(01)01235-3; Crawford ED, 2011, J UROLOGY, V186, P889, DOI 10.1016/j.juro.2011.04.083; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Derweesh IH, 2007, BJU INT, V100, P1060, DOI 10.1111/j.1464-410X.2007.07184.x; Fizazi K, 2012, LANCET ONCOL, V13, P983, DOI 10.1016/S1470-2045(12)70379-0; Heidenreich A, 2012, GUIDELINES PROSTATE; Iversen P, 2000, J UROLOGY, V164, P1579, DOI 10.1016/S0022-5347(05)67032-2; Klotz L, 2008, BJU INT, V102, P1531, DOI 10.1111/j.1464-410X.2008.08183.x; Lawton CA, 2005, J CLIN ONCOL, V23, P800, DOI 10.1200/JCO.2005.08.141; Loblaw DA, 2004, J CLIN ONCOL, V22, P2927, DOI 10.1200/jco.2004.04.579; Lu LT, 2012, BJU INT, V109, P1183, DOI 10.1111/j.1464-410X.2011.10434.x; MOFFAT LEF, 1990, EUR UROL, V18, P26; National Institute for Health and Clinical Excellence, 2008, PROST CANC DIAGN TRE; Potosky AL, 2001, J CLIN ONCOL, V19, P3750, DOI 10.1200/JCO.2001.19.17.3750; Ryan CJ, 2003, UROLOGY, V62, P87, DOI 10.1016/j.urology.2003.10.002; Saigal CS, 2007, CANCER-AM CANCER SOC, V110, P1493, DOI 10.1002/cncr.22933; Samson DJ, 2002, CANCER, V95, P361, DOI 10.1002/cncr.10647; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Seidenfeld J, 2000, ANN INTERN MED, V132, P566, DOI 10.7326/0003-4819-132-7-200004040-00009; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238; Strum SB, 1997, BRIT J UROL, V79, P933, DOI 10.1046/j.1464-410X.1997.00234.x; The Veterans Administration Co-operative Urological Research Group, 1967, SURG GYNECOL OBSTET, V124, P1011; Tyrrell CJ, 1998, EUR UROL, V33, P447, DOI 10.1159/000019634	29	9	9	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 9	2013	346								e8555	10.1136/bmj.e8555	http://dx.doi.org/10.1136/bmj.e8555			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070ZR	23303885				2022-12-24	WOS:000313554900010
J	Jost, TS				Jost, Timothy Stoltzfus			Religious Freedom and Women's Health - The Litigation on Contraception	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA	Washington & Lee University	Jost, TS (corresponding author), Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA.							Guttmacher Institute, 2012, STATE POLICIES IN BR; Institute of Medicine, 2011, CLINICAL PREVENTIVE; The Becket Fund for Religious Liberty, 2012, THE BECKET FUND FOR	3	9	9	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2013	368	1					4	6		10.1056/NEJMp1214605	http://dx.doi.org/10.1056/NEJMp1214605			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	062PA	23252500				2022-12-24	WOS:000312930600014
J	Hawkes, N				Hawkes, Nigel			MEDICINE IN DEVELOPING COUNTRIES Deworming debunked	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRESCHOOL-CHILDREN; TRIAL					nigel.hawkes1@btinternet.com						Alderman H, 2006, BRIT MED J, V333, P122, DOI 10.1136/bmj.38877.393530.7C; [Anonymous], COPENHAGEN CONSENSUS; [Anonymous], 2008, TIME; [Anonymous], 2012, COCHRANES INCOMPLETE; Awasthi S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000223; Baird S, 2011, WORMS AT WORK LONG R; Barrett W, 2011, FORBES; Bundy D, TRENDS PARASITOL FOR; Bundy D, 2011, NEW REASONS WHY SCHO; Dickson R, 2000, BMJ-BRIT MED J, V320, P1697, DOI 10.1136/bmj.320.7251.1697; Disease Control Priorities Project, 2008, DEWORMING CHILDREN B; GiveWell, COMBINATION DEWORMIN; GiveWell, 2011, ERRORS IN DCP2 COST; Ozier O, 2011, EXPLOITING EXTERNALI; Taylor-Robinson DC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub5; WHO, 2005, THE EVIDENCE IS IN D	16	16	16	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2013	346								e8558	10.1136/bmj.e8558	http://dx.doi.org/10.1136/bmj.e8558			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066QW	23284157				2022-12-24	WOS:000313236300014
J	Igonet, S; Rey, FA				Igonet, Sebastien; Rey, Felix A.			SnapShot: Viral and Eukaryotic Protein Fusogens	CELL			English	Editorial Material							FUSION		[Igonet, Sebastien; Rey, Felix A.] Inst Pasteur, CNRS, URA 3015, Unite Virol Struct, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Igonet, S (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.			Rey, Felix/0000-0002-9953-7988				Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Igonet S, 2011, P NATL ACAD SCI USA, V108, P19967, DOI 10.1073/pnas.1108910108	4	14	14	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1634	U264		10.1016/j.cell.2012.11.041	http://dx.doi.org/10.1016/j.cell.2012.11.041			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260148	Bronze			2022-12-24	WOS:000312890300026
J	Rosenzweig, A				Rosenzweig, Anthony			Cardiac Regeneration	SCIENCE			English	Editorial Material							PRESERVED EJECTION FRACTION; RANDOMIZED PHASE-1 TRIAL; CARDIOMYOCYTE PROLIFERATION; HEART-FAILURE; STEM-CELLS; MYOCARDIAL-INFARCTION; FIBROBLASTS; APOPTOSIS; MYOCYTES; THERAPY		[Rosenzweig, Anthony] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Cardiovasc, Boston, MA 02215 USA; [Rosenzweig, Anthony] Harvard Stem Cell Inst, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University	Rosenzweig, A (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Cardiovasc, Boston, MA 02215 USA.	arosenzw@bidmc.harvard.edu	Rosenzweig, Anthony/AAD-7893-2019		NHLBI NIH HHS [R01 HL122987] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; DeFrances Carol J, 2006, Adv Data, P1; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Porrello ER, 2011, CIRC RES, V109, P670, DOI 10.1161/CIRCRESAHA.111.248880; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rosenzweig A, 2006, NEW ENGL J MED, V355, P1274, DOI 10.1056/NEJMe068172; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278	27	24	28	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1549	1550		10.1126/science.1228951	http://dx.doi.org/10.1126/science.1228951			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258880				2022-12-24	WOS:000312533100036
J	Mills, E				Mills, Evan			The Greening of Insurance	SCIENCE			English	Editorial Material							CLIMATE; RESPONSES		Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mills, E (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	emills@lbl.gov						Bordoff J. E., 2008, PAY AS YOU DRIVE AUT; ClimateWise, 2011, CLIMATEWISE PRINC 4; Kron W, 2012, NAT HAZARD EARTH SYS, V12, P535, DOI 10.5194/nhess-12-535-2012; Leggett J., 1993, EUROPEAN ENV, V3, P3; Lloyd's, 2006, CLIM CHANG AD BUST, V360; Lloyd's, 2008, DIR DOCK; Michel-Kerjan E, 2011, SCIENCE, V333, P408, DOI 10.1126/science.1202616; Mills E, 2005, SCIENCE, V309, P1040, DOI 10.1126/science.1112121; Mills E., 1996, J SOC INSUR RES, V1996, P15; Mills E, 2012, B ATOM SCI, V68, P67, DOI 10.1177/0096340212464362; Mills E, 2009, GENEVA PAP R I-ISS P, V34, P323, DOI 10.1057/gpp.2009.14; Munich Reinsurance Co, 1973, FLOOD IN; Patton L., 2008, EUR BUS REV, V2008, P3005; Phelan L, 2011, ENVIRON POLICY GOV, V21, P112, DOI 10.1002/eet.565; Schmidt S, 2009, ENVIRON IMPACT ASSES, V29, P359, DOI 10.1016/j.eiar.2009.03.003; Swiss Reinsurance Co, 2011, HIDD RISK CLIM CHANG; Swiss Reinsurance Co, 2012, WORLD INS 2011; Tran S. M., 2008, J SCI TECHNOL LAW, V14, P73	18	35	35	4	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1424	1425		10.1126/science.1229351	http://dx.doi.org/10.1126/science.1229351			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053DN	23239720				2022-12-24	WOS:000312250800031
J	Wehrwein, P				Wehrwein, Peter			STEM CELLS Repeat to fade	NATURE			English	Editorial Material																		Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2011, AGING-US, V3, P555, DOI 10.18632/aging.100333; Garbe JC, 2012, CANCER RES, V72, P3687, DOI 10.1158/0008-5472.CAN-12-0157; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357	7	3	3	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					S12	S13		10.1038/492S12a	http://dx.doi.org/10.1038/492S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222667	Bronze			2022-12-24	WOS:000311893400007
J	Shepherd, A; Ivins, ER; Geruo, A; Barletta, VR; Bentley, MJ; Bettadpur, S; Briggs, KH; Bromwich, DH; Forsberg, R; Galin, N; Horwath, M; Jacobs, S; Joughin, I; King, MA; Lenaerts, JTM; Li, JL; Ligtenberg, SRM; Luckman, A; Luthcke, SB; McMillan, M; Meister, R; Milne, G; Mouginot, J; Muir, A; Nicolas, JP; Paden, J; Payne, AJ; Pritchard, H; Rignot, E; Rott, H; Sorensen, LS; Scambos, TA; Scheuchl, B; Schrama, EJO; Smith, B; Sundal, AV; van Angelen, JH; van de Berg, WJ; van den Broeke, MR; Vaughan, DG; Velicogna, I; Wahr, J; Whitehouse, PL; Wingham, DJ; Yi, DH; Young, D; Zwally, HJ				Shepherd, Andrew; Ivins, Erik R.; Geruo, A.; Barletta, Valentina R.; Bentley, Mike J.; Bettadpur, Srinivas; Briggs, Kate H.; Bromwich, David H.; Forsberg, Rene; Galin, Natalia; Horwath, Martin; Jacobs, Stan; Joughin, Ian; King, Matt A.; Lenaerts, Jan T. M.; Li, Jilu; Ligtenberg, Stefan R. M.; Luckman, Adrian; Luthcke, Scott B.; McMillan, Malcolm; Meister, Rakia; Milne, Glenn; Mouginot, Jeremie; Muir, Alan; Nicolas, Julien P.; Paden, John; Payne, Antony J.; Pritchard, Hamish; Rignot, Eric; Rott, Helmut; Sorensen, Louise Sandberg; Scambos, Ted A.; Scheuchl, Bernd; Schrama, Ernst J. O.; Smith, Ben; Sundal, Aud V.; van Angelen, Jan H.; van de Berg, Willem J.; van den Broeke, Michiel R.; Vaughan, David G.; Velicogna, Isabella; Wahr, John; Whitehouse, Pippa L.; Wingham, Duncan J.; Yi, Donghui; Young, Duncan; Zwally, H. Jay			A Reconciled Estimate of Ice-Sheet Mass Balance	SCIENCE			English	Article							PINE ISLAND GLACIER; RELATIVE SEA-LEVEL; ISOSTATIC-ADJUSTMENT; ANTARCTIC PENINSULA; WEST ANTARCTICA; GREENLAND; MODEL; CLIMATE; SURFACE; SHELF	We combined an ensemble of satellite altimetry, interferometry, and gravimetry data sets using common geographical regions, time intervals, and models of surface mass balance and glacial isostatic adjustment to estimate the mass balance of Earth's polar ice sheets. We find that there is good agreement between different satellite methods-especially in Greenland and West Antarctica-and that combining satellite data sets leads to greater certainty. Between 1992 and 2011, the ice sheets of Greenland, East Antarctica, West Antarctica, and the Antarctic Peninsula changed in mass by -142 +/- 49, +14 +/- 43, -65 +/- 26, and -20 +/- 14 gigatonnes year(-1), respectively. Since 1992, the polar ice sheets have contributed, on average, 0.59 +/- 0.20 millimeter year(-1) to the rate of global sea-level rise.	[Shepherd, Andrew; Briggs, Kate H.; Sundal, Aud V.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Ivins, Erik R.; Velicogna, Isabella] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Geruo, A.; Wahr, John] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Barletta, Valentina R.; Forsberg, Rene; Sorensen, Louise Sandberg] Tech Univ Denmark, DTU SPACE, Geodynam Dept, Natl Space Inst, DK-2880 Lyngby, Denmark; [Bentley, Mike J.; Whitehouse, Pippa L.] Univ Durham, Dept Geog, Durham DH1 3LE, England; [Bettadpur, Srinivas] Univ Texas Austin, Ctr Space Res, Austin, TX 78759 USA; [Bromwich, David H.; Nicolas, Julien P.] Ohio State Univ, Byrd Polar Res Ctr, Polar Meteorol Grp, Columbus, OH 43210 USA; [Bromwich, David H.; Nicolas, Julien P.] Ohio State Univ, Dept Geog, Atmospher Sci Program, Columbus, OH 43210 USA; [Galin, Natalia; Meister, Rakia; Muir, Alan; Wingham, Duncan J.] UCL, Dept Earth Sci, Ctr Polar Observat & Modelling, London WC1E 6BT, England; [Horwath, Martin] Tech Univ Munich, Inst Astron & Phys Geodasie, D-80333 Munich, Germany; [Jacobs, Stan] Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Joughin, Ian; Smith, Ben] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA; [King, Matt A.] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Lenaerts, Jan T. M.; Ligtenberg, Stefan R. M.; van Angelen, Jan H.; van de Berg, Willem J.; van den Broeke, Michiel R.] Univ Utrecht, Inst Marine & Atmospher Res, Utrecht, Netherlands; [Li, Jilu; Paden, John] Univ Kansas, Ctr Remote Sensing Ice Sheets, Lawrence, KS 66045 USA; [Luckman, Adrian] Swansea Univ, Coll Sci, Dept Geog, Swansea SA2 8PP, W Glam, Wales; [Luthcke, Scott B.] NASA, Goddard Space Flight Ctr, Planetary Geodynam Lab, Greenbelt, MD 20771 USA; [Milne, Glenn] Univ Ottawa, Dept Earth Sci, Ottawa, ON K1N 6N5, Canada; [Mouginot, Jeremie; Rignot, Eric; Velicogna, Isabella] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Payne, Antony J.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Pritchard, Hamish; Vaughan, David G.] British Antarctic Survey, Cambridge CB3 0ET, England; [Rott, Helmut] Univ Innsbruck, Inst Meteorol & Geophys, A-6020 Innsbruck, Austria; [Scambos, Ted A.] Univ Colorado, Natl Snow & Ice Data Ctr, Boulder, CO 80309 USA; [Schrama, Ernst J. O.] Delft Univ Technol, Fac Aerosp Engn, NL-2629 HS Delft, Netherlands; [Yi, Donghui] NASA, Goddard Space Flight Ctr, Cryospher Sci Lab, SGT Inc, Greenbelt, MD 20771 USA; [Young, Duncan] Univ Texas Austin, Inst Geophys, Austin, TX 78759 USA; [Zwally, H. Jay] NASA, Goddard Space Flight Ctr, Cryospher Sci Lab, Greenbelt, MD 20771 USA; [King, Matt A.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas 7001, Australia	University of Leeds; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Colorado System; University of Colorado Boulder; Technical University of Denmark; Durham University; University of Texas System; University of Texas Austin; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of London; University College London; Technical University of Munich; Columbia University; University of Washington; University of Washington Seattle; Newcastle University - UK; Utrecht University; University of Kansas; Swansea University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Ottawa; University of California System; University of California Irvine; University of Bristol; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Innsbruck; University of Colorado System; University of Colorado Boulder; Delft University of Technology; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Stinger Ghaffarian Technologies, Inc. (SGT); University of Texas System; University of Texas Austin; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Tasmania	Shepherd, A (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	ashepherd@leeds.ac.uk; erik.r.ivins@jpl.nasa.gov	Pritchard, Hamish Daniel/AAU-4696-2021; Van den Broeke, Michiel R./F-7867-2011; Luthcke, Scott B/D-6283-2012; A, Geruo/AAP-3565-2020; Bettadpur, Srinivas/M-3744-2014; King, Matt/B-4622-2008; Mouginot, Jeremie/G-7045-2015; payne, antony/A-8916-2008; Young, Duncan A./G-6256-2010; Bentley, Michael J/F-7386-2011; Velicogna, Isabella/R-5561-2018; Vaughan, David/C-8348-2011; Sørensen, Louise Sandberg/E-5282-2014; Rignot, Eric/A-4560-2014; Joughin, Ian R/A-2998-2008; Luckman, Adrian/GVS-1716-2022; Bromwich, David/C-9225-2016; Ligtenberg, Stefan/AAF-8290-2020; Horwath, Martin/F-9239-2011; Joughin, Ian/AAR-7778-2021; Lenaerts, Jan/D-9423-2012; Horwath, Martin/ABH-4320-2020; McMillan, Malcolm/K-7712-2014; van de Berg, Willem Jan/H-4385-2011	Van den Broeke, Michiel R./0000-0003-4662-7565; A, Geruo/0000-0001-5714-402X; King, Matt/0000-0001-5611-9498; Mouginot, Jeremie/0000-0001-9155-5455; payne, antony/0000-0001-8825-8425; Young, Duncan A./0000-0002-6866-8176; Bentley, Michael J/0000-0002-2048-0019; Velicogna, Isabella/0000-0002-9020-1898; Sørensen, Louise Sandberg/0000-0002-3771-4061; Rignot, Eric/0000-0002-3366-0481; Joughin, Ian R/0000-0001-6229-679X; Horwath, Martin/0000-0001-5797-244X; Joughin, Ian/0000-0001-6229-679X; Lenaerts, Jan/0000-0003-4309-4011; van de Berg, Willem Jan/0000-0002-8232-2040; SCHRAMA, ERNST/0000-0002-9654-4082; Muir, Alan/0000-0001-7754-088X; Luckman, Adrian/0000-0002-9618-5905; Bettadpur, Srinivas/0000-0003-3885-2228; Yi, Donghui/0000-0001-6363-5538; Whitehouse, Pippa/0000-0002-9092-3444; McMillan, Malcolm/0000-0002-5113-0177; Vaughan, David/0000-0002-9065-0570; Shepherd, Andrew/0000-0002-4914-1299; Forsberg, Rene/0000-0002-7288-9545; Barletta, Valentina Roberta/0000-0003-4427-0830	Phillip Leverhulme Prize award; European Union [125]; NASA [NNX09AE47G, NNX08AD64G]; Netherlands Organization for Scientific Research; Netherlands Polar Program; UK Natural Environment Research Council; NSF; Lamont Doherty Earth Observatory; Natural Environment Research Council [NE/F014260/1, earth010006, cpom20001, NE/I010874/1, NE/E014089/1, NE/E004806/1, NE/E007023/1, bas0100027] Funding Source: researchfish; NERC [NE/E004806/1, NE/E007023/1, cpom20001, NE/F014260/1, NE/I010874/1, NE/E014089/1] Funding Source: UKRI	Phillip Leverhulme Prize award; European Union(European Commission); NASA(National Aeronautics & Space Administration (NASA)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Polar Program; UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSF(National Science Foundation (NSF)); Lamont Doherty Earth Observatory; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This Ice Sheet Mass Balance Exercise (IMBIE) was facilitated by the European Space Agency and NASA and by a Phillip Leverhulme Prize awarded to A. S. The work was additionally supported by the European Union Framework Programme 7 ice2sea program (ice2sea publication 125), the Lamont Doherty Earth Observatory, NASA (grants NNX09AE47G and NNX08AD64G), the Netherlands Organization for Scientific Research, the Netherlands Polar Program, the UK Natural Environment Research Council, and the NSF. Antarctic glacier ice thickness data used in the IOM calculations were acquired by NASA IceBridge and the Centro de Estudios Cientifico Chile, and additional estimates were provided by J. Bamber and J. Griggs. E. van Meijgaard provided assistance with the RACMO model.	Ackert RP, 2011, EARTH PLANET SC LETT, V307, P83, DOI 10.1016/j.epsl.2011.04.015; Berthier E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051755; Bevis M, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002642; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; Boening C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053316; Bracegirdle TJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008933; Chen JL, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007789; Church JA, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P639; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Davis CH, 2005, SCIENCE, V308, P1898, DOI 10.1126/science.1110662; De Angelis H, 2003, SCIENCE, V299, P1560, DOI 10.1126/science.1077987; Ettema J, 2010, CRYOSPHERE, V4, P511, DOI 10.5194/tc-4-511-2010; Ettema J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038110; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fettweis X, 2011, CRYOSPHERE, V5, P359, DOI 10.5194/tc-5-359-2011; Fleming K, 2004, QUATERNARY SCI REV, V23, P1053, DOI 10.1016/j.quascirev.2003.11.001; Giovinetto MB, 2000, ANN GLACIOL-SER, V31, P171, DOI 10.3189/172756400781820200; Gogineni S, 2001, J GEOPHYS RES-ATMOS, V106, P33761, DOI 10.1029/2001JD900183; Goodwin I., 2003, J GEOPHYS RES, V108, P16; Gunter B, 2009, J GEODESY, V83, P1051, DOI 10.1007/s00190-009-0323-4; Hein AS, 2011, EARTH PLANET SC LETT, V307, P211, DOI 10.1016/j.epsl.2011.04.037; Hock R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037020; Holland DM, 2008, NAT GEOSCI, V1, P659, DOI 10.1038/ngeo316; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Ivins ER, 2005, ANTARCT SCI, V17, P541, DOI 10.1017/S0954102005002968; Ivins ER, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007607; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Jenkins A, 2010, NAT GEOSCI, V3, P468, DOI 10.1038/NGEO890; Johannessen OM, 2005, SCIENCE, V310, P1013, DOI 10.1126/science.1115356; Joughin I, 2004, NATURE, V432, P608, DOI 10.1038/nature03130; Joughin I, 2008, SCIENCE, V320, P781, DOI 10.1126/science.1153288; Joughin I, 2010, J GLACIOL, V56, P415, DOI 10.3189/002214310792447734; Krabill W, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021533; Krinner G, 2007, CLIM DYNAM, V28, P215, DOI 10.1007/s00382-006-0177-x; Lemke P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P337; Lenaerts JTM, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016145; Lenaerts JTM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050713; Li J, 2011, ANN GLACIOL, V52, P1, DOI 10.3189/172756411799096321; Ligtenberg SRM, 2011, CRYOSPHERE, V5, P809, DOI 10.5194/tc-5-809-2011; Luthcke SB, 2006, SCIENCE, V314, P1286, DOI 10.1126/science.1130776; Luthcke SB, 2008, J GLACIOL, V54, P767, DOI 10.3189/002214308787779933; Mackintosh A, 2011, NAT GEOSCI, V4, P195, DOI 10.1038/NGEO1061; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Monaghan AJ, 2006, SCIENCE, V313, P827, DOI 10.1126/science.1128243; Moon T, 2012, SCIENCE, V336, P576, DOI 10.1126/science.1219985; Munneke PK, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015113; OHMURA A, 1991, J GLACIOL, V37, P140; Payne AJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021284; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020697; Rignot E, 2002, SCIENCE, V297, P1502, DOI 10.1126/science.1073888; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Rignot E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035417; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Riva REM, 2009, EARTH PLANET SC LETT, V288, P516, DOI 10.1016/j.epsl.2009.10.013; Rott H, 2011, CRYOSPHERE, V5, P125, DOI 10.5194/tc-5-125-2011; Rott H, 1996, SCIENCE, V271, P788, DOI 10.1126/science.271.5250.788; Schrama EJO, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2009JB006847; Shepherd A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014183; Shepherd A, 2001, SCIENCE, V291, P862, DOI 10.1126/science.291.5505.862; Shepherd A, 2007, SCIENCE, V315, P1529, DOI 10.1126/science.1136776; Shepherd A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042496; Shuman CA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025227; Simpson MJR, 2009, QUATERNARY SCI REV, V28, P1631, DOI 10.1016/j.quascirev.2009.03.004; Tapley BD, 2004, SCIENCE, V305, P503, DOI 10.1126/science.1099192; Tarasov L, 2002, GEOPHYS J INT, V150, P198, DOI 10.1046/j.1365-246X.2002.01702.x; Tedesco M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014005; Thomas ID, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049277; Todd C, 2010, QUATERNARY SCI REV, V29, P1328, DOI 10.1016/j.quascirev.2010.02.001; Turner J., 2009, ANTARCTIC CLIMATE CH; Uotila P, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007482; van de Berg W. J., 2008, THESIS UTRECHT U UTR; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; van Meijgaard E., 2008, KNMI REGIONAL ATMOSP; Vaughan DG, 1999, J CLIMATE, V12, P933, DOI 10.1175/1520-0442(1999)012<0933:RONSMB>2.0.CO;2; Velicogna I, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023955; Velicogna I, 2006, SCIENCE, V311, P1754, DOI 10.1126/science.1123785; Velicogna I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040222; Velicogna I, 2006, NATURE, V443, P329, DOI 10.1038/nature05168; Wahr J, 2000, J GEOPHYS RES-SOL EA, V105, P16279, DOI 10.1029/2000JB900113; Whitehouse PL, 2012, GEOPHYS J INT, V190, P1464, DOI 10.1111/j.1365-246X.2012.05557.x; Whitehouse PL, 2012, QUATERNARY SCI REV, V32, P1, DOI 10.1016/j.quascirev.2011.11.016; Wingham DJ, 2006, PHILOS T R SOC A, V364, P1627, DOI 10.1098/rsta.2006.1792; Wingham DJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039126; Wingham DJ, 1998, SCIENCE, V282, P456, DOI 10.1126/science.282.5388.456; Zwally HJ, 2005, J GLACIOL, V51, P509, DOI 10.3189/172756505781829007; Zwally HJ, 2011, SURV GEOPHYS, V32, P351, DOI 10.1007/s10712-011-9123-5; Zwally HJ, 2011, J GLACIOL, V57, P88, DOI 10.3189/002214311795306682; ZWALLY HJ, 1989, SCIENCE, V246, P1587, DOI 10.1126/science.246.4937.1587; [No title captured]	93	992	1010	15	589	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1183	1189		10.1126/science.1228102	http://dx.doi.org/10.1126/science.1228102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197528	Green Submitted			2022-12-24	WOS:000311666200039
J	Joynt, KE; Jha, AK				Joynt, Karen E.; Jha, Ashish K.			Characteristics of Hospitals Receiving Penalties Under the Hospital Readmissions Reduction Program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							RATES; RACE; CARE		[Joynt, Karen E.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Joynt, KE (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	kjoynt@partners.org			NHLBI NIH HHS [1K23HL109177-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL109177] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Centers for Medicare & Medicaid Services, 2012, FY 2013 IPPS FIN RUL; Jha AK, 2009, NEW ENGL J MED, V361, P2637, DOI 10.1056/NEJMsa0904859; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P2517, DOI 10.1001/jama.289.19.2517; Vartak S, 2008, MED CARE, V46, P25, DOI 10.1097/MLR.0b013e3181484927	5	381	381	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					342	343		10.1001/jama.2012.94856	http://dx.doi.org/10.1001/jama.2012.94856			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074FT	23340629	Bronze			2022-12-24	WOS:000313799000015
J	Niwa, M; Jaaro-Peled, H; Tankou, S; Seshadri, S; Hikida, T; Matsumoto, Y; Cascella, NG; Kano, S; Ozaki, N; Nabeshima, T; Sawa, A				Niwa, Minae; Jaaro-Peled, Hanna; Tankou, Stephanie; Seshadri, Saurav; Hikida, Takatoshi; Matsumoto, Yurie; Cascella, Nicola G.; Kano, Shin-ichi; Ozaki, Norio; Nabeshima, Toshitaka; Sawa, Akira			Adolescent Stress-Induced Epigenetic Control of Dopaminergic Neurons via Glucocorticoids	SCIENCE			English	Article							PSYCHOTIC DEPRESSION; ENVIRONMENT; BRAIN; ADAPTATION; FEATURES; GENE	Environmental stressors during childhood and adolescence influence postnatal brain maturation and human behavioral patterns in adulthood. Accordingly, excess stressors result in adult-onset neuropsychiatric disorders. We describe an underlying mechanism in which glucocorticoids link adolescent stressors to epigenetic controls in neurons. In a mouse model of this phenomenon, a mild isolation stress affects the mesocortical projection of dopaminergic neurons in which DNA hypermethylation of the tyrosine hydroxylase gene is elicited, but only when combined with a relevant genetic risk for neuropsychiatric disorders. These molecular changes are associated with several neurochemical and behavioral deficits that occur in this mouse model, all of which are blocked by a glucocorticoid receptor antagonist. The biology and phenotypes of the mouse models resemble those of psychotic depression, a common and debilitating psychiatric disease.	[Niwa, Minae; Matsumoto, Yurie; Nabeshima, Toshitaka] Meijo Univ, Grad Sch Pharmaceut Sci, Dept Chem Pharmacol, Nagoya, Aichi 4688503, Japan; [Niwa, Minae; Jaaro-Peled, Hanna; Tankou, Stephanie; Seshadri, Saurav; Hikida, Takatoshi; Cascella, Nicola G.; Kano, Shin-ichi; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA; [Niwa, Minae; Matsumoto, Yurie; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan; [Hikida, Takatoshi] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto 6068501, Japan; [Nabeshima, Toshitaka] Meijo Univ, Comparat Cognit Sci Inst, Acad Frontier Project Private Univ, Nagoya, Aichi 4688503, Japan; [Nabeshima, Toshitaka] Meijo Univ, Dept Reg Pharmaceut Care & Sci, Nagoya, Aichi 4688503, Japan	Meijo University; Johns Hopkins University; Nagoya University; Kyoto University; Meijo University; Meijo University	Nabeshima, T (corresponding author), Meijo Univ, Grad Sch Pharmaceut Sci, Dept Chem Pharmacol, Nagoya, Aichi 4688503, Japan.	tnabeshi@meijo-u.ac.jp; asawa1@jhmi.edu	Kano, Shinichi/F-4144-2015; Niwa, Minae/G-5469-2011; Hikida, Takatoshi/J-5561-2017; Ozaki, Norio/M-8908-2014; Niwa, Minae/AAV-2639-2021	Kano, Shinichi/0000-0002-5171-3436; Niwa, Minae/0000-0002-8784-7815; Hikida, Takatoshi/0000-0002-8653-311X; Ozaki, Norio/0000-0002-7360-4898; Niwa, Minae/0000-0002-8784-7815	Stanley; RUSK; S-R; NARSAD; Maryland Stem Cell Research Fund; NIH [MH-084018, MH-094268, MH-069853, MH-085226, MH-088753, MH-092443, K99MH-094408]; JSPS-Korea; Ministry of Education, Culture, Sports, Science and Technology/Ministry of Health, Labour and Welfare of Japan (MEXT/MHLW); JSPS [22248033, 20390073, 22659213, 20007152, 23-639]; Strategic Research Program for Brain Sciences; MEXT/MHLW; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069853, P50MH094268, K99MH094408, R21MH085226, RC1MH088753, P20MH084018, R01MH092443] Funding Source: NIH RePORTER	Stanley; RUSK; S-R; NARSAD(NARSAD); Maryland Stem Cell Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS-Korea; Ministry of Education, Culture, Sports, Science and Technology/Ministry of Health, Labour and Welfare of Japan (MEXT/MHLW); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT/MHLW; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Talalay, J. Roeper, M. A. Landek-Salgado, and Y. Lema for helpful advice. Supported by Stanley, RUSK, S-R, NARSAD, the Maryland Stem Cell Research Fund, and NIH grants MH-084018, MH-094268, MH-069853, MH-085226, MH-088753, and MH-092443 (A. S.); by JSPS-Korea and the Ministry of Education, Culture, Sports, Science and Technology/Ministry of Health, Labour and Welfare of Japan (MEXT/MHLW) and JSPS grants 22248033, 20390073, and 22659213 (T.N.); by Strategic Research Program for Brain Sciences and MEXT/MHLW (N.O.); and by NARSAD, NIH grant K99MH-094408, and JSPS grants 20007152 and 23-639 (M.N.).	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Ago Y, 2008, NEUROPHARMACOLOGY, V55, P1355, DOI 10.1016/j.neuropharm.2008.08.026; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Brandon NJ, 2011, NAT REV NEUROSCI, V12, P707, DOI 10.1038/nrn3120; Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913; CORYELL W, 1984, J NERV MENT DIS, V172, P521, DOI 10.1097/00005053-198409000-00002; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; deKloet ER, 1996, CELL MOL NEUROBIOL, V16, P345; FLESHNER M, 1995, ENDOCRINOLOGY, V136, P5336, DOI 10.1210/en.136.12.5336; Flores BH, 2006, NEUROPSYCHOPHARMACOL, V31, P628, DOI 10.1038/sj.npp.1300884; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Hagerty T, 2001, J NEUROCHEM, V78, P1379, DOI 10.1046/j.1471-4159.2001.00521.x; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lee RS, 2011, PSYCHOPHARMACOLOGY, V218, P303, DOI 10.1007/s00213-011-2307-3; Meaney MJ, 2010, CHILD DEV, V81, P41, DOI 10.1111/j.1467-8624.2009.01381.x; Moffitt TE, 2005, ARCH GEN PSYCHIAT, V62, P473, DOI 10.1001/archpsyc.62.5.473; Morgan C, 2010, SCHIZOPHRENIA BULL, V36, P655, DOI 10.1093/schbul/sbq051; Murray RM, 2007, NAT REV NEUROSCI, V8, P885, DOI 10.1038/nrn2253; Niwa M, 2011, INT J NEUROPSYCHOPH, V14, P459, DOI 10.1017/S1461145710001239; Ohayon MM, 2002, AM J PSYCHIAT, V159, P1855, DOI 10.1176/appi.ajp.159.11.1855; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563	23	212	223	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2013	339	6117					335	339		10.1126/science.1226931	http://dx.doi.org/10.1126/science.1226931			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329051	Green Accepted			2022-12-24	WOS:000313622000049
J	Klein, HG				Klein, Harvey G.			Should Blood Be an Essential Medicine?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Klein, HG (corresponding author), NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA.							Akech SO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-256; American Association of Blood Banks (AABB), 2012, AABB STAND BLOOD BAN; European Directorate for the Quality of Medicines & Health Care, 2010, GUID PREP US QUAL AS; Klein HG, 2007, LANCET, V370, P415, DOI 10.1016/S0140-6736(07)61197-0; World Health organization, 2003, SEL US ESS MED	5	20	21	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					199	201		10.1056/NEJMp1213134	http://dx.doi.org/10.1056/NEJMp1213134			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YG	23323895				2022-12-24	WOS:000313549900002
J	Largeron, M; Fleury, MB				Largeron, Martine; Fleury, Maurice-Bernard			Bioinspired Oxidation Catalysts	SCIENCE			English	Editorial Material							AEROBIC OXIDATION; PRIMARY AMINES; IMINES; SYSTEM; ALCOHOLS; QUINONE		[Largeron, Martine; Fleury, Maurice-Bernard] Univ Paris 05, CNRS, Fac Sci Pharmaceut & Biol, UMR 8638, F-75270 Paris 06, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Largeron, M (corresponding author), Univ Paris 05, CNRS, Fac Sci Pharmaceut & Biol, UMR 8638, F-75270 Paris 06, France.	martine.largeron@parisdescartes.fr; maurice.fleury@parisdescartes.fr	largeron, martine/AAW-4958-2020	largeron, martine/0000-0002-1725-8118				Gnanaprakasam B, 2010, ANGEW CHEM INT EDIT, V49, P1468, DOI 10.1002/anie.200907018; Hu ZZ, 2012, ORG BIOMOL CHEM, V10, P1618, DOI 10.1039/c2ob06670j; Largeron M, 2008, CHEM-EUR J, V14, P996, DOI 10.1002/chem.200700876; Largeron M, 2012, ANGEW CHEM INT EDIT, V51, P5409, DOI 10.1002/anie.201200587; MURAHASHI SI, 1995, ANGEW CHEM INT EDIT, V34, P2443, DOI 10.1002/anie.199524431; Mure M, 2004, ACCOUNTS CHEM RES, V37, P131, DOI 10.1021/ar9703342; Mure M, 2002, BIOCHEMISTRY-US, V41, P9269, DOI 10.1021/bi020246b; Patil RD, 2011, ADV SYNTH CATAL, V353, P1695, DOI 10.1002/adsc.201100100; Que L, 2008, NATURE, V455, P333, DOI 10.1038/nature07371; Samec JSM, 2005, CHEM-EUR J, V11, P2327, DOI 10.1002/chem.200401082; Tian HW, 2012, ADV SYNTH CATAL, V354, P2671, DOI 10.1002/adsc.201200574; Watson AJA, 2010, SCIENCE, V329, P635, DOI 10.1126/science.1191843; Wendlandt AE, 2012, ORG LETT, V14, P2850, DOI 10.1021/ol301095j; Yamaguchi K, 2003, ANGEW CHEM INT EDIT, V42, P1480, DOI 10.1002/anie.200250779; Yuan H, 2012, J AM CHEM SOC, V134, P13970, DOI 10.1021/ja306934b	15	111	112	8	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					43	44		10.1126/science.1232220	http://dx.doi.org/10.1126/science.1232220			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288531				2022-12-24	WOS:000312985800044
J	Weaver, JF				Weaver, Jason F.			Entropies of Adsorbed Molecules Exceed Expectations	SCIENCE			English	Editorial Material									Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Weaver, JF (corresponding author), Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.	weaver@che.ufl.edu						Antony A, 2012, PHYS CHEM CHEM PHYS, V14, P12202, DOI 10.1039/c2cp41900a; Campbell CT, 2012, J AM CHEM SOC, V134, P18109, DOI 10.1021/ja3080117; Fichthorn KA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.196103; Tait SL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2400235	4	23	23	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					39	40		10.1126/science.1231552	http://dx.doi.org/10.1126/science.1231552			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288528				2022-12-24	WOS:000312985800041
J	Rogelj, J; McCollum, DL; Reisinger, A; Meinshausen, M; Riahi, K				Rogelj, Joeri; McCollum, David L.; Reisinger, Andy; Meinshausen, Malte; Riahi, Keywan			Probabilistic cost estimates for climate change mitigation	NATURE			English	Article							CARBON-CYCLE MODELS; ATMOSPHERE-OCEAN; SIMPLER MODEL; SCENARIOS; TARGETS	For more than a decade, the target of keeping global warming below 2 degrees C has been a key focus of the international climate debate(1). In response, the scientific community has published a number of scenario studies that estimate the costs of achieving such a target(2-5). Producing these estimates remains a challenge, particularly because of relatively well known, but poorly quantified, uncertainties, and owing to limited integration of scientific knowledge across disciplines(6). The integrated assessment community, on the one hand, has extensively assessed the influence of technological and socio-economic uncertainties on low-carbon scenarios and associated costs(2-4,7). The climate modelling community, on the other hand, has spent years improving its understanding of the geophysical response of the Earth system to emissions of greenhouse gases(8-12). This geophysical response remains a key uncertainty in the cost of mitigation scenarios but has been integrated with assessments of other uncertainties in only a rudimentary manner, that is, for equilibrium conditions(6,13). Here we bridge this gap between the two research communities by generating distributions of the costs associated with limiting transient global temperature increase to below specific values, taking into account uncertainties in four factors: geophysical, technological, social and political. Wefind that political choices that delay mitigation have the largest effect on the cost-risk distribution, followed by geophysical uncertainties, social factors influencing future energy demand and, lastly, technological uncertainties surrounding the availability of greenhouse gas mitigation options. Our information on temperature risk and mitigation costs provides crucial information for policy-making, because it clarifies the relative importance of mitigation costs, energy demand and the timing of global action in reducing the risk of exceeding a global temperature increase of 2 degrees C, or other limits such as 3 degrees C or 1.5 degrees C, across a wide range of scenarios.	[Rogelj, Joeri] ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Rogelj, Joeri; McCollum, David L.; Riahi, Keywan] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Reisinger, Andy] New Zealand Agr Greenhouse Gas Res Ctr, Palmerston North 4442, New Zealand; [Meinshausen, Malte] Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; [Meinshausen, Malte] Potsdam Inst Climate Impact Res, PRIMAP Grp, D-14412 Potsdam, Germany; [Riahi, Keywan] Graz Univ Technol, A-8010 Graz, Austria	Swiss Federal Institutes of Technology Domain; ETH Zurich; International Institute for Applied Systems Analysis (IIASA); University of Melbourne; Potsdam Institut fur Klimafolgenforschung; Graz University of Technology	Rogelj, J (corresponding author), ETH, Inst Atmospher & Climate Sci, Univ Str 16, CH-8092 Zurich, Switzerland.	joeri.rogelj@env.ethz.ch	Rogelj, Joeri/I-7108-2012; Riahi, Keywan/B-6426-2011; Reisinger, Andy R/E-1201-2016; Meinshausen, Malte/A-7037-2011; Meinshausen, Malte/AAG-7985-2019; Meinshausen, Malte/AAG-6505-2019	Rogelj, Joeri/0000-0003-2056-9061; Riahi, Keywan/0000-0001-7193-3498; Reisinger, Andy R/0000-0002-6631-7188; Meinshausen, Malte/0000-0003-4048-3521; Meinshausen, Malte/0000-0003-4048-3521; McCollum, David/0000-0003-1293-0179	Swiss National Science Foundation [200021-135067]; IIASA Peccei Award Grant	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); IIASA Peccei Award Grant	We thank V. Krey, P. Kolp and M. Strubegger for their support in developing the model set-up and extracting the results, R. Knutti and R. Socolow for comments and feedback during the writing process and S. Hatfield-Dodds, whose review comments substantially contributed to improving our manuscript. J.R. was supported by the Swiss National Science Foundation (project 200021-135067) and the IIASA Peccei Award Grant.	Archer D, 2009, ANNU REV EARTH PL SC, V37, P117, DOI 10.1146/annurev.earth.031208.100206; Bosetti V, 2009, CLIMATIC CHANGE, V96, P299, DOI 10.1007/s10584-009-9630-2; Clarke L, 2009, ENERG ECON, V31, pS64, DOI 10.1016/j.eneco.2009.10.013; den Elzen MGJ, 2010, CLIMATIC CHANGE, V99, P313, DOI 10.1007/s10584-010-9798-5; Edenhofer O, 2010, ENERG J, V31, P11; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Knutti R, 2008, J CLIMATE, V21, P2651, DOI 10.1175/2007JCLI2119.1; Krey V, 2009, ENERG ECON, V31, pS94, DOI 10.1016/j.eneco.2009.07.001; Mastrandrea M. D., 2010, GUIDANCE NOTE LEAD A, P3; Meehl G. A., 2007, IPCC CLIMATE CHANGE, P747; Meehl GA, 2005, B AM METEOROL SOC, V86, P89, DOI 10.1175/BAMS-86-1-89; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1457, DOI 10.5194/acp-11-1457-2011; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Nakicenovic N., 2000, IPCC SPECIAL REPORT; O'Neill BC, 2010, P NATL ACAD SCI USA, V107, P1011, DOI 10.1073/pnas.0903797106; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Randalls S, 2010, WIRES CLIM CHANGE, V1, P598, DOI 10.1002/wcc.62; Rao S, 2006, ENERG J, P177; Riahi K., 2012, GLOBAL ENERGY ASSESS, P1203; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Schaeffer M, 2008, P NATL ACAD SCI USA, V105, P20621, DOI 10.1073/pnas.0802416106; Smith SM, 2012, NAT CLIM CHANGE, V2, P535, DOI 10.1038/NCLIMATE1496; Smith SJ, 2006, TELLUS B, V58, P586, DOI 10.1111/j.1600-0889.2006.00217.x; UNEP, 2011, BRIDG EM GAP 15 20; United Nations, 2009, WORLD POP PROSP 2008; Vaughan NE, 2009, CLIMATIC CHANGE, V96, P29, DOI 10.1007/s10584-009-9573-7	28	218	223	4	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					79	83		10.1038/nature11787	http://dx.doi.org/10.1038/nature11787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23282364				2022-12-24	WOS:000312933800034
J	Goetz, L; Bethel, K; Topol, EJ				Goetz, Laura; Bethel, Kelly; Topol, Eric J.			Rebooting Cancer Tissue Handling in the Sequencing Era Toward Routine Use of Frozen Tumor Tissue	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROMISE		[Goetz, Laura; Topol, Eric J.] Scripps Translat Sci Inst, Scripps Genom Med, La Jolla, CA 92037 USA; [Goetz, Laura] Scripps Clin, Div Gen Surg, La Jolla, CA 92037 USA; [Bethel, Kelly] Scripps Clin, Div Pathol, La Jolla, CA 92037 USA; [Topol, Eric J.] Scripps Clin, Div Cardiovasc Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Topol, EJ (corresponding author), Scripps Translat Sci Inst, 3344 N Torrey Pines Ct, La Jolla, CA 92037 USA.	etopol@scripps.edu		Bethel, Kelly/0000-0002-7005-8641; Topol, Eric/0000-0002-1478-4729				Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Esteva FJ, 2010, NAT REV CLIN ONCOL, V7, P98, DOI 10.1038/nrclinonc.2009.216; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Klein C, 2012, JAMA-J AM MED ASSOC, V308, P1867, DOI 10.1001/2012.jama.10823; Kolata G, 2012, NY TIMES, pA1; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040	8	11	11	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2013	309	1					37	38		10.1001/jama.2012.70832	http://dx.doi.org/10.1001/jama.2012.70832			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TB	23280221				2022-12-24	WOS:000319113000023
J	Teng, MW; Bolovan-Fritts, C; Dar, RD; Womack, A; Simpson, ML; Shenk, T; Weinberger, LS				Teng, Melissa W.; Bolovan-Fritts, Cynthia; Dar, Roy D.; Womack, Andrew; Simpson, Michael L.; Shenk, Thomas; Weinberger, Leor S.			An Endogenous Accelerator for Viral Gene Expression Confers a Fitness Advantage	CELL			English	Article							IMMEDIATE-EARLY PROMOTER; HUMAN CYTOMEGALOVIRUS; ENDOTHELIAL-CELLS; ESCHERICHIA-COLI; INFECTED CELLS; PROTEIN; TRANSCRIPTION; IE2; REPLICATION; BINDING	Many signaling circuits face a fundamental tradeoff between accelerating their response speed while maintaining final levels below a cytotoxic threshold. Here, we describe a transcriptional circuitry that dynamically converts signaling inputs into faster rates without amplifying final equilibrium levels. Using time-lapse microscopy, we find that transcriptional activators accelerate human cytomegalovirus (CMV) gene expression in single cells without amplifying steady-state expression levels, and this acceleration generates a significant replication advantage. We map the accelerator to a highly self-cooperative transcriptional negative-feedback loop (Hill coefficient similar to 7) generated by homomultimerization of the virus's essential transactivator protein IE2 at nuclear PML bodies. Eliminating the IE2-accelerator circuit reduces transcriptional strength through mislocalization of incoming viral genomes away from PML bodies and carries a heavy fitness cost. In general, accelerators may provide a mechanism for signal-transduction circuits to respond quickly to external signals without increasing steady-state levels of potentially cytotoxic molecules.	[Teng, Melissa W.; Bolovan-Fritts, Cynthia; Dar, Roy D.; Weinberger, Leor S.] Gladstone Inst, San Francisco, CA 94158 USA; [Teng, Melissa W.; Weinberger, Leor S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Womack, Andrew; Shenk, Thomas] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Simpson, Michael L.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Diego; Princeton University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weinberger, LS (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.	leor.weinberger@gladstone.ucsf.edu	Simpson, Michael/A-8410-2011	Simpson, Michael/0000-0002-3933-3457; Dar, Roy/0000-0002-6006-4888	NSF; Center for Nanophase Materials Sciences; US Department of Energy; NIH [R01CA85786, K25GM083395]; NIH Center for Systems Biology at Princeton University [P50GM71508]; NATIONAL CANCER INSTITUTE [R01CA085786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, K25GM083395] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Center for Nanophase Materials Sciences(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for Systems Biology at Princeton University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Ferrell, L. Fortunato, M. Elowitz, E. Mocarski, D. Spector, T. Hwa, A. Hoffmann, R. Tsien, J. Nelson, C. Lilley, M. Weitzman, and R. Everett for providing reagents, equipment, helpful discussion, and critical review of previous versions of this manuscript. We thank S. Thiberge and the Lewis-Sigler Imaging Core for invaluable technical expertise. M.W.T. and A.W. acknowledge support from NSF Graduate Research Fellowships. M.L.S. acknowledges support from the Center for Nanophase Materials Sciences, sponsored by the US Department of Energy. T.S. received support from the NIH (R01CA85786) and the NIH Center for Systems Biology at Princeton University (P50GM71508). This work was supported by NIH award K25GM083395 (L.S.W.). L.S.W. conceived and designed the study. M.W.T., C.B.-F., and L.S.W. designed and performed the experiments. M.W.T., C.B.F., R.D.D., M.L.S., T.S. and L.S.W. analyzed the data. A.W. and T.S. provided reagents. M.W.T., C.B.F., and L.S.W. wrote the paper.	Alon U, 2007, INTRO SYSTEMS BIOL D; [Anonymous], 2006, CYTOMEGALOVIRUSES MO; Barrasa MI, 2005, J VIROL, V79, P1428, DOI 10.1128/JVI.79.3.1428-1437.2005; Black HS, 1999, P IEEE, V87, P379, DOI 10.1109/JPROC.1999.740032; Bolovan-Fritts C, 2001, J INFECT DIS, V184, P1252, DOI 10.1086/324010; Bolovan-Fritts CA, 2004, J VIROL, V78, P13173, DOI 10.1128/JVI.78.23.13173-13181.2004; Bresnahan WA, 2000, P NATL ACAD SCI USA, V97, P14506, DOI 10.1073/pnas.97.26.14506; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Carey M., 2009, TRANSCRIPTIONAL REGU; Cauwels A, 2007, ARCH BIOCHEM BIOPHYS, V462, P132, DOI 10.1016/j.abb.2007.01.021; CHEN J, 1994, J BIOL CHEM, V269, P12482; CHIOU CJ, 1993, J VIROL, V67, P6201, DOI 10.1128/JVI.67.10.6201-6214.1993; Choi KH, 2005, GLYCOCONJUGATE J, V22, P63, DOI 10.1007/s10719-005-0326-1; Deshaies RJ, 2001, CELL, V107, P819, DOI 10.1016/S0092-8674(01)00620-1; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dwarakanath RS, 2001, VIROLOGY, V284, P297, DOI 10.1006/viro.2001.0924; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Fan SS, 2005, J VIROL METHODS, V125, P23, DOI 10.1016/j.jviromet.2004.11.023; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Gebert S, 1997, J VIROL, V71, P7048, DOI 10.1128/JVI.71.9.7048-7060.1997; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hofmann H, 2000, J VIROL, V74, P2510, DOI 10.1128/JVI.74.6.2510-2524.2000; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Hummel M, 2002, J CLIN VIROL, V25, pS123; Isomura H, 2008, J VIROL, V82, P849, DOI 10.1128/JVI.01593-07; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; MACIAS MP, 1993, P NATL ACAD SCI USA, V90, P707, DOI 10.1073/pnas.90.2.707; Mocarski E.S., 2006, FIELDS VIROLOGY, P2708; Moorman NJ, 2008, CELL HOST MICROBE, V3, P253, DOI 10.1016/j.chom.2008.03.002; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Nevels M, 2004, J VIROL, V78, P7803, DOI 10.1128/JVI.78.14.7803-7812.2004; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Rosenke K, 2004, J VIROL, V78, P7818, DOI 10.1128/JVI.78.14.7818-7822.2004; Roth J, 2006, NEUROL CLIN, V24, P421, DOI 10.1016/j.ncl.2006.03.004; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Sanders RL, 2008, J VIROL, V82, P7059, DOI 10.1128/JVI.00675-08; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Sourvinos G, 2007, J VIROL, V81, P10123, DOI 10.1128/JVI.01009-07; Stinski MF, 2008, CURR TOP MICROBIOL, V325, P133; Stinski MF, 2008, MED MICROBIOL IMMUN, V197, P223, DOI 10.1007/s00430-007-0069-7; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2007, PLOS BIOL, V5, P67, DOI 10.1371/journal.pbio.0050009; Yu D, 2003, P NATL ACAD SCI USA, V100, P12396, DOI 10.1073/pnas.1635160100	47	42	44	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1569	1580		10.1016/j.cell.2012.11.051	http://dx.doi.org/10.1016/j.cell.2012.11.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260143	Bronze, Green Accepted			2022-12-24	WOS:000312890300020
J	Howard, S; Adams, J; White, M				Howard, Simon; Adams, Jean; White, Martin			CHRISTMAS 2012: RESEARCH Nutritional content of supermarket ready meals and recipes by television chefs in the United Kingdom: cross sectional study	BRITISH MEDICAL JOURNAL			English	Editorial Material							UK	Objectives To compare the energy and macronutrient content of main meals created by television chefs with ready meals sold by supermarkets, and to compare both with nutritional guidelines published by the World Health Organization and UK Food Standards Agency. Design Cross sectional study. Setting Three supermarkets with the largest share of the grocery market in the United Kingdom, 2010. Samples 100 main meal recipes from five bestselling cookery books by UK television chefs and 100 own brand ready meals from the three leading UK supermarkets. Main outcome measures Number of meals for which the nutritional content complied with WHO recommendations, and the proportion of nutrients classified as red, amber, or green using the UK FSA's "traffic light" system for labelling food. Results No recipe or ready meal fully complied with the WHO recommendations. The ready meals were more likely to comply with the recommended proportions of energy derived from carbohydrate (18% v 6%, P = 0.01) and sugars (83% v 81%, P = 0.05) and fibre density (56% v 14% P < 0.01). The recipes were more likely to comply with the recommended sodium density (36% v 4%, P < 0.01), although salt used for seasoning was not assessed. The distributions of traffic light colours under the FSA's food labelling recommendations differed: the modal traffic light was red for the recipes (47%) and green for ready meals (42%). Overall, the recipes contained significantly more energy (2530 kJ v 2067 kJ), protein (37.5 g v 27.9 g), fat (27.1 g v 17.2 g), and saturated fat (9.2 g v 6.8 g; P < 0.01 for all) and significantly less fibre (3.3 g v 6.5 g, P < 0.01) per portion than the ready meals. Conclusions Neither recipes created by television chefs nor ready meals sold by three of the leading UK supermarkets complied with WHO recommendations. Recipes were less healthy than ready meals, containing significantly more energy, protein, fat, and saturated fat, and less fibre per portion than the ready meals.	[Howard, Simon] NHS Tees, Stockton On Tees TS17 6SG, England; [Adams, Jean; White, Martin] Newcastle Univ, UKCRC Ctr Translat Res Publ Hlth, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Howard, S (corresponding author), NHS Tees, Stockton On Tees TS17 6SG, England.	simonhoward@nhs.net	Howard, Simon/I-4976-2015; Adams, Jean/G-2402-2010	Howard, Simon/0000-0002-6317-0942; Adams, Jean/0000-0002-5733-7830; White, Martin/0000-0002-1861-6757	Fuse, the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation; Cancer Research UK; Economic and Social Research Council [RES-590-38-0003]; Medical Research Council; National Institute for Health Research under the UKCRC; ESRC [ES/G007470/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish	Fuse, the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research under the UKCRC; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	At the time this research was done, MW was partly and JA fully supported by Fuse, the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence. Fuse receives funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council (No RES-590-38-0003), Medical Research Council, and the National Institute for Health Research, under the auspices of UKCRC. Views expressed do not necessarily represent those of the funders.	Adams J, 2011, BRIT J NUTR, V105, P810, DOI 10.1017/S0007114510004435; Adams J, 2009, EUR J PUBLIC HEALTH, V19, P144, DOI 10.1093/eurpub/ckn132; Alexy U, 2011, EUR J CLIN NUTR, V65, P160, DOI 10.1038/ejcn.2010.254; [Anonymous], EATW PLAT; [Anonymous], BBC NEWS ONLINE; [Anonymous], 2010, GUARDIAN; Bittman M., 2012, NY TIMES; British Heart Foundation, 2012, POL STAT UNH FOOD DR; Broadcasters' Audience Research Board, WEEKL TOP 30 PROGR; Caraher M., 2000, J STUDY FOOD SOC, V4, P27, DOI 10.2752/152897900786690805; Chilled Food Association, 2010, HIST UK CHILL FOODS; Consensus Action on Salt and Health, 2012, FOOD IND PROGR; Corrigan T., 2010, IS AM READY BRIT REA; Department of Health, 2009, CHANGE4LIFE MARK STR; DUBBERT PM, 1984, J APPL BEHAV ANAL, V17, P85, DOI 10.1901/jaba.1984.17-85; Fearnley-Whittingstall H., 2009, RIVER COTTAGE EVERYD; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Food Standards Agency, 2007, FRONT OF PACK TRAFF; Food Standards Agency, 2003, SALT READ MEALS SURV; Food Standards Agency, 2003, READ MEALS MARK; Garner E., 2009, TESCO SHARE TURNAROU; Harrison K, 2005, AM J PUBLIC HEALTH, V95, P1568, DOI 10.2105/AJPH.2004.048058; Hopkins J., 2008, Journal of Human Nutrition and Dietetics, V21, P389, DOI 10.1111/j.1365-277X.2008.00881_23.x; JOHNSON WG, 1990, ADDICT BEHAV, V15, P285, DOI 10.1016/0306-4603(90)90071-5; LACORS, 2010, UPD NUTR LAB TOL; Lawson N., 2010, KITCHEN RECIPES HEAR; Mintel Oxygen, 2010, CHILL FORZ READ MEAL; Morrisons, 2010, MARK OV ANN REP FIN; NHS Choices, 2010, QUICK HLTH MEALS; NHS Choices, 2011, 5 DAY RUN; Ofcom, 2010, HFSS ADV RESTR FIN R; Oliver J, 2010, JAMIES 30 MINUTE MEA; Oliver J., 2008, JAMIES MINISTRY FOOD; Oxford English Dictionary, 2008, TV DINN; Pascale L., 2011, BAKING MADE EASY; Reilly J, 2006, FRONT NUTR SCI, P201, DOI 10.1079/9780851990323.0201; RTS Resources, 2010, W EUR READ MEALS 201; Short F., 2003, Food Service Technology, V3, P177, DOI 10.1111/j.1471-5740.2003.00080.x; Sweney M., 2009, GUARDIAN; Triggle N., 2012, BBC NEWS ONLINE; UK Heart, 2012, CEL CHEFS TEA PART R; USDA, 2011, COOK MOR OFT HOM; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Windiets, 2012, WINDIETS DIET AN; World Health Organization, 2003, POP NUTR INT GOALS P, P54	45	61	62	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e7607	10.1136/bmj.e7607	http://dx.doi.org/10.1136/bmj.e7607			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IU	23247976	Green Published, hybrid			2022-12-24	WOS:000312698700001
J	Al Mamun, AM; Lombardo, MJ; Shee, C; Lisewski, AM; Gonzalez, C; Lin, DX; Nehring, RB; Saint-Ruf, C; Gibson, JL; Frisch, RL; Lichtarge, O; Hastings, PJ; Rosenberg, SM				Al Mamun, Abu Amar M.; Lombardo, Mary-Jane; Shee, Chandan; Lisewski, Andreas M.; Gonzalez, Caleb; Lin, Dongxu; Nehring, Ralf B.; Saint-Ruf, Claude; Gibson, Janet L.; Frisch, Ryan L.; Lichtarge, Olivier; Hastings, P. J.; Rosenberg, Susan M.			Identity and Function of a Large Gene Network Underlying Mutagenic Repair of DNA Breaks	SCIENCE			English	Article							STRESS-INDUCED MUTATION; ESCHERICHIA-COLI; SIGMA-FACTOR; EXPRESSION; DATABASE; CANCERS; SWITCH; CELLS	Mechanisms of DNA repair and mutagenesis are defined on the basis of relatively few proteins acting on DNA, yet the identities and functions of all proteins required are unknown. Here, we identify the network that underlies mutagenic repair of DNA breaks in stressed Escherichia coli and define functions for much of it. Using a comprehensive screen, we identified a network of >= 93 genes that function in mutation. Most operate upstream of activation of three required stress responses (RpoS, RpoE, and SOS, key network hubs), apparently sensing stress. The results reveal how a network integrates mutagenic repair into the biology of the cell, show specific pathways of environmental sensing, demonstrate the centrality of stress responses, and imply that these responses are attractive as potential drug targets for blocking the evolution of pathogens.	[Al Mamun, Abu Amar M.; Lombardo, Mary-Jane; Shee, Chandan; Lisewski, Andreas M.; Gonzalez, Caleb; Lin, Dongxu; Nehring, Ralf B.; Gibson, Janet L.; Frisch, Ryan L.; Lichtarge, Olivier; Hastings, P. J.; Rosenberg, Susan M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Saint-Ruf, Claude] Univ Paris, INSERM, U1001, F-75730 Paris 15, France; [Lichtarge, Olivier; Rosenberg, Susan M.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Rosenberg, SM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	smr@bcm.edu		Rosenberg, Susan M./0000-0003-1444-473X	NSF [0905536, 1062455]; NIH [GM79656, GM66099, DP1-CA174424, R01-GM64022, R01-GM53158, F32-GM095267, F32-GM19909]; Direct For Computer & Info Scie & Enginr [0905536] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [DP1CA174424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053158, R01GM079656, R25GM056929, R01GM066099, F32GM095267, F32GM019909, R01GM064022] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Nichols and C. A. Gross for earlier bioinformatic analysis and discussion; S. Gottesman, C. Herman, J. D. Wang, and J. Weissman for discussions; J. Casadesus, S. Gottesman, C. Herman, G. Ira, X. Pan, E. Rogers, T. Silhavy, and J. D. Wang for comments on the manuscript; and D. Satory for help with strains. Bioinformatics supported by NSF 0905536, 1062455, and NIH GM79656 and GM66099 grants (O.L., A. M. L.). R.B.N. was supported by NIH Director's Pioneer Award DP1-CA174424 (S. M. R.). Supported by NIH grants R01-GM64022 (P. J. H.), R01-GM53158 (S. M. R.) and fellowships F32-GM095267 (R. L. F.) and F32-GM19909 (M.-J.L.). The genes of mutagenic repair of DNA breaks are accessible at http://wiki.porteco.org/tools/simnetwork.	Ades SE, 2003, J BACTERIOL, V185, P2512, DOI 10.1128/JB.185.8.2512-2519.2003; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Bindra RS, 2007, CANCER METAST REV, V26, P249, DOI 10.1007/s10555-007-9061-3; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Friedrich T, 1998, BBA-BIOENERGETICS, V1364, P134, DOI 10.1016/S0005-2728(98)00024-3; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Gennis R. B., 1996, CELLULAR MOL BIOL, V1, P217; Gibson JL, 2010, MOL MICROBIOL, V77, P415, DOI 10.1111/j.1365-2958.2010.07213.x; Hernandez SB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002459; KLECKNER N, 1991, METHOD ENZYMOL, V204, P139; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; Mittelman D, 2010, CELL STRESS CHAPERON, V15, P463, DOI 10.1007/s12192-010-0205-y; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Prieto AI, 2006, GENETICS, V174, P575, DOI 10.1534/genetics.106.060889; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Rosenberg SM, 2012, BIOESSAYS, V34, P885, DOI 10.1002/bies.201200050; Roth JR, 2006, ANNU REV MICROBIOL, V60, P477, DOI 10.1146/annurev.micro.60.080805.142045; ROUVIERE PE, 1995, EMBO J, V14, P1032, DOI 10.1002/j.1460-2075.1995.tb07084.x; Shee C, 2012, CELL REP, V2, P714, DOI 10.1016/j.celrep.2012.08.033; Shee C, 2011, P NATL ACAD SCI USA, V108, P13659, DOI 10.1073/pnas.1104681108; STRATHERN JN, 1995, GENETICS, V140, P965; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973	28	139	141	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1344	1348		10.1126/science.1226683	http://dx.doi.org/10.1126/science.1226683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224554	Green Accepted			2022-12-24	WOS:000311991200067
J	Lindenmayer, DB; Laurance, WF; Franklin, JF				Lindenmayer, David B.; Laurance, William F.; Franklin, Jerry F.			Global Decline in Large Old Trees	SCIENCE			English	Editorial Material							LANDSCAPE; FUTURE; FIRE		[Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT 0200, Australia; [Laurance, William F.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld 4878, Australia; [Laurance, William F.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld 4878, Australia; [Franklin, Jerry F.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	Australian National University; James Cook University; James Cook University; University of Washington; University of Washington Seattle	Lindenmayer, DB (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, GPO Box 4, Canberra, ACT 0200, Australia.	david.lindenmayer@anu.edu.au	Lindenmayer, David B/P-7183-2017; Laurance, William F/B-2709-2012	Lindenmayer, David B/0000-0002-4766-4088; Laurance, William F/0000-0003-4430-9408				Anderegg WRL, 2013, NAT CLIM CHANGE, V3, P30, DOI 10.1038/nclimate1635; Asner GP, 2012, ECOL LETT, V15, P1211, DOI 10.1111/j.1461-0248.2012.01842.x; Fischer J, 2010, P NATL ACAD SCI USA, V107, P19597, DOI 10.1073/pnas.1008476107; Gibbons P, 2008, CONSERV BIOL, V22, P1309, DOI 10.1111/j.1523-1739.2008.00997.x; Jonsson MT, 2009, J VEG SCI, V20, P91, DOI 10.1111/j.1654-1103.2009.05394.x; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Laurance W, 2012, NEW SCI, V213, P39, DOI 10.1016/S0262-4079(12)60248-6; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lindenmayer D, 2009, FOREST PATTERN AND ECOLOGICAL PROCESS: A SYNTHESIS OF 25 YEARS OF RESEARCH, P1; Lutz JA, 2009, FOREST ECOL MANAG, V257, P2296, DOI 10.1016/j.foreco.2009.03.009; Mackey B, 2012, ECOL APPL, V22, P1852, DOI 10.1890/11-1479.1; Palik BJ, 2011, FOREST ECOL MANAG, V261, P128, DOI 10.1016/j.foreco.2010.09.041; Remm J, 2011, FOREST ECOL MANAG, V262, P579, DOI 10.1016/j.foreco.2011.04.028; Vanak AT, 2012, ECOGRAPHY, V35, P315, DOI 10.1111/j.1600-0587.2011.07213.x; VANPELT R, 2007, IDENTIFYING MATURE O	15	351	375	16	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1305	1306		10.1126/science.1231070	http://dx.doi.org/10.1126/science.1231070			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224548	Green Published			2022-12-24	WOS:000311991200055
J	Schlimpert, S; Klein, EA; Briegel, A; Hughes, V; Kahnt, J; Bolte, K; Maier, UG; Brun, YV; Jensen, GJ; Gitai, Z; Thanbichler, M				Schlimpert, Susan; Klein, Eric A.; Briegel, Ariane; Hughes, Velocity; Kahnt, Joerg; Bolte, Kathrin; Maier, Uwe G.; Brun, Yves V.; Jensen, Grant J.; Gitai, Zemer; Thanbichler, Martin			General Protein Diffusion Barriers Create Compartments within Bacterial Cells	CELL			English	Article							CAULOBACTER-CRESCENTUS; NUTRIENT-UPTAKE; CROSSBANDS; STALKS; MEMBRANE; PEPTIDOGLYCAN; MORPHOGENESIS; LOCALIZATION; INDICATORS; DIVISION	In eukaryotes, the differentiation of cellular extensions such as cilia or neuronal axons depends on the partitioning of proteins to distinct plasma membrane domains by specialized diffusion barriers. However, examples of this compartmentalization strategy are still missing for prokaryotes, although complex cellular architectures are also widespread among this group of organisms. This study reveals the existence of a protein-mediated membrane diffusion barrier in the stalked bacterium Caulobacter crescentus. We show that the Caulobacter cell envelope is compartmentalized by macromolecular complexes that prevent the exchange of both membrane and soluble proteins between the polar stalk extension and the cell body. The barrier structures span the cross-sectional area of the stalk and comprise at least four proteins that assemble in a cell-cycle-dependent manner. Their presence is critical for cellular fitness because they minimize the effective cell volume, allowing faster adaptation to environmental changes that require de novo synthesis of envelope proteins.	[Schlimpert, Susan; Thanbichler, Martin] Max Planck Inst Terr Microbiol, Max Planck Res Grp Prokaryot Cell Biol, D-35043 Marburg, Germany; [Kahnt, Joerg] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany; [Schlimpert, Susan; Thanbichler, Martin] Univ Marburg, Dept Biol, Microbiol Lab, D-35043 Marburg, Germany; [Bolte, Kathrin; Maier, Uwe G.] Univ Marburg, Dept Biol, Cell Biol Lab, D-35043 Marburg, Germany; [Klein, Eric A.; Gitai, Zemer] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Jensen, Grant J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Hughes, Velocity; Brun, Yves V.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Briegel, Ariane; Jensen, Grant J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Maier, Uwe G.; Thanbichler, Martin] LOEWE Ctr Synthet Microbiol, D-35043 Marburg, Germany	Max Planck Society; Max Planck Society; Philipps University Marburg; Philipps University Marburg; Princeton University; California Institute of Technology; Howard Hughes Medical Institute; Indiana University System; Indiana University Bloomington; California Institute of Technology	Thanbichler, M (corresponding author), Max Planck Inst Terr Microbiol, Max Planck Res Grp Prokaryot Cell Biol, Karl von Frisch Str 10, D-35043 Marburg, Germany.	thanbichler@mpi-marburg.mpg.de	Gitai, Zemer/AAI-6989-2021; Briegel, Ariane/AAC-1085-2021	Briegel, Ariane/0000-0003-3733-3725; Hughes, Velocity/0000-0002-3869-7726; Klein, Eric/0000-0003-3941-6233; Brun, Yves/0000-0002-9289-1909; Schlimpert, Susan/0000-0001-6364-8056	Max Planck Society; Human Frontier Science Program [RGY0069/2008-C]; National Institutes of Health (NIH) [DP2OD004389]; NRSA postdoctoral fellowship from National Institute of General Medical Sciences [F32GM906842]; NIH [GM51986, RO1 GM094800B]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM090684, R01GM051986, R01GM094800] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004389] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); Human Frontier Science Program(Human Frontier Science Program); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA postdoctoral fellowship from National Institute of General Medical Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Stephanie Wick for excellent technical assistance; Nikolay Ouzounov for helpful discussions; Juliane Kuhn, Patrick Viollier, and Grant Bowman for providing plasmids and strains; and Sarah Cheng for help with image segmentation. This work was supported by funds from the Max Planck Society to M. T., a Young Investigator Grant (RGY0069/2008-C) from the Human Frontier Science Program to Z.G. and M.T., a National Institutes of Health (NIH) Director's New Innovator Award (DP2OD004389) to Z.G., an NRSA postdoctoral fellowship (F32GM906842) from the National Institute of General Medical Sciences to E. A. K., NIH grant GM51986 to Y.V.B, and NIH grant RO1 GM094800B to G.J.J.	Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Divakaruni AV, 2007, MOL MICROBIOL, V66, P174, DOI 10.1111/j.1365-2958.2007.05910.x; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; Gonin M, 2000, J BACTERIOL, V182, P337, DOI 10.1128/JB.182.2.337-347.2000; Hughes HV, 2010, P NATL ACAD SCI USA, V107, P5599, DOI 10.1073/pnas.0909119107; Ingerson-Mahar M, 2010, NAT CELL BIOL, V12, P739, DOI 10.1038/ncb2087; Ireland MME, 2002, MOL MICROBIOL, V45, P1029, DOI 10.1046/j.1365-2958.2002.03071.x; JONES HC, 1973, J BACTERIOL, V116, P466, DOI 10.1128/JB.116.1.466-470.1973; Lang GI, 2009, P NATL ACAD SCI USA, V106, P5755, DOI 10.1073/pnas.0901620106; Le Blastier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014198; Marks ME, 2010, J BACTERIOL, V192, P3678, DOI 10.1128/JB.00255-10; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; Moll A, 2010, MOL MICROBIOL, V77, P90, DOI 10.1111/j.1365-2958.2010.07224.x; Murat D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000422; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Neugebauer H, 2005, J BACTERIOL, V187, P8300, DOI 10.1128/JB.187.24.8300-8311.2005; PAERL HW, 1982, ADV MICROB ECOL, V6, P75; POINDEXTER JLS, 1964, J CELL BIOL, V23, P587; POINDEXTER JS, 1978, J BACTERIOL, V135, P1141, DOI 10.1128/JB.135.3.1141-1145.1978; Poindexter JS, 1996, J BACTERIOL, V178, P3939, DOI 10.1128/jb.178.13.3939-3948.1996; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; SCHMIDT JM, 1966, J CELL BIOL, V28, P423, DOI 10.1083/jcb.28.3.423; SCHMIDT JM, 1973, ARCH MIKROBIOL, V89, P33, DOI 10.1007/BF00409397; SCHMIDT JM, 1975, J BACTERIOL, V124, P1601, DOI 10.1128/JB.124.3.1601-1603.1975; Seitz LC, 1998, J BACTERIOL, V180, P5235, DOI 10.1128/JB.180.19.5235-5239.1998; SMIT J, 1982, J CELL BIOL, V95, P41, DOI 10.1083/jcb.95.1.41; STALEY JT, 1973, NATURE, V246, P155, DOI 10.1038/246155a0; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Wagner JK, 2006, P NATL ACAD SCI USA, V103, P11772, DOI 10.1073/pnas.0602047103; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420	33	51	51	1	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1270	1282		10.1016/j.cell.2012.10.046	http://dx.doi.org/10.1016/j.cell.2012.10.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23201141	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000311999900016
J	Sandora, TJ; Goldmann, DA				Sandora, Thomas J.; Goldmann, Donald A.			Preventing Lethal Hospital Outbreaks of Antibiotic-Resistant Bacteria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sandora, Thomas J.; Goldmann, Donald A.] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; [Sandora, Thomas J.; Goldmann, Donald A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Goldmann, Donald A.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Goldmann, Donald A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Goldmann, Donald A.] Inst Healthcare Improvement, Cambridge, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Institute for Healthcare Improvement	Sandora, TJ (corresponding author), Boston Childrens Hosp, Div Infect Dis, Boston, MA USA.							Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Ursprung R, 2005, QUAL SAF HEALTH CARE, V14, P284, DOI 10.1136/qshc.2004.012542; Zawacki A, 2004, INFECT CONT HOSP EP, V25, P1083, DOI 10.1086/502348	5	36	36	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2168	2170		10.1056/NEJMp1212370	http://dx.doi.org/10.1056/NEJMp1212370			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048DO	23215553	Bronze			2022-12-24	WOS:000311890600002
J	Bertelsen, M; Linneberg, A; Rosenberg, T; Christoffersen, N; Vorum, H; Gade, E; Larsen, M				Bertelsen, Mette; Linneberg, Allan; Rosenberg, Thomas; Christoffersen, Nynne; Vorum, Henrik; Gade, Else; Larsen, Michael			Comorbidity in patients with branch retinal vein occlusion: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; FOLLOW-UP; PLASMA HOMOCYSTEINE; POOLED DATA; POPULATION; PREVALENCE; MORTALITY; METAANALYSIS; MORBIDITY; COHORT	Objectives To evaluate comorbidity before and after the diagnosis of branch retinal vein occlusion to determine whether it is a consequence of arterial thickening and therefore could serve as a diagnostic marker for other comorbidities and to evaluate the risk factors for the development of such occlusion. Design Case-control study with prospective follow-up data from Danish national registries. Setting Four secondary referral centres covering about 80% of the Danish population (4.4 million). Participants 1168 patients with photographically verified branch retinal vein occlusion and 116 800 controls alive and aged >= 40 when the occlusion was diagnosed in the corresponding case. Main outcome measures The risk of comorbidity 10 years and 1 year before the diagnosis of branch retinal vein occlusion and the incident comorbidity in a mean period of seven years after the diagnosis, with odds ratios and incidence rate ratios adjusted for age, sex, and year of diagnosis. Results Risk factors present 10 years and 1 year before the diagnosis of branch retinal vein occlusion included peripheral artery disease (odds ratio 1.83, 95% confidence interval 1.14 to 2.95), diabetes (1.74, 1.40 to 2.17) and arterial hypertension (2.16, 1.86 to 2.51). After the diagnosis, patients had an increased risk of developing arterial hypertension (incidence rate ratio 1.37, 95% confidence interval 1.15 to 1.57), diabetes (1.51, 1.17 to 2.04), congestive heart failure (1.41, 1.12 to 1.68), and cerebrovascular disease (1.49, 1.27 to 1.76). Conclusion Diabetes, hypertension, and peripheral artery disease are associated with an increased risk of developing branch retinal vein occlusion up to a decade later. Branch retinal vein occlusion was associated with an increased risk of subsequently developing hypertension, diabetes, congestive heart failure, and cerebrovascular disease, emphasising the importance of preventive initiatives. These results fit the assumption that branch retinal vein occlusion is a consequence of arterial thickening and that the arteriovenous crossing signs that precede it are hallmarks of arterial disease.	[Bertelsen, Mette; Larsen, Michael] Glostrup Cty Hosp, Dept Ophthalmol, DK-2600 Glostrup, Denmark; [Bertelsen, Mette; Rosenberg, Thomas; Christoffersen, Nynne; Larsen, Michael] Kennedy Ctr, Natl Eye Clin Visually Impaired, DK-2600 Glostrup, Denmark; [Bertelsen, Mette; Rosenberg, Thomas; Larsen, Michael] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Linneberg, Allan] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Vorum, Henrik] Aalborg Univ Hosp, Dept Ophthalmol, Aalborg, Denmark; [Gade, Else] Odense Univ Hosp, Dept Ophthalmol, DK-5000 Odense, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital	Bertelsen, M (corresponding author), Glostrup Cty Hosp, Dept Ophthalmol, Nordre Ringvej 57, DK-2600 Glostrup, Denmark.	mettebertelsen12@gmail.com	Bertelsen, Mette/AFO-7185-2022; Larsen, Michael/E-9620-2010	Larsen, Michael/0000-0002-5172-5891; Linneberg, Allan/0000-0002-0994-0184	Dag Lenards Foundation; Danish Diabetes Academy	Dag Lenards Foundation; Danish Diabetes Academy	We acknowledge the support of the Danish Diabetes Academy.; This study was funded by the Dag Lenards Foundation. The foundation had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the reports; or in the decision to submit the article for publication.	Andersen TF, 1999, DAN MED BULL, V46, P263; APPIAH AP, 1989, ANN OPHTHALMOL, V21, P153; Ariturk N, 1996, BRIT J OPHTHALMOL, V80, P633, DOI 10.1136/bjo.80.7.633; Cahill M, 2000, BRIT J OPHTHALMOL, V84, P154, DOI 10.1136/bjo.84.2.154; Cahill MT, 2003, AM J OPHTHALMOL, V136, P1136, DOI 10.1016/S0002-9394(03)00571-3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheung N, 2008, INVEST OPHTH VIS SCI, V49, P4297, DOI 10.1167/iovs.08-1826; Christoffersen N, 2007, OPHTHALMOLOGY, V114, P1186, DOI 10.1016/j.ophtha.2007.01.031; Chua B, 2005, AM J OPHTHALMOL, V139, P181, DOI 10.1016/j.ajo.2004.06.084; Cugati S, 2007, OPHTHALMOLOGY, V114, P520, DOI 10.1016/j.ophtha.2006.06.061; Eve Disease Case-Control Study Group, 1993, AM J OPHTHALMOL, V116, P286; FRUCHT J, 1984, BRIT J OPHTHALMOL, V68, P26, DOI 10.1136/bjo.68.1.26; Greiner K, 1999, AM J OPHTHALMOL, V128, P69, DOI 10.1016/S0002-9394(99)00074-4; Greiner Kathrin, 1999, International Ophthalmology, V23, P155, DOI 10.1023/A:1010639332737; Hayreh SS, 2001, AM J OPHTHALMOL, V131, P61, DOI 10.1016/S0002-9394(00)00709-1; Ho JD, 2009, AM J OPHTHALMOL, V147, P283, DOI 10.1016/j.ajo.2008.08.006; Hu CC, 2009, BRIT J OPHTHALMOL, V93, P717, DOI 10.1136/bjo.2008.151605; Janssen MCH, 2005, THROMB HAEMOSTASIS, V93, P1021, DOI 10.1160/TH04-11-0768; JOHNSTON RL, 1985, ARCH OPHTHALMOL-CHIC, V103, P1831; Kadayifcilar S, 2001, BRIT J OPHTHALMOL, V85, P1174, DOI 10.1136/bjo.85.10.1174; Kiire CA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e499; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kirwan JF, 1997, EYE, V11, P53, DOI 10.1038/eye.1997.11; Klein R, 2000, Trans Am Ophthalmol Soc, V98, P133; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P513, DOI 10.1001/archopht.126.4.513; Kuhli C, 2004, AM J OPHTHALMOL, V137, P459, DOI 10.1016/j.ajo.2003.10.024; Kuo RN, 2011, MED CARE, V49, P1031, DOI 10.1097/MLR.0b013e31822ebe11; Lidegaard O, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6423; Lim LL, 2008, BRIT J OPHTHALMOL, V92, P1316, DOI 10.1136/bjo.2008.140640; Majji AB, 1997, RETINA-J RET VIT DIS, V17, P200, DOI 10.1097/00006982-199705000-00005; Martin SC, 2002, BRIT J OPHTHALMOL, V86, P774, DOI 10.1136/bjo.86.7.774; Munch IC, 2012, ACTA OPHTHALMOL, V90, P613, DOI 10.1111/j.1755-3768.2011.2148.x; Pedersen CB, 2006, DAN MED BULL, V53, P441; RATH EZ, 1992, OPHTHALMOLOGY, V99, P509; Rehak J, 2008, CURR EYE RES, V33, P111, DOI 10.1080/02713680701851902; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; RUBINSTEIN K, 1976, BRIT J OPHTHALMOL, V60, P148, DOI 10.1136/bjo.60.2.148; Singer Donald R.J., 2002, Eur J Intern Med, V13, P160, DOI 10.1016/S0953-6205(02)00024-9; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Tsaloumas MD, 2000, EYE, V14, P821, DOI 10.1038/eye.2000.230; Weger M, 2005, OPHTHALMOLOGY, V112, P1910, DOI 10.1016/j.ophtha.2005.05.019; Werther W, 2011, ARCH OPHTHALMOL-CHIC, V129, P326, DOI 10.1001/archophthalmol.2011.2; Williamson TH, 1996, BRIT J OPHTHALMOL, V80, P203, DOI 10.1136/bjo.80.3.203; Wong TY, 2010, NEW ENGL J MED, V363, P2135, DOI 10.1056/NEJMcp1003934; Yasuda M, 2010, INVEST OPHTH VIS SCI, V51, P3205, DOI 10.1167/iovs.09-4453	45	57	58	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2012	345								e7885	10.1136/bmj.e7885	http://dx.doi.org/10.1136/bmj.e7885			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048FS	23204001	hybrid, Green Published			2022-12-24	WOS:000311896500004
J	Gatenby, R				Gatenby, Robert			PERSPECTIVE Finding cancer's first principles	NATURE			English	Editorial Material									[Gatenby, Robert] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Radiol, Tampa, FL 33682 USA; [Gatenby, Robert] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Integrated Math Oncol, Tampa, FL 33682 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Gatenby, R (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Dept Radiol, Tampa, FL 33682 USA.	robert.gatenby@moffitt.org							0	29	30	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					S55	S55		10.1038/491S55a	http://dx.doi.org/10.1038/491S55a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23320287	Bronze			2022-12-24	WOS:000311339800004
J	Motz, C; Schuhmann, KM; Kirchhofer, A; Moldt, M; Witte, G; Conzelmann, KK; Hopfner, KP				Motz, Carina; Schuhmann, Kerstin Monika; Kirchhofer, Axel; Moldt, Manuela; Witte, Gregor; Conzelmann, Karl-Klaus; Hopfner, Karl-Peter			Paramyxovirus V Proteins Disrupt the Fold of the RNA Sensor MDA5 to Inhibit Antiviral Signaling	SCIENCE			English	Article							RIG-I; PATTERN-RECOGNITION; STRUCTURAL BASIS; HELICASE LGP2; ACTIVATION; INSIGHTS; FILAMENTS; EVASION; DOMAIN; DDB1	The retinoic acid-inducible gene I (RIG-I)-like receptor (RLR) melanoma differentiation-associated protein 5 (MDA5) senses cytoplasmic viral RNA and activates antiviral innate immunity. To reveal how paramyxoviruses counteract this response, we determined the crystal structure of the MDA5 adenosine 5'-triphosphate (ATP)-hydrolysis domain in complex with the viral inhibitor V protein. The V protein unfolded the ATP-hydrolysis domain of MDA5 via a beta-hairpin motif and recognized a structural motif of MDA5 that is normally buried in the conserved helicase fold. This leads to disruption of the MDA5 ATP-hydrolysis site and prevention of RNA-bound MDA5 filament formation. The structure explains why V proteins inactivate MDA5, but not RIG-I, and mutating only two amino acids in RIG-I induces robust V protein binding. Our results suggest an inhibition mechanism of RLR signalosome formation by unfolding of receptor and inhibitor.	[Motz, Carina; Kirchhofer, Axel; Moldt, Manuela; Witte, Gregor; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, Munich, Germany; [Motz, Carina; Schuhmann, Kerstin Monika; Kirchhofer, Axel; Moldt, Manuela; Witte, Gregor; Conzelmann, Karl-Klaus; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, Munich, Germany; [Schuhmann, Kerstin Monika; Conzelmann, Karl-Klaus] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany; [Hopfner, Karl-Peter] Ctr Integrated Prot Sci, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Hopfner, KP (corresponding author), Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	hopfner@genzentrum.lmu.de	Hopfner, Karl-Peter/B-6864-2014; Witte, Gregor/B-4635-2011; Conzelmann, Karl-Klaus/L-7239-2013	Hopfner, Karl-Peter/0000-0002-4528-8357; Witte, Gregor/0000-0003-0313-0962; Conzelmann, Karl-Klaus/0000-0002-8614-3656	German Research Council [Deutsche Forschungsgemeinschaft (DFG)] [GRK1721]; NIH [U19AI083025]; Bavarian government (BioSysNet); Excellence Initiative of the German Ministry of Education and Science (Center for Integrated Proteins Science); DFG [GRK1202]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER	German Research Council [Deutsche Forschungsgemeinschaft (DFG)](German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bavarian government (BioSysNet); Excellence Initiative of the German Ministry of Education and Science (Center for Integrated Proteins Science); DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Cui and F. Civril for help in the initial stages of the project and K. Lammens, M. Bennett, and N. Fenn for technical advice. We thank O. Berninghausen, C. Ungewickel, and G. Pfeifer for help with EM. We thank the Max Planck Crystallization Facility (Max Planck Institute Martinsried) for screening of crystallization conditions. We thank T. Frohlich for mass spectrometry analysis, I. Mathes for N-terminal sequencing data, and C. Basquin for support in static light-scattering analysis. We thank the Swiss Light Source (Villingen, Switzerland), the European Synchrotron Radiation Facility (Grenoble, France), and the European Molecular Biology Laboratory (DESY, Hamburg, Germany) for beamtime and on-site support. The data reported in this paper are tabulated in the main paper and in the supplementary materials. Atomic coordinates and structure factors of the reported crystal structure have been deposited in the Protein Data Bank under accession code 4I1S. Details and supplementary materials are available on Science Online. The authors declare no conflict of interest. Correspondence and requests for materials should be addressed to K.-P. H. (hopfner@genzentrum.lmu.de). This work is funded by grants from the German Research Council [Deutsche Forschungsgemeinschaft (DFG) GRK1721] to K.-P. H. and G. W., NIH (U19AI083025), the Bavarian government (BioSysNet), and the Excellence Initiative of the German Ministry of Education and Science (Center for Integrated Proteins Science) to K.-P.H. A.K. and K.M.S. were funded by DFG GRK1202.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Andrejeva J, 2002, J VIROL, V76, P11379, DOI 10.1128/JVI.76.22.11379-11386.2002; Berke IC, 2012, P NATL ACAD SCI USA, V109, P18437, DOI 10.1073/pnas.1212186109; Berke IC, 2012, EMBO J, V31, P1714, DOI 10.1038/emboj.2012.19; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Childs KS, 2009, J VIROL, V83, P1465, DOI 10.1128/JVI.01768-08; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Childs K, 2012, J VIROL, V86, P3411, DOI 10.1128/JVI.06405-11; Civril F, 2011, EMBO REP, V12, P1127, DOI 10.1038/embor.2011.190; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Karlin D, 2002, VIROLOGY, V296, P251, DOI 10.1006/viro.2001.1296; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Parisien JP, 2009, J VIROL, V83, P7252, DOI 10.1128/JVI.00153-09; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Ramachandran A, 2010, J VIROL, V84, P11152, DOI 10.1128/JVI.01375-10; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schaap-Nutt A, 2011, J VIROL, V85, P4007, DOI 10.1128/JVI.02542-10; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	33	87	89	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120					690	693		10.1126/science.1230949	http://dx.doi.org/10.1126/science.1230949			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23328395				2022-12-24	WOS:000314585600041
J	Gouw, SC; van der Bom, JG; Ljung, R; Escuriola, C; Cid, AR; Claeyssens-Donadel, S; van Geet, C; Kenet, G; Makipernaa, A; Molinari, AC; Muntean, W; Kobelt, R; Rivard, G; Santagostino, E; Thomas, A; van den Berg, HM				Gouw, Samantha C.; van der Bom, Johanna G.; Ljung, Rolf; Escuriola, Carmen; Cid, Ana R.; Claeyssens-Donadel, Segolene; van Geet, Christel; Kenet, Gili; Makipernaa, Anne; Molinari, Angelo Claudio; Muntean, Wolfgang; Kobelt, Rainer; Rivard, George; Santagostino, Elena; Thomas, Angela; van den Berg, H. Marijke		PedNet RODIN Study Grp	Factor VIII Products and Inhibitor Development in Severe Hemophilia A	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREVIOUSLY UNTREATED PATIENTS; RECOMBINANT FACTOR-VIII; RISK-FACTORS; MUTATION TYPE; CANAL COHORT; CLASS-II; POLYMORPHISMS; CHILDREN; GENES	Background For previously untreated children with severe hemophilia A, it is unclear whether the type of factor VIII product administered and switching among products are associated with the development of clinically relevant inhibitory antibodies (inhibitor development). Methods We evaluated 574 consecutive patients with severe hemophilia A (factor VIII activity, <0.01 IU per milliliter) who were born between 2000 and 2010 and collected data on all clotting-factor administration for up to 75 exposure days. The primary outcome was inhibitor development, which was defined as at least two positive inhibitor tests with decreased in vivo recovery of factor VIII levels. Results Inhibitory antibodies developed in 177 of the 574 children (cumulative incidence, 32.4%); 116 patients had a high-titer inhibitory antibody, defined as a peak titer of at least 5 Bethesda units per milliliter (cumulative incidence, 22.4%). Plasma-derived products conferred a risk of inhibitor development that was similar to the risk with recombinant products (adjusted hazard ratio as compared with recombinant products, 0.96; 95% confidence interval [CI], 0.62 to 1.49). As compared with third-generation full-length recombinant products (derived from the full-length complementary DNA sequence of human factor VIII), second-generation full-length products were associated with an increased risk of inhibitor development (adjusted hazard ratio, 1.60; 95% CI, 1.08 to 2.37). The content of von Willebrand factor in the products and switching among products were not associated with the risk of inhibitor development. Conclusions Recombinant and plasma-derived factor VIII products conferred similar risks of inhibitor development, and the content of von Willebrand factor in the products and switching among products were not associated with the risk of inhibitor development. Second-generation full-length recombinant products were associated with an increased risk, as compared with third-generation products. (Funded by Bayer Healthcare and Baxter BioScience.)	[Gouw, Samantha C.] Wilhelmina Childrens Hosp, Dept Pediat, Utrecht, Netherlands; [Gouw, Samantha C.; van den Berg, H. Marijke] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [van der Bom, Johanna G.] Leiden Univ, Med Ctr, Leiden, Netherlands; [van der Bom, Johanna G.] Sanquin Fdn, Ctr Clin Transfus Res, Leiden, Netherlands; [Ljung, Rolf] Lund Univ, Dept Pediat, Malmo, Sweden; [Ljung, Rolf] Skanes Univ Sjukhus, Malmo Ctr Thrombosis & Hemostasis, Malmo, Sweden; [Escuriola, Carmen] JW Goethe Univ Hosp, Dept Pediat, Frankfurt, Germany; [Cid, Ana R.] Hosp Univ & Politecn La Fe, Unidad Hemostasia & Trombosis, Valencia, Spain; [Claeyssens-Donadel, Segolene] Ctr Hosp Univ, Ctr Reg Hemophilie, Toulouse, France; [van Geet, Christel] Univ Hosp Leuven, Dept Pediat, Louvain, Belgium; [van Geet, Christel] Katholieke Univ Leuven, Dept Cardiovasc Sci, Louvain, Belgium; [Kenet, Gili] Chaim Sheba Med Ctr, Minist Hlth, Natl Hemophilia Ctr, IL-52621 Tel Hashomer, Israel; [Makipernaa, Anne] Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland; [Molinari, Angelo Claudio] Osped Pediat Giannina Gaslini, Unita Trombosi Emostasi, Dipartimento Ematol Oncol, Genoa, Italy; [Santagostino, Elena] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy; [Muntean, Wolfgang] Univ Klin Kinder & Jugendheilkunde, Graz, Austria; [Kobelt, Rainer] Univ Bern, Wabern & Childrens Hosp, Hamophiliezentrum, Bern, Switzerland; [Rivard, George] Hop St Justine, Div Hematol Oncol, Montreal, PQ H3T 1C5, Canada; [Thomas, Angela] Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland	Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Lund University; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hospital Universitari i Politecnic La Fe; CHU de Toulouse; KU Leuven; University Hospital Leuven; KU Leuven; Chaim Sheba Medical Center; University of Helsinki; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Bern; Universite de Montreal	van den Berg, HM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Rm Stratenum 5-125,POB 85500, NL-3508 GA Utrecht, Netherlands.	h.m.vandeberg@umcutrecht.nl	Molinari, Angelo Claudio/AAA-7334-2020; Nolan, Beatrice/AAV-4356-2021; Kenet, Gili/AAF-8416-2020; van der Bom, Johanna G./G-1965-2018; Mancuso, Maria Elisa/AAT-4785-2020	Molinari, Angelo Claudio/0000-0002-8078-8402; Nolan, Beatrice/0000-0003-0145-4736; van der Bom, Johanna G./0000-0001-9095-2475; Gouw, Samantha/0000-0002-1957-4122; Fischer, Kathelijn/0000-0001-7126-6613; Mancuso, Maria Elisa/0000-0002-7113-4028; Oldenburg, Johannes/0000-0002-1585-4100; CHAMBOST, HERVE/0000-0002-5319-1969	Bayer Healthcare; Baxter BioScience	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Baxter BioScience	Supported by unrestricted research grants from Bayer Healthcare and Baxter BioScience.	Aledort LM, 1998, HAEMOPHILIA, V4, P68; Astermark J, 2007, J THROMB HAEMOST, V5, P263, DOI 10.1111/j.1538-7836.2007.02290.x; Astermark J, 2006, BLOOD, V107, P3167, DOI 10.1182/blood-2005-09-3918; Astermark J, 2001, HAEMOPHILIA, V7, P267, DOI 10.1046/j.1365-2516.2001.00510.x; Astermark J, 2006, BLOOD, V108, P3739, DOI 10.1182/blood-2006-05-024711; Bafunno V, 2010, HAEMOPHILIA, V16, P469, DOI 10.1111/j.1365-2516.2009.02150.x; Berntorp E, 1995, B WORLD HEALTH ORGAN, V73, P691; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Ettingshausen CE, 2006, HAEMOPHILIA, V12, P102, DOI 10.1111/j.1365-2516.2006.01373.x; Franchini M, 2012, CRIT REV ONCOL HEMAT, V81, P82, DOI 10.1016/j.critrevonc.2011.01.002; Giangrande PLF, 2002, HAEMOPHILIA, V8, P19, DOI 10.1046/j.1351-8216.2001.00133.x; Goudemand J, 2006, BLOOD, V107, P46, DOI 10.1182/blood-2005-04-1371; Gouw SC, 2007, J THROMB HAEMOST, V5, P1383, DOI 10.1111/j.1538-7836.2007.02595.x; Gouw SC, 2007, BLOOD, V109, P4693, DOI 10.1182/blood-2006-11-056317; Gouw SC, 2007, BLOOD, V109, P4648, DOI 10.1182/blood-2006-11-056291; Gouw SC, 2012, BLOOD, V119, P2922, DOI 10.1182/blood-2011-09-379453; Hay CRM, 2011, BLOOD, V117, P6367, DOI 10.1182/blood-2010-09-308668; Hay CRM, 1997, THROMB HAEMOSTASIS, V77, P234; Iorio A, 2010, J THROMB HAEMOST, V8, P1256, DOI 10.1111/j.1538-7836.2010.03823.x; Kreuz W, 2005, THROMB HAEMOSTASIS, V93, P457, DOI 10.1160/TH03-10-0643; Kurnik K, 2010, HAEMOPHILIA, V16, P256, DOI 10.1111/j.1365-2516.2009.02122.x; LEE ML, 1993, THROMB HAEMOSTASIS, V69, P87; Lozier JN, 2011, HAEMOPHILIA, V17, P641, DOI 10.1111/j.1365-2516.2010.02473.x; Maclean PS, 2011, HAEMOPHILIA, V17, P282, DOI 10.1111/j.1365-2516.2010.02422.x; Mancuso ME, 2012, J THROMB HAEMOST, V10, P781, DOI 10.1111/j.1538-7836.2012.04691.x; Mannucci PM, 2007, HAEMOPHILIA, V13, P65, DOI 10.1111/j.1365-2516.2007.01580.x; Oldenburg J, 1997, THROMB HAEMOSTASIS, V77, P238; Pavlova A, 2009, J THROMB HAEMOST, V7, P2006, DOI 10.1111/j.1538-7836.2009.03636.x; Santagostino E, 2005, BRIT J HAEMATOL, V130, P422, DOI 10.1111/j.1365-2141.2005.05605.x; Scharrer I, 2004, HAEMOPHILIA, V10, P197, DOI 10.1111/j.1365-2516.2004.00887.x; Schwaab R, 1995, THROMB HAEMOSTASIS, V74, P1402; Vlot AJ, 1998, THROMB HAEMOSTASIS, V79, P456; White GC, 2001, THROMB HAEMOSTASIS, V85, P560, DOI 10.1055/s-0037-1615621; Wight J, 2003, HAEMOPHILIA, V9, P418, DOI 10.1046/j.1365-2516.2003.00780.x	34	328	353	1	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					231	239		10.1056/NEJMoa1208024	http://dx.doi.org/10.1056/NEJMoa1208024			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YG	23323899				2022-12-24	WOS:000313549900007
J	Walther, TH; Gottselig, C; Grage, SL; Wolf, M; Vargiu, AV; Klein, MJ; Vollmer, S; Prock, S; Hartmann, M; Afonin, S; Stockwald, E; Heinzmann, H; Nolandt, OV; Wenzel, W; Ruggerone, P; Ulrich, AS				Walther, Torsten H.; Gottselig, Christina; Grage, Stephan L.; Wolf, Moritz; Vargiu, Attilio V.; Klein, Marco J.; Vollmer, Stefanie; Prock, Sebastian; Hartmann, Mareike; Afonin, Sergiy; Stockwald, Eva; Heinzmann, Hartmut; Nolandt, Olga V.; Wenzel, Wolfgang; Ruggerone, Paolo; Ulrich, Anne S.			Folding and Self-Assembly of the TatA Translocation Pore Based on a Charge Zipper Mechanism	CELL			English	Article							PROTEIN-TRANSPORT SYSTEM; TWIN-ARGININE TRANSLOCASE; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; MULTIENZYME COMPLEX; FOLDED PROTEINS; SIGNAL PEPTIDE; SALT BRIDGES; MEMBRANE; COMPONENT	We propose a concept for the folding and self-assembly of the pore-forming TatA complex from the Twin-arginine translocase and of other membrane proteins based on electrostatic "charge zippers." Each subunit of TatA consists of a transmembrane segment, an amphiphilic helix (APH), and a C-terminal densely charged region (DCR). The sequence of charges in the DCR is complementary to the charge pattern on the APH, suggesting that the protein can be "zipped up" by a ladder of seven salt bridges. The length of the resulting hairpin matches the lipid bilayer thickness, hence a transmembrane pore could self-assemble via intra- and intermolecular salt bridges. The steric feasibility was rationalized by molecular dynamics simulations, and experimental evidence was obtained by monitoring the monomer-oligomer equilibrium of specific charge mutants. Similar "charge zippers" are proposed for other membrane-associated proteins, e.g., the biofilm-inducing peptide TisB, the human antimicrobial peptide dermcidin, and the pestiviral E-RNS protein.	[Walther, Torsten H.; Gottselig, Christina; Grage, Stephan L.; Klein, Marco J.; Vollmer, Stefanie; Prock, Sebastian; Hartmann, Mareike; Afonin, Sergiy; Stockwald, Eva; Heinzmann, Hartmut; Nolandt, Olga V.; Ulrich, Anne S.] Karlsruhe Inst Technol, Inst Biol Interfaces IBG 2, Inst Organ Chem, D-76131 Karlsruhe, Germany; [Walther, Torsten H.; Gottselig, Christina; Grage, Stephan L.; Klein, Marco J.; Vollmer, Stefanie; Prock, Sebastian; Hartmann, Mareike; Afonin, Sergiy; Stockwald, Eva; Heinzmann, Hartmut; Nolandt, Olga V.; Ulrich, Anne S.] CFN, D-76131 Karlsruhe, Germany; [Wolf, Moritz; Wenzel, Wolfgang] KIT, Inst Nanotechnol, D-76021 Karlsruhe, Germany; [Wolf, Moritz; Wenzel, Wolfgang] CFN, D-76021 Karlsruhe, Germany; [Ruggerone, Paolo] Univ Cagliari, Ist Officina Mat, CNR UOS SLACS, I-09042 Monserrato, CA, Italy; [Ruggerone, Paolo] Univ Cagliari, Dipartimento Fis, I-09042 Monserrato, CA, Italy	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); University of Cagliari; University of Cagliari	Ulrich, AS (corresponding author), Karlsruhe Inst Technol, Inst Biol Interfaces IBG 2, Inst Organ Chem, Fritz Haber Weg 6, D-76131 Karlsruhe, Germany.	anne.ulrich@kit.edu	Ruggerone, Paolo/AAN-6032-2021; Vargiu, Attilio/G-2321-2011; Afonin, Sergii/T-2737-2019; Ulrich, Anne S/H-5519-2013; Wenzel, Wolfgang/B-3207-2009	Ruggerone, Paolo/0000-0003-0825-0824; Vargiu, Attilio/0000-0003-4013-8867; Afonin, Sergii/0000-0002-2356-4226; Ulrich, Anne S/0000-0001-5571-9483; Wenzel, Wolfgang/0000-0001-9487-4689; Walther, Torsten H./0000-0002-3708-0839; Klein, Marco Jan/0000-0003-1842-7590	YIG grant (KIT Karlsruhe, Germany); HPC Programme of the BW Stiftung; "Regione Autonoma della Sardegna" through a Research Fellow on fundings "PO Sardegna FSE Promozione della ricerca scientifica e dell'innovazione tecnologica in Sardegna" [L.R.7/2007]	YIG grant (KIT Karlsruhe, Germany); HPC Programme of the BW Stiftung; "Regione Autonoma della Sardegna" through a Research Fellow on fundings "PO Sardegna FSE Promozione della ricerca scientifica e dell'innovazione tecnologica in Sardegna"	We thank Ralf Heinzmann for the assistance in preparing the Graphical Abstract. A.S.U. and S.L.G. thank the DFG-Center for Functional Nanostructures (TP E1.2 & E3.4). T.H.W. is supported by a YIG grant (KIT Karlsruhe, Germany). M.W. and W.W. acknowledge funding by the HPC Programme of the BW Stiftung. P.R. and A.V.V. thank CINECA for computational support. A.V.V. acknowledges financial support from "Regione Autonoma della Sardegna" through a Research Fellow on fundings "PO Sardegna FSE 2007-2013, L.R.7/2007 Promozione della ricerca scientifica e dell'innovazione tecnologica in Sardegna".	Alder NN, 2003, CELL, V112, P231, DOI 10.1016/S0092-8674(03)00032-1; Barnett JP, 2008, J BIOL CHEM, V283, P2534, DOI 10.1074/jbc.M708134200; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berthelmann F, 2008, J BIOL CHEM, V283, P25281, DOI 10.1074/jbc.M707757200; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Burrack S, 2012, FASEB J, V26, P3292, DOI 10.1096/fj.12-207191; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chan CS, 2007, BIOCHEMISTRY-US, V46, P7396, DOI 10.1021/bi7005288; Dabney-Smith C, 2003, J BIOL CHEM, V278, P43027, DOI 10.1074/jbc.M307923200; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Frank RAW, 2005, STRUCTURE, V13, P1119, DOI 10.1016/j.str.2005.04.021; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; GO N, 1976, MACROMOLECULES, V9, P535, DOI 10.1021/ma60052a001; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Kim H, 2010, STRUCTURE, V18, P1443, DOI 10.1016/j.str.2010.09.011; Lange C, 2007, BBA-BIOMEMBRANES, V1768, P2627, DOI 10.1016/j.bbamem.2007.06.021; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Li YD, 2009, PROTEIN PEPTIDE LETT, V16, P706, DOI 10.2174/092986609788490096; MACK JW, 1993, J MOL BIOL, V232, P50, DOI 10.1006/jmbi.1993.1369; Mande SS, 1996, STRUCTURE, V4, P277, DOI 10.1016/S0969-2126(96)00032-9; Mori H, 2001, BBA-MOL CELL RES, V1541, P80, DOI 10.1016/S0167-4889(01)00150-1; Muller SD, 2007, BBA-BIOMEMBRANES, V1768, P3071, DOI 10.1016/j.bbamem.2007.09.008; MUSAFIA B, 1995, J MOL BIOL, V254, P761, DOI 10.1006/jmbi.1995.0653; Musser SM, 2000, EUR J BIOCHEM, V267, P2588, DOI 10.1046/j.1432-1327.2000.01269.x; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Palmer T, 2003, MICROBIOL-SGM, V149, P547, DOI 10.1099/mic.0.25900-0; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Paulmann M, 2012, J BIOL CHEM, V287, P8434, DOI 10.1074/jbc.M111.332270; Pop O, 2002, J BIOL CHEM, V277, P3268, DOI 10.1074/jbc.M110829200; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Sargent F, 2001, EUR J BIOCHEM, V268, P3361, DOI 10.1046/j.1432-1327.2001.02263.x; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Steinbrecher T, 2012, BIOPHYS J, V103, P1460, DOI 10.1016/j.bpj.2012.07.060; Tews BA, 2007, J BIOL CHEM, V282, P32730, DOI 10.1074/jbc.M706803200; Unoson C, 2008, MOL MICROBIOL, V70, P258, DOI 10.1111/j.1365-2958.2008.06416.x; van der Ploeg R, 2011, J BIOL CHEM, V286, P43759, DOI 10.1074/jbc.M111.243824; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; Warren G, 2009, J MOL BIOL, V388, P122, DOI 10.1016/j.jmb.2009.02.060; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westermann M, 2006, BBA-BIOMEMBRANES, V1758, P443, DOI 10.1016/j.bbamem.2006.03.018; White GF, 2010, J BIOL CHEM, V285, P2294, DOI 10.1074/jbc.M109.065458; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zhang LJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-114	57	57	60	1	93	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					316	326		10.1016/j.cell.2012.12.017	http://dx.doi.org/10.1016/j.cell.2012.12.017			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332763	Bronze			2022-12-24	WOS:000313719800026
J	Boumil, MM				Boumil, Marcia M.			Off-Label Marketing and the First Amendment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA	Massachusetts Department of Public Health; Tufts University	Boumil, MM (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA.								0	9	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					103	105		10.1056/NEJMp1214926	http://dx.doi.org/10.1056/NEJMp1214926			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066RO	23234470				2022-12-24	WOS:000313238100014
J	Spiegelhalter, D				Spiegelhalter, David			CHRISTMAS 2012: THOUGHTS FOR TODAY Using speed of ageing and "microlives" to communicate the effects of lifetime habits and environment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY; HEALTH; TIME		Univ Cambridge, Stat Lab, Cambridge CB3 0WB, England	University of Cambridge	Spiegelhalter, D (corresponding author), Univ Cambridge, Stat Lab, Cambridge CB3 0WB, England.	d.spiegelhalter@statslab.cam.ac.uk						Chapman GB, 1996, J EXP PSYCHOL LEARN, V22, P771, DOI 10.1037/0278-7393.22.3.771; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Haybittle JL, 1998, INT J EPIDEMIOL, V27, P885, DOI 10.1093/ije/27.5.885; Katzmarzyk PT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000828; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Nichols M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000957; Office of National Statistics, 2011, INT LIF TABL 2008 20; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Parkes G, 2008, BMJ-BRIT MED J, V336, P598, DOI 10.1136/bmj.39503.582396.25; Shaw M, 2000, BRIT MED J, V320, P53, DOI 10.1136/bmj.320.7226.53; Swindell WR, 2009, EXP GERONTOL, V44, P190, DOI 10.1016/j.exger.2008.10.005; Wells S, 2010, HEART, V96, P708, DOI 10.1136/hrt.2009.191320	12	10	10	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2012	345								e8223	10.1136/bmj.e8223	http://dx.doi.org/10.1136/bmj.e8223			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IU	23247978	Green Submitted			2022-12-24	WOS:000312698700018
J	Rao, V				Rao, Veena			Law on infant foods inhibits the marketing of complementary foods for infants, furthering undernutrition in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Govt Karnataka, Dept Hlth & Family Welf, Karnataka Nutr Mission, Bangalore 560009, Karnataka, India		Rao, V (corresponding author), Govt Karnataka, Dept Hlth & Family Welf, Karnataka Nutr Mission, Bangalore 560009, Karnataka, India.	nobel_6@hotmail.com						Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Government of India Ministry of Health and Family Welfare, 2005, NAT FAM HLTH SURV 3, V3; Unicef, IND CHILDR; World Health Organization, 2001, COMPL FEED REP GLOB; World Health Organization, 1981, INT COD MARK BREAST; World Health Organization (WHO), 2001, GLOB STRAT INF YOUNG; Zeigler J, 2006, CHILDRENS RIGHTS UN	7	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2012	345								e8131	10.1136/bmj.e8131	http://dx.doi.org/10.1136/bmj.e8131			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048FS	23204041	Green Submitted			2022-12-24	WOS:000311896500008
J	Misegades, LK; Winter, K; Harriman, K; Talarico, J; Messonnier, NE; Clark, TA; Martin, SW				Misegades, Lara K.; Winter, Kathleen; Harriman, Kathleen; Talarico, John; Messonnier, Nancy E.; Clark, Thomas A.; Martin, Stacey W.			Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EFFICACY; DIPHTHERIA; TETANUS	Context In 2010, California experienced its largest pertussis epidemic in more than 60 years; a substantial burden of disease was noted in the 7- to 10-year-old age group despite high diphtheria, tetanus, and acellular pertussis vaccine (DTaP) coverage, indicating the possibility of waning protection. Objective To evaluate the association between pertussis and receipt of 5 DTaP doses by time since fifth DTaP dose. Design, Setting, and Participants Case-control evaluation conducted in 15 California counties. Cases (n=682) were all suspected, probable, and confirmed pertussis cases among children aged 4 to 10 years reported from January through December 14, 2010; controls (n=2016) were children in the same age group who received care from the clinicians reporting the cases. Three controls were selected per case. Vaccination histories were obtained from medical records and immunization registries. Main Outcome Measures Primary outcomes were (1) odds ratios (ORs) for the association between pertussis and receipt of the 5-dose DTaP series and (2) ORs for the association between pertussis and time since completion (<12, 12-23, 24-35, 36-47, 48-59, or >= 60 months) of the 5-dose DTaP series. Logistic regression was used to calculate ORs, accounting for clustering by county and clinician, and vaccine effectiveness (VE) was estimated as (1-OR) x 100%. Results Among cases and controls, 53 (7.8%) and 19 (0.9%) had not received any pertussis-containing vaccines, respectively. Compared with controls, children with pertussis had a lower odds of having received all 5 doses of DTaP (OR, 0.11; 95% CI, 0.06-0.21 [estimated VE, 88.7%; 95% CI, 79.4%-93.8%]). When children were categorized by time since completion of the DTaP series, using an unvaccinated reference group, children with pertussis compared with controls were less likely to have received their fifth dose within the prior 12 months (19 [2.8%] vs 354 [17.6%], respectively; OR, 0.02; 95% CI, 0.01-0.04 [estimated VE, 98.1%; 95% CI, 96.1%-99.1%]). This association was evident with longer time since vaccination, with ORs increasing with time since the fifth dose. At 60 months or longer (n=231 cases [33.9%] and n=288 controls [14.3%]), the OR was 0.29 (95% CI, 0.15-0.54 [estimated VE, 71.2%; 95% CI, 45.8%-84.8%]). Accordingly, the estimated VE declined each year after receipt of the fifth dose of DTaP. Conclusion Among children in 15 California counties, children with pertussis, compared with controls, had lower odds of having received the 5-dose DTaP series; as time since last DTaP dose increased, the odds increased, which is consistent with a progressive decrease in estimated vaccine effectiveness each year after the final dose of pertussis vaccine. JAMA. 2012;308(20):2126-2132 www.jama.com	[Misegades, Lara K.; Messonnier, Nancy E.; Clark, Thomas A.; Martin, Stacey W.] US Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA; [Misegades, Lara K.] US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA; [Winter, Kathleen; Harriman, Kathleen; Talarico, John] Calif Dept Publ Hlth, Immunizat Branch, Richmond, VA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Misegades, LK (corresponding author), US Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,MS C25, Atlanta, GA 30329 USA.	lmisegades@cdc.gov						[Anonymous], 1996, MMWR Recomm Rep, V45, P1; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; Bisgard KM, 2005, PEDIATRICS, V116, pE285, DOI 10.1542/peds.2004-2759; Black Carla L., 2011, Morbidity and Mortality Weekly Report, V60, P1157; BORTOLUSSI R, 1995, PEDIATR INFECT DIS J, V14, P870, DOI 10.1097/00006454-199510000-00010; Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1; California Department of Health Services Immunization Branch, 2011, PERT REP; California Department of Public Health, 2010, PERT CDPH CAS DEF; Centers for Disease Control and Prevention, 2010, COV IND VACC VACC SE; Cherry JD, 2012, PEDIATRICS, V129, P968, DOI 10.1542/peds.2011-2594; Clark T, 2011, NAT IMM C MARCH 30 W; CODY CL, 1981, PEDIATRICS, V68, P650; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; Division of Integrated Surveillance Systems and Services National Center for Public Health Informatics Coordinating Center for Health Information and Service Centers for Disease Control and Prevention US Department of Health and Human Services, NAT NOT DIS SURV SYS; EDWARDS KM, 2004, VACCINES, P471; FINE PEM, 1987, REV INFECT DIS, V9, P866; Fitzmaurice G, 2000, NUTRITION, V16, P1114, DOI 10.1016/S0899-9007(00)00437-8; Friedrich MJ, 2011, JAMA-J AM MED ASSOC, V306, P27, DOI 10.1001/jama.2011.888; GROB PR, 1981, BRIT MED J, V282, P1925, DOI 10.1136/bmj.282.6280.1925; JENKINSON D, 1988, BRIT MED J, V296, P612, DOI 10.1136/bmj.296.6622.612; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; LAMBERT HJ, 1965, PUBLIC HEALTH REP, V80, P365, DOI 10.2307/4592424; LONG SS, 1990, PEDIATRICS, V85, P294; Mieszkowski Katharine, 2010, NY TIMES; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Preziosi MP, 2003, CLIN INFECT DIS, V37, P772, DOI 10.1086/377270; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rodrigues LC, 1999, EPIDEMIOL REV, V21, P56, DOI 10.1093/oxfordjournals.epirev.a017988; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Winter K, 2012, J PEDIAT, V2012, P20; Witt MA, 2012, CLIN INFECT DIS, V54, P1730, DOI 10.1093/cid/cis287	31	181	182	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2126	2132		10.1001/jama.2012.14939	http://dx.doi.org/10.1001/jama.2012.14939			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188029	Bronze			2022-12-24	WOS:000311537200027
J	Savage, N				Savage, Neil			MODELLING Computing cancer	NATURE			English	Editorial Material																		Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Mahoney AW, 2008, 2008 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P215; Stamper IJ, 2007, B MATH BIOL, V69, P2737, DOI 10.1007/s11538-007-9253-6; Swat MH, 2012, METHOD CELL BIOL, V110, P325, DOI 10.1016/B978-0-12-388403-9.00013-8	4	12	13	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					S62	S63		10.1038/491S62a	http://dx.doi.org/10.1038/491S62a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040RE	23320290				2022-12-24	WOS:000311339800008
J	Schrag, DP; Higgins, JA; Macdonald, FA; Johnston, DT				Schrag, Daniel P.; Higgins, John. A.; Macdonald, Francis A.; Johnston, David T.			Authigenic Carbonate and the History of the Global Carbon Cycle	SCIENCE			English	Article							ATMOSPHERIC OXYGEN; ORGANIC-MATTER; SEDIMENTS; OCEAN; EARTH; EXTINCTION; DELTA-C-13; EVOLUTION; ORIGIN; RECORD	We present a framework for interpreting the carbon isotopic composition of sedimentary rocks, which in turn requires a fundamental reinterpretation of the carbon cycle and redox budgets over Earth's history. We propose that authigenic carbonate, produced in sediment pore fluids during early diagenesis, has played a major role in the carbon cycle in the past. This sink constitutes a minor component of the carbon isotope mass balance under the modern, high levels of atmospheric oxygen but was much larger in times of low atmospheric O-2 or widespread marine anoxia. Waxing and waning of a global authigenic carbonate sink helps to explain extreme carbon isotope variations in the Proterozoic, Paleozoic, and Triassic.	[Schrag, Daniel P.; Macdonald, Francis A.; Johnston, David T.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Higgins, John. A.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Harvard University; Princeton University	Schrag, DP (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	daniel_schrag@harvard.edu		Johnston, David/0000-0002-2487-1084	NSF [OCE-0961372]; Canadian Institute for Advanced Research Junior Fellowship; Henry and Wendy Breck Foundation	NSF(National Science Foundation (NSF)); Canadian Institute for Advanced Research Junior Fellowship(Canadian Institute for Advanced Research (CIFAR)); Henry and Wendy Breck Foundation	The paper benefited from reviews from J. Hayes, R. Aller, and an anonymous reviewer. The authors acknowledge P. Hoffman for his helpful comments. This work was supported by NSF grant OCE-0961372 to D. P. S. and a Canadian Institute for Advanced Research Junior Fellowship to J. A. H. D. P. S. also thanks the Henry and Wendy Breck Foundation for support.	Aller RC, 1996, CONT SHELF RES, V16, P753, DOI 10.1016/0278-4343(95)00046-1; ANDERSON LG, 1987, MAR CHEM, V20, P361, DOI 10.1016/0304-4203(87)90068-5; Berner RA, 2009, AM J SCI, V309, P603, DOI 10.2475/07.2009.03; Bjerrum CJ, 2011, P NATL ACAD SCI USA, V108, P5542, DOI 10.1073/pnas.1101755108; Bjerrum CJ, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000713; Bristow TF, 2008, GEOLOGY, V36, P863, DOI 10.1130/G24968A.1; BROECKER WS, 1970, J GEOPHYS RES, V75, P3553, DOI 10.1029/JC075i018p03553; Catling DC, 2005, EARTH PLANET SC LETT, V237, P1, DOI 10.1016/j.epsl.2005.06.013; Chow N, 2000, J SEDIMENT RES, V70, P682, DOI 10.1306/2DC40930-0E47-11D7-8643000102C1865D; Derry LA, 2010, EARTH PLANET SC LETT, V294, P152, DOI 10.1016/j.epsl.2010.03.022; Duguid SMA, 2010, J SEDIMENT RES, V80, P236, DOI 10.2110/jsr.2010.027; Grotzinger JP, 2011, NAT GEOSCI, V4, P285, DOI [10.1038/ngeo1138, 10.1038/NGEO1138]; Halverson GP, 2005, GEOL SOC AM BULL, V117, P1181, DOI 10.1130/B25630.1; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; Hayes JM, 2006, PHILOS T R SOC B, V361, P931, DOI 10.1098/rstb.2006.1840; Higgins JA, 2009, EARTH PLANET SC LETT, V284, P25, DOI 10.1016/j.epsl.2009.03.039; Jiang GQ, 2007, EARTH PLANET SC LETT, V261, P303, DOI 10.1016/j.epsl.2007.07.009; Johnston DT, 2012, NATURE, V483, P320, DOI 10.1038/nature10854; Knauth LP, 2009, NATURE, V460, P728, DOI 10.1038/nature08213; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Kump LR, 2011, SCIENCE, V334, P1694, DOI 10.1126/science.1213999; Macdonald FA, 2010, SCIENCE, V327, P1241, DOI 10.1126/science.1183325; Maloof AC, 2010, GEOL SOC AM BULL, V122, P1731, DOI 10.1130/B30346.1; Meister P, 2007, SEDIMENTOLOGY, V54, P1007, DOI 10.1111/j.1365-3091.2007.00870.x; Meyer KM, 2011, EARTH PLANET SC LETT, V302, P378, DOI 10.1016/j.epsl.2010.12.033; Naehr TH, 2007, DEEP-SEA RES PT II, V54, P1268, DOI 10.1016/j.dsr2.2007.04.010; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; Prokoph A, 2008, EARTH-SCI REV, V87, P113, DOI 10.1016/j.earscirev.2007.12.003; Reimers CE, 1996, GEOCHIM COSMOCHIM AC, V60, P4037, DOI 10.1016/S0016-7037(96)00231-1; ROBERTS HH, 1994, GEO-MAR LETT, V14, P135, DOI 10.1007/BF01203725; Saltzman MR, 2011, P NATL ACAD SCI USA, V108, P3876, DOI 10.1073/pnas.1011836108; Schrag DP, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000219; Shen B, 2011, GEOCHIM COSMOCHIM AC, V75, P1357, DOI 10.1016/j.gca.2010.12.015; Sivan O, 2007, GEOBIOLOGY, V5, P141, DOI 10.1111/j.1472-4669.2007.00098.x; UREY HC, 1948, SCIENCE, V108, P489, DOI 10.1126/science.108.2810.489; Zhu ZB, 2002, CONT SHELF RES, V22, P2065, DOI 10.1016/S0278-4343(02)00071-7	37	309	329	26	377	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					540	543		10.1126/science.1229578	http://dx.doi.org/10.1126/science.1229578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372007				2022-12-24	WOS:000314270000049
J	Majumdar, S; Singh, A; Rio, DC				Majumdar, Sharmistha; Singh, Anita; Rio, Donald C.			The Human THAP9 Gene Encodes an Active P-Element DNA Transposase	SCIENCE			English	Article							V(D)J RECOMBINATION; BINDING DOMAIN; RAG PROTEINS; IN-VIVO; EVOLUTION; GENOME; REPAIR; MOBILE	The human genome contains similar to 50 genes that were derived from transposable elements or transposons, and many are now integral components of cellular gene expression programs. The human THAP9 gene is related to the Drosophila P-element transposase. Here, we show that human THAP9 can mobilize Drosophila P-elements in both Drosophila and human cells. Chimeric proteins formed between the Drosophila P-element transposase N-terminal THAP DNA binding domain and the C-terminal regions of human THAP9 can also mobilize Drosophila P elements. Our results indicate that human THAP9 is an active DNA transposase that, although "domesticated," still retains the catalytic activity to mobilize P transposable elements across species.	[Majumdar, Sharmistha; Singh, Anita; Rio, Donald C.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Rio, Donald C.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Rio, Donald C.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rio, DC (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	don_rio@berkeley.edu	MAJUMDAR, sharmistha/AAV-3512-2021; macedo santos, antónio/M-5737-2013	MAJUMDAR, sharmistha/0000-0003-4356-7237; macedo santos, antónio/0000-0003-2180-2718	NIH [R01GM48862, R01GM61987, R01 GM097352, R01GM104385, R01GM094890]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048862, R01GM094890, R01GM104385, R01GM061987, R01GM097352] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. M. Taliaferro, J. Aspden, and M. Francis for comments and discussion; R. Rawat for technical assistance; and C. J. Potter (Johns Hopkins Medical School) for helpful suggestions about the splinkerette PCR experiments. This work was supported by NIH grants R01GM48862, R01GM61987, R01 GM097352, R01GM104385, and R01GM094890. S. M. and D. C. R. conceived the experiments. S. M., A. S., and D. C. R. performed cell culture and molecular biological experiments and analyzed data. S. M. and D. C. R. wrote the paper. The authors declare no competing financial interests. Requests for materials should be addressed to the corresponding author.	Beall EL, 1996, GENE DEV, V10, P921, DOI 10.1101/gad.10.8.921; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Hagemann S, 2001, MOL BIOL EVOL, V18, P1979, DOI 10.1093/oxfordjournals.molbev.a003739; Hammer SE, 2005, MOL BIOL EVOL, V22, P833, DOI 10.1093/molbev/msi068; Horn C, 2007, NAT GENET, V39, P933, DOI 10.1038/ng0807-933; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee SH, 2005, P NATL ACAD SCI USA, V102, P18075, DOI 10.1073/pnas.0503676102; Mul YM, 1997, EMBO J, V16, P4441, DOI 10.1093/emboj/16.14.4441; Potter CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010168; Quesneville H, 2005, MOL BIOL EVOL, V22, P741, DOI 10.1093/molbev/msi064; Roussigne M, 2003, TRENDS BIOCHEM SCI, V28, P66, DOI 10.1016/S0968-0004(02)00013-0; Sabogal A, 2010, NAT STRUCT MOL BIOL, V17, P117, DOI 10.1038/nsmb.1742; Schaack S, 2010, TRENDS ECOL EVOL, V25, P537, DOI 10.1016/j.tree.2010.06.001; Shaheen M, 2010, GENETICA, V138, P559, DOI 10.1007/s10709-010-9452-1; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327	20	38	39	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					446	448		10.1126/science.1231789	http://dx.doi.org/10.1126/science.1231789			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349291	Green Accepted			2022-12-24	WOS:000313960700043
J	Schwartz, MA; Chen, CS				Schwartz, Martin A.; Chen, Christopher S.			Deconstructing Dimensionality	SCIENCE			English	Editorial Material							CELL-MATRIX ADHESIONS; MORPHOGENESIS; POLARITY		[Schwartz, Martin A.] Yale Univ, Sch Med, Cardiovasc Res Ctr, New Haven, CT 06511 USA; [Chen, Christopher S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	Yale University; University of Pennsylvania	Schwartz, MA (corresponding author), Yale Univ, Sch Med, Cardiovasc Res Ctr, 300 George St, New Haven, CT 06511 USA.	martin.schwartz@yale.edu; chrischen@seas.upenn.edu	Chen, Christopher S./ABD-8499-2021	Chen, Christopher S./0000-0003-2445-8449; schwartz, martin/0000-0002-2071-1243	NHLBI NIH HHS [R01 HL075092] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075092] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Benton G, 2009, J CELL PHYSIOL, V221, P18, DOI 10.1002/jcp.21832; Carrel A, 1912, J EXP MED, V15, P516, DOI 10.1084/jem.15.5.516; Chen X, 2012, TISSUE ENG PT A, V18, P2528, DOI [10.1089/ten.tea.2012.0094, 10.1089/ten.TEA.2012.0094]; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Eisen R, 2006, AM J PHYSIOL-CELL PH, V290, pC1297, DOI 10.1152/ajpcell.00287.2005; Harrison RG, 1914, J EXP ZOOL, V17, P521, DOI 10.1002/jez.1400170403; Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001; Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010; Liu KD, 2007, AM J PHYSIOL-RENAL, V293, pF1633, DOI 10.1152/ajprenal.00053.2007; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; McCaffrey LM, 2011, TRENDS CELL BIOL, V21, P727, DOI 10.1016/j.tcb.2011.06.005; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Santos E, 2012, TRENDS BIOTECHNOL, V30, P331, DOI 10.1016/j.tibtech.2012.03.005; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Wang YK, 2001, AM J PHYSIOL-CELL PH, V280, pC1440, DOI 10.1152/ajpcell.2001.280.6.C1440; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006	20	76	77	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2013	339	6118					402	404		10.1126/science.1233814	http://dx.doi.org/10.1126/science.1233814			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349278				2022-12-24	WOS:000313960700027
J	Reddi, AR; Culotta, VC				Reddi, Amit R.; Culotta, Valeria C.			SOD1 Integrates Signals from Oxygen and Glucose to Repress Respiration	CELL			English	Article							CASEIN KINASE-I; CU,ZN SUPEROXIDE-DISMUTASE; COPPER CHAPERONE CCS; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; NULL MUTANTS; H+-ATPASE; YEAST; ACTIVATION; MANGANESE	Cu/Zn superoxide dismutase (SOD1) is an abundant enzyme that has been best studied as a regulator of antioxidant defense. Using the yeast Saccharomyces cerevisiae, we report that SOD1 transmits signals from oxygen and glucose to repress respiration. The mechanism involves SOD1-mediated stabilization of two casein kinase 1-gamma (CK1 gamma) homologs, Yck1p and Yck2p, required for respiratory repression. SOD1 binds a C-terminal degron we identified in Yck1p/Yck2p and promotes kinase stability by catalyzing superoxide conversion to peroxide. The effects of SOD1 on CK1 gamma stability are also observed with mammalian SOD1 and CK1 gamma and in a human cell line. Therefore, in a single circuit, oxygen, glucose, and reactive oxygen can repress respiration through SOD1/CK1 gamma signaling. Our data therefore may provide mechanistic insight into how rapidly proliferating cells and many cancers accomplish glucose-mediated repression of respiration in favor of aerobic glycolysis.	[Reddi, Amit R.; Culotta, Valeria C.] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Culotta, VC (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	vculotta@jhsph.edu			JHU NIEHS center; NIH R37 [GM50016]; NIH NIGMS fellowship [F32 GM 093550]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050016, F32GM093550, R37GM050016] Funding Source: NIH RePORTER	JHU NIEHS center; NIH R37; NIH NIGMS fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Kavianpour, C. Vazquez, J. Gleason, D. Corrigan, and H. Chen for technical assistance and Professors M. Johnston, D. Thiele, L. Robinson, and J.-H. Kim for strains and plasmids. This work was supported by the JHU NIEHS center and by NIH R37 grant GM50016 (to V.C.C.). A.R.R. was supported by NIH NIGMS fellowship F32 GM 093550.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Alvarez HM, 2010, SCIENCE, V327, P331, DOI 10.1126/science.1179907; Barnese K, 2012, P NATL ACAD SCI USA, V109, P6892, DOI 10.1073/pnas.1203051109; Bensinger SJ, 2012, SEMIN CELL DEV BIOL, V23, P352, DOI 10.1016/j.semcdb.2012.02.003; BILINSKI T, 1985, BIOCHEM BIOPH RES CO, V130, P533, DOI 10.1016/0006-291X(85)90449-8; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; CHANG EC, 1990, J BACTERIOL, V172, P1840, DOI 10.1128/jb.172.4.1840-1845.1990; CHANG EC, 1989, J BIOL CHEM, V264, P12172; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; CULOTTA VC, 1995, J BIOL CHEM, V270, P29991; Davidson GS, 2011, MOL BIOL CELL, V22, P988, DOI 10.1091/mbc.E10-06-0499; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Estrada E, 1996, J BIOL CHEM, V271, P32064, DOI 10.1074/jbc.271.50.32064; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIACOMINI A, 1992, FEMS MICROBIOL LETT, V100, P87, DOI 10.1111/j.1574-6968.1992.tb05687.x; Gleason JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024741; GRALLA EB, 1991, J BACTERIOL, V173, P5918, DOI 10.1128/jb.173.18.5918-5920.1991; Halliwell B., 2007, FREE RADICALS BIOL M; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ho Y, 1997, P NATL ACAD SCI USA, V94, P581, DOI 10.1073/pnas.94.2.581; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Leitch JM, 2012, BIOCHEMISTRY-US, V51, P677, DOI 10.1021/bi201353y; Leitch JM, 2009, J BIOL CHEM, V284, P21863, DOI 10.1074/jbc.M109.000489; Liu ZC, 2008, MOL CELL BIOL, V28, P551, DOI 10.1128/MCB.00929-07; Luk E, 2005, J BIOL CHEM, V280, P22715, DOI 10.1074/jbc.M504257200; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Meng FJ, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-34; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; Munroe W, 2007, J INORG BIOCHEM, V101, P1875, DOI 10.1016/j.jinorgbio.2007.07.008; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566; PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954; Pasteur L, 1861, CR HEBD ACAD SCI, V52, P1260; Pasula S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-17; PERLIN DS, 1989, J BIOL CHEM, V264, P21857; Reddi AR, 2011, GENETICS, V189, P1261, DOI 10.1534/genetics.111.134007; Rinnerthaler M, 2012, P NATL ACAD SCI USA, V109, P8658, DOI 10.1073/pnas.1201629109; ROBINSON LC, 1992, P NATL ACAD SCI USA, V89, P28, DOI 10.1073/pnas.89.1.28; Ronald TKN, 2008, P NATL ACAD SCI USA, V105, P15166, DOI 10.1073/pnas.0807712105; Roth AF, 2011, MOL BIOL CELL, V22, P2702, DOI 10.1091/mbc.E11-02-0115; Sehati S, 2011, FREE RADICAL BIO MED, V50, P1591, DOI 10.1016/j.freeradbiomed.2011.03.004; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Sturtz LA, 2002, METHOD ENZYMOL, V349, P167, DOI 10.1016/S0076-6879(02)49332-9; Sun BM, 2004, MOL BIOL CELL, V15, P1397, DOI 10.1091/mbc.E03-09-0682; Tarpey MM, 2001, CIRC RES, V89, P224, DOI 10.1161/hh1501.094365; Wang XT, 1996, NATURE, V383, P434, DOI 10.1038/383434a0; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; White C, 2009, J CELL SCI, V122, P1315, DOI 10.1242/jcs.043216; Wood LK, 2009, J BIOL CHEM, V284, P404, DOI 10.1074/jbc.M807027200; Wu CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007061; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; ZHAI LM, 1995, J BIOL CHEM, V270, P12717, DOI 10.1074/jbc.270.21.12717; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	59	147	152	1	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					224	235		10.1016/j.cell.2012.11.046	http://dx.doi.org/10.1016/j.cell.2012.11.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332757	Bronze, Green Accepted			2022-12-24	WOS:000313719800019
J	Spence, D				Spence, Des			A conspiracy of anonymity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2013	346								f32	10.1136/bmj.f32	http://dx.doi.org/10.1136/bmj.f32			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070YU	23295249				2022-12-24	WOS:000313552300008
J	Roberts, SA; Davidson, AJ; McLean, L; Beynon, RJ; Hurst, JL				Roberts, Sarah A.; Davidson, Amanda J.; McLean, Lynn; Beynon, Robert J.; Hurst, Jane L.			Pheromonal Induction of Spatial Learning in Mice	SCIENCE			English	Article							SEXUAL PHEROMONES; SIGNALS; MOUSE; SCENT; ENVIRONMENT; ATTRACTION; BEHAVIOR; MALES	Many mammals use scent marking for sexual and competitive advertisement, but little is known about the mechanism by which scents are used to locate mates and competitors. We show that darcin, an involatile protein sex pheromone in male mouse urine, can rapidly condition preference for its remembered location among females and competitor males so that animals prefer to spend time in the site even when scent is absent. Learned spatial preference is conditioned through contact with darcin in a single trial and remembered for approximately 14 days. This pheromone-induced learning allows animals to relocate sites of particular social relevance and provides proof that pheromones such as darcin can be highly potent stimuli for social learning.	[Roberts, Sarah A.; Davidson, Amanda J.; Hurst, Jane L.] Univ Liverpool, Mammalian Behav & Evolut Grp, Inst Integrat Biol, Neston CH64 7TE, England; [McLean, Lynn; Beynon, Robert J.] Univ Liverpool, Inst Integrat Biol, Prot Funct Grp, Liverpool L69 7ZB, Merseyside, England	University of Liverpool; University of Liverpool	Hurst, JL (corresponding author), Univ Liverpool, Mammalian Behav & Evolut Grp, Inst Integrat Biol, Leahurst Campus, Neston CH64 7TE, England.	jane.hurst@liv.ac.uk	Beynon, Robert J/K-1408-2014; Hurst, Jane L/G-8793-2015; Roberts, Sarah/E-4936-2013	Beynon, Robert J/0000-0003-0857-495X; Hurst, Jane L/0000-0002-3728-9624; ROBERTS, SARAH/0000-0003-2193-5561	Biotechnology and Biological Science Research Council [BBC503897, BB/J002631/1]; Natural Environment Research Council [NE/G018650]; BBSRC [BB/J002631/1] Funding Source: UKRI; NERC [NE/G018650/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J002631/1] Funding Source: researchfish; Natural Environment Research Council [NE/G018650/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank J. Waters, R. Spencer, S. Jopson, and R. Humphries for technical help and members of the Mammalian Behavior & Evolution Group for helpful discussions. The study was funded by research grants to J. L. H. and R. J. B. from the Biotechnology and Biological Science Research Council (BBC503897 and BB/J002631/1) and the Natural Environment Research Council (NE/G018650). The data reported in this study are provided as raw data in the supplementary materials.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Bell MR, 2010, HORM BEHAV, V58, P410, DOI 10.1016/j.yhbeh.2010.05.017; Brown RE., 1985, SOCIAL ODOURS MAMMAL; Cheetham SA, 2009, PHYSIOL BEHAV, V96, P253, DOI 10.1016/j.physbeh.2008.10.005; Coureaud G, 2006, CURR BIOL, V16, P1956, DOI 10.1016/j.cub.2006.08.030; Gosling L. M., 1982, J COMP ETHOL, V60, P89; Gosling LM, 2001, ADV STUD BEHAV, V30, P169, DOI 10.1016/S0065-3454(01)80007-3; HARVEY S, 1989, J CHEM ECOL, V15, P2061, DOI 10.1007/BF01207438; Hurst JL, 2009, BEHAV BRAIN RES, V200, P295, DOI 10.1016/j.bbr.2008.12.020; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Johannesson K, 2008, EVOLUTION, V62, P3178, DOI 10.1111/j.1558-5646.2008.00510.x; LeMaster MP, 2001, ANIM BEHAV, V61, P827, DOI 10.1006/anbe.2000.1658; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Martinez-Ricos J, 2007, CHEM SENSES, V32, P139, DOI 10.1093/chemse/bjl039; Moncho-Bogani J, 2002, PHYSIOL BEHAV, V77, P167, DOI 10.1016/S0031-9384(02)00842-9; Morgan ED, 2009, PHYSIOL ENTOMOL, V34, P1, DOI 10.1111/j.1365-3032.2008.00658.x; Mudge JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r91; Pankevich DE, 2006, PHYSIOL BEHAV, V87, P781, DOI 10.1016/j.physbeh.2006.01.020; Paredes RG, 2009, ILAR J, V50, P15, DOI 10.1093/ilar.50.1.15; Ramm SA, 2008, P ROY SOC B-BIOL SCI, V275, P1727, DOI 10.1098/rspb.2008.0302; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; SCHWENDE FJ, 1986, J CHEM ECOL, V12, P277, DOI 10.1007/BF01045611	22	116	116	0	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2012	338	6113					1462	1465		10.1126/science.1225638	http://dx.doi.org/10.1126/science.1225638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239735				2022-12-24	WOS:000312250800046
J	Tottrup, AP; Klaassen, RHG; Kristensen, MW; Strandberg, R; Vardanis, Y; Lindstrom, A; Rahbek, C; Alerstam, T; Thorup, K				Tottrup, A. P.; Klaassen, R. H. G.; Kristensen, M. W.; Strandberg, R.; Vardanis, Y.; Lindstrom, A.; Rahbek, C.; Alerstam, T.; Thorup, K.			Drought in Africa Caused Delayed Arrival of European Songbirds	SCIENCE			English	Article							MIGRATORY BIRD		[Tottrup, A. P.; Kristensen, M. W.; Thorup, K.] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Nat Hist Museum, DK-2100 Copenhagen, Denmark; [Klaassen, R. H. G.; Strandberg, R.; Vardanis, Y.; Lindstrom, A.; Alerstam, T.] Lund Univ, Dept Biol, SE-22362 Lund, Sweden; [Klaassen, R. H. G.] Univ Groningen, Montagus Harrier Fdn, NL-9700 CC Groningen, Netherlands; [Klaassen, R. H. G.] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, NL-9700 CC Groningen, Netherlands	University of Copenhagen; Lund University; University of Groningen; University of Groningen	Tottrup, AP (corresponding author), Univ Copenhagen, Ctr Macroecol Evolut & Climate, Nat Hist Museum, Univ Pk 15, DK-2100 Copenhagen, Denmark.	aptottrup@bio.ku.dk	Thorup, Kasper/A-4835-2013; Rahbek, Carsten/D-9372-2013; Tøttrup, Anders P/N-3836-2013; Klaassen, Raymond/K-3027-2013; Willemoes, Mikkel/J-9391-2012; Rahbek, Carsten/L-1129-2013	Thorup, Kasper/0000-0002-0320-0601; Tøttrup, Anders P/0000-0001-8776-9629; Willemoes, Mikkel/0000-0001-9363-6304; Rahbek, Carsten/0000-0003-4585-0300	Swedish Research Council; Centre for Animal Movement Research; Villum Foundation; Swedish Environmental Protection Agency; Danish National Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Centre for Animal Movement Research; Villum Foundation(Villum Fonden); Swedish Environmental Protection Agency; Danish National Research Foundation(Danmarks Grundforskningsfond)	Danish Nature Agency (J.nr.SN 302-009) and ethical committees in Malmo/Lund (M112-09) approved the studies. Swedish Research Council, Centre for Animal Movement Research, Villum Foundation, Swedish Environmental Protection Agency and Danish National Research Foundation financed this study. Contribution no. 259 from Ottenby Bird Observatory. Tracking data are available at www.movebank.org (digital object identifier: 10.5441/001/1.8jg3h6n7).	GWINNER E, 1978, J COMP PHYSIOL, V125, P267, DOI 10.1007/BF00656605; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Wikelski M, 2007, J EXP BIOL, V210, P181, DOI 10.1242/jeb.02629; Wilcove D. S., 2008, NO WAY HOME; Wolff C, 2011, SCIENCE, V333, P743, DOI 10.1126/science.1203724	8	120	125	5	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1307	1307		10.1126/science.1227548	http://dx.doi.org/10.1126/science.1227548			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224549				2022-12-24	WOS:000311991200056
J	Jia, ZW; Mao, YR; Zhang, FJ; Ruan, YH; Ma, Y; Li, J; Guo, W; Liu, EW; Dou, ZH; Zhao, Y; Wang, L; Li, QQ; Xie, PY; Tang, HL; Han, J; Jin, X; Xu, J; Xiong, R; Zhao, DC; Li, P; Wang, X; Wang, LY; Qing, QQ; Ding, ZW; Chen, RY; Liu, ZF; Shao, YM				Jia, Zhongwei; Mao, Yurong; Zhang, Fujie; Ruan, Yuhua; Ma, Ye; Li, Jian; Guo, Wei; Liu, Enwu; Dou, Zhihui; Zhao, Yan; Wang, Lu; Li, Qianqian; Xie, Peiyan; Tang, Houlin; Han, Jing; Jin, Xia; Xu, Juan; Xiong, Ran; Zhao, Decai; Li, Ping; Wang, Xia; Wang, Liyan; Qing, Qianqian; Ding, Zhengwei; Chen, Ray Y.; Liu, Zhongfu; Shao, Yiming			Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HETEROSEXUAL TRANSMISSION; SEXUAL TRANSMISSION; DISCORDANT COUPLES; DRUG-RESISTANCE; VIRAL LOAD; MORTALITY; PREVALENCE; INFECTION; FEMALE	Background On the basis of the results of the randomised clinical trial HPTN 052 and observational studies, WHO has recommended that antiretroviral therapy be off ered to all HIV-infected individuals with uninfected partners of the opposite sex (serodiscordant couples) to reduce the risk of transmission. Whether or not such a public health approach is feasible and the outcomes are sustainable at a large scale and in a developing country setting has not previously been assessed. Methods In this retrospective observational cohort study, we included treated and treatment-naive HIV-positive individuals with HIV-negative partners of the opposite sex who had been added to the national HIV epidemiology and treatment databases between Jan 1, 2003 and Dec 31, 2011. We analysed the annual rate of HIV infection in HIVnegative partners during follow-up, stratifi ed by treatment status of the index partner. Cox proportional hazards analyses were done to examine factors related to HIV transmission. Findings Based on data from 38 862 serodiscordant couples, with 101 295.1 person-years of follow-up for the seronegative partners, rates of HIV infection were 2.6 per 100 person-years (95% CI 2.4-2.8) among the 14 805 couples in the treatment-naive cohort (median baseline CD4 count for HIV-positive partners 441 cells per mu l [IQR 314-590]) and 1.3 per 100 person-years (1.2-1.3) among the 24 057 couples in the treated cohort (median baseline CD4 count for HIV-positive partners 168 cells per mu l [62-269]). We calculated a 26% relative reduction in HIV transmission (adjusted hazard ratio 0.74, 95% CI 0.65-0.84) in the treated cohort. The reduction in transmission was seen across almost all demographic subgroups and was signifi cant in the fi rst year (0.64, 0.54-0.76), and among couples in which the HIV-positive partner had been infected by blood or plasma transfusion (0.76, 0.59-0.99) or heterosexual intercourse (0.69, 0.56-0.84), but not among couples in which the HIV-positive partner was infected by injecting drugs (0.98, 0.71-1.36). Interpretation Antiretroviral therapy for HIV-positive individuals in serodiscordant couples reduced HIV transmission across China, which suggests that the treatment-as-prevention approach is a feasible public health prevention strategy on a national scale in a developing country context. The durability and generalisability of such protection, however, needs to be further studied.	[Jia, Zhongwei] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Mao, Yurong; Zhang, Fujie; Ruan, Yuhua; Ma, Ye; Li, Jian; Guo, Wei; Liu, Enwu; Dou, Zhihui; Zhao, Yan; Wang, Lu; Xie, Peiyan; Tang, Houlin; Han, Jing; Jin, Xia; Xu, Juan; Xiong, Ran; Zhao, Decai; Li, Ping; Wang, Xia; Qing, Qianqian; Ding, Zhengwei; Liu, Zhongfu; Shao, Yiming] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 102206, Peoples R China; [Ruan, Yuhua; Xie, Peiyan; Li, Ping; Wang, Xia; Shao, Yiming] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China; [Ruan, Yuhua; Wang, Xia; Shao, Yiming] Collaborat Innovat Ctr Infect Dis, Hangzhou, Zhejiang, Peoples R China; [Jia, Zhongwei] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Takemi Program Int Hlth, Boston, MA 02115 USA; [Li, Qianqian] China Ocean Univ, Coll Math Sci, Qingdao, Peoples R China; [Xie, Peiyan; Li, Ping] Guangxi Med Univ, Sch Publ Hlth, Nanning, Peoples R China; [Chen, Ray Y.] NIAID, NIH, Bethesda, MD 20892 USA	Peking University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Harvard University; Harvard T.H. Chan School of Public Health; Ocean University of China; Guangxi Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shao, YM (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.	zhongfuliu@163.com; yshao08@gmail.com	Chen, Ray/T-5102-2019; tang, houlin/HGA-1502-2022; Chen, Ray/GRJ-6736-2022; Liu, Enwu/AGC-4748-2022; Wang, Xia/C-3298-2018	Liu, Enwu/0000-0003-2580-3523; Wang, Xia/0000-0002-1684-7076; Chen, Ray/0000-0001-6344-1442	Chinese Government's 12th Five-Year Plan; National Natural Science Foundation of China,; Canadian International Development Research Centre	Chinese Government's 12th Five-Year Plan; National Natural Science Foundation of China,(National Natural Science Foundation of China (NSFC)); Canadian International Development Research Centre	Chinese Government's 12th Five-Year Plan, the National Natural Science Foundation of China, and the Canadian International Development Research Centre.	Anglemyer A, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009153, 10.1002/14651858.CD009153.pub2]; [Anonymous], HIV TRANSM RISK; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Coburn BJ, 2011, LANCET INFECT DIS, V11, P263, DOI 10.1016/S1473-3099(11)70080-9; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; DEVINCENZI I, 1992, BRIT MED J, V304, P809; Dou ZH, 2010, INT J EPIDEMIOL, V39, pII56, DOI 10.1093/ije/dyq215; Dou ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013737; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Liu J, 2011, AIDS RES HUM RETROV, V27, P925, DOI [10.1089/aid.2010.0328, 10.1089/AID.2010.0328]; Ma Y, 2010, INT J EPIDEMIOL, V39, P973, DOI 10.1093/ije/dyp233; Ma Y, 2010, CLIN INFECT DIS, V50, P264, DOI 10.1086/649215; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Montaner JSG, 2010, JAIDS-J ACQ IMM DEF, V55, pS5, DOI 10.1097/QAI.0b013e3181f9c1f0; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; PADIAN NS, 1991, JAMA-J AM MED ASSOC, V266, P1664; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; State Council AIDS Working Committee Office & UN Theme Group on AIDS in China, 2011, JOINT ASS HIV AIDS P; Varghese B, 2002, SEX TRANSM DIS, V29, P38, DOI 10.1097/00007435-200201000-00007; Wang L, 2012, AIDS CARE, V24, P1059, DOI 10.1080/09540121.2012.661837; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; World Health Organization, 2012, GUID OR PREEXP PROPH; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	31	100	120	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2013	382	9899					1195	1203		10.1016/S0140-6736(12)61898-4	http://dx.doi.org/10.1016/S0140-6736(12)61898-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SL	23206835				2022-12-24	WOS:000325209100024
J	Talbot, TR; Talbot, HK				Talbot, Thomas R.; Talbot, H. Keipp			Influenza Prevention Update Examining Common Arguments Against Influenza Vaccination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Talbot, Thomas R.; Talbot, H. Keipp] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Talbot, Thomas R.] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Talbot, TR (corresponding author), Vanderbilt Univ, Med Ctr, A-2200 Med Ctr N,1161 21st Ave S, Nashville, TN 37232 USA.	tom.talbot@vanderbilt.edu		Talbot, Thomas/0000-0002-6139-212X				Ball Sarah W., 2012, Morbidity and Mortality Weekly Report, V61, P753; Centers for Disease Control and Prevention, 2011, SIT UPD SUMM WEEKL F; Centers for Disease Control and Prevention, PREV STRAT SEAS INFL; Grohskopf Lisa, 2012, Morbidity and Mortality Weekly Report, V61, P613; Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P32; Jain VK, 2012, IDWEEK SCI M OCT 17; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Talbot TR, 2012, INFECT CONT HOSP EP, V33, P981, DOI 10.1086/667772; Williams Walter W., 2012, Morbidity and Mortality Weekly Report, V61, P66	10	10	11	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2013	309	9					881	882		10.1001/jama.2013.453	http://dx.doi.org/10.1001/jama.2013.453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099PC	23334755				2022-12-24	WOS:000315632700021
J	Mugoni, V; Postel, R; Catanzaro, V; De Luca, E; Turco, E; Digilio, G; Silengo, L; Murphy, MP; Medana, C; Stainier, DYR; Bakkers, J; Santoro, MM				Mugoni, Vera; Postel, Ruben; Catanzaro, Valeria; De Luca, Elisa; Turco, Emilia; Digilio, Giuseppe; Silengo, Lorenzo; Murphy, Michael P.; Medana, Claudio; Stainier, Didier Y. R.; Bakkers, Jeroen; Santoro, Massimo M.			Ubiad1 Is an Antioxidant Enzyme that Regulates eNOS Activity by CoQ10 Synthesis	CELL			English	Article							CRYSTALLINE CORNEAL-DYSTROPHY; NITRIC-OXIDE SYNTHASE; PROTEIN S-NITROSYLATION; COENZYME-Q; OXIDATIVE STRESS; CARDIOVASCULAR-SYSTEM; VASCULAR-DISEASE; BLOOD-FLOW; RAT-LIVER; IN-VIVO	Protection against oxidative damage caused by excessive reactive oxygen species (ROS) by an antioxidant network is essential for the health of tissues, especially in the cardiovascular system. Here, we identified a gene with important antioxidant features by analyzing a null allele of zebrafish ubiad1, called barolo (bar). bar mutants show specific cardiovascular failure due to oxidative stress and ROS-mediated cellular damage. Human UBIAD1 is a nonmitochondrial prenyltransferase that synthesizes CoQ10 in the Golgi membrane compartment. Loss of UBIAD1 reduces the cytosolic pool of the antioxidant CoQ10 and leads to ROS-mediated lipid peroxidation in vascular cells. Surprisingly, inhibition of eNOS prevents Ubiad1-dependent cardiovascular oxidative damage, suggesting a crucial role for this enzyme and nonmitochondrial CoQ10 in NO signaling. These findings identify UBIAD1 as a nonmitochondrial CoQ10-forming enzyme with specific cardiovascular protective function via the modulation of eNOS activity.	[Mugoni, Vera; Catanzaro, Valeria; De Luca, Elisa; Turco, Emilia; Digilio, Giuseppe; Silengo, Lorenzo; Santoro, Massimo M.] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, I-10126 Turin, Italy; [Medana, Claudio] Univ Turin, Dept Chem, I-10126 Turin, Italy; [Postel, Ruben; Bakkers, Jeroen] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Postel, Ruben; Bakkers, Jeroen] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Postel, Ruben; Bakkers, Jeroen] Netherlands Heart Inst, NL-3584 CT Utrecht, Netherlands; [Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Stainier, Didier Y. R.] Max Planck Inst Heart & Lung Res, Dept Dev Genet, D-61231 Bad Nauheim, Germany	University of Turin; University of Turin; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Max Planck Society	Santoro, MM (corresponding author), Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, I-10126 Turin, Italy.	massimo.santoro@unito.it	Murphy, Michael P/C-2120-2009; Digilio, Giuseppe/HGU-5278-2022; Bakkers, Jeroen/H-5551-2011; SANTORO, MARIA/K-3250-2018; Medana, Claudio/A-6587-2010; De Luca, Elisa/L-2491-2017	Murphy, Michael P/0000-0003-1115-9618; Bakkers, Jeroen/0000-0002-9418-0422; SANTORO, MARIA/0000-0002-6228-1114; Medana, Claudio/0000-0002-9772-6814; Stainier, Didier/0000-0002-0382-0026; SANTORO, Massimo Mattia/0000-0003-4605-5085; De Luca, Elisa/0000-0001-9849-0703; Digilio, Giuseppe/0000-0003-2397-2913	HFSP Career Developmental Award; Marie Curie Action IRG [247852]; Telethon [GGP10185]; AIRC-MFAG [8911, FP7-NMP-2007-214539]; MRC [MC_U105663142] Funding Source: UKRI; Medical Research Council [MC_U105663142] Funding Source: researchfish	HFSP Career Developmental Award; Marie Curie Action IRG; Telethon(Fondazione Telethon); AIRC-MFAG(Fondazione AIRC per la ricerca sul cancro); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Federica Logrand, Marco Vincenti, Annalisa Camporeale, and Ellen Jane Corcoran for technical assistances as well as Pier Paolo Pandolfi, Guido Serini, Massimiliano Mazzone, Franz Enzmann and Silvio Aime for discussion, technical support and reagents. This work was supported by a HFSP Career Developmental Award (MMS), Marie Curie Action IRG 247852 (MMS), Telethon GGP10185(MMS), AIRC-MFAG 8911(MMS) and FP7-NMP-2007-214539 (JB). VM and MMS planned and discussed the whole project. RP positionally cloned the t31131 allele in JB's lab. Independently, MMS identified the s847 allele in DYRS' lab. RP performed ubiad1 expression analyses and cell transplantation experiments in zebrafish. MPM provided the MitoQ. ET produced the Ubiad1 MAb. VM and MMS performed all other experiments together with VC, GD, CM, EDL and LS. MMS wrote the manuscript and all authors commented on it. The authors declare no conflict of interests.	Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P413, DOI 10.1161/01.ATV.0000110785.96039.f6; Bentinger M, 2007, MITOCHONDRION, V7, pS41, DOI 10.1016/j.mito.2007.02.006; Bentinger M, 2008, BIOFACTORS, V32, P99, DOI 10.1002/biof.5520320112; Browning EA, 2012, ANNU REV PHYSIOL, V74, P403, DOI 10.1146/annurev-physiol-020911-153324; Chew GT, 2004, QJM-INT J MED, V97, P537, DOI 10.1093/qjmed/hch089; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Crane F.L., 1977, BIOMEDICAL CLIN ASPE, P3; Crane FL, 2001, J AM COLL NUTR, V20, P591, DOI 10.1080/07315724.2001.10719063; Crane FL, 2007, MITOCHONDRION, V7, pS2, DOI 10.1016/j.mito.2007.02.011; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Forsgren M, 2004, BIOCHEM J, V382, P519, DOI 10.1042/BJ20040261; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; Fritsche R, 2000, AM J PHYSIOL-REG I, V279, pR2200, DOI 10.1152/ajpregu.2000.279.6.R2200; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jin SW, 2007, DEV BIOL, V307, P29, DOI 10.1016/j.ydbio.2007.03.526; Jonassen T., 2000, COENZYME Q MOL MECH, P185; KALEN A, 1990, J BIOL CHEM, V265, P1158; KALEN A, 1987, ACTA CHEM SCAND B, V41, P70, DOI 10.3891/acta.chem.scand.41b-0070; Kumar A, 2009, PHARMACOL THERAPEUT, V124, P259, DOI 10.1016/j.pharmthera.2009.07.003; Kuster GM, 2010, ANTIOXID REDOX SIGN, V13, P1899, DOI 10.1089/ars.2010.3464; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Liu JY, 2011, J GENET GENOMICS, V38, P225, DOI 10.1016/j.jgg.2011.05.002; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Matlung HL, 2009, ANTIOXID REDOX SIGN, V11, P1699, DOI [10.1089/ars.2008.2408, 10.1089/ARS.2008.2408]; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Navas P, 2007, MITOCHONDRION, V7, pS34, DOI 10.1016/j.mito.2007.02.010; Nickerson ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010760; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; Pelster B, 2005, COMP BIOCHEM PHYS A, V142, P215, DOI 10.1016/j.cbpb.2005.05.036; Pepe S, 2007, MITOCHONDRION, V7, pS154, DOI 10.1016/j.mito.2007.02.005; Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Salviati L, 2005, NEUROLOGY, V65, P606, DOI 10.1212/01.wnl.0000172859.55579.a7; Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8; Schmidt TS, 2007, CLIN SCI, V113, P47, DOI 10.1042/CS20070108; Searles CD, 2006, AM J PHYSIOL-CELL PH, V291, pC803, DOI 10.1152/ajpcell.00457.2005; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stuehr D, 2001, J BIOL CHEM, V276, P14533, DOI 10.1074/jbc.R100011200; Sun JH, 2010, CIRC RES, V106, P285, DOI 10.1161/CIRCRESAHA.109.209452; SWIEZEWSKA E, 1993, J BIOL CHEM, V268, P1494; Trevisson E, 2011, CURR OPIN NEUROL, V24, P449, DOI 10.1097/WCO.0b013e32834ab528; Tsai KL, 2012, J NUTR BIOCHEM, V23, P458, DOI 10.1016/j.jnutbio.2011.01.011; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Wang L, 2011, BLOOD, V118, P4102, DOI 10.1182/blood-2011-05-353235; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; Werner E, 2004, J CELL SCI, V117, P143, DOI 10.1242/jcs.00937; Yellore VS, 2007, MOL VIS, V13, P1777	63	141	153	1	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					504	518		10.1016/j.cell.2013.01.013	http://dx.doi.org/10.1016/j.cell.2013.01.013			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374346	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000314362800020
J	Hirano, Y; Masuda, T; Naganos, S; Matsuno, M; Ueno, K; Miyashita, T; Horiuchi, J; Saitoe, M				Hirano, Yukinori; Masuda, Tomoko; Naganos, Shintaro; Matsuno, Motomi; Ueno, Kohei; Miyashita, Tomoyuki; Horiuchi, Junjiro; Saitoe, Minoru			Fasting Launches CRTC to Facilitate Long-Term Memory Formation in Drosophila	SCIENCE			English	Article							SENSITIVE COINCIDENCE DETECTOR; RUBINSTEIN-TAYBI-SYNDROME; ELEMENT-BINDING PROTEIN; COACTIVATOR TORC2; GENE-EXPRESSION; CREB; INSULIN; CONSOLIDATION; INDUCTION; MECHANISM	Canonical aversive long-term memory (LTM) formation in Drosophila requires multiple spaced trainings, whereas appetitive LTM can be formed after a single training. Appetitive LTM requires fasting prior to training, which increases motivation for food intake. However, we found that fasting facilitated LTM formation in general; aversive LTM formation also occurred after single-cycle training when mild fasting was applied before training. Both fasting-dependent LTM (fLTM) and spaced training-dependent LTM (spLTM) required protein synthesis and cyclic adenosine monophosphate response element-binding protein (CREB) activity. However, spLTM required CREB activity in two neural populations-mushroom body and DAL neurons-whereas fLTM required CREB activity only in mushroom body neurons. fLTM uses the CREB coactivator CRTC, whereas spLTM uses the coactivator CBP. Thus, flies use distinct LTM machinery depending on their hunger state.	[Hirano, Yukinori; Masuda, Tomoko; Naganos, Shintaro; Matsuno, Motomi; Ueno, Kohei; Miyashita, Tomoyuki; Saitoe, Minoru] Tokyo Metropolitan Inst Med Sci, Dept Sensory & Motor Syst, Tokyo 1560057, Japan; [Hirano, Yukinori] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Naganos, Shintaro; Horiuchi, Junjiro] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan	Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Tokyo Metropolitan University	Hirano, Y (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Sensory & Motor Syst, 2-1-6 Kamikitazawa, Tokyo 1560057, Japan.	hirano-yk@igakuken.or.jp; saito-mn@igakuken.or.jp	hirano, yukinori/M-6473-2018	hirano, yukinori/0000-0003-3313-637X; Saitoe, Minoru/0000-0001-9731-4214	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [21300144]; Japan Science and Technology Agency; PRESTO; MEXT/Japan Society for the Promotion of Science [24700415, 23700405]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); PRESTO; MEXT/Japan Society for the Promotion of Science	We thank M. Montminy, J. Yin, R. Davis, and T. Tabata for materials, and H. Tanimoto and H. Takemori for suggestions. Supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (grant-in-aid in innovative areas "Systems Molecular Ethology" and KAKENHI grant 21300144) (M. S.); the Japan Science and Technology Agency and PRESTO (Y.H.); and MEXT/Japan Society for the Promotion of Science KAKENHI grants 24700415 and 23700405 (M. M. and K.U.).	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Chen CC, 2012, SCIENCE, V335, P678, DOI 10.1126/science.1212735; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; Miyashita T, 2012, NEURON, V74, P887, DOI 10.1016/j.neuron.2012.03.039; Naganos S, 2012, NEUROSCI RES, V73, P49, DOI 10.1016/j.neures.2012.02.001; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; Perazzona B, 2004, J NEUROSCI, V24, P8823, DOI 10.1523/JNEUROSCI.4542-03.2004; Placais PY, 2013, SCIENCE, V339, P440, DOI 10.1126/science.1226018; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Wang B, 2008, CELL METAB, V7, P434, DOI 10.1016/j.cmet.2008.02.010; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Zhou Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000016	29	92	93	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					443	446		10.1126/science.1227170	http://dx.doi.org/10.1126/science.1227170			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349290				2022-12-24	WOS:000313960700042
J	Gelfand, I; Sahajpal, R; Zhang, XS; Izaurralde, RC; Gross, KL; Robertson, GP				Gelfand, Ilya; Sahajpal, Ritvik; Zhang, Xuesong; Izaurralde, R. Cesar; Gross, Katherine L.; Robertson, G. Philip			Sustainable bioenergy production from marginal lands in the US Midwest	NATURE			English	Article							LIFE-CYCLE ASSESSMENT; CLIMATE-CHANGE; PART II; BIOFUELS; ETHANOL; CORN; AGRICULTURE; GRASSLANDS; DIVERSITY; EMISSIONS	Legislation on biofuels production in the USA(1) and Europe(2,3) is directing food crops towards the production of grain-based ethanol(2,3), which can have detrimental consequences for soil carbon sequestration(4), nitrous oxide emissions(5), nitrate pollution(6), biodiversity(7) and human health(8). An alternative is to grow lignocellulosic (cellulosic) crops on 'marginal' lands(9). Cellulosic feedstocks can have positive environmental outcomes(10,11) and could make up a substantial proportion of future energy portfolios(12,13). However, the availability of marginal lands for cellulosic feedstock production, and the resulting greenhouse gas (GHG) emissions, remains uncertain. Here we evaluate the potential for marginal lands in ten Midwestern US states to produce sizeable amounts of biomass and concurrently mitigate GHG emissions. In a comparative assessment of six alternative cropping systems over 20 years, we found that successional herbaceous vegetation, once well established, has a direct GHG emissions mitigation capacity that rivals that of purpose-grown crops (-851 +/- 46 grams of CO2 equivalent emissions per square metre per year (gCO(2)e m(-2) yr(-1))). If fertilized, these communities have the capacity to produce about 63 +/- 5 gigajoules of ethanol energy per hectare per year. By contrast, an adjacent, no-till corn-soybean-wheat rotation produces on average 41 +/- 1 gigajoules of biofuel energy per hectare per year and has a net direct mitigation capacity of -397 +/- 32 gCO(2)e m(-2) yr(-1); a continuous corn rotation would probably produce about 62 +/- 7 gigajoules of biofuel energy per hectare per year, with 13% less mitigation. We also perform quantitative modelling of successional vegetation on marginal lands in the region at a resolution of 0.4 hectares, constrained by the requirement that each modelled location be within 80 kilometres of a potential biorefinery. Our results suggest that such vegetation could produce about 21 gigalitres of ethanol per year from around 11 million hectares, or approximately 25 per cent of the 2022 target for cellulosic biofuel mandated by the US Energy Independence and Security Act of 2007, with no initial carbon debt nor the indirect land-use costs associated with food-based biofuels. Other regional-scale aspects of biofuel sustainability(2), such as water quality(11,14) and biodiversity(15), await future study.	[Gelfand, Ilya; Sahajpal, Ritvik; Zhang, Xuesong; Izaurralde, R. Cesar; Gross, Katherine L.; Robertson, G. Philip] Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Gelfand, Ilya; Gross, Katherine L.; Robertson, G. Philip] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Sahajpal, Ritvik; Zhang, Xuesong; Izaurralde, R. Cesar] Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA; [Sahajpal, Ritvik; Izaurralde, R. Cesar] Univ Maryland, Dept Geog Sci, College Pk, MD 20740 USA; [Gross, Katherine L.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Robertson, G. Philip] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA	Michigan State University; United States Department of Energy (DOE); Michigan State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University System of Maryland; University of Maryland College Park; Michigan State University; Michigan State University	Gelfand, I (corresponding author), Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA.	igelfand@msu.edu; robert30@msu.edu	Gelfand, Ilya/AAT-1776-2020; zhang, xuesong/B-7907-2009; Izaurralde, Roberto César/E-5257-2019; Robertson, G Philip/H-3885-2011; Zhang, Xuesong/AAR-2455-2020; Gelfand, Ilya/J-9017-2012; Sahajpal, Ritvik/N-4565-2013	Gelfand, Ilya/0000-0002-8576-0978; zhang, xuesong/0000-0003-4711-7751; Robertson, G Philip/0000-0001-9771-9895; Gelfand, Ilya/0000-0002-8576-0978; Sahajpal, Ritvik/0000-0002-6418-289X; Izaurralde, Roberto/0000-0002-8797-9500	US DOE Office of Science [DE-FC02-07ER64494, KP1601050, DE-AC05-76RL01830]; US DOE Office of Energy Efficiency and Renewable Energy [DE-AC05-76RL01830, OBP 20469-19145]; US National Science Foundation LTER program [DEB 1027253]; NASA [NNH08ZDA001N]; MSU AgBioResearch	US DOE Office of Science(United States Department of Energy (DOE)); US DOE Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); US National Science Foundation LTER program; NASA(National Aeronautics & Space Administration (NASA)); MSU AgBioResearch	We thank S. Bohm, K. A. Kahmark, I. Shcherbak, and S. VanderWulp for help with data assembly; C. McMinn, J. Simmons and many others for field and laboratory assistance; J. R. Williams for EPIC model advice; and D. H. Manowitz for programming and computational assistance. We are additionally indebted to B. Bond-Lamberty, B. E. Dale, V. H. Dale, J. D. Hill, W. M. Post and T. O. West for comments on an earlier version of the manuscript. Financial support for this work was provided by the US DOE Office of Science (DE-FC02-07ER64494, KP1601050) and Office of Energy Efficiency and Renewable Energy (DE-AC05-76RL01830, OBP 20469-19145), the US National Science Foundation LTER program (DEB 1027253), NASA (NNH08ZDA001N), and MSU AgBioResearch. EPIC simulations were performed on the PNNL Evergreen computer cluster, which is supported by the US DOE Office of Science (DE-AC05-76RL01830).	Bailey C, 2011, BIOMASS BIOENERG, V35, P1408, DOI 10.1016/j.biombioe.2010.11.033; Clark CM, 2007, ECOL LETT, V10, P596, DOI 10.1111/j.1461-0248.2007.01053.x; Coleman M, 2006, BIOMASS BIOENERG, V30, P740, DOI 10.1016/j.biombioe.2006.01.001; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; Dominguez-Faus R, 2009, ENVIRON SCI TECHNOL, V43, P3005, DOI 10.1021/es802162x; Donner SD, 2008, P NATL ACAD SCI USA, V105, P4513, DOI 10.1073/pnas.0708300105; Eggemeyer KD, 2006, INT J PLANT SCI, V167, P991, DOI 10.1086/505797; Eranki PL, 2011, GCB BIOENERGY, V3, P427, DOI 10.1111/j.1757-1707.2011.01096.x; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Fischer G, 2010, BIOMASS BIOENERG, V34, P173, DOI 10.1016/j.biombioe.2009.07.009; Fornara DA, 2009, ECOLOGY, V90, P408, DOI 10.1890/08-0325.1; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Gelfand I, 2011, P NATL ACAD SCI USA, V108, P13864, DOI 10.1073/pnas.1017277108; Hill J, 2009, P NATL ACAD SCI USA, V106, P2077, DOI 10.1073/pnas.0812835106; Huo H, 2009, ENVIRON SCI TECHNOL, V43, P750, DOI 10.1021/es8011436; Izaurralde RC, 2006, ECOL MODEL, V192, P362, DOI 10.1016/j.ecolmodel.2005.07.010; Izaurralde RC, 2003, AGR FOREST METEOROL, V117, P97, DOI 10.1016/S0168-1923(03)00024-8; Johnson DM, 2010, PHOTOGRAMM ENG REM S, V76, P1201; Kim S, 2005, BIOMASS BIOENERG, V29, P426, DOI 10.1016/j.biombioe.2005.06.004; Klingebiel AA, 1961, USDA AGR HDB, V210; Kosola KR, 2001, OECOLOGIA, V129, P65, DOI 10.1007/s004420100694; Lal R, 2004, ENVIRON INT, V30, P981, DOI 10.1016/j.envint.2004.03.005; Landis DA, 2008, P NATL ACAD SCI USA, V105, P20552, DOI 10.1073/pnas.0804951106; Meehan TD, 2010, P NATL ACAD SCI USA, V107, P18533, DOI 10.1073/pnas.1008475107; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Oak Ridge National Laboratory, 2011, BIOEN CONV FACT; Ohlrogge J, 2009, SCIENCE, V324, P1019, DOI 10.1126/science.1171740; Ortin WGN, 2009, J SCI FOOD AGR, V89, P1754, DOI 10.1002/jsfa.3652; Patzek T. W., 2009, Bulletin of Science, Technology and Society, V29, P194, DOI 10.1177/0270467609334022; Perlack RD, 2011, ORNLTM2011224 US DOE; Plevin R. J., ENCY BIODIV IN PRESS; Plevin RJ, 2009, J IND ECOL, V13, P495, DOI 10.1111/j.1530-9290.2009.00138.x; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Robertson GP, 2011, ECOL APPL, V21, P1055, DOI 10.1890/09-0456.1; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Searchinger TD, 2009, SCIENCE, V326, P527, DOI 10.1126/science.1178797; Sheehan J, 1998, NRELSR58024089 USDA; Sinclair TR, 1999, ADV AGRON, V65, P215, DOI 10.1016/S0065-2113(08)60914-1; Soil Survey Staff, 2011, SOIL SURV GEOGR DAT; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Stein D, 2009, 2008 2009 CUSTOM MAC; Stoffel JL, 2010, FOREST ECOL MANAG, V259, P257, DOI 10.1016/j.foreco.2009.10.004; Syswerda SP, 2012, AGR ECOSYST ENVIRON, V149, P10, DOI 10.1016/j.agee.2011.12.007; Syswerda SP, 2011, SOIL SCI SOC AM J, V75, P92, DOI 10.2136/sssaj2009.0414; Tagil Sermin, 2008, Journal of Applied Sciences, V8, P910, DOI 10.3923/jas.2008.910.921; Tan GX, 2003, ECOL MODEL, V168, P357, DOI 10.1016/S0304-3800(03)00146-7; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Webster CR, 2010, BIOFUELS-UK, V1, P451, DOI 10.4155/BFS.10.18; West TO, 2002, AGR ECOSYST ENVIRON, V91, P217, DOI 10.1016/S0167-8809(01)00233-X; Williams J. R., 1995, Computer models of watershed hydrology., P909; Zhang X, 2010, GCB BIOENERGY, V2, P258, DOI 10.1111/j.1757-1707.2010.01046.x; Zhang X, 2010, OPEN STEM CELL J, V2, P2, DOI DOI 10.1155/2010/507560	55	483	490	22	903	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					514	+		10.1038/nature11811	http://dx.doi.org/10.1038/nature11811			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23334409				2022-12-24	WOS:000313871400034
J	van de Vooren, K; Curto, A; Garattini, L				van de Vooren, Katelijne; Curto, Alessandro; Garattini, Livio			Optional copayments on anti-cancer drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER; EXPERIENCE; CARE		[van de Vooren, Katelijne; Curto, Alessandro; Garattini, Livio] Mario Negri Inst Pharmacol Res, Ctr Hlth Econ, I-24020 Ranica, BG, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Garattini, L (corresponding author), Mario Negri Inst Pharmacol Res, Ctr Hlth Econ, I-24020 Ranica, BG, Italy.	livio.garattini@marionegri.it						de Souza JA, 2011, LANCET ONCOL, V12, P321, DOI 10.1016/S1470-2045(11)70043-2; Drummond M, 2012, EUR J HEALTH ECON, V13, P1, DOI 10.1007/s10198-011-0353-8; Drummond M, 2011, EUR J HEALTH ECON, V12, P263, DOI 10.1007/s10198-010-0274-y; Freemantle N, 1996, BRIT MED J, V312, P1469, DOI 10.1136/bmj.312.7044.1469; Galizzi MM, 2011, PHARMACOECONOMICS, V29, P17, DOI 10.2165/11537860-000000000-00000; Garattini L, 2012, J SEX MED; Garattini L, 2012, BMJ; Garattini L, 2012, EUR J HLTH EC; Garattini Livio, 2006, Eur J Health Econ, V7, P79, DOI 10.1007/s10198-005-0335-9; Garattini L, 2013, HEALTH POLICY, V109, P97, DOI 10.1016/j.healthpol.2012.08.017; Gemmill MC, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-12; Giuliani G, 1998, HEALTH POLICY, V44, P73, DOI 10.1016/S0168-8510(98)00012-8; NICE, 2012, CET BEV PAN TREATM M; NICE, 2008, APPR LIF EXT END LIF; Raftery J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b67; Richards M, 2008, REPORT SECRETARY STA; Stargardt T, 2010, EUR J HEALTH ECON, V11, P267, DOI 10.1007/s10198-009-0172-3; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; Tappenden P, 2007, HEALTH TECHNOL ASSES, V11, P1; Trivedi AN, 2010, NEW ENGL J MED, V362, P320, DOI 10.1056/NEJMsa0904533; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917	21	10	11	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2013	346								f349	10.1136/bmj.f349	http://dx.doi.org/10.1136/bmj.f349			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080CD	23347986				2022-12-24	WOS:000314217900002
J	Javaid, MK; Cooper, C				Javaid, M. Kassim; Cooper, Cyrus			Commentary: Opportunities to prevent fracture are being missed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Javaid, M. Kassim; Cooper, Cyrus] Univ Oxford, Oxford NIHR Musculoskeletal Biomed Res Unit, Oxford, England	University of Oxford	Javaid, MK (corresponding author), Univ Oxford, Oxford NIHR Musculoskeletal Biomed Res Unit, Oxford, England.	kassim.javaid@ndorms.ox.ac.uk		Cooper, Cyrus/0000-0003-3510-0709	Medical Research Council [U1475000001] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish; Medical Research Council [MC_UP_A620_1014, MC_U147585824, MC_UU_12011/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bolland MJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8669; Strom O, 2011, Arch Osteoporos, V6, P59, DOI 10.1007/s11657-011-0060-1; Treml J, FALLING STANDARDS BR	3	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2013	346								f278	10.1136/bmj.f278	http://dx.doi.org/10.1136/bmj.f278			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080BA	23338006				2022-12-24	WOS:000314215000004
J	Ludwig, DS; Blumenthal, SJ; Willett, WC				Ludwig, David S.; Blumenthal, Susan J.; Willett, Walter C.			Opportunities to Reduce Childhood Hunger and Obesity Restructuring the Supplemental Nutrition Assistance Program (the Food Stamp Program)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ludwig, David S.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, Boston, MA 02115 USA; [Blumenthal, Susan J.] New Amer Fdn, Washington, DC USA; [Blumenthal, Susan J.] Georgetown Sch Med, Washington, DC USA; [Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Ludwig, DS (corresponding author), Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24DK082730] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Blumenthal SJ., 2012, ACCESS, V28; Coleman-Jensen A, 2012, HOUSEHOLD FOOD SECUR; Kursmark M, 2009, CURR OPIN CLIN NUTR, V12, P310, DOI 10.1097/MCO.0b013e3283298e37; Nord M, 2009, USDA PUBLICATION, V28; POLHEMUS B, 2011, PEDIAT NUTR SURVEILL; Shenkin JD, 2010, AM J PUBLIC HEALTH, V100, P1562, DOI 10.2105/AJPH.2010.198549; Strayer M, 2012, CHARACTERISTICS SUPP; Zhang LN, 2012, PHYSIOL BEHAV, V105, P376, DOI 10.1016/j.physbeh.2011.08.035	8	31	31	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2567	2568		10.1001/jama.2012.45420	http://dx.doi.org/10.1001/jama.2012.45420			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268513				2022-12-24	WOS:000312916600018
J	Pos, W; Sethi, DK; Call, MJ; Schulze, MSED; Anders, AK; Pyrdol, J; Wucherpfennig, KW				Pos, Wouter; Sethi, Dhruv K.; Call, Melissa J.; Schulze, Monika-Sarah E. D.; Anders, Anne-Kathrin; Pyrdol, Jason; Wucherpfennig, Kai W.			Crystal Structure of the HLA-DM-HLA-DR1 Complex Defines Mechanisms for Rapid Peptide Selection	CELL			English	Article							CLASS-II MHC; HLA-DR MOLECULES; INVARIANT-CHAIN; ANTIGEN PRESENTATION; HISTOCOMPATIBILITY ANTIGEN; SURFACE EXPRESSION; DM SUSCEPTIBILITY; BINDING; DISSOCIATION; MICE	HLA-DR molecules bind microbial peptides in an endosomal compartment and present them on the cell surface for CD4 T cell surveillance. HLA-DM plays a critical role in the endosomal peptide selection process. The structure of the HLA-DM-HLA-DR complex shows major rearrangements of the HLA-DR peptide-binding groove. Flipping of a tryptophan away from the HLA-DR1 P1 pocket enables major conformational changes that position hydrophobic HLA-DR residues into the P1 pocket. These conformational changes accelerate peptide dissociation and stabilize the empty HLA-DR peptide-binding groove. Initially, incoming peptides have access to only part of the HLA-DR groove and need to compete with HLA-DR residues for access to the P2 site and the hydrophobic P1 pocket. This energetic barrier creates a rapid and stringent selection process for the highest-affinity binders. Insertion of peptide residues into the P2 and P1 sites reverses the conformational changes, terminating selection through DM dissociation.	[Pos, Wouter; Sethi, Dhruv K.; Call, Melissa J.; Schulze, Monika-Sarah E. D.; Anders, Anne-Kathrin; Pyrdol, Jason; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Anders, Anne-Kathrin; Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Program Immunol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Wucherpfennig, KW (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	kai_wucherpfennig@dfci.harvard.edu	Call, Melissa/HHZ-6671-2022	Call, Melissa/0000-0001-7684-5841	National Institutes of Health [RO1 NS044914, PO1 AI045757]; National Multiple Sclerosis Society; American Diabetes Association; Ruth L. Kirschstein National Research Service Award; National Center for Research Resources [5P41RR015301-10]; National Institute of General Medical Sciences from the National Institutes of Health [8P41 GM103403-10]; U.S. DOE [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P01CA100265] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057493, P01AI045757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); American Diabetes Association(American Diabetes Association); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); U.S. DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Drs. Eric Sundberg, Shannon Turley, Hao Wu, and Bana Jabri for reading the manuscript. This work was supported by grants from the National Institutes of Health (RO1 NS044914 and PO1 AI045757 to K.W.W.), postdoctoral fellowships from The National Multiple Sclerosis Society (D.K.S.) and the American Diabetes Association (W.P.), as well as a Ruth L. Kirschstein National Research Service Award (to M.J.C.). We thank the staff at the UCLA-DOE crystallization core and the CSIRO Collaborative Crystallization Centre, Melbourne, Australia, for setting up screens. Diffraction data were collected at the Advanced Photon Source using beamlines allocated to the Northeastern Collaborative Access Team. These beamlines are supported by grants from the National Center for Research Resources (5P41RR015301-10) and the National Institute of General Medical Sciences (8P41 GM103403-10) from the National Institutes of Health. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357.	Anders AK, 2011, NAT IMMUNOL, V12, P54, DOI 10.1038/ni.1967; Belmares MP, 2002, J IMMUNOL, V169, P5109, DOI 10.4049/jimmunol.169.9.5109; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Busch R, 1998, J BIOL CHEM, V273, P27557, DOI 10.1074/jbc.273.42.27557; Busch R, 2002, J IMMUNOL METHODS, V263, P111, DOI 10.1016/S0022-1759(02)00034-0; Castellino F, 1998, J IMMUNOL, V161, P4048; Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Fremont DH, 1998, IMMUNITY, V9, P385, DOI 10.1016/S1074-7613(00)80621-4; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; Grotenbreg GM, 2007, J BIOL CHEM, V282, P21425, DOI 10.1074/jbc.M702844200; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; Katz JF, 1996, J EXP MED, V184, P1747, DOI 10.1084/jem.184.5.1747; Koonce CH, 2003, J IMMUNOL, V170, P3751, DOI 10.4049/jimmunol.170.7.3751; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; Lazarski CA, 2006, J EXP MED, V203, P1319, DOI 10.1084/jem.20060058; Lovitch SB, 2003, J IMMUNOL, V171, P2183, DOI 10.4049/jimmunol.171.5.2183; Mage MG, 2012, J IMMUNOL, V189, P1391, DOI 10.4049/jimmunol.1200831; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Mosyak L, 1998, IMMUNITY, V9, P377, DOI 10.1016/S1074-7613(00)80620-2; Nelson CA, 1997, P NATL ACAD SCI USA, V94, P628, DOI 10.1073/pnas.94.2.628; Nicholson MJ, 2006, J IMMUNOL, V176, P4208, DOI 10.4049/jimmunol.176.7.4208; Painter CA, 2011, P NATL ACAD SCI USA, V108, P19329, DOI 10.1073/pnas.1108074108; Painter CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002403; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; Peaper DR, 2008, ANNU REV CELL DEV BI, V24, P343, DOI 10.1146/annurev.cellbio.24.110707.175347; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; REAY PA, 1992, EMBO J, V11, P2829, DOI 10.1002/j.1460-2075.1992.tb05350.x; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; ROCHE PA, 1990, J IMMUNOL, V144, P1849; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; Rupp B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018662; Sadegh-Nasseri S, 2008, TRENDS IMMUNOL, V29, P141, DOI 10.1016/j.it.2008.01.001; Sanderson F, 1996, IMMUNITY, V4, P87, DOI 10.1016/S1074-7613(00)80301-5; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Weber DA, 2001, J IMMUNOL, V167, P5167, DOI 10.4049/jimmunol.167.9.5167; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618	57	119	122	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1557	1568		10.1016/j.cell.2012.11.025	http://dx.doi.org/10.1016/j.cell.2012.11.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260142	Bronze, Green Accepted			2022-12-24	WOS:000312890300019
J	Ainsworth, C				Ainsworth, Claire			IMMUNOLOGY A many layered thing	NATURE			English	Editorial Material							PSORIASIS											Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; GOTTLIEB SL, 1995, NAT MED, V1, P442, DOI 10.1038/nm0595-442; Kennedy-Crispin M, 2012, J INVEST DERMATOL, V132, P105, DOI 10.1038/jid.2011.262; Oh CJ, 2000, J AM ACAD DERMATOL, V42, P829, DOI 10.1067/mjd.2000.105948; Tian SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044274; Valeyev NV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001024	6	6	7	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					552	554		10.1038/492S52a	http://dx.doi.org/10.1038/492S52a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23254971	Bronze			2022-12-24	WOS:000312488200003
J	Liu, SM; Kandoth, PK; Warren, SD; Yeckel, G; Heinz, R; Alden, J; Yang, CL; Jamai, A; El-Mellouki, T; Juvale, PS; Hill, J; Baum, TJ; Cianzio, S; Whitham, SA; Korkin, D; Mitchum, MG; Meksem, K				Liu, Shiming; Kandoth, Pramod K.; Warren, Samantha D.; Yeckel, Greg; Heinz, Robert; Alden, John; Yang, Chunling; Jamai, Aziz; El-Mellouki, Tarik; Juvale, Parijat S.; Hill, John; Baum, Thomas J.; Cianzio, Silvia; Whitham, Steven A.; Korkin, Dmitry; Mitchum, Melissa G.; Meksem, Khalid			A soybean cyst nematode resistance gene points to a new mechanism of plant resistance to pathogens	NATURE			English	Article							SERINE HYDROXYMETHYLTRANSFERASE; HETERODERA-GLYCINES; RHG1 LOCUS; EXPRESSION; POLYMORPHISMS; REGISTRATION; RESPONSES; DENSITY; STRESS; VECTOR	Soybean (Glycine max (L.) Merr.) is an important crop that provides a sustainable source of protein and oil worldwide. Soybean cyst nematode (Heterodera glycines Ichinohe) is a microscopic roundworm that feeds on the roots of soybean and is a major constraint to soybean production. This nematode causes more than US$1 billion in yield losses annually in the United States alone(1), making it the most economically important pathogen on soybean. Although planting of resistant cultivars forms the core management strategy for this pathogen, nothing is known about the nature of resistance. Moreover, the increase in virulent populations of this parasite on most known resistance sources necessitates the development of novel approaches for control. Here we report the map-based cloning of a gene at the Rhg4 (for resistance to Heterodera glycines 4) locus, a major quantitative trait locus contributing to resistance to this pathogen. Mutation analysis, gene silencing and transgenic complementation confirm that the gene confers resistance. The gene encodes a serine hydroxymethyltransferase, an enzyme that is ubiquitous in nature and structurally conserved across kingdoms. The enzyme is responsible for interconversion of serine and glycine and is essential for cellular one-carbon metabolism. Alleles of Rhg4 conferring resistance or susceptibility differ by two genetic polymorphisms that alter a key regulatory property of the enzyme. Our discovery reveals an unprecedented plant resistance mechanism against a pathogen. The mechanistic knowledge of the resistance gene can be readily exploited to improve nematode resistance of soybean, an increasingly important global crop.	[Liu, Shiming; Jamai, Aziz; El-Mellouki, Tarik; Meksem, Khalid] So Illinois Univ, Dept Plant Soil & Agr Syst, Carbondale, IL 62901 USA; [Kandoth, Pramod K.; Yeckel, Greg; Heinz, Robert; Alden, John; Mitchum, Melissa G.] Univ Missouri, Christopher S Bond Life Sci Ctr, Div Plant Sci, Columbia, MO 65211 USA; [Kandoth, Pramod K.; Yeckel, Greg; Heinz, Robert; Alden, John; Mitchum, Melissa G.] Univ Missouri, Interdisciplinary Plant Grp, Columbia, MO 65211 USA; [Warren, Samantha D.; Korkin, Dmitry] Univ Missouri, Christopher S Bond Life Sci Ctr, Dept Comp Sci, Columbia, MO 65211 USA; [Warren, Samantha D.; Korkin, Dmitry] Univ Missouri, Inst Informat, Columbia, MO 65211 USA; [Yang, Chunling; Juvale, Parijat S.; Hill, John; Baum, Thomas J.; Whitham, Steven A.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA; [Cianzio, Silvia] Iowa State Univ, Dept Agron, Ames, IA 50011 USA	Southern Illinois University System; Southern Illinois University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Iowa State University; Iowa State University	Meksem, K (corresponding author), So Illinois Univ, Dept Plant Soil & Agr Syst, Carbondale, IL 62901 USA.	goellnerm@missouri.edu; meksemk@siu.edu	Meksem, Khalid/AAD-3101-2022; Liu, Shiming/AAG-9495-2020	Meksem, Khalid/0000-0002-9469-9718; /0000-0002-4613-8422	Illinois-Missouri Biotechnology Alliance [2005-3]; United Soybean Board [0253, 3253, 2268, 1251]; USDA-NIFA [2006-35300-17195]; National Science Foundation Plant Genome Research Program [0820642]; Illinois Soybean Association; North Central Soybean Research Program; Iowa Soybean Association; Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship; Div Of Biological Infrastructure [0845196] Funding Source: National Science Foundation	Illinois-Missouri Biotechnology Alliance; United Soybean Board; USDA-NIFA(United States Department of Agriculture (USDA)); National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Illinois Soybean Association; North Central Soybean Research Program; Iowa Soybean Association; Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank X. Yang for technical assistance with soybean hairy root propagation and M. Kroll for proofreading the manuscript. We thank R. Hussey, W. Gassmann, P. Gresshoff, A. Bendahmane, D. Xu and B. McClure for critical reading of the manuscript. We thank K. Sharma and S. Puthur for use of the HPLC facility and technical help. This work was supported by the Illinois-Missouri Biotechnology Alliance (project 2005-3 to M.G.M. and K.M.), United Soybean Board (project 0253 to K.M., S.C. and M.G.M.; project 3253 to K.M. and S.C.; project 2268 to K.M. and M.G.M; project 1251 to J.H. and S.A.W.), USDA-NIFA (grant 2006-35300-17195 to K.M.), the National Science Foundation Plant Genome Research Program (grant 0820642 to S.A.W., J.H., M. G. M. and T.J.B.), the National Science Foundation CAREER Program (DBI-0845196 to D.K.), Missouri Soybean Merchandising Council (project 258 to M.G.M.), Illinois Soybean Association, North Central Soybean Research Program, Iowa Soybean Association, and a Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship (to S.D.W.).	Alfadhli S, 2000, MOL BIOCHEM PARASIT, V110, P283, DOI 10.1016/S0166-6851(00)00282-6; Bagnyukova TV, 2008, BRAIN RES, V1237, P44, DOI 10.1016/j.brainres.2008.07.073; BERNARD RL, 1988, CROP SCI, V28, P1027; Brown S, 2010, J NEMATOL, V42, P201; CALDWELL B. E., 1960, AGRON JOUR, V52, P635; Concibido VC, 2004, CROP SCI, V44, P1121, DOI 10.2135/cropsci2004.1121; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Dong K, 1997, GENETICS, V146, P1311; ENDO BY, 1965, PHYTOPATHOLOGY, V55, P375; HARTWIG EE, 1973, CROP SCI, V13, P287, DOI 10.2135/cropsci1973.0011183X001300020047x; Heil SG, 2001, MOL GENET METAB, V73, P164, DOI 10.1006/mgme.2001.3175; Hofmann J, 2010, PLANT J, V62, P1058, DOI 10.1111/j.1365-313X.2010.04217.x; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P510, DOI 10.1094/MPMI-20-5-0510; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kandoth PK, 2011, PLANT PHYSIOL, V155, P1960, DOI 10.1104/pp.110.167536; Kim YI, 2003, J NUTR, V133, p3731S, DOI 10.1093/jn/133.11.3731S; Koenning S. R., 2010, PLANT HLTH PROG; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lim U, 2005, J NUTR, V135, P1989, DOI 10.1093/jn/135.8.1989; Liu XH, 2011, FUNCT INTEGR GENOMIC, V11, P539, DOI 10.1007/s10142-011-0225-4; MATSON ARNOLD L., 1965, CROP SCI, V5, P477, DOI 10.2135/cropsci1965.0011183X000500050032x; Meksem, 2008, HDB PLANT FUNCTIONAL, P251, DOI DOI 10.1002/9783527622542.CH12; Meksem K, 2000, THEOR APPL GENET, V101, P747, DOI 10.1007/s001220051540; Meksem K, 2001, THEOR APPL GENET, V103, P710, DOI 10.1007/s001220100597; Melito S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-104; Niblack T. L., 2008, PLANT HLTH PROG; NIBLACK TL, 1993, J NEMATOL, V25, P880; Novakovic P, 2006, CARCINOGENESIS, V27, P916, DOI 10.1093/carcin/bgi312; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Skibola CF, 2002, BLOOD, V99, P3786, DOI 10.1182/blood.V99.10.3786; SMITH TJ, 1973, CROP SCI, V13, P495, DOI 10.2135/cropsci1973.0011183X001300040033x; STAUFFER GV, 1981, GENE, V14, P63, DOI 10.1016/0378-1119(81)90148-7; Wang JY, 2010, NEW PHYTOL, V187, P1003, DOI 10.1111/j.1469-8137.2010.03300.x; Xiao YL, 2005, PLANT PHYSIOL, V139, P1323, DOI 10.1104/pp.105.063479; Zhang CQ, 2010, PLANT PHYSIOL, V153, P52, DOI 10.1104/pp.109.151639; Zhang Y, 2008, ANAL BIOCHEM, V375, P367, DOI 10.1016/j.ab.2007.12.015	39	247	298	19	311	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					256	+		10.1038/nature11651	http://dx.doi.org/10.1038/nature11651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235880				2022-12-24	WOS:000312259300043
J	Watts, G				Watts, Geoff			PUBLIC HEALTH Sugar and the heart: old ideas revisited	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSUMPTION; RISK					geoff@scileg.freeserve.co.uk						Caprio S, 2012, NEW ENGL J MED, V367, P1462, DOI 10.1056/NEJMe1209884; de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Keys A. B., 1980, SEVEN COUNTRIES A MU; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Welsh JA, 2010, JAMA-J AM MED ASSOC, V303, P1490, DOI 10.1001/jama.2010.449; Yudkin J, 1957, LANCET, V270, P155; Yudkin J, 2012, PURE WHITE AND DEADL	8	7	7	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2013	346								e7800	10.1136/bmj.e7800	http://dx.doi.org/10.1136/bmj.e7800			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075ER	23321487				2022-12-24	WOS:000313867100002
J	Stephansson, O; Kieler, H; Haglund, B; Artama, M; Engeland, A; Furu, K; Gissler, M; Norgaard, M; Nielsen, RB; Zoega, H; Valdimarsdottir, U				Stephansson, Olof; Kieler, Helle; Haglund, Bengt; Artama, Miia; Engeland, Anders; Furu, Kari; Gissler, Mika; Norgaard, Mette; Nielsen, Rikke Beck; Zoega, Helga; Valdimarsdottir, Unnur			Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERSISTENT PULMONARY-HYPERTENSION; POPULATION-BASED COHORT; ANTIDEPRESSANT TREATMENT; SPONTANEOUS-ABORTIONS; MAJOR DEPRESSION; NORDIC COUNTRIES; OUTCOMES; PREVALENCE; REGISTERS; NEWBORN	Importance Maternal psychiatric disease is associated with adverse pregnancy outcomes. Use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy has been associated with congenital anomalies, neonatal withdrawal syndrome, and persistent pulmonary hypertension of the newborn. However, the risk of stillbirth and infant mortality when accounting for previous maternal psychiatric disease remains unknown. Objective To study risk of stillbirth and infant mortality associated with use of SSRIs during pregnancy. Design, Setting, and Participants Population-based cohort study from all Nordic countries (Denmark, Finland, Iceland, Norway, and Sweden) at different periods from 1996 through 2007. The study included women with singleton births. We obtained information on maternal use of SSRIs from prescription registries. Maternal characteristics, pregnancy, and neonatal outcomes were obtained from patient and medical birth registries. Main Outcome Measures We used logistic regression to estimate relative risks of stillbirth, neonatal death, and postneonatal death associated with SSRI use during pregnancy taking into account maternal characteristics and previous psychiatric hospitalization. Results Among 1 633 877 singleton births in the study, 6054 were stillbirths; 3609, neonatal deaths; and 1578, postneonatal deaths. A total of 29 228 (1.79%) of mothers had filled a prescription for an SSRI during pregnancy. Women exposed to an SSRI presented with higher rates of stillbirth (4.62 vs 3.69 per 1000, P=.01) and postneonatal death (1.38 vs 0.96 per 1000, P=.03) than those who did not. The rate of neonatal death was similar between groups (2.54 vs 2.21 per 1000, P=.24). Yet in multivariable models, SSRI use was not associated with stillbirth (adjusted odds ratio [OR], 1.17; 95% CI, 0.96-1.41; P=.12), neonatal death (adjusted OR, 1.23; 95% CI, 0.96-1.57; P=.11), or postneonatal death (adjusted OR, 1.34; 95% CI, 0.97-1.86; P=.08). Estimates were further attenuated when stratified by previous hospitalization for psychiatric disease. The adjusted OR for stillbirth in women with a previous hospitalization for psychiatric disease was 0.92 (95% CI, 0.66-1.28; P=.62) and was 1.07 (95% CI, 0.84-1.36; P=.59) for those who had not been previously hospitalized. The corresponding ORs for neonatal death were 0.89 (95% CI, 0.58-1.39; P=.62) for women who were hospitalized and 1.14 (95% CI, 0.84-1.56; P=.39) for women who were not. For postneonatal death, the ORs were 1.02 (95% CI, 0.61-1.69; P=.95) for women who were hospitalized and 1.10 (95% CI, 0.71-1.72; P=.66) for women who were not. Conclusions and Relevance Among women with singleton births in Nordic countries, no significant association was found between use of SSRIs during pregnancy and risk of stillbirth, neonatal mortality, or postneonatal mortality. However, decisions about use of SSRIs during pregnancy must take into account other perinatal outcomes and the risks associated with maternal mental illness.	[Stephansson, Olof; Kieler, Helle; Haglund, Bengt] Karolinska Inst, Dept Med Solna, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Stephansson, Olof; Kieler, Helle; Haglund, Bengt] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Stephansson, Olof] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden; [Artama, Miia; Gissler, Mika] THL Natl Inst Hlth & Welf, Helsinki, Finland; [Engeland, Anders; Furu, Kari] Norwegian Inst Publ Hlth, Dept Pharmacoepidemiol, Div Epidemiol, Oslo, Norway; [Engeland, Anders] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Furu, Kari] Univ Tromso, Dept Pharm, Tromso, Norway; [Norgaard, Mette; Nielsen, Rikke Beck] Aarhus Univ Hosp, Inst Clin Med, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Zoega, Helga; Valdimarsdottir, Unnur] Univ Iceland, Sch Hlth Sci, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Valdimarsdottir, Unnur] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Zoega, Helga] Mt Sinai Sch Med, Inst Translat Epidemiol, New York, NY USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Finland National Institute for Health & Welfare; Norwegian Institute of Public Health (NIPH); University of Bergen; UiT The Arctic University of Tromso; Aarhus University; University of Iceland; Harvard University; Harvard T.H. Chan School of Public Health; Icahn School of Medicine at Mount Sinai	Stephansson, O (corresponding author), Karolinska Univ Hosp Solna, Clin Epidemiol Unit, T2, SE-17176 Stockholm, Sweden.	olof.stephansson@ki.se	Zoega, Helga/M-1968-2015; Engeland, Anders/AAG-7437-2021	Kieler, Helle/0000-0001-9338-7133; Norgaard, Mette/0000-0001-6110-5891; Zoega, Helga/0000-0003-0761-9028; Gissler, Mika/0000-0001-8254-7525; Stephansson, Olof/0000-0003-1528-4563; Valdimarsdottir, Unnur/0000-0001-5382-946X	Swedish Pharmacy Company; Swedish Society of Medicine; MRC [MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1] Funding Source: researchfish	Swedish Pharmacy Company; Swedish Society of Medicine; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Swedish Pharmacy Company and by the authors' affiliations. Olof Stephansson was supported by a postdoctorate scholarship from the Swedish Society of Medicine.	Agency DM, 2011, RISK DEATH SER SID E; Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; Bakker MK, 2008, BRIT J CLIN PHARMACO, V65, P600, DOI 10.1111/j.1365-2125.2007.03048.x; Chalmers JWT, 1998, BRIT MED J, V317, P539; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Colvin Lyn, 2012, CNS Drugs, V26, pe1, DOI 10.2165/11634190-000000000-00000; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Gentile S, 2008, CNS SPECTRUMS, V13, P960, DOI 10.1017/S1092852900014012; Gissler M, 1997, EUR J EPIDEMIOL, V13, P169, DOI 10.1023/A:1007379029182; Hemels MEH, 2005, ANN PHARMACOTHER, V39, P803, DOI 10.1345/aph.1E547; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Kieler H, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8012; Klieger-Grossmann C, 2012, J CLIN PHARMACOL, V52, P766, DOI 10.1177/0091270011405524; Kulin NA, 1998, JAMA-J AM MED ASSOC, V279, P609, DOI 10.1001/jama.279.8.609; Lee AM, 2007, OBSTET GYNECOL, V110, P1102, DOI 10.1097/01.AOG.0000287065.59491.70; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; Nilsson E, 2008, BRIT J PSYCHIAT, V193, P311, DOI 10.1192/bjp.bp.107.045146; Rosen M, 2002, SCAND J PUBLIC HEALT, V30, P81, DOI 10.1080/140349401753683444; Sanz EJ, 2005, LANCET, V365, P482, DOI 10.1016/S0140-6736(05)17865-9; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Udechuku A, 2010, AUST NZ J PSYCHIAT, V44, P978, DOI 10.3109/00048674.2010.507543; Wisner KL, 2009, AM J PSYCHIAT, V166, P557, DOI 10.1176/appi.ajp.2008.08081170; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P403, DOI [10.1097/AOG.0b013e3181ba0632, 10.1016/j.genhosppsych.2009.04.003]	27	60	66	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2013	309	1					48	54		10.1001/jama.2012.153812	http://dx.doi.org/10.1001/jama.2012.153812			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TB	23280224	Bronze			2022-12-24	WOS:000319113000026
J	Kagan, JC				Kagan, Jonathan C.			Signaling Organelles of the Innate Immune System	CELL			English	Review							TOLL-LIKE RECEPTORS; INTERFERON REGULATORY FACTOR-3; NF-KAPPA-B; RIG-I; PATHOGEN RECOGNITION; ANTIVIRAL RESPONSES; PATTERN-RECOGNITION; ACCESSORY PROTEIN; ADAPTER MOLECULE; DROSOPHILA MYD88	There are at least five families of microbe-detection receptors that function to detect and eradicate potentially infectious microorganisms that enter multicellular eukaryotes. While a multitude of proteins regulating innate immune signal transduction have already been defined, continuous genetic screening for regulators of innate immunity may not yield as significant insight into the operation of these pathways as was obtained in the past. This diminished return on experimental investment suggests that we are approaching the asymptote of genetics-only approaches to study innate immunity. In contrast, it remains unclear how known regulators of innate immunity interact within the infrastructure of mammalian cells to execute their signaling functions. In this Perspective, I first highlight the locations within mammalian cells that permit innate immune signal transduction and then offer a model whereby structurally distinct proteins can be grouped functionally through their ability to assemble platforms of regulators on the signaling organelles of the innate immune system.	[Kagan, Jonathan C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kagan, Jonathan C.] Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Kagan, JC (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu			National Institutes of Health [AI093589, AI072955]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI072955, R01AI093589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This Perspective was not designed to comprehensively cover all aspects of innate immunity. As such, several important areas of host defense are not discussed or cited. The views expressed reflect my personal opinion and should not be considered a consensus in the field. I would like to thank members of my lab for helpful discussions during preparation of this manuscript. The National Institutes of Health grants AI093589 and AI072955 support the work performed in the laboratory of J.C.K. J.C.K. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Blanco AM, 2008, J NEUROCHEM, V106, P625, DOI 10.1111/j.1471-4159.2008.05425.x; Brikos C, 2007, MOL CELL PROTEOMICS, V6, P1551, DOI 10.1074/mcp.M600455-MCP200; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cambronne ED, 2006, TRAFFIC, V7, P929, DOI 10.1111/j.1600-0854.2006.00446.x; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Doyle SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1706; Du X, 1999, BLOOD CELL MOL DIS, V25, P328, DOI 10.1006/bcmd.1999.0262; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; Gioannini TL, 2005, J ENDOTOXIN RES, V11, P117, DOI 10.1179/096805105X35198; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Goodridge HS, 2012, TRAFFIC, V13, P1062, DOI 10.1111/j.1600-0854.2012.01382.x; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hidmark A, 2012, J IMMUNOL, V189, P2717, DOI 10.4049/jimmunol.1200898; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Korherr C, 1997, EUR J IMMUNOL, V27, P262, DOI 10.1002/eji.1830270139; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Li T, 2012, P NATL ACAD SCI USA, V109, P10558, DOI 10.1073/pnas.1203447109; Liu HM, 2012, CELL HOST MICROBE, V11, P528, DOI 10.1016/j.chom.2012.04.006; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Marek LR, 2012, IMMUNITY, V36, P612, DOI 10.1016/j.immuni.2012.01.019; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Ohnishi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038423; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Radons J, 2002, J BIOL CHEM, V277, P16456, DOI 10.1074/jbc.M201000200; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun HY, 2002, P NATL ACAD SCI USA, V99, P12871, DOI 10.1073/pnas.202396399; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Tissieres P, 2008, BLOOD, V111, P2122, DOI 10.1182/blood-2007-06-097782; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Triantafilou M, 2002, J CELL SCI, V115, P2603; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	105	74	76	1	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1168	1178		10.1016/j.cell.2012.11.011	http://dx.doi.org/10.1016/j.cell.2012.11.011			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217704	Green Accepted, Bronze			2022-12-24	WOS:000311999900008
J	Xu, YF; Xu, C; Kato, A; Tempel, W; Abreu, JG; Bian, CB; Hu, YG; Hu, D; Zhao, B; Cerovina, T; Diao, JB; Wu, FZ; He, HH; Cui, QY; Clark, E; Ma, C; Barbara, A; Veenstra, GJC; Xu, GL; Kaiser, UB; Liu, XS; Sugrue, SP; He, X; Min, JR; Kato, Y; Shi, YG				Xu, Yufei; Xu, Chao; Kato, Akiko; Tempel, Wolfram; Abreu, Jose Garcia; Bian, Chuanbing; Hu, Yeguang; Hu, Di; Zhao, Bin; Cerovina, Tanja; Diao, Jianbo; Wu, Feizhen; He, Housheng Hansen; Cui, Qingyan; Clark, Erin; Ma, Chun; Barbara, Andrew; Veenstra, Gert Jan C.; Xu, Guoliang; Kaiser, Ursula B.; Liu, X. Shirley; Sugrue, Stephen P.; He, Xi; Min, Jinrong; Kato, Yoichi; Shi, Yujiang Geno			Tet3 CXXC Domain and Dioxygenase Activity Cooperatively Regulate Key Genes for Xenopus Eye and Neural Development	CELL			English	Article							EMBRYONIC STEM-CELLS; DNA METHYLATION; MAMMALIAN DNA; SELF-RENEWAL; 5-HYDROXYMETHYLCYTOSINE; MOUSE; 5-METHYLCYTOSINE; PROTEINS; GENOME; 5-CARBOXYLCYTOSINE	Ten-Eleven Translocation (Tet) family of dioxygenases dynamically regulates DNA methylation and has been implicated in cell lineage differentiation and oncogenesis. Yet their functions and mechanisms of action in gene regulation and embryonic development are largely unknown. Here, we report that Xenopus Tet3 plays an essential role in early eye and neural development by directly regulating a set of key developmental genes. Tet3 is an active 5mC hydroxylase regulating the 5mC/5hmC status at target gene promoters. Biochemical and structural studies further demonstrate that the Tet3 CXXC domain is critical for specific Tet3 targeting. Finally, we show that the enzymatic activity and CXXC domain are both crucial for Tet3's biological function. Together, these findings define Tet3 as a transcription regulator and reveal a molecular mechanism by which the 5mC hydroxylase and DNA binding activities of Tet3 cooperate to control target gene expression and embryonic development.	[Xu, Chao; Tempel, Wolfram; Bian, Chuanbing; Cerovina, Tanja; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Xu, Yufei; Hu, Yeguang; Hu, Di; Clark, Erin; Ma, Chun; Barbara, Andrew; Kaiser, Ursula B.; Shi, Yujiang Geno] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens,Dept Med, Boston, MA 02115 USA; [Xu, Chao; Tempel, Wolfram; Bian, Chuanbing; Cerovina, Tanja; Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada; [Kato, Akiko; Kato, Yoichi] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Abreu, Jose Garcia; He, Xi] Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Hu, Di; Zhao, Bin; Diao, Jianbo; Wu, Feizhen; Ma, Chun] Fudan Univ, Inst Biomed Sci, Lab Epigenet, Shanghai 200032, Peoples R China; [He, Housheng Hansen; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [He, Housheng Hansen; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Cui, Qingyan; Xu, Guoliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Veenstra, Gert Jan C.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Liu, X. Shirley] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; [Sugrue, Stephen P.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	University of Toronto; Structural Genomics Consortium; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; State University System of Florida; Florida State University; Harvard University; Boston Children's Hospital; Harvard Medical School; Fudan University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Radboud University Nijmegen; Harvard University; Dana-Farber Cancer Institute; State University System of Florida; University of Florida	Min, JR (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.	jr.min@utoronto.ca; yoichi.kato@med.fsu.edu; yujiang_shi@hms.harvard.edu	Min, Jinrong/G-3449-2011; Xu, Chao/G-3885-2010; Wu, Feizhen/AGR-5215-2022; Wu, Feizhen/R-6415-2019; Abreu, Jose G/G-6159-2010; Abreu, Jose G/ABB-1199-2021; He, Hansen/ABD-8439-2020; Veenstra, Gert Jan C./D-4963-2012; Neurociencia, Inct/I-1011-2013	Min, Jinrong/0000-0001-5210-3130; Xu, Chao/0000-0003-0444-7080; Wu, Feizhen/0000-0002-1265-9887; Abreu, Jose G/0000-0002-9875-7786; Abreu, Jose G/0000-0002-1363-1755; He, Hansen/0000-0003-2898-3363; Veenstra, Gert Jan C./0000-0002-7787-4940; Cui, Qingyan/0000-0002-5029-4436	NIH [GM078458, GM087641, GM074241]; Brigham and Women's Hospital Biomedical Research Institute; Chinese Ministry of Education Project 985; CNPq (Brazil); Boston Children's Hospital Intellectual and Developmental Disabilities Research Center [P30 HD-18655]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through Ontario Genomics Institute; GlaxoSmithKline; Eli Lilly; Pfizer; Novartis Research Foundation; Life Technologies; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Wellcome Trust; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL EYE INSTITUTE [P30EY021721, R01EY007883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078458, R01GM074241, R15GM087641] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brigham and Women's Hospital Biomedical Research Institute; Chinese Ministry of Education Project 985; CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Boston Children's Hospital Intellectual and Developmental Disabilities Research Center; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Eli Lilly(Eli Lilly); Pfizer(Pfizer); Novartis Research Foundation; Life Technologies; Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Wellcome Trust(Wellcome TrustEuropean Commission); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Harland for helpful discussions, A Khorasani for critical reading of the manuscript and Q. Xu and L. Jiang for statistical analyses. We also thank R. Moon, W. Harris, J. Yang, X. Wang, M. Vetter and J.-P. Saint-Jeannet for valuable discussions and technical help. This work was supported by NIH grants GM078458 to Y.G.S., GM087641 to Y.K., and GM074241 to X.H., Brigham and Women's Hospital Biomedical Research Institute fund to sustain research excellence to Y.G.S., and Chinese Ministry of Education Project 985 to Biomedical Core Facility, Fudan University. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. J. G. A. was funded partially by CNPq (Brazil). Y.G.S. is a Pew Scholar. X. H. acknowledges support by Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (P30 HD-18655). The Structural Genomics Consortium is a registered charity (No. 1097737) that receives funds from Canadian Institutes for Health Research, Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Eli Lilly, Pfizer, Novartis Research Foundation, Life Technologies, Ontario Innovation Trust, Ontario Ministry for Research and Innovation and Wellcome Trust (JM). Argonne National Laboratory is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; BESTOR TH, 1993, CURR BIOL, V3, P384, DOI 10.1016/0960-9822(93)90209-7; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hsu CH, 2012, CELL REP, V2, P568, DOI 10.1016/j.celrep.2012.08.030; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Matarese F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.95; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Pradhan M, 2008, BIOCHEMISTRY-US, V47, P10000, DOI 10.1021/bi8011725; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Sakano D, 2010, DEV CELL, V18, P450, DOI 10.1016/j.devcel.2009.12.023; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	30	184	204	0	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1200	1213		10.1016/j.cell.2012.11.014	http://dx.doi.org/10.1016/j.cell.2012.11.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217707	Bronze, Green Accepted			2022-12-24	WOS:000311999900011
J	Bell, BP; Khabbaz, RF				Bell, Beth P.; Khabbaz, Rima F.			Responding to the Outbreak of Invasive Fungal Infections The Value of Public Health to Americans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bell, Beth P.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Khabbaz, Rima F.] Ctr Dis Control & Prevent, Off Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Bell, BP (corresponding author), Ctr Dis Control & Prevent, Mailstop C-12,1600 Clifton Rd, Atlanta, GA 30333 USA.	bzb8@cdc.gov						Centers for Disease Control and Prevention, MULT FUNG MEN OUTBR; Kainer MA, 2012, NEW ENGL J MED, V367, P2194, DOI 10.1056/NEJMoa1212972; National Association of County and City Health Officials, 2012, WNYC 0202; Smith RM, NEW ENGL J MED, DOI [10.1056/NEJMoa1213978, DOI 10.1056/NEJMOA1213978]; The Association of State and Territorial Health Officials, BUDG CUTS CONT AFF H	5	14	14	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2013	309	9					883	884		10.1001/jama.2013.526	http://dx.doi.org/10.1001/jama.2013.526			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099PC	23364868				2022-12-24	WOS:000315632700022
J	Waldman, RJ; Mintz, ED; Papowitz, HE				Waldman, Ronald J.; Mintz, Eric D.; Papowitz, Heather E.			The Cure for Cholera - Improving Access to Safe Water and Sanitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Waldman, Ronald J.] George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA; [Mintz, Eric D.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Papowitz, Heather E.] UNICEF, Hlth Sect, New York, NY USA	George Washington University; Centers for Disease Control & Prevention - USA; UNICEF	Waldman, RJ (corresponding author), George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA.		Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257				Guerrant RL, 2003, CLIN INFECT DIS, V37, P398, DOI 10.1086/376619; Hutton G, 2008, B WORLD HEALTH ORGAN, V86, P13, DOI 10.2471/BLT.07.046045; Mintz E, 2001, AM J PUBLIC HEALTH, V91, P1565, DOI 10.2105/AJPH.91.10.1565; UNICEF/WHO Joint Monitoring, 2012, PROGR DRINK WAT SAN; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P289	5	24	23	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					592	594		10.1056/NEJMp1214179	http://dx.doi.org/10.1056/NEJMp1214179			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194VA	23301693				2022-12-24	WOS:000322659600003
J	Marusyk, A; Polyak, K				Marusyk, Andriy; Polyak, Kornelia			Cancer Cell Phenotypes, in Fifty Shades of Grey	SCIENCE			English	Editorial Material							TUMOR HETEROGENEITY; STEM-CELLS		[Marusyk, Andriy] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Marusyk, A (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	kornelia_polyak@dfci.harvard.edu						Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Campbell LL, 2007, CELL CYCLE, V6, P2332, DOI 10.4161/cc.6.19.4914; Kern SE, 2007, CANCER RES, V67, P8985, DOI 10.1158/0008-5472.CAN-07-1971; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027	8	46	49	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					528	529		10.1126/science.1234415	http://dx.doi.org/10.1126/science.1234415			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372002				2022-12-24	WOS:000314270000043
J	Bhaumik, S				Bhaumik, Soumyadeep			NEGLECTED DISEASES Snakebite: a forgotten problem	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												soumyadeepbhaumik@rediffmail.com		Bhaumik, Soumyadeep/0000-0001-9579-4453				Agarwal R, 2005, EMERG MED J, V22, P397, DOI 10.1136/emj.2004.020727; [Anonymous], 2012, INDIAN EXPRESS; Ariaratnam CA, 2001, T ROY SOC TROP MED H, V95, P74, DOI 10.1016/S0035-9203(01)90339-6; de Silva HA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000435; Mohapatra B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001018; South Asian Cochrane Network and Centre, 2012, INT SNAK BIT OV CURR; Warrell DA, 2011, NATL MED J INDIA, V24, P321; WHO, 2010, WHO GUIDELINES PRODU; World Health Organization, 2008, GLOB BURD SNAK LIT A; [No title captured]	10	5	5	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2013	346								f628	10.1136/bmj.f628	http://dx.doi.org/10.1136/bmj.f628			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084BQ	23369843				2022-12-24	WOS:000314511500009
J	Arora, S				Arora, Sonal			Surgeons in training may benefit from mental visualisation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SKILLS		Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Surg & Canc, London W2 1NY, England	Imperial College London	Arora, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Surg & Canc, London W2 1NY, England.	sonal.arora06@imperial.ac.uk						Arora S, 2011, J AM COLL SURGEONS, V212, P225, DOI 10.1016/j.jamcollsurg.2010.09.025; Arora S, 2011, ANN SURG, V253, P265, DOI 10.1097/SLA.0b013e318207a789; Arora S, 2010, SURG ENDOSC, V24, P179, DOI 10.1007/s00464-009-0624-y; Bolles G., 2009, J DANCE ED, V9, P6, DOI [10.1080/15290824.2009.10387379, DOI 10.1080/15290824.2009.10387379]; Danzer Enrico, 2011, J Surg Educ, V68, P519, DOI 10.1016/j.jsurg.2011.06.004; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; Geoffrion R, 2012, BJOG-INT J OBSTET GY, V119, P1040, DOI 10.1111/j.1471-0528.2012.03398.x; Komesu Y, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.008; Sanders CW, 2008, MED EDUC, V42, P607, DOI 10.1111/j.1365-2923.2007.02964.x; WEINBERG R., 2008, J IMAGERY RES SPORT, V3, P1, DOI DOI 10.2202/1932-0191.1025	10	2	2	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2013	346								e8611	10.1136/bmj.e8611	http://dx.doi.org/10.1136/bmj.e8611			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070YU	23295370				2022-12-24	WOS:000313552300007
J	Kaplan, HG; Malmgren, JA				Kaplan, Henry G.; Malmgren, Judith A.			The Breast Cancer Overdiagnosis Conundrum: An Oncologist's Viewpoint	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							IMPACT		Swedish Canc Inst, Seattle, WA USA; HealthStat Consulting, Seattle, WA USA; Univ Washington, Sch Publ Hlth & Community Med, Seattle, WA 98195 USA	Swedish Cancer Institute; Swedish Medical Center; University of Washington; University of Washington Seattle	Kaplan, HG (corresponding author), 1221 E Madison St, Seattle, WA 98104 USA.	hank.kaplan@swedish.org	kaplan, henry/ABI-4845-2020		Kaplan Cancer Research Fund	Kaplan Cancer Research Fund	By the Kaplan Cancer Research Fund.	Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; Esserman LJ, 2011, BREAST CANCER RES TR, V130, P725, DOI 10.1007/s10549-011-1748-z; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Kaplan HG, 2006, CLIN BREAST CANCER, V7, P133, DOI 10.3816/CBC.2006.n.022; Malmgren JA, 2012, RADIOLOGY, V262, P797, DOI 10.1148/radiol.11111734; Malmgren JA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-131; Smith RA, 2007, CANCER-AM CANCER SOC, V109, P2205, DOI 10.1002/cncr.22671; Smith RA, 2012, ONCOLOGY-NY, V26, P471	10	5	5	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2013	158	1					60	+		10.7326/0003-4819-158-1-201301010-00011	http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065AV	23277900				2022-12-24	WOS:000313119900009
J	Partridge, L				Partridge, Linda			Diet and Healthy Aging	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CALORIC RESTRICTION; RHESUS-MONKEYS		[Partridge, Linda] Max Planck Inst Biol Aging, Cologne, Germany; [Partridge, Linda] UCL, Inst Healthy Aging, Dept Genet Evolut & Environm, London, England	Max Planck Society; University of London; University College London	Partridge, L (corresponding author), Max Planck Inst Biol Aging, Cologne, Germany.		Partridge, Linda/A-5501-2010; Partridge, Linda/E-7342-2015	Partridge, Linda/0000-0001-9615-0094				Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Weindruch R, 1988, RETARDATION AGING DI, P397	5	11	11	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2550	2551		10.1056/NEJMcibr1210447	http://dx.doi.org/10.1056/NEJMcibr1210447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059OG	23268671				2022-12-24	WOS:000312714200017
J	Woodcock, J; Khan, M; Yu, LX				Woodcock, Janet; Khan, Mansoor; Yu, Lawrence X.			Withdrawal of Generic Budeprion for Nonbioequivalence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Woodcock, Janet; Khan, Mansoor; Yu, Lawrence X.] US FDA, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Woodcock, J (corresponding author), US FDA, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA.		/AAE-3713-2022; Yu, Lawrence/L-6280-2016	Khan, Mansoor/0000-0003-3649-3874				*FOOD DRUG ADM, 2003, GUIDANCE FOR INDUSTR, P77671	1	40	42	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2463	2465		10.1056/NEJMp1212969	http://dx.doi.org/10.1056/NEJMp1212969			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059OG	23216549				2022-12-24	WOS:000312714200002
J	Crow, JM				Crow, James Mitchell			THERAPEUTICS Silencing psoriasis	NATURE			English	Editorial Material							MONOCLONAL-ANTIBODY; EFFICACY; SAFETY											Krueger G, 2001, ARCH DERMATOL, V137, P280; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Papp KA, 2012, BRIT J DERMATOL, V167, P668, DOI 10.1111/j.1365-2133.2012.11168.x; Papp K, 2012, LANCET, V380, P738, DOI 10.1016/S0140-6736(12)60642-4; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Rich P, 2013, BRIT J DERMATOL, V168, P402, DOI 10.1111/bjd.12112	7	26	28	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					558	559		10.1038/492S58a	http://dx.doi.org/10.1038/492S58a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23254974	Bronze			2022-12-24	WOS:000312488200006
J	Kuehn, BM				Kuehn, Bridget M.			Center Takes Broader Look at Preterm Birth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2448	2448		10.1001/jama.2012.90690	http://dx.doi.org/10.1001/jama.2012.90690			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23287891				2022-12-24	WOS:000312441400003
J	Dusheck, J				Dusheck, Jennie			ONCOLOGY Getting physical	NATURE			English	Editorial Material							CANCER											Adriani G, 2012, BIOMATERIALS, V33, P5504, DOI 10.1016/j.biomaterials.2012.04.027; Janmey P, 2012, ASSESSMENT PHYS SCI; Lambert G, 2011, NAT REV CANCER, V11, P375, DOI 10.1038/nrc3039; Michor F, 2011, NAT REV CANCER, V11, P657, DOI 10.1038/nrc3092; Zhang QC, 2012, ANNU REV CONDEN MA P, V3, P363, DOI 10.1146/annurev-conmatphys-020911-125109	5	6	6	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					S50	S51		10.1038/491S50a	http://dx.doi.org/10.1038/491S50a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23320286	Bronze			2022-12-24	WOS:000311339800002
J	Song, RS; Peng, W; Zhang, Y; Lv, FX; Wu, HK; Guo, JJ; Cao, YX; Pi, YB; Zhang, X; Jin, L; Zhang, M; Jiang, P; Liu, FH; Meng, SS; Zhang, XQ; Jiang, P; Cao, CM; Xiao, RP				Song, Ruisheng; Peng, Wei; Zhang, Yan; Lv, Fengxiang; Wu, Hong-Kun; Guo, Jiaojiao; Cao, Yongxing; Pi, Yanbin; Zhang, Xin; Jin, Li; Zhang, Mao; Jiang, Peng; Liu, Fenghua; Meng, Shaoshuai; Zhang, Xiuqin; Jiang, Ping; Cao, Chun-Mei; Xiao, Rui-Ping			Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders	NATURE			English	Article							SKELETAL-MUSCLE; NEGATIVE REGULATOR; RECEPTOR; GLUCOSE; OBESE; DEGRADATION; IRS1; CBL	Insulin resistance is a fundamental pathogenic factor present in various metabolic disorders including obesity and type 2 diabetes(1). Although skeletal muscle accounts for 70-90% of insulin-stimulated glucose disposal(2,3), the mechanism underlying muscle insulin resistance is poorly understood. Here we show in mice that muscle-specific mitsugumin 53 (MG53; also called TRIM72) mediates the degradation of the insulin receptor and insulin receptor substrate 1 (IRS1); and when upregulated, causes metabolic syndrome featuring insulin resistance, obesity, hypertension and dyslipidaemia. MG53 expression is markedly elevated in models of insulin resistance, and MG53 overexpression suffices to trigger muscle insulin resistance and metabolic syndrome sequentially. Conversely, ablation of MG53 prevents diet-induced metabolic syndrome by preserving the insulin receptor, IRS1 and insulin signalling integrity. Mechanistically, MG53 acts as an E3 ligase targeting the insulin receptor and IRS1 for ubiquitin-dependent degradation, comprising a central mechanism controlling insulin signal strength in skeletal muscle. These findings define MG53 as a novel therapeutic target for treating metabolic disorders and associated cardiovascular complications.	[Song, Ruisheng; Peng, Wei; Zhang, Yan; Lv, Fengxiang; Wu, Hong-Kun; Guo, Jiaojiao; Jin, Li; Zhang, Mao; Jiang, Peng; Liu, Fenghua; Meng, Shaoshuai; Zhang, Xiuqin; Jiang, Ping; Cao, Chun-Mei; Xiao, Rui-Ping] Peking Univ, Inst Mol Med, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Song, Ruisheng] Peking Univ, Hlth Sci Ctr, Inst Cardiovasc Sci, Beijing 100083, Peoples R China; [Cao, Yongxing; Pi, Yanbin; Zhang, Xin] Peking Univ, Hosp 3, Inst Sports Med, Beijing 100191, Peoples R China; [Xiao, Rui-Ping] Peking Univ, Ctr Life Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Xiao, RP (corresponding author), Peking Univ, Inst Mol Med, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China.	caochunmei@pku.edu.cn; xiaor@pku.edu.cn	Xiao, Rui-Ping/AAE-2629-2019; SONG, RUISHENG/W-4784-2019; Yimei, Wang/AAE-4083-2019	SONG, RUISHENG/0000-0002-6856-4721; Zhang, Mao/0000-0002-5283-6497; Wu, Hong-Kun/0000-0002-9459-6583; Meng, Shao-Shuai/0000-0002-1926-8483; Zhang, Xiuqin/0000-0001-8692-7146	National Basic Research Program of China [2012CB518000, 2013CB531200, 2012CB944501]; National Natural Science Foundation of China [81070674, 81070116, 3/22/002, 81130073]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank H. P. Cheng, G. Feng, X. Fu and L. P. Wei for discussions, and S. L. Guo, T. Zhang, X. H. Wang, D. Y. Chen, J. Y. Peng, L Huang, W. Q. Zhang, N. Hou, L. Pan, L. Chen and Y. L. Liu for their technical support. Special thanks to H. Takeshima and J. J. Ma for their support in providing MG53<SUP>-/-</SUP> mice. This work was supported by the National Basic Research Program of China (2012CB518000, 2013CB531200, 2012CB944501) and the National Natural Science Foundation of China (81070674, 81070116, 3/22/002 and 81130073).	Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628; Capozza F, 2005, AM J PHYSIOL-CELL PH, V288, pC1317, DOI 10.1152/ajpcell.00489.2004; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Grundy SM, 2006, J AM COLL CARDIOL, V47, P1093, DOI 10.1016/j.jacc.2005.11.046; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Laustsen PG, 2007, MOL CELL BIOL, V27, P1649, DOI 10.1128/MCB.01110-06; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; OLEFSKY J, 1976, METABOLISM, V25, P179, DOI 10.1016/0026-0495(76)90048-2; Ramos FJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1262, DOI 10.1152/ajpendo.00609.2005; RAO RH, 1993, DIABETES, V42, P1364, DOI 10.2337/diabetes.42.9.1364; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shi J, 2011, DEV CELL, V21, P835, DOI 10.1016/j.devcel.2011.09.011; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Thirone ACP, 2006, TRENDS ENDOCRIN MET, V17, P70, DOI 10.1016/j.tem.2006.01.005; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Zhang XQ, 2011, CIRCULATION, V124, P77, DOI 10.1161/CIRCULATIONAHA.110.990333; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	29	184	196	1	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					375	379		10.1038/nature11834	http://dx.doi.org/10.1038/nature11834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23354051				2022-12-24	WOS:000315312900043
J	Tantivess, S; Werayingyong, P; Chuengsaman, P; Teerawattananon, Y				Tantivess, Sripen; Werayingyong, Pitsaphun; Chuengsaman, Piyatida; Teerawattananon, Yot			Universal coverage of renal dialysis in Thailand: promise, progress, and prospects	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERITONEAL-DIALYSIS; SIMILAR OUTCOMES; HEMODIALYSIS; DISEASE; PACKAGE	Thailand's experience in introducing renal replacement therapy as part of its universal health coverage scheme shows the importance of evidence and stakeholders' active participation in all phases of policy development, say Sripen Tantivess and colleagues	[Tantivess, Sripen; Werayingyong, Pitsaphun; Teerawattananon, Yot] Minist Publ Hlth, HITAP, Nonthaburi, Thailand; [Chuengsaman, Piyatida] Banphaeo Hosp Publ Org, CAPD Serv, Bangkok, Thailand; [Chuengsaman, Piyatida] Training Ctr, Bangkok, Thailand	Ministry of Public Health - Thailand	Teerawattananon, Y (corresponding author), Minist Publ Hlth, HITAP, Nonthaburi, Thailand.	yot.t@hitap.net		Teerawattananon, Yot/0000-0003-2217-2930				[Anonymous], 2010, B WORLD HEALTH ORGAN, V88, P84, DOI 10.2471/BLT.10.010210; [Anonymous], STAK M 2012 SEPT 28; Anothayanon K, 2002, J HEALTH SCI, V11, P826; Dhanakijcharoen Prateep, 2011, J Med Assoc Thai, V94 Suppl 4, pS153; Evans T. G., 2012, INDEPENDENT ASSESSME, V10, P2001; Kearkiat P, 2012, REPORT THAILAND RENA; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; Mehrotra R, 2011, ARCH INTERN MED, V171, P110, DOI 10.1001/archinternmed.2010.352; National Health Security Office, 2007, FUND MAN MAN NAT HLT; Patcharanarumol W, 2011, GOOD HLTH LOW COST 2; Praditpornsilp K, 2008, THAILAND RENAL REPLA; Praditpornsilpa Kearkiat, 2011, J Med Assoc Thai, V94 Suppl 4, pS1; Prakongsai P, 2006, J HEALTH SCI, V15, P617; Prakongsai P, 2009, J INT DEV, V21, P291, DOI 10.1002/jid.1553; Teerawattananon Y, 2004, HEALTH POLICY PLANN, V19, pI31, DOI 10.1093/heapol/czh043; Teerawattananon Y, 2007, VALUE HEALTH, V10, P61, DOI 10.1111/j.1524-4733.2006.00145.x; Thai Renal Replacement Therayp (TRT) Committee, 2005, TRT REG ANN REP; Tungsiripat R, 2003, 0403 HEFP LOND SCH H; United States Renal Data System, 2004, ANN DAT REP 2001 INC; WHO, 2010, WOR HEALT REP, P1; Yeates K, 2012, NEPHROL DIAL TRANSPL, V27, P3568, DOI 10.1093/ndt/gfr674	21	49	51	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2013	346								f462	10.1136/bmj.f462	http://dx.doi.org/10.1136/bmj.f462			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084BQ	23369775	Bronze			2022-12-24	WOS:000314511500007
J	Moynihan, R				Moynihan, Ray			What is disease? And why it's a healthy question	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAST-CANCER		Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	RayMoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					Bewley S, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6894; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; McPherson K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3106; Moynihan R, 2006, BRIT MED J, V332, P745, DOI 10.1136/bmj.332.7544.745-a; Richards M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6843; ROSENBERG CE, 1989, MILBANK Q, V67, P1, DOI 10.2307/3350182; Rosenberg CE, 2002, MILBANK Q, V80, P237, DOI 10.1111/1468-0009.t01-1-00003; Rosenberg C, 2009, LANCET, V373, P802, DOI 10.1016/S0140-6736(09)60467-0; Tikkinen KAO, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001632; Wise J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7910	10	3	3	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 9	2013	346								f107	10.1136/bmj.f107	http://dx.doi.org/10.1136/bmj.f107			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070ZR	23303894				2022-12-24	WOS:000313554900007
J	Hopkins, DR				Hopkins, Donald R.			Disease Eradication	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LYMPHATIC FILARIASIS ELIMINATION; JANUARY 2010-SEPTEMBER 2011; POLIOMYELITIS ERADICATION; PROGRESS; DRACUNCULIASIS; AFRICA; ONCHOCERCIASIS; TRANSMISSION; NIGERIA		Carter Ctr, Atlanta, GA 30307 USA		Hopkins, DR (corresponding author), Carter Ctr, 453 Freedom Pky, Atlanta, GA 30307 USA.	sdsulli@emory.edu						Abdelwahab Jalaa, 2011, Morbidity and Mortality Weekly Report, V60, P1482; Alexander Jim, 2011, Morbidity and Mortality Weekly Report, V60, P1523; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P195; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P341; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P417; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P309; [Anonymous], 1993, MMWR Recomm Rep, V42, P1; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P377; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P199; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P321; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P25; [Anonymous], 2010, SCIENCE, V328, P850, DOI 10.1126/science.328.5980.850; [Anonymous], FIN RES REQ 2012 201; [Anonymous], 2011, MMWR-MORBID MORTAL W, V60, P1053; Cochi SL, 2011, DIS ERADICATION 21 C, V7; Djidina Mathias R., 2011, Morbidity and Mortality Weekly Report, V60, P744; Dorkenoo Ameyo, 2011, Morbidity and Mortality Weekly Report, V60, P989; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Goldman AS, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000067; Heymann DL, 2011, TROPICAL INFECT DIS, P40; Hopkins D.R, 1998, ERADICATION INFECT D; Hopkins Donald R., 2011, Morbidity and Mortality Weekly Report, V60, P1450; HOPKINS DR, 1981, SCIENCE, V212, P495, DOI 10.1126/science.6451929; Hopkins DR, 2005, AM J TROP MED HYG, V72, P1; HOPKINS DR, 1991, B WORLD HEALTH ORGAN, V69, P533; Hopkins DR, 2009, GLOBAL HLTH MAGAZINE, V3, P14; Mackenzie CD, 2012, TRENDS PARASITOL, V28, P16, DOI 10.1016/j.pt.2011.10.003; Molyneux DH, 2006, LANCET, V367, P966, DOI 10.1016/S0140-6736(06)68404-3; Nutman TB, 2011, TROPICAL INFECT DIS, P729; Ogbuanu I. U., 2011, Morbidity and Mortality Weekly Report, V60, P441; Ogden HG, 1987, HHS PUBLICATION; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; Pigman HA, 2005, CONQUERING POLIO; Richards FO, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001346; RUIZTIBEN E, 2008, INT ENCY PUBLIC HLTH, P294; Stepan Nancy Leys, 2011, ERADICATION RIDDING; WATTS SJ, 1987, AM J TROP MED HYG, V37, P119, DOI 10.4269/ajtmh.1987.37.119; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; World Health Assembly, 1997, WHA50 29 EL LYMPH FI	39	62	63	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2013	368	1					54	63		10.1056/NEJMra1200391	http://dx.doi.org/10.1056/NEJMra1200391			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062PA	23281976				2022-12-24	WOS:000312930600005
J	Farrell, L				Farrell, Liam			THE BEST MEDICINE Conversation with a pill	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2013	346								e8664	10.1136/bmj.e8664	http://dx.doi.org/10.1136/bmj.e8664			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066QW	23284160				2022-12-24	WOS:000313236300002
J	Hughes, V				Hughes, Virginia			MICROBIOME Cultural differences	NATURE			English	Editorial Material																		Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Poulain M, 2004, EXP GERONTOL, V39, P1423, DOI 10.1016/j.exger.2004.06.016; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	5	12	13	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					S14	S15		10.1038/492S14a	http://dx.doi.org/10.1038/492S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222668	Bronze			2022-12-24	WOS:000311893400008
J	Merie, C; Kober, L; Olsen, PS; Andersson, C; Gislason, G; Jensen, JS; Torp-Pedersen, C				Merie, Charlotte; Kober, Lars; Olsen, Peter Skov; Andersson, Charlotte; Gislason, Gunnar; Jensen, Jan Skov; Torp-Pedersen, Christian			Association of Warfarin Therapy Duration After Bioprosthetic Aortic Valve Replacement With Risk of Mortality, Thromboembolic Complications, and Bleeding	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VALVULAR HEART-DISEASE; ANTITHROMBOTIC THERAPY; TASK-FORCE; ANTICOAGULATION; MANAGEMENT; OCTOGENARIANS; GUIDELINES; CARDIOLOGY; VALIDITY; REGISTRY	Context The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined. Objective To perform a nationwide study of the association of warfarin treatment with the risk of thromboembolic complications, bleeding incidents, and cardiovascular deaths after bioprosthetic AVR surgery. Design, Setting, and Participants Through a search in the Danish National Patient Registry, 4075 patients were identified who had bioprosthetic AVR surgery performed between January 1, 1997, and December 31, 2009. Concomitant comorbidity and medication were retrieved. Poisson regression models were used to determine risk. Main Outcome Measures Incidence rate ratios (IRRs) of strokes, thromboembolic events, cardiovascular deaths, and bleeding incidents by discontinuing warfarin as opposed to continued treatment 30 to 89 days, 90 to 179 days, 180 to 364 days, 365 to 729 days, and at least 730 days after surgery. Results The median duration of follow-up was 6.57 person-years. Estimated rates of events per 100 person-years in patients not treated with warfarin compared with those treated with warfarin with comparative absolute risk were 7.00 (95% CI, 4.07-12.06) vs 2.69 (95% CI, 1.49-4.87; adjusted IRR, 2.46; 95% CI, 1.09-5.55) for strokes; 13.07 (95% CI, 8.76-19.50) vs 3.97 (95% CI, 2.43-6.48; adjusted IRR, 2.93; 95% CI, 1.54-5.55) for thromboembolic events; 11.86 (95% CI, 7.81-18.01) vs 5.37 (95% CI, 3.54-8.16; adjusted IRR, 2.32; 95% CI, 1.28-4.22) for bleeding incidents; and 31.74 (95% CI, 24.69-40.79) vs 3.83 (95% CI, 2.35-6.25; adjusted IRR, 7.61; 95% CI, 4.37-13.26) for cardiovascular deaths within 30 to 89 days after surgery; and 6.50 (95% CI, 4.67-9.06) vs 2.08 (95% CI, 0.99-4.36; adjusted IRR, 3.51; 95% CI, 1.54-8.03) for cardiovascular deaths within 90 to 179 days after surgery. Conclusion Discontinuation of warfarin treatment within 6 months after bioprosthetic AVR surgery was associated with increased cardiovascular death. JAMA. 2012;308(20):2118-2125 www.jama.com	[Merie, Charlotte; Andersson, Charlotte; Gislason, Gunnar; Jensen, Jan Skov; Torp-Pedersen, Christian] Copenhagen Univ Hosp Gentofte, Dept Cardiol, Copenhagen, Denmark; [Kober, Lars] Rigshosp, Dept Cardiol, Copenhagen Univ Hosp, Copenhagen, Denmark; [Olsen, Peter Skov] Rigshosp, Dept Cardiothorac Surg, Copenhagen Univ Hosp, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Merie, C (corresponding author), Copenhagen Univ Hosp Gentofte, Dept Cardiol, Niels Andersens Vej 65, DK-2900 Hellerup, Denmark.	c.merie@mail.dk	Torp-Pedersen, Christian/E-5931-2013; Gislason, Gunnar/B-7561-2009; Andersson, Charlotte/P-4849-2014	Gislason, Gunnar/0000-0002-0548-402X; Kober, Lars/0000-0002-6635-1466	Research Fund of the Department of Cardiology at Copenhagen-University Hospital Gentofte, Gentofte, Denmark; Danish Agency for Science, Technology, and Innovation [FSS-11-120873]; Cardiome; sanofi-aventis; Merck; Bristol-Meyers Squibb	Research Fund of the Department of Cardiology at Copenhagen-University Hospital Gentofte, Gentofte, Denmark; Danish Agency for Science, Technology, and Innovation; Cardiome; sanofi-aventis(Sanofi-Aventis); Merck(Merck & Company); Bristol-Meyers Squibb(Bristol-Myers Squibb)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kober reported receiving payment for giving lectures on unrelated issues from Servier as well as unrelated consultancy for Bayer. Dr Andersson reported receiving an independent research grant FSS-11-120873 unrelated to current study with 30 months salary and meeting expenses from the Danish Agency for Science, Technology, and Innovation. Dr Torp-Pedersen reported receiving consultancy fees for antiarrhythmic drugs from Cardiome, sanofi-aventis, Merck, and Bristol-Meyers Squibb. No other authors reported any financial disclosures.; This work was supported by the Research Fund of the Department of Cardiology at Copenhagen-University Hospital Gentofte, Gentofte, Denmark.	Aramendi JL, 1998, J HEART VALVE DIS, V7, P610; Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Brennan JM, 2012, J HEART VALVE DIS, V21, P78; Brown ML, 2008, J THORAC CARDIOV SUR, V135, P878, DOI 10.1016/j.jtcvs.2007.10.065; Bucerius J, 2003, ANN THORAC SURG, V75, P472, DOI 10.1016/S0003-4975(02)04370-9; Colli A, 2008, EUR J CARDIO-THORAC, V33, P531, DOI 10.1016/j.ejcts.2007.12.019; ElBardissi AW, 2010, J THORAC CARDIOV SUR, V139, P1137, DOI 10.1016/j.jtcvs.2009.10.064; Gaist D, 1997, DAN MED BULL, V44, P445; Gherli T, 2004, CIRCULATION, V110, P496, DOI 10.1161/01.CIR.0000137122.95108.52; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; HERAS M, 1995, J AM COLL CARDIOL, V25, P1111, DOI 10.1016/0735-1097(94)00563-6; Higgins J, 2011, J THORAC CARDIOV SUR, V142, P595, DOI 10.1016/j.jtcvs.2010.05.056; Kolh P, 2007, EUR J CARDIO-THORAC, V31, P600, DOI 10.1016/j.ejcts.2007.01.003; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Melby SJ, 2007, ANN THORAC SURG, V83, P1651, DOI 10.1016/j.athoracsur.2006.09.068; Mistiaen W, 2004, J THORAC CARDIOV SUR, V127, P1166, DOI 10.1016/j.jtcvs.2003.11.010; Nowell J, 2007, EUR J CARDIO-THORAC, V31, P578, DOI 10.1016/j.ejcts.2006.12.017; ORSZULAK TA, 1995, ANN THORAC SURG, V59, P462, DOI 10.1016/0003-4975(94)00862-2; Salem DN, 2008, CHEST, V133, p593S, DOI 10.1378/chest.08-0724; Salem DN, 2004, CHEST, V126, p457S, DOI 10.1378/chest.126.3_suppl.457S; Sundt TM, 2005, J THORAC CARDIOV SUR, V129, P1024, DOI 10.1016/j.jtcvs.2004.11.028; Thourani VH, 2011, ANN THORAC SURG, V91, P1798, DOI 10.1016/j.athoracsur.2011.02.015; Tiede DJ, 1998, MAYO CLIN PROC, V73, P665; Tjang YS, 2007, EUR J CARDIO-THORAC, V32, P469, DOI 10.1016/j.ejcts.2007.06.012; Vahanian A, 2007, EUR HEART J, V28, P230, DOI 10.1093/eurheartj/ehl428; Whitley WS, 2008, SEMIN CARDIOTHORAC V, V12, P290, DOI 10.1177/1089253208328583	27	155	157	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2118	2125		10.1001/jama.2012.54506	http://dx.doi.org/10.1001/jama.2012.54506			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188028	Bronze			2022-12-24	WOS:000311537200026
J	Juncadella, IJ; Kadl, A; Sharma, AK; Shim, YM; Hochreiter-Hufford, A; Borish, L; Ravichandran, KS				Juncadella, Ignacio J.; Kadl, Alexandra; Sharma, Ashish K.; Shim, Yun M.; Hochreiter-Hufford, Amelia; Borish, Larry; Ravichandran, Kodi S.			Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation	NATURE			English	Article							DUST MITE ALLERGEN; ASTHMA; RESPONSES; FAMILY; ENGULFMENT; MECHANISM; MIMICRY; PROTEIN; INNATE; MOUSE	Lung epithelial cells can influence immune responses to airway allergens(1,2). Airway epithelial cells also undergo apoptosis after encountering environmental allergens(3); yet, relatively little is known about how these are cleared, and their effect on airway inflammation. Here we show that airway epithelial cells efficiently engulf apoptotic epithelial cells and secrete anti-inflammatory cytokines, dependent upon intracellular signalling by the small GTPase Rac1. Inducible deletion of Rac1 expression specifically in airway epithelial cells in a mouse model resulted in defective engulfment by epithelial cells and aberrant anti-inflammatory cytokine production. Intranasal priming and challenge of these mice with house dust mite extract or ovalbumin as allergens led to exacerbated inflammation, augmented Th2 cytokines and airway hyper-responsiveness, with decreased interleukin (IL)-10 in bronchial lavages. Rac1-deficient epithelial cells produced much higher IL-33 upon allergen or apoptotic cell encounter, with increased numbers of nuocyte-like cells(1,4,5). Administration of exogenous IL-10 'rescued' the airway inflammation phenotype in Rac1-deficient mice, with decreased IL-33. Collectively, these genetic and functional studies suggest a new role for Rac1-dependent engulfment by airway epithelial cells and in establishing the anti-inflammatory environment, and that defects in cell clearance in the airways could contribute to inflammatory responses towards common allergens.	[Juncadella, Ignacio J.; Hochreiter-Hufford, Amelia; Borish, Larry; Ravichandran, Kodi S.] Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Juncadella, Ignacio J.; Hochreiter-Hufford, Amelia; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Juncadella, Ignacio J.; Hochreiter-Hufford, Amelia; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Kadl, Alexandra; Shim, Yun M.; Borish, Larry] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Sharma, Ashish K.] Univ Virginia, Dept Surg, Charlottesville, VA 22908 USA; [Borish, Larry] Univ Virginia, Ctr Asthma & Allerg Dis, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.	Ravi@virginia.edu	Kadl, Alexandra/AAV-3395-2021; Shim, Yun Michael/N-2049-2017	Shim, Yun Michael/0000-0002-3780-3371; Ravichandran, Kodi/0000-0001-9049-1410; Sharma, Ashish/0000-0002-1234-6039	Immunology Training Grant; NHLBI; American Asthma Foundation; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI100799, T32AI007496, R01AI057438] Funding Source: NIH RePORTER	Immunology Training Grant; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Asthma Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the members of the Ravichandran laboratory for their suggestions, especially J. Kinchen and P. Trampont. We thank J. Whitsett for the rtTA-CCSP/Cre mice, X. Liu for the TGF-beta responsive cell line PE25, and J. Steinke and J. Kennedy for providing human nasal epithelial cells. This work was supported by an Immunology Training Grant (I. J. J.), a F32 postdoctoral fellowship from the NHLBI (I. J. J.), and grants from the American Asthma Foundation and the National Institutes of Health (K. S. R.). K. S. R. has been a William Benter Senior Fellow of the American Asthma Foundation.	Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Borish L, 1996, J ALLERGY CLIN IMMUN, V97, P1288, DOI 10.1016/S0091-6749(96)70197-5; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; Daidoji T, 2008, J VIROL, V82, P11294, DOI 10.1128/JVI.01192-08; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Elliott MR, 2010, ANN NY ACAD SCI, V1209, P30, DOI 10.1111/j.1749-6632.2010.05764.x; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fahy JV, 2011, AM J RESP CRIT CARE, V184, P390, DOI 10.1164/rccm.201107-1258ED; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Jyonouchi H, 1999, APOPTOSIS, V4, P407, DOI 10.1023/A:1009607607603; Kirsch T, 2007, BLOOD, V109, P2854, DOI 10.1182/blood-2006-06-026187; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lloyd CM, 2010, CURR OPIN IMMUNOL, V22, P800, DOI 10.1016/j.coi.2010.10.006; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; NAYLOR BERNARD, 1962, THORAX, V17, P69, DOI 10.1136/thx.17.1.69; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Park D, 2009, CURR BIOL, V19, P346, DOI 10.1016/j.cub.2009.01.042; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Thomas WR, 2009, EXPERT REV CLIN IMMU, V5, P233, DOI [10.1586/eci.09.5, 10.1586/ECI.09.5]; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; White Steven R, 2011, J Allergy (Cairo), V2011, P948406, DOI 10.1155/2011/948406; Yamada Y, 2004, PEDIAT ALLERG IMM-UK, V15, P159, DOI 10.1111/j.1399-3038.2004.00155.x	30	195	205	4	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2013	493	7433					547	+		10.1038/nature11714	http://dx.doi.org/10.1038/nature11714			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23235830	Green Accepted			2022-12-24	WOS:000313871400041
J	Vinogradova, Y; Coupland, C; Hippisley-Cox, J				Vinogradova, Yana; Coupland, Carol; Hippisley-Cox, Julia			Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ORAL BISPHOSPHONATES; ESOPHAGEAL CANCER; WOMEN; COHORT; DRUGS; MEN; VALIDATION; DIAGNOSIS; VALIDITY; ENGLAND	Objective To investigate the association between use of bisphosphonates estimated from prescription information and risk of gastrointestinal cancers. Design Series of nested case-control studies. Setting General practices in the United Kingdom contributing to the QResearch primary care database (660) and the Clinical Practice Research Datalink (CPRD) (643). Participants Patients aged >= 50 with a diagnosis of a primary gastrointestinal cancer in 1997-2011, each matched with up to five controls by age, sex, practice, and calendar year. Main outcome measures Odds ratios for incident gastrointestinal cancers (colorectal, oesophageal, gastric) and use of bisphosphonates, adjusted for smoking status, ethnicity, comorbidities, and use of other drugs. Results 20 106 and 19 035 cases of colorectal cancer cases, 5364 and 5135 cases of oesophageal cancer cases, and 3155 and 3157 cases of gastric cancer were identified from QResearch and CPRD, respectively. Overall bisphosphonate use (at least one prescription) was not associated with risk of colorectal, oesophageal, or gastric cancers in either database. Adjusted odds ratios (95% confidence interval) for QResearch and CPRD were 0.97 (0.79 to 1.18) and 1.18 (0.97 to 1.43) for oesophageal cancer; 1.12 (0.87 to 1.44) and 0.79 (0.62 to 1.01) for gastric cancer; and 1.03 (0.94 to 1.14) and 1.10 (1.00 to 1.22) for colorectal cancer. Additional analyses showed no difference between types of bisphosphonate for risk of oesophageal and colorectal cancers. For gastric cancer, alendronate use was associated with an increased risk (1.47, 1.11 to 1.95; P=0.008), but only in data from the QResearch database and without any association with duration and with no definitive confirmation from sensitivity analysis. Conclusions In this series of population based case-control studies in two large primary care databases, exposure to bisphosphonates was not associated with an increased risk of common gastrointestinal cancers.	[Vinogradova, Yana; Coupland, Carol; Hippisley-Cox, Julia] Div Primary Care, Nottingham NG2 7RD, England		Vinogradova, Y (corresponding author), Div Primary Care, Univ Pk, Nottingham NG2 7RD, England.	yana.vinogradova@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Vinogradova, Yana/0000-0002-3030-5257; Coupland, Carol/0000-0002-2327-3306	division of primary care of University of Nottingham	division of primary care of University of Nottingham	This work was funded by the division of primary care of University of Nottingham.	Abrahamsen B, 2012, J BONE MINER RES, V27, P679, DOI 10.1002/jbmr.1481; Cardwell CR, 2012, INT J CANCER, V131, pE717, DOI 10.1002/ijc.27389; Cardwell CR, 2010, JAMA-J AM MED ASSOC, V304, P657, DOI 10.1001/jama.2010.1098; Chang ET, 2006, JNCI-J NATL CANCER I, V98, P61, DOI 10.1093/jnci/djj005; Corley DA, 2010, GASTROENTEROLOGY, V139, P93, DOI 10.1053/j.gastro.2010.03.055; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Croucher P, 2003, BREAST, V12, pS30, DOI 10.1016/S0960-9776(03)80161-3; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Rodriguez LAG, 2006, GUT, V55, P1538, DOI 10.1136/gut.2005.086579; Gonzalez-Perez A, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-28; Green J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4444; Guise TA, 2008, CANCER TREAT REV, V34, pS19, DOI 10.1016/j.ctrv.2008.03.006; Hecht SS, 2008, DEVITA HELLMAN ROSEN, P147; Henderson KD, 2008, DEVITA HELLMAN ROSEN, V1, P239; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hippisley-Cox J, 2004, HLTH INFORMATICS J, V10, P91, DOI 10.1177/1460458204042230; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; Ho YF, 2012, CANCER EPIDEM BIOMAR, V21, P993, DOI 10.1158/1055-9965.EPI-12-0259; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Khalili H, 2012, J CLIN ONCOL, V30, P3229, DOI 10.1200/JCO.2011.39.2670; Mai PL, 2011, JNCI-J NATL CANCER I, V103, P788, DOI 10.1093/jnci/djr114; Mauck KF, 2006, MAYO CLIN PROC, V81, P662, DOI 10.4065/81.5.662; McGlynn KA, 2008, INT J CANCER, V122, P1879, DOI 10.1002/ijc.23290; Mocellin S, 2011, BBA-REV CANCER, V1816, P172, DOI 10.1016/j.bbcan.2011.07.001; National Institute for Health and Clinical Excellence, 2008, AL ET RIS STRONT RAN; Parker C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4245; Pascoe SW, 2008, FAM PRACT, V25, P215, DOI 10.1093/fampra/cmn023; Pazianas M, 2012, OSTEOPOROSIS INT, V23, P2693, DOI 10.1007/s00198-012-1902-4; Recker RR, 2005, MAYO CLIN PROC, V80, P856, DOI 10.4065/80.7.856; Rennert G, 2011, J CLIN ONCOL, V29, P1146, DOI 10.1200/JCO.2010.33.7485; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Rustgi AK, 2008, DEVITA HELLMAN ROSEN, P989; Schutze M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1584; Siris ES, 2009, NEW ENGL J MED, V360, P1791; Stattin P, 2007, DIABETES CARE, V30, P561, DOI 10.2337/dc06-0922; Thomas E, 2000, INT J CANCER, V88, P497, DOI 10.1002/1097-0215(20001101)88:3<497::AID-IJC27>3.3.CO;2-A; Thomson ABR, 2002, J RHEUMATOL, V29, P1965; Vestergaard P, 2011, CALCIFIED TISSUE INT, V89, P434, DOI 10.1007/s00223-011-9539-4; Vestergaard P, 2010, CALCIFIED TISSUE INT, V86, P110, DOI 10.1007/s00223-009-9323-x; Vinogradova Y, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000548; Walker AJ, 2011, BRIT J CANCER, V104, P193, DOI 10.1038/sj.bjc.6605996; Watts NB, 2010, J CLIN ENDOCR METAB, V95, P1555, DOI 10.1210/jc.2009-1947; Wright E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047616; Wysowski DK, 2009, NEW ENGL J MED, V360, P89, DOI 10.1056/NEJMc0808738; Zografos GN, 2009, DIS ESOPHAGUS, V22, P633, DOI 10.1111/j.1442-2050.2009.00972.x	48	33	33	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 16	2013	346								f114	10.1136/bmj.f114	http://dx.doi.org/10.1136/bmj.f114			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075FI	23325866	Green Published, Green Submitted, hybrid			2022-12-24	WOS:000313868800002
J	Boden, WE; Franklin, BA; Wenger, NK				Boden, William E.; Franklin, Barry A.; Wenger, Nanette K.			Physical Activity and Structured Exercise for Patients With Stable Ischemic Heart Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL THERAPY; CORONARY; PREVENTION; INTENSITY		[Boden, William E.] Samuel Stratton VA Med Ctr, Dept Med, Albany, NY 12208 USA; [Boden, William E.] Albany Med Coll, Albany, NY 12208 USA; [Franklin, Barry A.] William Beaumont Hosp, Dept Prevent Cardiol Rehabil, Royal Oak, MI 48072 USA; [Franklin, Barry A.] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA; [Wenger, Nanette K.] Grady Mem Hosp, Dept Med, Div Cardiol, Atlanta, GA USA; [Wenger, Nanette K.] Emory Univ, Sch Med, Atlanta, GA USA	Albany Medical College; Beaumont Health; Oakland University; Emory University	Boden, WE (corresponding author), Samuel Stratton VA Med Ctr, Dept Med, 113 Holland Ave, Albany, NY 12208 USA.	william.boden@va.gov						Balady GJ, 2011, CIRCULATION, V124, P2951, DOI 10.1161/CIR.0b013e31823b21e2; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Boden WE, 2009, NEW ENGL J MED, V360, P2570, DOI 10.1056/NEJMe0904090; Borden WB, 2011, JAMA-J AM MED ASSOC, V305, P1882, DOI 10.1001/jama.2011.601; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Leon AS, 2005, CIRCULATION, V111, P369, DOI 10.1161/01.CIR.0000151788.08740.5C; Myers J, 2008, CLIN INVEST MED, V31, pE400; Rognmo O, 2012, CIRCULATION, V126, P1436, DOI 10.1161/CIRCULATIONAHA.112.123117; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Wen CP, 2012, LANCET, V380, P192, DOI 10.1016/S0140-6736(12)60954-4	10	33	35	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2013	309	2					143	144		10.1001/jama.2012.128367	http://dx.doi.org/10.1001/jama.2012.128367			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070NW	23299603				2022-12-24	WOS:000313517000020
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: sexual health medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFECTION					destwo@yahoo.co.uk						Centers for Disease Control and Prevention, 2012, HIV TRANSM RISK; Centers for Disease Control and Prevention, 2010, CDC AN NAT HERP PREV; Centers for Disease Control and Prevention, 2012, GEN HPV INF FACT SHE; ClinicalTrials.gov, 2012, HOM SELF TEST HIV IN; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Health Protection Agency, 2011, HIV UK 2011 REP; Scoular A, 2002, BRIT MED J, V324, P1366, DOI 10.1136/bmj.324.7350.1366; Spence Des, 2010, BMJ, V340, pc2547, DOI 10.1136/bmj.c2547; van Valkengoed IGM, 2004, INT J EPIDEMIOL, V33, P416, DOI 10.1093/ije/dyh029; Wallace LA, 2008, SEX TRANSM INFECT, V84, P171, DOI 10.1136/sti.2007.026047; Ward H, 2005, BRIT MED J, V330, P1173, DOI 10.1136/bmj.330.7501.1173	11	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2013	346								e8643	10.1136/bmj.e8643	http://dx.doi.org/10.1136/bmj.e8643			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066QW	23284162				2022-12-24	WOS:000313236300001
J	Arnheim-Dahlstrom, L; Hallgren, J; Weibull, CE; Sparen, P				Arnheim-Dahlstrom, Lisen; Hallgren, Jonas; Weibull, Caroline E.; Sparen, Par			Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GUILLAIN-BARRE-SYNDROME; YOUNG-CHILDREN; UNITED-STATES; A H1N1; IMMUNIZATION; CONVULSIONS; MORTALITY; MEASLES; MUMPS	Objective To assess the risk of epileptic seizures in people with and without epilepsy after vaccination with a monovalent AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix; Glaxo SmithKline, Sweden). Design Register based self controlled case series. Setting Three Swedish counties (source population 750 000). Participants 373 398 people (age 0-106, median 41.2) who were vaccinated. Vaccinated people with epileptic seizures, diagnosed as inpatients or outpatients, at any time from 90 days before until 90 days after any dose of vaccine. Main outcome measures Endpoints were admission to hospital or outpatient hospital care with epileptic seizures as the main diagnosis. The effect estimate of relative incidence was calculated as the incidence of epileptic seizures in period after exposure relative to the incidence of epileptic seizures in two control periods, one before and one after vaccination. Results 859 people experienced epileptic seizures during the study period. There was no increased risk of seizures in people with previously diagnosed epilepsy (relative incidence 1.01, 95% confidence interval 0.74 to 1.39) and a non-significant decrease in risk for people without epilepsy (0.67, 0.27 to 1.65) during the day 1-7 risk period (where day 1 is the day of vaccination). In a second risk period (day 8-30), there was a non-significant increased risk of seizures in people without epilepsy (1.11, 0.73 to 1.70) but no increase in risk for those with epilepsy (1.00, 0.83 to 1.21). Conclusions This study found no evidence of an increase in risk of presentation to hospital with epileptic seizures after vaccination with a monovalent AS03 adjuvanted pandemic H1N1 influenza vaccine.	[Arnheim-Dahlstrom, Lisen; Hallgren, Jonas; Weibull, Caroline E.; Sparen, Par] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden	Karolinska Institutet	Arnheim-Dahlstrom, L (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Nobels Vag 12A, S-17177 Stockholm, Sweden.	lisen.arnheim.dahlstrom@ki.se	Weibull, Caroline/AAJ-5755-2020	Sparen, Par/0000-0002-5184-8971	GlaxoSmithKline Biologicals in Belgium; GlaxoSmithKline	GlaxoSmithKline Biologicals in Belgium; GlaxoSmithKline(GlaxoSmithKline)	This work was supported by a grant from GlaxoSmithKline Biologicals in Belgium. The authors had full access to all the data in the study and had the full responsibility to submit the report for publication. The opinions presented in the report do not necessarily reflect those of the funders.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that all the authors received unconditional grants from GlaxoSmithKline for the submitted study.	[Anonymous], 1993, EPILEPSIA, V34, P592; Brown NJ, 2007, CURR OPIN NEUROL, V20, P181, DOI 10.1097/WCO.0b013e3280555160; Christensen J, 2007, EPILEPSY RES, V75, P162, DOI 10.1016/j.eplepsyres.2007.05.009; Dieleman J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3908; Epilepsy Foundation America, 2010, SEC EP FDN AM 2010; European Medicines Agency, 13 PAND PHARM UPD; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; GALE JL, 1994, JAMA-J AM MED ASSOC, V271, P37, DOI 10.1001/jama.271.1.37; Juurlink DN, 2006, ARCH INTERN MED, V166, P2217, DOI 10.1001/archinte.166.20.2217; Kaye JA, 2001, BRIT MED J, V322, P460, DOI 10.1136/bmj.322.7284.460; KULENKAMPFF M, 1974, ARCH DIS CHILD, V49, P46, DOI 10.1136/adc.49.1.46; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Leroy Z, 2012, VACCINE, V30, P2020, DOI 10.1016/j.vaccine.2011.12.042; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Mayet A, 2011, VACCINE, V29, P2576, DOI 10.1016/j.vaccine.2011.01.056; Mitrakrishnan S, 2011, VACCINE, V29, P6369, DOI 10.1016/j.vaccine.2011.04.126; Munch JS, 2010, INT MARIT HEALTH, V61, P246; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Polkinghorne BG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-291; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Shorvon S, 2008, EPILEPSIA, V49, P219, DOI 10.1111/j.1528-1167.2007.01478.x; Stowe J, 2011, VACCINE, V29, P9467, DOI 10.1016/j.vaccine.2011.10.029; Tomson T, 2000, J NEUROL, V247, P15, DOI 10.1007/s004150050004; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; van Puijenbroek EP, 2010, DRUG SAFETY, V33, P1097, DOI 10.2165/11539270-000000000-00000; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302	27	16	16	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 28	2012	345								e7594	10.1136/bmj.e7594	http://dx.doi.org/10.1136/bmj.e7594			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062PQ	23274350	hybrid, Green Published			2022-12-24	WOS:000312932200001
J	Price, RM				Price, Rebecca M.			How We Got Here: An Inquiry-Based Activity About Human Evolution	SCIENCE			English	Editorial Material									Univ Washington, Bothell, WA 98011 USA	University of Washington; University of Washington Bothell	Price, RM (corresponding author), Univ Washington, Box 358530,18115 Campus Way NE, Bothell, WA 98011 USA.	becca.price@uwb.edu						Bransford J.D., 2000, PEOPLE LEARN BRAIN M; Bybee R. W., 1997, ACHIEVING SCI LITERA; DeHaan RL, 2011, SCIENCE, V334, P1499, DOI 10.1126/science.1207918; Handelsman J, 2007, SCI TEACHING; Karukstis Kerry K, 2007, DEV SUSTAINING RES S; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175834; Meikle W. E., 2010, EVOLUTION ED OUTREAC, V3, P573; Price RM, 2012, AM BIOL TEACH, V74, P106, DOI 10.1525/abt.2012.74.2.8	8	3	3	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1554	1555		10.1126/science.1215221	http://dx.doi.org/10.1126/science.1215221			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258884				2022-12-24	WOS:000312533100040
J	Stagnaro-Green, A; Sullivan, S; Pearce, EN				Stagnaro-Green, Alex; Sullivan, Scott; Pearce, Elizabeth N.			Iodine Supplementation During Pregnancy and Lactation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; POSTPARTUM; MANAGEMENT		[Stagnaro-Green, Alex] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20037 USA; [Sullivan, Scott] Med Univ S Carolina, Dept Obstet Gynecol, Charleston, SC 29425 USA; [Pearce, Elizabeth N.] Boston Univ, Sch Med, Endocrinol Sect, Boston, MA 02118 USA	George Washington University; Medical University of South Carolina; Boston University	Stagnaro-Green, A (corresponding author), George Washington Univ, Sch Med & Hlth Sci, 2300 1 St,Ross Hall,Ste 712, Washington, DC 20037 USA.	alexsg@gwu.edu		Stagnaro-Green, Alex/0000-0003-2434-3852; Pearce, Elizabeth/0000-0003-3799-0354				[Anonymous], 2007, ASS IOD DEF DIS MON; Caldwell KL, 2011, THYROID, V21, P419, DOI 10.1089/thy.2010.0077; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Food and Nutrition Board, 2006, DIET REF INT, P320; Glinoer D, 2007, PUBLIC HEALTH NUTR, V10, P1542, DOI 10.1017/S1368980007360886; Gregory CO, 2009, THYROID, V19, P1019, DOI 10.1089/thy.2009.0166; Leung AM, 2009, NEW ENGL J MED, V360, P939, DOI 10.1056/NEJMc0807851; Obican SG, 2012, BIRTH DEFECTS RES A, V94, P677, DOI 10.1002/bdra.23051; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Zimmermann MB, 2012, CURR OPIN ENDOCRINOL, V19, P382, DOI 10.1097/MED.0b013e328357271a	10	26	31	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2463	2464		10.1001/jama.2012.45423	http://dx.doi.org/10.1001/jama.2012.45423			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23288022				2022-12-24	WOS:000312441400020
J	Shen, K; Arslan, S; Akopian, D; Ha, T; Shan, SO				Shen, Kuang; Arslan, Sinan; Akopian, David; Ha, Taekjip; Shan, Shu-ou			Activated GTPase movement on an RNA scaffold drives co-translational protein targeting	NATURE			English	Article							SIGNAL RECOGNITION PARTICLE; SINGLE-MOLECULE FRET; SRP RNA; CRYSTAL-STRUCTURE; RECEPTOR; RIBOSOME; COMPLEX; MECHANISM; TRANSLOCATION; COMPONENTS	Approximately one-third of the proteome is initially destined for the eukaryotic endoplasmic reticulum or the bacterial plasma membrane(1). The proper localization of these proteins is mediated by a universally conserved protein-targeting machinery, the signal recognition particle (SRP), which recognizes ribosomes carrying signal sequences(2-4) and, through interactions with the SRP receptor(5,6), delivers them to the protein-translocation machinery on the target membrane(7). The SRP is an ancient ribonucleoprotein particle containing an essential, elongated SRP RNA for which precise functions have remained elusive. Here we used single-molecule fluorescence microscopy to show that the Escherichia coli SRP-SRP receptor GTPase complex, after initial assembly at the tetra-loop end of SRP RNA, travels over 100 angstrom to the distal end of this RNA, where rapid GTP hydrolysis occurs. This movement is negatively regulated by the translating ribosome and, at a later stage, positively regulated by the SecYEG translocon, providing an attractive mechanism for ensuring the productive exchange of the targeting and translocation machineries at the ribosome exit site with high spatial and temporal accuracy. Our results show that large RNAs can act as molecular scaffolds that enable the easy exchange of distinct factors and precise timing of molecular events in a complex cellular process; this concept may be extended to similar phenomena in other ribonucleoprotein complexes.	[Shen, Kuang; Akopian, David; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Arslan, Sinan; Ha, Taekjip] Univ Illinois, Dept Phys, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	California Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	sshan@caltech.edu	Shen, Kuang/H-9441-2016; Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Arslan, Sinan/0000-0001-7270-8372	National Institutes of Health (NIH) [GM078024, GM45162, GM065367]; Caltech [350270]; Beckman Young Investigator award; David and Lucile Packard Fellowship in Science and Engineering; Henry Dreyfus Teacher-Scholar award; National Science Foundation Physics Frontiers Centers program [08222613]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367, R37GM045162, R01GM078024, R01GM045162] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech; Beckman Young Investigator award; David and Lucile Packard Fellowship in Science and Engineering(The David & Lucile Packard Foundation); Henry Dreyfus Teacher-Scholar award; National Science Foundation Physics Frontiers Centers program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Ban and members of the Shan group for comments on the manuscript, C. Richards, L. Cai, T. Zhiyentayev, K. Lee and R. Zhou for help with RNClabelling and the instrument and software setup, and C.L. Guo, S. Kouand H. Lester for discussions. This work is supported by National Institutes of Health (NIH) grant GM078024 to S.-o.S., an NIH instrument supplement to grant GM45162 to D.C. Rees, and Caltech matching fund 350270 for the single-molecule instruments. S.-o.S. was supported by the Beckman Young Investigator award, the David and Lucile Packard Fellowship in Science and Engineering, and the Henry Dreyfus Teacher-Scholar award. T.H. was supported by National Science Foundation Physics Frontiers Centers program (08222613) and NIH grant GM065367.	ALTHOFF S, 1994, NUCLEIC ACIDS RES, V22, P1933, DOI 10.1093/nar/22.11.1933; Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Dalal K, 2010, METHODS MOL BIOL, V619, P145, DOI 10.1007/978-1-60327-412-8_9; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Estrozi LF, 2011, NAT STRUCT MOL BIOL, V18, P88, DOI 10.1038/nsmb.1952; FerreDAmare AR, 1996, NUCLEIC ACIDS RES, V24, P977, DOI 10.1093/nar/24.5.977; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Hoskins AA, 2011, CURR OPIN CHEM BIOL, V15, P864, DOI 10.1016/j.cbpa.2011.10.010; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Schaffitzel C, 2007, J STRUCT BIOL, V158, P463, DOI 10.1016/j.jsb.2007.01.005; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; Shan SO, 2007, J CELL BIOL, V178, P611, DOI 10.1083/jcb.200702018; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; Shen K, 2011, RNA, V17, P892, DOI 10.1261/rna.2610411; Shen K, 2010, P NATL ACAD SCI USA, V107, P7698, DOI 10.1073/pnas.1002968107; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Sluis EO, 2002, FEBS LETT, V527, P159, DOI 10.1016/S0014-5793(02)03202-7; Yodh JG, 2010, Q REV BIOPHYS, V43, P185, DOI 10.1017/S0033583510000107; YUAN R, 1981, ANNU REV BIOCHEM, V50, P285, DOI 10.1146/annurev.bi.50.070181.001441; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049; Zhang X, 2011, P NATL ACAD SCI USA, V108, P6450, DOI 10.1073/pnas.1019051108; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106	38	62	63	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2012	492	7428					271	+		10.1038/nature11726	http://dx.doi.org/10.1038/nature11726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235881	Green Accepted			2022-12-24	WOS:000312259300046
J	Nikfardjam, M				Nikfardjam, Mariam			Omega-3 fatty acids and cardioprotection-IIb or not IIb?	LANCET			English	Editorial Material									Med Univ Vienna, A-1090 Vienna, Austria	Medical University of Vienna	Nikfardjam, M (corresponding author), Med Univ Vienna, A-1090 Vienna, Austria.	mariam.nikfardjam@meduniwien.ac.at						Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; ClinicalTrials.gov, RISK PREV STUD EV EF; ClinicalTrials.gov, VIT D OM 3 TRIAL VIT; ClinicalTrials.gov, STUD CARD EV IN DIAB; Kwak SM, 2012, ARCH INTERN MED, V172, P686, DOI 10.1001/archinternmed.2012.262; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d	7	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2012	380	9858					1976	1977		10.1016/S0140-6736(12)62039-X	http://dx.doi.org/10.1016/S0140-6736(12)62039-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051KI	23217853				2022-12-24	WOS:000312124900008
J	McMorran, BJ; Wieczorski, L; Drysdale, KE; Chan, JA; Huang, HM; Smith, C; Mitiku, C; Beeson, JG; Burgio, G; Foote, SJ				McMorran, Brendan J.; Wieczorski, Laura; Drysdale, Karen E.; Chan, Jo-Anne; Huang, Hong Ming; Smith, Clare; Mitiku, Chalachew; Beeson, James G.; Burgio, Gaetan; Foote, Simon J.			Platelet Factor 4 and Duffy Antigen Required for Platelet Killing of Plasmodium falciparum	SCIENCE			English	Article							ERYTHROCYTE CHEMOKINE RECEPTOR; SEVERE MALARIA; MICROBICIDAL PROTEINS; STAPHYLOCOCCUS-AUREUS; AFRICAN CHILDREN; BLOOD-CELLS; THROMBOCYTOPENIA; INFECTION; CHOLESTEROL; INHIBITION	Platelets restrict the growth of intraerythrocytic malaria parasites by binding to parasitized cells and killing the parasite within. Here, we show that the platelet molecule platelet factor 4 (PF4 or CXCL4) and the erythrocyte Duffy-antigen receptor (Fy) are necessary for platelet-mediated killing of Plasmodium falciparum parasites. PF4 is released by platelets on contact with parasitized red cells, and the protein directly kills intraerythrocytic parasites. This function for PF4 is critically dependent on Fy, which binds PF4. Genetic disruption of Fy expression inhibits binding of PF4 to parasitized cells and concomitantly prevents parasite killing by both human platelets and recombinant human PF4. The protective function afforded by platelets during a malarial infection may therefore be compromised in Duffy-negative individuals, who do not express Fy.	[McMorran, Brendan J.; Huang, Hong Ming; Burgio, Gaetan; Foote, Simon J.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [McMorran, Brendan J.; Wieczorski, Laura; Drysdale, Karen E.; Smith, Clare; Mitiku, Chalachew; Burgio, Gaetan; Foote, Simon J.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia; [Chan, Jo-Anne; Beeson, James G.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia	Macquarie University; University of Tasmania; Burnet Institute	McMorran, BJ (corresponding author), Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia.	brendan.mcmorran@mq.edu.au	Foote, Simon J/F-2802-2013; Burgio, Gaetan/B-6722-2015	Burgio, Gaetan/0000-0002-7434-926X; Smith, Clare M./0000-0003-2601-0955; McMorran, Brendan/0000-0003-1845-8872; Foote, Simon/0000-0002-9142-2107	National Health and Medical Research Council of Australia [605524, 490037]; Australian Cancer Research Foundation; National Collaborative Research Infrastructure Strategy of Australia; Bill and Melinda Gates Foundation Grand Challenges Explorations; Howard Hughes Medical Institute; Australian Research Council [DP120100061]; Victorian State Government Operational Infrastructure Support Scheme	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; National Collaborative Research Infrastructure Strategy of Australia(Australian GovernmentDepartment of Industry, Innovation and Science); Bill and Melinda Gates Foundation Grand Challenges Explorations(Bill & Melinda Gates Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Australian Research Council(Australian Research Council); Victorian State Government Operational Infrastructure Support Scheme	We thank the Australian Red Cross Blood Services in Hobart and Brisbane for providing red blood cells and antibodies, the platelet donors, and C. Flowers and R. McWhirter for phlebotomy. We also acknowledge funding support from the National Health and Medical Research Council of Australia (grants 605524 and 490037), the Australian Cancer Research Foundation, the National Collaborative Research Infrastructure Strategy of Australia, The Bill and Melinda Gates Foundation Grand Challenges Explorations, The Howard Hughes Medical Institute, Australian Research Council (grant DP120100061 and Future Fellowship to J.G.B.), and the Victorian State Government Operational Infrastructure Support Scheme. Ethics approval for the platelet donations was received from the Human Research Ethics Committee (Tasmania) Network (H0009004). Data are deposited in the Dryad Repository: http://dx.doi.org/10.5061/dryad.8sb5h	Adedapo Aduragbenro D., 2007, Journal of Vector Borne Diseases, V44, P266; Akimitsu N, 2004, PARASITOL RES, V93, P499, DOI 10.1007/s00436-004-1165-x; Allen SJ, 1996, QJM-INT J MED, V89, P779, DOI 10.1093/qjmed/89.10.779; CHAUDHURI A, 1994, J BIOL CHEM, V269, P7835; Chotivanich K, 2004, J INFECT DIS, V189, P1052, DOI 10.1086/381900; Erhart LM, 2004, AM J TROP MED HYG, V70, P8, DOI 10.4269/ajtmh.2004.70.8; Gerardin P, 2002, AM J TROP MED HYG, V66, P686, DOI 10.4269/ajtmh.2002.66.686; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; HORSTMANN RD, 1981, BLUT, V42, P157, DOI 10.1007/BF01026385; Howes RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1265; Kashiwazaki M, 2003, INT IMMUNOL, V15, P1219, DOI 10.1093/intimm/dxg121; Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x; Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556; LU ZH, 1995, J BIOL CHEM, V270, P26239; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; OCKENHOUSE CF, 1989, SCIENCE, V243, P1469, DOI 10.1126/science.2467377; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; Peterson JE, 2010, AM J HEMATOL, V85, P487, DOI 10.1002/ajh.21732; PEYRON F, 1989, PARASITOLOGY, V99, P317, DOI 10.1017/S0031182000059011; Polack B, 1997, HAEMOSTASIS, V27, P278; Samuel BU, 2001, J BIOL CHEM, V276, P29319, DOI 10.1074/jbc.M101268200; Srivastava Kalyan, 2008, Cell Host Microbe, V4, P179, DOI 10.1016/j.chom.2008.07.003; SZABO MC, 1995, J BIOL CHEM, V270, P25348, DOI 10.1074/jbc.270.43.25348; Tang YQ, 2002, INFECT IMMUN, V70, P6524, DOI 10.1128/IAI.70.12.6524-6533.2002; Tripathy R, 2007, PEDIATRICS, V120, pE454, DOI 10.1542/peds.2006-3171; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Xiong YQ, 2002, J INFECT DIS, V185, P348, DOI 10.1086/338514; Yeaman MR, 2007, BBA-BIOMEMBRANES, V1768, P609, DOI 10.1016/j.bbamem.2006.11.010; Yeaman MR, 1998, J CLIN INVEST, V101, P178, DOI 10.1172/JCI562; ZUCKER MB, 1991, P SOC EXP BIOL MED, V198, P693	32	111	111	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1348	1351		10.1126/science.1228892	http://dx.doi.org/10.1126/science.1228892			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224555	Green Published			2022-12-24	WOS:000311991200068
J	Eisenstein, M				Eisenstein, Michael			CENTENARIANS Great expectations	NATURE			English	Editorial Material							GENOME-WIDE ASSOCIATION											Andersen SL, 2012, J GERONTOL A-BIOL, V67, P395, DOI 10.1093/gerona/glr223; Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Bergman A, 2007, PLOS COMPUT BIOL, V3, P1648, DOI 10.1371/journal.pcbi.0030170; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Nebel A, 2011, MECH AGEING DEV, V132, P324, DOI 10.1016/j.mad.2011.06.008; Sebastiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029848	7	8	8	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					S6	S8		10.1038/492S6a	http://dx.doi.org/10.1038/492S6a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222673				2022-12-24	WOS:000311893400004
J	Waugh, DW; Primeau, F; DeVries, T; Holzer, M				Waugh, Darryn W.; Primeau, Francois; DeVries, Tim; Holzer, Mark			Recent Changes in the Ventilation of the Southern Oceans	SCIENCE			English	Article							RECENT CLIMATE-CHANGE; ANTHROPOGENIC CO2; DECADAL CHANGES; ANNULAR MODE; DISTRIBUTIONS; CIRCULATION; THERMOCLINE; ATMOSPHERE; AGES; ICE	Surface westerly winds in the Southern Hemisphere have intensified over the past few decades, primarily in response to the formation of the Antarctic ozone hole, and there is intense debate on the impact of this on the ocean's circulation and uptake and redistribution of atmospheric gases. We used measurements of chlorofluorocarbon-12 (CFC-12) made in the southern oceans in the early 1990s and mid-to late 2000s to examine changes in ocean ventilation. Our analysis of the CFC-12 data reveals a decrease in the age of subtropical subantarctic mode waters and an increase in the age of circumpolar deep waters, suggesting that the formation of the Antarctic ozone hole has caused large-scale coherent changes in the ventilation of the southern oceans.	[Waugh, Darryn W.] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Primeau, Francois] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [DeVries, Tim] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Holzer, Mark] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia; [Holzer, Mark] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA	Johns Hopkins University; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of New South Wales Sydney; Columbia University	Waugh, DW (corresponding author), Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA.	waugh@jhu.edu	Holzer, Mark/E-8735-2011; Waugh, Darryn W/K-3688-2016; Primeau, Francois W/A-7310-2011	Holzer, Mark/0000-0002-9568-1763; Waugh, Darryn W/0000-0001-7692-2798; Primeau, Francois W/0000-0001-7452-9415; DeVries, Tim/0000-0002-7771-9430	NSF [ANT-1043307, OCE-0928395, ATM-0854711]; Australian Research Council [DP120100674]; Div Atmospheric & Geospace Sciences [0854711] Funding Source: National Science Foundation; Division Of Ocean Sciences [0928395] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Australian Research Council(Australian Research Council); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank A. Gnanadesikan, T. Haine, and E. Y. Kwon for helpful conversations and J. Bullister, M. Warner, R. Fine, and the other scientists who provided the CFC-12 data for the WOCE and CLIVAR programs. D. W. W. acknowledges support from NSF grant ANT-1043307, F. P. acknowledges support from NSF grant OCE-0928395, and M. H. acknowledges support from NSF grant ATM-0854711 and Australian Research Council grant DP120100674.	Alvarez M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006475; Aoki S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022220; Boning CW, 2008, NAT GEOSCI, V1, P864, DOI 10.1038/ngeo362; Bryan FO, 2006, OCEAN MODEL, V15, P141, DOI 10.1016/j.ocemod.2006.01.002; DeVries T, 2011, J PHYS OCEANOGR, V41, P2381, DOI 10.1175/JPO-D-10-05011.1; Fine RA, 2011, ANNU REV MAR SCI, V3, P173, DOI 10.1146/annurev.marine.010908.163933; Gille ST, 2008, J CLIMATE, V21, P4749, DOI 10.1175/2008JCLI2131.1; Gnanadesikan A, 2007, OCEAN SCI, V3, P43, DOI 10.5194/os-3-43-2007; Hall A, 2002, J CLIMATE, V15, P3043, DOI 10.1175/1520-0442(2002)015<3043:SVITSH>2.0.CO;2; Ito T, 2010, NATURE, V463, P80, DOI 10.1038/nature08687; Khatiwala S, 2009, NATURE, V462, P346, DOI 10.1038/nature08526; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Lenton A, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002714; Lovenduski NS, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022727; Matear RJ, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000086; McDonagh EL, 2005, J CLIMATE, V18, P1575, DOI 10.1175/JCLI3350.1; McLandress C, 2011, J CLIMATE, V24, P1850, DOI 10.1175/2010JCLI3958.1; Meredith MP, 2012, J CLIMATE, V25, P99, DOI 10.1175/2011JCLI4204.1; Orsi A., 2001, LOCATIONS VARIOUS FR; Roemmich D, 2007, J PHYS OCEANOGR, V37, P162, DOI 10.1175/JPO3004.1; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Schlosser P., 2001, OCEAN CIRCULATION CL; Sen Gupta A, 2006, J CLIMATE, V19, P4457, DOI 10.1175/JCLI3843.1; Sigmond M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047120; Son SW, 2008, SCIENCE, V320, P1486, DOI 10.1126/science.1155939; Thompson DWJ, 2011, NAT GEOSCI, V4, P741, DOI [10.1038/ngeo1296, 10.1038/NGEO1296]; Toggweiler JR, 2008, NATURE, V451, P286, DOI 10.1038/nature06590; Waugh DW, 2006, TELLUS B, V58, P376, DOI 10.1111/j.1600-0889.2006.00222.x; Waugh DW, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001325	29	104	106	4	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					568	570		10.1126/science.1225411	http://dx.doi.org/10.1126/science.1225411			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129MC	23372011	Green Published			2022-12-24	WOS:000317843300001
J	Baum, M				Baum, Michael			PERSONAL VIEW Harms from breast cancer screening outweigh benefits if death caused by treatment is included	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RADIOTHERAPY; MORTALITY		UCL, Div Surg & Intervent Sci, London WC1E 6BT, England	University of London; University College London	Baum, M (corresponding author), UCL, Div Surg & Intervent Sci, Mortimer St, London WC1E 6BT, England.	michael@mbaum.freeserve.co.uk						Abe O, 2005, LANCET, V366, P2087; [Anonymous], ALL CAUS MORT RAT MO; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Burton RC, 2012, BREAST CANCER RES TR, V131, P949, DOI 10.1007/s10549-011-1794-6; Cancer Research UK, 2011, CANCERSTATS CANC STA; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; HAYBITTLE JL, 1989, BRIT MED J, V298, P1611, DOI 10.1136/bmj.298.6688.1611; Jones LW, 2012, J CLIN ONCOL, V30, P2530, DOI 10.1200/JCO.2011.39.9014; Lane JA, 2010, EUR J CANCER, V46, P3095, DOI 10.1016/j.ejca.2010.09.016; Law M, 2003, Health Technol Assess, V7, P1; Lind PA, 2003, INT J RADIAT ONCOL, V55, P914, DOI 10.1016/S0360-3016(02)04156-1; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; NHS Breast Screening & Association of Breast Surgery, 2011, AUD SCREEN DET BREAS; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6	15	51	51	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2013	346								f385	10.1136/bmj.f385	http://dx.doi.org/10.1136/bmj.f385			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BX	23344314				2022-12-24	WOS:000314217300010
J	Silverman, E				Silverman, Ed			DRUG MARKETING Off-label marketing: free speech or illegal promotion?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Pharmalot, Millburn, NJ USA		Silverman, E (corresponding author), Pharmalot, Millburn, NJ USA.	pharmalot@gmail.com							0	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2013	346								f320	10.1136/bmj.f320	http://dx.doi.org/10.1136/bmj.f320			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BG	23341546				2022-12-24	WOS:000314215600015
J	Stocker, TF				Stocker, Thomas F.			The Closing Door of Climate Targets	SCIENCE			English	Editorial Material							CUMULATIVE CARBON EMISSIONS		[Stocker, Thomas F.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Stocker, Thomas F.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland	University of Bern; University of Bern	Stocker, TF (corresponding author), Univ Bern, Inst Phys, CH-3012 Bern, Switzerland.	stocker@climate.unibe.ch	Stocker, Thomas/B-1273-2013					Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; Andres RJ, 2012, BIOGEOSCIENCES, V9, P1845, DOI 10.5194/bg-9-1845-2012; Bowerman NHA, 2011, PHILOS T R SOC A, V369, P45, DOI 10.1098/rsta.2010.0288; den Elzen M, 2007, GLOBAL ENVIRON CHANG, V17, P260, DOI 10.1016/j.gloenvcha.2006.10.003; Friedlingstein P, 2010, NAT GEOSCI, V3, P811, DOI 10.1038/ngeo1022; Matthews HD, 2009, NATURE, V459, P829, DOI 10.1038/nature08047; UNFCCC, 2009, COP ACC; UNFCCC, 2010, CANC AGR	8	85	88	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					280	282		10.1126/science.1232468	http://dx.doi.org/10.1126/science.1232468			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23196911				2022-12-24	WOS:000313622000031
J	Parekh, AK; Galloway, JM; Hong, YL; Wright, JS				Parekh, Anand K.; Galloway, James M.; Hong, Yuling; Wright, Janet S.			Aspirin in the Secondary Prevention of Cardiovascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Parekh, Anand K.] US Dept Hlth & Human Serv, Off Assistant Secretary Hlth, Washington, DC USA; [Galloway, James M.] US Dept Hlth & Human Serv, Off Assistant Secretary Hlth, Chicago, IL USA; [Hong, Yuling; Wright, Janet S.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Wright, Janet S.] Ctr Medicare & Medicaid Innovat, Baltimore, MD USA	Centers for Disease Control & Prevention - USA	Parekh, AK (corresponding author), US Dept Hlth & Human Serv, Off Assistant Secretary Hlth, Washington, DC USA.							Ademi Z, 2011, CARDIOVASC THER; [Anonymous], 2012, MMWR MORB MORTAL WKL, V61, P11; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046	5	16	17	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					204	205		10.1056/NEJMp1213380	http://dx.doi.org/10.1056/NEJMp1213380			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YG	23323896				2022-12-24	WOS:000313549900004
J	Ardaugh, BM; Graves, SE; Redberg, RF				Ardaugh, Brent M.; Graves, Stephen E.; Redberg, Rita F.			The 510(k) Ancestry of a Metal-on-Metal Hip Implant	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ardaugh, Brent M.] Boston Univ, Sch Med, Framingham Heart Study, Boston, MA 02118 USA; [Graves, Stephen E.] Australian Orthopaed Assoc, Natl Joint Replacement Registry, Adelaide, SA, Australia; [Graves, Stephen E.] Flinders Univ S Australia, Dept Surg, Adelaide, SA 5001, Australia; [Redberg, Rita F.] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA	Boston University; Framingham Heart Study; Flinders University South Australia; University of California System; University of California San Francisco	Ardaugh, BM (corresponding author), Boston Univ, Sch Med, Framingham Heart Study, Boston, MA 02118 USA.		Graves, Stephen E/A-9463-2016	Graves, Stephen E/0000-0002-1629-319X				Australian Orthopaedic Association National Joint Replacement Registry, 2012, REP INV PROSTH HIG S; Cabitza P, 1979, Arch Sci Med (Torino), V136, P45; Center for Devices and Radiological Health, CDRH 2012 STRAT PRIO; Institute of Medicine, 2011, MED DEV PUBL HLTH FD; RING PA, 1983, CLIN ORTHOP RELAT R, P115	5	71	71	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					97	100		10.1056/NEJMp1211581	http://dx.doi.org/10.1056/NEJMp1211581			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066RO	23301729	Bronze			2022-12-24	WOS:000313238100012
J	Webster, PJ				Webster, Peter J.			Improve weather forecasts for the developing world	NATURE			English	Editorial Material							BANGLADESH; FLOODS		Georgia Inst Technol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Webster, PJ (corresponding author), Georgia Inst Technol, Atlanta, GA 30332 USA.	pjw@eas.gatech.edu						Belanger JI, 2012, WEATHER FORECAST, V27, P757, DOI 10.1175/WAF-D-11-00083.1; Foresight, 2012, RED RISKS FUT DIS PR; Hopson TM, 2010, J HYDROMETEOROL, V11, P618, DOI 10.1175/2009JHM1006.1; Leutbecher M, 2008, J COMPUT PHYS, V227, P3515, DOI 10.1016/j.jcp.2007.02.014; Stephens GL, 2004, J CLIMATE, V17, P2213, DOI 10.1175/1520-0442(2004)017&lt;2213:OEFTMR&gt;2.0.CO;2; Teisberg T.J., 2009, BACKGROUND PAPER BEN; Webster PJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046346; Webster PJ, 2008, NAT GEOSCI, V1, P488, DOI 10.1038/ngeo257; Webster PJ, 2010, B AM METEOROL SOC, V91, P1493, DOI 10.1175/2010BAMS2911.1; Webster PJ, 2004, B AM METEOROL SOC, V85, P1745, DOI 10.1175/BAMS-85-11-1745	10	54	54	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					17	19		10.1038/493017a	http://dx.doi.org/10.1038/493017a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	062QC	23282347				2022-12-24	WOS:000312933800010
J	Reis, S; Grennfelt, P; Klimont, Z; Amann, M; ApSimon, H; Hettelingh, JP; Holland, M; LeGall, AC; Maas, R; Posch, M; Spranger, T; Sutton, MA; Williams, M				Reis, S.; Grennfelt, P.; Klimont, Z.; Amann, M.; ApSimon, H.; Hettelingh, J. -P.; Holland, M.; LeGall, A. -C.; Maas, R.; Posch, M.; Spranger, T.; Sutton, M. A.; Williams, M.			From Acid Rain to Climate Change	SCIENCE			English	Editorial Material									[Reis, S.; Sutton, M. A.] Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland; [Grennfelt, P.] Swedish Environm Res Inst, SE-40014 Gothenburg, Sweden; [Klimont, Z.; Amann, M.] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [ApSimon, H.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Hettelingh, J. -P.; Maas, R.; Posch, M.] Natl Inst Publ Hlth & Environm, NL-3721 MA Bilthoven, Netherlands; [Holland, M.] Ecometr Res & Consulting, Reading RG8 7PW, Berks, England; [LeGall, A. -C.] Natl Inst Ind Environm & Risks, F-60550 Verneuil En Halatte, France; [Spranger, T.] Fed Minist Environm Nat Conservat & Nucl Safety, D-11055 Berlin, Germany; [Williams, M.] Kings Coll London, Environm Res Grp, London SE1 9NH, England	UK Centre for Ecology & Hydrology (UKCEH); IVL Swedish Environmental Research Institute; International Institute for Applied Systems Analysis (IIASA); Imperial College London; Netherlands National Institute for Public Health & the Environment; Institut National de l'Environnement Industriel et des Risques (INERIS); University of London; King's College London	Reis, S (corresponding author), Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland.	srei@ceh.ac.uk	Klimont, Zbigniew/P-7641-2015; Sutton, Mark/K-2700-2012; Reis, Stefan/E-4713-2011; Klimont, Zbigniew/O-6683-2019	Klimont, Zbigniew/0000-0003-2630-198X; Sutton, Mark/0000-0002-1342-2072; Reis, Stefan/0000-0003-2428-8320; Klimont, Zbigniew/0000-0003-2630-198X; Williams, Martin/0000-0002-4677-6491	Natural Environment Research Council [ceh010023] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Amann M, 2011, ENVIRON MODELL SOFTW, V26, P1489, DOI 10.1016/j.envsoft.2011.07.012; [Anonymous], 2011, NEAR TERM CLIMATE PR; Dentener F., 2010, AIR POLLUTION STUDIE; Hettelingh JP, 2007, WATER AIR SOIL POLL, V7, P379; Holland M., 2011, COST BENEFIT ANAL RE; Mills G., 2011, OZONE POLLUTION HIDD; Posch M, 2011, ENVIRON POLLUT, V159, P2223, DOI 10.1016/j.envpol.2010.11.001; Raes F, 2007, SCIENCE, V318, P1386, DOI 10.1126/science.1147873; Rafaj P., 2012, ENVC3SER20110009 IIA; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Sundqvist G, 2011, POLIT SCI ENVIRON, P195; Sutton M.A, 2011, EUROPEAN NITROGEN AS, DOI DOI 10.1017/CBO9780511976988; UNECE, 2009, CLEAR AIR; UNECE, 2012, PART UNECE AIR POLL	15	103	107	5	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1153	1154		10.1126/science.1226514	http://dx.doi.org/10.1126/science.1226514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197517				2022-12-24	WOS:000311666200026
J	Willyard, C				Willyard, Cassandra			DIAGNOSTICS Playing detective	NATURE			English	Editorial Material																		Damania D, 2012, CANCER RES, V72, P2720, DOI 10.1158/0008-5472.CAN-11-3807; Gaster RS, 2009, NAT MED, V15, P1327, DOI 10.1038/nm.2032; Nandakumar V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029230; Wendel M, 2012, PHYS BIOL, V9, DOI [10.1088/1478-3967/9/1/016005, 10.1088/1478-3975/9/1/016005]	4	1	2	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					S64	S65		10.1038/491S64a	http://dx.doi.org/10.1038/491S64a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040RE	23320292				2022-12-24	WOS:000311339800009
J	Shapiro, MD; Kronenberg, Z; Li, C; Domyan, ET; Pan, HL; Campbell, M; Tan, H; Huff, CD; Hu, HF; Vickrey, AI; Nielsen, SCA; Stringham, SA; Hu, H; Willerslev, E; Gilbert, MTP; Yandell, M; Zhang, GJ; Wang, J				Shapiro, Michael D.; Kronenberg, Zev; Li, Cai; Domyan, Eric T.; Pan, Hailin; Campbell, Michael; Tan, Hao; Huff, Chad D.; Hu, Haofu; Vickrey, Anna I.; Nielsen, Sandra C. A.; Stringham, Sydney A.; Hu, Hao; Willerslev, Eske; Gilbert, M. Thomas P.; Yandell, Mark; Zhang, Guojie; Wang, Jun			Genomic Diversity and Evolution of the Head Crest in the Rock Pigeon	SCIENCE			English	Article							LINKAGE DISEQUILIBRIUM; POPULATIONS; DIVERGENCE; SPECIATION; ANCESTRY; BIRDS; MODEL	The geographic origins of breeds and the genetic basis of variation within the widely distributed and phenotypically diverse domestic rock pigeon (Columba livia) remain largely unknown. We generated a rock pigeon reference genome and additional genome sequences representing domestic and feral populations. We found evidence for the origins of major breed groups in the Middle East and contributions from a racing breed to North American feral populations. We identified the gene EphB2 as a strong candidate for the derived head crest phenotype shared by numerous breeds, an important trait in mate selection in many avian species. We also found evidence that this trait evolved just once and spread throughout the species, and that the crest originates early in development by the localized molecular reversal of feather bud polarity.	[Shapiro, Michael D.; Domyan, Eric T.; Vickrey, Anna I.; Stringham, Sydney A.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Kronenberg, Zev; Campbell, Michael; Huff, Chad D.; Yandell, Mark] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Li, Cai; Pan, Hailin; Tan, Hao; Hu, Haofu; Zhang, Guojie; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Li, Cai; Nielsen, Sandra C. A.; Willerslev, Eske; Gilbert, M. Thomas P.] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Huff, Chad D.; Hu, Hao] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Gilbert, M. Thomas P.] Murdoch Univ, Ancient DNA Lab, Perth, WA 6150, Australia; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-1165 Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-1165 Copenhagen, Denmark	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Beijing Genomics Institute (BGI); University of Copenhagen; University of Texas System; UTMD Anderson Cancer Center; Murdoch University; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Shapiro, MD (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	mike.shapiro@utah.edu; wangj@genomics.org.cn	Wang, Jun/A-7261-2013; Gilbert, Marcus TP/A-8936-2013; Willerslev, Eske/A-9619-2011; Zhang, Guojie/B-6188-2014; Zhang, Guojie/J-7273-2019; Hu, Hao/I-4399-2014; Willerslev, Eske/AAA-5686-2019; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Gilbert, Marcus TP/0000-0002-5805-7195; Willerslev, Eske/0000-0002-7081-6748; Zhang, Guojie/0000-0001-6860-1521; Zhang, Guojie/0000-0001-6860-1521; Hu, Haofu/0000-0001-8145-3009; Li, Cai/0000-0001-7843-2151; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	Burroughs Wellcome Fund Career Award in the Biomedical Sciences; NSF CAREER [DEB-1149160]; University of Utah Research Foundation; NIH [T32GM007464, T32HD07491]; NSF EDEN internship; NIH/NHGRI [R01HG004694]; NIH ARRA GO [RC2HG005619]; Danish National Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007491] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R44HG006579, RC2HG005619, R01HG004694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464, R01GM104390] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); University of Utah Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF EDEN internship; NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH ARRA GO; Danish National Research Foundation(Danmarks Grundforskningsfond); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the University of Washington Burke Museum for the C. rupestris tissue sample (UWBM 59803); J. Oldham, K. Wright, the Utah Pigeon Club, the National Pigeon Association, and A. and H. O. Christiansen for domestic pigeon samples; D. Clayton for feral samples; and D. Clayton, M. Horvath, D. Kingsley, R. Nielsen, and W. Warren for discussion and comments. Supported by a Burroughs Wellcome Fund Career Award in the Biomedical Sciences, NSF CAREER DEB-1149160, University of Utah Research Foundation (M. D. S.); NIH training grant T32GM007464 (S. A. S.); NIH training grant T32HD07491 (E. T. D.); an NSF EDEN internship (A. I. V.); NIH/NHGRI R01HG004694 and NIH ARRA GO RC2HG005619 (M.Y.); and the Danish National Research Foundation (M. T. P. G. and E. W.). We acknowledge a computer time allocation from the Center for High Performance Computing at the University of Utah. This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under accession no. AKCR00000000 (the first version described here is AKCR01000000; raw reads, SRA052637); RNA-seq data for annotation, accession no. GSE39333; and raw reads for resequenced genomes, accession no. SRA054391.	Aerts J, 2007, CYTOGENET GENOME RES, V117, P338, DOI 10.1159/000103196; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Balakrishnan CN, 2009, GENETICS, V181, P645, DOI 10.1534/genetics.108.094250; BAPTISTA Luis Felipe, 2009, Acta Zool. Mex, V25, P719; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Darwin C., 1859, ORIGIN SPECIES MEANS; Darwin C., 1868, VARIATION ANIMALS PL, V1; Driscoll CA, 2009, P NATL ACAD SCI USA, V106, P9971, DOI 10.1073/pnas.0901586106; Elder ME, 2001, J IMMUNOL, V166, P656, DOI 10.4049/jimmunol.166.1.656; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Johnson KP, 2001, AUK, V118, P874, DOI 10.1642/0004-8038(2001)118[0874:AMPOTD]2.0.CO;2; Kelsh RN, 2009, SEMIN CELL DEV BIOL, V20, P90, DOI 10.1016/j.semcdb.2008.10.001; Levi Wendell M., 1986, PIGEON; McKinnell IW, 2004, DEV BIOL, V270, P94, DOI 10.1016/j.ydbio.2004.02.007; Morgan TH, 1911, BIOL BULL-US, V21, P0215, DOI 10.2307/1536043; Mou C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001028; Price TD, 2002, GENETICA, V116, P311, DOI 10.1023/A:1021248913179; Sell A., 1994, BREEDING INHERITANCE; Stringham SA, 2012, CURR BIOL, V22, P302, DOI 10.1016/j.cub.2011.12.045; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Wang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034012; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111	24	175	183	7	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1063	1067		10.1126/science.1230422	http://dx.doi.org/10.1126/science.1230422			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23371554	Green Accepted			2022-12-24	WOS:000315452000038
J	Zimmermann, M; Lottersberger, F; Buonomo, SB; Sfeir, A; de Lange, T				Zimmermann, Michal; Lottersberger, Francisca; Buonomo, Sara B.; Sfeir, Agnel; de lange, Titia			53BP1 Regulates DSB Repair Using Rif1 to Control 5 ' End Resection	SCIENCE			English	Article							PROTEIN 53BP1; DNA; RECOMBINATION; TELOMERES; DOMAINS; CELLS; CTIP	The choice between double-strand break (DSB) repair by either homology-directed repair (HDR) or nonhomologous end joining (NHEJ) is tightly regulated. Defects in this regulation can induce genome instability and cancer. 53BP1 is critical for the control of DSB repair, promoting NHEJ, and inhibiting the 5' end resection needed for HDR. Using dysfunctional telomeres and genome-wide DSBs, we identify Rif1 as the main factor used by 53BP1 to impair 5' end resection. Rif1 inhibits resection involving CtIP, BLM, and Exo1; limits accumulation of BRCA1/BARD1 complexes at sites of DNA damage; and defines one of the mechanisms by which 53BP1 causes chromosomal abnormalities in Brca1-deficient cells. These data establish Rif1 as an important contributor to the control of DSB repair by 53BP1.	[Zimmermann, Michal; Lottersberger, Francisca; Sfeir, Agnel; de lange, Titia] Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10065 USA; [Zimmermann, Michal] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Zimmermann, Michal] Masaryk Univ, Fac Sci, CS-61137 Brno, Czech Republic; [Buonomo, Sara B.] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy	Rockefeller University; Masaryk University Brno; Masaryk University Brno; European Molecular Biology Laboratory (EMBL)	de Lange, T (corresponding author), Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10065 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X; Buonomo, Sara/0000-0002-0177-2884; Lottersberger, Francisca/0000-0002-0677-8986	Brno Ph.D. talent fellowship; Czech Science Foundation [P205/12/0550]; Breast Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049046] Funding Source: NIH RePORTER	Brno Ph.D. talent fellowship; Czech Science Foundation(Grant Agency of the Czech Republic); Breast Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. White for expert mouse husbandry and M. Nussenzweig for providing mutant 53BP1 constructs. M.Z. was supported by a Brno Ph.D. talent fellowship and by a grant from the Czech Science Foundation to Ctirad Hofr (P205/12/0550) (see supplementary materials for detailed acknowledgement). This work was supported by a grant from the Breast Cancer Research Foundation to T.d.L. T.d.L. is an American Cancer Society Research Professor.	Anbalagan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002024; Bonetti D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000966; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Buonomo SBC, 2009, J CELL BIOL, V187, P385, DOI 10.1083/jcb.200902039; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Huen MSY, 2010, MOL CELL, V37, P854, DOI 10.1016/j.molcel.2009.12.040; Morales JC, 2003, J BIOL CHEM, V278, P14971, DOI 10.1074/jbc.M212484200; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150; Xu LF, 2004, J CELL BIOL, V167, P819, DOI 10.1083/jcb.200408181; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388	21	427	441	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					700	704		10.1126/science.1231573	http://dx.doi.org/10.1126/science.1231573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23306437	Green Accepted			2022-12-24	WOS:000314585600044
J	Chen, WL; Han, CF; Xie, B; Hu, X; Yu, Q; Shi, LY; Wang, QQ; Li, DL; Wang, JL; Zheng, P; Liu, Y; Cao, XT				Chen, Weilin; Han, Chaofeng; Xie, Bin; Hu, Xiang; Yu, Qian; Shi, Liyun; Wang, Qingqing; Li, Dongling; Wang, Jianli; Zheng, Pan; Liu, Yang; Cao, Xuetao			Induction of Siglec-G by RNA Viruses Inhibits the Innate Immune Response by Promoting RIG-I Degradation	CELL			English	Article							NF-KAPPA-B; STRUCTURAL BASIS; NEGATIVE REGULATOR; UBIQUITIN LIGASE; C-CBL; RECOGNITION; ACTIVATION; PROTEIN; RECEPTORS; IDENTIFICATION	RIG-I is a critical RNA virus sensor that serves to initiate antiviral innate immunity. However, post-translational regulation of RIG-I signaling remains to be fully understood. We report here that RNA viruses, but not DNA viruses or bacteria, specifically upregulate lectin family member Siglecg expression in macrophages by RIG-I-or NF-kappa B-dependent mechanisms. Siglec-G-induced recruitment of SHP2 and the E3 ubiquitin ligase c-Cbl to RIG-I leads to RIG-I degradation via K48-linked ubiquitination at Lys813 by c-Cbl. By increasing type I interferon production, targeted inactivation of Siglecg protects mice against lethal RNA virus infection. Taken together, our data reveal a negative feedback loop of RIG-I signaling and identify a Siglec-G-mediated immune evasion pathway exploited by RNA viruses with implication in antiviral applications. These findings also provide insights into the functions and crosstalk of Siglec-G, a known adaptive response regulator, in innate immunity.	[Chen, Weilin; Xie, Bin; Shi, Liyun; Wang, Qingqing; Wang, Jianli; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China; [Han, Chaofeng; Yu, Qian; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Han, Chaofeng; Yu, Qian; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Hu, Xiang; Li, Dongling; Zheng, Pan; Liu, Yang; Cao, Xuetao] Chinese Acad Med Sci, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Hu, Xiang; Li, Dongling; Zheng, Pan; Liu, Yang; Cao, Xuetao] Chinese Acad Med Sci, Dept Immunol, Beijing 100005, Peoples R China	Zhejiang University; Naval Medical University; Naval Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Cao, XT (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China.	caoxt@immunol.org	Zheng, Pan/E-8691-2011; wang, jian/GVS-0711-2022	Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X; Han, Chaofeng/0000-0002-8489-6478; Shi, Liyun/0000-0003-3538-1571; Shi, Liyun/0000-0003-1767-0126	National Key Basic Research Program of China [2013CB530500, 2012CB910202]; National Natural Science Foundation of China [81273222, 81230074, 81123006]; National 125 Key Project [2012ZX10002-014, 2012AA020901]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036690] Funding Source: NIH RePORTER	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 125 Key Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Chanrong Ni for histological processing, Dr. Jing Jin, Dr. Nan Li for helpful discussion, Dr. Zhugang Wang for providing Rigi<SUP>-/-</SUP>mice, and Dr. Gensheng Feng for providing Shp2<SUP>fl</SUP> mice. This work was supported by the National Key Basic Research Program of China (2013CB530500 and 2012CB910202), the National Natural Science Foundation of China (81273222, 81230074, and 81123006), and the National 125 Key Project (2012ZX10002-014 and 2012AA020901). X.C. designed and supervised the research. W.C., C.H., B.X., X.H., and Q.Y. performed research. L.S., Q.W., D.L., J.W., P.Z., and Y.L. contributed new reagents/analytical tools. W.C., C.H., B.X., and X.C. analyzed data. W.C., C.H., and X.C. wrote the paper.	An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Chen GY, 2011, NAT BIOTECHNOL, V29, P428, DOI 10.1038/nbt.1846; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chernock RD, 2001, BLOOD, V97, P608, DOI 10.1182/blood.V97.3.608; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Ding C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000997; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hoffmann A, 2007, NAT IMMUNOL, V8, P694, DOI 10.1038/ni1480; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Munday J, 2001, BIOCHEM J, V355, P489, DOI 10.1042/0264-6021:3550489; Negishi H, 2012, NAT IMMUNOL, V13, P659, DOI 10.1038/ni.2307; Nielsen PJ, 1997, BLOOD, V89, P1058, DOI 10.1182/blood.V89.3.1058; O'Neill LAJ, 2011, CELL, V147, P259, DOI 10.1016/j.cell.2011.09.027; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Tanaka Y, 2008, MOL CELL BIOL, V28, P4805, DOI 10.1128/MCB.01784-07; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wang Y, 2007, CELL RES, V17, P858, DOI 10.1038/cr.2007.81; Whitney G, 2001, EUR J BIOCHEM, V268, P6083, DOI 10.1046/j.0014-2956.2001.02543.x; Xu S, 2012, NAT IMMUNOL, V13, P551, DOI 10.1038/ni.2283; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	42	195	210	8	122	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					467	478		10.1016/j.cell.2013.01.011	http://dx.doi.org/10.1016/j.cell.2013.01.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374343	Bronze			2022-12-24	WOS:000314362800017
J	Savage, N				Savage, Neil			PHYSIOLOGY Beating stroke	NATURE			English	Editorial Material							ATRIAL-FIBRILLATION; LIFETIME RISK; ABLATION											Furie KL, 2012, STROKE, V43, P3442, DOI 10.1161/STR.0b013e318266722a; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Narayan S. M., 2012, EP LAB DIGEST, V12, P1; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Rettmann ME, 2012, ACAD RADIOL, V19, P1332, DOI 10.1016/j.acra.2012.06.009	8	2	2	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					S12	S13		10.1038/493S12a	http://dx.doi.org/10.1038/493S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364765	Bronze			2022-12-24	WOS:000314219600010
J	Bowie, JU				Bowie, James U.			Membrane Protein Twists and Turns	SCIENCE			English	Editorial Material							TOPOLOGY; EVOLUTION		[Bowie, James U.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Bowie, James U.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bowie, JU (corresponding author), Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	bowie@mbi.ucla.edu			NIGMS NIH HHS [R01GM063919] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063919] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Cao Z, 2012, P NATL ACAD SCI USA, V109, P8121, DOI 10.1073/pnas.1201298109; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Lu Y, 2000, MOL BIOL CELL, V11, P2973, DOI 10.1091/mbc.11.9.2973; Luirink J, 2012, BBA-BIOENERGETICS, V1817, P965, DOI 10.1016/j.bbabio.2011.12.006; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101	15	25	25	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					398	399		10.1126/science.1228655	http://dx.doi.org/10.1126/science.1228655			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349275				2022-12-24	WOS:000313960700024
J	Vashi, AA; Fox, JP; Carr, BG; D'Onofrio, G; Pines, JM; Ross, JS; Gross, CP				Vashi, Anita A.; Fox, Justin P.; Carr, Brendan G.; D'Onofrio, Gail; Pines, Jesse M.; Ross, Joseph S.; Gross, Cary P.			Use of Hospital-Based Acute Care Among Patients Recently Discharged From the Hospital	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY; REHOSPITALIZATIONS; READMISSIONS; QUALITY; INTERVENTION; VISITS	Importance Current efforts to improve health care focus on hospital readmission rates as a marker of quality and on the effectiveness of transitions in care during the period after acute care is received. Emergency department (ED) visits are also a marker of hospital-based acute care following discharge but little is known about ED use during this period. Objectives To determine the degree to which ED visits and hospital readmissions contribute to overall use of acute care services within 30 days of discharge from acute care hospitals, to describe the reasons patients return for ED visits, and to describe these patterns among Medicare beneficiaries and those not covered by Medicare insurance. Design, Setting, and Participants Prospective study of patients aged 18 years or older (mean age: 53.4 years) who were discharged between July 1, 2008, and September 31, 2009, from acute care hospitals in 3 large, geographically diverse states (California, Florida, and Nebraska) with data recorded in the Healthcare Cost and Utilization Project state inpatient and ED databases. Main Outcome Measures The 3 primary outcomes during the 30-day period after hospital discharge were ED visits not resulting in admission (treat-and-release encounters), hospital readmissions from any source, and a combined measure of ED visits and hospital readmissions termed hospital-based acute care. Results The final cohort included 5 032 254 index hospitalizations among 4 028 555 unique patients. In the 30 days following discharge, 17.9% (95% CI, 17.9%-18.0%) of hospitalizations resulted in at least 1 acute care encounter. Of these 1 233 402 postdischarge acute care encounters, ED visits comprised 39.8% (95% CI, 39.7%-39.9%). For every 1000 discharges, there were 97.5 (95% CI, 97.2-97.8) ED treat-and-release visits and 147.6 (95% CI, 147.3-147.9) hospital readmissions in the 30 days following discharge. The number of ED treat-and-release visits ranged from a low of 22.4 (95% CI, 4.6-65.4) encounters per 1000 discharges for breast malignancy to a high of 282.5 (95% CI, 209.7-372.4) encounters per 1000 discharges for uncomplicated benign prostatic hypertrophy. Among the highest volume discharges, the most common reason patients returned to the ED was always related to their index hospitalization. Conclusions and Relevance After discharge from acute care hospitals in 3 states, ED visits within 30 days were common among adults and accounted for 39.8% of postdischarge hospital-based acute care visits. Improving care transitions should focus not only on decreasing readmissions but also on ED visits. JAMA. 2013;309(4):364-371 www.jama.com	[Vashi, Anita A.; Ross, Joseph S.; Gross, Cary P.] Yale Univ, Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, New Haven, CT 06520 USA; [Vashi, Anita A.; D'Onofrio, Gail] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06520 USA; [Ross, Joseph S.; Gross, Cary P.] Yale Univ, Sch Med, Gen Internal Med Sect, New Haven, CT 06520 USA; [Gross, Cary P.] Yale Univ, Sch Med, Canc Outcomes Policy & Effectiveness Res Ctr, New Haven, CT 06520 USA; [Gross, Cary P.] Yale Comprehens Canc Ctr, New Haven, CT USA; [Vashi, Anita A.] VA Connecticut Healthcare Syst, Dept Vet Affairs, West Haven, CT USA; [Fox, Justin P.] Wright State Univ, Boonshoft Sch Med, Dept Surg, Dayton, OH 45435 USA; [Carr, Brendan G.] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA; [Carr, Brendan G.] Univ Penn, Dept Biostat, Philadelphia, PA 19104 USA; [Carr, Brendan G.] Univ Penn, Dept Epidemiol, Philadelphia, PA 19104 USA; [Pines, Jesse M.] George Washington Univ, Dept Emergency Med, Washington, DC USA; [Pines, Jesse M.] George Washington Univ, Dept Hlth Policy, Washington, DC USA; [Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University System of Ohio; Wright State University Dayton; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; George Washington University; George Washington University; Yale University	Vashi, AA (corresponding author), Yale Univ, Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, 333 Cedar St,SHM 1E-61, New Haven, CT 06520 USA.	anita.vashi@yale.edu		Ross, Joseph/0000-0002-9218-3320; D'Onofrio, Gail/0000-0002-3833-1871	Pew Charitable Trusts; Agency for Healthcare Research and Quality [K08 AG032886]; National Institute on Aging; American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	Pew Charitable Trusts; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Carr reported being a senior policy advisor for the Office of the Assistant Secretary for Preparedness and Response. Dr Pines reported working as a senior advisor for the Centers for Medicare & Medicaid Services Innovation Center during the writing of this article. Dr Ross reported receiving funding from the Centers for Medicare & Medicaid Services to develop and maintain performance measures that are used for public reporting; and receiving funding from the Pew Charitable Trusts to examine regulatory issues at the US Food and Drug Administration. Drs Ross and Gross reported receiving funding as collaborators on the Yale University Open Access project, which is facilitating the objective analysis of Medtronic clinical trial data. Drs Ross and Gross are members of a scientific advisory board for FAIR Health Inc. No other disclosures were reported.; Dr Carr is supported by career development award K08 AG032886 from the Agency for Healthcare Research and Quality. Dr Ross is supported by the National Institute on Aging and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program.	Abarca F, 2011, AM SURGEON, V77, P65; Baer RB, 2001, ACAD EMERG MED, V8, P1091, DOI 10.1111/j.1553-2712.2001.tb01121.x; Brousseau DC, 2010, JAMA-J AM MED ASSOC, V303, P1288, DOI 10.1001/jama.2010.378; Brown R, RES DESIGN EVALUATIO; Bundled Payments for Care Improvement (BPCI) Initiative: General Information, BUNDL PAYM CAR IMPR; Burt Catharine W, 2008, Natl Health Stat Report, P1; Clark SL, 2010, AM J OBSTET GYNECOL, V203, pe1, DOI DOI 10.1155/2012/252676.5.K0REN; Clark SL, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.033; Coleman E A, 2001, Eff Clin Pract, V4, P49; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Coleman Eric A, 2007, Home Health Care Serv Q, V26, P93, DOI 10.1300/J027v26n04_07; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Friedman B, 2009, MED CARE, V47, P583, DOI 10.1097/MLR.0b013e31819434da; Goodman DC, 2011, HOSPITALIZATION DART; Harrison PL, 2011, POPUL HEALTH MANAG, V14, P27, DOI 10.1089/pop.2009.0076; Healthcare Cost and Utilization Project, STAT PAT DAT; Healthcare Cost and Utilization Project, STAT EM DEP DAT; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; Lautz TB, 2011, J PEDIATR SURG, V46, P1918, DOI 10.1016/j.jpedsurg.2011.04.012; Legrain S, 2011, J AM GERIATR SOC, V59, P2017, DOI 10.1111/j.1532-5415.2011.03628.x; Martin RCG, 2011, ANN SURG, V254, P591, DOI 10.1097/SLA.0b013e3182300a38; McCall N, 2010, EVALUATION MEDICARE; Morse RB, 2011, JAMA-J AM MED ASSOC, V306, P1454, DOI 10.1001/jama.2011.1385; Naylor MD, 2012, HEALTH AFFAIR, V31, P1623, DOI 10.1377/hlthaff.2012.0110; Peikes D, C EV MED COORD CAR D; Practice Management Information Corporation, 2005, INT CLASS DIS; Sharma G, 2010, ARCH INTERN MED, V170, P1664, DOI 10.1001/archinternmed.2010.345; Sommers A, 2011, PHYS VISITS HOSP DIS; Stone J, 2010, C MED HOSP READM ISS; US Department of Health and Human Services, PARTN PAT BETT CAR L	32	140	140	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					364	371		10.1001/jama.2012.216219	http://dx.doi.org/10.1001/jama.2012.216219			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074FT	23340638	Green Accepted, Bronze			2022-12-24	WOS:000313799000024
J	Lee, AM; Kanter, BR; Wang, D; Lim, JP; Zou, ME; Qiu, CC; McMahon, T; Dadgar, J; Fischbach-Weiss, SC; Messing, RO				Lee, Anna M.; Kanter, Benjamin R.; Wang, Dan; Lim, Jana P.; Zou, Mimi E.; Qiu, Chichen; McMahon, Thomas; Dadgar, Jahan; Fischbach-Weiss, Sarah C.; Messing, Robert O.			Prkcz null mice show normal learning and memory	NATURE			English	Article							KINASE M-ZETA; ANXIETY-LIKE BEHAVIOR; PKM-ZETA; DRUG REWARD; C-ZETA; MECHANISM; INHIBITION; PREFERENCE; 3-KINASE	Protein kinase M-zeta (PKM-zeta) is a constitutively active form of atypical protein kinase C that is exclusively expressed in the brain and implicated in the maintenance of long-term memory(1-9). Most studies that support a role for PKM-zeta in memory maintenance have used pharmacological PKM-zeta inhibitors such as the myristoylated zeta inhibitory peptide (ZIP) or chelerythrine. Here we use a genetic approach and target exon 9 of the Prkcz gene to generate mice that lack both protein kinase C-zeta (PKC-zeta) and PKM-zeta (Prkcz(-/-) mice). Prkcz(-/-) mice showed normal behaviour in a cage environment and in baseline tests of motor function and sensory perception, but displayed reduced anxiety-like behaviour. Notably, Prkcz(-/-) mice did not show deficits in learning or memory in tests of cued fear conditioning, novel object recognition, object location recognition, conditioned place preference for cocaine, or motor learning, when compared with wild-type littermates. ZIP injection into the nucleus accumbens reduced expression of cocaine-conditioned place preference in Prkcz(-/-) mice. In vitro, ZIP and scrambled ZIP inhibited PKM-zeta, PKC-iota and PKC-zeta with similar inhibition constant (K-i) values. Chelerythrine was a weak inhibitor of PKM-zeta (K-i = 76 mu M). Our findings show that absence of PKM-zeta does not impair learning and memory in mice, and that ZIP can erase reward memory even when PKM-zeta is not present.	[Lee, Anna M.; Kanter, Benjamin R.; Wang, Dan; Lim, Jana P.; Zou, Mimi E.; Qiu, Chichen; McMahon, Thomas; Dadgar, Jahan; Fischbach-Weiss, Sarah C.; Messing, Robert O.] Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Messing, RO (corresponding author), Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.	romes@gallo.ucsf.edu	Kanter, Benjamin R./AAA-4781-2022; Messing, Robert/D-3642-2015; Lee, Anna/AAH-4598-2020	Messing, Robert/0000-0002-5345-4431; Lee, Anna/0000-0003-4551-0082; Kanter, Benjamin/0000-0003-4114-090X	National Institutes of Health [AA017072]; Canadian Institute of Health Research; State of California for medical research on alcohol and drug abuse; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA017072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); State of California for medical research on alcohol and drug abuse; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank V. N. Kharazia and A. J. Lean for assistance. This work was supported by National Institutes of Health grant AA017072 (R.O.M.), a Canadian Institute of Health Research Post-doctoral Fellowship (A. M. L.), and funds provided by the State of California for medical research on alcohol and drug abuse to UCSF.	Brabant C, 2005, PSYCHOPHARMACOLOGY, V180, P33, DOI 10.1007/s00213-004-2138-6; Chen J, 2007, GENES BRAIN BEHAV, V6, P776, DOI 10.1111/j.1601-183X.2007.00311.x; Choi DS, 2002, J NEUROSCI, V22, P9905; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Hardt O, 2010, HIPPOCAMPUS, V20, P691, DOI 10.1002/hipo.20708; He YY, 2011, NEUROPSYCHOPHARMACOL, V36, P1972, DOI 10.1038/npp.2011.63; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Hodge CW, 2002, J CLIN INVEST, V110, P1003, DOI 10.1172/JCI200215903; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Li YQ, 2011, J NEUROSCI, V31, P5436, DOI 10.1523/JNEUROSCI.5884-10.2011; Lisman J, 2012, HIPPOCAMPUS, V22, P648, DOI 10.1002/hipo.20980; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Naik MU, 2000, J COMP NEUROL, V426, P243, DOI 10.1002/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Parsons RG, 2011, NAT NEUROSCI, V14, P295, DOI 10.1038/nn.2745; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shabashov D, 2012, J MOL NEUROSCI, V47, P546, DOI 10.1007/s12031-011-9671-7; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Wu-Zhang AX, 2012, J BIOL CHEM, V287, P12879, DOI 10.1074/jbc.M112.357244; Yao YD, 2013, NEUROPHARMACOLOGY, V64, P37, DOI 10.1016/j.neuropharm.2012.07.018	24	175	177	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					416	U163		10.1038/nature11803	http://dx.doi.org/10.1038/nature11803			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23283171	Green Accepted			2022-12-24	WOS:000313615900054
J	Hodder, SL; Justman, J; Hughes, JP; Wang, J; Haley, DF; Adimora, AA; Del Rio, C; Golin, CE; Kuo, I; Rompalo, A; Soto-Torres, L; Mannheimer, SB; Johnson-Lewis, L; Eshleman, SH; El-Sadr, WM				Hodder, Sally L.; Justman, Jessica; Hughes, James P.; Wang, Jing; Haley, Danielle F.; Adimora, Adaora A.; Del Rio, Carlos; Golin, Carol E.; Kuo, Irene; Rompalo, Anne; Soto-Torres, Lydia; Mannheimer, Sharon B.; Johnson-Lewis, LeTanya; Eshleman, Susan H.; El-Sadr, Wafaa M.		Womens HIV SeroIncidence Study	HIV Acquisition Among Women From Selected Areas of the United States A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							BEHAVIORAL SURVEILLANCE; RISK; MEN; SEX; INFECTION; BIAS	Background: Women account for 23% of newly diagnosed HIV infections in the United States, but there are few recent, well-characterized cohorts of U. S. women in whom behavior characteristics and HIV acquisition have been well-described. Objective: To evaluate HIV incidence and describe behaviors among U. S. women residing in areas of high HIV prevalence. Design: Multisite, longitudinal cohort of women who had HIV rapid testing and audio computer-assisted self-interviews at baseline and every 6 months for up to 12 months. (ClinicalTrials.gov: NCT00995176) Setting: 10 urban and periurban communities with high HIV prevalence and poverty rates, located in the northeastern and southeastern United States. Patients: Venue-based sampling was used to recruit women aged 18 to 44 years who recently had unprotected sex and had 1 or more additional personal or partner risk factors and no self-reported previous HIV diagnosis. Measurements: HIV prevalence and incidence, frequency of HIV risk behaviors, and health status perceptions. Results: Among 2099 high-risk women (85.9% black and 11.7% of Hispanic ethnicity), 32 (1.5%) were diagnosed with HIV infection at enrollment. Annual HIV incidence was 0.32% (95% CI, 0.14% to 0.74%). Older age, substance use, and knowing a partner had HIV were associated with HIV prevalence. Ten women died during the study (0.61% per year). Limitations: Longitudinal assessment of risk behaviors was limited to a maximum of 12 months. There were few incident HIV infections, precluding identification of characteristics predictive of HIV acquisition. Conclusion: This study enrolled a cohort of women with HIV incidence substantially higher than the Centers for Disease Control and Prevention national estimate in the general population of U. S. black women. Concerted efforts to improve preventive health care strategies for HIV and overall health status are needed for similar populations. Primary Funding Source: National Institutes of Health. Ann Intern Med. 2013;158:10-18.	[Hodder, Sally L.] Univ Med & Dent New Jersey, Dept Med, Div Infect Dis, Newark, NJ 07101 USA; Columbia Univ, Coll Phys & Surg, Int AIDS Care & Treatment Program, Joseph L Mailman Sch Publ Hlth, New York, NY USA; Columbia Univ Coll Phys & Surg, Harlem Hosp Ctr, New York, NY 10032 USA; Univ Washington, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; FHI 360, Durham, NC USA; Univ N Carolina, Sch Med, Chapel Hill, NC USA; Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; Emory Univ, Ctr AIDS Res, Atlanta, GA 30322 USA; George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; NIAID, NIH, Bethesda, MD 20892 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Columbia University; Columbia University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; FHI 360; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Emory University; Rollins School Public Health; Emory University; George Washington University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hodder, SL (corresponding author), Univ Med & Dent New Jersey, Dept Med, Div Infect Dis, 185 S Orange Ave,MSB I-506, Newark, NJ 07101 USA.	hoddersa@umdnj.edu	del Rio, Carlos/B-3763-2012; Justman, Jessica/AAA-3572-2020	del Rio, Carlos/0000-0002-0153-3517; 	National Institutes of Health; National Institute of Allergy and Infectious Diseases [UM1 AI068619, U01-AI068613, UM1-AI068613]; National Institute on Drug Abuse [UM1 AI068619, U01-AI068613, UM1-AI068613]; National Institute of Mental Health [UM1 AI068619, U01-AI068613, UM1-AI068613]; Centers for Innovative Research to Control AIDS, Mailman School of Public Health, Columbia University [5UM1A1069466]; University of North Carolina Clinical Trials Unit [AI069423]; University of North Carolina Clinical Trials Research Center of the Clinical and Translational Science Award [RR 025747]; University of North Carolina Center for AIDS Research [AI050410]; Emory University HIV/AIDS Clinical Trials Unit [5UO1AI069418]; Center for AIDS Research [P30 AI050409]; Clinical and Translational Science Award [UL1 RR025008, ULI RR025008]; Johns Hopkins Adult AIDS Clinical Trials Unit [AI069465]; Johns Hopkins Clinical and Translational Science Award [ULI RR025005]; Terry Beirn Community Programs for Clinical Research on AIDS Clinical Trials Unit; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008, UL1RR025747, UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069466, U01AI069418, U01AI068613, P30AI050410, UM1AI068613, U01AI069423, UM1AI069465, P30AI050409, UM1AI069423, U01AI069484, U01AI069465, UM1AI068619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Centers for Innovative Research to Control AIDS, Mailman School of Public Health, Columbia University; University of North Carolina Clinical Trials Unit; University of North Carolina Clinical Trials Research Center of the Clinical and Translational Science Award; University of North Carolina Center for AIDS Research; Emory University HIV/AIDS Clinical Trials Unit; Center for AIDS Research; Clinical and Translational Science Award; Johns Hopkins Adult AIDS Clinical Trials Unit; Johns Hopkins Clinical and Translational Science Award; Terry Beirn Community Programs for Clinical Research on AIDS Clinical Trials Unit; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health.; Grant Support: By the National Institute of Allergy and Infectious Diseases, National Institute on Drug Abuse, and National Institute of Mental Health (cooperative agreement UM1 AI068619, U01-AI068613, and UM1-AI068613); Centers for Innovative Research to Control AIDS, Mailman School of Public Health, Columbia University (5UM1A1069466); University of North Carolina Clinical Trials Unit (AI069423); University of North Carolina Clinical Trials Research Center of the Clinical and Translational Science Award (RR 025747); University of North Carolina Center for AIDS Research (AI050410); Emory University HIV/AIDS Clinical Trials Unit (5UO1AI069418), Center for AIDS Research (P30 AI050409), and Clinical and Translational Science Award (UL1 RR025008); Johns Hopkins Adult AIDS Clinical Trials Unit (AI069465) and Clinical and Translational Science Award (ULI RR025008); Johns Hopkins Clinical and Translational Science Award (ULI RR025005); and The Terry Beirn Community Programs for Clinical Research on AIDS Clinical Trials Unit.	Allen DR, 2009, PUBLIC HEALTH REP, V124, P26, DOI 10.1177/003335490912400106; Brookmeyer R, 1997, J ROY STAT SOC A STA, V160, P127, DOI 10.1111/1467-985X.00049; Centers for Disease Control and Prevention, 2011, HIV WOM; Centers for Disease Control and Prevention, HIV SURV WOM; DeNavas-Walt C., 2009, CURRENT POPULATION R, P60; DiClemente RJ, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e85; Dr Hodder, 1985, DROP; El-Sadr WM, 2010, NEW ENGL J MED, V362, P967, DOI 10.1056/NEJMp1000069; Eshleman SH, 2013, J INFECT DI IN PRESS; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Gallagher KM, 2007, PUBLIC HEALTH REP, V122, P32, DOI 10.1177/00333549071220S106; Haley D.F., ADM TECHNICAL LOGIST; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hodder L., OBTAINING FUNDING; Hodder S.L., PROVISION STUDY MAT; Hodder S.L., CRITICAL REVISION AR; Hodder S.L., DRAFTING ARTICLE; Hodder S.L., CONCEPTION DESIGN; Hodder S.L., ANAL INTERPRETATION; Hodder SL, 2010, JAIDS-J ACQ IMM DEF, V55, pS69, DOI 10.1097/QAI.0b013e3181fbbdf9; Laeyendecker O, 2013, J INFECT DI IN PRESS; LOCKE SE, 1992, JAMA-J AM MED ASSOC, V268, P1301, DOI 10.1001/jama.268.10.1301; MacKellar D, 1996, PUBLIC HEALTH REP, V111, P138; Masciotra S, 2010, 17 C RETR OPP INF SA; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Muhib FB, 2001, PUBLIC HEALTH REP, V116, P216, DOI 10.1093/phr/116.S1.216; Murphy SL, 2012, NATL VITAL STAT REPO, P60; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; UNAIDS, 2010, GLOB REP UNAIDS REP	34	73	74	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2013	158	1					10	U53		10.7326/0003-4819-158-1-201301010-00004	http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	065AV	23277896	Green Accepted			2022-12-24	WOS:000313119900003
J	Godlee, F				Godlee, Fiona			Withdraw approval for Tamiflu until NICE has full data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEURAMINIDASE INHIBITORS; METAANALYSIS; INFLUENZA					fgodlee@bmj.com						Burch J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13580; Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4848; Cohen D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5387; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5164; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Godlee F., 2009, BMJ-BRIT MED J, V338, pb463; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Smith J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5374; Turner David, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7350	9	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2012	345								e8415	10.1136/bmj.e8415	http://dx.doi.org/10.1136/bmj.e8415			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056MU	23236047				2022-12-24	WOS:000312495100017
J	Kumar, S				Kumar, Subrat			Extinction need not be forever	NATURE			English	Editorial Material									KIIT Univ, Sch Biotechnol, Bhubaneswar, India	Kalinga Institute of Industrial Technology (KIIT)	Kumar, S (corresponding author), KIIT Univ, Sch Biotechnol, Bhubaneswar, India.	subrat_kumar@yahoo.com	Kumar, Subrat/P-4225-2014	Kumar, Subrat/0000-0002-0659-6381					0	13	13	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2012	492	7427					9	9		10.1038/492009a	http://dx.doi.org/10.1038/492009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222570	Bronze			2022-12-24	WOS:000311893400014
J	Veronesi, G; Maisonneuve, P; Bellomi, M; Rampinelli, C; Durli, I; Bertolotti, R; Spaggiari, L				Veronesi, Giulia; Maisonneuve, Patrick; Bellomi, Massimo; Rampinelli, Cristiano; Durli, Iara; Bertolotti, Raffaella; Spaggiari, Lorenzo			Estimating Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							HIGH-RISK INDIVIDUALS; NATURAL-HISTORY; GROWTH-RATES; CT; STAGE; TRIAL; CARCINOMA; NODULES; DESIGN; MODEL	Background: Lung cancer screening may detect cancer that will never become symptomatic (overdiagnosis), leading to overtreatment. Changes in size on sequential low-dose computed tomography (LDCT) screening, expressed as volume-doubling time (VDT), may help to distinguish aggressive cancer from cases that are unlikely to become symptomatic. Objective: To assess VDT for screening-detected lung cancer as an indicator of overdiagnosis. Design: Retrospective estimation of the VDT of cancer detected in a prospective LDCT screening cohort. Setting: Nonrandomized, single-center screening study involving persons at high risk for lung cancer enrolled between 2004 and 2005 who received LDCT annually for 5 years. Patients: 175 study patients diagnosed with primary lung cancer. Measurements: VDT was measured on LDCT and classified as fast-growing (<400 days), slow-growing (between 400 and 599 days), or indolent (>= 600 days). Results: Fifty-five cases of cancer were diagnosed at baseline, and 120 were diagnosed subsequently. Of the latter group, 19 cases (15.8%) were new (not visible on previous scans) and fast-growing (median VDT, 52 days); 101 (84.2%) were progressive, including 70 (58.3%) fast-growing and 31 (25.8%) slow-growing (15.0%) or indolent (10.8%) cases. Lung cancer-specific mortality was significantly higher (9.2% per year) in patients with new compared with slow-growing or indolent (0.9% per year) cancer. Sixty percent of fast-growing progressive cancer and 45% of new cancer were stage I, for which survival was good. Limitations: This is a retrospective study. Volume-doubling time can only indicate overdiagnosis and was estimated for new cancer from 1 measurement (a diameter of 2 mm assumed the previous year). Conclusion: Slow-growing or indolent cancer comprised approximately 25% of incident cases, many of which may have been overdiagnosed. To limit overtreatment in these cases, minimally invasive limited resection and nonsurgical treatments should be investigated.	[Veronesi, Giulia] European Inst Oncol, Div Thorac Surg, I-20141 Milan, Italy; Univ Milan, Sch Med, Milan, Italy	IRCCS European Institute of Oncology (IEO); University of Milan	Veronesi, G (corresponding author), European Inst Oncol, Div Thorac Surg, Via Ripamonti 435, I-20141 Milan, Italy.	giulia.veronesi@ieo.it	Maisonneuve, Patrick/U-9789-2018; Veronesi, Giulia/AAA-6327-2021; Spaggiari, Lorenzo/G-7915-2012; Bellomi, Massimo/AAM-4352-2020; Bertolotti, Raffaella/AAO-4674-2020	Maisonneuve, Patrick/0000-0002-5309-4704; Veronesi, Giulia/0000-0001-9032-1278; Spaggiari, Lorenzo/0000-0002-1068-3541	Italian Association for Cancer Research	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	By the Italian Association for Cancer Research.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Altorki N, 2010, J CLIN ONCOL, V28, P3131, DOI 10.1200/JCO.2009.23.9749; Bach PB, 2008, LANCET ONCOL, V9, P693, DOI 10.1016/S1470-2045(08)70176-1; Baldwin DR, 2011, THORAX, V66, P308, DOI 10.1136/thx.2010.152066; Beadsmoore CJ, 2003, EUR J RADIOL, V45, P8, DOI 10.1016/S0720-048X(02)00287-5; Berland Lincoln L, 2009, J Am Coll Radiol, V6, P14, DOI 10.1016/j.jacr.2008.06.018; Bianchi F, 2011, EMBO MOL MED, V3, P495, DOI 10.1002/emmm.201100154; Carpagnano GE, 2008, AM J RESP CRIT CARE, V177, P337, DOI 10.1164/rccm.200707-1136OC; Detterbeck FC, 2008, J THORAC ONCOL, V3, P781, DOI 10.1097/JTO.0b013e31817c9230; Diederich S, 2004, EUR RADIOL, V14, P691, DOI 10.1007/s00330-003-2200-5; Fan J, 2012, ANN SURG ONCOL, V19, P661, DOI 10.1245/s10434-011-1931-9; Field JK, 2012, J THORAC ONCOL, V7, P10, DOI 10.1097/JTO.0b013e31823c58ab; FONTANA RS, 1991, CANCER-AM CANCER SOC, V67, P1155, DOI 10.1002/1097-0142(19910215)67:4+<1155::AID-CNCR2820671509>3.0.CO;2-0; Friberg S, 1997, J SURG ONCOL, V65, P284, DOI 10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2; GEDDES DM, 1979, BRIT J DIS CHEST, V73, P1, DOI 10.1016/0007-0971(79)90002-0; HARACH HR, 1985, CANCER, V56, P531, DOI DOI 10.1002/1097-0142(19850801)56:3!; Hasegawa M, 2000, BRIT J RADIOL, V73, P1252, DOI 10.1259/bjr.73.876.11205667; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Henschke CI, 2011, LUNG CANCER, V71, P328, DOI 10.1016/j.lungcan.2010.10.025; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Leo F, 1999, THORAC CARDIOV SURG, V47, P53, DOI 10.1055/s-2007-1013110; Lindell RM, 2009, CHEST, V136, P1586, DOI 10.1378/chest.09-0915; Maisonneuve P, 2011, CANCER PREV RES, V4, P1778, DOI 10.1158/1940-6207.CAPR-11-0026; McMahon PM, 2008, RADIOLOGY, V248, P278, DOI 10.1148/radiol.2481071446; Mulshine JL, 2005, NEW ENGL J MED, V352, P2714, DOI 10.1056/NEJMcp042630; Nakamura K, 2010, JPN J CLIN ONCOL, V40, P271, DOI 10.1093/jjco/hyp156; Pedersen Jesper H, 2009, J Thorac Oncol, V4, P608, DOI 10.1097/JTO.0b013e3181a0d98f; Raz DJ, 2007, CHEST, V132, P193, DOI 10.1378/chest.06-3096; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sone S, 2000, BRIT J RADIOL, V73, P137, DOI 10.1259/bjr.73.866.10884725; Swensen SJ, 2003, RADIOLOGY, V226, P756, DOI 10.1148/radiol.2263020036; USUDA K, 1994, CANCER, V74, P2239, DOI 10.1002/1097-0142(19941015)74:8<2239::AID-CNCR2820740806>3.0.CO;2-P; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; Veronesi G, 2010, ECANCERMEDICALSCIENC, V4, DOI 10.3332/ecancer.2010.186; Veronesi G, 2008, LUNG CANCER, V61, P340, DOI 10.1016/j.lungcan.2008.01.001; Veronesi G, 2008, J THORAC CARDIOV SUR, V136, P611, DOI 10.1016/j.jtcvs.2008.02.082; Veronesi G, 2011, J THORAC ONCOL, V6, P525, DOI 10.1097/JTO.0b013e318206dbcc; Veronesi G, 2011, CANCER PREV RES, V4, P34, DOI 10.1158/1940-6207.CAPR-10-0182; Veronesi G, 2010, J THORAC CARDIOV SUR, V140, P19, DOI 10.1016/j.jtcvs.2009.10.025; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Whitson BA, 2008, ANN THORAC SURG, V86, P2008, DOI 10.1016/j.athoracsur.2008.07.009; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251; Yankelevitz DF, 2003, CANCER, V97, P1271, DOI 10.1002/cncr.11185; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zhong L, 2005, AM J RESP CRIT CARE, V172, P1308, DOI 10.1164/rccm.200505-830OC	45	128	135	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2012	157	11					776	+		10.7326/0003-4819-157-11-201212040-00005	http://dx.doi.org/10.7326/0003-4819-157-11-201212040-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	049RC	23208167				2022-12-24	WOS:000312000100003
J	Abbas, YM; Pichmair, A; Gorna, MW; Superti-Furga, G; Nagar, B				Abbas, Yazan M.; Pichmair, Andreas; Gorna, Maria W.; Superti-Furga, Giulio; Nagar, Bhushan			Structural basis for viral 5 '-PPP-RNA recognition by human IFIT proteins	NATURE			English	Article							RIG-I; PATTERN-RECOGNITION; CRYSTAL-STRUCTURE; RNA RECOGNITION; STRANDED-RNA; ACTIVATION; INSIGHTS; ISG54	Interferon-induced proteins with tetratricopeptide repeats (IFITs) are innate immune effector molecules that are thought to confer antiviral defence through disruption of protein-protein interactions in the host translation-initiation machinery. However, it was recently discovered that IFITs can directly recognize viral RNA bearing a 5'-triphosphate group (PPP-RNA), which is a molecular signature that distinguishes it from host RNA. Here we report crystal structures of human IFIT5, its complex with PPP-RNAs, and an amino-terminal fragment of IFIT1. The structures reveal a new helical domain that houses a positively charged cavity designed to specifically engage only single-stranded PPP-RNA, thus, distinguishing it from the canonical cytosolic sensor of double-stranded viral PPP-RNA, retinoic acid-inducible gene I (RIG-I, also known as DDX58). Mutational analysis, proteolysis and gel-shift assays reveal that PPP-RNA is bound in a non-sequence-specific manner and requires a 5'-overhang of approximately three nucleotides. Abrogation of PPP-RNA binding in Inn and IFIT5 was found to cause a defect in the antiviral response by human embryonic kidney cells. These results demonstrate the mechanism by which IFIT proteins selectively recognize viral RNA, and lend insight into their downstream effector function.	[Abbas, Yazan M.; Nagar, Bhushan] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Abbas, Yazan M.; Nagar, Bhushan] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Pichmair, Andreas; Gorna, Maria W.; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Pichmair, Andreas] Max Planck Inst Biochem, D-82152 Martinsried, Germany	McGill University; McGill University; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Max Planck Society	Nagar, B (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada.	gsuperti@cemm.oeaw.ac.at; bhushan.nagar@mcgill.ca	Górna, Maria/F-4269-2014; Superti-Furga, Giulio/AAE-5681-2019; Superti-Furga, Giulio/F-4755-2015	Górna, Maria/0000-0002-1769-4542; Superti-Furga, Giulio/0000-0002-0570-1768	Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research (CIHR) [MOP-82929]; Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan; Canada Research Chair; Career Development Award from the Human Frontiers Science Program [CDA 0018/2006-C/1]; Austrian Academy of Sciences; i-FIVE ERC grant; EMBO [ATLF 463-2008]; CIHR Strategic Training Initiative in Chemical Biology	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Career Development Award from the Human Frontiers Science Program; Austrian Academy of Sciences; i-FIVE ERC grant; EMBO(European Molecular Biology Organization (EMBO)); CIHR Strategic Training Initiative in Chemical Biology(Canadian Institutes of Health Research (CIHR))	We thank S. Labiuk and P. Grochulski for X-ray data collection performed on beamline 08ID-1 at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research (CIHR), the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. Thanks also to all laboratory members for discussions and technical assistance. B.N. is supported by a Canada Research Chair, a Career Development Award from the Human Frontiers Science Program (CDA 0018/2006-C/1) and an operating grant from the CIHR (CIHR grant MOP-82929). Work in the G.S.-F. laboratory is funded by the Austrian Academy of Sciences and the i-FIVE ERC grant. A.P. is an EMBO Long-Term Fellowship recipient (ATLF 463-2008). Y.M.A. was supported by the CIHR Strategic Training Initiative in Chemical Biology.	Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Xiao SH, 2002, ANNU REV BIOCHEM, V71, P165, DOI 10.1146/annurev.biochem.71.110601.135352; Yang ZL, 2012, CELL RES, V22, P1328, DOI 10.1038/cr.2012.111; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	28	160	167	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					60	64		10.1038/nature11783	http://dx.doi.org/10.1038/nature11783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23334420	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000314741200033
J	Krumholz, HM				Krumholz, Harlan M.			Post-Hospital Syndrome - An Acquired, Transient Condition of Generalized Risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							READMISSION		[Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA.		, Harlan/AAI-2875-2020; Martin, Carmel Mary/B-6358-2011	Martin, Carmel Mary/0000-0001-8174-7859	NHLBI NIH HHS [U01 HL105270] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Friedmann JM, 1997, AM J CLIN NUTR, V65, P1714, DOI 10.1093/ajcn/65.6.1714; Jencks SF, 2009, NEW ENGL J MED, V360, P1418; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515	3	752	759	3	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					100	102		10.1056/NEJMp1212324	http://dx.doi.org/10.1056/NEJMp1212324			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066RO	23301730	Green Accepted			2022-12-24	WOS:000313238100013
J	Yancey, AK; Sallis, RE; Bastani, R				Yancey, Antronette K.; Sallis, Robert E.; Bastani, Roshan			Changing Physical Activity Participation for the Medical Profession	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WALKING; TALK; CARE		[Yancey, Antronette K.; Bastani, Roshan] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA 90095 USA; [Yancey, Antronette K.; Bastani, Roshan] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Div Canc Prevent & Control Res, Los Angeles, CA 90095 USA; [Yancey, Antronette K.; Bastani, Roshan] Univ Calif Los Angeles, Kaiser Permanente Ctr Hlth Equ, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Kaiser Permanente; University of California System; University of California Los Angeles	Yancey, AK (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, 650 Charles Young Dr,South Room 31-235 CHS, Los Angeles, CA 90095 USA.	ayancey@ucla.edu						Barr-Anderson DJ, 2011, AM J PREV MED, V40, P76, DOI 10.1016/j.amepre.2010.09.033; Bleich SN, 2012, OBESITY, V20, P999, DOI 10.1038/oby.2011.402; Boyle M, 2009, PEDIATRICS, V123, pS293, DOI 10.1542/peds.2008-2780H; Collins L, 2005, J NUTR EDUC BEHAV, V37, pS121, DOI 10.1016/S1499-4046(06)60212-1; Crawford PB, 2004, AM J PUBLIC HEALTH, V94, P1480, DOI 10.2105/AJPH.94.9.1480; Frank Erica, 2003, J Am Med Womens Assoc (1972), V58, P178; Frank E, 2009, CAN FAM PHYSICIAN, V55, P810; Lesser LI, 2012, JAMA-J AM MED ASSOC, V308, P983, DOI 10.1001/2012.jama.10427; Yancey AK, 2010, INSTANT RECESS BUILD	9	11	11	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2013	309	2					141	142		10.1001/jama.2012.127989	http://dx.doi.org/10.1001/jama.2012.127989			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070NW	23299602				2022-12-24	WOS:000313517000019
J	Helm, D				Helm, Dieter			The Kyoto approach has failed	NATURE			English	Editorial Material									Univ Oxford, New Coll, Oxford OX1 2JD, England	University of Oxford	Helm, D (corresponding author), Univ Oxford, New Coll, Oxford OX1 2JD, England.	dieter.helm@new.ox.ac.uk						[Anonymous], 2011, MED TERM COAL MARK R; BP, 2021, BPS STAT REV WORLD E; European Commission, 2008, 20 20 2020 EUR CLIM; European Parliament and the Council of the European Union, 2003, OFF J EUR UNION, VL275, P32; Helm D., 2007, TOO GOOD BE TRUE UKS; Helm D., 2012, 80 GRANTH RES I CLIM; Helm D., 2012, CARBON CRUNCH WERE G, P40; MacKay D., 2008, SUSTAINABLE ENERGY H; US Energy Information Administration, 2012, MONTHLY ENERGY R OCT	9	25	26	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					663	665		10.1038/491663a	http://dx.doi.org/10.1038/491663a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	044FY	23192129	Bronze			2022-12-24	WOS:000311606000016
J	Maddocks, ODK; Berkers, CR; Mason, SM; Zheng, L; Blyth, K; Gottlieb, E; Vousden, KH				Maddocks, Oliver D. K.; Berkers, Celia R.; Mason, Susan M.; Zheng, Liang; Blyth, Karen; Gottlieb, Eyal; Vousden, Karen H.			Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells	NATURE			English	Article							PYRUVATE-KINASE M2; P53-INDUCIBLE REGULATOR; RETINOBLASTOMA PROTEIN; CYCLE ARREST; DNA-DAMAGE; P53; APOPTOSIS; GLYCINE; TUMORS; MICE	Cancer cells acquire distinct metabolic adaptations to survive stress associated with tumour growth and to satisfy the anabolic demands of proliferation. The tumour suppressor protein p53 (also known as TP53) influences a range of cellular metabolic processes, including glycolysis(1,2), oxidative phosphorylation(3), glutaminolysis(4,5) and anti-oxidant response(6). In contrast to its role in promoting apoptosis during DNA-damaging stress, p53 can promote cell survival during metabolic stress(7), a function that may contribute not only to tumour suppression but also to non-cancer-associated functions of p53(8). Here we show that human cancer cells rapidly use exogenous serine and that serine deprivation triggered activation of the serine synthesis pathway and rapidly suppressed aerobic glycolysis, resulting in an increased flux to the tricarboxylic acid cycle. Transient p53-p21 (also known as CDKN1A) activation and cell-cycle arrest promoted cell survival by efficiently channelling depleted serine stores to glutathione synthesis, thus preserving cellular anti-oxidant capacity. Cells lacking p53 failed to complete the response to serine depletion, resulting in oxidative stress, reduced viability and severely impaired proliferation. The role of p53 in supporting cancer cell proliferation under serine starvation was translated to an in vivo model, indicating that serine depletion has a potential role in the treatment of p53-deficient tumours.	[Maddocks, Oliver D. K.; Berkers, Celia R.; Mason, Susan M.; Zheng, Liang; Blyth, Karen; Gottlieb, Eyal; Vousden, Karen H.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Vousden, KH (corresponding author), Beatson Inst Canc Res, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.vousden@beatson.gla.ac.uk	Gottlieb, Eyal/G-6450-2010; Berkers, Celia/I-3848-2016; Maddocks, Oliver/K-5410-2012	Gottlieb, Eyal/0000-0002-9770-0956; Maddocks, Oliver/0000-0002-5551-9091; Blyth, Karen/0000-0002-9304-439X; Berkers, Celia/0000-0003-0746-8565; Mason, Susan/0000-0002-3327-7693; Zheng, Liang/0000-0002-5346-4111	Cancer Research UK; Netherlands Organisation for Scientific Research	Cancer Research UK(Cancer Research UK); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was funded by Cancer Research UK. C. R. B. is a recipient of a Rubicon Fellowship from the Netherlands Organisation for Scientific Research. The authors thank A. Vigneron, B. Chaneton, M. O'Prey, E. Cheung, D. Athineos, G. Kalna, G. Mackay and B. Ludwig for advice and technical assistance.	ALMASAN A, 1995, P NATL ACAD SCI USA, V92, P5436, DOI 10.1073/pnas.92.12.5436; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dimri GP, 1996, MOL CELL BIOL, V16, P2987; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Gruning NM, 2011, NATURE, V480, P190, DOI 10.1038/480190a; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kalhan SC, 2012, J BIOL CHEM, V287, P19786, DOI 10.1074/jbc.R112.357194; Kondoh H, 2005, CANCER RES, V65, P177; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Locasale JW, 2011, CELL CYCLE, V10, P3812, DOI 10.4161/cc.10.22.18224; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Messina E, 2004, INT J CANCER, V108, P812, DOI 10.1002/ijc.11642; Okamura S, 1999, ONCOL RES, V11, P281; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Rose ML, 1999, CARCINOGENESIS, V20, P2075, DOI 10.1093/carcin/20.11.2075; Rose ML, 1999, CARCINOGENESIS, V20, P793, DOI 10.1093/carcin/20.5.793; SNELL K, 1986, TRENDS BIOCHEM SCI, V11, P241, DOI 10.1016/0968-0004(86)90184-2; SNELL K, 1990, ADV ENZYME REGUL, V30, P13; Stambolsky P, 2006, CELL DEATH DIFFER, V13, P2140, DOI 10.1038/sj.cdd.4401965; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Vigneron AM, 2010, GENE DEV, V24, P2430, DOI 10.1101/gad.1954310; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109	33	585	605	8	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2013	493	7433					542	+		10.1038/nature11743	http://dx.doi.org/10.1038/nature11743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23242140	Green Accepted			2022-12-24	WOS:000313871400040
J	Prasad, V; Jena, AB				Prasad, Vinay; Jena, Anupam B.			Prespecified Falsification End Points Can They Validate True Observational Associations?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FRACTURES; RISK		[Prasad, Vinay] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA; [Jena, Anupam B.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research	Jena, AB (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	jena@hcp.med.harvard.edu		Prasad, Vinayak/0000-0002-6110-8221				Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Cohen-Cole E, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2533; Ioannidis JPA, 2012, JAMA-J AM MED ASSOC, V308, P575, DOI 10.1001/jama.2012.8144; Jena AB, 2013, J GEN INTERN MED, V28, P223, DOI 10.1007/s11606-012-2211-5; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Park-Wyllie LY, 2011, JAMA-J AM MED ASSOC, V305, P783, DOI 10.1001/jama.2011.190; Thomas L, 2012, JAMA-J AM MED ASSOC, V308, P773, DOI 10.1001/jama.2012.9502	8	172	173	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2013	309	3					241	242		10.1001/jama.2012.96867	http://dx.doi.org/10.1001/jama.2012.96867			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070XG	23321761				2022-12-24	WOS:000313546800021
J	Lewandowski, B; De Bo, G; Ward, JW; Papmeyer, M; Kuschel, S; Aldegunde, MJ; Gramlich, PME; Heckmann, D; Goldup, SM; D'Souza, DM; Fernandes, AE; Leigh, DA				Lewandowski, Bartosz; De Bo, Guillaume; Ward, John W.; Papmeyer, Marcus; Kuschel, Sonja; Aldegunde, Maria J.; Gramlich, Philipp M. E.; Heckmann, Dominik; Goldup, Stephen M.; D'Souza, Daniel M.; Fernandes, Antony E.; Leigh, David A.			Sequence-Specific Peptide Synthesis by an Artificial Small-Molecule Machine	SCIENCE			English	Article							MULTISTEP ORGANIC-SYNTHESIS; RIBOSOME NOBEL LECTURE; CHEMICAL LIGATION; ANTIBIOTICS; ROTAXANES; CATALYSTS	The ribosome builds proteins by joining together amino acids in an order determined by messenger RNA. Here, we report on the design, synthesis, and operation of an artificial small-molecule machine that travels along a molecular strand, picking up amino acids that block its path, to synthesize a peptide in a sequence-specific manner. The chemical structure is based on a rotaxane, a molecular ring threaded onto a molecular axle. The ring carries a thiolate group that iteratively removes amino acids in order from the strand and transfers them to a peptide-elongation site through native chemical ligation. The synthesis is demonstrated with similar to 10(18) molecular machines acting in parallel; this process generates milligram quantities of a peptide with a single sequence confirmed by tandem mass spectrometry.	[Lewandowski, Bartosz; De Bo, Guillaume; Ward, John W.; Papmeyer, Marcus; Kuschel, Sonja; Leigh, David A.] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England; [Aldegunde, Maria J.; Gramlich, Philipp M. E.; Heckmann, Dominik; Goldup, Stephen M.; D'Souza, Daniel M.; Fernandes, Antony E.; Leigh, David A.] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland	University of Manchester; University of Edinburgh	Leigh, DA (corresponding author), Univ Manchester, Sch Chem, Oxford Rd, Manchester M13 9PL, Lancs, England.	david.leigh@manchester.ac.uk	De Bo, Guillaume/C-5861-2013; Ward, John/AAF-3691-2021; Leigh, David/K-5965-2015; Goldup, Stephen/F-1660-2011; Goldup, Stephen M/M-3136-2014	De Bo, Guillaume/0000-0003-2670-6370; Ward, John/0000-0001-7186-6416; Leigh, David/0000-0002-1202-4507; Goldup, Stephen/0000-0003-3781-0464; Goldup, Stephen M/0000-0003-3781-0464; Lewandowski, Bartosz/0000-0002-0342-4701; Fernandes, Antony/0000-0002-7993-2980	Engineering and Physical Sciences Research Council (UK); Fundacja na Rzecz Nauki Polskiej; Fonds de la Recherche Scientifique; Wallonie-Bruxelles International; European Union; Deutscher Akademischer Austausch Dienst; Deutsche Akademia der Naturforscher Leopoldina; Peter und Traudl Engelhorn-Stiftung; Engineering and Physical Sciences Research Council [EP/H021620/2, EP/H021620/1] Funding Source: researchfish; EPSRC [EP/H021620/1, EP/H021620/2] Funding Source: UKRI	Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Fundacja na Rzecz Nauki Polskiej; Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Wallonie-Bruxelles International; European Union(European Commission); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Akademia der Naturforscher Leopoldina; Peter und Traudl Engelhorn-Stiftung; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank V. Aucagne for useful suggestions during early versions of the molecular machine design. This research was funded by the Engineering and Physical Sciences Research Council (UK). We are grateful to the following organizations for postdoctoral fellowships: Fundacja na Rzecz Nauki Polskiej (to B. L.), Fonds de la Recherche Scientifique and Wallonie-Bruxelles International (to G. D. B.), the European Union 7th Framework Marie Curie Intra European Fellowship Program (to M.J.A.), Deutscher Akademischer Austausch Dienst (to P. M. E. G. and D. H.), and Deutsche Akademia der Naturforscher Leopoldina and Peter und Traudl Engelhorn-Stiftung (to D.M.D.).	Aucagne V, 2006, J AM CHEM SOC, V128, P2186, DOI 10.1021/ja056903f; Badi N, 2009, CHEM SOC REV, V38, P3383, DOI 10.1039/b806413j; Berg JM, 2006, BIOCHEMISTRY; Berna J, 2005, NAT MATER, V4, P704, DOI 10.1038/nmat1455; Blanco V, 2012, ANGEW CHEM INT EDIT, V51, P5166, DOI 10.1002/anie.201201364; Collier CP, 1999, SCIENCE, V285, P391, DOI 10.1126/science.285.5426.391; Crowley JD, 2009, CHEM SOC REV, V38, P1530, DOI 10.1039/b804243h; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Eelkema R, 2006, NATURE, V440, P163, DOI 10.1038/440163a; Green JE, 2007, NATURE, V445, P414, DOI 10.1038/nature05462; Gu HZ, 2010, NATURE, V465, P202, DOI 10.1038/nature09026; Hansen FK, 2011, ORG BIOMOL CHEM, V9, P7162, DOI 10.1039/c1ob05740e; He Y, 2011, J AM CHEM SOC, V133, P9972, DOI 10.1021/ja201361t; He Y, 2010, NAT NANOTECHNOL, V5, P778, DOI [10.1038/nnano.2010.190, 10.1038/NNANO.2010.190]; Juluri BK, 2009, ACS NANO, V3, P291, DOI 10.1021/nn8002373; Kay ER, 2007, ANGEW CHEM INT EDIT, V46, P72, DOI 10.1002/anie.200504313; McKee ML, 2012, J AM CHEM SOC, V134, P1446, DOI 10.1021/ja2101196; McKee ML, 2010, ANGEW CHEM INT EDIT, V49, P7948, DOI 10.1002/anie.201002721; Monnereau C, 2010, J AM CHEM SOC, V132, P1529, DOI 10.1021/ja908524x; Muraoka T, 2006, NATURE, V440, P512, DOI 10.1038/nature04635; Payne RJ, 2007, J AM CHEM SOC, V129, P13527, DOI 10.1021/ja073653p; Ramakrishnan V, 2010, ANGEW CHEM INT EDIT, V49, P4355, DOI 10.1002/anie.201001436; Schmittel M, 2012, ANGEW CHEM INT EDIT, V51, P3832, DOI 10.1002/anie.201108089; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Steitz TA, 2010, ANGEW CHEM INT EDIT, V49, P4381, DOI 10.1002/anie.201000708; Thordarson P, 2003, NATURE, V424, P915, DOI 10.1038/nature01925; Wang JB, 2011, SCIENCE, V331, P1429, DOI 10.1126/science.1199844; WURTHNER F, 1995, ANGEW CHEM INT EDIT, V34, P446, DOI 10.1002/anie.199504461; Yonath A, 2010, ANGEW CHEM INT EDIT, V49, P4340, DOI 10.1002/anie.201001297; Yoon HJ, 2010, SCIENCE, V330, P66, DOI 10.1126/science.1193928	30	520	527	11	581	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					189	193		10.1126/science.1229753	http://dx.doi.org/10.1126/science.1229753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307739	Green Submitted			2022-12-24	WOS:000313328200040
J	Clarke, PM; Walter, SJ; Hayen, A; Mallon, WJ; Heijmans, J; Studdert, DM				Clarke, Philip M.; Walter, Simon J.; Hayen, Andrew; Mallon, William J.; Heijmans, Jeroen; Studdert, David M.			Survival of the fittest: retrospective cohort study of the longevity of Olympic medallists in the modern era	BRITISH MEDICAL JOURNAL			English	Editorial Material							LEAGUE BASEBALL PLAYERS; PHYSICAL-ACTIVITY; LIFE EXPECTANCY; FOLLOW-UP; MORTALITY; HEALTH; EXPERIENCE; ACTORS	Objective To determine whether Olympic medallists live longer than the general population. Design Retrospective cohort study, with passive follow-up and conditional survival analysis to account for unidentified loss to follow-up. Setting and participants 15 174 Olympic athletes from nine country groups (United States, Germany, Nordic countries, Russia, United Kingdom, France, Italy, Canada, and Australia and New Zealand) who won medals in the Olympic Games held in 1896-2010. Medallists were compared with matched cohorts in the general population (by country, age, sex, and year of birth). Main outcome measures Relative conditional survival. Results More medallists than matched controls in the general population were alive 30 years after winning (relative conditional survival 1.08, 95% confidence interval 1.07 to 1.10). Medallists lived an average of 2.8 years longer than controls. Medallists in eight of the nine country groups had a significant survival advantage compared with controls. Gold, silver, and bronze medallists each enjoyed similar sized survival advantages. Medallists in endurance sports and mixed sports had a larger survival advantage over controls at 30 years (1.13, 1.09 to 1.17; 1.11, 1.09 to 1.13) than that of medallists in power sports (1.05, 1.01 to 1.08). Conclusions Olympic medallists live longer than the general population, irrespective of country, medal, or sport. This study was not designed to explain this effect, but possible explanations include genetic factors, physical activity, healthy lifestyle, and the wealth and status that come with international sporting glory.	[Clarke, Philip M.; Walter, Simon J.; Studdert, David M.] Univ Melbourne, Melbourne Sch Populat Hlth, Parkville, Vic 3052, Australia; [Hayen, Andrew] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Mallon, William J.] Triangle Orthopaed Associates, Durham, NC USA; [Heijmans, Jeroen] Software Improvement Grp SIG, NL-3134 EB Vlaardingen, Netherlands	University of Melbourne; University of New South Wales Sydney	Studdert, DM (corresponding author), Univ Melbourne, Melbourne Sch Populat Hlth, Parkville, Vic 3052, Australia.	d.studdert@unimelb.edu.au	Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537; Hayen, Andrew/0000-0003-4046-8030; Clarke, Philip/0000-0002-7555-5348				Alaranta A, 2006, INT J SPORTS MED, V27, P581, DOI 10.1055/s-2005-865826; Backmand H, 2003, INT J SPORTS MED, V24, P609; BEAGLEHOLE R, 1983, NEW ZEAL MED J, V96, P513; Coate D, 2012, SCAND J MED SCI SPOR, DOI [10.1111/j.1600-0838.2012.01449, DOI 10.1111/J.1600-0838.2012.01449]; Cutler D, 2006, J ECON PERSPECT, V20, P97, DOI 10.1257/jep.20.3.97; FIELLER EC, 1954, J ROY STAT SOC B, V16, P175; Gajewski AK, 2008, EUR J EPIDEMIOL, V23, P335, DOI 10.1007/s10654-008-9237-3; HAKULINEN T, 1982, BIOMETRICS, V38, P933, DOI 10.2307/2529873; Homer, 1998, ILIAD; Kamper E., 1992, GOLDEN BOOK OLYMPIC; Kujala UM, 2001, JAMA-J AM MED ASSOC, V285, P44, DOI 10.1001/jama.285.1.44; Kujala UM, 1996, JAMA-J AM MED ASSOC, V276, P216, DOI 10.1001/jama.276.3.216; Kuss O, 2010, SCAND J MED SCI SPOR, V13, P410; Mallon B, 2011, HIST DICT OLYMPIC MO; Mallon B, 2001, TOTAL OLYMPICS COMPL; Marmot M., 2005, PUBLIC HEALTH; MENOTTI A, 1990, EUR J EPIDEMIOL, V6, P257, DOI 10.1007/BF00150429; Redelmeier DA, 2001, ANN INTERN MED, V134, P955, DOI 10.7326/0003-4819-134-10-200105150-00009; Saint Onge JM, 2008, SOC SCI QUART, V89, P817; Sarna S, 1997, AGING-CLIN EXP RES, V9, P35, DOI 10.1007/BF03340126; SARNA S, 1993, MED SCI SPORT EXER, V25, P237; SCHNOHR P, 1971, LANCET, V2, P1364; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; SR Olympic Sports, 2012, OL STAT HIST; Sylvestre MP, 2006, ANN INTERN MED, V145, P361, DOI 10.7326/0003-4819-145-5-200609050-00009; TALLIS GM, 1988, STAT MED, V7, P483, DOI 10.1002/sim.4780070405; Teramoto M, 2010, J SCI MED SPORT, V13, P410, DOI 10.1016/j.jsams.2009.04.010; U.S. Department of Health and Human Services, 2008, PHYS ACT GUID ADV CO; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WATERBOR J, 1988, NEW ENGL J MED, V318, P1278, DOI 10.1056/NEJM198805123181917; YAMAJI K, 1977, Journal of Human Ergology, V6, P15	31	58	58	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 13	2012	345								e8308	10.1136/bmj.e8308	http://dx.doi.org/10.1136/bmj.e8308			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056MZ	23241272	Green Submitted			2022-12-24	WOS:000312495700007
J	Jonietz, E				Jonietz, Erika			MECHANICS The forces of cancer	NATURE			English	Editorial Material													Jain, Rakesh K/I-1384-2017; Munn, Lance L/L-3950-2016	Jain, Rakesh K/0000-0001-7571-3548; Munn, Lance L/0000-0003-0698-7232				Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054; Fallica B, 2011, INTEGR BIOL-UK, V3, P529, DOI 10.1039/c0ib00142b; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476	4	53	53	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					S56	S57		10.1038/491S56a	http://dx.doi.org/10.1038/491S56a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040RE	23320288	Bronze			2022-12-24	WOS:000311339800005
J	Diehl, GE; Longman, RS; Zhang, JX; Breart, B; Galan, C; Cuesta, A; Schwab, SR; Littman, DR				Diehl, Gretchen E.; Longman, Randy S.; Zhang, Jing-Xin; Breart, Beatrice; Galan, Carolina; Cuesta, Adolfo; Schwab, Susan R.; Littman, Dan R.			Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells	NATURE			English	Article							DENDRITIC CELLS; HOST; SALMONELLA; INFLAMMATION; TOLERANCE; RESPONSES; TISSUE	The intestinal microbiota has a critical role in immune system and metabolic homeostasis, but it must be tolerated by the host to avoid inflammatory responses that can damage the epithelial barrier separating the host from the luminal contents(1-6). Breakdown of this regulation and the resulting inappropriate immune response to commensals are thought to lead to the development of inflammatory bowel diseases such as Crohn's disease and ulcerative colitis(7). We proposed that the intestinal immune system is instructed by the microbiota to limit responses to luminal antigens. Here we demonstrate in mice that, at steady state, the microbiota inhibits the transport of both commensal and pathogenic bacteria from the lumen to a key immune inductive site, the mesenteric lymph nodes (MLNs). However, in the absence of Myd88 or under conditions of antibiotic-induced dysbiosis, non-invasive bacteria were trafficked to the MLNs in a CCR7-dependent manner, and induced both T-cell responses and IgA production. Trafficking was carried out by CX(3)CR1(hi) mononuclear phagocytes, an intestinal-cell population previously reported to be non-migratory(8). These findings define a central role for commensals in regulating the migration to the MLNs of CX(3)CR1(hi) mononuclear phagocytes endowed with the ability to capture luminal bacteria, thereby compartmentalizing the intestinal immune response to avoid inflammation.	[Diehl, Gretchen E.; Longman, Randy S.; Zhang, Jing-Xin; Breart, Beatrice; Galan, Carolina; Cuesta, Adolfo; Schwab, Susan R.; Littman, Dan R.] NYU, Sch Med, Kimmel Ctr Biol & Med, Mol Pathogenesis Program,Skirball Inst, New York, NY 10016 USA; [Longman, Randy S.] Columbia Univ, Dept Med, Div Digest & Liver Dis, New York, NY 10032 USA; [Cuesta, Adolfo; Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	New York University; Columbia University; Howard Hughes Medical Institute; New York University	Diehl, GE (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Mol Pathogenesis Program,Skirball Inst, New York, NY 10016 USA.	Gretchen.Diehl@med.nyu.edu	Breart, Beatrice/M-7123-2014	Schwab, Susan/0000-0002-0834-0822; Diehl, Gretchen/0000-0002-1841-2842	National Cancer Institute [5P30CA016087-32]; American Cancer Society; National Institutes of Health (NIH) [T32 CA009161, T32 DK083256-02, R01AI085166]; Human Frontier Science Program Long-Term Fellowship; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA016087, T32CA009161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK083256] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Yue and J. Hall for comments on the manuscript and members of the Littman laboratory for their suggestions. We thank the NYU Histology Core, which is supported in part by grant 5P30CA016087-32 from the National Cancer Institute. Supported by the American Cancer Society and National Institutes of Health (NIH) T32 CA009161 (G.E.D.), NIH T32 DK083256-02 (R.S.L.), Human Frontier Science Program Long-Term Fellowship (B.B.), NIH R01AI085166 (S.R.S) and the Howard Hughes Medical Institute (D.R.L.).	Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Griffin AJ, 2011, MUCOSAL IMMUNOL, V4, P371, DOI 10.1038/mi.2011.2; Hapfelmeier S, 2008, J EXP MED, V205, P437, DOI 10.1084/jem.20070633; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; MacPherson AJ, 2004, ANN NY ACAD SCI, V1029, P36, DOI 10.1196/annals.1309.005; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Rydstrom A, 2007, J IMMUNOL, V178, P5789, DOI 10.4049/jimmunol.178.9.5789; Sartor RB, 2007, J CLIN GASTROENTEROL, V41, pS37, DOI 10.1097/MCG.0b013e31802db364; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Thiennimitr P, 2012, CURR OPIN MICROBIOL, V15, P108, DOI 10.1016/j.mib.2011.10.002; Valdez Y, 2008, CELL MICROBIOL, V10, P1646, DOI 10.1111/j.1462-5822.2008.01155.x; Vallon-Eberhard A, 2006, J IMMUNOL, V176, P2465, DOI 10.4049/jimmunol.176.4.2465; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016	30	306	323	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					116	120		10.1038/nature11809	http://dx.doi.org/10.1038/nature11809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23334413	Green Accepted			2022-12-24	WOS:000314741200045
J	Kim, C; Wong, J; Wen, JY; Wang, SR; Wang, C; Spiering, S; Kan, NG; Forcales, S; Puri, PL; Leone, TC; Marine, JE; Calkins, H; Kelly, DP; Judge, DP; Chen, HSV				Kim, Changsung; Wong, Johnson; Wen, Jianyan; Wang, Shirong; Wang, Cheng; Spiering, Sean; Kan, Natalia G.; Forcales, Sonia; Puri, Pier Lorenzo; Leone, Teresa C.; Marine, Joseph E.; Calkins, Hugh; Kelly, Daniel P.; Judge, Daniel P.; Chen, Huei-Sheng Vincent			Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs	NATURE			English	Article							PLURIPOTENT STEM-CELLS; DIFFERENTIATION; MECHANISMS; DISEASE; METABOLISM; MODELS; HEART; GAMMA	Cellular reprogramming of somatic cells to patient-specific induced pluripotent stem cells.(iPSCs) enables in vitro modelling of human genetic disorders for pathogenic investigations and therapeutic screens(1-7). However, using iPSC-derived cardiomyocytes (iPSC-CMs) to model an adult-onset heart disease remains challenging owing to the uncertainty regarding the ability of relatively immature iPSC-CMs to fully recapitulate adult disease phenotypes. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited heart disease characterized by pathological fatty infiltration and cardiomyocyte loss predominantly in the right ventricles(8), which is associated with life-threatening ventricular arrhythmias. Over 50% of affected individuals have desmosome gene mutations, most commonly in PKP2, encoding plakophilin-2 (ref. 9). The median age at presentation of ARVD/C is 26 years(8). We used previously published methods(1,10) to generate iPSC lines from fibroblasts of two patients with ARVD/C and PKP2 mutations(11,12). Mutant PKP2 iPSC-CMs demonstrate abnormal plakoglobin nuclear translocation and decreased beta-catenin activity(13) in cardiogenic conditions; yet, these abnormal features are insufficient to reproduce the pathological phenotypes of ARVD/C in standard cardiogenic conditions. Here we show that induction of adult-like metabolic energetics from an embryonic/glycolytic state and abnormal peroxisome proliferator-activated receptor gamma (PPAR-gamma) activation underlie the pathogenesis of ARVD/C. By co-activating normal PPAR-alpha-dependent metabolism and abnormal PPAR-gamma pathway in beating embryoid bodies (EBs) with defined media, we established an efficient ARVD/C in vitro model within 2 months. This model manifests exaggerated lipogenesis and apoptosis in mutant PKP2 iPSC-CMs. iPSC-CMs with a homozygous PKP2 mutation also had calcium-handling deficits. Our study is the first to demonstrate that induction of adult-like metabolism has a critical role in establishing an adult-onset disease model using patient-specific iPSCs. Using this model, we revealed crucial pathogenic insights that metabolic derangement in adult-like metabolic milieu underlies ARVD/C pathologies, enabling us to propose novel disease-modifying therapeutic strategies.	[Kim, Changsung; Wong, Johnson; Wen, Jianyan; Wang, Shirong; Wang, Cheng; Chen, Huei-Sheng Vincent] Sanford Burnham Med Res Inst, Del E Webb Neurosci Aging & Stem Cell Res Ctr, La Jolla, CA 92037 USA; [Wen, Jianyan] China Japan Friendship Hosp, Dept Cardiovasc Surg, Beijing 100029, Peoples R China; [Spiering, Sean; Kan, Natalia G.; Forcales, Sonia; Puri, Pier Lorenzo] Sanford Burnham Med Res Inst, Muscle Regenerat & Dev Program, La Jolla, CA 92037 USA; [Puri, Pier Lorenzo] IRCCS Fdn Santa Lucia, Dulbecco Telethon Inst, I-00179 Rome, Italy; [Leone, Teresa C.; Kelly, Daniel P.] Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL 32827 USA; [Marine, Joseph E.; Calkins, Hugh; Judge, Daniel P.] Johns Hopkins Univ, Sch Med, Dept Med Cardiol, Baltimore, MD 21287 USA; [Chen, Huei-Sheng Vincent] Univ Calif San Diego, Dept Med Cardiol, San Diego, CA 92103 USA	Sanford Burnham Prebys Medical Discovery Institute; China-Japan Friendship Hospital; Sanford Burnham Prebys Medical Discovery Institute; Fondazione Telethon; Dulbecco Telethon Institute (DTI); IRCCS Santa Lucia; Sanford Burnham Prebys Medical Discovery Institute; Johns Hopkins University; University of California System; University of California San Diego	Chen, HSV (corresponding author), Sanford Burnham Med Res Inst, Del E Webb Neurosci Aging & Stem Cell Res Ctr, La Jolla, CA 92037 USA.	hsv_chen@burnham.org	Forcales, Sonia-V./B-2157-2013; Kelly, Daniel/ABG-2056-2021; Forcales, Sonia/AAU-8996-2020	Forcales, Sonia-V./0000-0002-7111-4959; Forcales, Sonia/0000-0002-7111-4959; Wong, Johnson/0000-0002-5838-8453; Judge, Daniel/0000-0002-3407-0248; wen, jianyan/0000-0001-5762-6504	Scripps Research Institute; NIH [RO1 HL058493, RO1 HL101189, RO1 AR056712, RO1 AR052779, RO1 HL105194]; California Institute of Regenerative Medicine (CIRM) [RS1-00171-1, RB2-01512, RB4-06276]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105194, R01HL058493, R01HL101189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052779, R01AR056712] Funding Source: NIH RePORTER; Fondazione Telethon Funding Source: Custom	Scripps Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Fondazione Telethon(Fondazione Telethon)	We thank the patients for their participation, microarray core facilities at SBMRI and Scripps Research Institute for their support T. Yi for technical assistance, and G. W. Rogers for assistance in metabolic assays. This work was supported by NIH grants (RO1 HL058493 and RO1 HL101189) (to D.P.K); NIH grants (RO1 AR056712 and RO1 AR052779) (to P.L.P); California Institute of Regenerative Medicine (CIRM) grants (RS1-00171-1, RB2-01512 and RB4-06276) and NIH grant (RO1 HL105194) (to H.-S.V.C).	Ali AT, 2006, ANAL BIOCHEM, V354, P247, DOI 10.1016/j.ab.2006.04.028; Awad MM, 2008, NAT CLIN PRACT CARD, V5, P258, DOI 10.1038/ncpcardio1182; Awad Mark M, 2006, Hum Mutat, V27, P1157, DOI 10.1002/humu.9461; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Calkins Hugh, 2008, Curr Cardiol Rep, V10, P367, DOI 10.1007/s11886-008-0059-4; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Dalal D, 2006, CIRCULATION, V113, P1641, DOI 10.1161/CIRCULATIONAHA.105.568642; Djouadi F, 2009, CARDIOVASC RES, V84, P83, DOI 10.1093/cvr/cvp183; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Kim C, 2010, STEM CELLS DEV, V19, P783, DOI 10.1089/scd.2009.0349; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Lombardi R, 2009, CIRC RES, V104, P1076, DOI 10.1161/CIRCRESAHA.109.196899; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Onay-Besikci A, 2006, MOL CELL BIOCHEM, V287, P1, DOI 10.1007/s11010-006-9123-9; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Scolletta S, 2010, BIOMED PHARMACOTHER, V64, P203, DOI 10.1016/j.biopha.2009.10.002; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taura D, 2009, FEBS LETT, V583, P1029, DOI 10.1016/j.febslet.2009.02.031; Waku T, 2010, EMBO J, V29, P3395, DOI 10.1038/emboj.2010.197; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	30	362	378	3	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					105	110		10.1038/nature11799	http://dx.doi.org/10.1038/nature11799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23354045	Green Accepted			2022-12-24	WOS:000314741200043
J	Foulquier, S; Steckelings, UM; Unger, T				Foulquier, Sebastien; Steckelings, Ulrike Muscha; Unger, Thomas			PERSPECTIVE A tale of two receptors	NATURE			English	Editorial Material							ANGIOTENSIN; STIMULATION		[Foulquier, Sebastien] Maastricht Univ, Sch Cardiovasc Dis, CARIM, Maastricht, Netherlands; [Steckelings, Ulrike Muscha] Univ So Denmark, Inst Mol Med, Odense, Denmark	Maastricht University; Maastricht University Medical Centre (MUMC); University of Southern Denmark	Foulquier, S (corresponding author), Maastricht Univ, Sch Cardiovasc Dis, CARIM, Maastricht, Netherlands.	s.foulquier@maastrichtuniversity.nl	Foulquier, Sébastien/AAE-6998-2019	Foulquier, Sébastien/0000-0002-2523-0748; Steckelings, Ulrike Muscha/0000-0002-5430-4275				Altarche-Xifro W, 2009, STEM CELLS, V27, P2488, DOI 10.1002/stem.171; Curato C, 2010, J IMMUNOL, V185, P6286, DOI 10.4049/jimmunol.0903681; Foulquier S, 2012, CURR HYPERTENS REP, V14, P403, DOI 10.1007/s11906-012-0291-6; Kaschina E, 2008, CIRCULATION, V118, P2523, DOI 10.1161/CIRCULATIONAHA.108.784868; Paulis L, 2012, HYPERTENSION, V59, P485, DOI 10.1161/HYPERTENSIONAHA.111.185496; Rehman A, 2012, HYPERTENSION, V59, P291, DOI 10.1161/HYPERTENSIONAHA.111.180158; Steckelings UM, 2010, J HYPERTENS, V28, pS50, DOI 10.1097/01.hjh.0000388495.66330.63	7	14	15	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					S9	S9		10.1038/493S9a	http://dx.doi.org/10.1038/493S9a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364772	Bronze			2022-12-24	WOS:000314219600008
J	Dharmarajan, K; Hsieh, AF; Lin, ZQ; Bueno, H; Ross, JS; Horwitz, LI; Barreto, JA; Kim, N; Bernheim, SM; Suter, LG; Drye, EE; Krumholz, HM				Dharmarajan, Kumar; Hsieh, Angela F.; Lin, Zhenqiu; Bueno, Hector; Ross, Joseph S.; Horwitz, Leora I.; Barreto-Filho, Jose Augusto; Kim, Nancy; Bernheim, Susannah M.; Suter, Lisa G.; Drye, Elizabeth E.; Krumholz, Harlan M.			Diagnoses and Timing of 30-Day Readmissions After Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESTRICTED ACTIVITY; INPATIENT CARE; RISK-FACTORS; REHOSPITALIZATION; QUALITY; MANAGEMENT; RATES; INTERVENTION; ASSOCIATION; PERFORMANCE	Importance To better guide strategies intended to reduce high rates of 30-day readmission after hospitalization for heart failure (HF), acute myocardial infarction (MI), or pneumonia, further information is needed about readmission diagnoses, readmission timing, and the relationship of both to patient age, sex, and race. Objective To examine readmission diagnoses and timing among Medicare beneficiaries readmitted within 30 days after hospitalization for HF, acute MI, or pneumonia. Design, Setting, and Patients We analyzed 2007-2009 Medicare fee-for-service claims data to identify patterns of 30-day readmission by patient demographic characteristics and time after hospitalization for HF, acute MI, or pneumonia. Readmission diagnoses were categorized using an aggregated version of the Centers for Medicare & Medicaid Services' Condition Categories. Readmission timing was determined by day after discharge. Main Outcome Measures We examined the percentage of 30-day readmissions occurring on each day (0-30) after discharge; the most common readmission diagnoses occurring during cumulative periods (days 0-3, 0-7, 0-15, and 0-30) and consecutive periods (days 0-3, 4-7, 8-15, and 16-30) after hospitalization; median time to readmission for common readmission diagnoses; and the relationship between patient demographic characteristics and readmission diagnoses and timing. Results From 2007 through 2009, we identified 329 308 30-day readmissions after 1 330 157 HF hospitalizations (24.8% readmitted), 108 992 30-day readmissions after 548 834 acute MI hospitalizations (19.9% readmitted), and 214 239 30-day readmissions after 1 168 624 pneumonia hospitalizations (18.3% readmitted). The proportion of patients readmitted for the same condition was 35.2% after the index HF hospitalization, 10.0% after the index acute MI hospitalization, and 22.4% after the index pneumonia hospitalization. Of all readmissions within 30 days of hospitalization, the majority occurred within 15 days of hospitalization: 61.0%, HF cohort; 67.6%, acute MI cohort; and 62.6%, pneumonia cohort. The diverse spectrum of readmission diagnoses was largely similar in both cumulative and consecutive periods after discharge. Median time to 30-day readmission was 12 days for patients initially hospitalized for HF, 10 days for patients initially hospitalized for acute MI, and 12 days for patients initially hospitalized for pneumonia and was comparable across common readmission diagnoses. Neither readmission diagnoses nor timing substantively varied by age, sex, or race. Conclusion and Relevance Among Medicare fee-for-service beneficiaries hospitalized for HF, acute MI, or pneumonia, 30-day readmissions were frequent throughout the month after hospitalization and resulted from a similar spectrum of readmission diagnoses regardless of age, sex, race, or time after discharge. JAMA. 2013;309(4):355-363 www.jama.com	[Dharmarajan, Kumar] Columbia Univ, Med Ctr, Dept Internal Med, Div Cardiol, New York, NY USA; [Dharmarajan, Kumar; Hsieh, Angela F.; Lin, Zhenqiu; Ross, Joseph S.; Horwitz, Leora I.; Barreto-Filho, Jose Augusto; Kim, Nancy; Bernheim, Susannah M.; Drye, Elizabeth E.; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Bueno, Hector] Hosp Gen Univ Gregorio Maranon, Dept Cardiol, Madrid, Spain; [Ross, Joseph S.; Horwitz, Leora I.; Kim, Nancy] Yale Univ, Sch Med, Dept Internal Med, Gen Internal Med Sect, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT USA	Columbia University; Yale University; General University Gregorio Maranon Hospital; Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	Horwitz, Leora/A-6959-2009; , Harlan/AAI-2875-2020; Horwitz, Leora/ABD-1292-2020; Bueno, Hector/I-3910-2015	Horwitz, Leora/0000-0003-1800-6040; Bueno, Hector/0000-0003-0277-7596; Ross, Joseph/0000-0002-9218-3320	AstraZeneca; Bayer; DaiichiSankyo; Eli Lilly; Novartis; Roche; Medtronic through Yale University; (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute [1U01HL105270-03]; National Heart, Lung, and Blood Institute [T32 HL007854]; National Institute on Aging and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program [K08 AG032886, K08 AG038336]; CAPES (Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior, Ministry of Education, Brazil) [3436-10-1]; Federal University of Sergipe, Brazil; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270, T32HL007854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG038336, K08AG032886] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); Bayer(Bayer AG); DaiichiSankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Novartis(Novartis); Roche(Roche Holding); Medtronic through Yale University; (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; CAPES (Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior, Ministry of Education, Brazil); Federal University of Sergipe, Brazil; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Bernheim, Drye, Horwitz, Kim, Krumholz, Lin, Ross, and Suter work under contract with the Centers for Medicare & Medicaid Services to develop and maintain performance measures. Dr Bueno reported that he has received speaking or advisory fees from AstraZeneca, Bayer, DaiichiSankyo, Eli Lilly, Novartis, and Roche. Dr Krumholz reported that he is chair of a cardiac scientific advisory board for UnitedHealth. Dr Ross reported that he is a member of a scientific advisory board for FAIR Health. Drs Krumholz and Ross are the recipients of a research grant from Medtronic through Yale University.; This study was funded by grant 1U01HL105270-03 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. Dr Dharmarajan is supported by grant T32 HL007854 from the National Heart, Lung, and Blood Institute; he is also supported as a Centers of Excellence Scholar in Geriatric Medicine at Yale by the John A. Hartford Foundation and the American Federation for Aging Research. Drs Ross and Horwitz are supported by grants K08 AG032886 and K08 AG038336 from the National Institute on Aging and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program, respectively. Dr Barreto-Filho is supported by grant 3436-10-1 from CAPES (Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior, Ministry of Education, Brazil) and the Federal University of Sergipe, Brazil.	Ashton CM, 1996, SOC SCI MED, V43, P1533, DOI 10.1016/S0277-9536(96)00049-4; ASHTON CM, 1995, ANN INTERN MED, V122, P415, DOI 10.7326/0003-4819-122-6-199503150-00003; Ashton CM, 1997, MED CARE, V35, P1044, DOI 10.1097/00005650-199710000-00006; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Calvillo-King L, 2013, J GEN INTERN MED, V28, P269, DOI 10.1007/s11606-012-2235-x; Centers for Medicare & Medicaid Services, 2011, MED HOSP QUAL CHARTB; Centers for Medicare & Medicaid Services Hospital Pay-for-Performance Workgroup, 2007, 1 PUBL SESS WASH DC; Chaudhry SI, 2010, NEW ENGL J MED, V363, P2301, DOI 10.1056/NEJMoa1010029; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Dunlay SM, 2012, ANN INTERN MED, V157, P11, DOI 10.7326/0003-4819-157-1-201207030-00004; Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419; Friedman MM, 1997, HEART LUNG, V26, P169, DOI 10.1016/S0147-9563(97)90053-4; Gill TM, 2010, JAMA-J AM MED ASSOC, V304, P1919, DOI 10.1001/jama.2010.1568; Gill TM, 2004, JAMA-J AM MED ASSOC, V292, P2115, DOI 10.1001/jama.292.17.2115; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Jasti H, 2008, CLIN INFECT DIS, V46, P550, DOI 10.1086/526526; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kiely DK, 2003, J GERONTOL A-BIOL, V58, P441, DOI 10.1093/gerona/58.5.M441; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; Koehler F, 2011, CIRCULATION, V123, P1873, DOI 10.1161/CIRCULATIONAHA.111.018473; Kortebein P, 2007, JAMA-J AM MED ASSOC, V297, P1772, DOI 10.1001/jama.297.16.1772-b; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Lindenauer PK, 2011, J HOSP MED, V6, P142, DOI 10.1002/jhm.890; Lindenauer Peter K, 2010, J Hosp Med, V5, pE12, DOI 10.1002/jhm.822; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; McBean A Marshall, 2006, Medicare Brief, P1; Medicare Payment Advisory Commission, 2007, PROM GREAT EFF MED; National Quality Forum, 2008, NAT VOL CONS STAND H; NAYLOR M, 1994, ANN INTERN MED, V120, P999, DOI 10.7326/0003-4819-120-12-199406150-00005; O'Connor CM, 2010, AM HEART J, V159, P841, DOI 10.1016/j.ahj.2010.02.023; Poch DS, 2009, SEMIN RESP CRIT CARE, V30, P26, DOI 10.1055/s-0028-1119806; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Riegel B, 2006, J CARD FAIL, V12, P211, DOI 10.1016/j.cardfail.2006.01.005; Ross JS, 2010, CIRC-HEART FAIL, V3, P97, DOI 10.1161/CIRCHEARTFAILURE.109.885210; SEARLE SR, 1980, AM STAT, V34, P216, DOI 10.2307/2684063; Skull SA, 2008, EPIDEMIOL INFECT, V136, P232, DOI 10.1017/S0950268807008564; Sochalski J, 2009, HEALTH AFFAIR, V28, P179, DOI 10.1377/hlthaff.28.1.179; Sullivan DH, 1999, JAMA-J AM MED ASSOC, V281, P2013, DOI 10.1001/jama.281.21.2013; Witte KKA, 2006, HEART, V92, P481, DOI 10.1136/hrt.2004.058073; Wong FKY, 2008, J ADV NURS, V62, P585, DOI 10.1111/j.1365-2648.2008.04631.x; Yoder JC, 2012, ARCH INTERN MED, V172, P68, DOI 10.1001/archinternmed.2011.603	49	700	710	4	59	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					355	363		10.1001/jama.2012.216476	http://dx.doi.org/10.1001/jama.2012.216476			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074FT	23340637	Bronze, Green Accepted			2022-12-24	WOS:000313799000023
J	Reid, IC				Reid, Ian C.			Are antidepressants overprescribed? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EFFICACY		Univ Aberdeen, Div Appl Med, Aberdeen, Scotland	University of Aberdeen	Reid, IC (corresponding author), Univ Aberdeen, Div Appl Med, Aberdeen, Scotland.	i.reid@abdn.ac.uk						Anderson IM, 2008, J PSYCHOPHARMACOL, V22, P343, DOI 10.1177/0269881107088441; Cameron IM, 2009, BRIT J GEN PRACT, V59, P644, DOI 10.3399/bjgp09X454061; Cuijpers P, 2010, PSYCHOL MED, V40, P211, DOI 10.1017/S0033291709006114; Fountoulakis KN, 2011, INT J NEUROPSYCHOPH, V14, P405, DOI 10.1017/S1461145710000957; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P572, DOI 10.1001/archgenpsychiatry.2011.2044; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; Lockhart P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X593848; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Moore M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3999; Munoz-Arroyo R, 2006, BRIT J GEN PRACT, V56, P423; NHS Scotland, 2012, PRESCR MED MED US ME; Penn E, 2012, THER ADV PSYCHOPHARM, V2, P179, DOI 10.1177/2045125312445469; Robinson P, 2009, HLTH SERV J     0209; Scottish Parliament, 2010, 3 SCOTT PARL PUBL AU	15	15	15	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2013	346								f190	10.1136/bmj.f190	http://dx.doi.org/10.1136/bmj.f190			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BG	23341567				2022-12-24	WOS:000314215600010
J	Torjesen, I				Torjesen, Ingrid			Sentinel node biopsy for melanoma: unnecessary treatment?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LYMPHADENECTOMY; METASTASES; RECURRENCE; DISSECTION					ingrid_torjesen@hotmail.com						Agnese DM, 2003, SURGERY, V134, P542, DOI 10.1016/S0039-6060(03)00275-7; Bilimoria KY, 2008, ANN SURG ONCOL, V15, P1566, DOI 10.1245/s10434-008-9885-2; Campanholi LL, 2011, J LYMPHOEDEMA, V6, P30; Cancer Research UK, CANC INC STAT; Cormier JN, 2005, J CLIN ONCOL, V23, P6054, DOI 10.1200/JCO.2005.21.360; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Morton D, 2010, ANN SURG ONCOL, V17, pS22; Morton DL, 2004, BRIT J DERMATOL, V151, P308, DOI 10.1111/j.1365-2133.2004.06133.x; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Morton DL, 2012, CLIN EXP METASTASIS; Morton DL, 1990, 42 ANN M SOC SURG ON; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; National Cancer Institute, MEL; National Institute for Health and Clinical Excellence, 2006, IMPR OUTC PEOPL SKIN; *OFF NAT STAT, 2003, CANC REG STAT ENGL 2; Reeves ME, 2003, ANN SURG ONCOL, V10, P27, DOI 10.1245/ASO.2003.03.020; Rosenberg SA, 2008, NAT CLIN PRACT ONCOL, V5, P1, DOI 10.1038/ncponc1022; Shamsian N, 2004, BMJ-BRIT MED J, V329, P1272; Skin Cancer Foundation, SKIN CANC FACTS; Thomas JM, 2008, NAT CLIN PRACT ONCOL, V5, P18, DOI 10.1038/ncponc1014; Thomas J Meirion, 2010, Skinmed, V8, P222; Wong SL, SENTINEL LYMPH NODE	22	25	25	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2013	346								e8645	10.1136/bmj.e8645	http://dx.doi.org/10.1136/bmj.e8645			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070ZH	23299845	Green Submitted			2022-12-24	WOS:000313553800010
J	Sinha, SK; Detsky, AS				Sinha, Samir K.; Detsky, Allan S.			Measure, Promote, and Reward Mobility to Prevent Falls in Older Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HOSPITALIZATION		[Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5S 1A1, Canada; [Sinha, Samir K.; Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Sinha, Samir K.; Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Sinha, Samir K.; Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), 600 Univ Ave,Room 429, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						ASHER RAJ, 1947, BRIT MED J, V2, P967, DOI 10.1136/bmj.2.4536.967; Brown R, 2009, POLYM TEST, V28, P1, DOI 10.1016/j.polymertesting.2008.12.001; Covinsky KE, 2011, JAMA-J AM MED ASSOC, V306, P1782, DOI 10.1001/jama.2011.1556; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Inouye SK, 2009, NEW ENGL J MED, V360, P2390, DOI 10.1056/NEJMp0900963; Oliver D, 2010, CLIN GERIATR MED, V26, P645, DOI 10.1016/j.cger.2010.06.005; Rizzuto D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5568; Valkenet K, 2011, CLIN REHABIL, V25, P99, DOI 10.1177/0269215510380830	8	12	12	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2573	2574		10.1001/jama.2012.68313	http://dx.doi.org/10.1001/jama.2012.68313			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268514				2022-12-24	WOS:000312916600021
J	Boehncke, WH				Boehncke, Wolf-Henning			PERSPECTIVE Don't be superficial	NATURE			English	Editorial Material							PSORIASIS; RISK		Univ Hosp Geneva, Dept Dermatol, Geneva, Switzerland	University of Geneva	Boehncke, WH (corresponding author), Univ Hosp Geneva, Dept Dermatol, Geneva, Switzerland.	wolf-henning.boehncke@hcuge.ch						Coimbra S, 2010, J EUR ACAD DERMATOL, V24, P1386, DOI 10.1111/j.1468-3083.2010.03647.x; Gelfand JM, 2007, ARCH DERMATOL, V143, P1493, DOI 10.1001/archderm.143.12.1493; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Karadag AS, 2010, INT J DERMATOL, V49, P642, DOI 10.1111/j.1365-4632.2009.04358.x; Kimball AB, 2008, J AM ACAD DERMATOL, V58, P1031, DOI 10.1016/j.jaad.2008.01.006; Ludwig RJ, 2007, BRIT J DERMATOL, V156, P271, DOI 10.1111/j.1365-2133.2006.07562.x; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X	8	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					555	555		10.1038/492S55a	http://dx.doi.org/10.1038/492S55a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23254972	Bronze, Green Published			2022-12-24	WOS:000312488200004
J	Garber, K				Garber, Ken			GENETICS Deep exploration	NATURE			English	Editorial Material							PSORIASIS											de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467	4	16	17	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					556	557		10.1038/492S56a	http://dx.doi.org/10.1038/492S56a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23254973	Bronze			2022-12-24	WOS:000312488200005
J	Ye, Y; Blaser, G; Horrocks, MH; Ruedas-Rama, MJ; Ibrahim, S; Zhukov, AA; Orte, A; Klenerman, D; Jackson, SE; Komander, D				Ye, Yu; Blaser, Georg; Horrocks, Mathew H.; Ruedas-Rama, Maria J.; Ibrahim, Shehu; Zhukov, Alexander A.; Orte, Angel; Klenerman, David; Jackson, Sophie E.; Komander, David			Ubiquitin chain conformation regulates recognition and activity of interacting proteins	NATURE			English	Article							FLUORESCENCE COINCIDENCE SPECTROSCOPY; LINEAR POLYUBIQUITIN CHAINS; KAPPA-B ACTIVATION; SINGLE-MOLECULE; STRUCTURAL BASIS; DIUBIQUITIN; BINDING; NMR; E2	Mechanisms of protein recognition have been extensively studied for single-domain proteins(1), but are less well characterized for dynamic multidomain systems. Ubiquitin chains represent a biologically important multidomain system that requires recognition by structurally diverse ubiquitin-interacting proteins(2,3). Ubiquitin chain conformations in isolation are often different from conformations observed in ubiquitin-interacting protein complexes, indicating either great dynamic flexibility or extensive chain remodelling upon binding. Using single-molecule fluorescence resonance energy transfer, we show that Lys 63-, Lys 48- and Met 1-linked diubiquitin exist in several distinct conformational states in solution. Lys 63- and Met 1-linked diubiquitin adopt extended 'open' and more compact 'closed' conformations, and ubiquitin-binding domains and deubiquitinases (DUBs) select pre-existing conformations. By contrast, Lys 48-linked diubiquitin adopts predominantly compact conformations. DUBs directly recognize existing conformations, but may also remodel ubiquitin chains to hydrolyse the isopeptide bond. Disruption of the Lys 48-diubiquitin interface changes conformational dynamics and affects DUB activity. Hence, conformational equilibria in ubiquitin chains provide an additional layer of regulation in the ubiquitin system, and distinct conformations observed in differently linked polyubiquitin may contribute to the specificity of ubiquitin-interacting proteins.	[Ye, Yu; Komander, David] MRC, Mol Biol Lab, Div Prot & Nucle Acids Chem, Cambridge CB2 0QH, England; [Blaser, Georg; Horrocks, Mathew H.; Ibrahim, Shehu; Zhukov, Alexander A.; Klenerman, David; Jackson, Sophie E.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Ruedas-Rama, Maria J.; Orte, Angel] Univ Granada, Fac Pharm, Dept Phys Chem, E-18071 Granada, Spain	MRC Laboratory Molecular Biology; University of Cambridge; University of Granada	Komander, D (corresponding author), MRC, Mol Biol Lab, Div Prot & Nucle Acids Chem, Cambridge CB2 0QH, England.	dk10012@cam.ac.uk; sej13@cam.ac.uk; dk@mrc-lmb.cam.ac.uk	Orte, Angel/J-4810-2012; Ye, Yu/D-5727-2019; Ruedas-Rama, Maria Jose/L-2277-2014; Ye, Yu/ABE-7107-2021	Orte, Angel/0000-0003-1905-4183; Ye, Yu/0000-0003-0441-6399; Ruedas-Rama, Maria Jose/0000-0003-0853-187X; Ye, Yu/0000-0003-0441-6399; Klenerman, David/0000-0001-7116-6954; Horrocks, Mathew/0000-0001-5495-5492; Jackson, Sophie/0000-0002-7470-9800	Medical Research Council [U105192732]; EMBO Young Investigator Program; BBSRC; Newton Trust; EMBO YIP small grant; EPSRC; Biotechnology and Biological Sciences Research Council [BB/F00219X/1] Funding Source: researchfish; Medical Research Council [MC_U105192732] Funding Source: researchfish; BBSRC [BB/F00219X/1] Funding Source: UKRI; MRC [MC_U105192732] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newton Trust; EMBO YIP small grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank members of the Komander, Jackson and Klenerman laboratories, R. Williams, S. Freund, C. Johnson, S. McLaughlin and A. Fersht for discussions. Work in the Komander laboratory is supported by the Medical Research Council (U105192732) and the EMBO Young Investigator Program. G. B. and S. I. were supported by the BBSRC, the Newton Trust and an EMBO YIP small grant to D.Ko. Work in the Klenerman laboratory is supported by EPSRC.	Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Clarke RW, 2007, ANAL CHEM, V79, P2771, DOI 10.1021/ac062188w; COOK WJ, 1992, J BIOL CHEM, V267, P16467; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirano T, 2011, J BIOL CHEM, V286, P37496, DOI 10.1074/jbc.M111.256354; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Iwai K, 2011, CELL CYCLE, V10, P3095, DOI 10.4161/cc.10.18.17437; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Lo Conte L, 1999, J MOL BIOL, V285, P2177; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Orte A, 2008, ANAL CHEM, V80, P8389, DOI 10.1021/ac8009092; Orte A, 2006, ANAL CHEM, V78, P7707, DOI 10.1021/ac061122y; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rohaim A, 2012, ACTA CRYSTALLOGR D, V68, P102, DOI 10.1107/S0907444911051195; Ryabov Y, 2006, PROTEINS, V63, P787, DOI 10.1002/prot.20917; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schaefer JB, 2011, J BIOL CHEM, V286, P45186, DOI 10.1074/jbc.M111.310094; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17	29	129	131	0	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2012	492	7428					266	270		10.1038/nature11722	http://dx.doi.org/10.1038/nature11722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23201676	Green Accepted, Green Submitted			2022-12-24	WOS:000312259300045
J	Newbatt, E; Beckles, Z; Ullman, R; Lumsden, MA				Newbatt, Emma; Beckles, Zosia; Ullman, Roz; Lumsden, Mary Ann		Guideline Dev Grp	Ectopic pregnancy and miscarriage: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Newbatt, Emma; Beckles, Zosia; Ullman, Roz] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Lumsden, Mary Ann] Univ Glasgow, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow	Ullman, R (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England.	rullman@ncc-wch.org.uk	Ramlakhan, Shammi/ABD-5794-2020; Riggs, Elisha/K-4267-2019; Beckles, Zosia/R-9630-2019	Ramlakhan, Shammi/0000-0003-1792-0842; Riggs, Elisha/0000-0003-0799-7467; Beckles, Zosia/0000-0003-4352-2266	NICE	NICE	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: EN, ZB, and RU have support from NICE for the submitted work; MAL receives travel, accommodation, and meetings expenses from the Royal College of Obstetricians and Gynaecologists for sitting on multiple committees, including the Guideline Development Group; MAL's institution receives consultancy fees from Abbott Pharmaceuticals (for drugs in heavy menstrual bleeding); no other financial relationships with any organisation that might have an interest in the submitted work; no other relationships or activities that could appear to have influenced the submitted work	HESonline Hospital Episode Statistics, 2010, NHS MAT STAT 2010 11; National Institute for Health and Clinical Excellence, 2012, MANAGEMENT OUTCOME E; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Poddar A, 2011, J OBSTET GYNAECOL, V31, P640, DOI 10.3109/01443615.2011.593650	4	28	29	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2012	345								e8136	10.1136/bmj.e8136	http://dx.doi.org/10.1136/bmj.e8136			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MU	23236034				2022-12-24	WOS:000312495100011
J	Xiong, W; Grillet, N; Elledge, HM; Wagner, TFJ; Zhao, B; Johnson, KR; Kazmierczak, P; Muller, U				Xiong, Wei; Grillet, Nicolas; Elledge, Heather M.; Wagner, Thomas F. J.; Zhao, Bo; Johnson, Kenneth R.; Kazmierczak, Piotr; Mueller, Ulrich			TMHS Is an Integral Component of the Mechanotransduction Machinery of Cochlear Hair Cells	CELL			English	Article							USHER-SYNDROME PROTEINS; HEARING-LOSS; TIP-LINK; MYOSIN VIIA; FAST ADAPTATION; GAMMA-SUBUNIT; ION CHANNELS; WALTZER MICE; MOUSE MODEL; CADHERIN-23	Hair cells are mechanosensors for the perception of sound, acceleration, and fluid motion. Mechanotransduction channels in hair cells are gated by tip links, which connect the stereocilia of a hair cell in the direction of their mechanical sensitivity. The molecular constituents of the mechanotransduction channels of hair cells are not known. Here, we show that mechanotransduction is impaired in mice lacking the tetraspan TMHS. TMHS binds to the tip-link component PCDH15 and regulates tip-link assembly, a process that is disrupted by deafness-causing Tmhs mutations. TMHS also regulates transducer channel conductance and is required for fast channel adaptation. TMHS therefore resembles other ion channel regulatory subunits such as the transmembrane alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor regulatory proteins (TARPs) of AMPA receptors that facilitate channel transport and regulate the properties of pore-forming channel subunits. We conclude that TMHS is an integral component of the hair cell's mechanotransduction machinery that functionally couples PCDH15 to the transduction channel.	[Xiong, Wei; Grillet, Nicolas; Elledge, Heather M.; Wagner, Thomas F. J.; Zhao, Bo; Kazmierczak, Piotr; Mueller, Ulrich] Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Johnson, Kenneth R.] Jackson Lab, Bar Harbor, ME 04609 USA	Scripps Research Institute; Jackson Laboratory	Muller, U (corresponding author), Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	umueller@scripps.edu	Zhao, Bo/S-6404-2019; Xiong, Wei/AAY-5944-2020; Kaźmierczak, Piotr/AAD-7059-2021	Xiong, Wei/0000-0002-2784-7696; Kaźmierczak, Piotr/0000-0002-4060-3055; Zhao, Bo/0000-0003-2881-5714; Grillet, Nicolas/0000-0001-8007-9246	NIH [DC005965, DC007704]; Dorris Neuroscience Center; Skaggs Institute for Chemical Biology; Bundy Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005965, R01DC004301, R01DC007704] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dorris Neuroscience Center; Skaggs Institute for Chemical Biology; Bundy Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	W.X. carried out the electrophysiological recordings, calcium imaging experiments, and the analysis of protein localization in transfected cells. W. X. and T.F.J.W. developed the electroporation technique. N.G. carried out in situ hybridizations and the analysis of hair cell morphology and tip links by SEM. W.X., N.G., T.F.J.W., and P.K. carried out immunolocalization experiments in hair cells. H. M. E. and B.Z. generated plasmid constructs and carried out co-immunoprecipitation experiments. K.R.J. provided TMHS mutant mice and generated the TMHS antibody. W. X., N.G., T.F.J.W., P. K., and U. M. contributed to the planning of the work. U. M. wrote the manuscript with help from W. X. and N.G. We thank S. W. Webb and S. R. Harkins-Perry for cloning constructs. This work was supported by the NIH (DC005965 and DC007704 to U. M.), the Dorris Neuroscience Center, the Skaggs Institute for Chemical Biology, and the Bundy Foundation (to W.X. and U.M.).	Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; Bahloul A, 2010, HUM MOL GENET, V19, P3557, DOI 10.1093/hmg/ddq271; Beurg M, 2006, J NEUROSCI, V26, P10992, DOI 10.1523/JNEUROSCI.2188-06.2006; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Caberlotto E, 2011, P NATL ACAD SCI USA, V108, P5825, DOI 10.1073/pnas.1017114108; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Grillet N, 2009, AM J HUM GENET, V85, P328, DOI 10.1016/j.ajhg.2009.07.017; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; JAY SD, 1990, SCIENCE, V248, P490, DOI 10.1126/science.2158672; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Lagziel A, 2005, DEV BIOL, V280, P295, DOI 10.1016/j.ydbio.2005.01.015; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Longo-Guess CM, 2007, MAMM GENOME, V18, P646, DOI 10.1007/s00335-007-9049-x; Longo-Guess CM, 2005, P NATL ACAD SCI USA, V102, P7894, DOI 10.1073/pnas.0500760102; Mchugh RK, 2006, ANAT REC PART A, V288A, P370, DOI 10.1002/ar.a.20297; Michalski N, 2009, PFLUG ARCH EUR J PHY, V459, P115, DOI 10.1007/s00424-009-0711-x; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Ricci AJ, 2005, J NEUROSCI, V25, P7831, DOI 10.1523/JNEUROSCI.1127-05.2005; Ricci AJ, 2003, NEURON, V40, P983, DOI 10.1016/S0896-6273(03)00721-9; Sakaguchi H, 2009, CURR OPIN OTOLARYNGO, V17, P388, DOI 10.1097/MOO.0b013e3283303472; Schwander M, 2007, J NEUROSCI, V27, P2163, DOI 10.1523/JNEUROSCI.4975-06.2007; Schwander M, 2009, P NATL ACAD SCI USA, V106, P5252, DOI 10.1073/pnas.0900691106; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Shabbir MI, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039834; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Waguespack J, 2007, J NEUROSCI, V27, P13890, DOI 10.1523/JNEUROSCI.2159-07.2007; Webb SW, 2011, DEVELOPMENT, V138, P1607, DOI 10.1242/dev.060061; Wilson SM, 2001, GENOMICS, V74, P228, DOI 10.1006/geno.2001.6554; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004	51	160	164	2	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1283	1295		10.1016/j.cell.2012.10.041	http://dx.doi.org/10.1016/j.cell.2012.10.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217710	Bronze, Green Accepted			2022-12-24	WOS:000311999900017
J	Chang, CY; Furlong, LA				Chang, Christina Y.; Furlong, Lesley-Anne			Microbial Stowaways in Topical Antiseptic Products	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chang, Christina Y.; Furlong, Lesley-Anne] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Chang, CY (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							[Anonymous], 2011, Morbidity and Mortality Weekly Report, V60, P347; [Anonymous], 2009, ALLERGY INFECT ASS M; FDA, ARCH REC MARK WITHDR; Weber DJ, 2007, ANTIMICROB AGENTS CH, V51, P4217, DOI 10.1128/AAC.00138-07	4	12	12	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2170	2173		10.1056/NEJMp1212680	http://dx.doi.org/10.1056/NEJMp1212680			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048DO	23215554				2022-12-24	WOS:000311890600003
J	von der Heyden, BP; Roychoudhury, AN; Mtshali, TN; Tyliszczak, T; Myneni, SCB				von der Heyden, B. P.; Roychoudhury, A. N.; Mtshali, T. N.; Tyliszczak, T.; Myneni, S. C. B.			Chemically and Geographically Distinct Solid-Phase Iron Pools in the Southern Ocean	SCIENCE			English	Article							SPECTROSCOPY	Iron is a limiting nutrient in many parts of the oceans, including the unproductive regions of the Southern Ocean. Although the dominant fraction of the marine iron pool occurs in the form of solid-phase particles, its chemical speciation and mineralogy are challenging to characterize on a regional scale. We describe a diverse array of iron particles, ranging from 20 to 700 nanometers in diameter, in the waters of the Southern Ocean euphotic zone. Distinct variations in the oxidation state and composition of these iron particles exist between the coasts of South Africa and Antarctica, with different iron pools occurring in different frontal zones. These speciation variations can result in solubility differences that may affect the production of bioavailable dissolved iron.	[von der Heyden, B. P.; Roychoudhury, A. N.; Mtshali, T. N.] Univ Stellenbosch, Dept Earth Sci, ZA-7602 Matieland, South Africa; [von der Heyden, B. P.; Myneni, S. C. B.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Mtshali, T. N.] CSIR, ZA-7600 Stellenbosch, South Africa; [Tyliszczak, T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA	Stellenbosch University; Princeton University; Council for Scientific & Industrial Research (CSIR) - South Africa; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Roychoudhury, AN (corresponding author), Univ Stellenbosch, Dept Earth Sci, Private Bag X1, ZA-7602 Matieland, South Africa.	roy@sun.ac.za		von der Heyden, Bjorn/0000-0002-4006-9278; Roychoudhury, Alakendra/0000-0002-5627-8891	National Research Foundation, South Africa (Blue Skies Program and SANAP); Stellenbosch University VR(R) fund; NSF (chemical sciences); U.S. Department of Energy (Office of Basic Energy Sciences and Subsurface Biogeochemical Research program); Princeton in Africa program	National Research Foundation, South Africa (Blue Skies Program and SANAP); Stellenbosch University VR(R) fund; NSF (chemical sciences); U.S. Department of Energy (Office of Basic Energy Sciences and Subsurface Biogeochemical Research program); Princeton in Africa program	Supported by grants from National Research Foundation, South Africa (Blue Skies Program and SANAP), Stellenbosch University VR(R) fund, NSF (chemical sciences), the U.S. Department of Energy (Office of Basic Energy Sciences and Subsurface Biogeochemical Research program), and the Princeton in Africa program. We thank the support staff at the Advanced Light Source for helping with data collection and sample preparation. This work benefited from discussions with F. Morel, D. Sigman, and four anonymous reviewers.	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; BALISTRIERI LS, 1983, GEOCHIM COSMOCHIM AC, V47, P1091, DOI 10.1016/0016-7037(83)90239-9; Bluhm H, 2006, J ELECTRON SPECTROSC, V150, P86, DOI 10.1016/j.elspec.2005.07.005; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Cassar N, 2007, SCIENCE, V317, P1067, DOI 10.1126/science.1144602; Chever F, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005880; Cornell RM, 2003, IRON OXIDES STRUCTUR, DOI [10.1002/3527602097.ins, DOI 10.1002/]; de Groot FMF, 2009, J PHYS CONF SER, V190, DOI 10.1088/1742-6596/190/1/012004; FITZPATRICK RW, 1982, GEODERMA, V27, P335, DOI 10.1016/0016-7061(82)90022-2; Kraemer SM, 2004, AQUAT SCI, V66, P3, DOI 10.1007/s00027-003-0690-5; Lam PJ, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002557; Nishioka J, 2005, MAR CHEM, V95, P51, DOI 10.1016/j.marchem.2004.06.040; Oakes M, 2012, ATMOS CHEM PHYS, V12, P745, DOI 10.5194/acp-12-745-2012; Pollard RT, 2002, DEEP-SEA RES PT II, V49, P3289, DOI 10.1016/S0967-0645(02)00084-X; Sunda W. G., 2001, BIOGEOCHEMISTRY IRON, P41; VANDERLAAN G, 1992, J PHYS-CONDENS MAT, V4, P4189, DOI 10.1088/0953-8984/4/16/019	16	68	69	3	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1199	1201		10.1126/science.1227504	http://dx.doi.org/10.1126/science.1227504			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197531				2022-12-24	WOS:000311666200043
J	Hu, HB; Brittain, GC; Chang, JH; Puebla-Osorio, N; Jin, J; Zal, A; Xiao, YC; Cheng, XH; Chang, MY; Fu, YX; Zal, T; Zhu, CM; Sun, SC				Hu, Hongbo; Brittain, George C.; Chang, Jae-Hoon; Puebla-Osorio, Nahum; Jin, Jin; Zal, Anna; Xiao, Yichuan; Cheng, Xuhong; Chang, Mikyoung; Fu, Yang-Xin; Zal, Tomasz; Zhu, Chengming; Sun, Shao-Cong			OTUD7B controls non-canonical NF-kappa B activation through deubiquitination of TRAF3	NATURE			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; HOMEOSTASIS; PATHWAY; KINASE; RESPONSES; CEZANNE; NIK	The non-canonical NF-kappa B pathway forms a major arm of NF-kappa B signalling that mediates important biological functions, including lymphoid organogenesis, B-lymphocyte function, and cell growth and survival(1-3). Activation of the non-canonical NF-kappa B pathway involves degradation of an inhibitory protein, TNF receptor-associated factor 3 (TRAF3), but how this signalling event is controlled is still unknown(1,2). Here we have identified the deubiquitinase OTUD7B as a pivotal regulator of the non-canonical NF-kappa B pathway. OTUD7B deficiency in mice has no appreciable effect on canonical NF-kappa B activation but causes hyperactivation of non-canonical NF-kappa B. In response to non-canonical NF-kappa B stimuli, OTUD7B binds and deubiquitinates TRAF3, thereby inhibiting TRAF3 proteolysis and preventing aberrant non-canonical NF-kappa B activation. Consequently, the OTUD7B deficiency results in B-cell hyper-responsiveness to antigens, lymphoid follicular hyperplasia in the intestinal mucosa, and elevated host-defence ability against an intestinal bacterial pathogen, Citrobacter rodentium. These findings establish OTUD7B as a crucial regulator of signal-induced non-canonical NF-kappa B activation and indicate a mechanism of immune regulation that involves OTUD7B-mediated deubiquitination and stabilization of TRAF3.	[Hu, Hongbo; Brittain, George C.; Chang, Jae-Hoon; Puebla-Osorio, Nahum; Jin, Jin; Zal, Anna; Xiao, Yichuan; Cheng, Xuhong; Chang, Mikyoung; Zal, Tomasz; Zhu, Chengming; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Fu, Yang-Xin] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Zal, Tomasz; Zhu, Chengming; Sun, Shao-Cong] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Chicago; University of Texas System; University of Texas Health Science Center Houston	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, 7455 Fannin St,Box 902, Houston, TX 77030 USA.	ssun@mdanderson.org	Hu, Hongbo/J-8059-2016	Hu, Hongbo/0000-0002-8177-7641; Zal, Tomasz/0000-0002-3469-4261; Puebla, Nahum/0000-0001-6498-5230; fu, yang-xin/0000-0001-8441-6617; Jin, Jin/0000-0001-7887-5972	National Institutes of Health [AI057555, AI064639, GM84459, CA137059, T32CA009598]; Sister Institution Network Fund of MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA137059, P30CA016672, T32CA009598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064639, R01AI057555, R37AI064639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sister Institution Network Fund of MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. Chen and P. Evans for expression vectors and J. Browning and Biogen for the anti-LT beta R antibody. We also thank the personnel from the flow cytometry, DNA analysis, animal facility, and histology Core facilities at The MD Anderson Cancer Center for technical assistance. This study was supported by grants from the National Institutes of Health (AI057555, AI064639 and GM84459 to S.-C.S.; CA137059 to T.Z.; T32CA009598 to G.C.B.) and the Sister Institution Network Fund of MD Anderson Cancer Center.	Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Dohi T, 2001, J IMMUNOL, V167, P2781, DOI 10.4049/jimmunol.167.5.2781; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Evans PC, 2001, BIOCHEM J, V357, P617, DOI 10.1042/0264-6021:3570617; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lorenz RG, 2003, J IMMUNOL, V170, P5475, DOI 10.4049/jimmunol.170.11.5475; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xie P, 2007, IMMUNITY, V27, P253, DOI 10.1016/j.immuni.2007.07.012; Xie P, 2011, J IMMUNOL, V186, P143, DOI 10.4049/jimmunol.1000290; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	27	150	164	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					371	374		10.1038/nature11831	http://dx.doi.org/10.1038/nature11831			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23334419	Green Accepted			2022-12-24	WOS:000315312900042
J	Liu, J; Wang, B; Cane, MA; Yim, SY; Lee, JY				Liu, Jian; Wang, Bin; Cane, Mark A.; Yim, So-Young; Lee, June-Yi			Divergent global precipitation changes induced by natural versus anthropogenic forcing	NATURE			English	Article							NORTHERN-HEMISPHERE TEMPERATURES; SEA-SURFACE TEMPERATURE; TROPICAL PACIFIC; CLIMATE-CHANGE; PAST MILLENNIUM; OSCILLATION; PATTERNS	As a result of global warming, precipitation is likely to increase in high latitudes and the tropics and to decrease in already dry subtropical regions(1). The absolute magnitude and regional details of such changes, however, remain intensely debated(2,3). As is well known from El Nino studies, sea-surface-temperature gradients across the tropical Pacific Ocean can strongly influence global rainfall(4,5). Palaeoproxy evidence indicates that the difference between the warm west Pacific and the colder east Pacific increased in past periods when the Earth warmed as a result of increased solar radiation(6-9). In contrast, in most model projections of future greenhouse warming this gradient weakens(2,10,11). It has not been clear how to reconcile these two findings. Here we show in climate model simulations that the tropical Pacific sea-surface-temperature gradient increases when the warming is due to increased solar radiation and decreases when it is due to increased greenhouse-gas forcing. For the same global surface temperature increase the latter pattern produces less rainfall, notably over tropical land, which explains why in the model the late twentieth century is warmer than in the Medieval Warm Period (around AD 1000-1250) but precipitation is less. This difference is consistent with the global tropospheric energy budget(12), which requires a balance between the latent heat released in precipitation and radiative cooling. The tropospheric cooling is less for increased greenhouse gases, which add radiative absorbers to the troposphere, than for increased solar heating, which is concentrated at the Earth's surface. Thus warming due to increased greenhouse gases produces a climate signature different from that of warming due to solar radiation changes.	[Liu, Jian] Nanjing Normal Univ, Sch Geog Sci, Minist Educ, Key Lab Virtual Geog Environm, Nanjing 210023, Jiangsu, Peoples R China; [Liu, Jian] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Bin; Yim, So-Young; Lee, June-Yi] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96825 USA; [Wang, Bin; Yim, So-Young; Lee, June-Yi] Univ Hawaii Manoa, Dept Meteorol, Honolulu, HI 96825 USA; [Cane, Mark A.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Nanjing Normal University; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Columbia University	Cane, MA (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	jliu@njnu.edu.cn; mcane@ldeo.columbia.edu	Lee, June-Yi/D-5752-2012; Lee, June-Yi/AAT-3407-2021	Lee, June-Yi/0000-0002-3986-9753; Lee, June-Yi/0000-0002-3986-9753; Cane, Mark/0000-0001-5408-2388	National Basic Research Program [2010CB950102, XDA05080800]; Natural Science Foundation of China [40871007]; Korean Ministry of Education, Science and Technology (MEST) [2011-0021927]; Department of Energy and NOAA [DE-SC0005108, NA08OAR4320912]; International Pacific Research Center; JAMSTEC; NOAA; NASA	National Basic Research Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Korean Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Department of Energy and NOAA; International Pacific Research Center; JAMSTEC; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); NASA(National Aeronautics & Space Administration (NASA))	This work was supported by the National Basic Research Program (award numbers 2010CB950102 and XDA05080800 to J.L.) and Natural Science Foundation of China (award number 40871007 to J.L. and B. W.). B. W. and J.-Y.L. acknowledge the Global Research Laboratory (GRL) Program from the Korean Ministry of Education, Science and Technology (MEST, 2011-0021927). M. A. C. was supported by grant DE-SC0005108 from the Department of Energy and NOAA grant NA08OAR4320912. B. W., S.-Y.Y. and J.-Y.L. acknowledge support from the International Pacific Research Center, which is funded jointly by JAMSTEC, NOAA and NASA. We thank E. Zorita for providing ECHO-G millennium run data, and A. Hense and S.-K. Min for providing ECHO-G A1B and greenhouse-gas run data.	Adams JB, 2003, NATURE, V426, P274, DOI 10.1038/nature02101; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Bauer E, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016639; Cane MA, 1997, SCIENCE, V275, P957, DOI 10.1126/science.275.5302.957; Clement AC, 1996, J CLIMATE, V9, P2190, DOI 10.1175/1520-0442(1996)009<2190:AODT>2.0.CO;2; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; Dore MHI, 2005, ENVIRON INT, V31, P1167, DOI 10.1016/j.envint.2005.03.004; Emile-Geay J, 2008, J CLIMATE, V21, P3134, DOI 10.1175/2007JCLI1884.1; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Lee JY, 2014, CLIM DYNAM, V42, P101, DOI 10.1007/s00382-012-1564-0; Legutke S., 1999, 18 ECHO G, P1; Liu J, 2009, J CLIMATE, V22, P2356, DOI 10.1175/2008JCLI2353.1; Mann ME, 2005, J CLIMATE, V18, P447, DOI 10.1175/JCLI-3276.1; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Mann ME, 2007, ANNU REV EARTH PL SC, V35, P111, DOI 10.1146/annurev.earth.35.031306.140042; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Meehl GA, 1996, NATURE, V382, P56, DOI 10.1038/382056a0; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Min SK, 2006, J CLIMATE, V19, P3237, DOI 10.1175/JCLI3784.1; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Pauling A, 2006, CLIM DYNAM, V26, P387, DOI 10.1007/s00382-005-0090-8; Rodgers KB, 2004, J CLIMATE, V17, P3761, DOI 10.1175/1520-0442(2004)017<3761:TPDVAI>2.0.CO;2; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Ropelewski CF, 1996, J CLIMATE, V9, P1043, DOI 10.1175/1520-0442(1996)009<1043:QSOPR>2.0.CO;2; Vecchi G. A., 2008, EOS T AM GEOPHYS UN, V89, P81, DOI DOI 10.1029/2008EO090002; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; von Storch H, 2004, SCIENCE, V306, P679, DOI 10.1126/science.1096109; WALLACE JM, 1992, J CLIMATE, V5, P561, DOI 10.1175/1520-0442(1992)005<0561:SVDOWS>2.0.CO;2; Wentz FJ, 2007, SCIENCE, V317, P233, DOI 10.1126/science.1140746; Zorita E, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021563	30	137	171	9	253	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					656	659		10.1038/nature11784	http://dx.doi.org/10.1038/nature11784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364744				2022-12-24	WOS:000314219600053
J	Paull, D; Emmanuele, V; Weiss, KA; Treff, N; Stewart, L; Hua, HQ; Zimmer, M; Kahler, DJ; Goland, RS; Noggle, SA; Prosser, R; Hirano, M; Sauer, MV; Egli, D				Paull, Daniel; Emmanuele, Valentina; Weiss, Keren A.; Treff, Nathan; Stewart, Latoya; Hua, Haiqing; Zimmer, Matthew; Kahler, David J.; Goland, Robin S.; Noggle, Scott A.; Prosser, Robert; Hirano, Michio; Sauer, Mark V.; Egli, Dieter			Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants	NATURE			English	Article							MEIOTIC SPINDLE; HUMAN EMBRYOS; CELL-LINES; STEM-CELLS; MOUSE; SEGREGATION; MTDNA; VITRIFICATION; MICROTUBULES; DEFICIENCY	Mitochondrial DNA mutations transmitted maternally within the oocyte cytoplasm often cause life-threatening disorders. Here we explore the use of nuclear genome transfer between unfertilized oocytes of two donors to prevent the transmission of mitochondrial mutations. Nuclear genome transfer did not reduce developmental efficiency to the blastocyst stage, and genome integrity was maintained provided that spontaneous oocyte activation was avoided through the transfer of incompletely assembled spindle-chromosome complexes. Mitochondrial DNA transferred with the nuclear genome was initially detected at levels below 1%, decreasing in blastocysts and stem-cell lines to undetectable levels, and remained undetectable after passaging for more than one year, clonal expansion, differentiation into neurons, cardiomyocytes or beta-cells, and after cellular reprogramming. Stem cells and differentiated cells had mitochondrial respiratory chain enzyme activities and oxygen consumption rates indistinguishable from controls. These results demonstrate the potential of nuclear genome transfer to prevent the transmission of mitochondrial disorders in humans.	[Paull, Daniel; Weiss, Keren A.; Stewart, Latoya; Hua, Haiqing; Zimmer, Matthew; Kahler, David J.; Noggle, Scott A.; Egli, Dieter] New York Stem Cell Fdn Lab, New York, NY 10032 USA; [Emmanuele, Valentina; Hirano, Michio] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Treff, Nathan] Reprod Med Associates New Jersey, Morristown, NJ 07960 USA; [Hua, Haiqing; Goland, Robin S.] Columbia Univ, Coll Phys & Surg, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; [Prosser, Robert; Sauer, Mark V.] Columbia Univ, Coll Phys & Surg, Ctr Womens Reprod Care, New York, NY 10019 USA; [Sauer, Mark V.] Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA	The New York Stem Cell Foundation; Columbia University; Reproductive Medicine Associates of New Jersey; Columbia University; Columbia University; Columbia University	Egli, D (corresponding author), New York Stem Cell Fdn Lab, New York, NY 10032 USA.	mvs9@columbia.edu; d.egli@nyscf.org	Kahler, David J/I-9275-2019	Kahler, David J/0000-0002-7144-2215; Noggle, Scott/0000-0002-0374-2240	New York Stem Cell Foundation; New York State Stem Cell Science award [C026184]; Bernard and Anne Spitzer Fund	New York Stem Cell Foundation; New York State Stem Cell Science award; Bernard and Anne Spitzer Fund	We thank S. Chang and K. Eggan for discussions, Z. Hall for critical reading of the manuscript, and L. Yu and O. Nahum for SNP-array preparation. We thank anonymous oocyte donors for participating in research, and M. Spencer for a Lykos laser system. This work was supported by the New York Stem Cell Foundation, the New York State Stem Cell Science award C026184, and the Bernard and Anne Spitzer Fund.	ASRM, 2012, FERTIL STERIL; Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153; Bianchi V, 2005, HUM REPROD, V20, P1078, DOI 10.1093/humrep/deh736; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; BOLHUIS PA, 1990, BIOCHEM BIOPH RES CO, V170, P994, DOI 10.1016/0006-291X(90)90490-E; BRINKLEY BR, 1975, ANN NY ACAD SCI, V253, P428, DOI 10.1111/j.1749-6632.1975.tb19218.x; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Egli D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1503; Ethics Comm Amer Soc Reprod Med, 2007, FERTIL STERIL, V88, P305, DOI 10.1016/j.fertnstert2007.01.104; Forman EJ, 2012, FERTIL STERIL, V98, P644, DOI 10.1016/j.fertnstert.2012.04.028; Fujikura J, 2012, DIABETOLOGIA, V55, P1689, DOI 10.1007/s00125-012-2508-2; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; GOOK DA, 1994, HUM REPROD, V9, P684, DOI 10.1093/oxfordjournals.humrep.a138572; Hyun CS, 2007, HUM REPROD, V22, P1991, DOI 10.1093/humrep/dem124; INOUE S, 1975, BIOPHYS J, V15, P725, DOI 10.1016/S0006-3495(75)85850-4; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; Larman MG, 2007, REPROD BIOMED ONLINE, V15, P692, DOI 10.1016/S1472-6483(10)60537-8; Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011; Lin DPC, 2004, FERTIL STERIL, V81, P73, DOI 10.1016/j.fertnstert.2003.05.005; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Meirelles FV, 1998, GENETICS, V148, P877; Mimaki M, 2010, ANN NEUROL, V68, P845, DOI 10.1002/ana.22111; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Nuffield Council on Bioethics, 2012, NOV TECHN PREV MIT D; Rosenwaks Z, 2010, NAT MED, V16, P645, DOI 10.1038/nm0610-645; SATHANANTHAN AH, 1991, P NATL ACAD SCI USA, V88, P4806, DOI 10.1073/pnas.88.11.4806; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004; Soc As Reprod Tech Amer Reprod Med, 2004, FERTIL STERIL, V81, P1207, DOI 10.1016/j.fertnstert.2004.01.017; Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326; Tachibana M, 2010, NAT PROTOC, V5, P1138, DOI 10.1038/nprot.2010.75; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wang Jing, 2011, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1906s68	47	173	186	1	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					632	+		10.1038/nature11800	http://dx.doi.org/10.1038/nature11800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23254936	Green Accepted			2022-12-24	WOS:000314219600048
J	Hackett, JA; Sengupta, R; Zylicz, JJ; Murakami, K; Lee, C; Down, TA; Surani, MA				Hackett, Jamie A.; Sengupta, Roopsha; Zylicz, Jan J.; Murakami, Kazuhiro; Lee, Caroline; Down, Thomas A.; Surani, M. Azim			Germline DNA Demethylation Dynamics and Imprint Erasure Through 5-Hydroxymethylcytosine	SCIENCE			English	Article							TET PROTEINS; MOUSE; METHYLATION; GENOME; CELL; 5-METHYLCYTOSINE; SPECIFICATION; MECHANISMS; CONVERSION; GENES	Mouse primordial germ cells (PGCs) undergo sequential epigenetic changes and genome-wide DNA demethylation to reset the epigenome for totipotency. Here, we demonstrate that erasure of CpG methylation (5mC) in PGCs occurs via conversion to 5-hydroxymethylcytosine (5hmC), driven by high levels of TET1 and TET2. Global conversion to 5hmC initiates asynchronously among PGCs at embryonic day (E) 9.5 to E10.5 and accounts for the unique process of imprint erasure. Mechanistically, 5hmC enrichment is followed by its protracted decline thereafter at a rate consistent with replication-coupled dilution. The conversion to 5hmC is an important component of parallel redundant systems that drive comprehensive reprogramming in PGCs. Nonetheless, we identify rare regulatory elements that escape systematic DNA demethylation in PGCs, providing a potential mechanistic basis for transgenerational epigenetic inheritance.	[Hackett, Jamie A.; Sengupta, Roopsha; Zylicz, Jan J.; Murakami, Kazuhiro; Lee, Caroline; Down, Thomas A.; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Hackett, Jamie A.; Sengupta, Roopsha; Zylicz, Jan J.; Murakami, Kazuhiro; Lee, Caroline; Surani, M. Azim] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QN, England; [Zylicz, Jan J.; Surani, M. Azim] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge; University of Cambridge	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England.	a.surani@gurdon.cam.ac.uk	Murakami, Kazuhiro/AAC-4569-2019	Zylicz, Jan/0000-0001-9622-5658; Hackett, Jamie/0000-0002-6237-3684; Surani, Azim/0000-0002-8640-4318; Murakami, Kazuhiro/0000-0003-1759-9542	Wellcome Trust [RG49135, RG44593, 083563]; Human Frontier Science Program	Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Science Program(Human Frontier Science Program)	We thank N. Miller for fluorescence-activated cell sorting analysis, F. Tang and W. Tang for experimental support, and G-L. Xu for reagents. This work was funded by the Wellcome Trust (RG49135, RG44593, and 083563) and the Human Frontier Science Program. Sequencing data have been deposited in the Sequence Read Archive (SRA060914).	Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Hackett JA, 2012, DEVELOPMENT, V139, P3623, DOI 10.1242/dev.081661; Hackett JA, 2012, TRENDS GENET, V28, P164, DOI 10.1016/j.tig.2012.01.005; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Qin CH, 2010, MOL CARCINOGEN, V49, P54, DOI 10.1002/mc.20576; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	25	530	549	1	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2013	339	6118					448	452		10.1126/science.1229277	http://dx.doi.org/10.1126/science.1229277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23223451	Green Accepted			2022-12-24	WOS:000313960700044
J	Menting, JG; Whittaker, J; Margetts, MB; Whittaker, LJ; Kong, GKW; Smith, BJ; Watson, CJ; Zakova, L; Kletvikova, E; Jiracek, J; Chan, SJ; Steiner, DF; Dodson, GG; Brzozowski, AM; Weiss, MA; Ward, CW; Lawrence, MC				Menting, John G.; Whittaker, Jonathan; Margetts, Mai B.; Whittaker, Linda J.; Kong, Geoffrey K. -W.; Smith, Brian J.; Watson, Christopher J.; Zakova, Lenka; Kletvikova, Emilia; Jiracek, Jiri; Chan, Shu Jin; Steiner, Donald F.; Dodson, Guy G.; Brzozowski, Andrzej M.; Weiss, Michael A.; Ward, Colin W.; Lawrence, Michael C.			How insulin engages its primary binding site on the insulin receptor	NATURE			English	Article							1ST 3 DOMAINS; DIABETES-ASSOCIATED MUTATIONS; LIGAND-INDUCED ACTIVATION; MOLECULAR REPLACEMENT; PROTEIN; AFFINITY; MODEL; REFINEMENT; PEPTIDE; ELEMENT	Insulin receptor signalling has a central role in mammalian biology, regulating cellular metabolism, growth, division, differentiation and survival(1,2). Insulin resistance contributes to the pathogenesis of type 2 diabetes mellitus and the onset of Alzheimer's disease(3); aberrant signalling occurs in diverse cancers, exacerbated by crosstalk with the homologous type 1 insulin-like growth factor receptor (IGF1R)(4). Despite more than three decades of investigation, the three-dimensional structure of the insulin-insulin receptor complex has proved elusive, confounded by the complexity of producing the receptor protein. Here we present the first view, to our knowledge, of the interaction of insulin with its primary binding site on the insulin receptor, on the basis of four crystal structures of insulin bound to truncated insulin receptor constructs. The direct interaction of insulin with the first leucine-rich-repeat domain (L1) of insulin receptor is seen to be sparse, the hormone instead engaging the insulin receptor carboxy-terminal alpha-chain (alpha CT) segment, which is itself remodelled on the face of L1 upon insulin binding. Contact between insulin and L1 is restricted to insulin B-chain residues. The aCT segment displaces the B-chain C-terminal beta-strand away from the hormone core, revealing the mechanism of a long-proposed conformational switch in insulin upon receptor engagement. This mode of hormone-receptor recognition is novel within the broader family of receptor tyrosine kinases(5). We support these findings by photo-crosslinking data that place the suggested interactions into the context of the holoreceptor and by isothermal titration calorimetry data that dissect the hormone-insulin receptor interface. Together, our findings provide an explanation for a wealth of biochemical data from the insulin receptor and IGF1R systems relevant to the design of therapeutic insulin analogues.	[Menting, John G.; Margetts, Mai B.; Kong, Geoffrey K. -W.; Smith, Brian J.; Ward, Colin W.; Lawrence, Michael C.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Whittaker, Jonathan; Whittaker, Linda J.; Weiss, Michael A.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Chem, Melbourne, Vic 3086, Australia; [Watson, Christopher J.; Dodson, Guy G.; Brzozowski, Andrzej M.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Zakova, Lenka; Kletvikova, Emilia; Jiracek, Jiri] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, CR-16610 Prague, Czech Republic; [Chan, Shu Jin; Steiner, Donald F.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Lawrence, Michael C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; Case Western Reserve University; La Trobe University; University of York - UK; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of Chicago; University of Melbourne	Lawrence, MC (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	michael.weiss@case.edu; lawrence@wehi.edu.au	Zakova, Lenka/Y-6234-2019; Zakova, Lenka/A-7119-2008; Jiracek, Jiri/A-7124-2008; Jiracek, Jiri/Y-6703-2019; Smith, Brian J/F-8282-2011; Lawrence, Michael C/A-5357-2009	Zakova, Lenka/0000-0001-6439-2574; Jiracek, Jiri/0000-0003-3848-2773; Jiracek, Jiri/0000-0003-3848-2773; Smith, Brian J/0000-0003-0498-1910; Lawrence, Michael/0000-0003-1999-0801; Menting, John/0000-0003-3638-3544	Australian National Health and Medical Research Council (NHMRC) [516729, 575539, 1005896]; Hazel and Pip Appel Fund; NHMRC [361646]; Victorian State Government; NIH [DK40949, DK13914, DK20595]; American Diabetes Association [1-11INI-31]; Grant Agency of the Czech Republic [P207/11/P430]; Research Project of the Academy of Sciences of the Czech Republic [RVO: 61388963]; BBSRC; UoY Research Priming Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013914, P60DK020595, R37DK013914, P30DK020595, R01DK040949] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Hazel and Pip Appel Fund; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Research Project of the Academy of Sciences of the Czech Republic(Czech Academy of Sciences); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UoY Research Priming Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This Letter is dedicated to our co-author, the late Guy Dodson, in recognition of his lifetime contribution to the study of the structure of insulin. This work was supported by Australian National Health and Medical Research Council (NHMRC) Project grants 516729, 575539 and 1005896 and the Hazel and Pip Appel Fund (to M. C. L.), NHMRC Independent Research Institutes Infrastructure Support Scheme Grant 361646 and Victorian State Government Operational Infrastructure Support Grant (to the Walter and Eliza Hall Institute of Medical Research), NIH grant no. DK40949(to M. A. W. and J.W.) and American Diabetes Association grant no. 1-11INI-31 (to J.W.), Grant Agency of the Czech Republic grant P207/11/P430 (to L.Z.), Research Project of the Academy of Sciences of the Czech Republic RVO: 61388963 (to the Institute of Organic Chemistry and Biochemistry), NIH grants DK13914 and DK20595 (to D. F. S.), a BBSRC PhD studentship (to C. J.W.) and the UoY Research Priming Fund(to the York Structural Biology Laboratory). Part of this research was undertaken on the MX2 beamline at the Australian Synchrotron (AS), Victoria, Australia. We thank the DLS for access to beamline I24 and the Australian International Synchrotron Access Program for travel funds. We thank P. Colman and J. Gulbis, our colleagues at CSIRO and the AS beam line staff for their support; J. Turkenburg for assistance in collecting data at DLS; K. Huang for assistance with midi-receptor photo-crosslinking; Q.-X. Hua and Y. Yang for discussion of NMR studies of insulin; S.-Q. Hu, S. H. Nakagawa, N. F. Phillips and S. Wang for assistance with insulin analogue synthesis; P. G. Katsoyannis for advice about the synthesis of photo-reactive insulin analogues and for providing an initial set of Pap analogues; K. Siddle for supplying the 83-7 and 83-14 hybridomas; L. Lu and the fermentation group CSIRO Materials Science and Engineering for large-scale cell culture.	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bricogne G., 2011, BUSTER VERSION 2 10; Brunger AT, 2009, ACTA CRYSTALLOGR D, V65, P128, DOI 10.1107/S0907444908043795; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Evans P, 2012, SCIENCE, V336, P986, DOI 10.1126/science.1222162; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; JONES TA, 1986, EMBO J, V5, P819, DOI 10.1002/j.1460-2075.1986.tb04287.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Kleywegt GJ, 1997, ACTA CRYSTALLOGR D, V53, P179, DOI 10.1107/S0907444996012279; Kristensen C, 1999, J BIOL CHEM, V274, P37351, DOI 10.1074/jbc.274.52.37351; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MARKUSSEN J, 1991, J BIOL CHEM, V266, P18814; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Menting JG, 2009, BIOCHEMISTRY-US, V48, P5492, DOI 10.1021/bi900261q; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; Sparrow LG, 2008, PROTEINS, V71, P426, DOI 10.1002/prot.21768; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Ward CW, 2012, CURR OPIN STRUC BIOL, V22, P360, DOI 10.1016/j.sbi.2012.03.014; Ward CW, 2009, BIOESSAYS, V31, P422, DOI 10.1002/bies.200800210; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Whittaker J, 2012, P NATL ACAD SCI USA, V109, P11166, DOI 10.1073/pnas.1205681109; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; Xu B, 2004, DIABETES, V53, P1599, DOI 10.2337/diabetes.53.6.1599; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w	52	264	284	3	308	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					241	U276		10.1038/nature11781	http://dx.doi.org/10.1038/nature11781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23302862	Green Accepted			2022-12-24	WOS:000313259600043
J	Boj, SF; van Es, JH; Huch, M; Li, VSW; Jose, A; Hatzis, P; Mokry, M; Haegebarth, A; van den Born, M; Chambon, P; Voshol, P; Dor, Y; Cuppen, E; Fillat, C; Clevers, H				Boj, Sylvia F.; van Es, Johan H.; Huch, Meritxell; Li, Vivian S. W.; Jose, Anabel; Hatzis, Pantelis; Mokry, Michal; Haegebarth, Andrea; van den Born, Maaike; Chambon, Pierre; Voshol, Peter; Dor, Yuval; Cuppen, Edwin; Fillat, Cristina; Clevers, Hans			Diabetes Risk Gene and Wnt Effector Tcf7l2/TCF4 Controls Hepatic Response to Perinatal and Adult Metabolic Demand	CELL			English	Article							BETA-CATENIN; LIVER; POLYMORPHISMS; EXPRESSION; GLUCOSE; CORRELATE; RECEPTOR	Most studies on TCF7L2 SNP variants in the pathogenesis of type 2 diabetes (T2D) focus on a role of the encoded transcription factor TCF4 in beta cells. Here, a mouse genetics approach shows that removal of TCF4 from beta cells does not affect their function, whereas manipulating TCF4 levels in the liver has major effects on metabolism. In Tcf7l2(-/-) mice, the immediate postnatal surge in liver metabolism does not occur. Consequently, pups die due to hypoglycemia. By combining chromatin immunoprecipitation with gene expression profiling, we identify a TCF4-controlled metabolic gene program that is acutely activated in the postnatal liver. In concordance, adult liver-specific Tcf7l2 knockout mice show reduced hepatic glucose production during fasting and display improved glucose homeostasis when maintained on high-fat diet. Furthermore, liver-specific TCF4 overexpression increases hepatic glucose production. These observations imply that TCF4 directly activates metabolic genes and that inhibition of Wnt signaling may be beneficial in metabolic disease.	[Boj, Sylvia F.; van Es, Johan H.; Huch, Meritxell; Li, Vivian S. W.; Hatzis, Pantelis; Mokry, Michal; Haegebarth, Andrea; van den Born, Maaike; Cuppen, Edwin; Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Boj, Sylvia F.; van Es, Johan H.; Huch, Meritxell; Li, Vivian S. W.; Hatzis, Pantelis; Mokry, Michal; Haegebarth, Andrea; van den Born, Maaike; Cuppen, Edwin; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Jose, Anabel; Fillat, Cristina] CIBERER, Barcelona 08036, Spain; [Jose, Anabel; Fillat, Cristina] IDIBAPS, Barcelona 08036, Spain; [Chambon, Pierre] Univ Strasbourg 1, IGBMC, F-67404 Illkirch Graffenstaden, France; [Voshol, Peter] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Cambridge CB2 0QQ, England; [Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Hebrew University of Jerusalem	Clevers, H (corresponding author), KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Cuppen, Edwin/F-5696-2011; Mokry, Michal/AAN-3809-2021; Cuppen, Edwin/H-2389-2016; van+Es, Johan/ABD-5411-2021; Fillat, Cristina/ABH-1674-2020	Cuppen, Edwin/0000-0002-0400-9542; Mokry, Michal/0000-0002-5298-4852; Cuppen, Edwin/0000-0002-0400-9542; Fillat, Cristina/0000-0002-0801-3338; Li, Vivian/0000-0003-2041-0085	Stichting Diabetes Onderzoek Nederland; Diabetes Fonds; EMBO [ALT-835-2007]; KWF/PF HUBR [2007-3956]; CGCII; long-term Marie Curie fellowship; Ti Pharm [T3-106]; MINECO [BIO2011-30299-C02-02]; Instituto de Salud Carlos III [IIS10/00014];  [EU/232814-stemcellmark];  [EU/236954-ICSC LGR5]	Stichting Diabetes Onderzoek Nederland; Diabetes Fonds; EMBO(European Molecular Biology Organization (EMBO)); KWF/PF HUBR; CGCII; long-term Marie Curie fellowship; Ti Pharm; MINECO(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); ; 	We thank H. Begthel, J. Korving, L. van Gurp, C. Kroon-Veenboer, and B. El Haddouti for technical assistance and T. Mahmoudi and J.D. Mul for their helpful discussions. This work was supported by Stichting Diabetes Onderzoek Nederland and the Diabetes Fonds. S.F.B. is supported by EMBO long-term fellowship (ALT-835-2007) and by EU/232814-stemcellmark; J.H.E. is supported by EU/232814-stemcellmark; V.S.W.L. is supported by KWF/PF HUBR 2007-3956; P.H. was supported by CGCII; A.H. was supported by KWF/PF HUBR 2007-3956; M.H. is supported by long-term Marie Curie fellowship and EU/236954-ICSC LGR5; M.B. is supported by Ti Pharm/T3-106; and A.J. and C.F. are supported by BIO2011-30299-C02-02 from MINECO and IIS10/00014 from Instituto de Salud Carlos III.	Apte U, 2007, AM J PHYSIOL-GASTR L, V292, pG1578, DOI 10.1152/ajpgi.00359.2006; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DASHTI N, 1979, BIOCHEM MED METAB B, V22, P365, DOI 10.1016/0006-2944(79)90024-3; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elbein SC, 2007, DIABETOLOGIA, V50, P1621, DOI 10.1007/s00125-007-0717-x; Fechner H, 1999, GENE THER, V6, P1520, DOI 10.1038/sj.gt.3301030; FERRE P, 1986, REPROD NUTR DEV, V26, P619, DOI 10.1051/rnd:19860413; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gregorieff A, 2004, EMBO J, V23, P1825, DOI 10.1038/sj.emboj.7600191; Gustafsson J, 2009, INDIAN J MED RES, V130, P618; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Huch M, 2009, NEOPLASIA, V11, P518, DOI 10.1593/neo.81674; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Mokry M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015092; Parrizas M, 2001, MOL CELL BIOL, V21, P3234, DOI 10.1128/MCB.21.9.3234-3243.2001; Pilgaard K, 2009, DIABETOLOGIA, V52, P1298, DOI 10.1007/s00125-009-1307-x; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; Savic D, 2011, GENOME RES, V21, P1417, DOI 10.1101/gr.123745.111; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Schuler M, 2004, GENESIS, V39, P167, DOI 10.1002/gene.20039; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Spear BT, 2006, CELL MOL LIFE SCI, V63, P2922, DOI 10.1007/s00018-006-6258-5; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Es JH, 2012, MOL CELL BIOL, V32, P1918, DOI 10.1128/MCB.06288-11; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187	38	166	173	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1595	1607		10.1016/j.cell.2012.10.053	http://dx.doi.org/10.1016/j.cell.2012.10.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260145	Bronze			2022-12-24	WOS:000312890300022
J	Shakur, H; Roberts, I; Piot, P; Horton, R; Krug, E; Mersch, J				Shakur, Haleema; Roberts, Ian; Piot, Peter; Horton, Richard; Krug, Etienne; Mersch, Jeannot			A promise to save 100 000 trauma patients	LANCET			English	Editorial Material									[Shakur, Haleema; Roberts, Ian; Piot, Peter] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Horton, Richard] The Lancet, London NW1 7BY, England; [Krug, Etienne] WHO, CH-1211 Geneva, Switzerland; [Mersch, Jeannot] European Federat Rd Traff Victims, Luxembourg, Luxembourg	University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Roberts, I (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	ian.roberts@lshtm.ac.uk		Shakur-Still, Haleema/0000-0002-6511-109X				Aeron-Thomas A, 2004, INVOLVEMENT IMPACT R; Guerriero C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018987; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Peden M., 2004, WORLD REPORT ROAD TR; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Roberts I, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004896.pub3; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5	9	13	15	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2062	2063		10.1016/S0140-6736(12)62037-6	http://dx.doi.org/10.1016/S0140-6736(12)62037-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245601				2022-12-24	WOS:000312387000008
J	Rawlins, M				Rawlins, Michael			We are asking more questions about NICE appraisal of Tamiflu	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Burch J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13580; NICE, 2011, TECHN APPR PROC GUID; NICE, 2002, SYST REV EFF COST EF	3	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 12	2012	345								e8420	10.1136/bmj.e8420	http://dx.doi.org/10.1136/bmj.e8420			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056MU	23236048				2022-12-24	WOS:000312495100018
J	Liu, Y; Rutlin, M; Huang, SY; Barrick, CA; Wang, F; Jones, KR; Tessarollo, L; Ginty, DD				Liu, Yin; Rutlin, Michael; Huang, Siyi; Barrick, Colleen A.; Wang, Fan; Jones, Kevin R.; Tessarollo, Lino; Ginty, David D.			Sexually Dimorphic BDNF Signaling Directs Sensory Innervation of the Mammary Gland	SCIENCE			English	Article							CELL-DEATH; NERVOUS-SYSTEM; IN-VIVO; TRKB; RECEPTOR; NEURONS; MOUSE; DIFFERENTIATION; ORGANIZATION; GENE	How neural circuits associated with sexually dimorphic organs are differentially assembled during development is unclear. Here, we report a sexually dimorphic pattern of mouse mammary gland sensory innervation and the mechanism of its formation. Brain-derived neurotrophic factor (BDNF), emanating from mammary mesenchyme and signaling through its receptor TrkB on sensory axons, is required for establishing mammary gland sensory innervation of both sexes at early developmental stages. Subsequently, in males, androgens promote mammary mesenchymal expression of a truncated form of TrkB, which prevents BDNF-TrkB signaling in sensory axons and leads to a rapid loss of mammary gland innervation independent of neuronal apoptosis. Thus, sex hormone regulation of a neurotrophic factor signal directs sexually dimorphic axonal growth and maintenance, resulting in generation of a sex-specific neural circuit.	[Liu, Yin; Rutlin, Michael; Huang, Siyi; Ginty, David D.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Barrick, Colleen A.; Tessarollo, Lino] NCI, Mouse Canc Genet Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Wang, Fan] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Jones, Kevin R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Howard Hughes Medical Institute; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University; University of Colorado System; University of Colorado Boulder	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu		Liu, Yin/0000-0002-2377-2703; JONES, KEVIN/0000-0002-3802-7562	NIH [NS34814, EY014998, DE019440]; NATIONAL CANCER INSTITUTE [ZIABC010391, ZIABC010390] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034814, P30NS050274, R37NS034814, R29NS034814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Ginty laboratory for assistance and discussions throughout the course of this project, and A. Kolodkin and R. Kuruvilla for comments on the manuscript. This work was supported by NIH grants NS34814 (D. D. G.), EY014998 (K.R.J.), and DE019440 (F. W.). D. D. G. is an investigator of the Howard Hughes Medical Institute. BDNFlox mice are covered under U. S. patent no. 4,959,317, which is licensed to Bristol-Myer Squibb Company, with the right to grant sublicenses. The mice are available for noncommercial biomedical research under a Material Transfer Agreement with the University of Colorado.	Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; BIFFO S, 1995, DEVELOPMENT, V121, P2461; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; da Silva S, 2011, P NATL ACAD SCI USA, V108, P3395, DOI 10.1073/pnas.1014411108; Dorsey SG, 2006, NEURON, V51, P21, DOI 10.1016/j.neuron.2006.06.009; Dunbar ME, 1999, DEVELOPMENT, V126, P3485; Forger NG, 2006, NEUROSCIENCE, V138, P929, DOI 10.1016/j.neuroscience.2005.07.006; Fryer RH, 1997, EXP NEUROL, V148, P616, DOI 10.1006/exnr.1997.6699; Gorski JA, 2003, J NEUROSCI, V23, P6856; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; NORDEEN EJ, 1985, SCIENCE, V229, P671, DOI 10.1126/science.4023706; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Robinson GW, 2007, NAT REV GENET, V8, P963, DOI 10.1038/nrg2227; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; WRIGHT LL, 1987, INT J DEV NEUROSCI, V5, P305, DOI 10.1016/0736-5748(87)90005-0	21	47	47	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1357	1360		10.1126/science.1228258	http://dx.doi.org/10.1126/science.1228258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224557	Green Accepted			2022-12-24	WOS:000311991200071
J	Sipp, D; Turner, L				Sipp, Douglas; Turner, Leigh			US Regulation of Stem Cells as Medical Products	SCIENCE			English	Editorial Material							FDA REGULATION; ENCEPHALOMYELITIS; RULES; TEXAS		[Sipp, Douglas] RIKEN, Ctr Dev Biol, Kobe, Hyogo 12345, Japan; [Turner, Leigh] Univ Minnesota, Ctr Bioeth, Minneapolis, MN 55455 USA; [Turner, Leigh] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN 55455 USA; [Turner, Leigh] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA	RIKEN; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sipp, D (corresponding author), RIKEN, Ctr Dev Biol, Kobe, Hyogo 12345, Japan.	sipp@cdb.riken.jp	Sipp, Doug/C-9218-2017	Sipp, Doug/0000-0002-5979-0938; Turner, Leigh/0000-0001-7283-6809				Alderazi YJ, 2012, J CHILD NEUROL, V27, P632, DOI 10.1177/0883073811422831; Carpenter D, 2010, PRINC STUD AM POLIT, P73; Cyranoski D, 2012, NATURE, V484, P149, DOI 10.1038/484149a; Cyranoski D, 2011, NATURE, V477, P377; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Fink DW, 2009, SCIENCE, V324, P1662, DOI 10.1126/science.1173712; Giannakopoulou A, 2011, EXP NEUROL, V230, P16, DOI 10.1016/j.expneurol.2010.04.011; Gottlieb S., 2012, WALL STREET J, pA13; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; Ikegaya H, 2012, NATURE, V489, P33, DOI 10.1038/489033c; Johnson L., 2012, HOUSTON PUBLIC  1026; Kaiser J, 2012, SCIENCE, V336, P284, DOI 10.1126/science.336.6079.284; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Levine AD, 2012, REGEN MED, V7, P451, DOI [10.2217/RME.12.43, 10.2217/rme.12.43]; Patra P.K., 2010, LAW TECHNOL SCI, V7, P295; Pera MF, 2012, SUBMISSION NHMRC PUB; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Steeves JD, 2011, YONSEI MED J, V52, P701, DOI 10.3349/ymj.2011.52.5.701; Thirabanjasak D, 2010, J AM SOC NEPHROL, V21, P1218, DOI 10.1681/ASN.2009111156; von Eschenbach Andrew, 2012, WALL STREET J, pA19	20	37	38	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1296	1297		10.1126/science.1229918	http://dx.doi.org/10.1126/science.1229918			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	049NZ	23224541				2022-12-24	WOS:000311991200048
J	Araki, R; Uda, M; Hoki, Y; Sunayama, M; Nakamura, M; Ando, S; Sugiura, M; Ideno, H; Shimada, A; Nifuji, A; Abe, M				Araki, Ryoko; Uda, Masahiro; Hoki, Yuko; Sunayama, Misato; Nakamura, Miki; Ando, Shunsuke; Sugiura, Mayumi; Ideno, Hisashi; Shimada, Akemi; Nifuji, Akira; Abe, Masumi			Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells	NATURE			English	Article							GROUND-STATE; C-MYC; MICE; GENERATION; FIBROBLASTS	The advantages of using induced pluripotent stem cells (iPSCs) instead of embryonic stem (ES) cells in regenerative medicine centre around circumventing concerns about the ethics of using ES cells and the likelihood of immune rejection of ES-cell-derived tissues(1,2). However, partial reprogramming and genetic instabilities in iPSCs(3-6) could elicit immune responses in transplant recipients even when iPSC-derived differentiated cells are transplanted. iPSCs are first differentiated into specific types of cells in vitro for subsequent transplantation. Although model transplantation experiments have been conducted using various iPSC-derived differentiated tissues(7-10) and immune rejections have not been observed, careful investigation of the immunogenicity of iPSC-derived tissue is becoming increasingly critical, especially as this has not been the focus of most studies done so far. A recent study reported immunogenicity of iPSC- but not ES-cell-derived teratomas(11) and implicated several causative genes. Nevertheless, some controversy has arisen regarding these findings(12). Here we examine the immunogenicity of differentiated skin and bone marrow tissues derived from mouse iPSCs. To ensure optimal comparison of iPSCs and ES cells, we established ten integration-free iPSC and seven ES-cell lines using an inbred mouse strain, C57BL/6. We observed no differences in the rate of success of transplantation when skin and bone marrow cells derived from iPSCs were compared with ES-cell-derived tissues. Moreover, we observed limited or no immune responses, including T-cell infiltration, for tissues derived from either iPSCs or ES cells, and no increase in the expression of the immunogenicity-causing Zg16 and Hormad1 genes in regressing skin and teratoma tissues. Our findings suggest limited immunogenicity of transplanted cells differentiated from iPSCs and ES cells.	[Araki, Ryoko; Uda, Masahiro; Hoki, Yuko; Sunayama, Misato; Nakamura, Miki; Ando, Shunsuke; Sugiura, Mayumi; Ideno, Hisashi; Nifuji, Akira; Abe, Masumi] Natl Inst Radiol Sci, Transcriptome Res Grp, Chiba 2638555, Japan; [Araki, Ryoko] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ideno, Hisashi; Shimada, Akemi; Nifuji, Akira] Tsurumi Univ, Sch Dent Med, Dept Pharmacol, Yokohama, Kanagawa 2308501, Japan	National Institutes for Quantum Science & Technology; Japan Science & Technology Agency (JST); Tsurumi University	Abe, M (corresponding author), Natl Inst Radiol Sci, Transcriptome Res Grp, Chiba 2638555, Japan.	abemasum@nirs.go.jp	Nifuji, Akira/AAX-7907-2021	Nifuji, Akira/0000-0002-8182-4380; Abe, Masumi/0000-0003-1550-2006	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [22592053, 23592784] Funding Source: KAKEN	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Yamanaka for providing the 2A plasmid vectors; K. Ito, N. Nakajima and K. Kawabata for technical advice on the transplantation experiments; H. Yoshida, K. Nishikawa, A. Ishibashi, R. Watanabe, M. Nakamura and T. Maeda for technical assistance. This work was partially funded by a research grant from Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency.	Araki R, 2011, STEM CELLS, V29, P1362, DOI 10.1002/stem.685; BILLINGHAM RE, 1951, J EXP BIOL, V28, P385; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Bubnic SJ, 2005, HEMATOLOGY, V10, P289, DOI 10.1080/10245330500093468; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chen Yao-Tseng, 2005, Cancer Immun, V5, P9; Dressel R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002622; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Jincho Y, 2010, J BIOL CHEM, V285, P26384, DOI 10.1074/jbc.M110.115915; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martins-Taylor K, 2012, STEM CELLS, V30, P22, DOI 10.1002/stem.705; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2011, CIRC RES, V109, P720, DOI 10.1161/RES.0b013e318232e187; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Puri MC, 2012, STEM CELLS, V30, P10, DOI 10.1002/stem.788; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Tucker BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018992; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	30	350	371	2	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					100	104		10.1038/nature11807	http://dx.doi.org/10.1038/nature11807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23302801				2022-12-24	WOS:000314741200042
J	Volk, LJ; Bachman, JL; Johnson, R; Yu, YL; Huganir, RL				Volk, Lenora J.; Bachman, Julia L.; Johnson, Richard; Yu, Yilin; Huganir, Richard L.			PKM-zeta is not required for hippocampal synaptic plasticity, learning and memory	NATURE			English	Article							PROTEIN-KINASE-M; LONG-TERM POTENTIATION; C-ZETA; ZIP; MAINTENANCE; INHIBITOR; MECHANISM; ERASURE; CELLS	Long-term potentiation (LTP), a well-characterized form of synaptic plasticity, has long been postulated as a cellular correlate of learning and memory. Although LTP can persist for long periods of time(1), the mechanisms underlying LTP maintenance, in the midst of ongoing protein turnover and synaptic activity, remain elusive. Sustained activation of the brain-specific protein kinase C (PKC) isoform protein kinase M-zeta (PKM-zeta) has been reported to be necessary for both LTP maintenance and long-term memory(2). Inhibiting PKM-zeta activity using a synthetic zeta inhibitory peptide (ZIP) based on the PKC-zeta pseudosubstrate sequence reverses established LTP in vitro and in vivo(3,4). More notably, infusion of ZIP eliminates memories for a growing list of experience-dependent behaviours, including active place avoidance(4), conditioned taste aversion(5), fear conditioning and spatial learning(6). However, most of the evidence supporting a role for PKM-zeta in LTP and memory relies heavily on pharmacological inhibition of PKM-zeta by ZIP. To further investigate the involvement of PKM-zeta in the maintenance of LTP and memory, we generated transgenic mice lacking PKC-zeta and PKM-zeta. We find that both conventional and conditional PKC zeta/PKM-zeta knockout mice show normal synaptic transmission and LTP at Schaffer collateral-CA1 synapses, and have no deficits in several hippocampal-dependent learning and memory tasks. Notably, ZIP still reverses LTP in PKC-zeta/PKM-zeta knockout mice, indicating that the effects of ZIP are independent of PKM-zeta.	[Volk, Lenora J.; Bachman, Julia L.; Johnson, Richard; Yu, Yilin; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu		Volk, Lenora/0000-0002-9074-4091	National Institute of Health [NS36715, T32MH15330]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715, P30NS050274] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Schutz for providing the CaMKII Cre-ER<SUP>T2</SUP> mice, M. Gallagher and D. Smith for advice on behaviour and M. Coulter for technical support. We also thank all members of the Huganir lab for discussion and support. This work was supported by grants from the National Institute of Health (NS36715) and the Howard Hughes Medical Institute (to R. L. H.). L.J.V. is supported by a training grant from the National Institute of Health (T32MH15330).	Abraham WC, 2002, J NEUROSCI, V22, P9626; DENNY JB, 1990, BRAIN RES, V534, P201, DOI 10.1016/0006-8993(90)90130-4; Erdmann G, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-63; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Hirai T, 2003, NEUROSCI LETT, V348, P151, DOI 10.1016/S0304-3940(03)00780-8; Huang Y Y, 1994, Learn Mem, V1, P74; Kim SJ, 2007, NEURON, V56, P582, DOI 10.1016/j.neuron.2007.10.030; Krotova K, 2006, BRIT J PHARMACOL, V148, P732, DOI 10.1038/sj.bjp.0706777; Kwapis JL, 2009, BEHAV NEUROSCI, V123, P844, DOI 10.1037/a0016343; Lim S, 2008, LIFE SCI, V82, P733, DOI 10.1016/j.lfs.2008.01.005; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Lisman J, 2012, HIPPOCAMPUS, V22, P648, DOI 10.1002/hipo.20980; Makuch L, 2011, NEURON, V71, P1022, DOI 10.1016/j.neuron.2011.08.017; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; Mei F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021568; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sacktor TC, 2012, HIPPOCAMPUS, V22, P645, DOI 10.1002/hipo.20978; Sacktor TC, 2008, PROG BRAIN RES, V169, P27, DOI 10.1016/S0079-6123(07)00002-7; Sajikumar S, 2005, J NEUROSCI, V25, P5750, DOI 10.1523/JNEUROSCI.1104-05.2005; Sajikumar S, 2011, P NATL ACAD SCI USA, V108, P2551, DOI 10.1073/pnas.1016849108; Serrano P, 2005, J NEUROSCI, V25, P1979, DOI 10.1523/JNEUROSCI.5132-04.2005; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shema R, 2011, SCIENCE, V331, P1207, DOI 10.1126/science.1200215; Wu-Zhang AX, 2012, J BIOL CHEM, V287, P12879, DOI 10.1074/jbc.M112.357244; Yao YD, 2013, NEUROPHARMACOLOGY, V64, P37, DOI 10.1016/j.neuropharm.2012.07.018	28	218	223	0	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					420	U169		10.1038/nature11802	http://dx.doi.org/10.1038/nature11802			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23283174	Green Accepted			2022-12-24	WOS:000313615900055
J	Di Meglio, T; Kratochwil, CF; Vilain, N; Loche, A; Vitobello, A; Yonehara, K; Hrycaj, SM; Roska, B; Peters, AHFM; Eichmann, A; Wellik, D; Ducret, S; Rijli, FM				Di Meglio, Thomas; Kratochwil, Claudius F.; Vilain, Nathalie; Loche, Alberto; Vitobello, Antonio; Yonehara, Keisuke; Hrycaj, Steven M.; Roska, Botond; Peters, Antoine H. F. M.; Eichmann, Anne; Wellik, Deneen; Ducret, Sebastien; Rijli, Filippo M.			Ezh2 Orchestrates Topographic Migration and Connectivity of Mouse Precerebellar Neurons	SCIENCE			English	Article							GUIDANCE; COMPLEX	We investigated the role of histone methyltransferase Ezh2 in tangential migration of mouse precerebellar pontine nuclei, the main relay between neocortex and cerebellum. By counteracting the sonic hedgehog pathway, Ezh2 represses Netrin1 in dorsal hindbrain, which allows normal pontine neuron migration. In Ezh2 mutants, ectopic Netrin1 derepression results in abnormal migration and supernumerary nuclei integrating in brain circuitry. Moreover, intrinsic topographic organization of pontine nuclei according to rostrocaudal progenitor origin is maintained throughout migration and correlates with patterned cortical input. Ezh2 maintains spatially restricted Hox expression, which, in turn, regulates differential expression of the repulsive receptor Unc5b in migrating neurons; together, they generate subsets with distinct responsiveness to environmental Netrin1. Thus, Ezh2-dependent epigenetic regulation of intrinsic and extrinsic transcriptional programs controls topographic neuronal guidance and connectivity in the cortico-ponto-cerebellar pathway.	[Di Meglio, Thomas; Kratochwil, Claudius F.; Vilain, Nathalie; Loche, Alberto; Vitobello, Antonio; Yonehara, Keisuke; Roska, Botond; Peters, Antoine H. F. M.; Ducret, Sebastien; Rijli, Filippo M.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Kratochwil, Claudius F.; Loche, Alberto; Vitobello, Antonio; Roska, Botond; Peters, Antoine H. F. M.; Rijli, Filippo M.] Univ Basel, CH-4056 Basel, Switzerland; [Hrycaj, Steven M.; Eichmann, Anne] Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr, New Haven, CT 06511 USA; [Eichmann, Anne] INSERM, CIRB, U1050, F-75005 Paris, France; [Wellik, Deneen] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	Friedrich Miescher Institute for Biomedical Research; University of Basel; Yale University; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Michigan System; University of Michigan	Rijli, FM (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	filippo.rijli@fmi.ch	Vitobello, Antonio/ABC-2970-2021; Kratochwil, Claudius F/B-1294-2013; Roska, Botond/AAD-7268-2021; Peters, Antoine/ABA-6283-2020; RIJLI, Filippo/AAP-2516-2020	Vitobello, Antonio/0000-0003-3717-8374; Kratochwil, Claudius F/0000-0002-5646-3114; RIJLI, Filippo/0000-0003-0515-0182; Peters, Antoine/0000-0002-0311-1887; Yonehara, Keisuke/0000-0001-9541-6671; Loche, Alberto/0000-0001-5974-6008	European Molecular Biology Organization Long-Term Fellowship; Swiss National Science Foundation [Sinergia CRSI33_127440]; Association pour la Recherche sur la Sclerose en Plaques; Novartis Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061402] Funding Source: NIH RePORTER	European Molecular Biology Organization Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Association pour la Recherche sur la Sclerose en Plaques; Novartis Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank K. Balint, F. Boukhtouche, Y.-Y. Lee, C.-Y. Liang, D. Kraus, T. Mathivet, F. Santagati, J. F. Spetz, and A. Yallowitz for technical support and discussion. We are grateful to M. Tessier-Lavigne, S. H. Orkin, E. Callaway, V. Castellani, P. Mehlen, O. Nyabi, and J. Haigh for gifts of mouse lines, probes, or reagents. The mouse transgenic lines r5-6::Cre, Hoxa2::Cre, r5post::Cre, r7post::Cre, MafB::CreERT2, Hoxa5::Cre, ROSA26::(lox-STOPlox) Hoxa2-IRES-EGFP generated in this research and their respective DNA constructs are available from F. M. R. under a material transfer agreement with the Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. The SAD G-eGFP and SAD G-mCherry G-deleted rabies viruses used in this research are available from E. M. Callaway under a material transfer agreement with Salk Institute for Biological Studies, La Jolla, CA, USA. T. D. is the recipient of a European Molecular Biology Organization Long-Term Fellowship. Work in F.M.R.'s laboratory is supported by the Swiss National Science Foundation (Sinergia CRSI33_127440), Association pour la Recherche sur la Sclerose en Plaques, and the Novartis Research Foundation.	ALTMAN J, 1987, J COMP NEUROL, V257, P529, DOI 10.1002/cne.902570405; Bloch-Gallego E, 1999, J NEUROSCI, V19, P4407; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Geisen MJ, 2008, PLOS BIOL, V6, P1178, DOI 10.1371/journal.pbio.0060142; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Kim D, 2011, J NEUROSCI, V31, P2167, DOI 10.1523/JNEUROSCI.5254-10.2011; Leergaard TB, 2007, FRONT NEUROSCI-SWITZ, V1, P211, DOI 10.3389/neuro.01.1.1.016.2007; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Nobrega-Pereira S, 2009, CEREB CORTEX, V19, pI107, DOI 10.1093/cercor/bhp044; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Tumpel S, 2009, CURR TOP DEV BIOL, V88, P103, DOI 10.1016/S0070-2153(09)88004-6; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2	16	83	84	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					204	207		10.1126/science.1229326	http://dx.doi.org/10.1126/science.1229326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307742	Green Accepted			2022-12-24	WOS:000313328200044
J	Eliasmith, C; Stewart, TC; Choo, X; Bekolay, T; DeWolf, T; Tang, C; Rasmussen, D				Eliasmith, Chris; Stewart, Terrence C.; Choo, Xuan; Bekolay, Trevor; DeWolf, Travis; Tang, Charlie; Rasmussen, Daniel			A Large-Scale Model of the Functioning Brain	SCIENCE			English	Article							ITEM; MEMORY	A central challenge for cognitive and systems neuroscience is to relate the incredibly complex behavior of animals to the equally complex activity of their brains. Recently described, large-scale neural models have not bridged this gap between neural activity and biological function. In this work, we present a 2.5-million-neuron model of the brain (called "Spaun") that bridges this gap by exhibiting many different behaviors. The model is presented only with visual image sequences, and it draws all of its responses with a physically modeled arm. Although simplified, the model captures many aspects of neuroanatomy, neurophysiology, and psychological behavior, which we demonstrate via eight diverse tasks.	[Eliasmith, Chris; Stewart, Terrence C.; Choo, Xuan; Bekolay, Trevor; DeWolf, Travis; Tang, Charlie; Rasmussen, Daniel] Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON N2J 3G1, Canada	University of Waterloo	Eliasmith, C (corresponding author), Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON N2J 3G1, Canada.	celiasmith@uwaterloo.ca	DeWolf, Travis/AAX-8363-2021	DeWolf, Travis/0000-0002-8780-5631; Bekolay, Trevor/0000-0001-5215-7999	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs program; Canadian Foundation for Innovation; Ontario Innovation Trust	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs program(Canada Research Chairs); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust	The development of Spaun was supported by the Natural Sciences and Engineering Research Council of Canada, the Canada Research Chairs program, the Canadian Foundation for Innovation, and the Ontario Innovation Trust. We thank M. van der Meer, B. Tripp, M. Laubach, and three anonymous reviewers for insightful comments on previous drafts. All models, scripts, and videos are deposited online at http://nengo.ca/ and http://models.nengo.ca/.	Ananthanarayanan R., 2007, P 2007 ACM IEEE C SU, P1, DOI DOI 10.1145/1362622.1362627; Chaaban I., 2007, TECHNICAL REPORT; de Garis H, 2010, NEUROCOMPUTING, V74, P3, DOI 10.1016/j.neucom.2010.08.004; Dosher BA, 1999, INT J PSYCHOL, V34, P276, DOI 10.1080/002075999399576; FORBES AR, 1964, BRIT J EDUC PSYCHOL, V34, P223, DOI 10.1111/j.2044-8279.1964.tb00632.x; Hadley RF, 2009, NEURAL COMPUT, V21, P510, DOI 10.1162/neco.2008.07-07-572; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; JAHNKE JC, 1968, J EXP PSYCHOL, V76, P618, DOI 10.1037/h0025692; MacNeil D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022885; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; MURDOCK BB, 1993, PSYCHOL REV, V100, P183, DOI 10.1037/0033-295X.100.2.183; Orlov T, 2002, CEREB CORTEX, V12, P306, DOI 10.1093/cercor/12.3.306; Pasternak T., 2003, HDB PSYCHOL, V3, P139; Ranzato M.A., 2007, NIPS P 20 INT C NEUR, V20, P1185; Raven J., 2004, MANUAL RAVENS PROGR; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Stewart TC, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00002; Todorov E, 2009, COGNITIVE NEUROSCIEN, V4; Vasilaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000586	20	474	491	3	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1202	1205		10.1126/science.1225266	http://dx.doi.org/10.1126/science.1225266			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197532				2022-12-24	WOS:000311666200044
J	Brenchley, R; Spannagl, M; Pfeifer, M; Barker, GLA; D'Amore, R; Allen, AM; McKenzie, N; Kramer, M; Kerhornou, A; Bolser, D; Kay, S; Waite, D; Trick, M; Bancroft, I; Gu, Y; Huo, N; Luo, MC; Sehgal, S; Gill, B; Kianian, S; Anderson, O; Kersey, P; Dvorak, J; McCombie, WR; Hall, A; Mayer, KFX; Edwards, KJ; Bevan, MW; Hall, N				Brenchley, Rachel; Spannagl, Manuel; Pfeifer, Matthias; Barker, Gary L. A.; D'Amore, Rosalinda; Allen, Alexandra M.; McKenzie, Neil; Kramer, Melissa; Kerhornou, Arnaud; Bolser, Dan; Kay, Suzanne; Waite, Darren; Trick, Martin; Bancroft, Ian; Gu, Yong; Huo, Naxin; Luo, Ming-Cheng; Sehgal, Sunish; Gill, Bikram; Kianian, Sharyar; Anderson, Olin; Kersey, Paul; Dvorak, Jan; McCombie, W. Richard; Hall, Anthony; Mayer, Klaus F. X.; Edwards, Keith J.; Bevan, Michael W.; Hall, Neil			Analysis of the breadwheat genome using whole-genome shotgun sequencing	NATURE			English	Article							TRANSPOSABLE ELEMENTS; WHEAT GENOME; GENE; EVOLUTION; DIVERSITY; IDENTIFICATION; DUPLICATIONS; INTEGRATION; TRITICEAE; FLOW	Bread wheat (Triticum aestivum) is a globally important crop, accounting for 20 per cent of the calories consumed by humans. Major efforts are underway worldwide to increase wheat production by extending genetic diversity and analysing key traits, and genomic resources can accelerate progress. But so far the very large size and polyploid complexity of the bread wheat genome have been substantial barriers to genome analysis. Here we report the sequencing of its large, 17-gigabase-pair, hexaploid genome using 454 pyrosequencing, and comparison of this with the sequences of diploid ancestral and progenitor genomes. We identified between 94,000 and 96,000 genes, and assigned two-thirds to the three component genomes (A, B and D) of hexaploid wheat. High-resolution synteny maps identified many small disruptions to conserved gene order. We show that the hexaploid genome is highly dynamic, with significant loss of gene family members on polyploidization and domestication, and an abundance of gene fragments. Several classes of genes involved in energy harvesting, metabolism and growth are among expanded gene families that could be associated with crop productivity. Our analyses, coupled with the identification of extensive genetic variation, provide a resource for accelerating gene discovery and improving this major crop.	[McKenzie, Neil; Waite, Darren; Trick, Martin; Bancroft, Ian; Bevan, Michael W.] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Brenchley, Rachel; D'Amore, Rosalinda; Kay, Suzanne; Hall, Anthony; Hall, Neil] Univ Liverpool, Ctr Genome Res, Liverpool L69 7ZB, Merseyside, England; [Spannagl, Manuel; Pfeifer, Matthias; Mayer, Klaus F. X.] Helmholtz Zentrum Munchen, MIPS IBIS, D-85764 Neuherberg, Germany; [Barker, Gary L. A.; Allen, Alexandra M.; Edwards, Keith J.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Kramer, Melissa; McCombie, W. Richard] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kerhornou, Arnaud; Bolser, Dan; Kersey, Paul] European Bioinformat Inst, Cambridge CB10 1SD, England; [Gu, Yong; Huo, Naxin; Anderson, Olin] USDA, Western Reg Lab, Albany, CA 94710 USA; [Luo, Ming-Cheng; Dvorak, Jan] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Sehgal, Sunish; Gill, Bikram] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Kianian, Sharyar] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58018 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Liverpool; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bristol; Cold Spring Harbor Laboratory; European Molecular Biology Laboratory (EMBL); United States Department of Agriculture (USDA); University of California System; University of California Davis; Kansas State University; North Dakota State University Fargo	Bevan, MW (corresponding author), John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England.	Anthony.Hall@liverpool.ac.uk; k.mayer@helmholtz-muenchen.de; k.j.edwards@bristol.ac.uk; michael.bevan@jic.ac.uk; Neil.Hall@liverpool.ac.uk	Luo, Ming-Cheng/C-5600-2011; Bolser, Dan/AAE-3087-2019; Pfeifer, Matthias/GRJ-4579-2022; Hall, Anthony/D-2844-2009; Allen, alexandra/C-7562-2019; Bancroft, Ian/AAH-3831-2020; Mayer, Klaus FX/M-7941-2015; Hall, Neil/A-8717-2013	Luo, Ming-Cheng/0000-0002-9744-5887; Bolser, Dan/0000-0002-3991-0859; Hall, Anthony/0000-0002-1806-020X; Mayer, Klaus FX/0000-0001-6484-1077; Hall, Neil/0000-0002-7995-3810; Kerhornou, Arnaud/0000-0002-2890-295X; Brenchley, Rachel/0000-0003-4062-8217; Kersey, Paul/0000-0002-7054-800X; McCombie, W. Richard/0000-0003-1899-0682; Barker, Gary/0000-0002-9018-9526; Spannagl, Manuel/0000-0003-0701-7035; Hall, Neil/0000-0003-2808-0009; Bancroft, Ian/0000-0001-7707-1171	UK Biological and Biotechnological Sciences Research Council (BBSRC) [BB/G012865, BB/G013985/1, BB/G013004/1]; Wolfson Merit Award from the Royal Society; BBSRC Strategic Programme [B/J004588/1]; EC TriticeaeGenome grant [212019]; TRITEX Project of the Plant20130 Initiative of the German Ministry of Education and Research grant [0315954C]; EC Transplant Grant [283496]; BBSRC Career Development Fellowship [BB/H022333/1]; US NSF [IOS-1032105, DBI-0923128, DBI-0701916, DBI-0822100]; USDA-NIFA [2008-35300-04588]; BBSRC [BB/I02347X/1, BB/G013985/1, BB/G024650/1, BB/H022333/1, BB/E004725/1, BB/G013004/1, BBS/E/T/000PR6193] Funding Source: UKRI; MRC [G0900753] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H022333/1, BBS/E/T/000PR6193, BB/G013004/1, BB/G024650/1, BB/G013985/1, BB/E004725/1, BB/I02347X/1] Funding Source: researchfish; Medical Research Council [G0900753] Funding Source: researchfish; Division Of Integrative Organismal Systems [1032105] Funding Source: National Science Foundation	UK Biological and Biotechnological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wolfson Merit Award from the Royal Society; BBSRC Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EC TriticeaeGenome grant; TRITEX Project of the Plant20130 Initiative of the German Ministry of Education and Research grant; EC Transplant Grant; BBSRC Career Development Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US NSF(National Science Foundation (NSF)); USDA-NIFA(United States Department of Agriculture (USDA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	DNA sequence was generated by The University of Liverpool Centre for Genomic Research (United Kingdom), 454 Life Sciences (United States), The Cold Spring Harbor Woodbury Genome Centre (United States) and The Genome Analysis Centre (United Kingdom). This work was supported by UK Biological and Biotechnological Sciences Research Council (BBSRC) grants BB/G012865, BB/G013985/1 and BB/G013004/1, to K.J.E., M.W.B. and N. Hall; a Wolfson Merit Award from the Royal Society, to N. Hall; BBSRC Strategic Programme grant B/J004588/1 (GRO), to M.W.B.; EC TriticeaeGenome grant number 212019, to K.F.X.M. and M.W.B.; The TRITEX Project of the Plant20130 Initiative of the German Ministry of Education and Research grant number 0315954C, to K.F.X.M.; EC Transplant Grant 283496, to K.F.X.M. and P.K., a BBSRC Career Development Fellowship BB/H022333/1, to A.H., US NSF grants IOS-1032105 and DBI-0923128, to W.R.M.; USDA-NIFA grant 2008-35300-04588, to B.G.; and US NSF grants DBI-0701916, to J.D., and DBI-0822100, to S. Kianian.	Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Buggs RJA, 2012, CURR BIOL, V22, P248, DOI 10.1016/j.cub.2011.12.027; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Dvorak J, 2006, MOL BIOL EVOL, V23, P1386, DOI 10.1093/molbev/msl004; Gill BS, 2004, GENETICS, V168, P1087, DOI 10.1534/genetics.104.034769; Gu YQ, 2004, PLANT PHYSIOL, V135, P459, DOI 10.1104/pp.103.038083; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; Hernandez P, 2012, PLANT J, V69, P377, DOI 10.1111/j.1365-313X.2011.04808.x; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; JIN YK, 1994, PLANT CELL, V6, P1177, DOI 10.1105/tpc.6.8.1177; Lee EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002411; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Massa AN, 2011, MOL BIOL EVOL, V28, P2537, DOI 10.1093/molbev/msr080; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mochida K, 2009, PLANT PHYSIOL, V150, P1135, DOI 10.1104/pp.109.138214; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Mun JH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r111; Nesbitt M, 1996, HULLED WHEATS, V4, P41; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Pumphrey M, 2009, GENETICS, V181, P1147, DOI 10.1534/genetics.108.096941; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; RILEY R, 1958, NATURE, V182, P713, DOI 10.1038/182713a0; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Salse J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-555; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sears E. R., 1966, CHROMOSOME MANIPULAT, P22; Shavrukov Y, 2009, BREEDING SCI, V59, P671, DOI 10.1270/jsbbs.59.671; SMITH DB, 1975, CHROMOSOMA, V50, P223, DOI 10.1007/BF00283468; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; United States Department of Agriculture, 2012, WASDE511 USDA; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang SW, 2011, BREEDING SCI, V61, P189, DOI 10.1270/jsbbs.61.189; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629	42	764	828	11	381	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					705	710		10.1038/nature11650	http://dx.doi.org/10.1038/nature11650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23192148	hybrid, Green Published, Green Accepted			2022-12-24	WOS:000311606000034
J	Gazda, L; Pokrzywa, W; Hellerschmied, D; Lowe, T; Forne, I; Mueller-Planitz, F; Hoppe, T; Clausen, T				Gazda, Linn; Pokrzywa, Wojciech; Hellerschmied, Doris; Loewe, Thomas; Forne, Ignasi; Mueller-Planitz, Felix; Hoppe, Thorsten; Clausen, Tim			The Myosin Chaperone UNC-45 Is Organized in Tandem Modules to Support Myofilament Formation in C. elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; ZEBRAFISH EMBRYOS; SKELETAL-MUSCLES; MOTOR DOMAIN; HEAVY-CHAIN; PROTEIN; MYOFIBRIL; COLOCALIZES; DEGRADATION; FILAMENTS	The UCS (UNC-45/CRO1/She4) chaperones play an evolutionarily conserved role in promoting myosin-dependent processes, including cytokinesis, endocytosis, RNA transport, and muscle development. To investigate the protein machinery orchestrating myosin folding and assembly, we performed a comprehensive analysis of Caenorhabditis elegans UNC-45. Our structural and biochemical data demonstrate that UNC-45 forms linear protein chains that offer multiple binding sites for cooperating chaperones and client proteins. Accordingly, Hsp70 and Hsp90, which bind to the TPR domain of UNC-45, could act in concert and with defined periodicity on captured myosin molecules. In vivo analyses reveal the elongated canyon of the UCS domain as a myosin-binding site and show that multimeric UNC-45 chains support organization of sarcomeric repeats. In fact, expression of transgenes blocking UNC-45 chain formation induces dominant-negative defects in the sarcomere structure and function of wild-type worms. Together, these findings uncover a filament assembly factor that directly couples myosin folding with myofilament formation.	[Gazda, Linn; Hellerschmied, Doris; Clausen, Tim] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Pokrzywa, Wojciech; Loewe, Thomas; Hoppe, Thorsten] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Pokrzywa, Wojciech; Loewe, Thomas; Hoppe, Thorsten] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Forne, Ignasi] Univ Munich, Adolf Butenandt Inst, Prot Anal Unit, D-81377 Munich, Germany; [Forne, Ignasi] Univ Munich, Ctr Integrated Prot Sci CIPSM, Prot Anal Unit, D-81377 Munich, Germany; [Mueller-Planitz, Felix] Univ Munich, Adolf Butenandt Inst, Mol Biol Unit, D-81377 Munich, Germany; [Mueller-Planitz, Felix] Univ Munich, Ctr Integrated Prot Sci CIPSM, Mol Biol Unit, D-81377 Munich, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Cologne; University of Cologne; University of Munich; University of Munich; University of Munich; University of Munich	Hoppe, T (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47A, D-50674 Cologne, Germany.	thorsten.hoppe@uni-koeln.de; clausen@imp.univie.ac.at	Mueller-Planitz, Felix/P-8461-2014; Forne, Ignasi/B-3837-2016; Pokrzywa, Wojciech/AAL-5766-2021; Hoppe, Thorsten/AAC-7880-2020	Mueller-Planitz, Felix/0000-0001-8273-6473; Pokrzywa, Wojciech/0000-0002-5110-4462; Hoppe, Thorsten/0000-0002-4734-9352; Hellerschmied, Doris/0000-0003-1431-2470; Clausen, Tim/0000-0003-1582-6924	NIH National Center for Research Resources; European Community Network of Excellence RUBICON [LSHC-CT-2005-018683]; Deutsche Forschungsgemeinschaft [CECAD, FOR885, SFB635, HO2541/1-1, HO2541/4-1]; Austrian Science Fund [FWF P22570-B09]; Boehringer Ingelheim; Austrian Science Fund (FWF) [P 22570] Funding Source: researchfish	NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); European Community Network of Excellence RUBICON; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund(Austrian Science Fund (FWF)); Boehringer Ingelheim(Boehringer Ingelheim); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to the beamline staff at the SLS and ESRF, in particular to Andrew McCarthy and MaxNanao, for their assistance during data collection; Mathias Madalinski for peptide synthesis; Axel Imhof and Peter Becker for providing access to the mass spectrometry infrastructure; the Caenorhabditis Genetics Center (funded by the NIH National Center for Research Resources) for strains; Richard I. Morimoto and Patricija van Oosten-Hawle for providing the Hsp90 antibody; and Peter G. Schultz for providing the pDULE-pBpa plasmid. With regards to author contributions, L.G. and T.C. performed the structural studies; L. G. and D.H. performed the protein biochemistry; T.L. prepared the UNC-45 antibody; W.P. performed C. elegans experiments; and I.F. and F.M.-P. performed MS analysis. T. C. outlined the structural and mechanistic part of the work and T. H. the C. elegans part. All authors contributed to writing the manuscript. This work was supported by grants from the European Community Network of Excellence RUBICON (LSHC-CT-2005-018683 to T.H.), the Deutsche Forschungsgemeinschaft (CECAD, FOR885, SFB635, HO2541/1-1, and HO2541/4-1 to T.H.), and the Austrian Science Fund (FWF P22570-B09 to D.H. and L.G.). The IMP is funded by Boehringer Ingelheim.	Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Bernick EP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-70; Craig R, 2006, CURR OPIN STRUC BIOL, V16, P204, DOI 10.1016/j.sbi.2006.03.006; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; Etard C, 2008, J CELL BIOL, V180, P1163, DOI 10.1083/jcb.200709128; Forne I, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012088; Gaiser AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025485; Gautel M, 2011, CURR OPIN CELL BIOL, V23, P39, DOI 10.1016/j.ceb.2010.12.001; Geach TJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-75; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Hutagalung AH, 2002, J CELL SCI, V115, P3983, DOI 10.1242/jcs.00107; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Kachur T, 2004, J CELL SCI, V117, P5313, DOI 10.1242/jcs.01389; Kachur TM, 2008, INT J MOL SCI, V9, P1863, DOI 10.3390/ijms9091863; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; Lee CF, 2011, STRUCTURE, V19, P397, DOI 10.1016/j.str.2011.01.002; Lord M, 2004, J CELL BIOL, V167, P315, DOI 10.1083/jcb.200404045; Melkani GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022579; Melkani GC, 2010, BIOCHEM BIOPH RES CO, V396, P317, DOI 10.1016/j.bbrc.2010.04.090; Myhre JL, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/712315; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Sanger JW, 2005, J MUSCLE RES CELL M, V26, P343, DOI 10.1007/s10974-005-9016-7; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shi H, 2010, P NATL ACAD SCI USA, V107, P21382, DOI 10.1073/pnas.1013038107; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Srikakulam R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002137; Stanley BA, 2007, CIRCULATION, V116, P170; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Toi H, 2003, MOL BIOL CELL, V14, P2237, DOI 10.1091/mbc.E02-09-0616; Venolia L, 1999, CELL MOTIL CYTOSKEL, V42, P163, DOI 10.1002/(SICI)1097-0169(1999)42:3&lt;163::AID-CM1&gt;3.0.CO;2-E; VENOLIA L, 1990, GENETICS, V126, P345; Walker Michael G., 2001, Mini-Reviews in Medicinal Chemistry, V1, P197, DOI 10.2174/1389557013407034; Wesche S, 2003, CURR BIOL, V13, P715, DOI 10.1016/S0960-9822(03)00264-1; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Yu Q, 2003, CURR BIOL, V13, pR525, DOI 10.1016/S0960-9822(03)00447-0	40	64	64	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					183	195		10.1016/j.cell.2012.12.025	http://dx.doi.org/10.1016/j.cell.2012.12.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332754	hybrid, Green Published			2022-12-24	WOS:000313719800016
J	Kohwi, M; Lupton, JR; Lai, SL; Miller, MR; Doe, CQ				Kohwi, Minoree; Lupton, Joshua R.; Lai, Sen-Lin; Miller, Michael R.; Doe, Chris Q.			Developmentally Regulated Subnuclear Genome Reorganization Restricts Neural Progenitor Competence in Drosophila	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; NUCLEAR LAMINA INTERACTIONS; CELL-FATE DETERMINATION; DNA-BINDING PROTEINS; TEMPORAL IDENTITY; NEUROBLAST COMPETENCE; DISTAL-ANTENNA; TRANSCRIPTION FACTORS; CEREBRAL-CORTEX; HUNCHBACK	Stem and/or progenitor cells often generate distinct cell types in a stereotyped birth order and over time lose competence to specify earlier-born fates by unknown mechanisms. In Drosophila, the Hunchback transcription factor acts in neural progenitors (neuroblasts) to specify early-born neurons, in part by indirectly inducing the neuronal transcription of its target genes, including the hunchback gene. We used in vivo immuno-DNA FISH and found that the hunchback gene moves to the neuroblast nuclear periphery, a repressive subnuclear compartment, precisely when competence to specify early-born fate is lost and several hours and cell divisions after termination of its transcription. hunchback movement to the lamina correlated with downregulation of the neuroblast nuclear protein, Distal antenna (Dan). Either prolonging Dan expression or disrupting lamina interfered with hunchback repositioning and extended neuroblast competence. We propose that neuroblasts undergo a developmentally regulated subnuclear genome reorganization to permanently silence Hunchback target genes that results in loss of progenitor competence.	[Kohwi, Minoree; Lupton, Joshua R.; Lai, Sen-Lin; Miller, Michael R.; Doe, Chris Q.] Univ Oregon, Howard Hughes Med Inst, Inst Mol Biol, Inst Neurosci, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon	Doe, CQ (corresponding author), Univ Oregon, Howard Hughes Med Inst, Inst Mol Biol, Inst Neurosci, Eugene, OR 97403 USA.	cdoe@uoneuro.uoregon.edu		Lai, Sen-Lin/0000-0002-7531-283X	Leukemia & Lymphoma Society; NICHD [HD072035]; NIH [HD27056]; HHMI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD027056, K99HD072035, R00HD072035] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058899] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Hui Zong, Rui Galvao, Chong Liu, Eric Selker, Mike Cleary, and Doe laboratory members for discussion and comments on the manuscript, Keiko Hirono for blind scoring of the hb FISH data, Fre'de'ric Bantignies for technical advice, Jennifer Curtiss for antibody and fly stocks, and Josh Udovich for technical assistance. We thank Janet Hanawalt and Marina Hirsch for copy editing. This work was supported by a Leukemia & Lymphoma Society career development award and a K99/R00 NIH grant from NICHD (HD072035) to M.K. and funding from the NIH (HD27056) and HHMI to C.Q.D.	Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032; Benito-Sipos J, 2011, DEVELOPMENT, V138, P5311, DOI 10.1242/dev.070946; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Carney TD, 2012, DEV BIOL, V361, P137, DOI 10.1016/j.ydbio.2011.10.020; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cleary MD, 2006, GENE DEV, V20, P429, DOI 10.1101/gad.1382206; Curtiss J, 2007, DEV BIOL, V306, P685, DOI 10.1016/j.ydbio.2007.04.006; DOE CQ, 1992, DEVELOPMENT, V116, P855; Elliott J, 2008, NEURON, V60, P26, DOI 10.1016/j.neuron.2008.08.008; Emerald BS, 2003, DEVELOPMENT, V130, P1171, DOI 10.1242/dev.00323; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Huang DH, 2002, MOL CELL BIOL, V22, P6261, DOI 10.1128/MCB.22.17.6261-6271.2002; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Kanai MI, 2005, DEV CELL, V8, P203, DOI 10.1016/j.devcel.2004.12.014; Kao CF, 2012, NEURON, V73, P677, DOI 10.1016/j.neuron.2011.12.018; Karlsson D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000368; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kohwi M, 2011, DEVELOPMENT, V138, P1727, DOI 10.1242/dev.061499; Kwan KY, 2012, DEVELOPMENT, V139, P1535, DOI 10.1242/dev.069963; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; MCCONNELL SK, 1989, TRENDS NEUROSCI, V12, P342, DOI 10.1016/0166-2236(89)90041-6; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; Mettler U, 2006, DEVELOPMENT, V133, P429, DOI 10.1242/dev.02229; Novotny T, 2002, DEVELOPMENT, V129, P1027; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910; Peric-Hupkes D, 2010, COLD SH Q B, V75, P517, DOI 10.1101/sqb.2010.75.014; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Rajapakse I, 2011, J CELL BIOL, V192, P711, DOI 10.1083/jcb.201010129; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Schmid A, 1999, DEVELOPMENT, V126, P4653; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Shevelyov YY, 2012, CURR ISSUES MOL BIOL, V14, P27; Siegmund T, 2002, DEV GENES EVOL, V212, P152, DOI 10.1007/s00427-002-0219-2; Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; Touma JJ, 2012, DEVELOPMENT, V139, P657, DOI 10.1242/dev.071589; Towbin BD, 2010, COLD SH Q B, V75, P555, DOI 10.1101/sqb.2010.75.041; Tran KD, 2008, DEVELOPMENT, V135, P3491, DOI 10.1242/dev.024349; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Wimmer EA, 2000, SCIENCE, V287, P2476, DOI 10.1126/science.287.5462.2476; Zhao R, 2009, CURR OPIN GENET DEV, V19, P172, DOI 10.1016/j.gde.2009.02.007; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	61	118	122	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					97	108		10.1016/j.cell.2012.11.049	http://dx.doi.org/10.1016/j.cell.2012.11.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332748	Bronze, Green Accepted			2022-12-24	WOS:000313719800009
J	Knobloch, M; Braun, SMG; Zurkirchen, L; von Schoultz, C; Zamboni, N; Arauzo-Bravo, MJ; Kovacs, WJ; Karalay, O; Suter, U; Machado, RAC; Roccio, M; Lutolf, MP; Semenkovich, CF; Jessberger, S				Knobloch, Marlen; Braun, Simon M. G.; Zurkirchen, Luis; von Schoultz, Carolin; Zamboni, Nicola; Arauzo-Bravo, Marcos J.; Kovacs, Werner J.; Karalay, Oezlem; Suter, Ueli; Machado, Raquel A. C.; Roccio, Marta; Lutolf, Matthias P.; Semenkovich, Clay F.; Jessberger, Sebastian			Metabolic control of adult neural stem cell activity by Fasn-dependent lipogenesis	NATURE			English	Article							FATTY-ACID SYNTHASE; TRANSGENIC MICE; SPOT 14; NEUROGENESIS; HOMEOSTASIS; GLUCOSE	Mechanisms controlling the proliferative activity of neural stem and progenitor cells (NSPCs) have a pivotal role to ensure life-long neurogenesis in the mammalian brain(1). How metabolic programs are coupled with NSPC activity remains unknown. Here we show that fatty acid synthase (Fasn), the key enzyme of de novo lipogenesis(2), is highly active in adult NSPCs and that conditional deletion of Fasn in mouse NSPCs impairs adult neurogenesis. The rate of de novo lipid synthesis and subsequent proliferation of NSPCs is regulated by Spot14, a gene previously implicated in lipid metabolism(3-5), that we found to be selectively expressed in low proliferating adult NSPCs. Spot14 reduces the availability of malonyl-CoA(6), which is an essential substrate for Fasn to fuel lipogenesis. Thus, we identify here a functional coupling between the regulation of lipid metabolism and adult NSPC proliferation.	[Knobloch, Marlen; Braun, Simon M. G.; Machado, Raquel A. C.; Jessberger, Sebastian] Univ Zurich, Fac Med, Brain Res Inst, CH-8057 Zurich, Switzerland; [Knobloch, Marlen; Braun, Simon M. G.; Zurkirchen, Luis; von Schoultz, Carolin; Kovacs, Werner J.; Karalay, Oezlem; Suter, Ueli; Machado, Raquel A. C.; Jessberger, Sebastian] Swiss Fed Inst Technol, Dept Biol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland; [Zamboni, Nicola] Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Arauzo-Bravo, Marcos J.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Roccio, Marta; Lutolf, Matthias P.] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Semenkovich, Clay F.] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA	University of Geneva; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Washington University (WUSTL)	Jessberger, S (corresponding author), Univ Zurich, Fac Med, Brain Res Inst, CH-8057 Zurich, Switzerland.	jessberger@hifo.uzh.ch	Jessberger, Sebastian/AAJ-4032-2020; Knobloch, Marlen/A-9565-2015; Kovacs, Werner/AAD-1107-2019; Suter, Ueli/A-1624-2010; Zamboni, Nicola/K-3042-2012; Marcos, Arauzo-Bravo/A-1706-2011; Lutolf, Matthias P/E-5914-2010	Knobloch, Marlen/0000-0002-7490-0285; Kovacs, Werner/0000-0002-4440-4344; Zamboni, Nicola/0000-0003-1271-1021; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Braun, Simon/0000-0003-2622-9914; Martinez Machado, Raquel Arminda/0000-0001-5912-2991; Semenkovich, Clay/0000-0003-1163-1871; Roccio, Marta/0000-0001-7568-9429; Jessberger, Sebastian/0000-0002-0056-8275	NCCR Neural Plasticity and Repair; Swiss National Science Foundation; TH grant [ETH-01 08-1]; Zurich Neuroscience Center (ZNZ); Novartis Foundation; Theodore Ott Foundation; EMBO Young Investigator program; Janggen-Pohn foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088083, P30DK020579, R01DK076729] Funding Source: NIH RePORTER	NCCR Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); TH grant; Zurich Neuroscience Center (ZNZ); Novartis Foundation(Novartis); Theodore Ott Foundation; EMBO Young Investigator program(European Molecular Biology Organization (EMBO)); Janggen-Pohn foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Aigner, D. C. Lie, F. H. Gage and members of the Jessberger group for conceptual input; S. Kobel, C. Fischer, K. Walter, P. Sidiropoulos, T. Buch, B. Becher, P. Pelczar, P. Lotscher, A. J. Eisch and D. C. Lagace for experimental help or reagents; and the Light Microscopy and Screening Center (LMSC) of the ETH Zurich and the BioImaging and Optics Platform (BIOP) of the EPFL for help with imaging. This study was supported by the NCCR Neural Plasticity and Repair, Swiss National Science Foundation, TH grant (ETH-01 08-1), Zurich Neuroscience Center (ZNZ), Novartis Foundation, Theodore Ott Foundation, and the EMBO Young Investigator program (to S. J.). M. K. was supported by the Janggen-Pohn foundation.	Aipoalani DL, 2010, ENDOCRINOLOGY, V151, P2071, DOI 10.1210/en.2009-1058; Campbell MC, 2003, ENDOCRINOLOGY, V144, P5242, DOI 10.1210/en.2002-0008; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Colbert CL, 2010, P NATL ACAD SCI USA, V107, P18820, DOI 10.1073/pnas.1012736107; Cordey M, 2008, STEM CELLS, V26, P2586, DOI 10.1634/stemcells.2008-0498; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Johansson T, 2010, GENESIS, V48, P264, DOI 10.1002/dvg.20612; Karalay O, 2011, P NATL ACAD SCI USA, V108, P5807, DOI 10.1073/pnas.1013456108; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Moncur JT, 1998, P NATL ACAD SCI USA, V95, P6989, DOI 10.1073/pnas.95.12.6989; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhu QH, 2001, ENDOCRINOLOGY, V142, P4363, DOI 10.1210/en.142.10.4363	20	315	326	4	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2013	493	7431					226	230		10.1038/nature11689	http://dx.doi.org/10.1038/nature11689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23201681	Green Accepted			2022-12-24	WOS:000313259600040
J	Losos, JB; Hillis, DM; Greene, HW				Losos, Jonathan B.; Hillis, David M.; Greene, Harry W.			Who Speaks with a Forked Tongue?	SCIENCE			English	Editorial Material							PHYLOGENY; MOLECULES; SELECTION; GENES		[Losos, Jonathan B.] Harvard Univ, Harvard Museum Comparat Zool, Cambridge, MA 02138 USA; [Hillis, David M.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Greene, Harry W.] Cornell Univ, Ithaca, NY 14853 USA	Harvard University; University of Texas System; University of Texas Austin; Cornell University	Losos, JB (corresponding author), Harvard Univ, Harvard Museum Comparat Zool, Cambridge, MA 02138 USA.	jlosos@oeb.harvard.edu; dhillis@austin.utexas.edu; hwg5@cornell.edu	Hillis, David/L-5421-2019					Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Blanga-Kanfi S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-71; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Edwards SV, 2009, P NATL ACAD SCI USA, V106, P8799, DOI 10.1073/pnas.0904103106; Gatesy J, 2001, TRENDS ECOL EVOL, V16, P562, DOI 10.1016/S0169-5347(01)02236-4; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; GRAUR D, 1991, NATURE, V351, P649, DOI 10.1038/351649a0; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Messenger SL, 1998, SYST BIOL, V47, P90, DOI 10.1080/106351598261058; Sullivan J, 2005, ANNU REV ECOL EVOL S, V36, P445, DOI 10.1146/annurev.ecolsys.36.102003.152633; Vitt LJ, 2003, AM NAT, V162, P44, DOI 10.1086/375172; Wake DB, 2011, SCIENCE, V331, P1032, DOI 10.1126/science.1188545; Wiens JJ, 2012, BIOL LETTERS, V8, P1043, DOI 10.1098/rsbl.2012.0703	14	57	60	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1428	1429		10.1126/science.1232455	http://dx.doi.org/10.1126/science.1232455			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239723				2022-12-24	WOS:000312250800034
J	Hu, B; Margolin, W; Molineux, IJ; Liu, J				Hu, Bo; Margolin, William; Molineux, Ian J.; Liu, Jun			The Bacteriophage T7 Virion Undergoes Extensive Structural Remodeling During Infection	SCIENCE			English	Article							ESCHERICHIA-COLI; DNA EJECTION; TAIL FIBERS; INITIATION; MECHANISM; MACHINES; DELIVERY; PROTEIN	Adsorption and genome ejection are fundamental to the bacteriophage life cycle, yet their molecular mechanisms are not well understood. We used cryo-electron tomography to capture T7 virions at successive stages of infection of Escherichia coli minicells at similar to 4-nm resolution. The six phage tail fibers were folded against the capsid, extending and orienting symmetrically only after productive adsorption to the host cell surface. Receptor binding by the tail triggered conformational changes resulting in the insertion of an extended tail, which functions as the DNA ejection conduit into the cell cytoplasm. After ejection, the extended phage tail collapsed or disassembled, which allowed resealing of the infected cell membrane. These structural studies provide a detailed series of intermediates during phage infection.	[Hu, Bo; Liu, Jun] Univ Texas Med Sch Houston, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Margolin, William] Univ Texas Med Sch Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Molineux, Ian J.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Austin	Molineux, IJ (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA.	molineux@austin.utexas.edu; jun.liu.1@uth.tmc.edu			National Institute on Allergy and Infection, NIH [R01AI087946]; Welch Foundation [AU-1714]; NIH [R01GM61074]; Human Frontier Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110243, R01GM061074] Funding Source: NIH RePORTER	National Institute on Allergy and Infection, NIH; Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Leiman, S. Norris, and Y. W. Yin for comments. B. H. and J.L. were supported in part by grants R01AI087946 from the National Institute on Allergy and Infection, NIH, and AU-1714 from the Welch Foundation. W. M. was supported by NIH grant R01GM61074 and a grant from the Human Frontier Science Program. EM maps have been deposited in the EM Data Bank (www.ebi.ac.uk/pdbe/emdb/) with accession nos. EMD-5534, 5535, 5536, and 5537. J.L. and I.J.M. designed research; B. H. and W. M. constructed the E. coli mutants; B. H. and J. L. collected and analyzed data; and B. H., W. M., J. L., and I. J. M. wrote the paper.	Adam G., 1968, STRUCTURAL CHEM MOL, P198; Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840; Casjens SR, 2012, ADV EXP MED BIOL, V726, P143, DOI 10.1007/978-1-4614-0980-9_7; Chang CY, 2010, VIROLOGY, V398, P176, DOI 10.1016/j.virol.2009.12.002; Garcia LR, 1996, J BACTERIOL, V178, P6921, DOI 10.1128/jb.178.23.6921-6929.1996; Garcia-Doval C, 2012, P NATL ACAD SCI USA, V109, P9390, DOI 10.1073/pnas.1119719109; Johnson JE, 2007, CURR OPIN STRUC BIOL, V17, P237, DOI 10.1016/j.sbi.2007.03.011; Kemp P, 2005, VIROLOGY, V340, P307, DOI 10.1016/j.virol.2005.06.039; Kemp P, 2004, MOL MICROBIOL, V53, P1251, DOI 10.1111/j.1365-2958.2004.04204.x; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Liu J, 2012, P NATL ACAD SCI USA, V109, pE1481, DOI 10.1073/pnas.1200781109; Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823; Moak M, 2004, MOL MICROBIOL, V51, P1169, DOI 10.1046/j.1365-2958.2003.03894.x; Moak M, 2000, MOL MICROBIOL, V37, P345, DOI 10.1046/j.1365-2958.2000.01995.x; Molineux IJ, 2001, MOL MICROBIOL, V40, P1, DOI 10.1046/j.1365-2958.2001.02357.x; Qimron U, 2006, P NATL ACAD SCI USA, V103, P19039, DOI 10.1073/pnas.0609428103; Rothenberg E, 2011, BIOPHYS J, V100, P2875, DOI 10.1016/j.bpj.2011.05.014; STEVEN AC, 1988, J MOL BIOL, V200, P351, DOI 10.1016/0022-2836(88)90246-X; Struthers-Schlinke JS, 2000, J MOL BIOL, V301, P35, DOI 10.1006/jmbi.2000.3940; ZIMKUS A Z, 1986, Molekulyarnaya Biologiya (Moscow), V20, P185	20	150	157	3	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					576	579		10.1126/science.1231887	http://dx.doi.org/10.1126/science.1231887			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23306440	Green Accepted			2022-12-24	WOS:000314270000058
J	Wu, B; Peisley, A; Richards, C; Yao, H; Zeng, XH; Lin, C; Chu, FX; Walz, T; Hur, S				Wu, Bin; Peisley, Alys; Richards, Claire; Yao, Hui; Zeng, Xiaohui; Lin, Cecilie; Chu, Feixia; Walz, Thomas; Hur, Sun			Structural Basis for dsRNA Recognition, Filament Formation, and Antiviral Signal Activation by MDA5	CELL			English	Article							RIG-I HELICASE; RNA-RECOGNITION; PATTERN-RECOGNITION; SENSOR; MECHANISM; INSIGHTS; SYSTEM; DOMAIN; LGP2	MDA5, a viral double-stranded RNA (dsRNA) receptor, shares sequence similarity and signaling pathways with RIG-I yet plays essential functions in antiviral immunity through distinct specificity for viral RNA. Revealing the molecular basis for the functional divergence, we report here the crystal structure of MDA5 bound to dsRNA, which shows how, using the same domain architecture, MDA5 recognizes the internal duplex structure, whereas RIG-I recognizes the terminus of dsRNA. We further show that MDA5 uses direct protein-protein contacts to stack along dsRNA in a head-to-tail arrangement, and that the signaling domain (tandem CARD), which decorates the outside of the core MDA5 filament, also has an intrinsic propensity to oligomerize into an elongated structure that activates the signaling adaptor, MAVS. These data support a model in which MDA5 uses long dsRNA as a signaling platform to cooperatively assemble the core filament, which in turn promotes stochastic assembly of the tandem CARD oligomers for signaling.	[Wu, Bin; Peisley, Alys; Hur, Sun] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lin, Cecilie; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Wu, Bin; Peisley, Alys; Richards, Claire; Hur, Sun] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Yao, Hui] Nankai Univ, Dept Biochem & Mol Biol, Tianjin 300071, Peoples R China; [Zeng, Xiaohui; Chu, Feixia] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Walz, Thomas] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Nankai University; University System Of New Hampshire; University of New Hampshire; Howard Hughes Medical Institute	Hur, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	hur@idi.harvard.edu	Wu, Bin/C-4715-2015	Wu, Bin/0000-0002-0883-8006; Peisley, Alys/0000-0002-8999-5440; Walz, Thomas/0000-0003-2606-2835	NIFA/USDA [H00567]; UNH Karabelis Fund; Pew Scholarship	NIFA/USDA(United States Department of Agriculture (USDA)); UNH Karabelis Fund; Pew Scholarship	The authors thank the NE-CAT beamline scientists for their assistance during data collection. F.C. acknowledges NIFA/USDA H00567 and UNH Karabelis Fund. T.W. is an Investigator in the Howard Hughes Medical Institute. S.H. is the recipient of a Pew Scholarship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Berke IC, 2012, P NATL ACAD SCI USA, V109, P18437, DOI 10.1073/pnas.1212186109; Berke IC, 2012, EMBO J, V31, P1714, DOI 10.1038/emboj.2012.19; Binder M, 2011, J BIOL CHEM, V286, P27278, DOI 10.1074/jbc.M111.256974; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Palsson-McDermott EM, 2007, BIOCHEM SOC T, V35, P1437, DOI 10.1042/BST0351437; Peisley A, 2012, P NATL ACAD SCI USA, V109, pE3340, DOI 10.1073/pnas.1208618109; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takahasi K, 2009, J BIOL CHEM, V284, P17465, DOI 10.1074/jbc.M109.007179; Triantafilou K., 2012, J CELL SCI; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851	25	357	362	1	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					276	289		10.1016/j.cell.2012.11.048	http://dx.doi.org/10.1016/j.cell.2012.11.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23273991	Bronze			2022-12-24	WOS:000313719800023
J	Besnard, J; Ruda, GF; Setola, V; Abecassis, K; Rodriguiz, RM; Huang, XP; Norval, S; Sassano, MF; Shin, AI; Webster, LA; Simeons, FRC; Stojanovski, L; Prat, A; Seidah, NG; Constam, DB; Bickerton, GR; Read, KD; Wetsel, WC; Gilbert, IH; Roth, BL; Hopkins, AL				Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.			Automated design of ligands to polypharmacological profiles	NATURE			English	Article							DE-NOVO DESIGN; DRUG-DISCOVERY; SMALL-MOLECULE; IDENTIFICATION; OPTIMIZATION; PHARMACOLOGY; ANTAGONISTS; INHIBITORS; PREDICTION; PROGRAM	The clinical efficacy and safety of a drug is determined by its activity profile across many proteins in the proteome. However, designing drugs with a specific multi-target profile is both complex and difficult. Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery. Here we describe a new approach for the automated design of ligands against profiles of multiple drug targets. The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug into brain-penetrable ligands with either specific polypharmacology or exquisite selectivity profiles for G-protein-coupled receptors. Overall, 800 ligand-target predictions of prospectively designed ligands were tested experimentally, of which 75% were confirmed to be correct. We also demonstrate target engagement in vivo. The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacology.	[Besnard, Jeremy; Ruda, Gian Filippo; Abecassis, Keren; Norval, Suzanne; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Bickerton, G. Richard; Read, Kevin D.; Gilbert, Ian H.; Hopkins, Andrew L.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Setola, Vincent; Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina Chapel Hill, Sch Med, Dept Pharmacol, NIMH Psychoact Drug Screening Program, Chapel Hill, NC 27759 USA; [Rodriguiz, Ramona M.; Shin, Antony I.; Wetsel, William C.] Duke Univ, Sch Med, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC 27710 USA; [Sassano, Maria F.; Roth, Bryan L.] Univ N Carolina Chapel Hill, Sch Med, Div Chem Biol & Med Chem, Chapel Hill, NC 27759 USA; [Prat, Annik; Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal IRCM, Lab Biochem Neuroendocrinol, Montreal, PQ H2W 1R7, Canada; [Constam, Daniel B.] Ecole Polytech Fed Lausanne EPFL SV ISREC, CH-1015 Lausanne, Switzerland; [Wetsel, William C.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA	University of Dundee; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Duke University; Duke University; Duke University	Hopkins, AL (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland.	bryan_roth@med.unc.edu; a.hopkins@dundee.ac.uk	Prat, Annik/S-6757-2018; Roth, Bryan L/F-3928-2010; Seidah, Nabil/I-3596-2013; sassano, maria/G-4941-2013; Roth, Bryan/ABE-7032-2020; Hopkins, Andrew/H-5138-2011	Prat, Annik/0000-0002-8007-5277; Seidah, Nabil/0000-0001-6503-9342; Roth, Bryan/0000-0002-0561-6520; Hopkins, Andrew/0000-0003-1977-018X; Gilbert, Ian/0000-0002-5238-1314; Ruda, Gian Filippo/0000-0001-6150-2715; /0000-0001-6426-0598; Setola, Vincent/0000-0002-9791-2270; Constam, Daniel B./0000-0002-6256-3891; Besnard, Jeremy/0000-0001-5452-8183	SULSA [HR07019]; BBSRC Doctoral Training Programme; BBSRC Pathfinder [BB/FOF/PF/15/09]; BBSRC [BB/J010510/1]; University of Dundee's Pump Priming Fund for Translational Medical Research; National Institutes of Health (NIH) [MH082441]; Wellcome Trust [WT 083481]; North Carolina Biotechnology Center; Michael Hooker Chair of Pharmacology; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061887, U19MH082441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/J010510/1] Funding Source: researchfish	SULSA; BBSRC Doctoral Training Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Pathfinder(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Dundee's Pump Priming Fund for Translational Medical Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); North Carolina Biotechnology Center; Michael Hooker Chair of Pharmacology; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by SULSA (HR07019), the BBSRC Doctoral Training Programme, the BBSRC Pathfinder (BB/FOF/PF/15/09) and the BBSRC Follow On Fund schemes (BB/J010510/1) (A.L.H.), the University of Dundee's Pump Priming Fund for Translational Medical Research (I.H.G. and A.L.H.) and by grants from the National Institutes of Health (NIH) supporting drug discovery receptor pharmacology (B.L.R.) and the NIH grant MH082441 (W.C.W.). The chemical synthesis and informatics benefits from the infrastructure investments from the Wellcome Trust Strategic Award (WT 083481). We thank J. Overington for StARlite and ChEMBL. We wish to thank D. Murugesan for compound purification and C. Means and T. Rhodes for helping with the open field, hole-board and zero-maze tests. We also wish to thank C. Elms and J. Zhou for their support in the husbandry and generation of the mice used for behavioural testing. We also wish to thank F. Y. Li for customizing the software configuration for the hole-board tests. Some of the equipment used in the behavioural testing was purchased with a grant from the North Carolina Biotechnology Center. B.L.R. also received support from the Michael Hooker Chair of Pharmacology.	Alig L, 2008, J MED CHEM, V51, P2115, DOI 10.1021/jm701487t; Arnsten AFT, 2000, NEUROPSYCHOPHARMACOL, V23, P405, DOI 10.1016/S0893-133X(00)00133-0; Bemis GW, 1996, J MED CHEM, V39, P2887, DOI 10.1021/jm9602928; Bender A, 2007, COMB CHEM HIGH T SCR, V10, P719, DOI 10.2174/138620707782507313; Brotz-Oesterhelt H, 2008, CURR OPIN PHARMACOL, V8, P564, DOI 10.1016/j.coph.2008.06.008; Brown N, 2004, J COMPUT AID MOL DES, V18, P761, DOI 10.1007/s10822-004-6986-2; Brown N, 2004, J CHEM INF COMP SCI, V44, P1079, DOI 10.1021/ci034290p; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Cannon EO, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-3; Deb K., 2006, INT J COMPUT INTELL, V2, P273, DOI DOI 10.5019/J.IJCIR.2006.67; Dey F, 2008, J CHEM INF MODEL, V48, P679, DOI 10.1021/ci700424b; Ertl P, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-8; Fanelli F., 2008, ANTITARGETS, P155; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; GILLET V, 1993, J COMPUT AID MOL DES, V7, P127, DOI 10.1007/BF00126441; Gillet VJ, 2002, J MOL GRAPH MODEL, V20, P491, DOI 10.1016/S1093-3263(01)00150-4; Glick M, 2006, J CHEM INF MODEL, V46, P193, DOI 10.1021/ci050374h; Heikkila T, 2006, BIOORG MED CHEM LETT, V16, P88, DOI 10.1016/j.bmcl.2005.09.045; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huang XP, 2010, ASSAY DRUG DEV TECHN, V8, P727, DOI 10.1089/adt.2010.0331; Hughes JD, 2008, BIOORG MED CHEM LETT, V18, P4872, DOI 10.1016/j.bmcl.2008.07.071; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Knowles J. D., 2007, P 9 ANN C GEN EV COM, P773; Kryssanov VV, 2001, ARTIF INTELL ENG, V15, P329, DOI 10.1016/S0954-1810(01)00023-1; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu Q, 2007, J MED CHEM, V50, P5392, DOI 10.1021/jm070750k; Lober S, 2011, TRENDS PHARMACOL SCI, V32, P148, DOI 10.1016/j.tips.2010.12.003; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Martin RE, 2007, J MED CHEM, V50, P6291, DOI 10.1021/jm701143p; Morphy R, 2005, J MED CHEM, V48, P6523, DOI 10.1021/jm058225d; Nicolaou CA, 2007, CURR OPIN DRUG DISC, V10, P316; Nicolaou CA, 2009, J CHEM INF MODEL, V49, P295, DOI 10.1021/ci800308h; Obrezanova O, 2008, J COMPUT AID MOL DES, V22, P431, DOI 10.1007/s10822-008-9193-8; Obrezanova O, 2007, J CHEM INF MODEL, V47, P1847, DOI 10.1021/ci7000633; Ortega R, 2009, BIOORG MED CHEM LETT, V19, P1773, DOI 10.1016/j.bmcl.2009.01.067; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Pogorelov VM, 2005, NEUROPSYCHOPHARMACOL, V30, P1818, DOI 10.1038/sj.npp.1300724; Porton B, 2010, GENES BRAIN BEHAV, V9, P257, DOI 10.1111/j.1601-183X.2009.00555.x; Ribeiz SRI, 2010, CNS DRUGS, V24, P303, DOI 10.2165/11530260-000000000-00000; Roche O, 2007, BIOORG MED CHEM LETT, V17, P3670, DOI 10.1016/j.bmcl.2007.04.056; Rogers D, 2005, J BIOMOL SCREEN, V10, P682, DOI 10.1177/1087057105281365; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Ruda GF, 2010, J MED CHEM, V53, P6071, DOI 10.1021/jm1004754; Schneider, 2002, ADAPTIVE SYSTEMS DRU; Schneider G, 2000, J COMPUT AID MOL DES, V14, P487, DOI 10.1023/A:1008184403558; Schneider G, 2011, FUTURE MED CHEM, V3, P415, DOI [10.4155/FMC.11.8, 10.4155/fmc.11.8]; Schneider G, 2009, TRENDS BIOTECHNOL, V27, P18, DOI 10.1016/j.tibtech.2008.09.005; Stahl M, 2002, J COMPUT AID MOL DES, V16, P459, DOI 10.1023/A:1021242018286; Stewart KD, 2006, BIOORGAN MED CHEM, V14, P7011, DOI 10.1016/j.bmc.2006.06.024; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Vidal D, 2010, MOL INFORM, V29, P543, DOI 10.1002/minf.201000055; Vinkers HM, 2003, J MED CHEM, V46, P2765, DOI 10.1021/jm030809x; Wermuth CG, 2006, DRUG DISCOV TODAY, V11, P160, DOI 10.1016/S1359-6446(05)03686-X; Zhao W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-225	58	521	530	6	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					215	+		10.1038/nature11691	http://dx.doi.org/10.1038/nature11691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235874	Green Accepted, Green Submitted			2022-12-24	WOS:000312259300034
J	Cui, GH; Jun, SB; Jin, X; Pham, MD; Vogel, SS; Lovinger, DM; Costa, RM				Cui, Guohong; Jun, Sang Beom; Jin, Xin; Pham, Michael D.; Vogel, Steven S.; Lovinger, David M.; Costa, Rui M.			Concurrent activation of striatal direct and indirect pathways during action initiation	NATURE			English	Article							BASAL GANGLIA; IN-VIVO; NEURONS; POPULATIONS; CIRCUITS	The basal ganglia are subcortical nuclei that control voluntary actions, and they are affected by a number of debilitating neurological disorders(1-4). The prevailing model of basal ganglia function proposes that two orthogonal projection circuits originating from distinct populations of spiny projection neurons (SPNs) in the striatum(5,6)-the so-called direct and indirect pathways have opposing effects on movement: activity of direct-pathway SPNs is thought to facilitate movement, whereas activity of indirect-pathway SPNs is presumed to inhibit movement(1,2). This model has been difficult to test owing to the lack of methods to selectively measure the activity of direct- and indirect-pathway SPNs in freely moving animals: Here we develop a novel in vivo method to specifically measure direct- and indirect-pathway SPN activity, using Cre-dependent viral expression of the genetically encoded calcium indicator (GECI) GCaMP3 in the dorsal striatum of D1-Cre (direct-pathway-specific(6,7)) and A2A-Cre (indirect-pathway-specific(8,9)) mice. Using fibre optics and time-correlated single-photon counting (TCSPC) in mice performing an operant task, we observed transient-increases in neural activity in both direct- and indirect-pathway SPNs when animals initiated actions, but not when they were inactive. Concurrent activation of SPNs from both pathways in one hemisphere preceded the initiation of contraversive movements and predicted the occurrence of specific movements within 500 ms. These observations challenge the classical view of basal ganglia function and may have implications for understanding the origin of motor symptoms in basal ganglia disorders.	[Cui, Guohong; Jin, Xin; Pham, Michael D.; Lovinger, David M.; Costa, Rui M.] NIAAA, Sect Vivo Neural Funct, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA; [Jun, Sang Beom] Ewha Womans Univ, Dept Elect Engn, Seoul 120750, South Korea; [Jin, Xin] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Vogel, Steven S.] NIAAA, Sect Cellular Biophoton, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Lovinger, David M.] NIAAA, Sect Synapt Pharmacol, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA; [Costa, Rui M.] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal; [Costa, Rui M.] Champalimaud Ctr Unknown, P-1400038 Lisbon, Portugal	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Ewha Womans University; Salk Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Fundacao Champalimaud; Instituto Gulbenkian de Ciencia; Fundacao Champalimaud	Vogel, SS (corresponding author), NIAAA, Sect Cellular Biophoton, Lab Mol Physiol, NIH, 5625 Fishers Lane, Bethesda, MD 20892 USA.	stevevog@mail.nih.gov; lovindav@mail.nih.gov; ruicosta@fchampalimaud.org	Cui, Guohong/E-4089-2019	Cui, Guohong/0000-0002-4555-028X; Costa, Rui M./0000-0003-0495-8374; Vogel, Steven/0000-0002-3005-2667	Division of Intramural Clinical and Biological Research of the NIAAA; European Research Council [STG 243393]; International Early Career Scientist grant from the Howard Hughes Medical Institute; National Research Foundation of Korea [2011-0029485, 2012-0004003]; SmartIT Convergence System Research Center from the Korean government (MEST) [SIRC-2011-0031866]; Ellison Medical Foundation [AG-NS-0944-12]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416, ZIAAA000452] Funding Source: NIH RePORTER	Division of Intramural Clinical and Biological Research of the NIAAA; European Research Council(European Research Council (ERC)European Commission); International Early Career Scientist grant from the Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Research Foundation of Korea(National Research Foundation of Korea); SmartIT Convergence System Research Center from the Korean government (MEST); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank C. R. Gerfen for gifts of multiple bacterial artificial chromosome (BAC) transgenic mouse lines; L. L. Looger and the Howard Hughes Medical Institute (HHMI) for permission to use AAV GCaMP3 vectors and GCaMP3 mice; S. R. Ikeda for assistance with Ca<SUP>2+</SUP> imaging in brain slices; G. Luo for mouse genotyping; C. Thaler for assistance with FLIM curve analysis; B. Mathur and M. Davis for assistance with brain slice electrophysiology and histology; and A. Martin for assistance with AAV vector injection. This work was supported by the Division of Intramural Clinical and Biological Research of the NIAAA, European Research Council STG 243393, an International Early Career Scientist grant from the Howard Hughes Medical Institute to R.M.C., a National Research Foundation of Korea grant (2011-0029485,2012-0004003) and SmartIT Convergence System Research Center (SIRC-2011-0031866) from the Korean government (MEST) to S.B.J., and by an Ellison Medical Foundation grant (AG-NS-0944-12) to X.J.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Bateup HS, 2010, P NATL ACAD SCI USA, V107, P14845, DOI 10.1073/pnas.1009874107; Brown P, 2007, CURR OPIN NEUROBIOL, V17, P656, DOI 10.1016/j.conb.2007.12.001; Chan CS, 2005, NEUROSIGNALS, V14, P281, DOI 10.1159/000093043; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Elangovan M, 2002, J MICROSC-OXFORD, V205, P3, DOI 10.1046/j.0022-2720.2001.00984.x; FULLER DRG, 1975, BRAIN RES, V96, P337, DOI 10.1016/0006-8993(75)90744-1; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Goldberg JH, 2012, NAT NEUROSCI, V15, P620, DOI 10.1038/nn.3047; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365; Nambu A, 2008, CURR OPIN NEUROBIOL, V18, P595, DOI 10.1016/j.conb.2008.11.001; Parent A, 2000, TRENDS NEUROSCI, V23, pS20, DOI 10.1016/S1471-1931(00)00022-7; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schiffmann SN, 2007, PROG NEUROBIOL, V83, P277, DOI 10.1016/j.pneurobio.2007.05.001; SCHIFFMANN SN, 1991, J NEUROCHEM, V57, P1062, DOI 10.1111/j.1471-4159.1991.tb08257.x; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Schweitzer D, 2007, MICROSC RES TECHNIQ, V70, P410, DOI 10.1002/jemt.20427; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012	30	705	719	4	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					238	242		10.1038/nature11846	http://dx.doi.org/10.1038/nature11846			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23354054	Green Accepted			2022-12-24	WOS:000315137700040
J	Arkhipov, A; Shan, YB; Das, R; Endres, NF; Eastwood, MP; Wemmer, DE; Kuriyan, J; Shaw, DE				Arkhipov, Anton; Shan, Yibing; Das, Rahul; Endres, Nicholas F.; Eastwood, Michael P.; Wemmer, David E.; Kuriyan, John; Shaw, David E.			Architecture and Membrane Interactions of the EGF Receptor	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; TRANSMEMBRANE DOMAIN; JUXTAMEMBRANE REGION; ONCOGENIC MUTATIONS; LIGAND-BINDING; ACTIVATION; DIMERIZATION; KINASE	Dimerization-driven activation of the intracellular kinase domains of the epidermal growth factor receptor (EGFR) upon extracellular ligand binding is crucial to cellular pathways regulating proliferation, migration, and differentiation. Inactive EGFR can exist as both monomers and dimers, suggesting that the mechanism regulating EGFR activity may be subtle. The membrane itself may play a role but creates substantial difficulties for structural studies. Our molecular dynamics simulations of membrane-embedded EGFR suggest that, in ligand-bound dimers, the extracellular domains assume conformations favoring dimerization of the transmembrane helices near their N termini, dimerization of the juxtamembrane segments, and formation of asymmetric (active) kinase dimers. In ligand-free dimers, by holding apart the N termini of the transmembrane helices, the extracellular domains instead favor C-terminal dimerization of the transmembrane helices, juxtamembrane segment dissociation and membrane burial, and formation of symmetric (inactive) kinase dimers. Electrostatic interactions of EGFR's intracellular module with the membrane are critical in maintaining this coupling.	[Arkhipov, Anton; Shan, Yibing; Eastwood, Michael P.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Das, Rahul; Endres, Nicholas F.; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Das, Rahul; Endres, Nicholas F.; Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	D. E. Shaw Research; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Columbia University	Shan, YB (corresponding author), DE Shaw Res, New York, NY 10036 USA.	yibing.shan@deshawresearch.com; david.shaw@deshawresearch.com	Arkhipov, Anton/AAE-7801-2020; Das, Rahul/AAU-5123-2020	Arkhipov, Anton/0000-0003-1106-8310; Das, Rahul/0000-0001-7841-8229	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; National Cancer Institute (NCI) [2-R01-CA096504-06]; NATIONAL CANCER INSTITUTE [R01CA096504] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Morten Jensen, Stefano Piana, and Kresten Lindorff-Larsen for helpful discussions, Ansgar Philipsen for assistance with graphics, and Mollie Kirk and Berkman Frank for editorial assistance. N.F.E. was a Leukemia and Lymphoma Society Fellow. R.D. was supported by postdoctoral fellowships from the Natural Sciences and Engineering Research Council of Canada (2009-2011) and the Canadian Institutes of Health Research (2011-2012). This work was supported by a grant from the National Cancer Institute (NCI) to J.K. (2-R01-CA096504-06).	Alvarado D, 2009, NATURE, V461, P287, DOI 10.1038/nature08297; Bessman NJ, 2012, NAT STRUCT MOL BIOL, V19, P1, DOI 10.1038/nsmb.2221; Bocharov EV, 2008, J BIOL CHEM, V283, P6950, DOI 10.1074/jbc.M709202200; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Choowongkomon K, 2005, J BIOL CHEM, V280, P24043, DOI 10.1074/jbc.M502698200; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; Du Y, 2012, J AM CHEM SOC, V134, P6720, DOI 10.1021/ja211941d; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Holt A, 2010, EUR BIOPHYS J BIOPHY, V39, P609, DOI 10.1007/s00249-009-0567-1; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kastner J, 2009, J STRUCT BIOL, V167, P117, DOI 10.1016/j.jsb.2009.04.007; Kim C, 2012, NATURE, V481, P209, DOI 10.1038/nature10697; Landau M, 2008, BBA-REV CANCER, V1785, P12, DOI 10.1016/j.bbcan.2007.08.001; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Liu P, 2012, PROTEIN SCI, V21, P152, DOI 10.1002/pro.753; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Mattoon D, 2004, P NATL ACAD SCI USA, V101, P923, DOI 10.1073/pnas.0307286101; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Mi LZ, 2011, NAT STRUCT MOL BIOL, V18, P984, DOI 10.1038/nsmb.2092; Michailidis IE, 2011, PFLUG ARCH EUR J PHY, V461, P387, DOI 10.1007/s00424-010-0904-3; Odaka M, 1997, J BIOCHEM-TOKYO, V122, P116; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Riese DJ, 2007, BIOESSAYS, V29, P558, DOI 10.1002/bies.20582; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Scheck RA, 2012, ACS CHEM BIOL, V7, P1367, DOI 10.1021/cb300216f; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Shaw D. E., 2009, P C HIGH PERF COMP N, V39, P1, DOI DOI 10.1145/1654059.1654099; STERNBERG MJE, 1989, NATURE, V339, P587, DOI 10.1038/339587a0; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Wang ZH, 2011, NAT STRUCT MOL BIOL, V18, P1388, DOI 10.1038/nsmb.2168; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	45	337	341	1	155	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					557	569		10.1016/j.cell.2012.12.030	http://dx.doi.org/10.1016/j.cell.2012.12.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374350	Bronze, Green Accepted			2022-12-24	WOS:000314362800024
J	Casazza, K; Fontaine, KR; Astrup, A; Birch, LL; Brown, AW; Brown, MMB; Durant, N; Dutton, G; Foster, EM; Heymsfield, SB; McIver, K; Mehta, T; Menachemi, N; Newby, PK; Pate, R; Rolls, BJ; Sen, B; Smith, DL; Thomas, DM; Allison, DB				Casazza, Krista; Fontaine, Kevin R.; Astrup, Arne; Birch, Leann L.; Brown, Andrew W.; Brown, Michelle M. Bohan; Durant, Nefertiti; Dutton, Gareth; Foster, E. Michael; Heymsfield, Steven B.; McIver, Kerry; Mehta, Tapan; Menachemi, Nir; Newby, P. K.; Pate, Russell; Rolls, Barbara J.; Sen, Bisakha; Smith, Daniel L., Jr.; Thomas, Diana M.; Allison, David B.			Myths, Presumptions, and Facts about Obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEIGHT-LOSS; ENERGY-INTAKE; PHYSICAL-ACTIVITY; EXERCISE; INTERVENTIONS; ASSOCIATION; MAINTENANCE; CONSUMPTION; DISEASE; BALANCE	BACKGROUND Many beliefs about obesity persist in the absence of supporting scientific evidence (presumptions); some persist despite contradicting evidence (myths). The promulgation of unsupported beliefs may yield poorly informed policy decisions, inaccurate clinical and public health recommendations, and an unproductive allocation of research resources and may divert attention away from useful, evidence-based information. METHODS Using Internet searches of popular media and scientific literature, we identified, reviewed, and classified obesity-related myths and presumptions. We also examined facts that are well supported by evidence, with an emphasis on those that have practical implications for public health, policy, or clinical recommendations. RESULTS We identified seven obesity-related myths concerning the effects of small sustained increases in energy intake or expenditure, establishment of realistic goals for weight loss, rapid weight loss, weight-loss readiness, physical-education classes, breast-feeding, and energy expended during sexual activity. We also identified six presumptions about the purported effects of regularly eating breakfast, early childhood experiences, eating fruits and vegetables, weight cycling, snacking, and the built (i.e., human-made) environment. Finally, we identified nine evidence-supported facts that are relevant for the formulation of sound public health, policy, or clinical recommendations. CONCLUSIONS False and scientifically unsupported beliefs about obesity are pervasive in both scientific literature and the popular press. (Funded by the National Institutes of Health.)	[Casazza, Krista; Brown, Michelle M. Bohan; Smith, Daniel L., Jr.; Allison, David B.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Fontaine, Kevin R.] Univ Alabama Birmingham, Dept Hlth Behav, Birmingham, AL 35294 USA; [Durant, Nefertiti] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; [Dutton, Gareth] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Foster, E. Michael; Menachemi, Nir; Sen, Bisakha] Univ Alabama Birmingham, Dept Hlth Care Org & Policy, Birmingham, AL 35294 USA; [Mehta, Tapan; Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Brown, Andrew W.; Allison, David B.] Univ Alabama Birmingham, Sch Publ Hlth, Off Energet, Nutr Obes Res Ctr, Birmingham, AL 35294 USA; [Astrup, Arne] Univ Copenhagen, OPUS Ctr, Copenhagen, Denmark; [Astrup, Arne] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Birch, Leann L.] Penn State Univ, Dept Dev & Family Studies, University Pk, PA 16802 USA; [Rolls, Barbara J.] Penn State Univ, Dept Nutrit Sci, University Pk, PA 16802 USA; [Heymsfield, Steven B.] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [McIver, Kerry; Pate, Russell] Univ S Carolina, Childrens Phys Act Res Grp, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Newby, P. K.] Boston Univ, Dept Pediat, Program Grad Med Nutr Sci, Boston, MA 02215 USA; [Newby, P. K.] Boston Univ, Dept Epidemiol, Program Grad Med Nutr Sci, Boston, MA 02215 USA; [Newby, P. K.] Boston Univ, Program Gastron Culinary Arts & Wine Studies, Boston, MA 02215 USA; [Thomas, Diana M.] Montclair State Univ, Ctr Quantitat Obes Res, Montclair, NJ USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Copenhagen; University of Copenhagen; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Boston University; Boston University; Boston University; Montclair State University	Allison, DB (corresponding author), Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA.	dallison@uab.edu	Heymsfield, Steven B/N-1968-2017; Robles-Sardin, Alma E/M-7714-2015; Brown, Andrew W/N-1826-2013; Bohan Brown, Michelle/L-7778-2014; Rolls, Barbara J/AAE-3899-2019; Astrup, Arne/B-1407-2015	Heymsfield, Steven B/0000-0003-1127-9425; Robles-Sardin, Alma E/0000-0003-2044-7793; Brown, Andrew W/0000-0002-1758-8205; Bohan Brown, Michelle/0000-0002-7959-9225; Astrup, Arne/0000-0001-8968-8996; Smith Jr, Daniel/0000-0002-1602-2023; Allison, David/0000-0003-3566-9399	National Institutes of Health [P30DK056336]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK062710, R00DK083333, P30DK026687, P01DK042618, P30DK056336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in part by a grant (P30DK056336) from the National Institutes of Health.	Astrup A, 2000, Obes Rev, V1, P17, DOI 10.1046/j.1467-789x.2000.00004.x; BOHLEN JG, 1984, ARCH INTERN MED, V144, P1745, DOI 10.1001/archinte.144.9.1745; Brisbois TD, 2012, OBES REV, V13, P347, DOI 10.1111/j.1467-789X.2011.00965.x; Carroll S, 2004, SPORTS MED, V34, P371, DOI 10.2165/00007256-200434060-00004; Casazza K., 2012, Nutrition Today, V47, P33; Dobbins M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651; Fairman KA, 2011, J MANAGE CARE PHARM, V17, P224, DOI 10.18553/jmcp.2011.17.3.224; Federal Trade Commission, 2001, DIET SUPPL ADV GUID; Ferdinand AO, 2012, AM J PUBLIC HEALTH, V102, pE7, DOI 10.2105/AJPH.2012.300740; Fontaine KR, 1999, J AM DIET ASSOC, V99, P664, DOI 10.1016/S0002-8223(99)00159-5; Gillman MW, 2011, INT J EPIDEMIOL, V40, P681, DOI 10.1093/ije/dyr085; Hall KD, 2012, AM J CLIN NUTR, V95, P989, DOI 10.3945/ajcn.112.036350; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; Hewitt JK, 1997, BEHAV GENET, V27, P353, DOI 10.1023/A:1025687930765; Heymsfield SB, 2011, AM J CLIN NUTR, V94, P3, DOI 10.3945/ajcn.111.018630; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213; Horta BL, 2007, EVIDENCE LONG TERM E; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Kahneman D., 2011, THINKING FAST SLOW; Kramer MS, 2008, PEDIATRICS, V121, pE435, DOI 10.1542/peds.2007-1248; Kriemler S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c785; Lilienfeld SO, 2009, PERSPECT PSYCHOL SCI, V4, P390, DOI 10.1111/j.1745-6924.2009.01144.x; Linde JA, 2005, INT J OBESITY, V29, P1002, DOI 10.1038/sj.ijo.0802990; McLean N, 2003, INT J OBESITY, V27, P987, DOI 10.1038/sj.ijo.0802383; Middleton KMR, 2012, OBES REV, V13, P509, DOI 10.1111/j.1467-789X.2011.00972.x; Nackers LM, 2010, INT J BEHAV MED, V17, P161, DOI 10.1007/s12529-010-9092-y; Rolls BJ, 2004, NUTR REV, V62, P1, DOI [10.1301/nr.2004.jan.1-17, 10.1301/nr.2004.jan.1&ndash;17, 10.1111/j.1753-4887.2004.tb00001.x]; SCHLUNDT DG, 1992, AM J CLIN NUTR, V55, P645, DOI 10.1093/ajcn/55.3.645; Shermer M., 2007, WHY PEOPLE BELIEVE W; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; TAUBES G, 1995, SCIENCE, V269, P164, DOI 10.1126/science.7618077; Thomas Diana M., 2011, Journal of Biological Dynamics, V5, P579, DOI 10.1080/17513758.2010.508541; Thomas DM, 2010, AM J CLIN NUTR, V92, P1326, DOI 10.3945/ajcn.2010.29687; Vasselli JR, 2005, OBES RES, V13, P693, DOI 10.1038/oby.2005.78; Whately, 1875, ELEMENTS LOGIC; Whybrow S, 2007, OBESITY, V15, P673, DOI 10.1038/oby.2007.567; Wing RR, 2001, OBES RES, V9, p271S, DOI 10.1038/oby.2001.130; Wright SM, 2011, NAT REV ENDOCRINOL, V7, P69, DOI 10.1038/nrendo.2010.231; Wu T, 2009, OBES REV, V10, P313, DOI 10.1111/j.1467-789X.2008.00547.x	40	286	294	1	248	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2013	368	5					446	454		10.1056/NEJMsa1208051	http://dx.doi.org/10.1056/NEJMsa1208051			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080BE	23363498	Green Published, Green Accepted			2022-12-24	WOS:000314215400009
J	Tye, KM; Mirzabekov, JJ; Warden, MR; Ferenczi, EA; Tsai, HC; Finkelstein, J; Kim, SY; Adhikari, A; Thompson, KR; Andalman, AS; Gunaydin, LA; Witten, IB; Deisseroth, K				Tye, Kay M.; Mirzabekov, Julie J.; Warden, Melissa R.; Ferenczi, Emily A.; Tsai, Hsing-Chen; Finkelstein, Joel; Kim, Sung-Yon; Adhikari, Avishek; Thompson, Kimberly R.; Andalman, Aaron S.; Gunaydin, Lisa A.; Witten, Ilana B.; Deisseroth, Karl			Dopamine neurons modulate neural encoding and expression of depression-related behaviour	NATURE			English	Article							STRESS-INDUCED ANHEDONIA; VENTRAL TEGMENTAL AREA; SOCIAL DEFEAT; ANIMAL-MODEL; AVERSIVE STIMULI; REWARD CIRCUIT; GABA NEURONS; SUSCEPTIBILITY; MICE; INHIBITION	Major depression is characterized by diverse debilitating symptoms that include hopelessness and anhedonia(1). Dopamine neurons involved in reward and motivation(2-9) are among many neural populations that have been hypothesized to be relevant(10), and certain antidepressant treatments, including medications and brain stimulation therapies, can influence the complex dopamine system. Until now it has not been possible to test this hypothesis directly, even in animal models, as existing therapeutic interventions are unable to specifically target dopamine neurons. Here we investigated directly the causal contributions of defined dopamine neurons to multidimensional depression-like phenotypes induced by chronic mild stress, by integrating behavioural, pharmacological, optogenetic and electrophysiological methods in freely moving rodents. We found that bidirectional control (inhibition or excitation) of specified midbrain dopamine neurons immediately and bidirectionally modulates (induces or relieves) multiple independent depression symptoms caused by chronic stress. By probing the circuit implementation of these effects, we observed that optogenetic recruitment of these dopamine neurons potently alters the neural encoding of depression-related behaviours in the downstream nucleus accumbens of freely moving rodents, suggesting that processes affecting depression symptoms may involve alterations in the neural encoding of action in limbic circuitry.	[Tye, Kay M.] MIT, Picower Inst Learning & Memory Brain & Cognit Sci, Cambridge, MA 02139 USA; [Tye, Kay M.; Mirzabekov, Julie J.; Warden, Melissa R.; Ferenczi, Emily A.; Tsai, Hsing-Chen; Finkelstein, Joel; Kim, Sung-Yon; Adhikari, Avishek; Thompson, Kimberly R.; Andalman, Aaron S.; Gunaydin, Lisa A.; Witten, Ilana B.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ferenczi, Emily A.; Tsai, Hsing-Chen; Kim, Sung-Yon; Deisseroth, Karl] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Tye, KM (corresponding author), MIT, Picower Inst Learning & Memory Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	kaytye@mit.edu; deissero@stanford.edu	Core, Vector/CAF-4832-2022; Adhikari, Avishek/N-1284-2015; Kim, Sung-Yon/AAO-8405-2020; Andalman, Aaron S/C-7694-2011; Adhikari, Avishek/AAF-4444-2021; Adhikari, Avishek/A-3339-2012; Warden, Melissa R/M-9300-2016; Tye, Kay/J-6158-2013	Adhikari, Avishek/0000-0002-9187-9211; Kim, Sung-Yon/0000-0003-0791-7308; Adhikari, Avishek/0000-0002-9187-9211; Adhikari, Avishek/0000-0002-9187-9211; Warden, Melissa R/0000-0003-2240-3997; Tye, Kay/0000-0002-2435-0182	Helen Hay Whitney Foundation; NRSA [F32 MH880102]; JPB Foundation; NARSAD; Wiegers Family Fund; NIMH; NIDA; DARPA REPAIR Program; Keck Foundation; McKnight Foundation; Gatsby Charitable Foundation; Snyder Foundation; Woo Foundation; Albert Yu and Mary Bechman Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP2DA035149] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; NARSAD(NARSAD); Wiegers Family Fund; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DARPA REPAIR Program; Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Gatsby Charitable Foundation; Snyder Foundation; Woo Foundation; Albert Yu and Mary Bechman Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank T. Davidson, S. Pak, C. Ramakrishnan, L. Grosenick, Z. Chen and the members of the Deisseroth Laboratory for support. I. B. W. was supported by the Helen Hay Whitney Foundation; K. M. T was supported by NRSA fellowship F32 MH880102 and the JPB Foundation; K. R. T., M. R. W. and K. D. are NARSAD grant awardees. K. D. was supported by the Wiegers Family Fund and by the NIMH, the NIDA, the DARPA REPAIR Program, the Keck Foundation, the McKnight Foundation, the Gatsby Charitable Foundation, the Snyder Foundation, the Woo Foundation and the Albert Yu and Mary Bechman Foundation. All tools and methods described are distributed and supported freely (http://www.optogenetics.org).	Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; FREEMAN AS, 1987, BRAIN RES, V405, P46, DOI 10.1016/0006-8993(87)90988-7; Friedman A, 2008, J MOL NEUROSCI, V34, P201, DOI 10.1007/s12031-007-9016-8; GRACE AA, 1984, J NEUROSCI, V4, P2877; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Ikemoto S, 2004, NEUROPHARMACOLOGY, V47, P190, DOI 10.1016/j.neuropharm.2004.07.012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P709; Koob GF, 1996, MOL PSYCHIATR, V1, P186; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lammel S., 2012, NATURE; Lemke MR, 2000, J PSYCHIATR RES, V34, P277, DOI 10.1016/S0022-3956(00)00017-0; Lemos J.C., 2012, NATURE          0919; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tanaka K, 2012, J NEUROSCI, V32, P4319, DOI 10.1523/JNEUROSCI.5952-11.2012; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Valenti O, 2012, EUR J NEUROSCI, V35, P1312, DOI 10.1111/j.1460-9568.2012.08038.x; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Willner P., 1991, EUR NEUROPSYCHOPHARM, V1, P295; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028	34	640	668	15	336	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2013	493	7433					537	+		10.1038/nature11740	http://dx.doi.org/10.1038/nature11740			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23235822	Green Published, Green Accepted			2022-12-24	WOS:000313871400039
J	Ostuni, R; Piccolo, V; Barozzi, I; Polletti, S; Termanini, A; Bonifacio, S; Curina, A; Prosperini, E; Ghisletti, S; Natoli, G				Ostuni, Renato; Piccolo, Viviana; Barozzi, Iros; Polletti, Sara; Termanini, Alberto; Bonifacio, Silvia; Curina, Alessia; Prosperini, Elena; Ghisletti, Serena; Natoli, Gioacchino			Latent Enhancers Activated by Stimulation in Differentiated Cells	CELL			English	Article							GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTORS; REGULATORY ELEMENTS; CHROMATIN IMMUNOPRECIPITATION; GENE-EXPRESSION; MACROPHAGE; DYNAMICS; METHYLATIONS; PATHWAYS; DISTINCT	According to current models, once the cell has reached terminal differentiation, the enhancer repertoire is completely established and maintained by cooperatively acting lineage-specific transcription factors (TFs). TFs activated by extracellular stimuli operate within this predetermined repertoire, landing close to where master regulators are constitutively bound. Here, we describe latent enhancers, defined as regions of the genome that in terminally differentiated cells are unbound by TFs and lack the histone marks characteristic of enhancers but acquire these features in response to stimulation. Macrophage stimulation caused sequential binding of stimulus-activated and lineage-determining TFs to these regions, enabling deposition of enhancer marks. Once unveiled, many of these enhancers did not return to a latent state when stimulation ceased; instead, they persisted and mediated a faster and stronger response upon restimulation. We suggest that stimulus-specific expansion of the cis-regulatory repertoire provides an epigenomic memory of the exposure to environmental agents.	[Ostuni, Renato; Piccolo, Viviana; Barozzi, Iros; Polletti, Sara; Termanini, Alberto; Bonifacio, Silvia; Curina, Alessia; Prosperini, Elena; Ghisletti, Serena; Natoli, Gioacchino] European Inst Oncol IEO, Dept Expt Oncol, I-20139 Milan, Italy	IRCCS European Institute of Oncology (IEO)	Ostuni, R (corresponding author), European Inst Oncol IEO, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy.	renato.ostuni@ieo.eu; gioacchino.natoli@ieo.eu	Barozzi, Iros/GLQ-8907-2022; Ghisletti, Serena/AAO-6437-2021; Termanini, Alberto/AAB-9934-2019; PROSPERINI, ELENA/AAB-1952-2021; Natoli, gioacchino/ABB-8679-2020; Ostuni, Renato/AAB-8832-2022; Natoli, gioacchino/J-2100-2018; Polletti, Sara/AAA-9543-2021; Polletti, Sara/K-3948-2018	Barozzi, Iros/0000-0003-0690-3473; Termanini, Alberto/0000-0002-9697-906X; Ostuni, Renato/0000-0003-0460-3426; Polletti, Sara/0000-0002-5433-0502; Polletti, Sara/0000-0002-5433-0502; Ghisletti, Serena/0000-0002-7087-5553; Natoli, Gioacchino/0000-0003-0711-2411	EMBO fellowship [ASTF 210-2012]; European Research Council [268757-NORM]	EMBO fellowship(European Molecular Biology Organization (EMBO)); European Research Council(European Research Council (ERC)European Commission)	We thank D. Voehringer and A. Planas for the generous gift of Stat6- and Stat1-deficient bone marrows, respectively; B. Amati for critical comments to the manuscript; I. Amit (Weizmann Institute, Rehovot) for training in the HT-ChIP protocol; L. Rotta, M. Riboni, S. Minardi (Cogentech, Milan), and S. Bianchi (IIT@SEMM) for the preparation and processing of sequencing libraries; K. Ferrari and D. Pasini (IEO) for sharing reagents. Sequence data in fastq format were prepared by H. Muller and the Computational Research Unit of the Center for Genomic Sciences of IIT@SEMM and hosted on the IIT@SEMM computational infrastructure. Training in HT-ChIP was supported by a short-term EMBO fellowship (ASTF 210-2012) to R.O. This study was supported by the European Research Council (advanced grant 268757-NORM to G.N.). R.O. and S.P. carried out the ChIP-seq and RNA-Seq experiments, their validation and functional assays with the help of S.B., A.C., E.P., and S.G. V.P. and I. B. analyzed data with the help of A.T. G.N. designed the study with the help of R.O. and S.G. and wrote the paper.	Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Barozzi I, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-51; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Elo LL, 2010, IMMUNITY, V32, P852, DOI 10.1016/j.immuni.2010.06.011; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Huang M, 2002, NAT CELL BIOL, V4, P774, DOI 10.1038/ncb855; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Liu H, 2002, MOL CELL BIOL, V22, P6471, DOI 10.1128/MCB.22.18.6471-6479.2002; Matsumoto M, 1999, BIOL CHEM, V380, P699, DOI 10.1515/BC.1999.087; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Natoli G, 2011, GENE DEV, V25, P101, DOI 10.1101/gad.2018811; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106	57	521	536	3	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					157	171		10.1016/j.cell.2012.12.018	http://dx.doi.org/10.1016/j.cell.2012.12.018			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332752	Bronze			2022-12-24	WOS:000313719800014
J	Rai, AK; Rai, A; Ramaiya, AJ; Jha, R; Mallik, R				Rai, Arpan K.; Rai, Ashim; Ramaiya, Avin J.; Jha, Rupam; Mallik, Roop			Molecular Adaptations Allow Dynein to Generate Large Collective Forces inside Cells	CELL			English	Article							TUG-OF-WAR; CYTOPLASMIC DYNEIN; CARGO TRANSPORT; OPTICAL TRAPS; PHAGOSOMES; MOTORS; PROCESSIVITY; ENDOSOMES; MOVEMENT; PROTEOME	Many cellular processes require large forces that are generated collectively by multiple cytoskeletal motor proteins. Understanding how motors generate force as a team is therefore fundamentally important but is poorly understood. Here, we demonstrate optical trapping at single-molecule resolution inside cells to quantify force generation by motor teams driving single phagosomes. In remarkable paradox, strong kinesins fail to work collectively, whereas weak and detachment-prone dyneins team up to generate large forces that tune linearly in strength and persistence with dynein number. Based on experimental evidence, we propose that leading dyneins in a load-carrying team take short steps, whereas trailing dyneins take larger steps. Dyneins in such a team bunch close together and therefore share load better to overcome low/intermediate loads. Up against higher load, dyneins "catch bond'' tenaciously to the microtubule, but kinesins detach rapidly. Dynein therefore appears uniquely adapted to work in large teams, which may explain how this motor executes bewilderingly diverse cellular processes.	[Rai, Arpan K.; Rai, Ashim; Ramaiya, Avin J.; Jha, Rupam; Mallik, Roop] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Mallik, R (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	roop@tifr.res.in		mallik, roop/0000-0001-6820-6556; Jha, Rupam/0000-0003-0332-2542	Wellcome Trust, UK [WT079214MA]	Wellcome Trust, UK(Wellcome Trust)	R.M. thanks S. Gross and S. Cermelli for help with animal cell culture. We thank G. Griffiths and E. Hoffman for help with phagosome isolation. P. Barak, V. Soppina, A. Dubey, N. Buwa, and D. Choudhury are thanked for help with experiments. S. Nair, M. Gopalakrishnan, R. Vale, and S.J. King are thanked for comments on the manuscript. S.J. King is acknowledged for help with purification of kinesin-1 and dynein. We thank the following for sharing reagents: T. Schroer (CC1); K. Verhey (kinesin-1 antibodies); A. Bershadsky (EB1-GFP). R.M. acknowledges funding through an International Senior Research Fellowship from the Wellcome Trust, UK (grant WT079214MA).	Al-Haddad AH, 2001, MOL BIOL CELL, V12, P2742, DOI 10.1091/mbc.12.9.2742; Bhat D, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/046003; Blocker A, 1997, J CELL BIOL, V137, P113, DOI 10.1083/jcb.137.1.113; Capitanio M, 2002, REV SCI INSTRUM, V73, P1687, DOI 10.1063/1.1460929; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Desjardins M, 2003, CURR OPIN CELL BIOL, V15, P498, DOI 10.1016/S0955-0674(03)00083-8; DeWitt MA, 2012, SCIENCE, V335, P221, DOI 10.1126/science.1215804; Driver JW, 2011, BIOPHYS J, V101, P386, DOI 10.1016/j.bpj.2011.05.067; Duclos S, 2000, J CELL SCI, V113, P3531; Dufrene YF, 2011, NAT METHODS, V8, P123, DOI 10.1038/nmeth0211-123; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gross SP, 2003, METHOD ENZYMOL, V361, P162; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Hendricks AG, 2012, P NATL ACAD SCI USA, V109, P18447, DOI 10.1073/pnas.1215462109; Hirakawa E, 2000, P NATL ACAD SCI USA, V97, P2533, DOI 10.1073/pnas.050585297; Jamison DK, 2010, BIOPHYS J, V99, P2967, DOI 10.1016/j.bpj.2010.08.025; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kunwar A, 2011, P NATL ACAD SCI USA, V108, P18960, DOI 10.1073/pnas.1107841108; Leidel C, 2012, BIOPHYS J, V103, P492, DOI 10.1016/j.bpj.2012.06.038; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Nan XL, 2008, CHEMPHYSCHEM, V9, P707, DOI 10.1002/cphc.200700839; Petrov DY, 2007, BIOPHYS J, V92, P2953, DOI 10.1529/biophysj.106.097253; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Rice SE, 2003, METHOD ENZYMOL, V361, P112; Schroeder HW, 2010, CURR BIOL, V20, P687, DOI 10.1016/j.cub.2010.03.024; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Sims PA, 2009, CHEMPHYSCHEM, V10, P1511, DOI 10.1002/cphc.200900113; Singh MP, 2005, P NATL ACAD SCI USA, V102, P12059, DOI 10.1073/pnas.0501570102; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Soppina V, 2009, BIOTECHNIQUES, V46, P543, DOI 10.2144/000113124; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; Vershinin M, 2008, TRAFFIC, V9, P882, DOI 10.1111/j.1600-0854.2008.00741.x; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Viana NB, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021914; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Walter WJ, 2012, P NATL ACAD SCI USA, V109, P5289, DOI 10.1073/pnas.1116315109; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Wu MS, 2005, EMBO J, V24, P1491, DOI 10.1038/sj.emboj.7600643	51	193	195	1	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					172	182		10.1016/j.cell.2012.11.044	http://dx.doi.org/10.1016/j.cell.2012.11.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332753	Bronze			2022-12-24	WOS:000313719800015
J	Schloissnig, S; Arumugam, M; Sunagawa, S; Mitreva, M; Tap, J; Zhu, A; Waller, A; Mende, DR; Kultima, JR; Martin, J; Kota, K; Sunyaev, SR; Weinstock, GM; Bork, P				Schloissnig, Siegfried; Arumugam, Manimozhiyan; Sunagawa, Shinichi; Mitreva, Makedonka; Tap, Julien; Zhu, Ana; Waller, Alison; Mende, Daniel R.; Kultima, Jens Roat; Martin, John; Kota, Karthik; Sunyaev, Shamil R.; Weinstock, George M.; Bork, Peer			Genomic variation landscape of the human gut microbiome	NATURE			English	Article							SALT HYDROLASE ACTIVITY; IV SECRETION SYSTEMS; ESCHERICHIA-COLI; HELICOBACTER-PYLORI; POPULATION-GENETICS; HUMAN FECES; DIVERSITY; BACTERIAL; EVOLUTION; RECONSTRUCTION	Whereas large-scale efforts have rapidly advanced the understanding and practical impact of human genomic variation, the practical impact of variation is largely unexplored in the human microbiome. We therefore developed a framework for metagenomic variation analysis and applied it to 252 faecal metagenomes of 207 individuals from Europe and North America. Using 7.4 billion reads aligned to 101 reference species, we detected 10.3 million single nucleotide polymorphisms (SNPs), 107,991 short insertions/deletions, and 1,051 structural variants. The average ratio of non-synonymous to synonymous polymorphism rates of 0.11 was more variable between gut microbial species than across human hosts. Subjects sampled at varying time intervals exhibited individuality and temporal stability of SNP variation patterns, despite considerable composition changes of their gut microbiota. This indicates that individual-specific strains are not easily replaced and that an individual might have a unique metagenomic genotype, which may be exploitable for personalized diet or drug intake.	[Schloissnig, Siegfried; Arumugam, Manimozhiyan; Sunagawa, Shinichi; Tap, Julien; Zhu, Ana; Waller, Alison; Mende, Daniel R.; Kultima, Jens Roat; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Mitreva, Makedonka; Martin, John; Kota, Karthik; Weinstock, George M.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Sunyaev, Shamil R.] Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	European Molecular Biology Laboratory (EMBL); Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	gweinsto@genome.wustl.edu; bork@embl.de	Arumugam, Manimozhiyan/E-1211-2011; Mende, Daniel R/I-3662-2019; Sunagawa, Shinichi/Q-5950-2019; Tap, Julien/E-5760-2010; Bork, Peer/F-1813-2013; Powell, Sean/B-2374-2009; ravegnini, gloria/K-1330-2016; Arumugam, Manimozhiyan/AAJ-2394-2020; Weinstock, George M/C-6314-2013	Arumugam, Manimozhiyan/0000-0002-0886-9101; Mende, Daniel R/0000-0001-6831-4557; Sunagawa, Shinichi/0000-0003-3065-0314; Tap, Julien/0000-0001-8998-5413; Bork, Peer/0000-0002-2627-833X; Powell, Sean/0000-0002-0994-5911; ravegnini, gloria/0000-0002-7774-402X; Arumugam, Manimozhiyan/0000-0002-0886-9101; Weinstock, George M/0000-0002-2997-4592; Schloissnig, Siegfried/0000-0003-4574-8330; Mitreva, Makedonka/0000-0001-9572-3436	EMBL; European Community [HEALTH-F4-2007-201052]; IHMS [HEALTH-F4-2010-261376]; National Institutes of Health [U54HG003079, U54HG004968]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U54HG004968] Funding Source: NIH RePORTER	EMBL; European Community(European Commission); IHMS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors are grateful to J. Korbel and the members of the Bork group at EMBL for discussions and assistance, especially S. Powell for performing some of the computations. We thank the EMBL IT core facility and Y. Yuan for managing the high-performance computing resources. We would like to thank J. I. Gordon for providing three of the samples used. We are also grateful to the European MetaHIT consortium and the NIH Common Fund Human Microbiome Project Consortium for generating and making available the data sets used in this study. The research leading to these results has received funding from EMBL, the European Community's Seventh Framework Programme via the MetaHIT (HEALTH-F4-2007-201052) and IHMS (HEALTH-F4-2010-261376) grants as well as from the National Institutes of Health grants U54HG003079 and U54HG004968.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Allen EE, 2007, P NATL ACAD SCI USA, V104, P1883, DOI 10.1073/pnas.0604851104; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bagel S, 1999, ANTIMICROB AGENTS CH, V43, P868, DOI 10.1128/AAC.43.4.868; Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P1615, DOI [10.1099/ijs.0.02143-0, 10.1099/00207713-52-5-1615]; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Friedman R, 2004, GENETICS, V167, P1507, DOI 10.1534/genetics.104.026344; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; HOLDEMAN LV, 1974, INT J SYST BACTERIOL, V24, P260, DOI 10.1099/00207713-24-2-260; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; KUNZ BA, 1983, GENETICS, V105, P489; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Nagai H, 2003, CELL MICROBIOL, V5, P373, DOI 10.1046/j.1462-5822.2003.00285.x; Novichkov PS, 2009, J BACTERIOL, V191, P65, DOI 10.1128/JB.01237-08; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Simmons SL, 2008, PLOS BIOL, V6, P1427, DOI 10.1371/journal.pbio.0060177; Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Suzuki R, 2012, INFECT GENET EVOL, V12, P203, DOI 10.1016/j.meegid.2011.12.002; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Yamaoka Y, 2009, CLIN MICROBIOL INFEC, V15, P829, DOI 10.1111/j.1469-0691.2009.02967.x; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	48	523	557	12	378	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					45	50		10.1038/nature11711	http://dx.doi.org/10.1038/nature11711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23222524	Green Accepted, Green Submitted			2022-12-24	WOS:000312933800027
J	Vos, T; Flaxman, AD; Naghavi, M; Lozano, R; Michaud, C; Ezzati, M; Shibuya, K; Salomon, JA; Abdalla, S; Aboyans, V; Abraham, J; Ackerman, I; Aggarwal, R; Ahn, SY; Ali, MK; Alvarado, M; Anderson, HR; Anderson, LM; Andrews, KG; Atkinson, C; Baddour, LM; Bahalim, AN; Barker-Collo, S; Barrero, LH; Bartels, DH; Basanez, MG; Baxter, A; Bell, ML; Benjamin, EJ; Bennett, D; Bernabe, E; Bhalla, K; Bhandari, B; Bikbov, B; Bin Abdulhak, A; Birbeck, G; Black, JA; Blencowe, H; Blore, JD; Blyth, F; Bolliger, I; Bonaventure, A; Boufous, SA; Bourne, R; Boussinesq, M; Braithwaite, T; Brayne, C; Bridgett, L; Brooker, S; Brooks, P; Brugha, TS; Bryan-Hancock, C; Bucello, C; Buchbinder, R; Buckle, GR; Budke, CM; Burch, M; Burney, P; Burstein, R; Calabria, B; Campbell, B; Canter, CE; Carabin, H; Carapetis, J; Carmona, L; Cella, C; Charlson, F; Chen, HL; Cheng, ATA; Chou, D; Chugh, SS; Coffeng, LE; Colan, SD; Colquhoun, S; Colson, KE; Condon, J; Connor, MD; Cooper, LT; Corriere, M; Cortinovis, M; de Vaccaro, KC; Couser, W; Cowie, BC; Criqui, MH; Cross, M; Dabhadkar, KC; Dahiya, M; Dahodwala, N; Damsere-Derry, J; Danaei, G; Davis, A; De Leo, D; Degenhardt, L; Dellavalle, R; Delossantos, A; Denenberg, J; Derrett, S; Des Jarlais, DC; Dharmaratne, SD; Dherani, M; Diaz-Torne, C; Dolk, H; Dorsey, ER; Driscoll, T; Duber, H; Ebel, B; Edmond, K; Elbaz, A; Ali, SE; Erskine, H; Erwin, PJ; Espindola, P; Ewoigbokhan, SE; Farzadfar, F; Feigin, V; Felson, DT; Ferrari, A; Ferri, CP; Fevre, EM; Finucane, MM; Flaxman, S; Flood, L; Foreman, K; Forouzanfar, MH; Fowkes, FGR; Franklin, R; Fransen, M; Freeman, MK; Gabbe, BJ; Gabriel, SE; Gakidou, E; Ganatra, HA; Garcia, B; Gaspari, F; Gillum, RF; Gmel, G; Gosselin, R; Grainger, R; Groeger, J; Guillemin, F; Gunnell, D; Gupta, R; Haagsma, J; Hagan, H; Halasa, YA; Hall, W; Haring, D; Haro, JM; Harrison, JE; Havmoeller, R; Hay, RJ; Higashi, H; Hill, C; Hoen, B; Hoffman, H; Hotez, PJ; Hoy, D; Huang, JJ; Ibeanusi, SE; Jacobsen, KH; James, SL; Jarvis, D; Jasrasaria, R; Jayaraman, S; Johns, N; Jonas, JB; Karthikeyan, G; Kassebaum, N; Kawakami, N; Keren, A; Khoo, JP; King, CH; Knowlton, LM; Kobusingye, O; Koranteng, A; Krishnamurthi, R; Lalloo, R; Laslett, LL; Lathlean, T; Leasher, JL; Lee, YY; Leigh, J; Lim, SS; Limb, E; Lin, JK; Lipnick, M; Lipshultz, SE; Liu, W; Loane, M; Ohno, SL; Lyons, R; Ma, JX; Mabweijano, J; MacIntyre, MF; Malekzadeh, R; Mallinger, L; Manivannan, S; Marcenes, W; March, L; Margolis, DJ; Marks, GB; Marks, R; Matsumori, A; Matzopoulos, R; Mayosi, BM; McAnulty, JH; McDermott, MM; McGill, N; McGrath, J; Medina-Mora, ME; Meltzer, M; Mensah, GA; Merriman, TR; Meyer, AC; Miglioli, V; Miller, M; Miller, TR; Mitchell, PB; Mocumbi, AO; Moffitt, TE; Mokdad, AA; Monasta, L; Montico, M; Moradi-Lakeh, M; Moran, A; Morawska, L; Mori, R; Murdoch, ME; Mwaniki, MK; Naidoo, K; Nair, MN; Naldi, L; Narayan, KMV; Nelson, PK; Nelson, RG; Nevitt, MC; Newton, CR; Nolte, S; Norman, P; Norman, R; O'Donnell, M; O'Hanlon, S; Olives, C; Omer, SB; Ortblad, K; Osborne, R; Ozgediz, D; Page, A; Pahari, B; Pandian, JD; Rivero, AP; Patten, SB; Pearce, N; Padilla, RP; Perez-Ruiz, F; Perico, N; Pesudovs, K; Phillips, D; Phillips, MR; Pierce, K; Pion, S; Polanczyk, GV; Polinder, S; Pope, CA; Popova, S; Porrini, E; Pourmalek, F; Prince, M; Pullan, RL; Ramaiah, KD; Ranganathan, D; Razavi, H; Regan, M; Rehm, JT; Rein, DB; Remuzzi, G; Richardson, K; Rivara, FP; Roberts, T; Robinson, C; De Leon, FR; Ronfani, L; Room, R; Rosenfeld, LC; Rushton, L; Sacco, RL; Saha, S; Sampson, U; Sanchez-Riera, L; Sanman, E; Schwebel, DC; Scott, JG; Segui-Gomez, M; Shahraz, S; Shepard, DS; Shin, H; Shivakoti, R; Singh, D; Singh, GM; Singh, JA; Singleton, J; Sleet, DA; Sliwa, K; Smith, E; Smith, JL; Stapelberg, NJC; Steer, A; Steiner, T; Stolk, WA; Stovner, LJ; Sudfeld, C; Syed, S; Tamburlini, G; Tavakkoli, M; Taylor, HR; Taylor, JA; Taylor, WJ; Thomas, B; Thomson, WM; Thurston, GD; Tleyjeh, IM; Tonelli, M; Towbin, JRA; Truelsen, T; Tsilimbaris, MK; Ubeda, C; Undurraga, EA; van der Werf, MJ; van Os, J; Vavilala, MS; Venketasubramanian, N; Wang, MR; Wang, WZ; Watt, K; Weatherall, DJ; Weinstock, MA; Weintraub, R; Weisskopf, MG; Weissman, MM; White, RA; Whiteford, H; Wiersma, ST; Wilkinson, JD; Williams, HC; Williams, SRM; Witt, E; Wolfe, F; Woolf, AD; Wulf, S; Yeh, PH; Zaidi, AKM; Zheng, ZJ; Zonies, D; Lopez, AD; Murray, CJL				Vos, Theo; Flaxman, Abraham D.; Naghavi, Mohsen; Lozano, Rafael; Michaud, Catherine; Ezzati, Majid; Shibuya, Kenji; Salomon, Joshua A.; Abdalla, Safa; Aboyans, Victor; Abraham, Jerry; Ackerman, Ilana; Aggarwal, Rakesh; Ahn, Stephanie Y.; Ali, Mohammed K.; Alvarado, Miriam; Anderson, H. Ross; Anderson, Laurie M.; Andrews, Kathryn G.; Atkinson, Charles; Baddour, Larry M.; Bahalim, Adil N.; Barker-Collo, Suzanne; Barrero, Lope H.; Bartels, David H.; Basanez, Maria-Gloria; Baxter, Amanda; Bell, Michelle L.; Benjamin, Emelia J.; Bennett, Derrick; Bernabe, Eduardo; Bhalla, Kavi; Bhandari, Bishal; Bikbov, Boris; Bin Abdulhak, Aref; Birbeck, Gretchen; Black, James A.; Blencowe, Hannah; Blore, Jed D.; Blyth, Fiona; Bolliger, Ian; Bonaventure, Audrey; Boufous, Soufi Ane; Bourne, Rupert; Boussinesq, Michel; Braithwaite, Tasanee; Brayne, Carol; Bridgett, Lisa; Brooker, Simon; Brooks, Peter; Brugha, Traolach S.; Bryan-Hancock, Claire; Bucello, Chiara; Buchbinder, Rachelle; Buckle, Geoff Rey; Budke, Christine M.; Burch, Michael; Burney, Peter; Burstein, Roy; Calabria, Bianca; Campbell, Benjamin; Canter, Charles E.; Carabin, Helene; Carapetis, Jonathan; Carmona, Loreto; Cella, Claudia; Charlson, Fiona; Chen, Honglei; Cheng, Andrew Tai-Ann; Chou, David; Chugh, Sumeet S.; Coffeng, Luc E.; Colan, Steven D.; Colquhoun, Samantha; Colson, K. Ellicott; Condon, John; Connor, Myles D.; Cooper, Leslie T.; Corriere, Matthew; Cortinovis, Monica; de Vaccaro, Karen Courville; Couser, William; Cowie, Benjamin C.; Criqui, Michael H.; Cross, Marita; Dabhadkar, Kaustubh C.; Dahiya, Manu; Dahodwala, Nabila; Damsere-Derry, James; Danaei, Goodarz; Davis, Adrian; De Leo, Diego; Degenhardt, Louisa; Dellavalle, Robert; Delossantos, Allyne; Denenberg, Julie; Derrett, Sarah; Des Jarlais, Don C.; Dharmaratne, Samath D.; Dherani, Mukesh; Diaz-Torne, Cesar; Dolk, Helen; Dorsey, E. Ray; Driscoll, Tim; Duber, Herbert; Ebel, Beth; Edmond, Karen; Elbaz, Alexis; Ali, Suad Eltahir; Erskine, Holly; Erwin, Patricia J.; Espindola, Patricia; Ewoigbokhan, Stalin E.; Farzadfar, Farshad; Feigin, Valery; Felson, David T.; Ferrari, Alize; Ferri, Cleusa P.; Fevre, Eric M.; Finucane, Mariel M.; Flaxman, Seth; Flood, Louise; Foreman, Kyle; Forouzanfar, Mohammad H.; Fowkes, Francis Gerry R.; Franklin, Richard; Fransen, Marlene; Freeman, Michael K.; Gabbe, Belinda J.; Gabriel, Sherine E.; Gakidou, Emmanuela; Ganatra, Hammad A.; Garcia, Bianca; Gaspari, Flavio; Gillum, Richard F.; Gmel, Gerhard; Gosselin, Richard; Grainger, Rebecca; Groeger, Justina; Guillemin, Francis; Gunnell, David; Gupta, Ramyani; Haagsma, Juanita; Hagan, Holly; Halasa, Yara A.; Hall, Wayne; Haring, Diana; Maria Haro, Josep; Harrison, James E.; Havmoeller, Rasmus; Hay, Roderick J.; Higashi, Hideki; Hill, Catherine; Hoen, Bruno; Hoffman, Howard; Hotez, Peter J.; Hoy, Damian; Huang, John J.; Ibeanusi, Sydney E.; Jacobsen, Kathryn H.; James, Spencer L.; Jarvis, Deborah; Jasrasaria, Rashmi; Jayaraman, Sudha; Johns, Nicole; Jonas, Jost B.; Karthikeyan, Ganesan; Kassebaum, Nicholas; Kawakami, Norito; Keren, Andre; Khoo, Jon-Paul; King, Charles H.; Knowlton, Lisa Marie; Kobusingye, Olive; Koranteng, Adofo; Krishnamurthi, Rita; Lalloo, Ratilal; Laslett, Laura L.; Lathlean, Tim; Leasher, Janet L.; Lee, Yong Yi; Leigh, James; Lim, Stephen S.; Limb, Elizabeth; Lin, John Kent; Lipnick, Michael; Lipshultz, Steven E.; Liu, Wei; Loane, Maria; Ohno, Summer Lockett; Lyons, Ronan; Ma, Jixiang; Mabweijano, Jacqueline; MacIntyre, Michael F.; Malekzadeh, Reza; Mallinger, Leslie; Manivannan, Sivabalan; Marcenes, Wagner; March, Lyn; Margolis, David J.; Marks, Guy B.; Marks, Robin; Matsumori, Akira; Matzopoulos, Richard; Mayosi, Bongani M.; McAnulty, John H.; McDermott, Mary M.; McGill, Neil; McGrath, John; Elena Medina-Mora, Maria; Meltzer, Michele; Mensah, George A.; Merriman, Tony R.; Meyer, Ana-Claire; Miglioli, Valeria; Miller, Matthew; Miller, Ted R.; Mitchell, Philip B.; Mocumbi, Ana Olga; Moffitt, Terrie E.; Mokdad, Ali A.; Monasta, Lorenzo; Montico, Marcella; Moradi-Lakeh, Maziar; Moran, Andrew; Morawska, Lidia; Mori, Rintaro; Murdoch, Michele E.; Mwaniki, Michael K.; Naidoo, Kovin; Nair, M. Nathan; Naldi, Luigi; Narayan, K. M. Venkat; Nelson, Paul K.; Nelson, Robert G.; Nevitt, Michael C.; Newton, Charles R.; Nolte, Sandra; Norman, Paul; Norman, Rosana; O'Donnell, Martin; O'Hanlon, Simon; Olives, Casey; Omer, Saad B.; Ortblad, Katrina; Osborne, Richard; Ozgediz, Doruk; Page, Andrew; Pahari, Bishnu; Pandian, Jeyaraj Durai; Rivero, Andrea Panozo; Patten, Scott B.; Pearce, Neil; Perez Padilla, Rogelio; Perez-Ruiz, Fernando; Perico, Norberto; Pesudovs, Konrad; Phillips, David; Phillips, Michael R.; Pierce, Kelsey; Pion, Sebastien; Polanczyk, Guilherme V.; Polinder, Suzanne; Pope, C. Arden, III; Popova, Svetlana; Porrini, Esteban; Pourmalek, Farshad; Prince, Martin; Pullan, Rachel L.; Ramaiah, Kapa D.; Ranganathan, Dharani; Razavi, Homie; Regan, Mathilda; Rehm, Juergen T.; Rein, David B.; Remuzzi, Guiseppe; Richardson, Kathryn; Rivara, Frederick P.; Roberts, Thomas; Robinson, Carolyn; De Leon, Felipe Rodriguez; Ronfani, Luca; Room, Robin; Rosenfeld, Lisa C.; Rushton, Lesley; Sacco, Ralph L.; Saha, Sukanta; Sampson, Uchechukwu; Sanchez-Riera, Lidia; Sanman, Ella; Schwebel, David C.; Scott, James Graham; Segui-Gomez, Maria; Shahraz, Saeid; Shepard, Donald S.; Shin, Hwashin; Shivakoti, Rupak; Singh, David; Singh, Gitanjali M.; Singh, Jasvinder A.; Singleton, Jessica; Sleet, David A.; Sliwa, Karen; Smith, Emma; Smith, Jennifer L.; Stapelberg, Nicolas J. C.; Steer, Andrew; Steiner, Timothy; Stolk, Wilma A.; Stovner, Lars Jacob; Sudfeld, Christopher; Syed, Sana; Tamburlini, Giorgio; Tavakkoli, Mohammad; Taylor, Hugh R.; Taylor, Jennifer A.; Taylor, William J.; Thomas, Bernadette; Thomson, W. Murray; Thurston, George D.; Tleyjeh, Imad M.; Tonelli, Marcello; Towbin, Jeff Rey A.; Truelsen, Thomas; Tsilimbaris, Miltiadis K.; Ubeda, Clotilde; Undurraga, Eduardo A.; van der Werf, Marieke J.; van Os, Jim; Vavilala, Monica S.; Venketasubramanian, N.; Wang, Mengru; Wang, Wenzhi; Watt, Kerrianne; Weatherall, David J.; Weinstock, Martin A.; Weintraub, Robert; Weisskopf, Marc G.; Weissman, Myrna M.; White, Richard A.; Whiteford, Harvey; Wiersma, Steven T.; Wilkinson, James D.; Williams, Hywel C.; Williams, Sean R. M.; Witt, Emma; Wolfe, Frederick; Woolf, Anthony D.; Wulf, Sarah; Yeh, Pon-Hsiu; Zaidi, Anita K. M.; Zheng, Zhi-Jie; Zonies, David; Lopez, Alan D.; Murray, Christopher J. L.			Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010	LANCET			English	Article							IRON-DEFICIENCY ANEMIA; DEPRESSIVE DISORDER; HEARING IMPAIRMENT; COGNITIVE FUNCTION; MENTAL-DISORDERS; LIFE EXPECTANCY; 187 COUNTRIES; PREVALENCE; HEALTH; POPULATION	Background Non-fatal health outcomes from diseases and injuries are a crucial consideration in the promotion and monitoring of individual and population health. The Global Burden of Disease (GBD) studies done in 1990 and 2000 have been the only studies to quantify non-fatal health outcomes across an exhaustive set of disorders at the global and regional level. Neither effort quantified uncertainty in prevalence or years lived with disability (YLDs). Methods Of the 291 diseases and injuries in the GBD cause list, 289 cause disability. For 1160 sequelae of the 289 diseases and injuries, we undertook a systematic analysis of prevalence, incidence, remission, duration, and excess mortality. Sources included published studies, case notification, population-based cancer registries, other disease registries, antenatal clinic serosurveillance, hospital discharge data, ambulatory care data, household surveys, other surveys, and cohort studies. For most sequelae, we used a Bayesian meta-regression method, DisMod-MR, designed to address key limitations in descriptive epidemiological data, including missing data, inconsistency, and large methodological variation between data sources. For some disorders, we used natural history models, geospatial models, back-calculation models (models calculating incidence from population mortality rates and case fatality), or registration completeness models (models adjusting for incomplete registration with health-system access and other covariates). Disability weights for 220 unique health states were used to capture the severity of health loss. YLDs by cause at age, sex, country, and year levels were adjusted for comorbidity with simulation methods. We included uncertainty estimates at all stages of the analysis. Findings Global prevalence for all ages combined in 2010 across the 1160 sequelae ranged from fewer than one case per 1 million people to 350 000 cases per 1 million people. Prevalence and severity of health loss were weakly correlated (correlation coefficient -0.37). In 2010, there were 777 million YLDs from all causes, up from 583 million in 1990. The main contributors to global YLDs were mental and behavioural disorders, musculoskeletal disorders, and diabetes or endocrine diseases. The leading specific causes of YLDs were much the same in 2010 as they were in 1990: low back pain, major depressive disorder, iron-deficiency anaemia, neck pain, chronic obstructive pulmonary disease, anxiety disorders, migraine, diabetes, and falls. Age-specific prevalence of YLDs increased with age in all regions and has decreased slightly from 1990 to 2010. Regional patterns of the leading causes of YLDs were more similar compared with years of life lost due to premature mortality. Neglected tropical diseases, HIV/AIDS, tuberculosis, malaria, and anaemia were important causes of YLDs in sub-Saharan Africa. Interpretation Rates of YLDs per 100 000 people have remained largely constant over time but rise steadily with age. Population growth and ageing have increased YLD numbers and crude rates over the past two decades. Prevalences of the most common causes of YLDs, such as mental and behavioural disorders and musculoskeletal disorders, have not decreased. Health systems will need to address the needs of the rising numbers of individuals with a range of disorders that largely cause disability but not mortality. Quantification of the burden of non-fatal health outcomes will be crucial to understand how well health systems are responding to these challenges. Effective and affordable strategies to deal with this rising burden are an urgent priority for health systems in most parts of the world.	[Baxter, Amanda; Erskine, Holly; Ferrari, Alize; Khoo, Jon-Paul; Saha, Sukanta; Whiteford, Harvey] Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Vos, Theo; Blore, Jed D.; Charlson, Fiona; Higashi, Hideki; Lee, Yong Yi; Norman, Rosana; Page, Andrew; Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Scott, James Graham] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [McGrath, John] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Flaxman, Abraham D.; Naghavi, Mohsen; Lozano, Rafael; Ahn, Stephanie Y.; Alvarado, Miriam; Andrews, Kathryn G.; Atkinson, Charles; Bolliger, Ian; Burstein, Roy; Campbell, Benjamin; Chou, David; Colson, K. Ellicott; Delossantos, Allyne; Dharmaratne, Samath D.; Forouzanfar, Mohammad H.; Freeman, Michael K.; Gakidou, Emmanuela; Haring, Diana; James, Spencer L.; Jasrasaria, Rashmi; Johns, Nicole; Lim, Stephen S.; Ohno, Summer Lockett; MacIntyre, Michael F.; Mallinger, Leslie; Mokdad, Ali A.; Nair, M. Nathan; Ortblad, Katrina; Phillips, David; Pierce, Kelsey; Ranganathan, Dharani; Roberts, Thomas; Rosenfeld, Lisa C.; Sanman, Ella; Wang, Mengru; Wulf, Sarah; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Anderson, Laurie M.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98121 USA; [Kassebaum, Nicholas] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98121 USA; [Michaud, Catherine] China Med Board, Boston, MA USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Finucane, Mariel M.] Harvard Univ, Dept Biostat, Boston, MA 02115 USA; [Salomon, Joshua A.; Danaei, Goodarz; Lin, John Kent; Miller, Matthew; Singh, Gitanjali M.; Sudfeld, Christopher; Tavakkoli, Mohammad; Weisskopf, Marc G.; White, Richard A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Liu, Wei] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA; [Knowlton, Lisa Marie] Harvard Univ, Harvard Humanitarian Initiat, Boston, MA 02115 USA; [Colan, Steven D.] Harvard Univ, Boston Childrens Hosp, Boston, MA 02115 USA; [Jayaraman, Sudha] Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA; [Bartels, David H.; Bhalla, Kavi] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Aboyans, Victor] Dupuytren Univ Hosp, Dept Cardiol, Limoges, France; [Abraham, Jerry] Univ Texas San Antonio, San Antonio, TX USA; [Steer, Andrew] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Weintraub, Robert] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Degenhardt, Louisa] Univ Melbourne, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia; [Room, Robin] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia; [Aggarwal, Rakesh] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India; [Omer, Saad B.] Emory Univ, Sch Publ Hlth, Atlanta, GA USA; [Omer, Saad B.] Emory Univ, Sch Med, Atlanta, GA USA; [Anderson, H. Ross; Gupta, Ramyani; Limb, Elizabeth] St Georges Univ London, London, England; [Baddour, Larry M.; Erwin, Patricia J.; Gabriel, Sherine E.] Mayo Clin, Rochester, MN USA; [Barker-Collo, Suzanne] Univ Auckland, Auckland 1, New Zealand; [Barrero, Lope H.] Pontificia Univ Javeriana, Sch Engn, Dept Ind Engn, Bogota, Colombia; [Bell, Michelle L.; Huang, John J.; Ozgediz, Doruk] Yale Univ, New Haven, CT USA; [Felson, David T.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Bennett, Derrick] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Bennett, Derrick] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Bernabe, Eduardo] Kings Coll London, Inst Dent, London WC2R 2LS, England; [Hay, Roderick J.] Kings Coll London, Hosp NHS Trust, London WC2R 2LS, England; [Prince, Martin] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Dahiya, Manu] Queen Mary Univ London, Inst Dent, London, England; [Bikbov, Boris] Moscow State Univ Med & Dent, Res Inst Transplantol & Artificial Organs, Moscow, Russia; [Bin Abdulhak, Aref; Tleyjeh, Imad M.] King Fahad Med City, Riyadh, Saudi Arabia; [Birbeck, Gretchen] Michigan State Univ, E Lansing, MI 48824 USA; [Black, James A.] MRC, Epidemiol Unit, Cambridge, England; [Blencowe, Hannah; Brooker, Simon; Edmond, Karen; Pearce, Neil; Pullan, Rachel L.; Smith, Jennifer L.] London Sch Hyg & Trop Med, London WC1, England; [Smith, Emma] Univ Sydney, No Clin Sch, Dept Rheumatol, Sydney, NSW 2006, Australia; [Fransen, Marlene] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [March, Lyn; Sanchez-Riera, Lidia] Univ Sydney, Inst Bone & Joint Res, Sydney, NSW 2006, Australia; [Driscoll, Tim; Leigh, James] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Bonaventure, Audrey; Elbaz, Alexis] INSERM, Paris, France; [Calabria, Bianca; Degenhardt, Louisa; Nelson, Paul K.; Singleton, Jessica] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Bucello, Chiara; Mitchell, Philip B.] Univ New S Wales, Sydney, NSW, Australia; [Bourne, Rupert] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England; [Braithwaite, Tasanee] Moorfields Eye Hosp, London, England; [Brayne, Carol; Richardson, Kathryn] Univ Cambridge, Cambridge, England; [Brugha, Traolach S.] Univ Leicester, Leicester, Leics, England; [Bryan-Hancock, Claire; Flood, Louise; Harrison, James E.; Lathlean, Tim; Pesudovs, Konrad] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Buchbinder, Rachelle] Cabrini Inst, Malvern, Vic, Australia; [Gabbe, Belinda J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Buckle, Geoff Rey; Manivannan, Sivabalan] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Budke, Christine M.] Texas A&M Univ, College Stn, TX USA; [Burch, Michael] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Canter, Charles E.] Washington Univ, St Louis, MO USA; [Carabin, Helene] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Carapetis, Jonathan] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Carmona, Loreto] Univ Camilo Jose Cela, Villanueva De La Canada, Spain; [Cella, Claudia; Cortinovis, Monica; Gaspari, Flavio; Miglioli, Valeria; Perico, Norberto; Remuzzi, Guiseppe] Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy; [Chen, Honglei] NIEHS, Res Triangle Pk, NC 27709 USA; [Cheng, Andrew Tai-Ann] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Havmoeller, Rasmus] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Polinder, Suzanne] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Colquhoun, Samantha; Condon, John] Menzies Sch Hlth Res, Darwin, NT, Australia; [Connor, Myles D.] Natl Hlth Serv, Edinburgh, Midlothian, Scotland; [Connor, Myles D.; Fowkes, Francis Gerry R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Connor, Myles D.] Univ Witwatersrand, Johannesburg, South Africa; [Cooper, Leslie T.] Loyola Univ, Sch Med, Chicago, IL 60611 USA; [Corriere, Matthew] Wake Forest Univ, Sch Publ Hlth Sci, Winston Salem, NC 27109 USA; [de Vaccaro, Karen Courville] Hosp Dr Gustavo N Collado, Puerto Chitre, Panama; [Cowie, Benjamin C.] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Criqui, Michael H.; Denenberg, Julie] Univ Calif San Diego, San Diego, CA 92103 USA; [Dahodwala, Nabila; Margolis, David J.] Univ Penn, Philadelphia, PA 19104 USA; [Damsere-Derry, James] Bldg & Rd Res Inst, Kumasi, Ghana; [Davis, Adrian] MRC Hearing & Commun Grp, Manchester, Lancs, England; [Lalloo, Ratilal] Griffith Univ, Sch Dent & Oral Hlth, Brisbane, Qld 4111, Australia; [Lalloo, Ratilal] Griffith Univ, Populat & Social Hlth Res Program, Brisbane, Qld 4111, Australia; [Dellavalle, Robert] Denver VA Med Ctr, Denver, CO USA; [Derrett, Sarah; Grainger, Rebecca; Merriman, Tony R.; Taylor, William J.; Thomson, W. Murray] Univ Otago, Dunedin, New Zealand; [Des Jarlais, Don C.] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Dharmaratne, Samath D.] Univ Peradeniya, Peradeniya, Sri Lanka; [Dherani, Mukesh] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Diaz-Torne, Cesar] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Dolk, Helen; Loane, Maria] Univ Ulster, Ulster, Ireland; [Ali, Suad Eltahir] Fed Minist Hlth, Khartoum, Sudan; [Espindola, Patricia] Hosp Maciel, Montevideo, Uruguay; [Ewoigbokhan, Stalin E.] Emerald Publ Hlth Consulting Serv Ltd, Abuja, Nigeria; [Malekzadeh, Reza] Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran; [Feigin, Valery] Auckland Tech Univ, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Polanczyk, Guilherme V.] Univ Fed Sao Paulo, Sch Med, Sao Paulo, Brazil; [Flaxman, Seth] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Franklin, Richard] Royal Life Saving Soc, Sydney, NSW, Australia; [Franklin, Richard; Watt, Kerrianne] James Cook Univ, Townsville, Qld 4811, Australia; [Gillum, Richard F.] Howard Univ, Coll Med, Washington, DC USA; [Gmel, Gerhard] Addict Info Switzerland, Lausanne, Switzerland; [Nevitt, Michael C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Groeger, Justina] Suny Downstate Med Ctr, Coll Med, Brooklyn, NY 11203 USA; [Sleet, David A.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Guillemin, Francis] Univ Lorraine, Nancy, France; [Gunnell, David] Univ Bristol, Bristol, Avon, England; [Hagan, Holly; Thurston, George D.] NYU, New York, NY USA; [Halasa, Yara A.; Shahraz, Saeid; Shepard, Donald S.; Undurraga, Eduardo A.] Brandeis Univ, Waltham, MA USA; [Maria Haro, Josep] Univ Barcelona, CIBERSAM, St Bio De Llobregat, Spain; [Havmoeller, Rasmus] Karolinska Univ Hosp, Stockholm, Sweden; [Hill, Catherine] Queen Elizabeth Hosp, Adelaide, SA, Australia; [Hoen, Bruno] Univ Franche Comte, F-25030 Besancon, France; [Hoen, Bruno] Ctr Hosp Reg Univ Besancon, Besancon, France; [Hoffman, Howard] NIDCD, NIH, Bethesda, MD USA; [Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Waco, TX USA; [Ibeanusi, Sydney E.] Univ Port Harcourt, Port Harcourt, Nigeria; [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA 22030 USA; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Karthikeyan, Ganesan] All India Inst Med Sci, New Delhi, India; [Keren, Andre] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Cardiol, IL-91010 Jerusalem, Israel; [King, Charles H.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Kobusingye, Olive] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Kobusingye, Olive] Univ S Africa, Johannesburg, South Africa; [Koranteng, Adofo] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Laslett, Laura L.] Univ Tasmania, Hobart, Tas 7001, Australia; [Leasher, Janet L.] Nova SE Univ, Ft Lauderdale, FL 33314 USA; [Lipshultz, Steven E.; Sacco, Ralph L.; Wilkinson, James D.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Lyons, Ronan] Swansea Univ, Swansea, W Glam, Wales; [Ma, Jixiang] China Ctr Dis Control, Natl Ctr Noncommunicable Dis Control & Prevent, Beijing, Peoples R China; [Mabweijano, Jacqueline] Mulago Hosp, Kampala, Uganda; [Matsumori, Akira] Asian Pacific Soc Cardiol, Kyoto, Japan; [Matzopoulos, Richard] MRC, Tygerberg, South Africa; [Sliwa, Karen] Univ Cape Town, Hatter Inst, ZA-7925 Cape Town, South Africa; [Mensah, George A.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [McAnulty, John H.] Legacy Hlth Syst, Portland, OR USA; [McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA; [Elena Medina-Mora, Maria] Natl Inst Psychiat Ramon de la Fuente, Mexico City, DF, Mexico; [Meltzer, Michele] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Mocumbi, Ana Olga] Natl Inst Hlth, Maputo, Mozambique; [Mocumbi, Ana Olga] Univ Eduardo Mondlane, Maputo, Mozambique; [Moffitt, Terrie E.] Duke Univ, Durham, NC USA; [Monasta, Lorenzo; Montico, Marcella; Ronfani, Luca; Tamburlini, Giorgio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Weissman, Myrna M.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Morawska, Lidia] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Murdoch, Michele E.] Watford Dist Gen Hosp, Watford, England; [Mwaniki, Michael K.] Kemri Wellcome Trust, Kilifi, Kenya; [Naidoo, Kovin] Univ KwaZulu Natal, AVRI, Durban, South Africa; [Naldi, Luigi] Ctr Studi GISED, Bergamo, Italy; [Nolte, Sandra] Charite, D-13353 Berlin, Germany; [O'Donnell, Martin] Natl Univ Ireland Galway, HRB Clin Res Facil, Galway, Ireland; [Osborne, Richard] Deakin Univ, Melbourne, Vic, Australia; [Pahari, Bishnu] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Pandian, Jeyaraj Durai] Betty Cowan Res & Innovat Ctr, Ludhiana, Punjab, India; [Rivero, Andrea Panozo] Hosp Joan 23, La Paz, Bolivia; [Patten, Scott B.] Univ Calgary, Calgary, AB, Canada; [Perez Padilla, Rogelio] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Perez-Ruiz, Fernando] Hosp Univ Cruces, Baracaldo, Spain; [Phillips, Michael R.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Zheng, Zhi-Jie] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Pope, C. Arden, III] Brigham Young Univ, Provo, UT 84602 USA; [Popova, Svetlana; Rehm, Juergen T.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Porrini, Esteban] Hosp Univ Canarias, Tenerif, Spain; [Pourmalek, Farshad] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Ramaiah, Kapa D.] Vector Control Res Ctr, Pondicherry, India; [Razavi, Homie] Ctr Dis Anal, Louisville, CO USA; [Regan, Mathilda] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Rein, David B.] Univ Chicago, NORC, Chicago, IL 60637 USA; [De Leon, Felipe Rodriguez] Complejo Hosp Caja Seguro Social, Panama City, Panama; [Room, Robin] Turning Point Alcohol & Drug Ctr, Ctr Alcohol Policy Res, Fitzroy, SA, Australia; [Sampson, Uchechukwu] Vanderbilt Univ, Nashville, TN USA; [Schwebel, David C.; Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA; [Segui-Gomez, Maria] Minist Interior, Madrid, Spain; [Shin, Hwashin] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Singh, David] Queens Med Ctr, Honolulu, HI USA; [Stovner, Lars Jacob] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Syed, Sana; Zaidi, Anita K. M.] Agwa Khan Univ, Karachi, Pakistan; [Taylor, Jennifer A.] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Tonelli, Marcello] Univ Alberta, Alberta Kidney Dis Network, Edmonton, AB, Canada; [Towbin, Jeff Rey A.] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Truelsen, Thomas] Copenhagen Univ Hosp, Dept Neurol, Herlev, Denmark; [Tsilimbaris, Miltiadis K.] Univ Crete, Sch Med, Iraklion, Greece; [Ubeda, Clotilde] ANLIS, Inst Nacl Epidemiol, Malbran, Argentina; [van der Werf, Marieke J.] KNCV TB Fdn, The Hague, Netherlands; [van Os, Jim] Maastricht Univ Med Ctr, Maastricht, Netherlands; [Venketasubramanian, N.] Natl Univ Singapore, Singapore 117548, Singapore; [Wang, Wenzhi] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Weinstock, Martin A.] Brown Univ, Providence, RI 02912 USA; [Weintraub, Robert] Royal Childrens Hosp, Melbourne, Vic, Australia; [Weintraub, Robert] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Williams, Hywel C.] Univ Nottingham, Nottingham NG7 2RD, England; [Williams, Sean R. M.] Univ Western Sydney, Campbelltown, NSW, Australia; [Wolfe, Frederick] Arthrit Res, Wichita, KS USA; [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, England; [Yeh, Pon-Hsiu] London Sch Econ, London WC2A 2AE, England; [Zonies, David] Landstuhl Reg Med Ctr, Landstuhl, Germany; [Nelson, Robert G.] NIDDK, NIH, Bethesda, MD USA	Queensland Centre for Mental Health Research; University of Queensland; University of Queensland; University of Queensland; University of Queensland; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Imperial College London; University of Tokyo; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; CHU Limoges; University of Texas System; University of Texas at San Antonio (UTSA); University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Emory University; Emory University; St Georges University London; Mayo Clinic; University of Auckland; Pontificia Universidad Javeriana; Yale University; Boston University; University of Oxford; University of Oxford; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; Queen Mary University London; Moscow State University of Medicine & Dentistry; V.I. Shumakov Federal Research Center of Transplantology & Artificial Organs; Michigan State University; University of London; London School of Hygiene & Tropical Medicine; University of Sydney; University of Sydney; University of Sydney; University of Sydney; Institut National de la Sante et de la Recherche Medicale (Inserm); University of New South Wales Sydney; University of New South Wales Sydney; Anglia Ruskin University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Cambridge; University of Leicester; Flinders University South Australia; Cabrini Health; Monash University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Texas A&M University System; Texas A&M University College Station; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Washington University (WUSTL); University of Oklahoma System; University of Oklahoma Health Sciences Center; Telethon Kids Institute; University of Western Australia; Camilo Jose Cela University; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Academia Sinica - Taiwan; Cedars Sinai Medical Center; Erasmus University Rotterdam; Erasmus MC; Charles Darwin University; Menzies School of Health Research; NHS Blood & Transplant (NHSBT); University of Edinburgh; University of Witwatersrand; Loyola University Chicago; Wake Forest University; Victorian Infectious Diseases Reference Laboratory; University of California System; University of California San Diego; University of Pennsylvania; Griffith University; Griffith University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Otago; Harvard University; Beth Israel Deaconess Medical Center; University of Peradeniya; University of Liverpool; Hospital of Santa Creu i Sant Pau; Ulster University; Tehran University of Medical Sciences; Universidade Federal de Sao Paulo (UNIFESP); Carnegie Mellon University; James Cook University; Howard University; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Centers for Disease Control & Prevention - USA; Universite de Lorraine; University of Bristol; New York University; Brandeis University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Karolinska Institutet; Karolinska University Hospital; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Baylor College of Medicine; University of Port Harcourt; George Mason University; Ruprecht Karls University Heidelberg; All India Institute of Medical Sciences (AIIMS) New Delhi; Hebrew University of Jerusalem; Case Western Reserve University; Makerere University; University of South Africa; Kwame Nkrumah University Science & Technology; University of Tasmania; Nova Southeastern University; University of Miami; Swansea University; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Mulago National Referral Hospital; University of Cape Town; University of Cape Town; Legacy Health; Northwestern University; Feinberg School of Medicine; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Jefferson University; Pacific Institute for Research & Evaluation (PIRE); Eduardo Mondlane University; Duke University; IRCCS Burlo Garofolo; Columbia University; Queensland University of Technology (QUT); National Center for Child Health & Development - Japan; Watford General Hospital; University of Kwazulu Natal; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; Deakin University; B.P. Koirala Institute of Health Sciences; University of Calgary; Hospital Universitario Cruces; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Brigham Young University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Universidad de la Laguna; University of British Columbia; Indian Council of Medical Research (ICMR); ICMR - Vector Control Research Center (VCRC); University of California System; University of California Berkeley; University of Chicago; Caja del Seguro Social (CSS); Complejo Hospitalario Doctor Arnulfo Arias Madrid; Turning Point Alcohol & Drug Centre - Australia; Vanderbilt University; University of Alabama System; University of Alabama Birmingham; Health Canada; The Queen's Medical Center; Norwegian University of Science & Technology (NTNU); Drexel University; University of Alberta; Cincinnati Children's Hospital Medical Center; University of Copenhagen; University of Crete; KNCV Tuberculosis Foundation; Maastricht University; Maastricht University Medical Centre (MUMC); National University of Singapore; Beijing Neurosurgical Institute; Capital Medical University; Brown University; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Nottingham; Western Sydney University; National Data Bank for Rheumatic Diseases; Royal Cornwall Hospital; University of London; London School Economics & Political Science; Landstuhl Regional Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@uw.edu	Lee, Yong Yi/C-1373-2015; Prince, Martin J/A-9170-2010; Oliveira, Claudia DL/G-8618-2011; Room, Robin/ABF-7460-2021; Harrison, James/B-8958-2009; Newton, Charles RJC/B-7578-2014; Tonelli, Marcello/B-3028-2009; Krishnamurthi, Rita/AAU-7841-2021; Polanczyk, Guilherme V./AAF-6142-2021; Choobkar, Saeed/AAA-3212-2020; Venketasubramanian, Narayanaswamy/GPP-5948-2022; Pandian, Jeyaraj Durai/AAV-5591-2020; van Os, Jim/C-2113-2014; Coffeng, Luc/AAL-6631-2021; Charlson, Fiona/R-8963-2019; Braithwaite, Tasanee/AAZ-1118-2020; Newton, Charles/V-7872-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Erskine, Holly/K-5244-2012; Franklin, Richard Charles/H-1731-2012; Ortblad, Katrina/ABF-9070-2020; Jarvis, Deborah/E-6494-2011; Sudfeld, Christopher/AAW-3856-2021; Malekzadeh, Reza/U-1382-2017; Baxter, Amanda/E-5449-2011; Carabin, Helene/B-7600-2016; Ali, Mohammed K/N-9833-2013; Brayne, Carol/AAA-4285-2020; Jayaraman, Sudha/AAH-3059-2019; Thurston, George/ABB-1359-2021; Osborne, Richard H/A-9447-2010; Bernabe, Eduardo/R-3441-2017; Ronfani, Luca/B-6668-2013; Laslett, Laura/G-3973-2011; Scott, James G/D-5900-2012; Ganatra, Hammad A/P-8652-2019; Lathlean, Tim/K-3653-2013; Polanczyk, Guilherme V/C-2345-2012; Medina-Mora, María Elena I/T-5937-2018; Brugha, Traolach/T-9326-2019; Aggarwal, Rakesh/D-1583-2009; Moffitt, Terrie E/D-5295-2011; Grainger, Rebecca/I-1866-2012; Courville, Karen/AAW-1462-2021; Zonies, David/B-6497-2011; Pourmalek, Farshad/A-8188-2010; Steer, Andrew C/C-2840-2013; Lozano, Rafael/T-5352-2018; Cowie, Benjamin/HFZ-9941-2022; Colan, Steven/ABB-4580-2020; Elbaz, Alexis/F-8952-2017; Karthikeyan, Ganesan/D-5767-2012; Naldi, Luigi/AFM-8982-2022; Moradi-Lakeh, Maziar/ABC-9793-2021; Bennett, Derrick/AFL-9254-2022; Truelsen, Thomas/AAY-1549-2020; Condon, John R/N-2281-2013; SHIN, HS/AAE-5381-2022; Pope, C. Arden/ABD-5522-2021; Naidoo, Kovin Shunmugam/AAF-5914-2020; Pesudovs, Konrad/T-9403-2019; Nolte, Sandra/B-7498-2008; Feigin, Valery/AAF-2313-2019; Patten, Scott/B-4434-2011; Norman, Paul E/C-5485-2013; Marks, Guy B./F-5058-2013; Monasta, Lorenzo/B-1388-2012; Jacobsen, Kathryn H./B-5857-2008; Salomon, Joshua/S-1929-2019; , Bennett/O-7998-2019; Bell, Michelle/Y-4608-2018; Saha, Sukanta/K-3774-2012; Charlson, Fiona J/F-5290-2011; Whiteford, Harvey A/A-4840-2009; Buchbinder, Rachelle/G-2952-2011; McGrath, John Joseph/G-5493-2010; Bikbov, Boris/I-4594-2013; Montico, Marcella/B-5290-2013; Gunnell, David/ABE-6653-2020; Aboyans, Victor/AAN-8308-2020; Matzopoulos, Richard/AAL-9965-2021; O'Donnell, Martin/ABE-7459-2020; Phillips, Michael Robert/AAE-7585-2021; Bennett, Derrick/AAH-1220-2022; Lopez, Alan/AAA-2734-2022; van Os, Jim/V-8884-2019; Anderson, Hugh R/A-7417-2016; Thomson, William Murray/AAC-8575-2019; Hall, Wayne D/A-3283-2008; Hill, Catherine L/AAE-7152-2019; Mokdad, Ali H./AAD-1232-2022; Perico, Norberto/ABH-3222-2020; Room, Robin/ABH-8505-2020; PEREZ-RUIZ, FERNANDO/E-4844-2012; Ebel, Beth/F-4544-2014; Cheng, Andrew/O-1159-2018; Singh, Jasvinder/R-6172-2019; Ferrari, Alize J/G-1746-2011; Degenhardt, Louisa J/D-4515-2012; Carapetis, Jonathan R/H-8933-2014; Ferri, Cleusa Pinheiro/B-2922-2010; Bin Abdulhak, Aref/AAK-4348-2020; Haro, Josep Maria/D-1423-2011; Naldi, Luigi/K-6343-2016; Higashi, Hideki/D-3797-2011; Lalloo, Ratilal/O-5624-2014; Salomon, Joshua A/D-3898-2009; RUIZ, FERNANDO PEREZ/X-1980-2019; Bin Abdulhak, Aref/AAM-9492-2020; Dellavalle, Robert/L-2020-2013; Stovner, Lars Jacob/D-5025-2014; Schwebel, David/GXH-9944-2022; Lopez, Alan D/F-1487-2010; Thomson, William Murray/A-4971-2008; Boussinesq, Michel/J-7256-2016; Black, James A/A-5917-2010; Narayan, K.M. Venkat/J-9819-2012; PACELLA, ROSANA E./F-2774-2010; Sacco, Ralph/Y-9278-2019; Carmona, Loreto/A-2748-2014; Díaz-Torné, César/AAG-2419-2020; Bolliger, Ian W/C-4207-2016; Davis, Adrian C/E-6022-2015; Blore, Jed/K-6331-2012; Leasher, Janet/B-8889-2016; Morawska, Lidia/B-4140-2011; Watt, Kerrianne/G-2520-2010; Remuzzi, Giuseppe/V-9766-2017; Undurraga, Eduardo A./I-3739-2014; Benjamin, Emelia/E-7103-2011	Lee, Yong Yi/0000-0003-2359-6823; Prince, Martin J/0000-0003-1379-7146; Room, Robin/0000-0002-5618-385X; Harrison, James/0000-0001-9893-8491; Newton, Charles RJC/0000-0002-6999-5507; Tonelli, Marcello/0000-0002-0846-3187; Krishnamurthi, Rita/0000-0003-0869-2083; Polanczyk, Guilherme V./0000-0003-2311-3289; Coffeng, Luc/0000-0002-4425-2264; Charlson, Fiona/0000-0003-2876-5040; Braithwaite, Tasanee/0000-0002-3025-4066; Newton, Charles/0000-0002-6999-5507; Erskine, Holly/0000-0003-3119-9211; Franklin, Richard Charles/0000-0003-1864-4552; Ortblad, Katrina/0000-0002-5675-8836; Sudfeld, Christopher/0000-0002-3203-3638; Malekzadeh, Reza/0000-0002-9820-6335; Baxter, Amanda/0000-0001-8198-9022; Brayne, Carol/0000-0001-5307-663X; Jayaraman, Sudha/0000-0003-1094-5836; Osborne, Richard H/0000-0002-9081-2699; Bernabe, Eduardo/0000-0002-1858-3713; Ronfani, Luca/0000-0001-5710-3914; Laslett, Laura/0000-0002-4336-0095; Scott, James G/0000-0002-0744-0688; Ganatra, Hammad A/0000-0001-9534-2780; Polanczyk, Guilherme V/0000-0003-2311-3289; Medina-Mora, María Elena I/0000-0001-9300-0752; Brugha, Traolach/0000-0002-9786-9591; Aggarwal, Rakesh/0000-0001-9689-494X; Moffitt, Terrie E/0000-0002-8589-6760; Grainger, Rebecca/0000-0001-9201-8678; Courville, Karen/0000-0002-4182-6736; Pourmalek, Farshad/0000-0002-2134-0771; Lozano, Rafael/0000-0002-7356-8823; Cowie, Benjamin/0000-0002-7087-5895; Elbaz, Alexis/0000-0001-9724-5490; Karthikeyan, Ganesan/0000-0002-2073-2917; Naldi, Luigi/0000-0002-3160-2835; Moradi-Lakeh, Maziar/0000-0001-7381-5305; Bennett, Derrick/0000-0002-9170-8447; Condon, John R/0000-0003-4952-0990; SHIN, HS/0000-0002-7263-6257; Pesudovs, Konrad/0000-0002-6322-9369; Nolte, Sandra/0000-0001-6185-9423; Patten, Scott/0000-0001-9871-4041; Norman, Paul E/0000-0003-3406-0506; Marks, Guy B./0000-0002-8976-8053; Monasta, Lorenzo/0000-0001-7774-548X; Jacobsen, Kathryn H./0000-0002-4198-6246; Salomon, Joshua/0000-0003-3929-5515; Bell, Michelle/0000-0002-3965-1359; Charlson, Fiona J/0000-0003-2876-5040; Whiteford, Harvey A/0000-0003-4667-6623; Buchbinder, Rachelle/0000-0002-0597-0933; McGrath, John Joseph/0000-0002-4792-6068; Bikbov, Boris/0000-0002-1925-7506; Montico, Marcella/0000-0003-0377-8232; Gunnell, David/0000-0002-0829-6470; Matzopoulos, Richard/0000-0001-9063-6210; O'Donnell, Martin/0000-0002-7347-7761; Phillips, Michael Robert/0000-0002-5973-2439; Bennett, Derrick/0000-0002-9170-8447; van Os, Jim/0000-0002-7245-1586; Hall, Wayne D/0000-0003-1984-0096; Hill, Catherine L/0000-0001-8289-4922; Mokdad, Ali H./0000-0002-4994-3339; Perico, Norberto/0000-0002-3147-4327; Cheng, Andrew/0000-0002-2698-0516; Singh, Jasvinder/0000-0003-3485-0006; Ferrari, Alize J/0000-0002-7863-9117; Degenhardt, Louisa J/0000-0002-8513-2218; Carapetis, Jonathan R/0000-0002-1182-9792; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Haro, Josep Maria/0000-0002-3984-277X; Naldi, Luigi/0000-0002-3160-2835; Higashi, Hideki/0000-0002-5534-0905; Lalloo, Ratilal/0000-0001-5822-1269; Salomon, Joshua A/0000-0003-3929-5515; RUIZ, FERNANDO PEREZ/0000-0002-5268-1894; Bin Abdulhak, Aref/0000-0001-9988-8609; Dellavalle, Robert/0000-0001-8132-088X; Lopez, Alan D/0000-0001-5818-6512; Thomson, William Murray/0000-0003-0588-6843; Boussinesq, Michel/0000-0001-6312-0681; Black, James A/0000-0002-2200-3179; Narayan, K.M. Venkat/0000-0001-8621-5405; PACELLA, ROSANA E./0000-0002-9742-1957; Carmona, Loreto/0000-0002-4401-2551; Díaz-Torné, César/0000-0001-6275-7699; Bolliger, Ian W/0000-0001-8055-297X; Davis, Adrian C/0000-0001-7134-7528; Blore, Jed/0000-0002-3649-8686; Burney, Peter/0000-0001-8635-5678; Boufous, Soufiane/0000-0002-5686-1729; Gabbe, Belinda/0000-0001-7096-7688; Tsilimbaris, Miltiadis/0000-0002-0130-1150; Malekzadeh, Reza/0000-0003-1043-3814; Shivakoti, Rupak/0000-0002-2773-9310; Groeger, Justina/0000-0003-0324-3385; Sanchez Riera, Lidia/0000-0003-0774-2480; Phillips, David/0000-0003-2569-1015; Gmel, Gerhard/0000-0001-9403-9405; Aboyans, Victor/0000-0002-0322-9818; Lin, John/0000-0003-2490-4453; Bonaventure, Audrey/0000-0001-6665-8145; Fevre, Eric/0000-0001-8931-4986; Leasher, Janet/0000-0002-8779-5162; O'donnell, Colm/0000-0002-8004-450X; Morawska, Lidia/0000-0002-0594-9683; Jarvis, Deborah/0000-0002-1753-3896; Buckle, Geoffrey/0000-0001-7721-0397; Mock, Charles/0000-0002-0564-568X; Farzadfar, Farshad/0000-0001-8288-4046; Mitchell, Philip/0000-0002-7954-5235; Watt, Kerrianne/0000-0002-2275-081X; Porrini, Esteban/0000-0002-3056-4662; Wolfe, Frederick/0000-0002-2801-6413; Cella, Claudia/0000-0002-9210-0775; Woolf, Anthony/0000-0001-8482-8056; Mocumbi, Ana/0000-0002-9564-2860; Tleyjeh, Imad/0000-0002-5551-0353; Syed, Sana/0000-0003-0954-0583; Rein, David/0000-0002-1271-5789; Duber, Herbert/0000-0002-5077-3170; Lathlean, Timothy/0000-0001-7340-1567; Mori, Rintaro/0000-0001-7656-6156; Shibuya, Kenji/0000-0003-2528-7530; Smith, Emma/0000-0001-6510-2583; Kobusingye, Olive/0000-0003-2413-599X; Blencowe, Hannah/0000-0003-1556-3159; Merriman, Tony/0000-0003-0844-8726; Budke, Christine/0000-0002-4750-0905; Derrett, Sarah/0000-0003-2867-0498; Remuzzi, Giuseppe/0000-0002-6194-3446; Undurraga, Eduardo A./0000-0002-4425-1253; Basanez, Maria-Gloria/0000-0001-5031-3361; Calabria, Bianca/0000-0001-6444-4696; Loane, Maria/0000-0002-1206-3637; Benjamin, Emelia/0000-0003-4076-2336; Cooper, Leslie/0000-0003-1002-3313; Razavi, Homie/0000-0002-2658-6930; Ackerman, Ilana/0000-0002-6028-1612; williams, hywel/0000-0002-5646-3093; Feigin, Valery L./0000-0002-6372-1740; Barrero, Lope/0000-0003-1503-0264; Felson, David/0000-0002-2668-2447; Dherani, Mukesh/0000-0002-3055-9636; Knowlton, Lisa Marie/0000-0001-6046-5035; Ali, Mohammed/0000-0001-7266-2503; Pearce, Neil/0000-0002-9938-7852; Weissman, Myrna/0000-0003-3490-3075; Pion, Sebastien/0000-0002-9468-7020; Pandian, Jeyaraj/0000-0003-0028-1968; Stolk, Wilma/0000-0001-9509-1328; Johns, Nicole/0000-0003-4513-4582; Pullan, Rachel/0000-0001-9844-1362; White, Richard Aubrey/0000-0002-6747-1726; King, Charles/0000-0001-8349-9270; Taylor, Hugh/0000-0002-9437-784X; Hotez, Peter/0000-0001-8770-1042; Alvarado, Miriam/0000-0003-2864-9410; Mayosi, Bongani/0000-0001-6641-8950; WILKINSON, JAMES/0000-0003-1945-5622; Colquhoun, Samantha/0000-0002-6750-1147; Miller, Ted/0000-0002-0958-2639; O'Hanlon, Simon/0000-0002-6852-3911; Mensah, George/0000-0002-0387-5326; Chen, Honglei/0000-0003-3446-7779; Ebel, Beth/0000-0001-9310-8325	Berlin Heart Honoraria; Lundbeck; Medtronic; Prana Biotechnology; Safework Australia; Assurance-Maladie (CNAMTS) InVS; Inserm; CHU de Nancy; CHU de Nice; Conseil Regional de Lorraine; Societe Francaise de Negma-Lerads; Pfizer; Pierre Fabre Medicaments; Sanofi-Aventis France; Spanish Health Ministry; Hospital de Cruces Rheumatology Association; Novartis; National Council for Scientific and Technological Development (CNPq, Brazil); European Chemical Industry Council (CEFIC); CONCAWE (Conservation of Clean Air and Water Europe); Takeda; Savient; Ardea; Regeneron; Allergan; URL pharmaceuticals; 36 companies; National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS); National Institute on Aging (NIA); National Cancer Institute (NCI); Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); Moscow State University of Medicine and Dentistry, Moscow, Russia; Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow, Russia; International Society of Nephrology; Wellcome Trust [098045, 085308]; Department of Health London for the National Health Service Information Centre; University of Leicester; Australian National Health and Medical Research Council (NHMRC); Monash University; Cabrini Health; BUPA Foundation; NIH, the National Institute of Environmental Health Sciences; Africa Programme for Onchocerciasis Control (WHO/APOC); NIH [K23 AG034236]; Parkinson Council; Australian NHMRC; US Department of Veterans Affairs; Health Research Council of New Zealand; University of Otago; National Institute for Stroke and Applied Neurosciences; Swedish Research Council [2011-1071]; Bill and Melinda Gates Foundation; Australian National Health and Medical Research Council; World Health Organization; World Mental Health Japan (WMH-J); Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Japan Ministry of Health, Labour, and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]; Australian Government; National Health and Medical Research Council of Australia; Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation; Royal Hobart Hospital Research Foundation; University of Tasmania; Tehran University of Medical Sciences; South African Medical Research Council Burden of Disease Research Unit; University of Cape Town School of Public Health and Family Medicine; Brien Holden Vision Institute; National Drug and Alcohol Research Centre (UNSW, Australia); Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant [ES015459]; Burke Global Health Fellowship; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; European Center for Injury Prevention, Universidad de Navarra; National Institute of Environmental Health Sciences [ES00260]; Wellcome Trust UK; Medical Research Council UK; Anthony Cerami and Ann Dunne Research Trust; AUT University; MRC [G0901214] Funding Source: UKRI; Medical Research Council [G0801056B, G0901214] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES015459, ZIAES101986, P30ES000260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG034236] Funding Source: NIH RePORTER	Berlin Heart Honoraria; Lundbeck(Lundbeck Corporation); Medtronic(Medtronic); Prana Biotechnology; Safework Australia; Assurance-Maladie (CNAMTS) InVS; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CHU de Nancy; CHU de Nice; Conseil Regional de Lorraine(Region Grand-Est); Societe Francaise de Negma-Lerads; Pfizer(Pfizer); Pierre Fabre Medicaments; Sanofi-Aventis France(Sanofi-Aventis); Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government); Hospital de Cruces Rheumatology Association; Novartis(Novartis); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); European Chemical Industry Council (CEFIC); CONCAWE (Conservation of Clean Air and Water Europe); Takeda(Takeda Pharmaceutical Company Ltd); Savient; Ardea; Regeneron(Regeneron); Allergan(AbbVieAllergan); URL pharmaceuticals; 36 companies; National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); Moscow State University of Medicine and Dentistry, Moscow, Russia; Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow, Russia; International Society of Nephrology; Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health London for the National Health Service Information Centre; University of Leicester; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); Cabrini Health; BUPA Foundation; NIH, the National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Africa Programme for Onchocerciasis Control (WHO/APOC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson Council; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); US Department of Veterans Affairs(US Department of Veterans Affairs); Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago; National Institute for Stroke and Applied Neurosciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); World Health Organization(World Health Organization); World Mental Health Japan (WMH-J); Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Japan Ministry of Health, Labour, and Welfare; Australian Government(Australian GovernmentCGIAR); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation; Royal Hobart Hospital Research Foundation; University of Tasmania; Tehran University of Medical Sciences(Tehran University of Medical Sciences); South African Medical Research Council Burden of Disease Research Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Cape Town School of Public Health and Family Medicine; Brien Holden Vision Institute; National Drug and Alcohol Research Centre (UNSW, Australia); Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant; Burke Global Health Fellowship; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; European Center for Injury Prevention, Universidad de Navarra; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Wellcome Trust UK(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Anthony Cerami and Ann Dunne Research Trust; AUT University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	C E Canter has worked as an Optum Health consultant, Blue Cross Blue Shield consultant, and received Berlin Heart Honoraria and travel fees. E R Dorsey has received payments for consulting services from Lundbeck and Medtronic and research support from Lundbeck and Prana Biotechnology. T Driscoll was supported in part by funding from the National Occupational Health and Safety Commission (now Safework Australia). M Ezzati chaired a session and gave a talk at the World Cardiology Congress (WCC), with travel cost reimbursed by the World Heart Federation. At the WCC, he also gave a talk at a session organised by PepsiCo with no financial or other remuneration. F Guillemin did a study on osteoarthritis epidemiology in an institution that received grants from public sources: Assurance-Maladie (CNAMTS) InVS, Inserm, CHU de Nancy, CHU de Nice, Conseil Regional de Lorraine, Societe Francaise de Negma-Lerads, Pfizer, Pierre Fabre Medicaments, Sanofi-Aventis France. H J Hoffman is a US Federal Government employee of the National Institutes of Health (NIH). P J Hotez reports holding several positions: Dean, National School of Tropical Medicine, Baylor College of Medicine; Director, Sabin Vaccine Institute Texas Children's Hospital Center for Vaccine Development; and President, Sabin Vaccine Institute. He also is an inventor on several patents: 5,527,937 "Hookworm Anticoagulant"; 5,753,787 "Nucleic Acids for Ancylostoma Secreted Proteins"; 7,303,752 B2 "Hookworm vaccine"; 12/492,734 "Human Hookworm Vaccine"; 61/077,256 "Multivalent Anthelminthic Vaccine"; and PCT-20100701/0.20.5.18 "Malaria Transmission blocking vaccine". G A Mensah is a former employee of PepsiCo. F Perez-Ruiz was an advisor for Ardea, Menarini, Novartis, Metabolex; was a member of the Speaker's Bureau for Menarini, Novartis; an advisor for educational issues for Savient; led investigation grants for the Spanish Health Ministry, Hospital de Cruces Rheumatology Association; and was principal investigator in clinical trials for Ardea. G V Polanczyk has served as a speaker or consultant to Eli-Lily, Novartis, Janssen-Cilag, and Shire Pharmaceuticals, developed educational material for Janssen-Cilag, and received an independent investigator grant from Novartis and from the National Council for Scientific and Technological Development (CNPq, Brazil). L Rushton received honorarium for board membership of the European Centre for Ecotoxicology and Toxicology of Chemicals and received research grants to Imperial College London (as PI) from the European Chemical Industry Council (CEFIC) and CONCAWE (Conservation of Clean Air and Water Europe). J A Singh has received research grants from Takeda and Savient and consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals, and Novartis. J A Singh is a member of the executive of OMERACT, an organisation that develops outcome measures in rheumatology and receives arms-length funding from 36 companies; a member of the American College of Rheumatology's Guidelines Subcommittee of the Quality of Care Committee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. J A Singh is supported by research grants from the National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), National Institute on Aging (NIA), National Cancer Institute (NCI) and the Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs) and is also supported by the resources and the use of facilities at the VA Medical Center at Birmingham, Alabama, USA.; We would like to thank the countless individuals who have contributed to the Global Burden of Disease Study 2010 in various capacities. We would also like to specifically acknowledge the important contribution to this work from multiple staff members of the World Health Organization. We also wish to express our gratitude to the following organizations that hosted consultations during the final stages of the analytic process, providing valuable feedback about the results and the data to improve the study's findings overall: Pan American Health Organization; Eastern Mediterranean Regional Office of WHO; UNAIDS; Ministry of Health, Brazil; China Centers for Disease Control; and the University of Zambia. We would like to thank Lori M Newman, Jordis Ott, Poul Erik Petersen, Shekhar Saxena, and Gretchen A Stevens for their collaboration and input into the analyses and estimates. Finally, we would like to acknowledge the extensive support from all staff members at the Institute for Health Metrics and Evaluation and specifically thank: James Bullard, Andrew Ernst, and Serkan Yalcin for their tireless support of the computational infrastructure required to produce the results; Linda A Ettinger for her expert administrative support in order to facilitate communication and coordination amongst the authors; Peter Speyer, Abigail McLain, Katherine Leach-Kemon, and Eden Stork for their persistent and valuable work to gain access to and catalog as much data as possible to inform the estimates; Erin C Mullany for her systematic efforts in organizing drafts of papers, formatting correspondence with expert groups, and preparing the final manuscript; Brad Bell for his review, critiques, and insights about the DisMod-MR software which helped to improve its performance and results; and Jiaji Du for his work developing the user interface for the DisMod-MR software so that multiple expert groups could use it and easily assess the results. The following individuals would like to acknowledge various forms of institutional support. J P Abraham, B Bartels, and P Yeh recognize the support of the World Bank Global Road Safety Facility and Department of Global Health & Population, Harvard School of Public Health, and the World Health Organization Violence and Injury Prevention. B Bikbov acknowledges support from the Moscow State University of Medicine and Dentistry, Moscow, Russia; Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow, Russia; International Society of Nephrology. R Bourne acknowledges the Vision & Eye Research Unit, Postgraduate Medical Institute, Anglia Ruskin University, Cambridge, UK. S Brooker is supported by a Wellcome Trust Senior Fellowship in Basic Biomedical Science (098045). T S Brugha received funding from the Department of Health London, for the National Health Service Information Centre, by the University of Leicester. R Buchbinder is partially funded by an Australian National Health and Medical Research Council (NHMRC) Practitioner Fellowship, Monash University and Cabrini Health. P Burney and D Jarvis acknowledge that the Chronic Respiratory Disease Group received support from the BUPA Foundation, who had no role in study design, data collection and analysis, interpretation of data, decision to publish, or preparation of the manuscript. C Cella, M Cortinovis, F Gaspari, V Miglioli, and N Perico on behalf of the entire Genitourinary Expert Group acknowledge the International Society of Nephrology (ISN).; H Chen acknowledges that his participation in this study was in part supported by the intramural research program of the NIH, the National Institute of Environmental Health Sciences. L E Coffeng and W A Stolk received financial support from the Africa Programme for Onchocerciasis Control (WHO/APOC) for their work on onchocerciasis. B C Cowie received institutional support from the Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia. M Cross and L March acknowledge the University of Sydney (USYD); Institute of Bone and Joint Research, University of Sydney, Department of Rheumatology, Royal North Shore Hospital, St Leonards NSW 2065 Australia. N Dahodwala was supported by NIH grant K23 AG034236 and the Parkinson Council while working on this project. L Degenhardt is supported by an Australian NHMRC Senior Research Fellowship and funding to support her work for illicit drug dependence was provided by the Australian National Drug and Alcohol Research Centre of the University of New South Wales, Australia. R Dellavalle was supported by the US Department of Veterans Affairs while contributing to this study. S Derrett acknowledges the Health Research Council of New Zealand and the University of Otago for their support. V Feigin and R Krishnamurthi were supported by the National Institute for Stroke and Applied Neurosciences, AUT University. E Fevre acknowledges the Wellcome Trust for grant 085308. W Hall was supported by an NHMRC Australia Fellowship. R Havmoeller was supported by a grant from the Swedish Research Council (#2011-1071). D Hoy was supported by the Bill and Melinda Gates Foundation and the Australian National Health and Medical Research Council. K H Jacobsen was supported by the World Health Organization for her work on hepatitis A. N Kawakami notes that the collection of data ultimately used in this study was supported by the following grants: The World Mental Health Japan (WMH-J) is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labour, and Welfare. He would like to thank staff members, field coordinators, and interviewers of the WMH Japan 2002-2004 Survey. L L Laslett is supported by an Australian Government Australian Postgraduate Award. She also notes that the TasOAC study, the results of which were used in this research, was supported by the National Health and Medical Research Council of Australia; Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation, Royal Hobart Hospital Research Foundation, and University of Tasmania Institutional Research Grants Scheme. R Malekzadeh funding from research grant of Tehran University of Medical Sciences to do the related studies. R Matzopoulos acknowledges the two institutions that support his research work: South African Medical Research Council Burden of Disease Research Unit; and the University of Cape Town School of Public Health and Family Medicine. T Merriman acknowledges the Health Research Council of New Zealand. K Naidoo was supported by the Brien Holden Vision Institute. P Nelson was supported by the National Drug and Alcohol Research Centre (UNSW, Australia). R G Nelson acknowledges his research was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. C Olives was funded in part by the Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant (ES015459).; D Ozgediz acknowledges the staff and collaborators at the Mulago Hospital and Makerere University in Kampala, Uganda. K Pesudovs received institutional support from Flinders University. R Room's position at the University of Melbourne and Turning Point Alcohol and Drug Centre is funded by the Foundation for Alcohol Research and Education and the Victorian Department of Health. J A Salomon received support from the Burke Global Health Fellowship while working on this study. U Sampson received funding support from the Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation and the Vanderbilt Clinical and Translational Scholars Award. L Sanchez-Riera acknowledges the Spanish Society of Rheumatology (Sociedad Espanola de Reumatologia). M Segui-Gomez's participation was partly supported by funds from the European Center for Injury Prevention, Universidad de Navarra. E Smith acknowledges the Department of Health and Ageing, Commonwealth Government of Australia, Institute of Bone and Joint Research (IBJR), University of Sydney (USYD). G D Thurston was supported in part by Center grant ES00260 from the National Institute of Environmental Health Sciences. D J Weatherall was supported by the Wellcome Trust UK, the Medical Research Council UK and the Anthony Cerami and Ann Dunne Research Trust.	Agency for Healthcare Research and Quality, US MED EXP PAN SURV; ALTER G, 1989, POP STUD-J DEMOG, V43, P25, DOI 10.1080/0032472031000143836; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2021, CANC INCIDENCE 5 CON; Australian Bureau of Statistics A, NAT SURV MENT HLTH W; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Beaglehole R., 2003, WORLD HLTH REPORT 20; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Bhidayasiri R, 2011, NEUROEPIDEMIOLOGY, V37, P222, DOI 10.1159/000334440; Brody J A, 1990, Aging (Milano), V2, P283; Brooker S, 2001, TROP MED INT HEALTH, V6, P998, DOI 10.1046/j.1365-3156.2001.00798.x; Brooker S, 2010, INT J PARASITOL, V40, P1137, DOI 10.1016/j.ijpara.2010.04.004; Brooks PM., 2004, APLAR J RHEUMATOL, V7, P272, DOI [10.1111/j.1479-8077.2004.00102.x, DOI 10.1111/J.1479-8077.2004.00102.X]; Canadian Institute of Health Information, 2011, NAT AMB CAR REP SYST; CDC National Center for Health Statistics, 1993, NAT AMB MED CAR SURV; CDC National Center for Health Statistics, 1992, NAT HOSP AMB MED CAR; Chen Wan-qing, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P374; Clements ACA, 2009, B WORLD HEALTH ORGAN, V87, P921, DOI 10.2471/BLT.08.058933; Cohen A., 2002, WORLD MENTAL HLTH CA; Dodhia H, 2008, J PUBLIC HEALTH-UK, V30, P313, DOI 10.1093/pubmed/fdn015; Doll R., 1966, CANC INCIDENCE 5 CON, VI; Doll R, 1970, CANC INCIDENCE 5 CON, VII; Eaton WW, 2007, ACTA PSYCHIAT SCAND, V116, P182, DOI 10.1111/j.1600-0447.2007.01017.x; Eppig C, 2010, P ROY SOC B-BIOL SCI, V277, P3801, DOI 10.1098/rspb.2010.0973; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Friedman C, 2004, J OCCUP ENVIRON MED, V46, P3, DOI 10.1097/01.jom.0000105915.59342.9a; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gates GA, 2002, J AM GERIATR SOC, V50, P482, DOI 10.1046/j.1532-5415.2002.50114.x; Ghys PD, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010199; Global Initiative for Chronic Obstructive Lung Disease, 2011, GLOB STRAT DIAGN MAN; Goldman LS, 1999, J GEN INTERN MED, V14, P569, DOI 10.1046/j.1525-1497.1999.03478.x; GRUENBERG EM, 1977, MILBANK FUND Q, V55, P3, DOI 10.2307/3349592; Hickman M., 2002, B NARCOTICS, VLIV, P15, DOI DOI 10.1016/J.DRUGOPO.2005.02.05; HOFMAN A, 1991, INT J EPIDEMIOL, V20, P736, DOI 10.1093/ije/20.3.736; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Hsairi M, 2003, Sante Publique, V15, P25; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S20; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S22; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S18; Iwata N, 2002, PSYCHIAT RES, V110, P281, DOI 10.1016/S0165-1781(02)00102-6; Jablensky A, 2000, AUST NZ J PSYCHIAT, V34, P221, DOI 10.1046/j.1440-1614.2000.00728.x; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Johansson S R, 1991, Health Transit Rev, V1, P39; Kapteyn A, 2007, AM ECON REV, V97, P461, DOI 10.1257/aer.97.1.461; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; King CH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000209; King G, 2004, AM POLIT SCI REV, V98, P191, DOI 10.1017/S000305540400108X; Kominski GF, 2002, PUBLIC HEALTH REP, V117, P185, DOI 10.1016/S0033-3549(04)50125-5; KRAMER M, 1980, ACTA PSYCHIAT SCAND, V62, P382, DOI 10.1111/j.1600-0447.1980.tb07714.x; Kristensen N, 2008, LABOUR ECON, V15, P96, DOI 10.1016/j.labeco.2006.11.001; Leonard H, 2003, PAEDIATR PERINAT EP, V17, P58, DOI 10.1046/j.1365-3016.2003.00469.x; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lozoff B, 1996, J PEDIATR-US, V129, P382, DOI 10.1016/S0022-3476(96)70070-7; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; Manton KG, 2008, J GERONTOL B-PSYCHOL, V63, pS269, DOI 10.1093/geronb/63.5.S269; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Mathers Colin D, 2006, Popul Health Metr, V4, P4, DOI 10.1186/1478-7954-4-4; Mayr WT, 2003, NEUROLOGY, V61, P1373, DOI 10.1212/01.WNL.0000094316.90240.EB; Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; MUIR CS, 1987, IARC SCI PUBLICATION, V88; Munos MK, 2010, INT J EPIDEMIOL, V39, P56, DOI 10.1093/ije/dyq022; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJ, GLOBAL BURDEN DIS CO; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Murray CJL., 1996, GLOBAL HLTH STAT COM, V1996; New York Heart Association, 1964, DIS HEART BLOOD VESS; Olshansky S.J., 1991, J AGING HEALTH, V3, P194, DOI DOI 10.1177/089826439100300205; PARKIN DM, 1992, IARC SCI PUBLICATION, V120; PARKIN DM, 1997, IARC SCI PUBLICATION, V143; Parkin DM, 2002, IARC SCI PUBLICATION, VVIII; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; RCGP Research & Surveillance Centre, 2009, WEEKL RET SERV ANN R; RCGP Research & Surveillance Centre, 2005, WEEKL RET SERV ANN R; RCGP Research & Surveillance Centre, 2008, WEEKL RET SERV ANN R; RCGP Research & Surveillance Centre, 2007, WEEKL RET SERV ANN R; RCGP Research & Surveillance Centre, 2010, WEEKL RET SERV ANN R; RCGP Research & Surveillance Centre, 2006, WEEKL RET SERV ANN R; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Schopper D, 2000, INT J EPIDEMIOL, V29, P871, DOI 10.1093/ije/29.5.871; Schur N, 2013, ACTA TROP, V128, P365, DOI 10.1016/j.actatropica.2011.10.006; Simeon DT, 1995, W INDIAN MED J, P27; Soriano JB, 2003, INT J TUBERC LUNG D, V7, P415; Strickland D, 2004, MOVEMENT DISORD, V19, P318, DOI 10.1002/mds.10619; Sugawara N, 2011, ANN GEN PSYCHIATR, V10, DOI 10.1186/1744-859X-10-27; UNAIDS, 2011, SPECTR EPP 2011; US National Institutes of Health National Institute on Alcohol Abuse and Alcoholism, NAT EP SURV ALC REL; van Baal Pieter H M, 2006, Popul Health Metr, V4, P1, DOI 10.1186/1478-7954-4-1; VERBRUGGE LM, 1984, MILBANK FUND Q, V62, P475, DOI 10.2307/3349861; Wallhagen MI, 2008, RES GERONTOL NURS, V1, P80, DOI 10.3928/19404921-20080401-08; WALTER T, 1989, PEDIATRICS, V84, P7; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Waterhouse J., 1976, IARC SCI PUBLICATION, V15; Waterhouse JA, 1982, IARC SCI PUBLICATION, VIV; Watkins WE, 1996, T ROY SOC TROP MED H, V90, P156, DOI 10.1016/S0035-9203(96)90121-2; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2010, WOR HEALT REP, P1; WHO, 2001, WORLD HLTH REPORT 20; Woolf AD, 2000, ANN RHEUM DIS, V59, P81, DOI 10.1136/ard.59.2.81; Woolf AD, 2001, BMJ-BRIT MED J, V322, P1079, DOI 10.1136/bmj.322.7294.1079; World Health Organization, 2004, WORLD HLTH REP 2004; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Zhou SC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-188	108	4506	4745	51	1435	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2163	2196		10.1016/S0140-6736(12)61729-2	http://dx.doi.org/10.1016/S0140-6736(12)61729-2			34	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245607	Green Accepted, Green Published, Green Submitted			2022-12-24	WOS:000312387000015
J	Werner, EW; Mei, TS; Burckle, AJ; Sigman, MS				Werner, Erik W.; Mei, Tian-Sheng; Burckle, Alexander J.; Sigman, Matthew S.			Enantioselective Heck Arylations of Acyclic Alkenyl Alcohols Using a Redox-Relay Strategy	SCIENCE			English	Article							WACKER-TYPE OXIDATION; ALLYLIC ALCOHOLS; ASYMMETRIC HECK; DIAZONIUM SALTS; CATALYST; DIFUNCTIONALIZATION; KETONES; GAMMA	Progress in the development of asymmetric Heck couplings of arenes and acyclic olefins has been limited by a tenuous understanding of the factors that dictate selectivity in migratory insertion and beta-hydride elimination. On the basis of key mechanistic insight recently garnered in the exploration of selective Heck reactions, we report here an enantioselective variant that delivers beta-, gamma-, or delta-aryl carbonyl products from acyclic alkenol substrates. The catalyst system imparts notable regioselectivity during migratory insertion and promotes the migration of the alkene's unsaturation toward the alcohol to ultimately form the ketone product. The reaction uses aryldiazonium salts as the arene source, yields enantiomeric products from opposite starting alkene configurations, and uses a readily accessible ligand. The racemic nature of the alkenol substrate does not bias the enantioselection.	[Werner, Erik W.; Mei, Tian-Sheng; Burckle, Alexander J.; Sigman, Matthew S.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Sigman, MS (corresponding author), Univ Utah, Dept Chem, 315 South 1400 East, Salt Lake City, UT 84112 USA.	sigman@chem.utah.edu	mei, tiansheng/H-5293-2011; Mei, Tian-Sheng/Y-3266-2019	Mei, Tian-Sheng/0000-0002-4985-1071	NIH [R01GM063540]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063540] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant R01GM063540.	AYYAR KS, 1968, CAN J CHEMISTRY, V46, P1467, DOI 10.1139/v68-242; Beletskaya IP, 2000, CHEM REV, V100, P3009, DOI 10.1021/cr9903048; Berthiol F, 2006, TETRAHEDRON, V62, P4372, DOI 10.1016/j.tet.2006.02.061; Bouquillon S, 2001, J ORGANOMET CHEM, V634, P153, DOI 10.1016/S0022-328X(01)01149-4; Burns NZ, 2009, ANGEW CHEM INT EDIT, V48, P2854, DOI 10.1002/anie.200806086; Calo V, 2007, J ORG CHEM, V72, P2596, DOI 10.1021/jo070005f; Dounay AB, 2003, CHEM REV, V103, P2945, DOI 10.1021/cr020039h; Harper KC, 2012, NAT CHEM, V4, P366, DOI [10.1038/nchem.1297, 10.1038/NCHEM.1297]; Harper KC, 2011, SCIENCE, V333, P1875, DOI 10.1126/science.1206997; Hayashi T, 2003, CHEM REV, V103, P2829, DOI 10.1021/cr020022z; Jensen KH, 2010, J AM CHEM SOC, V132, P17471, DOI 10.1021/ja108106h; Jensen KH, 2009, J AM CHEM SOC, V131, P17074, DOI 10.1021/ja909030c; KIKUKAWA K, 1981, TETRAHEDRON, V37, P31, DOI 10.1016/S0040-4020(01)97711-7; Kikushima K, 2011, J AM CHEM SOC, V133, P6902, DOI 10.1021/ja200664x; LAROCK RC, 1989, TETRAHEDRON LETT, V30, P6629, DOI 10.1016/S0040-4039(00)70636-8; Mc Cartney D, 2011, CHEM SOC REV, V40, P5122, DOI 10.1039/c1cs15101k; McDonald RI, 2011, ORG LETT, V13, P2830, DOI 10.1021/ol200784y; MELPOLDER JB, 1976, J ORG CHEM, V41, P265, DOI 10.1021/jo00864a017; Michel BW, 2011, J AM CHEM SOC, V133, P8317, DOI 10.1021/ja2017043; Michel BW, 2009, J AM CHEM SOC, V131, P6076, DOI 10.1021/ja901212h; Richter JM, 2008, J AM CHEM SOC, V130, P17938, DOI 10.1021/ja806981k; Roglans A, 2006, CHEM REV, V106, P4622, DOI 10.1021/cr0509861; Shibasaki M, 2004, ADV SYNTH CATAL, V346, P1533, DOI 10.1002/adsc.200404203; Sigman MS, 2012, ACCOUNTS CHEM RES, V45, P874, DOI 10.1021/ar200236v; Smith SW, 2009, J AM CHEM SOC, V131, P14231, DOI 10.1021/ja9061823; Tanaka K, 1999, CHEM PHARM BULL, V47, P1053; Taylor JG, 2011, EUR J ORG CHEM, V2011, P1403, DOI 10.1002/ejoc.201001620; Urkalan KB, 2009, ANGEW CHEM INT EDIT, V48, P3146, DOI 10.1002/anie.200900218; Werner EW, 2011, J AM CHEM SOC, V133, P9692, DOI 10.1021/ja203164p; Werner EW, 2010, J AM CHEM SOC, V132, P13981, DOI 10.1021/ja1060998; Yonehara K, 2000, J ORGANOMET CHEM, V603, P40, DOI 10.1016/S0022-328X(00)00069-3; Yoo KS, 2007, ORG LETT, V9, P3933, DOI 10.1021/ol701584f; Yoo KS, 2010, J ORG CHEM, V75, P95, DOI 10.1021/jo901977n; Zultanski SL, 2011, J AM CHEM SOC, V133, P15362, DOI 10.1021/ja2079515	34	334	332	11	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1455	1458		10.1126/science.1229208	http://dx.doi.org/10.1126/science.1229208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239733	Green Accepted			2022-12-24	WOS:000312250800044
J	Berdahl, A; Torney, CJ; Ioannou, CC; Faria, JJ; Couzin, ID				Berdahl, Andrew; Torney, Colin J.; Ioannou, Christos C.; Faria, Jolyon J.; Couzin, Iain D.			Emergent Sensing of Complex Environments by Mobile Animal Groups	SCIENCE			English	Article							SALMON ONCORHYNCHUS-TSHAWYTSCHA; BEHAVIOR; AVOIDANCE; MOVEMENTS; HATCHERY; WRONGS; SIZE	The capacity for groups to exhibit collective intelligence is an often-cited advantage of group living. Previous studies have shown that social organisms frequently benefit from pooling imperfect individual estimates. However, in principle, collective intelligence may also emerge from interactions between individuals, rather than from the enhancement of personal estimates. Here, we reveal that this emergent problem solving is the predominant mechanism by which a mobile animal group responds to complex environmental gradients. Robust collective sensing arises at the group level from individuals modulating their speed in response to local, scalar, measurements of light and through social interaction with others. This distributed sensing requires only rudimentary cognition and thus could be widespread across biological taxa, in addition to being appropriate and cost-effective for robotic agents.	[Berdahl, Andrew; Torney, Colin J.; Ioannou, Christos C.; Faria, Jolyon J.; Couzin, Iain D.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Ioannou, Christos C.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	Princeton University; University of Bristol	Berdahl, A (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	aberdahl@princeton.edu; icouzin@princeton.edu	Couzin, Iain D./Q-6862-2018; Torney, Colin/C-6082-2015	Couzin, Iain D./0000-0001-8556-4558; Torney, Colin/0000-0003-1673-7835; Ioannou, Christos/0000-0002-9739-889X	NSF [PHY-0848755, EAGER-1251585, CNH-1211972]; U.S. Office of Naval Research [N00014-09-1-1074]; U.S. Army Research Office [W911NG-11-1-0385]; Leverhulme Early Career Fellowship; Natural Sciences and Engineering Research Council of Canada; Yukon Foundation; Direct For Biological Sciences [1251585] Funding Source: National Science Foundation; Direct For Mathematical & Physical Scien [0848755] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); U.S. Office of Naval Research(Office of Naval Research); U.S. Army Research Office; Leverhulme Early Career Fellowship(Leverhulme Trust); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Yukon Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank J. Herbert-Read for experimental assistance, N. O. Handegard for providing code and advice for track linking, and A. Haenssen for technical support. Suggestions from members of the Couzin laboratory and two anonymous reviewers greatly improved this manuscript. Funded by NSF awards PHY-0848755, EAGER-1251585, and CNH-1211972; U.S. Office of Naval Research award N00014-09-1-1074; U.S. Army Research Office grant W911NG-11-1-0385; Leverhulme Early Career Fellowship; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship Fellowship; and the Yukon Foundation. All experiments were conducted in accordance with federal and state regulations and were approved by the Princeton University Institutional Animal Care and Use Committee. Code freely available at http://icouzin.princeton.edu.	Bauer S, 2011, ANIMAL MIGRATION: A SYNTHESIS, P68; Camperi M, 2012, INTERFACE FOCUS, V2, P715, DOI 10.1098/rsfs.2012.0026; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; Codling EA, 2007, ECOLOGY, V88, P1864, DOI 10.1890/06-0854.1; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Franks NR, 2002, PHILOS T R SOC B, V357, P1567, DOI 10.1098/rstb.2002.1066; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; Grunbaum D, 1998, EVOL ECOL, V12, P503, DOI 10.1023/A:1006574607845; HALL DJ, 1979, J FISH RES BOARD CAN, V36, P1029, DOI 10.1139/f79-145; HALL LW, 1982, J TOXICOL ENV HEALTH, V10, P1017, DOI 10.1080/15287398209530313; Hard JJ, 1999, CAN J FISH AQUAT SCI, V56, P578, DOI 10.1139/cjfas-56-4-578; HUTH A, 1994, ECOL MODEL, V75, P135, DOI 10.1016/0304-3800(94)90013-2; Kils U., 1987, THESIS U KIEL GERMAN; LARKIN PA, 1969, J FISH RES BOARD CAN, V26, P1372, DOI 10.1139/f69-121; McNicol RE, 1996, ENVIRON BIOL FISH, V47, P311, DOI 10.1007/BF00000503; Pitcher T. J., 1993, BEHAV TELEOST FISHES, V2, P369; Poli Riccardo, 2007, Swarm Intelligence, V1, P33, DOI 10.1007/s11721-007-0002-0; QUINN TP, 1984, CAN J FISH AQUAT SCI, V41, P1078, DOI 10.1139/f84-126; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Schaefer KM, 2007, MAR BIOL, V152, P503, DOI 10.1007/s00227-007-0689-x; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; STEELE CW, 1991, J FISH BIOL, V38, P553, DOI 10.1111/j.1095-8649.1991.tb03142.x; Torney C, 2009, P NATL ACAD SCI USA, V106, P22055, DOI 10.1073/pnas.0907929106; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147	26	307	312	4	215	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					574	576		10.1126/science.1225883	http://dx.doi.org/10.1126/science.1225883			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372013	Green Submitted			2022-12-24	WOS:000314270000057
J	Kikuchi, S; Bedard, J; Hirano, M; Hirabayashi, Y; Oishi, M; Imai, M; Takase, M; Ide, T; Nakai, M				Kikuchi, Shingo; Bedard, Jocelyn; Hirano, Minako; Hirabayashi, Yoshino; Oishi, Maya; Imai, Midori; Takase, Mai; Ide, Toru; Nakai, Masato			Uncovering the Protein Translocon at the Chloroplast Inner Envelope Membrane	SCIENCE			English	Article							IMPORT MACHINERY; IN-VIVO; TIC20; CHANNEL; ARABIDOPSIS; FORMS; BIOGENESIS; COMPONENTS; APPARATUS; COMPLEX	Chloroplasts require protein translocons at the outer and inner envelope membranes, termed TOC and TIC, respectively, to import thousands of cytoplasmically synthesized preproteins. However, the molecular identity of the TIC translocon remains controversial. Tic20 forms a 1-megadalton complex at the inner membrane and directly interacts with translocating preproteins. We purified the 1-megadalton complex from Arabidopsis, comprising Tic20 and three other essential components, one of which is encoded by the enigmatic open reading frame ycf1 in the chloroplast genome. All four components, together with well-known TOC components, were found stoichiometrically associated with different translocating preproteins. When reconstituted into planar lipid bilayers, the purified complex formed a preprotein-sensitive channel. Thus, this complex constitutes a general TIC translocon.	[Kikuchi, Shingo; Bedard, Jocelyn; Hirabayashi, Yoshino; Oishi, Maya; Imai, Midori; Takase, Mai; Nakai, Masato] Osaka Univ, Inst Prot Res, Lab Regulat Biol React, Suita, Osaka 5650871, Japan; [Hirano, Minako; Ide, Toru] Grad Sch Creat New Photon Ind, Nishi Ku, Hamamatsu, Shizuoka 4311202, Japan	Osaka University	Nakai, M (corresponding author), Osaka Univ, Inst Prot Res, Lab Regulat Biol React, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	nakai@protein.osaka-u.ac.jp	Ide, Toru/L-7110-2015	Kikuchi, Shingo/0000-0001-9033-6242; Hirano, Minako/0000-0002-7246-0087	Ministry of Education, Culture, Sports, Science and Technology, Japan [20059022, 22020024, 24117511, 24657073, 21107518, 22370059, 23770190, 23113519]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22020024, 22370059, 24117511] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Iwasaki, N. Miyazaki, S. Thompson, T. Takao, C. Awada, H. Mori, and J. Mima for helpful suggestions and valuable discussions; P. Jarvis, D. Schnell, and I. Nishimura for vectors; the Arabidopsis Biological Resource Center, Institut National de la Recherche Agronomique, and Cold Spring Harbor Laboratory for the T-DNA lines; and RIKEN Bioresource Center for the full-length cDNAs. Supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (20059022, 22020024, 24117511, and 24657073, M. N.; 21107518 and 22370059, T. I.; 23770190 and 23113519, M. H.) and by a Japan Society for the Promotion of Science postdoctoral fellowship for foreign researchers (J. B.). S. K., J. B., Y.H., M.O., M. I., M. T., and M. N. performed biochemical and genetic analyses; M. H. and T. I. performed electrophysiological analyses; M. N. conceived and supervised the whole project and wrote the paper.	Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Boudreau E, 1997, MOL GEN GENET, V253, P649, DOI 10.1007/s004380050368; Chen XJ, 2002, PLANT CELL, V14, P641, DOI 10.1105/tpc.010336; Chou ML, 2006, J CELL BIOL, V175, P893, DOI 10.1083/jcb.200609172; Chou ML, 2003, EMBO J, V22, P2970, DOI 10.1093/emboj/cdg281; Cline K, 2008, CURR OPIN PLANT BIOL, V11, P585, DOI 10.1016/j.pbi.2008.10.008; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hirabayashi Y, 2011, PLANT CELL PHYSIOL, V52, P469, DOI 10.1093/pcp/pcr010; Inaba T, 2003, J BIOL CHEM, V278, P38617, DOI 10.1074/jbc.M306367200; Jackson DT, 1998, J BIOL CHEM, V273, P16583, DOI 10.1074/jbc.273.26.16583; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kasmati AR, 2011, PLANT J, V66, P877, DOI 10.1111/j.1365-313X.2011.04551.x; Kessler F, 1996, P NATL ACAD SCI USA, V93, P7684, DOI 10.1073/pnas.93.15.7684; KESSLER F, 1994, SCIENCE, V266, P1035, DOI 10.1126/science.7973656; Kessler F, 2009, CURR OPIN CELL BIOL, V21, P494, DOI 10.1016/j.ceb.2009.03.004; Kikuchi S, 2009, PLANT CELL, V21, P1781, DOI 10.1105/tpc.108.063552; Kouranov A, 1998, J CELL BIOL, V143, P991, DOI 10.1083/jcb.143.4.991; Kovacs-Bogdan E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-133; Kovermann P, 2002, MOL CELL, V9, P363, DOI 10.1016/S1097-2765(02)00446-X; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Liang QJ, 2010, PHYSIOL PLANTARUM, V140, P380, DOI 10.1111/j.1399-3054.2010.01407.x; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; Schwenkert S, 2011, BBA-BIOMEMBRANES, V1808, P901, DOI 10.1016/j.bbamem.2010.07.021; Teng YS, 2006, PLANT CELL, V18, P2247, DOI 10.1105/tpc.106.044305; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726	27	219	227	4	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					571	574		10.1126/science.1229262	http://dx.doi.org/10.1126/science.1229262			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372012				2022-12-24	WOS:000314270000056
J	Vrontou, S; Wong, AM; Rau, KK; Koerber, HR; Anderson, DJ				Vrontou, Sophia; Wong, Allan M.; Rau, Kristofer K.; Koerber, H. Richard; Anderson, David J.			Genetic identification of C fibres that detect massage-like stroking of hairy skin in vivo	NATURE			English	Article							UNMYELINATED TACTILE AFFERENTS; SENSORY NEURONS; MICE; TOUCH; PAIN; POPULATIONS; PREFERENCE; PARADIGM; SUBSETS; REWARD	Stroking of the skin produces pleasant sensations that can occur during social interactions with conspecifics, such as grooming(1). Despite numerous physiological studies (reviewed in ref. 2), molecularly defined sensory neurons that detect pleasant stroking of hairy skin(3,4) in vivo have not been reported. Previously, we identified a rare population of unmyelinated sensory neurons in mice that express the G-protein-coupled receptor MRGPRB4 (refs 5, 6). These neurons exclusively innervate hairy skin with large terminal arborizations(7) that resemble the receptive fields of C-tactile (CT) afferents in humans(8). Unlike other molecularly defined mechanosensory C-fibre subtypes(9,10), MRGPRB(+) neurons could not be detectably activated by sensory stimulation of the skin ex vivo. Therefore, we developed a preparation for calcium imaging in the spinal projections of these neurons during stimulation of the periphery in intact mice. Here we show that MRGPRB41 neurons are activated by massage-like stroking of hairy skin, but not by noxious punctate mechanical stimulation. By contrast, a different population of C fibres expressing MRGPRD(11) was activated by pinching but not by stroking, consistent with previous physiological and behavioural data(10,12). Pharmacogenetic activation of Mrgprb4-expressing neurons in freely behaving mice promoted conditioned place preference(13), indicating that such activation is positively reinforcing and/or anxiolytic. These data open the way to understanding the function of MRGPRB4 neurons during natural behaviours, and provide a general approach to the functional chargenetically identified subsets of somatosensory neurons in vivo.	[Vrontou, Sophia; Wong, Allan M.; Anderson, David J.] CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; [Wong, Allan M.; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Rau, Kristofer K.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA; [Koerber, H. Richard] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15261 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Louisville; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Anderson, DJ (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.	wuwei@caltech.edu			NIH [5PO1NS-48499, 5R01 NS023476]; EMBO; Human Frontiers Science Program; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS048499, R01NS023725, R01NS023476] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program(Human Frontier Science Program); Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Robertson for programming and imaging data analysis; M. Walsh and T. Heitzman for the stimulus delivery system and associated electronics; M. Zelikowsky for help with statistical analysis of behavioural data; H. Inagaki for experimental advice and comments on the manuscript; S. Pease for help with generation of knock-in mice; N. Verduzco, K. Lee and R. Sauza for mice colony maintenance; M. Visel and J. Flannery for training in AAV8 preparation; A. Anderson and C. Pagan for initial experiments using their stereotaxic apparatus; J. Zhang and A. Basbaum for teaching the dorsal laminectomy and for comments on the manuscript; D. Davalos, K. Akassoglou and H. Johanssen for help with the in vivo imaging preparation; L. Lagnado and B. Odermatt for SypHyand SyGCamp2 plasmids; C. Shea and M. Martinez for technical assistance; H. Oates-Barker for laboratory management and G. Mancuso for administrative assistance. This work was supported by NIH grants 5PO1NS-48499 and 5R01 NS023476, and by fellowships from EMBO and the Human Frontiers Science Program (S.V.) and the Helen Hay Whitney Foundation (A.M.W.). D.J.A. is an Investigator of the Howard Hughes Medical Institute.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Berry JA, 2012, NEURON, V74, P530, DOI 10.1016/j.neuron.2012.04.007; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Cunningham CL, 2003, PSYCHOPHARMACOLOGY, V170, P409, DOI 10.1007/s00213-003-1559-y; Davalos D, 2008, J NEUROSCI METH, V169, P1, DOI 10.1016/j.jneumeth.2007.11.011; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Dunbar RIM, 2010, NEUROSCI BIOBEHAV R, V34, P260, DOI 10.1016/j.neubiorev.2008.07.001; Dussor G, 2008, J NEUROPHYSIOL, V99, P1581, DOI 10.1152/jn.01396.2007; EDIN BB, 1995, J NEUROSCI, V15, P830; Foust KD, 2008, HUM GENE THER, V19, P61, DOI 10.1089/hum.2007.093; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hamilton SG, 2001, J PHYSIOL-LONDON, V534, P437, DOI 10.1111/j.1469-7793.2001.00437.x; Johannssen HC, 2010, J PHYSIOL-LONDON, V588, P3397, DOI 10.1113/jphysiol.2010.191833; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; LaBuda CJ, 2000, EXP NEUROL, V163, P490, DOI 10.1006/exnr.2000.7395; Le Foll B, 2005, PSYCHOPHARMACOLOGY, V178, P481, DOI 10.1007/s00213-004-2021-5; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; McGlone F, 2007, CAN J EXP PSYCHOL, V61, P173, DOI 10.1037/cjep2007019; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Morrison I, 2010, EXP BRAIN RES, V204, P305, DOI 10.1007/s00221-009-2007-y; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Olausson H, 2010, NEUROSCI BIOBEHAV R, V34, P185, DOI 10.1016/j.neubiorev.2008.09.011; Panksepp JB, 2007, GENES BRAIN BEHAV, V6, P661, DOI 10.1111/j.1601-183X.2006.00295.x; Panksepp J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021236; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Raymond CS, 2010, GENESIS, V48, P603, DOI 10.1002/dvg.20659; Shields SD, 2010, PAIN, V151, P422, DOI 10.1016/j.pain.2010.08.001; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Wessberg J, 2003, J NEUROPHYSIOL, V89, P1567, DOI 10.1152/jn.00256.2002; Woodbury CJ, 2001, J COMP NEUROL, V436, P304; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	39	162	165	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					669	+		10.1038/nature11810	http://dx.doi.org/10.1038/nature11810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364746	Green Accepted			2022-12-24	WOS:000314219600056
J	Willmund, F; del Alamo, M; Pechmann, S; Chen, TT; Albanese, V; Dammer, EB; Peng, JM; Frydman, J				Willmund, Felix; del Alamo, Marta; Pechmann, Sebastian; Chen, Taotao; Albanese, Veronique; Dammer, Eric B.; Peng, Junmin; Frydman, Judith			The Cotranslational Function of Ribosome-Associated Hsp70 in Eukaryotic Protein Homeostasis	CELL			English	Article							IN-VIVO; CHAPERONE NETWORKS; TRIGGER FACTOR; PREDICTION; DNAK; SPECIFICITY; MACHINERY; GENOME; VITRO; SSB	In eukaryotic cells a molecular chaperone network associates with translating ribosomes, assisting the maturation of emerging nascent polypeptides. Hsp70 is perhaps the major eukaryotic ribosome-associated chaperone and the first reported to bind cotranslationally to nascent chains. However, little is known about the underlying principles and function of this interaction. Here, we use a sensitive and global approach to define the cotranslational substrate specificity of the yeast Hsp70 SSB. We find that SSB binds to a subset of nascent polypeptides whose intrinsic properties and slow translation rates hinder efficient cotranslational folding. The SSB-ribosome cycle and substrate recognition is modulated by its ribosome-bound cochaperone, RAC. Deletion of SSB leads to widespread aggregation of newly synthesized polypeptides. Thus, cotranslationally acting Hsp70 meets the challenge of folding the eukaryotic proteome by stabilizing its longer, more slowly translated, and aggregation-prone nascent polypeptides.	[Willmund, Felix; del Alamo, Marta; Pechmann, Sebastian; Chen, Taotao; Albanese, Veronique; Frydman, Judith] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Willmund, Felix; del Alamo, Marta; Pechmann, Sebastian; Chen, Taotao; Albanese, Veronique; Frydman, Judith] Stanford Univ, BioX Program, Stanford, CA 94305 USA; [Dammer, Eric B.] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Dammer, Eric B.] Emory Univ, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Peng, Junmin] St Jude Childrens Res Hosp, Dept Struct Biol & Dev Neurobiol, Memphis, TN 38105 USA	Stanford University; Stanford University; Emory University; Emory University; St Jude Children's Research Hospital	Frydman, J (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Dammer, Eric B/V-8652-2019; Peng, Junmin/N-2614-2018	Dammer, Eric B/0000-0003-2947-7606; Peng, Junmin/0000-0003-0472-7648; Chen, Taotao/0000-0002-9359-8069; , judith/0000-0003-2302-6943; del Alamo, Marta/0000-0002-8254-9990; Willmund, Felix/0000-0002-3988-4590	EMBO; Spanish Ministry of Education/FECYT postdoctoral fellowship;  [NIH1RO1 GM-56433];  [NIH R21RR025822];  [NIHF32AG038259]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056433, R01GM056433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG038259] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); Spanish Ministry of Education/FECYT postdoctoral fellowship; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Patrick Brown and Dr. Dan Hogan for help and advice with the microarray experiments. We also thank Dr. Raul Andino, Karolin Dorn, and members of the J.F. laboratory for critical reading of the manuscript; Dr. Elke Deuerling for the kind gift of anti-Sse antibody as well as the protocol for aggregate isolation; and Dr. Scott W. Moye-Rowley for the kind gift of the anti-Ssz1 antibody. This work was supported by the Grant NIH1RO1 GM-56433 to J.F. and NIH R21RR025822 to J.P., as well as NIHF32AG038259 to E.B.D. F.W. and S.P. were supported by the EMBO Long-term Fellowship. M.d.A was partially supported by the Spanish Ministry of Education/FECYT postdoctoral fellowship.	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Albanese V, 2010, J CELL BIOL, V189, P69, DOI 10.1083/jcb.201001054; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; DELEAGE G, 1987, PROTEIN ENG, V1, P289, DOI 10.1093/protein/1.4.289; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Duncan CDS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002398; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Inada T, 2002, RNA, V8, P948, DOI 10.1017/S1355838202026018; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Koonin EV, 2000, CELL, V101, P573, DOI 10.1016/S0092-8674(00)80867-3; Koplin A, 2010, J CELL BIOL, V189, P57, DOI 10.1083/jcb.200910074; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lin MM, 2012, P NATL ACAD SCI USA, V109, P9851, DOI 10.1073/pnas.1207382109; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Luheshi LM, 2008, CURR OPIN CHEM BIOL, V12, P25, DOI 10.1016/j.cbpa.2008.02.011; Malmstrom L, 2007, PLOS BIOL, V5, P758, DOI 10.1371/journal.pbio.0050076; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; O'Brien EP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1850; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Peisker K, 2010, BBA-MOL CELL RES, V1803, P662, DOI 10.1016/j.bbamcr.2010.03.005; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Tartaglia GG, 2010, J MOL BIOL, V400, P579, DOI 10.1016/j.jmb.2010.03.066; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; von Plehwe U, 2009, GENE DEV, V23, P2102, DOI 10.1101/gad.529409; Wang ML, 2011, P NATL ACAD SCI USA, V108, P11954, DOI 10.1073/pnas.1017361108; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Zheng OY, 2008, PROTEIN SCI, V17, P1256, DOI 10.1110/ps.034660.108	49	173	175	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					196	209		10.1016/j.cell.2012.12.001	http://dx.doi.org/10.1016/j.cell.2012.12.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332755	Green Accepted, Bronze			2022-12-24	WOS:000313719800017
J	Xue, YC; Ouyang, KF; Huang, J; Zhou, Y; Ouyang, H; Li, HR; Wang, G; Wu, QJ; Wei, CL; Bi, YZ; Jiang, L; Cai, ZQ; Sun, H; Zhang, K; Zhang, Y; Chen, J; Fu, XD				Xue, Yuanchao; Ouyang, Kunfu; Huang, Jie; Zhou, Yu; Ouyang, Hong; Li, Hairi; Wang, Gang; Wu, Qijia; Wei, Chaoliang; Bi, Yanzhen; Jiang, Li; Cai, Zhiqiang; Sun, Hui; Zhang, Kang; Zhang, Yi; Chen, Ju; Fu, Xiang-Dong			Direct Conversion of Fibroblasts to Neurons by Reprogramming PTB-Regulated MicroRNA Circuits	CELL			English	Article							TRACT-BINDING PROTEIN; MESSENGER-RNA STABILITY; ADULT NEUROGENESIS; FUNCTIONAL-NEURONS; MOUSE; CELLS; REST; DIFFERENTIATION; PATHWAY; EXPRESSION	The induction of pluripotency or trans-differentiation of one cell type to another can be accomplished with cell-lineage-specific transcription factors. Here, we report that repression of a single RNA binding polypyrimidine-tract-binding (PTB) protein, which occurs during normal brain development via the action of miR-124, is sufficient to induce trans-differentiation of fibroblasts into functional neurons. Besides its traditional role in regulated splicing, we show that PTB has a previously undocumented function in the regulation of microRNA functions, suppressing or enhancing microRNA targeting by competitive binding on target mRNA or altering local RNA secondary structure. A key event during neuronal induction is the relief of PTB-mediated blockage of microRNA action on multiple components of the REST complex, thereby derepressing a large array of neuronal genes, including miR-124 and multiple neuronal-specific transcription factors, in nonneuronal cells. This converts a negative feedback loop to a positive one to elicit cellular reprogramming to the neuronal lineage.	[Xue, Yuanchao; Huang, Jie; Zhou, Yu; Wu, Qijia; Bi, Yanzhen; Jiang, Li; Cai, Zhiqiang; Sun, Hui; Zhang, Yi; Fu, Xiang-Dong] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Xue, Yuanchao; Zhou, Yu; Li, Hairi; Wei, Chaoliang; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ouyang, Kunfu; Wang, Gang; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ouyang, Hong; Zhang, Kang; Fu, Xiang-Dong] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	Wuhan University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Fu, XD (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	xdfu@ucsd.edu	Zhang, Kang/Y-2740-2019; Wei, Chaoliang/A-9008-2013; Chen, Ju/E-5579-2011; Zhou, Yu/AAP-9964-2021; ouyang, kunfu/B-3073-2011	Zhang, Kang/0000-0002-4549-1697; ouyang, kunfu/0000-0003-0292-375X; Huang, Jie/0000-0003-3842-6181; Zhang, Yi/0000-0003-1035-6134; Zhou, Yu/0000-0002-2102-9377; Ouyang, Hong/0000-0002-7622-7733; XUE, YUANCHAO/0000-0002-8113-2333	China 973 program [2011CB811300, 2012CB910800]; Chinese 111 program [B06018]; NIH [GM049369, GM052872, HG004659]; NIH Director's Transformative RO1 Program [EY021374]; NATIONAL EYE INSTITUTE [R01EY021374] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052872, R01GM049369] Funding Source: NIH RePORTER	China 973 program(National Basic Research Program of China); Chinese 111 program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Transformative RO1 Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to Drs. Gordon Gill, Dongxian Zhang, and Wei Xiong for insightful advice during the course of this investigation and to Drs. Gordon Gill, Amy Pasquinelli, Bruce Hamilton, and Larry Goldstein for critical reading of the manuscript. We thank Drs. Douglas Black, Robert Darnell, Samuel Pfaff, Alysson Muotri, and Geoff Rosenfeld for generous gifts of antibodies and Drs. Zhiping Pang and Marius Wernig for sharing detailed experimental protocols. This work was supported by the China 973 program (2011CB811300, 2012CB910800), the Chinese 111 program grant (B06018), and grants from NIH (GM049369, GM052872, HG004659). H.O. and K.Z. were supported by NIH Director's Transformative RO1 Program (EY021374).	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Aoki H, 2012, DEVELOPMENT, V139, P667, DOI 10.1242/dev.072272; Auld KL, 2006, CELL CYCLE, V5, P1503, DOI 10.4161/cc.5.14.2979; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baudet ML, 2012, NAT NEUROSCI, V15, P29, DOI 10.1038/nn.2979; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Coutinho-Mansfield GC, 2007, GENE DEV, V21, P1573, DOI 10.1101/gad.1575607; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Gao ZL, 2011, J NEUROSCI, V31, P9772, DOI 10.1523/JNEUROSCI.1604-11.2011; Hakamata Y, 2001, BIOCHEM BIOPH RES CO, V286, P779, DOI 10.1006/bbrc.2001.5452; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; Kosinski PA, 2003, J IMMUNOL, V170, P979, DOI 10.4049/jimmunol.170.2.979; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pautz A, 2006, J BIOL CHEM, V281, P32294, DOI 10.1074/jbc.M603915200; Porter JF, 2008, J IMMUNOL, V181, P3336, DOI 10.4049/jimmunol.181.5.3336; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Raj B, 2011, MOL CELL, V43, P843, DOI 10.1016/j.molcel.2011.08.014; Regulski Elizabeth E., 2008, V419, P53, DOI 10.1007/978-1-59745-033-1_4; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Tillmar L, 2002, MOL MED, V8, P263, DOI 10.1007/BF03402152; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Watanabe Y, 2004, GENE DEV, V18, P889, DOI 10.1101/gad.1179004; Woo KC, 2009, NUCLEIC ACIDS RES, V37, P26, DOI 10.1093/nar/gkn893; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yang N, 2011, CELL STEM CELL, V9, P517, DOI 10.1016/j.stem.2011.11.015; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564; Zheng S, 2012, NAT NEUROSCI, V15, P381, DOI 10.1038/nn.3026; Zibetti C, 2010, J NEUROSCI, V30, P2521, DOI 10.1523/JNEUROSCI.5500-09.2010	50	364	390	3	126	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					82	96		10.1016/j.cell.2012.11.045	http://dx.doi.org/10.1016/j.cell.2012.11.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23313552	Bronze, Green Accepted			2022-12-24	WOS:000313719800008
J	Howland, J; Rohsenow, DJ				Howland, Jonathan; Rohsenow, Damaris J.			Risks of Energy Drinks Mixed With Alcohol	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLLEGE-STUDENTS; CONSUMPTION; CONSEQUENCES; IMPAIRMENT		[Howland, Jonathan] Boston Univ, Dept Emergency Med, Boston, MA 02118 USA; [Rohsenow, Damaris J.] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA; [Rohsenow, Damaris J.] VA Med Ctr, Providence, RI USA	Boston University; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Howland, J (corresponding author), Boston Univ, Dept Emergency Med, 1 Boston Med Ctr Pl,Dowling 1 S, Boston, MA 02118 USA.	jhowl@bu.edu		Howland, Jonathan/0000-0001-8079-1188				Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P365, DOI 10.1111/j.1530-0277.2010.01352.x; Fillmore MT, 2002, J STUD ALCOHOL, V63, P745, DOI 10.15288/jsa.2002.63.745; Liguori A, 2001, DRUG ALCOHOL DEPEN, V63, P123, DOI 10.1016/S0376-8716(00)00196-4; Malinauskas BM, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-35; O'Brien MC, 2008, ACAD EMERG MED, V15, P453, DOI 10.1111/j.1553-2712.2008.00085.x; Peacock A, 2012, ALCOHOL CLIN EXP RES, V36, P2008, DOI 10.1111/j.1530-0277.2012.01820.x; Thombs DL, 2010, ADDICT BEHAV, V35, P325, DOI 10.1016/j.addbeh.2009.11.004; Woolsey C, 2010, J APPL SPORT PSYCHOL, V22, P65, DOI 10.1080/10413200903403224	8	52	52	1	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2013	309	3					245	246		10.1001/jama.2012.187978	http://dx.doi.org/10.1001/jama.2012.187978			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070XG	23330172				2022-12-24	WOS:000313546800023
J	Kretz, M; Siprashvili, Z; Chu, C; Webster, DE; Zehnder, A; Qu, K; Lee, CS; Flockhart, RJ; Groff, AF; Chow, J; Johnston, D; Kim, GE; Spitale, RC; Flynn, RA; Zheng, GXY; Aiyer, S; Raj, A; Rinn, JL; Chang, HY; Khavari, PA				Kretz, Markus; Siprashvili, Zurab; Chu, Ci; Webster, Dan E.; Zehnder, Ashley; Qu, Kun; Lee, Carolyn S.; Flockhart, Ross J.; Groff, Abigail F.; Chow, Jennifer; Johnston, Danielle; Kim, Grace E.; Spitale, Robert C.; Flynn, Ryan A.; Zheng, Grace X. Y.; Aiyer, Subhadra; Raj, Arjun; Rinn, John L.; Chang, Howard Y.; Khavari, Paul A.			Control of somatic tissue differentiation by the long non-coding RNA TINCR	NATURE			English	Article							GENE; CHROMATIN; COMPLEXES; REPRESSION; EXPRESSION; MUTATIONS; STAUFEN; SUITE; SHAPE	Several of the thousands of human long non-coding RNAs (lncRNAs) have been functionally characterized(1-4); however, potential roles for lncRNAs in somatic tissue differentiation remain poorly understood. Here we show that a 3.7-kilobase lncRNA, terminal differentiation-induced ncRNA (TINCR), controls human epidermal differentiation by a post-transcriptional mechanism. TINCR is required for high messenger RNA abundance of key differentiation genes, many of which are mutated in human skin diseases, including FLG, LOR, ALOXE3, ALOX12B, ABCA12, CASP14 and ELOVL3. TINCR-deficient epidermis lacked terminal differentiation ultrastructure, including keratohyalin granules and intact lamellar bodies. Genome-scale RNA interactome analysis revealed that TINCR interacts with a range of differentiation mRNAs. TINCR-mRNA interaction occurs through a 25-nucleotide 'TINCR box' motif that is strongly enriched in interacting mRNAs and required for TINCR binding. A high-throughput screen to analyse TINCR binding capacity to approximately 9,400 human recombinant proteins revealed direct binding of TINCR RNA to the staufen1 (STAU1) protein. STAU1-deficient tissue recapitulated the impaired differentiation seen with TINCR depletion. Loss of UPF1 and UPF2, both of which are required for STAU1-mediated RNA decay, however, did not have differentiation effects. Instead, the TINCR-STAU1 complex seems to mediate stabilization of differentiation mRNAs, such as KRT80. These data identify TINCR as a key lncRNA required for somatic tissue differentiation, which occurs through lncRNA binding to differentiation mRNAs to ensure their expression.	[Kretz, Markus; Siprashvili, Zurab; Chu, Ci; Webster, Dan E.; Zehnder, Ashley; Qu, Kun; Lee, Carolyn S.; Flockhart, Ross J.; Groff, Abigail F.; Chow, Jennifer; Johnston, Danielle; Kim, Grace E.; Spitale, Robert C.; Flynn, Ryan A.; Zheng, Grace X. Y.; Chang, Howard Y.; Khavari, Paul A.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Aiyer, Subhadra; Raj, Arjun] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Chang, Howard Y.] Howard Hughes Med Inst, Stanford, CA 94305 USA; [Khavari, Paul A.] Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA	Stanford University; University of Pennsylvania; Harvard University; Howard Hughes Medical Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Chang, HY (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.	howchang@stanford.edu; khavari@stanford.edu	Kretz, Markus/ABB-8490-2021; Qu, Kun/G-3359-2012	Flynn, Ryan/0000-0001-5013-0442; Rinn, John/0000-0002-7231-7539; Webster, Dan/0000-0001-6874-8451; Raj, Arjun/0000-0002-2915-6960; Lee, Carolyn/0000-0002-6511-3757	US Veterans Affairs Office of Research and Development; National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [AR49737]; NIH [R01-HG004361]; California Institute for Regenerative Medicine; NATIONAL CANCER INSTITUTE [R01CA142635, T32CA009302] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007422, R01AR049737] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008514] Funding Source: NIH RePORTER	US Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by US Veterans Affairs Office of Research and Development funding to P. A. K. and National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases) grant AR49737 to P. A. K., and by NIH R01-HG004361 and California Institute for Regenerative Medicine to H.Y.C. H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bond AM, 2009, NAT NEUROSCI, V12, P1020, DOI 10.1038/nn.2371; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Dugre-Brisson S, 2005, NUCLEIC ACIDS RES, V33, P4797, DOI 10.1093/nar/gki794; Eckl KM, 2009, J INVEST DERMATOL, V129, P1421, DOI 10.1038/jid.2008.409; Elias PM, 2005, J INVEST DERMATOL, V125, P183, DOI 10.1111/j.0022-202X.2005.23668.x; Furic L, 2008, RNA, V14, P324, DOI 10.1261/rna.720308; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; O'Driscoll J, 2002, CLIN EXP DERMATOL, V27, P243, DOI 10.1046/j.1365-2230.2002.01031.x; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sakai K, 2009, J INVEST DERMATOL, V129, P2306, DOI 10.1038/jid.2009.23; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Virtanen M, 2003, J INVEST DERMATOL, V121, P1013, DOI 10.1046/j.1523-1747.2003.12534.x; Wan DF, 2004, P NATL ACAD SCI USA, V101, P15724, DOI 10.1073/pnas.0404089101; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; Young TL, 2005, CURR BIOL, V15, P501, DOI 10.1016/j.cub.2005.02.027; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	661	703	4	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					231	U245		10.1038/nature11661	http://dx.doi.org/10.1038/nature11661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23201690	Green Accepted			2022-12-24	WOS:000313259600041
J	Bagdonaite, J; Jansen, P; Henkel, C; Bethlem, HL; Menten, KM; Ubachs, W				Bagdonaite, Julija; Jansen, Paul; Henkel, Christian; Bethlem, Hendrick L.; Menten, Karl M.; Ubachs, Wim			A Stringent Limit on a Drifting Proton-to-Electron Mass Ratio from Alcohol in the Early Universe	SCIENCE			English	Article							FINE-STRUCTURE CONSTANT; RADIO-SOURCE PKS1830-211; PKS 1830-211; MOLECULAR ABSORPTION; HYPERFINE-STRUCTURE; GRAVITATIONAL LENS; REST FREQUENCIES; METHANOL; REDSHIFT; Z=0.89	The standard model of physics is built on the fundamental constants of nature, but it does not provide an explanation for their values, nor require their constancy over space and time. Here we set a limit on a possible cosmological variation of the proton-to-electron mass ratio m by comparing transitions in methanol observed in the early universe with those measured in the laboratory. From radio-astronomical observations of PKS1830-211, we deduced a constraint of Delta mu/mu = (0.0 +/- 1.0) x 10(-7) at redshift z = 0.89, corresponding to a look-back time of 7 billion years. This is consistent with a null result.	[Bagdonaite, Julija; Jansen, Paul; Bethlem, Hendrick L.; Ubachs, Wim] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Henkel, Christian; Menten, Karl M.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Henkel, Christian] King Abdulaziz Univ, Dept Astron, Jeddah 21413, Saudi Arabia	Vrije Universiteit Amsterdam; Max Planck Society; King Abdulaziz University	Ubachs, W (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, De Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	w.m.g.ubachs@vu.nl	Bethlem, Hendrick Lucas/B-2831-2008; Ubachs, W./K-3256-2019; Ubachs, Wim/F-5649-2011	Bethlem, Hendrick Lucas/0000-0003-4575-8512; Ubachs, W./0000-0001-7840-3756; Ubachs, Wim/0000-0001-7840-3756	Foundation for Fundamental Research on Matter program "Broken Mirrors & Drifting Constants"; Netherlands Organization for Scientific Research via a VIDI grant; European Research Council via a Starting Grant	Foundation for Fundamental Research on Matter program "Broken Mirrors & Drifting Constants"; Netherlands Organization for Scientific Research via a VIDI grant; European Research Council via a Starting Grant	This work is supported by the Foundation for Fundamental Research on Matter program "Broken Mirrors & Drifting Constants." H. L. B. acknowledges support from the Netherlands Organization for Scientific Research via a VIDI grant and by the European Research Council via a Starting Grant. We thank the staff of the Effelsberg radio telescope for their hospitality and support. The raw data of the radioastronomical observations are available upon request from the Max Planck Institute for Radio Astronomy at Bonn (kmenten@mpifr-bonn.mpg.de).	Barrow JD, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.043521; BRECKENRIDGE SM, 1995, ASTROPHYS J, V438, P504, DOI 10.1086/175095; Chengalur JN, 1999, ASTRON ASTROPHYS, V343, pL79; Ellingsen SP, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/1/L7; Henkel C, 2009, ASTRON ASTROPHYS, V500, P725, DOI 10.1051/0004-6361/200811475; HEUVEL JEM, 1973, J MOL SPECTROSC, V45, P282, DOI 10.1016/0022-2852(73)90159-8; Jansen P, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.062505; Jansen P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.100801; JAUNCEY DL, 1991, NATURE, V352, P132, DOI 10.1038/352132a0; Kanekar N, 2011, ASTROPHYS J LETT, V728, DOI 10.1088/2041-8205/728/1/L12; King JA, 2012, MON NOT R ASTRON SOC, V422, P3370, DOI 10.1111/j.1365-2966.2012.20852.x; Leurini S, 2004, ASTRON ASTROPHYS, V422, P573, DOI 10.1051/0004-6361:20047046; Levshakov SA, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/26; Lidman C, 1999, ASTROPHYS J, V514, pL57, DOI 10.1086/311949; LIN CC, 1959, REV MOD PHYS, V31, P841, DOI 10.1103/RevModPhys.31.841; Lovas FJ, 2004, J PHYS CHEM REF DATA, V33, P177, DOI 10.1063/1.1633275; Malec AL, 2010, MON NOT R ASTRON SOC, V403, P1541, DOI 10.1111/j.1365-2966.2009.16227.x; Menten KM, 2008, ASTRON ASTROPHYS, V492, P725, DOI 10.1051/0004-6361:200810041; Muller HSP, 2004, ASTRON ASTROPHYS, V428, P1019, DOI 10.1051/0004-6361:20041384; Muller S, 2011, ASTRON ASTROPHYS, V535, DOI 10.1051/0004-6361/201117096; Muller S, 2008, ASTRON ASTROPHYS, V491, P739, DOI 10.1051/0004-6361:200810392; Murphy MT, 2008, SCIENCE, V320, P1611, DOI 10.1126/science.1156352; Murphy MT, 2003, MON NOT R ASTRON SOC, V345, P609, DOI 10.1046/j.1365-8711.2003.06970.x; Reinhold E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.151101; Smolin L, 2004, PHYSICA A, V340, P705, DOI 10.1016/j.physa.2004.05.021; van Veldhoven J, 2004, EUR PHYS J D, V31, P337, DOI 10.1140/epjd/e2004-00160-9; van Weerdenburg F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.180802; Webb JK, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.191101; Webb JK, 1999, PHYS REV LETT, V82, P884, DOI 10.1103/PhysRevLett.82.884; Wiklind T, 1996, NATURE, V379, P139, DOI 10.1038/379139a0	30	98	98	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					46	48		10.1126/science.1224898	http://dx.doi.org/10.1126/science.1224898			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23239626	Green Submitted			2022-12-24	WOS:000312985800046
J	Doerfel, LK; Wohlgemuth, I; Kothe, C; Peske, F; Urlaub, H; Rodnina, MV				Doerfel, Lili K.; Wohlgemuth, Ingo; Kothe, Christina; Peske, Frank; Urlaub, Henning; Rodnina, Marina V.			EF-P Is Essential for Rapid Synthesis of Proteins Containing Consecutive Proline Residues	SCIENCE			English	Article							ELONGATION-FACTOR-P; PEPTIDE-BOND FORMATION; TRANSFER-RNA; TRANSLATION ELONGATION; POSTTRANSLATIONAL MODIFICATION; RIBOSOME-RESCUE; SSRA; TERMINATION; VIRULENCE; HYPUSINE	Elongation factor P (EF-P) is a translation factor of unknown function that has been implicated in a great variety of cellular processes. Here, we show that EF-P prevents ribosome from stalling during synthesis of proteins containing consecutive prolines, such as PPG, PPP, or longer proline strings, in natural and engineered model proteins. EF-P promotes peptide-bond formation and stabilizes the peptidyl-transfer RNA in the catalytic center of the ribosome. EF-P is posttranslationally modified by a hydroxylated beta-lysine attached to a lysine residue. The modification enhances the catalytic proficiency of the factor mainly by increasing its affinity to the ribosome. We propose that EF-P and its eukaryotic homolog, eIF5A, are essential for the synthesis of a subset of proteins containing proline stretches in all cells.	[Doerfel, Lili K.; Wohlgemuth, Ingo; Kothe, Christina; Peske, Frank; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany; [Wohlgemuth, Ingo; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Goettingen, Dept Clin Chem, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society; University of Gottingen	Rodnina, MV (corresponding author), Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany.	rodnina@mpibpc.mpg.de	Rodnina, Marina V./AAD-4667-2019	Rodnina, Marina V./0000-0003-0105-3879; Wohlgemuth, Ingo/0000-0001-9121-7675	Max Planck Society; Deutsche Forschungsgemeinschaft	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank W. Wintermeyer for critically reading the manuscript; W. Holtkamp and J. Mittelstaet for the translation assay and M1 and M2 peptide markers; D. Gorlich and C. Enke for the antibody against EF-P; and O. Geintzer, S. Kappler, T. Wiles, M. Zimmermann, T. Uhlendorf, A. Bursy, and U. Plessmann for expert technical assistance. The work was funded by the Max Planck Society and by grants from the Deutsche Forschungsgemeinschaft.	Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; GLICK BR, 1979, EUR J BIOCHEM, V97, P23, DOI 10.1111/j.1432-1033.1979.tb13081.x; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Heurgue-Hamard V, 1998, EMBO J, V17, P808, DOI 10.1093/emboj/17.3.808; Holmes A, 2010, INFECT IMMUN, V78, P4445, DOI 10.1128/IAI.00635-10; Johansson M, 2011, P NATL ACAD SCI USA, V108, P79, DOI 10.1073/pnas.1012612107; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Park JH, 2012, J BIOL CHEM, V287, P2579, DOI 10.1074/jbc.M111.309633; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sallee NA, 2008, NATURE, V454, P1005, DOI 10.1038/nature07170; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sunohara T, 2002, RNA, V8, P1416, DOI 10.1017/S1355838202020198; Tanner DR, 2009, J BIOL CHEM, V284, P34809, DOI 10.1074/jbc.M109.039040; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Zou SB, 2011, VIRULENCE, V2, P147, DOI 10.4161/viru.2.2.15039	26	303	311	4	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					85	88		10.1126/science.1229017	http://dx.doi.org/10.1126/science.1229017			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23239624				2022-12-24	WOS:000312985800057
J	Sheth, R; Marcon, L; Bastida, MF; Junco, M; Quintana, L; Dahn, R; Kmita, M; Sharpe, J; Ros, MA				Sheth, Rushikesh; Marcon, Luciano; Felix Bastida, M.; Junco, Marisa; Quintana, Laura; Dahn, Randall; Kmita, Marie; Sharpe, James; Ros, Maria A.			Hox Genes Regulate Digit Patterning by Controlling the Wavelength of a Turing-Type Mechanism	SCIENCE			English	Article							REACTION-DIFFUSION MODEL; SONIC-HEDGEHOG; LIMB; GLI3; EXPRESSION; NUMBER; FINS; DOWNSTREAM; REVEALS; HOXD-13	The formation of repetitive structures (such as stripes) in nature is often consistent with a reaction-diffusion mechanism, or Turing model, of self-organizing systems. We used mouse genetics to analyze how digit patterning (an iterative digit/nondigit pattern) is generated. We showed that the progressive reduction in Hoxa13 and Hoxd11-Hoxd13 genes (hereafter referred to as distal Hox genes) from the Gli3-null background results in progressively more severe polydactyly, displaying thinner and densely packed digits. Combined with computer modeling, our results argue for a Turing-type mechanism underlying digit patterning, in which the dose of distal Hox genes modulates the digit period or wavelength. The phenotypic similarity with fish-fin endoskeleton patterns suggests that the pentadactyl state has been achieved through modification of an ancestral Turing-type mechanism.	[Kmita, Marie] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Sharpe, James] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain; [Sheth, Rushikesh; Felix Bastida, M.; Junco, Marisa; Ros, Maria A.] Univ Cantabria, Soc El Desarrollo Reg Cantabria, Consejo Super Invest Cient, Fac Med,Inst Biomed Biotecnol, Santander 39011, Spain; [Marcon, Luciano; Quintana, Laura; Sharpe, James] CRG, EMBL, Syst Biol Res Unit, Barcelona 08003, Spain; [Marcon, Luciano; Quintana, Laura; Sharpe, James] Univ Pompeu Fabra, Barcelona 08003, Spain; [Felix Bastida, M.; Ros, Maria A.] Univ Cantabria, Dept Anat & Biol Celular, Santander 39011, Spain	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; ICREA; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); Pompeu Fabra University; Universidad de Cantabria	Kmita, M (corresponding author), Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.	marie.kmita@ircm.qc.ca; james.sharpe@crg.eu; marian.ros@unican.es	Marcon, Luciano LM/X-9975-2018; Sharpe, James/AAB-7948-2019; kmita, marie/AAU-9620-2020; Sharpe, James/L-1150-2014; Ros, Maria A./K-8160-2014; Marcon, Luciano/AAK-5535-2020	Marcon, Luciano LM/0000-0003-0957-9170; Sharpe, James/0000-0002-1434-9743; Ros, Maria A./0000-0002-1224-7671; Marcon, Luciano/0000-0003-0957-9170; Kmita, Marie/0000-0003-4021-0478	Spanish Ministry of Science and Innovation [BFU2011-24972]; Canadian Institutes of Health Research [MOP-82880]; Formacion Profesorado Universitario fellowship from the Spanish Ministry of Science and Innovation; EMBL-CRG Systems Biology Program; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Formacion Profesorado Universitario fellowship from the Spanish Ministry of Science and Innovation; EMBL-CRG Systems Biology Program; ICREA(ICREA)	We thank D. Duboule and P. Chambon for the mutant mice, A. Munteanu for comments on the mathematical analysis, and M. Torres and M. Towers for critical reading of the manuscript. This work was supported by grant BFU2011-24972 from the Spanish Ministry of Science and Innovation to M. A. R. and by grant MOP-82880 from the Canadian Institutes of Health Research to M. K. R. S. was supported by a Formacion Profesorado Universitario fellowship from the Spanish Ministry of Science and Innovation; L. M. was supported by a fellowship from the EMBL-CRG Systems Biology Program.	Bastida MF, 2008, CURR OPIN GENET DEV, V18, P374, DOI 10.1016/j.gde.2008.06.009; Chen YT, 2004, DEVELOPMENT, V131, P2339, DOI 10.1242/dev.01115; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Davis AP, 1996, DEVELOPMENT, V122, P1175; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; Freitas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000754; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Goff DJ, 1997, DEVELOPMENT, V124, P627; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Knezevic V, 1997, DEVELOPMENT, V124, P4523; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Lopez-Rios J, 2012, DEV CELL, V22, P837, DOI 10.1016/j.devcel.2012.01.006; MAINI PK, 1991, INT REV CYTOL, V129, P91; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; Miura T, 2004, B MATH BIOL, V66, P627, DOI 10.1016/j.bulm.2003.09.009; Miura T, 2006, J THEOR BIOL, V240, P562, DOI 10.1016/j.jtbi.2005.10.016; NEWMAN SA, 1979, SCIENCE, V205, P662, DOI 10.1126/science.462174; Newman SA, 1996, BIOESSAYS, V18, P171, DOI 10.1002/bies.950180302; Schneider I, 2011, P NATL ACAD SCI USA, V108, P12782, DOI 10.1073/pnas.1109993108; Sheth R, 2007, DEV BIOL, V310, P430, DOI 10.1016/j.ydbio.2007.07.023; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Woltering JM, 2010, DEV CELL, V18, P526, DOI 10.1016/j.devcel.2010.04.002; Zakany J, 1997, P NATL ACAD SCI USA, V94, P13695, DOI 10.1073/pnas.94.25.13695; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681	31	237	239	4	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1476	1480		10.1126/science.1226804	http://dx.doi.org/10.1126/science.1226804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239739	Green Accepted			2022-12-24	WOS:000312250800050
J	Lekomtsev, S; Su, KC; Pye, VE; Blight, K; Sundaramoorthy, S; Takaki, T; Collinson, LM; Cherepanov, P; Divecha, N; Petronczki, M				Lekomtsev, Sergey; Su, Kuan-Chung; Pye, Valerie E.; Blight, Ken; Sundaramoorthy, Sriramkumar; Takaki, Tohru; Collinson, Lucy M.; Cherepanov, Peter; Divecha, Nullin; Petronczki, Mark			Centralspindlin links the mitotic spindle to the plasma membrane during cytokinesis	NATURE			English	Article							CONTRACTILE RING; BINDING DOMAIN; RHOGEF ECT2; PROTEIN; COMPLEX; ABSCISSION; GTPASE; ACTIN; MICROTUBULES; PI(4,5)P-2	At the end of cell division, cytokinesis splits the cytoplasm of nascent daughter cells and partitions segregated sister genomes(1,2). To coordinate cell division with chromosome segregation, the mitotic spindle controls cytokinetic events at the cell envelope. The spindle midzone stimulates the actomyosin-driven contraction of the cleavage furrow, which proceeds until the formation of a microtubule-rich intercellular bridge with the midbody at its centre. The midbody directs the final membrane abscission reaction(1,2) and has been proposed to attach the cleavage furrow to the intercellular bridge(3). How the mitotic spindle is connected to the plasma membrane during cytokinesis is not understood. Here we identify a plasma membrane tethering activity in the centralspindlin protein complex, a conserved component of the spindle midzone and midbody(4). We demonstrate that the C1 domain of the centralspindlin subunit MgcRacGAP associates with the plasma membrane by interacting with polyanionic phosphoinositide lipids. Using X-ray crystallography we determine the structure of this atypical C1 domain. Mutations in the hydrophobic cap and in basic residues of the C1 domain of MgcRacGAP prevent association of the protein with the plasma membrane, and abrogate cytokinesis in human and chicken cells. Artificial membrane tethering of centralspindlin restores cell division in the absence of the C1 domain of MgcRacGAP. Although C1 domain function is dispensable for the formation of the midzone and midbody, it promotes contractility and is required for the attachment of the plasma membrane to the midbody, a long-postulated function of this organelle(3). Our analysis suggests that centralspindlin links the mitotic spindle to the plasma membrane to secure the final cut during cytokinesis in animal cells.	[Lekomtsev, Sergey; Su, Kuan-Chung; Sundaramoorthy, Sriramkumar; Takaki, Tohru; Petronczki, Mark] Canc Res UK London Res Inst, Clare Hall Labs, Cell Div, S Mimms EN6 3LD, Herts, England; [Lekomtsev, Sergey; Su, Kuan-Chung; Sundaramoorthy, Sriramkumar; Takaki, Tohru; Petronczki, Mark] Canc Res UK London Res Inst, Clare Hall Labs, Aneuploidy Lab, S Mimms EN6 3LD, Herts, England; [Pye, Valerie E.; Cherepanov, Peter] Canc Res UK London Res Inst, Clare Hall Labs, Chromatin Struct & Mobile DNA Lab, S Mimms EN6 3LD, Herts, England; [Blight, Ken; Collinson, Lucy M.] Canc Res UK London Res Inst, Electron Microscopy Unit, London WC2A 3PX, England; [Divecha, Nullin] Univ Manchester, Paterson Inst Canc Res, Inositide Lab, Manchester M20 4BX, Lancs, England	Cancer Research UK; Cancer Research UK; Cancer Research UK; Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester	Petronczki, M (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Cell Div, Blanche Lane, S Mimms EN6 3LD, Herts, England.	mark.petronczki@cancer.org.uk	Cherepanov, Peter P/F-6859-2010; Sundaramoorthy, Sriramkumar/AAS-2912-2021	Cherepanov, Peter P/0000-0002-0634-538X; Petronczki, Mark/0000-0003-0139-5692; divecha, nullin/0000-0001-9695-6039; Collinson, Lucy/0000-0003-0260-613X; Pye, Valerie E/0000-0001-9616-2992	Cancer Research UK; EMBO; Cancer Research UK [15272] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); EMBO(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK)	We would like to thank W. Bement, W. Earnshaw, J. Gannon, D. Gerlich, M. Glotzer, G. Hammond, M. Hikida, H. Hochegger, R. Irvine, M. Kurosaki, B. Larijani, P. Parker, A. Piekny, R. Prekeris, E. Sahai, K. Samejima and M. Symons for reagents and advice. Work in the Petronczki laboratory is supported by Cancer Research UK and the EMBO Young Investigator Programme. S.L. acknowledges support from an EMBO Long-Term Fellowship.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Bastos RN, 2012, J CELL BIOL, V198, P865, DOI 10.1083/jcb.201204107; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Canman JC, 2008, SCIENCE, V322, P1543, DOI 10.1126/science.1163086; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Dambournet D, 2011, NAT CELL BIOL, V13, P981, DOI 10.1038/ncb2279; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Hutterer A, 2009, CURR BIOL, V19, P2043, DOI 10.1016/j.cub.2009.10.050; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kechad A, 2012, CURR BIOL, V22, P197, DOI 10.1016/j.cub.2011.11.062; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Loria A, 2012, CURR BIOL, V22, P213, DOI 10.1016/j.cub.2011.12.019; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Pavicic-Kaltenbrunner V, 2007, MOL BIOL CELL, V18, P4992, DOI 10.1091/mbc.E07-05-0468; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Simon GC, 2008, EMBO J, V27, P1791, DOI 10.1038/emboj.2008.112; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Su KC, 2011, DEV CELL, V21, P1104, DOI 10.1016/j.devcel.2011.11.003; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Yamada T, 2006, EXP CELL RES, V312, P3517, DOI 10.1016/j.yexcr.2006.07.026; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zavortink M, 2005, J CELL SCI, V118, P5381, DOI 10.1242/jcs.02652; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	44	104	105	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					276	+		10.1038/nature11773	http://dx.doi.org/10.1038/nature11773			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235882				2022-12-24	WOS:000312259300047
J	Ruas, JL; White, JP; Rao, RR; Kleiner, S; Brannan, KT; Harrison, BC; Greene, NP; Wu, J; Estall, JL; Irving, BA; Lanza, IR; Rasbach, KA; Okutsu, M; Nair, KS; Yan, Z; Leinwand, LA; Spiegelman, BM				Ruas, Jorge L.; White, James P.; Rao, Rajesh R.; Kleiner, Sandra; Brannan, Kevin T.; Harrison, Brooke C.; Greene, Nicholas P.; Wu, Jun; Estall, Jennifer L.; Irving, Brian A.; Lanza, Ian R.; Rasbach, Kyle A.; Okutsu, Mitsuharu; Nair, K. Sreekumaran; Yan, Zhen; Leinwand, Leslie A.; Spiegelman, Bruce M.			A PGC-1 alpha Isoform Induced by Resistance Training Regulates Skeletal Muscle Hypertrophy	CELL			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; MICE; GROWTH; MASS; HOMEOSTASIS; EXPRESSION; PROTECTS; ATROPHY; FIBERS; DRIVES	PGC-1 alpha is a transcriptional coactivator induced by exercise that gives muscle many of the best known adaptations to endurance-type exercise but has no effects on muscle strength or hypertrophy. We have identified a form of PGC-1 alpha (PGC-1 alpha 4) that results from alternative promoter usage and splicing of the primary transcript. PGC-1 alpha 4 is highly expressed in exercised muscle but does not regulate most known PGC-1 alpha targets such as the mitochondrial OXPHOS genes. Rather, it specifically induces IGF1 and represses myostatin, and expression of PGC-1 alpha 4 in vitro and in vivo induces robust skeletal muscle hypertrophy. Importantly, mice with skeletal muscle-specific transgenic expression of PGC-1 alpha 4 show increased muscle mass and strength and dramatic resistance to the muscle wasting of cancer cachexia. Expression of PGC-1 alpha 4 is preferentially induced in mouse and human muscle during resistance exercise. These studies identify a PGC-1 alpha protein that regulates and coordinates factors involved in skeletal muscle hypertrophy.	[Ruas, Jorge L.; White, James P.; Rao, Rajesh R.; Kleiner, Sandra; Brannan, Kevin T.; Wu, Jun; Estall, Jennifer L.; Rasbach, Kyle A.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Cell Biol, Boston, MA 02115 USA; [Harrison, Brooke C.; Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Greene, Nicholas P.; Okutsu, Mitsuharu; Yan, Zhen] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Irving, Brian A.; Lanza, Ian R.; Nair, K. Sreekumaran] Mayo Clin, Div Endocrinol, Endocrine Res Unit, Rochester, MN 55905 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Colorado System; University of Colorado Boulder; University of Virginia; Mayo Clinic	Ruas, JL (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.	jorge.ruas@ki.se; bruce_spiegelman@dfci.harvard.edu	Ruas, Jorge/AAE-6094-2019; Irving, Brian/B-9683-2016; Greene, Nicholas/A-6076-2013; Greene, Nicholas/G-7399-2015	Ruas, Jorge/0000-0002-1110-2606; Irving, Brian/0000-0002-4131-9523; Greene, Nicholas/0000-0002-9504-9362; Lanza, Ian/0000-0002-9858-3384; Yan, Zhen/0000-0002-4826-9813; Estall, Jennifer/0000-0002-9838-1440; LEINWAND, LESLIE/0000-0003-1470-4810; Greene, Nicholas/0000-0001-9621-2005	NIH [DK061562, 5K01AR55676-2, T32HL07284, AR050429, GM29090]; Novartis; Wenner-Gren Foundations, Sweden; AHA [09POST2010078, 12SDG8070003]; Novartis, Inc.;  [RR024151];  [AG09531]; Novo Nordisk Fonden [NNF12OC1016062] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119937, T32HL007284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050429, K01AR055676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061562, K01DK094824, R56DK054477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009531] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); Wenner-Gren Foundations, Sweden; AHA(American Heart Association); Novartis, Inc.; ; ; Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. Srikripa Devarakonda and Sibylle Jager for valuable discussions. ERR alpha and ERR gamma KO myoblasts were a kind gift from Dr. Zhidan Wu (Novartis Institutes for Biomedical Research). The MEF2C/Myogenin promoter cassette was kindly provided by Dr. Eric Olson (University of Texas Southwestern Medical Center). LLC cells were kindly donated by Dr. Jose M. Garcia (Baylor College of Medicine). This project was supported by grants (DK061562) from the NIH and from Novartis to B.M.S. J.L.R. was supported in part by a grant from the Wenner-Gren Foundations, Sweden. This research was supported in part by grants to B. C. H. (NIH, 5K01AR55676-2), N.P.G. (NIH, T32HL07284), J.W. (AHA, 09POST2010078 and 12SDG8070003), B.A.I. (RR024151 and AG09531), Z.Y. (NIH, AR050429), and L. A. L. (NIH, GM29090). B. M. S. is a shareholder and consultant to Ember Therapeutics and has received funding in the form of sponsored research from Novartis, Inc.	Adams GR, 2002, J APPL PHYSIOL, V93, P1159, DOI 10.1152/japplphysiol.01264.2001; Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Axell AM, 2006, AM J PHYSIOL-ENDOC M, V291, pE506, DOI 10.1152/ajpendo.00058.2006; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Busquets S, 2012, J CACHEXIA SARCOPENI, V3, P37, DOI 10.1007/s13539-011-0049-z; Chakkalakal JV, 2010, DEVELOPMENT, V137, P3489, DOI 10.1242/dev.053348; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Dinchuk JE, 2010, ENDOCRINOLOGY, V151, P4123, DOI 10.1210/en.2010-0032; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; FLORINI JR, 1987, MUSCLE NERVE, V10, P577, DOI 10.1002/mus.880100702; Gentry B, 2011, MUSCLE NERVE, V43, P49, DOI 10.1002/mus.21796; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; MCMILLAN DN, 1992, J ANIM SCI, V70, P3014, DOI 10.2527/1992.70103014x; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Megeney LA, 1996, DEV GENET, V19, P139, DOI 10.1002/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Nair KS, 2005, AM J CLIN NUTR, V81, P953; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; White JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024650; Yoshioka T, 2009, J MATER CYCLES WASTE, V11, P1, DOI 10.1007/s10163-008-0223-3; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	40	433	453	3	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1319	1331		10.1016/j.cell.2012.10.050	http://dx.doi.org/10.1016/j.cell.2012.10.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217713	Bronze, Green Accepted			2022-12-24	WOS:000311999900020
J	Stensmyr, MC; Dweck, HKM; Farhan, A; Ibba, I; Strutz, A; Mukunda, L; Linz, J; Grabe, V; Steck, K; Lavista-Llanos, S; Wicher, D; Sachse, S; Knaden, M; Becher, PG; Seki, Y; Hansson, BS				Stensmyr, Marcus C.; Dweck, Hany K. M.; Farhan, Abu; Ibba, Irene; Strutz, Antonia; Mukunda, Latha; Linz, Jeanine; Grabe, Veit; Steck, Kathrin; Lavista-Llanos, Sofia; Wicher, Dieter; Sachse, Silke; Knaden, Markus; Becher, Paul G.; Seki, Yoichi; Hansson, Bill S.			A Conserved Dedicated Olfactory Circuit for Detecting Harmful Microbes in Drosophila	CELL			English	Article							ANTENNAL LOBE; SENSORY INPUT; NEURONS; GEOSMIN; PHEROMONE; BEHAVIOR; SYSTEM; REPRESENTATIONS; INTERNEURONS; ORGANIZATION	Flies, like all animals, need to find suitable and safe food. Because the principal food source for Drosophila melanogaster is yeast growing on fermenting fruit, flies need to distinguish fruit with safe yeast from yeast covered with toxic microbes. We identify a functionally segregated olfactory circuit in flies that is activated exclusively by geosmin. This microbial odorant constitutes an ecologically relevant stimulus that alerts flies to the presence of harmful microbes. Geosmin activates only a single class of sensory neurons expressing the olfactory receptor Or56a. These neurons target the DA2 glomerulus and connect to projection neurons that respond exclusively to geosmin. Activation of DA2 is sufficient and necessary for aversion, overrides input from other olfactory pathways, and inhibits positive chemotaxis, oviposition, and feeding. The geosmin detection system is a conserved feature in the genus Drosophila that provides flies with a sensitive, specific means of identifying unsuitable feeding and breeding sites.	[Stensmyr, Marcus C.; Dweck, Hany K. M.; Farhan, Abu; Ibba, Irene; Strutz, Antonia; Mukunda, Latha; Linz, Jeanine; Grabe, Veit; Steck, Kathrin; Lavista-Llanos, Sofia; Wicher, Dieter; Sachse, Silke; Knaden, Markus; Seki, Yoichi; Hansson, Bill S.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, D-07745 Jena, Germany; [Becher, Paul G.] Swedish Univ Agr Sci, Div Chem Ecol, S-23053 Alnarp, Sweden	Max Planck Society; Swedish University of Agricultural Sciences	Stensmyr, MC (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Hans Knoll Str 8, D-07745 Jena, Germany.	mstensmyr@ice.mpg.de; hansson@ice.mpg.de	Abu, Farhan/AAH-8596-2020; Sachse, Silke/M-8484-2014; Hansson, Bill S/G-2774-2013; Knaden, Markus/E-2151-2015; Becher, Paul/ABF-4450-2020	Abu, Farhan/0000-0002-7385-5590; Sachse, Silke/0000-0002-9769-8067; Hansson, Bill S/0000-0002-4811-1223; Knaden, Markus/0000-0002-6710-1071; Becher, Paul/0000-0001-5058-2668; Steck, Kathrin/0000-0003-2711-2873; Stensmyr, Marcus/0000-0003-4009-9212; Grabe, Veit/0000-0002-0736-2771; Seki, Yoichi/0000-0002-3337-4768	Max Planck Society; German Federal Ministry of Education and Research; Swedish research council Formas	Max Planck Society(Max Planck Society); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Swedish research council Formas(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by the Max Planck Society, the German Federal Ministry of Education and Research (A. S., V. G., and S. S.), and the Swedish research council Formas (P. G. B.). We wish to thank S. Caron and F. Maderspacher for valuable comments on the manuscript, E. Wheeler for editorial assistance, and R. Stieber, K. Weniger, and S. Kaltofen for technical support. We thank I. Urru for assisting with odor collections, S. Koczsan and J. Rybak for morphological analysis, and M. Thoma for providing help with the Flywalk experiments.	Arndt C, 1999, MICROBIOL-SGM, V145, P1989, DOI 10.1099/13500872-145-8-1989; Becher PG, 2010, J CHEM ECOL, V36, P599, DOI 10.1007/s10886-010-9794-2; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Castillo MA, 1999, J AGR FOOD CHEM, V47, P2120, DOI 10.1021/jf981010a; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; GERBER NN, 1965, APPL MICROBIOL, V13, P935, DOI 10.1128/AEM.13.6.935-938.1965; Guo S, 2007, MOL BIOL EVOL, V24, P1198, DOI 10.1093/molbev/msm038; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Juttner F, 2007, APPL ENVIRON MICROB, V73, P4395, DOI 10.1128/AEM.02250-06; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Knaden M, 2012, CELL REPORTS, V1, P392, DOI 10.1016/j.celrep.2012.03.002; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; MATTHEIS JP, 1992, APPL ENVIRON MICROB, V58, P3170, DOI 10.1128/AEM.58.9.3170-3172.1992; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Sargsyan V, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00005; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Seki Y, 2010, J NEUROPHYSIOL, V104, P1007, DOI 10.1152/jn.00249.2010; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stokl J, 2010, CURR BIOL, V20, P1846, DOI 10.1016/j.cub.2010.09.033; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tinbergen, 1951, STUDY INSTINCT; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; Yoshida T., 2000, Drosophila Information Service, V83, P18; Young WF, 1996, WATER RES, V30, P331, DOI 10.1016/0043-1354(95)00173-5	47	360	371	12	176	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1345	1357		10.1016/j.cell.2012.09.046	http://dx.doi.org/10.1016/j.cell.2012.09.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217715	Bronze			2022-12-24	WOS:000311999900022
J	Smith, RM; Schaefer, MK; Kainer, MA; Wise, M; Finks, J; Duwve, J; Fontaine, E; Chu, A; Carothers, B; Reilly, A; Fiedler, J; Wiese, AD; Feaster, C; Gibson, L; Griese, S; Purfield, A; Cleveland, AA; Benedict, K; Harris, JR; Brandt, ME; Blau, D; Jernigan, J; Weber, JT; Park, BJ				Smith, Rachel M.; Schaefer, Melissa K.; Kainer, Marion A.; Wise, Matthew; Finks, Jennie; Duwve, Joan; Fontaine, Elizabeth; Chu, Alvina; Carothers, Barbara; Reilly, Amy; Fiedler, Jay; Wiese, Andrew D.; Feaster, Christine; Gibson, Lex; Griese, Stephanie; Purfield, Anne; Cleveland, Angela A.; Benedict, Kaitlin; Harris, Julie R.; Brandt, Mary E.; Blau, Dianna; Jernigan, John; Weber, J. Todd; Park, Benjamin J.		Multistate Fungal Infection	Fungal Infections Associated with Contaminated Methylprednisolone Injections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACET JOINT INJECTION; LOW-BACK-PAIN; ASPERGILLUS MENINGITIS; CLADOSPORIUM-CLADOSPORIOIDES; CORTICOSTEROID INJECTION; MULTISTATE OUTBREAK; STEROID INJECTIONS; EPIDURAL ABSCESS; UNITED-STATES; SRI-LANKA	BackgroundFungal infections are rare complications of injections for treatment of chronic pain. In September 2012, we initiated an investigation into fungal infections associated with injections of preservative-free methylprednisolone acetate that was purchased from a single compounding pharmacy. MethodsThree lots of methylprednisolone acetate were recalled by the pharmacy; examination of unopened vials later revealed fungus. Notification of all persons potentially exposed to implicated methylprednisolone acetate was conducted by federal, state, and local public health officials and by staff at clinical facilities that administered the drug. We collected clinical data on standardized case-report forms, and we tested for the presence of fungi in isolates and specimens by examining cultures and performing polymerase-chain-reaction assays and histopathological and immunohistochemical testing. ResultsBy October 19, 2012, more than 99% of 13,534 potentially exposed persons had been contacted. As of July 1, 2013, there were 749 reported cases of infection in 20 states, with 61 deaths (8%). Laboratory evidence of Exserohilum rostratum was present in specimens from 153 case patients (20%). Additional data were available for 728 case patients (97%); 229 of these patients (31%) had meningitis with no other documented infection. Case patients had received a median of 1 injection (range, 1 to 6) of implicated methylprednisolone acetate. The median age of the patients was 64 years (range, 15 to 97), and the median incubation period (the number of days from the last injection to the date of the first diagnosis) was 47 days (range, 0 to 249); 40 patients (5%) had a stroke. ConclusionsAnalysis of data from a large, multistate outbreak of fungal infections showed substantial morbidity and mortality. The infections were associated with injection of a contaminated glucocorticoid medication from a single compounding pharmacy. Rapid public health actions included prompt recall of the implicated product, notification of exposed persons, and early outreach to clinicians.	[Smith, Rachel M.; Griese, Stephanie; Purfield, Anne] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Sci Educ & Profess Dev Program Off, Atlanta, GA USA; [Smith, Rachel M.; Purfield, Anne; Cleveland, Angela A.; Benedict, Kaitlin; Harris, Julie R.; Brandt, Mary E.; Park, Benjamin J.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30329 USA; [Schaefer, Melissa K.; Wise, Matthew; Jernigan, John; Weber, J. Todd] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA; [Blau, Dianna] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Kainer, Marion A.; Wiese, Andrew D.] Tennessee Dept Hlth, Nashville, TN USA; [Finks, Jennie; Fiedler, Jay] Bur Epidemiol, Michigan Dept Community Hlth, Lansing, MI USA; [Duwve, Joan; Feaster, Christine] Indiana State Dept Hlth, Indianapolis, IN 46202 USA; [Fontaine, Elizabeth; Gibson, Lex] Virginia Dept Hlth, Richmond, VA USA; [Chu, Alvina] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA; [Carothers, Barbara] New Jersey Dept Hlth, Trenton, NJ USA; [Reilly, Amy] Florida Dept Hlth, Tallahassee, FL USA; [Griese, Stephanie] North Carolina Div Publ Hlth, Raleigh, NC USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Tennessee Department Health; MDHHS - Michigan Department of Health & Human Services; Maryland Department of Health & Mental Hygiene; New Jersey Department of Health & Senior Services; Florida Department of Health	Park, BJ (corresponding author), Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30329 USA.	bpark1@cdc.gov	Cleveland, Angela Ahlquist/Q-2778-2019; Wiese, Andrew/D-2200-2019; Wiese, Andrew D/U-9745-2017	Cleveland, Angela Ahlquist/0000-0003-1375-8964; Wiese, Andrew/0000-0002-0699-4224; Wiese, Andrew D/0000-0002-0699-4224; Jernigan, John/0000-0001-8163-925X; Kainer, Marion/0000-0001-7678-8744				ADAM RD, 1986, MEDICINE, V65, P203, DOI 10.1097/00005792-198607000-00001; [Anonymous], 2012, ARCH UPD FUNG MEN; [Anonymous], 2012, CDC FDA JOINT TEL IN; Balajee SA, 2009, J CLIN MICROBIOL, V47, P3138, DOI 10.1128/JCM.01070-09; Centers for Disease Control and Prevention, 2012, MULT FUNG MEN OUTBR; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1109; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P310; Chew FLM, 2009, JPN J OPHTHALMOL, V53, P657, DOI 10.1007/s10384-009-0722-3; Civen R, 2006, CLIN INFECT DIS, V43, P831, DOI 10.1086/507336; Clinical and Laboratory Standards Institute, 2008, MM18A CLSI; Cooper AB, 1996, CAN J ANAESTH, V43, P471, DOI 10.1007/BF03018109; DOUER D, 1987, J MED VET MYCOL, V25, P235; Duquia RP, 2010, MYCOSES, V53, P541, DOI 10.1111/j.1439-0507.2009.01745.x; Gade L, 2013, EUKARYOT CELL, V12, P677, DOI 10.1128/EC.00046-13; Gaul C, 2005, PAIN, V116, P407, DOI 10.1016/j.pain.2005.05.032; GRAY RG, 1981, SEMIN ARTHRITIS RHEU, V10, P231, DOI 10.1016/0049-0172(81)90001-9; Gunaratne PS, 2007, NEW ENGL J MED, V356, P754, DOI 10.1056/NEJMc062547; Hoelzer BC, 2008, EUR J PAIN, V12, P261, DOI 10.1016/j.ejpain.2007.05.005; Hooten WM, 2004, MAYO CLIN PROC, V79, P682, DOI 10.4065/79.5.682; Kabbara Abdallah, 2004, Pain Physician, V7, P269; Kainer MA, 2012, NEW ENGL J MED, V367, P2194, DOI 10.1056/NEJMoa1212972; Kolbe ABL, 2007, ACTA RADIOL, V48, P687, DOI 10.1080/02841850701342153; Lalueza A, 2011, ENDOSCOPY, V43, pE9, DOI 10.1055/s-0030-1255804; Lockhart SR, J CLIN MICR IN PRESS; Main Street Family Pharmacy, 2013, LLC ISS VOL NAT REC; MCGINNIS MR, 1986, J CLIN MICROBIOL, V24, P250, DOI 10.1128/JCM.24.2.250-259.1986; Medprep Consulting Inc, 2013, ANN VOL NAT REC ALL; OSTENSSON A, 1991, BRIT J RHEUMATOL, V30, P35; Park MS, 2007, YONSEI MED J, V48, P711, DOI 10.3349/ymj.2007.48.4.711; Pettit AC, 2012, NEW ENGL J MED, V367, P2119, DOI 10.1056/NEJMoa1212292; Ritter JM, 2013, AM J PATHOL, V183, P881, DOI 10.1016/j.ajpath.2013.05.007; Rodrigo N, 2007, INT J OBSTET ANESTH, V16, P256, DOI 10.1016/j.ijoa.2006.06.010; Saigal G, 2004, AM J NEURORADIOL, V25, P642; Simopoulos Thomas T, 2008, Pain Physician, V11, P693; Smith RM, 2013, NEW ENGL J MED, V368, P2535, DOI 10.1056/NEJMc1306560; Staal JB, 2009, SPINE, V34, P49, DOI 10.1097/BRS.0b013e3181909558; Terr AI, 2001, ANN ALLERG ASTHMA IM, V87, P57, DOI 10.1016/S1081-1206(10)62343-5; Verweij PE, 1999, J CLIN MICROBIOL, V37, P1186, DOI 10.1128/JCM.37.4.1186-1189.1999; Viscoli C, 2002, J CLIN MICROBIOL, V40, P1496, DOI 10.1128/JCM.40.4.1496-1499.2002	39	128	132	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1598	1609		10.1056/NEJMoa1213978	http://dx.doi.org/10.1056/NEJMoa1213978			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239MZ	23252499				2022-12-24	WOS:000326031100009
J	Neuert, G; Munsky, B; Tan, RZ; Teytelman, L; Khammash, M; van Oudenaarden, A				Neuert, Gregor; Munsky, Brian; Tan, Rui Zhen; Teytelman, Leonid; Khammash, Mustafa; van Oudenaarden, Alexander			Systematic Identification of Signal-Activated Stochastic Gene Regulation	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; EXPRESSION; TRANSCRIPTION; FLUCTUATIONS; ADAPTATION; RECRUITMENT; DEPENDENCE; PATHWAY; NOISE	Although much has been done to elucidate the biochemistry of signal transduction and gene regulatory pathways, it remains difficult to understand or predict quantitative responses. We integrate single-cell experiments with stochastic analyses, to identify predictive models of transcriptional dynamics for the osmotic stress response pathway in Saccharomyces cerevisiae. We generate models with varying complexity and use parameter estimation and cross-validation analyses to select the most predictive model. This model yields insight into several dynamical features, including multistep regulation and switchlike activation for several osmosensitive genes. Furthermore, the model correctly predicts the transcriptional dynamics of cells in response to different environmental and genetic perturbations. Because our approach is general, it should facilitate a predictive understanding for signal-activated transcription of other genes in other pathways or organisms.	[Neuert, Gregor; Tan, Rui Zhen; Teytelman, Leonid; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Neuert, Gregor; Tan, Rui Zhen; Teytelman, Leonid; van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [Neuert, Gregor; Tan, Rui Zhen; Teytelman, Leonid; van Oudenaarden, Alexander] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Neuert, Gregor] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Munsky, Brian] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Munsky, Brian] Los Alamos Natl Lab, Informat Sci Grp, Los Alamos, NM 87545 USA; [Khammash, Mustafa] ETH Zuerich, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Tan, Rui Zhen] ASTAR, Bioinformat Inst, Singapore 138671, Singapore; [Tan, Rui Zhen] Harvard Univ, Sch Med, Harvard Univ Grad Biophys Program, Boston, MA 02115 USA; [Khammash, Mustafa] Univ Calif Santa Barbara, Ctr Control Dynam Syst & Computat, Santa Barbara, CA 93106 USA; [Khammash, Mustafa] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA; [van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [van Oudenaarden, Alexander] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Vanderbilt University; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Harvard University; Harvard Medical School; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	a.vanoudenaarden@hubrecht.eu	van Oudenaarden, Alexander/AAA-1705-2019; Teytelman, Lenny/AAX-2835-2021; Munsky, Brian/A-1947-2016	Teytelman, Lenny/0000-0001-8573-8351; Munsky, Brian/0000-0001-6147-7329	NSF [ECCS-0835847, ECCS-0835623]; Human Frontier Science Program [RGP0061/2011]; National Institutes of Health-National Cancer Institute Physical Sciences Oncology Center at Massachusetts Institute of Technology [U54CA143874]; NIH [1DP1OD003936]; Los Alamos National Laboratory-Laboratory Directed Research and Development; Deutsche Forschungsgemeinschaft (Forschungs Stipendium); A*STAR program, Singapore; NATIONAL CANCER INSTITUTE [U54CA143874, DP1CA174420] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Human Frontier Science Program(Human Frontier Science Program); National Institutes of Health-National Cancer Institute Physical Sciences Oncology Center at Massachusetts Institute of Technology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Los Alamos National Laboratory-Laboratory Directed Research and Development(United States Department of Energy (DOE)Los Alamos National Laboratory); Deutsche Forschungsgemeinschaft (Forschungs Stipendium)(German Research Foundation (DFG)); A*STAR program, Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the NSF (ECCS-0835847) and Human Frontier Science Program (RGP0061/2011) to M. K.; the NSF (ECCS-0835623), National Institutes of Health-National Cancer Institute Physical Sciences Oncology Center at Massachusetts Institute of Technology (U54CA143874), and an NIH Pioneer award (1DP1OD003936) to A.v.O.; Los Alamos National Laboratory-Laboratory Directed Research and Development to B. M.; the Deutsche Forschungsgemeinschaft (Forschungs Stipendium) to G.N.; and the A*STAR program, Singapore, to R.Z.T. We thank F. van Werven for the yeast crosses and N. Hengartner, B. Pando, S. Klemm, J. van Zon, and M. Wall for discussions on the model. We also thank M. Bienko, N. Crosetto, C. Engert, S. Itzkovitz, J. P. Junker, S. Klemm, S. Semrau, J. van Zon, and H. Youk for comments on the manuscript.	Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Bumgarner SL, 2012, MOL CELL, V45, P470, DOI 10.1016/j.molcel.2011.11.029; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Ferreira C, 2005, MOL BIOL CELL, V16, P2068, DOI 10.1091/mbc.E04-10-0884; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; KO MSH, 1990, EMBO J, V9, P2835, DOI 10.1002/j.1460-2075.1990.tb07472.x; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Munsky B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145882; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Munsky B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.75; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Pelet S, 2011, SCIENCE, V332, P732, DOI 10.1126/science.1198851; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Zechner C, 2012, P NATL ACAD SCI USA, V109, P8340, DOI 10.1073/pnas.1200161109	26	168	168	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					584	587		10.1126/science.1231456	http://dx.doi.org/10.1126/science.1231456			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372015	Green Accepted			2022-12-24	WOS:000314270000060
J	Chaudhury, D; Walsh, JJ; Friedman, AK; Juarez, B; Ku, SM; Koo, JW; Ferguson, D; Tsai, HC; Pomeranz, L; Christoffel, DJ; Nectow, AR; Ekstrand, M; Domingos, A; Mazei-Robison, MS; Mouzon, E; Lobo, MK; Neve, RL; Friedman, JM; Russo, SJ; Deisseroth, K; Nestler, EJ; Han, MH				Chaudhury, Dipesh; Walsh, Jessica J.; Friedman, Allyson K.; Juarez, Barbara; Ku, Stacy M.; Koo, Ja Wook; Ferguson, Deveroux; Tsai, Hsing-Chen; Pomeranz, Lisa; Christoffel, Daniel J.; Nectow, Alexander R.; Ekstrand, Mats; Domingos, Ana; Mazei-Robison, Michelle S.; Mouzon, Ezekiell; Lobo, Mary Kay; Neve, Rachael L.; Friedman, Jeffrey M.; Russo, Scott J.; Deisseroth, Karl; Nestler, Eric J.; Han, Ming-Hu			Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons	NATURE			English	Article							VENTRAL TEGMENTAL AREA; SOCIAL DEFEAT STRESS; ANTIDEPRESSANT ACTION; REWARD CIRCUIT; IN-VIVO; SUSCEPTIBILITY; STIMULATION; INHIBITION; EXPRESSION; RESPONSES	Ventral tegmental area(VTA) dopamine neurons in the brain's reward circuit have a crucial role in mediating stress responses(1-4), including determining susceptibility versus resilience to social-stress-induced behavioural abnormalities(5). VTA dopamine neurons show two in vivo patterns of firing: low frequency tonic firing and high frequency phasic firing(6-8). Phasic firing of the neurons, which is well known to encode reward signals(6,7,9), is upregulated by repeated social-defeat stress, a highly validated mouse model of depression(5,8,10-13). Surprisingly, this pathophysiological effect is seen in susceptible mice only, with no apparent change in firing rate in resilient individuals(5,8). However, direct evidence-in real time-linking dopamine neuron phasic firing in promoting the susceptible (depression-like) phenotype is lacking. Here we took advantage of the temporal precision and cell-type and projection-pathway specificity of optogenetics to show that enhanced phasic firing of these neurons mediates susceptibility to social-defeat stress in freely behaving mice. We show that optogenetic induction of phasic, but not tonic, firing in VTA dopamine neurons of mice undergoing a subthreshold social-defeat paradigm rapidly induced a susceptible phenotype as measured by social avoidance and decreased sucrose preference. Optogenetic phasic stimulation of these neurons also quickly induced a susceptible phenotype in previously resilient mice that had been subjected to repeated social-defeat stress. Furthermore, we show differences in projection-pathway specificity in promoting stress susceptibility: phasic activation of VTA neurons projecting to the nucleus accumbens (NAc), but not to the medial prefrontal cortex (mPFC), induced susceptibility to social-defeat stress. Conversely, optogenetic inhibition of the VTA-NAc projection induced resilience, whereas inhibition of the VTA-mPFC projection promoted susceptibility. Overall, these studies reveal novel firing-pattern-and neural-circuit-specific mechanisms of depression.	[Chaudhury, Dipesh; Walsh, Jessica J.; Friedman, Allyson K.; Juarez, Barbara; Ku, Stacy M.; Nestler, Eric J.; Han, Ming-Hu] Mt Sinai Sch Med, Friedman Brain Inst, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Walsh, Jessica J.; Juarez, Barbara; Ku, Stacy M.; Koo, Ja Wook; Ferguson, Deveroux; Christoffel, Daniel J.; Mazei-Robison, Michelle S.; Mouzon, Ezekiell; Lobo, Mary Kay; Russo, Scott J.; Nestler, Eric J.; Han, Ming-Hu] Mt Sinai Sch Med, Friedman Brain Inst, Fishberg Dept Neurosci, New York, NY 10029 USA; [Tsai, Hsing-Chen; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Tsai, Hsing-Chen; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Pomeranz, Lisa; Nectow, Alexander R.; Ekstrand, Mats; Domingos, Ana; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10056 USA; [Neve, Rachael L.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Stanford University; Stanford University; Howard Hughes Medical Institute; Rockefeller University; Massachusetts Institute of Technology (MIT)	Han, MH (corresponding author), Mt Sinai Sch Med, Friedman Brain Inst, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	ming-hu.han@mssm.edu	Mazei-Robison, Michelle/I-4304-2017; Lobo, Mary Kay/K-7734-2015; Han, Ming-Hu/G-8836-2012; Russo, Scott/R-7107-2019; Core, Vector/CAF-4832-2022	Mazei-Robison, Michelle/0000-0002-2372-1420; Lobo, Mary Kay/0000-0002-9419-2079; Russo, Scott/0000-0002-6470-1805; Walsh, Jessica/0000-0001-8466-8451; Domingos, Ana/0000-0002-7938-4814; Juarez, Barbara/0000-0001-7897-8031; Ferguson, Deveroux/0000-0001-9302-5992; Christoffel, Dan/0000-0002-6303-5134; Ekstrand, Mats/0000-0003-0019-9462; Pomeranz, Lisa/0000-0002-8117-7355; Friedman, Allyson/0000-0002-8190-3011	National Institute of Mental Health [R01 MH092306]; Johnson & Johnson IMHRO Rising Star Translational Research Award; National Research Service Awards [F31 MH095425, F32 MH096464]; Mount Sinai PREP [R25 GM064118]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM064118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH096678, K99MH094405, T32MH020016, T32MH087004, P50MH096890, R01MH092306, F32MH096464, F31MH095425, F31MH108326] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Johnson & Johnson IMHRO Rising Star Translational Research Award; National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mount Sinai PREP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (R01 MH092306 to D. C. and M. H. H.), Johnson & Johnson IMHRO Rising Star Translational Research Award (M. H. H.), the National Research Service Awards (F31 MH095425 to J.J.W. and F32 MH096464 to A. K. F) and the Mount Sinai PREP R25 GM064118 (B.J.). We would like to thank K. Roy for help with some of the schematics in the figures, and we thank R. Cachope and J. Cheer for help with chronic fibre implantation techniques.	Anstrom KK, 2009, NEUROSCIENCE, V161, P3, DOI 10.1016/j.neuroscience.2009.03.023; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Giacobbe P, 2009, EXP NEUROL, V219, P44, DOI 10.1016/j.expneurol.2009.04.028; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Han H. M., 2011, 50 ANN M ACNP; Hemmeter UM, 2010, EXPERT REV NEUROTHER, V10, P1101, DOI [10.1586/ern.10.83, 10.1586/ERN.10.83]; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Iniguez SD, 2010, J NEUROSCI, V30, P7652, DOI 10.1523/JNEUROSCI.0951-10.2010; Inyushin MU, 2010, NEUROSCIENCE, V167, P287, DOI 10.1016/j.neuroscience.2010.01.052; Krishnan V, 2008, AM J PSYCHIAT, V165, P1109, DOI 10.1176/appi.ajp.2008.08071076; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Radulescu AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012695; Razzoli M, 2011, BEHAV BRAIN RES, V218, P253, DOI 10.1016/j.bbr.2010.11.050; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Valenti O, 2012, EUR J NEUROSCI, V35, P1312, DOI 10.1111/j.1460-9568.2012.08038.x; Venzala E., 2012, EUR NEUROPSYCHOPHARM, DOI 10.1016/jeuroneuro.2012.05.010; Willner P, 2005, J AFFECT DISORDERS, V86, P37, DOI 10.1016/j.jad.2004.12.010; Willner P, 1997, INT CLIN PSYCHOPHARM, V12, pS7, DOI 10.1097/00004850-199707003-00002; Yadid G, 2008, PROG BRAIN RES, V172, P265, DOI 10.1016/S0079-6123(08)00913-8	37	693	712	19	421	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					532	+		10.1038/nature11713	http://dx.doi.org/10.1038/nature11713			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23235832	Green Accepted			2022-12-24	WOS:000313871400038
J	DuBois, RM; Vaney, MC; Tortorici, MA; Al Kurdi, R; Barba-Spaeth, G; Krey, T; Rey, FA				DuBois, Rebecca M.; Vaney, Marie-Christine; Tortorici, M. Alejandra; Al Kurdi, Rana; Barba-Spaeth, Giovanna; Krey, Thomas; Rey, Felix A.			Functional and evolutionary insight from the crystal structure of rubella virus protein E1	NATURE			English	Article							BORNE ENCEPHALITIS-VIRUS; ENVELOPE PROTEIN; FUSION PROTEIN; GLYCOPROTEIN; RECEPTOR; RESPONSES; SURFACE; DOMAIN; ENTRY; FORM	Little is known about the three-dimensional organization of rubella virus, which causes a relatively mild measles-like disease in children but leads to serious congenital health problems when contracted in utero(1). Although rubella virus belongs to the same family as the mosquito-borne alphaviruses, in many respects it is more similar to other aerosol-transmitted human viruses such as the agents of measles and mumps. Although the use of the triple MMR (measles, mumps and rubella) live vaccine has limited its incidence in western countries, congenital rubella syndrome remains an important health problem in the developing world. Here we report the 1.8 angstrom resolution crystal structure of envelope glycoprotein E1, the main antigen and sole target of neutralizing antibodies against rubella virus. E1 is the main player during entry into target cells owing to its receptor-binding and membrane-fusion functions. The structure reveals the epitope and the neutralization mechanism of an important category of protecting antibodies against rubella infection. It also shows that rubella virus E1 is a class II fusion protein, which had hitherto only been structurally characterized for the arthropod-borne alphaviruses and flaviviruses. In addition, rubella virus E1 has an extensive membrane-fusion surface that includes a metal site, reminiscent of the T-cell immunoglobulin and mucin family of cellular proteins that bind phosphatidylserine lipids at the plasma membrane of cells undergoing apoptosis. Such features have not been seen in any fusion protein crystallized so far. Structural comparisons show that the class II fusion proteins from alphaviruses and flaviviruses, despite belonging to different virus families, are closer to each other than they are to rubella virus E1. This suggests that the constraints on arboviruses imposed by alternating cycles between vertebrates and arthropods resulted in more conservative evolution. By contrast, in the absence of this constraint, the strictly human rubella virus seems to have drifted considerably into a unique niche as sole member of the Rubivirus genus.	[DuBois, Rebecca M.; Vaney, Marie-Christine; Tortorici, M. Alejandra; Al Kurdi, Rana; Barba-Spaeth, Giovanna; Krey, Thomas; Rey, Felix A.] Inst Pasteur, Dept Virol, Unite Virol Struct, F-75724 Paris 15, France; [DuBois, Rebecca M.; Vaney, Marie-Christine; Tortorici, M. Alejandra; Al Kurdi, Rana; Barba-Spaeth, Giovanna; Krey, Thomas; Rey, Felix A.] CNRS, URA 3015, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Rey, FA (corresponding author), Inst Pasteur, Dept Virol, Unite Virol Struct, F-75724 Paris 15, France.	rey@pasteur.fr		DuBois, Rebecca/0000-0003-4185-5673; Barba Spaeth, Giovanna/0000-0003-2069-9501; Rey, Felix/0000-0002-9953-7988; Tortorici, M. Alejandra/0000-0002-2260-2577	'Pasteur-Howard' fellowship; Merck-Serono from the French Government [ANR-10-LABX-62-IBEID];  [ANR-05-MIIM-012-02-Dentry]	'Pasteur-Howard' fellowship; Merck-Serono from the French Government; 	We thank A. Haouz of Institut Pasteur and the PXI beam line staff at the Swiss Light Source and PROXIMA 1 beam line at SOLEIL synchrotron facilities for assistance; C. Vonrhein at Global Phasing for expertise in phase determination; G. Bricogne for input, G. Dupras and J.M. Mallet at Ecole Normale Superieure in Paris for the synthesis of galactose-3-sulphate used in co-crystallization trials; and J. Casasnovas, L. Chernomordik, Y. Gaudin, S. Harrison, F. Heinz, M. Kielian and J. Lepault for discussion. R. M. D. was supported by a 'Pasteur-Howard' fellowship. This work was mainly funded by grant ANR-05-MIIM-012-02-Dentry to F. A. R., who also acknowledges support from Merck-Serono from the French Government's Investissements d'Avenir program: Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' (grant no. ANR-10-LABX-62-IBEID).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Backovic M, 2009, P NATL ACAD SCI USA, V106, P2880, DOI 10.1073/pnas.0810530106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battisti AJ, 2012, J VIROL, V86, P11078, DOI 10.1128/JVI.01390-12; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G, 2009, BUSTER VERSION 2 8 0; Castile JD, 1999, INT J PHARM, V188, P87, DOI 10.1016/S0378-5173(99)00207-0; Cong HL, 2011, J VIROL, V85, P11038, DOI 10.1128/JVI.05398-11; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gibbons DL, 2003, CELL, V114, P573, DOI 10.1016/S0092-8674(03)00683-4; Goldstein D. A., 1990, CLIN METHODS HIST PH, P677; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Hobman T., 2007, FIELDS VIROLOGY, P1069; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadlec J, 2008, NAT STRUCT MOL BIOL, V15, P1024, DOI 10.1038/nsmb.1484; KATOW S, 1988, J GEN VIROL, V69, P2797, DOI 10.1099/0022-1317-69-11-2797; KATOW S, 1985, J CLIN MICROBIOL, V21, P449, DOI 10.1128/JCM.21.3.449-451.1985; Kee SH, 2004, MICROBIOL IMMUNOL, V48, P823, DOI 10.1111/j.1348-0421.2004.tb03614.x; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; MASTROMARINO P, 1990, MED MICROBIOL IMMUN, V179, P105; MITCHELL LA, 1992, J CLIN MICROBIOL, V30, P1841, DOI 10.1128/JCM.30.7.1841-1847.1992; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08; Petruzziello R, 1996, J GEN VIROL, V77, P303, DOI 10.1099/0022-1317-77-2-303; Qiu ZY, 2000, J VIROL, V74, P6637, DOI 10.1128/JVI.74.14.6637-6642.2000; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014; Santiago C, 2007, IMMUNITY, V26, P299, DOI 10.1016/j.immuni.2007.01.014; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Stiasny K, 2004, J VIROL, V78, P3178, DOI 10.1128/JVI.78.6.3178-3183.2004; Stiasny K, 2002, J VIROL, V76, P3784, DOI 10.1128/JVI.76.8.3784-3790.2002; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; WOLINSKY JS, 1993, J VIROL, V67, P961, DOI 10.1128/JVI.67.2.961-968.1993	41	71	78	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					552	+		10.1038/nature11741	http://dx.doi.org/10.1038/nature11741			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23292515				2022-12-24	WOS:000313871400042
J	Pereira, HM; Ferrier, S; Walters, M; Geller, GN; Jongman, RHG; Scholes, RJ; Bruford, MW; Brummitt, N; Butchart, SHM; Cardoso, AC; Coops, NC; Dulloo, E; Faith, DP; Freyhof, J; Gregory, RD; Heip, C; Hoft, R; Hurtt, G; Jetz, W; Karp, DS; McGeoch, MA; Obura, D; Onoda, Y; Pettorelli, N; Reyers, B; Sayre, R; Scharlemann, JPW; Stuart, SN; Turak, E; Walpole, M; Wegmann, M				Pereira, H. M.; Ferrier, S.; Walters, M.; Geller, G. N.; Jongman, R. H. G.; Scholes, R. J.; Bruford, M. W.; Brummitt, N.; Butchart, S. H. M.; Cardoso, A. C.; Coops, N. C.; Dulloo, E.; Faith, D. P.; Freyhof, J.; Gregory, R. D.; Heip, C.; Hoeft, R.; Hurtt, G.; Jetz, W.; Karp, D. S.; McGeoch, M. A.; Obura, D.; Onoda, Y.; Pettorelli, N.; Reyers, B.; Sayre, R.; Scharlemann, J. P. W.; Stuart, S. N.; Turak, E.; Walpole, M.; Wegmann, M.			Essential Biodiversity Variables	SCIENCE			English	Editorial Material							GLOBAL BIODIVERSITY; INDICATORS; SYSTEM; MAP		[Pereira, H. M.] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal; [Geller, G. N.] CALTECH, Jet Prop Lab, Pasadena, CA 91125 USA; [Jongman, R. H. G.] Alterra, Wageningen Ur, Netherlands; [Bruford, M. W.] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Coops, N. C.] Univ British Columbia, Dept Forest Resource Management, Vancouver, BC V5Z 1M9, Canada; [Faith, D. P.] Australian Museum, Sydney, NSW 2000, Australia; [Hurtt, G.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Jetz, W.] Yale Univ, New Haven, CT 06520 USA; [Karp, D. S.] Stanford Univ, Ctr Conservat Biol, Stanford, CA 94305 USA; [McGeoch, M. A.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Onoda, Y.] Kyoto Univ, Grad Sch Agr, Kyoto 6068501, Japan; [Pettorelli, N.] Zool Soc London, Inst Zool, London, England; [Sayre, R.] US Geol Survey, Washington, DC USA; [Scharlemann, J. P. W.] Univ Sussex, Sch Life Sci, Brighton BN1 9RH, E Sussex, England; [Turak, E.] Off Environm & Heritage, Sydney, NSW, Australia; [Wegmann, M.] Univ Wurzburg, Dept Geog & Geol, Wurzburg, Germany	Universidade de Lisboa; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Wageningen University & Research; Cardiff University; University of British Columbia; Australian Museum; University System of Maryland; University of Maryland College Park; Yale University; Stanford University; Monash University; Kyoto University; Zoological Society of London; United States Department of the Interior; United States Geological Survey; University of Sussex; Office of Environment & Heritage - New South Wales; University of Wurzburg	Pereira, HM (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal.	hpereira@fc.ul.pt	Butchart, Stuart HM/Y-2711-2018; Bruford, Michael W/D-3750-2009; Pereira, Henrique/B-3975-2009; Walters, Michele/AAH-2327-2019; Reyers, Belinda/AAF-6225-2019; Ferrier, Simon/C-1490-2009; Hurtt, George/A-8450-2012; Jetz, Walter/ABF-1517-2020; Butchart, Stuart/AAJ-1852-2021; Bruford, Michael/Y-7463-2019; Scharlemann, Jorn/A-4737-2008; Pettorelli, Nathalie/AAW-8438-2021; Coops, Nicholas C/J-1543-2012; Coops, Nicholas/L-3652-2019; McGeoch, Melodie A/F-8353-2011; Onoda, Yusuke/L-7179-2015	Bruford, Michael W/0000-0001-6357-6080; Pereira, Henrique/0000-0003-1043-1675; Reyers, Belinda/0000-0002-2194-8656; Ferrier, Simon/0000-0001-7884-2388; Hurtt, George/0000-0001-7278-202X; Butchart, Stuart/0000-0002-1140-4049; Bruford, Michael/0000-0001-6357-6080; Scharlemann, Jorn/0000-0002-2834-6367; Coops, Nicholas C/0000-0002-0151-9037; Coops, Nicholas/0000-0002-0151-9037; McGeoch, Melodie A/0000-0003-3388-2241; Onoda, Yusuke/0000-0001-6245-2342; Wegmann, Martin/0000-0003-0335-9601; Walters, Michele/0000-0001-8302-3408; Gregory, Richard/0000-0002-7419-5053; Turak, Eren/0000-0001-7383-9112; Scholes, Robert/0000-0001-5537-6935; Obura, David/0000-0003-2256-6649; Geller, Gary/0000-0002-4490-6002; Jetz, Walter/0000-0002-1971-7277				Bubb P., 2011, NATL INDICATORS MONI; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; CBD, 2010, DEC X 2 STRAT PLAN B; Feld CK, 2009, OIKOS, V118, P1862, DOI 10.1111/j.1600-0706.2009.17860.x; Ferrier S, 2011, BIOSCIENCE, V61, P96, DOI 10.1525/bio.2011.61.2.2; GCOS, 2010, IMPL PLAN GLOB OBS S, P180; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Guralnick RP, 2007, ECOL LETT, V10, P663, DOI 10.1111/j.1461-0248.2007.01063.x; IOC, 2011, FRAM OC OBS IN PRESS, V7, P26; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Martin LJ, 2012, FRONT ECOL ENVIRON, V10, P195, DOI 10.1890/110154; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pereira HM, 2012, ANNU REV ENV RESOUR, V37, P25, DOI 10.1146/annurev-environ-042911-093511; Scholes RJ, 2012, CURR OPIN ENV SUST, V4, P139, DOI 10.1016/j.cosust.2011.12.005; Secretariat of the CBD, 2011, REP AD HOC TECHN EXP; Tallis H, 2012, BIOSCIENCE, V62, P977, DOI 10.1525/bio.2012.62.11.7; Turner DP, 2011, FRONT ECOL ENVIRON, V9, P111, DOI 10.1890/090171; Wilson EO, 2000, SCIENCE, V289, P2279	19	821	858	26	681	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2013	339	6117					277	278		10.1126/science.1229931	http://dx.doi.org/10.1126/science.1229931			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071UW	23329036	Green Submitted			2022-12-24	WOS:000313622000029
J	Li, XC; Dang, SY; Yan, CY; Gong, XQ; Wang, JW; Shi, YG				Li, Xiaochun; Dang, Shangyu; Yan, Chuangye; Gong, Xinqi; Wang, Jiawei; Shi, Yigong			Structure of a presenilin family intramembrane aspartate protease	NATURE			English	Article							GAMMA-SECRETASE REVEALS; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; CATALYTIC PORE; TRANSMEMBRANE DOMAIN-4; COMPLEX; PROTEOLYSIS; BINDING; PEN-2; MODEL	Presenilin and signal peptide peptidase (SPP) are intramembrane aspartyl proteases that regulate important biological functions in eukaryotes. Mechanistic understanding of presenilin and SPP has been hamperedby lack of relevant structural information. Here we report the crystal structure of a presenilin/SPP homologue (PSH) from the archaeon Methanoculleus marisnigri JR1. The protease, comprising nine transmembrane segments (TMs), adopts a previously unreported protein fold. The amino-terminal domain, consisting of TM1-6, forms a horseshoe-shaped structure, surrounding TM7-9 of the carboxy-terminal domain. The two catalytic aspartate residues are located on the cytoplasmic side of TM6 and TM7, spatially close to each other and approximately 8 angstrom into the lipid membrane surface. Water molecules gain constant access to the catalytic aspartates through a large cavity between the amino-and carboxy-terminal domains. Structural analysis reveals insights into the presenilin/SPP family of intramembrane proteases.	[Li, Xiaochun; Dang, Shangyu; Yan, Chuangye; Gong, Xinqi; Shi, Yigong] Tsinghua Univ, Minist Educ, Key Lab Prot Sci, Sch Life Sci,Ctr Struct Biol, Beijing 100084, Peoples R China; [Li, Xiaochun; Dang, Shangyu; Yan, Chuangye; Gong, Xinqi; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Li, Xiaochun; Dang, Shangyu; Yan, Chuangye; Gong, Xinqi; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Wang, Jiawei] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Minist Educ, Key Lab Prot Sci, Sch Life Sci,Ctr Struct Biol, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021; Wang, Jiawei/D-1144-2010	Wang, Jiawei/0000-0001-9893-8539; Li, Xiaochun/0000-0002-0177-0803; Shi, Yigong/0000-0003-2030-168X; Yan, Chuangye/0000-0001-9338-8048; Dang, Shangyu/0000-0001-9141-1865	Ministry of Science and Technology [2009CB918801]; National Natural Science Foundation of China [30888001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank J. He and Q. Wang at Shanghai Synchrotron Radiation Facility beamline BL17U and K. Hasegawa and T. Kumasaka at the SPring-8 beamline BL41XU for assistance. This work was supported by funds from the Ministry of Science and Technology (grant number 2009CB918801), and National Natural Science Foundation of China project 30888001.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Cervantes S, 2004, J BIOL CHEM, V279, P36519, DOI 10.1074/jbc.M404832200; Chiang PM, 2012, NEUROBIOL AGING, V33, P277, DOI 10.1016/j.neurobiolaging.2009.12.028; COOPER JB, 1990, J MOL BIOL, V214, P199, DOI 10.1016/0022-2836(90)90156-G; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2012, ACTA CRYSTALLOGR D, V68, P328, DOI 10.1107/S0907444911039655; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Evin G, 2005, BIOCHEMISTRY-US, V44, P4332, DOI 10.1021/bi0481702; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu J, 2011, NATURE, V475, P528, DOI 10.1038/nature10218; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyashita H, 2011, J BIOL CHEM, V286, P26188, DOI 10.1074/jbc.M111.260273; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Torres-Arancivia C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013072; Urban S, 2009, NAT REV MICROBIOL, V7, P411, DOI 10.1038/nrmicro2130; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179	60	158	160	2	200	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					56	+		10.1038/nature11801	http://dx.doi.org/10.1038/nature11801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23254940				2022-12-24	WOS:000312933800029
J	Mick, DU; Dennerlein, S; Wiese, H; Reinhold, R; Pacheu-Grau, D; Lorenzi, I; Sasarman, F; Weraarpachai, W; Shoubridge, EA; Warscheid, B; Rehling, P				Mick, David U.; Dennerlein, Sven; Wiese, Heike; Reinhold, Robert; Pacheu-Grau, David; Lorenzi, Isotta; Sasarman, Florin; Weraarpachai, Woranontee; Shoubridge, Eric A.; Warscheid, Bettina; Rehling, Peter			MITRAC Links Mitochondrial Protein Translocation to Respiratory-Chain Assembly and Translational Regulation	CELL			English	Article							CYTOCHROME-C-OXIDASE; F1F0-ATP SYNTHASE; COX I; COMPLEX; YEAST; SUPERCOMPLEX; BIOGENESIS; DEFICIENCY; EXPRESSION; MUTATIONS	Mitochondrial respiratory-chain complexes assemble from subunits of dual genetic origin assisted by specialized assembly factors. Whereas core subunits are translated on mitochondrial ribosomes, others are imported after cytosolic translation. How imported subunits are ushered to assembly intermediates containing mitochondria-encoded subunits is unresolved. Here, we report a comprehensive dissection of early cytochrome c oxidase assembly intermediates containing proteins required for normal mitochondrial translation and reveal assembly factors promoting biogenesis of human respiratory-chain complexes. We find that TIM21, a subunit of the inner-membrane presequence translocase, is also present in the major assembly intermediates containing newly mitochondria-synthesized and imported respiratory-chain subunits, which we term MITRAC complexes. Human TIM21 is dispensable for protein import but required for integration of early-assembling, presequence-containing subunits into respiratory-chain intermediates. We establish an unexpected molecular link between the TIM23 transport machinery and assembly of respiratory-chain complexes that regulate mitochondrial protein synthesis in response to their assembly state.	[Mick, David U.; Dennerlein, Sven; Reinhold, Robert; Pacheu-Grau, David; Lorenzi, Isotta; Rehling, Peter] Univ Gottingen, Dept Biochem 2, D-37073 Gottingen, Germany; [Wiese, Heike; Warscheid, Bettina] Univ Freiburg, Fac Biol, Inst Biol 2, D-79104 Freiburg, Germany; [Sasarman, Florin; Weraarpachai, Woranontee; Shoubridge, Eric A.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada; [Sasarman, Florin; Weraarpachai, Woranontee; Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Rehling, Peter] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	University of Gottingen; University of Freiburg; McGill University; McGill University; Max Planck Society	Rehling, P (corresponding author), Univ Gottingen, Dept Biochem 2, D-37073 Gottingen, Germany.	peter.rehling@medizin.uni-goettingen.de	Pacheu-Grau, David/A-9074-2017; Mick, David/AAW-3726-2021	Pacheu-Grau, David/0000-0003-2645-3983; Mick, David/0000-0003-1427-9412; Warscheid, Bettina/0000-0001-5096-1975; Wiese, Heike/0000-0002-8941-3762	Deutsche Forschungsgemeinschaft [SFB860]; Excellence Initiative of the German Federal Government [EXC 294 BIOSS]; Excellence Initiative of the German State, Government [EXC 294 BIOSS]; CIHR; Max-Planck-Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State, Government; CIHR(Canadian Institutes of Health Research (CIHR)); Max-Planck-Society(Max Planck Society)	We thank C. Schulz, M. Deckers, and B. Schrul for helpful discussion; J. Melin for critical reading of the manuscript; D. Gorlich for his support; and M. Balleininger, M. Wissel, B. Knapp, and K. Lobenwein for technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft, SFB860, Excellence Initiative of the German Federal & State, Governments (EXC 294 BIOSS) (B.W.), operating grant from the CIHR (E.A.S.), and the Max-Planck-Society (P.R.). E.A.S. is an HHMI international scholar.	Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Lazarou M, 2009, FEBS J, V276, P6701, DOI 10.1111/j.1742-4658.2009.07384.x; Mashkevich G, 1997, J BIOL CHEM, V272, P14356, DOI 10.1074/jbc.272.22.14356; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Peralta S, 2012, J BIOL CHEM, V287, P24174, DOI 10.1074/jbc.M112.343764; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Reinhold R, 2011, HUM MOL GENET, V20, P2379, DOI 10.1093/hmg/ddr145; Saddar S, 2008, J BIOL CHEM, V283, P6677, DOI 10.1074/jbc.M708440200; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Szklarczyk R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r12; Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wagner K, 2009, J MOL BIOL, V392, P855, DOI 10.1016/j.jmb.2009.07.059; Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	32	148	157	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1528	1541		10.1016/j.cell.2012.11.053	http://dx.doi.org/10.1016/j.cell.2012.11.053			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260140	Bronze, Green Submitted			2022-12-24	WOS:000312890300017
J	Latos, PA; Pauler, FM; Koerner, MV; Senergin, HB; Hudson, QJ; Stocsits, RR; Allhoff, W; Stricker, SH; Klement, RM; Warczok, KE; Aumayr, K; Pasierbek, P; Barlow, DP				Latos, Paulina A.; Pauler, Florian M.; Koerner, Martha V.; Senergin, H. Basak; Hudson, Quanah J.; Stocsits, Roman R.; Allhoff, Wolfgang; Stricker, Stefan H.; Klement, Ruth M.; Warczok, Katarzyna E.; Aumayr, Karin; Pasierbek, Pawel; Barlow, Denise P.			Airn Transcriptional Overlap, But Not Its lncRNA Products, Induces Imprinted Igf2r Silencing	SCIENCE			English	Article							RNA; EXPRESSION; GROWTH	Mammalian imprinted genes often cluster with long noncoding (lnc) RNAs. Three lncRNAs that induce parental-specific silencing show hallmarks indicating that their transcription is more important than their product. To test whether Airn transcription or product silences the Igf2r gene, we shortened the endogenous lncRNA to different lengths. The results excluded a role for spliced and unspliced Airn lncRNA products and for Airn nuclear size and location in silencing Igf2r. Instead, silencing only required Airn transcriptional overlap of the Igf2r promoter, which interferes with RNA polymerase II recruitment in the absence of repressive chromatin. Such a repressor function for lncRNA transcriptional overlap reveals a gene silencing mechanism that may be widespread in the mammalian genome, given the abundance of lncRNA transcripts.	[Latos, Paulina A.; Pauler, Florian M.; Koerner, Martha V.; Senergin, H. Basak; Hudson, Quanah J.; Allhoff, Wolfgang; Stricker, Stefan H.; Klement, Ruth M.; Warczok, Katarzyna E.; Barlow, Denise P.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Stocsits, Roman R.; Aumayr, Karin] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Pasierbek, Pawel] Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Pauler, FM (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Lazarettgasse 14, A-1090 Vienna, Austria.	fpauler@cemm.oeaw.ac.at; dbarlow@cemm.oeaw.ac.at	Hudson, Quanah/I-9837-2014; Stricker, Stefan H/A-4930-2015; Stricker, Stefan/A-7410-2013	Hudson, Quanah/0000-0002-3407-4388; Stricker, Stefan H/0000-0002-5488-8530; 	Austrian Science Fund FWF [F4302-B09, W1207-B09]; Genome Research in Austria [GEN-AU 820980]	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Genome Research in Austria	We thank E. F. Wagner and A. Wutz for the R2 Delta and D3 ES cell lines, and G. Superti-Furga, C. Bock, and A. P. Bird for comments on the manuscript. Array data (GSE41444) are available at www.ncbi.nlm.nih.gov/geo. Supported by grants from Austrian Science Fund FWF (F4302-B09 and W1207-B09) and Genome Research in Austria (GEN-AU 820980).	Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Hudson QJ, 2011, DEV BIOL, V353, P420, DOI 10.1016/j.ydbio.2011.02.017; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Kowalczyk MS, 2012, NATURE, V482, P310, DOI 10.1038/482310a; Latos PA, 2009, DEVELOPMENT, V136, P437, DOI 10.1242/dev.032060; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palmer AC, 2011, TRANSCR-AUSTIN, V2, P9, DOI 10.4161/trns.2.1.13511; Regha K, 2007, MOL CELL, V27, P353, DOI 10.1016/j.molcel.2007.06.024; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sleutels F, 2003, EMBO J, V22, P3696, DOI 10.1093/emboj/cdg341; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Williamson CM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001347; Wutz A, 2001, DEVELOPMENT, V128, P1881; Yamasaki Y, 2005, HUM MOL GENET, V14, P2511, DOI 10.1093/hmg/ddi255	19	332	344	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1469	1472		10.1126/science.1228110	http://dx.doi.org/10.1126/science.1228110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239737				2022-12-24	WOS:000312250800048
J	Arnon, TI; Horton, RM; Grigorova, IL; Cyster, JG				Arnon, Tal I.; Horton, Robert M.; Grigorova, Irina L.; Cyster, Jason G.			Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress	NATURE			English	Article							IMMUNE-COMPLEXES; LYMPHOCYTES; ANTIGEN; ABSENCE; ACTIVATION; EXPRESSION; RETENTION; TRANSPORT; SELECTION; CD19	The splenic marginal zone is a unique microenvironment where resident immune cells are exposed to the open blood circulation(1,2). Even though it has an important role in responses against bloodborne antigens, lymphocyte migration in the marginal zone has not been intravitally visualized due to challenges associated with achieving adequate imaging depth in this abdominal organ. Here we develop a two-photon microscopy procedure to study marginal zone and follicular B-cell movement in the live mouse spleen. We show that marginal zone B cells are highly motile and exhibit long membrane extensions. Marginal zone B cells shuttle between the marginal zone and follicles with at least one-fifth of the cells exchanging between compartments per hour, a behaviour that explains their ability to deliver antigens rapidly from the open blood circulation to the secluded follicles. Follicular B cells also transit from follicles to the marginal zone, but unlike marginal zone B cells, they fail to undergo integrin-mediated adhesion, become caught in fluid flow and are carried into the red pulp. Follicular B-cell egress via the marginal zone is sphingosine-1-phosphate receptor-1 (S1PR1)-dependent. This study shows that marginal zone B cells migrate continually between marginal zone and follicles and establishes the marginal zone as a site of S1PR1-dependent B-cell exit from follicles. The results also show how adhesive differences of similar cells critically influence their behaviour in the same microenvironment.	[Arnon, Tal I.; Horton, Robert M.; Grigorova, Irina L.; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Arnon, Tal I.; Horton, Robert M.; Grigorova, Irina L.; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	Jason.Cyster@ucsf.edu	Grigorova, Irina/AAR-8795-2020	Grigorova, Irina/0000-0002-4963-7403; Arnon, Tal/0000-0003-4629-5820	Jane Coffin Child's fellowship; National Institutes of Health [AI74847]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	Jane Coffin Child's fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Miller for help with the microscope stage mount, T. Phan for advice regarding mouse surgery, J. An for technical assistance and O. M Bannard, J. R. Muppidi, M. Barnes and A. Reboldi for comments on the manuscript. T. I. A. was supported by a Jane Coffin Child's fellowship and J. G. C. is an Investigator of the Howard Hughes Medical Institute. This work was supported in part by National Institutes of Health grant AI74847.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Arnon TI, 2011, SCIENCE, V333, P1898, DOI 10.1126/science.1208248; Barral P, 2012, EMBO J, V31, P2378, DOI 10.1038/emboj.2012.87; Boscacci RT, 2010, BLOOD, V116, P915, DOI 10.1182/blood-2009-11-254334; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; Green JA, 2012, IMMUNOL REV, V247, P36, DOI 10.1111/j.1600-065X.2012.01114.x; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; KRAAL G, 1995, AM J PATHOL, V147, P763; Kraal G, 2006, INT REV CYTOL, V250, P175, DOI 10.1016/S0074-7696(06)50005-1; KUMARARATNE DS, 1981, EUR J IMMUNOL, V11, P865, DOI 10.1002/eji.1830111104; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; MACLENNAN ICM, 1982, IMMUNOL TODAY, V3, P305, DOI 10.1016/0167-5699(82)90032-9; Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.3.CO;2-G; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; Morris MA, 2005, EUR J IMMUNOL, V35, P3570, DOI 10.1002/eji.200526218; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; SCHMIDT EE, 1993, SCANNING MICROSCOPY, V7, P613; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; You YY, 2009, J IMMUNOL, V182, P7343, DOI 10.4049/jimmunol.0804295	36	142	143	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					684	+		10.1038/nature11738	http://dx.doi.org/10.1038/nature11738			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23263181	Green Accepted, Green Submitted			2022-12-24	WOS:000314219600059
J	Gardosi, J; Madurasinghe, V; Williams, M; Malik, A; Francis, A				Gardosi, Jason; Madurasinghe, Vichithranie; Williams, Mandy; Malik, Asad; Francis, Andre			Maternal and fetal risk factors for stillbirth: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GESTATIONAL-AGE FETUSES; ANTENATAL DETECTION; BIRTH-WEIGHT; DEATH; CLASSIFICATION; SMOKE; WOMEN	Objective To assess the main risk factors associated with stillbirth in a multiethnic English maternity population. Design Cohort study. Setting National Health Service region in England. Population 92 218 normally formed singletons including 389 stillbirths from 24 weeks of gestation, delivered during 2009-11. Main outcome measure Risk of stillbirth. Results Multivariable analysis identified a significant risk of stillbirth for parity (para 0 and para >= 3), ethnicity (African, African-Caribbean, Indian, and Pakistani), maternal obesity (body mass index >= 30), smoking, pre-existing diabetes, and history of mental health problems, antepartum haemorrhage, and fetal growth restriction (birth weight below 10th customised birthweight centile). As potentially modifiable risk factors, maternal obesity, smoking in pregnancy, and fetal growth restriction together accounted for 56.1% of the stillbirths. Presence of fetal growth restriction constituted the highest risk, and this applied to pregnancies where mothers did not smoke (adjusted relative risk 7.8, 95% confidence interval 6.6 to 10.9), did smoke (5.7, 3.6 to 10.9), and were exposed to passive smoke only (10.0, 6.6 to 15.8). Fetal growth restriction also had the largest population attributable risk for stillbirth and was fivefold greater if it was not detected antenatally than when it was (32.0% v 6.2%). In total, 195 of the 389 stillbirths in this cohort had fetal growth restriction, but in 160 (82%) it had not been detected antenatally. Antenatal recognition of fetal growth restriction resulted in delivery 10 days earlier than when it was not detected: median 270 (interquartile range 261-279) days v 280 (interquartile range 273-287) days. The overall stillbirth rate (per 1000 births) was 4.2, but only 2.4 in pregnancies without fetal growth restriction, increasing to 9.7 with antenatally detected fetal growth restriction and 19.8 when it was not detected. Conclusion Most normally formed singleton stillbirths are potentially avoidable. The single largest risk factor is unrecognised fetal growth restriction, and preventive strategies need to focus on improving antenatal detection.	[Gardosi, Jason; Madurasinghe, Vichithranie; Williams, Mandy; Malik, Asad; Francis, Andre] W Midlands Perinatal Inst, Birmingham B6 5RQ, W Midlands, England; [Gardosi, Jason] Univ Warwick, Sch Med, Coventry CV4 7AL, W Midlands, England	University of Warwick	Gardosi, J (corresponding author), W Midlands Perinatal Inst, Birmingham B6 5RQ, W Midlands, England.	jason.gardosi@pi.nhs.uk	Francis, Andre/AAY-3807-2021; Gardosi, Jason/GXN-1375-2022	Madurasinghe, Vichithranie/0000-0002-3853-3422; Gardosi, Jason/0000-0002-3230-1292	NHS West Midlands Strategic Health Authority	NHS West Midlands Strategic Health Authority	Data collection and analytical staff were financially supported by NHS West Midlands Strategic Health Authority and all primary care trusts. The funders had no influence on the study design, analysis, interpretation, writing up of the manuscript, or the decision to submit for publication.	ALFIREVIC Z, 1995, AM J OBSTET GYNECOL, V172, P1379, DOI 10.1016/0002-9378(95)90466-2; [Anonymous], 2012, KEY HLTH DAT W MIDL; [Anonymous], 2009, SAV BAB LIV REP STIL; [Anonymous], 2012, W MIDL COR MAT DAT V; [Anonymous], 2012, GROW GEST REL OPT WE; [Anonymous], 2012, PREGN NOT; [Anonymous], 2012, PER EP EL REC PEER; [Anonymous], 2011, W MIDL PER KPI REP Q; Bai J, 2002, AM J OBSTET GYNECOL, V186, P274, DOI 10.1067/mob.2002.119639; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2469, DOI 10.1001/jama.2011.1798; Confidential Enquiry into Maternal and Child Health, 2009, PER MORT 2007, P21; Confidential Enquiry into Maternal and Child Health (CEMACH), 2008, PER MORT 2006 ENGL W; De Jong CLD, 2000, ULTRASOUND OBST GYN, V15, P36, DOI 10.1046/j.1469-0705.2000.00001.x; Figueras F, 2011, AM J OBSTET GYNECOL, V204, P288, DOI 10.1016/j.ajog.2010.08.055; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Froen JF, 2004, ACTA OBSTET GYNECOL, P81; Gardosi J, 1999, BRIT J OBSTET GYNAEC, V106, P309, DOI 10.1111/j.1471-0528.1999.tb08267.x; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Gardosi J, 1998, BRIT J OBSTET GYNAEC, V105, P524, DOI 10.1111/j.1471-0528.1998.tb10153.x; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P168, DOI 10.1046/j.1469-0705.1995.06030168.x; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Gardosi J, 2001, CESDI 8 ANN REPORT C, P40; Gardosi J, 2012, ARCH DIS CHILD-FETAL, V97, pF314, DOI 10.1136/fetalneonatal-2012-301708; GENEST DR, 1992, OBSTET GYNECOL, V80, P575; Goy J, 2008, PAEDIATR PERINAT EP, V22, P314, DOI 10.1111/j.1365-3016.2008.00947.x; Hollier LM, 2000, OBSTET GYNECOL, V96, P701, DOI 10.1016/S0029-7844(00)01019-X; King-Hele S, 2009, ARCH DIS CHILD-FETAL, V94, pF105, DOI 10.1136/adc.2007.135459; KOOPERBERG C, 1991, EPIDEMIOLOGY, V2, P363, DOI 10.1097/00001648-199109000-00009; Korteweg FJ, 2008, PLACENTA, V29, P71, DOI 10.1016/j.placenta.2007.07.003; Leonardi-Bee J, 2011, PEDIATRICS, V127, P734, DOI 10.1542/peds.2010-3041; Lindqvist PG, 2005, ULTRASOUND OBST GYN, V25, P258, DOI 10.1002/uog.1806; McCowan LME, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1081; Office of National Statistics, 2012, DEATH REG SUMM TABL; Persson M, 2009, DIABETES CARE, V32, P2005, DOI 10.2337/dc09-0656; Reeske A, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-63; Roex A, 2012, AUST NZ J OBSTET GYN, V52, P78, DOI 10.1111/j.1479-828X.2011.01408.x; Schick S, 2005, TOB CONTROL, V14, P396, DOI 10.1136/tc.2005.011288; Stacey T, 2012, AUST NZ J OBSTET GYN, DOI [10.1111/j.1479-828X.2011.01406, DOI 10.1111/J.1479-828X.2011.01406]; Vergani P, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.098	41	473	482	0	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2013	346								f108	10.1136/bmj.f108	http://dx.doi.org/10.1136/bmj.f108			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080CD	23349424	Green Submitted, hybrid, Green Published			2022-12-24	WOS:000314217900010
J	Burd, CE; Sorrentino, JA; Clark, KS; Darr, DB; Krishnamurthy, J; Deal, AM; Bardeesy, N; Castrillon, DH; Beach, DH; Sharpless, NE				Burd, Christin E.; Sorrentino, Jessica A.; Clark, Kelly S.; Darr, David B.; Krishnamurthy, Janakiraman; Deal, Allison M.; Bardeesy, Nabeel; Castrillon, Diego H.; Beach, David H.; Sharpless, Norman E.			Monitoring Tumorigenesis and Senescence In Vivo with a p16(INK4a)-Luciferase Model	CELL			English	Article							P16(INK4A) TUMOR-SUPPRESSOR; CELLULAR SENESCENCE; FIBROBLAST SENESCENCE; METASTATIC MELANOMA; TRANSGENIC MICE; STEM-CELLS; LIFE-SPAN; T-CELLS; EXPRESSION; CANCER	Monitoring cancer and aging in vivo remains experimentally challenging. Here, we describe a luciferase knockin mouse (p16(LUC)), which faithfully reports expression of p16(INK4a), a tumor suppressor and aging biomarker. Lifelong assessment of luminescence in p16(+/LUC) mice revealed an exponential increase with aging, which was highly variable in a cohort of contemporaneously housed, syngeneic mice. Expression of p16(INK4a) with aging did not predict cancer development, suggesting that the accumulation of senescent cells is not a principal determinant of cancer-related death. In 14 of 14 tested tumor models, expression of p16(LUC) was focally activated by early neoplastic events, enabling visualization of tumors with sensitivity exceeding other imaging modalities. Activation of p16(INK4a) was noted in the emerging neoplasm and surrounding stromal cells. This work suggests that p16(INK4a) activation is a characteristic of all emerging cancers, making the p16(LUC) allele a sensitive, unbiased reporter of neoplastic transformation.	[Burd, Christin E.; Clark, Kelly S.; Darr, David B.; Krishnamurthy, Janakiraman; Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Burd, Christin E.; Clark, Kelly S.; Darr, David B.; Krishnamurthy, Janakiraman; Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA; [Burd, Christin E.; Sorrentino, Jessica A.; Clark, Kelly S.; Darr, David B.; Krishnamurthy, Janakiraman; Deal, Allison M.; Sharpless, Norman E.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Bardeesy, Nabeel] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Canc Ctr, Boston, MA 02114 USA; [Castrillon, Diego H.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Beach, David H.] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, London E1 2AT, England	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of London; Queen Mary University London	Sharpless, NE (corresponding author), Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA.	nes@med.unc.edu	, Animal Studies Core/ADK-4234-2022; , Animal Studies Core/AAF-4432-2022; , BRIC Small Animal Imaging Facility/AEV-1023-2022; Ariel, Pablo/AGJ-4118-2022; , Pathology Services Core/CEZ-2246-2022	, BRIC Small Animal Imaging Facility/0000-0002-0535-3214; Sharpless, Norman/0000-0001-7078-9455	NIH [AG024379, CA137181, CA163896, AG036817]; Paul Glenn Foundation; Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [R01CA137181, R01CA163896, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024379, R00AG036817, K99AG036817] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul Glenn Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Yuan, K. Guley, and the UNC BRIC Small Animal Imaging Facility for imaging assistance; A. Moisan (MGH Cancer) for technical assistance; C.G. Pena (UT Southwestern), E.A. Akbay (UT Southwestern), D.T. Gammons (UNC), W.Y. Kim (UNC), and W. Liu (UNC) for providing reagents; the UNC Animal Clinical Chemistry, Animal Histopathology, and Gene Expression Laboratories, as well as G. Aloisio (UT Southwestern), for tissue processing and routine genotyping; the UNC Microscopy Services Laboratory and UNC Animal Studies facility for technical assistance; and the UNC Mouse Phase I unit for providing animals and expertise. This work was supported by the NIH (AG024379; CA137181; CA163896; AG036817), the Paul Glenn Foundation, and the Burroughs Wellcome Fund.	Austad SN, 1997, EXP GERONTOL, V32, P23, DOI 10.1016/S0531-5565(96)00059-9; Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Berent-Maoz B, 2012, BLOOD, V119, P5715, DOI 10.1182/blood-2011-12-400002; Bishop CL, 2010, MOL CELL, V40, P533, DOI 10.1016/j.molcel.2010.10.027; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Chin L, 1997, GENE DEV, V11, P2822, DOI 10.1101/gad.11.21.2822; Chrisp CE, 1996, VET PATHOL, V33, P735, DOI 10.1177/030098589603300620; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Contreras CM, 2010, DIS MODEL MECH, V3, P181, DOI 10.1242/dmm.004440; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Gadd M, 2001, CANCER RES, V61, P8811; Goldman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018269; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jeck WR, 2012, AGING CELL, V11, P727, DOI 10.1111/j.1474-9726.2012.00871.x; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Koppelstaetter C, 2008, AGING CELL, V7, P491, DOI 10.1111/j.1474-9726.2008.00398.x; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lemster BH, 2008, J IMMUNOL, V180, P1979, DOI 10.4049/jimmunol.180.3.1979; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Liu WJ, 2012, CANCER CELL, V21, P751, DOI 10.1016/j.ccr.2012.03.048; Liu Y, 2011, BLOOD, V117, P3257, DOI 10.1182/blood-2010-09-304402; Liu Y, 2009, AGING CELL, V8, P439, DOI 10.1111/j.1474-9726.2009.00489.x; MAROULAKOU IG, 1994, P NATL ACAD SCI USA, V91, P11236, DOI 10.1073/pnas.91.23.11236; Maroulakou IG, 1999, ONCOGENE, V18, P5435, DOI 10.1038/sj.onc.1202926; McGlynn LM, 2009, AGING CELL, V8, P45, DOI 10.1111/j.1474-9726.2008.00447.x; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Natarajan E, 2003, AM J PATHOL, V163, P477, DOI 10.1016/S0002-9440(10)63677-2; Nielsen GP, 1999, LAB INVEST, V79, P1137; O'Neill K, 2010, J PATHOL, V220, P317, DOI 10.1002/path.2656; Ohtani N, 2007, P NATL ACAD SCI USA, V104, P15034, DOI 10.1073/pnas.0706949104; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Pavey S, 1999, CANCER RES, V59, P4185; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808; Uhrbom L, 2004, NAT MED, V10, P1257, DOI 10.1038/nm1120; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Yamakoshi K, 2009, J CELL BIOL, V186, P393, DOI 10.1083/jcb.200904105; Zindy F, 2003, P NATL ACAD SCI USA, V100, P15930, DOI 10.1073/pnas.2536808100; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	64	245	255	3	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					340	351		10.1016/j.cell.2012.12.010	http://dx.doi.org/10.1016/j.cell.2012.12.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332765	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000313719800028
J	Eulalio, A; Mano, M; Dal Ferro, M; Zentilin, L; Sinagra, G; Zacchigna, S; Giacca, M				Eulalio, Ana; Mano, Miguel; Dal Ferro, Matteo; Zentilin, Lorena; Sinagra, Gianfranco; Zacchigna, Serena; Giacca, Mauro			Functional screening identifies miRNAs inducing cardiac regeneration	NATURE			English	Article							ZEBRAFISH HEART REGENERATION; DNA-SYNTHESIS; CELL-CYCLE; CARDIOMYOCYTE DEDIFFERENTIATION; MITOTIC DIVISION; GENE-EXPRESSION; HYPERTROPHY; MICRORNAS; PROLIFERATION; RNA	In mammals, enlargement of the heart during embryonic development is primarily dependent on the increase in cardiomyocyte numbers. Shortly after birth, however, cardiomyocytes stop proliferating and further growth of the myocardium occurs through hypertrophic enlargement of the existing myocytes. As a consequence of the minimal renewal of cardiomyocytes during adult life, repair of cardiac damage through myocardial regeneration is very limited. Here we show that the exogenous administration of selected microRNAs (miRNAs) markedly stimulates cardiomyocyte proliferation and promotes cardiac repair. We performed a high-content microscopy, high-throughput functional screening for human miRNAs that promoted neonatal cardiomyocyte proliferation using a whole-genome miRNA library. Forty miRNAs strongly increased both DNA synthesis and cytokinesis in neonatal mouse and rat cardiomyocytes. Two of these miRNAs (hsa-miR-590 and hsa-miR-199a) were further selected for testing and were shown to promote cell cycle re-entry of adult cardiomyocytes ex vivo and to promote cardiomyocyte proliferation in both neonatal and adult animals. After myocardial infarction in mice, these miRNAs stimulated marked cardiac regeneration and almost complete recovery of cardiac functional parameters. The miRNAs identified hold great promise for the treatment of cardiac pathologies consequent to cardiomyocyte loss.	[Eulalio, Ana; Mano, Miguel; Dal Ferro, Matteo; Zentilin, Lorena; Zacchigna, Serena; Giacca, Mauro] ICGEB, Mol Med Lab, I-34149 Trieste, Italy; [Dal Ferro, Matteo; Sinagra, Gianfranco] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Dal Ferro, Matteo; Sinagra, Gianfranco] Azienda Osped Univ Osped Riuniti Trieste, Ctr Translat Cardiol, I-34129 Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trieste; University of Trieste	Giacca, M (corresponding author), ICGEB, Mol Med Lab, I-34149 Trieste, Italy.	giacca@icgeb.org	Giacca, Mauro/J-9287-2016; sinagra, gianfranco gs/P-7643-2014; Eulalio, Ana/D-3083-2013; Mano, Miguel/A-4462-2013; Dal Ferro, Matteo/GPP-6060-2022; Sinagra, Gianfranco/AAE-3943-2020; ZACCHIGNA, SERENA/E-9496-2017	Giacca, Mauro/0000-0003-2927-7225; Eulalio, Ana/0000-0002-7355-0674; Mano, Miguel/0000-0003-1922-4824; Dal Ferro, Matteo/0000-0002-2310-0448; SINAGRA, GIANFRANCO/0000-0003-2700-8478; ZACCHIGNA, SERENA/0000-0001-6705-3076	FEBS Long Term Fellowship; European Research Council (ERC) [250124]; Project CTC from the Fondazione CRTrieste, Trieste, Italy	FEBS Long Term Fellowship; European Research Council (ERC)(European Research Council (ERC)); Project CTC from the Fondazione CRTrieste, Trieste, Italy	The authors are grateful to M. Dapas and M. Zotti for technical support in AAV production, to M. Sturnega for help in animal experimentation and to S. Kerbavcic for editorial assistance. A. E. is recipient of a FEBS Long Term Fellowship. This work was supported by Advanced Grant 250124 from the European Research Council (ERC) to M. G. and from Project CTC from the Fondazione CRTrieste, Trieste, Italy.	Ahuja P, 2004, J CELL SCI, V117, P3295, DOI 10.1242/jcs.01159; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Arsic N, 2003, MOL THER, V7, P450, DOI 10.1016/S1525-0016(03)00034-0; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006; Bird SD, 2003, CARDIOVASC RES, V58, P423, DOI 10.1016/S0008-6363(03)00253-0; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Collesi C, 2008, J CELL BIOL, V183, P117, DOI 10.1083/jcb.200806091; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Fredj S, 2005, J CELL PHYSIOL, V202, P891, DOI 10.1002/jcp.20197; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; KAJSTURA J, 1994, CIRC RES, V74, P383, DOI 10.1161/01.RES.74.3.383; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Katare R, 2011, CIRC RES, V108, P1238, DOI 10.1161/CIRCRESAHA.110.239111; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAG AC, 1983, TISSUE CELL, V15, P597, DOI 10.1016/0040-8166(83)90010-1; Nishida Kazuhiko, 2008, Circ J, V72 Suppl A, pA17, DOI 10.1253/circj.CJ-08-0669; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Porrello ER, 2011, CIRC RES, V109, P670, DOI 10.1161/CIRCRESAHA.111.248880; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Pouliquin P, 2009, EUR BIOPHYS J BIOPHY, V39, P91, DOI 10.1007/s00249-009-0494-1; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; REISS K, 1993, EXP CELL RES, V207, P348, DOI 10.1006/excr.1993.1202; ROBLEDO M, 1956, AM J PATHOL, V32, P1215; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Trivedi CM, 2010, DEV CELL, V19, P450, DOI 10.1016/j.devcel.2010.08.012; van Amerongen MJ, 2008, J CELL MOL MED, V12, P2233, DOI 10.1111/j.1582-4934.2008.00439.x; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Xiao L, 2001, J MOL CELL CARDIOL, V33, P779, DOI 10.1006/jmcc.2001.1348; Zentilin L, 2010, FASEB J, V24, P1467, DOI 10.1096/fj.09-143180; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	50	701	737	12	219	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					376	+		10.1038/nature11739	http://dx.doi.org/10.1038/nature11739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23222520				2022-12-24	WOS:000312488200045
J	Truman, AW; Kristjansdottir, K; Wolfgeher, D; Hasin, N; Polier, S; Zhang, H; Perrett, S; Prodromou, C; Jones, GW; Kron, SJ				Truman, Andrew W.; Kristjansdottir, Kolbrun; Wolfgeher, Donald; Hasin, Naushaba; Polier, Sigrun; Zhang, Hong; Perrett, Sarah; Prodromou, Chrisostomos; Jones, Gary W.; Kron, Stephen J.			CDK-Dependent Hsp70 Phosphorylation Controls G1 Cyclin Abundance and Cell-Cycle Progression	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; CLN3 CYCLIN; GENE-EXPRESSION; CHAPERONE YDJ1; G(1) ARREST; PHO85; DEGRADATION; INHIBITOR; TARGETS	In budding yeast, the essential functions of Hsp70 chaperones Ssa1-4 are regulated through expression level, isoform specificity, and cochaperone activity. Suggesting a novel regulatory paradigm, we find that phosphorylation of Ssa1 T36 within a cyclin-dependent kinase (CDK) consensus site conserved among Hsp70 proteins alters cochaperone and client interactions. T36 phosphorylation triggers displacement of Ydj1, allowing Ssa1 to bind the G1 cyclin Cln3 and promote its degradation. The stress CDK Pho85 phosphorylates T36 upon nitrogen starvation or pheromone stimulation, destabilizing Cln3 to delay onset of S phase. In turn, the mitotic CDK Cdk1 phosphorylates T36 to block Cln3 accumulation in G2/M. Suggesting broad conservation from yeast to human, CDK-dependent phosphorylation of Hsc70 T38 similarly regulates Cyclin D1 binding and stability. These results establish an active role for Hsp70 chaperones as signal transducers mediating growth control of G1 cyclin abundance and activity.	[Truman, Andrew W.; Kristjansdottir, Kolbrun; Wolfgeher, Donald; Kron, Stephen J.] Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA; [Truman, Andrew W.; Kristjansdottir, Kolbrun; Wolfgeher, Donald; Kron, Stephen J.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Hasin, Naushaba; Jones, Gary W.] Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland; [Polier, Sigrun; Prodromou, Chrisostomos] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Zhang, Hong; Perrett, Sarah] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	University of Chicago; University of Chicago; Maynooth University; University of Sussex; Chinese Academy of Sciences; Institute of Biophysics, CAS	Kron, SJ (corresponding author), Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA.	skron@uchicago.edu	Truman, Andrew/I-8454-2019; Perrett, Sarah/AAS-9483-2020; Prodromou, Chrisostomos/ABA-9133-2021; Kristjansdottir, Kolla/V-4952-2019	Truman, Andrew/0000-0002-6409-3723; Perrett, Sarah/0000-0003-0137-0997; Prodromou, Chrisostomos/0000-0003-4320-1147; Kristjansdottir, Kolla/0000-0001-7054-2444; Kron, Stephen/0000-0003-1518-2436; Jones, Gary/0000-0002-7565-934X	NIGMS [GM60443]; NUI Maynooth John and Pat Hume postgraduate scholarship; Wellcome Trust [095605/Z11/Z]; 973 Program [2012CB911000/2013CB910700]; Medical Research Council [G0801130B] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA164492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060443] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NUI Maynooth John and Pat Hume postgraduate scholarship; Wellcome Trust(Wellcome TrustEuropean Commission); 973 Program(National Basic Research Program of China); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank M. Mollapour and S. Takahashi for insightful scientific discussion and A. Amon and P. Nash for helpful comments. We are grateful to E. Craig, M. Aldea, M. Polymenis, C. De Virgilio, D. Levin, P. Piper, B. Zetter, J. Buchner, S. Rospert, D. Klionsky, B. Andrews, and M. Tyers for providing materials used in this study. This work was supported by a generous gift from The Foglia Foundation and Mr. and Mrs. Vincent Foglia (A. W. T., S. J. K.) and NIGMS grant GM60443 (S. J. K.). N.H. was supported by a NUI Maynooth John and Pat Hume postgraduate scholarship. C. P. was funded by a Wellcome Trust Senior Investigator Award (095605/Z11/Z). S. P. and H.Z. were supported by the 973 Program (2012CB911000/2013CB910700).	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Benanti JA, 2012, SEMIN CELL DEV BIOL, V23, P492, DOI 10.1016/j.semcdb.2012.04.005; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; CAPLAN AJ, 1991, J CELL BIOL, V114, P609, DOI 10.1083/jcb.114.4.609; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Craig E.A., 2011, HSP70 CHAPERONES ELS; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; DICOMO CJ, 1995, MOL CELL BIOL, V15, P1835; Diehl JA, 2003, MOL CELL BIOL, V23, P1764, DOI 10.1128/MCB.23.5.1764-1774.2003; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; Ferrezuelo F, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r67; Ferrezuelo F, 2009, CELL CYCLE, V8, P239, DOI 10.4161/cc.8.2.7543; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; Huang DQ, 1998, MOL CELL BIOL, V18, P3289, DOI 10.1128/MCB.18.6.3289; Jaiswal H, 2011, MOL CELL BIOL, V31, P1160, DOI 10.1128/MCB.00986-10; Jones G, 2004, MOL CELL BIOL, V24, P3928, DOI 10.1128/MCB.24.9.3928-3937.2004; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kung C, 2005, P NATL ACAD SCI USA, V102, P3587, DOI 10.1073/pnas.0407170102; Mandal AK, 2008, MOL CELL BIOL, V28, P4434, DOI 10.1128/MCB.00543-08; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mazanka E, 2010, MOL BIOL CELL, V21, P2809, DOI 10.1091/mbc.E10-02-0174; Measday V, 1997, MOL CELL BIOL, V17, P1212, DOI 10.1128/MCB.17.3.1212; Meimaridou E, 2009, J MOL ENDOCRINOL, V42, P1, DOI 10.1677/JME-08-0116; Moffat J, 2000, Prog Cell Cycle Res, V4, P97; Mollapour M, 2010, CELL CYCLE, V9, P2310, DOI 10.4161/cc.9.12.12054; Newcomb LL, 2003, EUKARYOT CELL, V2, P143, DOI 10.1128/EC.2.1.143-149.2003; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Nishizawa M, 1998, MOL BIOL CELL, V9, P2393, DOI 10.1091/mbc.9.9.2393; Sharma D, 2011, P NATL ACAD SCI USA, V108, P13665, DOI 10.1073/pnas.1107421108; Sharma D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006644; SHERLOCK G, 1993, J GEN MICROBIOL, V139, P2531, DOI 10.1099/00221287-139-11-2531; Tan YSH, 2003, J BIOL CHEM, V278, P147, DOI 10.1074/jbc.M208058200; Timblin BK, 1996, GENETICS, V143, P57; Trotter EW, 2001, P NATL ACAD SCI USA, V98, P7313, DOI 10.1073/pnas.121172998; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; Verges E, 2007, MOL CELL, V26, P649, DOI 10.1016/j.molcel.2007.04.023; Wijnen H, 1999, GENETICS, V153, P1131; Wysocki R, 2006, NAT STRUCT MOL BIOL, V13, P908, DOI 10.1038/nsmb1139; YAGLOM J, 1995, MOL CELL BIOL, V15, P731; Yaglom JA, 1996, MOL CELL BIOL, V16, P3679; Yang ZF, 2010, MOL CELL, V38, P250, DOI 10.1016/j.molcel.2010.02.033	47	93	95	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1308	1318		10.1016/j.cell.2012.10.051	http://dx.doi.org/10.1016/j.cell.2012.10.051			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217712	Green Accepted, Green Published, hybrid			2022-12-24	WOS:000311999900019
J	Lund, LH; Benson, L; Dahlstrom, U; Edner, M				Lund, Lars H.; Benson, Lina; Dahlstrom, Ulf; Edner, Magnus			Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONVERTING-ENZYME-INHIBITOR; LEFT-VENTRICULAR FUNCTION; PROPENSITY SCORE; CARDIOVASCULAR EVENTS; CANDESARTAN; REDUCTION; MORBIDITY; TRIAL; METAANALYSIS; PERINDOPRIL	Context Heart failure with preserved ejection fraction (HFPEF) may be as common and as lethal as heart failure with reduced ejection fraction (HFREF). Three randomized trials of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ie, renin-angiotensin system [RAS] antagonists) did not reach primary end points but may have had selection bias or been underpowered. Objective To test the hypothesis that use of RAS antagonists is associated with reduced all-cause mortality in an unselected population with HFPEF. Design, Setting, and Patients Prospective study using the Swedish Heart Failure Registry of 41 791 unique patients registered from 64 hospitals and 84 outpatient clinics between 2000 and 2011. Of these, 16 216 patients with HFPEF (ejection fraction >= 40%; mean [SD] age, 75 [11] years; 46% women) were either treated (n=12 543) or not treated (n=3673) with RAS antagonists. Propensity scores for RAS antagonist use were derived from 43 variables. The association between use of RAS antagonists and all-cause mortality was assessed in a cohort matched 1: 1 based on age and propensity score and in the overall cohort with adjustment for propensity score as a continuous covariate. To assess consistency, separate age and propensity score-matched analyses were performed according to RAS antagonist dose in patients with HFPEF and in 20 111 patients with HFREF (ejection fraction <40%) in the same registry. Main Outcome Measure All-cause mortality. Results In the matched HFPEF cohort, 1-year survival was 77% (95% CI, 75%-78%) for treated patients vs 72% (95% CI, 70%-73%) for untreated patients, with a hazard ratio (HR) of 0.91 (95% CI, 0.85-0.98; P=.008). In the overall HFPEF cohort, crude 1-year survival was 86% (95% CI, 86%-87%) for treated patients vs 69% (95% CI, 68%-71%) for untreated patients, with a propensity score-adjusted HR of 0.90 (95% CI, 0.85-0.96; P=.001). In the HFPEF dose analysis, the HR was 0.85 (95% CI, 0.78-0.83) for 50% or greater of target dose vs no treatment (P<.001) and 0.94 (95% CI, 0.87-1.02) for less than 50% of target dose vs no treatment (P=.14). In the age and propensity score-matched HFREF analysis, the HR was 0.80 (95% CI, 0.74-0.86; P<.001). Conclusion Among patients with heart failure and preserved ejection fraction, the use of RAS antagonists was associated with lower all-cause mortality. JAMA. 2012;308(20):2108-2117 www.jama.com	[Lund, Lars H.] Karolinska Univ Hosp, Sect Heart Failure, Dept Cardiol, S-17176 Stockholm, Sweden; [Lund, Lars H.; Edner, Magnus] Karolinska Inst, Dept Med, Unit Cardiol, Stockholm, Sweden; [Benson, Lina] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Dahlstrom, Ulf] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden; [Dahlstrom, Ulf] Linkoping Univ Hosp, Dept Cardiol, Cty Council Ostergotland, S-58185 Linkoping, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Linkoping University; City Council Ostergotland; Linkoping University	Lund, LH (corresponding author), Karolinska Univ Hosp, Sect Heart Failure, Dept Cardiol, N305, S-17176 Stockholm, Sweden.	lars.lund@alumni.duke.edu		Benson, Lina/0000-0002-5393-0055	AstraZeneca; Thoratec; Heart-Ware; Swedish National Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Swedish Society of Cardiology; Swedish Heart-Lung Foundation [20080409, 20100419]; Stockholm County Council [00556-2009, 20110120]	AstraZeneca(AstraZeneca); Thoratec; Heart-Ware; Swedish National Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Swedish Society of Cardiology; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Lund reported receiving institutional research grants and speaker's and consulting fees from AstraZeneca, Thoratec, and Heart-Ware. No other disclosures were reported.; The Swedish Heart Failure Registry is funded by the Swedish National Board of Health and Welfare, the Swedish Association of Local Authorities and Regions, the Swedish Society of Cardiology, and the Swedish Heart-Lung Foundation. This study received no specific funding. Dr Lund was supported by grants 20080409 and 20100419 from the Swedish Heart-Lung Foundation, grants 00556-2009 and 20110120 from the Stockholm County Council, and an unrestricted research grant from AstraZeneca.	Berry C, 2012, EUR HEART J, V33, P1750, DOI 10.1093/eurheartj/ehr254; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Desai A, 2007, CURR OPIN CARDIOL, V22, P578; Eklind-Cervenka M, 2011, JAMA-J AM MED ASSOC, V305, P175, DOI 10.1001/jama.2010.1949; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Fox KM, 2003, LANCET, V362, P782; Fu MQ, 2012, INT J CARDIOL, V155, P33, DOI 10.1016/j.ijcard.2011.01.081; Guyatt G., 2008, USERS GUIDES MEDICAL; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Henkel DM, 2008, CIRC-HEART FAIL, V1, P91, DOI 10.1161/CIRCHEARTFAILURE.107.743146; Hogg K, 2005, PROG CARDIOVASC DIS, V47, P357, DOI 10.1016/j.pcad.2005.02.001; Jonsson A, 2010, EUR J HEART FAIL, V12, P25, DOI 10.1093/eurjhf/hfp175; Kitzman DW, 2002, JAMA-J AM MED ASSOC, V288, P2144, DOI 10.1001/jama.288.17.2144; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Lenzen MJ, 2004, EUR HEART J, V25, P1214, DOI 10.1016/j.ehj.2004.06.006; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; McMurray J, 2006, EUR HEART J, V27, P2257, DOI 10.1093/eurheartj/ehl249; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Meune C, 2011, J CARDIOVASC PHARM T, V16, P368, DOI 10.1177/1074248410391667; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Shah NR, 2000, JAMA-J AM MED ASSOC, V284, P3127, DOI 10.1001/jama.284.24.3127; Solomon SD, 2005, CIRCULATION, V112, P3738, DOI 10.1161/CIRCULATIONAHA.105.561423; Solomon SD, 2004, CIRCULATION, V110, P2180, DOI 10.1161/01.CIR.0000144474.65922.AA; Steinberg BA, 2012, CIRCULATION, V126, P65, DOI 10.1161/CIRCULATIONAHA.111.080770; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; Wright JW, 2008, HEART FAIL REV, V13, P367, DOI 10.1007/s10741-007-9060-z; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zile MR, 2010, CIRCULATION, V121, P1393, DOI 10.1161/CIRCULATIONAHA.109.909614	38	123	125	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2108	2117		10.1001/jama.2012.14785	http://dx.doi.org/10.1001/jama.2012.14785			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188027	Bronze			2022-12-24	WOS:000311537200025
J	Barzilay, EJ; Schaad, N; Magloire, R; Mung, KS; Boncy, J; Dahourou, GA; Mintz, ED; Steenland, MW; Vertefeuille, JF; Tappero, JW				Barzilay, Ezra J.; Schaad, Nicolas; Magloire, Roc; Mung, Kam S.; Boncy, Jacques; Dahourou, Georges A.; Mintz, Eric D.; Steenland, Maria W.; Vertefeuille, John F.; Tappero, Jordan W.			Cholera Surveillance during the Haiti Epidemic - The First 2 Years	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSMISSION; OUTBREAK; DISEASE	BACKGROUND In October 2010, nearly 10 months after a devastating earthquake, Haiti was stricken by epidemic cholera. Within days after detection, the Ministry of Public Health and Population established a National Cholera Surveillance System (NCSS). METHODS The NCSS used a modified World Health Organization case definition for cholera that included acute watery diarrhea, with or without vomiting, in persons of all ages residing in an area in which at least one case of Vibrio cholerae O1 infection had been confirmed by culture. RESULTS Within 29 days after the first report, cases of V. cholerae O1 (serotype Ogawa, biotype El Tor) were confirmed in all 10 administrative departments (similar to states or provinces) in Haiti. Through October 20, 2012, the public health ministry reported 604,634 cases of infection, 329,697 hospitalizations, and 7436 deaths from cholera and isolated V. cholerae O1 from 1675 of 2703 stool specimens tested (62.0%). The cumulative attack rate was 5.1% at the end of the first year and 6.1% at the end of the second year. The cumulative case fatality rate consistently trended downward, reaching 1.2% at the close of year 2, with departmental cumulative rates ranging from 0.6% to 4.6% (median, 1.4%). Within 3 months after the start of the epidemic, the rolling 14-day case fatality rate was 1.0% and remained at or below this level with few, brief exceptions. Overall, the cholera epidemic in Haiti accounted for 57% of all cholera cases and 53% of all cholera deaths reported to the World Health Organization in 2010 and 58% of all cholera cases and 37% of all cholera deaths in 2011. CONCLUSIONS A review of NCSS data shows that during the first 2 years of the cholera epidemic in Haiti, the cumulative attack rate was 6.1%, with cases reported in all 10 departments. Within 3 months after the first case was reported, there was a downward trend in mortality, with a 14-day case fatality rate of 1.0% or less in most areas.	[Barzilay, Ezra J.; Schaad, Nicolas; Dahourou, Georges A.; Mintz, Eric D.; Steenland, Maria W.; Vertefeuille, John F.; Tappero, Jordan W.] Ctr Dis Control & Prevent, Atlanta, GA 30329 USA; [Magloire, Roc] Minist Sante Publ & Populat, Direct Epidemiol Lab & Rech, Port Au Prince, Haiti; [Mung, Kam S.] Pan Amer Hlth Org, Port Au Prince, Haiti; [Boncy, Jacques] Minist Sante Publ & Populat, Lab Natl Sante Publ, Port Au Prince, Haiti; [Dahourou, Georges A.; Vertefeuille, John F.] Ctr Dis Control & Prevent, Haiti Off, Port Au Prince, Haiti	Centers for Disease Control & Prevention - USA; Pan American Health Organization	Barzilay, EJ (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS A-05, Atlanta, GA 30329 USA.	ebarzilay@cdc.gov						Abrams JY, 2012, EPIDEMIOL INFECT, V1, P1; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Andrews JR, 2011, LANCET, V377, P1248, DOI 10.1016/S0140-6736(11)60273-0; [Anonymous], 2012, Wkly Epidemiol Rec, V87; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P325; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P933; [Anonymous], 2011, HAITI CHOLERA TRAINI; [Anonymous], 2011, HAIT CHOL OUTBR SIT; [Anonymous], 1993, MMWR-MORBID MORTAL W, V42, P639; Bauernfeind A, 2004, CHOLERA GUIDELINES; Brunkard Joan M., 2012, Morbidity and Mortality Weekly Report, V61, P309; Chao DL, 2011, P NATL ACAD SCI USA, V108, P7081, DOI 10.1073/pnas.1102149108; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Dowell SF, 2011, NEW ENGL J MED, V364, P300, DOI 10.1056/NEJMp1100118; Ernst S, 2011, EMERG INFECT DIS, V17, P2155, DOI 10.3201/eid1711.110815; European Centre for Disease Prevention and Control, 2012, OUTBR CHOL CUB POT R; Farmer P, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001145; Gerard JA, 2012, AM SOC TROP MED HYG; German R R, 2001, MMWR Recomm Rep, V50, P1; Global Task force on Cholera Control, 2004, WHOCDSCPEZFK20044; Ivers LC, 2010, LANCET, V376, P2048, DOI 10.1016/S0140-6736(10)62243-X; Jackson BR, 2012, SERO EPIDEMIOLOGIC S; Jenson D, 2011, EMERG INFECT DIS, V17, P2130, DOI 10.3201/eid1711.110958; Koo D, 1996, Bull Pan Am Health Organ, V30, P134; Jimenez ML, 2011, EMERG INFECT DIS, V17, P2172, DOI 10.3201/eid1711.111263; Fernandez MAL, 2009, T ROY SOC TROP MED H, V103, P137, DOI 10.1016/j.trstmh.2008.07.017; NALIN DR, 1978, LANCET, V2, P856; Newton AE, 2011, EMERG INFECT DIS, V17, P2166, DOI 10.3201/eid1711.110808; PALMER DL, 1976, J INFECT DIS, V134, P8, DOI 10.1093/infdis/134.1.8; Pan American Health Organization, 2012, CHOL SIT UPD; Pan American Health Organization Division of Vaccines and Immunization, 2012, 20 M TECHN ADV GROUP; Periago MR, 2012, LANCET, V379, pE12, DOI 10.1016/S0140-6736(12)60031-2; Pun SB, 2011, EMERG INFECT DIS, V17, P2178, DOI [10.3201/eid1711.110981, 10.3201/eid1707.110059]; Rapid establishment of an internally displaced persons disease surveillance system after an earthquake-Haiti, 2010, MMWR MORB MORTAL WKL, V59, P939; Routh JA, 2011, EMERG INFECT DIS, V17, P2139, DOI 10.3201/eid1711.110747; Ryan ET, 2011, EMERG INFECT DIS, V17, P2175, DOI 10.3201/eid1711.110849; Shikanga OT, 2009, AM J TROP MED HYG, V81, P1085, DOI 10.4269/ajtmh.2009.09-0400; Siddique AK, 2010, EPIDEMIOL INFECT, V138, P347, DOI 10.1017/S0950268809990550; Sjolund-Karlsson M, 2011, EMERG INFECT DIS, V17, P2151, DOI 10.3201/eid1711.110720; SWERDLOW DL, 1994, J INFECT DIS, V170, P468, DOI 10.1093/infdis/170.2.468; Talkington D, 2011, EMERG INFECT DIS, V17, P2122, DOI 10.3201/eid1711.110805; Talkington DF, 2012, 2012 AM SOC MICR GEN; Tappero JW, 2011, EMERG INFECT DIS, V17, P2087, DOI 10.3201/eid1711.110827; Tauxe Robert, 1994, P321; Tauxe RV, 2011, EMERG INFECT DIS, V17, P2094, DOI 10.3201/eid1711.110857; Tuite AR, 2011, ANN INTERN MED, V154, P593, DOI 10.7326/0003-4819-154-9-201105030-00334; UNICEF, 2010, PROGR SAN DRINK WAT; World Health Organization, 1993, GUID CHOL CONTR	48	143	147	0	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					599	609		10.1056/NEJMoa1204927	http://dx.doi.org/10.1056/NEJMoa1204927			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194VA	23301694	Bronze			2022-12-24	WOS:000322659600005
J	Jiang, P; Du, WJ; Mancuso, A; Wellen, KE; Yang, XL				Jiang, Peng; Du, Wenjing; Mancuso, Anthony; Wellen, Kathryn E.; Yang, Xiaolu			Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; ATP-CITRATE LYASE; CELLULAR SENESCENCE; ONCOGENIC RAS; PREMATURE SENESCENCE; INSULIN-SECRETION; TUMOR SUPPRESSION; CELLS; RESTORATION; ACETYLATION	Cellular senescence both protects multicellular organisms from cancer and contributes to their ageing(1). The pre-eminent tumour suppressor p53 has an important role in the induction and maintenance of senescence, but how it carries out this function remains poorly understood(1-3). In addition, although increasing evidence supports the idea that metabolic changes underlie many cell-fate decisions and p53-mediated tumour suppression, few connections between metabolic enzymes and senescence have been established. Here we describe a new mechanism by which p53 links these functions. We show that p53 represses the expression of the tricarboxylic-acid-cycle-associated malic enzymes ME1 and ME2 in human and mouse cells. Both malic enzymes are important for NADPH production, lipogenesis and glutamine metabolism, but ME2 has a more profound effect. Through the inhibition of malic enzymes, p53 regulates cell metabolism and proliferation. Downregulation of ME1 and ME2 reciprocally activates p53 through distinct MDM2- and AMP-activated protein kinase-mediated mechanisms in a feed-forward manner, bolstering this pathway and enhancing p53 activation. Downregulation of ME1 and ME2 also modulates the outcome of p53 activation, leading to strong induction of senescence, but not apoptosis, whereas enforced expression of either malic enzyme suppresses senescence. Our findings define physiological functions of malic enzymes, demonstrate a positive-feedback mechanism that sustains p53 activation, and reveal a connection between metabolism and senescence mediated by p53.	[Jiang, Peng; Du, Wenjing; Mancuso, Anthony; Wellen, Kathryn E.; Yang, Xiaolu] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Jiang, Peng; Du, Wenjing; Mancuso, Anthony; Wellen, Kathryn E.; Yang, Xiaolu] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Yang, XL (corresponding author), Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA.	xyang@mail.med.upenn.edu	Jiang, Peng/A-1946-2013	Jiang, Peng/0000-0002-4218-0092	National Institutes of Health [CA088868]; US Department of Defense [W81XWH-10-1-0468]; NATIONAL CANCER INSTITUTE [P30CA016520, R01CA088868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. J. Birnbaum, B. Vogelstein, W. El-Deiry and M. Lazar for reagents; M. J. Bennett, S. Patel, A. Stonestrom and M. Brewer for technical assistance; and A. Stonestrom for help with manuscript preparation. This work was supported by grants from the National Institutes of Health (CA088868) and the US Department of Defense (W81XWH-10-1-0468) to X.Y.	Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Blattler SM, 2007, P NATL ACAD SCI USA, V104, P1045, DOI 10.1073/pnas.0610216104; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang GG, 2003, BIOCHEMISTRY-US, V42, P12721, DOI 10.1021/bi035251+; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cossarizza A, 2009, NAT PROTOC, V4, P1790, DOI 10.1038/nprot.2009.189; Ferbeyre G, 2000, GENE DEV, V14, P2015; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; HSU RY, 1982, MOL CELL BIOCHEM, V43, P3; Jiang P, 2006, MOL CELL BIOL, V26, P9071, DOI 10.1128/MCB.01025-06; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; NAGEL WO, 1980, J BIOL CHEM, V255, P3849; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; SAUER LA, 1980, J BIOL CHEM, V255, P3844; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WASILENKO WJ, 1985, CANCER LETT, V28, P35, DOI 10.1016/0304-3835(85)90089-8; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhang J, 2007, J CLIN INVEST, V117, P2962, DOI 10.1172/JCI30710	33	315	330	10	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2013	493	7434					689	+		10.1038/nature11776	http://dx.doi.org/10.1038/nature11776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23334421	Green Accepted			2022-12-24	WOS:000314219600060
J	Barik, J; Marti, F; Morel, C; Fernandez, SP; Lanteri, C; Godeheu, G; Tassin, JP; Mombereau, C; Faure, P; Tronche, F				Barik, Jacques; Marti, Fabio; Morel, Carole; Fernandez, Sebastian P.; Lanteri, Christophe; Godeheu, Gerard; Tassin, Jean-Pol; Mombereau, Cedric; Faure, Philippe; Tronche, Francois			Chronic Stress Triggers Social Aversion via Glucocorticoid Receptor in Dopaminoceptive Neurons	SCIENCE			English	Article							VENTRAL TEGMENTAL AREA; NIGRAL DOPAMINE NEURONS; NUCLEUS-ACCUMBENS; FIRING PATTERN; AGGRESSION; COCAINE; ANXIETY; DEFEAT; BRAIN; SUSCEPTIBILITY	Repeated traumatic events induce long-lasting behavioral changes that are key to organism adaptation and that affect cognitive, emotional, and social behaviors. Rodents subjected to repeated instances of aggression develop enduring social aversion and increased anxiety. Such repeated aggressions trigger a stress response, resulting in glucocorticoid release and activation of the ascending dopamine (DA) system. We bred mice with selective inactivation of the gene encoding the glucocorticoid receptor (GR) along the DA pathway, and exposed them to repeated aggressions. GR in dopaminoceptive but not DA-releasing neurons specifically promoted social aversion as well as dopaminergic neurochemical and electrophysiological neuroadaptations. Anxiety and fear memories remained unaffected. Acute inhibition of the activity of DA-releasing neurons fully restored social interaction in socially defeated wild-type mice. Our data suggest a GR-dependent neuronal dichotomy for the regulation of emotional and social behaviors, and clearly implicate GR as a link between stress resiliency and dopaminergic tone.	[Barik, Jacques; Tronche, Francois] CNRS, UMR 7224, Mol Genet Neurophysiol & Behav Grp, F-75005 Paris, France; [Barik, Jacques; Lanteri, Christophe; Godeheu, Gerard; Tassin, Jean-Pol; Tronche, Francois] INSERM, U952S, F-75005 Paris, France; [Barik, Jacques; Marti, Fabio; Morel, Carole; Fernandez, Sebastian P.; Lanteri, Christophe; Godeheu, Gerard; Tassin, Jean-Pol; Mombereau, Cedric; Faure, Philippe; Tronche, Francois] Univ Paris 06, F-75005 Paris, France; [Barik, Jacques; Marti, Fabio; Morel, Carole; Fernandez, Sebastian P.; Mombereau, Cedric; Faure, Philippe; Tronche, Francois] Lab Excellence Labex Biol Psychiat Lab, F-75005 Paris, France; [Marti, Fabio; Morel, Carole; Faure, Philippe] CNRS, UMR7102, Neurophysiol & Behav Grp, F-75005 Paris, France; [Fernandez, Sebastian P.] INSERM, U839, Neurotransmiss & Dev Grp, F-75005 Paris, France; [Lanteri, Christophe; Godeheu, Gerard; Tassin, Jean-Pol] CNRS, UMR7224, Physiopathol Addict & Relapse Grp, F-75005 Paris, France; [Mombereau, Cedric] INSERM, U839, Mol & Cellular Mech Cort Dev Grp, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Barik, J (corresponding author), CNRS, UMR 7224, Mol Genet Neurophysiol & Behav Grp, F-75005 Paris, France.	jacques.barik@snv.jussieu.fr; francois.tronche@upmc.fr	TRONCHE, François/F-3895-2011	Faure, Philippe/0000-0003-3573-4971; BARIK, Jacques/0000-0002-4276-0927; Tassin, Jean-Pol/0000-0001-6658-9581; marti, fabio/0000-0002-3604-457X; Fernandez, Sebastian/0000-0003-0683-5562	CNRS; INSERM; Agence Nationale de la Recherche (TIMMS); UPMC (Emergence program); Region Ile-de-France (NeRF); European Union; Bettencourt Schueller Foundation; Mission Interministerielle de Lutte contre la Dependance et la Toxicomanie; Fondation pour la Recherche Medicale	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche (TIMMS)(French National Research Agency (ANR)); UPMC (Emergence program); Region Ile-de-France (NeRF)(Region Ile-de-France); European Union(European Commission); Bettencourt Schueller Foundation; Mission Interministerielle de Lutte contre la Dependance et la Toxicomanie; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank S. Wonnacott for critical reading of the manuscript, and staff from the IFR83 animal facility for assistance. This work was funded by CNRS, INSERM, the Agence Nationale de la Recherche (TIMMS grants), the UPMC (Emergence program), the Region Ile-de-France (NeRF), the European Union (FP7 STREPs PheComp and NovelTune), the Bettencourt Schueller Foundation, and the Mission Interministerielle de Lutte contre la Dependance et la Toxicomanie. J.B. has been supported by the Fondation pour la Recherche Medicale. The authors declare no competing financial interests.	Ambroggi F, 2009, NAT NEUROSCI, V12, P247, DOI 10.1038/nn.2282; Anzalone A, 2012, J NEUROSCI, V32, P9023, DOI 10.1523/JNEUROSCI.0918-12.2012; Barik J, 2010, BIOL PSYCHIAT, V68, P231, DOI 10.1016/j.biopsych.2010.03.037; Beiderbeck DI, 2012, PSYCHONEUROENDOCRINO, V37, P1969, DOI 10.1016/j.psyneuen.2012.04.011; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Dalley JW, 2009, SEMIN CELL DEV BIOL, V20, P403, DOI 10.1016/j.semcdb.2009.01.002; de Kloet ER, 2008, EUR J PHARMACOL, V585, P473, DOI 10.1016/j.ejphar.2008.03.011; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRACE AA, 1984, J NEUROSCI, V4, P2866; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Haller J, 2006, NEUROSCI BIOBEHAV R, V30, P292, DOI 10.1016/j.neubiorev.2005.01.005; Haller J, 2000, J NEUROENDOCRINOL, V12, P431; Huhman KL, 2006, HORM BEHAV, V50, P640, DOI 10.1016/j.yhbeh.2006.06.022; Kelleher I, 2008, BRIT J PSYCHIAT, V193, P378, DOI 10.1192/bjp.bp.108.049536; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lemberger T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-4; Marinelli M., 2006, CNS & Neurological Disorders-Drug Targets, V5, P79, DOI 10.2174/187152706784111542; Marinelli Michela, 2007, P41, DOI 10.1016/B978-012370632-4/50006-1; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Omelchenko N, 2009, SYNAPSE, V63, P895, DOI 10.1002/syn.20668; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Valenti O, 2011, J NEUROSCI, V31, P4280, DOI 10.1523/JNEUROSCI.5310-10.2011; Veenema AH, 2003, HORM BEHAV, V43, P197, DOI 10.1016/S0018-506X(02)00013-2; Wei Q, 2004, P NATL ACAD SCI USA, V101, P11851, DOI 10.1073/pnas.0402208101; Xia YF, 2011, J NEUROSCI, V31, P7811, DOI 10.1523/JNEUROSCI.1504-11.2011; Zweifel LS, 2011, NAT NEUROSCI, V14, P620, DOI 10.1038/nn.2808	32	131	137	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					332	335		10.1126/science.1226767	http://dx.doi.org/10.1126/science.1226767			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329050				2022-12-24	WOS:000313622000048
J	Redecke, L; Nass, K; DePonte, DP; White, TA; Rehders, D; Barty, A; Stellato, F; Liang, MN; Barends, TRM; Boutet, S; Williams, GJ; Messerschmidt, M; Seibert, MM; Aquila, A; Arnlund, D; Bajt, S; Barth, T; Bogan, MJ; Caleman, C; Chao, TC; Doak, RB; Fleckenstein, H; Frank, M; Fromme, R; Galli, L; Grotjohann, I; Hunter, MS; Johansson, LC; Kassemeyer, S; Katona, G; Kirian, RA; Koopmann, R; Kupitz, C; Lomb, L; Martin, AV; Mogk, S; Neutze, R; Shoeman, RL; Steinbrener, J; Timneanu, N; Wang, DJ; Weierstall, U; Zatsepin, NA; Spence, JCH; Fromme, P; Schlichting, I; Duszenko, M; Betzel, C; Chapman, HN				Redecke, Lars; Nass, Karol; DePonte, Daniel P.; White, Thomas A.; Rehders, Dirk; Barty, Anton; Stellato, Francesco; Liang, Mengning; Barends, Thomas R. M.; Boutet, Sebastien; Williams, Garth J.; Messerschmidt, Marc; Seibert, M. Marvin; Aquila, Andrew; Arnlund, David; Bajt, Sasa; Barth, Torsten; Bogan, Michael J.; Caleman, Carl; Chao, Tzu-Chiao; Doak, R. Bruce; Fleckenstein, Holger; Frank, Matthias; Fromme, Raimund; Galli, Lorenzo; Grotjohann, Ingo; Hunter, Mark S.; Johansson, Linda C.; Kassemeyer, Stephan; Katona, Gergely; Kirian, Richard A.; Koopmann, Rudolf; Kupitz, Chris; Lomb, Lukas; Martin, Andrew V.; Mogk, Stefan; Neutze, Richard; Shoeman, Robert L.; Steinbrener, Jan; Timneanu, Nicusor; Wang, Dingjie; Weierstall, Uwe; Zatsepin, Nadia A.; Spence, John C. H.; Fromme, Petra; Schlichting, Ilme; Duszenko, Michael; Betzel, Christian; Chapman, Henry N.			Natively Inhibited Trypanosoma brucei Cathepsin B Structure Determined by Using an X-ray Laser	SCIENCE			English	Article							PROTEIN-STRUCTURE DETERMINATION; HUMAN AFRICAN TRYPANOSOMIASIS; CYSTEINE PROTEASES; OCCLUDING LOOP; ACTIVE-SITE; PROPEPTIDE; PAPAIN; NANOCRYSTALLOGRAPHY; CRYSTALLOGRAPHY; DISEASE	The Trypanosoma brucei cysteine protease cathepsin B (TbCatB), which is involved in host protein degradation, is a promising target to develop new treatments against sleeping sickness, a fatal disease caused by this protozoan parasite. The structure of the mature, active form of TbCatB has so far not provided sufficient information for the design of a safe and specific drug against T. brucei. By combining two recent innovations, in vivo crystallization and serial femtosecond crystallography, we obtained the room-temperature 2.1 angstrom resolution structure of the fully glycosylated precursor complex of TbCatB. The structure reveals the mechanism of native TbCatB inhibition and demonstrates that new biomolecular information can be obtained by the "diffraction-before-destruction" approach of x-ray free-electron lasers from hundreds of thousands of individual microcrystals.	[Redecke, Lars; Rehders, Dirk] Univ Hamburg, Inst Biochem & Mol Biol, Joint Lab Struct Biol Infect & Inflammat, D-22607 Hamburg, Germany; [Redecke, Lars; Rehders, Dirk] Deutsch Elekt Synchrotron DESY, Med Univ Lubeck, Inst Biochem, D-22607 Hamburg, Germany; [Redecke, Lars] Med Univ Lubeck, German Ctr Infect Res, D-23538 Lubeck, Germany; [Barends, Thomas R. M.; Kassemeyer, Stephan; Lomb, Lukas; Shoeman, Robert L.; Steinbrener, Jan; Schlichting, Ilme] DESY, Ctr Free Elect Laser Sci CFEL, Max Planck Adv Study Grp, D-22607 Hamburg, Germany; [Nass, Karol; Galli, Lorenzo; Chapman, Henry N.] Univ Hamburg, Dept Phys, D-22761 Hamburg, Germany; [Barends, Thomas R. M.; Kassemeyer, Stephan; Lomb, Lukas; Shoeman, Robert L.; Steinbrener, Jan; Schlichting, Ilme] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Boutet, Sebastien; Williams, Garth J.; Messerschmidt, Marc; Seibert, M. Marvin] Natl Accelerator Lab, Stanford Linear Accelerator Ctr SLAC, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Arnlund, David; Johansson, Linda C.; Katona, Gergely; Neutze, Richard] Univ Gothenburg, Dept Chem & Mol Biol, SE-40530 Gothenburg, Sweden; [Barth, Torsten; Koopmann, Rudolf; Mogk, Stefan; Duszenko, Michael] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Bogan, Michael J.] SLAC Natl Accelerator Lab, Photon Ultrafast Laser Sci & Engn PULSE Inst, Menlo Pk, CA 94025 USA; [Chao, Tzu-Chiao; Fromme, Raimund; Grotjohann, Ingo; Hunter, Mark S.; Kupitz, Chris; Fromme, Petra] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Doak, R. Bruce; Kirian, Richard A.; Wang, Dingjie; Weierstall, Uwe; Zatsepin, Nadia A.; Spence, John C. H.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Frank, Matthias] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Timneanu, Nicusor] Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden; [Betzel, Christian] DESY, Univ Hamburg, Inst Biochem & Mol Biol, D-22607 Hamburg, Germany	University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Lubeck; German Center for Infection Research; University of Lubeck; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; University of Hamburg; Max Planck Society; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Gothenburg; Eberhard Karls University of Tubingen; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Uppsala University; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg	Betzel, C (corresponding author), DESY, Univ Hamburg, Inst Biochem & Mol Biol, Notkestr 85, D-22607 Hamburg, Germany.	christian.betzel@uni-hamburg.de; henry.chapman@desy.de	Fromme, Raimund/C-8885-2012; Neutze, Richard/A-7573-2010; Bajt, Sasa/O-4695-2019; Chao, Tzu-Chiao/A-6400-2013; FRS, Henry N Chapman/G-2153-2010; Zatsepin, Nadia/AAF-2451-2019; Fromme, Raimund/AAG-6578-2019; Messerschmidt, Marc/F-3796-2010; Barty, Anton/K-5137-2014; Johansson, Linda/B-1240-2011; Stellato, Francesco/AAZ-4379-2020; Kirian, Richard/M-3750-2013; Nass, Karol/K-1970-2012; Betzel, Christian/G-8105-2018; Katona, Gergely/B-3491-2008; Bajt, Sasa/G-2228-2010; Timneanu, Nicusor/C-7691-2012; Fromme, Raimund/W-5838-2019; Frank, Matthias/O-9055-2014; Schlichting, Ilme/I-1339-2013; Johansson, Linda/O-6893-2019; Messerschmidt, Marc/Y-8929-2019	Fromme, Raimund/0000-0003-4835-1080; Neutze, Richard/0000-0003-0986-6153; Bajt, Sasa/0000-0002-7163-7602; FRS, Henry N Chapman/0000-0002-4655-1743; Messerschmidt, Marc/0000-0002-8641-3302; Barty, Anton/0000-0003-4751-2727; Johansson, Linda/0000-0003-4776-5142; Nass, Karol/0000-0001-8843-1566; Betzel, Christian/0000-0002-3879-5019; Katona, Gergely/0000-0002-2031-8716; Timneanu, Nicusor/0000-0001-7328-0400; Fromme, Raimund/0000-0003-4835-1080; Johansson, Linda/0000-0003-4776-5142; Messerschmidt, Marc/0000-0002-8641-3302; Johansson, Linda/0000-0002-8931-0683; MARTIN, ANDREW/0000-0003-3704-1829; Kirian, Richard/0000-0001-7197-3086; Zatsepin, Nadia/0000-0003-1757-0205; Aquila, Andrew/0000-0003-0358-2774; Koopmann, Rudolf/0000-0002-7416-6340; Chao, Tzu-Chiao/0000-0001-8781-6958; White, Thomas/0000-0002-8407-0270; Frank, Matthias/0000-0002-5244-0791; Seibert, Mark Marvin/0000-0003-0251-0744	German Federal Ministry for Education and Research [01KX0806, 01KX0807]; Hamburg Ministry of Science and Research; Joachim Herz Stiftung, Hamburg Initiative for Excellence in Research; Hamburg School for Structure and Dynamics in Infection (SDI); Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Inflammation at interfaces" [EXC 306]; DFG; Landesgraduiertenforderung Baden-Wurttemberg; Max Planck Society; Swedish Research Council; Swedish Strategic Research Foundation; Swedish Foundation for International Cooperation in Research and Higher Education; U.S. Department of Energy Office of Basic Energy Sciences through PULSE Institute at SLAC; U.S. Department of Energy through Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; University of California Office of the President Lab Fee Program [118036]; NSF [MCB-1021557, MCB-1120997]; NIH [1R01GM095583]; Div Of Molecular and Cellular Bioscience [1021557] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094599, R01GM095583] Funding Source: NIH RePORTER	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Hamburg Ministry of Science and Research; Joachim Herz Stiftung, Hamburg Initiative for Excellence in Research; Hamburg School for Structure and Dynamics in Infection (SDI); Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Inflammation at interfaces"(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Landesgraduiertenforderung Baden-Wurttemberg; Max Planck Society(Max Planck SocietyFoundation CELLEX); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Swedish Foundation for International Cooperation in Research and Higher Education; U.S. Department of Energy Office of Basic Energy Sciences through PULSE Institute at SLAC(United States Department of Energy (DOE)); U.S. Department of Energy through Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); University of California Office of the President Lab Fee Program(University of California System); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Experiments were carried out in February 2011 at the LCLS, a national user facility operated by Stanford University on behalf of the U. S. Department of Energy, Office of Basic Energy Sciences. This work was supported by the following agencies: the German Federal Ministry for Education and Research (grants 01KX0806 and 01KX0807), the Hamburg Ministry of Science and Research and Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research and the Hamburg School for Structure and Dynamics in Infection (SDI), the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Inflammation at interfaces" (EXC 306), the DFG, the Landesgraduiertenforderung Baden-Wurttemberg, the Max Planck Society, the Swedish Research Council, the Swedish Strategic Research Foundation, the Swedish Foundation for International Cooperation in Research and Higher Education, the U.S. Department of Energy Office of Basic Energy Sciences through PULSE Institute at SLAC, the U.S. Department of Energy through Lawrence Livermore National Laboratory under the contract DE-AC52-07NA27344 and supported by the University of California Office of the President Lab Fee Program (award no. 118036), the NSF (award MCB-1021557 and MCB-1120997), and the NIH (award 1R01GM095583).	Abdulla MH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000298; Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; Barty A, 2012, NAT PHOTONICS, V6, P35, DOI [10.1038/nphoton.2011.297, 10.1038/NPHOTON.2011.297]; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Boutet S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035024; Bryant C, 2009, BIOORG MED CHEM LETT, V19, P6218, DOI 10.1016/j.bmcl.2009.08.098; Chagas JR, 1996, FEBS LETT, V392, P233, DOI 10.1016/0014-5793(96)00822-8; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Chen YM, 1996, FEBS LETT, V393, P24, DOI 10.1016/0014-5793(96)00847-2; Dubin G, 2005, CELL MOL LIFE SCI, V62, P653, DOI 10.1007/s00018-004-4445-9; Fairlamb AH, 2003, TRENDS PARASITOL, V19, P488, DOI 10.1016/j.pt.2003.09.002; Frearson JA, 2010, NATURE, V464, P728, DOI 10.1038/nature08893; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; Kerr ID, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000701; Kirian RA, 2010, OPT EXPRESS, V18, P5713, DOI 10.1364/OE.18.005713; Koopmann R, 2012, NAT METHODS, V9, P259, DOI [10.1038/NMETH.1859, 10.1038/nmeth.1859]; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; Podobnik M, 1997, J MOL BIOL, V271, P774, DOI 10.1006/jmbi.1997.1218; Quraishi O, 1999, BIOCHEMISTRY-US, V38, P5017, DOI 10.1021/bi981950o; Riekel C, 2004, J SYNCHROTRON RADIAT, V11, P4, DOI 10.1107/S090904950302541X; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Southworth-Davies RJ, 2007, STRUCTURE, V15, P1531, DOI 10.1016/j.str.2007.10.013; Tomoo K, 2010, CURR TOP MED CHEM, V10, P696, DOI 10.2174/156802610791113441; Weierstall U, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3693040; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312; Yamamoto Y, 2002, CURR PROTEIN PEPT SC, V3, P231, DOI 10.2174/1389203024605331	29	330	341	1	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					227	230		10.1126/science.1229663	http://dx.doi.org/10.1126/science.1229663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23196907	Green Accepted			2022-12-24	WOS:000313328200050
J	Rollauer, SE; Tarry, MJ; Graham, JE; Jaaskelainen, M; Jager, F; Johnson, S; Krehenbrink, M; Liu, SM; Lukey, MJ; Marcoux, J; McDowell, MA; Rodriguez, F; Roversi, P; Stansfeld, PJ; Robinson, CV; Sansom, MSP; Palmer, T; Hogbom, M; Berks, BC; Lea, SM				Rollauer, Sarah E.; Tarry, Michael J.; Graham, James E.; Jaaskelainen, Mari; Jaeger, Franziska; Johnson, Steven; Krehenbrink, Martin; Liu, Sai-Man; Lukey, Michael J.; Marcoux, Julien; McDowell, Melanie A.; Rodriguez, Fernanda; Roversi, Pietro; Stansfeld, Phillip J.; Robinson, Carol V.; Sansom, Mark S. P.; Palmer, Tracy; Hogbom, Martin; Berks, Ben C.; Lea, Susan M.			Structure of the TatC core of the twin-arginine protein transport system	NATURE			English	Article							SEC-INDEPENDENT PROTEIN; CYSTEINE SCANNING MUTAGENESIS; SIGNAL PEPTIDE; TRANSLOCASE COMPONENT; PATHWAY; TOPOLOGY; BINDING; FORM; COMPLEXES; EFFICIENT	The twin-arginine translocation (Tat) pathway is one of two general protein transport systems found in the prokaryotic cytoplasmic membrane and is conserved in the thylakoid membrane of plant chloroplasts. The defining, and highly unusual, property of the Tat pathway is that it transports folded proteins, a task that must be achieved without allowing appreciable ion leakage across the membrane. The integral membrane TatC protein is the central component of the Tat pathway. TatC captures substrate proteins by binding their signal peptides. TatC then recruits TatA family proteins to form the active translocation complex. Here we report the crystal structure of TatC from the hyperthermophilic bacterium Aquifex aeolicus. This structure provides a molecular description of the core of the Tat translocation system and a framework for understanding the unique Tat transport mechanism.	[Rollauer, Sarah E.; Graham, James E.; Krehenbrink, Martin; Liu, Sai-Man; Lukey, Michael J.; Rodriguez, Fernanda; Stansfeld, Phillip J.; Sansom, Mark S. P.; Berks, Ben C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Rollauer, Sarah E.; Graham, James E.; Johnson, Steven; Liu, Sai-Man; Lukey, Michael J.; McDowell, Melanie A.; Roversi, Pietro; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Tarry, Michael J.; Jaaskelainen, Mari; Hogbom, Martin] Stockholm Univ, Dept Biochem & Biophys, Stockholm Ctr Biomembrane Res, S-10691 Stockholm, Sweden; [Jaeger, Franziska; Palmer, Tracy] Univ Dundee, Div Mol Microbiol, Coll Life Sci, Dundee DD1 5EH, Scotland; [Marcoux, Julien; Robinson, Carol V.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	University of Oxford; University of Oxford; Stockholm University; University of Dundee; University of Oxford	Berks, BC (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	ben.berks@bioch.ox.ac.uk; susan.lea@path.ox.ac.uk	Roversi, Pietro/AAK-4241-2021; Marcoux, Julien/I-3908-2012; Jaeger, Franziska/AGY-9260-2022; Rollauer, Sarah/L-4576-2016; Johnson, Steven J/F-9182-2016; Jaeger, Franziska/I-4764-2017; Stansfeld, Phill/C-6213-2011; Sansom, Mark S.P./C-5157-2009; Stansfeld, Phillip James/AAA-9228-2020; Lea, Susan M/B-7678-2009; Roversi, Pietro/F-8925-2011	Roversi, Pietro/0000-0001-9280-9437; Jaeger, Franziska/0000-0002-6823-4589; Rollauer, Sarah/0000-0002-2116-3170; Johnson, Steven J/0000-0002-7877-3543; Jaeger, Franziska/0000-0002-6823-4589; Stansfeld, Phill/0000-0001-8800-7669; Sansom, Mark S.P./0000-0001-6360-7959; Stansfeld, Phillip James/0000-0001-8800-7669; Lea, Susan M/0000-0001-9287-8053; Roversi, Pietro/0000-0001-9280-9437; Palmer, Tracy/0000-0001-9043-2592; robinson, carol/0000-0001-7829-5505; Marcoux, Julien/0000-0001-7321-7436; Lukey, Michael/0000-0003-3608-3883; Graham, James/0000-0002-8639-7592; Berks, Ben/0000-0001-9685-4067; McDowell, Melanie/0000-0002-5231-8809; Hogbom, Martin/0000-0001-5574-9383	Wellcome Trust [083599, 092970MA]; Swedish Foundation for Strategic Research; Swedish Research Council [2010-5061]; E.P. Abrahams Cephalosporin Trust; Biotechnology and Biological Sciences Research Council [BB/E023347/1, BB/1019855/1]; Medical Research Council [G1001640, G0900888]; European Research Council; James Martin 21st Century School Vaccine Design Institute; BBSRC [BB/H000267/1, BB/E023347/1, BB/I019855/1, BB/F02150X/1] Funding Source: UKRI; MRC [G1001640] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F02150X/1, BB/H000267/1, B19456, BBS/B/16011, BEP17032, BB/I019855/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); E.P. Abrahams Cephalosporin Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); James Martin 21st Century School Vaccine Design Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. Byrne, G. Orriss and R. Owens for their contributions to the early stages of this project; R. Keller for advice; and J. Willemde Gier, D. Daley and R. Huber for providing strains and reagents. This work was supported by the Wellcome Trust (studentships to S.E.R., J.E.G. and M.A.M.; grant 083599, P.R.; grant 092970MA, M.S.P.S.), the Swedish Foundation for Strategic Research ('Future research leaders 4' to M.H.), the Swedish Research Council (grant 2010-5061 to M.H.), the E.P. Abrahams Cephalosporin Trust (M.K. and F.R.), the Biotechnology and Biological Sciences Research Council (studentship, M.J.L.; grant BB/E023347/1, S-M.L.; grant BB/1019855/1, P.J.S.), the Medical Research Council (grant G1001640, F.J.; grant G0900888, S.J.), and the European Research Council (Advanced Grant IMPRESS, J.M. and C.V.R.). Work in S.M.L.'s group is funded by the James Martin 21st Century School Vaccine Design Institute.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BARKAN A, 1986, EMBO J, V5, P1421, DOI 10.1002/j.1460-2075.1986.tb04378.x; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G.B.E., 2011, BUSTER 2 11 2; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; Celedon J. M., 2012, BIOCH BIOPHYS ACTA; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Fritsch MJ, 2012, MOL MICROBIOL, V84, P1108, DOI 10.1111/j.1365-2958.2012.08080.x; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gouffi K, 2002, FEBS LETT, V525, P65, DOI 10.1016/S0014-5793(02)03069-7; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Jeong KJ, 2004, J MOL BIOL, V341, P901, DOI 10.1016/j.jmb.2004.05.078; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kneuper H, 2012, MOL MICROBIOL, V85, P945, DOI 10.1111/j.1365-2958.2012.08151.x; Koch S, 2012, J BIOL CHEM, V287, P14420, DOI 10.1074/jbc.M112.354555; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; Maldonado B, 2011, J MOL MICROB BIOTECH, V20, P168, DOI 10.1159/000329076; Monticelli L, 2008, J COMPUT CHEM, V29, P1740, DOI 10.1002/jcc.20935; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; MOULD RM, 1991, J BIOL CHEM, V266, P12189; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Punginelli C, 2007, J BACTERIOL, V189, P5482, DOI 10.1128/JB.00647-07; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Scott KA, 2008, STRUCTURE, V16, P621, DOI 10.1016/j.str.2008.01.014; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Stansfeld PJ, 2011, J CHEM THEORY COMPUT, V7, P1157, DOI 10.1021/ct100569y; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; Tarry M, 2012, PROTEIN EXPRES PURIF, V82, P373, DOI 10.1016/j.pep.2012.02.003; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Zoufaly S, 2012, J BIOL CHEM, V287, P13430, DOI 10.1074/jbc.M112.343798	63	128	129	2	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					210	+		10.1038/nature11683	http://dx.doi.org/10.1038/nature11683			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23201679	Green Accepted			2022-12-24	WOS:000312259300033
J	Horn, S; Figl, A; Rachakonda, PS; Fischer, C; Sucker, A; Gast, A; Kadel, S; Moll, I; Nagore, E; Hemminki, K; Schadendorf, D; Kumar, R				Horn, Susanne; Figl, Adina; Rachakonda, P. Sivaramakrishna; Fischer, Christine; Sucker, Antje; Gast, Andreas; Kadel, Stephanie; Moll, Iris; Nagore, Eduardo; Hemminki, Kari; Schadendorf, Dirk; Kumar, Rajiv			TERT Promoter Mutations in Familial and Sporadic Melanoma	SCIENCE			English	Article							CANCER; GENE; TRANSCRIPTION; BINDING; ELK-1	Cutaneous melanoma occurs in both familial and sporadic forms. We investigated a melanoma-prone family through linkage analysis and high-throughput sequencing and identified a disease-segregating germline mutation in the promoter of the telomerase reverse transcriptase (TERT) gene, which encodes the catalytic subunit of telomerase. The mutation creates a new binding motif for Ets transcription factors and ternary complex factors (TCFs) near the transcription start and, in reporter gene assays, caused up to twofold increase in transcription. We then screened the TERT promoter in sporadic melanoma and observed recurrent ultraviolet signature somatic mutations in 125 of 168 (74%) of human cell lines derived from metastatic melanomas, 45 of 53 corresponding metastatic tumor tissues (85%), and 25 of 77 (33%) primary melanomas. The majority of those mutations occurred at two positions in the TERT promoter and also generated binding motifs for Ets/TCF transcription factors.	[Horn, Susanne; Figl, Adina; Rachakonda, P. Sivaramakrishna; Gast, Andreas; Kadel, Stephanie; Hemminki, Kari; Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany; [Horn, Susanne; Figl, Adina; Sucker, Antje; Gast, Andreas; Kadel, Stephanie; Moll, Iris; Schadendorf, Dirk] Univ Hosp Essen, Dept Dermatol, D-45122 Essen, Germany; [Fischer, Christine] Heidelberg Univ, Inst Human Genet, D-69120 Heidelberg, Germany; [Nagore, Eduardo] Inst Valenciano Oncol, Dept Dermatol, Valencia, Spain; [Hemminki, Kari] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; Ruprecht Karls University Heidelberg; Instituto Valenciano De Oncologia; Lund University	Schadendorf, D (corresponding author), Univ Hosp Essen, Dept Dermatol, D-45122 Essen, Germany.	dirk.schadendorf@uk-essen.de; r.kumar@dkfz.de	Schadendorf, Dirk/AAE-8206-2019; Kumar, Rajiv/H-6431-2019; Nagore, Eduardo/Z-2126-2019	Kumar, Rajiv/0000-0002-6093-0395; Nagore, Eduardo/0000-0003-3433-8707; Rachakonda, Sivaramakrishna/0000-0002-2319-2821	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank Eurofins MWG Operon (Ebersberg, Germany) for sequencing service and M. Kircher and U. Stenzel for comments on sequence analysis. The study was partially supported by a grant from Deutsche Forschungsgemeinschaft (DFG). The mutation data reported in this manuscript are deposited in www.sanger.ac.uk/genetics/CGP/cosmic/.	AKIYAMA Y, 1995, TFSEARCH; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; JANKNECHT R, 1995, ONCOGENE, V10, P1209; Kujoth GC, 1998, CELL GROWTH DIFFER, V9, P523; Kumar R, 2003, CLIN CANCER RES, V9, P3362; LEE WK, 1991, J MOL BIOL, V220, P599, DOI 10.1016/0022-2836(91)90103-D; RAO VN, 1994, ONCOGENE, V9, P1855; SHORE P, 1995, NUCLEIC ACIDS RES, V23, P4698, DOI 10.1093/nar/23.22.4698; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200	12	1218	1251	3	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					959	961		10.1126/science.1230062	http://dx.doi.org/10.1126/science.1230062			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23348503				2022-12-24	WOS:000315149600050
J	Qin, J; Wu, SP; Creighton, CJ; Dai, FY; Xie, X; Cheng, CM; Frolov, A; Ayala, G; Lin, X; Feng, XH; Ittmann, MM; Tsai, SJ; Tsai, MJ; Tsai, SY				Qin, Jun; Wu, San-Pin; Creighton, Chad J.; Dai, Fangyan; Xie, Xin; Cheng, Chiang-Min; Frolov, Anna; Ayala, Gustavo; Lin, Xia; Feng, Xin-Hua; Ittmann, Michael M.; Tsai, Shaw-Jenq; Tsai, Ming-Jer; Tsai, Sophia Y.			COUP-TFII inhibits TGF-beta-induced growth barrier to promote prostate tumorigenesis	NATURE			English	Article							TRANSCRIPTION FACTOR-II; GENE-EXPRESSION; CANCER; ORPHAN; ANGIOGENESIS; SUPPRESSION; METASTASIS; RECURRENCE; MOUSE	Mutations in phosphatase and tensin homologue (PTEN) or genomic alterations in the phosphatidylinositol-3-OH kinase-signalling pathway are the most common genetic alterations reported in human prostate cancer(1-4). However, the precise mechanism underlying how indolent tumours with PTEN alterations acquire metastatic potential remains poorly understood. Recent studies suggest that upregulation of transforming growth factor (TGF)-beta signalling triggered by PTEN loss will form a growth barrier as a defence mechanism to constrain prostate cancer progression(5), underscoring that TGF-beta signalling might represent a pre-invasive checkpoint to prevent PTEN-mediated prostate tumorigenesis. Here we show that COUP transcription factor II (COUP-TFII, also known as NR2F2)(6-9), a member of the nuclear receptor superfamily, serves as a key regulator to inhibit SMAD4-dependent transcription, and consequently overrides the TGF-beta-dependent checkpoint for PTEN-null indolent tumours. Overexpression of COUP-TFII in the mouse prostate epithelium cooperates with PTEN deletion to augment malignant progression and produce an aggressive metastasis-prone tumour. The functional counteraction between COUP-TFII and SMAD4 is reinforced by genetically engineered mouse models in which conditional loss of SMAD4 diminishes the inhibitory effects elicited by COUP-TFII ablation. The biological significance of COUP-TFII in prostate carcinogenesis is substantiated by patient sample analysis, in which COUP-TFII expression or activity is tightly correlated with tumour recurrence and disease progression, whereas it is inversely associated with TGF-beta signalling. These findings reveal that the destruction of the TGF-beta-dependent barrier by COUP-TFII is crucial for the progression of PTEN-mutant prostate cancer into a life-threatening disease, and supports COUP-TFII as a potential drug target for the intervention of metastatic human prostate cancer.	[Qin, Jun; Wu, San-Pin; Dai, Fangyan; Xie, Xin; Cheng, Chiang-Min; Feng, Xin-Hua; Tsai, Shaw-Jenq; Tsai, Ming-Jer; Tsai, Sophia Y.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Dai, Fangyan; Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Frolov, Anna; Ayala, Gustavo; Ittmann, Michael M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Tsai, Shaw-Jenq] Natl Cheng Kung Univ, Dept Physiol, Coll Med, Tainan 701, Taiwan; [Tsai, Ming-Jer; Tsai, Sophia Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; National Cheng Kung University; Baylor College of Medicine	Tsai, MJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	mtsai@bcm.edu; stsai@bcm.edu	Tsai, Shaw-Jenq/AAG-6569-2019; , San Pin Wu/AAF-8371-2020; Dai, Fangyan/J-8927-2016; Ayala, Gustavo/ABC-6625-2020	, San Pin Wu/0000-0001-9626-784X; TSAI, SHAW-JENQ/0000-0002-3569-5813	DERC Center [P30 DK079638]; National Institutes of Health [DK62434, DK59820, DK45641, HL76448]; Dan L. Duncan Cancer Center; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638, R01DK045641, R37DK045641, P01DK059820, U19DK062434] Funding Source: NIH RePORTER	DERC Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dan L. Duncan Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Wu for the Pten<SUP>flox/flox</SUP> mice, F. Wang for ARR2PB-Cre (PB-Cre) transgenic mice and E. J. Robertson for the Smad4<SUP>flox/flox</SUP> mice. We thank H. K. Graves and L.-Y. Yu-Lee for editorial assistance and S. Elledge for comments. We also thank the Baylor Microarray Core supported by the DERC Center (P30 DK079638) for the microarray analysis. This work was supported by grants from the National Institutes of Health DK62434, DK59820 (S.Y.T. and M.-J.T.), DK45641 (M.-J.T.) and HL76448 (S.Y.T.), and the Dan L. Duncan Cancer Center.	Agoulnik IU, 2006, CANCER RES, V66, P10594, DOI 10.1158/0008-5472.CAN-06-1023; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Creighton CJ, 2008, J CLIN ONCOL, V26, P4078, DOI 10.1200/JCO.2007.13.4429; Creighton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034546; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Hodgson MC, 2011, CANCER RES, V71, P572, DOI 10.1158/0008-5472.CAN-10-2314; Jin CL, 2003, PROSTATE, V57, P160, DOI 10.1002/pros.10283; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Li LP, 2009, CELL METAB, V9, P77, DOI 10.1016/j.cmet.2008.12.002; Lin FJ, 2011, ENDOCR REV, V32, P404, DOI 10.1210/er.2010-0021; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Nagasaki S, 2009, CANCER SCI, V100, P639, DOI 10.1111/j.1349-7006.2008.01078.x; Nakagawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002318; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Park JH, 2002, AM J PATHOL, V161, P727, DOI 10.1016/S0002-9440(10)64228-9; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Qin J, 2010, CANCER RES, V70, P8812, DOI 10.1158/0008-5472.CAN-10-0551; Qin J, 2010, P NATL ACAD SCI USA, V107, P3687, DOI 10.1073/pnas.0914619107; Shin SW, 2009, ONCOL REP, V21, P101, DOI 10.3892/or_00000195; Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu SP, 2010, MOL ENDOCRINOL, V24, P1297, DOI 10.1210/me.2010-0068; Yeh HY, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-70; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	37	130	138	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					236	U252		10.1038/nature11674	http://dx.doi.org/10.1038/nature11674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23201680	Green Accepted			2022-12-24	WOS:000313259600042
J	Tsai, NP; Wilkerson, JR; Guo, WR; Maksimova, MA; DeMartino, GN; Cowan, CW; Huber, KM				Tsai, Nien-Pei; Wilkerson, Julia R.; Guo, Weirui; Maksimova, Marina A.; DeMartino, George N.; Cowan, Christopher W.; Huber, Kimberly M.			Multiple Autism-Linked Genes Mediate Synapse Elimination via Proteasomal Degradation of a Synaptic Scaffold PSD-95	CELL			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; MESSENGER-RNA; OL-PROTOCADHERIN; TRANSLATION; MEF2; ENDOCYTOSIS; TRAFFICKING; EXPRESSION; DIVERSITY	The activity-dependent transcription factor myocyte enhancer factor 2 (MEF2) induces excitatory synapse elimination in mouse neurons, which requires fragile X mental retardation protein (FMRP), an RNA-binding protein implicated in human cognitive dysfunction and autism. We report here that protocadherin 10 (Pcdh10), an autism-spectrum disorders gene, is necessary for this process. MEF2 and FMRP cooperatively regulate the expression of Pcdh10. Upon MEF2 activation, PSD-95 is ubiquitinated by the ubiquitin E3 ligase murine double minute 2 (Mdm2) and then binds to Pcdh10, which links it to the proteasome for degradation. Blockade of the Pcdh10-proteasome interaction inhibits MEF2-induced PSD-95 degradation and synapse elimination. In FMRP-lacking neurons, elevated protein levels of eukaryotic translation elongation factor 1 alpha (EF1 alpha), an Mdm2-interacting protein and FMRP target mRNA, sequester Mdm2 and prevent MEF2-induced PSD-95 ubiquitination and synapse elimination. Together, our findings reveal roles for multiple autism-linked genes in activity-dependent synapse elimination.	[Tsai, Nien-Pei; Wilkerson, Julia R.; Guo, Weirui; Maksimova, Marina A.; Huber, Kimberly M.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Cowan, Christopher W.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Cowan, Christopher W.] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Huber, KM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	kimberly.huber@utsouthwestern.edu	Guo, Weirui/G-2868-2015; Cowan, Christopher W/I-2497-2014; Huber, Kimberly/X-5534-2019; Litvinova, Marina/C-6154-2017	WILKERSON, JULIA/0000-0002-7497-2270; Litvinova, Marina/0000-0002-2622-6548	National Institutes of Health [NS045711, HD052731, F32HD069111, F32HD062120]; Simons Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052731, F32HD069111] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD062120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027664] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grants from the National Institutes of Health NS045711, HD052731 (K.M.H.), F32HD069111 (N.-P.T.), F32HD062120 (J.R.W.) and from the Simons Foundations (K.M.H. and C.W.C.). We would also like to thank L. Ormazabal, N. Cabalo, F. Niere, K. Loerwald, T. Zang, D. Thompson, X. Li, and B. Chen for technical assistance; Dr. M. Rosen for the GST-Pcdh10 constructs; Dr. J. Gibson for helpful discussions; and Drs. Robert and Jennifer Darnell for sharing their FMRP-CLIP target list prior to publication.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Berry-Kravis E, 2002, DEV MED CHILD NEUROL, V44, P724; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Dolen G, 2010, PHARMACOL THERAPEUT, V127, P78, DOI 10.1016/j.pharmthera.2010.02.008; Dolezelova P, 2012, CELL CYCLE, V11, P953, DOI 10.4161/cc.11.5.19445; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Frum R, 2007, J PROTEOME RES, V6, P1410, DOI 10.1021/pr060584p; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; Haas KF, 2007, MOL CELL NEUROSCI, V35, P64, DOI 10.1016/j.mcn.2007.02.002; Hirano S, 1999, J NEUROSCI, V19, P995; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Kim YC, 2011, J BIOL CHEM, V286, P26652, DOI 10.1074/jbc.M111.246793; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Morishita H, 2007, CURR OPIN CELL BIOL, V19, P584, DOI 10.1016/j.ceb.2007.09.006; Morishita H, 2006, J BIOL CHEM, V281, P33650, DOI 10.1074/jbc.M603298200; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Niere F, 2012, J NEUROSCI, V32, P5924, DOI 10.1523/JNEUROSCI.4650-11.2012; Novara F, 2010, CLIN GENET, V78, P471, DOI 10.1111/j.1399-0004.2010.01413.x; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; Pan F, 2010, P NATL ACAD SCI USA, V107, P17768, DOI 10.1073/pnas.1012496107; Pfeiffer BE, 2010, NEURON, V66, P191, DOI 10.1016/j.neuron.2010.03.017; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Rezvani K, 2007, J NEUROSCI, V27, P10508, DOI 10.1523/JNEUROSCI.3353-07.2007; Sturgill JF, 2009, J NEUROSCI, V29, P12845, DOI 10.1523/JNEUROSCI.1841-09.2009; Sung YJ, 2003, J BIOL CHEM, V278, P15669, DOI 10.1074/jbc.M211117200; Tian XY, 2010, MOL CELL NEUROSCI, V44, P94, DOI 10.1016/j.mcn.2010.01.012; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Woods GF, 2011, J NEUROSCI, V31, P12129, DOI 10.1523/JNEUROSCI.6662-10.2011; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; Zhang MQ, 2007, P NATL ACAD SCI USA, V104, P10057, DOI 10.1073/pnas.0700169104	41	187	190	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1581	1594		10.1016/j.cell.2012.11.040	http://dx.doi.org/10.1016/j.cell.2012.11.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260144	Bronze, Green Accepted			2022-12-24	WOS:000312890300021
J	Ko, F; Vitale, S; Chou, CF; Cotch, MF; Saaddine, J; Friedman, DS				Ko, Fang; Vitale, Susan; Chou, Chiu-Fang; Cotch, Mary Frances; Saaddine, Jinan; Friedman, David S.			Prevalence of Nonrefractive Visual Impairment in US Adults and Associated Risk Factors, 1999-2002 and 2005-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TYPE-2 DIABETES-MELLITUS; UNITED-STATES; TEMPORAL TRENDS; RETINOPATHY; CHILDREN; ADOLESCENTS; PERSPECTIVE; HEALTH	Context Over the past decade, chronic illnesses with ophthalmic sequelae such as diabetes and diabetic retinopathy have increased. Objectives To estimate prevalence of nonrefractive visual impairment and to describe its relationship with demographic and systemic risk factors including diagnosed diabetes. Design, Setting, and Participants The National Health and Nutrition Examination Survey (NHANES) examined a representative sample of the US noninstitutionalized population. In 1999-2002 and 2005-2008, 9471 and 10 480 participants aged 20 years or older received questionnaires, laboratory tests, and physical examinations. Visual acuity of less than 20/40 aided by autorefractor was classified as nonrefractive visual impairment. Main Outcome Measure Nonrefractive visual impairment. Results Weighted prevalence of nonrefractive visual impairment increased 21% among US adults aged 20 years and older from 1.4% in 1999-2002 to 1.7% in 2005-2008 (P=.03); and increased 40% among non-Hispanic whites aged 20-39 years from 0.5% to 0.7% (P=.008). In multivariable analyses, statistically significant risk factors for nonrefractive visual impairment in 1999-2002 included age (per year odds ratio [OR], 1.07; 95% CI, 1.05-1.09), poverty (OR, 2.18; 95% CI, 1.31-3.64), lack of insurance (OR, 1.85; 95% CI, 1.16-2.95), and diabetes with 10 or more years since diagnosis (OR, 1.93; 95% CI, 1.15-3.25). In 2005-2008, risk factors included age (OR, 1.05; 95% CI, 1.04-1.07), poverty (OR, 2.23; 95% CI, 1.55-3.22), education less than high school (OR, 2.11; 95% CI, 1.54-2.90), and diabetes with 10 or more years since diagnosis (OR, 2.67; 95% CI, 1.64-4.37). Prevalence of diabetes with 10 or more years since diagnosis increased 22% overall from 2.8% to 3.6% (P=.02); and 133% among non-Hispanic whites aged 20-39 years from 0.3% to 0.7% (P<.001). Conclusion Prevalence of nonrefractive visual impairment was significantly higher in 2005-2008 than in 1999-2002 and may be attributable, in part, to higher prevalence of diabetes, an associated risk factor that increased in prevalence during this time period. JAMA. 2012;308(22):2361-2368 www.jama.com	[Ko, Fang; Friedman, David S.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Dana Ctr Prevent Ophthalmol, Baltimore, MD 21205 USA; [Friedman, David S.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Vitale, Susan; Cotch, Mary Frances] NEI, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA; [Chou, Chiu-Fang; Saaddine, Jinan] Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Centers for Disease Control & Prevention - USA	Friedman, DS (corresponding author), Wilmer 120,600 N Wolfe St, Baltimore, MD 21287 USA.	david.friedman@jhu.edu		Friedman, David/0000-0002-2055-5797; vitale, susan/0000-0002-5972-6848; Cotch, Mary Frances/0000-0002-2046-4350	National Eye Institute (ARVO); Pepose; David Friedman Research Grant Award; Centers for Disease Control and Prevention (CDC) [1U58DP002653-01]; National Center for Health Statistics (NCHS); CDC; National Institutes of Health (NIH) [Z01EY000402]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP002653] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [Z01EY000402, ZIAEY000402] Funding Source: NIH RePORTER	National Eye Institute (ARVO); Pepose; David Friedman Research Grant Award; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Health Statistics (NCHS); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Friedman reports having consulted for Alcon, Bausch and Lomb, Merck, Pfizer, Allergan, Nidek, and QLT. Dr Ko reports receipt of support for travel to meetings for the study or other purposes from the National Eye Institute (ARVO travel grant), a Pepose travel grant, and a David Friedman Research Grant Award for provision of writing assistance, medicines, equipment, or administratrive support. The remaining authors report no disclosures.; This study was supported by the Centers for Disease Control and Prevention (CDC) grant 1U58DP002653-01 and the David Friedman Research Grant Award. The National Health and Nutrition Examination Survey (NHANES) is sponsored by the National Center for Health Statistics (NCHS), CDC. Funding for the vision component was provided by the National Eye Institute (NEI), National Institutes of Health (NIH), Intramural Research Program grant Z01EY000402.	Acton KJ, 2002, AM J PUBLIC HEALTH, V92, P1485, DOI 10.2105/AJPH.92.9.1485; Berglund PA., 2009, SAS GLOB FOR 2009 MA, P246; Beydoun MA, 2009, OBESITY, V17, P169, DOI 10.1038/oby.2008.492; Burrows Nilka R., 2011, Morbidity and Mortality Weekly Report, V60, P1549; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Centers for Disease Control and Prevention, 2004, ANTIBIOTIC RESISTANC; Cheung BMY, 2009, AM J MED, V122, P443, DOI 10.1016/j.amjmed.2008.09.047; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Cugati S, 2006, DIABETES RES CLIN PR, V74, P301, DOI 10.1016/j.diabres.2006.04.002; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Frick KD, 2007, ARCH OPHTHALMOL-CHIC, V125, P544, DOI 10.1001/archopht.125.4.544; Hovind P, 2003, DIABETES CARE, V26, P1258, DOI 10.2337/diacare.26.4.1258; Kaufman FR, 2002, J PEDIATR ENDOCR MET, V15, P737; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; KLEIN R, 1991, DIABETES CARE, V14, P914, DOI 10.2337/diacare.14.10.914; Klein R., 1995, DIABETES AM, V2nd ed., P293, DOI DOI 10.1063/1.1522643; Klein R, 2010, DIABETES, V59, P1853, DOI 10.2337/db09-1904; Klein R, 2010, OPHTHALMOLOGY, V117, P63, DOI 10.1016/j.ophtha.2009.06.051; LeCaire T, 2006, AM J EPIDEMIOL, V164, P143, DOI 10.1093/aje/kwj166; Lytle LA, 2012, ABDOM IMAGING, V37, P719, DOI 10.1007/s00261-012-9861-y; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; *NAT HLTH NUTR EX, PUBL US DAT FIL; *NAT HLTH NUTR EX, VIS PROC MAN; National Health and Nutrition Examination Survey, LAB PROC MAN; National Health and Nutrition Examination Survey, HYP TEST; National Health and Nutrition Examination Survey, AN REP GUID; Palaniappan L, 2003, AM J HYPERTENS, V16, P952, DOI 10.1016/S0895-7061(03)01009-4; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; Roberts CB, 2010, ARCH OPHTHALMOL-CHIC, V128, P766, DOI 10.1001/archophthalmol.2010.86; Vitale S, 2006, JAMA-J AM MED ASSOC, V295, P2158, DOI 10.1001/jama.295.18.2158; Yuan YC., 2000, MULTIPLE IMPUTATION; Zambelli-Weiner A, AM J OPHTHALMOL, DOI [10.1016/j.ajo.2012.03 .018, DOI 10.1016/J.AJO.2012.03]; Zhang XZ, 2008, ARCH OPHTHALMOL-CHIC, V126, P1421, DOI 10.1001/archopht.126.10.1421; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	37	57	58	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2012	308	22					2361	2368		10.1001/jama.2012.85685	http://dx.doi.org/10.1001/jama.2012.85685			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051MW	23232894	Green Accepted			2022-12-24	WOS:000312132400026
J	Soldner, F; Jaenisch, R				Soldner, Frank; Jaenisch, Rudolf			iPSC Disease Modeling	SCIENCE			English	Editorial Material							PLURIPOTENT; GENERATION		[Soldner, Frank; Jaenisch, Rudolf] Whitehead Inst, Cambridge, MA 02142 USA; [Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Soldner, F (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu			NATIONAL CANCER INSTITUTE [R01CA084198] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA084198] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kim H, 2011, CELL STEM CELL, V8, P695, DOI 10.1016/j.stem.2011.04.002; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Majewski J, 2011, TRENDS GENET, V27, P72, DOI 10.1016/j.tig.2010.10.006; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Onder TT, 2012, CURR OPIN GENET DEV, V22, P500, DOI 10.1016/j.gde.2012.05.005; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424	21	116	121	0	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1155	1156		10.1126/science.1227682	http://dx.doi.org/10.1126/science.1227682			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197518				2022-12-24	WOS:000311666200027
J	Huang, FW; Hodis, E; Xu, MJ; Kryukov, GV; Chin, L; Garraway, LA				Huang, Franklin W.; Hodis, Eran; Xu, Mary Jue; Kryukov, Gregory V.; Chin, Lynda; Garraway, Levi A.			Highly Recurrent TERT Promoter Mutations in Human Melanoma	SCIENCE			English	Article								Systematic sequencing of human cancer genomes has identified many recurrent mutations in the protein-coding regions of genes but rarely in gene regulatory regions. Here, we describe two independent mutations within the core promoter of telomerase reverse transcriptase (TERT), the gene coding for the catalytic subunit of telomerase, which collectively occur in 50 of 70 (71%) melanomas examined. These mutations generate de novo consensus binding motifs for E-twenty-six (ETS) transcription factors, and in reporter assays, the mutations increased transcriptional activity from the TERT promoter by two-to fourfold. Examination of 150 cancer cell lines derived from diverse tumor types revealed the same mutations in 24 cases (16%), with preliminary evidence of elevated frequency in bladder and hepatocellular cancer cells. Thus, somatic mutations in regulatory regions of the genome may represent an important tumorigenic mechanism.	[Huang, Franklin W.; Hodis, Eran; Xu, Mary Jue; Kryukov, Gregory V.; Garraway, Levi A.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Huang, Franklin W.; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Huang, Franklin W.; Hodis, Eran; Xu, Mary Jue; Garraway, Levi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hodis, Eran; Xu, Mary Jue] MIT, Harvard Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Garraway, LA (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	levi_garraway@dfci.harvard.edu	Kryukov, Gregory V/A-9592-2008; Gotoh, Osamu/B-4704-2012	Kryukov, Gregory/0000-0002-6131-9483	NIH [T32 CA009172]; Mittelman Family Fellowship; National Institute of General Medical Sciences [T32GM07753]; American Cancer Society; NIH New Innovator Award [DP2OD002750]; National Cancer Institute [R33CA126674]; Novartis Institutes for Biomedical Research; Melanoma Research Alliance; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE [T32CA009172, R33CA126674, P01CA163222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mittelman Family Fellowship; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Novartis Institutes for Biomedical Research; Melanoma Research Alliance; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. N. Wagner, D. Schadendorf, J. A. Wargo, and D. S. B. Hoon for contribution of samples; K. Cibulskis for assistance with whole-genome sequence data analysis; and E. Nickerson for coordination of validation/extension studies. This work was supported by NIH grant T32 CA009172 (F. W. H.), the Mittelman Family Fellowship (F. W. H.), National Institute of General Medical Sciences grant T32GM07753 (E. H.), the American Cancer Society (M. J. X.), NIH New Innovator Award DP2OD002750 (L. A. G.), National Cancer Institute grant R33CA126674 (L. A. G.), the Novartis Institutes for Biomedical Research (G. V. K. and L. A. G.), the Melanoma Research Alliance (L. A. G.), and the Starr Cancer Consortium (L. C. and L. A. G.). L. A. G. is on the Scientific Advisory Board of Millennium Pharmaceuticals, is a paid consultant for and holds equity in Foundation Medicine, and is a paid consultant for and sponsored research recipient from Novartis. The BAM files for the CCLE Whole Genome Sequencing data corresponding to the TERT locus can be accessed at ftp://tertguest:broad@ftp.broadinstitute.org.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bennett D. C., 2008, MELANOMA RES, V21, P27; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Pirker C, 2003, MELANOMA RES, V13, P483, DOI 10.1097/00008390-200310000-00007; Rutter JL, 1998, CANCER RES, V58, P5321; Zhang A., 2000, CANCER RES, V22, P6320	10	1260	1286	6	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					957	959		10.1126/science.1229259	http://dx.doi.org/10.1126/science.1229259			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23348506	Green Accepted			2022-12-24	WOS:000315149600049
J	Das Thakur, M; Salangsang, F; Landman, AS; Sellers, WR; Pryer, NK; Levesque, MP; Dummer, R; McMahon, M; Stuart, DD				Das Thakur, Meghna; Salangsang, Fernando; Landman, Allison S.; Sellers, William R.; Pryer, Nancy K.; Levesque, Mitchell P.; Dummer, Reinhard; McMahon, Martin; Stuart, Darrin D.			Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance	NATURE			English	Article							RAF INHIBITOR RESISTANCE; BRAF; BRAF(V600E); SENESCENCE; PATHWAY; CANCER	Mutational activation of BRAF is the most prevalent genetic alteration in human melanoma, with >= 50% of tumours expressing the BRAF(V600E) oncoprotein(1,2). Moreover, the marked tumour regression and improved survival of late-stage BRAF-mutated melanoma patients in response to treatment with vemurafenib demonstrates the essential role of oncogenic BRAF in melanoma maintenance(3,4). However, as most patients relapse with lethal drug-resistant disease, understanding and preventing mechanism(s) of resistance is critical to providing improved therapy(5). Here we investigate the cause and consequences of vemurafenib resistance using two independently derived primary human melanoma xenograft models in which drug resistance is selected by continuous vemurafenib administration. In one of these models, resistant tumours show continued dependency on BRAF(V600E)-> MEK -> ERK signalling owing to elevated BRAF(V600E) expression. Most importantly, we demonstrate that vemurafenib-resistant melanomas become drug dependent for their continued proliferation, such that cessation of drug administration leads to regression of established drug-resistant tumours. We further demonstrate that a discontinuous dosing strategy, which exploits the fitness disadvantage displayed by drug-resistant cells in the absence of the drug, forestalls the onset of lethal drug-resistant disease. These data highlight the concept that drug-resistant cells may also display drug dependency, such that altered dosing may prevent the emergence of lethal drug resistance. Such observations may contribute to sustaining the durability of the vemurafenib response with the ultimate goal of curative therapy for the subset of melanoma patients with BRAF mutations.	[Das Thakur, Meghna; Salangsang, Fernando; Pryer, Nancy K.; Stuart, Darrin D.] Novartis Inst Biomed Res, Emeryville, CA 94608 USA; [Landman, Allison S.; McMahon, Martin] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Landman, Allison S.; McMahon, Martin] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Sellers, William R.] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Levesque, Mitchell P.; Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	Novartis; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Novartis; University of Zurich; University Zurich Hospital	Stuart, DD (corresponding author), Novartis Inst Biomed Res, Emeryville, CA 94608 USA.	mcmahon@cc.ucsf.edu; darrin.stuart@novartis.com			NIBR Presidential Postdoctoral Fellowship; Melanoma Research Alliance; National Cancer Institute [R01-CA176839]; National Research Service Award T32 training grant [HL007185]; NATIONAL CANCER INSTITUTE [R01CA176839] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007185] Funding Source: NIH RePORTER	NIBR Presidential Postdoctoral Fellowship; Melanoma Research Alliance; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research Service Award T32 training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the members of the Novartis Institutes for BioMedical Reseach (NIBR) Pharmacology department for technical support, comments and discussions during the course of this work. We thank C. Voliva, N. Aziz and E. Collisson for discussions. We thank B. Weisburd and the rest of the NIBR Bioinformatics department for assistance with exome sequencing data analysis. We thank S. Kaufman for sharing her knowledge of cell-based assays. We thank V. Marsh, N. Rosen, P. Poulikakos and D. Solit for providing additional advice and reagents. M.D.T. was supported by an NIBR Presidential Postdoctoral Fellowship. M.M. acknowledges support from the Melanoma Research Alliance and the National Cancer Institute (R01-CA176839). A.S.L. was supported by a National Research Service Award T32 training grant HL007185.	Bennett DC, 2008, PIGM CELL MELANOMA R, V21, P27, DOI 10.1111/j.1755-148X.2007.00433.x; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chmielecki J, 2012, J THORAC ONCOL, V7, P434, DOI 10.1097/JTO.0b013e31823c5aee; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Fecher LA, 2008, CURR OPIN ONCOL, V20, P183, DOI 10.1097/CCO.0b013e3282f5271c; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hingorani SR, 2003, CANCER RES, V63, P5198; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Petti C, 2006, CANCER RES, V66, P6503, DOI 10.1158/0008-5472.CAN-05-4671; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Seghers AC, 2012, MELANOMA RES, V22, P466, DOI 10.1097/CMR.0b013e3283541541; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Tap WD, 2010, NEOPLASIA, V12, P637, DOI 10.1593/neo.10414; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	22	524	535	3	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					251	255		10.1038/nature11814	http://dx.doi.org/10.1038/nature11814			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23302800	Green Accepted			2022-12-24	WOS:000315137700043
J	Miller, RA; Chu, QW; Xie, JX; Foretz, M; Viollet, B; Birnbaum, MJ				Miller, Russell A.; Chu, Qingwei; Xie, Jianxin; Foretz, Marc; Viollet, Benoit; Birnbaum, Morris J.			Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP	NATURE			English	Article							ADENYLATE-CYCLASE ACTIVITY; DIABETES-MELLITUS; RESPIRATORY-CHAIN; PROTEIN-KINASE; ENERGY-STATE; METFORMIN; ADENOSINE; LIVER; INHIBITION; GLUCOSE	Glucose production by the liver is essential for providing a substrate for the brain during fasting. The inability of insulin to suppress hepatic glucose output is a major aetiological factor in the hyperglycaemia of type-2 diabetes mellitus and other diseases of insulin resistance(1,2). For fifty years, one of the few classes of therapeutics effective in reducing glucose production has been the biguanides, which include phenformim and metformin, the latter the most frequently prescribed drug for type-2 diabetes(3). Nonetheless, the mechanism of action of biguanides remains imperfectly understood. The suggestion a decade ago that metformin reduces glucose synthesis through activation of the enzyme AMP-activated protein kinase (AMPK) has recently been challenged by genetic loss-of-function experiments(4). Here we provide a novel mechanism by which metformin antagonizes the action of glucagon, thus reducing fasting glucose levels. In mouse hepatocytes, metformin leads to the accumulation of AMP and related nucleotides, which inhibit adenylate cyclase, reduce levels of cyclic AMP and protein kinase A (PICA) activity, abrogate phosphorylation of critical protein targets of PICA, and block glucagon-dependent glucose output from hepatocytes. These data support a mechanism of action for metformin involving antagonism of glucagon, and suggest an approach for the development of antidiabetic drugs.	[Miller, Russell A.; Chu, Qingwei; Birnbaum, Morris J.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Xie, Jianxin] Cell Signaling Technol Inc, Danvers, MA 01923 USA; [Foretz, Marc; Viollet, Benoit] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] CNRS, UMR8104, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, F-75006 Paris, France	University of Pennsylvania; Pennsylvania Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Birnbaum, MJ (corresponding author), Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.	birnbaum@mail.med.upenn.edu	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017; FORETZ, Marc/O-7334-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; Birnbaum, Morris/0000-0001-9972-8680	National Institutes of Health (NIH) [RO1 DK56886, PO1 DK49210, F32 DK079572]; Association pour l'Etude des Diabetes et des Maladies Metaboliques (ALFEDIAM); Programme National de Recherche sur le Diabete (PNRD); Institut Benjamin Delessert; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, P01DK049210, F32DK079572, R01DK056886] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association pour l'Etude des Diabetes et des Maladies Metaboliques (ALFEDIAM); Programme National de Recherche sur le Diabete (PNRD); Institut Benjamin Delessert; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants RO1 DK56886 and PO1 DK49210 (M.J.B.) and F32 DK079572 (R.A.M.), the Association pour l'Etude des Diabetes et des Maladies Metaboliques (ALFEDIAM) (to M.F.), the Programme National de Recherche sur le Diabete (PNRD) (to M.F. and B.V.) and the Institut Benjamin Delessert (to M.F.). Microscopy was performed in the University of Pennsylvania Cell and Developmental Biology Microscopy Core Facility. The Transgenic/Knockout, Mouse Phenotypipg, Viral Vector and Biomarker Cores of the University of Pennsylvania Diabetes and Endocrinology Research Center (NIH grant P30 DK19525) were instrumental in this work.	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Berglund ED, 2009, J CLIN INVEST, V119, P2412, DOI 10.1172/JCI38650; BLUME AJ, 1975, J BIOL CHEM, V250, P5003; D'Alessio D, 2011, DIABETES OBES METAB, V13, P126, DOI 10.1111/j.1463-1326.2011.01449.x; DEFRONZO RA, 1982, DIABETOLOGIA, V23, P313; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; FAIN JN, 1979, MOL CELL BIOCHEM, V25, P143; FAIN JN, 1972, J BIOL CHEM, V247, P6866; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; GAWLER DJ, 1989, J ENDOCRINOL, V122, P207, DOI 10.1677/joe.0.1220207; Goodarzi MO, 2005, DIABETES OBES METAB, V7, P654, DOI 10.1111/j.1463-1326.2004.00448.x; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; JOHNSON RA, 1989, MOL PHARMACOL, V35, P681; LONDOS C, 1977, J BIOL CHEM, V252, P5951; MASSON S, 1992, BIOCHEMISTRY-US, V31, P7488, DOI 10.1021/bi00148a008; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Post Sr, 2000, METH MOL B, V136, P363; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; STOLL B, 1992, BIOCHEM J, V287, P217, DOI 10.1042/bj2870217; Torres TP, 2011, J PHARMACOL EXP THER, V337, P610, DOI 10.1124/jpet.110.177899; TUCKER GT, 1981, BRIT J CLIN PHARMACO, V12, P235; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; YU B, 1994, BIOCHEM PHARMACOL, V48, P949, DOI 10.1016/0006-2952(94)90365-4; Zhang TT, 2009, J MOL ENDOCRINOL, V42, P57, DOI 10.1677/JME-08-0130; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	30	571	606	6	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					256	260		10.1038/nature11808	http://dx.doi.org/10.1038/nature11808			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23292513	Green Accepted			2022-12-24	WOS:000315137700044
J	Weber, M; Hauschild, R; Schwarz, J; Moussion, C; de Vries, I; Legler, DF; Luther, SA; Bollenbach, T; Sixt, M				Weber, Michele; Hauschild, Robert; Schwarz, Jan; Moussion, Christine; de Vries, Ingrid; Legler, Daniel F.; Luther, Sanjiv A.; Bollenbach, Tobias; Sixt, Michael			Interstitial Dendritic Cell Guidance by Haptotactic Chemokine Gradients	SCIENCE			English	Article							MIGRATION; CCL21; CHEMOTAXIS; SITES	Directional guidance of cells via gradients of chemokines is considered crucial for embryonic development, cancer dissemination, and immune responses. Nevertheless, the concept still lacks direct experimental confirmation in vivo. Here, we identify endogenous gradients of the chemokine CCL21 within mouse skin and show that they guide dendritic cells toward lymphatic vessels. Quantitative imaging reveals depots of CCL21 within lymphatic endothelial cells and steeply decaying gradients within the perilymphatic interstitium. These gradients match the migratory patterns of the dendritic cells, which directionally approach vessels from a distance of up to 90-micrometers. Interstitial CCL21 is immobilized to heparan sulfates, and its experimental delocalization or swamping the endogenous gradients abolishes directed migration. These findings functionally establish the concept of haptotaxis, directed migration along immobilized gradients, in tissues.	[Weber, Michele; Hauschild, Robert; Schwarz, Jan; Moussion, Christine; de Vries, Ingrid; Bollenbach, Tobias; Sixt, Michael] IST Austria Inst Sci & Technol Austria, A-3400 Klosterneuburg, Austria; [Legler, Daniel F.] Univ Konstanz, Biotechnol Inst Thurgau BITg, CH-8280 Kreuzlingen, Switzerland; [Luther, Sanjiv A.] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Institute of Science & Technology - Austria; University of Lausanne	Sixt, M (corresponding author), IST Austria Inst Sci & Technol Austria, Campus 1, A-3400 Klosterneuburg, Austria.	Sixt@ist.ac.at	Bollenbach, Tobias/AAK-3206-2020; Schwarz, Jan Oliver/AAH-7583-2020; Luther, Sanjiv/AAP-6525-2020; Luther, Sanjiv A/B-4380-2016; , Sanjiv/B-4380-2016	Bollenbach, Tobias/0000-0003-4398-476X; Luther, Sanjiv/0000-0002-8758-957X; Luther, Sanjiv A/0000-0002-8758-957X; Sixt, Michael/0000-0002-6620-9179; , Sanjiv/0000-0002-0614-561X; Weber, Michele/0000-0003-2056-3751; Legler, Daniel F./0000-0001-8610-4764	Humboldt Foundation; German Research Foundation [Si1323-1,2]; Human Frontier Science Program [HFSP-RGP0058/2011]; European Research Council [ERC StG 281556]; Swiss National Science Foundation [31003A_127474, 130488]	Humboldt Foundation(Alexander von Humboldt Foundation); German Research Foundation(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank M. Frank for technical assistance and S. Cremer, P. Schmalhorst, and E. Kiermaier for critical reading of the manuscript. This work was supported by a Humboldt Foundation postdoctoral fellowship (to M. W.), the German Research Foundation (Si1323-1,2 to M. S.), the Human Frontier Science Program (HFSP-RGP0058/2011 to M. S.), the European Research Council (ERC StG 281556 to M. S.), and the Swiss National Science Foundation (31003A_127474 to D.F.L., 130488 to S.A.L.). The authors declare no conflicts of interest. The data reported in the manuscript are tabulated in the main paper and in the supplementary materials.	Alon R, 2010, IMMUNITY, V33, P654, DOI 10.1016/j.immuni.2010.11.012; Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Bao XF, 2010, IMMUNITY, V33, P817, DOI 10.1016/j.immuni.2010.10.018; Bax M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006987; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Britschgi MR, 2010, EUR J IMMUNOL, V40, P1266, DOI 10.1002/eji.200939921; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; de Paz LL, 2007, ACS CHEM BIOL, V2, P735, DOI 10.1021/cb700159m; Ehrlich LIR, 2009, IMMUNITY, V31, P986, DOI 10.1016/j.immuni.2009.09.020; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Haessler U, 2011, P NATL ACAD SCI USA, V108, P5614, DOI 10.1073/pnas.1014920108; Hirose J, 2002, BBA-GEN SUBJECTS, V1571, P219, DOI 10.1016/S0304-4165(02)00232-5; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Muller P, 2011, DEV CELL, V21, P145, DOI 10.1016/j.devcel.2011.06.001; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; ROT A, 1993, EUR J IMMUNOL, V23, P303, DOI 10.1002/eji.1830230150; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Wei SH, 2003, IMMUNOL REV, V195, P136, DOI 10.1034/j.1600-065X.2003.00076.x	29	370	375	4	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2013	339	6117					328	332		10.1126/science.1228456	http://dx.doi.org/10.1126/science.1228456			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329049	Green Submitted			2022-12-24	WOS:000313622000047
J	Masaki, T; Qu, JR; Cholewa-Waclaw, J; Burr, K; Raaum, R; Rambukkana, A				Masaki, Toshihiro; Qu, Jinrong; Cholewa-Waclaw, Justyna; Burr, Karen; Raaum, Ryan; Rambukkana, Anura			Reprogramming Adult Schwann Cells to Stem Cell-like Cells by Leprosy Bacilli Promotes Dissemination of Infection	CELL			English	Article							PERIPHERAL-NERVE REGENERATION; VIABLE MYCOBACTERIUM-LEPRAE; MUSCLE REGENERATION; PULMONARY GRANULOMA; IN-VIVO; DEMYELINATION; PREDILECTION; ACTIVATION; EXPRESSION; RECEPTOR	Differentiated cells possess a remarkable genomic plasticity that can be manipulated to reverse or change developmental commitments. Here, we show that the leprosy bacterium hijacks this property to reprogram adult Schwann cells, its preferred host niche, to a stage of progenitor/stem-like cells (pSLC) of mesenchymal trait by downregulating Schwann cell lineage/differentiation-associated genes and up-regulating genes mostly of mesoderm development. Reprogramming accompanies epigenetic changes and renders infected cells highly plastic, migratory, and immunomodulatory. We provide evidence that acquisition of these properties by pSLC promotes bacterial spread by two distinct mechanisms: direct differentiation to mesenchymal tissues, including skeletal and smooth muscles, and formation of granuloma-like structures and subsequent release of bacteria-laden macrophages. These findings support a model of host cell reprogramming in which a bacterial pathogen uses the plasticity of its cellular niche for promoting dissemination of infection and provide an unexpected link between cellular reprogramming and host-pathogen interaction.	[Masaki, Toshihiro; Cholewa-Waclaw, Justyna; Rambukkana, Anura] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland; [Masaki, Toshihiro; Cholewa-Waclaw, Justyna; Burr, Karen; Rambukkana, Anura] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh EH16 4UU, Midlothian, Scotland; [Rambukkana, Anura] Univ Edinburgh, Ctr Infect Dis, Edinburgh EH16 4UU, Midlothian, Scotland; [Masaki, Toshihiro; Qu, Jinrong; Raaum, Ryan; Rambukkana, Anura] Rockefeller Univ, New York, NY 10065 USA	University of Edinburgh; University of Edinburgh; University of Edinburgh; Rockefeller University	Rambukkana, A (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Little France Campus, Edinburgh EH16 4UU, Midlothian, Scotland.	a.rambuka@ed.ac.uk	Raaum, Ryan L/B-4609-2008	Raaum, Ryan L/0000-0003-4723-5475; rambukkana, anura/0000-0002-6286-9145	American Leprosy Missions; Hospitaler Order of St. Lazarus of Jerusalem; NIAID [AI45816, NS45187]; Order of MALTALEP Foundation; Rockefeller University; University of Edinburgh; Medical Research Council [G0700711B] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045187] Funding Source: NIH RePORTER	American Leprosy Missions; Hospitaler Order of St. Lazarus of Jerusalem; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Order of MALTALEP Foundation; Rockefeller University; University of Edinburgh; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Ian Wilmut and Emil Gotschlich for critical reading of the manuscript. We are grateful to Emil Gotschlich, Paul Nurse, Michael Young, Vincent Fi-schetti, Thomas Sakmar (Rockefeller University), John Savill, Jonathan Sackl, Nick Hastie (University of Edinburgh), and James Krahenbuhl (National Hansen's Disease Programs; NHDP) for their support during the initial and final phases of this study. Our thanks to Richard Truman (NHDP) for providing Fite's staining of infected mouse tissue sections; members of the core facilities at the Rockefeller University and the University of Edinburgh for their invaluable assistance; Joe Dybaas, Jennifer Smith, Clara Eastby, Paola Basilico, and Maxmilien Grandclaudon (Rambukkana laboratory) for their participation and technical assistance; and members of Genome Exploration and EpigenDx for technical assistance and data analysis. Mycobacterium leprae were provided by The Laboratory Research Branch of NHDP, Baton Rouge, LA with funding from The American Leprosy Missions and the Hospitaler Order of St. Lazarus of Jerusalem. This work was funded in part by grants from NIAID (AI45816) and NINDS (NS45187), The Order of MALTALEP Foundation, The Rockefeller University, and the University of Edinburgh.	Bold TD, 2009, CELL, V136, P17, DOI 10.1016/j.cell.2008.12.032; Buatois V, 2010, J IMMUNOL, V185, P2544, DOI 10.4049/jimmunol.1000182; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chiu BC, 2004, AM J PATHOL, V164, P1021, DOI 10.1016/S0002-9440(10)63189-6; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; FALKOW S, 1991, CELL, V65, P1099, DOI 10.1016/0092-8674(91)90003-H; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; GUPTA JC, 1975, INT J LEPROSY, V43, P348; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; Hoogduijn MJ, 2010, INT IMMUNOPHARMACOL, V10, P1496, DOI 10.1016/j.intimp.2010.06.019; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JOB CK, 1989, INT J LEPROSY, V57, P532; Kaur S, 1981, Lepr India, V53, P52; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Lahiri R, 2010, J INFECT DIS, V201, P1736, DOI 10.1086/652499; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Li Y, 2009, BLOOD, V113, P2342, DOI 10.1182/blood-2008-07-168138; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MIKO TL, 1993, LANCET, V342, P521, DOI 10.1016/0140-6736(93)91647-5; MODLIN RL, 1988, SPRINGER SEMIN IMMUN, V10, P359, DOI 10.1007/BF02053846; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2; Pearson J M, 1970, Lepr Rev, V41, P155; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Qiu BQ, 2001, AM J PATHOL, V158, P1503, DOI 10.1016/S0002-9440(10)64101-6; Rambukkana A, 1998, SCIENCE, V282, P2076, DOI 10.1126/science.282.5396.2076; Rambukkana A, 1997, CELL, V88, P811, DOI 10.1016/S0092-8674(00)81927-3; Rambukkana A, 2002, SCIENCE, V296, P927, DOI 10.1126/science.1067631; Rambukkana A, 2010, PROG NEUROBIOL, V91, P102, DOI 10.1016/j.pneurobio.2009.12.002; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; SHETTY VP, 1988, J NEUROL SCI, V88, P115, DOI 10.1016/0022-510X(88)90210-9; Shi DQ, 2004, BLOOD, V104, P290, DOI 10.1182/blood-2003-03-0688; STONER GL, 1979, LANCET, V2, P994; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tapinos N, 2005, P NATL ACAD SCI USA, V102, P9188, DOI 10.1073/pnas.0501196102; Tapinos N, 2006, NAT MED, V12, P961, DOI 10.1038/nm1433; Theise ND, 2003, NATURE, V425, P21, DOI 10.1038/425021a; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Truman RW, 2001, INT J LEPROSY, V69, P1; Weider M., 2012, DEV CELL, V23, P193; Werneck LC, 1999, ARQ NEURO-PSIQUIAT, V57, P723, DOI 10.1590/S0004-282X1999000500001; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	50	151	155	2	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					51	67		10.1016/j.cell.2012.12.014	http://dx.doi.org/10.1016/j.cell.2012.12.014			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332746	Bronze, Green Accepted			2022-12-24	WOS:000313719800006
J	Martin, CH; Wainwright, PC				Martin, Christopher H.; Wainwright, Peter C.			Multiple Fitness Peaks on the Adaptive Landscape Drive Adaptive Radiation in the Wild	SCIENCE			English	Article							DISRUPTIVE SELECTION; BODY-SIZE; EVOLUTION; DIVERSIFICATION; DIVERGENCE; FINCHES	The relationship between phenotype and fitness can be visualized as a rugged landscape. Multiple fitness peaks on this landscape are predicted to drive early bursts of niche diversification during adaptive radiation. We measured the adaptive landscape in a nascent adaptive radiation of Cyprinodon pupfishes endemic to San Salvador Island, Bahamas, and found multiple coexisting high-fitness regions driven by increased competition at high densities, supporting the early burst model. Hybrids resembling the generalist phenotype were isolated on a local fitness peak separated by a valley from a higher-fitness region corresponding to trophic specialization. This complex landscape could explain both the rarity of specialists across many similar environments due to stabilizing selection on generalists and the rapid morphological diversification rate of specialists due to their higher fitness.	[Martin, Christopher H.] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Martin, CH (corresponding author), Univ Calif Davis, Dept Evolut & Ecol, 1 Shields Ave, Davis, CA 95616 USA.	chmartin@ucdavis.edu	NAME, NO/AAA-3691-2021	Martin, Christopher/0000-0001-7989-9124	NSF [DDIG DEB-1010849]; Gerace Research Centre; Center for Population Biology; Direct For Biological Sciences [0924489] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Gerace Research Centre; Center for Population Biology; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funded by NSF grant DDIG DEB-1010849, the Gerace Research Centre, and the Center for Population Biology. Permits were approved by the Bahamian government and the University of California, Davis. G. Mount and S. Romero assisted with research; T. Schoener, M. Turelli, A. Hendry, D. Nychka, L. Schmitz, and C. Boettiger provided feedback. C. H. M. designed the study, raised funding, performed research, collected and analyzed data, and wrote the paper. P. C. W. contributed materials, discussed design and results, and commented on the manuscript.	Benkman CW, 2003, EVOLUTION, V57, P1176; Calsbeek R, 2007, EVOLUTION, V61, P2493, DOI 10.1111/j.1558-5646.2007.00206.x; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Harmon LJ, 2010, EVOLUTION, V64, P2385, DOI 10.1111/j.1558-5646.2010.01025.x; Hendry AP, 2009, P ROY SOC B-BIOL SCI, V276, P753, DOI 10.1098/rspb.2008.1321; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; LANDE R, 1979, EVOLUTION, V33, P402, DOI [10.2307/2407630, 10.1111/j.1558-5646.1979.tb04694.x]; Martin CH, 2012, AM NAT, V180, pE90, DOI 10.1086/667586; Martin CH, 2011, EVOLUTION, V65, P2197, DOI 10.1111/j.1558-5646.2011.01294.x; McBride CS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000529; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; SCHLUTER D, 1984, AM NAT, V123, P175, DOI 10.1086/284196; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Svensson E, 2000, EVOLUTION, V54, P1396; Svensson EI, 2012, ADAPTIVE LANDSCAPE IN EVOLUTIONARY BIOLOGY, P1; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	19	111	111	0	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					208	211		10.1126/science.1227710	http://dx.doi.org/10.1126/science.1227710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307743				2022-12-24	WOS:000313328200045
J	Mellen, M; Ayata, P; Dewell, S; Kriaucionis, S; Heintz, N				Mellen, Marian; Ayata, Pinar; Dewell, Scott; Kriaucionis, Skirmantas; Heintz, Nathaniel			MeCP2 Binds to 5hmC Enriched within Active Genes and Accessible Chromatin in the Nervous System	CELL			English	Article							TRANSLATIONAL PROFILING APPROACH; DNA METHYLATION; RETT-SYNDROME; HISTONE H1; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; PHOSPHORYLATION; EXPRESSION; WIDE; QUANTIFICATION	The high level of 5-hydroxymethylcytosine (5hmC) present in neuronal genomes suggests that mechanisms interpreting 5hmC in the CNS may differ from those present in embryonic stem cells. Here, we present quantitative, genome-wide analysis of 5hmC, 5-methylcytosine (5mC), and gene expression in differentiated CNS cell types in vivo. We report that 5hmC is enriched in active genes and that, surprisingly, strong depletion of 5mC is observed over these regions. The contribution of these epigenetic marks to gene expression depends critically on cell type. We identify methyl-CpG-binding protein 2 (MeCP2) as the major 5hmC-binding protein in the brain and demonstrate that MeCP2 binds 5hmC- and 5mC-containing DNA with similar high affinities. The Rett-syndrome-causing mutation R133C preferentially inhibits 5hmC binding. These findings support a model in which 5hmC and MeCP2 constitute a cell-specific epigenetic mechanism for regulation of chromatin structure and gene expression.	[Kriaucionis, Skirmantas] Univ Oxford, ORCRB, Ludwig Inst Canc Res, Lab Epigenet Mech, Oxford OX3 7DQ, England; [Mellen, Marian; Ayata, Pinar; Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10065 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA	Ludwig Institute for Cancer Research; University of Oxford; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Kriaucionis, S (corresponding author), Univ Oxford, ORCRB, Ludwig Inst Canc Res, Lab Epigenet Mech, Oxford OX3 7DQ, England.	skirmantas.kriaucionis@ludwig.ox.ac.uk; heintz@rockefeller.edu	Kriaucionis, Skirmantas/A-2986-2015	Kriaucionis, Skirmantas/0000-0002-2273-5994; Mellen, Marian/0000-0003-1056-4371; Ayata, Pinar/0000-0001-7621-832X	Howard Hughes Medical Institute; Simons Foundation Autism Research Initiative; Conte Center PHS [MH090963]; Ludwig Institute for Cancer Research; Spanish MECD; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH090963] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Simons Foundation Autism Research Initiative; Conte Center PHS; Ludwig Institute for Cancer Research; Spanish MECD(Spanish Government); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Howard Hughes Medical Institute (N.H.), Simons Foundation Autism Research Initiative (N.H.), Conte Center PHS MH090963 (N.H.), Ludwig Institute for Cancer Research (S.K.), and Spanish MECD (M.M.). We wish to thank Chun-Xiao Song and Chuan He for kindly providing 5hmC pull down reagents, Jim Selfridge and Adrian Bird for providing Mecp2-null mouse brains, and Brian Lang at GE Healthcare. We would further like to thank Beatriz Lopez and Betsy Gauthier for their assistance, and Jean-Pierre Roussarie, Anne Schaefer, Emmanuelle Jordi, and Ron Gejman for their advice. We also thank Connie Zhao, Christina Caserio, and Wenxiang Zhang from the Rockefeller University Genomics Resource Center; Svetlana Mazel, Selamawit Tadesse, Xiao Li, and Stanka Semova from the Rockefeller University Flow Cytometry Resource Center; and Henrik Molina, Joseph Fernandez, Milica Tesic Mark, and Susan Powell from The Rockefeller University Proteomics Resource Center.	Adkins NL, 2011, BIOCHEM CELL BIOL, V89, P1, DOI 10.1139/O10-112; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bebbington A, 2008, NEUROLOGY, V70, P868, DOI 10.1212/01.wnl.0000304752.50773.ec; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; CAMPOY FJ, 1995, J BIOL CHEM, V270, P26473, DOI 10.1074/jbc.270.44.26473; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chandler SP, 1999, BIOCHEMISTRY-US, V38, P7008, DOI 10.1021/bi990224y; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Gonzales ML, 2012, MOL CELL BIOL, V32, P2894, DOI 10.1128/MCB.06728-11; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Karymov MA, 2001, FASEB J, V15, P2631, DOI 10.1096/fj.01-0345com; Klose RJ, 2004, J BIOL CHEM, V279, P46490, DOI 10.1074/jbc.M408284200; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; LANGE W, 1975, CELL TISSUE RES, V157, P115; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Lopez-Serra L, 2006, CANCER RES, V66, P8342, DOI 10.1158/0008-5472.CAN-06-1932; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Palay S. L., 1974, CEREBELLAR CORTEX CY; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Rutlin M, 2011, NEURON, V72, P3, DOI 10.1016/j.neuron.2011.09.017; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tao JF, 2009, INT REV NEUROBIOL, V89, P147, DOI 10.1016/S0074-7742(09)89007-7; Thambirajah AA, 2012, NUCLEIC ACIDS RES, V40, P2884, DOI 10.1093/nar/gkr1066; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	46	666	692	7	122	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1417	1430		10.1016/j.cell.2012.11.022	http://dx.doi.org/10.1016/j.cell.2012.11.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260135	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000312890300009
J	Rhee, HW; Zou, P; Udeshi, ND; Martell, JD; Mootha, VK; Carr, SA; Ting, AY				Rhee, Hyun-Woo; Zou, Peng; Udeshi, Namrata D.; Martell, Jeffrey D.; Mootha, Vamsi K.; Carr, Steven A.; Ting, Alice Y.			Proteomic Mapping of Mitochondria in Living Cells via Spatially Restricted Enzymatic Tagging	SCIENCE			English	Article							PROTOPORPHYRINOGEN OXIDASE; CROSS-LINK; HEME; PEROXIDASE; BIOTINYLATION; BIOSYNTHESIS; MICROSCOPY; TYRAMIDE; DISEASE; COMPLEX	Microscopy and mass spectrometry (MS) are complementary techniques: The former provides spatiotemporal information in living cells, but only for a handful of recombinant proteins at a time, whereas the latter can detect thousands of endogenous proteins simultaneously, but only in lysed samples. Here, we introduce technology that combines these strengths by offering spatially and temporally resolved proteomic maps of endogenous proteins within living cells. Our method relies on a genetically targetable peroxidase enzyme that biotinylates nearby proteins, which are subsequently purified and identified by MS. We used this approach to identify 495 proteins within the human mitochondrial matrix, including 31 not previously linked to mitochondria. The labeling was exceptionally specific and distinguished between inner membrane proteins facing the matrix versus the intermembrane space (IMS). Several proteins previously thought to reside in the IMS or outer membrane, including protoporphyrinogen oxidase, were reassigned to the matrix by our proteomic data and confirmed by electron microscopy. The specificity of peroxidase-mediated proteomic mapping in live cells, combined with its ease of use, offers biologists a powerful tool for understanding the molecular composition of living cells.	[Rhee, Hyun-Woo; Zou, Peng; Martell, Jeffrey D.; Ting, Alice Y.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Udeshi, Namrata D.; Mootha, Vamsi K.; Carr, Steven A.; Ting, Alice Y.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02115 USA; [Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ting, AY (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	ating@mit.edu	Rhee, Hyun-Woo/AAS-4268-2021; Carr, Steven A./AAH-8366-2019; Zou, Peng/S-1309-2017; Rhee, Hyun-Woo/AAS-3508-2021	Rhee, Hyun-Woo/0000-0002-3817-3455; Zou, Peng/0000-0002-9798-5242; Ting, Alice/0000-0002-8277-5226	NIH [DP1 OD003961, R01 GM077465]; Dreyfus Foundation; American Chemical Society; Broad Institute of MIT and Harvard; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003961] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dreyfus Foundation; American Chemical Society(American Chemical Society); Broad Institute of MIT and Harvard; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank N. Watson (Whitehead Institute Keck Microscopy Facility) and E. Vasile (Koch Institute Microscopy Core Facility) for performing EM imaging, H. B. Fraser for assistance with data analysis and manuscript editing, C. Uttamapinant for picoyl azide-AF647, X. Zhuang and her lab for advice on STORM, H. A. Dailey for advice on CPOX and PPOX, and S. Calvo for assistance with data analysis. Funding was provided by the NIH (grants DP1 OD003961 to A.Y.T. and R01 GM077465 to V. K. M.), the Dreyfus Foundation (A.Y.T.), the American Chemical Society (A.Y.T.), and the Broad Institute of MIT and Harvard (S. A. C.). The authors have no conflicting financial interests. A patent application relating to the use of enzymes for proteomic mapping in live cells has been filed by MIT. Proteomic data can be found in supplementary tables S1 to S9. The authors will make the genetic constructs used in this work widely available to the academic community through Addgene (www.addgene.org/).	Amini F, 2002, ANGEW CHEM INT EDIT, V41, P356, DOI 10.1002/1521-3773(20020118)41:2<356::AID-ANIE356>3.0.CO;2-M; Bendayan M, 2001, SCIENCE, V291, P1363, DOI 10.1126/science.291.5507.1363; Bhaskar B, 2003, J MOL BIOL, V328, P157, DOI 10.1016/S0022-2836(03)00179-7; Choi-Rhee E, 2004, PROTEIN SCI, V13, P3043, DOI 10.1110/ps.04911804; DEYBACH JC, 1985, EUR J BIOCHEM, V149, P431, DOI 10.1111/j.1432-1033.1985.tb08943.x; ELDER GH, 1978, BIOCHEM J, V172, P345, DOI 10.1042/bj1720345; FERREIRA GC, 1988, J BIOL CHEM, V263, P3835; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; GRANDCHAMP B, 1978, BIOCHEM J, V176, P97, DOI 10.1042/bj1760097; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; Kotani N, 2008, P NATL ACAD SCI USA, V105, P7405, DOI 10.1073/pnas.0710346105; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; Mayer G, 1997, J HISTOCHEM CYTOCHEM, V45, P1449, DOI 10.1177/002215549704501101; Minamihata K, 2011, BIOCONJUGATE CHEM, V22, P2332, DOI 10.1021/bc200420v; Morriswood B, 2013, EUKARYOT CELL, V12, P356, DOI 10.1128/EC.00326-12; Mortensen A, 1997, J AGR FOOD CHEM, V45, P2970, DOI 10.1021/jf970010s; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Qin XH, 2011, FASEB J, V25, P653, DOI 10.1096/fj.10-170811; Rogers MS, 2008, BIOCHEMISTRY-US, V47, P10428, DOI 10.1021/bi8010835; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Schonhuber W, 1997, APPL ENVIRON MICROB, V63, P3268; Wishart J. F., 2010, RECENT TRENDS RAD CH, P577	26	691	703	13	368	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1328	1331		10.1126/science.1230593	http://dx.doi.org/10.1126/science.1230593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23371551	Green Submitted, Green Accepted			2022-12-24	WOS:000316053400040
J	Wu, JX; Sun, LJ; Chen, X; Du, FH; Shi, HP; Chen, C; Chen, ZJJ				Wu, Jiaxi; Sun, Lijun; Chen, Xiang; Du, Fenghe; Shi, Heping; Chen, Chuo; Chen, Zhijian J.			Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA	SCIENCE			English	Article								Cytosolic DNA induces type I interferons and other cytokines that are important for antimicrobial defense but can also result in autoimmunity. This DNA signaling pathway requires the adaptor protein STING and the transcription factor IRF3, but the mechanism of DNA sensing is unclear. We found that mammalian cytosolic extracts synthesized cyclic guanosine monophosphate-adenosine monophosphate (cyclic GMP-AMP, or cGAMP) in vitro from adenosine triphosphate and guanosine triphosphate in the presence of DNA but not RNA. DNA transfection or DNA virus infection of mammalian cells also triggered cGAMP production. cGAMP bound to STING, leading to the activation of IRF3 and induction of interferon-beta. Thus, cGAMP in metazoans and functions as an endogenous second messenger that triggers interferon production in response to cytosolic DNA.	[Wu, Jiaxi; Sun, Lijun; Chen, Xiang; Du, Fenghe; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Sun, Lijun; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Shi, Heping; Chen, Chuo] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Sun, Lijun/ABD-4470-2021; Wu, Jiaxi/K-3322-2016; shi, heping/G-3238-2015; Chen, Zhijian/C-6039-2012	Wu, Jiaxi/0000-0002-6976-4784; Chen, Zhijian/0000-0002-8475-8251; Chen, Chuo/0000-0002-3118-4901	NIH [AI-093967, GM-079554]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079554] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Tanaka for generating HEK293T-STING and L929-shSTING cell lines; J. Bell, B. Levine, and L. Deng for VSV, HSV-1, and VACV, respectively; R. Debose-Boyd for the PFO plasmid; and V. Sperandio for V. cholerae strain C6709. Supported by NIH grants AI-093967 (Z.J.C.) and GM-079554 (C. C.). Z.J.C. is an investigator of Howard Hughes Medical Institute.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Blumenthal SA, 2012, PERSPECT BIOL MED, V55, P236, DOI 10.1353/pbm.2012.0017; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Mossman KL, 2002, J VIROL, V76, P1995, DOI 10.1128/JVI.76.4.1995-1998.2002; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029	17	1258	1351	23	318	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					826	830		10.1126/science.1229963	http://dx.doi.org/10.1126/science.1229963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23258412	Green Accepted			2022-12-24	WOS:000314874400051
J	Rilstone, JJ; Alkhater, RA; Minassian, BA				Rilstone, Jennifer J.; Alkhater, Reem A.; Minassian, Berge A.			Brain Dopamine-Serotonin Vesicular Transport Disease and Its Treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACID DECARBOXYLASE DEFICIENCY; MONOAMINE TRANSPORTER-2; SEQUENCE VARIANTS; GENE; PARKINSONISM; AMPHETAMINE; MUTATIONS; FEATURES; VMAT2; MICE	We describe a disease encompassing infantile-onset movement disorder (including severe parkinsonism and nonambulation), mood disturbance, autonomic instability, and developmental delay, and we describe evidence supporting its causation by a mutation in SLC18A2 (which encodes vesicular monoamine transporter 2 [VMAT2]). VMAT2 translocates dopamine and serotonin into synaptic vesicles and is essential for motor control, stable mood, and autonomic function. Treatment with levodopa was associated with worsening, whereas treatment with direct dopamine agonists was followed by immediate ambulation, near-complete correction of the movement disorder, and resumption of development.	[Rilstone, Jennifer J.; Alkhater, Reem A.; Minassian, Berge A.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Rilstone, Jennifer J.; Minassian, Berge A.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Alkhater, Reem A.; Minassian, Berge A.] Hosp Sick Children, Div Neurol, Dept Pediat, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Minassian, BA (corresponding author), Hosp Sick Children, Rm 6536B,555 Univ Ave, Toronto, ON M5G 1X8, Canada.	reema.alkhater@mail.utoronto.ca; berge.minassian@sickkids.ca			Canadian Institutes of Health Research; National Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Supported by the Canadian Institutes of Health Research. Dr. Minassian holds the University of Toronto Michael Bahen Chair in Epilepsy Research. Ms. Rilstone was supported by the Vanier Canada Graduate Scholarship from the National Sciences and Engineering Research Council of Canada.	Bainbridge MN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002243; Brun L, 2010, NEUROLOGY, V75, P576; Brun L, 2010, NEUROLOGY, V75, P64, DOI 10.1212/WNL.0b013e3181e620ae; Burman J, 2004, PHARMACOGENETICS, V14, P587, DOI 10.1097/00008571-200409000-00003; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Eiden LE, 2011, ANN NY ACAD SCI, V1216, P86, DOI 10.1111/j.1749-6632.2010.05906.x; ERICKSON JD, 1993, J NEUROCHEM, V61, P2314, DOI 10.1111/j.1471-4159.1993.tb07476.x; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; Fukui M, 2007, J NEUROSCI, V27, P10520, DOI 10.1523/JNEUROSCI.4388-06.2007; Glatt CE, 2001, NAT GENET, V27, P435, DOI 10.1038/86948; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hyland K, 2008, CLIN CHEM, V54, P633, DOI 10.1373/clinchem.2007.099986; Iwasa H, 2001, J HUM GENET, V46, P158, DOI 10.1007/s100380170106; Jeon Sung-Man, 2010, Exp Neurobiol, V19, P155, DOI 10.5607/en.2010.19.3.155; Kurian MA, 2011, LANCET NEUROL, V10, P721, DOI 10.1016/S1474-4422(11)70141-7; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Lee HCH, 2012, CLIN CHIM ACTA, V413, P126, DOI 10.1016/j.cca.2011.09.008; Longo N, 2009, J INHERIT METAB DIS, V32, P333, DOI 10.1007/s10545-009-1067-2; Mooslehner KA, 2001, MOL CELL BIOL, V21, P5321, DOI 10.1128/MCB.21.16.5321-5331.2001; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; Pons R, 2004, NEUROLOGY, V62, P1058, DOI 10.1212/WNL.62.7.1058; Pons R, 2009, J INHERIT METAB DIS, V32, P321, DOI 10.1007/s10545-008-1007-6; Swoboda KJ, 1999, NEUROLOGY, V53, P1205, DOI 10.1212/WNL.53.6.1205; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; Yeung WL, 2012, J CHILD NEUROL, V27, P829, DOI 10.1177/0883073812448570	27	112	119	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2013	368	6					543	550		10.1056/NEJMoa1207281	http://dx.doi.org/10.1056/NEJMoa1207281			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083VU	23363473				2022-12-24	WOS:000314494100005
J	Kreso, A; O'Brien, CA; van Galen, P; Gan, OI; Notta, F; Brown, AMK; Ng, K; Ma, J; Wienholds, E; Dunant, C; Pollett, A; Gallinger, S; McPherson, J; Mullighan, CG; Shibata, D; Dick, JE				Kreso, Antonija; O'Brien, Catherine A.; van Galen, Peter; Gan, Olga I.; Notta, Faiyaz; Brown, Andrew M. K.; Ng, Karen; Ma, Jing; Wienholds, Erno; Dunant, Cyrille; Pollett, Aaron; Gallinger, Steven; McPherson, John; Mullighan, Charles G.; Shibata, Darryl; Dick, John E.			Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer	SCIENCE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GENE-EXPRESSION; INITIATING CELLS; TUMOR-GROWTH; STEM-CELLS; EVOLUTION; ORIGINS; STOCHASTICITY; HETEROGENEITY; BIODIVERSITY	Intratumoral heterogeneity arises through the evolution of genetically diverse subclones during tumor progression. However, it remains unknown whether cells within single genetic clones are functionally equivalent. By combining DNA copy number alteration (CNA) profiling, sequencing, and lentiviral lineage tracking, we followed the repopulation dynamics of 150 single lentivirus-marked lineages from 10 human colorectal cancers through serial xenograft passages in mice. CNA and mutational analysis distinguished individual clones and showed that clones remained stable upon serial transplantation. Despite this stability, the proliferation, persistence, and chemotherapy tolerance of lentivirally marked lineages were variable within each clone. Chemotherapy promoted the dominance of previously minor or dormant lineages. Thus, apart from genetic diversity, tumor cells display inherent functional variability in tumor propagation potential, which contributes to both cancer growth and therapy tolerance.	[Kreso, Antonija; O'Brien, Catherine A.; van Galen, Peter; Gan, Olga I.; Notta, Faiyaz; Wienholds, Erno; Dick, John E.] Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Campbell Family Inst, Toronto, ON M5G 1L7, Canada; [Kreso, Antonija; Notta, Faiyaz; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [O'Brien, Catherine A.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5L 1F4, Canada; [O'Brien, Catherine A.] Univ Toronto, Dept Surg, Toronto, ON M5L 1F4, Canada; [Brown, Andrew M. K.; Ng, Karen; McPherson, John] Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada; [Ma, Jing; Mullighan, Charles G.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Dunant, Cyrille] Univ Toronto, Dept Civil Engn, Toronto, ON M5S 1A4, Canada; [Pollett, Aaron] Mt Sinai Hosp, Dept Pathol, Toronto, ON M5G 1X5, Canada; [Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred Litwin Ctr Canc Genet, Toronto, ON M7H 2B9, Canada; [Shibata, Darryl] Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; St Jude Children's Research Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Southern California	Dick, JE (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Campbell Family Inst, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca	Mullighan, Charles/H-3253-2011; McPherson, John D/D-2633-2017; Pollett, Aaron/AAQ-2540-2021; Pollett, Aaron/J-2308-2016; Gallinger, Steven/E-4575-2013	Mullighan, Charles/0000-0002-1871-1850; McPherson, John D/0000-0001-8049-9347; Pollett, Aaron/0000-0001-5121-8788; Pollett, Aaron/0000-0001-5121-8788; van Galen, Peter/0000-0002-0735-1570; Dunant, Cyrille/0000-0001-5176-4439; Dick, John/0000-0002-9527-8317; O'Brien, Catherine/0000-0003-0682-3879	Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; Summit Award; Canadian Institutes for Health Research; Netherlands Organisation for Scientific Research; NIH [R21 CA149990-01]; Canada Research Chair; Princess Margaret Hospital Foundation; Ontario Ministry of Health and Long Term Care (OMOHLTC); province of Ontario; NATIONAL CANCER INSTITUTE [R21CA149990] Funding Source: NIH RePORTER	Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; Summit Award; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Princess Margaret Hospital Foundation; Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); province of Ontario; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Gibson, A. Khandani, and P. Penttila for experimental support and members of the Dick lab, especially M. Doedens, J. Wang, M. Milyavsky, and E. Laurenti for technical support and critical assessment of this work, as well as UHN biobank for specimens, the Clinical Applications of Core Technology (Affymetrix) Laboratory of the Hartwell Center for Bioinformatics and Biotechnology of St. Jude Children's Research Hospital, and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital. Supported by Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research and a Summit Award with funds from the province of Ontario, the Canadian Institutes for Health Research, the Netherlands Organisation for Scientific Research, NIH grant R21 CA149990-01, a Canada Research Chair, the Princess Margaret Hospital Foundation, and the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC.	ABULAFI AM, 1994, BRIT J SURG, V81, P7, DOI 10.1002/bjs.1800810106; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Roche-Lestienne C, 2003, NEW ENGL J MED, V348, P2265, DOI 10.1056/NEJMc035089; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825	30	518	544	1	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					543	548		10.1126/science.1227670	http://dx.doi.org/10.1126/science.1227670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23239622	Green Accepted			2022-12-24	WOS:000314270000050
J	Yu, M; Bardia, A; Wittner, B; Stott, SL; Smas, ME; Ting, DT; Isakoff, SJ; Ciciliano, JC; Wells, MN; Shah, AM; Concannon, KF; Donaldson, MC; Sequist, LV; Brachtel, E; Sgroi, D; Baselga, J; Ramaswamy, S; Toner, M; Haber, DA; Maheswaran, S				Yu, Min; Bardia, Aditya; Wittner, Ben S.; Stott, Shannon L.; Smas, Malgorzata E.; Ting, David T.; Isakoff, Steven J.; Ciciliano, Jordan C.; Wells, Marissa N.; Shah, Ajay M.; Concannon, Kyle F.; Donaldson, Maria C.; Sequist, Lecia V.; Brachtel, Elena; Sgroi, Dennis; Baselga, Jose; Ramaswamy, Sridhar; Toner, Mehmet; Haber, Daniel A.; Maheswaran, Shyamala			Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition	SCIENCE			English	Article							TRANSITION; EMT; DISSEMINATION; METASTASIS	Epithelial-mesenchymal transition (EMT) of adherent epithelial cells to a migratory mesenchymal state has been implicated in tumor metastasis in preclinical models. To investigate its role in human cancer, we characterized EMT in circulating tumor cells (CTCs) from breast cancer patients. Rare primary tumor cells simultaneously expressed mesenchymal and epithelial markers, but mesenchymal cells were highly enriched in CTCs. Serial CTC monitoring in 11 patients suggested an association of mesenchymal CTCs with disease progression. In an index patient, reversible shifts between these cell fates accompanied each cycle of response to therapy and disease progression. Mesenchymal CTCs occurred as both single cells and multicellular clusters, expressing known EMT regulators, including transforming growth factor (TGF)-beta pathway components and the FOXC1 transcription factor. These data support a role for EMT in the blood-borne dissemination of human breast cancer.	[Yu, Min; Bardia, Aditya; Wittner, Ben S.; Stott, Shannon L.; Smas, Malgorzata E.; Ting, David T.; Isakoff, Steven J.; Ciciliano, Jordan C.; Wells, Marissa N.; Concannon, Kyle F.; Donaldson, Maria C.; Sequist, Lecia V.; Brachtel, Elena; Sgroi, Dennis; Baselga, Jose; Ramaswamy, Sridhar; Haber, Daniel A.; Maheswaran, Shyamala] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Stott, Shannon L.; Shah, Ajay M.; Toner, Mehmet] Harvard Univ, Sch Med, Ctr Bioengn Med, Charlestown, MA 02129 USA; [Bardia, Aditya; Isakoff, Steven J.; Sequist, Lecia V.; Baselga, Jose; Ramaswamy, Sridhar; Haber, Daniel A.] Harvard Univ, Sch Med, Dept Med, Charlestown, MA 02129 USA; [Brachtel, Elena; Sgroi, Dennis] Harvard Univ, Sch Med, Dept Pathol, Charlestown, MA 02129 USA; [Toner, Mehmet; Maheswaran, Shyamala] Harvard Univ, Sch Med, Dept Surg, Charlestown, MA 02129 USA; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute	Haber, DA (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	haber@helix.mgh.harvard.edu; maheswaran@helix.mgh.harvard.edu	Stott, Shannon L./AAC-5311-2019; Sgroi, Dennis/AAV-2487-2021; Isakoff, Steven/ABE-3566-2020; Ting, David/F-4389-2017	Donaldson Collier, Maria/0000-0001-6403-6713; Yu, Min/0000-0002-3969-8720; Ting, David/0000-0002-3261-2322	Breast Cancer Research Foundation; Stand Up To Cancer; Susan G. Komen for the Cure [KG090412]; NIBIB [EB008047]; NCI [CA129933]; National Cancer Institute-MGH Federal Share Program; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA129933, K12CA087723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB012493, R01EB008047] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Stand Up To Cancer; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute-MGH Federal Share Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We are grateful to all the patients who participated in this study; we thank D. Juric, C. Koris, and the Massachusetts General Hospital (MGH) clinical research coordinators for help with clinical studies; A. Gilman, B. Brannigan, and M. Zeinali for technical support; F. Ozsolak and P. Milos (Helicos) for RNA sequencing; A. Forrest-Hay and Q. Nguyen (Affymetrix) for RNA-ISH reagents; L. Libby for mouse studies; and J. Walsh for expertise with microscopy. This work was supported by grants from the Breast Cancer Research Foundation (D. A. H.), Stand Up To Cancer (D. A. H., M. T., and S. M.), Susan G. Komen for the Cure KG090412 (S. M.), NIBIB EB008047 (M. T., D. A. H.), NCI CA129933 (D. A. H.), the National Cancer Institute-MGH Federal Share Program (S. M.), and the Howard Hughes Medical Institute (M.Y. and D. A. H.). The MGH and M. T. have filed a patent for the HB (Herringbone) microchip (U.S. patent 09816815.4). Sequencing data have been deposited in the Gene Expression Omnibus database (accession no. GSE41245).	Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Cho EH, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016001; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Ilina O, 2009, J CELL SCI, V122, P3203, DOI 10.1242/jcs.036525; Jeong H, 2012, HISTOPATHOLOGY, V60, pE87, DOI 10.1111/j.1365-2559.2012.04195.x; Jiang Z, 2011, CELL CYCLE, V10, P1563, DOI 10.4161/cc.10.10.15703; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim YN, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/306879; Krebs MG, 2012, J THORAC ONCOL, V7, P306, DOI 10.1097/JTO.0b013e31823c5c16; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Lecharpentier A, 2011, BRIT J CANCER, V105, P1338, DOI 10.1038/bjc.2011.405; Ledford H, 2011, NATURE, V472, P273, DOI 10.1038/472273a; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ozsolak F, 2010, NAT METHODS, V7, P619, DOI [10.1038/NMETH.1480, 10.1038/nmeth.1480]; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Payne RE, 2012, BRIT J CANCER, V106, P1790, DOI 10.1038/bjc.2012.137; Pecot CV, 2011, CANCER DISCOV, V1, P580, DOI 10.1158/2159-8290.CD-11-0215; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Yu M, 2009, GENE DEV, V23, P1737, DOI 10.1101/gad.1809309	29	1742	1830	16	666	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					580	584		10.1126/science.1228522	http://dx.doi.org/10.1126/science.1228522			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372014	Green Accepted			2022-12-24	WOS:000314270000059
J	Shen, YD; Wollam, J; Magner, D; Karalay, O; Antebi, A				Shen, Yidong; Wollam, Joshua; Magner, Daniel; Karalay, Oezlem; Antebi, Adam			A Steroid Receptor-MicroRNA Switch Regulates Life Span in Response to Signals from the Gonad	SCIENCE			English	Article							STEM-CELLS; LONGEVITY; DAF-16	Although the gonad primarily functions in procreation, it also affects animal life span. Here, we show that removal of the Caenorhabditis elegans germ line triggers a switch in the regulatory state of the organism to promote longevity, co-opting components involved in larval developmental timing circuits. These components include the DAF-12 steroid receptor, which is involved in the larval stage two-to-stage three (L2-L3) transition and up-regulates members of the let-7 microRNA (miRNA) family. The miRNAs target an early larval nuclear factor lin-14 and akt-1/kinase, thereby stimulating DAF-16/FOXO signaling to extend life. Our studies suggest that metazoan life span is coupled to the gonad through elements of a developmental timer.	[Shen, Yidong; Wollam, Joshua; Magner, Daniel; Karalay, Oezlem; Antebi, Adam] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Shen, Yidong; Wollam, Joshua; Magner, Daniel; Antebi, Adam] Baylor Coll Med, Huffington Ctr Aging, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Antebi, Adam] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany	Max Planck Society; Baylor College of Medicine; University of Cologne	Antebi, A (corresponding author), Max Planck Inst Biol Ageing, Joseph Stelzmann Str 9B, D-50931 Cologne, Germany.	antebi@age.mpg.de	Shen, Yi/GRS-3602-2022		European Molecular Biology Organization; National Institute on Aging/NIH; Ellison Medical Foundation; Max Planck Society; Sybacol/Bundesministerium fur Bildung und Forschung; CECAD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027498] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); National Institute on Aging/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); Max Planck Society(Max Planck Society); Sybacol/Bundesministerium fur Bildung und Forschung; CECAD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Montino for technical help; M. Denzel for manuscript comments; S. Lo (Chang-Qung University) for plasmids; and I. Greenwald (Columbia University), H. Aguilaniu (ENS de Lyon), C. Kenyon (University of California San Francisco), and the Caenorhabditis Genetics Center for strains. This work was supported by an European Molecular Biology Organization fellowship (Y.S.) and the National Institute on Aging/NIH, the Ellison Medical Foundation, the Max Planck Society, Sybacol/Bundesministerium fur Bildung und Forschung, and CECAD (A. A.). Strain pha-1(e2123);arEx1273(lin-14::gfp) is available from Iva Greenwald (Columbia University) subject to a materials transfer agreement with the Howard Hughes Medical Institute.	Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Bethke A, 2009, SCIENCE, V324, P95, DOI 10.1126/science.1164899; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Boulias K, 2012, CELL METAB, V15, P439, DOI 10.1016/j.cmet.2012.02.014; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Gerisch B, 2007, P NATL ACAD SCI USA, V104, P5014, DOI 10.1073/pnas.0700847104; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; Hammell CM, 2009, P NATL ACAD SCI USA, V106, P18668, DOI 10.1073/pnas.0908131106; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lapierre LR, 2011, CURR BIOL, V21, P1507, DOI 10.1016/j.cub.2011.07.042; McCormick M, 2012, AGING CELL, V11, P192, DOI 10.1111/j.1474-9726.2011.00768.x; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Resnick TD, 2010, DEV DYNAM, V239, P1477, DOI 10.1002/dvdy.22260; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wollam J, 2011, AGING CELL, V10, P879, DOI 10.1111/j.1474-9726.2011.00733.x; Yamawaki TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000468; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	21	73	77	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1472	1476		10.1126/science.1228967	http://dx.doi.org/10.1126/science.1228967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239738	Green Accepted			2022-12-24	WOS:000312250800049
J	Axelsson, E; Ratnakumar, A; Arendt, ML; Maqbool, K; Webster, MT; Perloski, M; Liberg, O; Arnemo, JM; Hedhammar, A; Lindblad-Toh, K				Axelsson, Erik; Ratnakumar, Abhirami; Arendt, Maja-Louise; Maqbool, Khurram; Webster, Matthew T.; Perloski, Michele; Liberg, Olof; Arnemo, Jon M.; Hedhammar, Ake; Lindblad-Toh, Kerstin			The genomic signature of dog domestication reveals adaptation to a starch-rich diet	NATURE			English	Article							MALTASE-GLUCOAMYLASE GENE; GLUCOSE; TRANSPORTERS; SELECTION; HISTORY; SPERM	The domestication of dogs. was an important episode in the development of human civilization. The precise timing and location of this event is debated(1-5) and little is known about the genetic changes that accompanied the transformation of ancient wolves into domestic dogs. Here we conduct whole-genome resequencimg of dogs and wolves to identify 3.8 million genetic variants used to identify 36 genomic regions that probably represent targets for selection during dog domestication. Nineteen of these regions contain genes important in brain function, eight of which belong to nervous system development pathways and potentially underlie behavioural changes central to dog domestication(6). Ten genes with key roles in starch digestion and fat metabolism also show signals of selection. We identify candidate mutations in key genes and provide functional support for an increased starch digestion in dogs relative to wolves. Our results indicate that novel adaptations allowing the early ancestors of modern dogs to thrive on a diet rich in starch, relative to the carnivorous diet of wolves, constituted a crucial step in the early domestication of dogs.	[Axelsson, Erik; Ratnakumar, Abhirami; Arendt, Maja-Louise; Maqbool, Khurram; Webster, Matthew T.; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, S-75237 Uppsala, Sweden; [Perloski, Michele; Lindblad-Toh, Kerstin] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02139 USA; [Liberg, Olof] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, S-73091 Riddarhyttan, Sweden; [Arnemo, Jon M.] Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Dept Forestry & Wildlife Management, NO-2418 Elverum, Norway; [Arnemo, Jon M.] Swedish Univ Agr Sci, Fac Forest Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Hedhammar, Ake] Swedish Univ Agr Sci, Dept Clin Sci, Sci Life Lab, S-75651 Uppsala, Sweden	Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Swedish University of Agricultural Sciences; Inland Norway University of Applied Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Axelsson, E (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, S-75237 Uppsala, Sweden.	Erik.Axelsson@imbim.uu.se; kersli@broadinstitute.org	Arendt, Maja/AAZ-3783-2021; Axelsson, Erik/A-6119-2009	Hedhammar, Ake/0000-0001-7048-3851; Arendt, Maja Louise/0000-0003-1404-172X; Maqbool, Khurram/0000-0003-2981-2582; Webster, Matthew/0000-0003-1141-2863	SSF; Swedish Research Council; Swedish Research Council Formas; Uppsala University; EURYI; ESF; Higher Education Commission, Pakistan	SSF(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Uppsala University; EURYI(European Science Foundation (ESF)); ESF(European Commission); Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	We thank Jarvzoo, Nordens ark and the Canine Biobank at Uppsala University and the Swedish University of Agricultural Sciences for providing samples, Uppsala Genomics Platform at SciLifeLab Uppsala for generating the resequencing data, the UPPNEX platform for assisting with computational infrastructure for data analysis and the Broad Institute Genomics Platform for validation genotyping. The project was funded by the SSF, the Swedish Research Council, the Swedish Research Council Formas, Uppsala University and a EURYI to K.L.-T. funded by the ESF supporting also E.A.; K.M. was funded by the Higher Education Commission, Pakistan.	Andersson L, 2009, COLD SH Q B, V74, P319, DOI 10.1101/sqb.2009.74.039; BELYAEV DK, 1979, J HERED, V70, P301, DOI 10.1093/oxfordjournals.jhered.a109263; Boomgaarden I, 2009, BIOCHEM GENET, V47, P739, DOI 10.1007/s10528-009-9273-z; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Coppinger R., 2001, DOGS STARTLING NEW U; DAVIS SJM, 1978, NATURE, V276, P608, DOI 10.1038/276608a0; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Fang MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000341; Gardner AJ, 2006, REPROD FERT DEVELOP, V18, P53, DOI 10.1071/RD05122; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; HEDIGER MA, 1991, BIOCHIM BIOPHYS ACTA, V1064, P360, DOI 10.1016/0005-2736(91)90323-Z; Koike N, 2007, J BIOL CHEM, V282, P15843, DOI 10.1074/jbc.M701570200; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; MEISLER MH, 1993, CRIT REV ORAL BIOL M, V4, P503, DOI 10.1177/10454411930040033501; Mochizuki K, 2010, MOL NUTR FOOD RES, V54, P1445, DOI 10.1002/mnfr.200900467; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Nichols BL, 2003, P NATL ACAD SCI USA, V100, P1432, DOI 10.1073/pnas.0237170100; Ovodov ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022821; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; SIMPSON JW, 1984, VET RES COMMUN, V8, P303, DOI 10.1007/BF02214725; Skoglund P, 2011, MOL BIOL EVOL, V28, P1505, DOI 10.1093/molbev/msq342; Tokuhiro K, 2012, P NATL ACAD SCI USA, V109, P3850, DOI 10.1073/pnas.1117963109; Varga ZM, 2001, DEVELOPMENT, V128, P3497; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Weston MC, 2011, NEURON, V69, P1147, DOI 10.1016/j.neuron.2011.02.002; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009	30	558	576	14	627	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					360	364		10.1038/nature11837	http://dx.doi.org/10.1038/nature11837			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23354050				2022-12-24	WOS:000316650500041
J	Bieniossek, C; Papai, G; Schaffitzel, C; Garzoni, F; Chaillet, M; Scheer, E; Papadopoulos, P; Tora, L; Schultz, P; Berger, I				Bieniossek, Christoph; Papai, Gabor; Schaffitzel, Christiane; Garzoni, Frederic; Chaillet, Maxime; Scheer, Elisabeth; Papadopoulos, Petros; Tora, Laszlo; Schultz, Patrick; Berger, Imre			The architecture of human general transcription factor TFIID core complex	NATURE			English	Article							CRYSTAL-STRUCTURE; TERMINAL DOMAIN; YEAST; IDENTIFICATION; SUBCOMPLEX; SUBUNIT; OCTAMER; TAFS	The initiation of gene transcription by RNA polymerase II is regulated by a plethora of proteins in human cells. The first general transcription factor to bind gene promoters is transcription factor IID (TFIID). TFIID triggers pre-initiation complex formation, functions as a coactivator by interacting with transcriptional activators and reads epigenetic marks(1-3). TFIID is a megadalton-sized multiprotein complex composed of TATA-box-binding protein (TBP) and 13 TBP-associated factors (TAFs)(3). Despite its crucial role, the detailed architecture and assembly mechanism of TFIID remain elusive. Histone fold domains are prevalent in TAFs, and histone-like tetramer and octamer structures have been proposed in TFIID4-6. A functional core-TFIID subcomplex was revealed in Drosophila nuclei, consisting of a subset of TAFs (TAF4, TAF5, TAF6, TAF9 and TAF12)(7). These core subunits are thought to be present in two copies in holo-TFIID, in contrast to TBP and other TAFs that are present in a single copy(8), conveying a transition from symmetry to asymmetry in the TFIID assembly pathway. Here we present the structure of human core-TFIID determined by cryoelectron microscopy at 11.6 angstrom resolution. Our structure reveals a two-fold symmetric, interlaced architecture, with pronounced protrusions, that accommodates all conserved structural features of the TAFs including the histone folds. We further demonstrate that binding of one TAF8-TAF10 complex breaks the original symmetry of core-TFIID. We propose that the resulting asymmetric structure serves as a functional scaffold to nucleate holo-TFIID assembly, by accreting one copy each of the remaining TAFs and TBP.	[Bieniossek, Christoph; Schaffitzel, Christiane; Garzoni, Frederic; Chaillet, Maxime; Berger, Imre] UJF CNRS EMBL, Unite Mixte Int UMI 3265, European Mol Biol Lab EMBL Grenoble Outstn, F-38042 Grenoble 9, France; [Bieniossek, Christoph; Schaffitzel, Christiane; Garzoni, Frederic; Chaillet, Maxime; Berger, Imre] UJF CNRS EMBL, Unite Mixte Int UMI 3265, Unit Virus Host Cell Interact UVHCI, F-38042 Grenoble 9, France; [Papai, Gabor; Schultz, Patrick] IGBMC, Dept Integrated Struct Biol, F-67404 Illkirch Graffenstaden, France; [Papai, Gabor; Scheer, Elisabeth; Tora, Laszlo; Schultz, Patrick] INSERM, U964, F-67400 Paris, France; [Papai, Gabor; Scheer, Elisabeth; Tora, Laszlo; Schultz, Patrick] CNRS Illkirch, UMR7104, F-67000 Strasbourg, France; [Papai, Gabor; Scheer, Elisabeth; Tora, Laszlo; Schultz, Patrick] Univ Strasbourg, F-67000 Strasbourg, France; [Scheer, Elisabeth; Tora, Laszlo] IGBMC, Dept Funct Genom & Canc, F-67404 Illkirch Graffenstaden, France; [Papadopoulos, Petros] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands	European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Erasmus University Rotterdam; Erasmus MC	Schultz, P (corresponding author), IGBMC, Dept Integrated Struct Biol, 1 Rue Laurent Fries,BP10142, F-67404 Illkirch Graffenstaden, France.	patrick.schultz@igbmc.fr; iberger@embl.fr	Tora, Laszlo/E-9999-2018; Papadopoulos, Petros/B-1913-2015	Tora, Laszlo/0000-0001-7398-2250; Papadopoulos, Petros/0000-0002-8342-329X; Papai, Gabor/0000-0002-2779-8679; Berger, Imre/0000-0001-7518-9045; schultz, patrick/0000-0002-7310-6186; Chaillet, Maxime/0000-0001-6812-4147; Berger-Schaffitzel, Christiane Helene/0000-0002-1516-9760	European Research Council (ERC); Agence Nationale de la Recherche (ANR); EC Marie Curie Action; EC; Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National pour la Recherche Scientifique (CNRS); Association pour la Recherche sur le Cancer (ARC); Fondation pour la Recherche Medicale (FRM); ANR; ChromAct; TFIID-Complexes	European Research Council (ERC)(European Research Council (ERC)European Commission); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); EC Marie Curie Action(European Commission); EC(European CommissionEuropean Commission Joint Research Centre); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR)); ChromAct; TFIID-Complexes	We thank all members of the Berger, Schultz and Tora laboratories for advice and discussions. We are grateful to C. Romier for providing the X-ray structure of the TAF6 C-terminal domain before publication. We thank J. Demmers for mass spectrometric analyses and F. Grosveld for discussions. The EMBL, IBS and IGBMC core facilities are acknowledged for services. We are indebted to G. Schoehn for maintaining the electron microscopes in Grenoble. T. J. Richmond is acknowledged for advice and support. C. B. is a fellow of the joint European Commission (EC)/EMBL interdisciplinary research opportunities program (EIPOD). C. S. is recipient of a European Research Council (ERC) Starting Grant and an Agence Nationale de la Recherche (ANR) Jeunes Chercheuses award. I. B. acknowledges support from the EC Marie Curie Action and the EC Framework Programme (FP) 7 projects INSTRUCT, PCUBE, BioSTRUCT-X, 4D-CellFate and ComplexINC. P. S. acknowledges support from the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National pour la Recherche Scientifique (CNRS), the Association pour la Recherche sur le Cancer (ARC) and the Fondation pour la Recherche Medicale (FRM). This work was supported by the ANR Projets Blancs puzzle-fit (to P. S.), ChromAct (to P. S. and L. T.) and TFIID-Complexes (to L.T., P.S. and I.B.).	Andel F, 1999, SCIENCE, V286, P2153, DOI 10.1126/science.286.5447.2153; Bell B, 2001, MOL CELL, V8, P591, DOI 10.1016/S1097-2765(01)00325-2; Bhattacharya S, 2007, P NATL ACAD SCI USA, V104, P1189, DOI 10.1073/pnas.0610297104; Brand M, 1999, SCIENCE, V286, P2151, DOI 10.1126/science.286.5447.2151; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Chen Z, 2003, J BIOL CHEM, V278, P35172, DOI 10.1074/jbc.M304241200; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; Demeny MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000316; Dubrovskaya V, 1996, EMBO J, V15, P3702, DOI 10.1002/j.1460-2075.1996.tb00740.x; Fitzgerald DJ, 2007, STRUCTURE, V15, P275, DOI 10.1016/j.str.2007.01.016; Grob P, 2006, STRUCTURE, V14, P511, DOI 10.1016/j.str.2005.11.020; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; Mengus G, 2005, EMBO J, V24, P2753, DOI 10.1038/sj.emboj.7600748; Papai G, 2011, CURR OPIN GENET DEV, V21, P219, DOI 10.1016/j.gde.2011.01.009; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; Papai G, 2009, STRUCTURE, V17, P363, DOI 10.1016/j.str.2009.01.006; Romier C, 2007, J MOL BIOL, V368, P1292, DOI 10.1016/j.jmb.2007.02.039; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Scheer E, 2012, J BIOL CHEM, V287, P27580, DOI 10.1074/jbc.M112.379206; Selleck W, 2001, NAT STRUCT BIOL, V8, P695, DOI 10.1038/90408; Soutoglou E, 2005, MOL CELL BIOL, V25, P4092, DOI 10.1128/MCB.25.10.4092-4104.2005; Timmers HTM, 2005, TRENDS BIOCHEM SCI, V30, P7, DOI 10.1016/j.tibs.2004.11.007; Wang XP, 2007, P NATL ACAD SCI USA, V104, P7839, DOI 10.1073/pnas.0608570104; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0	30	110	114	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					699	702		10.1038/nature11791	http://dx.doi.org/10.1038/nature11791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23292512				2022-12-24	WOS:000314219600062
J	Zarnack, K; Konig, J; Tajnik, M; Martincorena, I; Eustermann, S; Stevant, I; Reyes, A; Anders, S; Luscombe, NM; Ule, J				Zarnack, Kathi; Koenig, Julian; Tajnik, Mojca; Martincorena, Inigo; Eustermann, Sebastian; Stevant, Isabelle; Reyes, Alejandro; Anders, Simon; Luscombe, Nicholas M.; Ule, Jernej			Direct Competition between hnRNP C and U2AF65 Protects the Transcriptome from the Exonization of Alu Elements	CELL			English	Article							PRE-MESSENGER-RNA; GENOME-WIDE ANALYSIS; HUMAN-DISEASE GENES; POLYPYRIMIDINE-TRACT; NUCLEOTIDE STRUCTURE; COMPUTATIONAL TOOLS; SPLICING REGULATION; MUTATION PATTERN; BINDING-PROTEIN; REVEALS	There are similar to 650,000 Alu elements in transcribed regions of the human genome. These elements contain cryptic splice sites, so they are in constant danger of aberrant incorporation into mature transcripts. Despite posing a major threat to transcriptome integrity, little is known about the molecular mechanisms preventing their inclusion. Here, we present a mechanism for protecting the human transcriptome from the aberrant exonization of transposable elements. Quantitative iCLIP data show that the RNA-binding protein hnRNP C competes with the splicing factor U2AF65 at many genuine and cryptic splice sites. Loss of hnRNP C leads to formation of previously suppressed Alu exons, which severely disrupt transcript function. Minigene experiments explain disease-associated mutations in Alu elements that hamper hnRNP C binding. Thus, by preventing U2AF65 binding to Alu elements, hnRNP C plays a critical role as a genome-wide sentinel protecting the transcriptome. The findings have important implications for human evolution and disease.	[Zarnack, Kathi; Martincorena, Inigo; Stevant, Isabelle; Luscombe, Nicholas M.] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Koenig, Julian; Tajnik, Mojca; Eustermann, Sebastian; Ule, Jernej] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Tajnik, Mojca] Univ Ljubljana, Fac Med, SI-1104 Ljubljana, Slovenia; [Reyes, Alejandro; Anders, Simon] EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany; [Luscombe, Nicholas M.] UCL, UCL Genet Inst, Dept Genet Environm & Evolut, London WC1E 6BT, England; [Luscombe, Nicholas M.] CancRes UK London Res Inst, London WC2A 3LY, England; [Luscombe, Nicholas M.] Grad Univ, Okinawa Inst Sci & Technol, Onna Son, Okinawa 9040495, Japan	European Molecular Biology Laboratory (EMBL); MRC Laboratory Molecular Biology; University of Ljubljana; European Molecular Biology Laboratory (EMBL); University of London; University College London; Okinawa Institute of Science & Technology Graduate University	Luscombe, NM (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	nicholas.luscombe@ucl.ac.uk; jule@mrc-lmb.cam.ac.uk	Ule, Jernej/C-6315-2013; Reyes, Alejandro/D-8258-2017; Anders, Simon/D-4087-2011	Ule, Jernej/0000-0002-2452-4277; Reyes, Alejandro/0000-0001-8717-6612; Anders, Simon/0000-0003-4868-1805; Zarnack, Kathi/0000-0003-3527-3378; Konig, Julian/0000-0002-9398-5421; Martincorena, Inigo/0000-0003-1122-4416; Stevant, Isabelle/0000-0002-0193-2526	European Research Council [206726-CLIP]; Medical Research Council [U105185858]; EMBL EIPOD fellowship; Long-term Human Frontiers Science Program fellowship; MRC [MC_U105185858] Funding Source: UKRI; Cancer Research UK [16358] Funding Source: researchfish; Medical Research Council [MC_U105185858] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBL EIPOD fellowship; Long-term Human Frontiers Science Program fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank all members of the Ule and Luscombe laboratories for assistance and discussion, in particular Zhen Wang and Miha Modic for sharing RNA samples from TIA1/TIAL and TDP-43 knockdown cells. We thank Tomaz Curk, Gregor Rot, and Crt Gorup for their work on the iCount pipeline, as well as James Hadfield for high-throughput sequencing. We are grateful for materials, data, and advice provided by Chris Smith, Miguel Coelho, Miriam Llorian, Wing-Fung (Wilfred) Wu, Michael Sattler, Yun Zhang, Frederic Allain, Zuzana Cienikova, Gene Yeo, Stephanie Huelga, Gil Ast, Galit Lev-Maor, Noa Sela, Juan Valcarcel, Joao Tavanez, and Gautier Koscielny. This work was supported by the European Research Council (grant 206726-CLIP) and the Medical Research Council (grant U105185858) (to J.U.), an EMBL EIPOD fellowship (to K.Z.), and a Long-term Human Frontiers Science Program fellowship (to J.K.).	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BEYER AL, 1977, CELL, V11, P127, DOI 10.1016/0092-8674(77)90323-3; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4250, DOI 10.1093/nar/gkm402; CARAS IW, 1987, NATURE, V325, P545, DOI 10.1038/325545a0; CHOI YD, 1986, SCIENCE, V231, P1534, DOI 10.1126/science.3952495; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Dhir A, 2010, FEBS J, V277, P841, DOI 10.1111/j.1742-4658.2009.07520.x; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Fedorova L, 2003, GENETICA, V118, P123, DOI 10.1023/A:1024145407467; Forch P, 2002, EMBO J, V21, P6882, DOI 10.1093/emboj/cdf668; Gal-Mark N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000717; GORLACH M, 1994, J BIOL CHEM, V269, P23074; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hasler J, 2007, CELL MOL LIFE SCI, V64, P1793, DOI 10.1007/s00018-007-7084-0; Hedges DJ, 2007, MUTAT RES-FUND MOL M, V616, P46, DOI 10.1016/j.mrfmmm.2006.11.021; Heiner M, 2010, RNA BIOL, V7, P56, DOI 10.4161/rna.7.1.10402; HUANG M, 1994, MOL CELL BIOL, V14, P518, DOI 10.1128/MCB.14.1.518; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Konig J, 2011, JOVE-J VIS EXP, DOI 10.3791/2638; Kreahling J, 2004, TRENDS GENET, V20, P1, DOI 10.1016/j.tig.2003.11.001; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lin L, 2009, HUM MOL GENET, V18, P2204, DOI 10.1093/hmg/ddp152; Llorian M, 2010, NAT STRUCT MOL BIOL, V17, P1114, DOI 10.1038/nsmb.1881; Mackereth CD, 2011, NATURE, V475, P408, DOI 10.1038/nature10171; Meili D, 2009, HUM MUTAT, V30, P823, DOI 10.1002/humu.20969; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; NORTON PA, 1994, NUCLEIC ACIDS RES, V22, P3854, DOI 10.1093/nar/22.19.3854; Tavanez JP, 2012, MOL CELL, V45, P314, DOI 10.1016/j.molcel.2011.11.033; Sauliere J, 2006, MOL CELL BIOL, V26, P8755, DOI 10.1128/MCB.00893-06; Schmitz J, 2011, BIOCHIMIE, V93, P1928, DOI 10.1016/j.biochi.2011.07.014; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Shen SH, 2011, P NATL ACAD SCI USA, V108, P2837, DOI 10.1073/pnas.1012834108; Singh R, 2000, RNA, V6, P901, DOI 10.1017/S1355838200000376; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Sorek R, 2007, RNA, V13, P1603, DOI 10.1261/rna.682507; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Toll-Riera M, 2009, MOL BIOL EVOL, V26, P603, DOI 10.1093/molbev/msn281; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Varon R, 2003, NAT GENET, V35, P185, DOI 10.1038/ng1243; Vorechovsky I, 2006, NUCLEIC ACIDS RES, V34, P4630, DOI 10.1093/nar/gkl535; Vorechovsky I, 2010, HUM GENET, V127, P135, DOI 10.1007/s00439-009-0752-4; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Wang Z, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000530; Warf MB, 2009, P NATL ACAD SCI USA, V106, P9203, DOI 10.1073/pnas.0900342106; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003	59	285	298	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					453	466		10.1016/j.cell.2012.12.023	http://dx.doi.org/10.1016/j.cell.2012.12.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374342	hybrid, Green Published			2022-12-24	WOS:000314362800016
J	Korobova, F; Ramabhadran, V; Higgs, HN				Korobova, Farida; Ramabhadran, Vinay; Higgs, Henry N.			An Actin-Dependent Step in Mitochondrial Fission Mediated by the ER-Associated Formin INF2	SCIENCE			English	Article							MARIE-TOOTH-DISEASE; MUTATIONS; PROTEIN; DYNAMICS; POLYMERIZATION; MOVEMENT; FUSION; FAMILY	Mitochondrial fission is fundamentally important to cellular physiology. The dynamin-related protein Drp1 mediates fission, and interaction between mitochondrion and endoplasmic reticulum (ER) enhances fission. However, the mechanism for Drp1 recruitment to mitochondria is unclear, although previous results implicate actin involvement. Here, we found that actin polymerization through ER-localized inverted formin 2 (INF2) was required for efficient mitochondrial fission in mammalian cells. INF2 functioned upstream of Drp1. Actin filaments appeared to accumulate between mitochondria and INF2-enriched ER membranes at constriction sites. Thus, INF2-induced actin filaments may drive initial mitochondrial constriction, which allows Drp1-driven secondary constriction. Because INF2 mutations can lead to Charcot-Marie-Tooth disease, our results provide a potential cellular mechanism for this disease state.	[Korobova, Farida; Higgs, Henry N.] Dartmouth, Geisel Sch Med, Dept Biochem, Hanover, NH 03755 USA; [Ramabhadran, Vinay] Tufts Univ, Sackler Sch Grad Biomed Sci, Howard Hughes Med Inst, Boston, MA 02111 USA	Dartmouth College; Howard Hughes Medical Institute; Tufts University	Higgs, HN (corresponding author), Dartmouth, Geisel Sch Med, Dept Biochem, Hanover, NH 03755 USA.	henry.higgs@dartmouth.edu		Higgs, Henry/0000-0002-2917-9644	NIH [GM069818, DK88826]; NSF [DBI1039423]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069818] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Zick, J. Moseley, B. Wickner, and C. Barlowe for useful discussions; A. Lavanway for help with the microscopes; and M. Richio-Dalton for her tireless energy. Portions of this publication are covered in a pending patent application. "Methods for modulating mitochondrial function via INF2," H. Higgs author, Patent DC512US. L. Supported by NIH grants GM069818 and DK88826 to H.N.H. Funds to purchase the Nikon A1RSi confocal workstation were provided by NSF award DBI1039423.	Boyer O, 2011, NEW ENGL J MED, V365, P2377, DOI 10.1056/NEJMoa1109122; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Cartoni R, 2009, EXP NEUROL, V218, P268, DOI 10.1016/j.expneurol.2009.05.003; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Chhabra ES, 2009, J CELL SCI, V122, P1430, DOI 10.1242/jcs.040691; Correia SC, 2012, ADV EXP MED BIOL, V724, P205, DOI 10.1007/978-1-4614-0653-2_16; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; DuBoff B, 2012, NEURON, V75, P618, DOI 10.1016/j.neuron.2012.06.026; Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; Hoppins S, 2012, SCIENCE, V337, P1052, DOI 10.1126/science.1224709; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Legesse-Miller A, 2003, MOL BIOL CELL, V14, P1953, DOI 10.1091/mbc.E02-10-0657; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Ramabhadran V, 2012, J BIOL CHEM, V287, P34234, DOI 10.1074/jbc.M112.365122; Ramabhadran V, 2011, MOL BIOL CELL, V22, P4822, DOI 10.1091/mbc.E11-05-0457; Vital A, 2012, NEUROMUSCULAR DISORD, V22, P735, DOI 10.1016/j.nmd.2012.04.001; Wozniak MJ, 2009, J CELL SCI, V122, P1979, DOI 10.1242/jcs.041962; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	25	490	499	5	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					464	467		10.1126/science.1228360	http://dx.doi.org/10.1126/science.1228360			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349293	Green Accepted			2022-12-24	WOS:000313960700048
J	Ma, C; Su, LJ; Seven, AB; Xu, YB; Rizo, J				Ma, Cong; Su, Lijing; Seven, Alpay B.; Xu, Yibin; Rizo, Josep			Reconstitution of the Vital Functions of Munc18 and Munc13 in Neurotransmitter Release	SCIENCE			English	Article							DEPENDENT MEMBRANE-FUSION; SYNAPTIC VESICLE FUSION; NEURONAL SNARE COMPLEX; CRYSTAL-STRUCTURE; ALPHA-SNAP; C2B DOMAIN; SYNAPTOTAGMIN; EXOCYTOSIS; DOCKING; CALCIUM	Neurotransmitter release depends critically on Munc18-1, Munc13, the Ca2+ sensor synaptotagmin-1, and the soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein (SNAP) receptors (SNAREs) syntaxin-1, synaptobrevin, and SNAP-25. In vitro reconstitutions have shown that syntaxin-1-SNAP-25 liposomes fuse efficiently with synaptobrevin liposomes in the presence of synaptotagmin-1-Ca2+, but neurotransmitter release also requires Munc18-1 and Munc13 in vivo. We found that Munc18-1 could displace SNAP-25 from syntaxin-1 and that fusion of syntaxin-1-Munc18-1 liposomes with synaptobrevin liposomes required Munc13, in addition to SNAP-25 and synaptotagmin-1-Ca2+. Moreover, when starting with syntaxin-1-SNAP-25 liposomes, NSF-alpha-SNAP disassembled the syntaxin-1-SNAP-25 heterodimers and abrogated fusion, which then required Munc18-1 and Munc13. We propose that fusion does not proceed through syntaxin-1-SNAP-25 heterodimers but starts with the syntaxin-1-Munc18-1 complex; Munc18-1 and Munc13 then orchestrate membrane fusion together with the SNAREs and synaptotagmin-1-Ca2+ in an NSF- and SNAP-resistant manner.	[Ma, Cong] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Ma, Cong] Huazhong Univ Sci & Technol, Inst Biochem & Biophys, Wuhan 430074, Peoples R China; [Ma, Cong; Su, Lijing; Seven, Alpay B.; Xu, Yibin; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Ma, Cong; Su, Lijing; Seven, Alpay B.; Xu, Yibin; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Ma, Cong; Su, Lijing; Seven, Alpay B.; Xu, Yibin; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ma, C (corresponding author), Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China.	cong.ma7@gmail.com; jose@arnie.swmed.edu			Welch Foundation [I-1304]; National Science Foundation of China [31200618]; NIH [NS37200, NS40944]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037200, R01NS040944] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Sun for expert technical assistance; Y. Liu for initial efforts to reconstitute syntaxin-1-Munc18-1 complexes; and W. Li, W. Wickner, and M. Brown for fruitful discussions. This work was supported by grant I-1304 from the Welch Foundation (to J.R.), grant 31200618 from the National Science Foundation of China (to C. M.), and grants NS37200 and NS40944 from the NIH (to J.R.).	Basu J, 2005, NAT STRUCT MOL BIOL, V12, P1017, DOI 10.1038/nsmb1001; Boswell KL, 2012, J CELL BIOL, V197, P301, DOI 10.1083/jcb.201109132; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Diao JJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00109; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Lee HK, 2010, SCIENCE, V328, P760, DOI 10.1126/science.1187722; Li W, 2011, STRUCTURE, V19, P1443, DOI 10.1016/j.str.2011.07.012; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Pei JM, 2009, J MOL BIOL, V391, P509, DOI 10.1016/j.jmb.2009.06.054; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shin OH, 2010, NAT STRUCT MOL BIOL, V17, P280, DOI 10.1038/nsmb.1758; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508	35	257	260	7	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2013	339	6118					421	425		10.1126/science.1230473	http://dx.doi.org/10.1126/science.1230473			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23258414	Green Accepted			2022-12-24	WOS:000313960700036
J	Simakov, O; Marletaz, F; Cho, SJ; Edsinger-Gonzales, E; Havlak, P; Hellsten, U; Kuo, DH; Larsson, T; Lv, J; Arendt, D; Savage, R; Osoegawa, K; de Jong, P; Grimwood, J; Chapman, JA; Shapiro, H; Aerts, A; Otillar, RP; Terry, AY; Boore, JL; Grigoriev, IV; Lindberg, DR; Seaver, EC; Weisblat, DA; Putnam, NH; Rokhsar, DS				Simakov, Oleg; Marletaz, Ferdinand; Cho, Sung-Jin; Edsinger-Gonzales, Eric; Havlak, Paul; Hellsten, Uffe; Kuo, Dian-Han; Larsson, Tomas; Lv, Jie; Arendt, Detlev; Savage, Robert; Osoegawa, Kazutoyo; de Jong, Pieter; Grimwood, Jane; Chapman, Jarrod A.; Shapiro, Harris; Aerts, Andrea; Otillar, Robert P.; Terry, Astrid Y.; Boore, Jeffrey L.; Grigoriev, Igor V.; Lindberg, David R.; Seaver, Elaine C.; Weisblat, David A.; Putnam, Nicholas H.; Rokhsar, Daniel S.			Insights into bilaterian evolution from three spiralian genomes	NATURE			English	Article							SCHMIDTEA-MEDITERRANEA; SCHISTOSOMA-MANSONI; GENES; TREE; REPERTOIRE; RESOLUTION; ORGANISM; LIFE	Current genomic perspectives on animal diversity neglect two prominent phyla, the molluscs and annelids, that together account for nearly one-third of known marine species and are important both ecologically and as experimental systems in classical embryology(1-3). Here we describe the draft genomes of the owl limpet (Lottia gigantea), a marine polychaete (Capitella teleta) and a freshwater leech (Helobdella robusta), and compare them with other animal genomes to investigate the origin and diversification of bilaterians from a genomic perspective. We find that the genome organization, gene structure and functional content of these species are more similar to those of some invertebrate deuterostome genomes (for example, amphioxus and sea urchin) than those of other protostomes that have been sequenced to date (flies, nematodes and flatworms). The conservation of these genomic features enables us to expand the inventory of genes present in the last common bilaterian ancestor, establish the tripartite diversification of bilaterians using multiple genomic characteristics and identify ancient conserved long-and short-range genetic linkages across metazoans. Superimposed on this broadly conserved pan-bilaterian background we find examples of lineage-specific genome evolution, including varying rates of rearrangement, intron gain and loss, expansions and contractions of gene families, and the evolution of clade-specific genes that produce the unique content of each genome.	[Simakov, Oleg; Marletaz, Ferdinand; Larsson, Tomas; Arendt, Detlev] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Simakov, Oleg; Cho, Sung-Jin; Edsinger-Gonzales, Eric; Kuo, Dian-Han; Weisblat, David A.; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Havlak, Paul; Lv, Jie; Putnam, Nicholas H.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA; [Hellsten, Uffe; Grimwood, Jane; Chapman, Jarrod A.; Shapiro, Harris; Aerts, Andrea; Otillar, Robert P.; Terry, Astrid Y.; Boore, Jeffrey L.; Grigoriev, Igor V.; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Savage, Robert] Williams Coll, Dept Biol, Thompson Biol Lab, Williamstown, MA 01267 USA; [Osoegawa, Kazutoyo; de Jong, Pieter] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Grimwood, Jane] Hudson Alpha Inst Biotechnol, Huntsville, AL 35806 USA; [Lindberg, David R.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Seaver, Elaine C.] Univ Hawaii Manoa, Kewalo Marine Lab, Honolulu, HI 96813 USA; [Putnam, Nicholas H.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Rokhsar, Daniel S.] Okinawa Inst Sci & Technol, Onna Son, Okinawa 9040495, Japan	European Molecular Biology Laboratory (EMBL); University of California System; University of California Berkeley; Rice University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Williams College; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Berkeley; University of Hawaii System; University of Hawaii Manoa; Rice University; Okinawa Institute of Science & Technology Graduate University	Putnam, NH (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, POB 1892, Houston, TX 77251 USA.	nputnam@gmail.com; dsrokhsar@gmail.com	LU, JIE/AAP-6595-2020; Lindberg, David R/D-8138-2011; Marlétaz, Ferdinand/H-3018-2019; Simakov, Oleg/G-4572-2015; Putnam, Nicholas/B-9968-2008; Simakov, Oleg/AAV-2494-2020; Terry, Astrid Y/A-2538-2011; Grimwood, Jane/ABD-5737-2021	LU, JIE/0000-0001-5071-8959; Marlétaz, Ferdinand/0000-0001-8124-4266; Simakov, Oleg/0000-0002-3585-4511; Putnam, Nicholas/0000-0002-1315-782X; Simakov, Oleg/0000-0002-3585-4511; Terry, Astrid Y/0000-0002-5234-1224; Rokhsar, Daniel/0000-0002-8704-2224; Edsinger, Eric/0000-0002-1012-1506; Grigoriev, Igor/0000-0002-3136-8903; Kuo, Dian-Han/0000-0002-6461-2562	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Gordon and Betty Moore Foundation; National Science Foundation (NSF) [EF-0850294, I0S-0922792]; National Institutes of Health (NIH) [RO1 GM 074619]; Boehringer Ingelheim Fonds; US National Human Genome Research Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074619] Funding Source: NIH RePORTER; Direct For Biological Sciences [0850294] Funding Source: National Science Foundation	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim); US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under contract no. DE-AC02-05CH11231. Early work on the analysis of these genomes was also supported by the Gordon and Betty Moore Foundation through a grant to the Center for Integrative Genomics at the University of California. D. S. R. thanks R. Melmon for a grant in support of this project. N.H.P. is supported by the National Science Foundation (NSF) under grant EF-0850294; D. A. W. is supported by the National Institutes of Health (NIH; RO1 GM 074619) and NSF (I0S-0922792); and O.S. is supported by Boehringer Ingelheim Fonds. E.E-G. was supported by a training grant from the US National Human Genome Research Institute. We thank A. Meyer and J. Gerhart for helpful discussions.	Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Cho SJ, 2010, MOL BIOL EVOL, V27, P1645, DOI 10.1093/molbev/msq052; Conklin EG, 1897, EMBRYOLOGY CREPIDULA; de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; Frobius AC, 2006, GENE EXPR PATTERNS, V6, P985, DOI 10.1016/j.modgep.2006.04.002; Henry JQ, 2007, INTEGR COMP BIOL, V47, P865, DOI 10.1093/icb/icm035; Maloof AC, 2010, GEOL SOC AM BULL, V122, P1731, DOI 10.1130/B30346.1; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Purschke G, 2005, HYDROBIOLOGIA, V535, P53, DOI 10.1007/s10750-004-4358-5; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Rokas A, 2003, EVOL DEV, V5, P346, DOI 10.1046/j.1525-142X.2003.03042.x; Roy SW, 2008, MOL BIOL EVOL, V25, P620, DOI 10.1093/molbev/msn035; Roy SW, 2005, P NATL ACAD SCI USA, V102, P4403, DOI 10.1073/pnas.0409891102; Schistosoma japonicum Genome Sequencing and Functional Analysis Consortium, 2009, NATURE, V460, P345; Shimeld SM, 2010, DEV BIOL, V340, P234, DOI 10.1016/j.ydbio.2010.01.015; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Telford MJ, 2011, TRENDS GENET, V27, P186, DOI 10.1016/j.tig.2011.02.003; Wilson EB, 1892, J MORPHOL, V6, P361; Zamanian M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-596	28	409	422	7	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					526	531		10.1038/nature11696	http://dx.doi.org/10.1038/nature11696			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23254933	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-24	WOS:000313871400037
J	Senyo, SE; Steinhauser, ML; Pizzimenti, CL; Yang, VK; Cai, L; Wang, M; Wu, TD; Guerquin-Kern, JL; Lechene, CP; Lee, RT				Senyo, Samuel E.; Steinhauser, Matthew L.; Pizzimenti, Christie L.; Yang, Vicky K.; Cai, Lei; Wang, Mei; Wu, Ting-Di; Guerquin-Kern, Jean-Luc; Lechene, Claude P.; Lee, Richard T.			Mammalian heart renewal by pre-existing cardiomyocytes	NATURE			English	Article							STEM-CELLS; MOUSE; REGENERATION; TURNOVER	Although recent studies have revealed that heart cells are generated in adult mammals, the frequency of generation and the source of new heart cells are not yet known. Some studies suggest a high rate of stem cell activity with differentiation of progenitors to cardiomyocytes(1). Other studies suggest that new cardiomyocytes are born at a very low rate(2-4), and that they may be derived from the division of pre-existing cardiomyocytes. Here we show, by combining two different pulse-chase approaches-genetic fate-mapping with stable isotope labelling, and multi-isotope imaging mass spectrometry-that the genesis of cardiomyocytes occurs at a low rate by the division of pre-existing cardiomyocytes during normal ageing, a process that increases adjacent to areas of myocardial injury. We found that cell cycle activity during normal ageing and after injury led to polyploidy and multinucleation, but also to new diploid, mononucleate cardiomyocytes. These data reveal pre-existing cardiomyocytes as the dominant source of cardiomyocyte replacement in normal mammalian myocardial homeostasis as well as after myocardial injury.	[Senyo, Samuel E.; Steinhauser, Matthew L.; Pizzimenti, Christie L.; Yang, Vicky K.; Cai, Lei; Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Cambridge, MA 02139 USA; [Senyo, Samuel E.; Steinhauser, Matthew L.; Pizzimenti, Christie L.; Yang, Vicky K.; Cai, Lei; Wang, Mei; Lechene, Claude P.; Lee, Richard T.] Harvard Univ, Sch Med, Cambridge, MA 02139 USA; [Wu, Ting-Di; Guerquin-Kern, Jean-Luc] INSERM, U759, F-91405 Orsay, France; [Wu, Ting-Di; Guerquin-Kern, Jean-Luc] Inst Curie, Lab Microscopie Ion, F-91405 Orsay, France; [Wang, Mei; Lechene, Claude P.] Natl Resource Imaging Mass Spectrometry, Cambridge, MA 02139 USA; [Wang, Mei; Lechene, Claude P.] Brigham & Womens Hosp, Dept Med, Div Genet, Cambridge, MA 02139 USA; [Lee, Richard T.] Harvard Stem Cell Inst, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Harvard University; Brigham & Women's Hospital; Harvard University	Lee, RT (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Cambridge, MA 02139 USA.	rlee@partners.org	Guerquin-Kern, Jean-Luc/M-5000-2018; Steinhauser, Matthew L./GVT-6393-2022	Guerquin-Kern, Jean-Luc/0000-0002-8610-0146; Steinhauser, Matthew L./0000-0001-5287-9246; Senyo, Samuel/0000-0002-9206-6845; WU, Ting-Di/0000-0002-6398-0363; Lee, Richard/0000-0003-4687-1381	National Institutes of Health (NIH) [F32 HL108570, K08 DK090147, EB001974, AG034641, AG032977, AG040019]; American Heart Association (AHA FTF); Future Leaders in Cardiovascular Medicine; Watkins Cardiovascular Leadership Award; Ellison Medical Foundation [AG-SS-2215-08]; Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL108570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P20EB001974, P41EB001974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040019, R21AG034641, R01AG032977] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA FTF)(American Heart Association); Future Leaders in Cardiovascular Medicine; Watkins Cardiovascular Leadership Award; Ellison Medical Foundation(Lawrence Ellison Foundation); Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Gannon for surgical assistance; J. Lammerding and P. Isserman for assistance with microscopy and IP Lab software; and C. MacGillivray for histology; and J. C. Poczatek and Z. Kaufman for assistance with OpenMIMS Data Analysis and image data processing. S. E. S. is funded by the National Institutes of Health (NIH; F32 HL108570). M. L. S. is funded by the American Heart Association (AHA FTF), Future Leaders in Cardiovascular Medicine, Watkins Cardiovascular Leadership Award and the NIH (K08 DK090147). C. P. L. is funded by the NIH (EB001974 and AG034641) and the Ellison Medical Foundation (AG-SS-2215-08). R. T. L. is funded by the NIH (AG032977 and AG040019) and the Harvard Stem Cell Institute.	ADLER CP, 1986, J MOL CELL CARDIOL, V18, P39, DOI 10.1016/S0022-2828(86)80981-6; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2011, EXP CELL RES, V317, P188, DOI 10.1016/j.yexcr.2010.08.017; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Dong F, 2012, CIRCULATION, V126, P314, DOI 10.1161/CIRCULATIONAHA.111.082453; Hosoda T, 2011, J THROMB HAEMOST, V9, P151, DOI 10.1111/j.1538-7836.2011.04363.x; Hosoda T, 2009, P NATL ACAD SCI USA, V106, P17169, DOI 10.1073/pnas.0903089106; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Hu VW, 2002, FASEB J, V16, P1456, DOI 10.1096/fj.02-0142fje; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; KATZBERG AA, 1977, AM J ANAT, V149, P489, DOI 10.1002/aja.1001490406; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; KLEIN PD, 1986, J CLIN PHARMACOL, V26, P378, DOI 10.1002/j.1552-4604.1986.tb03544.x; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745	27	862	904	7	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					433	U186		10.1038/nature11682	http://dx.doi.org/10.1038/nature11682			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23222518	Green Accepted, Green Submitted			2022-12-24	WOS:000313615900058
J	Zong, CH; Lu, SJ; Chapman, AR; Xie, XS				Zong, Chenghang; Lu, Sijia; Chapman, Alec R.; Xie, X. Sunney			Genome-Wide Detection of Single-Nucleotide and Copy-Number Variations of a Single Human Cell	SCIENCE			English	Article							GENETIC-ANALYSIS; MUTATION-RATES; HUMAN CANCERS; TUMOR-CELLS; AMPLIFICATION; DNA; EVOLUTION; POLYMERASE; PRIMER; PCR	Kindred cells can have different genomes because of dynamic changes in DNA. Single-cell sequencing is needed to characterize these genomic differences but has been hindered by whole-genome amplification bias, resulting in low genome coverage. Here, we report on a new amplification method-multiple annealing and looping-based amplification cycles (MALBAC)-that offers high uniformity across the genome. Sequencing MALBAC-amplified DNA achieves 93% genome coverage >= 1x for a single human cell at 25x mean sequencing depth. We detected digitized copy-number variations (CNVs) of a single cancer cell. By sequencing three kindred cells, we were able to identify individual single-nucleotide variations (SNVs), with no false positives detected. We directly measured the genome-wide mutation rate of a cancer cell line and found that purine-pyrimidine exchanges occurred unusually frequently among the newly acquired SNVs.	[Zong, Chenghang; Lu, Sijia; Chapman, Alec R.; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Chapman, Alec R.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Zong, Chenghang/F-3243-2013	Zong, Chenghang/0000-0002-8337-8038	U.S. National Institutes of Health National Human Genome Research Institute [HG005097-1, HG005613-01]; Bill & Melinda Gates Foundation [OPP42867]; NIH [NIH/NIGMS T32 GM008313]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005613, R01HG005097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health National Human Genome Research Institute grants (HG005097-1 and HG005613-01) and in part by Bill & Melinda Gates Foundation OPP42867 to X.S.X. A.R.C. was supported by an NIH Molecular Biophysics Training grant (NIH/NIGMS T32 GM008313). We thank P. Choi for his involvement in the early stage of the project and J. Lu and L. Song for their assistance on the experiments. We thank J. Yong for his help on single-cell expansion and isolation and Y. Zhang at Biodynamic and Optical Imaging Center (BIOPIC) at Peking University for assistance on sequencing. The sequencing data are deposited at the National Center for Biotechnology Information with accession no. SRA060929. C.Z., S.L., and X.S.X. are authors on a patent applied for by Harvard University that covers the MALBAC technology.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Blainey PC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1074; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Dietmaier W, 1999, AM J PATHOL, V154, P83, DOI 10.1016/S0002-9440(10)65254-6; Drake JW, 1998, GENETICS, V148, P1667; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Gundry M, 2012, NUCLEIC ACIDS RES, V40, P2032, DOI 10.1093/nar/gkr949; Hanson EK, 2005, ANAL BIOCHEM, V346, P246, DOI 10.1016/j.ab.2005.08.017; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Lao Kaiqin, 2008, Biotechnol J, V3, P378, DOI 10.1002/biot.200700253; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; MacArthur D, 2012, NATURE, V487, P427, DOI 10.1038/487427a; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rochette PJ, 2005, J MOL BIOL, V352, P44, DOI 10.1016/j.jmb.2005.06.033; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	31	709	877	13	444	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1622	1626		10.1126/science.1229164	http://dx.doi.org/10.1126/science.1229164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258894	Green Accepted, Green Submitted			2022-12-24	WOS:000312533100054
J	van der Harst, P; Zhang, WH; Leach, IM; Rendon, A; Verweij, N; Sehmi, J; Paul, DS; Elling, U; Allayee, H; Li, XZ; Radhakrishnan, A; Tan, ST; Voss, K; Weichenberger, CX; Albers, CA; Al-Hussani, A; Asselbergs, FW; Ciullo, M; Danjou, F; Dina, C; Esko, T; Evans, DM; Franke, L; Goegele, M; Hartiala, J; Hersch, M; Holm, H; Hottenga, JJ; Kanoni, S; Kleber, ME; Lagou, V; Langenberg, C; Lopez, LM; Lyytikainen, LP; Melander, O; Murgia, F; Nolte, IM; O'Reilly, PF; Padmanabhan, S; Parsa, A; Pirastu, N; Porcu, E; Portas, L; Prokopenko, I; Ried, JS; Shin, SY; Tang, CS; Teumer, A; Traglia, M; Ulivi, S; Westra, HJ; Yang, J; Zhao, JH; Anni, F; Abdellaoui, A; Attwood, A; Balkau, B; Bandinelli, S; Bastardot, F; Benyamin, B; Boehm, BO; Cookson, WO; Das, D; de Bakker, PIW; de Boer, RA; de Geus, EJC; de Moor, MH; Dimitriou, M; Domingues, FS; Doring, A; Engstrom, G; Eyjolfsson, GI; Ferrucci, L; Fischer, K; Galanello, R; Garner, SF; Genser, B; Gibson, QD; Girotto, G; Gudbjartsson, DF; Harris, SE; Hartikainen, AL; Hastie, CE; Hedblad, B; Illig, T; Jolley, J; Kahonen, M; Kema, IP; Kemp, JP; Liang, LM; Lloyd-Jones, H; Loos, RJF; Meacham, S; Medland, SE; Meisinger, C; Memari, Y; Mihailov, E; Miller, K; Moffatt, MF; Nauck, M; Novatchkova, M; Nutile, T; Olafsson, I; Onundarson, PT; Parracciani, D; Penninx, BW; Perseu, L; Piga, A; Pistis, G; Pouta, A; Puc, U; Raitakari, O; Ring, SM; Robino, A; Ruggiero, D; Ruokonen, A; Saint-Pierre, A; Sala, C; Salumets, A; Sambrook, J; Schepers, H; Schmidt, CO; Sillje, HHW; Sladek, R; Smit, JH; Starr, JM; Stephens, J; Sulem, P; Tanaka, T; Thorsteinsdottir, U; Tragante, V; van Gilst, WH; van Pelt, LJ; van Veldhuisen, DJ; Volker, U; Whitfield, JB; Willemsen, G; Winkelmann, BR; Wirnsberger, G; Algra, A; Cucca, F; d'Adamo, AP; Danesh, J; Deary, IJ; Dominiczak, AF; Elliott, P; Fortina, P; Froguel, P; Gasparini, P; Greinacher, A; Hazen, SL; Jarvelin, MR; Khaw, KT; Lehtimaki, T; Maerz, W; Martin, NG; Metspalu, A; Mitchell, BD; Montgomery, GW; Moore, C; Navis, G; Pirastu, M; Pramstaller, PP; Ramirez-Solis, R; Schadt, E; Scott, J; Shuldiner, AR; Smith, GD; Smith, JG; Snieder, H; Sorice, R; Spector, TD; Stefansson, K; Stumvoll, M; Tang, WHW; Toniolo, D; Tonjes, A; Visscher, PM; Vollenweider, P; Wareham, NJ; Wolffenbuttel, BHR; Boomsma, DI; Beckmann, JS; Dedoussis, GV; Deloukas, P; Ferreira, MA; Sanna, S; Uda, M; Hicks, AA; Penninger, JM; Gieger, C; Kooner, JS; Ouwehand, WH; Soranzo, N; Chambers, JC				van der Harst, Pim; Zhang, Weihua; Leach, Irene Mateo; Rendon, Augusto; Verweij, Niek; Sehmi, Joban; Paul, Dirk S.; Elling, Ulrich; Allayee, Hooman; Li, Xinzhong; Radhakrishnan, Aparna; Tan, Sian-Tsung; Voss, Katrin; Weichenberger, Christian X.; Albers, Cornelis A.; Al-Hussani, Abtehale; Asselbergs, Folkert W.; Ciullo, Marina; Danjou, Fabrice; Dina, Christian; Esko, Tonu; Evans, David M.; Franke, Lude; Goegele, Martin; Hartiala, Jaana; Hersch, Micha; Holm, Hilma; Hottenga, Jouke-Jan; Kanoni, Stavroula; Kleber, Marcus E.; Lagou, Vasiliki; Langenberg, Claudia; Lopez, Lorna M.; Lyytikainen, Leo-Pekka; Melander, Olle; Murgia, Federico; Nolte, Ilja M.; O'Reilly, Paul F.; Padmanabhan, Sandosh; Parsa, Afshin; Pirastu, Nicola; Porcu, Eleonora; Portas, Laura; Prokopenko, Inga; Ried, Janina S.; Shin, So-Youn; Tang, Clara S.; Teumer, Alexander; Traglia, Michela; Ulivi, Sheila; Westra, Harm-Jan; Yang, Jian; Zhao, Jing Hua; Anni, Franco; Abdellaoui, Abdel; Attwood, Antony; Balkau, Beverley; Bandinelli, Stefania; Bastardot, Francois; Benyamin, Beben; Boehm, Bernhard O.; Cookson, William O.; Das, Debashish; de Bakker, Paul I. W.; de Boer, Rudolf A.; de Geus, Eco J. C.; de Moor, Marleen H.; Dimitriou, Maria; Domingues, Francisco S.; Doering, Angela; Engstrom, Gunnar; Eyjolfsson, Gudmundur Ingi; Ferrucci, Luigi; Fischer, Krista; Galanello, Renzo; Garner, Stephen F.; Genser, Bernd; Gibson, Quince D.; Girotto, Giorgia; Gudbjartsson, Daniel Fannar; Harris, Sarah E.; Hartikainen, Anna-Liisa; Hastie, Claire E.; Hedblad, Bo; Illig, Thomas; Jolley, Jennifer; Kahonen, Mika; Kema, Ido P.; Kemp, John P.; Liang, Liming; Lloyd-Jones, Heather; Loos, Ruth J. F.; Meacham, Stuart; Medland, Sarah E.; Meisinger, Christa; Memari, Yasin; Mihailov, Evelin; Miller, Kathy; Moffatt, Miriam F.; Nauck, Matthias; Novatchkova, Maria; Nutile, Teresa; Olafsson, Isleifur; Onundarson, Pall T.; Parracciani, Debora; Penninx, Brenda W.; Perseu, Lucia; Piga, Antonio; Pistis, Giorgio; Pouta, Anneli; Puc, Ursula; Raitakari, Olli; Ring, Susan M.; Robino, Antonietta; Ruggiero, Daniela; Ruokonen, Aimo; Saint-Pierre, Aude; Sala, Cinzia; Salumets, Andres; Sambrook, Jennifer; Schepers, Hein; Schmidt, Carsten Oliver; Sillje, Herman H. W.; Sladek, Rob; Smit, Johannes H.; Starr, John M.; Stephens, Jonathan; Sulem, Patrick; Tanaka, Toshiko; Thorsteinsdottir, Unnur; Tragante, Vinicius; van Gilst, Wiek H.; van Pelt, L. Joost; van Veldhuisen, Dirk J.; Voelker, Uwe; Whitfield, John B.; Willemsen, Gonneke; Winkelmann, Bernhard R.; Wirnsberger, Gerald; Algra, Ale; Cucca, Francesco; d'Adamo, Adamo Pio; Danesh, John; Deary, Ian J.; Dominiczak, Anna F.; Elliott, Paul; Fortina, Paolo; Froguel, Philippe; Gasparini, Paolo; Greinacher, Andreas; Hazen, Stanley L.; Jarvelin, Marjo-Riitta; Khaw, Kay Tee; Lehtimaki, Terho; Maerz, Winfried; Martin, Nicholas G.; Metspalu, Andres; Mitchell, Braxton D.; Montgomery, Grant W.; Moore, Carmel; Navis, Gerjan; Pirastu, Mario; Pramstaller, Peter P.; Ramirez-Solis, Ramiro; Schadt, Eric; Scott, James; Shuldiner, Alan R.; Smith, George Davey; Smith, J. Gustav; Snieder, Harold; Sorice, Rossella; Spector, Tim D.; Stefansson, Kari; Stumvoll, Michael; Tang, W. H. Wilson; Toniolo, Daniela; Toenjes, Anke; Visscher, Peter M.; Vollenweider, Peter; Wareham, Nicholas J.; Wolffenbuttel, Bruce H. R.; Boomsma, Dorret I.; Beckmann, Jacques S.; Dedoussis, George V.; Deloukas, Panos; Ferreira, Manuel A.; Sanna, Serena; Uda, Manuela; Hicks, Andrew A.; Penninger, Josef Martin; Gieger, Christian; Kooner, Jaspal S.; Ouwehand, Willem H.; Soranzo, Nicole; Chambers, John C.			Seventy-five genetic loci influencing the human red blood cell	NATURE			English	Article							GENOME-WIDE ASSOCIATION; HEMOGLOBIN LEVELS; VARIANTS; EXPRESSION; PROTEIN; COHORT; DOMAIN; LEVEL; MOUSE; STEM	Anaemia is a chief determinant of global ill health, contributing to cognitive impairment, growth retardation and impaired physical capacity. To understand further the genetic factors influencing red blood cells, we carried out a genome-wide association study of haemoglobin concentration and related parameters in up to 135,367 individuals. Here we identify 75 independent genetic loci associated with one or more red blood cell phenotypes at P < 10(-8), which together explain 4-9% of the phenotypic variance per trait. Using expression quantitative trait loci and bioinformatic strategies, we identify 121 candidate genes enriched in functions relevant to red blood cell biology. The candidate genes are expressed preferentially in red blood cell precursors, and 43 have haematopoietic phenotypes in Mus musculus or Drosophila melanogaster. Through open-chromatin and coding-variant analyses we identify potential causal genetic variants at 41 loci. Our findings provide extensive new insights into genetic mechanisms and biological pathways controlling red blood cell formation and function.	[Zhang, Weihua; Al-Hussani, Abtehale; O'Reilly, Paul F.; Elliott, Paul; Jarvelin, Marjo-Riitta; Chambers, John C.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London W2 1PG, England; [van der Harst, Pim; Leach, Irene Mateo; Verweij, Niek; de Boer, Rudolf A.; Sillje, Herman H. W.; van Gilst, Wiek H.; van Veldhuisen, Dirk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [van der Harst, Pim; Franke, Lude; Westra, Harm-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Zhang, Weihua; Sehmi, Joban; Tan, Sian-Tsung; Miller, Kathy; Kooner, Jaspal S.; Chambers, John C.] Ealing Hosp NHS Trust, Uxbridge UB1 3HW, Middx, England; [Rendon, Augusto; Radhakrishnan, Aparna; Voss, Katrin; Albers, Cornelis A.; Attwood, Antony; Garner, Stephen F.; Jolley, Jennifer; Lloyd-Jones, Heather; Meacham, Stuart; Sambrook, Jennifer; Stephens, Jonathan; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge CB2 0XY, England; [Rendon, Augusto; Radhakrishnan, Aparna; Voss, Katrin; Albers, Cornelis A.; Attwood, Antony; Garner, Stephen F.; Jolley, Jennifer; Lloyd-Jones, Heather; Meacham, Stuart; Sambrook, Jennifer; Stephens, Jonathan; Ouwehand, Willem H.] NHS Blood & Transplant, Cambridge CB2 0PT, England; [Rendon, Augusto] Inst Publ Hlth, MRC Biostat Unit, Cambridge CB2 2SR, England; [Rendon, Augusto; Radhakrishnan, Aparna; Voss, Katrin; Attwood, Antony; Garner, Stephen F.; Jolley, Jennifer; Lloyd-Jones, Heather; Meacham, Stuart; Sambrook, Jennifer; Stephens, Jonathan; Ouwehand, Willem H.] NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England; [Sehmi, Joban; Tan, Sian-Tsung; Cookson, William O.; Moffatt, Miriam F.; Scott, James; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W12 0NN, England; [Paul, Dirk S.; Radhakrishnan, Aparna; Albers, Cornelis A.; Kanoni, Stavroula; Shin, So-Youn; Attwood, Antony; Meacham, Stuart; Memari, Yasin; Ramirez-Solis, Ramiro; Deloukas, Panos; Ouwehand, Willem H.; Soranzo, Nicole] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Elling, Ulrich; Novatchkova, Maria; Puc, Ursula; Wirnsberger, Gerald; Penninger, Josef Martin] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Allayee, Hooman; Hartiala, Jaana] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Li, Xinzhong] Univ London Imperial Coll Sci Technol & Med, Inst Clin Sci, London W12 0NN, England; [Li, Xinzhong; Chambers, John C.] Royal Brompton & Harefield NHS Fdn Trust, NIHR Cardiovasc Biomed Res Unit, London SW3 6NP, England; [Li, Xinzhong; Chambers, John C.] Univ London Imperial Coll Sci Technol & Med, London SW3 6NP, England; [Weichenberger, Christian X.; Goegele, Martin; Domingues, Francisco S.; Saint-Pierre, Aude; Pramstaller, Peter P.; Hicks, Andrew A.] European Acad Bozen Bolzano EURAC, Ctr Biomed, I-39100 Bolzano, Italy; [Asselbergs, Folkert W.; Tragante, Vinicius] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, NL-3508 Utrecht, Netherlands; [Asselbergs, Folkert W.; de Bakker, Paul I. W.; Algra, Ale] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 Utrecht, Netherlands; [Asselbergs, Folkert W.; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 Utrecht, Netherlands; [Ciullo, Marina; Mihailov, Evelin; Nutile, Teresa; Ruggiero, Daniela; Sorice, Rossella] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, I-80131 Naples, Italy; [Danjou, Fabrice; Anni, Franco; Galanello, Renzo] Univ Cagliari, Osped Reg Microcitemie ASL8, Dipartimento Sci Biomed & Biotecnol, I-09121 Cagliari, Italy; [Dina, Christian] INSERM, UMR 1087, F-44007 Nantes 1, France; [Dina, Christian] CNRS, UMR 6291, F-44007 Nantes 1, France; [Dina, Christian] Univ Nantes, Sch Med, F-44000 Nantes, France; [Esko, Tonu; Fischer, Krista; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Evans, David M.; Kemp, John P.; Smith, George Davey] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol BS8 2BN, Avon, England; [Hersch, Micha; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Hersch, Micha] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Holm, Hilma; Gudbjartsson, Daniel Fannar; Sulem, Patrick; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Hottenga, Jouke-Jan; Abdellaoui, Abdel; de Geus, Eco J. C.; de Moor, Marleen H.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Kleber, Marcus E.; Genser, Bernd; Maerz, Winfried] Heidelberg Univ, Med Fac Mannheim, Mannheim Inst Publ Hlth Social & Prevent Med, D-68167 Mannheim, Germany; [Kleber, Marcus E.] LURIC Study Nonprofit LLC, D-79098 Freiburg, Germany; [Lagou, Vasiliki; Prokopenko, Inga] Univ Oxford, Radcliffe Dept Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Lagou, Vasiliki; Prokopenko, Inga] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Langenberg, Claudia; Zhao, Jing Hua; Loos, Ruth J. F.; Wareham, Nicholas J.] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Lopez, Lorna M.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Lopez, Lorna M.; Harris, Sarah E.; Starr, John M.; Deary, Ian J.; Visscher, Peter M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Tampere Univ Hosp, Fimlab Labs, Dept Clin Chem, FIN-33521 Tampere, Finland; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Univ Tampere, Sch Med, Dept Clin Chem, FIN-33521 Tampere, Finland; [Melander, Olle; Engstrom, Gunnar; Hedblad, Bo; Smith, J. Gustav] Lund Univ, Dept Clin Sci, SE-20502 Malmo, Sweden; [Murgia, Federico; Portas, Laura; Pirastu, Mario] Natl Res Council Italy, Inst Populat Genet, I-07100 Sassari, Italy; [Nolte, Ilja M.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Padmanabhan, Sandosh; Hastie, Claire E.; Dominiczak, Anna F.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Parsa, Afshin; Gibson, Quince D.; Mitchell, Braxton D.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Pirastu, Nicola; Girotto, Giorgia; Robino, Antonietta; d'Adamo, Adamo Pio; Gasparini, Paolo] Univ Trieste, IRCCS Burlo Garofolo Trieste, Inst Maternal & Child Hlth, I-34137 Trieste, Italy; [Porcu, Eleonora; Perseu, Lucia; Cucca, Francesco; Sanna, Serena; Uda, Manuela] Cittadella Univ Monserrato, CNR, Ist Ric Genet & Biomed, I-09042 Cagliari, Italy; [Ried, Janina S.; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Tang, Clara S.; Benyamin, Beben; Medland, Sarah E.; Whitfield, John B.; Martin, Nicholas G.; Montgomery, Grant W.; Visscher, Peter M.; Ferreira, Manuel A.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Teumer, Alexander; Voelker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Traglia, Michela; Pistis, Giorgio; Sala, Cinzia; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Yang, Jian; Visscher, Peter M.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4102, Australia; [Balkau, Beverley] INSERM, U1018, CESP Ctr Res Epidemiol & Populat Hlth, F-94807 Villejuif, France; [Balkau, Beverley] Univ Paris 11, UMRS 1018, F-94807 Villejuif, France; [Bandinelli, Stefania] Azienda Sanit Firenze, Geriatr Unit, I-50125 Florence, Italy; [Bastardot, Francois; Vollenweider, Peter] Univ Lausanne, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Benyamin, Beben; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Boehm, Bernhard O.] Univ Hosp, Dept Med, Div Endocrinol & Diabet, D-89075 Ulm, Germany; [Das, Debashish] UCL, Hatter Cardiovasc Inst, London WC1E 6HX, England; [de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [de Bakker, Paul I. W.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Dimitriou, Maria; Dedoussis, George V.] Harokopio Univ, Athens 17671, Greece; [Doering, Angela] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, D-85764 Neuherberg, Germany; [Doering, Angela; Meisinger, Christa] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Eyjolfsson, Gudmundur Ingi] Lab Mjodd, IS-108 Reykjavik, Iceland; [Ferrucci, Luigi; Tanaka, Toshiko] NIA, Clin Res Branch, Baltimore, MD 21250 USA; [Gibson, Quince D.] Univ Fed Bahia, Inst Saude Colet, BR-40110040 Salvador, BA, Brazil; [Harris, Sarah E.] Univ Edinburgh, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Sci Obstet & Gynecol, FIN-90220 Oulu, Finland; [Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, D-30625 Hannover, Germany; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, FIN-33521 Tampere, Finland; [Kahonen, Mika] Univ Tampere, Sch Med, Dept Clin Physiol, FIN-33521 Tampere, Finland; [Kema, Ido P.; van Pelt, L. Joost] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, NL-9700 RB Groningen, Netherlands; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Biostat, Dept Epidemiol, Boston, MA 02115 USA; [Memari, Yasin] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany; [Olafsson, Isleifur] Landspitali Univ Hosp, Dept Clin Biochem, IS-101 Reykjavik, Iceland; [Onundarson, Pall T.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Onundarson, Pall T.] Landspitali Univ Hosp, Hematol Lab, IS-101 Reykjavik, Iceland; [Onundarson, Pall T.] Landspitali Univ Hosp, Coagulat Disorder Ctr, IS-101 Reykjavik, Iceland; [Parracciani, Debora] Genet Pk Ogliastra, Perdasdefogu, Sardinia, Italy; [Penninx, Brenda W.; Smit, Johannes H.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Psychiat, NL-1081 BT Amsterdam, Netherlands; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9700 RB Groningen, Netherlands; [Penninx, Brenda W.] Leiden Univ, Med Ctr, Dept Psychiat, NL-2333 Leiden, Netherlands; [Piga, Antonio] Univ Turin, Dept Clin & Biol Sci, Div Pediat, I-10043 Turin, Italy; [Piga, Antonio] Univ Turin, Dept Clin & Biol Sci, Thalassemia Ctr, I-10043 Turin, Italy; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, FIN-90220 Oulu, Finland; [Pouta, Anneli] Natl Inst Hlth & Welf, FIN-90101 Oulu, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20521 Turku, Finland; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, FIN-20521 Turku, Finland; [Ring, Susan M.] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England; [Ruokonen, Aimo] Univ Oulu, Inst Diagnost, FIN-90014 Oulu, Finland; [Salumets, Andres] Competence Ctr Reprod Med & Biol, EE-50410 Tartu, Estonia; [Salumets, Andres] Univ Tartu, Inst Gen & Mol Pathol, EE-51014 Tartu, Estonia; [Schepers, Hein] Univ Groningen, Univ Med Ctr Groningen, Dept Expt Hematol, NL-9700 RB Groningen, Netherlands; [Schepers, Hein] Univ Groningen, Univ Med Ctr Groningen, Dept Stem Cell Biol, NL-9700 RB Groningen, Netherlands; [Schmidt, Carsten Oliver] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Sladek, Rob] McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Sladek, Rob] McGill Univ, Fac Med, Dept Med, Montreal, PQ H3A 1B1, Canada; [Starr, John M.] Univ Edinburgh, Western Gen Hosp, Geriatr Med Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Winkelmann, Bernhard R.] ClinPhen Study Ctr, D-60594 Frankfurt, Germany; [Algra, Ale] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol & Neurosurg, Utrecht Stroke Ctr, NL-3584 CG Utrecht, Netherlands; [Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Danesh, John; Moore, Carmel] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Elliott, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [Fortina, Paolo] Thomas Jefferson Univ, Coll Med, Dept Canc Biol, Philadelphia, PA 19107 USA; [Fortina, Paolo] Univ Roma La Sapienza, Dipartimento Med Mol, I-00161 Rome, Italy; [Froguel, Philippe] Lille Pasteur Inst, CNRS, UMR 8199, F-59100 Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London W2 1PG, England; [Greinacher, Andreas] Univ Med Greifswald, Inst Immunol & Transfus Med, D-17487 Greifswald, Germany; [Hazen, Stanley L.; Tang, W. H. Wilson] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Lifecourse snd Serv, FIN-90101 Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, FIN-90220 Oulu, Finland; [Khaw, Kay Tee] Addenbrookes Hosp, Clin Gerontol Unit, Cambridge CB2 2QQ, England; [Maerz, Winfried] Synlab Acad, D-68165 Mannheim, Germany; [Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 RB Groningen, Netherlands; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, I-39100 Bolzano, Italy; [Pramstaller, Peter P.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Schadt, Eric] Mt Sinai Sch Med, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Baltimore, MD 21201 USA; [Smith, J. Gustav] Lund Univ, Dept Cardiol, S-22185 Lund, Sweden; [Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Stumvoll, Michael; Toenjes, Anke] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany; [Stumvoll, Michael; Toenjes, Anke] Univ Leipzig, IFB Adipos Dis, D-04103 Leipzig, Germany; [Toniolo, Daniela] CNR, Inst Mol Genet, I-27100 Pavia, Italy; [Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 RB Groningen, Netherlands; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Kooner, Jaspal S.; Chambers, John C.] Imperial Coll Healthcare NHS Trust, London W12 0HS, England	Imperial College London; University of Groningen; University of Groningen; University of Cambridge; MRC Biostatistics Unit; University of Cambridge; University of Cambridge; Imperial College London; Wellcome Trust Sanger Institute; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Southern California; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; European Academy of Bozen-Bolzano; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Cagliari; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Universite de Franche-Comte; University of Tartu; University of Tartu; University of Bristol; University of Lausanne; Swiss Institute of Bioinformatics; Vrije Universiteit Amsterdam; Ruprecht Karls University Heidelberg; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Edinburgh; University of Edinburgh; Tampere University; Tampere University Hospital; Tampere University; Lund University; Consiglio Nazionale delle Ricerche (CNR); University of Groningen; University of Glasgow; University System of Maryland; University of Maryland Baltimore; IRCCS Burlo Garofolo; University of Trieste; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Cagliari; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; QIMR Berghofer Medical Research Institute; Greifswald Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Queensland; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Azienda Sanitaria di Firenze; University of Lausanne; University of Queensland; Ulm University; University of London; University College London; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harokopio University Athens; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Universidade Federal da Bahia; University of Edinburgh; University of Oulu; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Tampere University; Tampere University Hospital; Tampere University; University of Groningen; Harvard University; Harvard T.H. Chan School of Public Health; University of London; King's College London; Greifswald Medical School; Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital; Landspitali National University Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Turin; University of Turin; University of Oulu; Finland National Institute for Health & Welfare; University of Turku; University of Turku; University of Bristol; University of Oulu; University of Tartu; University of Groningen; University of Groningen; Greifswald Medical School; McGill University; McGill University; University of Edinburgh; Utrecht University; Utrecht University Medical Center; University of Sassari; University of Cambridge; Imperial College London; Jefferson University; Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Imperial College London; Greifswald Medical School; Cleveland Clinic Foundation; Finland National Institute for Health & Welfare; University of Oulu; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; SYNLAB Group; University of Groningen; Krankenhaus Bozen; University of Lubeck; Icahn School of Medicine at Mount Sinai; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lund University; University of London; King's College London; Leipzig University; Leipzig University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Groningen; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Imperial College London	Chambers, JC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London W2 1PG, England.	p.van.der.harst@umcg.nl; christian.gieger@helmholtz-muenchen.de; j.kooner@ic.ac.uk; who1000@cam.ac.uk; ns6@sanger.ac.uk; john.chambers@ic.ac.uk	Hartiala, Jaana A/GLR-1825-2022; Evans, David M/H-6325-2013; Deary, Ian J/C-6297-2009; Onundarson, Pall T./AAJ-1037-2020; Martin, Nicholas/R-9235-2019; Benyamin, Beben/D-9195-2012; Salumets, Andres/J-2278-2015; Bastardot, Francois/J-4013-2017; d'Adamo, Adamo Pio/G-4064-2011; Stefansson, Kari/AAE-7187-2019; Austin, Eric Douglas/A-6070-2013; Lopez, Lorna/AAR-4912-2020; Verweij, Niek/A-4499-2017; Colaus, PsyColaus/K-6607-2013; Yang, Jian/A-5852-2010; Sladek, Robert/R-2391-2019; Penninger, Josef M/I-6860-2013; li, xin/HHS-9461-2022; Deloukas, Panos/B-2922-2013; Penninx, Brenda WJH/S-7627-2017; Traglia, Michela/AAX-5816-2020; de Boer, Rudolf/ABE-9879-2020; Ulivi, Sheila/H-3700-2013; Medland, Sarah/AAT-7595-2020; Dominiczak, Anna F/P-9390-2017; Beckmann, Jacques S/A-9772-2008; bandinelli, stefania/AAL-4570-2020; Tang, Wai Hong Wilson/I-1238-2013; Ciullo, Marina/AAE-3041-2020; Loos, Ruth/GON-5877-2022; Teumer, Alexander/S-7438-2019; de Bakker, Paul IW/B-8730-2009; Gasparini, Paolo/B-6173-2014; Ferreira, Manuel A R/D-3609-2013; Pirastu, Nicola/AHB-6226-2022; Bastardot, François/P-7809-2019; Fortina, Paolo/ABE-8350-2020; Hazen, Stanley L/ABD-5845-2021; van Veldhuisen, Dirk Jan/E-8967-2014; Toniolo, Daniela/AAE-2969-2019; Pramstaller, Peter P/C-2357-2008; Padmanabhan, Sandosh/S-3963-2016; Davey Smith, George/A-7407-2013; Prokopenko, Inga/H-3241-2014; Dina, Christian R/D-3535-2015; Cookson, William/HHC-1790-2022; Kemp, John P./R-3091-2018; Wolffenbuttel, Bruce/A-8419-2011; Meisinger, Christine/B-5358-2014; Danjou, Fabrice/D-1563-2014; Stumvoll, Michael/ABE-1121-2021; Medland, Sarah E/C-7630-2013; Prokopenko, Inga/AAU-9895-2020; Franke, Lude/P-7036-2016; Lyytikäinen, Leo-Pekka/C-8544-2016; Sala, Cinzia Felicita/AAN-1900-2020; Kanoni, Stavroula/AAN-7161-2021; ruggiero, daniela/K-5638-2016; Boomsma, Dorret I/AAX-4470-2020; Dedoussis, George/AAN-7252-2021; Lagou, Vasiliki/N-8451-2013; Khaw, Kay-Tee/AAZ-3209-2021; de Geus, Eco J.C./M-9318-2015; van Gilst, Wiek/R-1806-2019; FROGUEL, Philippe/O-6799-2017; Uda, Manuela/AAC-2645-2019; Raitakari, Olli/AAQ-7389-2021; Mitchell, Braxton/CAF-0876-2022; Visscher, Peter/ABB-6151-2020; Albers, Kees/A-4170-2015; Langenberg, Claudia/ABG-9067-2021; zhang, weihua/GXV-1334-2022; Verweij, Niek/ABC-6249-2021; sanna, serena/H-3009-2019; Montgomery, Grant W/B-7148-2008; Hicks, Andrew Anthony/E-9518-2017; de Moor, Marleen/J-7434-2019; Asselbergs, Folkert W./ABD-6752-2021; Paul, Dirk S./H-3469-2019; Schmidt, Carsten Oliver/AAH-2778-2019; Lehtimäki, Terho/AAD-1094-2022; Pirastu, Nicola/G-4358-2011; Loos, Ruth J F/Q-2862-2016; Boehm, Bernhard Otto/F-8750-2015; Robino, Antonietta/K-9398-2016; Girotto, Giorgia/I-9452-2018	Hartiala, Jaana A/0000-0003-4883-9318; Evans, David M/0000-0003-0663-4621; Deary, Ian J/0000-0002-1733-263X; Martin, Nicholas/0000-0003-4069-8020; Benyamin, Beben/0000-0001-5608-2293; Salumets, Andres/0000-0002-1251-8160; Bastardot, Francois/0000-0003-4060-0353; d'Adamo, Adamo Pio/0000-0001-9367-4909; Austin, Eric Douglas/0000-0002-1709-9022; Lopez, Lorna/0000-0002-0241-9783; Yang, Jian/0000-0003-2001-2474; Sladek, Robert/0000-0002-2730-1204; Penninger, Josef M/0000-0002-8194-3777; Deloukas, Panos/0000-0001-9251-070X; Penninx, Brenda WJH/0000-0001-7779-9672; Ulivi, Sheila/0000-0003-3606-835X; Medland, Sarah/0000-0003-1382-380X; Dominiczak, Anna F/0000-0003-4913-3608; Beckmann, Jacques S/0000-0002-9741-1900; Ciullo, Marina/0000-0002-9621-9984; Teumer, Alexander/0000-0002-8309-094X; de Bakker, Paul IW/0000-0001-7735-7858; Ferreira, Manuel A R/0000-0001-9059-1825; Bastardot, François/0000-0003-4060-0353; Toniolo, Daniela/0000-0001-9545-6032; Davey Smith, George/0000-0002-1407-8314; Prokopenko, Inga/0000-0003-1624-7457; Dina, Christian R/0000-0002-7722-7348; Kemp, John P./0000-0002-9105-2249; Wolffenbuttel, Bruce/0000-0001-9262-6921; Danjou, Fabrice/0000-0002-4976-2327; Stumvoll, Michael/0000-0001-6225-8240; Medland, Sarah E/0000-0003-1382-380X; Franke, Lude/0000-0002-5159-8802; Lyytikäinen, Leo-Pekka/0000-0002-7200-5455; Kanoni, Stavroula/0000-0002-1691-9615; ruggiero, daniela/0000-0003-3898-7827; Dedoussis, George/0000-0002-7798-6221; de Geus, Eco J.C./0000-0001-6022-2666; van Gilst, Wiek/0000-0003-2968-8585; FROGUEL, Philippe/0000-0003-2972-0784; Uda, Manuela/0000-0002-4890-6456; Visscher, Peter/0000-0002-2143-8760; Albers, Kees/0000-0003-4115-3727; Langenberg, Claudia/0000-0002-5017-7344; Verweij, Niek/0000-0002-4303-7685; sanna, serena/0000-0002-3768-1749; Montgomery, Grant W/0000-0002-4140-8139; Hicks, Andrew Anthony/0000-0001-6320-0411; de Moor, Marleen/0000-0001-7177-5637; Asselbergs, Folkert W./0000-0002-1692-8669; Paul, Dirk S./0000-0002-8230-0116; Schmidt, Carsten Oliver/0000-0001-5266-9396; Lehtimäki, Terho/0000-0002-2555-4427; Loos, Ruth J F/0000-0002-8532-5087; Portas, Laura/0000-0003-1789-1893; Domingues, Francisco/0000-0003-4567-4562; Meacham, Stuart/0000-0002-3667-6059; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Gieger, Christian/0000-0001-6986-9554; Fortina, Paolo/0000-0002-5898-2081; Tang, W. H. Wilson/0000-0002-8335-735X; Radhakrishnan, Aparna/0000-0002-8153-9037; Esko, Tonu/0000-0003-1982-6569; Willemsen, Gonneke/0000-0003-3755-0236; s, hema/0000-0002-3440-9475; Genser, Bernd/0000-0001-5787-0902; Ouwehand, Willem/0000-0002-7744-1790; Robino, Antonietta/0000-0003-2152-2353; Tang, Clara/0000-0003-0265-2638; Volker, Uwe/0000-0002-5689-3448; Kahonen, Mika/0000-0002-4510-7341; CUCCA, Francesco/0000-0002-7414-1995; Ramirez-Solis, Ramiro/0000-0003-4182-173X; Weichenberger, Christian X./0000-0002-2176-0274; Kleber, Marcus/0000-0003-0663-7275; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Engstrom, Gunnar/0000-0002-8618-9152; O'Reilly, Paul/0000-0001-7515-0845; Shuldiner, Alan/0000-0001-9921-4305; Padmanabhan, Sandosh/0000-0003-3869-5808; Soranzo, Nicole/0000-0003-1095-3852; Gogele, Martin/0000-0003-4785-4348; Lagou, Vasiliki/0000-0003-3165-8940; Stephens, Jonathan/0000-0003-2020-9330; Pirastu, Nicola/0000-0002-5363-3886; Gasparini, Paolo/0000-0002-0859-0856; Meisinger, Christa/0000-0002-9026-6544; Melander, Olle/0000-0002-2581-484X; Girotto, Giorgia/0000-0003-4507-6589; Pramstaller, Peter P/0000-0002-9831-8302; NUTILE, TERESA/0000-0001-7062-8352; van Pelt, Joost/0000-0001-5538-1806; Rendon, Augusto/0000-0001-8994-0039; Schepers, Hein/0000-0002-7731-3318; Whitfield, John/0000-0002-1103-0876; Memari, Yasin/0000-0002-1747-542X; Mitchell, Braxton/0000-0003-4920-4744; Murgia, Federico/0000-0002-3608-845X; Gudbjartsson, Daniel/0000-0002-5222-9857	MRC [G0801056, G0700704, MC_U106188470, G1002084, G0600705] Funding Source: UKRI; Austrian Science Fund (FWF) [I 434] Funding Source: researchfish; Medical Research Council [G0801056B, G0700704B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10136, NF-SI-0611-10275, RP-PG-0310-1002] Funding Source: researchfish; Wellcome Trust [096964/Z/11/Z] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042157] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA165001] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, K12RR023250, U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113452, U01HL072515, P01HL076491, R01HL103931, R01HL088119, R01HL103866, R01HL059367, R01HL087641, P01HL098055, R01HL087679, R01HL086694, U01HL084756] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518, R01GM053275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268, R01MH081802, U24MH068457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018728] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010098] Funding Source: NIH RePORTER; Austrian Science Fund FWF [I 434] Funding Source: Medline; British Heart Foundation [RG/09/012/28096, RG/08/014/24067] Funding Source: Medline; Cancer Research UK [14136] Funding Source: Medline; Medical Research Council [MC_U106188470, MC_U106179471, G1000143, G0801056, G9815508, G1002084, G0600705, G0401527, G0700704] Funding Source: Medline; NCATS NIH HHS [UL1 TR000439] Funding Source: Medline; NCI NIH HHS [R01 CA165001] Funding Source: Medline; NCRR NIH HHS [U54 RR020278, UL1 RR025005, K12 RR023250] Funding Source: Medline; NHGRI NIH HHS [U01 HG004402] Funding Source: Medline; NHLBI NIH HHS [HHSN268201100005C, HHSN268201100009C, HHSN268201100007C, R01 HL087679, HHSN268201100008C, HHSN268201100010C, R01 HL059367, P20 HL113452, U01 HL084756, R01 HL103931, P01 HL098055, R01 HL088119, HHSN268201100012C, U01 HL072515, R01 HL103866, HHSN268201100011C, R01 HL086694, R01 HL087641, P01 HL076491, HHSN268201100006C] Funding Source: Medline; NIA NIH HHS [R01 AG018728, N01AG12109] Funding Source: Medline; NICHD NIH HHS [R01 HD042157] Funding Source: Medline; NIDA NIH HHS [HHSN271201100005C] Funding Source: Medline; NIDDK NIH HHS [P30 DK072488] Funding Source: Medline; NIGMS NIH HHS [R01 GM053275, U01 GM074518] Funding Source: Medline; NIMH NIH HHS [R01 MH081802, RL1 MH083268, U24 MH068457] Funding Source: Medline; NLM NIH HHS [R01 LM010098] Funding Source: Medline; Wellcome Trust [092731, 097117] Funding Source: Medline; Chief Scientist Office [CZB/4/505, ETM/55] Funding Source: Medline; Department of Health [RP-PG-0310-1002] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Austrian Science Fund FWF(Austrian Science Fund (FWF)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Wellcome Trust(Wellcome Trust); Chief Scientist Office; Department of Health		An XU, 2008, BRIT J HAEMATOL, V141, P367, DOI 10.1111/j.1365-2141.2008.07091.x; ANDERSON RJ, 1990, J TRAUMA, V30, P1059, DOI 10.1097/00005373-199009000-00001; Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Berhane S, 2011, VIROLOGY, V421, P149, DOI 10.1016/j.virol.2011.09.025; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Camaschella C, 2011, CURR OPIN PEDIATR, V23, P14, DOI 10.1097/MOP.0b013e3283425591; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Das S, 2001, J BIOL CHEM, V276, P6720, DOI 10.1074/jbc.M008863200; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ding KY, 2012, MAYO CLIN PROC, V87, P461, DOI 10.1016/j.mayocp.2012.01.016; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Galanello R, 2009, BLOOD, V114, P3935, DOI 10.1182/blood-2009-04-217901; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Goto A, 2001, BIOCHEM J, V359, P99, DOI 10.1042/0264-6021:3590099; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Paul DS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002139; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pickrell JK, 2011, BIOINFORMATICS, V27, P2144, DOI 10.1093/bioinformatics/btr354; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Scanlon KS, 2000, OBSTET GYNECOL, V96, P741, DOI 10.1016/S0029-7844(00)00982-0; Shah RC, 2011, NEUROLOGY, V77, P219, DOI 10.1212/WNL.0b013e318225aaa9; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; van Wijk R, 2003, BLOOD, V101, P345, DOI 10.1182/blood-2002-06-1851; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	47	236	237	0	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					369	+		10.1038/nature11677	http://dx.doi.org/10.1038/nature11677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23222517	Green Accepted, Green Published			2022-12-24	WOS:000312488200044
J	Xu, KX; Wu, ZJ; Groner, AC; He, HSHS; Cai, CM; Lis, RT; Wu, XQ; Stack, EC; Loda, M; Liu, T; Xu, H; Cato, L; Thornton, JE; Gregory, RI; Morrissey, C; Vessella, RL; Montironi, R; Magi-Galluzzi, C; Kantoff, PW; Balk, SP; Liu, XS; Brown, M				Xu, Kexin; Wu, Zhenhua Jeremy; Groner, Anna C.; He, Housheng Hansen; Cai, Changmeng; Lis, Rosina T.; Wu, Xiaoqiu; Stack, Edward C.; Loda, Massimo; Liu, Tao; Xu, Han; Cato, Laura; Thornton, James E.; Gregory, Richard I.; Morrissey, Colm; Vessella, Robert L.; Montironi, Rodolfo; Magi-Galluzzi, Cristina; Kantoff, Philip W.; Balk, Steven P.; Liu, X. Shirley; Brown, Myles			EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent	SCIENCE			English	Article							GENE-EXPRESSION; HISTONE METHYLTRANSFERASE; SUPPRESSES METHYLATION; PHOSPHORYLATION; LYSINE-27; COMPLEX; PROGRESSION; PROTEIN; AKT	Epigenetic regulators represent a promising new class of therapeutic targets for cancer. Enhancer of zeste homolog 2 (EZH2), a subunit of Polycomb repressive complex 2 (PRC2), silences gene expression via its histone methyltransferase activity. We found that the oncogenic function of EZH2 in cells of castration-resistant prostate cancer is independent of its role as a transcriptional repressor. Instead, it involves the ability of EZH2 to act as a coactivator for critical transcription factors including the androgen receptor. This functional switch is dependent on phosphorylation of EZH2 and requires an intact methyltransferase domain. Hence, targeting the non-PRC2 function of EZH2 may have therapeutic efficacy for treating metastatic, hormone-refractory prostate cancer.	[Xu, Kexin; Wu, Zhenhua Jeremy; Groner, Anna C.; He, Housheng Hansen; Liu, Tao; Xu, Han; Cato, Laura; Liu, X. Shirley; Brown, Myles] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; [Xu, Kexin; Groner, Anna C.; He, Housheng Hansen; Lis, Rosina T.; Wu, Xiaoqiu; Stack, Edward C.; Loda, Massimo; Cato, Laura; Kantoff, Philip W.; Brown, Myles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Xu, Kexin; Groner, Anna C.; He, Housheng Hansen; Cai, Changmeng; Lis, Rosina T.; Wu, Xiaoqiu; Stack, Edward C.; Loda, Massimo; Cato, Laura; Kantoff, Philip W.; Balk, Steven P.; Brown, Myles] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Wu, Zhenhua Jeremy; He, Housheng Hansen; Liu, Tao; Xu, Han; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Wu, Zhenhua Jeremy; He, Housheng Hansen; Liu, Tao; Xu, Han; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Cai, Changmeng; Balk, Steven P.] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA; [Lis, Rosina T.; Wu, Xiaoqiu; Stack, Edward C.; Loda, Massimo] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Lis, Rosina T.; Stack, Edward C.; Loda, Massimo] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Loda, Massimo] Kings Coll London, Div Canc Studies, London SE1 8UB, England; [Thornton, James E.; Gregory, Richard I.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Thornton, James E.; Gregory, Richard I.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Morrissey, Colm; Vessella, Robert L.] Univ Washington, Med Ctr, Dept Urol, Seattle, WA 98195 USA; [Vessella, Robert L.] Puget Sound VA Hlth Care Syst, Seattle, WA 98108 USA; [Montironi, Rodolfo] Polytech Univ Marche Reg, United Hosp, Sect Pathol Anat, I-60126 Ancona, Italy; [Magi-Galluzzi, Cristina] Cleveland Clin, Pathol & Lab Med Inst, Glickman Urol & Kidney Inst, Dept Canc Biol,Taussig Canc Inst, Cleveland, OH 44195 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of London; King's College London; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Washington; University of Washington Seattle; Marche Polytechnic University; Cleveland Clinic Foundation	Liu, XS (corresponding author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA.	xsliu@jimmy.harvard.edu; myles_brown@dfci.harvard.edu	Liu, Tao/AAO-6310-2021; Brown, Myles/AAX-5332-2021; Liu, Tao/G-3585-2010; He, Hansen/ABD-8439-2020; Brown, Myles/B-6906-2008; Magi-Galluzzi, Cristina/AAW-6484-2020; Cai, Changmeng/AAE-6835-2020	Liu, Tao/0000-0002-8818-8313; Brown, Myles/0000-0002-8213-1658; Liu, Tao/0000-0002-8818-8313; He, Hansen/0000-0003-2898-3363; Kantoff, Philip/0000-0001-7275-0597; Cai, Changmeng/0000-0002-8701-2586; Liu, Tao/0000-0003-0446-9001	Prostate Cancer Foundation (PCF); Swiss National Science Foundation; NSF; A. David Mazzone Project Development Award; PCF Challenge Awards; U.S. Department of Defense Idea Development Award [PC100950]; National Cancer Institute [CA131945, CA89021, CA90381]; NIH [CA166507, CA111803, CA090381, GM99409, CA85859, CA097186]; NATIONAL CANCER INSTITUTE [P50CA090381, P01CA089021, P50CA097186, R01CA131945, R01CA111803, K99CA166507, R00CA166507, P01CA085859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099409] Funding Source: NIH RePORTER	Prostate Cancer Foundation (PCF); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NSF(National Science Foundation (NSF)); A. David Mazzone Project Development Award; PCF Challenge Awards; U.S. Department of Defense Idea Development Award(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Huang, A. Chinnaiyan, Y. Shang, and D. Reinberg for sharing their reagents, and Y. Qiu, X. Yang, J. Xu, and M. Ni for technical support and advice. Supported by a Prostate Cancer Foundation (PCF) Young Investigator Award (K. X.); a Swiss National Science Foundation prospective researcher fellowship (A. C. G.); a NSF graduate research fellowship (J. E. T.); an A. David Mazzone Project Development Award (M. B.); PCF Challenge Awards (S. P. B. and M. B.); U.S. Department of Defense Idea Development Award PC100950 (S. P. B.); National Cancer Institute grants CA131945, CA89021, and CA90381 (M. L.); and NIH grants CA166507 (C. C.), CA111803 (S. P. B.), CA090381 (M. B., S. P. B., P. W. K.), GM99409 (X. S. L.), and CA85859 and CA097186 (C. M., R. L. V.). All data sets have been deposited in the Gene Expression Omnibus database (GSE39461). M. B. serves as a consultant to Novartis Pharmaceuticals.	Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Joshi P, 2008, J BIOL CHEM, V283, P27757, DOI 10.1074/jbc.M804442200; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; LaJeunesse D, 1996, DEVELOPMENT, V122, P2189; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	22	571	591	4	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1465	1469		10.1126/science.1227604	http://dx.doi.org/10.1126/science.1227604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239736	Green Accepted			2022-12-24	WOS:000312250800047
J	Bar-Peled, L; Sabatini, DM				Bar-Peled, Liron; Sabatini, David M.			SnapShot: mTORC1 Signaling at the Lysosomal Surface	CELL			English	Editorial Material							GROWTH-CONTROL; UPSTREAM; TOR		[Bar-Peled, Liron; Sabatini, David M.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Bar-Peled, L (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.			/0000-0002-1446-7256				Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Russell RC, 2011, DEVELOPMENT, V138, P3343, DOI 10.1242/dev.058230	10	30	30	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1390	+	1390.e1	10.1016/j.cell.2012.11.038	http://dx.doi.org/10.1016/j.cell.2012.11.038			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217718	Bronze			2022-12-24	WOS:000311999900027
J	Ke, YG; Ong, LL; Shih, WM; Yin, P				Ke, Yonggang; Ong, Luvena L.; Shih, William M.; Yin, Peng			Three-Dimensional Structures Self-Assembled from DNA Bricks	SCIENCE			English	Article							NANOSCALE SHAPES; FOLDING DNA; ORIGAMI; RNA; LATTICES; NANOTECHNOLOGY; CRYSTAL; DESIGN; MOTOR	We describe a simple and robust method to construct complex three-dimensional (3D) structures by using short synthetic DNA strands that we call "DNA bricks." In one-step annealing reactions, bricks with hundreds of distinct sequences self-assemble into prescribed 3D shapes. Each 32-nucleotide brick is a modular component; it binds to four local neighbors and can be removed or added independently. Each 8-base pair interaction between bricks defines a voxel with dimensions of 2.5 by 2.5 by 2.7 nanometers, and a master brick collection defines a "molecular canvas" with dimensions of 10 by 10 by 10 voxels. By selecting subsets of bricks from this canvas, we constructed a panel of 102 distinct shapes exhibiting sophisticated surface features, as well as intricate interior cavities and tunnels.	[Ke, Yonggang; Ong, Luvena L.; Shih, William M.; Yin, Peng] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Ke, Yonggang; Shih, William M.] Harvard Univ, Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ke, Yonggang; Shih, William M.] Harvard Univ, Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ong, Luvena L.] MIT, Harvard Massachusetts Inst Technol MIT Div Hlth S, Cambridge, MA 02139 USA; [Yin, Peng] Harvard Univ, Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Yin, P (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	py@hms.harvard.edu		/0000-0001-5317-3018	Office of Naval Research (ONR) Young Investigator Program award [N000141110914]; ONR grant [N000141010827, N000014091118, N000141010241]; Army Research Office [W911NF1210238]; NSF [CCF1054898]; NIH [1DP2OD007292, 1DP2OD004641]; Wyss Institute Faculty Startup Fund; Wyss Institute Faculty Grant; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004641, DP2OD007292] Funding Source: NIH RePORTER; Division of Computing and Communication Foundations [1054898] Funding Source: National Science Foundation	Office of Naval Research (ONR) Young Investigator Program award(Office of Naval Research); ONR grant; Army Research Office; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wyss Institute Faculty Startup Fund; Wyss Institute Faculty Grant; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The authors thank M. Dai for technical assistance; E. Winfree, B. Wei, and S. Woo for discussions; and D. Pastuszak for assistance in draft preparation. This work is supported by an Office of Naval Research (ONR) Young Investigator Program award N000141110914, an ONR grant N000141010827, an Army Research Office grant W911NF1210238, an NSF CAREER award CCF1054898, an NIH Director's New Innovator award 1DP2OD007292, and a Wyss Institute Faculty Startup Fund to P.Y., and by a Wyss Institute Faculty Grant, ONR grants N000014091118 and N000141010241, and an NIH Director's New Innovator award 1DP2OD004641 to W.M.S.. L.L.O. is supported by an NSF graduate research fellowship. Y.K. conceived the project, designed and performed the experiments, analyzed the data, and wrote the paper; L.L.O. designed and performed the experiments, analyzed the data, and wrote the paper; W.M.S. conceived the project, discussed the results, and wrote the paper; P.Y. conceived, designed, and supervised the study, interpreted the data, and wrote the paper. The DNA sequences for the nanostructures can be found in the supplementary materials. A provisional patent has been filed based on this work.	Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Choi HMT, 2010, NAT BIOTECHNOL, V28, P1208, DOI 10.1038/nbt.1692; Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Ke YG, 2012, J AM CHEM SOC, V134, P1770, DOI 10.1021/ja209719k; Ke YG, 2009, J AM CHEM SOC, V131, P15903, DOI 10.1021/ja906381y; Ke YG, 2009, NANO LETT, V9, P2445, DOI 10.1021/nl901165f; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Lin CX, 2006, CHEMPHYSCHEM, V7, P1641, DOI 10.1002/cphc.200600260; Lin CX, 2012, NAT CHEM, V4, P832, DOI 10.1038/NCHEM.1451; Omabegho T, 2009, SCIENCE, V324, P67, DOI 10.1126/science.1170336; Park SH, 2006, ANGEW CHEM INT EDIT, V45, P735, DOI 10.1002/anie.200503797; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Rothemund PWK, 2012, NATURE, V485, P584, DOI 10.1038/485584a; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; Schulman R, 2012, P NATL ACAD SCI USA, V109, P6405, DOI 10.1073/pnas.1117813109; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Severcan I, 2010, NAT CHEM, V2, P772, DOI [10.1038/nchem.733, 10.1038/NCHEM.733]; Sherman WB, 2004, NANO LETT, V4, P1203, DOI 10.1021/nl049527q; Shih WM, 2010, CURR OPIN STRUC BIOL, V20, P276, DOI 10.1016/j.sbi.2010.03.009; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhang DY, 2011, NAT CHEM, V3, P103, DOI 10.1038/NCHEM.957; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274	43	824	852	16	707	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2012	338	6111					1177	1183		10.1126/science.1227268	http://dx.doi.org/10.1126/science.1227268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197527	Green Accepted			2022-12-24	WOS:000311666200038
J	Manosas, M; Perumal, SK; Croquette, V; Benkovic, SJ				Manosas, Maria; Perumal, Senthil K.; Croquette, Vincent; Benkovic, Stephen J.			Direct Observation of Stalled Fork Restart via Fork Regression in the T4 Replication System	SCIENCE			English	Article							MAMMALIAN-CELLS; DNA-REPLICATION; UVSW PROTEIN; BACTERIOPHAGE-T4; REPAIR; MODEL; HELICASE; RECOMBINATION; REPLISOME; REVERSAL	The restart of a stalled replication fork is a major challenge for DNA replication. Depending on the nature of the damage, different repair processes might be triggered; one is template switching, which is a bypass of a leading-strand lesion via fork regression. Using magnetic tweezers to study the T4 bacteriophage enzymes, we have reproduced in vitro the complete process of template switching. We show that the UvsW DNA helicase in cooperation with the T4 holoenzyme can overcome leading-strand lesion damage by a pseudostochastic process, periodically forming and migrating a four-way Holliday junction. The initiation of the repair process requires partial replisome disassembly via the departure of the replicative helicase. The results support the role of fork regression pathways in DNA repair.	[Manosas, Maria; Croquette, Vincent] Univ Paris Diderot, Univ Paris 06, Ecole Normale Super, Lab Phys Stat,CNRS, F-75005 Paris, France; [Manosas, Maria] Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Spain; [Croquette, Vincent] Ecole Normale Super, Dept Biol, F-75005 Paris, France; [Perumal, Senthil K.; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Manosas, Maria] Inst Sanidad Carlos III, CIBER BBN Bioingn Biomat & Nanomed, Madrid, Spain	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; University of Barcelona; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Croquette, V (corresponding author), Univ Paris Diderot, Univ Paris 06, Ecole Normale Super, Lab Phys Stat,CNRS, 24 Rue Lhomond, F-75005 Paris, France.	vincent.croquette@lps.ens.fr; sjb1@psu.edu		Manosas Castejon, Maria/0000-0001-8001-4055; Croquette, Vincent/0000-0003-1400-0039	Human Frontier Science Program; U.S. National Institutes of Health [GM013306]; ERC [Magreps 267 862]; Juan de la Cierva Program MICINN-JDC; Engineering and Physical Sciences Research Council [EP/H006702/1] Funding Source: researchfish; EPSRC [EP/H006702/1] Funding Source: UKRI	Human Frontier Science Program(Human Frontier Science Program); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); Juan de la Cierva Program MICINN-JDC; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank B. Michel and D. Bensimon for useful comments on the manuscript and M. M. Spiering for DNA substrates. This work was supported by a Human Frontier Science Program grant (to V.C. and S.J.B.), U.S. National Institutes of Health grant GM013306 (to S.J.B.), ERC grant Magreps 267 862 (to V.C.), and Juan de la Cierva Program MICINN-JDC (to M.M). M.M. conducted single-molecule assays and performed the analysis. S.K.P. conducted ensemble assays, analyzed data, and prepared DNA and proteins. V.C. built the magnetic tweezers. M.M., S.K.P., V.C., and S.J.B. wrote the paper. Materials and methods are available as supplementary materials.	Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; CarlesKinch K, 1997, EMBO J, V16, P4142, DOI 10.1093/emboj/16.13.4142; CHASE JW, 1986, ANNU REV BIOCHEM, V55, P103, DOI 10.1146/annurev.biochem.55.1.103; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; FUJIWARA Y, 1976, MUTAT RES, V37, P91, DOI 10.1016/0027-5107(76)90058-0; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; HACKER KJ, 1994, J BIOL CHEM, V269, P24221; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Long DT, 2009, EMBO REP, V10, P394, DOI 10.1038/embor.2009.13; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Manosas M, 2012, NUCLEIC ACIDS RES, V40, P6174, DOI 10.1093/nar/gks253; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; Nelson SW, 2007, J BIOL CHEM, V282, P407, DOI 10.1074/jbc.M608153200; Nelson SW, 2010, J MOL BIOL, V401, P743, DOI 10.1016/j.jmb.2010.06.027; VENKATESAN M, 1982, J BIOL CHEM, V257, P2426; Webb MR, 2007, J BIOL CHEM, V282, P34401, DOI 10.1074/jbc.M705913200; Yeeles JTP, 2011, SCIENCE, V334, P235, DOI 10.1126/science.1209111	19	63	64	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1217	1220		10.1126/science.1225437	http://dx.doi.org/10.1126/science.1225437			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197534	Green Accepted			2022-12-24	WOS:000311666200048
J	Ude, S; Lassak, J; Starosta, AL; Kraxenberger, T; Wilson, DN; Jung, K				Ude, Susanne; Lassak, Juergen; Starosta, Agata L.; Kraxenberger, Tobias; Wilson, Daniel N.; Jung, Kirsten			Translation Elongation Factor EF-P Alleviates Ribosome Stalling at Polyproline Stretches	SCIENCE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PEPTIDE-BOND FORMATION; COLI CAD OPERON; SALMONELLA-ENTERICA; ESCHERICHIA-COLI; TRANSFER-RNA; POSTTRANSLATIONAL MODIFICATION; PROTEIN-SYNTHESIS; POXA; IDENTIFICATION	Translation elongation factor P (EF-P) is critical for virulence in bacteria. EF-P is present in all bacteria and orthologous to archaeal and eukaryotic initiation factor 5A, yet the biological function has so far remained enigmatic. Here, we demonstrate that EF-P is an elongation factor that enhances translation of polyproline-containing proteins: In the absence of EF-P, ribosomes stall at polyproline stretches, whereas the presence of EF-P alleviates the translational stalling. Moreover, we demonstrate the physiological relevance of EF-P to fine-tune the expression of the polyproline-containing pH receptor CadC to levels necessary for an appropriate stress response. Bacterial, archaeal, and eukaryotic cells have hundreds to thousands of polyproline-containing proteins of diverse function, suggesting that EF-P and a/eIF-5A are critical for copy-number adjustment of multiple pathways across all kingdoms of life.	[Ude, Susanne; Lassak, Juergen; Starosta, Agata L.; Kraxenberger, Tobias; Wilson, Daniel N.; Jung, Kirsten] Univ Munich, Ctr Integrated Prot Sci Munich CiPSM, Munich, Germany; [Ude, Susanne; Lassak, Juergen; Kraxenberger, Tobias; Jung, Kirsten] Univ Munich, Dept Biol 1, D-82152 Martinsried, Germany; [Starosta, Agata L.; Wilson, Daniel N.] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Starosta, Agata L.; Wilson, Daniel N.] Univ Munich, Dept Biochem, D-81377 Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Wilson, DN (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich CiPSM, Munich, Germany.	wilson@genzentrum.de; jung@lmu.de	Wilson, Daniel/AAE-8504-2019; Lassak, Jürgen Michael/Q-2128-2019; Starosta, Agata/D-9535-2017	Wilson, Daniel/0000-0003-3816-3828; Lassak, Jürgen Michael/0000-0003-3936-3389; Starosta, Agata/0000-0003-3915-5723	Excellence Cluster "Center for integrated Protein Science" Munich [Exc114/1]; European Molecular Biology Organization; Deutsche Forschungsgemeinschaft [JU270/5-3, WI3285/1-1]; AXA Postdoctoral fellowship	Excellence Cluster "Center for integrated Protein Science" Munich; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); AXA Postdoctoral fellowship(AXA Research Fund)	This work was supported by the Excellence Cluster "Center for integrated Protein Science" Munich (Exc114/1), the European Molecular Biology Organization young investigator program (to D.N.W.) and grants JU270/5-3 (K.J.) and WI3285/1-1 (D.N.W.) from the Deutsche Forschungsgemeinschaft. A.L.S. is funded by an AXA Postdoctoral fellowship.	Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Bearson SMD, 2011, FOODBORNE PATHOG DIS, V8, P725, DOI 10.1089/fpd.2010.0796; Bearson SMD, 2006, APPL ENVIRON MICROB, V72, P2829, DOI 10.1128/AEM.72.4.2829-2836.2006; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; de Crecy E, 2007, APPL MICROBIOL BIOT, V77, P489, DOI 10.1007/s00253-007-1168-5; Fritz G, 2009, J MOL BIOL, V393, P272, DOI 10.1016/j.jmb.2009.08.037; Garmendia J, 2003, MICROBIOL-SGM, V149, P2385, DOI 10.1099/mic.0.26397-0; GLICK BR, 1979, EUR J BIOCHEM, V97, P23, DOI 10.1111/j.1432-1033.1979.tb13081.x; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Kaniga K, 1998, INFECT IMMUN, V66, P5599, DOI 10.1128/IAI.66.12.5599-5606.1998; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; Lucas RL, 2000, J BACTERIOL, V182, P1872, DOI 10.1128/JB.182.7.1872-1882.2000; MENG SY, 1992, J BACTERIOL, V174, P2670, DOI 10.1128/jb.174.8.2670-2678.1992; Muto H, 2008, BIOCHEM BIOPH RES CO, V366, P1043, DOI 10.1016/j.bbrc.2007.12.072; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Neely MN, 1996, J BACTERIOL, V178, P5522, DOI 10.1128/jb.178.18.5522-5528.1996; Park JH, 2012, J BIOL CHEM, V287, P2579, DOI 10.1074/jbc.M111.309633; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Peng WT, 2001, J BACTERIOL, V183, P36, DOI 10.1128/JB.183.1.36-45.2001; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Zou SB, 2012, J BACTERIOL, V194, P413, DOI 10.1128/JB.05864-11	25	285	295	6	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					82	85		10.1126/science.1228985	http://dx.doi.org/10.1126/science.1228985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23239623				2022-12-24	WOS:000312985800056
J	Wordsworth, R; Pierrehumbert, R				Wordsworth, Robin; Pierrehumbert, Raymond			Hydrogen-Nitrogen Greenhouse Warming in Earth's Early Atmosphere	SCIENCE			English	Article							CLIMATE; EVOLUTION; PLANETS; ARCHAEA; GA	Understanding how Earth has sustained surface liquid water throughout its history remains a key challenge, given that the Sun's luminosity was much lower in the past. Here we show that with an atmospheric composition consistent with the most recent constraints, the early Earth would have been significantly warmed by H-2-N-2 collision-induced absorption. With two to three times the present-day atmospheric mass of N-2 and a H-2 mixing ratio of 0.1, H-2-N-2 warming would be sufficient to raise global mean surface temperatures above 0 degrees C under 75% of present-day solar flux, with CO2 levels only 2 to 25 times the present-day values. Depending on their time of emergence and diversification, early methanogens may have caused global cooling via the conversion of H-2 and CO2 to CH4, with potentially observable consequences in the geological record.	[Wordsworth, Robin; Pierrehumbert, Raymond] Univ Chicago, Dept Geol Sci, Chicago, IL 60637 USA	University of Chicago	Wordsworth, R (corresponding author), Univ Chicago, Dept Geol Sci, Chicago, IL 60637 USA.	rwordsworth@uchicago.edu		Pierrehumbert, Raymond/0000-0002-5887-1197				Abbot DS, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/178; Blank CE, 2009, GEOBIOLOGY, V7, P495, DOI 10.1111/j.1472-4669.2009.00219.x; BORYSOW A, 1986, ASTROPHYS J, V303, P495, DOI 10.1086/164096; Catling DC, 2006, SCIENCE, V311, DOI 10.1126/science.1117827; Dhuime B, 2012, SCIENCE, V335, P1334, DOI 10.1126/science.1216066; Driese SG, 2011, PRECAMBRIAN RES, V189, P1, DOI 10.1016/j.precamres.2011.04.003; Feulner G, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000375; Goldblatt C, 2009, NAT GEOSCI, V2, P891, DOI 10.1038/NGEO692; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; Haqq-Misra JD, 2008, ASTROBIOLOGY, V8, P1127, DOI 10.1089/ast.2007.0197; House CH, 2003, GEOBIOLOGY, V1, P15, DOI 10.1046/j.1472-4669.2003.00004.x; Kasting J. F, 2012, GLOBAL OXYGEN CYCLE, P93; Kharecha P, 2005, GEOBIOLOGY, V3, P53, DOI 10.1111/j.1472-4669.2005.00049.x; MCKAY CP, 1991, SCIENCE, V253, P1118, DOI 10.1126/science.11538492; Pavlov AA, 2001, J GEOPHYS RES-PLANET, V106, P23267, DOI 10.1029/2000JE001448; Peck WH, 2001, GEOCHIM COSMOCHIM AC, V65, P4215, DOI 10.1016/S0016-7037(01)00711-6; Pierrehumbert R, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/1/L13; Pope EC, 2012, P NATL ACAD SCI USA, V109, P4371, DOI 10.1073/pnas.1115705109; Rosing MT, 2010, NATURE, V464, P744, DOI 10.1038/nature08955; SAGAN C, 1972, SCIENCE, V177, P52, DOI 10.1126/science.177.4043.52; Sleep NH, 2001, J GEOPHYS RES-PLANET, V106, P1373, DOI 10.1029/2000JE001247; Som SM, 2012, NATURE, V484, P359, DOI 10.1038/nature10890; Stevenson DJ, 1999, NATURE, V400, P32, DOI 10.1038/21811; Tian F, 2006, SCIENCE, V311, DOI 10.1126/science.1118412; Tian F, 2005, SCIENCE, V308, P1014, DOI 10.1126/science.1106983; Tian F, 2011, EARTH PLANET SC LETT, V308, P417, DOI 10.1016/j.epsl.2011.06.011; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WATSON AJ, 1981, ICARUS, V48, P150, DOI 10.1016/0019-1035(81)90101-9; Wordsworth R, 2012, ICARUS, V219, P267, DOI 10.1016/j.icarus.2012.02.035; Wordsworth RD, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201015053; Young GM, 1998, J GEOL, V106, P523, DOI 10.1086/516039	31	131	134	2	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					64	67		10.1126/science.1225759	http://dx.doi.org/10.1126/science.1225759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288536	Green Submitted			2022-12-24	WOS:000312985800051
J	Lane, N; Martin, WF				Lane, Nick; Martin, William F.			The Origin of Membrane Bioenergetics	CELL			English	Review							OXIDATION-REDUCTION POTENTIALS; EARLY EVOLUTION; COMPLEX; FERREDOXIN; LIFE; EMERGENCE; REDOX; CELLS; FIXATION; BACTERIA	Harnessing energy as ion gradients across membranes is as universal as the genetic code. We leverage new insights into anaerobe metabolism to propose geochemical origins that account for the ubiquity of chemiosmotic coupling, and Na+/H+ transporters in particular. Natural proton gradients acting across thin FeS walls within alkaline hydrothermal vents could drive carbon assimilation, leading to the emergence of protocells within vent pores. Protocell membranes that were initially leaky would eventually become less permeable, forcing cells dependent on natural H+ gradients to pump Na+ ions. Our hypothesis accounts for the Na+/H+ promiscuity of bioenergetic proteins, as well as the deep divergence between bacteria and archaea.	[Lane, Nick] UCL, Res Dept Genet Evolut & Environm, London WC1E 6BT, England; [Martin, William F.] Univ Dusseldorf, Inst Mol Evolut, D-40225 Dusseldorf, Germany	University of London; University College London; Heinrich Heine University Dusseldorf	Lane, N (corresponding author), UCL, Res Dept Genet Evolut & Environm, Darwin Bldg,Gower St, London WC1E 6BT, England.	nick.lane@ucl.ac.uk	Martin, William F./O-5446-2015	Martin, William F./0000-0003-1478-6449; Lane, Nick/0000-0002-5433-3973	UCL Provost's Venture Research Fellowship; Leverhulme Trust; European Research Council	UCL Provost's Venture Research Fellowship; Leverhulme Trust(Leverhulme Trust); European Research Council(European Research Council (ERC)European Commission)	We thank Filipa Sousa, Mike Russell, Wolfgang Nitschke, John Allen, Peter Rich, Ana Hidalgo, Don Braben, Frank Harold, Manuela Pereira, John Baross, Volker Muller, Georg Fuchs, and Rolf Thauer for discussions and for criticisms of earlier versions of this paper. N.L. is grateful to the UCL Provost's Venture Research Fellowship and the Leverhulme Trust for funding. W.F.M. thanks the European Research Council for funding.	Amend JP, 2009, ACS SYM SER, V1025, P63; Arndt NT, 2012, ANNU REV EARTH PL SC, V40, P521, DOI 10.1146/annurev-earth-042711-105316; Baaske P, 2007, P NATL ACAD SCI USA, V104, P9346, DOI 10.1073/pnas.0609592104; BARBER MJ, 1982, BIOCHEMISTRY-US, V21, P1638, DOI 10.1021/bi00536a026; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; Batista AP, 2012, IUBMB LIFE, V64, P492, DOI 10.1002/iub.1050; Baymann F, 2003, PHILOS T ROY SOC B, V358, P267, DOI 10.1098/rstb.2002.1184; Bender G, 2011, METALLOMICS, V3, P797, DOI 10.1039/c1mt00042j; Branciamore S, 2009, J MOL EVOL, V69, P458, DOI 10.1007/s00239-009-9278-6; Buckel W., 2012, BIOCH BIOPHYS ACTA; Chaves MRM, 2011, SEDIMENT TRANSPORT, P313; Chen KS, 2002, NAT STRUCT BIOL, V9, P188, DOI 10.1038/nsb751; Corrado ME, 1996, EUR J BIOCHEM, V239, P662, DOI 10.1111/j.1432-1033.1996.0662u.x; ECK RV, 1966, SCIENCE, V152, P363, DOI 10.1126/science.152.3720.363; Ferry JG, 2010, ANNU REV MICROBIOL, V64, P453, DOI 10.1146/annurev.micro.112408.134051; FUCHS G, 1986, FEMS MICROBIOL LETT, V39, P181, DOI 10.1111/j.1574-6968.1986.tb01859.x; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; HARMS U, 1995, EUR J BIOCHEM, V228, P640, DOI 10.1111/j.1432-1033.1995.0640m.x; Harold F. M., 1986, VITAL FORCE STUDY BI; Hedderich R, 2004, J BIOENERG BIOMEMBR, V36, P65, DOI 10.1023/B:JOBB.0000019599.43969.33; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Kaster AK, 2011, P NATL ACAD SCI USA, V108, P2981, DOI 10.1073/pnas.1016761108; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Kelley DS, 2002, ANNU REV EARTH PL SC, V30, P385, DOI 10.1146/annurev.earth.30.091201.141331; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; Koonin EV, 2005, TRENDS GENET, V21, P647, DOI 10.1016/j.tig.2005.09.006; Lane N, 2010, BIOESSAYS, V32, P271, DOI 10.1002/bies.200900131; Lang SQ, 2010, GEOCHIM COSMOCHIM AC, V74, P941, DOI 10.1016/j.gca.2009.10.045; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Maden BEH, 2000, BIOCHEM J, V350, P609, DOI 10.1042/0264-6021:3500609; MADEN BEH, 1995, TRENDS BIOCHEM SCI, V20, P337, DOI 10.1016/S0968-0004(00)89069-6; Marreiros B.C., 2012, BIOCH BIOPHYS ACTA; Martin W, 2003, PHILOS T R SOC B, V358, P59, DOI 10.1098/rstb.2002.1183; Martin W, 2007, PHILOS T R SOC B, V362, P1887, DOI 10.1098/rstb.2006.1881; Martin WF, 2012, FEBS LETT, V586, P485, DOI 10.1016/j.febslet.2011.09.031; Mast CB, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.188102; MILLER SL, 1988, NATURE, V334, P609, DOI 10.1038/334609a0; MITCHELL P, 1975, FEBS LETT, V56, P1, DOI 10.1016/0014-5793(75)80098-6; Morowitz H., 1968, ENERGY FLOW BIOL; Mulkidjanian AY, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-13; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Mulkidjanian AY, 2012, P NATL ACAD SCI USA, V109, pE821, DOI 10.1073/pnas.1117774109; Nitschke W, 2009, J MOL EVOL, V69, P481, DOI 10.1007/s00239-009-9289-3; Phillips R, 2009, P NATL ACAD SCI USA, V106, P21465, DOI 10.1073/pnas.0907732106; Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439; Pohorille A, 2009, RES MICROBIOL, V160, P449, DOI 10.1016/j.resmic.2009.06.004; Proskurowski G, 2008, SCIENCE, V319, P604, DOI 10.1126/science.1151194; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; Russell MJ, 2004, TRENDS BIOCHEM SCI, V29, P358, DOI 10.1016/j.tibs.2004.05.007; RUSSELL MJ, 1993, TERRA NOVA, V5, P343, DOI 10.1111/j.1365-3121.1993.tb00267.x; Saladino R, 2012, PHYS LIFE REV, V9, P84, DOI 10.1016/j.plrev.2011.12.002; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; Schuchmann K, 2012, J BIOL CHEM, V287, P31165, DOI 10.1074/jbc.M112.395038; Shock E, 2010, GEOFLUIDS, V10, P161, DOI 10.1111/j.1468-8123.2010.00277.x; Shock Everett L., 1998, P59; Sleep NH, 2004, P NATL ACAD SCI USA, V101, P12818, DOI 10.1073/pnas.0405289101; Stetter KO, 2006, PHILOS T R SOC B, V361, P1837, DOI 10.1098/rstb.2006.1907; Storbeck S, 2010, ARCHAEA, V2010, DOI 10.1155/2010/175050; Surin S, 2007, FEMS MICROBIOL LETT, V269, P301, DOI 10.1111/j.1574-6968.2007.00655.x; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; vandeVossenberg JLCM, 1995, MOL MICROBIOL, V18, P925, DOI 10.1111/j.1365-2958.1995.18050925.x; WACHTERSHAUSER G, 1988, SYST APPL MICROBIOL, V10, P207; White RH, 2004, BIOCHEMISTRY-US, V43, P7618, DOI 10.1021/bi0495127; Wolthers M, 2005, GEOCHIM COSMOCHIM AC, V69, P3469, DOI 10.1016/j.gca.2005.01.027; Zahnle K, 2007, SPACE SCI REV, V129, P35, DOI 10.1007/s11214-007-9225-z	67	222	230	9	225	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1406	1416		10.1016/j.cell.2012.11.050	http://dx.doi.org/10.1016/j.cell.2012.11.050			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260134	Bronze			2022-12-24	WOS:000312890300008
J	Williams, C; Hoppe, HJ; Rezgui, D; Strickland, M; Forbes, BE; Grutzner, F; Frago, S; Ellis, RZ; Wattana-Amorn, P; Prince, SN; Zaccheo, OJ; Nolan, CM; Mungall, AJ; Jones, EY; Crump, MP; Hassan, AB				Williams, Christopher; Hoppe, Hans-Juergen; Rezgui, Dellel; Strickland, Madeleine; Forbes, Briony E.; Grutzner, Frank; Frago, Susana; Ellis, Rosamund Z.; Wattana-Amorn, Pakorn; Prince, Stuart N.; Zaccheo, Oliver J.; Nolan, Catherine M.; Mungall, Andrew J.; Jones, E. Yvonne; Crump, Matthew P.; Hassan, A. Bassim			An Exon Splice Enhancer Primes IGF2:IGF2R Binding Site Structure and Function Evolution	SCIENCE			English	Article							GROWTH-FACTOR-II; 6-PHOSPHATE RECEPTOR; INSIGHTS; ORIGIN	Placental development and genomic imprinting coevolved with parental conflict over resource distribution to mammalian offspring. The imprinted genes IGF2 and IGF2R code for the growth promoter insulin-like growth factor 2 (IGF2) and its inhibitor, mannose 6-phosphate (M6P)/IGF2 receptor (IGF2R), respectively. M6P/IGF2R of birds and fish do not recognize IGF2. In monotremes, which lack imprinting, IGF2 specifically bound M6P/IGF2R via a hydrophobic CD loop. We show that the DNA coding the CD loop in monotremes functions as an exon splice enhancer (ESE) and that structural evolution of binding site loops (AB, HI, FG) improved therian IGF2 affinity. We propose that ESE evolution led to the fortuitous acquisition of IGF2 binding by M6P/IGF2R that drew IGF2R into parental conflict; subsequent imprinting may then have accelerated affinity maturation.	[Hoppe, Hans-Juergen; Rezgui, Dellel; Frago, Susana; Prince, Stuart N.; Zaccheo, Oliver J.; Hassan, A. Bassim] Univ Oxford, Sir William Dunn Sch Pathol, Oxford Mol Pathol Inst, Canc Res UK Tumour Growth Control Grp, Oxford OX1 3RE, England; [Williams, Christopher; Strickland, Madeleine; Ellis, Rosamund Z.; Wattana-Amorn, Pakorn; Crump, Matthew P.] Univ Bristol, Sch Chem, Dept Organ & Biol Chem, Bristol BS8 1TS, Avon, England; [Forbes, Briony E.; Grutzner, Frank] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Nolan, Catherine M.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Mungall, Andrew J.] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Jones, E. Yvonne] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Canc Res UK Receptor Struct Res Grp, Oxford OX3 7BN, England	University of Oxford; University of Bristol; University of Adelaide; University College Dublin; British Columbia Cancer Agency; Cancer Research UK; University of Oxford; Wellcome Centre for Human Genetics	Hassan, AB (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford Mol Pathol Inst, Canc Res UK Tumour Growth Control Grp, S Parks Rd, Oxford OX1 3RE, England.	matt.crump@bristol.ac.uk; bass.hassan@path.ox.ac.uk	Mungall, Andrew J./U-7067-2018; Wiliams, Christopher/P-4904-2015; Grutzner, Frank/ABB-2820-2021; Frago, Susana/L-1477-2017; Strickland, Madeleine/L-8425-2019; Jones, Yvonne/J-2293-2016; Wattana-Amorn, Pakorn/GPK-6717-2022; Jones, Yvonne/N-8111-2019; Forbes, Briony/R-1838-2019; Grutzner, Frank/AAD-5834-2020	Mungall, Andrew J./0000-0002-0905-2742; Wiliams, Christopher/0000-0001-5806-9842; Grutzner, Frank/0000-0002-3088-7314; Frago, Susana/0000-0002-1369-1328; Strickland, Madeleine/0000-0001-8160-070X; Jones, Yvonne/0000-0002-3834-1893; Wattana-Amorn, Pakorn/0000-0002-4780-7122; Jones, Yvonne/0000-0002-3834-1893; Forbes, Briony/0000-0003-4360-9927; Crump, Matthew/0000-0002-7868-5818; Hassan, Andrew/0000-0002-2517-6681; Hoppe, Hans/0000-0002-5107-876X	Cancer Research UK [C429, C375]; Wellcome Trust; Science Foundation Ireland; Algerian Government; National Health and Medical Research Council; Australian Research Council (ARC, Australia);  [EP1945663B];  [US20090304651A]; Cancer Research UK [9891] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Algerian Government; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC, Australia)(Australian Research Council); ; ; Cancer Research UK(Cancer Research UK)	We thank C. Graham, J. Crosby, N. Barclay, C. Ponting, E. Tsend-Ayush, S.-C. Ong, S. Murphy, and N. Proudfoot. Work supported by Cancer Research UK (A.B.H., M.P.C., and E.Y.J., C429, C375), Wellcome Trust (M.P.C. NMR facility), Science Foundation Ireland (C.M.N.), Algerian Government (D.R.), National Health and Medical Research Council and Australian Research Council (ARC, Australia; B.E.F. and F.G. are ARC Research Fellows). The research described in this manuscript is the subject of a worldwide patent application on improved affinity mutants of IGF2R domain 11 IGF2WO2007020402A, granted in Europe as EP1945663B and pending in the United States as US20090304651A. The ensembles of NMR structures and associated NMR chemical shifts have been deposited with the protein database and BioMagResBank with the following accession codes: chicken, 2L21/17110; echidna, 2L5W/17287; opossum, 2L2G/17134; domain 11<SUP>E4</SUP>, 2L2A/17128; domain 11<SUP>E4</SUP>/IGF2 complex, 2L29/17127. The authors declare that there are no competing financial interests.	Brown J, 2002, EMBO J, V21, P1054, DOI 10.1093/emboj/21.5.1054; Brown J, 2008, EMBO J, V27, P265, DOI 10.1038/sj.emboj.7601938; CANFIELD WM, 1989, J BIOL CHEM, V264, P7100; Chess A, 2012, NAT REV GENET, V13, P421, DOI 10.1038/nrg3239; Delaine C, 2007, J BIOL CHEM, V282, P18886, DOI 10.1074/jbc.M700531200; Dewey CN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-311; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; HAIG D, 1991, CELL, V64, P1045; Hore TA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000169; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Killian JK, 2001, J EXP ZOOL, V291, P205, DOI 10.1002/jez.1070; Killian JK, 2001, HUM MOL GENET, V10, P1721, DOI 10.1093/hmg/10.17.1721; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; Pask AJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r1; Renfree MB, 2009, ANNU REV GENOM HUM G, V10, P241, DOI 10.1146/annurev-genom-082908-150026; TRIVERS RL, 1974, AM ZOOL, V14, P249; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Warnecke T, 2009, BIOCHEM SOC T, V37, P756, DOI 10.1042/BST0370756; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Williams C, 2007, STRUCTURE, V15, P1065, DOI 10.1016/j.str.2007.07.007; Xiao XS, 2007, P NATL ACAD SCI USA, V104, P18583, DOI 10.1073/pnas.0707349104; Yandell CA, 1999, J BIOL CHEM, V274, P27076, DOI 10.1074/jbc.274.38.27076; Zaccheo OJ, 2006, J MOL BIOL, V359, P403, DOI 10.1016/j.jmb.2006.03.046	24	30	31	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1209	1213		10.1126/science.1228633	http://dx.doi.org/10.1126/science.1228633			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197533	Green Accepted			2022-12-24	WOS:000311666200046
J	Ernst, A; Avvakumov, G; Tong, JF; Fan, YH; Zhao, YL; Alberts, P; Persaud, A; Walker, JR; Neculai, AM; Neculai, D; Vorobyov, A; Garg, P; Beatty, L; Chan, PK; Juang, YC; Landry, MC; Yeh, C; Zeqiraj, E; Karamboulas, K; Allali-Hassani, A; Vedadi, M; Tyers, M; Moffat, J; Sicheri, F; Pelletier, L; Durocher, D; Raught, B; Rotin, D; Yang, JH; Moran, MF; Dhe-Paganon, S; Sidhu, SS				Ernst, Andreas; Avvakumov, George; Tong, Jiefei; Fan, Yihui; Zhao, Yanling; Alberts, Philipp; Persaud, Avinash; Walker, John R.; Neculai, Ana-Mirela; Neculai, Dante; Vorobyov, Andrew; Garg, Pankaj; Beatty, Linda; Chan, Pak-Kei; Juang, Yu-Chi; Landry, Marie-Claude; Yeh, Christina; Zeqiraj, Elton; Karamboulas, Konstantina; Allali-Hassani, Abdellah; Vedadi, Masoud; Tyers, Mike; Moffat, Jason; Sicheri, Frank; Pelletier, Laurence; Durocher, Daniel; Raught, Brian; Rotin, Daniela; Yang, Jianhua; Moran, Michael F.; Dhe-Paganon, Sirano; Sidhu, Sachdev S.			A Strategy for Modulation of Enzymes in the Ubiquitin System	SCIENCE			English	Article							DEUBIQUITINATING ENZYME; STRUCTURAL BASIS; SPECIFICITY; LIGASE; CANCER; TRAFFICKING; RECOGNITION; ENDOCYTOSIS; INHIBITION; PROTEASES	The ubiquitin system regulates virtually all aspects of cellular function. We report a method to target the myriad enzymes that govern ubiquitination of protein substrates. We used massively diverse combinatorial libraries of ubiquitin variants to develop inhibitors of four deubiquitinases (DUBs) and analyzed the DUB-inhibitor complexes with crystallography. We extended the selection strategy to the ubiquitin conjugating (E2) and ubiquitin ligase (E3) enzymes and found that ubiquitin variants can also enhance enzyme activity. Last, we showed that ubiquitin variants can bind selectively to ubiquitin-binding domains. Ubiquitin variants exhibit selective function in cells and thus enable orthogonal modulation of specific enzymatic steps in the ubiquitin system.	[Ernst, Andreas; Neculai, Ana-Mirela; Vorobyov, Andrew; Garg, Pankaj; Beatty, Linda; Karamboulas, Konstantina; Moffat, Jason; Sidhu, Sachdev S.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, 160 Coll St, Toronto, ON M5S 3E1, Canada; [Avvakumov, George; Walker, John R.; Neculai, Dante; Allali-Hassani, Abdellah; Vedadi, Masoud; Dhe-Paganon, Sirano] MaRS Ctr, Struct Genom Consortium, 101 Coll St,Suite 700, Toronto, ON M5G 1L7, Canada; [Tong, Jiefei; Alberts, Philipp; Persaud, Avinash; Rotin, Daniela; Moran, Michael F.] Hosp Sick Children, Toronto, ON M5G 1L7, Canada; [Fan, Yihui; Zhao, Yanling; Yang, Jianhua] Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Pediat, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Persaud, Avinash; Rotin, Daniela] Univ Toronto, Dept Biochem, Toronto, ON M5S 3E1, Canada; [Chan, Pak-Kei; Tyers, Mike] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, Canada; [Juang, Yu-Chi; Landry, Marie-Claude; Yeh, Christina; Zeqiraj, Elton; Tyers, Mike; Sicheri, Frank; Pelletier, Laurence; Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Yeh, Christina; Moffat, Jason; Sicheri, Frank; Pelletier, Laurence; Durocher, Daniel; Moran, Michael F.; Sidhu, Sachdev S.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Moffat, Jason; Moran, Michael F.; Sidhu, Sachdev S.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Moffat, Jason; Raught, Brian; Sidhu, Sachdev S.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Moffat, Jason; Raught, Brian; Sidhu, Sachdev S.] Univ Toronto, McLaughlin Ctr Mol Med, Toronto, ON M5G 1L7, Canada; [Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Baylor College of Medicine; Texas Children's Cancer Center; University of Toronto; Universite de Montreal; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Sidhu, SS (corresponding author), Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, 160 Coll St, Toronto, ON M5S 3E1, Canada.	sachdev.sidhu@utoronto.ca	Moffat, Jason/AAC-1110-2020; Durocher, Daniel/A-7733-2010; 高, 雨莉/HGU-8187-2022; Tyers, Michael/ABE-3194-2021; Pelletier, Laurence/F-8858-2013; Neculai, Dante/M-2884-2013; Moran, Michael/GYD-3631-2022; Neculai, Dante/A-9923-2011; Ernst, Andreas/M-3013-2019; Sicheri, Frank/F-8856-2013	Moffat, Jason/0000-0002-5663-8586; Durocher, Daniel/0000-0003-3863-8635; Neculai, Dante/0000-0001-8887-9168; Zeqiraj, Elton/0000-0003-0239-5926; /0000-0002-5255-895X	Canadian Institutes for Health Research [MOP-111149, MOP-13494, MOP-57795, MOP-102536, 1097737]; NIH-National Institute of Neurological Disorders and Stroke [1R01NS072420-01]; Canada Research Chairs in Structural Principles of Signal Transduction; Canadian Foundation for Innovation, Systems and Synthetic Biology; Molecular Signatures; Canada Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072420] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NIH-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canada Research Chairs in Structural Principles of Signal Transduction(Canada Research Chairs); Canadian Foundation for Innovation, Systems and Synthetic Biology; Molecular Signatures; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank I. Pot and J.J. Adams for helpful comments on the manuscript and Y. Li for cloning protease constructs. This project was supported by operating grants from the Canadian Institutes for Health Research to S. S. S. (MOP-111149), D. R. (MOP-13494), F. S., M. T. (MOP-57795), and M. F. M. (MOP-102536). J.Y. receives funding from a NIH-National Institute of Neurological Disorders and Stroke grant (1R01NS072420-01). F. S., D. R., M. T., and M. F. M. hold Canada Research Chairs (Tier 1) in Structural Principles of Signal Transduction, Canadian Foundation for Innovation, Systems and Synthetic Biology, and Molecular Signatures, respectively. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A. E., G. A., S. D., and S. S. S. designed the study. A. E., A. V., P. G., and L. B. performed phage display selections, protein purification, and in vitro inhibition assays. G. A., A.-M.N., D.N., J.W., Y.-C.J., and S. D. purified proteins used in this study and solved all the crystal structures. J.T. and M. F. M. performed intracellular USP8 inhibition experiments. Y. F., Y.Z., and J.Y. performed intracellular USP21 inhibition experiments. Y.-C.J., M.-C. L., C. Y., E.Z, F. S., L. P., M. T., and D. D. purified proteins used as targets for phage display selections. K. K. and J.M. performed initial intracellular characterizations of Ub variants. A. A.-H. and M. V. performed in vitro enzymatic assays. P.-K.C. and B. R. provided Ub variants expressing stable cell lines and performed mass spectrometry experiments. P. A., A. P., and D. R. performed NEDD4 ubiquitination experiments; A. E. and S. S. S. analyzed data, prepared figures, and wrote the paper. S. S. S., L. B., and A. E. are inventors on a pending patent, "Specific Active Site Inhibitors of Enzymes or Substrate Binding Partners and Methods of Producing the Same" (PCT/US11/39601).	Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; Berlin I, 2010, J BIOL CHEM, V285, P34909, DOI 10.1074/jbc.M109.016287; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Colland F, 2010, BIOCHEM SOC T, V38, P137, DOI 10.1042/BST0380137; Cooper EM, 2010, J BIOL CHEM, V285, P10344, DOI 10.1074/jbc.M109.059667; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Daviet L, 2008, BIOCHIMIE, V90, P270, DOI 10.1016/j.biochi.2007.09.013; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Edelmann MJ, 2008, BBA-MOL BASIS DIS, V1782, P809, DOI 10.1016/j.bbadis.2008.08.010; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fellouse F. A., 2005, PHAGE DISPLAY BIIOTE, V3, P111; Grunda JM, 2006, J NEURO-ONCOL, V80, P261, DOI 10.1007/s11060-006-9191-4; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kapuria V, 2010, CANCER RES, V70, P9265, DOI 10.1158/0008-5472.CAN-10-1530; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Meijer IMJ, 2011, CELL SIGNAL, V23, P458, DOI 10.1016/j.cellsig.2010.10.023; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wilkinson KD, 2005, METHOD ENZYMOL, V399, P37, DOI 10.1016/S0076-6879(05)99003-4; Xu GF, 2010, J BIOL CHEM, V285, P969, DOI 10.1074/jbc.M109.042689; Yang YL, 2009, CANCER SCI, V100, P24, DOI 10.1111/j.1349-7006.2008.01013.x; Zhang XN, 2011, EMBO J, V30, P2177, DOI 10.1038/emboj.2011.125	46	194	206	3	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					590	595		10.1126/science.1230161	http://dx.doi.org/10.1126/science.1230161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23287719	Green Accepted			2022-12-24	WOS:000314270000062
J	Wang, J; Wurm, Y; Nipitwattanaphon, M; Riba-Grognuz, O; Huang, YC; Shoemaker, D; Keller, L				Wang, John; Wurm, Yannick; Nipitwattanaphon, Mingkwan; Riba-Grognuz, Oksana; Huang, Yu-Ching; Shoemaker, DeWayne; Keller, Laurent			A Y-like social chromosome causes alternative colony organization in fire ants	NATURE			English	Article							GENE; GP-9; FITNESS; GENOME; LIFE; RED	Intraspecific variability in social organization is common, yet the underlying causes are rarely known(1-3). In the fire ant Solenopsis invicta, the existence of two divergent forms of social organization is under the control of a single Mendelian genomic element marked by two variants of an odorant-binding protein gene(4-8). Here we characterize the genomic region responsible for this important social polymorphism, and show that it is part of a pair of heteromorphic chromosomes that have many of the key properties of sex chromosomes. The two variants, hereafter referred to as the social B and social b (SB and Sb) chromosomes, are characterized by a large region of approximately 13 megabases (55% of the chromosome) in which recombination is completely suppressed between SB and Sb. Recombination seems to occur normally between the SB chromosomes but not between Sb chromosomes because Sb/Sb individuals are non-viable. Genomic comparisons revealed limited differentiation between SB and Sb, and the vast majority of the 616 genes identified in the non-recombining region are present in the two variants. The lack of recombination over more than half of the two heteromorphic social chromosomes can be explained by at least one large inversion of around 9 megabases, and this absence of recombination has led to the accumulation of deleterious mutations, including repetitive elements in the non-recombining region of Sb compared with the homologous region of SB. Importantly, most of the genes with demonstrated expression differences between individuals of the two social forms reside in the non-recombining region. These findings highlight how genomic rearrangements can maintain divergent adaptive social phenotypes involving many genes acting together by locally limiting recombination.	[Wang, John; Wurm, Yannick; Nipitwattanaphon, Mingkwan; Riba-Grognuz, Oksana; Keller, Laurent] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Wang, John; Huang, Yu-Ching] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Wurm, Yannick] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Wurm, Yannick; Riba-Grognuz, Oksana] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Shoemaker, DeWayne] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA	University of Lausanne; Academia Sinica - Taiwan; University of London; Queen Mary University London; Swiss Institute of Bioinformatics; United States Department of Agriculture (USDA)	Wang, J (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	johnwang@gate.sinica.edu.tw; y.wurm@qmul.ac.uk; laurent.keller@unil.ch	keller, laurent/AAI-7175-2020; Wurm, Yannick/A-9525-2009	Wurm, Yannick/0000-0002-3140-2809; keller, laurent/0000-0002-5046-9953; Riba Grognuz, Oksana/0000-0002-2961-2655; Shoemaker, DeWayne/0000-0003-3659-8393	Biodiversity Research Center (Academia Sinica, Taiwan), Taiwan NSC [100-2311-B-001-015-MY3]; NERC; BBSRC [BB/K004204/1]; USDA; Swiss NSF; ERC; Biotechnology and Biological Sciences Research Council [BB/K004204/1] Funding Source: researchfish	Biodiversity Research Center (Academia Sinica, Taiwan), Taiwan NSC; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); USDA(United States Department of Agriculture (USDA)); Swiss NSF(Swiss National Science Foundation (SNSF)); ERC(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank C. Stoffel, C. La Mendola, N.-C. Chang, C.-Y. Kaoand C.-C. Lee for helping with genotyping and molecular biology; the DEE-UNIL animal caretakers for ant husbandry; E. Johnson and P. Etter for RADseq advice; R. Nichols, J. Meunier and R. Verity for statistical advice; K. Harshman and M.-Y. Lu for Illumina sequencing support; R. Wang for FISH support; and B. Charlesworth, D. Charlesworth, H. Kaessmann, L. Ometto, J. Pannel, N. Perrin, M. Reuter, P. Reymond and K. Ross for comments. Some computations were performed at the Vital-IT (http://www.vital-it.ch) Center for high-performance computing (HPC) of the SIB Swiss Institute of Bioinformatics and the EPSRC-funded MidPlus HPC centre. This work was supported by the Biodiversity Research Center (Academia Sinica, Taiwan), Taiwan NSC grant 100-2311-B-001-015-MY3, grants from NERC and the BBSRC (BB/K004204/1), a USDA grant, several grants from the Swiss NSF and an ERC Advanced Grant.	Bachtrog D, 2006, CURR BIOL, V16, P1694, DOI 10.1016/j.cub.2006.07.053; Bachtrog D, 2011, TRENDS GENET, V27, P350, DOI 10.1016/j.tig.2011.05.005; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bergero R, 2011, CURR BIOL, V21, P1470, DOI 10.1016/j.cub.2011.07.032; Blomquist GJ, 2003, INSECT PHEROMONE BIO; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Charlesworth B, 2010, ELEMENTS EVOLUTIONAR; CLARKE CA, 1968, PHILOS T ROY SOC B, V254, P37, DOI 10.1098/rstb.1968.0013; Correns C., 1908, BER DEUT BOT GES, P686; DeHeer CJ, 1999, AM NAT, V153, P660, DOI 10.1086/303205; FELDMAN MW, 1986, P NATL ACAD SCI USA, V83, P4824, DOI 10.1073/pnas.83.13.4824; GLANCEY BM, 1976, ANN ENTOMOL SOC AM, V69, P469, DOI 10.1093/aesa/69.3.469; Gotzek D, 2007, Q REV BIOL, V82, P201, DOI 10.1086/519965; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; KELLER L, 1995, TRENDS ECOL EVOL, V10, P355, DOI 10.1016/S0169-5347(00)89133-8; KELLER L, 1993, SCIENCE, V260, P1107, DOI 10.1126/science.260.5111.1107; Keller L, 1999, J EVOLUTION BIOL, V12, P672, DOI 10.1046/j.1420-9101.1999.00064.x; KELLER L, 1995, FUNCT ECOL, V9, P667, DOI 10.2307/2390159; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Krieger MJB, 2005, MOL BIOL EVOL, V22, P2090, DOI 10.1093/molbev/msi203; Lawson LP, 2012, P ROY SOC B-BIOL SCI, V279, P3217, DOI 10.1098/rspb.2012.0315; MATHER K, 1950, EVOLUTION, V4, P340, DOI 10.2307/2405601; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Ross KG, 1998, P NATL ACAD SCI USA, V95, P14232, DOI 10.1073/pnas.95.24.14232; Wang J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000127; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	30	247	249	5	270	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					664	668		10.1038/nature11832	http://dx.doi.org/10.1038/nature11832			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23334415	Green Published			2022-12-24	WOS:000314219600055
J	Wakamoto, Y; Dhar, N; Chait, R; Schneider, K; Signorino-Gelo, F; Leibler, S; McKinney, JD				Wakamoto, Yuichi; Dhar, Neeraj; Chait, Remy; Schneider, Katrin; Signorino-Gelo, Francois; Leibler, Stanislas; McKinney, John D.			Dynamic Persistence of Antibiotic-Stressed Mycobacteria	SCIENCE			English	Article							BACTERIAL PERSISTENCE; PHENOTYPIC VARIABILITY; ESCHERICHIA-COLI; OXIDATIVE STRESS; MECHANISM; ENVIRONMENTS; TOLERANCE; GROWTH; NOISE; CELLS	Exposure of an isogenic bacterial population to a cidal antibiotic typically fails to eliminate a small fraction of refractory cells. Historically, fractional killing has been attributed to infrequently dividing or nondividing "persisters." Using microfluidic cultures and time-lapse microscopy, we found that Mycobacterium smegmatis persists by dividing in the presence of the drug isoniazid (INH). Although persistence in these studies was characterized by stable numbers of cells, this apparent stability was actually a dynamic state of balanced division and death. Single cells expressed catalase-peroxidase (KatG), which activates INH, in stochastic pulses that were negatively correlated with cell survival. These behaviors may reflect epigenetic effects, because KatG pulsing and death were correlated between sibling cells. Selection of lineages characterized by infrequent KatG pulsing could allow nonresponsive adaptation during prolonged drug exposure.	[Wakamoto, Yuichi; Dhar, Neeraj; Schneider, Katrin; Signorino-Gelo, Francois; McKinney, John D.] Swiss Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Chait, Remy; Leibler, Stanislas] Rockefeller Univ, Lab Living Matter, New York, NY 10021 USA; [Leibler, Stanislas] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Leibler, Stanislas] Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Rockefeller University; Institute for Advanced Study - USA; Institute for Advanced Study - USA	McKinney, JD (corresponding author), Swiss Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland.	john.mckinney@epfl.ch	Dhar, Neeraj/K-8171-2013	Dhar, Neeraj/0000-0002-5887-8137; Chait, Remy/0000-0003-0876-3187	Charles H. Revson Foundation; New York Community Trust; Harvey L. Karp Discovery Fellowship; JST PRESTO Program; Bill and Melinda Gates Foundation; NIH [HL088906]; Swiss National Science Foundation [310030_135639]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088906] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24657014] Funding Source: KAKEN	Charles H. Revson Foundation; New York Community Trust; Harvey L. Karp Discovery Fellowship; JST PRESTO Program; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by fellowships from the Charles H. Revson Foundation and the Heiser Program for Research in Leprosy and Tuberculosis of the New York Community Trust (N.D.); a Harvey L. Karp Discovery Fellowship and the JST PRESTO Program (Y.W.); and the Bill and Melinda Gates Foundation, NIH grant HL088906, and Swiss National Science Foundation grant 310030_135639 (J.D.M.).	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Balaban NQ, 2011, CURR OPIN GENET DEV, V21, P768, DOI 10.1016/j.gde.2011.10.001; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bigger JW, 1944, LANCET, V2, P497; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Coates ARM, 2008, TRENDS PHARMACOL SCI, V29, P143, DOI 10.1016/j.tips.2007.12.001; Cogan NG, 2006, J THEOR BIOL, V238, P694, DOI 10.1016/j.jtbi.2005.06.017; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dhar N, 2010, P NATL ACAD SCI USA, V107, P12275, DOI 10.1073/pnas.1003219107; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Gardner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000752; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Hobby GL, 1944, P SOC EXP BIOL MED, V56, P181, DOI 10.3181/00379727-56-14643; Hobby GL, 1942, P SOC EXP BIOL MED, V50, P281, DOI 10.3181/00379727-50-13773; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Iuchi S, 1996, J BIOCHEM-TOKYO, V120, P1055; Keren I, 2011, MBIO, V2, DOI 10.1128/mBio.00100-11; KUBITSCHEK HE, 1964, MUTAT RES, V1, P113, DOI 10.1016/0027-5107(64)90013-2; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Lipsitch M, 1997, ANTIMICROB AGENTS CH, V41, P363, DOI 10.1128/AAC.41.2.363; Locke JCW, 2011, SCIENCE, V334, P366, DOI 10.1126/science.1208144; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Wu YX, 2012, ANTIMICROB AGENTS CH, V56, P4922, DOI 10.1128/AAC.00921-12	39	357	365	2	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					91	95		10.1126/science.1229858	http://dx.doi.org/10.1126/science.1229858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288538				2022-12-24	WOS:000312985800059
J	Bomers, MK; van Agtmael, MA; Luik, H; van Veen, MC; Vandenbroucke-Grauls, CMJE; Smulders, YM				Bomers, Marije K.; van Agtmael, Michiel A.; Luik, Hotsche; van Veen, Merk C.; Vandenbroucke-Grauls, Christina M. J. E.; Smulders, Yvo M.			Using a dog's superior olfactory sensitivity to identify Clostridium difficile in stools and patients: proof of principle study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CANINE SCENT DETECTION; LABORATORY DIAGNOSIS; EPIDEMIOLOGY; INFECTION; CANCER; COLONIZATION; ACQUISITION; OUTBREAK; DIARRHEA; DELAYS	Objective To investigate whether a dog's superior olfactory sensitivity can be used to detect Clostridium difficile in stool samples and hospital patients. Design Proof of principle study, using a case-control design. Setting Two large Dutch teaching hospitals. Participants A 2 year old beagle trained to identify the smell of C difficile and tested on 300 patients (30 with C difficile infection and 270 controls). Intervention The dog was guided along the wards by its trainer, who was blinded to the participants' infection status. Each detection round concerned 10 patients (one case and nine controls). The dog was trained to sit or lie down when C difficile was detected. Main outcome measures Sensitivity and specificity for detection of C difficile in stool samples and in patients. Results The dog's sensitivity and specificity for identifying C difficile in stool samples were both 100% (95% confidence interval 91% to 100%). During the detection rounds, the dog correctly identified 25 of the 30 cases (sensitivity 83%, 65% to 94%) and 265 of the 270 controls (specificity 98%, 95% to 99%). Conclusion A trained dog was able to detect C difficile with high estimated sensitivity and specificity, both in stool samples and in hospital patients infected with C difficile.	[Bomers, Marije K.; van Agtmael, Michiel A.; Smulders, Yvo M.] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, NL-1007 MB Amsterdam, Netherlands; [Luik, Hotsche] HL&HONDEN, Edam, Netherlands; [van Veen, Merk C.] St Lucas Andreas Hosp, Dept Internal Med, Amsterdam, Netherlands; [Vandenbroucke-Grauls, Christina M. J. E.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Sint Lucas Andreas Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Bomers, MK (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Internal Med, POB 7057, NL-1007 MB Amsterdam, Netherlands.	m.bomers@vumc.nl	Smulders, YM/AAG-7506-2021; Vandenbroucke-Grauls, Christina/AAO-7953-2020	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Bomers, Marije/0000-0003-0399-6926				BARTLETT JG, 1977, J INFECT DIS, V136, P701, DOI 10.1093/infdis/136.5.701; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS12, DOI 10.1086/521863; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Burdette SD, 2007, CLIN INFECT DIS, V44, P1142, DOI 10.1086/513033; CLABOTS CR, 1992, J INFECT DIS, V166, P561, DOI 10.1093/infdis/166.3.561; Cornu JN, 2011, EUR UROL, V59, P197, DOI 10.1016/j.eururo.2010.10.006; Crobach MJT, 2009, CLIN MICROBIOL INFEC, V15, P1053, DOI 10.1111/j.1469-0691.2009.03098.x; Delmee M, 2001, CLIN MICROBIOL INFEC, V7, P411, DOI 10.1046/j.1198-743x.2001.00294.x; Ehmann R, 2012, EUR RESPIR J, V39, P669, DOI 10.1183/09031936.00051711; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Frenz MB, 2003, QJM-INT J MED, V96, P579, DOI 10.1093/qjmed/hcg098; GEORGE RH, 1978, BRIT MED J, V1, P695, DOI 10.1136/bmj.1.6114.695; Hensgens MPM, 2011, EUR J CLIN MICROBIOL, V30, P587, DOI 10.1007/s10096-010-1127-4; Horvath G, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-643; IsselTarver L, 1997, GENETICS, V145, P185; Johansen A, 2002, AGE AGEING, V31; Karre T, 2011, J CLIN MICROBIOL, V49, P725, DOI 10.1128/JCM.01028-10; Kufelnicka AM, 2011, CLIN INFECT DIS, V52, P1451, DOI 10.1093/cid/cir201; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Lefebvre SL, 2008, AM J INFECT CONTROL, V36, P78, DOI 10.1016/j.ajic.2007.09.005; Lit L, 2011, ANIM COGN, V14, P387, DOI 10.1007/s10071-010-0373-2; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; McCulloch M, 2006, INTEGR CANCER THER, V5, P30, DOI 10.1177/1534735405285096; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Muto CA, 2007, CLIN INFECT DIS, V45, P1266, DOI 10.1086/522654; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; Samore MH, 1996, AM J MED, V100, P32, DOI 10.1016/S0002-9343(96)90008-X; Scheurer D, 2008, J HOSP MED, V3, P156, DOI 10.1002/jhm.277; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Sonoda H, 2011, GUT, V60, P814, DOI 10.1136/gut.2010.218305; WILLIAMS H, 1989, LANCET, V1, P734; Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712	34	65	69	0	62	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2012	345								e7396	10.1136/bmj.e7396	http://dx.doi.org/10.1136/bmj.e7396			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MZ	23241268	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000312495700001
J	Nagano, AJ; Sato, Y; Mihara, M; Antonio, BA; Motoyama, R; Itoh, H; Nagamura, Y; Izawa, T				Nagano, Atsushi J.; Sato, Yutaka; Mihara, Motohiro; Antonio, Baltazar A.; Motoyama, Ritsuko; Itoh, Hironori; Nagamura, Yoshiaki; Izawa, Takeshi			Deciphering and Prediction of Transcriptome Dynamics under Fluctuating Field Conditions	CELL			English	Article							CIRCADIAN CLOCK; GENE-EXPRESSION; ARABIDOPSIS; RICE; PHYTOCHROME; REGULATORS	Determining the drivers of gene expression patterns is more straightforward in laboratory conditions than in the complex fluctuating environments where organisms typically live. We gathered transcriptome data from the leaves of rice plants in a paddy field along with the corresponding meteorological data and used them to develop statistical models for the endogenous and external influences on gene expression. Our results indicate that the transcriptome dynamics are predominantly governed by endogenous diurnal rhythms, ambient temperature, plant age, and solar radiation. The data revealed diurnal gates for environmental stimuli to influence transcription and pointed to relative influences exerted by circadian and environmental factors on different metabolic genes. The model also generated predictions for the influence of changing temperatures on transcriptome dynamics. We anticipate that our models will help translate the knowledge amassed in laboratories to problems in agriculture and that our approach to deciphering the transcriptome fluctuations in complex environments will be applicable to other organisms.	[Nagano, Atsushi J.; Itoh, Hironori; Izawa, Takeshi] Natl Inst Agrobiol Sci, Photosynthesis & Photobiol Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Sato, Yutaka; Antonio, Baltazar A.; Motoyama, Ritsuko; Nagamura, Yoshiaki] Natl Inst Agrobiol Sci, Genome Resource Ctr, Tsukuba, Ibaraki 3058602, Japan; [Mihara, Motohiro; Izawa, Takeshi] Natl Inst Agrobiol Sci, Plant Genom Res Unit, Tsukuba, Ibaraki 3058602, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan	Nagamura, Y (corresponding author), Natl Inst Agrobiol Sci, Genome Resource Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	nagamura@affrc.go.jp; tizawa@nias.affrc.go.jp	Nagano, Atsushi J./A-2957-2019	Nagano, Atsushi J./0000-0001-7891-5049; Izawa, Takeshi/0000-0001-5109-0024	Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [RTR-0004, GPN0001, RTR-0002]	Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan)	We thank M. Ebihara for her experimental assistance; M. Fukata for maintaining the FiT-DB database and registration of some microarray data to GEO; Dr. S. Ishida for useful advice on the annotation enrichment analysis; H. Minami, K. Kamatsuki, N. Namiki for assistance in analysis of microarray data and registration to GEO; and Dr. N. Sakurai for providing the gene lists in KaPPA-View4. This work was supported by grants from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation; RTR-0004 and GPN0001 to T. I. and RTR-0002 to Y.N.).	Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; IPCC, 2007, CONTRIBUTION WORKING; Itoh H, 2010, NAT GENET, V42, P635, DOI 10.1038/ng.606; Izawa T, 2012, PLANT CELL ENVIRON, V35, P1729, DOI 10.1111/j.1365-3040.2012.02555.x; Izawa T, 2011, PLANT CELL, V23, P1741, DOI 10.1105/tpc.111.083238; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Morita S., 2009, Bulletin of the National Agricultural Research Center for Kyushu Okinawa Region, P1; Richards CL, 2012, PLOS GENET, V8, P482, DOI 10.1371/journal.pgen.1002662; Ronald P, 2011, GENETICS, V188, P11, DOI 10.1534/genetics.111.128553; Salazar JD, 2009, CELL, V139, P1170, DOI 10.1016/j.cell.2009.11.029; Sato Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-10; Shinomura T, 1996, P NATL ACAD SCI USA, V93, P8129, DOI 10.1073/pnas.93.15.8129; Shinomura T, 2000, PLANT PHYSIOL, V122, P147, DOI 10.1104/pp.122.1.147	17	139	143	1	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1358	1369		10.1016/j.cell.2012.10.048	http://dx.doi.org/10.1016/j.cell.2012.10.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217716	Bronze			2022-12-24	WOS:000311999900023
J	Stensola, H; Stensola, T; Solstad, T; Froland, K; Moser, MB; Moser, EI				Stensola, Hanne; Stensola, Tor; Solstad, Trygve; Froland, Kristian; Moser, May-Britt; Moser, Edvard I.			The entorhinal grid map is discretized	NATURE			English	Article							SPATIAL REPRESENTATION; FUNCTIONAL ARCHITECTURE; THETA OSCILLATIONS; PATH-INTEGRATION; SINGLE NEURONS; CELLS; INTERFERENCE; DIRECTION; CORTEX; MONKEY	The medial entorhinal cortex (MEC) is part of the brain's circuit for dynamic representation of self-location. The metric of this representation is provided by grid cells, cells with spatial firing fields that tile environments in a periodic hexagonal pattern. Limited anatomical sampling has obscured whether the grid system operates as a unified system or a conglomerate of independent modules. Here we show with recordings from up to 186 grid cells in individual rats that grid cells cluster into a small number of layer-spanning anatomically overlapping modules with distinct scale, orientation, asymmetry and theta-frequency modulation. These modules can respond independently to changes in the geometry of the environment. The discrete topography of the grid-map, and the apparent autonomy of the modules, differ from the graded topography of maps for continuous variables in several sensory systems, raising the possibility that the modularity of the grid map is a product of local self-organizing network dynamics.	[Stensola, Hanne; Stensola, Tor; Solstad, Trygve; Froland, Kristian; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, MTFS, N-7491 Trondheim, Norway; [Stensola, Hanne; Stensola, Tor; Solstad, Trygve; Froland, Kristian; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Ctr Biol Memory, N-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, MTFS, Olav Kyrres Gate 9, N-7491 Trondheim, Norway.	hanne.stensola@ntnu.no; tor.stensola@ntnu.no; edvard.moser@ntnu.no		Stensola, Tor/0000-0002-5485-6141; Stensola, Hanne/0000-0002-5823-944X	European Research Council ('CIRCUIT') [232608]; Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway	European Research Council ('CIRCUIT'); Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway	We thank A. M. Amundgard, K. Haugen, K. Jenssen, E. Krakvik, R. Skjerpeng, and H. Waade for technical assistance, J. Whitlock for implanting an animal in the tangential group, and T. Bonhoeffer, B. Dunn, B. McNaughton, Y. Roudi, A. Treves and A. Witoelar for helpful discussion. The work was supported by an Advanced Investigator Grant from the European Research Council ('CIRCUIT', Grant Agreement no. 232608), the Kavli Foundation and the Centre of Excellence scheme of the Research Council of Norway.	Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Blair HT, 2007, J NEUROSCI, V27, P3211, DOI 10.1523/JNEUROSCI.4724-06.2007; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Couey J.J., 2012, SOC NEC ABSTR, V702.06; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Giocomo LM, 2011, NEURON, V71, P589, DOI 10.1016/j.neuron.2011.07.023; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; HEVNER RF, 1992, J COMP NEUROL, V326, P451, DOI 10.1002/cne.903260310; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; IKEDA J, 1989, BRAIN RES, V505, P176, DOI 10.1016/0006-8993(89)90134-0; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; Kropff E, 2008, HIPPOCAMPUS, V18, P1256, DOI 10.1002/hipo.20520; Krupic J, 2012, SCIENCE, V337, P853, DOI 10.1126/science.1222403; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mhatre H, 2012, HIPPOCAMPUS, V22, P320, DOI 10.1002/hipo.20901; Monaco JD, 2011, J NEUROSCI, V31, P9414, DOI 10.1523/JNEUROSCI.1433-11.2011; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; PAYNE BR, 1981, BRAIN RES, V211, P445, DOI 10.1016/0006-8993(81)90971-9; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Sperry RW, 1943, J COMP NEUROL, V79, P33, DOI 10.1002/cne.900790104; Sreenivasan S, 2011, NAT NEUROSCI, V14, P1330, DOI 10.1038/nn.2901; TOLHURST DJ, 1981, EXP BRAIN RES, V44, P340; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Witter MP, 2006, TRENDS NEUROSCI, V29, P671, DOI 10.1016/j.tins.2006.10.003; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Zilli EA, 2010, J NEUROSCI, V30, P13850, DOI 10.1523/JNEUROSCI.0547-10.2010	50	362	368	1	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					72	78		10.1038/nature11649	http://dx.doi.org/10.1038/nature11649			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222610				2022-12-24	WOS:000311893400047
J	Klattenhoff, CA; Scheuermann, JC; Surface, LE; Bradley, RK; Fields, PA; Steinhauser, ML; Ding, HM; Butty, VL; Torrey, L; Haas, S; Abo, R; Tabebordbar, M; Lee, RT; Burge, CB; Boyer, LA				Klattenhoff, Carla A.; Scheuermann, Johanna C.; Surface, Lauren E.; Bradley, Robert K.; Fields, Paul A.; Steinhauser, Matthew L.; Ding, Huiming; Butty, Vincent L.; Torrey, Lillian; Haas, Simon; Abo, Ryan; Tabebordbar, Mohammadsharif; Lee, Richard T.; Burge, Christopher B.; Boyer, Laurie A.			Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment	CELL			English	Article							STEM-CELL DIFFERENTIATION; MESENCHYMAL TRANSITIONS; MASTER REGULATOR; PROGENITOR CELLS; GENE STRUCTURE; MESP1; MOUSE; HEART; CHROMATIN; EVOLUTION	Long noncoding RNAs (lncRNAs) are often expressed in a development-specific manner, yet little is known about their roles in lineage commitment. Here, we identified Braveheart (Bvht), a heart-associated lncRNA in mouse. Using multiple embryonic stem cell (ESC) differentiation strategies, we show that Bvht is required for progression of nascentmesoderm toward a cardiac fate. We find that Bvht is necessary for activation of a core cardiovascular gene network and functions upstream of mesoderm posterior 1 (MesP1), a master regulator of a common multipotent cardiovascular progenitor. We also show that Bvht interacts with SUZ12, a component of polycombrepressive complex 2 (PRC2), during cardiomyocyte differentiation, suggesting that Bvht mediates epigenetic regulation of cardiac commitment. Finally, we demonstrate a role for Bvht in maintaining cardiac fate in neonatal cardiomyocytes. Together, our work provides evidence for a long noncoding RNA with critical roles in the establishment of the cardiovascular lineage during mammalian development.	[Klattenhoff, Carla A.; Scheuermann, Johanna C.; Surface, Lauren E.; Bradley, Robert K.; Fields, Paul A.; Ding, Huiming; Butty, Vincent L.; Torrey, Lillian; Haas, Simon; Abo, Ryan; Tabebordbar, Mohammadsharif; Burge, Christopher B.; Boyer, Laurie A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Bradley, Robert K.; Burge, Christopher B.] MIT, Program Computat & Syst Biol, Cambridge, MA 02139 USA; [Steinhauser, Matthew L.; Lee, Richard T.] Harvard Univ, Div Cardiovasc Med, Sch Med, Dept Med,Brigham & Womens Hosp, Cambridge, MA 02139 USA; [Tabebordbar, Mohammadsharif] ACECR, Dept Stem Cells & Dev Biol, Royan Inst Stem Cell Biol & Technol, Tehran, Iran; [Lee, Richard T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Academic Center for Education, Culture & Research (ACECR); Harvard University	Boyer, LA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lboyer@mit.edu	Burge, Christopher B./AAH-2177-2020; Steinhauser, Matthew L./GVT-6393-2022	Steinhauser, Matthew L./0000-0001-5287-9246; Surface, Lauren/0000-0003-4055-0237; Fields, Paul/0000-0002-9608-6464; Bradley, Robert/0000-0002-8046-1063; Lee, Richard/0000-0003-4687-1381; Haas, Simon/0000-0001-9227-2051; Butty, Vincent/0000-0003-1173-2429	Damon Runyon Cancer Research Foundation [DRG 2032-09, DFS 04-12]; NIH [K08 (DK090147)]; Watkins Cardiovascular Leadership Award; EMBO long-term fellowship; NHLBI Bench [U01HL098179, U01HL098188]; Richard and Susan Smith Family Foundation, Chestnut Hill, MA; Pew Scholar's Program in the Biomedical Sciences; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098179, U01HL098188] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090147] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Watkins Cardiovascular Leadership Award; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); NHLBI Bench; Richard and Susan Smith Family Foundation, Chestnut Hill, MA; Pew Scholar's Program in the Biomedical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Boyer lab, especially Sera Thornton, for helpful discussions and critical evaluation of the manuscript and members of the Burge lab, especially Jason Merkin and Jessica Hurt, for sharing unpublished data. We also thank MIT BioMicro Center members Fugen Li, Kevin K. Thai, and Stuart Levine for bioinformatics and technical support. We are especially grateful to Nadya Dimitrova and Tyler Jacks for miR143/145 conditional KO ESC lines and Cedric Blanpain for inducible MesP1 and pMesP1-GFP reporter ESC lines and for providing gene expression data. R.K.B. was supported by the Damon Runyon Cancer Research Foundation (DRG 2032-09 and DFS 04-12). M.L.S. was supported by NIH K08 (DK090147) and the Watkins Cardiovascular Leadership Award. C.A.K. is a Novartis Scholar of the Life Sciences Research Foundation. J.C.S. is supported by an EMBO long-term fellowship. This work was supported by the NHLBI Bench to Bassinet Program (U01HL098179 and U01HL098188) (L.A.B.); the Richard and Susan Smith Family Foundation, Chestnut Hill, MA (L.A.B.); and the Pew Scholar's Program in the Biomedical Sciences (L.A.B.).	Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Bondue A, 2011, J CELL BIOL, V192, P751, DOI 10.1083/jcb.201007063; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chang CP, 2012, ANNU REV PHYSIOL, V74, P41, DOI 10.1146/annurev-physiol-020911-153242; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Congrains A, 2012, ATHEROSCLEROSIS, V220, P449, DOI 10.1016/j.atherosclerosis.2011.11.017; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Costello I, 2011, NAT CELL BIOL, V13, P1084, DOI 10.1038/ncb2304; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; David R, 2011, CARDIOVASC RES, V92, P115, DOI 10.1093/cvr/cvr158; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Esteban MA, 2012, CURR OPIN GENET DEV, V22, P423, DOI 10.1016/j.gde.2012.09.004; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hu WQ, 2012, EMBO REP, V13, P971, DOI 10.1038/embor.2012.145; Ishii N, 2006, J HUM GENET, V51, P1087, DOI 10.1007/s10038-006-0070-9; Islas JF, 2012, P NATL ACAD SCI USA, V109, P13016, DOI 10.1073/pnas.1120299109; Kattman SJ, 2007, TRENDS CARDIOVAS MED, V17, P240, DOI 10.1016/j.tcm.2007.08.004; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kretz M., 2012, NATURE; Kretz M, 2012, GENE DEV, V26, P338, DOI 10.1101/gad.182121.111; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Lim SM, 2009, STEM CELLS, V27, P363, DOI 10.1634/stemcells.2008-1008; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; McCulley DJ, 2012, CURR TOP DEV BIOL, V100, P253, DOI 10.1016/B978-0-12-387786-4.00008-7; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mercola M, 2011, GENE DEV, V25, P299, DOI 10.1101/gad.2018411; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1996, DEVELOPMENT, V122, P2769; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; Simoes FC, 2011, DEVELOPMENT, V138, P3235, DOI 10.1242/dev.059634; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Steinhauser ML, 2011, EMBO MOL MED, V3, P701, DOI 10.1002/emmm.201100175; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]	65	688	746	3	209	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					570	583		10.1016/j.cell.2013.01.003	http://dx.doi.org/10.1016/j.cell.2013.01.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23352431	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000314362800025
J	Xu, K; Zhong, GS; Zhuang, XW				Xu, Ke; Zhong, Guisheng; Zhuang, Xiaowei			Actin, Spectrin, and Associated Proteins Form a Periodic Cytoskeletal Structure in Axons	SCIENCE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; ERYTHROCYTE-MEMBRANE SKELETON; INITIAL SEGMENT; CELLS; DYNAMICS; VISUALIZATION; LOCALIZATION; MICROTUBULES; ORGANIZATION; ANKYRIN(G)	Actin and spectrin play important roles in neurons, but their organization in axons and dendrites remains unclear. We used stochastic optical reconstruction microscopy to study the organization of actin, spectrin, and associated proteins in neurons. Actin formed ringlike structures that wrapped around the circumference of axons and were evenly spaced along axonal shafts with a periodicity of similar to 180 to 190 nanometers. This periodic structure was not observed in dendrites, which instead contained long actin filaments running along dendritic shafts. Adducin, an actin-capping protein, colocalized with the actin rings. Spectrin exhibited periodic structures alternating with those of actin and adducin, and the distance between adjacent actin-adducin rings was comparable to the length of a spectrin tetramer. Sodium channels in axons were distributed in a periodic pattern coordinated with the underlying actin-spectrin-based cytoskeleton.	[Xu, Ke; Zhong, Guisheng; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	Xu, Ke/A-9476-2011	Xu, Ke/0000-0002-2788-194X	NIH; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096450] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Rasband for providing the beta IV-spectrin and sodium channel antibodies and M. Ericsson, B. Kasthuri, R. Schalek, G. Hao, and C. Speer for help in the preparation of hippocampal tissue slices. This work is supported in part by the NIH and the Collaborative Innovation Award from the HHMI. X.Z. is a HHMI investigator.	Baines AJ, 2010, PROTOPLASMA, V244, P99, DOI 10.1007/s00709-010-0181-1; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1982, NATURE, V299, P126, DOI 10.1038/299126a0; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Brachet A, 2010, J CELL BIOL, V191, P383, DOI 10.1083/jcb.201003042; BYERS TJ, 1985, P NATL ACAD SCI USA, V82, P6153, DOI 10.1073/pnas.82.18.6153; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Egner A, 2007, BIOPHYS J, V93, P3285, DOI 10.1529/biophysj.107.112201; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Izeddin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015611; Kapitein LC, 2011, MOL CELL NEUROSCI, V46, P9, DOI 10.1016/j.mcn.2010.08.015; Kole MHP, 2012, NEURON, V73, P235, DOI 10.1016/j.neuron.2012.01.007; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; LEVINE J, 1981, J CELL BIOL, V90, P631, DOI 10.1083/jcb.90.3.631; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; LIU SC, 1987, J CELL BIOL, V104, P527, DOI 10.1083/jcb.104.3.527; Pielage J, 2008, NEURON, V58, P195, DOI 10.1016/j.neuron.2008.02.017; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; SCHNAPP BJ, 1982, J CELL BIOL, V94, P667, DOI 10.1083/jcb.94.3.667; Tatavarty V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007724; Urban NT, 2011, BIOPHYS J, V101, P1277, DOI 10.1016/j.bpj.2011.07.027; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	36	755	781	8	378	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					452	456		10.1126/science.1232251	http://dx.doi.org/10.1126/science.1232251			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23239625	Green Accepted			2022-12-24	WOS:000313960700045
J	Jolma, A; Yan, J; Whitington, T; Toivonen, J; Nitta, KR; Rastas, P; Morgunova, E; Enge, M; Taipale, M; Wei, GH; Palin, K; Vaquerizas, JM; Vincentelli, R; Luscombe, NM; Hughes, TR; Lemaire, P; Ukkonen, E; Kivioja, T; Taipale, J				Jolma, Arttu; Yan, Jian; Whitington, Thomas; Toivonen, Jarkko; Nitta, Kazuhiro R.; Rastas, Pasi; Morgunova, Ekaterina; Enge, Martin; Taipale, Mikko; Wei, Gonghong; Palin, Kimmo; Vaquerizas, Juan M.; Vincentelli, Renaud; Luscombe, Nicholas M.; Hughes, Timothy R.; Lemaire, Patrick; Ukkonen, Esko; Kivioja, Teemu; Taipale, Jussi			DNA-Binding Specificities of Human Transcription Factors	CELL			English	Article							STRUCTURAL BASIS; HIGH-RESOLUTION; SIMPLE-MODELS; IN-VITRO; RECOGNITION; PROTEIN; DETERMINANTS; EVOLUTION; SEQUENCE; DOMAINS	Although the proteins that read the gene regulatory code, transcription factors (TFs), have been largely identified, it is not well known which sequences TFs can recognize. We have analyzed the sequence-specific binding of human TFs using high-throughput SELEX and ChIP sequencing. A total of 830 binding profiles were obtained, describing 239 distinctly different binding specificities. The models represent the majority of human TFs, approximately doubling the coverage compared to existing systematic studies. Our results reveal additional specificity determinants for a large number of factors for which a partial specificity was known, including a commonly observed A- or T-rich stretch that flanks the core motifs. Global analysis of the data revealed that homodimer orientation and spacing preferences, and base-stacking interactions, have a larger role in TF-DNA binding than previously appreciated. We further describe a binding model incorporating these features that is required to understand binding of TFs to DNA.	[Jolma, Arttu; Yan, Jian; Whitington, Thomas; Nitta, Kazuhiro R.; Morgunova, Ekaterina; Enge, Martin; Kivioja, Teemu; Taipale, Jussi] Karolinska Inst, Sci Life Ctr, Dept Biosci & Nutr, S-14183 Huddinge, Sweden; [Jolma, Arttu; Taipale, Mikko; Wei, Gonghong; Palin, Kimmo; Kivioja, Teemu; Taipale, Jussi] Univ Helsinki, Genome Scale Biol Program, Helsinki 00014, Finland; [Toivonen, Jarkko; Rastas, Pasi; Ukkonen, Esko; Kivioja, Teemu] Univ Helsinki, Dept Comp Sci, Helsinki 00014, Finland; [Vaquerizas, Juan M.; Luscombe, Nicholas M.] EMBL European Bioinformat Inst, Cambridge CB10 1SD, England; [Vincentelli, Renaud] Univ Aix Marseille, CNRS UMR7257, F-13288 Marseille 9, France; [Hughes, Timothy R.] Univ Toronto, Donnelly Ctr, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Lemaire, Patrick] CRBM, F-34293 Montpellier, France	Karolinska Institutet; University of Helsinki; University of Helsinki; European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Aix-Marseille Universite; University of Toronto; University of Toronto; Universite de Montpellier	Taipale, J (corresponding author), Karolinska Inst, Sci Life Ctr, Dept Biosci & Nutr, S-14183 Huddinge, Sweden.	jussi.taipale@ki.se	Vaquerizas, Juan M/AAY-2339-2020; Morgunova, Ekaterina/G-2479-2018; Yan, Jian/B-2631-2018; Lemaire, Patrick/P-8228-2019; Wei, Gonghong/C-6263-2014; Palin, Kimmo/ABG-5710-2020; Jolma, Arttu/AAK-9649-2021; Enge, Martin/GYQ-5073-2022; Lemaire, Patrick/B-5560-2012; Vaquerizas, Juan M/F-2676-2011	Vaquerizas, Juan M/0000-0002-6583-6541; Morgunova, Ekaterina/0000-0002-7754-9021; Yan, Jian/0000-0002-1267-2870; Lemaire, Patrick/0000-0003-4925-2009; Palin, Kimmo/0000-0002-4621-6128; Lemaire, Patrick/0000-0003-4925-2009; Vaquerizas, Juan M/0000-0002-6583-6541; Taipale, Mikko/0000-0003-3811-1761; Jolma, Arttu/0000-0002-2543-7490; Enge, Martin/0000-0001-8748-8931; Ukkonen, Esko/0000-0002-5978-1505; Rastas, Pasi/0000-0003-2768-1339; Toivonen, Jarkko/0000-0002-6843-5831; Wei, Gong-Hong/0000-0001-6546-9334; Nitta, Kazuhiro/0000-0003-3151-0962	Academy of Finland; Knut and Alice Wallenberg Foundation; Vetenskapsradet; Cancer-fonden; ERC Advanced Grant GROWTHCONTROL; EU FP7 project SYSCOL; CIHR Operating Grant [MOP-77721]; Cancer Research UK [16358] Funding Source: researchfish	Academy of Finland(Academy of Finland); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Vetenskapsradet(Swedish Research Council); Cancer-fonden(Swedish Cancer Society); ERC Advanced Grant GROWTHCONTROL; EU FP7 project SYSCOL; CIHR Operating Grant(Canadian Institutes of Health Research (CIHR)); Cancer Research UK(Cancer Research UK)	We apologize to the authors of original work not cited. Due to the broad scope of this work, and editorial limits on citations, we were largely limited to citing review articles, databases, and more recent original articles not yet reviewed or incorporated into databases. We thank Drs. M. Taipale, M.O. Lombardia, and B. Schmierer for critical review of the manuscript, and R. Nurmi, S. Miettinen, A. Zetterlund, S. Talukder, G. Breard, A. Yang, A. Cote, and H. Zheng for technical assistance. This project was supported by Academy of Finland, Knut and Alice Wallenberg Foundation, Vetenskapsradet, Cancer-fonden, ERC Advanced Grant GROWTHCONTROL, the EU FP7 project SYSCOL to J. Taipale, and CIHR Operating Grant MOP-77721 to T.R.H.	AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; Agius P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000916; Amoutzias GD, 2007, MOL BIOL EVOL, V24, P827, DOI 10.1093/molbev/msl211; Babayeva ND, 2010, CELL CYCLE, V9, P3054, DOI 10.4161/cc.9.14.12257; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Geggier S, 2010, P NATL ACAD SCI USA, V107, P15421, DOI 10.1073/pnas.1004809107; GIGUERE V, 1995, MOL CELL BIOL, V15, P2517; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Jolma A, 2011, SUBCELL BIOCHEM, V52, P155, DOI 10.1007/978-90-481-9069-0_7; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; KIM J, 1995, NUCLEIC ACIDS RES, V23, P2531, DOI 10.1093/nar/23.13.2531; Lamber EP, 2008, EMBO J, V27, P2006, DOI 10.1038/emboj.2008.117; Morris Q, 2011, NAT BIOTECHNOL, V29, P483, DOI 10.1038/nbt.1892; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Pape UJ, 2008, BIOINFORMATICS, V24, P350, DOI 10.1093/bioinformatics/btm610; Pardee K, 2011, SUBCELL BIOCHEM, V52, P123, DOI 10.1007/978-90-481-9069-0_6; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Roulet E, 2000, J MOL BIOL, V297, P833, DOI 10.1006/jmbi.2000.3614; Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Sharon E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000154; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; SOLANO R, 1995, EMBO J, V14, P1773, DOI 10.1002/j.1460-2075.1995.tb07166.x; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; STRUHL K, 1987, CELL, V50, P841, DOI 10.1016/0092-8674(87)90511-3; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Walhout AJM, 2011, METHOD CELL BIOL, V106, P271, DOI 10.1016/B978-0-12-544172-8.00010-4; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893; Zheng GH, 2010, NUCLEIC ACIDS RES, V38, pD267, DOI 10.1093/nar/gkp959; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666	47	746	752	4	179	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					327	339		10.1016/j.cell.2012.12.009	http://dx.doi.org/10.1016/j.cell.2012.12.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332764	Bronze			2022-12-24	WOS:000313719800027
J	Strugatsky, D; McNulty, R; Munson, K; Chen, CK; Soltis, SM; Sachs, G; Luecke, H				Strugatsky, David; McNulty, Reginald; Munson, Keith; Chen, Chiung-Kuang; Soltis, S. Michael; Sachs, George; Luecke, Hartmut			Structure of the proton-gated urea channel from the gastric pathogen Helicobacter pylori	NATURE			English	Article							PH; PROTEIN; COMPLEX; SYSTEM	Half the world's population is chronically infected with Helico-bacter pylori(1), causing gastritis, gastric ulcers and an increased incidence of gastric adenocarcinoma(2). Its proton-gated inner-membrane urea channel, HpUreI, is essential for survival in the acidic environment of the stomach(3). The channel is closed at neutral pH and opens at acidic pH to allow the rapid access of urea to cytoplasmic urease(4). Urease produces NH3 and CO2, neutralizing entering protons and thus buffering the periplasm to a pH of roughly 6.1 even in gastric juice at a pH below 2.0. Here we report the structure of HpUreI, revealing six protomers assembled in a hexameric ring surrounding a central bilayer plug of ordered lipids. Each protomer encloses a channel formed by a twisted bundle of six transmembrane helices. The bundle defines a previously unobserved fold comprising a two-helix hairpin motif repeated three times around the central axis of the channel, without the inverted repeat of mammalian-type urea transporters. Both the channel and the protomer interface contain residues conserved in the AmiS/UreI superfamily, suggesting the preservation of channel architecture and oligomeric state in this superfamily. Predominantly aromatic or aliphatic side chains line the entire channel and define two consecutive constriction sites in the middle of the channel. Mutation of Trp 153 in the cytoplasmic constriction site to Ala or Phe decreases the selectivity for urea in comparison with thiourea, suggesting that solute interaction with Trp 153 contributes specificity. The previously unobserved hexameric channel structure described here provides a new model for the permeation of urea and other small amide solutes in prokaryotes and archaea.	[Strugatsky, David; Munson, Keith; Sachs, George] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90073 USA; [Strugatsky, David; Munson, Keith; Sachs, George] Greater W Angeles Hlth Care Syst, Los Angeles, CA 90073 USA; [McNulty, Reginald; Chen, Chiung-Kuang; Luecke, Hartmut] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Soltis, S. Michael] Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Luecke, Hartmut] Univ Calif Irvine, Ctr Biomembrane Syst, Irvine, CA 92697 USA; [Luecke, Hartmut] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Luecke, Hartmut] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92697 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Sachs, G (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90073 USA.	gsachs@ucla.edu; hudel@uci.edu		McNulty, Reginald/0000-0003-2101-1377	National Institutes of Health (NIH) [R01AI78000, P30CA062203]; National Cancer Institute institutional training grant [5T32CA9054-34]; University of California Irvine Center for Biomembrane Systems; NIH [R01DK53462, R01DK58333]; US Veterans Administration; DOE Office of Biological and Environmental Research; HIN, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; National Institute of General Medical Sciences; NATIONAL CANCER INSTITUTE [P30CA062203, T32CA009054] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058333] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute institutional training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of California Irvine Center for Biomembrane Systems; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Veterans Administration(US Department of Veterans Affairs); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); HIN, National Center for Research Resources, Biomedical Technology Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the following for assistance with X-ray data collection at the Stanford Synchrotron Radiation Lightsource (T. Doukov), the Advanced Photon Source (D. Cascio & R. Rajashankar), the Advanced Light Source (J. Nix) and the Swiss Light Source (C. Schulze-Briese). We also thank J. Whitelegge for mass spectrometry characterization of potential heavy atom derivatives; D. R. Scott for the urease assays; B. Hirayama for advice on the oocyte experiments; N. Echols and T. Terwilliger for assistance with the development version of the program Phenix; A. Murzin for fold characterization; T. Silkov for pseudosymmetry analysis; and D. R. Scott, F. Tombola, V. De Souza, K. Luecke, S. Luecke and J. Lanyi for general suggestions. This work was supported by National Institutes of Health (NIH) grants R01AI78000 and P30CA062203, National Cancer Institute institutional training grant 5T32CA9054-34, the University of California Irvine Center for Biomembrane Systems (H. L.), NIH grants R01DK53462 and R01DK58333 (G. S.) and the US Veterans Administration (G. S). Portions of this research were performed at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the US Department of Energy (DOE) Office of Science by Stanford University. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the HIN, National Center for Research Resources, Biomedical Technology Program (P41RR001209) and the National Institute of General Medical Sciences.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Callenberg KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012722; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Furnham N, 2006, STRUCTURE, V14, P1313, DOI 10.1016/j.str.2006.06.014; Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; Gray LR, 2011, BIOCHEMISTRY-US, V50, P8656, DOI 10.1021/bi200887a; Hong W, 2003, J MED MICROBIOL, V52, P211, DOI 10.1099/jmm.0.05072-0; Huysmans GHM, 2012, BIOCHEM J, V445, P157, DOI 10.1042/BJ20120169; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-303; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Levin EJ, 2012, P NATL ACAD SCI USA, V109, P11194, DOI 10.1073/pnas.1207362109; Levin EJ, 2009, NATURE, V462, P757, DOI 10.1038/nature08558; Lu W, 2011, SCIENCE, V332, P352, DOI 10.1126/science.1199098; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MeyerRosberg K, 1996, GASTROENTEROLOGY, V111, P886, DOI 10.1016/S0016-5085(96)70056-2; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; ORBACH E, 1980, J GEN PHYSIOL, V75, P427, DOI 10.1085/jgp.75.4.427; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; POUNDER RE, 1995, ALIMENT PHARM THERAP, V9, P33; Scott DR, 2010, J BACTERIOL, V192, P94, DOI 10.1128/JB.00848-09; Scott DR, 2000, INFECT IMMUN, V68, P470, DOI 10.1128/IAI.68.2.470-477.2000; Scott DR, 2002, GASTROENTEROLOGY, V123, P187, DOI 10.1053/gast.2002.34218; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Skouloubris S, 1998, INFECT IMMUN, V66, P4517; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weeks DL, 2000, SCIENCE, V287, P482, DOI 10.1126/science.287.5452.482; Weeks DL, 2001, MOL MICROBIOL, V40, P1249, DOI 10.1046/j.1365-2958.2001.02466.x; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	33	58	63	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					255	U144		10.1038/nature11684	http://dx.doi.org/10.1038/nature11684			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23222544	Green Accepted, Green Submitted			2022-12-24	WOS:000313259600046
J	Fugger, L; McVean, G; Bell, JI				Fugger, Lars; McVean, Gil; Bell, John I.			Genomewide Association Studies and Common Disease - Realizing Clinical Utility	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fugger, Lars] Univ Oxford, Weatherall Inst Med, Oxford, England; [Fugger, Lars] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [McVean, Gil] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Bell, John I.] Univ Oxford, Off Regius Prof Med, Oxford, England	University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Fugger, L (corresponding author), Univ Oxford, Weatherall Inst Med, Oxford, England.			McVean, Gil/0000-0002-5012-4162	Medical Research Council [MC_UU_12010/3, G1000800I] Funding Source: Medline; Wellcome Trust [090532] Funding Source: Medline; Medical Research Council [G1000800i] Funding Source: researchfish; Rosetrees Trust [M210] Funding Source: researchfish; MRC [MC_UU_12010/3] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Gudjonsson JE, 2012, J AM ACAD DERMATOL, V67, P139, DOI 10.1016/j.jaad.2011.06.037; Rosenblum MD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003504; Travers ME, 2011, HUM GENET, V130, P41, DOI 10.1007/s00439-011-1023-8; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2	5	26	29	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2012	367	25					2370	2371		10.1056/NEJMp1212285	http://dx.doi.org/10.1056/NEJMp1212285			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056ZP	23252523				2022-12-24	WOS:000312531600003
J	Itakura, E; Kishi-Itakura, C; Mizushima, N				Itakura, Eisuke; Kishi-Itakura, Chieko; Mizushima, Noboru			The Hairpin-type Tail-Anchored SNARE Syntaxin 17 Targets to Autophagosomes for Fusion with Endosomes/Lysosomes	CELL			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; MAMMALIAN-CELLS; ATG PROTEINS; HOMOLOG; SYSTEM; TRAFFICKING; BIOGENESIS; STARVATION; TRANSPORT	The lysosome is a degradative organelle, and its fusion with other organelles is strictly regulated. In contrast to fusion with the late endosome, the mechanisms underlying autophagosome-lysosome fusion remain unknown. Here, we identify syntaxin 17 (Stx17) as the autophagosomal SNARE required for fusion with the endosome/lysosome. Stx17 localizes to the outer membrane of completed autophagosomes but not to the isolation membrane (unclosed intermediate structures); for this reason, the lysosome does not fuse with the isolation membrane. Stx17 interacts with SNAP-29 and the endosomal/lysosomal SNARE VAMP8. Depletion of Stx17 causes accumulation of autophagosomes without degradation. Stx17 has a unique C-terminal hairpin structure mediated by two tandem transmembrane domains containing glycine zipper-like motifs, which is essential for its association with the autophagosomal membrane. These findings reveal a mechanism by which the SNARE protein is available to the completed autophagosome.	[Itakura, Eisuke; Kishi-Itakura, Chieko; Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU)	Mizushima, N (corresponding author), Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Tokyo 1130033, Japan.	nmizu@m.u-tokyo.ac.jp	Itakura, Eisuke/AAY-7977-2021; Mizushima, Noboru/C-3635-2009	Itakura, Eisuke/0000-0001-7248-9333; Mizushima, Noboru/0000-0002-6258-6444	Funding Program for Next Generation World-Leading Researchers; Takeda Science Foundation; Japan Society for the Promotion of Science for Young Scientists	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Taki Nishimura (Tokyo Medical and Dental University) for help with RNAi experiments, Masaaki Komatsu (Tokyo Metropolitan Institute of Medical Science) for providing Atg3 KO MEFs, and Toshio Kitamura (The University of Tokyo) and Shoji Yamaoka (Tokyo Medical and Dental University) for the retroviral vectors and Plat-E cells, and Atsushi Miyawaki (RIKEN) for providing Venus and SECFP. We also thank Ramanujan S. Hegde and Sichen Shao (MRC Laboratory of Molecular Biology) for critical reading of this manuscript and helpful discussions. This work was supported by the Funding Program for Next Generation World-Leading Researchers, and the Takeda Science Foundation (to N.M.) and grants for a research fellowship of the Japan Society for the Promotion of Science for Young Scientists (to E.I.).	Atlashkin V, 2003, MOL CELL BIOL, V23, P5198, DOI 10.1128/MCB.23.15.5198-5207.2003; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Brosig B, 1998, PROTEIN SCI, V7, P1052; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dilcher M, 2001, J BIOL CHEM, V276, P34537, DOI 10.1074/jbc.M101551200; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Furuta N, 2010, MOL BIOL CELL, V21, P1001, DOI 10.1091/mbc.E09-08-0693; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Fader CM, 2009, BBA-MOL CELL RES, V1793, P1901, DOI 10.1016/j.bbamcr.2009.09.011; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Noda T, 2009, CELL DEATH DIFFER, V16, P984, DOI 10.1038/cdd.2009.54; Ohashi Y, 2010, MOL BIOL CELL, V21, P3998, DOI 10.1091/mbc.E10-05-0457; Pedrazzini E, 2000, J CELL BIOL, V148, P899, DOI 10.1083/jcb.148.5.899; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Renna M, 2011, J CELL SCI, V124, P469, DOI 10.1242/jcs.076489; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sato M, 2011, MOL BIOL CELL, V22, P2579, DOI 10.1091/mbc.E11-04-0279; Sato TK, 1998, MOL CELL BIOL, V18, P5308, DOI 10.1128/MCB.18.9.5308; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; von Mollard GF, 1999, MOL BIOL CELL, V10, P1719, DOI 10.1091/mbc.10.6.1719; Weng N, 2007, J BIOL CHEM, V282, P9635, DOI 10.1074/jbc.M611108200; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747	51	772	794	6	118	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1256	1269		10.1016/j.cell.2012.11.001	http://dx.doi.org/10.1016/j.cell.2012.11.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217709	Bronze			2022-12-24	WOS:000311999900015
J	Pierce, SE; Ahlberg, PE; Hutchinson, JR; Molnar, JL; Sanchez, S; Tafforeau, P; Clack, JA				Pierce, Stephanie E.; Ahlberg, Per E.; Hutchinson, John R.; Molnar, Julia L.; Sanchez, Sophie; Tafforeau, Paul; Clack, Jennifer A.			Vertebral architecture in the earliest stem tetrapods	NATURE			English	Article							AXIAL SKELETON; EVOLUTION; ICHTHYOSTEGA; MORPHOLOGY	The construction of the vertebral column has been used as a key anatomical character in defining and diagnosing early tetrapod groups(1). Rhachitomous vertebrae(2)-in which there is a dorsally placed neural arch and spine, an anteroventially placed intercentrum and paired, posterodorsally placed pleurocentra have long been considered the ancestral morphology for tetrapods(1,3-6). Nonetheless, very little is known about vertebral anatomy in the earliest stem tetrapods, because most specimens remain trapped in surrounding matrix, obscuring Important anatomical features(7-9). Here we describe the three-dimensional vertebral architecture of the Late Devonian stem tetrapod Ichthyostega using propagation phase-contrast X-ray synchrotron. microtomography. Our scans reveal a diverse array of new morphological, and associated developmental and functional, characteristics, including a possible posterior-to-anterior vertebral ossification sequence and the first evolutionary appearance of ossified sternal elements. One of the most intriguing features relates to the positional relationships between the vertebral elements, with the pleurocentra being unexpectedly sutured or fused to the intercentra that directly succeed them, indicating a 'reverse' rhachitomous design(10). Comparison of Ichthyostega with two other stem tetrapods, Acanthostegi and Pederpess, shows that reverse rhachitomous vertebrae may be the ancestral condition for limbed vertebrates. This study fundamentally revises our current understanding' of vertebral column evolution in the earliest tetrapods and raises questions about the presumed vertebral architecture of tetrapodomorph fish(12,13) and later, more crownward, tetrapods.	[Pierce, Stephanie E.; Clack, Jennifer A.] Univ Cambridge, Dept Zool, Univ Museum Zool, Cambridge CB2 3EJ, England; [Pierce, Stephanie E.; Hutchinson, John R.; Molnar, Julia L.] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, Hatfield AL9 7TA, Herts, England; [Pierce, Stephanie E.; Hutchinson, John R.; Molnar, Julia L.] Univ London Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England; [Ahlberg, Per E.; Sanchez, Sophie] Uppsala Univ, Subdept Evolut & Dev, Dept Organismal Biol, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Sanchez, Sophie; Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of Cambridge; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; Uppsala University; European Synchrotron Radiation Facility (ESRF)	Pierce, SE (corresponding author), Univ Cambridge, Dept Zool, Univ Museum Zool, Downing St, Cambridge CB2 3EJ, England.	spierce@rvc.ac.uk	Ahlberg, Per/E-8086-2013; Hutchinson, John/AAH-1593-2020; Sanchez, Sophie/AAE-1168-2022; Molnar, Julia/AAR-3371-2021	Tafforeau, Paul/0000-0002-5962-1683; Sanchez, Sophie/0000-0002-3611-6836; Hutchinson, John/0000-0002-6767-7038; Molnar, Julia/0000-0003-1455-0487; Ahlberg, Per/0000-0001-9054-2900	NERC [NE/G005877/1, NE/G00711X/1]; ERC [233111]; Natural Environment Research Council [NE/G00711X/1, NE/G005877/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ERC(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the European Synchrotron Radiation facility (ESRF) in Grenoble, France, for access to beamline ID19; S. Schmidt for support using the mu CT scanner at Abertay University; J. Liston and the Glasgow Huntenan Museum for access to fossils in their care; and G. Cuny for access to collections housed in the Geological Museum at the University of Copenhagen. This research was supported by NERC grants NE/G005877/1 and NE/G00711X/1 (J.A.C., J.R.H. and S.E.P.) and ERC grant 233111 (P.E.A. and S.S.).	Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; Aoyama H, 2000, MECH DEVELOP, V99, P71, DOI 10.1016/S0925-4773(00)00481-0; Benton M.J., 2005, VERTEBRATE PALAEONTO; Callier V, 2009, SCIENCE, V324, P364, DOI 10.1126/science.1167542; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Carroll RL, 1999, EVOL DEV, V1, P36; Clack JA, 2002, NATURE, V418, P72, DOI 10.1038/nature00824; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Cope E. D., 1878, AM NAT, V5, P324; Cote S, 2002, J VERTEBR PALEONTOL, V22, P487, DOI 10.1671/0272-4634(2002)022[0487:VDITDS]2.0.CO;2; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Fleming A, 2004, DEVELOPMENT, V131, P873, DOI 10.1242/dev.00952; Hildebrand M., 2001, ANAL VERTEBRATE STRU; Jarvik E., 1952, Meddelelser om Gronland, V114, P1; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Jarvik Erik, 1996, Fossils and Strata, V40, P1; Long JH, 1997, J EXP BIOL, V200, P65; MILNER AR, 1994, T ROY SOC EDIN-EARTH, V84, P331; Morin-Kensicki EM, 2002, DEVELOPMENT, V129, P3851; Panchen A. L., 1977, PROBLEMS VERTEBRATE, P289; PANCHEN AL, 1967, EVOLUTION, V21, P24, DOI 10.1111/j.1558-5646.1967.tb00127.x; Pierce SE, 2011, J ANAT, V219, P502, DOI 10.1111/j.1469-7580.2011.01406.x; Pierce SE, 2012, NATURE, V486, P523, DOI 10.1038/nature11124; Romer A. S., 1947, B MUS COMP ZOOL HARV, V99, P368; ROMER ALFRED S., 1964, BULL MUS COMP ZOOL HARVARD UNIV, V131, P129; Shishkin M.A., 1989, Progress in Zoology, V35, P180; Slijper EJ., 1946, COMP BIOL ANATOMICAL; Vorobyeva E., 1991, P68; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286	30	43	43	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2013	494	7436					226	229		10.1038/nature11825	http://dx.doi.org/10.1038/nature11825			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23334417	Green Published			2022-12-24	WOS:000315137700037
J	Prota, AE; Bargsten, K; Zurwerra, D; Field, JJ; Diaz, JF; Altmann, KH; Steinmetz, MO				Prota, Andrea E.; Bargsten, Katja; Zurwerra, Didier; Field, Jessica J.; Fernando Diaz, Jose; Altmann, Karl-Heinz; Steinmetz, Michel O.			Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents	SCIENCE			English	Article							ALPHA-BETA-TUBULIN; EPOTHILONE-A; BINDING MODE; GDP-TUBULIN; COMPLEX; TAXOL; DIMER	Microtubule-stabilizing agents (MSAs) are efficacious chemotherapeutic drugs widely used for the treatment of cancer. Despite the importance of MSAs for medical applications and basic research, their molecular mechanisms of action on tubulin and microtubules remain elusive. We determined high-resolution crystal structures of ab-tubulin in complex with two unrelated MSAs, zampanolide and epothilone A. Both compounds were bound to the taxane pocket of beta-tubulin and used their respective side chains to induce structuring of the M-loop into a short helix. Because the M-loop establishes lateral tubulin contacts in microtubules, these findings explain how taxane-site MSAs promote microtubule assembly and stability. Further, our results offer fundamental structural insights into the control mechanisms of microtubule dynamics.	[Prota, Andrea E.; Bargsten, Katja; Steinmetz, Michel O.] Paul Scherrer Inst, Villigen, Switzerland; [Zurwerra, Didier; Altmann, Karl-Heinz] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, Zurich, Switzerland; [Field, Jessica J.] Victoria Univ Wellington, Ctr Biodiscovery, Wellington, New Zealand; [Fernando Diaz, Jose] CSIC, CIB, Madrid, Spain	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; Victoria University Wellington; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Steinmetz, MO (corresponding author), Paul Scherrer Inst, Villigen, Switzerland.	michel.steinmetz@psi.ch	Steinmetz, Michel O/AAA-3349-2022; Díaz, J. Fernando/U-3532-2017; Díaz, J. Fernando/M-6853-2019; Prota, Andrea Enrico/R-9526-2019	Steinmetz, Michel O/0000-0001-6157-3687; Díaz, J. Fernando/0000-0003-2743-3319; Díaz, J. Fernando/0000-0003-2743-3319; Prota, Andrea Enrico/0000-0003-0875-5339	European Molecular Biology Organization; Genesis Oncology Trust; Ministerio de Economia y Competitividad [BIO2010-16351]; Comunidad Autonoma de Madrid [S2010/BMD-2457]; Roche Research Foundation; Swiss National Science Foundation [310030B_138659]; Swiss SystemsX.ch initiative [BIP-2011/122]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Genesis Oncology Trust; Ministerio de Economia y Competitividad(Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); Roche Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss SystemsX.ch initiative	We thank R. Kammerer, F. Winkler, and Y. Barral for critical reading of the manuscript; V. de Lucas de Segovia for providing calf brains for tubulin purification; and V. Olieric and M. Wang for excellent technical assistance with the collection of x-ray data at beamline X06SA and X06DA of the Swiss Light Source (Paul Scherrer Institut, Villigen, Switzerland). J.J.F. received a short-term fellowship from the European Molecular Biology Organization and a Professional Development Grant from the Genesis Oncology Trust. This work was supported by grants from the Ministerio de Economia y Competitividad (BIO2010-16351) and the Comunidad Autonoma de Madrid (S2010/BMD-2457) (to J.F.D.), a Ph.D. fellowship from the Roche Research Foundation (to D.Z.), and grants from the Swiss National Science Foundation (310030B_138659) and the Swiss SystemsX.ch initiative (BIP-2011/122) (to M.O.S.). Coordinates have been deposited at the Protein Data Bank (PDB) under identification (ID) nos. 4I4T (T<INF>2</INF>R-TTL-Zampa), 4I50 (T<INF>2</INF>R-TTL-EpoA), and 4I55 (T<INF>2</INF>R-TTL).	Altmann KH, 2007, CHEMMEDCHEM, V2, P396, DOI 10.1002/cmdc.200600206; Ayaz P, 2012, SCIENCE, V337, P857, DOI 10.1126/science.1221698; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P2747, DOI 10.1021/bi00062a003; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P10067, DOI 10.1021/bi00089a023; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Elie-Caille C, 2007, CURR BIOL, V17, P1765, DOI 10.1016/j.cub.2007.08.063; Field JJ, 2012, CHEM BIOL, V19, P686, DOI 10.1016/j.chembiol.2012.05.008; Fourniol FJ, 2010, J CELL BIOL, V191, P463, DOI 10.1083/jcb.201007081; Lechleider RJ, 2008, CLIN CANCER RES, V14, P4378, DOI 10.1158/1078-0432.CCR-08-0015; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Mitra A, 2008, BIOPHYS J, V95, P3252, DOI 10.1529/biophysj.108.133884; Nettles JH, 2009, TOP CURR CHEM, V286, P209, DOI 10.1007/128_2008_24; Nettles JH, 2004, SCIENCE, V305, P866, DOI 10.1126/science.1099190; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Pecqueur L, 2012, P NATL ACAD SCI USA, V109, P12011, DOI 10.1073/pnas.1204129109; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Reese M, 2007, ANGEW CHEM INT EDIT, V46, P1864, DOI 10.1002/anie.200604505; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Zurwerra D, 2012, CHEM-EUR J, V18, P16868, DOI 10.1002/chem.201202553	21	345	352	14	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					587	590		10.1126/science.1230582	http://dx.doi.org/10.1126/science.1230582			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23287720	Green Accepted, Green Submitted			2022-12-24	WOS:000314270000061
J	Efeyan, A; Zoncu, R; Chang, S; Gumper, I; Snitkin, H; Wolfson, RL; Kirak, O; Sabatini, DD; Sabatini, DM				Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Gumper, Iwona; Snitkin, Harriet; Wolfson, Rachel L.; Kirak, Oktay; Sabatini, David D.; Sabatini, David M.			Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival	NATURE			English	Article							INDUCTION; MECHANISM; LYSOSOME; REVEALS; KINASE; SENSES	The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates organismal growth in response to many environmental cues, including nutrients and growth factors(1). Cell-based studies showed that mTORC1 senses amino acids through the RagA-D family of GTPases(2,3) (also known as RRAGA, B, C and D), but their importance in mammalian physiology is unknown. Here we generate knock-in mice that express a constitutively active form of RagA (RagA(GTP)) from its endogenous promoter. RagA(GTP/GTP) mice develop normally, but fail to survive postnatal day 1. When delivered by Caesarean section, fasted RagA(GTP/GTP) neonates die almost twice as rapidly as wild-type littermates. Within an hour of birth, wild-type neonates strongly inhibit mTORC1, which coincides with profound hypoglycaemia and a decrease in plasma amino-acid concentrations. In contrast, mTORC1 inhibition does not occur in RagA(GTP/GTP) neonates, despite identical reductions in blood nutrient amounts. With prolonged fasting, wild-type neonates recover their plasma glucose concentrations, but RagA(GTP/GTP) mice remain hypoglycaemic until death, despite using glycogen at a faster rate. The glucose homeostasis defect correlates with the inability of fasted RagA(GTP/GTP) neonates to trigger autophagy and produce amino acids for de novo glucose production. Because profound hypoglycaemia does not inhibit mTORC1 inRagA(GTP/GTP) neonates, we considered the possibility that the Rag pathway signals glucose as well as amino-acid sufficiency to mTORC1. Indeed, mTORC1 is resistant to glucose deprivation in RagA(GTP/GTP) fibroblasts, and glucose, like amino acids, controls its recruitment to the lysosomal surface, the site of mTORC1 activation. Thus, the Rag GTPases signal glucose and amino-acid concentrations to mTORC1, and have an unexpectedly key role in neonates in autophagy induction and thus nutrient homeostasis and viability.	[Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Wolfson, Rachel L.; Kirak, Oktay; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Wolfson, Rachel L.; Sabatini, David M.] Broad Inst Harvard & Massachusetts Inst Technol, Seven Cambridge Ctr, Cambridge, MA 02142 USA; [Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Wolfson, Rachel L.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Wolfson, Rachel L.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Wolfson, Rachel L.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Gumper, Iwona; Snitkin, Harriet; Sabatini, David D.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); New York University	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Efeyan, Alejo/J-8197-2016; Kirak, Oktay/H-6347-2013	Efeyan, Alejo/0000-0002-3806-6799; Kirak, Oktay/0000-0002-6524-4685; /0000-0002-1446-7256	National Institutes of Health [R01 CA129105, R01 CA103866, R37 AI047389]; American Federation for Aging; Starr Foundation; Koch Institute Frontier Research Program; Ellison Medical Foundation; Human Frontiers Science Program; Jane Coffin Childs Memorial Fund for Medical Research; LAM Foundation; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging; Starr Foundation; Koch Institute Frontier Research Program; Ellison Medical Foundation(Lawrence Ellison Foundation); Human Frontiers Science Program(Human Frontier Science Program); Jane Coffin Childs Memorial Fund for Medical Research; LAM Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Sabatini laboratory for suggestions, and A. Hutchins for technical assistance. We thank R. Shaw for providing the AMPK-DKO MEFs, D. Ron for the GCN2-KO MEFs and M. Barbacid for the transcriptional STOP cassette. This work was supported by grants from the National Institutes of Health (R01 CA129105, R01 CA103866 and R37 AI047389) and awards from the American Federation for Aging, Starr Foundation, Koch Institute Frontier Research Program, and the Ellison Medical Foundation to D. M. S., fellowships from the Human Frontiers Science Program to A. E., and the Jane Coffin Childs Memorial Fund for Medical Research and the LAM Foundation to R.Z. D. M. S. in an investigator of Howard Hughes Medical Institute.	Birsoy K, 2011, DEVELOPMENT, V138, P4709, DOI 10.1242/dev.067710; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hirose E, 1998, J CELL SCI, V111, P11; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	23	297	306	5	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					679	+		10.1038/nature11745	http://dx.doi.org/10.1038/nature11745			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23263183	Green Accepted, Green Submitted			2022-12-24	WOS:000314219600058
J	Tan, DZ; Marzluff, WF; Dominski, Z; Tong, L				Tan, Dazhi; Marzluff, William F.; Dominski, Zbigniew; Tong, Liang			Structure of Histone mRNA Stem-Loop, Human Stem-Loop Binding Protein, and 3 ' hExo Ternary Complex	SCIENCE			English	Article							U7 SNRNP; HAIRPIN; 3'-END; SITE; PHOSPHORYLATION; 3'-EXONUCLEASE; INTERACTS; DOMAIN; GENE; END	Metazoan replication-dependent histone messenger RNAs (mRNAs) have a conserved stem-loop (SL) at their 3'-end. The stem-loop binding protein (SLBP) specifically recognizes the SL to regulate histone mRNA metabolism, and the 3'-5' exonuclease 3'hExo trims its 3'-end after processing. We report the crystal structure of a ternary complex of human SLBP RNA binding domain, human 3'hExo, and a 26-nucleotide SL RNA. Only one base of the SL is recognized specifically by SLBP, and the two proteins primarily recognize the shape of the RNA. SLBP and 3'hExo have no direct contact with each other, and induced structural changes in the loop of the SL mediate their cooperative binding. The 3' flanking sequence is positioned in the 3'hExo active site, but the ternary complex limits the extent of trimming.	[Tan, Dazhi; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Marzluff, William F.; Dominski, Zbigniew] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Marzluff, William F.; Dominski, Zbigniew] Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA	Columbia University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu		Tan, Dazhi/0000-0002-1862-8125; Tong, Liang/0000-0002-0563-6468	NIH [GM077175, GM029832]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029832, R01GM077175] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Whalen, S. Myers, R. Jackimowicz, and H. Robinson for access to the X29A beamline at the National Synchrotron Light Source. Supported by NIH grants GM077175 (L.T.) and GM029832 (W.F.M. and Z.D.). The structure has been deposited at the Protein Data Bank (accession code 4HXH).	Ansel KM, 2008, NAT STRUCT MOL BIOL, V15, P523, DOI 10.1038/nsmb.1417; Battle DJ, 2001, RNA, V7, P123, DOI 10.1017/S1355838201001820; Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Borchers CH, 2006, P NATL ACAD SCI USA, V103, P3094, DOI 10.1073/pnas.0511289103; Cheng Y, 2004, J MOL BIOL, V343, P305, DOI 10.1016/j.jmb.2004.08.055; DeJong ES, 2002, RNA, V8, P83, DOI 10.1017/S1355838202013869; Dominski Z, 1999, MOL CELL BIOL, V19, P3561; Dominski Z, 2003, MOL CELL, V12, P295, DOI 10.1016/S1097-2765(03)00278-8; Dominski Z, 2001, MOL CELL BIOL, V21, P2008, DOI 10.1128/MCB.21.6.2008-2017.2001; Dominski Z, 2007, GENE, V396, P373, DOI 10.1016/j.gene.2007.04.021; Gabel HW, 2008, NAT STRUCT MOL BIOL, V15, P531, DOI 10.1038/nsmb.1411; Hoefig KP, 2013, NAT STRUCT MOL BIOL, V20, P73, DOI 10.1038/nsmb.2450; Jaeger S, 2004, FEBS LETT, V556, P265, DOI 10.1016/S0014-5793(03)01433-9; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Martin F, 2000, NUCLEIC ACIDS RES, V28, P1594, DOI 10.1093/nar/28.7.1594; Martin F, 1997, EMBO J, V16, P769, DOI 10.1093/emboj/16.4.769; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Michel F, 2000, RNA, V6, P1539, DOI 10.1017/S135583820000056X; MOWRY KL, 1987, SCIENCE, V238, P1682, DOI 10.1126/science.2825355; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Thomas MF, 2012, BLOOD, V120, P130, DOI 10.1182/blood-2011-11-394072; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; WILLIAMS AS, 1995, NUCLEIC ACIDS RES, V23, P654, DOI 10.1093/nar/23.4.654; Yang XC, 2006, J BIOL CHEM, V281, P30447, DOI 10.1074/jbc.M602947200; Yang XC, 2009, MOL CELL BIOL, V29, P4045, DOI 10.1128/MCB.00296-09; Zanier K, 2002, RNA, V8, P29, DOI 10.1017/S1355838202014061; Zhang MY, 2012, BIOCHEMISTRY-US, V51, P3215, DOI 10.1021/bi2018255; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	28	84	85	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2013	339	6117					318	321		10.1126/science.1228705	http://dx.doi.org/10.1126/science.1228705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329046	Green Accepted, Green Submitted			2022-12-24	WOS:000313622000044
J	Bondy-Denomy, J; Pawluk, A; Maxwell, KL; Davidson, AR				Bondy-Denomy, Joe; Pawluk, April; Maxwell, Karen L.; Davidson, Alan R.			Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system	NATURE			English	Article							GENOME SEQUENCE; PSEUDOMONAS; RNA; RESISTANCE; PHAGE; INTERFERENCE; DEFENSE; DNA	A widespread system used by bacteria for protection against potentially dangerous foreign DNA molecules consists of the clustered regularly interspaced short palindromic repeats (CRISPR) coupled with cas (CRISPR-associated) genes(1). Similar to RNA interference in eukaryotes(2), these CRISPR/Cas systems use small RNAs for sequence-specific detection and neutralization of invading genomes(3). Here we describe the first examples of genes that mediate the inhibition of a CRISPR/Cas system. Five distinct 'anti-CRISPR' genes were found in the genomes of bacteriophages infecting Pseudomonas aeruginosa. Mutation of the anti-CRISPR gene of a phage rendered it unable to infect bacteria with a functional CRISPR/Cas system, and the addition of the same gene to the genome of a CRISPR/Cas-targeted phage allowed it to evade the CRISPR/Cas system. Phage-encoded anti-CRISPR genes may represent a widespread mechanism for phages to overcome the highly prevalent CRISPR/Cas systems. The existence of anti-CRISPR genes presents new avenues for the elucidation of CRISPR/Cas functional mechanisms and provides new insight into the co-evolution of phages and bacteria.	[Bondy-Denomy, Joe; Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Pawluk, April; Davidson, Alan R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Maxwell, Karen L.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada	University of Toronto; University of Toronto; University of Toronto	Davidson, AR (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	alan.davidson@utoronto.ca		Maxwell, Karen/0000-0002-0211-5480; Pawluk, April/0000-0002-6136-2086	Canadian Institutes for Health Research [MOP- 6279, XNE86943]; CIHR Canada Graduate Scholarship Doctoral Award	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); CIHR Canada Graduate Scholarship Doctoral Award(Canadian Institutes of Health Research (CIHR))	We thank D. Guttman, Y.-H. Cho, K. Cady and G. O'Toole for providing P. aeruginosa strains and phages. We also thank K. Severinov for providing the M13 phage and E. coli strains required for assaying the type 1-E system. We thank J. Brumell, A. Spence and W. Navarre for reading the manuscript. We also thank D. Bona for technical assistance. This work was supported by an Operating Grant to K. L. M. (fund number MOP- 6279) and an Emerging Team Grant to A. R. D. and K. L. M. (fund number XNE86943), both of which were from the Canadian Institutes for Health Research. J. B. D. was supported by a CIHR Canada Graduate Scholarship Doctoral Award.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Battle SE, 2008, J BACTERIOL, V190, P7130, DOI 10.1128/JB.00785-08; Braid MD, 2004, J BACTERIOL, V186, P6560, DOI 10.1128/JB.186.19.6560-6574.2004; Brouns S. J. J., 2012, COLD SPRING HARB PER, V4; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cady KC, 2011, MICROBIOL-SGM, V157, P430, DOI 10.1099/mic.0.045732-0; Cady KC, 2012, J BACTERIOL, V194, P5728, DOI 10.1128/JB.01184-12; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; Chung IY, 2012, J VIROL, V86, P8336, DOI 10.1128/JVI.01127-12; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Heo YJ, 2007, MICROBIOL-SGM, V153, P2885, DOI 10.1099/mic.0.2007/007260-0; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Morgan GJ, 2002, J MOL BIOL, V317, P337, DOI 10.1006/jmbi.2002.5437; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Wang PW, 2004, J BACTERIOL, V186, P400, DOI 10.1128/JB.186.2.400-410.2004; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08	31	471	500	31	418	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					429	U181		10.1038/nature11723	http://dx.doi.org/10.1038/nature11723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23242138	Green Accepted			2022-12-24	WOS:000313615900057
J	Jia, X; Zhang, J; Sun, WX; He, WZ; Jiang, HY; Chen, DR; Murchie, AIH				Jia, Xu; Zhang, Jing; Sun, Wenxia; He, Weizhi; Jiang, Hengyi; Chen, Dongrong; Murchie, Alastair I. H.			Riboswitch Control of Aminoglycoside Antibiotic Resistance	CELL			English	Article							PEPTIDYL TRANSFERASE CENTER; RIBOSOMAL-RNA METHYLASE; HIV-1 TAR RNA; NASCENT PEPTIDE; MESSENGER-RNA; TRANSLATIONAL REGULATION; BACILLUS-SUBTILIS; GENE-EXPRESSION; BINDING; BACTERIA	The majority of riboswitches are regulatory RNAs that regulate gene expression by binding small-molecule metabolites. Here we report the discovery of an aminoglycoside-binding riboswitch that is widely distributed among antibiotic-resistant bacterial pathogens. This riboswitch is present in the leader RNA of the resistance genes that encode the aminoglycoside acetyl transferase (AAC) and aminoglycoside adenyl transferase (AAD) enzymes that confer resistance to aminoglycoside antibiotics through modification of the drugs. We show that expression of the AAC and AAD resistance genes is regulated by aminoglycoside binding to a secondary structure in their 50 leader RNA. Reporter gene expression, direct measurements of drug RNA binding, chemical probing, and UV crosslinking combined with mutational analysis demonstrate that the leader RNA functions as an aminoglycoside-sensing riboswitch in which drug binding to the leader RNA leads to the induction of aminoglycosides antibiotic resistance.	[Jia, Xu; Zhang, Jing; Sun, Wenxia; He, Weizhi; Jiang, Hengyi; Chen, Dongrong; Murchie, Alastair I. H.] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Key Lab Mol Med,Minist Educ, Shanghai 200032, Peoples R China; [Jia, Xu; Zhang, Jing; Sun, Wenxia; He, Weizhi; Jiang, Hengyi; Chen, Dongrong; Murchie, Alastair I. H.] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Jia, Xu; Zhang, Jing; Sun, Wenxia; He, Weizhi; Jiang, Hengyi; Chen, Dongrong; Murchie, Alastair I. H.] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China; [Jia, Xu] Chengdu Med Coll, Dept Biomed Sci, Chengdu 610083, Peoples R China	Fudan University; Fudan University; Fudan University; Chengdu Medical College	Murchie, AIH (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Key Lab Mol Med,Minist Educ, Shanghai 200032, Peoples R China.	drchen@fudan.edu.cn; aihm@fudan.edu.cn	He, Weizhi/GQQ-5629-2022	He, Weizhi/0000-0002-8061-4947	National Key 973 [2010CB912602]; City of Shanghai Key project [09DJ1400601]; Natural Science Foundation [31170749, 31100543]	National Key 973; City of Shanghai Key project; Natural Science Foundation(National Natural Science Foundation of China (NSFC))	We thank Professor Eric Westhof (University of Strasbourg) for constructive and insightful discussions. We thank Drs Di Qu, Ming Gui Wang and Jin Wei Huang (Fudan University) for the gift of the RMTB plasmid and Acinetobacter baumannii strain. This work was supported by National Key 973 grant (2010CB912602). City of Shanghai Key project grant (09DJ1400601). Natural Science Foundation grant 31170749 to A.M and 31100543 to W.X.S.	Armstrong ES, 2010, CURR OPIN MICROBIOL, V13, P565, DOI 10.1016/j.mib.2010.09.004; Bailey M, 2008, ANTIMICROB AGENTS CH, V52, P866, DOI 10.1128/AAC.01266-07; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; DAVIES J, 1968, J BIOL CHEM, V243, P3312; Davis B, 2004, J MOL BIOL, V336, P343, DOI 10.1016/j.jmb.2003.12.046; Doi Y, 2004, ANTIMICROB AGENTS CH, V48, P491, DOI 10.1128/AAC.48.2.491-496.2004; DUBNAU D, 1984, CRC CR REV BIOCH MOL, V16, P103, DOI 10.3109/10409238409102300; DUVALL EJ, 1984, J BACTERIOL, V158, P784, DOI 10.1128/JB.158.3.784-790.1984; Ehresmann Chantal, 2004, RNA Biol, V1, P66; Famulok M, 1996, BIOCHEMISTRY-US, V35, P4265, DOI 10.1021/bi952479r; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Fuchs RT, 2006, NAT STRUCT MOL BIOL, V13, P226, DOI 10.1038/nsmb1059; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Grundy FJ, 2003, P NATL ACAD SCI USA, V100, P12057, DOI 10.1073/pnas.2133705100; Grundy FJ, 2006, CRIT REV BIOCHEM MOL, V41, P329, DOI 10.1080/10409230600914294; GRYCZAN TJ, 1984, MOL GEN GENET, V194, P357, DOI 10.1007/BF00425544; Hall RM, 2007, NAT REV MICROBIOL, V5, P1; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; Hendrix M, 1997, J AM CHEM SOC, V119, P3641, DOI 10.1021/ja964290o; Hermann T, 1999, J MED CHEM, V42, P1250, DOI 10.1021/jm981108g; Jacquier H, 2009, MOL MICROBIOL, V72, P1475, DOI 10.1111/j.1365-2958.2009.06736.x; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lentzen G, 2003, CHEM BIOL, V10, P769, DOI 10.1016/S1074-5521(03)00173-X; Liebert CA, 1999, MICROBIOL MOL BIOL R, V63, P507, DOI 10.1128/MMBR.63.3.507-522.1999; Lovett PS, 1996, MICROBIOL REV, V60, P366, DOI 10.1128/MMBR.60.2.366-385.1996; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Marzi S, 2007, CELL, V130, P1019, DOI 10.1016/j.cell.2007.07.008; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P727, DOI 10.1128/AAC.43.4.727; Murchie AIH, 2004, J MOL BIOL, V336, P625, DOI 10.1016/j.jmb.2003.12.028; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Porse BT, 1999, P NATL ACAD SCI USA, V96, P9003, DOI 10.1073/pnas.96.16.9003; Ramu H, 2011, MOL CELL, V41, P321, DOI 10.1016/j.molcel.2010.12.031; Serganov A, 2003, EMBO J, V22, P1898, DOI 10.1093/emboj/cdg170; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; SWIATLO E, 1987, J ANTIMICROB CHEMOTH, V19, P27, DOI 10.1093/jac/19.1.27; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; VONAHSEN U, 1991, NATURE, V353, P368, DOI 10.1038/353368a0; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P797, DOI 10.1128/AAC.39.4.797; Yu FY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-184; ZAPP ML, 1993, CELL, V74, P969, DOI 10.1016/0092-8674(93)90720-B; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181	50	61	72	1	119	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					68	81		10.1016/j.cell.2012.12.019	http://dx.doi.org/10.1016/j.cell.2012.12.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332747	Bronze			2022-12-24	WOS:000313719800007
J	Paterson, AH; Wendel, JF; Gundlach, H; Guo, H; Jenkins, J; Jin, DC; Llewellyn, D; Showmaker, KC; Shu, SQ; Udall, J; Yoo, MJ; Byers, R; Chen, W; Doron-Faigenboim, A; Duke, MV; Gong, L; Grimwood, J; Grover, C; Grupp, K; Hu, GJ; Lee, TH; Li, JP; Lin, LF; Liu, T; Marler, BS; Page, JT; Roberts, AW; Romanel, E; Sanders, WS; Szadkowski, E; Tan, X; Tang, HB; Xu, CM; Wang, JP; Wang, ZN; Zhang, D; Zhang, L; Ashrafi, H; Bedon, F; Bowers, JE; Brubaker, CL; Chee, PW; Das, S; Gingle, AR; Haigler, CH; Harker, D; Hoffmann, LV; Hovav, R; Jones, DC; Lemke, C; Mansoor, S; Rahman, MU; Rainville, LN; Rambani, A; Reddy, UK; Rong, JK; Saranga, Y; Scheffler, BE; Scheffler, JA; Stelly, DM; Triplett, BA; Van Deynze, A; Vaslin, MFS; Waghmare, VN; Walford, SA; Wright, RJ; Zaki, EA; Zhang, TZ; Dennis, ES; Mayer, KFX; Peterson, DG; Rokhsar, DS; Wang, XY; Schmutz, J				Paterson, Andrew H.; Wendel, Jonathan F.; Gundlach, Heidrun; Guo, Hui; Jenkins, Jerry; Jin, Dianchuan; Llewellyn, Danny; Showmaker, Kurtis C.; Shu, Shengqiang; Udall, Joshua; Yoo, Mi-jeong; Byers, Robert; Chen, Wei; Doron-Faigenboim, Adi; Duke, Mary V.; Gong, Lei; Grimwood, Jane; Grover, Corrinne; Grupp, Kara; Hu, Guanjing; Lee, Tae-ho; Li, Jingping; Lin, Lifeng; Liu, Tao; Marler, Barry S.; Page, Justin T.; Roberts, Alison W.; Romanel, Elisson; Sanders, William S.; Szadkowski, Emmanuel; Tan, Xu; Tang, Haibao; Xu, Chunming; Wang, Jinpeng; Wang, Zining; Zhang, Dong; Zhang, Lan; Ashrafi, Hamid; Bedon, Frank; Bowers, John E.; Brubaker, Curt L.; Chee, Peng W.; Das, Sayan; Gingle, Alan R.; Haigler, Candace H.; Harker, David; Hoffmann, Lucia V.; Hovav, Ran; Jones, Donald C.; Lemke, Cornelia; Mansoor, Shahid; Rahman, Mehboob Ur; Rainville, Lisa N.; Rambani, Aditi; Reddy, Umesh K.; Rong, Jun-kang; Saranga, Yehoshua; Scheffler, Brian E.; Scheffler, Jodi A.; Stelly, David M.; Triplett, Barbara A.; Van Deynze, Allen; Vaslin, Maite F. S.; Waghmare, Vijay N.; Walford, Sally A.; Wright, Robert J.; Zaki, Essam A.; Zhang, Tianzhen; Dennis, Elizabeth S.; Mayer, Klaus F. X.; Peterson, Daniel G.; Rokhsar, Daniel S.; Wang, Xiyin; Schmutz, Jeremy			Repeated polyploidization of Gossypium genomes and the evolution of spinnable cotton fibres	NATURE			English	Article							DNA; SEQUENCE; RECOMBINATION; ARABIDOPSIS; PLANTS; ORGANIZATION; BARBADENSE; PATHWAYS; ANCIENT; PROTEIN	Polyploidy often confers emergent properties, such as the higher fibre productivity and quality of tetraploid cottons than diploid cottons bred for the same environments(1). Here we show that an abrupt five-to sixfold ploidy increase approximately 60 million years (Myr) ago, and allopolyploidy reuniting divergent Gossypium genomes approximately 1-2 Myr ago(2), conferred about 30-36-fold duplication of ancestral angiosperm (flowering plant) genes in elite cottons (Gossypium hirsutum and Gossypium barbadense), genetic complexity equalled only by Brassica(3) among sequenced angiosperms. Nascent fibre evolution, before allopolyploidy, is elucidated by comparison of spinnable-fibred Gossypium herbaceum A and non-spinnable Gossypium longicalyx F genomes to one another and the outgroup D genome of non-spinnable Gossypium raimondii. The sequence of a G. hirsutum A(t)D(t) (in which 't' indicates tetraploid) cultivar reveals many non-reciprocal DNA exchanges between subgenomes that may have contributed to phenotypic innovation and/or other emergent properties such as ecological adaptation by polyploids. Most DNA-level novelty in G. hirsutum recombines alleles from the D-genome progenitor native to its New World habitat and the Old World A-genome progenitor in which spinnable fibre evolved. Coordinated expression changes in proximal groups of functionally distinct genes, including a nuclear mitochondrial DNA block, may account for clusters of cotton-fibre quantitative trait loci affecting diverse traits. Opportunities abound for dissecting emergent properties of other polyploids, particularly angiosperms, by comparison to diploid progenitors and outgroups.	[Paterson, Andrew H.; Guo, Hui; Lee, Tae-ho; Li, Jingping; Lin, Lifeng; Marler, Barry S.; Tan, Xu; Tang, Haibao; Wang, Zining; Zhang, Dong; Bowers, John E.; Das, Sayan; Gingle, Alan R.; Lemke, Cornelia; Mansoor, Shahid; Rainville, Lisa N.; Rong, Jun-kang; Wang, Xiyin] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Wendel, Jonathan F.; Yoo, Mi-jeong; Gong, Lei; Grover, Corrinne; Grupp, Kara; Hu, Guanjing; Szadkowski, Emmanuel; Xu, Chunming] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Gundlach, Heidrun; Mayer, Klaus F. X.] German Res Ctr Environm Hlth GmbH, MIPS IBIS Inst Bioinformat & Syst Biol, D-85764 Neuherberg, Germany; [Jenkins, Jerry; Shu, Shengqiang; Grimwood, Jane; Rokhsar, Daniel S.; Schmutz, Jeremy] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94595 USA; [Jenkins, Jerry; Grimwood, Jane; Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Jin, Dianchuan; Chen, Wei; Liu, Tao; Wang, Jinpeng; Zhang, Lan; Wang, Xiyin] Hebei United Univ, Sch Life Sci, Ctr Genom & Computat Biol, Tangshan 063000, Hebei, Peoples R China; [Jin, Dianchuan; Chen, Wei; Liu, Tao; Wang, Jinpeng; Zhang, Lan; Wang, Xiyin] Hebei United Univ, Sch Sci, Tangshan 063000, Hebei, Peoples R China; [Llewellyn, Danny; Bedon, Frank; Brubaker, Curt L.; Walford, Sally A.; Dennis, Elizabeth S.] CSIRO Plant Ind, Canberra, ACT 2601, Australia; [Showmaker, Kurtis C.; Sanders, William S.; Peterson, Daniel G.] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [Udall, Joshua; Byers, Robert; Page, Justin T.; Harker, David; Rambani, Aditi] Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA; [Doron-Faigenboim, Adi; Hovav, Ran] Agr Res Org, Inst Plant Sci, Dept Field Crops, IL-50250 Bet Dagan, Israel; [Duke, Mary V.; Scheffler, Brian E.; Scheffler, Jodi A.] USDA ARS, Jamie Whitten Delta States Res Ctr, Stoneville, MS 38776 USA; [Roberts, Alison W.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [Romanel, Elisson] Univ Fed Rio de Janeiro, Dept Genet, BR-21941901 Rio De Janeiro, Brazil; [Tang, Haibao] J Craig Venter Inst, Rockville, MD 20850 USA; [Xu, Chunming] NE Normal Univ, Inst Cytol & Genet, Unit Plant Epigenet, Key Lab Mol Epigenet MOE, Changchun 5268, Peoples R China; [Ashrafi, Hamid; Van Deynze, Allen] Univ Calif Davis, Plant Reprod Biol Extens Ctr, Davis, CA 95616 USA; [Brubaker, Curt L.] Bayer CropSci, B-9052 Ghent, Belgium; [Chee, Peng W.] Univ Georgia, Coastal Plain Expt Stn, Tifton, GA 31793 USA; [Haigler, Candace H.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Haigler, Candace H.] N Carolina State Univ, Dept Plant Biol, Raleigh, NC 27695 USA; [Hoffmann, Lucia V.] EMBRAPA, Ctr Nacl Pesquisa Algodao, BR-75375000 Santo Antonio De Goias, Go, Brazil; [Jones, Donald C.] Cotton Inc, Cary, NC 27513 USA; [Mansoor, Shahid; Rahman, Mehboob Ur] Natl Inst Biotechnol & Genet Engn, Faisalabad 38000, Pakistan; [Reddy, Umesh K.] W Virginia State Univ, Dept Biol, Institute, WV 25112 USA; [Saranga, Yehoshua] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; [Stelly, David M.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Triplett, Barbara A.] USDA ARS, New Orleans, LA 70124 USA; [Vaslin, Maite F. S.] Univ Fed Rio de Janeiro, Dept Microbiol, BR-21941971 Rio De Janeiro, Brazil; [Waghmare, Vijay N.] Cent Inst Cotton Res, Nagpur 440010, Maharashtra, India; [Wright, Robert J.] Texas Tech Univ, Dept Plant Sci, Lubbock, TX 79415 USA; [Zaki, Essam A.] Genet Engn & Biotechnol Res Inst, Nucle Acids Dept, Alexandria 21934, Egypt; [Zhang, Tianzhen] Nanjing Agr Univ, Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China	University System of Georgia; University of Georgia; Iowa State University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; HudsonAlpha Institute for Biotechnology; North China University of Science & Technology; North China University of Science & Technology; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Mississippi State University; Brigham Young University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; United States Department of Agriculture (USDA); University of Rhode Island; Universidade Federal do Rio de Janeiro; J. Craig Venter Institute; Northeast Normal University - China; University of California System; University of California Davis; Bayer AG; Bayer CropScience; University System of Georgia; University of Georgia; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Cotton Incorporated; Pakistan Institute of Engineering & Applied Science; West Virginia State University; Hebrew University of Jerusalem; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); Universidade Federal do Rio de Janeiro; Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Cotton Research; Texas Tech University System; Texas Tech University; Nanjing Agricultural University	Paterson, AH (corresponding author), Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA.	paterson@plantbio.uga.edu; jschmutz@hudsonalpha.org	Vaslin, Maite F/G-5074-2011; Schmutz, Jeremy/N-3173-2013; Romanel, Elisson AC/F-1933-2013; Grover, Corrinne E/K-3194-2019; Yoo, Michelle/L-3668-2019; Hu, Guanjing/AAA-4497-2020; Stelly, David/ABC-7400-2020; Bowers, John/AAD-7601-2019; Yoo, Mi-Jeong/ABH-9752-2020; Saranga, Yehoshua/GXV-3347-2022; Dennis, Elizabeth S/A-6074-2008; Romanel, Elisson AC/E-5888-2019; Jenkins, Jerry/ABE-6479-2020; Mayer, Klaus FX/M-7941-2015; Chen, Wei/W-8311-2019; Grimwood, Jane/ABD-5737-2021; Bowers, John/B-9245-2009; Hoffmann, Lucia Vieira/C-1161-2013; Zaki, Essam/K-8456-2015; Bedon, Frank/B-5497-2011; Rahman, Mehboob-ur-/I-7983-2015; Chen, Wei/O-6774-2017; Walford, Sally/B-5488-2011; Rambani, Aditi/I-2573-2019; Llewellyn, Danny J/D-5230-2009; Tang, Haibao/A-6715-2011	Vaslin, Maite F/0000-0002-7252-7050; Schmutz, Jeremy/0000-0001-8062-9172; Romanel, Elisson AC/0000-0002-4794-4215; Grover, Corrinne E/0000-0003-3878-5459; Hu, Guanjing/0000-0001-8552-7394; Stelly, David/0000-0002-3468-4119; Yoo, Mi-Jeong/0000-0003-4991-2636; Dennis, Elizabeth S/0000-0002-7850-591X; Romanel, Elisson AC/0000-0002-4794-4215; Jenkins, Jerry/0000-0002-7943-3997; Mayer, Klaus FX/0000-0001-6484-1077; Bowers, John/0000-0001-8984-9796; Hoffmann, Lucia Vieira/0000-0003-2150-1990; Zaki, Essam/0000-0002-3906-623X; Bedon, Frank/0000-0002-9940-5926; Chen, Wei/0000-0002-6857-7696; Rambani, Aditi/0000-0002-3691-6737; Llewellyn, Danny J/0000-0001-9535-8707; Tang, Haibao/0000-0002-3460-8570; Gundlach, Heidrun/0000-0002-6757-0943; Scheffler, Brian/0000-0003-1968-8952; Ashrafi, Hamid/0000-0002-2094-2367; Xu, Chunming/0000-0002-0986-0993; Rokhsar, Daniel/0000-0002-8704-2224; Shu, Shengqiang/0000-0002-4336-8994; Haigler, Candace/0000-0001-7810-4035; Showmaker, Kurt/0000-0002-6317-9402; Mansoor, Shahid/0000-0001-7418-1826; Bowers, John/0000-0001-5693-2796; Peterson, Daniel/0000-0002-0274-5968; Guo, Hui/0000-0001-7830-8564	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; US National Science Foundation [DBI 98-72630, DBI 02-11700, DBI 02-08311, IIP-0917856, IIP-1127755, IOS 1025947]; USDA [ARS-58-6402-7-241, 58-6402-1-644, 58-6402-1-645, ARS 6402-21310-003-00, NRI 00-52100-9685, 02-35301-12045]; Bayer CropScience; Consortium for Plant Biotechnology Research; Cotton, Inc.; Georgia State Support Committee; Texas State Support Committee; Pakistan-US Science and Technology Cooperation Program; US-Egypt Science and Technology Cooperation Program; Fulbright Scholar Program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [PDJ150690/2012-6]; Fundacao de Amparo a Pesquisa Pensa Rio [E-26/110.324/2010]; Texas AgriLife; Brigham Young University (BYU); Direct For Biological Sciences [1025947] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [0841821] Funding Source: National Science Foundation	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF)); USDA(United States Department of Agriculture (USDA)); Bayer CropScience(Bayer AG); Consortium for Plant Biotechnology Research; Cotton, Inc.(Cotton R&D Corp); Georgia State Support Committee; Texas State Support Committee; Pakistan-US Science and Technology Cooperation Program; US-Egypt Science and Technology Cooperation Program(Science and Technology Development Fund (STDF)United States Agency for International Development (USAID)US-Egypt Science and Technology Joint Fund); Fulbright Scholar Program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa Pensa Rio; Texas AgriLife; Brigham Young University (BYU); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work, conducted by the US Department of Energy Joint Genome Institute, is supported by the Office of Science of the US Department of Energy under Contract no. DE-AC02-05CH11231. The authors appreciate financial support from the US National Science Foundation (DBI 98-72630 to A.H.P., J.F.W., A.R.G.; DBI 02-11700 to J.F.W., A.H.P., J.U., A.R.G.; DBI 02-08311, IIP-0917856; IIP-1127755 to A.H.P.; IOS 1025947 to C.H.H.), USDA (ARS-58-6402-7-241, 58-6402-1-644 and 58-6402-1-645 to D.G.P.; ARS 6402-21310-003-00 to B.E.S.; NRI 00-52100-9685 and 02-35301-12045 to A.H.P.), Bayer CropScience and The Consortium for Plant Biotechnology Research (A.H.P.), Cotton, Inc. (P.W.C., D.C.J., A.H.P., D.M.S., A.V.-D., J.F.W.), Georgia State Support Committee (P.W.C., A.H.P.), Texas State Support Committee (R.J.W.), Pakistan-US Science and Technology Cooperation Program (P.W.C., S.M., A.H.P., M.u.R.), US-Egypt Science and Technology Cooperation Program (A.H.P., E.A.Z.), Fulbright Scholar Program (S.M., E.A.Z.), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico PDJ150690/2012-6 (E.R.), Fundacao de Amparo a Pesquisa Pensa Rio E-26/110.324/2010 (M.F.S.V.), Texas AgriLife (D.M.S.), and Brigham Young University (BYU) Mentored Environment Grants (J.U.). RNA-seq reads were mapped by students on Marylou at the Fulton Supercomputer Center at BYU. We thank L.S. Dure III, G.O. Myers, J. McD Stewart, T.A. Wilkins and J. Zhu for co-endorsing the sequencing of G. raimondii by the US Department of Energy.	ADKISSON PL, 1982, SCIENCE, V216, P19, DOI 10.1126/science.216.4541.19; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Carvalho MR, 2011, AM J BOT, V98, P1337, DOI 10.3732/ajb.1000539; Cronn R, 2003, EVOLUTION, V57, P2475, DOI 10.1111/j.0014-3820.2003.tb01493.x; Doblin MS, 2010, FUNCT PLANT BIOL, V37, P357, DOI 10.1071/FP09279; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Flagel LE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-302; GEEVER RF, 1989, THEOR APPL GENET, V77, P553, DOI 10.1007/BF00274278; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haigler CH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00104; Hendrix B, 2005, ANN BOT-LONDON, V95, P789, DOI 10.1093/aob/mci078; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; KADIR ZBA, 1976, CHROMOSOMA, V56, P85, DOI 10.1007/BF00293732; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim HJ, 2004, PLANTA, V218, P516, DOI 10.1007/s00425-003-1133-1; Lin LF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-395; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Muravenko OV, 1998, GENOME, V41, P616, DOI 10.1139/gen-41-4-616; REINISCH AJ, 1994, GENETICS, V138, P829; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Rong J, 2005, GENOME RES, V15, P1198, DOI 10.1101/gr.3907305; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Rong J, 2007, GENETICS, V176, P2577, DOI 10.1534/genetics.107.074518; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; WALBOT V, 1976, J MOL BIOL, V101, P503, DOI 10.1016/0022-2836(76)90242-4; WANG GL, 1995, THEOR APPL GENET, V91, P1153, DOI 10.1007/BF00223934; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang XY, 2011, PLANT CELL, V23, P27, DOI 10.1105/tpc.110.080622; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; WENDEL JF, 1995, MOL PHYLOGENET EVOL, V4, P298, DOI 10.1006/mpev.1995.1027; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Zhao XP, 1998, GENOME RES, V8, P479, DOI 10.1101/gr.8.5.479	42	831	906	13	368	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					423	+		10.1038/nature11798	http://dx.doi.org/10.1038/nature11798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23257886	Green Published, hybrid			2022-12-24	WOS:000312488200055
J	Murray, CJL; Vos, T; Lozano, R; Naghavi, M; Flaxman, AD; Michaud, C; Ezzati, M; Shibuya, K; Salomon, JA; Abdalla, S; Aboyans, V; Abraham, J; Ackerman, I; Aggarwal, R; Ahn, SY; Ali, MK; Alvarado, M; Anderson, HR; Anderson, LM; Andrews, KG; Atkinson, C; Baddour, LM; Bahalim, AN; Barker-Collo, S; Barrero, LH; Bartels, DH; Basanez, MG; Baxter, A; Bell, ML; Benjamin, EJ; Bennett, D; Bernabe, E; Bhalla, K; Bhandari, B; Bikbov, B; Bin Abdulhak, A; Birbeck, G; Black, JA; Blencowe, H; Blore, JD; Blyth, F; Bolliger, I; Bonaventure, A; Boufous, SA; Bourne, R; Boussinesq, M; Braithwaite, T; Brayne, C; Bridgett, L; Brooker, S; Brooks, P; Brugha, TS; Bryan-Hancock, C; Bucello, C; Buchbinder, R; Buckle, G; Budke, CM; Burch, M; Burney, P; Burstein, R; Calabria, B; Campbell, B; Canter, CE; Carabin, H; Carapetis, J; Carmona, L; Cella, C; Charlson, F; Chen, HL; Cheng, ATA; Chou, D; Chugh, SS; Coffeng, LE; Colan, SD; Colquhoun, S; Colson, KE; Condon, J; Connor, MD; Cooper, LT; Corriere, M; Cortinovis, M; De Vaccaro, KC; Couser, W; Cowie, BC; Criqui, MH; Cross, M; Dabhadkar, KC; Dahiya, M; Dahodwala, N; Damsere-Derry, J; Danaei, G; Davis, A; De Leo, D; Degenhardt, L; Dellavalle, R; Delossantos, A; Denenberg, J; Derrett, S; Des Jarlais, DC; Dharmaratne, SD; Dherani, M; Diaz-Torne, C; Dolk, H; Dorsey, ER; Driscoll, T; Duber, H; Ebel, B; Edmond, K; Elbaz, A; Ali, SE; Erskine, H; Erwin, PJ; Espindola, P; Ewoigbokhan, SE; Farzadfar, F; Feigin, V; Felson, DT; Ferrari, A; Ferri, CP; Fevre, EM; Finucane, MM; Flaxman, S; Flood, L; Foreman, K; Forouzanfar, MH; Fowkes, FGR; Fransen, M; Freeman, MK; Gabbe, BJ; Gabriel, SE; Gakidou, E; Ganatra, HA; Garcia, B; Gaspari, F; Gillum, RF; Gmel, G; Gonzalez-Medina, D; Gosselin, R; Grainger, R; Grant, B; Groeger, J; Guillemin, F; Gunnell, D; Gupta, R; Haagsma, J; Hagan, H; Halasa, YA; Hall, W; Haring, D; Haro, JM; Harrison, JE; Havmoeller, R; Hay, RJ; Higashi, H; Hill, C; Hoen, B; Hoffman, H; Hotez, PJ; Hoy, D; Huang, JJ; Ibeanusi, SE; Jacobsen, KH; James, SL; Jarvis, D; Jasrasaria, R; Jayaraman, S; Johns, N; Jonas, JB; Karthikeyan, G; Kassebaum, N; Kawakami, N; Keren, A; Khoo, JP; King, CH; Knowlton, LM; Kobusingye, O; Koranteng, A; Krishnamurthi, R; Laden, F; Lalloo, R; Laslett, LL; Lathlean, T; Leasher, JL; Lee, YY; Leigh, J; Levinson, D; Lim, SS; Limb, E; Lin, JK; Lipnick, M; Lipshultz, SE; Liu, W; Loane, M; Ohno, SL; Lyons, R; Mabweijano, J; MacIntyre, MF; Malekzadeh, R; Mallinger, L; Manivannan, S; Marcenes, W; March, L; Margolis, DJ; Marks, GB; Marks, R; Matsumori, A; Matzopoulos, R; Mayosi, BM; McAnulty, JH; McDermott, MM; McGill, N; McGrath, J; Medina-Mora, ME; Meltzer, M; Mensah, GA; Merriman, TR; Meyer, AC; Miglioli, V; Miller, M; Miller, TR; Mitchell, PB; Mock, C; Mocumbi, AO; Moffitt, TE; Mokdad, AA; Monasta, L; Montico, M; Moradi-Lakeh, M; Moran, A; Morawska, L; Mori, R; Murdoch, ME; Mwaniki, MK; Naidoo, K; Nair, MN; Naldi, L; Narayan, KMV; Nelson, PK; Nelson, RG; Nevitt, MC; Newton, CR; Nolte, S; Norman, P; Norman, R; O'Donnell, M; O'Hanlon, S; Olives, C; Omer, SB; Ortblad, K; Osborne, R; Ozgediz, D; Page, A; Pahari, B; Pandian, JD; Rivero, AP; Patten, SB; Pearce, N; Padilla, RP; Perez-Ruiz, F; Perico, N; Pesudovs, K; Phillips, D; Phillips, MR; Pierce, K; Pion, S; Polanczyk, GV; Polinder, S; Pope, CA; Popova, S; Porrini, E; Pourmalek, F; Prince, M; Pullan, RL; Ramaiah, KD; Ranganathan, D; Razavi, H; Regan, M; Rehm, JT; Rein, DB; Remuzzi, G; Richardson, K; Rivara, FP; Roberts, T; Robinson, C; De Leon, FR; Ronfani, L; Room, R; Rosenfeld, LC; Rushton, L; Sacco, RL; Saha, S; Sampson, U; Sanchez-Riera, L; Sanman, E; Schwebel, DC; Scott, JG; Segui-Gomez, M; Shahraz, S; Shepard, DS; Shin, H; Shivakoti, R; Singh, D; Singh, GM; Singh, JA; Singleton, J; Sleet, DA; Sliwa, K; Smith, E; Smith, JL; Stapelberg, NJC; Steer, A; Steiner, T; Stolk, WA; Stovner, LJ; Sudfeld, C; Syed, S; Tamburlini, G; Tavakkoli, M; Taylor, HR; Taylor, JA; Taylor, WJ; Thomas, B; Thomson, WM; Thurston, GD; Tleyjeh, IM; Tonelli, M; Towbin, JRA; Truelsen, T; Tsilimbaris, MK; Ubeda, C; Undurraga, EA; van der Werf, MJ; van Os, J; Vavilala, MS; Venketasubramanian, N; Wang, MR; Wang, WZ; Watt, K; Weatherall, DJ; Weinstock, MA; Weintraub, R; Weisskopf, MG; Weissman, MM; White, RA; Whiteford, H; Wiebe, N; Wiersma, ST; Wilkinson, JD; Williams, HC; Williams, SRM; Witt, E; Wolfe, F; Woolf, AD; Wulf, S; Yeh, PH; Zaidi, AKM; Zheng, ZJ; Zonies, D; Lopez, AD				Murray, Christopher J. L.; Vos, Theo; Lozano, Rafael; Naghavi, Mohsen; Flaxman, Abraham D.; Michaud, Catherine; Ezzati, Majid; Shibuya, Kenji; Salomon, Joshua A.; Abdalla, Safa; Aboyans, Victor; Abraham, Jerry; Ackerman, Ilana; Aggarwal, Rakesh; Ahn, Stephanie Y.; Ali, Mohammed K.; Alvarado, Miriam; Anderson, H. Ross; Anderson, Laurie M.; Andrews, Kathryn G.; Atkinson, Charles; Baddour, Larry M.; Bahalim, Adil N.; Barker-Collo, Suzanne; Barrero, Lope H.; Bartels, David H.; Basanez, Maria-Gloria; Baxter, Amanda; Bell, Michelle L.; Benjamin, Emelia J.; Bennett, Derrick; Bernabe, Eduardo; Bhalla, Kavi; Bhandari, Bishal; Bikbov, Boris; Bin Abdulhak, Aref; Birbeck, Gretchen; Black, James A.; Blencowe, Hannah; Blore, Jed D.; Blyth, Fiona; Bolliger, Ian; Bonaventure, Audrey; Boufous, Soufi Ane; Bourne, Rupert; Boussinesq, Michel; Braithwaite, Tasanee; Brayne, Carol; Bridgett, Lisa; Brooker, Simon; Brooks, Peter; Brugha, Traolach S.; Bryan-Hancock, Claire; Bucello, Chiara; Buchbinder, Rachelle; Buckle, Geoffrey; Budke, Christine M.; Burch, Michael; Burney, Peter; Burstein, Roy; Calabria, Bianca; Campbell, Benjamin; Canter, Charles E.; Carabin, Helene; Carapetis, Jonathan; Carmona, Loreto; Cella, Claudia; Charlson, Fiona; Chen, Honglei; Cheng, Andrew Tai-Ann; Chou, David; Chugh, Sumeet S.; Coffeng, Luc E.; Colan, Steven D.; Colquhoun, Samantha; Colson, K. Ellicott; Condon, John; Connor, Myles D.; Cooper, Leslie T.; Corriere, Matthew; Cortinovis, Monica; De Vaccaro, Karen Courville; Couser, William; Cowie, Benjamin C.; Criqui, Michael H.; Cross, Marita; Dabhadkar, Kaustubh C.; Dahiya, Manu; Dahodwala, Nabila; Damsere-Derry, James; Danaei, Goodarz; Davis, Adrian; De Leo, Diego; Degenhardt, Louisa; Dellavalle, Robert; Delossantos, Allyne; Denenberg, Julie; Derrett, Sarah; Des Jarlais, Don C.; Dharmaratne, Samath D.; Dherani, Mukesh; Diaz-Torne, Cesar; Dolk, Helen; Dorsey, E. Ray; Driscoll, Tim; Duber, Herbert; Ebel, Beth; Edmond, Karen; Elbaz, Alexis; Ali, Suad Eltahir; Erskine, Holly; Erwin, Patricia J.; Espindola, Patricia; Ewoigbokhan, Stalin E.; Farzadfar, Farshad; Feigin, Valery; Felson, David T.; Ferrari, Alize; Ferri, Cleusa P.; Fevre, Eric M.; Finucane, Mariel M.; Flaxman, Seth; Flood, Louise; Foreman, Kyle; Forouzanfar, Mohammad H.; Fowkes, Francis Gerry R.; Fransen, Marlene; Freeman, Michael K.; Gabbe, Belinda J.; Gabriel, Sherine E.; Gakidou, Emmanuela; Ganatra, Hammad A.; Garcia, Bianca; Gaspari, Flavio; Gillum, Richard F.; Gmel, Gerhard; Gonzalez-Medina, Diego; Gosselin, Richard; Grainger, Rebecca; Grant, Bridget; Groeger, Justina; Guillemin, Francis; Gunnell, David; Gupta, Ramyani; Haagsma, Juanita; Hagan, Holly; Halasa, Yara A.; Hall, Wayne; Haring, Diana; Maria Haro, Josep; Harrison, James E.; Havmoeller, Rasmus; Hay, Roderick J.; Higashi, Hideki; Hill, Catherine; Hoen, Bruno; Hoffman, Howard; Hotez, Peter J.; Hoy, Damian; Huang, John J.; Ibeanusi, Sydney E.; Jacobsen, Kathryn H.; James, Spencer L.; Jarvis, Deborah; Jasrasaria, Rashmi; Jayaraman, Sudha; Johns, Nicole; Jonas, Jost B.; Karthikeyan, Ganesan; Kassebaum, Nicholas; Kawakami, Norito; Keren, Andre; Khoo, Jon-Paul; King, Charles H.; Knowlton, Lisa Marie; Kobusingye, Olive; Koranteng, Adofo; Krishnamurthi, Rita; Laden, Francine; Lalloo, Ratilal; Laslett, Laura L.; Lathlean, Tim; Leasher, Janet L.; Lee, Yong Yi; Leigh, James; Levinson, Daphna; Lim, Stephen S.; Limb, Elizabeth; Lin, John Kent; Lipnick, Michael; Lipshultz, Steven E.; Liu, Wei; Loane, Maria; Ohno, Summer Lockett; Lyons, Ronan; Mabweijano, Jacqueline; MacIntyre, Michael F.; Malekzadeh, Reza; Mallinger, Leslie; Manivannan, Sivabalan; Marcenes, Wagner; March, Lyn; Margolis, David J.; Marks, Guy B.; Marks, Robin; Matsumori, Akira; Matzopoulos, Richard; Mayosi, Bongani M.; McAnulty, John H.; McDermott, Mary M.; McGill, Neil; McGrath, John; Elena Medina-Mora, Maria; Meltzer, Michele; Mensah, George A.; Merriman, Tony R.; Meyer, Ana-Claire; Miglioli, Valeria; Miller, Matthew; Miller, Ted R.; Mitchell, Philip B.; Mock, Charles; Mocumbi, Ana Olga; Moffitt, Terrie E.; Mokdad, Ali A.; Monasta, Lorenzo; Montico, Marcella; Moradi-Lakeh, Maziar; Moran, Andrew; Morawska, Lidia; Mori, Rintaro; Murdoch, Michele E.; Mwaniki, Michael K.; Naidoo, Kovin; Nair, M. Nathan; Naldi, Luigi; Narayan, K. M. Venkat; Nelson, Paul K.; Nelson, Robert G.; Nevitt, Michael C.; Newton, Charles R.; Nolte, Sandra; Norman, Paul; Norman, Rosana; O'Donnell, Martin; O'Hanlon, Simon; Olives, Casey; Omer, Saad B.; Ortblad, Katrina; Osborne, Richard; Ozgediz, Doruk; Page, Andrew; Pahari, Bishnu; Pandian, Jeyaraj Durai; Panozo Rivero, Andrea; Patten, Scott B.; Pearce, Neil; Perez Padilla, Rogelio; Perez-Ruiz, Fernando; Perico, Norberto; Pesudovs, Konrad; Phillips, David; Phillips, Michael R.; Pierce, Kelsey; Pion, Sebastien; Polanczyk, Guilherme V.; Polinder, Suzanne; Pope, C. Arden, III; Popova, Svetlana; Porrini, Esteban; Pourmalek, Farshad; Prince, Martin; Pullan, Rachel L.; Ramaiah, Kapa D.; Ranganathan, Dharani; Razavi, Homie; Regan, Mathilda; Rehm, Juergen T.; Rein, David B.; Remuzzi, Guiseppe; Richardson, Kathryn; Rivara, Frederick P.; Roberts, Thomas; Robinson, Carolyn; Rodriguez De Leon, Felipe; Ronfani, Luca; Room, Robin; Rosenfeld, Lisa C.; Rushton, Lesley; Sacco, Ralph L.; Saha, Sukanta; Sampson, Uchechukwu; Sanchez-Riera, Lidia; Sanman, Ella; Schwebel, David C.; Scott, James Graham; Segui-Gomez, Maria; Shahraz, Saeid; Shepard, Donald S.; Shin, Hwashin; Shivakoti, Rupak; Singh, David; Singh, Gitanjali M.; Singh, Jasvinder A.; Singleton, Jessica; Sleet, David A.; Sliwa, Karen; Smith, Emma; Smith, Jennifer L.; Stapelberg, Nicolas J. C.; Steer, Andrew; Steiner, Timothy; Stolk, Wilma A.; Stovner, Lars Jacob; Sudfeld, Christopher; Syed, Sana; Tamburlini, Giorgio; Tavakkoli, Mohammad; Taylor, Hugh R.; Taylor, Jennifer A.; Taylor, William J.; Thomas, Bernadette; Thomson, W. Murray; Thurston, George D.; Tleyjeh, Imad M.; Tonelli, Marcello; Towbin, Jeff Rey A.; Truelsen, Thomas; Tsilimbaris, Miltiadis K.; Ubeda, Clotilde; Undurraga, Eduardo A.; van der Werf, Marieke J.; van Os, Jim; Vavilala, Monica S.; Venketasubramanian, N.; Wang, Mengru; Wang, Wenzhi; Watt, Kerrianne; Weatherall, David J.; Weinstock, Martin A.; Weintraub, Robert; Weisskopf, Marc G.; Weissman, Myrna M.; White, Richard A.; Whiteford, Harvey; Wiebe, Natasha; Wiersma, Steven T.; Wilkinson, James D.; Williams, Hywel C.; Williams, Sean R. M.; Witt, Emma; Wolfe, Frederick; Woolf, Anthony D.; Wulf, Sarah; Yeh, Pon-Hsiu; Zaidi, Anita K. M.; Zheng, Zhi-Jie; Zonies, David; Lopez, Alan D.			Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010	LANCET			English	Article							PUBLIC-HEALTH UTILITY; ECONOMIC COST; RISK-FACTORS; MORTALITY; POPULATION; COUNTRIES; EXPECTANCY; AUSTRALIA; COPD; LOST	Background Measuring disease and injury burden in populations requires a composite metric that captures both premature mortality and the prevalence and severity of ill-health. The 1990 Global Burden of Disease study proposed disability-adjusted life years (DALYs) to measure disease burden. No comprehensive update of disease burden worldwide incorporating a systematic reassessment of disease and injury-specific epidemiology has been done since the 1990 study. We aimed to calculate disease burden worldwide and for 21 regions for 1990, 2005, and 2010 with methods to enable meaningful comparisons over time. Methods We calculated DALYs as the sum of years of life lost (YLLs) and years lived with disability (YLDs). DALYs were calculated for 291 causes, 20 age groups, both sexes, and for 187 countries, and aggregated to regional and global estimates of disease burden for three points in time with strictly comparable definitions and methods. YLLs were calculated from age-sex-country-time-specific estimates of mortality by cause, with death by standardised lost life expectancy at each age. YLDs were calculated as prevalence of 1160 disabling sequelae, by age, sex, and cause, and weighted by new disability weights for each health state. Neither YLLs nor YLDs were age-weighted or discounted. Uncertainty around cause-specific DALYs was calculated incorporating uncertainty in levels of all-cause mortality, cause-specific mortality, prevalence, and disability weights. Findings Global DALYs remained stable from 1990 (2.503 billion) to 2010 (2.490 billion). Crude DALYs per 1000 decreased by 23% (472 per 1000 to 361 per 1000). An important shift has occurred in DALY composition with the contribution of deaths and disability among children (younger than 5 years of age) declining from 41% of global DALYs in 1990 to 25% in 2010. YLLs typically account for about half of disease burden in more developed regions (high-income Asia Pacific, western Europe, high-income North America, and Australasia), rising to over 80% of DALYs in sub-Saharan Africa. In 1990, 47% of DALYs worldwide were from communicable, maternal, neonatal, and nutritional disorders, 43% from non-communicable diseases, and 10% from injuries. By 2010, this had shifted to 35%, 54%, and 11%, respectively. Ischaemic heart disease was the leading cause of DALYs worldwide in 2010 (up from fourth rank in 1990, increasing by 29%), followed by lower respiratory infections (top rank in 1990; 44% decline in DALYs), stroke (fifth in 1990; 19% increase), diarrhoeal diseases (second in 1990; 51% decrease), and HIV/AIDS (33rd in 1990; 351% increase). Major depressive disorder increased from 15th to 11th rank (37% increase) and road injury from 12th to 10th rank (34% increase). Substantial heterogeneity exists in rankings of leading causes of disease burden among regions. Interpretation Global disease burden has continued to shift away from communicable to non-communicable diseases and from premature death to years lived with disability. In sub-Saharan Africa, however, many communicable, maternal, neonatal, and nutritional disorders remain the dominant causes of disease burden. The rising burden from mental and behavioural disorders, musculoskeletal disorders, and diabetes will impose new challenges on health systems. Regional heterogeneity highlights the importance of understanding local burden of disease and setting goals and targets for the post-2015 agenda taking such patterns into account. Because of improved definitions, methods, and data, these results for 1990 and 2010 supersede all previously published Global Burden of Disease results.	[Baxter, Amanda; Erskine, Holly; Ferrari, Alize; Khoo, Jon-Paul; Saha, Sukanta; Whiteford, Harvey] Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Vos, Theo; Blore, Jed D.; Charlson, Fiona; Higashi, Hideki; Lee, Yong Yi; Norman, Rosana; Page, Andrew; Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Scott, James Graham] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [McGrath, John] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Murray, Christopher J. L.; Lozano, Rafael; Naghavi, Mohsen; Flaxman, Abraham D.; Ahn, Stephanie Y.; Alvarado, Miriam; Andrews, Kathryn G.; Atkinson, Charles; Bolliger, Ian; Burstein, Roy; Campbell, Benjamin; Chou, David; Colson, K. Ellicott; Delossantos, Allyne; Dharmaratne, Samath D.; Forouzanfar, Mohammad H.; Freeman, Michael K.; Gakidou, Emmanuela; Gonzalez-Medina, Diego; Haring, Diana; James, Spencer L.; Jasrasaria, Rashmi; Johns, Nicole; Lim, Stephen S.; Ohno, Summer Lockett; MacIntyre, Michael F.; Mallinger, Leslie; Mokdad, Ali A.; Nair, M. Nathan; Ortblad, Katrina; Phillips, David; Pierce, Kelsey; Ranganathan, Dharani; Roberts, Thomas; Rosenfeld, Lisa C.; Sanman, Ella; Wang, Mengru; Wulf, Sarah] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Anderson, Laurie M.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98121 USA; [Kassebaum, Nicholas] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98121 USA; [Michaud, Catherine] China Med Board, Boston, MA USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Finucane, Mariel M.] Harvard Univ, Dept Biostat, Boston, MA 02115 USA; [Salomon, Joshua A.; Danaei, Goodarz; Laden, Francine; Lin, John Kent; Miller, Matthew; Singh, Gitanjali M.; Sudfeld, Christopher; Tavakkoli, Mohammad; Weisskopf, Marc G.; White, Richard A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Liu, Wei] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA; [Knowlton, Lisa Marie] Harvard Univ, Harvard Humanitarian Initiat, Boston, MA 02115 USA; [Colan, Steven D.] Harvard Univ, Boston Childrens Hosp, Boston, MA 02115 USA; [Jayaraman, Sudha] Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA; [Bartels, David H.; Bhalla, Kavi] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Aboyans, Victor] Dupuytren Univ Hosp, Dept Cardiol, Limoges, France; [Abraham, Jerry] Univ Texas San Antonio, San Antonio, TX USA; [Steer, Andrew] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Weintraub, Robert] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Degenhardt, Louisa] Univ Melbourne, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia; [Room, Robin] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia; [Aggarwal, Rakesh] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India; [Omer, Saad B.] Emory Univ, Sch Publ Hlth, Atlanta, GA USA; [Omer, Saad B.] Emory Univ, Sch Med, Atlanta, GA USA; [Anderson, H. Ross; Gupta, Ramyani; Limb, Elizabeth] St Georges Univ London, London, England; [Baddour, Larry M.; Erwin, Patricia J.; Gabriel, Sherine E.] Mayo Clin, Rochester, MN USA; [Barker-Collo, Suzanne] Univ Auckland, Auckland 1, New Zealand; [Barrero, Lope H.] Pontificia Univ Javeriana, Sch Engn, Dept Ind Engn, Bogota, Colombia; [Bell, Michelle L.; Huang, John J.; Ozgediz, Doruk] Yale Univ, New Haven, CT USA; [Felson, David T.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Bennett, Derrick] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Bennett, Derrick] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Bernabe, Eduardo] Kings Coll London, Inst Dent, London WC2R 2LS, England; [Hay, Roderick J.] Kings Coll London, Hosp NHS Trust, London WC2R 2LS, England; [Prince, Martin] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Dahiya, Manu] Queen Mary Univ London, Inst Dent, London, England; [Bikbov, Boris] Moscow State Univ Med & Dent, Res Inst Transplantol & Artificial Organs, Moscow, Russia; [Bin Abdulhak, Aref; Tleyjeh, Imad M.] King Fahad Med City, Riyadh, Saudi Arabia; [Birbeck, Gretchen] Michigan State Univ, E Lansing, MI 48824 USA; [Black, James A.] MRC, Epidemiol Unit, Cambridge, England; [Blencowe, Hannah; Brooker, Simon; Edmond, Karen; Pearce, Neil; Pullan, Rachel L.; Smith, Jennifer L.] London Sch Hyg & Trop Med, London WC1, England; [Smith, Emma] Univ Sydney, No Clin Sch, Dept Rheumatol, Sydney, NSW 2006, Australia; [Fransen, Marlene] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [March, Lyn; Sanchez-Riera, Lidia] Univ Sydney, Inst Bone & Joint Res, Sydney, NSW 2006, Australia; [Driscoll, Tim; Leigh, James] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Bonaventure, Audrey; Elbaz, Alexis] INSERM, Paris, France; [Calabria, Bianca; Degenhardt, Louisa; Nelson, Paul K.; Singleton, Jessica] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Bucello, Chiara; Mitchell, Philip B.] Univ New S Wales, Sydney, NSW, Australia; [Bourne, Rupert] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England; [Braithwaite, Tasanee] Moorfields Eye Hosp, London, England; [Brayne, Carol; Richardson, Kathryn] Univ Cambridge, Cambridge, England; [Brugha, Traolach S.] Univ Leicester, Leicester, Leics, England; [Bryan-Hancock, Claire; Flood, Louise; Harrison, James E.; Lathlean, Tim; Pesudovs, Konrad] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Buchbinder, Rachelle] Cabrini Inst, Malvern, Vic, Australia; [Gabbe, Belinda J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Buckle, Geoffrey; Manivannan, Sivabalan] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Budke, Christine M.] Texas A&M Univ, College Stn, TX USA; [Burch, Michael] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Canter, Charles E.] Washington Univ, St Louis, MO USA; [Carabin, Helene] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Carapetis, Jonathan] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Carmona, Loreto] Univ Camilo Jose Cela, Villanueva De La Canada, Spain; [Cella, Claudia; Cortinovis, Monica; Gaspari, Flavio; Miglioli, Valeria; Perico, Norberto; Remuzzi, Guiseppe] Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy; [Chen, Honglei] NIEHS, Res Triangle Pk, NC 27709 USA; [Cheng, Andrew Tai-Ann] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Havmoeller, Rasmus] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Polinder, Suzanne] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Colquhoun, Samantha; Condon, John] Menzies Sch Hlth Res, Darwin, NT, Australia; [Connor, Myles D.] Natl Hlth Serv, Edinburgh, Midlothian, Scotland; [Connor, Myles D.; Fevre, Eric M.; Fowkes, Francis Gerry R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Connor, Myles D.] Univ Witwatersrand, Johannesburg, South Africa; [Cooper, Leslie T.] Loyola Univ, Sch Med, Chicago, IL 60611 USA; [Corriere, Matthew] Wake Forest Univ, Sch Publ Hlth Sci, Winston Salem, NC 27109 USA; [De Vaccaro, Karen Courville] Hosp Dr Gustavo N Collado, Puerto Chitre, Panama; [Cowie, Benjamin C.] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Criqui, Michael H.; Denenberg, Julie] Univ Calif San Diego, San Diego, CA 92103 USA; [Dahodwala, Nabila; Margolis, David J.] Univ Penn, Philadelphia, PA 19104 USA; [Damsere-Derry, James] Bldg & Rd Res Inst, Kumasi, Ghana; [Davis, Adrian] MRC Hearing & Commun Grp, Manchester, Lancs, England; [Lalloo, Ratilal] Griffith Univ, Sch Dent & Oral Hlth, Brisbane, Qld 4111, Australia; [Lalloo, Ratilal] Griffith Univ, Populat & Social Hlth Res Program, Brisbane, Qld 4111, Australia; [Dellavalle, Robert] Denver VA Med Ctr, Denver, VA USA; [Derrett, Sarah; Grainger, Rebecca; Merriman, Tony R.; Taylor, William J.; Thomson, W. Murray] Univ Otago, Dunedin, New Zealand; [Des Jarlais, Don C.] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Dharmaratne, Samath D.] Univ Peradeniya, Peradeniya, Sri Lanka; [Dherani, Mukesh] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Diaz-Torne, Cesar] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Dolk, Helen; Loane, Maria] Univ Ulster, Ulster, Ireland; [Ali, Suad Eltahir] Fed Minist Hlth, Khartoum, Sudan; [Espindola, Patricia] Hosp Maciel, Montevideo, Uruguay; [Ewoigbokhan, Stalin E.] Emerald Publ Hlth Consulting Serv Ltd, Abuja, Nigeria; [Malekzadeh, Reza] Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran; [Feigin, Valery] Auckland Tech Univ, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Polanczyk, Guilherme V.] Univ Fed Sao Paulo, Sch Med, Sao Paulo, Brazil; [Flaxman, Seth] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Watt, Kerrianne] James Cook Univ, Townsville, Qld 4811, Australia; [Gillum, Richard F.] Howard Univ, Coll Med, Washington, DC USA; [Gmel, Gerhard] Addict Info Switzerland, Lausanne, Switzerland; [Nevitt, Michael C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Groeger, Justina] Suny Downstate Med Ctr, Coll Med, Brooklyn, NY 11203 USA; [Sleet, David A.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Guillemin, Francis] Univ Lorraine, Nancy, France; [Gunnell, David] Univ Bristol, Bristol, Avon, England; [Hagan, Holly; Thurston, George D.] NYU, New York, NY USA; [Halasa, Yara A.; Shahraz, Saeid; Shepard, Donald S.; Undurraga, Eduardo A.] Brandeis Univ, Waltham, MA USA; [Maria Haro, Josep] Univ Barcelona, CIBERSAM, St Boi De Llobregat, Spain; [Havmoeller, Rasmus] Karolinska Univ Hosp, Stockholm, Sweden; [Hill, Catherine] Queen Elizabeth Hosp, Adelaide, SA, Australia; [Hoen, Bruno] Univ Franche Comte, F-25030 Besancon, France; [Hoen, Bruno] Ctr Hosp Reg Univ Besancon, Besancon, France; [Hoffman, Howard] NIDCD, NIH, Bethesda, MD USA; [Nelson, Robert G.] NIDDK, NIH, Bethesda, MD USA; [Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Waco, TX USA; [Ibeanusi, Sydney E.] Univ Port Harcourt, Port Harcourt, Nigeria; [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA 22030 USA; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Karthikeyan, Ganesan] All India Inst Med Sci, New Delhi, India; [Keren, Andre] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Cardiol, IL-91010 Jerusalem, Israel; [King, Charles H.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Kobusingye, Olive] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Kobusingye, Olive] Univ S Africa, Johannesburg, South Africa; [Koranteng, Adofo] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Laslett, Laura L.] Univ Tasmania, Hobart, Tas 7001, Australia; [Leasher, Janet L.] Nova SE Univ, Ft Lauderdale, FL 33314 USA; [Levinson, Daphna] Minist Hlth, Jerusalem, Israel; [Lipshultz, Steven E.; Sacco, Ralph L.; Wilkinson, James D.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Lyons, Ronan] Swansea Univ, Swansea, W Glam, Wales; [Mabweijano, Jacqueline] Mulago Hosp, Kampala, Uganda; [Matsumori, Akira] Asian Pacific Soc Cardiol, Kyoto, Japan; [Matzopoulos, Richard] MRC, Tygerberg, South Africa; [Sliwa, Karen] Univ Cape Town, Hatter Inst, ZA-7925 Cape Town, South Africa; [Mensah, George A.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [McAnulty, John H.] Legacy Hlth Syst, Portland, OR USA; [McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA; [Elena Medina-Mora, Maria] Natl Inst Psychiat Ramon de la Fuente, Mexico City, DF, Mexico; [Meltzer, Michele] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Mocumbi, Ana Olga] Natl Inst Hlth, Maputo, Mozambique; [Mocumbi, Ana Olga] Univ Eduardo Mondlane, Maputo, Mozambique; [Moffitt, Terrie E.] Duke Univ, Durham, NC USA; [Monasta, Lorenzo; Montico, Marcella; Ronfani, Luca; Tamburlini, Giorgio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Weissman, Myrna M.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Morawska, Lidia] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Murdoch, Michele E.] Watford Dist Gen Hosp, Watford, England; [Mwaniki, Michael K.] Kemri Wellcome Trust, Kilifi, Kenya; [Naidoo, Kovin] Univ KwaZulu Natal, AVRI, Durban, South Africa; [Naldi, Luigi] Ctr Studi GISED, Bergamo, Italy; [Nolte, Sandra] Charite, D-13353 Berlin, Germany; [O'Donnell, Martin] Natl Univ Ireland Galway, HRB Clin Res Facil, Galway, Ireland; [Osborne, Richard] Deakin Univ, Melbourne, Vic, Australia; [Pahari, Bishnu] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Pandian, Jeyaraj Durai] Betty Cowan Res & Innovat Ctr, Ludhiana, Punjab, India; [Panozo Rivero, Andrea] Hosp Joan 23, La Paz, Bolivia; [Patten, Scott B.] Univ Calgary, Calgary, AB, Canada; [Perez Padilla, Rogelio] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Perez-Ruiz, Fernando] Hosp Univ Cruces, Baracaldo, Spain; [Phillips, Michael R.] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Shanghai 200030, Peoples R China; [Zheng, Zhi-Jie] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Pope, C. Arden, III] Brigham Young Univ, Provo, UT 84602 USA; [Popova, Svetlana; Rehm, Juergen T.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Porrini, Esteban] Hosp Univ Canarias, Tenerif, Spain; [Pourmalek, Farshad] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Ramaiah, Kapa D.] Vector Control Res Ctr, Pondicherry, India; [Razavi, Homie] Ctr Dis Anal, Louisville, CO USA; [Regan, Mathilda] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Rein, David B.] Univ Chicago, NORC, Chicago, IL 60637 USA; [Rodriguez De Leon, Felipe] Complejo Hosp Caja Seguro Social, Panama City, Panama; [Room, Robin] Turning Point Alcohol & Drug Ctr, Ctr Alcohol Policy Res, Fitzroy, SA, Australia; [Sampson, Uchechukwu] Vanderbilt Univ, Nashville, TN USA; [Schwebel, David C.; Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA; [Segui-Gomez, Maria] Minist Interior, Madrid, Spain; [Shin, Hwashin] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Singh, David] Queens Med Ctr, Honolulu, HI USA; [Stovner, Lars Jacob] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Syed, Sana; Zaidi, Anita K. M.] Aga Khan Univ, Karachi, Pakistan; [Taylor, Jennifer A.] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Tonelli, Marcello] Univ Alberta, Alberta Kidney Dis Network, Edmonton, AB, Canada; [Towbin, Jeff Rey A.] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Truelsen, Thomas] Copenhagen Univ Hosp, Dept Neurol, Herlev, Denmark; [Tsilimbaris, Miltiadis K.] Univ Crete, Sch Med, Iraklion, Greece; [Ubeda, Clotilde] ANLIS, Inst Nacl Epidemiol, Malbran, Argentina; [van der Werf, Marieke J.] KNCV TB Fdn, The Hague, Netherlands; [van Os, Jim] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Venketasubramanian, N.] Natl Univ Singapore, Singapore 117548, Singapore; [Wang, Wenzhi] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Weinstock, Martin A.] Brown Univ, Providence, RI 02912 USA; [Weintraub, Robert] Royal Childrens Hosp, Melbourne, Vic, Australia; [Weintraub, Robert] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Williams, Hywel C.] Univ Nottingham, Nottingham NG7 2RD, England; [Williams, Sean R. M.] Hollywood Orthopaed Grp, Perth, WA, Australia; [Wolfe, Frederick] Arthrit Res, Wichita, KS USA; [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, England; [Yeh, Pon-Hsiu] London Sch Econ, London WC2A 2AE, England; [Zonies, David] Landstuhl Reg Med Ctr, Landstuhl, Germany	Queensland Centre for Mental Health Research; University of Queensland; University of Queensland; University of Queensland; University of Queensland; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Imperial College London; University of Tokyo; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; CHU Limoges; University of Texas System; University of Texas at San Antonio (UTSA); University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Emory University; Emory University; St Georges University London; Mayo Clinic; University of Auckland; Pontificia Universidad Javeriana; Yale University; Boston University; University of Oxford; University of Oxford; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; Queen Mary University London; Moscow State University of Medicine & Dentistry; V.I. Shumakov Federal Research Center of Transplantology & Artificial Organs; Michigan State University; University of London; London School of Hygiene & Tropical Medicine; University of Sydney; University of Sydney; University of Sydney; University of Sydney; Institut National de la Sante et de la Recherche Medicale (Inserm); University of New South Wales Sydney; University of New South Wales Sydney; Anglia Ruskin University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Cambridge; University of Leicester; Flinders University South Australia; Cabrini Health; Monash University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Texas A&M University System; Texas A&M University College Station; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Washington University (WUSTL); University of Oklahoma System; University of Oklahoma Health Sciences Center; Telethon Kids Institute; University of Western Australia; Camilo Jose Cela University; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Academia Sinica - Taiwan; Cedars Sinai Medical Center; Erasmus University Rotterdam; Erasmus MC; Charles Darwin University; Menzies School of Health Research; NHS Blood & Transplant (NHSBT); University of Edinburgh; University of Witwatersrand; Loyola University Chicago; Wake Forest University; Victorian Infectious Diseases Reference Laboratory; University of California System; University of California San Diego; University of Pennsylvania; Griffith University; Griffith University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Otago; Harvard University; Beth Israel Deaconess Medical Center; University of Peradeniya; University of Liverpool; Hospital of Santa Creu i Sant Pau; Ulster University; Tehran University of Medical Sciences; Universidade Federal de Sao Paulo (UNIFESP); Carnegie Mellon University; James Cook University; Howard University; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Centers for Disease Control & Prevention - USA; Universite de Lorraine; University of Bristol; New York University; Brandeis University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Karolinska Institutet; Karolinska University Hospital; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Baylor College of Medicine; University of Port Harcourt; George Mason University; Ruprecht Karls University Heidelberg; All India Institute of Medical Sciences (AIIMS) New Delhi; Hebrew University of Jerusalem; Case Western Reserve University; Makerere University; University of South Africa; Kwame Nkrumah University Science & Technology; University of Tasmania; Nova Southeastern University; University of Miami; Swansea University; Mulago National Referral Hospital; University of Cape Town; University of Cape Town; Legacy Health; Northwestern University; Feinberg School of Medicine; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Jefferson University; Pacific Institute for Research & Evaluation (PIRE); Eduardo Mondlane University; Duke University; IRCCS Burlo Garofolo; Columbia University; Queensland University of Technology (QUT); National Center for Child Health & Development - Japan; Watford General Hospital; University of Kwazulu Natal; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; Deakin University; B.P. Koirala Institute of Health Sciences; University of Calgary; Hospital Universitario Cruces; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Brigham Young University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Universidad de la Laguna; University of British Columbia; Indian Council of Medical Research (ICMR); ICMR - Vector Control Research Center (VCRC); University of California System; University of California Berkeley; University of Chicago; Caja del Seguro Social (CSS); Complejo Hospitalario Doctor Arnulfo Arias Madrid; Turning Point Alcohol & Drug Centre - Australia; Vanderbilt University; University of Alabama System; University of Alabama Birmingham; Health Canada; The Queen's Medical Center; Norwegian University of Science & Technology (NTNU); Aga Khan University; Drexel University; University of Alberta; Cincinnati Children's Hospital Medical Center; University of Copenhagen; University of Crete; KNCV Tuberculosis Foundation; Maastricht University; National University of Singapore; Beijing Neurosurgical Institute; Capital Medical University; Brown University; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Nottingham; National Data Bank for Rheumatic Diseases; Royal Cornwall Hospital; University of London; London School Economics & Political Science; Landstuhl Regional Medical Center	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@uw.edu	Feigin, Valery/AAF-2313-2019; Hill, Catherine L/AAE-7152-2019; Cowie, Benjamin/HFZ-9941-2022; McGrath, John Joseph/G-5493-2010; Steer, Andrew C/C-2840-2013; Hall, Wayne D/A-3283-2008; O'Donnell, Martin/ABE-7459-2020; Boussinesq, Michel/J-7256-2016; Phillips, Michael Robert/AAE-7585-2021; Polanczyk, Guilherme V/C-2345-2012; Narayan, K.M. Venkat/J-9819-2012; Krishnamurthi, Rita/AAU-7841-2021; Sacco, Ralph/Y-9278-2019; Erskine, Holly/K-5244-2012; Naldi, Luigi/AFM-8982-2022; Montico, Marcella/B-5290-2013; Elbaz, Alexis/F-8952-2017; Schwebel, David/GXH-9944-2022; Carmona, Loreto/A-2748-2014; Singh, Jasvinder/R-6172-2019; Perico, Norberto/ABH-3222-2020; PACELLA, ROSANA E./F-2774-2010; Jarvis, Deborah/E-6494-2011; Moffitt, Terrie E/D-5295-2011; Charlson, Fiona/R-8963-2019; Brayne, Carol/AAA-4285-2020; Buchbinder, Rachelle/G-2952-2011; Thomson, William Murray/AAC-8575-2019; Cheng, Andrew/O-1159-2018; Coffeng, Luc/AAL-6631-2021; Gunnell, David/ABE-6653-2020; Laslett, Laura/G-3973-2011; Bell, Michelle/Y-4608-2018; Moradi-Lakeh, Maziar/ABC-9793-2021; Lozano, Rafael/T-5352-2018; Salomon, Joshua A/D-3898-2009; Courville, Karen/AAW-1462-2021; Black, James A/A-5917-2010; Pesudovs, Konrad/T-9403-2019; Ronfani, Luca/B-6668-2013; Wiebe, Natasha/V-7803-2019; Bin Abdulhak, Aref/AAK-4348-2020; Charlson, Fiona J/F-5290-2011; Monasta, Lorenzo/B-1388-2012; Lopez, Alan/AAA-2734-2022; Sudfeld, Christopher/AAW-3856-2021; Grainger, Rebecca/I-1866-2012; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Naldi, Luigi/K-6343-2016; Thurston, George/ABB-1359-2021; Lee, Yong Yi/C-1373-2015; Thomson, William Murray/A-4971-2008; Dellavalle, Robert/L-2020-2013; RUIZ, FERNANDO PEREZ/X-1980-2019; Ferri, Cleusa Pinheiro/B-2922-2010; Room, Robin/ABF-7460-2021; Ali, Mohammed K/N-9833-2013; Norman, Paul E/C-5485-2013; Newton, Charles RJC/B-7578-2014; Bennett, Derrick/AAH-1220-2022; Lopez, Alan D/F-1487-2010; Patten, Scott/B-4434-2011; Mokdad, Ali H./AAD-1232-2022; Bennett, Derrick/AFL-9254-2022; Ferrari, Alize J/G-1746-2011; van Os, Jim/V-8884-2019; Naidoo, Kovin Shunmugam/AAF-5914-2020; Nolte, Sandra/B-7498-2008; Haro, Josep Maria/D-1423-2011; Pandian, Jeyaraj Durai/AAV-5591-2020; Scott, James G/D-5900-2012; Bernabe, Eduardo/R-3441-2017; Osborne, Richard H/A-9447-2010; van Os, Jim/C-2113-2014; Zonies, David/B-6497-2011; Jacobsen, Kathryn H./B-5857-2008; Newton, Charles/V-7872-2019; Anderson, Hugh R/A-7417-2016; Matzopoulos, Richard/AAL-9965-2021; Karthikeyan, Ganesan/D-5767-2012; Díaz-Torné, César/AAG-2419-2020; , Bennett/O-7998-2019; Ganatra, Hammad A/P-8652-2019; Tonelli, Marcello/B-3028-2009; Aboyans, Victor/AAN-8308-2020; Harrison, James/B-8958-2009; Condon, John R/N-2281-2013; Saha, Sukanta/K-3774-2012; Carapetis, Jonathan R/H-8933-2014; Prince, Martin J/A-9170-2010; Pope, C. Arden/ABD-5522-2021; Aggarwal, Rakesh/D-1583-2009; Bin Abdulhak, Aref/AAM-9492-2020; Braithwaite, Tasanee/AAZ-1118-2020; Pourmalek, Farshad/A-8188-2010; Colan, Steven/ABB-4580-2020; Salomon, Joshua/S-1929-2019; Ortblad, Katrina/ABF-9070-2020; Davis, Adrian C/E-6022-2015; Lalloo, Ratilal/O-5624-2014; Room, Robin/ABH-8505-2020; Higashi, Hideki/D-3797-2011; SHIN, HS/AAE-5381-2022; Polanczyk, Guilherme V./AAF-6142-2021; Lathlean, Tim/K-3653-2013; Bikbov, Boris/I-4594-2013; Bolliger, Ian W/C-4207-2016; Whiteford, Harvey A/A-4840-2009; Marks, Guy B./F-5058-2013; Carabin, Helene/B-7600-2016; Stovner, Lars Jacob/D-5025-2014; Baxter, Amanda/E-5449-2011; Jayaraman, Sudha/AAH-3059-2019; Degenhardt, Louisa J/D-4515-2012; Truelsen, Thomas/AAY-1549-2020; Brugha, Traolach/T-9326-2019; Venketasubramanian, Narayanaswamy/GPP-5948-2022; Medina-Mora, María Elena I/T-5937-2018; PEREZ-RUIZ, FERNANDO/E-4844-2012; Malekzadeh, Reza/U-1382-2017; Undurraga, Eduardo A./I-3739-2014; Benjamin, Emelia/E-7103-2011; Leasher, Janet/B-8889-2016; Remuzzi, Giuseppe/V-9766-2017; Blore, Jed/K-6331-2012; Watt, Kerrianne/G-2520-2010; Morawska, Lidia/B-4140-2011	Hill, Catherine L/0000-0001-8289-4922; Cowie, Benjamin/0000-0002-7087-5895; McGrath, John Joseph/0000-0002-4792-6068; Hall, Wayne D/0000-0003-1984-0096; O'Donnell, Martin/0000-0002-7347-7761; Boussinesq, Michel/0000-0001-6312-0681; Phillips, Michael Robert/0000-0002-5973-2439; Polanczyk, Guilherme V/0000-0003-2311-3289; Narayan, K.M. Venkat/0000-0001-8621-5405; Krishnamurthi, Rita/0000-0003-0869-2083; Erskine, Holly/0000-0003-3119-9211; Naldi, Luigi/0000-0002-3160-2835; Montico, Marcella/0000-0003-0377-8232; Elbaz, Alexis/0000-0001-9724-5490; Carmona, Loreto/0000-0002-4401-2551; Singh, Jasvinder/0000-0003-3485-0006; Perico, Norberto/0000-0002-3147-4327; PACELLA, ROSANA E./0000-0002-9742-1957; Moffitt, Terrie E/0000-0002-8589-6760; Charlson, Fiona/0000-0003-2876-5040; Brayne, Carol/0000-0001-5307-663X; Buchbinder, Rachelle/0000-0002-0597-0933; Cheng, Andrew/0000-0002-2698-0516; Coffeng, Luc/0000-0002-4425-2264; Gunnell, David/0000-0002-0829-6470; Laslett, Laura/0000-0002-4336-0095; Bell, Michelle/0000-0002-3965-1359; Moradi-Lakeh, Maziar/0000-0001-7381-5305; Lozano, Rafael/0000-0002-7356-8823; Salomon, Joshua A/0000-0003-3929-5515; Courville, Karen/0000-0002-4182-6736; Black, James A/0000-0002-2200-3179; Pesudovs, Konrad/0000-0002-6322-9369; Ronfani, Luca/0000-0001-5710-3914; Wiebe, Natasha/0000-0002-5613-1582; Charlson, Fiona J/0000-0003-2876-5040; Monasta, Lorenzo/0000-0001-7774-548X; Sudfeld, Christopher/0000-0002-3203-3638; Grainger, Rebecca/0000-0001-9201-8678; Naldi, Luigi/0000-0002-3160-2835; Lee, Yong Yi/0000-0003-2359-6823; Thomson, William Murray/0000-0003-0588-6843; Dellavalle, Robert/0000-0001-8132-088X; RUIZ, FERNANDO PEREZ/0000-0002-5268-1894; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Room, Robin/0000-0002-5618-385X; Norman, Paul E/0000-0003-3406-0506; Newton, Charles RJC/0000-0002-6999-5507; Bennett, Derrick/0000-0002-9170-8447; Lopez, Alan D/0000-0001-5818-6512; Patten, Scott/0000-0001-9871-4041; Mokdad, Ali H./0000-0002-4994-3339; Bennett, Derrick/0000-0002-9170-8447; Ferrari, Alize J/0000-0002-7863-9117; van Os, Jim/0000-0002-7245-1586; Nolte, Sandra/0000-0001-6185-9423; Haro, Josep Maria/0000-0002-3984-277X; Scott, James G/0000-0002-0744-0688; Bernabe, Eduardo/0000-0002-1858-3713; Osborne, Richard H/0000-0002-9081-2699; Jacobsen, Kathryn H./0000-0002-4198-6246; Newton, Charles/0000-0002-6999-5507; Matzopoulos, Richard/0000-0001-9063-6210; Karthikeyan, Ganesan/0000-0002-2073-2917; Díaz-Torné, César/0000-0001-6275-7699; Ganatra, Hammad A/0000-0001-9534-2780; Tonelli, Marcello/0000-0002-0846-3187; Harrison, James/0000-0001-9893-8491; Condon, John R/0000-0003-4952-0990; Carapetis, Jonathan R/0000-0002-1182-9792; Prince, Martin J/0000-0003-1379-7146; Aggarwal, Rakesh/0000-0001-9689-494X; Bin Abdulhak, Aref/0000-0001-9988-8609; Braithwaite, Tasanee/0000-0002-3025-4066; Pourmalek, Farshad/0000-0002-2134-0771; Salomon, Joshua/0000-0003-3929-5515; Ortblad, Katrina/0000-0002-5675-8836; Davis, Adrian C/0000-0001-7134-7528; Lalloo, Ratilal/0000-0001-5822-1269; Higashi, Hideki/0000-0002-5534-0905; SHIN, HS/0000-0002-7263-6257; Polanczyk, Guilherme V./0000-0003-2311-3289; Bikbov, Boris/0000-0002-1925-7506; Bolliger, Ian W/0000-0001-8055-297X; Whiteford, Harvey A/0000-0003-4667-6623; Marks, Guy B./0000-0002-8976-8053; Baxter, Amanda/0000-0001-8198-9022; Jayaraman, Sudha/0000-0003-1094-5836; Degenhardt, Louisa J/0000-0002-8513-2218; Brugha, Traolach/0000-0002-9786-9591; Medina-Mora, María Elena I/0000-0001-9300-0752; Malekzadeh, Reza/0000-0002-9820-6335; WILKINSON, JAMES/0000-0003-1945-5622; Hotez, Peter/0000-0001-8770-1042; Shibuya, Kenji/0000-0003-2528-7530; Weissman, Myrna/0000-0003-3490-3075; Lin, John/0000-0003-2490-4453; Chen, Honglei/0000-0003-3446-7779; Knowlton, Lisa Marie/0000-0001-6046-5035; White, Richard Aubrey/0000-0002-6747-1726; Colquhoun, Samantha/0000-0002-6750-1147; O'Hanlon, Simon/0000-0002-6852-3911; Undurraga, Eduardo A./0000-0002-4425-1253; Porrini, Esteban/0000-0002-3056-4662; Lathlean, Timothy/0000-0001-7340-1567; Stolk, Wilma/0000-0001-9509-1328; Pandian, Jeyaraj/0000-0003-0028-1968; Smith, Emma/0000-0001-6510-2583; O'donnell, Colm/0000-0002-8004-450X; Mensah, George/0000-0002-0387-5326; Benjamin, Emelia/0000-0003-4076-2336; Farzadfar, Farshad/0000-0001-8288-4046; Mocumbi, Ana/0000-0002-9564-2860; Calabria, Bianca/0000-0001-6444-4696; Leasher, Janet/0000-0002-8779-5162; Burney, Peter/0000-0001-8635-5678; Pullan, Rachel/0000-0001-9844-1362; Budke, Christine/0000-0002-4750-0905; Tsilimbaris, Miltiadis/0000-0002-0130-1150; Remuzzi, Giuseppe/0000-0002-6194-3446; Cella, Claudia/0000-0002-9210-0775; Boufous, Soufiane/0000-0002-5686-1729; Cooper, Leslie/0000-0003-1002-3313; Basanez, Maria-Gloria/0000-0001-5031-3361; Mori, Rintaro/0000-0001-7656-6156; Mock, Charles/0000-0002-0564-568X; Merriman, Tony/0000-0003-0844-8726; Groeger, Justina/0000-0003-0324-3385; Kobusingye, Olive/0000-0003-2413-599X; Phillips, David/0000-0003-2569-1015; Pearce, Neil/0000-0002-9938-7852; Syed, Sana/0000-0003-0954-0583; Derrett, Sarah/0000-0003-2867-0498; Ebel, Beth/0000-0001-9310-8325; Alvarado, Miriam/0000-0003-2864-9410; Felson, David/0000-0002-2668-2447; King, Charles/0000-0001-8349-9270; Wolfe, Frederick/0000-0002-2801-6413; Mayosi, Bongani/0000-0001-6641-8950; Johns, Nicole/0000-0003-4513-4582; williams, hywel/0000-0002-5646-3093; Loane, Maria/0000-0002-1206-3637; Miller, Ted/0000-0002-0958-2639; Fevre, Eric/0000-0001-8931-4986; Jarvis, Deborah/0000-0002-1753-3896; Barrero, Lope/0000-0003-1503-0264; Blore, Jed/0000-0002-3649-8686; Dherani, Mukesh/0000-0002-3055-9636; Sanchez Riera, Lidia/0000-0003-0774-2480; Watt, Kerrianne/0000-0002-2275-081X; Ackerman, Ilana/0000-0002-6028-1612; Sleet, David/0000-0002-6165-3289; Rein, David/0000-0002-1271-5789; Taylor, Hugh/0000-0002-9437-784X; Gmel, Gerhard/0000-0001-9403-9405; Razavi, Homie/0000-0002-2658-6930; Pion, Sebastien/0000-0002-9468-7020; Morawska, Lidia/0000-0002-0594-9683; Shivakoti, Rupak/0000-0002-2773-9310; Tleyjeh, Imad/0000-0002-5551-0353; Bonaventure, Audrey/0000-0001-6665-8145; Duber, Herbert/0000-0002-5077-3170; Taylor, William/0000-0001-6075-8479; Blencowe, Hannah/0000-0003-1556-3159; Buckle, Geoffrey/0000-0001-7721-0397; Gabbe, Belinda/0000-0001-7096-7688; Malekzadeh, Reza/0000-0003-1043-3814; Feigin, Valery L./0000-0002-6372-1740; Woolf, Anthony/0000-0001-8482-8056; Mitchell, Philip/0000-0002-7954-5235; Ali, Mohammed/0000-0001-7266-2503; Aboyans, Victor/0000-0002-0322-9818	Berlin Heart Honoraria; Lundbeck; Medtronic; Prana Biotechnology; Safework Australia; Assurance-Maladie (CNAMTS) InVS; Inserm; CHU de Nancy; CHU de Nice; Conseil Regional de Lorraine; Societe Francaise de Negma-Lerads; Pfizer; Pierre Fabre Medicaments; Sanofi-Afentis France; Spanish Health Ministry; Hospital de Cruces Rheumatology Association; Novartis; National Council for Scientific and Technological Development (CNPq, Brazil); Takeda; Savient; Ardea; Regeneron; Allergan; URL pharmaceuticals; 36 companies; National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS); National Institutes of Aging (NIA); National Cancer Institute (NCI); Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); Wellcome Trust [098045, 085308]; Department of Health London for the National Health Service Information Centre; University of Leicester; Australian National Health and Medical Research Council (NHMRC); Monash University; Cabrini Health; BUPA Foundation; NIH; National Institute of Environmental Health Sciences; Africa Programme for Onchocerciasis Control (WHO/APOC); Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia; NIH [K23 AG034236]; Parkinson Council; Australian NHMRC; US Department of Veterans Affairs; Health Research Council of New Zealand; University of Otago; National Institute for Stroke and Applied Neurosciences; AUT University; NHMRC; Swedish Research Council [2011-1071]; Bill and Melinda Gates Foundation; Australian National Health and Medical Research Council; World Health Organization; World Mental Health Japan (WMH-J); Japan Ministry of Health, Labour, and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]; Australian Government; National Health and Medical Research Council of Australia; Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation; Royal Hobart Hospital Research Foundation; University of Tasmania; Tehran University of Medical Sciences; South African Medical Research Council Burden of Disease Research Unit; University of Cape Town School of Public Health and Family Medicine; Brien Holden Vision Institute; National Drug and Alcohol Research Centre (UNSW, Australia); Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant [ES015459]; Foundation for Alcohol Research and Education; Victorian Department of Health; Burke Global Health Fellowship; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; Spanish Society of Rheumatology (Sociedad Espanola de Reumatologia); European Center for Injury Prevention, Universidad de Navarra; Department of Health and Ageing; Commonwealth Government of Australia; Institute of Bone and Joint Research (IBJR); University of Sydney (USYD); National Institute of Environmental Health Sciences [ES00260]; Wellcome Trust UK; Medical Research Council UK; Anthony Cerami and Ann Dunne Research Trust; Medical Research Council [G0801056B, G0901214] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish; MRC [G0901214] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK069062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, ZIAES101986, T32ES015459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG034236] Funding Source: NIH RePORTER	Berlin Heart Honoraria; Lundbeck(Lundbeck Corporation); Medtronic(Medtronic); Prana Biotechnology; Safework Australia; Assurance-Maladie (CNAMTS) InVS; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CHU de Nancy; CHU de Nice; Conseil Regional de Lorraine(Region Grand-Est); Societe Francaise de Negma-Lerads; Pfizer(Pfizer); Pierre Fabre Medicaments; Sanofi-Afentis France; Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government); Hospital de Cruces Rheumatology Association; Novartis(Novartis); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Takeda(Takeda Pharmaceutical Company Ltd); Savient; Ardea; Regeneron(Regeneron); Allergan(AbbVieAllergan); URL pharmaceuticals; 36 companies; National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Aging (NIA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health London for the National Health Service Information Centre; University of Leicester; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); Cabrini Health; BUPA Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Africa Programme for Onchocerciasis Control (WHO/APOC); Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson Council; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); US Department of Veterans Affairs(US Department of Veterans Affairs); Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago; National Institute for Stroke and Applied Neurosciences; AUT University; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Swedish Research Council(Swedish Research CouncilEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); World Health Organization(World Health Organization); World Mental Health Japan (WMH-J); Japan Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Australian Government(Australian GovernmentCGIAR); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation; Royal Hobart Hospital Research Foundation; University of Tasmania; Tehran University of Medical Sciences(Tehran University of Medical Sciences); South African Medical Research Council Burden of Disease Research Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Cape Town School of Public Health and Family Medicine; Brien Holden Vision Institute; National Drug and Alcohol Research Centre (UNSW, Australia); Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant; Foundation for Alcohol Research and Education; Victorian Department of Health; Burke Global Health Fellowship; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; Spanish Society of Rheumatology (Sociedad Espanola de Reumatologia); European Center for Injury Prevention, Universidad de Navarra; Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Commonwealth Government of Australia(Australian Government); Institute of Bone and Joint Research (IBJR); University of Sydney (USYD); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Wellcome Trust UK(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Anthony Cerami and Ann Dunne Research Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	C E Canter has worked as an Optum Health consultant, Blue Cross Blue Shield consultant, and received Berlin Heart Honoraria and travel fees. E R Dorsey has received payments for consulting services from Lundbeck and Medtronic and research support from Lundbeck and Prana Biotechnology. T Driscoll was supported in part by funding from the National Occupational Health and Safety Commission (now Safework Australia). M Ezzati chaired a session and gave a talk at the World Cardiology Congress (WCC), with travel cost reimbursed by the World Heart Federation. At the WCC, he also gave a talk at a session organised by PepsiCo with no financial or other remuneration. F Guillemin conducted a study on osteoarthritis epidemiology in an institution that received grants from public sources: Assurance-Maladie (CNAMTS) InVS, Inserm, CHU de Nancy, CHU de Nice, Conseil Regional de Lorraine, Societe Francaise de Negma-Lerads, Pfizer, Pierre Fabre Medicaments, Sanofi-Afentis France. H J Hoffman is a US Federal Government employee of the National Institutes of Health (NIH). P J Hotez reports holding several positions: Dean, National School of Tropical Medicine, Baylor College of Medicine; Director, Sabin Vaccine Institute Texas Children's Hospital Center for Vaccine Development; and President, Sabin Vaccine Institute. He also is an inventor on several patents: 5,527,937 "Hookworm Anticoagulant"; 5,753,787 "Nucleic Acids for Ancylostoma Secreted Proteins"; 7,303,752 B2 "Hookworm vaccine"; 12/492,734 "Human Hookworm Vaccine"; 61/077,256 "Multivalent Anthelminthic Vaccine"; and PCT-20100701/0.20.5.18 "Malaria Transmission blocking vaccine". G Mensah is a former employee of PepsiCo. F Perez-Ruiz was an advisor for Ardea, Menarini, Novartis, Metabolex; was a member of the Speaker's Bureau for Menarini, Novartis; an advisor for educational issues for Savient; led investigation grants for the Spanish Health Ministry, Hospital de Cruces Rheumatology Association; and was principal investigator in clinical trials for Ardea. G V Polanczyk has served as a speaker and/or consultant to Eli-Lily, Novartis, Janssen-Cilag, and Shire Pharmaceuticals, developed educational material for Janssen-Cilag, and received an independent investigator grant from Novartis and from the National Council for Scientific and Technological Development (CNPq, Brazil). L Rushton received honorarium for board membership of the European Centre for Ecotoxicology and Toxicology of Chemicals and received research grants to Imperial College London (as PI) from the European Chemical Industry Council (CEFIC) and CONCAWE (Conservation of Clean Air and Water Europe). J A Singh has received research grants from Takeda and Savient and consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis. J A Singh is a member of the executive of OMERACT, an organisation that develops outcome measures in rheumatology and receives arms-length funding from 36 companies; a member of the American College of Rheumatology's Guidelines Subcommittee of the Quality of Care Committee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. J A Singh is supported by research grants from the National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Aging (NIA), National Cancer Institute (NCI), and the Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs) and is also supported by the resources and the use of facilities at the VA Medical Center at Birmingham, AL, USA.; We would like to thank the countless individuals who have contributed to the Global Burden of Disease 2010 study in various capacities. We would like to specifically acknowledge the important contribution to this work from multiple staff members of the World Health Organization. We also wish to express our gratitude to the following organisations that hosted consultations during the final stages of the analytic process, providing valuable feedback about the results and the data to improve the study's findings overall: Pan American Health Organization; Eastern Mediterranean Regional Office of WHO; UNAIDS; Ministry of Health, Brazil; China Centers for Disease Control; and the University of Zambia. We would like to thank Lori M Newman, Jordis Ott, Poul Erik Petersen, Shekhar Saxena, and Gretchen A Stevens for their collaboration and input into the analyses and estimates. Finally, we would like to acknowledge the extensive support from all staff members at the Institute for Health Metrics and Evaluation and specifically thank: James Bullard, Andrew Ernst, and Serkan Yalcin for their tireless support of the computational infrastructure required to produce the results; Linda A Ettinger for her expert administrative support in order to facilitate communication and coordination amongst the authors; Peter Speyer, Abigail McLain, Katherine Leach-Kemon, and Eden Stork for their persistent and valuable work to gain access to and catalog as much data as possible to inform the estimates; and Erin C Mullany for her systematic efforts in organising drafts of papers, formatting correspondence with expert groups, and preparing the final manuscript. The following individuals would like to acknowledge various forms of institutional support. J P Abraham, B Bartels, and P Yeh recognise the support of the World Bank Global Road Safety Facility and Department of Global Health & Population, Harvard School of Public Health, and the World Health Organization Violence and Injury Prevention. B Bikbov acknowledges support from the Moscow State University of Medicine and Dentistry, Moscow, Russia; Academician V I Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow, Russia; International Society of Nephrology. R Bourne acknowledges the Vision & Eye Research Unit, Postgraduate Medical Institute, Anglia Ruskin University, Cambridge, UK. S Brooker is supported by a Wellcome Trust Senior Fellowship in Basic Biomedical Science (098045). T S Brugha received funding from the Department of Health London, for the National Health Service Information Centre, by the University of Leicester. R Buchbinder is partially funded by an Australian National Health and Medical Research Council (NHMRC) Practitioner Fellowship, Monash University, and Cabrini Health. P Burney and D Jarvis acknowledge the Chronic Respiratory Disease group received funding from the BUPA Foundation. They had no role in study design, data collection and analysis, interpretation of data, decision to publish, or preparation of the manuscript. C Cella, M Cortinovis, F Gaspari, V Miglioli, and N Perico, on behalf of the entire Genitourinary Expert Group, acknowledge the International Society of Nephrology (ISN). H Chen acknowledges that his participation in this study was in part supported by the intramural research program of the NIH, the National Institute of Environmental Health Sciences. L E Coffeng, and W A Stolk received financial support from the Africa Programme for Onchocerciasis Control (WHO/APOC) for their work on onchocerciasis.; B C Cowie received institutional support from the Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia. M Cross and L March acknowledge the University of Sydney (USYD); Institute of Bone and Joint Research, University of Sydney, Department of Rheumatology, Royal North Shore Hospital, St Leonards NSW 2065 Australia. N Dahodwala was supported by NIH grant K23 AG034236 and the Parkinson Council while working on this project. L Degenhardt is supported by an Australian NHMRC Senior Research Fellowship and funding to support her work for illicit drug dependence was provided by the Australian National Drug and Alcohol Research Centre of the University of New South Wales, Australia. R Dellavalle was supported by the US Department of Veterans Affairs while contributing to this study. S Derrett acknowledges the Health Research Council of New Zealand and the University of Otago for their support. V Feigin and R Krishnamurthi were supported by the National Institute for Stroke and Applied Neurosciences, AUT University. E Fevre acknowledges the Wellcome Trust for grant 085308. W Hall was supported by an NHMRC Australia Fellowship. R Havmoeller was supported by a grant from the Swedish Research Council (#2011-1071). D Hoy was supported by the Bill and Melinda Gates Foundation and the Australian National Health and Medical Research Council. K H Jacobsen was supported by the World Health Organization for her work on hepatitis A. N Kawakami notes that the collection of data ultimately used in this study was supported by the following grants: The World Mental Health Japan (WMH-J) is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labour, and Welfare. He would like to thank staff members, field coordinators, and interviewers of the WMH Japan 2002-2004 Survey. L L Laslett is supported by an Australian Government Australian Postgraduate Award. She also notes that the TasOAC study, the results of which were used in this research, was supported by the National Health and Medical Research Council of Australia; Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation, Royal Hobart Hospital Research Foundation, and University of Tasmania Institutional Research Grants Scheme. R Malekzadeh received funding from a research grant of Tehran University of Medical Sciences to do the related studies. R Matzopoulos acknowledges the two institutions that support his research work: South African Medical Research Council Burden of Disease Research Unit; and the University of Cape Town School of Public Health and Family Medicine. T Merriman acknowledges the Health Research Council of New Zealand. K Naidoo was supported by the Brien Holden Vision Institute. P Nelson was supported by the National Drug and Alcohol Research Centre (UNSW, Australia). R G Nelson acknowledges his research was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. C Olives was funded in part by the Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant (ES015459). D Ozgediz acknowledges the staff and collaborators at the Mulago Hospital and Makerere University in Kampala, Uganda. K Pesudovs received institutional support from Flinders University.; R Room's position at the University of Melbourne and Turning Point Alcohol and Drug Centre is funded by the Foundation for Alcohol Research and Education and the Victorian Department of Health. J A Salomon received support from the Burke Global Health Fellowship while working on this study. U Sampson received funding support from the Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation and the Vanderbilt Clinical and Translational Scholars Award. L Sanchez-Riera acknowledges the Spanish Society of Rheumatology (Sociedad Espanola de Reumatologia). M Segui-Gomez's participation was partly supported by funds from the European Center for Injury Prevention, Universidad de Navarra. E Smith acknowledges the Department of Health and Ageing, Commonwealth Government of Australia, Institute of Bone and Joint Research (IBJR), University of Sydney (USYD). G D Thurston was supported in part by Center grant ES00260 from the National Institute of Environmental Health Sciences. D J Weatherall was supported by the Wellcome Trust UK, the Medical Research Council UK and the Anthony Cerami and Ann Dunne Research Trust.	Adair T, 2012, INT J TUBERC LUNG D, V16, P1699, DOI 10.5588/ijtld.12.0251; Ahern RM, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-8; [Anonymous], 2002, WORLD MORTALITY 2000; [Anonymous], WORLD HLTH REP 2004; [Anonymous], 2006, HIGHL HLTH EST 2005; [Anonymous], 2011, VIET NAM BURD DIS IN; [Anonymous], MALAWI MED J; [Anonymous], 2005, NCMH BACKGR PAP BURD; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Bundhamcharoen K, 2002, THAI WORKING GROUP B; Bundhamcharoen K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-53; Carp FM, 2000, ELDER ABUSE FAMILY I; Lopez FC, 2009, REV ESP SALUD PUBLIC, V83, P137, DOI [10.1590/S1135-57272009000100011, 10.1590/s1135-57272009000100011]; Chalk R, 1998, VIOLENCE FAMILIES AS; CHAMIE M, 1995, DISABIL REHABIL, V17, P323, DOI 10.3109/09638289509166718; Chapman G, 2006, TROP MED INT HEALTH, V11, P660, DOI 10.1111/j.1365-3156.2006.01601.x; Coyte PC, 1998, ARTHRIT CARE RES, V11, P315, DOI 10.1002/art.1790110503; de Salud M, 2004, ESTUDIO CARGA ENFERM; Departamento de Epidemiologia MINSAL, 2007, EST CARG ENF CARG AT; Dgedge M, 2001, B WORLD HEALTH ORGAN, V79, P546; Dodhia H, 2008, J PUBLIC HEALTH-UK, V30, P313, DOI 10.1093/pubmed/fdn015; Escobar M, 1994, CARGA ENFERMEDAD COL; Fouad D, 2007, ECOMOD2007 C; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Friedman C, 2004, J OCCUP ENVIRON MED, V46, P3, DOI 10.1097/01.jom.0000105915.59342.9a; Fukuda Y, 1999, J HLTH WELFARE STAT, V46, P28; Gadelha AMJ, 1998, PROJETO CARGA DOENCA; Genova-Maleras R, 2012, PUBLIC HEALTH, V126, P1024, DOI 10.1016/j.puhe.2012.08.012; Green S, 2007, BURDEN DIS ILLNESS U; Grosse SD, 2009, PUBLIC HEALTH REP, V124, P197, DOI 10.1177/003335490912400206; Heise L L, 1998, Violence Against Women, V4, P262, DOI 10.1177/1077801298004003002; Hsairi M, 2003, Sante Publique, V15, P25; Hu GP, 2010, CHEST, V138, P20, DOI 10.1378/chest.08-2114; Hurley Susan F, 2007, Cost Eff Resour Alloc, V5, P2, DOI 10.1186/1478-7547-5-2; Hyder AA, 1998, AM J PUBLIC HEALTH, V88, P196, DOI 10.2105/AJPH.88.2.196; Hyder AA, 2000, AM J PUBLIC HEALTH, V90, P1235, DOI 10.2105/AJPH.90.8.1235; Hyder AA, 2012, AM J PUBLIC HEALTH, V102, P1061, DOI 10.2105/AJPH.2011.300563; Ikeda S, 1998, J HLTH CARE SOC, V8, P83; Jankovic S, 2007, EUR J PUBLIC HEALTH, V17, P80, DOI 10.1093/eurpub/ckl072; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Kominski GF, 2002, PUBLIC HEALTH REP, V117, P185, DOI 10.1016/S0033-3549(04)50125-5; Kosen S, 1998, ESTIMATION NATL BURD; Kurmi OP, 2010, THORAX, V65, P221, DOI 10.1136/thx.2009.124644; Lai T, 2009, EUR J PUBLIC HEALTH, V19, P541, DOI 10.1093/eurpub/ckp038; Lapostolle A, 2008, EUR J PUBLIC HEALTH, V18, P195, DOI 10.1093/eurpub/ckm109; Leonardi M, 2006, LANCET, V368, P1219, DOI 10.1016/S0140-6736(06)69498-1; Logan WPD, 1950, POP STUD-J DEMOG, V4, P132, DOI 10.2307/2172133; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lozada P, 1999, PESO ENFERMEDAD ECUA; Lozano R, 2009, CARGA ENFERMEDAD MUN; Lozano R., 1995, J INT DEV, V7, P555, DOI DOI 10.1002/JID.3380070314; Lozano R., 1997, PESO ENFERMEDAD MEXI, P23; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mariotti S, 2003, EUR J EPIDEMIOL, V18, P513, DOI 10.1023/A:1024635401206; Marks G, 1997, HLTH ADULT BRITAIN 1; Mathers CD, 2000, MED J AUSTRALIA, V172, P592, DOI 10.5694/j.1326-5377.2000.tb124125.x; Mathers CD, 2001, LANCET, V357, P1685, DOI 10.1016/S0140-6736(00)04824-8; Mathers CD, 2001, B WORLD HEALTH ORGAN, V79, P1076; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Mathur P., 2011, INDIAN J COMMUNITY M, V36, pS72, DOI [10.4103/0970-0218.94713, DOI 10.4103/0970-0218.94713]; McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009; Melse JM, 2000, AM J PUBLIC HEALTH, V90, P1241, DOI 10.2105/AJPH.90.8.1241; Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11; Ministerio de Salud de Costa Rica, 2008, MED CARG ENF COST RI; Ministry of Health, 2004, BURD DIS FIN REP; Ministry of Health, 2001, MIN HLTH PUBL HLTH I; Murray, 2002, SUMMARY MEASURES POP, P205; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Murray CJL., 1996, GLOBAL HLTH STAT COM, V1996; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Norman R., 2006, REVISED BURDEN DIS E; Oh IH, 2011, J KOREAN MED ASSOC, V54, P646, DOI 10.5124/jkma.2011.54.6.646; Peden M., 2004, WORLD REPORT ROAD TR; Peterson S, 1998, SJUKDOMSBORDAN SVERI; Phua HP, 2009, SINGAP MED J, V50, P468; Polinder S, 2012, EPIDEMIOL REV, V34, P17, DOI 10.1093/epirev/mxr022; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Reiss A, 1993, VIOLENCE FAMILIES UN; Rodriguez J, 2008, CARGA ENFERMEDAD COL; Rodriguez J, 2000, CARGA GLOBAL ENFERME; Salas Vergara J, 1996, ESTUDIO PRIORIDADES; Salomon J.A., 2003, HLTH SYSTEMS PERFORM, P301; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Samutharuk B., 1999, MEASUREMENT DIS BURD; Schiamberg LB, 1999, J ELDER ABUSE NEGL, V11, P79, DOI 10.1300/J084v11n01_05; Schopper D, 2000, INT J EPIDEMIOL, V29, P871, DOI 10.1093/ije/29.5.871; Seuc AH, 2010, CAD SAUDE PUBLICA, V26, P615, DOI 10.1590/S0102-311X2010000300018; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; The Thai Working Group on Burden of Disease and Injury, 2004, J HEALTH SCI, V13, P239; Thomas C, 2004, DISABIL SOC, V19, P569, DOI 10.1080/0968759042000252506; United Nations, UN ROAD SAF; Velasquez Valdivia A., 2006, ANALISIS ESTUDIO CAR; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; *WHO, WORLD HLTH REP 1999; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, WORLD HLTH REP 2002; World Health Organization, WORLD HLTH REP 2001; World Health Organization, REG BURD DIS EST 200; World Health Organization, 2010, VIOLENCE PREVENTION; World Health Organization, WORLD HLTH REP 2000; YELIN E, 1995, ARTHRITIS RHEUM, V38, P1351, DOI 10.1002/art.1780381002; Yoon SJ, 2007, J KOREAN MED SCI, V22, P518, DOI 10.3346/jkms.2007.22.3.518; Yusoff AF, MALAYSIAN BURDEN DIS; Zhou SC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-188	112	5513	5743	53	1491	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2197	2223		10.1016/S0140-6736(12)61689-4	http://dx.doi.org/10.1016/S0140-6736(12)61689-4			27	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245608	Green Submitted			2022-12-24	WOS:000312387000016
J	Basset, Y; Cizek, L; Cuenoud, P; Didham, RK; Guilhaumon, F; Missa, O; Novotny, V; Odegaard, F; Roslin, T; Schmidl, J; Tishechkin, AK; Winchester, NN; Roubik, DW; Aberlenc, HP; Bail, J; Barrios, H; Bridle, JR; Castano-Meneses, G; Corbara, B; Curletti, G; da Rocha, WD; de Bakker, D; Delabie, JHC; Dejean, A; Fagan, LL; Floren, A; Kitching, RL; Medianero, E; Miller, SE; de Oliveira, EG; Orivel, J; Pollet, M; Rapp, M; Ribeiro, SP; Roisin, Y; Schmidt, JB; Sorensen, L; Leponce, M				Basset, Yves; Cizek, Lukas; Cuenoud, Philippe; Didham, Raphael K.; Guilhaumon, Francois; Missa, Olivier; Novotny, Vojtech; Odegaard, Frode; Roslin, Tomas; Schmidl, Juergen; Tishechkin, Alexey K.; Winchester, Neville N.; Roubik, David W.; Aberlenc, Henri-Pierre; Bail, Johannes; Barrios, Hector; Bridle, Jon R.; Castano-Meneses, Gabriela; Corbara, Bruno; Curletti, Gianfranco; da Rocha, Wesley Duarte; de Bakker, Domir; Delabie, Jacques H. C.; Dejean, Alain; Fagan, Laura L.; Floren, Andreas; Kitching, Roger L.; Medianero, Enrique; Miller, Scott E.; de Oliveira, Evandro Gama; Orivel, Jerome; Pollet, Marc; Rapp, Mathieu; Ribeiro, Servio P.; Roisin, Yves; Schmidt, Jesper B.; Sorensen, Line; Leponce, Maurice			Arthropod Diversity in a Tropical Forest	SCIENCE			English	Article							HOST-SPECIFICITY; SPECIES RICHNESS; HERBIVOROUS INSECTS; BETA-DIVERSITY; ANT FAUNA; BIODIVERSITY	Most eukaryotic organisms are arthropods. Yet, their diversity in rich terrestrial ecosystems is still unknown. Here we produce tangible estimates of the total species richness of arthropods in a tropical rainforest. Using a comprehensive range of structured protocols, we sampled the phylogenetic breadth of arthropod taxa from the soil to the forest canopy in the San Lorenzo forest, Panama. We collected 6144 arthropod species from 0.48 hectare and extrapolated total species richness to larger areas on the basis of competing models. The whole 6000-hectare forest reserve most likely sustains 25,000 arthropod species. Notably, just 1 hectare of rainforest yields >60% of the arthropod biodiversity held in the wider landscape. Models based on plant diversity fitted the accumulated species richness of both herbivore and nonherbivore taxa exceptionally well. This lends credence to global estimates of arthropod biodiversity developed from plant models.	[Basset, Yves; Roubik, David W.] Smithsonian Trop Res Inst, Panama City, Panama; [Basset, Yves; Cizek, Lukas; Novotny, Vojtech] Univ S Bohemia, Ceske Budejovice 37005, Czech Republic; [Basset, Yves] Univ Panama, Panama City, Panama; [Cizek, Lukas; Novotny, Vojtech] Acad Sci Czech Republ, Ceske Budejovice 37005, Czech Republic; [Cuenoud, Philippe] Museum Hist Nat Ville Geneve, CH-1208 Geneva, Switzerland; [Didham, Raphael K.] Univ Western Australia, Perth, WA 6009, Australia; [Didham, Raphael K.] CSIRO Ecosyst Sci, Perth, WA 6009, Australia; [Guilhaumon, Francois] Univ Evora, Catedra Rui Nabeiro, P-7004516 Evora, Portugal; [Missa, Olivier] Univ York, York YO10 5DD, N Yorkshire, England; [Odegaard, Frode] Norwegian Inst Nat Res, N-7485 Trondheim, Norway; [Roslin, Tomas] Univ Helsinki, FIN-00014 Helsinki, Finland; [Schmidl, Juergen; Bail, Johannes] Univ Erlangen Nurnberg, D-91058 Erlangen, Germany; [Tishechkin, Alexey K.] Santa Barbara Museum Nat Hist, Santa Barbara, CA 93105 USA; [Winchester, Neville N.] Univ Victoria, Victoria, BC V8W 2Y2, Canada; [Aberlenc, Henri-Pierre] Cirad, F-34988 Montferrier Sur Lez, France; [Bridle, Jon R.] Univ Bristol, Bristol BS8 1UD, Avon, England; [Castano-Meneses, Gabriela] Univ Nacl Autonoma Mexico, Mexico City 0510, DF, Mexico; [Corbara, Bruno] Univ Blaise Pascal, F-63000 Clermont Ferrand, France; [Curletti, Gianfranco] Museo Civico Storia Nat, I-10022 Carmagnola, Italy; [da Rocha, Wesley Duarte; Delabie, Jacques H. C.] Ctr Pesquisas Cacau, BR-45600000 Itabuna, Brazil; [da Rocha, Wesley Duarte; Delabie, Jacques H. C.] Univ Estadual Santa Cruz, BR-45662900 Ilheus, Brazil; [de Bakker, Domir] Inst Royal Sci Nat Belgique, B-1000 Brussels, Belgium; [Dejean, Alain] Univ Toulouse 3, F-31062 Toulouse, France; [Floren, Andreas] Univ Wurzburg, D-97070 Wurzburg, Germany; [Kitching, Roger L.] Griffith Univ, Nathan, Qld 4111, Australia; [Miller, Scott E.] Natl Museum Nat Hist, Washington, DC 20008 USA; [de Oliveira, Evandro Gama] Ctr Univ UNA, Belo Horizonte, MG, Brazil; [Orivel, Jerome] CNRS, F-97379 Kourou, France; [Pollet, Marc] Res Inst Nat & Forest, B-1070 Brussels, Belgium; [Rapp, Mathieu] Museum Hist Nat, CH-2000 Neuchatel, Switzerland; [Ribeiro, Servio P.] Univ Fed Ouro Preto, BR-35400000 Ouro Preto, MG, Brazil; [Roisin, Yves] Univ Libre Bruxelles, B-1050 Brussels, Belgium; [Schmidt, Jesper B.; Sorensen, Line] Nat Hist Museum Denmark, DK-2100 Copenhagen, Denmark	Smithsonian Institution; Smithsonian Tropical Research Institute; University of South Bohemia Ceske Budejovice; Universidad de Panama; Czech Academy of Sciences; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Evora; University of York - UK; Norwegian Institute Nature Research; University of Helsinki; University of Erlangen Nuremberg; University of Victoria; CIRAD; University of Bristol; Universidad Nacional Autonoma de Mexico; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universidade Estadual de Santa Cruz; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Wurzburg; Griffith University; Smithsonian Institution; Smithsonian National Museum of Natural History; Centro Universitario UNA; Centre National de la Recherche Scientifique (CNRS); Research Institute for Nature & Forest; Universidade Federal de Ouro Preto; Universite Libre de Bruxelles	Basset, Y (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	bassety@si.edu	Basset, Yves F/B-6642-2014; Ribeiro, Sérvio Pontes/AAG-1146-2020; Novotny, Vojtech/G-9434-2014; Roslin, Tomas/E-8648-2016; Delabie, Jacques H C/F-3405-2010; Ribeiro, Sérvio/G-1887-2012; Missa, Olivier/G-2687-2012; Guilhaumon, François/C-3240-2009; Cizek, Lukas/K-7111-2015; Cizek, Lukas/G-7905-2014; Guilhaumon, francois/GPX-7180-2022; Didham, Raphael K/B-5953-2011	Basset, Yves F/0000-0002-1942-5717; Ribeiro, Sérvio Pontes/0000-0002-0191-8759; Novotny, Vojtech/0000-0001-7918-8023; Roslin, Tomas/0000-0002-2957-4791; Delabie, Jacques H C/0000-0002-2695-1061; Ribeiro, Sérvio/0000-0002-0191-8759; Missa, Olivier/0000-0002-4330-5192; Cizek, Lukas/0000-0002-6447-2002; Cizek, Lukas/0000-0002-6447-2002; Guilhaumon, francois/0000-0003-4707-8932; Miller, Scott/0000-0002-4138-1378; Roisin, Yves/0000-0001-6635-3552; CORBARA, Bruno/0000-0003-4232-8234; Orivel, Jerome/0000-0002-5636-3228; Dejean, Alain/0000-0002-3561-2248; Bridle, Jonathan/0000-0002-5999-0307	STRI; United Nations Environment Programme; Smithsonian Institution (Walcott Fund); European Science Foundation; Global Canopy Programme; SolVin-Solvay SA	STRI(Smithsonian InstitutionSmithsonian Tropical Research Institute); United Nations Environment Programme; Smithsonian Institution (Walcott Fund)(Smithsonian InstitutionSmithsonian National Museum of Natural History); European Science Foundation(European Science Foundation (ESF)European Commission); Global Canopy Programme; SolVin-Solvay SA(Solvay SA)	IBISCA-Panama is an initiative of Pro-Natura International, Ocean Vert, the universities Blaise Pascal and of Panama, and the Smithsonian Tropical Research Institute (STRI), with core funding from SolVin-Solvay SA, STRI, the United Nations Environment Programme, the Smithsonian Institution (Walcott Fund), the European Science Foundation, and the Global Canopy Programme. J. Herrera, E. Andrade, M. Samaniego, S. J. Wright, N. Baiben, S. Bechet, J. Belleguic, T. Aubert, K. Jordan, G. Ebersolt, D. Cleyet-Marrel, L. Pyot, O. Pascal, P. Basset, and E. Bauhaus helped with logistics in the field. A. Barba, R. Cabrera, A. Cornejo, I. Diaz, A. F. R. do Carmo, I. C. do Nascimento, E. A. dos Santos, M. Gonzalez, A. Hernandez, M. Manumbor, M. Mogia, S. Pinzon, B. Perez, L. S. Ramos-Lacau, and O. Valdez helped with initial sorting of the arthropod and plant material. Data (as of 10 May 2012) have been deposited in the Dryad repository: http://dx.doi.org/10.5061/dryad.f3p75.	Basset Y, 2001, PLANT ECOL, V153, P87, DOI 10.1023/A:1017581406101; BASSET Y, 2003, ARTHROPODS TROPICAL; Bonebrake TC, 2010, BIOL CONSERV, V143, P1831, DOI 10.1016/j.biocon.2010.04.044; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Hamilton AJ, 2011, AM NAT, V177, P544, DOI 10.1086/659643; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Kitching Roger L., 2011, Memoirs of the Queensland Museum, V55, P235; Lewinsohn TM, 2008, ECOL LETT, V11, P398, DOI 10.1111/j.1461-0248.2008.01155.x; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; Longino JT, 1997, ECOL APPL, V7, P1263, DOI 10.1890/1051-0761(1997)007[1263:BAUSIC]2.0.CO;2; May RM, 2004, PHILOS T ROY SOC B, V359, P733, DOI 10.1098/rstb.2003.1455; May RM, 2010, SCIENCE, V329, P41, DOI 10.1126/science.1191058; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Novotny V, 2004, CONSERV BIOL, V18, P227, DOI 10.1111/j.1523-1739.2004.00293.x; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Odegaard F, 2006, BIODIVERS CONSERV, V15, P83, DOI 10.1007/s10531-004-3106-5; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Strong D.R., 1984, INSECTS PLANTS COMMU; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	24	320	354	17	579	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1481	1484		10.1126/science.1226727	http://dx.doi.org/10.1126/science.1226727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239740	Green Submitted			2022-12-24	WOS:000312250800051
J	Curtis, BA; Tanifuji, G; Burki, F; Gruber, A; Irimia, M; Maruyama, S; Arias, MC; Ball, SG; Gile, GH; Hirakawa, Y; Hopkins, JF; Kuo, A; Rensing, SA; Schmutz, J; Symeonidi, A; Elias, M; Eveleigh, RJM; Herman, EK; Klute, MJ; Nakayama, T; Obornik, M; Reyes-Prieto, A; Armbrust, EV; Aves, SJ; Beiko, RG; Coutinho, P; Dacks, JB; Durnford, DG; Fast, NM; Green, BR; Grisdale, CJ; Hempel, F; Henrissat, B; Hoppner, MP; Ishida, KI; Kim, E; Koreny, LK; Kroth, PG; Liu, Y; Malik, SB; Maier, UG; McRose, D; Mock, T; Neilson, JAD; Onodera, NT; Poole, AM; Pritham, EJ; Richards, TA; Rocap, G; Roy, SW; Sarai, C; Schaack, S; Shirato, S; Slamovits, CH; Spencer, DF; Suzuki, S; Worden, AZ; Zauner, S; Barry, K; Bell, C; Bharti, AK; Crow, JA; Grimwood, J; Kramer, R; Lindquist, E; Lucas, S; Salamov, A; McFadden, GI; Lane, CE; Keeling, PJ; Gray, MW; Grigoriev, IV; Archibald, JM				Curtis, Bruce A.; Tanifuji, Goro; Burki, Fabien; Gruber, Ansgar; Irimia, Manuel; Maruyama, Shinichiro; Arias, Maria C.; Ball, Steven G.; Gile, Gillian H.; Hirakawa, Yoshihisa; Hopkins, Julia F.; Kuo, Alan; Rensing, Stefan A.; Schmutz, Jeremy; Symeonidi, Aikaterini; Elias, Marek; Eveleigh, Robert J. M.; Herman, Emily K.; Klute, Mary J.; Nakayama, Takuro; Obornik, Miroslav; Reyes-Prieto, Adrian; Armbrust, E. Virginia; Aves, Stephen J.; Beiko, Robert G.; Coutinho, Pedro; Dacks, Joel B.; Durnford, Dion G.; Fast, Naomi M.; Green, Beverley R.; Grisdale, Cameron J.; Hempel, Franziska; Henrissat, Bernard; Hoeppner, Marc P.; Ishida, Ken-Ichiro; Kim, Eunsoo; Koreny, Lude. K.; Kroth, Peter G.; Liu, Yuan; Malik, Shehre-Banoo; Maier, Uwe G.; McRose, Darcy; Mock, Thomas; Neilson, Jonathan A. D.; Onodera, Naoko T.; Poole, Anthony M.; Pritham, Ellen J.; Richards, Thomas A.; Rocap, Gabrielle; Roy, Scott W.; Sarai, Chihiro; Schaack, Sarah; Shirato, Shu; Slamovits, Claudio H.; Spencer, David F.; Suzuki, Shigekatsu; Worden, Alexandra Z.; Zauner, Stefan; Barry, Kerrie; Bell, Callum; Bharti, Arvind K.; Crow, John A.; Grimwood, Jane; Kramer, Robin; Lindquist, Erika; Lucas, Susan; Salamov, Asaf; McFadden, Geoffrey I.; Lane, Christopher E.; Keeling, Patrick J.; Gray, Michael W.; Grigoriev, Igor V.; Archibald, John M.			Algal genomes reveal evolutionary mosaicism and the fate of nucleomorphs	NATURE			English	Article							GENE-TRANSFER; NUCLEUS; CHLORARACHNIOPHYTE; PROTEINS; SEQUENCE; GREEN; RED; CRYPTOPHYTES; EUKARYOTES; HISTORY	Cryptophyte and chlorarachniophyte algae are transitional forms in the widespread secondary endosymbiotic acquisition of photosynthesis by engulfment of eukaryotic algae. Unlike most secondary plastid-bearing algae, miniaturized versions of the endosymbiont nuclei (nucleomorphs) persist in cryptophytes and chlorarachniophytes. To determine why, and to address other fundamental questions about eukaryote-eukaryote endosymbiosis, we sequenced the nuclear genomes of the cryptophyte Guillardia theta and the chlorarachniophyte Bigelowiella natans. Both genomes have >21,000 protein genes and are intron rich, and B. natans exhibits unprecedented alternative splicing for a single-celled organism. Phylogenomic analyses and subcellular targeting predictions reveal extensive genetic and biochemical mosaicism, with both host-and endosymbiont-derived genes servicing the mitochondrion, the host cell cytosol, the plastid and the remnant endosymbiont cytosol of both algae. Mitochondrion-to-nucleus gene transfer still occurs in both organisms but plastid-to-nucleus and nucleomorph-to-nucleus transfers do not, which explains why a small residue of essential genes remains locked in each nucleomorph.	[Curtis, Bruce A.; Tanifuji, Goro; Maruyama, Shinichiro; Gile, Gillian H.; Hopkins, Julia F.; Eveleigh, Robert J. M.; Malik, Shehre-Banoo; Onodera, Naoko T.; Slamovits, Claudio H.; Spencer, David F.; Grigoriev, Igor V.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Curtis, Bruce A.; Tanifuji, Goro; Maruyama, Shinichiro; Nakayama, Takuro; Onodera, Naoko T.; Spencer, David F.] Dalhousie Univ, Ctr Comparat Genom & Evolutionary Bioinformat, Halifax, NS B3H 4R2, Canada; [Curtis, Bruce A.; Tanifuji, Goro; Burki, Fabien; Maruyama, Shinichiro; Nakayama, Takuro; Reyes-Prieto, Adrian] Univ British Columbia, Integrated Microbial Biodivers Program, Canadian Inst Adv Res, Vancouver, BC V6T 1Z4, Canada; [Burki, Fabien; Hirakawa, Yoshihisa] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Gruber, Ansgar] Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany; [Irimia, Manuel] Univ Toronto, Dept Med Res, Toronto, ON M5S 3E1, Canada; [Arias, Maria C.; Ball, Steven G.] Banting & Best Sci & Technol Lille, F-59655 Villeneuve Dascq, France; [Kuo, Alan] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Rensing, Stefan A.; Schmutz, Jeremy] Univ Freiburg, Fac Biol, D-79085 Freiburg, Germany; [Schmutz, Jeremy] HudsonAlpha Genome Sequencing Ctr, Huntsville, AL 35806 USA; [Elias, Marek] Univ Ostrava, Fac Sci, Dept Biol & Ecol, Life Sci Res Ctr, Ostrava 71000, Czech Republic; [Eveleigh, Robert J. M.] Genome Quebec, Montreal, PQ H3A 1A4, Canada; [Herman, Emily K.; Klute, Mary J.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; [Obornik, Miroslav] Univ S Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Obornik, Miroslav] Univ S Bohemia, Biol Ctr, Ceske Budejovice 37005, Czech Republic; [Obornik, Miroslav] Acad Sci Czech Republ, Inst Microbiol, Trebon 37981, Czech Republic; [Reyes-Prieto, Adrian] Univ New Brunswick, Dept Biol, Fredericton, NB E3B 5A3, Canada; [Armbrust, E. Virginia] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Aves, Stephen J.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4QD, Devon, England; [Beiko, Robert G.] Dalhousie Univ, Fac Comp Sci, Halifax, NS B3H 4R2, Canada; [Coutinho, Pedro] Aix Marseille Univ, CNRS UMR 7257, F-13228 Marseille, France; [Hempel, Franziska] LOEWE Zentrum Synthet Mikrobiol Synmikro, D-35032 Marburg, Germany; [Hoeppner, Marc P.] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Ishida, Ken-Ichiro] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kim, Eunsoo] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Liu, Yuan] Nat Hist Museum, London SW7 5BD, England; [McRose, Darcy] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Mock, Thomas] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Poole, Anthony M.] Univ Canterbury, Biomol Interact Ctr, Christchurch 8140, New Zealand; [Pritham, Ellen J.] Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; [Roy, Scott W.] San Francisco State Univ, San Francisco, CA 94132 USA; [Schaack, Sarah] Reed Coll, Portland, OR 97202 USA; [Kramer, Robin] Natl Ctr Genome Resources, Santa Fe, NM 87505 USA; [McFadden, Geoffrey I.] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia; [Lane, Christopher E.] Univ Rhode Isl, Kingston, RI 02881 USA	Dalhousie University; Dalhousie University; Canadian Institute for Advanced Research (CIFAR); University of British Columbia; University of British Columbia; University of Konstanz; University of Toronto; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Freiburg; HudsonAlpha Institute for Biotechnology; University of Ostrava; University of Alberta; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of New Brunswick; University of Washington; University of Washington Seattle; University of Exeter; Dalhousie University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Uppsala University; University of Tsukuba; American Museum of Natural History (AMNH); Natural History Museum London; Monterey Bay Aquarium Research Institute; University of East Anglia; University of Canterbury; California State University System; San Francisco State University; Reed College - Oregon; National Center for Genome Resources (NCGR); University of Melbourne; University of Rhode Island	Archibald, JM (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada.	john.archibald@dal.ca	Irimia, Manuel/E-3040-2010; Henrissat, Bernard/J-2475-2012; Grimwood, Jane/ABD-5737-2021; Koreny, Ludek/G-9766-2014; Maruyama, Shinichiro/AAO-4764-2021; NAKAYAMA, Takuro/AAT-9444-2020; Barry, Kerrie Whitelaw/AAA-5500-2020; Slamovits, Claudio/E-2591-2011; Worden, Alexandra Z./AAD-6567-2019; Green, Beverley R./AAJ-5199-2021; Schmutz, Jeremy/N-3173-2013; Mock, Thomas/A-3127-2008; Dacks, Joel/AAE-3308-2021; McFadden, Geoffrey McFadden I/F-7667-2014; Tanifuji, Goro/O-9172-2015; Burki, Fabien/F-4818-2010; Elias, Marek/D-6851-2014; Arias, Maria Cecilia/H-4886-2012; Hirakawa, Yoshihisa/A-6119-2012; Kroth, Peter G/A-9728-2008; Obornik, Miroslav/G-9350-2014; Gruber, Ansgar/B-9587-2008	Irimia, Manuel/0000-0002-2179-2567; Henrissat, Bernard/0000-0002-3434-8588; NAKAYAMA, Takuro/0000-0001-5135-0156; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Slamovits, Claudio/0000-0003-3050-1474; Green, Beverley R./0000-0002-4021-9387; Schmutz, Jeremy/0000-0001-8062-9172; Mock, Thomas/0000-0001-9604-0362; Dacks, Joel/0000-0003-4520-5694; McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Elias, Marek/0000-0003-0066-6542; Kroth, Peter G/0000-0003-4734-8955; Gruber, Ansgar/0000-0002-5876-4391; Grisdale, Cameron/0000-0003-1923-6972; Burki, Fabien/0000-0002-8248-8462; Grigoriev, Igor/0000-0002-3136-8903; Koreny, Ludek/0000-0002-9979-3172; Worden, Alexandra/0000-0002-9888-9324; Malik, Shehre-Banoo/0000-0003-0833-0648; Rocap, Gabrielle/0000-0001-7253-611X; Gray, Michael/0000-0001-7125-2625; Aves, Stephen/0000-0002-5600-900X; McRose, Darcy/0000-0001-9637-7176; Keeling, Patrick/0000-0002-7644-0745; Poole, Anthony/0000-0001-9940-2824; Ball, Steven/0000-0003-1629-1650; Hirakawa, Yoshihisa/0000-0002-3780-354X; Richards, Thomas/0000-0002-9692-0973	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Natural Sciences and Engineering Research Council of Canada; Biotechnology and Biological Sciences Research Council [BB/G00885X/1, BB/G00885X/2] Funding Source: researchfish; Alberta Innovates [201001324] Funding Source: researchfish; BBSRC [BB/G00885X/2, BB/G00885X/1] Funding Source: UKRI	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alberta Innovates; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract no. DE-AC02-05CH11231. RNA-seq data used in the paper were generated by the National Center for Genome Resources as part of the Gordon and Betty Moore Foundation's Marine Microbial Eukaryote Transcriptome Project. B. A. C. and J.F.H. were supported by a Special Research Opportunities Grant from the Natural Sciences and Engineering Research Council of Canada awarded to J.M.A. and M. W. G. J.M.A., P.J.K., M. W. G. and C. H. S. are members of the Canadian Institute for Advanced Research, Program in Integrated Microbial Biodiversity. G. I. M. is an Australian Research Council Federation Fellow and a Howard Hughes International Scholar. We thank R. A. Andersen (Bigelow Laboratories) for assistance with single-cell isolations, C. X. Chan for a tree-sorting PERL script, H. Gutierrez for help with SM protein family annotation, and B. Read for permission to analyse the Emiliania huxleyi genome sequenced by the JGI.	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Archibald JM, 2003, P NATL ACAD SCI USA, V100, P7678, DOI 10.1073/pnas.1230951100; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Barbrook AC, 2006, TRENDS PLANT SCI, V11, P101, DOI 10.1016/j.tplants.2005.12.004; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bradley RK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001229; Burki F, 2012, GENOME BIOL EVOL, V4, P738, DOI 10.1093/gbe/evs049; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Curtis BA, 2010, CURR BIOL, V20, pR919, DOI 10.1016/j.cub.2010.09.038; Deschamps P, 2006, EUKARYOT CELL, V5, P954, DOI 10.1128/EC.00380-05; Deschamps P, 2012, GENOME BIOL EVOL, V4, P795, DOI 10.1093/gbe/evs053; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; Freitag J, 2012, NATURE, V485, P522, DOI 10.1038/nature11051; Gile GH, 2008, MOL BIOL EVOL, V25, P1967, DOI 10.1093/molbev/msn147; Gilson PR, 2006, P NATL ACAD SCI USA, V103, P9566, DOI 10.1073/pnas.0600707103; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gould SB, 2006, MOL BIOL EVOL, V23, P2413, DOI 10.1093/molbev/msl113; GRAY MW, 1992, INT REV CYTOL, V141, P233, DOI 10.1016/S0074-7696(08)62068-9; HIBBERD DJ, 1984, J PHYCOL, V20, P310, DOI 10.1111/j.0022-3646.1984.00310.x; HILL DRA, 1986, PHYCOLOGIA, V25, P521, DOI 10.2216/i0031-8884-25-4-521.1; Hirakawa Y, 2011, MOL MICROBIOL, V80, P1439, DOI 10.1111/j.1365-2958.2011.07643.x; Hirakawa Y, 2010, MOL BIOL EVOL, V27, P1538, DOI 10.1093/molbev/msq038; Irimia M, 2008, MOL BIOL EVOL, V25, P375, DOI 10.1093/molbev/msm262; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kugrens Paul, 2003, P715, DOI 10.1016/B978-012741550-5/50022-2; Lane CE, 2007, P NATL ACAD SCI USA, V104, P19908, DOI 10.1073/pnas.0707419104; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; MARTIN W, 1993, P NATL ACAD SCI USA, V90, P8692, DOI 10.1073/pnas.90.18.8692; McFadden G. I., 1997, Phycological Research, V45, P145, DOI 10.1111/j.1440-1835.1997.tb00087.x; Moog D, 2011, GENOME BIOL EVOL, V3, P375, DOI 10.1093/gbe/evr031; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Noutsos C, 2007, TRENDS GENET, V23, P597, DOI 10.1016/j.tig.2007.08.016; Ota S, 2011, PHYCOLOGIA, V50, P317, DOI 10.2216/09-102.1; Palmer JD, 2003, J PHYCOL, V39, P4, DOI 10.1046/j.1529-8817.2003.02185.x; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Ricchetti M, 2004, PLOS BIOL, V2, P1313, DOI 10.1371/journal.pbio.0020273; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Richly E, 2004, MOL BIOL EVOL, V21, P1972, DOI 10.1093/molbev/msh210; Rogers MB, 2007, MOL BIOL EVOL, V24, P54, DOI 10.1093/molbev/msl129; Smith DR, 2011, GENOME BIOL EVOL, V3, P743, DOI [10.1093/gbe/evr068, 10.1093/gbe/evr001]; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; Stegemann S, 2006, PLANT CELL, V18, P2869, DOI 10.1105/tpc.106.046466; Stiller JW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-484; Tanifuji G, 2011, GENOME BIOL EVOL, V3, P44, DOI 10.1093/gbe/evq082; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Woehle C, 2011, GENOME BIOL EVOL, V3, P1220, DOI 10.1093/gbe/evr100; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	50	263	270	1	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					59	65		10.1038/nature11681	http://dx.doi.org/10.1038/nature11681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23201678	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-24	WOS:000311893400045
J	Clark, VE; Erson-Omay, EZ; Serin, A; Yin, J; Cotney, J; Ozduman, K; Avsar, T; Li, J; Murray, PB; Henegariu, O; Yilmaz, S; Gunel, JM; Carrion-Grant, G; Yilmaz, B; Grady, C; Tanrikulu, B; Bakircioglu, M; Kaymakcalan, H; Caglayan, AO; Sencar, L; Ceyhun, E; Atik, AF; Bayri, Y; Bai, HW; Kolb, LE; Hebert, RM; Omay, SB; Mishra-Gorur, K; Choi, M; Overton, JD; Holland, EC; Mane, S; State, MW; Bilguevar, K; Baehring, JM; Gutin, PH; Piepmeier, JM; Vortmeyer, A; Brennan, CW; Pamir, MN; Kilic, T; Lifton, RP; Noonan, JP; Yasuno, K; Gunel, M				Clark, Victoria E.; Erson-Omay, E. Zeynep; Serin, Akdes; Yin, Jun; Cotney, Justin; Oezduman, Koray; Avsar, Timuin; Li, Jie; Murray, Phillip B.; Henegariu, Octavian; Yilmaz, Saliha; Guenel, Jennifer Moliterno; Carrion-Grant, Geneive; Yilmaz, Baran; Grady, Conor; Tanrikulu, Bahattin; Bakircioglu, Mehmet; Kaymakcalan, Hande; Caglayan, Ahmet Okay; Sencar, Leman; Ceyhun, Emre; Atik, A. Fatih; Bayri, Yasar; Bai, Hanwen; Kolb, Luis E.; Hebert, Ryan M.; Omay, S. Bulent; Mishra-Gorur, Ketu; Choi, Murim; Overton, John D.; Holland, Eric C.; Mane, Shrikant; State, Matthew W.; Bilguevar, Kaya; Baehring, Joachim M.; Gutin, Philip H.; Piepmeier, Joseph M.; Vortmeyer, Alexander; Brennan, Cameron W.; Pamir, M. Necmettin; Kilic, Tuerker; Lifton, Richard P.; Noonan, James P.; Yasuno, Katsuhito; Guenel, Murat			Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO	SCIENCE			English	Article								We report genomic analysis of 300 meningiomas, the most common primary brain tumors, leading to the discovery of mutations in TRAF7, a proapoptotic E3 ubiquitin ligase, in nearly one-fourth of all meningiomas. Mutations in TRAF7 commonly occurred with a recurrent mutation ( K409Q) in KLF4, a transcription factor known for its role in inducing pluripotency, or with AKT1(E17K), a mutation known to activate the PI3K pathway. SMO mutations, which activate Hedgehog signaling, were identified in similar to 5% of non-NF2 mutant meningiomas. These non-NF2 meningiomas were clinically distinctive-nearly always benign, with chromosomal stability, and originating from the medial skull base. In contrast, meningiomas with mutant NF2 and/or chromosome 22 loss were more likely to be atypical, showing genomic instability, and localizing to the cerebral and cerebellar hemispheres. Collectively, these findings identify distinct meningioma subtypes, suggesting avenues for targeted therapeutics.	[Clark, Victoria E.; Erson-Omay, E. Zeynep; Serin, Akdes; Murray, Phillip B.; Henegariu, Octavian; Yilmaz, Saliha; Carrion-Grant, Geneive; Grady, Conor; Tanrikulu, Bahattin; Omay, S. Bulent; Mishra-Gorur, Ketu; Bilguevar, Kaya; Yasuno, Katsuhito; Guenel, Murat] Yale Univ, Sch Med, Dept Neurosurg, Yale Program Brain Tumor Res, New Haven, CT 06510 USA; [Clark, Victoria E.; Erson-Omay, E. Zeynep; Serin, Akdes; Yin, Jun; Cotney, Justin; Murray, Phillip B.; Henegariu, Octavian; Yilmaz, Saliha; Carrion-Grant, Geneive; Grady, Conor; Bakircioglu, Mehmet; Caglayan, Ahmet Okay; Sencar, Leman; Ceyhun, Emre; Choi, Murim; Mane, Shrikant; Bilguevar, Kaya; Lifton, Richard P.; Noonan, James P.; Yasuno, Katsuhito; Guenel, Murat] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Oezduman, Koray] Acibadem Univ, Dept Neurosurg, Sch Med, TR-34848 Istanbul, Turkey; [Avsar, Timuin] Istanbul Tech Univ, Dr Orhan Ocalgiray Mol Biology Biotechnol & Genet, TR-34469 Istanbul, Turkey; [Li, Jie; Vortmeyer, Alexander] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Guenel, Jennifer Moliterno] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Guenel, Jennifer Moliterno; Gutin, Philip H.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10065 USA; [Yilmaz, Baran; Tanrikulu, Bahattin; Atik, A. Fatih; Bayri, Yasar] Marmara Univ, Dept Neurosurg, Sch Med, TR-34854 Istanbul, Turkey; [Kaymakcalan, Hande] Bahcesehir Univ, Dept Genet & Bioinformat, TR-34353 Istanbul, Turkey; [Kaymakcalan, Hande] Yale Univ, Ctr Genome Anal, Sch Med, West Haven, CT 06516 USA; [Overton, John D.; Mane, Shrikant] Yale Univ, Ctr Genome Anal, Sch Med, West Haven, CT 06516 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, Brain Tumor Ctr, New York, NY 10065 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurol & Surg, New York, NY 10065 USA; [State, Matthew W.] Yale Univ, Sch Med, Dept Genet, Yale Program Neurogenet, New Haven, CT 06510 USA; [State, Matthew W.] Yale Univ, Sch Med, Dept Psychiat, Yale Program Neurogenet, New Haven, CT 06510 USA; [State, Matthew W.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Baehring, Joachim M.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Piepmeier, Joseph M.] Yale Univ, Sch Med, Dept Neurosurg, Yale Program Brain Tumor Res, New Haven, CT 06510 USA; [Brennan, Cameron W.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Brennan, Cameron W.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Kilic, Tuerker] Bahcesehir Univ, Dept Neurosurg, TR-34349 Istanbul, Turkey; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06510 USA; [Noonan, James P.] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06520 USA; [Guenel, Murat] Yale Univ, Sch Med, Yale Program Neurogenet, New Haven, CT 06510 USA	Yale University; Yale University; Acibadem University; Istanbul Technical University; Yale University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Marmara University; Bahcesehir University; Yale University; Yale University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yale University; Yale University; Yale University; Yale University; Yale University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Bahcesehir University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Gunel, M (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, Yale Program Brain Tumor Res, 333 Cedar St, New Haven, CT 06510 USA.	murat.gunel@yale.edu	AVSAR, TIMUCIN/W-2624-2019; Kaymakcalan, Hande/AFP-2191-2022; Brennan, Cameron/R-7082-2019; Choi, Murim/AAP-9120-2021; Cotney, Justin L/ABE-8500-2021; Noonan, James/ABF-1320-2021; Ceyhun, Emre/A-8025-2018; Tanrıkulu, Bahattin/E-7144-2016; Kaymakcalan, Hande/AAO-4208-2021; Yasuno, Katsuhito/E-1960-2012; Kilic, Turker/M-3670-2018; Yin, Jun/A-7502-2010; State, Matthew/W-2256-2019; Caglayan, Ahmet O/D-1066-2012; Ozduman, Koray/D-7007-2015; Bayri, Yasar/B-1287-2017	AVSAR, TIMUCIN/0000-0001-8841-4811; Brennan, Cameron/0000-0003-4064-8891; Cotney, Justin L/0000-0001-8230-2157; Ceyhun, Emre/0000-0001-6209-1700; Tanrıkulu, Bahattin/0000-0002-9096-8685; Kaymakcalan, Hande/0000-0001-7736-7634; Yasuno, Katsuhito/0000-0002-3606-532X; Kilic, Turker/0000-0003-4237-808X; Yin, Jun/0000-0003-4543-1229; Caglayan, Ahmet O/0000-0002-2332-322X; Carrion-Grant, Geneive/0000-0001-5465-370X; State, Matthew/0000-0003-1624-8302; Pamir, M Necmettin/0000-0002-5958-8625; Ozduman, Koray/0000-0002-3543-0401; Bayri, Yasar/0000-0003-1707-6055	Gregory M. Kiez and Mehmet Kutman Foundation; NIH [T32GM07205]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	Gregory M. Kiez and Mehmet Kutman Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the patients and their families who have contributed to this study. This study was supported by the Gregory M. Kiez and Mehmet Kutman Foundation. R. P. L. is an investigator of the Howard Hughes Institute. V. E. C. is supported by NIH T32GM07205. All somatic mutations identified through exome sequencing of meningiomas are reported in the supplementary materials and submitted to the Catalogue of Somatic Mutations in Cancer (COSMIC) database (http://cancer.sanger.ac.uk/cancergenome/projects/cosmic, submission ID COSP30702). Yale University has filed a provisional patent application based on the results of this study.	Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Cui QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013180; Riemenschneider MJ, 2006, LANCET NEUROL, V5, P1045, DOI 10.1016/S1474-4422(06)70625-1; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Schmitz U, 2001, BRIT J CANCER, V84, P199, DOI 10.1054/bjoc.2000.1583; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Xu LG, 2004, J BIOL CHEM, V279, P17278, DOI 10.1074/jbc.C400063200	11	503	511	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1077	1080		10.1126/science.1233009	http://dx.doi.org/10.1126/science.1233009			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23348505	Green Accepted			2022-12-24	WOS:000315452000042
J	Hickman, MA; Zeng, GS; Forche, A; Hirakawa, MP; Abbey, D; Harrison, BD; Wang, YM; Su, CH; Bennett, RJ; Wang, Y; Berman, J				Hickman, Meleah A.; Zeng, Guisheng; Forche, Anja; Hirakawa, Matthew P.; Abbey, Darren; Harrison, Benjamin D.; Wang, Yan-Ming; Su, Ching-hua; Bennett, Richard J.; Wang, Yue; Berman, Judith			The 'obligate diploid' Candida albicans forms mating-competent haploids	NATURE			English	Article							GENE DISRUPTION; CHROMOSOME LOSS; PLOIDY; HETEROZYGOSITY; MORPHOGENESIS; PROTEINS; MUTANTS; REVEAL; SYSTEM	Candida albicans, the most prevalent human fungal pathogen, is considered to be an obligate diploid that carries recessive lethal mutations throughout the genome. Here we demonstrate that C. albicans has a viable haploid state that can be derived from diploid cells under in vitro and in vivo conditions, and that seems to arise through a concerted chromosome loss mechanism. Haploids undergo morphogenetic changes like those of diploids, including the yeast-hyphal transition, chlamydospore formation and a white-opaque switch that facilitates mating. Haploid opaque cells of opposite mating type mate efficiently to regenerate the diploid form, restoring heterozygosity and fitness. Homozygous diploids arise spontaneously by auto-diploidization, and both haploids and auto-diploids show a similar reduction in fitness, in vitro and in vivo, relative to heterozygous diploids, indicating that homozygous cell types are transient in mixed populations. Finally, we constructed stable haploid strains with multiple auxotrophies that will facilitate molecular and genetic analyses of this important pathogen.	[Hickman, Meleah A.; Abbey, Darren; Harrison, Benjamin D.; Berman, Judith] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Zeng, Guisheng; Wang, Yan-Ming; Wang, Yue] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Forche, Anja] Bowdoin Coll, Brunswick, ME 04011 USA; [Hirakawa, Matthew P.; Bennett, Richard J.] Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; [Su, Ching-hua] Taipei Med Univ, Dept Microbiol & Immunol, Taipei, Taiwan; [Berman, Judith] Tel Aviv Univ, George Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Ramat Aviv, Israel	University of Minnesota System; University of Minnesota Twin Cities; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Bowdoin College; Brown University; Taipei Medical University; Tel Aviv University	Berman, J (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	jberman@umn.edu	Berman, Judith/AAS-5115-2021; Wang, Yue/AGN-6053-2022; Berman, Judith/ABA-8528-2021; Zeng, Guisheng/GXW-1870-2022; Wang, Yue/H-2107-2011	Berman, Judith/0000-0002-8577-0084; Bennett, Richard/0000-0001-7563-484X; Wang, Yue/0000-0002-1211-2822; Hirakawa, Matthew/0000-0002-2041-9496; ZENG, GUISHENG/0000-0002-8920-5525	NRSA [F32GM096536-02]; National Institute of Allergy and Infectious Diseases (NIAID) [R15-AI090633-01A1, R01 AI0624273, AI081560, AI081704, AI0624273]; training grant for Graduate Assistance in Areas of National Need [P200A100100]; National Institute of Dental & Craniofacial Research [T32DE007288]; Burroughs Wellcome Fund; Agency for Science, Technology, & Research, Singapore; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI087401, R01AI081704, R15AI090633, R01AI062427, R21AI081560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096536] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); training grant for Graduate Assistance in Areas of National Need; National Institute of Dental & Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Agency for Science, Technology, & Research, Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank M. McClellan, K. Matter, E. Voigt and F. Y. Chan for technical assistance, S. Filler and J. Becker for work involving mouse models of infection, F. M. Chang and T. Y. Ou for contributing to the isolation of the progenitor of GZY792, and L. Burrack, J. Heitman, M. Kupiec, K. Nielsen and N. Pavelka for comments on the manuscript M.A.H. is supported by an NRSA post-doctoral fellowship (F32GM096536-02). A.F. is supported by the National Institute of Allergy and Infectious Diseases (NIAID) (R15-AI090633-01A1 and R01 AI0624273). M.P.H. is supported by a training grant for Graduate Assistance in Areas of National Need (P200A100100). B.D.H. is supported by the National Institute of Dental & Craniofacial Research (T32DE007288). R.J.B. is supported by the NIAID (AI081560 and AI081704) and a PATH Award from the Burroughs Wellcome Fund. Y.W. is supported by Agency for Science, Technology, & Research, Singapore. J.B. is supported by the NIAID (AI0624273).	Abbey D, 2011, G3-GENES GENOM GENET, V1, P523, DOI 10.1534/g3.111.000885; Alby K, 2009, NATURE, V460, P890, DOI 10.1038/nature08252; Andaluz E, 2011, MOL MICROBIOL, V79, P1462, DOI 10.1111/j.1365-2958.2011.07532.x; BARTON RC, 1992, MOL MICROBIOL, V6, P171, DOI 10.1111/j.1365-2958.1992.tb01998.x; Bennett RJ, 2003, EMBO J, V22, P2505, DOI 10.1093/emboj/cdg235; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Berman J, 2012, TRENDS GENET, V28, P197, DOI 10.1016/j.tig.2012.01.004; CHAFFIN WL, 1984, J GEN MICROBIOL, V130, P431; Citiulo F, 2009, FEMS YEAST RES, V9, P1051, DOI 10.1111/j.1567-1364.2009.00533.x; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; Douglas LM, 2009, INFECT IMMUN, V77, P4150, DOI 10.1128/IAI.00683-09; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Forche A, 2011, MBIO, V2, DOI 10.1128/mBio.00129-11; Forche A, 2003, FUNGAL GENET BIOL, V39, P38, DOI 10.1016/S1087-1845(02)00585-6; Forche A, 2008, PLOS BIOL, V6, P1084, DOI 10.1371/journal.pbio.0060110; Forche A, 2009, GENETICS, V182, P799, DOI 10.1534/genetics.109.103325; FREED J J, 1970, Proceedings of the National Academy of Sciences of the United States of America, V65, P337, DOI 10.1073/pnas.65.2.337; Graser Y, 1996, P NATL ACAD SCI USA, V93, P12473, DOI 10.1073/pnas.93.22.12473; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kelly MT, 2004, MOL MICROBIOL, V53, P969, DOI 10.1111/j.1365-2958.2004.04185.x; KELLY R, 1987, MOL CELL BIOL, V7, P199, DOI 10.1128/MCB.7.1.199; KURTZ MB, 1989, MOL GEN GENET, V217, P47, DOI 10.1007/BF00330941; Kwon-Chung K., 1983, GENETIC ANAL CANDIDA, P230; Lockhart SR, 2002, GENETICS, V162, P737; Magee BB, 2000, SCIENCE, V289, P310, DOI 10.1126/science.289.5477.310; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Miller MG, 2002, CELL, V110, P293, DOI 10.1016/S0092-8674(02)00837-1; Morschhauser J, 1999, MOL MICROBIOL, V32, P547, DOI 10.1046/j.1365-2958.1999.01393.x; MORTIMER RK, 1958, RADIAT RES, V9, P312, DOI 10.2307/3570795; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; OLAIYA AF, 1979, J BACTERIOL, V140, P1043, DOI 10.1128/JB.140.3.1043-1049.1979; Reedy JL, 2009, CURR BIOL, V19, P891, DOI 10.1016/j.cub.2009.04.058; RIGGSBY WS, 1982, MOL CELL BIOL, V2, P853, DOI 10.1128/MCB.2.7.853; SARACHEK A, 1986, CURR GENET, V10, P685, DOI 10.1007/BF00410917; SARACHEK A, 1981, ARCH MICROBIOL, V129, P1, DOI 10.1007/BF00417169; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; SLUTSKY B, 1987, J BACTERIOL, V169, P189, DOI 10.1128/JB.169.1.189-197.1987; Solis NV, 2012, NAT PROTOC, V7, P637, DOI 10.1038/nprot.2012.011; Soll DR, 2003, EUKARYOT CELL, V2, P390, DOI 10.1128/EC.2.3.390-397.2003; SUZUKI T, 1982, J BACTERIOL, V152, P893; Tsai JH, 2011, J CELL SCI, V124, P1955, DOI 10.1242/jcs.006387; VAN DER WALT J. P., 1967, ANTONIE VAN LEEU WENHOEK J MICROBIOL SEROL, V33, P246; Wang Y, 2009, CURR OPIN MICROBIOL, V12, P644, DOI 10.1016/j.mib.2009.09.002; WHELAN WL, 1982, MOL GEN GENET, V187, P477, DOI 10.1007/BF00332632; WHELAN WL, 1980, MOL GEN GENET, V180, P107, DOI 10.1007/BF00267358; Yi MS, 2009, SCIENCE, V326, P430, DOI 10.1126/science.1175151; Zeng GS, 2012, MOL BIOL CELL, V23, P3485, DOI 10.1091/mbc.E12-03-0231	50	189	195	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					55	59		10.1038/nature11865	http://dx.doi.org/10.1038/nature11865			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23364695	Green Accepted			2022-12-24	WOS:000314741200032
J	Yan, J; Xiang, JL; Lin, YT; Ma, JG; Zhang, JY; Zhang, H; Sun, JS; Danial, NN; Liu, J; Lin, AN				Yan, Jie; Xiang, Jialing; Lin, Yutin; Ma, Jingui; Zhang, Jiyan; Zhang, Hao; Sun, Jisheng; Danial, Nika N.; Liu, Jing; Lin, Anning			Inactivation of BAD by IKK Inhibits TNF alpha-Induced Apoptosis Independently of NF-kappa B Activation	CELL			English	Article							TUMOR-NECROSIS-FACTOR; SEVERE LIVER DEGENERATION; CELL-DEATH; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; FEEDBACK INHIBITION; KINASE ACTIVATION; JNK ACTIVATION; DEFICIENT MICE; PHOSPHORYLATION	The I kappa B kinase complex (IKK) is a key regulator of immune responses, inflammation, cell survival, and tumorigenesis. The prosurvival function of IKK centers on activation of the transcription factor NF-kappa B, whose target gene products inhibit caspases and prevent prolonged JNK activation. Here, we report that inactivation of the BH3-only protein BAD by IKK independently of NF-kappa B activation suppresses TNF alpha-induced apoptosis. TNF alpha-treated Ikk beta(-/-) mouse embryonic fibroblasts (MEFs) undergo apoptosis significantly faster than MEFs deficient in both RelA and cRel due to lack of inhibition of BAD by IKK. IKK phosphorylates BAD at serine-26 (Ser26) and primes it for inactivation. Elimination of Ser26 phosphorylation promotes BAD proapoptotic activity, thereby accelerating TNF alpha-induced apoptosis in cultured cells and increasing mortality in animals. Our results reveal that IKK inhibits TNF alpha-induced apoptosis through two distinct but cooperative mechanisms: activation of the survival facto r NF-kappa B and inactivation of the proapoptotic BH3-only BAD protein.	[Yan, Jie; Ma, Jingui; Zhang, Jiyan; Lin, Anning] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Xiang, Jialing; Lin, Yutin] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA; [Zhang, Jiyan] Inst Basic Med Sci, Dept Mol Immunol, Beijing 100850, Peoples R China; [Zhang, Hao; Sun, Jisheng; Lin, Anning] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Danial, Nika N.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Liu, Jing] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA	University of Chicago; Illinois Institute of Technology; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; Dana-Farber Cancer Institute; Northwestern University; Feinberg School of Medicine	Lin, AN (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	anninglin@bsd.uchicago.edu		Sun, Jisheng/0000-0003-0814-1118; Zhang, Jiyan/0000-0001-8011-8719	National Basic Research Program of China [2012CB910801]; National Natural Science Foundation of China [31130035]; Chinese Academy of Sciences [SIBS2010CSP001]; National Institutes of Health [CA100460, CA128114, GM081603]; NATIONAL CANCER INSTITUTE [R01CA100460, R01CA128114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095313, R01GM081603, R01GM103868] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Drs. David A. Brenner, Joseph A. DiDonato, Michael Karin, Stanley Korsmeyer, and Frank Mercurio for reagents that make this work possible. This work is partially supported by National Basic Research Program of China (2012CB910801), National Natural Science Foundation of China (31130035), Chinese Academy of Sciences (SIBS2010CSP001), and National Institutes of Health grants CA100460 (to A.L.), CA128114 (to J.X.), and GM081603 (to J.L.).	Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Baldwin AS, 2012, IMMUNOL REV, V246, P327, DOI 10.1111/j.1600-065X.2012.01095.x; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; Dragovich T, 1998, ONCOGENE, V17, P3207, DOI 10.1038/sj.onc.1202587; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grossmann M, 1999, P NATL ACAD SCI USA, V96, P11848, DOI 10.1073/pnas.96.21.11848; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu J, 2007, ONCOGENE, V26, P3267, DOI 10.1038/sj.onc.1210417; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Rudolph D, 2000, GENE DEV, V14, P854; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Tang FM, 2002, MOL CELL BIOL, V22, P8571, DOI 10.1128/MCB.22.24.8571-8579.2002; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Xiang J, 2000, J GENE MED, V2, P97, DOI 10.1002/(SICI)1521-2254(200003/04)2:2<97::AID-JGM99>3.0.CO;2-S; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	45	73	75	0	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					304	315		10.1016/j.cell.2012.12.021	http://dx.doi.org/10.1016/j.cell.2012.12.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332762	Green Accepted, Bronze			2022-12-24	WOS:000313719800025
J	Walensky, RP; Sax, PE; Nakamura, YM; Weinstein, MC; Pei, PP; Freedberg, KA; Paltiel, AD; Schackman, BR				Walensky, Rochelle P.; Sax, Paul E.; Nakamura, Yoriko M.; Weinstein, Milton C.; Pei, Pamela P.; Freedberg, Kenneth A.; Paltiel, A. David; Schackman, Bruce R.			Economic Savings Versus Health Losses: The Cost-Effectiveness of Generic Antiretroviral Therapy in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							TREATMENT-NAIVE PATIENTS; COMBINATION THERAPY; HIV-1 INFECTION; DOUBLE-BLIND; EFFICACY; EMTRICITABINE; TENOFOVIR; VIRUS; ADHERENCE; REGIMEN	Background: U. S. HIV treatment guidelines recommend branded once-daily, 1-pill efavirenz-emtricitabine-tenofovir as first-line antiretroviral therapy (ART). With the anticipated approval of generic efavirenz in the United States, a once-daily, 3-pill alternative (generic efavirenz, generic lamivudine, and tenofovir) will decrease cost but may reduce adherence and virologic suppression. Objective: To assess the clinical effect, costs, and cost-effectiveness of a 3-pill, generic-based regimen compared with a branded, co-formulated regimen and to project the potential national savings in the first year of a switch to generic-based ART. Design: Mathematical simulation of HIV disease. Setting: United States. Patients: HIV-infected persons. Intervention: No ART (for comparison); 3-pill, generic-based ART; and branded ART. Measurements: Quality-adjusted life expectancy, costs, and incremental cost-effectiveness ratios (ICERs) in dollars per qualityadjusted life-year (QALY). Results: Compared with no ART, generic-based ART has an ICER of $ 21 100/QALY. Compared with generic-based ART, branded ART increases lifetime costs by $ 42 500 and per-person survival gains by 0.37 QALYs for an ICER of $ 114 800/QALY. Estimated first-year savings, if all eligible U. S. patients start or switch to generic-based ART, are $ 920 million. Most plausible assumptions about generic-based ART efficacy and costs lead to branded ART ICERs greater than $ 100 000/QALY. Limitation: The efficacy and price reduction associated with generic drugs are unknown, and estimates are intended to be conservative. Conclusion: Compared with a slightly less effective generic-based regimen, the cost-effectiveness of first-line branded ART exceeds $ 100 000/QALY. Generic-based ART in the United States could yield substantial budgetary savings to HIV programs.	[Walensky, Rochelle P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med,Brigham & Womens Hosp, Div Infect Dis,Med Practice Evaluat Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02114 USA; Yale Univ, Sch Med, New Haven, CT USA; Weill Cornell Med Coll, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Yale University; Cornell University	Walensky, RP (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,Brigham & Womens Hosp, Div Infect Dis,Med Practice Evaluat Ctr, 50 Staniford St,9th Floor, Boston, MA 02114 USA.		Schackman, Bruce R./J-8208-2019	Schackman, Bruce R./0000-0002-1132-2932; Walensky, Rochelle P./0000-0002-8795-379X	National Institute of Allergy and Infectious Diseases [R37-AI42006, R01-AI093269]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042006, R01AI093269, R01AI042006, P30AI060354] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	By grants R37-AI42006 and R01-AI093269 from the National Institute of Allergy and Infectious Diseases.	Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; [Anonymous], 2010, NAT HIV AIDS STRAT U; [Anonymous], 2012, ECONOMIST; Bamezai A, 2005, ANN EMERG MED, V45, P483, DOI 10.1016/j.annemergmed.2004.08.029; Bangsberg DR, 2010, AIDS, V24, P2835, DOI 10.1097/QAD.0b013e328340a209; Berndt ER, 2007, HEALTH AFFAIR, V26, P790, DOI 10.1377/hlthaff.26.3.790; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Braithwaite RS, 2003, MED DECIS MAKING, V23, P562; Buscher A, 2012, INT J STD AIDS, V23, P351, DOI 10.1258/ijsa.2011.011292; Centers for Disease Control and Prevention, 2011, NEW HOP STOPP HIV TE; Centers for Medicare & Medicaid Services, 2012, CLIN LAB FEE SHED; Cohen C, 2012, 52 INT C ANT CHEM SA; Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744; Department of Economic and Social Affairs Population Division, 2009, WORLD POP PROSP 2008; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V38, P96, DOI 10.1097/00126334-200501010-00017; Gold MR, 1996, COST EFFECTIVENESS H; Gopalappa C, 2012, JAIDS-J ACQ IMM DEF, V61, P99, DOI 10.1097/QAI.0b013e31825bd862; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; *I MED, 2003, HIDD COSTS VAL LOST; Johnson M, 2005, AIDS, V19, P685, DOI 10.1097/01.aids.0000166091.39317.99; Johnson MA, 2006, JAIDS-J ACQ IMM DEF, V43, P153, DOI 10.1097/01.qai.0000242449.67155.1a; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Levinson D., 2005, MEDICAID DRUG PRICE; Linas BP, 2012, CLIN INFECT DIS, V55, P279, DOI 10.1093/cid/cis382; Martin EG, 2012, JAIDS-J ACQ IMM DEF, V60, P72, DOI 10.1097/QAI.0b013e31824c0dd4; McKinnell JA, 2010, AIDS PATIENT CARE ST, V24, P79, DOI 10.1089/apc.2009.0220; *NAT TECHN INF SER, 1995, MULT AIDS COH STUD M; National Alliance of State & Territorial AIDS Directors, 2011, HIV VIR HEP COINF; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; Oguamanam A. C. O., 2012, THESIS MORGAN STATE; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUID US ANT AG HIV 1; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Rousseau FS, 2003, J INFECT DIS, V188, P1652, DOI 10.1086/379667; Rydzak CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012647; Sax PE, 2012, LANCET, V379, P2439, DOI 10.1016/S0140-6736(12)60917-9; Sax PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031591; Sax PE, 2012, GEN LAM HAS ARR HIV; Schinazi RF, 2003, JAIDS-J ACQ IMM DEF, V34, P243, DOI 10.1097/00126334-200310010-00017; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; Shenouda N., 2009, RED BOOK; Svicher V, 2010, JAIDS-J ACQ IMM DEF, V55, P336, DOI 10.1097/QAI.0b013e3181e6763f; Swiss HIV Cohort Study & Mother and Child HIV Cohort Study, 2012, SWISS HIV COHORT STU; Tang MW, 2012, CLIN INFECT DIS, V54, P862, DOI 10.1093/cid/cir1034; The Henry J. Kaiser Family Foundation, 2012, US FED FUND HIV AIDS; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; U.S. Food and Drug Administration, 2012, FACTS GEN DRUGS; U.S. Food and Drug Administration, 2012, APPR TENT APPR ANT A; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; United States Food and Drug Administration, 2012, OR BOOK APPR DRUG PR; University HealthSystem Consortium, 2009, 2006 2008 COST DAT; Valdiserri R, 2011, PROPOSED NATL HIV AI; Walensky RP, 2010, CLIN INFECT DIS, V51, P392, DOI 10.1086/655130; Weinstein M C, 2001, Value Health, V4, P348, DOI 10.1046/j.1524-4733.2001.45061.x	60	111	111	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2					84	+		10.7326/0003-4819-158-2-201301150-00002	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-00002			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23318310	Green Accepted			2022-12-24	WOS:000314029400014
J	Shi, XS; Bi, YC; Yang, W; Guo, XD; Jiang, Y; Wan, CJ; Li, LY; Bai, YB; Guo, J; Wang, YJ; Chen, XJ; Wu, B; Sun, HB; Liu, WL; Wang, JF; Xu, CQ				Shi, Xiaoshan; Bi, Yunchen; Yang, Wei; Guo, Xingdong; Jiang, Yan; Wan, Chanjuan; Li, Lunyi; Bai, Yibing; Guo, Jun; Wang, Yujuan; Chen, Xiangjun; Wu, Bo; Sun, Hongbin; Liu, Wanli; Wang, Junfeng; Xu, Chenqi			Ca2+ regulates T-cell receptor activation by modulating the charge property of lipids	NATURE			English	Article							IMMUNOLOGICAL SYNAPSE; PLASMA-MEMBRANE; CRAC CHANNEL; K+ CHANNEL; PROTEINS; BINDING; ORAI; PHOSPHORYLATION; RECOGNITION; SIGNALS	Ionic protein-lipid interactions are critical for the structure and function of membrane receptors, ion channels, integrins and many other proteins(1-7). However, the regulatory mechanism of these interactions is largely unknown. Here we show that Ca2+ can bind directly to anionic phospholipids and thus modulate membrane protein function. The activation of T-cell antigen receptor-CD3 complex (TCR), a key membrane receptor for adaptive immunity, is regulated by ionic interactions between positively charged CD3 epsilon/zeta cytoplasmic domains (CD3(CD)) and negatively charged phospholipids in the plasma membrane(1,8-10). Crucial tyrosines are buried in the membrane and are largely protected from phosphorylation in resting T cells. It is not clear how CD3CD dissociates from the membrane in antigen-stimulated T cells. The antigen engagement of even a single TCR triggers a Ca2+ influx(11) and TCR-proximal Ca2+ concentration is higher than the average cytosolic Ca2+ concentration(12). Our biochemical, live-cell fluorescence resonance energy transfer and NMR experiments showed that an increase in Ca2+ concentration induced the dissociation of CD3CD from the membrane and the solvent exposure of tyrosine residues. As a consequence, CD3 tyrosine phosphorylation was significantly enhanced by Ca2+ influx. Moreover, when compared with wild-type cells, Ca2+ channel-deficient T cells had substantially lower levels of CD3 phosphorylation after stimulation. The effect of Ca2+ on facilitating CD3 phosphorylation is primarily due to the charge of this ion, as demonstrated by the fact that replacing Ca2+ with the non-physiological ion Sr2+ resulted in the same feedback effect. Finally, P-31 NMR spectroscopy showed that Ca2+ bound to the phosphate group in anionic phospholipids at physiological concentrations, thus neutralizing the negative charge of phospholipids. Rather than initiating CD3 phosphorylation, this regulatory pathway of Ca2+ has a positive feedback effect on amplifying and sustaining CD3 phosphorylation and should enhance T-cell sensitivity to foreign antigens. Our study thus provides a new regulatory mechanism of Ca2+ to T-cell activation involving direct lipid manipulation.	[Bi, Yunchen; Wan, Chanjuan; Wang, Yujuan; Wu, Bo; Sun, Hongbin; Wang, Junfeng] Chinese Acad Sci, High Magnet Field Lab, Hefei Inst Phys Sci, Hefei 230031, Anhui, Peoples R China; [Shi, Xiaoshan; Yang, Wei; Guo, Xingdong; Jiang, Yan; Li, Lunyi; Bai, Yibing; Guo, Jun; Xu, Chenqi] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Shi, Xiaoshan; Yang, Wei; Guo, Xingdong; Jiang, Yan; Li, Lunyi; Bai, Yibing; Guo, Jun; Xu, Chenqi] Chinese Acad Sci, Natl Ctr Prot Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 201203, Peoples R China; [Chen, Xiangjun; Liu, Wanli] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tsinghua University	Wang, JF (corresponding author), Chinese Acad Sci, High Magnet Field Lab, Hefei Inst Phys Sci, 350 Shushanhu Rd, Hefei 230031, Anhui, Peoples R China.	junfeng@hmfl.ac.cn; cqxu@sibcb.ac.cn	liu, wanli/H-5690-2011; Sun, Hongbin/C-9721-2015; Shi, Xiaoshan/AAH-7734-2021	liu, wanli/0000-0003-2624-6802; Sun, Hongbin/0000-0002-7712-0655; Shi, Xiaoshan/0000-0001-7931-8684; Bai, Yibing/0000-0002-2944-5367; Xu, Chenqi/0000-0002-4968-6782; Wu, Bo/0000-0003-4556-0477; Yang, Wei/0000-0001-9438-7215; Liu, Wanli/0000-0003-0395-2800	National Basic Research Program of China (973 Program) [2011CB910901, 2012CB910804, 2012CB917202]; National Science Foundation of China [31070738]; Chinese Academy of Sciences [KSCX2-EW-J-11]; Shanghai Municipal Commission for Science and Technology [10PJ1411500]; Young Talent Program of Shanghai Institutes for Biological Sciences, CAS [2010KIP101]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Commission for Science and Technology; Young Talent Program of Shanghai Institutes for Biological Sciences, CAS	We would like to thank R. Lewis for his gift of CJ-1 Jurkat cell line; S.-c. Sun, A. Lin, D. Li, J. J. Chou, H. Gu and M. Lei for discussions. C. X. is funded by the National Basic Research Program of China (973 Program, no. 2011CB910901 and no. 2012CB910804), the National Science Foundation of China (no. 31070738), the Chinese Academy of Sciences (Hundred Talents Program and no. KSCX2-EW-J-11), the Shanghai Municipal Commission for Science and Technology (10PJ1411500) and the Young Talent Program of Shanghai Institutes for Biological Sciences, CAS (no. 2010KIP101). J. W. is funded by the National Basic Research Program of China (973 Program, no. 2012CB917202) and the Chinese Academy of Sciences (Hundred Talents Program).	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; DeFord-Watts LM, 2011, J IMMUNOL, V186, P6839, DOI 10.4049/jimmunol.1002721; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kim C, 2012, NATURE, V481, P209, DOI 10.1038/nature10697; Kuhns MS, 2008, CELL, V135, P594, DOI 10.1016/j.cell.2008.10.033; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Paddock C, 2011, BLOOD, V117, P6012, DOI 10.1182/blood-2010-11-317867; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Quintana A, 2011, EMBO J, V30, P3895, DOI 10.1038/emboj.2011.289; Sigalov AB, 2006, BIOCHEMISTRY-US, V45, P15731, DOI 10.1021/bi061108f; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zilly FE, 2011, EMBO J, V30, P1209, DOI 10.1038/emboj.2011.53	31	156	168	13	274	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					111	+		10.1038/nature11699	http://dx.doi.org/10.1038/nature11699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23201688				2022-12-24	WOS:000312933800041
J	Lu, SJ; Zong, CH; Fan, W; Yang, MY; Li, JS; Chapman, AR; Zhu, P; Hu, XS; Xu, LY; Yan, LY; Bai, F; Qiao, J; Tang, FC; Li, RQ; Xie, XS				Lu, Sijia; Zong, Chenghang; Fan, Wei; Yang, Mingyu; Li, Jinsen; Chapman, Alec R.; Zhu, Ping; Hu, Xuesong; Xu, Liya; Yan, Liying; Bai, Fan; Qiao, Jie; Tang, Fuchou; Li, Ruiqiang; Xie, X. Sunney			Probing Meiotic Recombination and Aneuploidy of Single Sperm Cells by Whole-Genome Sequencing	SCIENCE			English	Article							HOT-SPOTS; RATES; MAP; AMPLIFICATION; PATTERNS; MEN	Meiotic recombination creates genetic diversity and ensures segregation of homologous chromosomes. Previous population analyses yielded results averaged among individuals and affected by evolutionary pressures. We sequenced 99 sperm from an Asian male by using the newly developed amplification method-multiple annealing and looping-based amplification cycles-to phase the personal genome and map recombination events at high resolution, which are nonuniformly distributed across the genome in the absence of selection pressure. The paucity of recombination near transcription start sites observed in individual sperm indicates that such a phenomenon is intrinsic to the molecular mechanism of meiosis. Interestingly, a decreased crossover frequency combined with an increase of autosomal aneuploidy is observable on a global per-sperm basis.	[Fan, Wei; Yang, Mingyu; Li, Jinsen; Zhu, Ping; Hu, Xuesong; Xu, Liya; Bai, Fan; Tang, Fuchou; Li, Ruiqiang; Xie, X. Sunney] Peking Univ, Biodynam Opt Imaging Ctr, Sch Life Sci, Beijing 100871, Peoples R China; [Lu, Sijia; Zong, Chenghang; Chapman, Alec R.; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Chapman, Alec R.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA; [Yan, Liying; Qiao, Jie] Peking Univ, Ctr Reprod Med, Hosp 3, Beijing 100191, Peoples R China; [Yan, Liying; Qiao, Jie] Minist Educ, Key Lab Assisted Reprod, Beijing 100191, Peoples R China; [Li, Ruiqiang] Peking Univ, Peking Tsinghua Ctr Life Sci, Sch Life Sci, Beijing 100871, Peoples R China	Peking University; Harvard University; Harvard University; Peking University; Peking University	Li, RQ (corresponding author), Peking Univ, Biodynam Opt Imaging Ctr, Sch Life Sci, Beijing 100871, Peoples R China.	lirq@pku.edu.cn; xie@chemistry.harvard.edu	Zong, Chenghang/F-3243-2013; Galaxy, Yuuki/S-4013-2017; Xu, Liya/AAV-5387-2021	Galaxy, Yuuki/0000-0002-7135-520X; Zhu, Ping/0000-0002-4521-7524; Fan, Wei/0000-0001-5036-8733; Zong, Chenghang/0000-0002-8337-8038; Bai, Fan/0000-0001-6119-8936	U.S. NIH National Human Genome Research Institute [HG005097-1, HG005613-01]; Peking University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005097, RC2HG005613] Funding Source: NIH RePORTER	U.S. NIH National Human Genome Research Institute; Peking University(Peking University); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by U.S. NIH National Human Genome Research Institute grants (HG005097-1 and HG005613-01) to X. S. X. and by funding from Peking University to the Biodynamic Optical Imaging Center (BIOPIC). The computing was carried out at the National Supercomputer Center in Tianjin, China, and the calculations were performed on TianHe-1. We thank G. S. Young for assistance in sample prep and N. Kleckner and J. Zhang for critical comments on the manuscript. The sequencing data has been deposited with the National Center for Biotechnology Information; the accession number is SRA060945. C.Z., S.L., and X.S.X. are authors on a patent applied for by Harvard University that covers the MALBAC technology.	Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Downie SE, 1997, MOL HUM REPROD, V3, P815, DOI 10.1093/molehr/3.9.815; Epstein CJ., 2007, CONSEQUENCES CHROMOS; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Ferguson KA, 2007, HUM MOL GENET, V16, P2870, DOI 10.1093/hmg/ddm246; Fledel-Alon A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000658; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Ma L, 2010, NAT METHODS, V7, P299, DOI [10.1038/NMETH.1443, 10.1038/nmeth.1443]; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; SPRIGGS EL, 1995, CYTOGENET CELL GENET, V71, P47, DOI 10.1159/000134060; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	36	219	256	2	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1627	1630		10.1126/science.1229112	http://dx.doi.org/10.1126/science.1229112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258895	Green Accepted, Green Submitted			2022-12-24	WOS:000312533100055
J	Yamamoto, S; Charng, WL; Rana, NA; Kakuda, S; Jaiswal, M; Bayat, V; Xiong, B; Zhang, K; Sandoval, H; David, G; Wang, H; Haltiwanger, RS; Bellen, HJ				Yamamoto, Shinya; Charng, Wu-Lin; Rana, Nadia A.; Kakuda, Shinako; Jaiswal, Manish; Bayat, Vafa; Xiong, Bo; Zhang, Ke; Sandoval, Hector; David, Gabriela; Wang, Hao; Haltiwanger, Robert S.; Bellen, Hugo J.			A Mutation in EGF Repeat-8 of Notch Discriminates Between Serrate/Jagged and Delta Family Ligands	SCIENCE			English	Article							DORSAL-VENTRAL BOUNDARY; FRINGE; ACTIVATION; BINDING; GLYCOSYLTRANSFERASE; MODULATION; DOMAIN; HEAD	Notch signaling affects many developmental and cellular processes and has been implicated in congenital disorders, stroke, and numerous cancers. The Notch receptor binds its ligands Delta and Serrate and is able to discriminate between them in different contexts. However, the specific domains in Notch responsible for this selectivity are poorly defined. Through genetic screens in Drosophila, we isolated a mutation, Notch(jigsaw), that affects Serrate-but not Delta-dependent signaling. Notch(jigsaw) carries a missense mutation in epidermal growth factor repeat-8 (EGFr-8) and is defective in Serrate binding. A homologous point mutation in mammalian Notch2 also exhibits defects in signaling of a mammalian Serrate homolog, Jagged1. Hence, an evolutionarily conserved valine in EGFr-8 is essential for ligand selectivity and provides a molecular handle to study numerous Notch-dependent signaling events.	[Yamamoto, Shinya; Charng, Wu-Lin; Bayat, Vafa; Xiong, Bo; David, Gabriela; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Rana, Nadia A.; Kakuda, Shinako; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Jaiswal, Manish; Sandoval, Hector; Wang, Hao; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Jaiswal, Manish; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Bayat, Vafa] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Zhang, Ke; Bellen, Hugo J.] Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Baylor College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	hbellen@bcm.edu	Yamamoto, Shinya/ABB-2837-2021; Xiong, Bo/M-3605-2014; Zhang, Ke/B-8598-2018; Bayat, Vafa/ABG-2774-2021	Yamamoto, Shinya/0000-0003-2172-8036; Zhang, Ke/0000-0002-4794-8355; Xiong, Bo/0000-0002-2695-9100; Sandoval, Hector/0000-0002-9186-7384; Bellen, Hugo/0000-0001-5992-5989; Jaiswal, Manish/0000-0001-8360-8289; Bayat, Vafa/0000-0002-1524-0520	NIH [1RC4GM096355-01, 5R01GM061126-12, 5T32-HD055200, 5R01GM067858]; Intellectual and Developmental Disabilities Research Center [NIH 5P30HD024064]; Nakajima Foundation; Taiwan Merit Scholarships Program; National Science Council [NSC-095-SAF-I-564-015-TMS]; Edward and Josephine Hudson Scholarship Fund; Houston Laboratory and Population Science Training Program in Gene-Environment Interaction from the Burroughs Wellcome Fund [1008200]; Research Education and Career Horizon Institutional Research and Academic Career Development Award Fellowship [5K12GM084897]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM084897, R01GM061126, RC4GM096355, R01GM067858] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intellectual and Developmental Disabilities Research Center; Nakajima Foundation; Taiwan Merit Scholarships Program; National Science Council(Ministry of Science and Technology, Taiwan); Edward and Josephine Hudson Scholarship Fund; Houston Laboratory and Population Science Training Program in Gene-Environment Interaction from the Burroughs Wellcome Fund; Research Education and Career Horizon Institutional Research and Academic Career Development Award Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Bloomington Drosophila Stock Center, the Vienna Drosophila RNAi Center, and the Developmental Studies Hybridoma Bank for distribution of flies and antibodies. We are grateful to S. Artavanis-Tsakonas, G. Bornkamm, S. Bray, S. Chiba, P. Heitzler, H. Hiral, K. Irvine, H. Jafar-Nejad, A. Martinez-Arias, M. Milan, L. Strobl, G. Weinmaster, and C. Wesley for flies and reagents. We thank K. Schulze for critical reading and editing of the manuscript. We acknowledge S. Gibbs, A. Jawaid, Y. Chen, C. Benitez, B. McNulty, A. Lin-Moore, D. Bei, L. Wang, Y. Kawagishi, and T. Busby for technical assistance. We thank R. Kopan, S. Blacklow, M. Milan, K. Cook, N. Giagtzoglou, K. Venken, H. Tsuda, C. Yao, and H. Takeuchi for helpful comments and discussion. This research was supported in part by the NIH (1RC4GM096355-01 to H.J.B. and 5R01GM061126-12 to R. S. H). Confocal microscopy at Baylor College of Medicine is supported by the Intellectual and Developmental Disabilities Research Center (NIH 5P30HD024064). S. Y. was supported by a fellowship from the Nakajima Foundation. W.-L. C. was supported by Taiwan Merit Scholarships Program sponsored by the National Science Council (NSC-095-SAF-I-564-015-TMS). V. B. received support from the NIH (5T32-HD055200) and the Edward and Josephine Hudson Scholarship Fund. B. X. was supported by the Houston Laboratory and Population Science Training Program in Gene-Environment Interaction from the Burroughs Wellcome Fund (grant 1008200). H. S. received support from a supplement to NIH 5R01GM067858 and the Research Education and Career Horizon Institutional Research and Academic Career Development Award Fellowship 5K12GM084897. H.J.B. is a Howard Hughes Medical Institute Investigator.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Becam I, 2010, CURR BIOL, V20, P554, DOI 10.1016/j.cub.2010.01.058; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; DECELIS JF, 1993, P NATL ACAD SCI USA, V90, P4037, DOI 10.1073/pnas.90.9.4037; deCelis JF, 1996, DEVELOPMENT, V122, P359; Haberman AS, 2003, DEV BIOL, V258, P443, DOI 10.1016/S0012-1606(03)00140-4; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Klein T, 1998, DEVELOPMENT, V125, P2951; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; McBride KL, 2008, HUM MOL GENET, V17, P2886, DOI 10.1093/hmg/ddn187; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; McKellar SH, 2007, J THORAC CARDIOV SUR, V134, P290, DOI 10.1016/j.jtcvs.2007.02.041; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Mohamed SA, 2006, BIOCHEM BIOPH RES CO, V345, P1460, DOI 10.1016/j.bbrc.2006.05.046; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Pei ZF, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-4; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Zeng CY, 1998, GENE DEV, V12, P1086, DOI 10.1101/gad.12.8.1086	28	70	72	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1229	1232		10.1126/science.1228745	http://dx.doi.org/10.1126/science.1228745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197537	Green Accepted			2022-12-24	WOS:000311666200051
J	Arnold, CD; Gerlach, D; Stelzer, C; Boryn, LM; Rath, M; Stark, A				Arnold, Cosmas D.; Gerlach, Daniel; Stelzer, Christoph; Boryn, Lukasz M.; Rath, Martina; Stark, Alexander			Genome-Wide Quantitative Enhancer Activity Maps Identified by STARR-seq	SCIENCE			English	Article							OPEN CHROMATIN; GENE; DISSECTION; EXPRESSION	Genomic enhancers are important regulators of gene expression, but their identification is a challenge, and methods depend on indirect measures of activity. We developed a method termed STARR-seq to directly and quantitatively assess enhancer activity for millions of candidates from arbitrary sources of DNA, which enables screens across entire genomes. When applied to the Drosophila genome, STARR-seq identifies thousands of cell type-specific enhancers across a broad continuum of strengths, links differential gene expression to differences in enhancer activity, and creates a genome-wide quantitative enhancer map. This map reveals the highly complex regulation of transcription, with several independent enhancers for both developmental regulators and ubiquitously expressed genes. STARR-seq can be used to identify and quantify enhancer activity in other eukaryotes, including humans.	[Arnold, Cosmas D.; Gerlach, Daniel; Stelzer, Christoph; Boryn, Lukasz M.; Rath, Martina; Stark, Alexander] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Stark, A (corresponding author), Res Inst Mol Pathol IMP, A-1030 Vienna, Austria.	stark@starklab.org	Stark, Alexander/D-1473-2012	Stark, Alexander/0000-0003-2611-0841; Gerlach, Daniel/0000-0001-9338-3765	European Research Council (ERC) Starting Grant [242922]; Boehringer Ingelheim GmbH	European Research Council (ERC) Starting Grant(European Research Council (ERC)); Boehringer Ingelheim GmbH(Boehringer Ingelheim)	We thank H. K. Akyuz, M. Pagani, K. Schernhuber, D. Spies, H. Tagoh, M. Busslinger, S. Westermann, J. M. Peters, J. Zuber (IMP), J. Brennecke and group, U. Elling [Institute of Molecular Biotechnology (IMBA)], and the IMP/IMBA BioOptics and Graphics Services for help. Deep sequencing was performed at the CSF Next-Generation Sequencing Unit (http://csf.ac.at); Vienna Tile (VT) lines were obtained from the Dickson laboratory via the Vienna Drosophila RNAi Center (http://stockcenter.vdrc.at). C. D. A., L. M. B., and M. R. are supported by a European Research Council (ERC) Starting Grant (no. 242922) awarded to A. S. Basic research at the IMP is supported by Boehringer Ingelheim GmbH. C. D. A. and A. S. are authors on a patent application for STARR-seq (EP 12 004 520.8) filed by Boehringer Ingelheim International GmbH. All constructs are available from the authors subject to a Material Transfer Agreement. All deep sequencing data are available at www.starklab.org and GEO (series accession number GSE40739).	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Parry TJ, 2010, GENE DEV, V24, P2013, DOI 10.1101/gad.1951110; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Yanez-Cuna JO, 2013, TRENDS GENET, V29, P11, DOI 10.1016/j.tig.2012.09.007	21	542	556	5	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1074	1077		10.1126/science.1232542	http://dx.doi.org/10.1126/science.1232542			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23328393				2022-12-24	WOS:000315452000041
J	Huch, M; Dorrell, C; Boj, SF; van Es, JH; Li, VSW; van de Wetering, M; Sato, T; Hamer, K; Sasaki, N; Finegold, MJ; Haft, A; Vries, RG; Grompe, M; Clevers, H				Huch, Meritxell; Dorrell, Craig; Boj, Sylvia F.; van Es, Johan H.; Li, Vivian S. W.; van de Wetering, Marc; Sato, Toshiro; Hamer, Karien; Sasaki, Nobuo; Finegold, Milton J.; Haft, Annelise; Vries, Robert G.; Grompe, Markus; Clevers, Hans			In vitro expansion of single Lgr5(+) liver stem cells induced by Wnt-driven regeneration	NATURE			English	Article							PROGENITOR CELLS; MOUSE-LIVER; DIFFERENTIATION; EXPRESSION; MICE; HEPATOCYTES; EPITHELIUM; RECEPTORS; COLON; GENE	The Wnt target gene Lgr5 (leucine-rich-repeat-containing G-protein-coupled receptor 5) marks actively dividing stem cells in Wnt-driven, self-renewing tissues such as small intestine and colon(1), stomach(2) and hair follicles(3). A three-dimensional culture system allows long-term clonal expansion of single Lgr5(+) stem cells into transplantable organoids (budding cysts) that retain many characteristics of the original epithelial architecture(2,4,5). A crucial component of the culture medium is the Wnt agonist RSPO1(6), the recently discovered ligand of LGR5(7,8). Here we show that Lgr5-lacZ is not expressed in healthy adult liver, however, small Lgr5-LacZ(+) cells appear near bile ducts upon damage, coinciding with robust activation of Wnt signalling. As shown by mouse lineage tracing using a new Lgr5-IRES-creERT2 knock-in allele, damage-induced Lgr5(+) cells generate hepatocytes and bile ducts in vivo. Single Lgr5(+) cells from damaged mouse liver can be clonally expanded as organoids in Rspo1-based culture medium over several months. Such clonal organoids can be induced to differentiate in vitro and to generate functional hepatocytes upon transplantation into Fah(-/-) mice. These findings indicate that previous observations concerning Lgr5(+) stem cells in actively self-renewing tissues can also be extended to damage-induced stem cells in a tissue with a low rate of spontaneous proliferation.	[Huch, Meritxell; Boj, Sylvia F.; van Es, Johan H.; Li, Vivian S. W.; van de Wetering, Marc; Sato, Toshiro; Hamer, Karien; Sasaki, Nobuo; Vries, Robert G.; Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands; [Huch, Meritxell; Boj, Sylvia F.; van Es, Johan H.; Li, Vivian S. W.; van de Wetering, Marc; Sato, Toshiro; Hamer, Karien; Sasaki, Nobuo; Vries, Robert G.; Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Dorrell, Craig; Haft, Annelise; Grompe, Markus] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Pape Family Pediat Res Inst, Portland, OR 97239 USA; [Finegold, Milton J.] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Oregon Health & Science University; Baylor College of Medicine	Clevers, H (corresponding author), Hubrecht Inst Dev Biol & Stem Cell Res, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Sasaki, Nobuo/HDO-8251-2022; Sato, Toshiro/J-3522-2014; van+Es, Johan/ABD-5411-2021	Sasaki, Nobuo/0000-0002-8798-7244; Sato, Toshiro/0000-0001-8353-8137; Li, Vivian/0000-0003-2041-0085; Grompe, Markus/0000-0002-6616-4345	 [EU/236954];  [EU/232814];  [Ti Pharma/T3-106]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051592, P30DK056338] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Begthel, A. Buijs, W. Karthaus, C. Kroon-Veenboer, M. van den Born, S. van der Brink, and L. Zeinstra for technical assistance. This work was supported by grants to M.H. (EU/236954), S.F.B. (EU/232814), and V.S.W.L. and J.H.v.E. (Ti Pharma/T3-106).	Akhurst B, 2001, HEPATOLOGY, V34, P519, DOI 10.1053/jhep.2001.26751; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kamiya A, 2009, GASTROENTEROLOGY, V137, P1114, DOI 10.1053/j.gastro.2009.06.001; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Lemaigre FP, 2009, GASTROENTEROLOGY, V137, P62, DOI 10.1053/j.gastro.2009.03.035; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Michalopoulos GK, 2001, AM J PATHOL, V159, P1877, DOI 10.1016/S0002-9440(10)63034-9; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Preisegger KH, 1999, LAB INVEST, V79, P103; Sackett SD, 2009, HEPATOLOGY, V49, P920, DOI 10.1002/hep.22705; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STOWELL RE, 1950, AMA ARCH PATHOL, V50, P519; Tanimizu N, 2004, J CELL SCI, V117, P3165, DOI 10.1242/jcs.01169; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318	30	913	982	9	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					247	250		10.1038/nature11826	http://dx.doi.org/10.1038/nature11826			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23354049	Green Accepted			2022-12-24	WOS:000315137700042
J	Berry, JG; Toomey, SL; Zaslavsky, AM; Jha, AK; Nakamura, MM; Klein, DJ; Feng, JY; Shulman, S; Chiang, VK; Kaplan, W; Hall, M; Schuster, MA				Berry, Jay G.; Toomey, Sara L.; Zaslavsky, Alan M.; Jha, Ashish K.; Nakamura, Mari M.; Klein, David J.; Feng, Jeremy Y.; Shulman, Shanna; Chiang, Vincent K.; Kaplan, William; Hall, Matt; Schuster, Mark A.			Pediatric Readmission Prevalence and Variability Across Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE; CHILDRENS HOSPITALS; SOCIOECONOMIC-STATUS; QUALITY MEASURES; HEART-FAILURE; INSURANCE; OUTCOMES; PROGRAM; INITIATIVES; PERFORMANCE	Importance Readmission rates are used as an indicator of the quality of care that patients receive during a hospital admission and after discharge. Objective To determine the prevalence of pediatric readmissions and the magnitude of variation in pediatric readmission rates across hospitals. Design, Setting, and Patients We analyzed 568 845 admissions at 72 children's hospitals between July 1, 2009, and June 30, 2010, in the National Association of Children's Hospitals and Related Institutions Case Mix Comparative data set. We estimated hierarchical regression models for 30-day readmission rates by hospital, accounting for age and Chronic Condition Indicators. Hospitals with adjusted readmission rates that were 1 SD above and below the mean were defined as having "high" and "low" rates, respectively. Main Outcome Measures Thirty-day unplanned readmissions following admission for any diagnosis and for the 10 admission diagnoses with the highest readmission prevalence. Planned readmissions were identified with procedure codes from the International Classification of Diseases, Ninth Revision, Clinical Modification. Results The 30-day unadjusted readmission rate for all hospitalized children was 6.5% (n=36 734). Adjusted rates were 28.6% greater in hospitals with high vs low readmission rates (7.2% [95% CI, 7.1%-7.2%] vs 5.6% [95% CI, 5.6%-5.6%]). For the 10 admission diagnoses with the highest readmission prevalence, the adjusted rates were 17.0% to 66.0% greater in hospitals with high vs low readmission rates. For example, sickle cell rates were 20.1% (95% CI, 20.0%-20.3%) vs 12.7% (95% CI, 12.6%-12.8%) in high vs low hospitals, respectively. Conclusions and Relevance Among patients admitted to acute care pediatric hospitals, the rate of unplanned readmissions at 30 days was 6.5%. There was significant variability in readmission rates across conditions and hospitals. These data may be useful for hospitals' quality improvement efforts. JAMA. 2013;309(4):372-380 www.jama.com	[Berry, Jay G.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA; [Nakamura, Mari M.] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; [Chiang, Vincent K.] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Zaslavsky, Alan M.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Berry, Jay G.; Toomey, Sara L.; Nakamura, Mari M.; Chiang, Vincent K.; Schuster, Mark A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Hall, Matt] Childrens Hosp Assoc, Overland Pk, KS USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Children's Mercy Hospital	Berry, JG (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Gen Pediat, 300 Longwood Ave, Boston, MA 02115 USA.	jay.berry@childrens.harvard.edu	Hall, Matt/AAT-1349-2021; Feng, Jeremy Y/A-4592-2014	Hall, Matt/0000-0001-7778-5887; Feng, Jeremy Y/0000-0002-6912-1922	Agency for Healthcare Research and Quality [U18 HS020513]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [K23 HD058092]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS020513] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD058092] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding was provided by the Agency for Healthcare Research and Quality (U18 HS020513, Principal Investigator: Dr Schuster). Dr Berry was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (K23 HD058092).	3M Health Information Systems, ALL PAT REF DIAGN RE; Agency for Healthcare Research and Quality, CHIPRA MEAS CHIPRA C; Agency for Healthcare Research and Quality, CHRON COND IND; Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project, 2016, INTR HCUP KIDS INP D; [Anonymous], US ADM DAT MON ACC I; [Anonymous], CREAT NAT CHILDR HOS; [Anonymous], CAS MIX PROGR DAT; [Anonymous], HOSP CAR OUTC EFF ME; [Anonymous], VAR HEALTHC DOES IT; Axon RN, 2011, JAMA-J AM MED ASSOC, V305, P504, DOI 10.1001/jama.2011.72; Bautista J, 2012, 2012 AM ASS NEUR M A; Bernheim SM, 2011, 2011 MEASURES MAINTE; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Berry JG, 2008, NEUROSURGERY, V62, P445, DOI 10.1227/01.neu.0000316012.20797.04; Berry JG, 2011, JAMA-J AM MED ASSOC, V305, P682, DOI 10.1001/jama.2011.122; BILLINGS J, 1993, HEALTH AFFAIR, V12, P162, DOI 10.1377/hlthaff.12.1.162; Bourgeois FC, 2010, ARCH INTERN MED, V170, P1989, DOI 10.1001/archinternmed.2010.439; Bradley EH, 2012, J AM COLL CARDIOL, V60, P607, DOI 10.1016/j.jacc.2012.03.067; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205; Carrns Ann, 2010, US News World Rep, V147, P22; Cassedy A, 2008, AMBUL PEDIATR, V8, P321, DOI 10.1016/j.ambp.2008.04.007; Castro M, 2003, AM J RESP CRIT CARE, V168, P1095, DOI 10.1164/rccm.200208-877OC; Cheney J, 2005, J PEDIATR-US, V147, P622, DOI 10.1016/j.jpeds.2005.06.040; Chi MJ, 2011, ARCH GERONTOL GERIAT, V52, P284, DOI 10.1016/j.archger.2010.04.017; Cohen E, 2011, PEDIATRICS, V127, P529, DOI 10.1542/peds.2010-0910; Coye Molly Joel, 2008, Hosp Health Netw, V82, P24; Dougherty D, 2011, ACAD PEDIATR, V11, pS1, DOI 10.1016/j.acap.2011.02.009; Eselius LL, 2008, HEALTH SERV RES, V43, P2014, DOI 10.1111/j.1475-6773.2008.00894.x; Farewell Carrns A., 2010, US NEWS WORLD REP, V147, P22; Favole JA, 2009, WALL STREET J, pD4; Feudtner C, 2010, J PEDIATR-US, V157, P98, DOI 10.1016/j.jpeds.2010.01.049; Feudtner C, 2009, PEDIATRICS, V123, P286, DOI 10.1542/peds.2007-3395; Frei-Jones MJ, 2009, PEDIATR BLOOD CANCER, V52, P481, DOI 10.1002/pbc.21854; Friedman B, 2006, MED CARE RES REV, V63, P327, DOI 10.1177/1077558706287042; Fung V, 2010, MED CARE, V48, P140, DOI 10.1097/MLR.0b013e3181bd4dc3; HealthCare. gov, PARTN PAT BETT CAR L; Hernandez AF, 2011, JAMA-J AM MED ASSOC, V305, P715, DOI 10.1001/jama.2011.167; Ho C, 2013, J CHILD NEUROL, V28, P40, DOI 10.1177/0883073812439345; Hong R, 2007, J EMERG MED, V32, P149, DOI 10.1016/j.jemermed.2006.05.042; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Morse RB, 2011, JAMA-J AM MED ASSOC, V306, P1454, DOI 10.1001/jama.2011.1385; Nasir K, 2010, MED CARE, V48, P477, DOI 10.1097/MLR.0b013e3181d5fb24; Parker JD, 2000, PEDIATRICS, V106, P942; Rice-Townsend S, 2013, ANN SURG, V257, P758, DOI 10.1097/SLA.0b013e318268a663; Rice-Townsend S, 2012, J PEDIATR SURG, V47, P1170, DOI 10.1016/j.jpedsurg.2012.03.025; Schuster MA, 2008, JAMA-J AM MED ASSOC, V300, P1047, DOI 10.1001/jama.300.9.1047; Sedman AB, 2004, PEDIATRICS, V114, P965, DOI 10.1542/peds.2004-0650; Sommers A, PHYS VISITS HOSP DIS; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; VINSON JM, 1990, J AM GERIATR SOC, V38, P1290, DOI 10.1111/j.1532-5415.1990.tb03450.x; Wennberg JE, 2002, BRIT MED J, V325, P961, DOI 10.1136/bmj.325.7370.961; Zickafoose JS, 2011, ACAD PEDIATR, V11, P305, DOI 10.1016/j.acap.2011.03.006	54	273	273	3	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					372	380		10.1001/jama.2012.188351	http://dx.doi.org/10.1001/jama.2012.188351			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	074FT	23340639	Bronze, Green Accepted			2022-12-24	WOS:000313799000025
J	Gu, WF; Lee, HC; Chaves, D; Youngman, EM; Pazour, GJ; Conte, D; Mello, CC				Gu, Weifeng; Lee, Heng-Chi; Chaves, Daniel; Youngman, Elaine M.; Pazour, Gregory J.; Conte, Darryl, Jr.; Mello, Craig C.			CapSeq and CIP-TAP Identify Pol II Start Sites and Reveal Capped Small RNAs as C. elegans piRNA Precursors	CELL			English	Article							POLYMERASE-II; DIVERGENT TRANSCRIPTION; EPIGENETIC MEMORY; PRIMAL RNAS; PIWI; GERMLINE; PROMOTER; COMPLEX; IDENTIFICATION; BIOGENESIS	Piwi-interacting (pi) RNAs are germline-expressed small RNAs linked to epigenetic programming. C. elegans piRNAs are thought to be transcribed as independent gene-like loci. To test this idea and to identify potential transcription start (TS) sites for piRNA precursors, we developed CapSeq, an efficient enzymatic method for 5' anchored RNA profiling. Using CapSeq, we identify candidate TS sites, defined by 70-90 nt sequence tags, for >50% of annotated Pol II loci. Surprisingly, however, these CapSeq tags failed to identify the overwhelming majority of piRNA loci. Instead, we show that the likely piRNA precursors are similar to 26 nt capped small (cs) RNAs that initiate precisely 2 nt upstream of mature piRNAs and that piRNA processing or stability requires a U at the csRNA +3 position. Finally, we identify a heretofore unrecognized class of piRNAs processed from csRNAs that are expressed at promoters genome wide, nearly doubling the number of piRNAs available for genome surveillance.	[Gu, Weifeng; Lee, Heng-Chi; Chaves, Daniel; Youngman, Elaine M.; Pazour, Gregory J.; Conte, Darryl, Jr.; Mello, Craig C.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Mello, Craig C.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	craig.mello@umassmed.edu	Youngman, Elaine/E-7072-2013; Youngman, Elaine/O-7449-2019	Lee, Heng-Chi/0000-0001-8154-906X; Pazour, Gregory/0000-0002-6285-8796	Ruth L. Kirschstein National Research Service Award [GM099372]; NIH [GM058800]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM058800, F32GM099372, R01GM058800, R01GM060992] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Mello lab for useful discussions, Tom Blumenthal for providing spliced leader sequences, Stephen Jones for providing mouse sample, Zhiping Weng for providing information about the mouse database, and Ellen Kittler for deep sequencing. H.-C.L. is supported by a Ruth L. Kirschstein National Research Service Award (GM099372). C.C.M. is a Howard Hughes Medical Institute Investigator and is supported by NIH grant GM058800.	Allen MA, 2011, GENOME RES, V21, P255, DOI 10.1101/gr.113811.110; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrecka J, 2008, P NATL ACAD SCI USA, V105, P135, DOI 10.1073/pnas.0703815105; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Beyret E, 2012, CELL RES, V22, P1429, DOI 10.1038/cr.2012.120; Blumenthal T., 1997, RNA PROCESSING GENE; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BRENNER S, 1974, GENETICS, V77, P71; Cecere G, 2012, MOL CELL, V47, P734, DOI 10.1016/j.molcel.2012.06.021; Chen CY, 2009, P NATL ACAD SCI USA, V106, P127, DOI 10.1073/pnas.0811689106; Conte D, 2010, CELL, V140, P452, DOI 10.1016/j.cell.2010.02.005; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; de Hoon M, 2008, BIOTECHNIQUES, V44, P627, DOI 10.2144/000112802; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gu WF, 2011, METHODS MOL BIOL, V725, P251, DOI 10.1007/978-1-61779-046-1_17; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Haussecker D, 2008, NAT STRUCT MOL BIOL, V15, P714, DOI 10.1038/nsmb.1440; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lamm AT, 2011, GENOME RES, V21, P265, DOI 10.1101/gr.108845.110; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Mituyama T, 2009, NUCLEIC ACIDS RES, V37, pD89, DOI 10.1093/nar/gkn805; Morton JJ, 2011, RNA, V17, P327, DOI 10.1261/rna.2447111; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; RASMUSSEN EB, 1995, J MOL BIOL, V252, P522, DOI 10.1006/jmbi.1995.0517; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Vasale JJ, 2010, P NATL ACAD SCI USA, V107, P3582, DOI 10.1073/pnas.0911908107; Yamamoto YY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-67	57	133	137	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1488	1500		10.1016/j.cell.2012.11.023	http://dx.doi.org/10.1016/j.cell.2012.11.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260138	Bronze, Green Accepted			2022-12-24	WOS:000312890300014
J	Li, JH; Cone, JE; Kahn, AR; Brackbill, RM; Farfel, MR; Greene, CM; Hadler, JL; Stayner, LT; Stellman, SD				Li, Jiehui; Cone, James E.; Kahn, Amy R.; Brackbill, Robert M.; Farfel, Mark R.; Greene, Carolyn M.; Hadler, James L.; Stayner, Leslie T.; Stellman, Steven D.			Association Between World Trade Center Exposure and Excess Cancer Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CENTER HEALTH REGISTRY; YORK-CITY FIREFIGHTERS; MULTIPLE-MYELOMA; CENTER DISASTER; PROSTATE-CANCER; COLLAPSE; COHORT; WORKERS; MORTALITY; SYMPTOMS	Context The terrorist attacks of September 11, 2001, resulted in the release of known and suspected carcinogens into the environment. There is public concern that exposures may have resulted in increased cancers. Objective To evaluate cancer incidence among persons enrolled in the World Trade Center Health Registry. Design, Setting, and Participants Observational study of 55 778 New York State residents enrolled in the World Trade Center Health Registry in 2003-2004, including rescue/recovery workers (n=21 850) and those not involved in rescue/recovery (n=33 928), who were followed up from enrollment through December 31, 2008. Within-cohort comparisons using Cox proportional hazards models assessed the relationship between intensity of World Trade Center exposure and selected cancers. Main Outcome Measures Cases were identified through linkage with 11 state cancer registries. Standardized incidence ratios (SIRs) adjusted for age, race/ethnicity, and sex were computed with 2003-2008 New York State rates as the reference, focusing on cancers diagnosed in 2007-2008 as being most likely to be related to exposure during September 11 and its aftermath. The total and site-specific incidence rate differences (RDs) per 100 000 person-years between the study population and the New York State population in 2007-2008 also were calculated. Results There were 1187 incident cancers diagnosed, with an accumulated 253 269 person-years (439 cancers among rescue/recovery workers and 748 among those not involved in rescue/recovery). The SIR for all cancer sites combined in 2007-2008 was not significantly elevated (SIR, 1.14 [95% CI, 0.99 to 1.30]; RD, 67 [95% CI, -6 to 126] per 100 000 person-years among rescue/recovery workers vs SIR, 0.92 [95% CI, 0.83 to 1.03]; RD, -45 [95% CI, -106 to 15] per 100 000 person-years among those not involved in rescue/recovery). Among rescue/recovery workers, the SIRs had significantly increased by 2007-2008 for 3 cancer sites and were 1.43 (95% CI, 1.11 to 1.82) for prostate cancer (n=67; RD, 61 [95% CI, 20 to 91] per 100 000 person-years), 2.02 (95% CI, 1.07 to 3.45) for thyroid cancer (n=13; RD, 16 [95% CI, 2 to 23] per 100 000 person-years), and 2.85 (95% CI, 1.15 to 5.88) for multiple myeloma (n=7; RD, 11 [95% CI, 2 to 14] per 100 000 person-years). No increased incidence was observed in 2007-2008 among those not involved in rescue/recovery. Using within-cohort comparisons, the intensity of World Trade Center exposure was not significantly associated with cancer of the lung, prostate, thyroid, non-Hodgkin lymphoma, or hematological cancer in either group. Conclusions Among persons enrolled in the World Trade Center Health Registry, there was an excess risk for prostate cancer, thyroid cancer, and myeloma in 20072008 compared with that for New York State residents; however, these findings were based on a small number of events and multiple comparisons. No significant associations were observed with intensity of World Trade Center exposures. Longer follow-up for typically long-latency cancers and attention to specific cancer sites are needed. JAMA. 2012;308(23):2479-2488 www.jama.com	[Li, Jiehui] New York City Dept Hlth & Mental Hyg, World Trade Ctr Hlth Registry, Long Isl City, NY 11101 USA; [Kahn, Amy R.] New York State Dept Hlth, Bur Canc Epidemiol, Albany, NY USA; [Stayner, Leslie T.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA; [Stellman, Steven D.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	New York City Department of Health & Mental Hygiene; State University of New York (SUNY) System; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Columbia University	Li, JH (corresponding author), New York City Dept Hlth & Mental Hyg, World Trade Ctr Hlth Registry, 42-09 28th St,7th Floor, Long Isl City, NY 11101 USA.	jli3@health.nyc.gov			National Institute for Occupational Safety and Health [1U50/OH009739]; Agency for Toxic Substances and Disease Registry [U50/ATU272750]; National Center for Environmental Health of the Centers for Disease Control and Prevention; New York City Department of Health and Mental Hygiene; New York State Department of Health; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U50OH009739] Funding Source: NIH RePORTER	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Agency for Toxic Substances and Disease Registry(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Environmental Health of the Centers for Disease Control and Prevention; New York City Department of Health and Mental Hygiene; New York State Department of Health; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This study was supported by cooperative agreement 1U50/OH009739 from the National Institute for Occupational Safety and Health and cooperative agreement U50/ATU272750 from the Agency for Toxic Substances and Disease Registry, which included support from the National Center for Environmental Health of the Centers for Disease Control and Prevention, and the New York City Department of Health and Mental Hygiene. Ms Kahn was supported by the New York State Department of Health.	Ahmed S, 2010, AM J ROENTGENOL, V195, P1066, DOI 10.2214/AJR.10.4506; Aldrich TK, 2010, NEW ENGL J MED, V362, P1263, DOI 10.1056/NEJMoa0910087; ARMENIAN HK, 1974, AM J EPIDEMIOL, V99, P92, DOI 10.1093/oxfordjournals.aje.a121599; BOFFETTA P, 1989, INT J CANCER, V43, P554, DOI 10.1002/ijc.2910430404; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; Breslow N. E., 1987, STATISTICAL METHODS, V2, P69; Cahill TA, 2004, AEROSOL SCI TECH, V38, P165, DOI 10.1080/02786820490250836; DEMERS PA, 1993, AM J IND MED, V23, P629, DOI 10.1002/ajim.4700230410; Edelman P, 2003, ENVIRON HEALTH PERSP, V111, P1906, DOI 10.1289/ehp.6315; Farfel M, 2008, J URBAN HEALTH, V85, P880, DOI 10.1007/s11524-008-9317-4; Horii Y, 2010, ENVIRON SCI TECHNOL, V44, P5188, DOI 10.1021/es100282d; HOWE GR, 1990, AM J EPIDEMIOL, V132, P1039, DOI 10.1093/oxfordjournals.aje.a115745; Jordan HT, 2011, LANCET, V378, P879, DOI 10.1016/S0140-6736(11)60966-5; Kipen HM, 2005, TXB CLIN OCCUPATIONA; Lioy PJ, 2002, ENVIRON HEALTH PERSP, V110, P703, DOI 10.1289/ehp.02110703; McGee JK, 2003, ENVIRON HEALTH PERSP, V111, P972, DOI 10.1289/ehp.5930; Moline JM, 2009, J OCCUP ENVIRON MED, V51, P896, DOI 10.1097/JOM.0b013e3181ad49c8; Murphy J, 2007, STAT MED, V26, P1688, DOI 10.1002/sim.2806; National Cancer Institute, SEER SIT REC ICD O 3; New York State Department of Health, 1976, PERC CANC DIAGN EARL; Perlman SE, 2011, LANCET, V378, P925, DOI 10.1016/S0140-6736(11)60967-7; Pleil JD, 2004, P NATL ACAD SCI USA, V101, P11685, DOI 10.1073/pnas.0404499101; POTOSKY AL, 1995, JAMA-J AM MED ASSOC, V273, P548, DOI 10.1001/jama.273.7.548; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Rinsky RA, 2002, AM J IND MED, V42, P474, DOI 10.1002/ajim.10138; Russi MB, 2005, TXB CLIN OCCUPATIONA; Savitz DA, 2008, MT SINAI J MED, V75, P77, DOI 10.1002/msj.20023; SHORE RE, 1985, J NATL CANCER I, V74, P1177; Stellman SD, 2006, ENV OCCUPATIONAL MED, P1236; Weakley J, 2011, PREV MED, V53, P364, DOI 10.1016/j.ypmed.2011.09.001; Williams ED, 2004, BRIT J CANCER, V90, P2219, DOI 10.1038/sj.bjc.6601860; Wisnivesky JP, 2011, LANCET, V378, P888, DOI 10.1016/S0140-6736(11)61180-X; Zeig-Owens R, 2011, LANCET, V378, P898, DOI 10.1016/S0140-6736(11)60989-6	34	80	80	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2479	2488		10.1001/jama.2012.110980	http://dx.doi.org/10.1001/jama.2012.110980			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23288447	Green Published			2022-12-24	WOS:000312441400024
J	Zhuravleva, A; Clerico, EM; Gierasch, LM				Zhuravleva, Anastasia; Clerico, Eugenia M.; Gierasch, Lila M.			An Interdomain Energetic Tug-of-War Creates the Allosterically Active State in Hsp70 Molecular Chaperones	CELL			English	Article							SUBSTRATE-BINDING DOMAIN; CONFORMATIONAL-CHANGES; STRUCTURAL BASIS; WEIGHT PROTEINS; METHYL-GROUPS; DNAK; ATPASE; MUTATIONS; MECHANISM; INSIGHTS	The allosteric mechanism of Hsp70 molecular chaperones enables ATP binding to the N-terminal nucleotide-binding domain (NBD) to alter substrate affinity to the C-terminal substrate-binding domain (SBD) and substrate binding to enhance ATP hydrolysis. Cycling between ATP-bound and ADP/substrate-bound states requires Hsp70s to visit a state with high ATPase activity and fast on/off kinetics of substrate binding. We have trapped this "allosterically active'' state for the E. coli Hsp70, DnaK, and identified how interactions among the NBD, the beta subdomain of the SBD, the SBD alpha-helical lid, and the conserved hydrophobic interdomain linker enable allosteric signal transmission between ligand-binding sites. Allostery in Hsp70s results from an energetic tug-of-war between domain conformations and formation of two orthogonal interfaces: between the NBD and SBD, and between the helical lid and the beta subdomain of the SBD. The resulting energetic tension underlies Hsp70 functional properties and enables them to be modulated by ligands and cochaperones and "tuned'' through evolution.	[Zhuravleva, Anastasia; Clerico, Eugenia M.; Gierasch, Lila M.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Gierasch, Lila M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.	gierasch@biochem.umass.edu		Zhuravleva, Anastasia/0000-0001-6165-8509	NIH [GM027616]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027616] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM027616. We thank Fabian Romano and Alejandro Heuck for assistance with the time-resolved fluorescence measurements.	Ahmad A, 2011, P NATL ACAD SCI USA, V108, P18966, DOI 10.1073/pnas.1111220108; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bhattacharya A, 2009, J MOL BIOL, V388, P475, DOI 10.1016/j.jmb.2009.01.062; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; BUKAU B, 1990, EMBO J, V9, P4027, DOI 10.1002/j.1460-2075.1990.tb07624.x; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Chang L, 2011, CHEM BIOL, V18, P210, DOI 10.1016/j.chembiol.2010.12.010; Clerico EM, 2010, BIOPOLYMERS, V94, P742, DOI 10.1002/bip.21426; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fernandez-Saiz V, 2006, J BIOL CHEM, V281, P7479, DOI 10.1074/jbc.M512744200; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Keller R, 2004, THESIS ETH ZURICH; Kumar DP, 2011, J MOL BIOL, V411, P1099, DOI 10.1016/j.jmb.2011.07.001; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Manley G, 2012, ARCH BIOCHEM BIOPHYS, V519, P223, DOI 10.1016/j.abb.2011.10.023; Mapa K, 2010, MOL CELL, V38, P89, DOI 10.1016/j.molcel.2010.03.010; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; MCCARTY JS, 1991, P NATL ACAD SCI USA, V88, P9513, DOI 10.1073/pnas.88.21.9513; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; Revington M, 2004, J BIOL CHEM, V279, P33958, DOI 10.1074/jbc.M313967200; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Ruschak AM, 2010, J BIOMOL NMR, V46, P75, DOI 10.1007/s10858-009-9376-1; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Sharma D, 2011, P NATL ACAD SCI USA, V108, P13665, DOI 10.1073/pnas.1107421108; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Swain JF, 2006, J BIOL CHEM, V281, P1605, DOI 10.1074/jbc.M509356200; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Tugarinov V, 2005, CHEMBIOCHEM, V6, P1567, DOI 10.1002/cbic.200500110; Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; WILBANKS SM, 1995, BIOCHEMISTRY-US, V34, P12095, DOI 10.1021/bi00038a002; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2011, P NATL ACAD SCI USA, V108, P6987, DOI 10.1073/pnas.1014448108	52	186	187	0	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1296	1307		10.1016/j.cell.2012.11.002	http://dx.doi.org/10.1016/j.cell.2012.11.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217711	Green Accepted, Bronze			2022-12-24	WOS:000311999900018
J	Goldman, N; Bertone, P; Chen, SY; Dessimoz, C; LeProust, EM; Sipos, B; Birney, E				Goldman, Nick; Bertone, Paul; Chen, Siyuan; Dessimoz, Christophe; LeProust, Emily M.; Sipos, Botond; Birney, Ewan			Towards practical, high-capacity, low-maintenance information storage in synthesized DNA	NATURE			English	Article							CHAIN	Digital production, transmission and storage have revolutionized how we access and use information but have also made archiving an increasingly complex task that requires active, continuing maintenance of digital media. This challenge has focused some interest on DNA as an attractive target for information storage(1) because of its capacity for high-density information encoding, longevity under easily achieved conditions(2-4) and proven track record as an information bearer. Previous DNA-based information storage approaches have encoded only trivial amounts of information(5-7) or were not amenable to scaling-up(8), and used no robust error-correction and lacked examination of their cost-efficiency for large-scale information archival(9). Here we describe a scalable method that can reliably store more information than has been handled before. We encoded computer files totalling 739 kilobytes of hard-disk storage and with an estimated Shannon information(10) of 5.2 x 10(6) bits into a DNA code, synthesized this DNA, sequenced it and reconstructed the original files with 100% accuracy. Theoretical analysis indicates that our DNA-based storage scheme could be scaled far beyond current global information volumes and offers a realistic technology for large-scale, long-term and infrequently accessed digital archiving. In fact, current trends in technological advances are reducing DNA synthesis costs at a pace that should make our scheme cost-effective for sub-50-year archiving within a decade.	[Goldman, Nick; Bertone, Paul; Dessimoz, Christophe; Sipos, Botond; Birney, Ewan] European Bioinformat Inst, Hinxton CB10 1SD, England; [Chen, Siyuan; LeProust, Emily M.] Genom LSSU, Agilent Technol, Santa Clara, CA 95051 USA	European Molecular Biology Laboratory (EMBL); Agilent Technologies	Goldman, N (corresponding author), European Bioinformat Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SD, England.	goldman@ebi.ac.uk	Bertone, Paul/A-6600-2013; Bertone, Paul/Z-3734-2019; Chen, Siyuan/C-6163-2012; Dessimoz, Christophe/D-3678-2011	Bertone, Paul/0000-0001-5059-4829; Bertone, Paul/0000-0001-5059-4829; Dessimoz, Christophe/0000-0002-2170-853X; Birney, Ewan/0000-0001-8314-8497; Sipos, Botond/0000-0002-9046-3302; Goldman, Nick/0000-0001-8486-2211	Swiss National Science Foundation [136461]; EMBL	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EMBL	At the University of Cambridge: D. MacKay and G. Mitchison for advice on codes for run-length-limited channels. At CERN: B. Jones for discussions on data archival. At EBI: A. Loytynoja for custom multiple sequence alignment software, H. Marsden for computing base calls and for detecting an error in the original parity-check encoding, T. Massingham for computing base calls and advice on code theory and K. Gori, D. Henk, R. Loos, S. Parks and R. Schwarz for assistance with revisions to the manuscript. In the Genomics Core Facility at EMBL Heidelberg: V. Benes for advice on Next-Generation Sequencing protocols, D. Pavlinic for sequencing and J. Blake for data handling. C.D. is supported by a fellowship from the Swiss National Science Foundation (grant 136461). B.S. is supported by an EMBL Interdisciplinary Postdoctoral Fellowship under Marie Curie Actions (COFUND).	Ailenberg M, 2009, BIOTECHNIQUES, V47, P747, DOI 10.2144/000113218; Anchordoquy TJ, 2007, CELL PRESERV TECHNOL, V5, P180, DOI 10.1089/cpt.2007.0511; [Anonymous], 2012, SVALB GLOB SEED VAUL; [Anonymous], 2012, ECONOMIST, V403, P56; Baker M., 2006, P 1 ACM SIGOPS EUROS, P221; BAUM EB, 1995, SCIENCE, V268, P583, DOI 10.1126/science.7725109; Bessone N, 2010, J PHYS CONF SER, V219, DOI 10.1088/1742-6596/219/6/062038; Bonnet J, 2010, NUCLEIC ACIDS RES, V38, P1531, DOI 10.1093/nar/gkp1060; Brand S., 1999, CLOCK LONG NOW; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; Clelland CT, 1999, NATURE, V399, P533, DOI 10.1038/21092; Cox JPL, 2001, TRENDS BIOTECHNOL, V19, P247, DOI 10.1016/S0167-7799(01)01671-7; ERLICH HA, 1991, SCIENCE, V252, P1643, DOI 10.1126/science.2047872; Gantz J., 2011, IDC IVIEW; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Kac E., 1999, GENESIS; Kari L., 2009, ALGORITHMS THEORY CO, V2, P31; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; MacKay D. J. C., 2003, INFORM THEORY INFERE; Massingham T, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r13; MONACO AP, 1994, TRENDS BIOTECHNOL, V12, P280, DOI 10.1016/0167-7799(94)90140-6; Niedringhaus TP, 2011, ANAL CHEM, V83, P4327, DOI 10.1021/ac2010857; Paun G., 1998, DNA COMPUTING NEW CO, DOI DOI 10.1007/978-3-662-03563-4; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Yuille M, 2010, CELL TISSUE BANK, V11, P241, DOI 10.1007/s10561-009-9150-3	28	490	565	36	407	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					77	80		10.1038/nature11875	http://dx.doi.org/10.1038/nature11875			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23354052	Green Accepted			2022-12-24	WOS:000314741200037
J	Gaudry, Q; Hong, EJ; Kain, J; de Bivort, BL; Wilson, RI				Gaudry, Quentin; Hong, Elizabeth J.; Kain, Jamey; de Bivort, Benjamin L.; Wilson, Rachel I.			Asymmetric neurotransmitter release enables rapid odour lateralization in Drosophila	NATURE			English	Article							OLFACTORY LOCAL INTERNEURONS; ANTENNAL LOBE; MELANOGASTER; CIRCUIT; NEURONS; OSMOTROPOTAXIS; INFORMATION; MARKER; SYSTEM; GENE	In Drosophila, most individual olfactory receptor neurons (ORNs) project bilaterally to both sides of the brain(1,2). Having bilateral rather than unilateral projections may represent a useful redundancy. However, bilateral ORN projections to the brain should also compromise the ability to lateralize odours. Nevertheless, walking or flying Drosophila reportedly turn towards the antenna that is more strongly stimulated by odour(3-5). Here we show that each ORN spike releases approximately 40% more neurotransmitter from the axon branch ipsilateral to the soma than from the contralateral branch. As a result, when an odour activates the antennae asymmetrically, ipsilateral central neurons begin to spike a few milliseconds before contralateral neurons, and at a 30 to 50% higher rate than contralateral neurons. We show that a walking fly can detect a 5% asymmetry in total ORN input to its left and right antennal lobes, and can turn towards the odour in less time than it requires the fly to complete a stride. These results demonstrate that neurotransmitter release properties can be tuned independently at output synapses formed by a single axon onto two target cells with identical functions and morphologies. Our data also show that small differences in spike timing and spike rate can produce reliable differences in olfactory behaviour.	[Gaudry, Quentin; Hong, Elizabeth J.; Wilson, Rachel I.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Kain, Jamey; de Bivort, Benjamin L.] Harvard Univ, Rowland Inst, Cambridge, MA 02142 USA; [de Bivort, Benjamin L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [de Bivort, Benjamin L.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu		Wilson, Rachel/0000-0001-8573-9266	National Institutes of Health [R01DC008174]; Rowland Junior Fellows Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rowland Junior Fellows Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to M. Dickinson, V. Jayaraman, L. Luo, D. Tracey and L. Vosshall for gifts of fly stocks. A. Baker helped construct and improve the spherical treadmill apparatus. Members of the Wilson laboratory provided feedback on the manuscript. This work was supported by a research project grant from the National Institutes of Health (R01DC008174). R. I. W. is an HHMI Early Career Scientist. B.L.d.B. and J.K. were supported by the Rowland Junior Fellows Program.	Agarwal G, 2011, J NEUROPHYSIOL, V105, P1711, DOI 10.1152/jn.00591.2010; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Bhandawat V, 2010, J EXP BIOL, V213, P3625, DOI 10.1242/jeb.040402; BORST A, 1982, J COMP PHYSIOL, V147, P479, DOI 10.1007/BF00612013; Chintapalli VR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032577; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Das A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-33; Duistermars BJ, 2009, CURR BIOL, V19, P1301, DOI 10.1016/j.cub.2009.06.022; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; FLUGGE CHARLOTTE, 1934, ZEITSCHR WISS BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V20, P463; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; HANGART.W, 1967, Z VERGL PHYSIOL, V57, P103, DOI 10.1007/BF00303068; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Kazama H, 2011, J NEUROSCI, V31, P7619, DOI 10.1523/JNEUROSCI.5984-10.2011; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; KENNEDY JS, 1969, ENTOMOL EXP APPL, V12, P487, DOI 10.1007/BF00297080; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LOCKERY SR, 1990, J NEUROSCI, V10, P1816; MARTIN H, 1965, NATURE, V208, P59, DOI 10.1038/208059a0; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Pelkey KA, 2007, CURR OPIN NEUROBIOL, V17, P366, DOI 10.1016/j.conb.2007.04.008; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; STRAUSS R, 1990, J COMP PHYSIOL A, V167, P403, DOI 10.1007/BF00192575; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	36	87	87	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2013	493	7432					424	U175		10.1038/nature11747	http://dx.doi.org/10.1038/nature11747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23263180	Green Submitted, Green Accepted			2022-12-24	WOS:000313615900056
J	Schwitalla, S; Fingerle, AA; Cammareri, P; Nebelsiek, T; Goktuna, SI; Ziegler, PK; Canli, O; Heijmans, J; Huels, DJ; Moreaux, G; Rupec, RA; Gerhard, M; Schmid, R; Barker, N; Clevers, H; Lang, R; Neumann, J; Kirchner, T; Taketo, MM; van den Brink, GR; Sansom, OJ; Arkan, MC; Greten, FR				Schwitalla, Sarah; Fingerle, Alexander A.; Cammareri, Patrizia; Nebelsiek, Tim; Goektuna, Serkan I.; Ziegler, Paul K.; Canli, Ozge; Heijmans, Jarom; Huels, David J.; Moreaux, Guenievre; Rupec, Rudolf A.; Gerhard, Markus; Schmid, Roland; Barker, Nick; Clevers, Hans; Lang, Roland; Neumann, Jens; Kirchner, Thomas; Taketo, Makoto M.; van den Brink, Gijs R.; Sansom, Owen J.; Arkan, Melek C.; Greten, Florian R.			Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties	CELL			English	Article							NF-KAPPA-B; BETA-CATENIN; PANCREATIC-CANCER; TUMOR PROGRESSION; MOUSE MODEL; IN-VIVO; INFLAMMATION; EXPRESSION; IKK; APC	Cell-type plasticity within a tumor has recently been suggested to cause a bidirectional conversion between tumor-initiating stem cells and nonstem cells triggered by an inflammatory stroma. NF-kappa B represents a key transcription factor within the inflammatory tumor microenvironment. However, NF-kappa B's function in tumor-initiating cells has not been examined yet. Using a genetic model of intestinal epithelial cell (IEC)-restricted constitutive Wnt-activation, which comprises the most common event in the initiation of colon cancer, we demonstrate that NF-kappa B modulates Wnt signaling and show that IEC-specific ablation of RelA/p65 retards crypt stem cell expansion. In contrast, elevated NF-kappa B signaling enhances Wnt activation and induces dedifferentiation of nonstem cells that acquire tumor-initiating capacity. Thus, our data support the concept of bidirectional conversion and highlight the importance of inflammatory signaling for dedifferentiation and generation of tumor-initiating cells in vivo.	[Schwitalla, Sarah; Nebelsiek, Tim; Goektuna, Serkan I.; Ziegler, Paul K.; Canli, Ozge; Arkan, Melek C.; Greten, Florian R.] Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, D-81675 Munich, Germany; [Fingerle, Alexander A.] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, D-81675 Munich, Germany; [Gerhard, Markus] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Schmid, Roland] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-81675 Munich, Germany; [Cammareri, Patrizia; Huels, David J.; Moreaux, Guenievre; Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Heijmans, Jarom; van den Brink, Gijs R.] Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 BK Amsterdam, Netherlands; [Rupec, Rudolf A.] Univ Munich, Dept Dermatol & Allergol, D-80337 Munich, Germany; [Neumann, Jens; Kirchner, Thomas] Univ Munich, Inst Pathol, D-80337 Munich, Germany; [Barker, Nick] Inst Med Biol, Singapore 138648, Singapore; [Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Lang, Roland] Univ Hosp Erlangen, Inst Clin Microbiol Immunol & Hyg, D-91054 Erlangen, Germany; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Beatson Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of Munich; University of Munich; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Erlangen Nuremberg; Kyoto University	Greten, FR (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, D-81675 Munich, Germany.	florian.greten@lrz.tum.de	Gerhard, Markus/N-3387-2014; Greten, Florian R/AAF-5196-2020; Barker, Nick/A-5535-2011; Gerhard, Markus/P-8996-2019; Lang, Roland/C-3287-2011; Barker, Nick/AAS-2774-2020; Sch/AAA-9548-2021; Barker, Nick/AAE-9833-2021; Ziegler, Paul/AAO-4379-2021	Gerhard, Markus/0000-0001-9110-3950; Greten, Florian R/0000-0002-3928-6080; Gerhard, Markus/0000-0001-9110-3950; Barker, Nick/0000-0003-3566-4475; Ziegler, Paul/0000-0002-7703-7747; Huels, David/0000-0001-6154-1183; Sansom, Owen J./0000-0001-9540-3010; Heijmans, Jarom/0000-0001-9615-7851; Cammareri, Patrizia/0000-0002-5888-6903; Huels, Roland/0000-0002-1970-744X; Lang, Roland/0000-0003-0502-3677; Goktuna, Serkan/0000-0001-6169-768X	European Research Council [ROSCAN-281967]; Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe; Cancer Research UK [12481] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Cancer Research UK(Cancer Research UK)	We thank Kristin Retzlaff, Saskia Ettl, and Kerstin Burmeister for technical assistance; Jorg Mages and Angela Servatius for generation of microarray data; and Matthias Schiemann for FACS sorting as well as Michael Allgauer for help with in situ hybridization. We are grateful to Sylvie Robine for generously providing villin-creER<SUP>T2</SUP> mice. We thank Bert Vogelstein and Kenneth Kinzler for providing beta-catenin<SUP>S33Y</SUP> and TCF4 plasmids as well as TOPFLASH and FOPFLASH reporter constructs. We also thank Masayuki Miura for providing ERAI-transgenic mice and the pCAX-F-XBP1 Delta DBD-venus plasmid. This work was supported by grants from the European Research Council (ROSCAN-281967), Deutsche Forschungsgemeinschaft, and Deutsche Krebshilfe to F.R.G.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; COLE JW, 1963, CANCER, V16, P998, DOI 10.1002/1097-0142(196308)16:8<998::AID-CNCR2820160806>3.0.CO;2-C; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Preston SL, 2003, CANCER RES, V63, P3819; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rupec RA, 2005, IMMUNITY, V22, P479, DOI 10.1016/j.immuni.2005.02.009; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vlantis K, 2011, J CLIN INVEST, V121, P2781, DOI 10.1172/JCI45349; Wagner M, 2001, GENE DEV, V15, P286, DOI 10.1101/gad.184701; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104	48	721	742	3	167	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					25	38		10.1016/j.cell.2012.12.012	http://dx.doi.org/10.1016/j.cell.2012.12.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23273993	Bronze			2022-12-24	WOS:000313719800004
J	Cobb, KM; Westphal, N; Sayani, HR; Watson, JT; Di Lorenzo, E; Cheng, H; Edwards, RL; Charles, CD				Cobb, Kim M.; Westphal, Niko; Sayani, Hussein R.; Watson, Jordan T.; Di Lorenzo, Emanuele; Cheng, H.; Edwards, R. L.; Charles, Christopher D.			Highly Variable El Nino-Southern Oscillation Throughout the Holocene	SCIENCE			English	Article							TROPICAL PACIFIC CLIMATE; NINO/SOUTHERN-OSCILLATION; VARIABILITY; OCEAN; ENSO; MIDHOLOCENE	The El Nino-Southern Oscillation (ENSO) drives large changes in global climate patterns from year to year, yet its sensitivity to continued anthropogenic greenhouse forcing is uncertain. We analyzed fossil coral reconstructions of ENSO spanning the past 7000 years from the Northern Line Islands, located in the center of action for ENSO. The corals document highly variable ENSO activity, with no evidence for a systematic trend in ENSO variance, which is contrary to some models that exhibit a response to insolation forcing over this same period. Twentieth-century ENSO variance is significantly higher than average fossil coral ENSO variance but is not unprecedented. Our results suggest that forced changes in ENSO, whether natural or anthropogenic, may be difficult to detect against a background of large internal variability.	[Cobb, Kim M.; Sayani, Hussein R.; Di Lorenzo, Emanuele] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Westphal, Niko; Watson, Jordan T.; Charles, Christopher D.] Scripps Inst Oceanog, La Jolla, CA 92037 USA; [Cheng, H.] Xi An Jiao Tong Univ, Inst Global Environm Change, Xian 710049, Peoples R China; [Cheng, H.; Edwards, R. L.] Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA	University System of Georgia; Georgia Institute of Technology; University of California System; University of California San Diego; Scripps Institution of Oceanography; Xi'an Jiaotong University; University of Minnesota System; University of Minnesota Twin Cities	Cobb, KM (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.	kcobb@eas.gatech.edu	CHENG, HAI/H-3413-2017; Edwards, R. Lawrence/I-3124-2014; Di Lorenzo, Emanuele/E-9107-2012; Watson, Jordan/U-9798-2019	CHENG, HAI/0000-0002-5305-9458; Edwards, R. Lawrence/0000-0002-7027-5881; Di Lorenzo, Emanuele/0000-0002-1935-7363; Watson, Jordan/0000-0002-1686-0377; Cobb, Kim/0000-0002-2125-9164	NSF-Division of Ocean Sciences [0752091]; National Natural Science Foundation of China [41230524]; NSF-Division of Atmospheric Sciences [1103403]; U.S. Department of Energy (DOE) [DOE-SC0005597]; Division Of Ocean Sciences [0752091] Funding Source: National Science Foundation	NSF-Division of Ocean Sciences(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSF-Division of Atmospheric Sciences; U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors acknowledge field support from the Norwegian Cruise Lines, the National Geographic Waitt program, and the Palmyra Atoll Research Consortium. The research was funded by NSF-Division of Ocean Sciences award 0752091 to K.M.C. and C.D.C., National Natural Science Foundation of China award 41230524 to H.C., NSF-Division of Atmospheric Sciences award 1103403 to R.L.E. and H.C., and U.S. Department of Energy (DOE) award DOE-SC0005597 to E.D.L. A. Wittenberg and C. Ammann generously provided the NINO3.4 time series from the long control runs of the NOAA-GFDL-CM2.1 and NCAR-CCSM4 models, respectively. Data availability: All data and metadata are archived at NCDC (ftp://ftp.ncdc.noaa.gov/pub/data/paleo/coral/east_pacific/line-islands2013.txt).	Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; Brown J, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001512; Clement AC, 2000, PALEOCEANOGRAPHY, V15, P731, DOI 10.1029/1999PA000466; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; Cobb KM, 2001, GEOPHYS RES LETT, V28, P2209, DOI 10.1029/2001GL012919; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Conroy JL, 2008, QUATERNARY SCI REV, V27, P1166, DOI 10.1016/j.quascirev.2008.02.015; Deser C, 2012, J CLIMATE, V25, P2622, DOI 10.1175/JCLI-D-11-00301.1; Evans MN, 1999, J GEOPHYS RES-OCEANS, V104, P13409, DOI 10.1029/1999JC900001; Fairbanks RG, 1997, CORAL REEFS, V16, pS93, DOI 10.1007/s003380050245; Koutavas A, 2006, GEOLOGY, V34, P993, DOI 10.1130/G22810A.1; Liu ZY, 2000, GEOPHYS RES LETT, V27, P2265, DOI 10.1029/2000GL011452; McGregor HV, 2011, GEOCHIM COSMOCHIM AC, V75, P3930, DOI 10.1016/j.gca.2011.04.017; McGregor HV, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019972; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; Nurhati IS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040270; Otto-Bliesner BL, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018553; Rodbell DT, 1999, SCIENCE, V283, P516, DOI 10.1126/science.283.5401.516; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Stevenson S, 2012, J CLIMATE, V25, P2129, DOI 10.1175/JCLI-D-11-00252.1; Thompson DM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048224; Timmermann A, 2007, J CLIMATE, V20, P4147, DOI 10.1175/JCLI4240.1; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Wang X, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2007GL030766, 10.1029/2007GL031149]; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Wittenberg AT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038710; Wittenberg AT, 2006, J CLIMATE, V19, P698, DOI 10.1175/JCLI3631.1; Woodroffe CD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015868; Zaunbrecher LK, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001788; Zheng W, 2008, CLIM DYNAM, V30, P745, DOI 10.1007/s00382-007-0320-3	30	297	303	22	360	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					67	70		10.1126/science.1228246	http://dx.doi.org/10.1126/science.1228246			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288537				2022-12-24	WOS:000312985800052
J	Yu, Y; Chen, Y; Kim, B; Wang, H; Zhao, C; He, X; Liu, L; Liu, W; Wu, LMN; Mao, M; Chan, JR; Wu, J; Lu, QR				Yu, Yang; Chen, Ying; Kim, Bongwoo; Wang, Haibo; Zhao, Chuntao; He, Xuelian; Liu, Lei; Liu, Wei; Wu, Lai Man N.; Mao, Meng; Chan, Jonah R.; Wu, Jiang; Lu, Q. Richard			Olig2 Targets Chromatin Remodelers to Enhancers to Initiate Oligodendrocyte Differentiation	CELL			English	Article							COMPLEX; TRANSCRIPTION; MYELINATION; BIOLOGY; LESIONS; ROLES; CNS	Establishment of oligodendrocyte identity is crucial for subsequent events of myelination in the CNS. Here, we demonstrate that activation of ATP-dependent SWI/SNF chromatin-remodeling enzyme Smarca4/Brg1 at the differentiation onset is necessary and sufficient to initiate and promote oligodendrocyte lineage progression and maturation. Genome-wide multistage studies by ChIP-seq reveal that oligodendrocyte-lineage determination factor Olig2 functions as a prepatterning factor to direct Smarca4/Brg1 to oligodendrocyte-specific enhancers. Recruitment of Smarca4/Brg1 to distinct subsets of myelination regulatory genes is developmentally regulated. Functional analyses of Smarca4/Brg1 and Olig2 co-occupancy relative to chromatin epigenetic marking uncover stage-specific cis-regulatory elements that predict sets of transcriptional regulators controlling oligodendrocyte differentiation. Together, our results demonstrate that regulation of the functional specificity and activity of a Smarca4/Brg1-dependent chromatin-remodeling complex by Olig2, coupled with transcriptionally linked chromatin modifications, is critical to precisely initiate and establish the transcriptional program that promotes oligodendrocyte differentiation and subsequent myelination of the CNS.	[Yu, Yang; He, Xuelian; Liu, Lei; Liu, Wei; Mao, Meng] Sichuan Univ, W China Hosp 2, Key Lab Pediat Dis & Birth Defects, Inst Stem Cell & Dev Biol,Minist Educ,Dept Pediat, Chengdu 61004, Peoples R China; [Yu, Yang; He, Xuelian; Liu, Lei; Liu, Wei; Mao, Meng] Sichuan Univ, W China Hosp 2, Key Lab Pediat Dis & Birth Defects, Inst Stem Cell & Dev Biol,Minist Educ,Dept Obstet, Chengdu 61004, Peoples R China; [Yu, Yang; Chen, Ying; Kim, Bongwoo; Wang, Haibo; Zhao, Chuntao; He, Xuelian; Liu, Lei; Liu, Wei; Wu, Lai Man N.; Wu, Jiang; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Yu, Yang; Chen, Ying; Kim, Bongwoo; Wang, Haibo; Zhao, Chuntao; He, Xuelian; Liu, Lei; Liu, Wei; Wu, Lai Man N.; Wu, Jiang; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Kent Waldrep Fdn Ctr Basic Neurosci Res Nerve Gro, Dallas, TX 75390 USA; [Wu, Jiang] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Kim, Bongwoo; Chan, Jonah R.] Konkuk Univ, Dept Anim Biotechnol, Seoul 143701, South Korea; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	Sichuan University; Sichuan University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Konkuk University; University of California System; University of California San Francisco	Lu, QR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	qrichard.lu@utsouthwestern.edu		zhao, chuntao/0000-0002-2226-3827	US National Institutes of Health [R01NS072427, R01NS075243]; National Multiple Sclerosis Society [RG4568]; National Science Foundation of China [NSFC: 81270757]; program for Changjiang scholars and innovative research team in University [IRT0935]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072427, R01NS075243, R01NS078092] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for Changjiang scholars and innovative research team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank Tom Hu, Nana Li, Shujun Bai, Akiko Nishiyama, Huashun Li, Vanessa Schmid, and Sara Hildebrand for experimental support. We thank Drs. Lee Kraus, Charles Stiles, John Svaren, Jianrong Li, and Ed Hurlock for critical comments and suggestions. This study was funded in part by grants from the US National Institutes of Health (R01NS072427 and R01NS075243) and the National Multiple Sclerosis Society (RG4568) to Q.R.L., and National Science Foundation of China (NSFC: 81270757) to M.M., and program for Changjiang scholars and innovative research team in University (IRT0935).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Berger J, 2001, CURR OPIN NEUROL, V14, P305, DOI 10.1097/00019052-200106000-00007; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Li HL, 2011, NEURON, V69, P918, DOI 10.1016/j.neuron.2011.01.030; Li HL, 2009, CURR OPIN NEUROBIOL, V19, P479, DOI 10.1016/j.conb.2009.08.004; Liu ZJ, 2007, DEV BIOL, V302, P683, DOI 10.1016/j.ydbio.2006.10.007; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mazzoni EO, 2011, NAT METHODS, V8, P1056, DOI [10.1038/NMETH.1775, 10.1038/nmeth.1775]; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Nielsen JA, 2002, J CELL SCI, V115, P4071, DOI 10.1242/jcs.00103; PETERSON CL, 1994, P NATL ACAD SCI USA, V91, P2905, DOI 10.1073/pnas.91.8.2905; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; SumiIchinose C, 1997, MOL CELL BIOL, V17, P5976, DOI 10.1128/MCB.17.10.5976; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Thurnherr T, 2006, J NEUROSCI, V26, P10110, DOI 10.1523/JNEUROSCI.2158-06.2006; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Weider M, 2012, DEV CELL, V23, P193, DOI 10.1016/j.devcel.2012.05.017; Weng QJ, 2012, NEURON, V73, P713, DOI 10.1016/j.neuron.2011.12.021; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Yue T, 2006, J NEUROSCI, V26, P1275, DOI 10.1523/JNEUROSCI.4717-05.2006; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	46	225	234	1	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					248	261		10.1016/j.cell.2012.12.006	http://dx.doi.org/10.1016/j.cell.2012.12.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332759	Bronze, Green Accepted			2022-12-24	WOS:000313719800021
J	Quoidbach, J; Gilbert, DT; Wilson, TD				Quoidbach, Jordi; Gilbert, Daniel T.; Wilson, Timothy D.			The End of History Illusion	SCIENCE			English	Article							MECHANICAL TURK; AVAILABILITY; CONSTRUCTION; FUTURE	We measured the personalities, values, and preferences of more than 19,000 people who ranged in age from 18 to 68 and asked them to report how much they had changed in the past decade and/or to predict how much they would change in the next decade. Young people, middle-aged people, and older people all believed they had changed a lot in the past but would change relatively little in the future. People, it seems, regard the present as a watershed moment at which they have finally become the person they will be for the rest of their lives. This "end of history illusion" had practical consequences, leading people to overpay for future opportunities to indulge their current preferences.	[Quoidbach, Jordi; Gilbert, Daniel T.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Quoidbach, Jordi] Natl Fund Sci Res, Brussels, Belgium; [Wilson, Timothy D.] Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA	Harvard University; Fonds de la Recherche Scientifique - FNRS; University of Virginia	Gilbert, DT (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	gilbert@wjh.harvard.edu			NSF [BCS-0722132]; NATIONAL INSTITUTE ON AGING [P01AG020166] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge the support of Research Grant BCS-0722132 from NSF to D.T.G. and T.D.W. Raw data from all studies are on deposit at the Inter-university Consortium for Political and Social Research (deposit no. 32668) and can be accessed at www.icpsr.umich.edu.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Lachman ME, 1997, MIDLIFE DEV INVENTOR; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Mroczek DK, 1998, J PERS SOC PSYCHOL, V75, P1333, DOI 10.1037/0022-3514.75.5.1333; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Prenda KM, 2001, PSYCHOL AGING, V16, P206, DOI 10.1037//0882-7974.16.2.206; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Robinson MD, 2002, PSYCHOL BULL, V128, P934, DOI 10.1037//0033-2909.128.6.934; ROSS M, 1989, PSYCHOL REV, V96, P341, DOI 10.1037/0033-295X.96.2.341; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; SCHWARZ N, 1991, J PERS SOC PSYCHOL, V61, P195, DOI 10.1037/0022-3514.61.2.195; Sedikides C, OXFORD HDB HUMAN MOT, P303; Swann W.B., 2011, HDB THEORIES SOCIAL, V2, P23, DOI DOI 10.4135/9781446249222.N27; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9	16	132	132	2	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					96	98		10.1126/science.1229294	http://dx.doi.org/10.1126/science.1229294			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	063HC	23288539				2022-12-24	WOS:000312985800060
J	Zhang, C; Srinivasan, Y; Arlow, DH; Fung, JJ; Palmer, D; Zheng, YW; Green, HF; Pandey, A; Dror, RO; Shaw, DE; Weis, WI; Coughlin, SR; Kobilka, BK				Zhang, Cheng; Srinivasan, Yoga; Arlow, Daniel H.; Fung, Juan Jose; Palmer, Daniel; Zheng, Yaowu; Green, Hillary F.; Pandey, Anjali; Dror, Ron O.; Shaw, David E.; Weis, William I.; Coughlin, Shaun R.; Kobilka, Brian K.			High-resolution crystal structure of human protease-activated receptor 1	NATURE			English	Article							THROMBIN-RECEPTOR; AGONIST RECOGNITION; FORCE-FIELD; MEMBRANE-PROTEINS; OPIOID RECEPTOR; MECHANISM; BINDING; SODIUM; SPECIFICITY; TRAFFICKING	Protease-activated receptor 1 (PAR1) is the prototypical member of a family of G-protein-coupled receptors that mediate cellular responses to thrombin and related proteases. Thrombin irreversibly activates PAR1 by cleaving the amino-terminal exodomain of the receptor, which exposes a tethered peptide ligand that binds the heptahelical bundle of the receptor to affect G-protein activation. Here we report the 2.2 angstrom resolution crystal structure of human PAR1 bound to vorapaxar, a PAR1 antagonist. The structure reveals an unusual mode of drug binding that explains how a small molecule binds virtually irreversibly to inhibit receptor activation by the tethered ligand of PAR1. In contrast to deep, solvent-exposed binding pockets observed in other peptide-activated G-protein-coupled receptors, the vorapaxar-binding pocket is superficial but has little surface exposed to the aqueous solvent. Protease-activated receptors are important targets for drug development. The structure reported here will aid the development of improved PAR1 antagonists and the discovery of antagonists to other members of this receptor family.	[Srinivasan, Yoga; Palmer, Daniel; Zheng, Yaowu; Coughlin, Shaun R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Zhang, Cheng; Fung, Juan Jose; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Arlow, Daniel H.; Green, Hillary F.; Dror, Ron O.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Pandey, Anjali] Portola Pharmaceut, San Francisco, CA 94080 USA; [Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University; D. E. Shaw Research; Stanford University	Coughlin, SR (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 555 Mission Bay Blvd S,S452P, San Francisco, CA 94158 USA.	shaun.coughlin@ucsf.edu; kobilka@stanford.edu	Weis, William I/G-1437-2011; Zhang, Cheng/O-4372-2015; Palmer, Daniel/J-2967-2014; Palmer, Daniel/Q-7595-2016	Weis, William I/0000-0002-5583-6150; Zhang, Cheng/0000-0001-9042-4007; Palmer, Daniel/0000-0002-7954-9332; Palmer, Daniel/0000-0002-7954-9332; Dror, Ron/0000-0002-6418-2793; Kobilka, Brian/0000-0001-5958-3990	National Institutes of Health [NS028471, HL44907, HL65590]; Mathers Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065590, R01HL065185, R01HL044907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge support from the National Institutes of Health, grants NS028471 (B. K. K.), and HL44907 and HL65590 (S. R. C.), and from the Mathers Foundation (B.K.K. and W.I.W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAHOU WF, 1994, BLOOD, V84, P4195, DOI 10.1182/blood.V84.12.4195.bloodjournal84124195; Blackhart BD, 2000, MOL PHARMACOL, V58, P1178, DOI 10.1124/mol.58.6.1178; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; Chackalamannil S, 2005, J MED CHEM, V48, P5884, DOI 10.1021/jm0502236; CHEN J, 1994, J BIOL CHEM, V269, P16041; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cornelissen I, 2010, P NATL ACAD SCI USA, V107, P18605, DOI 10.1073/pnas.1013309107; COSTA T, 1990, MOL PHARMACOL, V37, P383; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P669, DOI 10.1016/S0006-2952(00)00360-9; Garcia-Lopez MT, 2010, CURR MED CHEM, V17, P109, DOI 10.2174/092986710790112639; GERSZTEN RE, 1994, NATURE, V368, P648, DOI 10.1038/368648a0; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; HEIN L, 1994, J BIOL CHEM, V269, P27719; HORSTMAN DA, 1990, J BIOL CHEM, V265, P21590; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ISHII K, 1995, J BIOL CHEM, V270, P16435, DOI 10.1074/jbc.270.27.16435; ISHII K, 1993, J BIOL CHEM, V268, P9780; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kosoglou T, 2012, EUR J CLIN PHARMACOL, V68, P249, DOI 10.1007/s00228-011-1120-6; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Lerner DJ, 1996, J BIOL CHEM, V271, P13943, DOI 10.1074/jbc.271.24.13943; LIU LW, 1991, J BIOL CHEM, V266, P16977; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P3266, DOI 10.1021/bi00177a018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; NANEVICZ T, 1995, J BIOL CHEM, V270, P21619, DOI 10.1074/jbc.270.37.21619; Nanevicz T, 1996, J BIOL CHEM, V271, P702, DOI 10.1074/jbc.271.2.702; Neve KA, 2001, MOL PHARMACOL, V60, P373, DOI 10.1124/mol.60.2.373; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Selent J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000884; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shapiro MJ, 1998, J BIOL CHEM, V273, P29009, DOI 10.1074/jbc.273.44.29009; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Shaw D.E., 2009, P C HIGH PERF COMP N, P1, DOI DOI 10.1145/1654059.1654126; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Soto AG, 2010, J BIOL CHEM, V285, P18781, DOI 10.1074/jbc.M110.111088; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Wilson MH, 2001, MOL PHARMACOL, V59, P929, DOI 10.1124/mol.59.4.929; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	70	336	350	3	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					387	+		10.1038/nature11701	http://dx.doi.org/10.1038/nature11701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23222541	Green Accepted, Green Submitted			2022-12-24	WOS:000312488200047
J	Redford, KH; Jensen, DB; Breheny, JJ				Redford, Kent H.; Jensen, Deborah B.; Breheny, James J.			Integrating the Captive and the Wild	SCIENCE			English	Editorial Material									[Redford, Kent H.] Archipelago Consulting, Irvington, NY 10533 USA; [Jensen, Deborah B.] Woodland Pk Zoo, Seattle, WA 98130 USA; [Breheny, James J.] Wildlife Conservat Soc, Bronx, NY 10460 USA	Wildlife Conservation Society	Redford, KH (corresponding author), Archipelago Consulting, Irvington, NY 10533 USA.							Finkelstein ME, 2012, P NATL ACAD SCI USA, V109, P11449, DOI 10.1073/pnas.1203141109; Hamede R, 2012, CONSERV BIOL, V26, P124, DOI 10.1111/j.1523-1739.2011.01747.x; Lacy R., 2010, P 65 WAZA ANN C TECH; Lacy RC, 2013, ZOO BIOL, V32, P19, DOI 10.1002/zoo.21029; Miller KA, 2012, CONSERV BIOL, V26, P790, DOI 10.1111/j.1523-1739.2012.01902.x; Pritchard DJ, 2012, ORYX, V46, P18, DOI 10.1017/S0030605310001766; Randall DA, 2004, EMERG INFECT DIS, V10, P2214, DOI 10.3201/eid1012.040080; Redford KH, 2011, BIOSCIENCE, V61, P39, DOI 10.1525/bio.2011.61.1.9; Roman Joe, 2011, LISTED DISPATCHES AM; Scott JM, 2010, CONSERV LETT, V3, P91, DOI 10.1111/j.1755-263X.2010.00096.x; Shepherdson D., 2004, P SPEC RISK 2004 PAT; SOULE M, 1986, ZOO BIOL, V5, P101, DOI 10.1002/zoo.1430050205; Valladares-Padua Claudio B., 2002, P301; Vander Haegen WM, 2009, J WILDLIFE MANAGE, V73, P1402, DOI 10.2193/2008-484; Volis S, 2010, BIODIVERS CONSERV, V19, P2441, DOI 10.1007/s10531-010-9849-2	15	43	52	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1157	1158		10.1126/science.1228899	http://dx.doi.org/10.1126/science.1228899			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197520				2022-12-24	WOS:000311666200029
J	Haberg, SE; Trogstad, L; Gunnes, N; Wilcox, AJ; Gjessing, HK; Samuelsen, SO; Skrondal, A; Cappelen, I; Engeland, A; Aavitsland, P; Madsen, S; Buajordet, I; Furu, K; Nafstad, P; Vollset, SE; Feiring, B; Nokleby, H; Magnus, P; Stoltenberg, C				Haberg, Siri E.; Trogstad, Lill; Gunnes, Nina; Wilcox, Allen J.; Gjessing, Hakon K.; Samuelsen, Sven Ove; Skrondal, Anders; Cappelen, Inger; Engeland, Anders; Aavitsland, Preben; Madsen, Steinar; Buajordet, Ingebjorg; Furu, Kari; Nafstad, Per; Vollset, Stein Emil; Feiring, Berit; Nokleby, Hanne; Magnus, Per; Stoltenberg, Camilla			Risk of Fetal Death after Pandemic Influenza Virus Infection or Vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEDICAL BIRTH REGISTRY; PREGNANT-WOMEN; HOSPITALIZATIONS; VALIDATION; OUTCOMES; ILLNESS; NORWAY	Background During the 2009 influenza A (H1N1) pandemic, pregnant women were at risk for severe influenza illness. This concern was complicated by questions about vaccine safety in pregnant women that were raised by anecdotal reports of fetal deaths after vaccination. Methods We explored the safety of influenza vaccination of pregnant women by linking Norwegian national registries and medical consultation data to determine influenza diagnosis, vaccination status, birth outcomes, and background information for pregnant women before, during, and after the pandemic. We used Cox regression models to estimate hazard ratios for fetal death, with the gestational day as the time metric and vaccination and pandemic exposure as time-dependent exposure variables. Results There were 117,347 eligible pregnancies in Norway from 2009 through 2010. Fetal mortality was 4.9 deaths per 1000 births. During the pandemic, 54% of pregnant women in their second or third trimester were vaccinated. Vaccination during pregnancy substantially reduced the risk of an influenza diagnosis (adjusted hazard ratio, 0.30; 95% confidence interval [CI], 0.25 to 0.34). Among pregnant women with a clinical diagnosis of influenza, the risk of fetal death was increased (adjusted hazard ratio, 1.91; 95% CI, 1.07 to 3.41). The risk of fetal death was reduced with vaccination during pregnancy, although this reduction was not significant (adjusted hazard ratio, 0.88; 95% CI, 0.66 to 1.17). Conclusions Pandemic influenza virus infection in pregnancy was associated with an increased risk of fetal death. Vaccination during pregnancy reduced the risk of an influenza diagnosis. Vaccination itself was not associated with increased fetal mortality and may have reduced the risk of influenza-related fetal death during the pandemic. (Funded by the Norwegian Institute of Public Health.)	[Haberg, Siri E.; Trogstad, Lill; Gunnes, Nina; Gjessing, Hakon K.; Samuelsen, Sven Ove; Skrondal, Anders; Cappelen, Inger; Engeland, Anders; Aavitsland, Preben; Furu, Kari; Nafstad, Per; Vollset, Stein Emil; Feiring, Berit; Nokleby, Hanne; Magnus, Per; Stoltenberg, Camilla] Norwegian Inst Publ Hlth, N-0403 Oslo, Norway; [Samuelsen, Sven Ove; Nafstad, Per; Magnus, Per] Univ Oslo, Oslo, Norway; [Madsen, Steinar; Buajordet, Ingebjorg] Norwegian Med Agcy, Oslo, Norway; [Gjessing, Hakon K.; Engeland, Anders; Vollset, Stein Emil] Univ Bergen, Bergen, Norway; [Furu, Kari] Univ Tromso, Tromso, Norway; [Wilcox, Allen J.] NIEHS, Durham, NC USA; [Skrondal, Anders] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Norwegian Institute of Public Health (NIPH); University of Oslo; University of Bergen; UiT The Arctic University of Tromso; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of London; London School of Hygiene & Tropical Medicine	Haberg, SE (corresponding author), Norwegian Inst Publ Hlth, POB 4404, N-0403 Oslo, Norway.	siri.haberg@fhi.no	Engeland, Anders/AAG-7437-2021; Gjessing, Hakon K/A-5871-2012; Wilcox, Allen J/C-7723-2019; Skrondal, Anders/C-7342-2008; Stoltenberg, Camilla/G-5090-2017	Wilcox, Allen J/0000-0002-3376-1311; Skrondal, Anders/0000-0002-8171-2282	Norwegian Institute of Public Health; Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044003] Funding Source: NIH RePORTER	Norwegian Institute of Public Health; Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the Norwegian Institute of Public Health. Dr. Wilcox was supported by the Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health.	Aalen OO, 2008, STAT BIOL HEALTH, P1; Bloom-Feshbach K, 2011, J INFECT DIS, V204, P1157, DOI 10.1093/infdis/jir510; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; de Blasio BF, 2012, PLOS ONE, V7, P327, DOI 10.1371/journal.pone.0030018; Engeland A, 2009, ACTA OBSTET GYN SCAN, V88, P1083, DOI 10.1080/00016340903128454; European Medicines Agency, 2010, 22 PAND PHARM UPD; Fell Deshayne B, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2011.300606; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; KOSMAK GW, 1919, AM J OBSTET, V79, P238; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nishiura H, 2009, EUR J OBSTET GYN R B, V147, P115, DOI 10.1016/j.ejogrb.2009.07.009; Norwegian Institute of Public Health, 2010, STAT REP NEW INFL A; Norwegian Institute of Public Health, SURV SYST COMM DIS; Norwegian Medicines Agency, 2010, REP ADV EV 2010; Pasternak B, 2012, JAMA-J AM MED ASSOC, V308, P165, DOI 10.1001/jama.2012.6131; Pasternak B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2794; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Rasmussen S, 2003, ACTA OBSTET GYN SCAN, V82, P109, DOI 10.1034/j.1600-0412.2003.00009.x; Reid A, 2001, POP STUD-J DEMOG, V55, P213, DOI 10.1080/00324720127696; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; *STRAT ADV GROUP E, 2009, WKLY EPIDEMIOL REC, V84, P301; Trogstad L, 2012, EURO SURVEILL, V17; WHO, 2009, INFL SEAS; Xu RH, 2012, PHARMACOEPIDEM DR S, V21, P844, DOI 10.1002/pds.3301; Yates L, 2010, HEALTH TECHNOL ASSES, V14, P121	28	214	219	0	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2013	368	4					333	340		10.1056/NEJMoa1207210	http://dx.doi.org/10.1056/NEJMoa1207210			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075KX	23323868	Green Accepted			2022-12-24	WOS:000313885900006
J	Kim, J; Kim, YC; Fang, C; Russell, RC; Kim, JH; Fan, W; Liu, R; Zhong, Q; Guan, KL				Kim, Joungmok; Kim, Young Chul; Fang, Chong; Russell, Ryan C.; Kim, Jeong Hee; Fan, Weiliang; Liu, Rong; Zhong, Qing; Guan, Kun-Liang			Differential Regulation of Distinct Vps34 Complexes by AMPK in Nutrient Stress and Autophagy	CELL			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE COMPLEXES; ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; BECLIN 1; MEDIATED PHOSPHORYLATION; MAMMALIAN AUTOPHAGY; ATG PROTEINS; UVRAG; HVPS34; RUBICON	Autophagy is a stress response protecting cells from unfavorable conditions, such as nutrient starvation. The class III phosphatidylinositol-3 kinase, Vps34, forms multiple complexes and regulates both intra-cellular vesicle trafficking and autophagy induction. Here, we show that AMPK plays a key role in regulating different Vps34 complexes. AMPK inhibits the nonautophagy Vps34 complex by phosphorylating T163/S165 in Vps34 and therefore suppresses overall PI(3) P production and protects cells from starvation. In parallel, AMPK activates the proautophagy Vps34 complex by phosphorylating S91/S94 in Beclin1 to induce autophagy. Atg14L, an autophagy-essential gene present only in the proautophagy Vps34 complex, inhibits Vps34 phosphorylation but increases Beclin1 phosphorylation by AMPK. As such, Atg14L dictates the differential regulation (either inhibition or activation) of different Vps34 complexes in response to glucose starvation. Our study reveals an intricate molecular regulation of Vps34 complexes by AMPK in nutrient stress response and autophagy.	[Kim, Joungmok; Kim, Jeong Hee] Kyung Hee Univ, Sch Dent, Res Ctr Tooth & Periodontal Tissue Regenerat, Dept Oral Biochem & Mol Biol, Seoul 130701, South Korea; [Kim, Joungmok; Kim, Young Chul; Fang, Chong; Russell, Ryan C.; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92130 USA; [Kim, Joungmok; Kim, Young Chul; Fang, Chong; Russell, Ryan C.; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92130 USA; [Fan, Weiliang; Liu, Rong; Zhong, Qing] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem Biophys & Struct Biol, Berkeley, CA 94720 USA	Kyung Hee University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Berkeley	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92130 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022; Zhong, Qing/GLT-4858-2022	Zhong, Qing/0000-0001-6979-955X; Kim, Young Chul/0000-0002-6782-2186; Kim, Jeong Hee/0000-0002-3884-4503; Russell, Ryan/0000-0003-3364-8869	National Institutes of Health (NIH); Department of Defense (DOD); Bio & Medical Technology Development Program of National Research Foundation of Korea (NRF); Korean government (MEST) [2012M3A9C6049936]; NATIONAL CANCER INSTITUTE [R01CA108941, R01CA132809, R01CA133228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051586] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DOD)(United States Department of Defense); Bio & Medical Technology Development Program of National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Guan lab for discussions and reagents. This work was supported by grants from the National Institutes of Health (NIH) and the Department of Defense (DOD) (K.-L.G.) and by the Bio & Medical Technology Development Program of National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST, No. 2012M3A9C6049936 to J.K.).	Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Furuya T, 2010, MOL CELL, V38, P500, DOI 10.1016/j.molcel.2010.05.009; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Johnson EE, 2006, J CELL SCI, V119, P1219, DOI 10.1242/jcs.02833; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kwon KY, 2011, BIOCHEM BIOPH RES CO, V416, P343, DOI 10.1016/j.bbrc.2011.11.038; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noble CG, 2008, J BIOL CHEM, V283, P26274, DOI 10.1074/jbc.M804723200; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Obara K, 2011, J LIPIDS, V2011, DOI 10.1155/2011/498768; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Ropolo A, 2007, J BIOL CHEM, V282, P37124, DOI 10.1074/jbc.M706956200; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Vergne I, 2010, FEBS LETT, V584, P1313, DOI 10.1016/j.febslet.2010.02.054; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	34	530	566	1	101	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					290	303		10.1016/j.cell.2012.12.016	http://dx.doi.org/10.1016/j.cell.2012.12.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332761	Green Accepted, Bronze			2022-12-24	WOS:000313719800024
J	Le, T; Wright, EJ; Smith, DM; He, WJ; Catano, G; Okulicz, JF; Young, JA; Clark, RA; Richman, DD; Little, SJ; Ahuja, SK				Le, Tuan; Wright, Edwina J.; Smith, Davey M.; He, Weijing; Catano, Gabriel; Okulicz, Jason F.; Young, Jason A.; Clark, Robert A.; Richman, Douglas D.; Little, Susan J.; Ahuja, Sunil K.			Enhanced CD4+T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LYMPHOID-TISSUE STRUCTURE; SOCIETY-USA PANEL; T-CELLS; PRIMARY INFECTION; AIDS; SEROCONVERSION; CD4; RECOMMENDATIONS; RECONSTITUTION	Background The relationship between the timing of the initiation of antiretroviral therapy (ART) after infection with human immunodeficiency virus type 1 (HIV-1) and the recovery of CD4+ T-cell counts is unknown. Methods In a prospective, observational cohort of persons with acute or early HIV-1 infection, we determined the trajectory of CD4+ counts over a 48-month period in partially overlapping study sets: study set 1 included 384 participants during the time window in which they were not receiving ART and study set 2 included 213 participants who received ART soon after study entry or sometime thereafter and had a suppressed plasma HIV viral load. We investigated the likelihood and rate of CD4+ T-cell recovery to 900 or more cells per cubic millimeter within 48 months while the participants were receiving viral-load-suppressive ART. Results Among the participants who were not receiving ART, CD4+ counts increased spontaneously, soon after HIV-1 infection, from the level at study entry (median, 495 cells per cubic millimeter; interquartile range, 383 to 622), reached a peak value (median, 763 cells per cubic millimeter; interquartile range, 573 to 987) within approximately 4 months after the estimated date of infection, and declined progressively thereafter. Recovery of CD4+ counts to 900 or more cells per cubic millimeter was seen in approximately 64% of the participants who initiated ART earlier (<= 4 months after the estimated date of HIV infection) as compared with approximately 34% of participants who initiated ART later (>4 months) (P<0.001). After adjustment for whether ART was initiated when the CD4+ count was 500 or more cells per cubic millimeter or less than 500 cells per cubic millimeter, the likelihood that the count would increase to 900 or more cells per cubic millimeter was lower by 65% (odds ratio, 0.35), and the rate of recovery was slower by 56% (rate ratio, 0.44), if ART was initiated later rather than earlier. There was no association between the plasma HIV RNA level at the time of initiation of ART and CD4+ T-cell recovery. Conclusions A transient, spontaneous restoration of CD4+ T-cell counts occurs in the 4-month time window after HIV-1 infection. Initiation of ART during this period is associated with an enhanced likelihood of recovery of CD4+ counts. (Funded by the National Institute of Allergy and Infectious Diseases and others.)	[Le, Tuan; He, Weijing; Catano, Gabriel; Clark, Robert A.; Ahuja, Sunil K.] S Texas Vet Hlth Care Syst, Vet Affairs Res Ctr AIDS & HIV Infect 1, San Antonio, TX 78229 USA; [Le, Tuan; He, Weijing; Catano, Gabriel; Clark, Robert A.; Ahuja, Sunil K.] S Texas Vet Hlth Care Syst, Ctr Personalized Med, San Antonio, TX USA; [Le, Tuan; He, Weijing; Catano, Gabriel; Clark, Robert A.; Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Okulicz, Jason F.] San Antonio Mil Med Ctr, Infect Dis Serv, Ft Sam Houston, TX USA; [Wright, Edwina J.] Monash Univ, Alfred Hosp, Dept Infect Dis, Burnet Inst, Melbourne, Vic 3181, Australia; [Wright, Edwina J.] Monash Univ, Dept Infect Dis, Melbourne, Vic 3004, Australia; [Smith, Davey M.; Richman, Douglas D.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Smith, Davey M.; Young, Jason A.; Richman, Douglas D.; Little, Susan J.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Richman, Douglas D.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; San Antonio Military Medical Center; Burnet Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego	Ahuja, SK (corresponding author), S Texas Vet Hlth Care Syst, Vet Affairs Res Ctr AIDS & HIV Infect 1, San Antonio, TX 78229 USA.	slittle@ucsd.edu; ahujas@uthscsa.edu	Little, Susan/AAA-6116-2019; Catano, Gabriel/AAQ-5387-2020; Clark, Robert/Q-6764-2019; Wright, Edwina J/I-2950-2014	Clark, Robert/0000-0002-4892-3619; Wright, Edwina J/0000-0001-8626-782X; Lipton, Stuart/0000-0002-3490-1259; Smith, Davey/0000-0003-3603-1733	Veterans Affairs (VA) Center for AIDS and HIV Infection; VA Center for Personalized Medicine of the South Texas Veterans Health Care System; National Institutes of Health (NIH) [UL1TR000149, R37 AI046326]; NIH [AI43638, AI69432, MH62512, AI74621, MH083552, AI077304, AI007384, AI080193, AI096113]; International AIDS Vaccine Initiative [DMS0714991]; California HIV/AIDS Research Program [RN07-SD-702]; VA Career Development Award-2; National Health and Medical Research Council of Australia; Doris Duke Distinguished Clinical Scientist Award, a VA MERIT; Elizabeth Glaser Pediatric AIDS Foundation; Burroughs Welcome Clinical Scientist Award in Translational Research; Senior Scholar Award from the Max and Minnie Tomerlin Voelcker Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149, UL1TR001120] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069432, U01AI043638, T32AI007384, U19AI096113, R24AI106039, P01AI080193, UM1AI069432, R21AI077304, R37AI046326, P01AI074621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083552, P30MH062512] Funding Source: NIH RePORTER	Veterans Affairs (VA) Center for AIDS and HIV Infection(US Department of Veterans Affairs); VA Center for Personalized Medicine of the South Texas Veterans Health Care System; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; California HIV/AIDS Research Program; VA Career Development Award-2; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Doris Duke Distinguished Clinical Scientist Award, a VA MERIT; Elizabeth Glaser Pediatric AIDS Foundation; Burroughs Welcome Clinical Scientist Award in Translational Research; Senior Scholar Award from the Max and Minnie Tomerlin Voelcker Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by the Veterans Affairs (VA) Center for AIDS and HIV Infection and VA Center for Personalized Medicine of the South Texas Veterans Health Care System and a MERIT grant (R37 AI046326) and a Clinical and Translational Science Award (UL1TR000149) from the National Institutes of Health (NIH) (all for the work at San Antonio) and by grants from the NIH (AI43638, AI69432, MH62512, AI74621, MH083552, AI077304, AI007384, AI080193, and AI096113), the International AIDS Vaccine Initiative (DMS0714991), and the California HIV/AIDS Research Program (RN07-SD-702) (all for the work at San Diego). Dr. Le was supported by a VA Career Development Award-2, Dr. Wright by an Early Career Fellowship from the National Health and Medical Research Council of Australia, and Dr. Ahuja by the Doris Duke Distinguished Clinical Scientist Award, a VA MERIT award, the Elizabeth Glaser Pediatric AIDS Foundation, the Burroughs Welcome Clinical Scientist Award in Translational Research, and the Senior Scholar Award from the Max and Minnie Tomerlin Voelcker Fund.	Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Archin NM, 2012, NATURE, V489, DOI 10.1038/nature11455; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Belloso WH, 2010, HIV MED, V11, P554, DOI 10.1111/j.1468-1293.2010.00824.x; BOFILL M, 1992, CLIN EXP IMMUNOL, V88, P243, DOI 10.1111/j.1365-2249.1992.tb03068.x; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; COOPER DA, 1988, J INFECT DIS, V157, P889, DOI 10.1093/infdis/157.5.889; Drechsler H, 2012, 19 INT AIDS C WASH D; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Fernandez S, 2011, J INFECT DIS, V204, P1927, DOI 10.1093/infdis/jir659; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; GAINES H, 1990, AIDS, V4, P995, DOI 10.1097/00002030-199010000-00008; Hecht FM, 2006, J INFECT DIS, V194, P725, DOI 10.1086/506616; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; LAURENCE J, 1993, ANN INTERN MED, V119, P55, DOI 10.7326/0003-4819-119-1-199307010-00010; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Lori F, 1999, J INFECT DIS, V180, P1827, DOI 10.1086/315113; Maman D, 2012, AIDS, V26, P1393, DOI 10.1097/QAD.0b013e328352d054; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2011, GUID US ANT AG HIV 1; Rajasuriar R, 2010, J INFECT DIS, V202, P1254, DOI 10.1086/656369; Schacker T, 1997, ANN INTERN MED, V126, P174, DOI 10.7326/0003-4819-126-2-199701150-00024; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Shete A, 2010, INDIAN J MED RES, V132, P667; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437; Zeng M, 2012, BLOOD, V120, P1856, DOI 10.1182/blood-2012-03-418624; Zeng M, 2012, TRENDS IMMUNOL, V33, P306, DOI 10.1016/j.it.2012.04.002	33	252	264	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					218	230		10.1056/NEJMoa1110187	http://dx.doi.org/10.1056/NEJMoa1110187			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YG	23323898	Green Accepted			2022-12-24	WOS:000313549900006
J	Maurice, CF; Haiser, HJ; Turnbaugh, PJ				Maurice, Corinne Ferrier; Haiser, Henry Joseph; Turnbaugh, Peter James			Xenobiotics Shape the Physiology and Gene Expression of the Active Human Gut Microbiome	CELL			English	Article							FLOW-CYTOMETRY; BACTERIA; METABOLISM; ABSORPTION; DIVERSITY; COMMUNITY; DIGOXIN	The human gut contains trillions of microorganisms that influence our health by metabolizing xenobiotics, including host-targeted drugs and antibiotics. Recent efforts have characterized the diversity of this host-associated community, but it remains unclear which microorganisms are active and what perturbations influence this activity. Here, we combine flow cytometry, 16S rRNA gene sequencing, and metatranscriptomics to demonstrate that the gut contains a distinctive set of active microorganisms, primarily Firmicutes. Short-term exposure to a panel of xenobiotics significantly affected the physiology, structure, and gene expression of this active gut microbiome. Xenobiotic-responsive genes were found across multiple bacterial phyla, encoding antibiotic resistance, drug metabolism, and stress response pathways. These results demonstrate the power of moving beyond surveys of microbial diversity to better understand metabolic activity, highlight the unintended consequences of xenobiotics, and suggest that attempts at personalized medicine should consider interindividual variations in the active human gut microbiome.	[Maurice, Corinne Ferrier; Haiser, Henry Joseph; Turnbaugh, Peter James] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University	Turnbaugh, PJ (corresponding author), Harvard Univ, FAS Ctr Syst Biol, 52 Oxford St, Cambridge, MA 02138 USA.	pturnbaugh@fas.harvard.edu	Haiser, Henry/AAN-5187-2020	Maurice, Corinne/0000-0001-7187-3472; Turnbaugh, Peter/0000-0002-0888-2875	NIH [P50 GM068763]; Canadian Institutes of Health Research [MFE-112991]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Rob Knight and Donna Berg-Lyons for contributing barcoded 16S rRNA primers; Claire Reardon, Jiangwen Zhang, and Christian Daly for sequencing support; Brian Tilton and Thierry Bouvier for flow cytometry assistance; and Curtis Huttenhower, Nicola Segata, and Jovian Yu for bioinformatics support. We are indebted to our colleagues Andrew Murray, Erin O'Shea, Bodo Stern, Lawrence David, Julie Button, Rachel Dutton, and Benjamin Wolfe for their helpful suggestions. This work was supported by the NIH (P50 GM068763) and the Canadian Institutes of Health Research (MFE-112991).	Baselt R.C., 2008, DISPOSITION TOXIC DR; Ben-Amor K, 2005, APPL ENVIRON MICROB, V71, P4679, DOI 10.1128/AEM.71.8.4679-4689.2005; Blaut M, 2011, CURR TOP MICROBIOL I; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P2050, DOI 10.1111/j.1462-2920.2007.01321.x; Bouvier T, 2011, MICROB ECOL, V62, P669, DOI 10.1007/s00248-011-9862-3; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Davey Hazel M., 2003, Current Issues in Molecular Biology, V5, P9; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Gasol JM, 1999, APPL ENVIRON MICROB, V65, P4475; Guillebault D, 2010, APPL ENVIRON MICROB, V76, P7352, DOI 10.1128/AEM.00621-10; Haiser HJ, 2012, SCIENCE, V336, P1253, DOI 10.1126/science.1224396; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jellett JF, 1996, MAR ECOL PROG SER, V136, P213, DOI 10.3354/meps136213; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Jochem FJ, 2004, MAR BIOL, V145, P1213, DOI 10.1007/s00227-004-1406-7; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Joux F, 2000, MICROBES INFECT, V2, P1523, DOI 10.1016/S1286-4579(00)01307-1; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, V2, P243, DOI DOI 10.1002/9780470281840.CH8; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Le Blay G, 2007, LETT APPL MICROBIOL, V45, P252, DOI 10.1111/j.1472-765X.2007.02178.x; Lee HH, 2012, NAT CHEM BIOL, V8, P6, DOI 10.1038/nchembio.740; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; LINDENBAUM J, 1981, NEW ENGL J MED, V305, P789, DOI 10.1056/NEJM198110013051403; MAGNUSSON JO, 1982, BRIT J CLIN PHARMACO, V14, P284, DOI 10.1111/j.1365-2125.1982.tb01976.x; Martinez JL, 2011, FEMS MICROBIOL REV, V35, P768, DOI 10.1111/j.1574-6976.2011.00282.x; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Mortimer FC, 2000, ANTIMICROB AGENTS CH, V44, P676, DOI 10.1128/AAC.44.3.676-681.2000; Novo DJ, 2000, ANTIMICROB AGENTS CH, V44, P827, DOI 10.1128/AAC.44.4.827-834.2000; Peris-Bondia F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022448; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; RAAFLAUB J, 1975, EUR J CLIN PHARMACOL, V8, P261, DOI 10.1007/BF00567125; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shapiro HH, 2000, J MICROBIOL METH, V42, P3, DOI 10.1016/S0167-7012(00)00167-6; SMITH GE, 1974, XENOBIOTICA, V4, P477, DOI 10.3109/00498257409052100; SOMOGYI AA, 1995, PHARMACEUT RES, V12, P149, DOI 10.1023/A:1016215510223; Sousa T, 2008, INT J PHARMACEUT, V363, P1, DOI 10.1016/j.ijpharm.2008.07.009; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang YY, 2009, ISME J, V3, P889, DOI 10.1038/ismej.2009.46; Wickens HJ, 2000, ANTIMICROB AGENTS CH, V44, P682, DOI 10.1128/AAC.44.3.682-687.2000; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zubkov MV, 2004, J MAR BIOL ASSOC UK, V84, P519, DOI 10.1017/S002531540400952Xh	48	525	549	9	280	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					39	50		10.1016/j.cell.2012.10.052	http://dx.doi.org/10.1016/j.cell.2012.10.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332745	Green Accepted, Bronze			2022-12-24	WOS:000313719800005
J	Ascano, M; Mukherjee, N; Bandaru, P; Miller, JB; Nusbaum, JD; Corcoran, DL; Langlois, C; Munschauer, M; Dewell, S; Hafner, M; Williams, Z; Ohler, U; Tuschl, T				Ascano, Manuel, Jr.; Mukherjee, Neelanjan; Bandaru, Pradeep; Miller, Jason B.; Nusbaum, Jeffrey D.; Corcoran, David L.; Langlois, Christine; Munschauer, Mathias; Dewell, Scott; Hafner, Markus; Williams, Zev; Ohler, Uwe; Tuschl, Thomas			FMRP targets distinct mRNA sequence elements to regulate protein expression	NATURE			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; PAR-CLIP; SYNAPTIC FUNCTION; BINDING PROTEIN; CGG-REPEAT; GENE; IDENTIFICATION; MUTATION; AUTISM	Fragile X syndrome (FXS) is a multi-organ disease that leads to mental retardation, macro-orchidism in males and premature ovarian insufficiency in female carriers. FXS is also a prominent monogenic disease associated with autism spectrum disorders (ASDs). FXS is typically caused by the loss of fragile X mental retardation 1 (FMR1) expression, which codes for the RNA-binding protein FMRP. Here we report the discovery of distinct RNA-recognition elements that correspond to the two independent RNA-binding domains of FMRP, in addition to the binding sites within the messenger RNA targets for wild-type and I304N mutant FMRP isoforms and the FMRP paralogues FXR1P and FXR2P (also known as FXR1 and FXR2). RNA-recognition-element frequency, ratio and distribution determine target mRNA association with FMRP. Among highly enriched targets, we identify many genes involved in ASD and show that FMRP affects their protein levels in human cell culture, mouse ovaries and human brain. Notably, we discovered that these targets are also dysregulated in Fmr1(-/-) mouse ovaries showing signs of premature follicular overdevelopment. These results indicate that FMRP targets share signalling pathways across different cellular contexts. As the importance of signalling pathways in both FXS and ASD is becoming increasingly apparent, our results provide a ranked list of genes as basis for the pursuit of new therapeutic targets for these neurological disorders.	[Ascano, Manuel, Jr.; Bandaru, Pradeep; Miller, Jason B.; Nusbaum, Jeffrey D.; Munschauer, Mathias; Hafner, Markus; Williams, Zev; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA; [Mukherjee, Neelanjan; Corcoran, David L.; Ohler, Uwe] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Langlois, Christine; Williams, Zev] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Program Early & Recurrent Pregnancy Loss, Bronx, NY 10461 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Duke University; Yeshiva University; Albert Einstein College of Medicine; Rockefeller University	Tuschl, T (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA.	uwe.ohler@duke.edu; ttuschl@rockefeller.edu	Hafner, Markus/O-7100-2018; Ascano, Manuel/ABA-3586-2020; Munschauer, Mathias/AAK-2789-2020	Hafner, Markus/0000-0002-4336-6518; Ascano, Manuel/0000-0002-9370-5493; Munschauer, Mathias/0000-0001-6143-4548; Corcoran, David/0000-0001-7460-9247; Mukherjee, Neelanjan/0000-0003-0017-1400; Nusbaum, Jeffrey/0000-0001-5024-8256	NIH/NCRR/RU CCTS [UL1RR024143]; NSF [MCB-0822033]; Simons Foundation Autism Research Initiative [CEN5300891]; NIH [R01 MH080442, K08 HD068546]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD068546] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080442] Funding Source: NIH RePORTER	NIH/NCRR/RU CCTS; NSF(National Science Foundation (NSF)); Simons Foundation Autism Research Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Human tissue was obtained from the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore. We would like to thank the following members of the Tuschl laboratory for their support and assistance: G. Wardle, N. Renwick and I. Ben-Dov. We would like to thank J. Keene for his advice throughout the project. We would like to acknowledge M. Khorshid, L. Burger and M. Zavolan for analysing PAR-CLIP data at the initial stages of the project and discussions. We would like to thank the Memorial Sloan-Kettering Cancer Center in-situ core for their assistance with the mouse histology. Finally, we would like to express our appreciation to all members of the Tuschl laboratory for their assistance and collegiality. This work was supported, in part, by the following agencies: NIH/NCRR/RU CCTS (M. A., UL1RR024143), NSF (U.O., MCB-0822033), Simons Foundation Autism Research Initiative (T. T., CEN5300891) and NIH (T. T., R01 MH080442; Z.W., K08 HD068546).	Ascano M, 2012, WIRES RNA, V3, P159, DOI 10.1002/wrna.1103; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; BAKKER CE, 1994, CELL, V78, P23; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Ceman S, 1999, MOL CELL BIOL, V19, P7925; Chevere-Torres I, 2012, NEUROBIOL DIS, V45, P1101, DOI 10.1016/j.nbd.2011.12.028; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Davidovic L, 2007, HUM MOL GENET, V16, P3047, DOI 10.1093/hmg/ddm263; De Rubeis S, 2012, ADV EXP MED BIOL, V970, P517, DOI 10.1007/978-3-7091-0932-8_23; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Fridell RA, 1996, EMBO J, V15, P5408, DOI 10.1002/j.1460-2075.1996.tb00924.x; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Georgiev S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r19; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Gross C, 2012, NEUROPSYCHOPHARMACOL, V37, P178, DOI 10.1038/npp.2011.137; Gross C, 2010, J NEUROSCI, V30, P10624, DOI 10.1523/JNEUROSCI.0402-10.2010; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hagerman R, 2012, RESULTS PROBL CELL D, V54, P297, DOI 10.1007/978-3-642-21649-7_17; Hoell J., 2013, HDB RNA BIOCH, V1; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; Oostra BA, 2009, BBA-GEN SUBJECTS, V1790, P467, DOI 10.1016/j.bbagen.2009.02.007; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; VERKERK AJMH, 1993, HUM MOL GENET, V2, P399, DOI 10.1093/hmg/2.4.399; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052	50	466	474	0	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					382	+		10.1038/nature11737	http://dx.doi.org/10.1038/nature11737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23235829	Green Accepted			2022-12-24	WOS:000312488200046
J	Zwiers, R; Zantvoord, FWA; Engelaer, FM; van Bodegom, D; van der Ouderaa, FJG; Westendorp, RGJ				Zwiers, R.; Zantvoord, F. W. A.; Engelaer, F. M.; van Bodegom, D.; van der Ouderaa, F. J. G.; Westendorp, R. G. J.			Mortality in former Olympic athletes: retrospective cohort analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; LIFE EXPECTANCY; HEALTH-BENEFITS; SOCCER PLAYERS; LONGEVITY; SPORTS; DISEASE; EXERCISE; INJURIES	Objective To assess the mortality risk in subsequent years (adjusted for year of birth, nationality, and sex) of former Olympic athletes from disciplines with different levels of exercise intensity. Design Retrospective cohort study. Setting Former Olympic athletes. Participants 9889 athletes (with a known age at death) who participated in the Olympic Games between 1896 and 1936, representing 43 types of disciplines with different levels of cardiovascular, static, and dynamic intensity exercise; high or low risk of bodily collision; and different levels of physical contact. Main outcome measure All cause mortality. Results Hazard ratios for mortality among athletes from disciplines with moderate cardiovascular intensity (1.01, 95% confidence interval 0.96 to 1.07) or high cardiovascular intensity (0.98, 0.92 to 1.04) were similar to those in athletes from disciplines with low cardiovascular intensity. The underlying static and dynamic components in exercise intensity showed similar non-significant results. Increased mortality was seen among athletes from disciplines with a high risk of bodily collision (hazard ratio 1.11, 1.06 to 1.15) and with high levels of physical contact (1.16, 1.11 to 1.22). In a multivariate analysis, the effect of high cardiovascular intensity remained similar (hazard ratio 1.05, 0.89 to 1.25); the increased mortality associated with high physical contact persisted (hazard ratio 1.13, 1.06 to 1.21), but that for bodily collision became non-significant (1.03, 0.98 to 1.09) as a consequence of its close relation with physical contact. Conclusions Among former Olympic athletes, engagement in disciplines with high intensity exercise did not bring a survival benefit compared with disciplines with low intensity exercise. Those who engaged in disciplines with high levels of physical contact had higher mortality than other Olympians later in life.	[Zwiers, R.; Zantvoord, F. W. A.; Engelaer, F. M.; van Bodegom, D.; van der Ouderaa, F. J. G.; Westendorp, R. G. J.] Leyden Acad Vital & Ageing, NL-2333 AA Leiden, Netherlands; [Engelaer, F. M.; van Bodegom, D.; Westendorp, R. G. J.] Leiden Univ, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Engelaer, FM (corresponding author), Leyden Acad Vital & Ageing, Rijnsburgerweg 10, NL-2333 AA Leiden, Netherlands.	Engelaer@leydenacademy.nl	Van Der Ouderaa, Frans/AAA-8580-2020	van Bodegom, David/0000-0002-5691-8342				BACKX FJG, 1991, AM J SPORT MED, V19, P124, DOI 10.1177/036354659101900206; Bauman A E, 2004, J Sci Med Sport, V7, P6, DOI 10.1016/S1440-2440(04)80273-1; BEAGLEHOLE R, 1983, NEW ZEAL MED J, V96, P513; Belli S, 2005, EUR J EPIDEMIOL, V20, P237, DOI 10.1007/s10654-004-6879-7; Bianco M, 2007, INT J SPORTS MED, V28, P697, DOI 10.1055/s-2007-964863; BLAIR SN, 1992, ANNU REV PUBL HEALTH, V13, P99, DOI 10.1146/annurev.pu.13.050192.000531; Blair SN, 1996, RES Q EXERCISE SPORT, V67, P193, DOI 10.1080/02701367.1996.10607943; Erlichman J, 2002, Obes Rev, V3, P257, DOI 10.1046/j.1467-789X.2002.00077.x; Gajewski AK, 2008, EUR J EPIDEMIOL, V23, P335, DOI 10.1007/s10654-008-9237-3; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Hootman JM, 2007, J ATHL TRAINING, V42, P311; KARVONEN MJ, 1974, MED SCI SPORT EXER, V6, P49; Kokkinos P, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/924945; KUJALA UM, 1994, METABOLISM, V43, P1255, DOI 10.1016/0026-0495(94)90219-4; Kujala UM, 2001, JAMA-J AM MED ASSOC, V285, P44, DOI 10.1001/jama.285.1.44; Kuss O, 2011, SCAND J MED SCI SPOR, V21, pE260, DOI 10.1111/j.1600-0838.2010.01269.x; LEE IM, 1995, JAMA-J AM MED ASSOC, V273, P1179, DOI 10.1001/jama.273.15.1179; Lee IM, 2001, MED SCI SPORT EXER, V33, pS459, DOI 10.1097/00005768-200106001-00016; Lippi G, 2006, CLIN CHEM LAB MED, V44, P322, DOI 10.1515/CCLM.2006.056; Melzer K, 2004, CURR OPIN CLIN NUTR, V7, P641, DOI 10.1097/00075197-200411000-00009; MENOTTI A, 1990, EUR J EPIDEMIOL, V6, P257, DOI 10.1007/BF00150429; Mitchell JH, 2005, J AM COLL CARDIOL, V45, P1364, DOI 10.1016/j.jacc.2005.02.015; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; SARNA S, 1993, MED SCI SPORT EXER, V25, P237; SCHNOHR P, 1971, LANCET, V2, P1364; Sports Reference, 2011, OL STAT HIST; Taioli E, 2007, EUR J PUBLIC HEALTH, V17, P600, DOI 10.1093/eurpub/ckm035; Teramoto M, 2010, J SCI MED SPORT, V13, P410, DOI 10.1016/j.jsams.2009.04.010; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Waterbor J, 1998, NEW ENGL J MED, V318, P1278; Williams MA, 2007, CIRCULATION, V116, P572, DOI 10.1161/CIRCULATIONAHA.107.185214; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25; YAMAJI K, 1977, Journal of Human Ergology, V6, P15	35	30	30	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2012	345								e7456	10.1136/bmj.e7456	http://dx.doi.org/10.1136/bmj.e7456			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MZ	23241269	Green Submitted, hybrid, Green Published			2022-12-24	WOS:000312495700002
J	Webber, BJ; Seguin, PG; Burnett, DG; Clark, LL; Otto, JL				Webber, Bryant J.; Seguin, Peter G.; Burnett, Daniel G.; Clark, Leslie L.; Otto, Jean L.			Prevalence of and Risk Factors for Autopsy-Determined Atherosclerosis Among US Service Members, 2001-2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY ATHEROSCLEROSIS; NATURAL-HISTORY; PUBLIC-HEALTH; DISEASE; MORTALITY; ASSOCIATIONS; SOLDIERS; TRENDS	Context Autopsies of US service members killed in the Korean and Vietnam wars demonstrated that atherosclerotic changes in the coronary arteries can appear early in the second and third decades of life, long before ischemic heart disease becomes clinically apparent. Objective To estimate the current prevalence of coronary and aortic atherosclerosis in the US armed forces. Design, Setting, and Participants Cross-sectional study of all US service members who died of combat or unintentional injuries in support of Operations Enduring Freedom and Iraqi Freedom/New Dawn between October 2001 and August 2011 and whose cardiovascular autopsy reports were available at the time of data collection in January 2012. Prevalence of atherosclerosis was analyzed by various demographic characteristics and medical history. Classifications of coronary atherosclerosis severity were determined prior to data analysis and designed to provide consistency with previous military studies: minimal (fatty streaking only), moderate (10%-49% luminal narrowing of >= 1 vessel), and severe (>= 50% narrowing >= 1 of vessel). Main Outcome Measures Prevalence of coronary and aortic atherosclerosis in the US armed forces and by age, sex, self-reported race/ethnicity, education, occupation, service branch and component, military rank, body mass index at military entrance, and International Classification of Diseases, Ninth Revision, Clinical Modification, diagnoses of cardiovascular risk factors. Results Of the 3832 service members included in the analysis, the mean age was 25.9 years (range, 18-59 years) and 98.3% were male. The prevalence of any coronary atherosclerosis was 8.5% (95% Cl, 7.6%-9.4%); severe coronary atherosclerosis was present in 2.3% (95% Cl, 1.8%-2.7%), moderate in 4.7% (95% CI,4.0%-5.3%), and minimal in 1.5% (95% Cl, 1.1%-1.9%). Service members with atherosclerosis were significantly older (mean [SD] age, 30.5 [8.1] years) than those without (mean [SD] age, 25.3 [5.6] years; P<.001). Comparing atherosclerosis prevalence among with those with no cardiovascular risk factor diagnoses (11.1% [95% Cl, 10.1%-12.1%]), there was a greater prevalence among those with a diagnosis of dyslipidemia (50.0% [95% Cl, 30.3%-69.7%]; age-adjusted prevalence ratio [PR], 2.09 [95% Cl, 1.43-3.06]), hypertension (43.6% [95% Cl, 27.3%-59.9%]; age-adjusted PR, 1.88 [95% Cl, 1.34-2.65]), or obesity (22.3% [95% Cl, 15.9%-28.7%]; age-adjusted PR, 1.47 [95% Cl, 1.10-1.96]), but smoking (14.1% [95% Cl, 8.0%-20.2%]) was not significantly associated with a higher prevalence of atherosclerosis (age-adjusted PR, 1.12 [95% Cl, 0.73-1.74]). Conclusion Among deployed US service members who died of combat or unintentional injuries and received autopsies, the prevalence of atherosclerosis varied by age and cardiovascular risk factors. JAMA. 2012;308(24):2577-2583 www.jama.com	[Webber, Bryant J.] Uniformed Serv Univ Hlth Sci, PMB, Bethesda, MD 20814 USA; [Seguin, Peter G.] Armed Forces Med Examiner Syst, Dover AFB, DE USA; [Clark, Leslie L.; Otto, Jean L.] Armed Forces Hlth Surveillance Ctr, Silver Spring, MD USA; [Otto, Jean L.] Adv Mil Med Inc, Henry M Jackson Fdn, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Air Force; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Webber, BJ (corresponding author), Uniformed Serv Univ Hlth Sci, PMB, 4301 Jones Bridge Rd,Room A1040A, Bethesda, MD 20814 USA.	bryant.webber@usuhs.edu	Webber, Bryant/ABI-7744-2020	Webber, Bryant/0000-0002-2099-2671; Burnett, Daniel/0000-0003-1277-0486	Uniformed Services University of the Health Sciences (USUHS); Armed Forces Medical Examiner System (AFMES); Armed Forces Health Surveillance Center (AFHSC)	Uniformed Services University of the Health Sciences (USUHS); Armed Forces Medical Examiner System (AFMES); Armed Forces Health Surveillance Center (AFHSC)	This study was supported by the Uniformed Services University of the Health Sciences (USUHS), Armed Forces Medical Examiner System (AFMES), and Armed Forces Health Surveillance Center (AFHSC).	[Anonymous], 1968, AG ADJ DEATH RAT 69, P1968; [Anonymous], 2004, DOD PHYS FITN BOD PR; Armed services exchange policy, 2005, ARM SERV EXCH POL IN; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; BOOZE CF, 1987, AVIAT SPACE ENVIR MD, V58, P297; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P986; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1227; Commander Submarine Force Atlantic Commander Submarine Force US Pacific Fleet, 2010, SUBM FORC TOB CESS P; ENOS WF, 1955, JAMA-J AM MED ASSOC, V158, P912, DOI 10.1001/jama.1955.02960110018005; ENOS WF, 1953, JAMA-J AM MED ASSOC, V152, P1090, DOI 10.1001/jama.1953.03690120006002; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Gardner JW, 2000, MIL MED, V165, P57, DOI 10.1093/milmed/165.suppl_2.57; Hatzfeld JJ, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110136; HOLME I, 1985, AM J CARDIOL, V55, P40, DOI 10.1016/0002-9149(85)90296-6; Hourani LL, 2008, 2008 DEP DEF SURV HL; Joseph A, 1993, J AM COLL CARDIOL, V22, P459, DOI 10.1016/0735-1097(93)90050-B; Joseph AM, 2005, MIL MED, V170, P874, DOI 10.7205/MILMED.170.10.874; JUDSON JJ, 1971, J AMER MED ASSOC, V216, P1185; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Long-term trends in diagnosed diabetes, 2012, LONG TERM TRENDS DIA; MCGILL HC, 1990, JAMA-J AM MED ASSOC, V264, P3018; Minino Arialdi M, 2011, Natl Vital Stat Rep, V59, P1; Nakashima Y, 2008, CARDIOVASC RES, V79, P14, DOI 10.1093/cvr/cvn099; National Heart Lung and Blood Institute, EXP PAN INT GUID CAR; Ogden Cynthia L, 2004, Adv Data, P1; PETTYJOHN FS, 1975, AVIAT SPACE ENVIR MD, V46, P1299; QuickStats, 2009, MMWR-MORBID MORTAL W, V58, P1045; REED DM, 1987, AM J EPIDEMIOL, V126, P214, DOI 10.1093/aje/126.2.214; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Smoke-free DoD facilities, 2001, SMOK FREE DOD FAC IN; STRONG JP, 1986, JAMA-J AM MED ASSOC, V256, P2863, DOI 10.1001/jama.256.20.2863; STRONG JP, 1962, AM J PATHOL, V40, P37; Taneja N, 2002, AVIAT SPACE ENVIR MD, V73, P1025; TEJADA C, 1968, LAB INVEST, V18, P509; Tobacco use in the Air Force, 2012, TOB US AIR FORC INST; UEMURA K, 1964, B WORLD HEALTH ORGAN, V31, P297; Wilkins JT, 2012, JAMA-J AM MED ASSOC, V308, P1795, DOI 10.1001/jama.2012.14312; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; Yoon Sung Sug Sarah, 2010, NCHS Data Brief, P1; Zhdanov VS, 1999, INT J CARDIOL, V68, P95, DOI 10.1016/S0167-5273(98)00339-8	43	85	92	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2577	2583		10.1001/jama.2012.70830	http://dx.doi.org/10.1001/jama.2012.70830			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268516	Bronze			2022-12-24	WOS:000312916600023
J	Fanfair, RN; Benedict, K; Bos, J; Bennett, SD; Lo, YC; Adebanjo, T; Etienne, K; Deak, E; Derado, G; Shieh, WJ; Drew, C; Zaki, S; Sugerman, D; Gade, L; Thompson, EH; Sutton, DA; Engelthaler, DM; Schupp, JM; Brandt, ME; Harris, JR; Lockhart, SR; Turabelidze, G; Park, BJ				Fanfair, Robyn Neblett; Benedict, Kaitlin; Bos, John; Bennett, Sarah D.; Lo, Yi-Chun; Adebanjo, Tolu; Etienne, Kizee; Deak, Eszter; Derado, Gordana; Shieh, Wun-Ju; Drew, Clifton; Zaki, Sherif; Sugerman, David; Gade, Lalitha; Thompson, Elizabeth H.; Sutton, Deanna A.; Engelthaler, David M.; Schupp, James M.; Brandt, Mary E.; Harris, Julie R.; Lockhart, Shawn R.; Turabelidze, George; Park, Benjamin J.			Necrotizing Cutaneous Mucormycosis after a Tornado in Joplin, Missouri, in 2011	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOPHYSOMYCES-ELEGANS; SOFT-TISSUE; TSUNAMI SURVIVOR; ZYGOMYCOSIS; OUTBREAK; INFECTIONS; EPIDEMIOLOGY; MANAGEMENT; FASCIITIS; RHIZOPUS	BACKGROUND Mucormycosis is a fungal infection caused by environmentally acquired molds. We investigated a cluster of cases of cutaneous mucormycosis among persons injured during the May 22, 2011, tornado in Joplin, Missouri. METHODS We defined a case as a soft-tissue infection in a person injured during the tornado, with evidence of a mucormycete on culture or immunohistochemical testing plus DNA sequencing. We conducted a case-control study by reviewing medical records and conducting interviews with case patients and hospitalized controls. DNA sequencing and whole-genome sequencing were performed on clinical specimens to identify species and assess strain-level differences, respectively. RESULTS A total of 13 case patients were identified, 5 of whom (38%) died. The patients had a median of 5 wounds (range, 1 to 7); 11 patients (85%) had at least one fracture, 9 (69%) had blunt trauma, and 5 (38%) had penetrating trauma. All case patients had been located in the zone that sustained the most severe damage during the tornado. On multivariate analysis, infection was associated with penetrating trauma (adjusted odds ratio for case patients vs. controls, 8.8; 95% confidence interval [CI], 1.1 to 69.2) and an increased number of wounds (adjusted odds ratio, 2.0 for each additional wound; 95% CI, 1.2 to 3.2). Sequencing of the D1-D2 region of the 28S ribosomal DNA yielded Apophysomyces trapeziformis in all 13 case patients. Whole-genome sequencing showed that the apophysomyces isolates were four separate strains. CONCLUSIONS We report a cluster of cases of cutaneous mucormycosis among Joplin tornado survivors that were associated with substantial morbidity and mortality. Increased awareness of fungi as a cause of necrotizing soft-tissue infections after a natural disaster is warranted.	[Fanfair, Robyn Neblett; Benedict, Kaitlin; Bennett, Sarah D.; Adebanjo, Tolu; Etienne, Kizee; Deak, Eszter; Gade, Lalitha; Brandt, Mary E.; Harris, Julie R.; Lockhart, Shawn R.; Park, Benjamin J.] Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA USA; [Derado, Gordana] Ctr Dis Control & Prevent, Biostat Off, Atlanta, GA USA; [Fanfair, Robyn Neblett; Bennett, Sarah D.; Lo, Yi-Chun] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA USA; [Shieh, Wun-Ju; Drew, Clifton; Zaki, Sherif] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Sugerman, David] Ctr Dis Control & Prevent, Div Injury Response, Atlanta, GA USA; [Bos, John; Lo, Yi-Chun; Turabelidze, George] Missouri Dept Hlth & Senior Serv, Jefferson, AR USA; [Thompson, Elizabeth H.; Sutton, Deanna A.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Engelthaler, David M.; Schupp, James M.] Translat Genom Res Inst, Flagstaff, AZ USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Texas System; University of Texas Health San Antonio; Translational Genomics Research Institute	Park, BJ (corresponding author), 1600 Clifton Rd,MS C-09, Atlanta, GA 30333 USA.	bpark1@cdc.gov						Alexander BD, 2010, AM J TRANSPLANT, V10, P2161, DOI 10.1111/j.1600-6143.2010.03216.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andresen D, 2005, LANCET, V365, P876, DOI 10.1016/S0140-6736(05)71046-1; [Anonymous], 2011, MMWR MORB MORTAL WKL, V60, P992; [Anonymous], 2005, EM WOUND MAN HEALTHC; [Anonymous], 2003, TORN BEING PREP; Antoniadou A, 2009, CLIN MICROBIOL INFEC, V15, P55, DOI 10.1111/j.1469-0691.2009.02982.x; Balajee SA, 2008, J MICROBIOL METH, V73, P252, DOI 10.1016/j.mimet.2008.02.011; Chamilos G, 2008, CLIN INFECT DIS, V47, P503, DOI 10.1086/590004; Christiaens G, 2005, J HOSP INFECT, V61, P88, DOI 10.1016/j.jhin.2004.12.011; Daley WR, 2005, AM J EPIDEMIOL, V161, P1144, DOI 10.1093/aje/kwi142; Etienne K, 2011, PLOS ONE IN PRESS; Gomes MZR, 2011, CLIN MICROBIOL REV, V24, P411, DOI 10.1128/CMR.00056-10; Guarner J, 2011, CLIN MICROBIOL REV, V24, P247, DOI 10.1128/CMR.00053-10; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; HUFFNAGLE KE, 1992, J MED VET MYCOL, V30, P83; Ibrahim AS, 2008, CURR OPIN INFECT DIS, V21, P620, DOI 10.1097/QCO.0b013e3283165fd1; Ivers LC, 2006, CURR OPIN INFECT DIS, V19, P408, DOI 10.1097/01.qco.0000244044.85393.9e; Jain D, 2006, MODERN PATHOL, V19, P1221, DOI 10.1038/modpathol.3800639; Kimura M, 1999, ARCH PATHOL LAB MED, V123, P386; Kindo A J, 2007, Indian J Med Microbiol, V25, P285; Kontoyiannis DP, 2011, BLOOD, V118, P1216, DOI 10.1182/blood-2011-03-316430; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; LeMaile-Williams M, 2006, CLIN INFECT DIS, V43, pE83, DOI 10.1086/508277; Maravi-Poma E, 2004, INTENS CARE MED, V30, P724, DOI 10.1007/s00134-003-2132-1; Meis JF, 2009, CLIN MICROBIOL INFEC, V15, P10, DOI 10.1111/j.1469-0691.2009.02973.x; Munoz-Cadavid C, 2010, J CLIN MICROBIOL, V48, P2147, DOI 10.1128/JCM.00459-10; National Weather Service. Springfield MO, 2011, JOPL TORN EV SUMM; Oklahoma State Department of Health, 2006, TORN MORT QUEST MED; PATINO JF, 1991, WORLD J SURG, V15, P240, DOI 10.1007/BF01659059; Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579; Skiada A, 2009, CLIN MICROBIOL INFEC, V15, P41, DOI 10.1111/j.1469-0691.2009.02979.x; Snell BJ, 2007, PLAST RECONSTR SURG, V119, P448, DOI 10.1097/01.prs.0000233624.34950.f8; Spellberg B, 2005, CLIN MICROBIOL REV, V18, P556, DOI 10.1128/CMR.18.3.556-569.2005; Sun HY, 2011, LANCET INFECT DIS, V11, P301, DOI 10.1016/S1473-3099(10)70316-9; U.S. Army Corps of Engineers, JOPL MISS TORN PATH; Wang Jue, 2002, Surg Infect (Larchmt), V3, P283, DOI 10.1089/109629602761624243; Weddle G, 2011, 49 ANN M INF DIS SOC; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	39	212	213	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2214	2225		10.1056/NEJMoa1204781	http://dx.doi.org/10.1056/NEJMoa1204781			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048DO	23215557				2022-12-24	WOS:000311890600008
J	Shoji-Kawata, S; Sumpter, R; Leveno, M; Campbell, GR; Zou, ZJ; Kinch, L; Wilkins, AD; Sun, QH; Pallauf, K; MacDuff, D; Huerta, C; Virgin, HW; Helms, JB; Eerland, R; Tooze, SA; Xavier, R; Lenschow, DJ; Yamamoto, A; King, D; Lichtarge, O; Grishin, NV; Spector, SA; Kaloyanova, DV; Levine, B				Shoji-Kawata, Sanae; Sumpter, Rhea, Jr.; Leveno, Matthew; Campbell, Grant R.; Zou, Zhongju; Kinch, Lisa; Wilkins, Angela D.; Sun, Qihua; Pallauf, Kathrin; MacDuff, Donna; Huerta, Carlos; Virgin, Herbert W.; Helms, J. Bernd; Eerland, Ruud; Tooze, Sharon A.; Xavier, Ramnik; Lenschow, Deborah J.; Yamamoto, Ai; King, David; Lichtarge, Olivier; Grishin, Nick V.; Spector, Stephen A.; Kaloyanova, Dora V.; Levine, Beth			Identification of a candidate therapeutic autophagy-inducing peptide	NATURE			English	Article							PROTEIN; DISEASE; PATHOGENESIS; MACROPHAGES; LOCALIZES; INFECTION; BECLIN-1; PATHWAY; COMPLEX; BINDING	The lysosomal degradation pathway of autophagy has a crucial role in defence against infection, neurodegenerative disorders, cancer and ageing. Accordingly, agents that induce autophagy may have broad therapeutic applications. One approach to developing such agents is to exploit autophagy manipulation strategies used by microbial virulence factors. Here we show that a peptide, Tat-beclin 1-derived from a region of the autophagy protein, beclin 1, which binds human immunodeficiency virus (HIV)-1 Nef-is a potent inducer of autophagy, and interacts with a newly identified negative regulator of autophagy, GAPR-1 (also called GLIPR2). Tat-beclin 1 decreases the accumulation of polyglutamine expansion protein aggregates and the replication of several pathogens (including HIV-1) in vitro, and reduces mortality in mice infected with chikungunya or West Nile virus. Thus, through the characterization of a domain of beclin 1 that interacts with HIV-1 Nef, we have developed an autophagy-inducing peptide that has potential efficacy in the treatment of human diseases.	[Shoji-Kawata, Sanae; Sumpter, Rhea, Jr.; Leveno, Matthew; Zou, Zhongju; Sun, Qihua; Pallauf, Kathrin; Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Shoji-Kawata, Sanae; Sumpter, Rhea, Jr.; Leveno, Matthew; Zou, Zhongju; Sun, Qihua; Levine, Beth] Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Campbell, Grant R.; Spector, Stephen A.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Campbell, Grant R.; Spector, Stephen A.] Rady Childrens Hosp, San Diego, CA 92123 USA; [Zou, Zhongju; Kinch, Lisa; Grishin, Nick V.; Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Kinch, Lisa; Huerta, Carlos; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wilkins, Angela D.; Lichtarge, Olivier] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [MacDuff, Donna; Virgin, Herbert W.; Lenschow, Deborah J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Helms, J. Bernd; Eerland, Ruud; Kaloyanova, Dora V.] Univ Utrecht, Dept Biochem & Cell Biol, NL-3508 TD Utrecht, Netherlands; [Helms, J. Bernd; Eerland, Ruud; Kaloyanova, Dora V.] Univ Utrecht, Inst Biomembranes, NL-3508 TD Utrecht, Netherlands; [Tooze, Sharon A.] Canc Res UK, London Res Inst, London EC1V 4AD, England; [Xavier, Ramnik] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Lenschow, Deborah J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Yamamoto, Ai] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [King, David] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor College of Medicine; Washington University (WUSTL); Utrecht University; Utrecht University; Cancer Research UK; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Washington University (WUSTL); Columbia University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Texas System; University of Texas Southwestern Medical Center Dallas	Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu	Campbell, Grant/C-9018-2011; Sumpter, Jr., Rhea/N-8152-2018; Pallauf, Kathrin/Z-5966-2019; MacDuff, Donna/AAD-2786-2019	Campbell, Grant/0000-0003-3927-1994; Pallauf, Kathrin/0000-0002-7223-2738; MacDuff, Donna/0000-0002-6183-6827; Virgin, Herbert/0000-0001-8580-7628; Kinch, Lisa/0000-0003-3041-2615; Tooze, Sharon/0000-0002-2182-3116	NIH [U54AI057156, K08 AI099150, ROI NS077874, RO1 GM094575, ROI GM066099, ROI GM079656, ROI NS063973, ROI NS050199, U54AI057160, ROI DK083756, ROI DK086502, T32 GM008297]; NSF [CCF-0905536]; NWO-ALW Open Program [817.02.023]; Cancer Research UK; Welch Foundation [I-15-5]; Cancer Research UK [15153] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156, U54AI057160, K08AI099150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086502, R01DK083756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079656, T32GM008297, R01GM094575, R01GM066099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063973, R01NS077874, R01NS050199, R01NS077111, R01NS084912] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NWO-ALW Open Program; Cancer Research UK(Cancer Research UK); Welch Foundation(The Welch Foundation); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Diamond, J. L Foster, M. Gale, N. Mizushima, D. Sabatini, M. Shiloh and T. Yoshimori for supplying critical reagent; and H. Ball, A. Bugde and E.-L Eskelinen for assistance with-peptide synthesis, infrared imaging and EM interpretation, respectively. This work was supported by NIH grants U54AI057156 (B.L), K08 AI099150 (R.S.), ROI NS077874 (S.A.S), RO1 GM094575 (N.V.G.), ROI GM066099 (O.L.), ROI GM079656 (O.L.), ROI NS063973 (A.Y.), ROI NS050199 (A.Y.), U54AI057160 (H.W.V., D.J.L.), ROI DK083756 (R.X), ROI DK086502 (R.X.), and T32 GM008297 (C.H.); NSF CCF-0905536 (O.L); an NWO-ALW Open Program Grant 817.02.023 (J.B.H.); Cancer Research UK (SAT.); and a Welch Foundation Award I-15-5 (N.V.G.).	BAYER P, 1995, J MOL BIOL, V247, P529, DOI 10.1016/S0022-2836(05)80133-0; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Campbell GR, 2011, J BIOL CHEM, V286, P18890, DOI 10.1074/jbc.M110.206110; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Eberle HB, 2002, J CELL SCI, V115, P827; Fischer PM, 2003, CURR PROTEIN PEPT SC, V4, P339, DOI 10.2174/1389203033487054; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Griffin DE, 2010, PROG NEUROBIOL, V91, P95, DOI 10.1016/j.pneurobio.2009.12.003; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Huang WJ, 2012, CELL RES, V22, P473, DOI 10.1038/cr.2012.24; Johnson RT, 1996, CLIN INFECT DIS, V23, P219, DOI 10.1093/clinids/23.2.219; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; van den Berg A, 2011, CURR OPIN BIOTECH, V22, P888, DOI 10.1016/j.copbio.2011.03.008; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	27	539	569	3	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2013	494	7436					201	206		10.1038/nature11866	http://dx.doi.org/10.1038/nature11866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23364696	Green Accepted			2022-12-24	WOS:000315137700032
J	Shao, W; Zhang, SZ; Tang, M; Zhang, XH; Zhou, Z; Yin, YQ; Zhou, QB; Huang, YY; Liu, YJ; Wawrousek, E; Chen, T; Li, SB; Xu, M; Zhou, JN; Hu, G; Zhou, JW				Shao, Wei; Zhang, Shu-zhen; Tang, Mi; Zhang, Xin-hua; Zhou, Zheng; Yin, Yan-qing; Zhou, Qin-bo; Huang, Yuan-yuan; Liu, Ying-jun; Wawrousek, Eric; Chen, Teng; Li, Sheng-bin; Xu, Ming; Zhou, Jiang-ning; Hu, Gang; Zhou, Jia-wei			Suppression of neuroinflammation by astrocytic dopamine D2 receptors via alpha B-crystallin	NATURE			English	Article							HUMAN-BRAIN; INFLAMMATION; MICROGLIA; PATHWAY; INNATE; MICE	Chronic neuroinflammation is a common feature of the ageing brain and some neurodegenerative disorders. However, the molecular and cellular mechanisms underlying the regulation of innate immunity in the central nervous system remain elusive. Here we show that the astrocytic dopamine D2 receptor (DRD2) modulates innate immunity through alpha B-crystallin (CRYAB), which is known to suppress neuroinflammation(1,2). We demonstrate that knockout mice lacking Drd2 showed remarkable inflammatory response in multiple central nervous system regions and increased the vulnerability of nigral dopaminergic neurons to neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity(3). Astrocytes null for Drd2 became hyper-responsive to immune stimuli with a marked reduction in the level of CRYAB. Preferential ablation of Drd2 in astrocytes robustly activated astrocytes in the substantia nigra. Gain- or loss-of-function studies showed that CRYAB is critical for DRD2-mediated modulation of innate immune response in astrocytes. Furthermore, treatment of wildtype mice with the selective DRD2 agonist quinpirole increased resistance of the nigral dopaminergic neurons to MPTP through partial suppression of inflammation. Our study indicates that astrocytic DRD2 activation normally suppresses neuroinflammation in the central nervous system through a CRYAB-dependent mechanism, and provides a new strategy for targeting the astrocyte-mediated innate immune response in the central nervous system during ageing and disease.	[Shao, Wei; Zhang, Shu-zhen; Tang, Mi; Zhang, Xin-hua; Zhou, Zheng; Yin, Yan-qing; Zhou, Qin-bo; Huang, Yuan-yuan; Liu, Ying-jun; Zhou, Jia-wei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Tang, Mi; Hu, Gang] Nanjing Med Univ, Dept Pharmacol, Jiangsu Key Lab Neurodegenerat, Nanjing 210029, Jiangsu, Peoples R China; [Wawrousek, Eric] NEI, NIH, Bethesda, MD 20892 USA; [Chen, Teng; Li, Sheng-bin] Xi An Jiao Tong Univ, Sch Med, Dept Forens Sci, Xian 710061, Shanxi, Peoples R China; [Xu, Ming] Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA; [Zhou, Jiang-ning] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Brain Funct & Dis, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing Medical University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Xi'an Jiaotong University; University of Chicago; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, JW (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai 200031, Peoples R China.	jwzhou@ion.ac.cn	Wawrousek, Eric/A-4547-2008; Zhou, Zheng/AAA-8079-2020; Liu, Yingjun/AAW-5353-2020; Zhou, JiangNing/N-3374-2013; Shao, Wei/GNW-5579-2022	Liu, Yingjun/0000-0003-1543-1965; Shao, Wei/0000-0002-8782-4904; Zhang, Xin-hua/0000-0002-5702-6733; Zhou, Qinbo/0000-0002-7967-2138; Zhou, Jiawei/0000-0002-1844-9178	Chinese Academy of Sciences; National Basic Research Program of China [2011CBA00408, 2011CB504102]; Natural Science Foundation of China [31021063, 31123002]; Shanghai Metropolitan Fund for Research and Development; NATIONAL EYE INSTITUTE [ZICEY000458] Funding Source: NIH RePORTER	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Metropolitan Fund for Research and Development; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank B. Zhang and Y.J. Yan for technical assistance; L. Zhu for technical support in DNA microarray analysis; the Optical Imaging Center of ION and the Cell Biology Analysis Center of IBCB for technical support in confocal microscopy; T. L. Hagemann for providing the CRYAB construct; R. Quinlan for anti-CRYAB antibodies, Y. Q. Ding for providing the Drd1 and Drd2 gene null mice; we also thank Shanghai Research Center for Model Organisms for creating Drd2-floxed mice. This work was supported by grants from the Chinese Academy of Sciences, National Basic Research Program of China (nos 2011CBA00408 and 2011CB504102), Natural Science Foundation of China (nos 31021063 and 31123002), and Shanghai Metropolitan Fund for Research and Development.	ANTONINI A, 1993, ANN NY ACAD SCI, V695, P81, DOI 10.1111/j.1749-6632.1993.tb23033.x; Bal A, 1994, Brain Res Mol Brain Res, V23, P204; Bhat R, 2009, NEURON, V64, P123, DOI 10.1016/j.neuron.2009.09.015; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Cai L, 2011, NEUROSCIENCE, V181, P196, DOI 10.1016/j.neuroscience.2011.02.059; Casper KB, 2007, GENESIS, V45, P292, DOI 10.1002/dvg.20287; Hagemann TL, 2009, HUM MOL GENET, V18, P1190, DOI 10.1093/hmg/ddp013; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Kaasinen V, 2000, NEUROBIOL AGING, V21, P683, DOI 10.1016/S0197-4580(00)00149-4; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Luo XY, 2009, J NEUROCHEM, V108, P952, DOI 10.1111/j.1471-4159.2008.05845.x; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Saijo K, 2010, ADV IMMUNOL, V106, P21, DOI 10.1016/S0065-2776(10)06002-5; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; SEEMAN P, 1987, SYNAPSE, V1, P399, DOI 10.1002/syn.890010503; Xu M, 1997, NEURON, V19, P837, DOI 10.1016/S0896-6273(00)80965-4; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	22	269	288	6	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					90	94		10.1038/nature11748	http://dx.doi.org/10.1038/nature11748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23242137				2022-12-24	WOS:000314741200040
J	Cannon, B				Cannon, Bill			BIOCHEMISTRY TO BEHAVIOUR	NATURE			English	Editorial Material																			0	51	54	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2013	493	7434					S2	S3		10.1038/493S2a	http://dx.doi.org/10.1038/493S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	080CU	23364768	Bronze			2022-12-24	WOS:000314219600004
J	Nygaard, R; Zou, YZ; Dror, RO; Mildorf, TJ; Arlow, DH; Manglik, A; Pan, AC; Liu, CW; Fung, JJ; Bokoch, MP; Thian, FS; Kobilka, TS; Shaw, DE; Mueller, L; Prosser, RS; Kobilka, BK				Nygaard, Rie; Zou, Yaozhong; Dror, Ron O.; Mildorf, Thomas J.; Arlow, Daniel H.; Manglik, Aashish; Pan, Albert C.; Liu, Corey W.; Fung, Juan Jose; Bokoch, Michael P.; Thian, Foon Sun; Kobilka, Tong Sun; Shaw, David E.; Mueller, Luciano; Prosser, R. Scott; Kobilka, Brian K.			The Dynamic Process of beta(2)-Adrenergic Receptor Activation	CELL			English	Article							PROTEIN-COUPLED RECEPTOR; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; MECHANISM; EFFICACY; REVEALS; STATE	G-protein-coupled receptors (GPCRs) can modulate diverse signaling pathways, often in a ligand-specific manner. The full range of functionally relevant GPCR conformations is poorly understood. Here, we use NMR spectroscopy to characterize the conformational dynamics of the transmembrane core of the beta(2)-adrenergic receptor (beta(2)AR), a prototypical GPCR. We labeled beta(2)AR with (CH3)-C-13 epsilon-methionine and obtained HSQC spectra of unliganded receptor as well as receptor bound to an inverse agonist, an agonist, and a G-protein-mimetic nanobody. These studies provide evidence for conformational states not observed in crystal structures, as well as substantial conformational heterogeneity in agonistand inverse-agonist-bound preparations. They also show that for beta(2)AR, unlike rhodopsin, an agonist alone does not stabilize a fully active conformation, suggesting that the conformational link between the agonist-binding pocket and the G-proteincoupling surface is not rigid. The observed heterogeneity may be important for beta(2)AR's ability to engage multiple signaling and regulatory proteins.	[Nygaard, Rie; Zou, Yaozhong; Manglik, Aashish; Fung, Juan Jose; Bokoch, Michael P.; Thian, Foon Sun; Kobilka, Tong Sun; Kobilka, Brian K.] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Liu, Corey W.] Stanford Univ, Stanford Magnet Resonance Lab, Sch Med, Stanford, CA 94305 USA; [Dror, Ron O.; Mildorf, Thomas J.; Arlow, Daniel H.; Pan, Albert C.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Prosser, R. Scott] Univ Toronto, UTM, Dept Chem, Mississauga, ON L5L 1C6, Canada; [Mueller, Luciano] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA	Stanford University; Stanford University; D. E. Shaw Research; University of Toronto; University Toronto Mississauga; Bristol-Myers Squibb	Kobilka, BK (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA.	kobilka@stanford.edu	Bokoch, Michael P./J-2637-2019; Nygaard, Rie/B-7351-2013; Pan, Albert/G-1475-2013	Bokoch, Michael P./0000-0003-1387-9547; Kobilka, Brian/0000-0001-5958-3990; Pan, Albert/0000-0001-5050-5603; Dror, Ron/0000-0002-6418-2793	National Institutes of Health [NS028471]; Mathers Foundation; Lundbeck Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028471, R01NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge support from National Institutes of Health Grant NS028471 (B.K.K.) and the Mathers Foundation (B.K.K.). We thank Prof. Joseph Puglisi for encouragement and advice. We thank Dr. Soren Rasmussen for help with protein preparation. We acknowledge support from the Lundbeck Foundation (R.N.). We thank Paul Maragakis and Kresten Lindorff-Larsen for helpful comments.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bose-Basu B, 2004, BIOCHEMISTRY-US, V43, P8911, DOI 10.1021/bi049641n; Butterfoss GL, 2010, J BIOMOL NMR, V48, P31, DOI 10.1007/s10858-010-9436-6; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DellaVecchia MJ, 2007, J MOL BIOL, V373, P282, DOI 10.1016/j.jmb.2007.07.045; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Dror RO, 2010, J GEN PHYSIOL, V135, P555, DOI 10.1085/jgp.200910373; Farrens DL, 2010, PHOTOCH PHOTOBIO SCI, V9, P1466, DOI 10.1039/c0pp00283f; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Hansen DF, 2008, J BIOMOL NMR, V41, P113, DOI 10.1007/s10858-008-9251-5; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kofuku Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2046; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Rajagopal K, 2005, J CLIN INVEST, V115, P2971, DOI 10.1172/JCI26950; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Shaw D. E., 2009, P C HIGH PERF COMP N, V39, P1, DOI DOI 10.1145/1654059.1654099; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Wishart DS, 2011, PROG NUCL MAG RES SP, V58, P62, DOI 10.1016/j.pnmrs.2010.07.004; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801	40	575	584	12	368	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					532	542		10.1016/j.cell.2013.01.008	http://dx.doi.org/10.1016/j.cell.2013.01.008			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374348	Green Accepted, Bronze			2022-12-24	WOS:000314362800022
J	Zhu, J; Adli, M; Zou, JY; Verstappen, G; Coyne, M; Zhang, XL; Durham, T; Miri, M; Deshpande, V; De Jager, PL; Bennett, DA; Houmard, JA; Muoio, DM; Onder, TT; Camahort, R; Cowan, CA; Meissner, A; Epstein, CB; Shoresh, N; Bernstein, BE				Zhu, Jiang; Adli, Mazhar; Zou, James Y.; Verstappen, Griet; Coyne, Michael; Zhang, Xiaolan; Durham, Timothy; Miri, Mohammad; Deshpande, Vikram; De Jager, Philip L.; Bennett, David A.; Houmard, Joseph A.; Muoio, Deborah M.; Onder, Tamer T.; Camahort, Ray; Cowan, Chad A.; Meissner, Alexander; Epstein, Charles B.; Shoresh, Noam; Bernstein, Bradley E.			Genome-wide Chromatin State Transitions Associated with Developmental and Environmental Cues	CELL			English	Article							EPIGENETIC SIGNATURE; PLURIPOTENT; ORGANIZATION; SENESCENCE; DYNAMICS; REVEALS; COMPLEX; IMPACT; GENES; CELLS	Differences in chromatin organization are key to the multiplicity of cell states that arise from a single genetic background, yet the landscapes of in vivo tissues remain largely uncharted. Here, we mapped chromatin genome-wide in a large and diverse collection of human tissues and stem cells. The maps yield unprecedented annotations of functional genomic elements and their regulation across developmental stages, lineages, and cellular environments. They also reveal global features of the epigenome, related to nuclear architecture, that also vary across cellular phenotypes. Specifically, developmental specification is accompanied by progressive chromatin restriction as the default state transitions from dynamic remodeling to generalized compaction. Exposure to serum in vitro triggers a distinct transition that involves de novo establishment of domains with features of constitutive heterochromatin. We describe how these global chromatin state transitions relate to chromosome and nuclear architecture, and discuss their implications for lineage fidelity, cellular senescence, and reprogramming.	[Zhu, Jiang; Adli, Mazhar; Zou, James Y.; Verstappen, Griet; Coyne, Michael; Zhang, Xiaolan; Durham, Timothy; De Jager, Philip L.; Camahort, Ray; Cowan, Chad A.; Meissner, Alexander; Epstein, Charles B.; Shoresh, Noam; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zhu, Jiang; Adli, Mazhar; Zou, James Y.; Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Zhu, Jiang; Adli, Mazhar; Zou, James Y.; Miri, Mohammad; Deshpande, Vikram; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Zhu, Jiang; Adli, Mazhar; Zou, James Y.; Miri, Mohammad; Deshpande, Vikram; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Zhu, Jiang; Adli, Mazhar; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Zhu, Jiang; Adli, Mazhar; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Zou, James Y.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Verstappen, Griet; Camahort, Ray; Cowan, Chad A.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [De Jager, Philip L.] Brigham & Womens Hosp, Program Translat NeuroPsychiat Genom, Inst Neurosci, Dept Neurol, Boston, MA 02215 USA; [De Jager, Philip L.] Brigham & Womens Hosp, Program Translat NeuroPsychiat Genom, Inst Neurosci, Dept Psychiat, Boston, MA 02215 USA; [De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Houmard, Joseph A.] E Carolina Univ, Dept Exercise & Sport Sci, Greenville, NC 27858 USA; [Muoio, Deborah M.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Onder, Tamer T.] Koc Univ, Sch Med, Istanbul, Turkey	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Rush University; University of North Carolina; East Carolina University; Duke University; Koc University	Adli, M (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	adli@virginia.edu; bernstein.bradley@mgh.harvard.edu	Onder, Tamer T/H-3330-2013; Onder, Tamer/O-3669-2019; Muoio, Debbie Marie/E-1147-2012; Zhu, Jiang/E-3049-2013	Onder, Tamer T/0000-0002-2372-9158; Onder, Tamer/0000-0002-2372-9158; Muoio, Deborah/0000-0003-3760-9277; Epstein, Charles B./0000-0001-8358-8345	NIH Common Fund [U01 ES017155]; National Human Genome Research Institute [U54 HG004570]; National Heart, Lung and Blood Institute [U01 HL100395]; National Institute on Aging [P30 AG10161]; Howard Hughes Medical Institute; Starr Cancer Consortium; Burroughs Wellcome Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100395] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015819, P30AG010161, R01AG036042] Funding Source: NIH RePORTER	NIH Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Starr Cancer Consortium; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge members of the Broad Institute's Epigenomics Program and Genome Sequencing and Analysis Program, and the NIH Epigenomics Mapping Consortium for constructive comments. We thank Kevin Eggan for ES and iPS lines; Allen Powe and Steve Stice for neural cells; Greg Lauwers and the MGH Tissue Repository for tissue procurement; and David Flowers, Irwin Bernstein, John Stamatoyannopoulos and Shelly Heimfeld for blood samples. We also thank Leslie Gaffney and Lauren Solomon for assistance with figures. This research was supported by the NIH Common Fund (U01 ES017155); the National Human Genome Research Institute (U54 HG004570); the National Heart, Lung and Blood Institute (U01 HL100395); the National Institute on Aging (P30 AG10161); the Howard Hughes Medical Institute; the Starr Cancer Consortium; and the Burroughs Wellcome Fund.	Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020; Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Dhara SK, 2008, J CELL BIOCHEM, V105, P633, DOI 10.1002/jcb.21891; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hardy S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000687; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	42	374	380	1	118	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					642	654		10.1016/j.cell.2012.12.033	http://dx.doi.org/10.1016/j.cell.2012.12.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23333102	Bronze, Green Accepted			2022-12-24	WOS:000314362800031
J	Rosenbluh, J; Nijhawan, D; Cox, AG; Li, XN; Neal, JT; Schafer, EJ; Zack, TI; Wang, XX; Tsherniak, A; Schinzel, AC; Shao, DD; Schumacher, SE; Weir, BA; Vazquez, F; Cowley, GS; Root, DE; Mesirov, JP; Beroukhim, R; Kuo, CJ; Goessling, W; Hahn, WC				Rosenbluh, Joseph; Nijhawan, Deepak; Cox, Andrew G.; Li, Xingnan; Neal, James T.; Schafer, Eric J.; Zack, Travis I.; Wang, Xiaoxing; Tsherniak, Aviad; Schinzel, Anna C.; Shao, Diane D.; Schumacher, Steven E.; Weir, Barbara A.; Vazquez, Francisca; Cowley, Glenn S.; Root, David E.; Mesirov, Jill P.; Beroukhim, Rameen; Kuo, Calvin J.; Goessling, Wolfram; Hahn, William C.			beta-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis	CELL			English	Article							YES-ASSOCIATED PROTEIN; HIPPO PATHWAY; CELL-PROLIFERATION; SIGNALING PATHWAY; ZEBRAFISH EMBRYOS; GROWTH-CONTROL; COLON-CANCER; ORGAN SIZE; PHOSPHORYLATION; ACTIVATION	Wnt/beta-catenin signaling plays a key role in the pathogenesis of colon and other cancers; emerging evidence indicates that oncogenic beta-catenin regulates several biological processes essential for cancer initiation and progression. To decipher the role of beta-catenin in transformation, we classified beta-catenin activity in 85 cancer cell lines in which we performed genome-scale loss-of-function screens and found that beta-catenin active cancers are dependent on a signaling pathway involving the transcriptional regulator YAP1. Specifically, we found that YAP1 and the transcription factor TBX5 form a complex with beta-catenin. Phosphorylation of YAP1 by the tyrosine kinase YES1 leads to localization of this complex to the promoters of antiapoptotic genes, including BCL2L1 and BIRC5. A small-molecule inhibitor of YES1 impeded the proliferation of beta-catenin-dependent cancers in both cell lines and animal models. These observations define a beta-catenin-YAP1-TBX5 complex essential to the transformation and survival of beta-catenin-driven cancers.	[Rosenbluh, Joseph; Nijhawan, Deepak; Schafer, Eric J.; Wang, Xiaoxing; Schinzel, Anna C.; Shao, Diane D.; Weir, Barbara A.; Vazquez, Francisca; Goessling, Wolfram; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Zack, Travis I.; Schumacher, Steven E.; Beroukhim, Rameen; Hahn, William C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Rosenbluh, Joseph; Nijhawan, Deepak; Cox, Andrew G.; Schafer, Eric J.; Wang, Xiaoxing; Schinzel, Anna C.; Shao, Diane D.; Beroukhim, Rameen; Goessling, Wolfram; Hahn, William C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Cox, Andrew G.; Goessling, Wolfram] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; [Rosenbluh, Joseph; Nijhawan, Deepak; Schafer, Eric J.; Zack, Travis I.; Wang, Xiaoxing; Tsherniak, Aviad; Schinzel, Anna C.; Shao, Diane D.; Schumacher, Steven E.; Weir, Barbara A.; Vazquez, Francisca; Cowley, Glenn S.; Root, David E.; Mesirov, Jill P.; Beroukhim, Rameen; Hahn, William C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Cox, Andrew G.; Goessling, Wolfram] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Li, Xingnan; Neal, James T.; Kuo, Calvin J.] Stanford Univ, Sch Med, Div Hematol, Dept Med, Stanford, CA 94305 USA; [Zack, Travis I.] Harvard Univ, Program Biophys, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Stanford University; Harvard University	Hahn, WC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA.	william_hahn@dfci.harvard.edu	Schumacher, Steven/E-9821-2013; Shao, Diane/GRO-3470-2022; Vazquez, Francisca/AAA-3751-2020; Mesirov, Jill/AGF-7626-2022; Vazquez, Francisca/ABC-4620-2020	Schumacher, Steven/0000-0002-6819-5647; Vazquez, Francisca/0000-0002-2857-4685; Cox, Andrew/0000-0003-4189-9422; Tsherniak, Aviad/0000-0002-3797-1877; Neal, James/0000-0002-3962-8570; Rosenbluh, Joseph/0000-0001-9815-8049; Kuo, Calvin/0000-0002-7427-5985; Shao, Diane/0000-0003-2087-4082; Goessling, Wolfram/0000-0001-9972-1569	NIH/NCI [R01 CA140545, RC2 CA148268, U54 CA143798, U01 DK085527, U01 CA151920, R01 DK085720, U54 CA112962, R01 DK090311]; Pew Charitable Trust; Fidelity Foundation; Stanford University; DoD [W81XWH-10-1-0062]; Conquer Cancer Foundation; Sass Foundation; SPORE career development award [P50 CA127003]; NIH [F32 GM090437]; NATIONAL CANCER INSTITUTE [U54CA143798, R01CA140545, U01CA151920, R01CA109467, P50CA127003, RC2CA148268, U54CA112962, F32CA124082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090311, R01DK085720, U01DK085527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074024, T32GM007753, F32GM090437] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pew Charitable Trust; Fidelity Foundation; Stanford University(Stanford University); DoD(United States Department of Defense); Conquer Cancer Foundation; Sass Foundation; SPORE career development award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Hahn lab for helpful discussions and L. Gafney and L. Solomon for assistance with graphic arts. This work was supported in part by NIH/NCI grants R01 CA140545 (W.C.H.), RC2 CA148268 (W.C.H.), U54 CA143798 (R.B.), U01 DK085527 (C.J.K.), U01 CA151920 (C.J.K.), R01 DK085720 (C.J.K.), U54 CA112962 (A.T., J.P.M., and W.C.H.), R01 DK090311 (W.G.), the Pew Charitable Trust (W.G.), a Fidelity Foundation grant (C.J.K.), a Stanford University Dean's Fellowship (J.T.N.), a DoD breast cancer postdoctoral fellowship W81XWH-10-1-0062 (X.W.), Conquer Cancer Foundation Young Investigator Award and Sass Foundation Fellowship (D.N.), a SPORE career development award P50 CA127003 (J.R.), and an NIH F32 postdoctoral fellowship F32 GM090437 (J.R.). J.R. is a John Svenson postdoctoral fellow. W.C.H. and R.B. are consultants for Novartis Pharmaceuticals.	Angus-Hill ML, 2011, P NATL ACAD SCI USA, V108, P4914, DOI 10.1073/pnas.1102300108; Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cheesman SE, 2011, P NATL ACAD SCI USA, V108, P4570, DOI 10.1073/pnas.1000072107; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Jiang Q, 2009, BIOCHEM BIOPH RES CO, V384, P114, DOI 10.1016/j.bbrc.2009.04.070; Jopling C, 2007, MECH DEVELOP, V124, P129, DOI 10.1016/j.mod.2006.10.003; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Mori AD, 2004, CURR OPIN CARDIOL, V19, P211, DOI 10.1097/00001573-200405000-00004; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mudumana SP, 2004, DEV DYNAM, V230, P165, DOI 10.1002/dvdy.20032; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nautiyal J, 2011, INT J CANCER, V128, P951, DOI 10.1002/ijc.25410; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; PENA SV, 1995, GASTROENTEROLOGY, V108, P117, DOI 10.1016/0016-5085(95)90015-2; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sullivan-Brown J, 2011, NAT PROTOC, V6, P46, DOI 10.1038/nprot.2010.165; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Tsai WB, 2005, DEV BIOL, V277, P129, DOI 10.1016/j.ydbio.2004.08.052; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang M, 2012, DEVELOPMENT, V139, P2009, DOI 10.1242/dev.074435; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	58	530	549	6	90	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1457	1473		10.1016/j.cell.2012.11.026	http://dx.doi.org/10.1016/j.cell.2012.11.026			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23245941	Bronze, Green Accepted			2022-12-24	WOS:000312890300012
J	Paley, MA; Kroy, DC; Odorizzi, PM; Johnnidis, JB; Dolfi, DV; Barnett, BE; Bikoff, EK; Robertson, EJ; Lauer, GM; Reiner, SL; Wherry, EJ				Paley, Michael A.; Kroy, Daniela C.; Odorizzi, Pamela M.; Johnnidis, Jonathan B.; Dolfi, Douglas V.; Barnett, Burton E.; Bikoff, Elizabeth K.; Robertson, Elizabeth J.; Lauer, Georg M.; Reiner, Steven L.; Wherry, E. John			Progenitor and Terminal Subsets of CD8(+) T Cells Cooperate to Contain Chronic Viral Infection	SCIENCE			English	Article							TRANSCRIPTION FACTOR; PD-1 EXPRESSION; HIV-1 INFECTION; CUTTING EDGE; EXHAUSTION; BET; RESPONSES; ANTIGEN; CD4(+); DIFFERENTIATION	Chronic infections strain the regenerative capacity of antiviral T lymphocyte populations, leading to failure in long-term immunity. The cellular and molecular events controlling this regenerative capacity, however, are unknown. We found that two distinct states of virus-specific CD8(+) T cells exist in chronically infected mice and humans. Differential expression of the T-box transcription factors T-bet and Eomesodermin (Eomes) facilitated the cooperative maintenance of the pool of antiviral CD8(+) T cells during chronic viral infection. T-bet(hi) cells displayed low intrinsic turnover but proliferated in response to persisting antigen, giving rise to Eomes(hi) terminal progeny. Genetic elimination of either subset resulted in failure to control chronic infection, which suggests that an imbalance in differentiation and renewal could underlie the collapse of immunity in humans with chronic infections.	[Paley, Michael A.; Odorizzi, Pamela M.; Johnnidis, Jonathan B.; Dolfi, Douglas V.; Barnett, Burton E.; Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Paley, Michael A.; Odorizzi, Pamela M.; Johnnidis, Jonathan B.; Dolfi, Douglas V.; Barnett, Burton E.; Wherry, E. John] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Kroy, Daniela C.; Lauer, Georg M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02115 USA; [Bikoff, Elizabeth K.; Robertson, Elizabeth J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Reiner, Steven L.] Univ Penn, Abramson Family Canc Res Inst, Dept Med, Philadelphia, PA 19104 USA; [Reiner, Steven L.] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Oxford; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wherry, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu	Wherry, John/ABI-1280-2020; Lauer, Georg/J-1467-2018	Lauer, Georg/0000-0002-9792-4271; Paley, Michael/0000-0001-8724-3176	Deutsche Forschungsgemeinschaft [r3839/1-1]; NIH [T32-AI-07324, AI0663445, AI061699, AI076458, AI083022, AI078897, HHSN266200500030C, AI082630]; Dana Foundation; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007324, R01AI042370, R01AI061699, R01AI076458, U19AI082630, U19AI083022, R56AI076458, P01AI078897, T32AI007632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Wherry, Reiner, and Artis labs for helpful comments and the UPenn Flow Cytometry Core for cell sorting. We thank E. Crosby for isolation of skin lymphocytes. Supported by Deutsche Forschungsgemeinschaft grant r3839/1-1 (D.C.K.); NIH grants T32-AI-07324 (M.A.P.), AI0663445 (G.M.L.), AI061699 and AI076458 (S.L.R.), AI083022, AI078897, and HHSN266200500030C (E.J.W.), and AI082630 (E.J.W. and G.M.L.); and the Dana Foundation (E.J.W. and G.M.L.). E.J.W. has a patent licensing agreement on therapeutic targeting of the PD-1 pathway (U.S. patent application no. 20070122378).	Arnold SJ, 2009, GENESIS, V47, P775, DOI 10.1002/dvg.20562; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2010, J VIROL, V84, P2078, DOI 10.1128/JVI.01579-09; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Casazza JP, 2001, J VIROL, V75, P6508, DOI 10.1128/JVI.75.14.6508-6516.2001; Ciocca ML, 2012, J IMMUNOL, V188, P4145, DOI 10.4049/jimmunol.1200176; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Hellerstein M, 1999, NAT MED, V5, P83, DOI 10.1038/4772; Hellerstein MK, 2003, J CLIN INVEST, V112, P956, DOI 10.1172/JCI200317533; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kasprowicz V, 2008, J VIROL, V82, P3154, DOI 10.1128/JVI.02474-07; Lechner F, 2000, EUR J IMMUNOL, V30, P2479, DOI 10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; McCune JM, 2000, J CLIN INVEST, V105, pR1, DOI 10.1172/JCI8647; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Nakamoto N, 2008, GASTROENTEROLOGY, V134, P1927, DOI 10.1053/j.gastro.2008.02.033; Ribeiro-dos-Santos P, 2012, BLOOD, V119, P4928, DOI 10.1182/blood-2011-12-395186; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101	31	569	583	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2012	338	6111					1220	1225		10.1126/science.1229620	http://dx.doi.org/10.1126/science.1229620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197535	Green Accepted			2022-12-24	WOS:000311666200049
J	Heneka, MT; Kummer, MP; Stutz, A; Delekate, A; Schwartz, S; Vieira-Saecker, A; Griep, A; Axt, D; Remus, A; Tzeng, TC; Gelpi, E; Halle, A; Korte, M; Latz, E; Golenbock, DT				Heneka, Michael T.; Kummer, Markus P.; Stutz, Andrea; Delekate, Andrea; Schwartz, Stephanie; Vieira-Saecker, Ana; Griep, Angelika; Axt, Daisy; Remus, Anita; Tzeng, Te-Chen; Gelpi, Ellen; Halle, Annett; Korte, Martin; Latz, Eicke; Golenbock, Douglas T.			NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice	NATURE			English	Article							LONG-TERM POTENTIATION; AMYLOID CLEARANCE; BETA; MICROGLIA; CNS; INTERLEUKIN-1-BETA; EXPRESSION; IL-1-BETA; ENZYME; MEMORY	Alzheimer's disease is the world's most common dementing illness. Deposition of amyloid-beta peptide drives cerebral neuroinflammation by activating microglia(1,2). Indeed, amyloid-beta activation of the NLRP3 inflammasome in microglia is fundamental for interleukin-1 beta maturation and subsequent inflammatory events(3). However, it remains unknown whether NLRP3 activation contributes to Alzheimer's disease in vivo. Here we demonstrate strongly enhanced active caspase-1 expression in human mild cognitive impairment and brains with Alzheimer's disease, suggesting a role for the inflammasome in this neurodegenerative disease. Nlrp3(-/-) or Casp1(-/-) mice carrying mutations associated with familial Alzheimer's disease were largely protected from loss of spatial memory and other sequelae associated with Alzheimer's disease, and demonstrated reduced brain caspase-1 and interleukin-1 beta activation as well as enhanced amyloid-beta clearance. Furthermore, NLRP3 inflammasome deficiency skewed microglial cells to an M2 phenotype and resulted in the decreased deposition of amyloid-beta in the APP/PS1 model of Alzheimer's disease. These results show an important role for the NLRP3/caspase-1 axis in the pathogenesis of Alzheimer's disease, and suggest that NLRP3 inflammasome inhibition represents a new therapeutic intervention for the disease.	[Heneka, Michael T.; Kummer, Markus P.; Schwartz, Stephanie; Vieira-Saecker, Ana; Griep, Angelika; Axt, Daisy] Univ Bonn, Dept Neurol, Clin Neurosci Unit, D-53127 Bonn, Germany; [Heneka, Michael T.; Latz, Eicke] DZNE, D-53175 Bonn, Germany; [Stutz, Andrea; Latz, Eicke] Univ Bonn, Inst Innate Immun, D-53127 Bonn, Germany; [Delekate, Andrea; Remus, Anita; Korte, Martin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Cellular Neurobiol, D-38106 Braunschweig, Germany; [Tzeng, Te-Chen; Latz, Eicke; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Tzeng, Te-Chen; Latz, Eicke; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Gelpi, Ellen] Univ Barcelona, Hosp Clin, IDIBAPS, Neurol Tissue Bank, E-08036 Barcelona, Spain; [Halle, Annett] Ctr Adv European Studies & Res CAESAR, D-53175 Bonn, Germany; [Korte, Martin] AG NIND, HZI, Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Braunschweig University of Technology; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Center of Advanced European Studies & Research (CAESAR); Helmholtz Association; Helmholtz-Center for Infection Research	Latz, E (corresponding author), DZNE, D-53175 Bonn, Germany.	michael.Heneka@ukb.uni-bonn.de; eicke.latz@uni-bonn.de; douglas.golenbock@umassmed.edu	Heneka, Michael/AAE-8011-2019; Latz, Eicke/H-3951-2014; Heneka, Michael/E-8072-2015	Latz, Eicke/0000-0003-1488-5666; Heneka, Michael/0000-0003-4996-1630; Kummer, Markus P./0000-0002-0993-2918	Dana Foundation; National Institutes of Health; Deutsche Forschungsgemeinschaft; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713, U19AI084048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054060] Funding Source: NIH RePORTER	Dana Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Dana Foundation (E. L.), the National Institutes of Health (E. L., D. T. G.) and the Deutsche Forschungsgemeinschaft (E. L., M. T. H.). We thank G. Nunez and V. M. Dixit for providing anti-caspase-1 Abs. We thank B. De Strooper and L. Serneels for the BACE1 knockout mice and discussion. We also thank H. Jacobsen for the BACE1 transgenic mice.	Bamberger ME, 2003, J NEUROSCI, V23, P2665; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Ho VM, 2011, SCIENCE, V334, P623, DOI 10.1126/science.1209236; Jager S, 2009, J NEUROCHEM, V111, P1369, DOI 10.1111/j.1471-4159.2009.06420.x; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Murray CA, 1998, J NEUROSCI, V18, P2974; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Walker JM, 2011, BEHAV BRAIN RES, V222, P169, DOI 10.1016/j.bbr.2011.03.049; Wang QW, 2004, J NEUROSCI, V24, P6049, DOI 10.1523/JNEUROSCI.0233-04.2004	30	1542	1635	35	491	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					674	+		10.1038/nature11729	http://dx.doi.org/10.1038/nature11729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23254930	Green Accepted, Green Submitted			2022-12-24	WOS:000314219600057
J	Tabach, Y; Billi, AC; Hayes, GD; Newman, MA; Zuk, O; Gabel, H; Kamath, R; Yacoby, K; Chapman, B; Garcia, SM; Borowsky, M; Kim, JK; Ruvkun, G				Tabach, Yuval; Billi, Allison C.; Hayes, Gabriel D.; Newman, Martin A.; Zuk, Or; Gabel, Harrison; Kamath, Ravi; Yacoby, Keren; Chapman, Brad; Garcia, Susana M.; Borowsky, Mark; Kim, John K.; Ruvkun, Gary			Identification of small RNA pathway genes using patterns of phylogenetic conservation and divergence	NATURE			English	Article							SYSTEMATIC IDENTIFICATION; INTERFERENCE; POLYMERASE; PROTEINS; COMPLEX; DCR-1; SIRNA	Genetic and biochemical analyses of RNA interference (RNAi) and microRNA (miRNA) pathways have revealed proteins such as Argonaute and Dicer as essential cofactors that process and present small RNAs to their targets. Well-validated small RNA pathway cofactors such as these show distinctive patterns of conservation or divergence in particular animal, plant, fungal and protist species. We compared 86 divergent eukaryotic genome sequences to discern sets of proteins that show similar phylogenetic profiles with known small RNA cofactors. A large set of additional candidate small RNA cofactors have emerged from functional genomic screens for defects in miRNA-or short interfering RNA (siRNA)-mediated repression in Caenorhabditis elegans and Dro-sophila melanogaster(1,2), and from proteomic analyses of proteins co-purifying with validated small RNA pathway proteins(3,4). The phylogenetic profiles of many of these candidate small RNA pathway proteins are similar to those of known small RNA cofactor proteins. We used a Bayesian approach to integrate the phylogenetic profile analysis with predictions from diverse transcriptional coregulation and proteome interaction data sets to assign a probability for each protein for a role in a small RNA pathway. Testing high-confidence candidates from this analysis for defects in RNAi silencing, we found that about one-half of the predicted small RNA cofactors are required for RNAi silencing. Many of the newly identified small RNA pathway proteins are orthologues of proteins implicated in RNA splicing. In support of a deep connection between the mechanism of RNA splicing and small-RNA-mediated gene silencing, the presence of the Argonaute proteins and other small RNA components in the many species analysed strongly correlates with the number of introns in those species.	[Tabach, Yuval; Hayes, Gabriel D.; Newman, Martin A.; Gabel, Harrison; Kamath, Ravi; Yacoby, Keren; Chapman, Brad; Garcia, Susana M.; Borowsky, Mark; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Tabach, Yuval; Hayes, Gabriel D.; Newman, Martin A.; Gabel, Harrison; Kamath, Ravi; Garcia, Susana M.; Borowsky, Mark; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Billi, Allison C.; Kim, John K.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Billi, Allison C.; Kim, John K.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Zuk, Or] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu	Tabach, Yuval/Q-8488-2019; Billi, Allison/AAP-1684-2021	D. A. Garcia, Susana Maria/0000-0002-1638-7575; Chapman, Brad/0000-0002-3026-1856	NIH [GM088565, GM44619, GM098647]; Pew Charitable Trusts; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044619, R01GM098647, T32GM007544, R01GM088565] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Duchaine for access to his ERI-1 proteomic data before it was published and to S. Fischer, C. Zhang and T. Montgomery for helpful discussions. The work was supported by NIH GM088565 and the Pew Charitable Trusts (J.K.K.) and NIH GM44619 and GM098647 (G.R.).	Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Bernstein DA, 2012, P NATL ACAD SCI USA, V109, P523, DOI 10.1073/pnas.1118859109; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Cui MX, 2006, PLOS GENET, V2, P719, DOI 10.1371/journal.pgen.0020074; Drinnenberg IA, 2011, SCIENCE, V333, P1592, DOI 10.1126/science.1209575; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Enault F, 2003, BIOINFORMATICS, V19, pi105, DOI 10.1093/bioinformatics/btg1013; Gabaldon T, 2005, EVOL BIOINFORM, V1, P51; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Montgomery TA, 2012, PLOS GENET, V8, P72, DOI 10.1371/journal.pgen.1002616; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Parry DH, 2007, CURR BIOL, V17, P2013, DOI 10.1016/j.cub.2007.10.058; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pontes O, 2008, CURR OPIN GENET DEV, V18, P197, DOI 10.1016/j.gde.2008.01.008; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Thivierge C, 2012, NAT STRUCT MOL BIOL, V19, P90, DOI 10.1038/nsmb.2186; Yelina NE, 2010, P NATL ACAD SCI USA, V107, P13948, DOI 10.1073/pnas.0911341107; Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014; Zhou R, 2008, MOL CELL, V32, P592, DOI 10.1016/j.molcel.2008.10.018	28	102	102	1	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					694	698		10.1038/nature11779	http://dx.doi.org/10.1038/nature11779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364702	Green Accepted, Green Submitted			2022-12-24	WOS:000314219600061
J	Coelho, PS; Brustad, EM; Kannan, A; Arnold, FH				Coelho, Pedro S.; Brustad, Eric M.; Kannan, Arvind; Arnold, Frances H.			Olefin Cyclopropanation via Carbene Transfer Catalyzed by Engineered Cytochrome P450 Enzymes	SCIENCE			English	Article							STEREOSELECTIVE CYCLOPROPANATION; IRON; PROMISCUITY	Transition metal-catalyzed transfers of carbenes, nitrenes, and oxenes are powerful methods for functionalizing C = C and C-H bonds. Nature has evolved a diverse toolbox for oxene transfers, as exemplified by the myriad monooxygenation reactions catalyzed by cytochrome P450 enzymes. The isoelectronic carbene transfer to olefins, a widely used C-C bond-forming reaction in organic synthesis, has no biological counterpart. Here we report engineered variants of cytochrome P450(BM3) that catalyze highly diastereo- and enantioselective cyclopropanation of styrenes from diazoester reagents via putative carbene transfer. This work highlights the capacity to adapt existing enzymes for the catalysis of synthetically important reactions not previously observed in nature.	[Coelho, Pedro S.; Kannan, Arvind; Arnold, Frances H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Brustad, Eric M.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Brustad, Eric M.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA	California Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Arnold, FH (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	frances@cheme.caltech.edu		Arnold, Frances H./0000-0002-4027-364X	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-06ER15762]; Ruth M. Kirschstein National Institutes of Health (NIH) from the National Institute of General Medical Sciences [F32GM087102]; University of North Carolina Chapel Hill; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087102] Funding Source: NIH RePORTER	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); Ruth M. Kirschstein National Institutes of Health (NIH) from the National Institute of General Medical Sciences; University of North Carolina Chapel Hill; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through grant DE-FG02-06ER15762. E.M.B. was supported by a Ruth M. Kirschstein National Institutes of Health (NIH) postdoctoral fellowship, award number F32GM087102, from the National Institute of General Medical Sciences and a generous startup fund from the University of North Carolina Chapel Hill. P.S.C., E.M.B., and F.H.A. have filed through the California Institute of Technology a provisional patent application that is based on the results presented here. The authors thank Z. J. Wang for helpful discussions during the preparation of the manuscript.	Bornscheuer UT, 2004, ANGEW CHEM INT EDIT, V43, P6032, DOI 10.1002/anie.200460416; Breslow R, 2009, J BIOL CHEM, V284, P1337, DOI 10.1074/jbc.X800011200; Caballero A, 2009, EUR J INORG CHEM, P1137, DOI 10.1002/ejic.200800944; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Groves JT, 2003, P NATL ACAD SCI USA, V100, P3569, DOI 10.1073/pnas.0830019100; Hyster TK, 2012, SCIENCE, V338, P500, DOI 10.1126/science.1226132; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Lebel H, 2003, CHEM REV, V103, P977, DOI 10.1021/cr010007e; Lewis JC, 2009, CHIMIA, V63, P309, DOI 10.2533/chimia.2009.309; Morandi B, 2012, SCIENCE, V335, P1471, DOI 10.1126/science.1218781; Nicolas I, 2008, COORDIN CHEM REV, V252, P727, DOI 10.1016/j.ccr.2007.09.003; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Wessjohann LA, 2003, CHEM REV, V103, P1625, DOI 10.1021/cr0100188; Whitehouse CJC, 2012, CHEM SOC REV, V41, P1218, DOI 10.1039/c1cs15192d; WOLF JR, 1995, J AM CHEM SOC, V117, P9194, DOI 10.1021/ja00141a011	16	495	508	25	589	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					307	310		10.1126/science.1231434	http://dx.doi.org/10.1126/science.1231434			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23258409				2022-12-24	WOS:000313622000040
J	Nardini, M; Gnesutta, N; Donati, G; Gatta, R; Forni, C; Fossati, A; Vonrhein, C; Moras, D; Romier, C; Bolognesi, M; Mantovani, R				Nardini, Marco; Gnesutta, Nerina; Donati, Giacomo; Gatta, Raffaella; Forni, Claudia; Fossati, Andrea; Vonrhein, Clemens; Moras, Dino; Romier, Christophe; Bolognesi, Martino; Mantovani, Roberto			Sequence-Specific Transcription Factor NF-Y Displays Histone-like DNA Binding and H2B-like Ubiquitination	CELL			English	Article							CRYSTAL-STRUCTURE; CCAAT-BOX; H2B UBIQUITYLATION; FOLD PROTEINS; MINOR-GROOVE; COMPLEX; ARABIDOPSIS; CHROMATIN; PROMOTER; CONSTANS	The sequence-specific transcription factor NF-Y binds the CCAAT box, one of the sequence elements most frequently found in eukaryotic promoters. NF-Y is composed of the NF-YA and NF-YB/NF-YC subunits, the latter two hosting histone-fold domains (HFDs). The crystal structure of NF-Y bound to a 25 bp CCAAT oligonucleotide shows that the HFD dimer binds to the DNA sugar-phosphate backbone, mimicking the nucleosome H2A/H2B-DNA assembly. NF-YA both binds to NF-YB/NF-YC and inserts an a helix deeply into the DNA minor groove, providing sequence-specific contacts to the CCAAT box. Structural considerations and mutational data indicate that NF-YB ubiquitination at Lys138 precedes and is equivalent to H2B Lys120 monoubiquitination, important in transcriptional activation. Thus, NF-Y is a sequence-specific transcription factor with nucleosome-like properties of nonspecific DNA binding and helps establish permissive chromatin modifications at CCAAT promoters. Our findings suggest that other HFD-containing proteins may function in similar ways.	[Nardini, Marco; Gnesutta, Nerina; Donati, Giacomo; Gatta, Raffaella; Forni, Claudia; Fossati, Andrea; Bolognesi, Martino; Mantovani, Roberto] Univ Milan, Dipartimento BioSci, I-20133 Milan, Italy; [Bolognesi, Martino] Univ Milan, Ist Biofis, CNR, I-20133 Milan, Italy; [Bolognesi, Martino] Univ Milan, CIMAINA, I-20133 Milan, Italy; [Vonrhein, Clemens] Global Phasing Ltd, Cambridge CB3 0AX, England; [Moras, Dino; Romier, Christophe] IGBMC, Dept Biol & Genom Struct, F-67404 Illkirch Graffenstaden, France	University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; University of Milan; Global Phasing Limited; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bolognesi, M (corresponding author), Univ Milan, Dipartimento BioSci, Via Celoria 26, I-20133 Milan, Italy.	martino.bolognesi@unimi.it; mantor@unimi.it	Gnesutta, Nerina/I-5432-2015; Nardini, Marco/B-7842-2017; Fossati, Andrea/AAN-3814-2020; Bolognesi, Martino/B-7924-2017	Gnesutta, Nerina/0000-0002-2465-8881; Nardini, Marco/0000-0002-3718-2165; Fossati, Andrea/0000-0001-9368-4058; Bolognesi, Martino/0000-0002-9253-5170; DONATI, Giacomo/0000-0002-0370-8288; Romier, Christophe/0000-0002-3680-935X	Regione Lombardia Nepente; CNRS; INSERM; Universite de Strasbourg (UDS); European Commission [LSHG-CT-2006-031220]	Regione Lombardia Nepente(Regione Lombardia); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Strasbourg (UDS); European Commission(European CommissionEuropean Commission Joint Research Centre)	M.N., N.G., G.D., R.G., C.F., and A.F. performed the experiments; M.N. and C.V. analyzed the X-ray data; and M.N., N.G., D.M., C.R., M.B., and R. M. planned the experiments, analyzed the data, and wrote the manuscript. We thank David Horner for comments on the manuscript. This work was supported by Regione Lombardia Nepente grant (to R.M.), and by institutional funds from the CNRS, INSERM, the Universite de Strasbourg (UDS), and the European Commission SPINE2-Complexes project (contract No. LSHG-CT-2006-031220).	Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Bi WM, 1997, J BIOL CHEM, V272, P26562, DOI 10.1074/jbc.272.42.26562; Bricogne G., 2010, BUSTER VERSION 2 9; Cai XN, 2007, PLANT PHYSIOL, V145, P98, DOI 10.1104/pp.107.102079; Chen NZ, 2007, J BIOCHEM MOL BIOL, V40, P1083; Corona DFV, 2000, EMBO J, V19, P3049, DOI 10.1093/emboj/19.12.3049; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Diebold ML, 2011, J STRUCT BIOL, V175, P178, DOI 10.1016/j.jsb.2011.02.001; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Gatta R, 2010, CELL CYCLE, V9, P2149, DOI 10.4161/cc.9.11.11839; Gazit K, 2009, J BIOL CHEM, V284, P26286, DOI 10.1074/jbc.M109.011486; Hartlepp KF, 2005, MOL CELL BIOL, V25, P9886, DOI 10.1128/MCB.25.22.9886-9896.2005; Hsu JY, 2008, GENE DEV, V22, P2353, DOI 10.1101/gad.1681808; Juo ZS, 1996, J MOL BIOL, V261, P239, DOI 10.1006/jmbi.1996.0456; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Kukimoto I, 2004, MOL CELL, V13, P265, DOI 10.1016/S1097-2765(03)00523-9; Kumimoto RW, 2010, PLANT J, V63, P379, DOI 10.1111/j.1365-313X.2010.04247.x; Laribee RN, 2007, GENE DEV, V21, P737, DOI 10.1101/gad.1541507; Li Q, 1998, EMBO J, V17, P6300, DOI 10.1093/emboj/17.21.6300; Li Y, 2000, J BIOL CHEM, V275, P23247, DOI 10.1074/jbc.M002548200; Liberati C, 1999, J MOL BIOL, V285, P1441, DOI 10.1006/jmbi.1998.2384; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; RONCHI A, 1995, NUCLEIC ACIDS RES, V23, P4565, DOI 10.1093/nar/23.22.4565; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Zemzoumi K, 1999, J MOL BIOL, V286, P327, DOI 10.1006/jmbi.1998.2496	48	179	193	2	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					132	143		10.1016/j.cell.2012.11.047	http://dx.doi.org/10.1016/j.cell.2012.11.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332751	Green Submitted, Bronze			2022-12-24	WOS:000313719800012
J	Alonzo, F; Kozhaya, L; Rawlings, SA; Reyes-Robles, T; DuMont, AL; Myszka, DG; Landau, NR; Unutmaz, D; Torres, VJ				Alonzo, Francis, III; Kozhaya, Lina; Rawlings, Stephen A.; Reyes-Robles, Tamara; DuMont, Ashley L.; Myszka, David G.; Landau, Nathaniel R.; Unutmaz, Derya; Torres, Victor J.			CCR5 is a receptor for Staphylococcus aureus leukotoxin ED	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN-COUPLED RECEPTORS; CHEMOKINE RECEPTORS; HIV-1 INFECTION; BIOSENSOR TECHNOLOGY; SMALL-MOLECULE; CORECEPTOR; RESISTANT; CELLS; IDENTIFICATION	Pore-forming toxins are critical virulence factors for many bacterial pathogens and are central to Staphylococcus aureus-mediated killing of host cells. S. aureus encodes pore-forming bi-component leukotoxins that are toxic towards neutrophils, but also specifically target other immune cells. Despite decades since the first description of staphylococcal leukocidal activity, the host factors responsible for the selectivity of leukotoxins towards different immune cells remain unknown. Here we identify the human immunodeficiency virus (HIV) co-receptor CCR5 as a cellular determinant required for cytotoxic targeting of subsets of myeloid cells and T lymphocytes by the S. aureus leukotoxin ED (LukED). We further demonstrate that LukED-dependent cell killing is blocked by CCR5 receptor antagonists, including the HIV drug maraviroc. Remarkably, CCR5-deficient mice are largely resistant to lethal S. aureus infection, highlighting the importance of CCR5 targeting in S. aureus pathogenesis. Thus, depletion of CCR5(+) leukocytes by LukED suggests a new immune evasion mechanism of S. aureus that can be therapeutically targeted.	[Alonzo, Francis, III; Kozhaya, Lina; Rawlings, Stephen A.; Reyes-Robles, Tamara; DuMont, Ashley L.; Landau, Nathaniel R.; Unutmaz, Derya; Torres, Victor J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Unutmaz, Derya] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Unutmaz, Derya] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Myszka, David G.] Biosensor Tools LLC, Salt Lake City, UT 84103 USA	New York University; New York University; New York University	Torres, VJ (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	derya.unutmaz@nyumc.org; victor.torres@nyumc.org	Rawlings, Stephen/ABA-6797-2020	Rawlings, Stephen/0000-0003-3637-1447; Torres, Victor/0000-0002-7126-0489; Unutmaz, Derya/0000-0001-8898-6633	New York University School of Medicine Development Funds; American Heart Association Scientist Development Grant [09SDG2060036]; National Institutes of Health (NIH) [R56-AI091856-01A1]; NIH [T32-AI007180, R42-MH084372-02A1, R21-AI087973, R01-AI065303]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087973, T32AI007180, R01AI065303, R56AI091856, F32AI098395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R42MH084372] Funding Source: NIH RePORTER	New York University School of Medicine Development Funds; American Heart Association Scientist Development Grant(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Torres laboratory, D. R. Littman, M. Lu, and A. Darwin for reading this manuscript. We also thank V. KewalRamani for providing reagents, and S. Polsky for assistance with purification of PBMCs. This research was supported by New York University School of Medicine Development Funds, an American Heart Association Scientist Development Grant (09SDG2060036) to V.J.T. and National Institutes of Health (NIH) grants R56-AI091856-01A1 to V.J.T., NIH training grant T32-AI007180 to F. A., A. L. D. and S. A. R., NIH R42-MH084372-02A1 to D. G. M., and NIH R21-AI087973 and R01-AI065303 grants to D.U.	Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Alonzo F, 2012, MOL MICROBIOL, V83, P423, DOI 10.1111/j.1365-2958.2011.07942.x; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Berro R, 2011, J VIROL, V85, P8227, DOI 10.1128/JVI.00767-11; Bischofberger M, 2012, CELL HOST MICROBE, V12, P266, DOI 10.1016/j.chom.2012.08.005; Caccuri F, 2012, P NATL ACAD SCI USA, V109, P14580, DOI 10.1073/pnas.1206605109; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; DeLeo FR, 2011, P NATL ACAD SCI USA, V108, P18091, DOI 10.1073/pnas.1111084108; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Didigu CA, 2012, VIRUSES-BASEL, V4, P309, DOI 10.3390/v4020309; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; DuMont AL, 2011, MOL MICROBIOL, V79, P814, DOI 10.1111/j.1365-2958.2010.07490.x; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Giagulli C, 2012, BLOOD, V119, P2274, DOI 10.1182/blood-2011-06-364083; Golding H, 2003, BLOOD, V102, P3280, DOI 10.1182/blood-2003-04-1096; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Hedrick PW, 2006, TRENDS GENET, V22, P293, DOI 10.1016/j.tig.2006.04.007; Hummel S, 2005, GENES IMMUN, V6, P371, DOI 10.1038/sj.gene.6364172; Lalani AS, 1999, SCIENCE, V286, P1968, DOI 10.1126/science.286.5446.1968; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lucotte G, 2002, INFECT GENET EVOL, V1, P201, DOI 10.1016/S1567-1348(02)00027-8; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Menestrina G, 2003, FEBS LETT, V552, P54, DOI 10.1016/S0014-5793(03)00850-0; Moore PCL, 2002, J MED MICROBIOL, V51, P516, DOI 10.1099/0022-1317-51-6-516; Morner A, 1999, J VIROL, V73, P2343; Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017; Navratilova I, 2006, ANAL BIOCHEM, V355, P132, DOI 10.1016/j.ab.2006.04.021; Navratilova I, 2006, ANAL BIOCHEM, V353, P278, DOI 10.1016/j.ab.2006.03.049; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Panton PN, 1932, LANCET, V1, P506; Rahbar R, 2009, J VIROL, V83, P2226, DOI 10.1128/JVI.01655-08; Rich RL, 2009, ANAL BIOCHEM, V386, P98, DOI 10.1016/j.ab.2008.12.011; Saita Y, 2007, INT IMMUNOPHARMACOL, V7, P1528, DOI 10.1016/j.intimp.2007.07.019; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Stenlund P, 2003, ANAL BIOCHEM, V316, P243, DOI 10.1016/S0003-2697(03)00046-0; Strizki JM, 2005, ANTIMICROB AGENTS CH, V49, P4911, DOI 10.1128/AAC.49.12.4911-4919.2005; Van de Velde H., 1894, CELLULE, V10, P403; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; von Eiff C, 2004, DIAGN MICR INFEC DIS, V49, P157, DOI 10.1016/j.diagmicrobio.2004.03.009; Wan Q, 2011, J EXP MED, V208, P1875, DOI 10.1084/jem.20102516; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	44	205	212	4	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					51	+		10.1038/nature11724	http://dx.doi.org/10.1038/nature11724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23235831	Green Accepted			2022-12-24	WOS:000312933800028
J	Merkin, J; Russell, C; Chen, P; Burge, CB				Merkin, Jason; Russell, Caitlin; Chen, Ping; Burge, Christopher B.			Evolutionary Dynamics of Gene and Isoform Regulation in Mammalian Tissues	SCIENCE			English	Article							TIGHT JUNCTIONS; TRANSCRIPTOME; CONSERVATION; EXPRESSION; ERK	Most mammalian genes produce multiple distinct messenger RNAs through alternative splicing, but the extent of splicing conservation is not clear. To assess tissue-specific transcriptome variation across mammals, we sequenced complementary DNA from nine tissues from four mammals and one bird in biological triplicate, at unprecedented depth. We find that while tissue-specific gene expression programs are largely conserved, alternative splicing is well conserved in only a subset of tissues and is frequently lineage-specific. Thousands of previously unknown, lineage-specific, and conserved alternative exons were identified; widely conserved alternative exons had signatures of binding by MBNL, PTB, RBFOX, STAR, and TIA family splicing factors, implicating them as ancestral mammalian splicing regulators. Our data also indicate that alternative splicing often alters protein phosphorylatability, delimiting the scope of kinase signaling.	[Merkin, Jason; Russell, Caitlin; Chen, Ping; Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Burge, Christopher B.] MIT, Dept Biol Engn, Cambridge, MA 02142 USA; [Chen, Ping] Univ Helsinki, Syst Biol Lab, Res Programs Unit, FIN-00014 Helsinki, Finland; [Chen, Ping] Univ Helsinki, Inst Biomed Biochem & Dev Biol, FIN-00014 Helsinki, Finland	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Helsinki; University of Helsinki	Burge, CB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	cburge@mit.edu	Burge, Christopher B./AAH-2177-2020; Chen, Ping/AAL-8264-2020	Chen, Ping/0000-0002-8068-1891	Broad Institute SPARC grant; NIH training grant; Academy of Finland (Center of Excellence in Cancer Genetics Research); Sigrid Juselius Foundation; FICS; NIH [OD011092]; NSF [0821391]; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	Broad Institute SPARC grant; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland (Center of Excellence in Cancer Genetics Research); Sigrid Juselius Foundation(Sigrid Juselius Foundation); FICS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.M. and C. B. B. designed the study and wrote the manuscript. J.M. collected tissue samples, extracted RNA, conducted computational analyses, and prepared figures. C. R. prepared RNA-Seq libraries and developed protocols. P. C. contributed computational analyses. We thank A. Robertson for analysis of coding potential of alternative isoforms; E. Wang for help with the Mbnl1 CLIP analysis; D. Treacy for assistance with library preparation; S. McGeary, D. Page, A. Pai, C. Lin, and members of the Burge lab for comments on the manuscript; and the MIT BioMicro Center for assistance with sequencing. This work was supported by a Broad Institute SPARC grant (C. B. B.), by an NIH training grant (J.M.), by a fellowship from the Academy of Finland (Center of Excellence in Cancer Genetics Research), Sigrid Juselius Foundation and FICS (P. C.), by NIH grant OD011092 to the Oregon National Primate Research Center, by grant 0821391 from the NSF, and by grants from the NIH (to C. B. B.). Sequence data associated with this manuscript have been submitted to NCBI Gene Expession Omnibus (accession no. GSE41637).	Aggarwal S, 2011, BIOCHEM J, V433, P51, DOI 10.1042/BJ20100249; Baek D, 2005, P NATL ACAD SCI USA, V102, P12813, DOI 10.1073/pnas.0506139102; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Jelen N, 2007, PLOS GENET, V3, P1838, DOI 10.1371/journal.pgen.0030173; Ladd AN, 2002, GENOME BIOL, V3; Lareau LF, 2007, ADV EXP MED BIOL, V623, P190, DOI 10.1007/978-0-387-77374-2_12; Lev-Maor G, 2007, PLOS GENET, V3, P2221, DOI 10.1371/journal.pgen.0030203; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mruk DD, 2010, PHILOS T R SOC B, V365, P1621, DOI 10.1098/rstb.2010.0010; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Sabath E, 2008, J CELL SCI, V121, P814, DOI 10.1242/jcs.014878; Samak G, 2011, AM J PHYSIOL-GASTR L, V301, pG50, DOI 10.1152/ajpgi.00494.2010; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Tang XL, 2010, NUCLEIC ACIDS RES, V38, P6610, DOI 10.1093/nar/gkq547; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Xiao XS, 2009, NAT STRUCT MOL BIOL, V16, P1094, DOI 10.1038/nsmb.1661; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102	30	561	581	6	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1593	1599		10.1126/science.1228186	http://dx.doi.org/10.1126/science.1228186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258891	Green Submitted, Green Accepted			2022-12-24	WOS:000312533100046
J	Sobczak, JPJ; Martin, TG; Gerling, T; Dietz, H				Sobczak, Jean-Philippe J.; Martin, Thomas G.; Gerling, Thomas; Dietz, Hendrik			Rapid Folding of DNA into Nanoscale Shapes at Constant Temperature	SCIENCE			English	Article							SINGLE-STRANDED-DNA; ORIGAMI; PROTEINS; STATE	We demonstrate that, at constant temperature, hundreds of DNA strands can cooperatively fold a long template DNA strand within minutes into complex nanoscale objects. Folding occurred out of equilibrium along nucleation-driven pathways at temperatures that could be influenced by the choice of sequences, strand lengths, and chain topology. Unfolding occurred in apparent equilibrium at higher temperatures than those for folding. Folding at optimized constant temperatures enabled the rapid production of three-dimensional DNA objects with yields that approached 100%. The results point to similarities with protein folding in spite of chemical and structural differences. The possibility for rapid and high-yield assembly will enable DNA nanotechnology for practical applications.	[Sobczak, Jean-Philippe J.; Martin, Thomas G.; Gerling, Thomas; Dietz, Hendrik] Tech Univ Munich, Dept Phys, Walter Schottky Inst, D-85748 Garching, Germany	Technical University of Munich	Dietz, H (corresponding author), Tech Univ Munich, Dept Phys, Walter Schottky Inst, Coulombwall 4A, D-85748 Garching, Germany.	dietz@tum.de		Dietz, Hendrik/0000-0003-1270-3662	Deutsche Forschungsgemeinschaft through the Excellence Cluster CIPSM; Deutsche Forschungsgemeinschaft [SFB863]; Technische Universitat Munchen Institute for Advanced Study; European Research Council [256270]	Deutsche Forschungsgemeinschaft through the Excellence Cluster CIPSM; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Technische Universitat Munchen Institute for Advanced Study; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft through the Excellence Cluster CIPSM and the SFB863, the Technische Universitat Munchen Institute for Advanced Study, and a European Research Council Starting Grant to H. D. (GA no. 256270). We thank E. Lin Shiao for preliminary experiments, M. Schickinger for the design of the gearlike object, C. Castro for the design of the hinged-bar object, F. Praetorius for preparing scaffold DNA, and B. Wei and P. Yin for supplying DNA strands for tile-based DNA objects. Additional data described in this work can be found in the online supplementary materials.	Alberts B, 2002, MOL BIOL CELL; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Jungmann R, 2008, J AM CHEM SOC, V130, P10062, DOI 10.1021/ja8030196; Ke YG, 2012, J AM CHEM SOC, V134, P1770, DOI 10.1021/ja209719k; Ke YG, 2009, J AM CHEM SOC, V131, P15903, DOI 10.1021/ja906381y; Ke YG, 2009, NANO LETT, V9, P2445, DOI 10.1021/nl901165f; Kim DN, 2012, NUCLEIC ACIDS RES, V40, P2862, DOI 10.1093/nar/gkr1173; Liedl T, 2010, NAT NANOTECHNOL, V5, P520, DOI [10.1038/NNANO.2010.107, 10.1038/nnano.2010.107]; Liu WY, 2011, ANGEW CHEM INT EDIT, V50, P264, DOI 10.1002/anie.201005911; Martin TG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2095; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/nnano.2011.187, 10.1038/NNANO.2011.187]; Porter LL, 2012, P NATL ACAD SCI USA, V109, P9420, DOI 10.1073/pnas.1202604109; PRIVALOV PL, 1989, ANNU REV BIOPHYS BIO, V18, P47, DOI 10.1146/annurev.biophys.18.1.47; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Wei RS, 2012, ANGEW CHEM INT EDIT, V51, P4864, DOI 10.1002/anie.201200688; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274; Zipper H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh101	30	193	195	2	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1458	1461		10.1126/science.1229919	http://dx.doi.org/10.1126/science.1229919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239734				2022-12-24	WOS:000312250800045
J	Sebastian, C; Zwaans, BMM; Silberman, DM; Gymrek, M; Goren, A; Zhong, L; Ram, O; Truelove, J; Guimaraes, AR; Toiber, D; Cosentino, C; Greenson, JK; MacDonald, AI; McGlynn, L; Maxwell, F; Edwards, J; Giacosa, S; Guccione, E; Weissleder, R; Bernstein, BE; Regev, A; Shiels, PG; Lombard, DB; Mostoslavsky, R				Sebastian, Carlos; Zwaans, Bernadette M. M.; Silberman, Dafne M.; Gymrek, Melissa; Goren, Alon; Zhong, Lei; Ram, Oren; Truelove, Jessica; Guimaraes, Alexander R.; Toiber, Debra; Cosentino, Claudia; Greenson, Joel K.; MacDonald, Alasdair I.; McGlynn, Liane; Maxwell, Fraser; Edwards, Joanne; Giacosa, Sofia; Guccione, Ernesto; Weissleder, Ralph; Bernstein, Bradley E.; Regev, Aviv; Shiels, Paul G.; Lombard, David B.; Mostoslavsky, Raul			The Histone Deacetylase SIRT6 Is a Tumor Suppressor that Controls Cancer Metabolism	CELL			English	Article							MULTIPLE INTESTINAL NEOPLASIA; C-MYC; GENE-EXPRESSION; RIBOSOMAL DNA; TUMORIGENESIS; TRANSCRIPTION; GLYCOLYSIS; PHYSIOLOGY; INTEGRITY; MUTATION	Reprogramming of cellular metabolism is a key event during tumorigenesis. Despite being known for decades (Warburg effect), the molecular mechanisms regulating this switch remained unexplored. Here, we identify SIRT6 as a tumor suppressor that regulates aerobic glycolysis in cancer cells. Importantly, loss of SIRT6 leads to tumor formation without activation of known oncogenes, whereas transformed SIRT6-deficient cells display increased glycolysis and tumor growth, suggesting that SIRT6 plays a role in both establishment and maintenance of cancer. By using a conditional SIRT6 allele, we show that SIRT6 deletion in vivo increases the number, size, and aggressiveness of tumors. SIRT6 also functions as a regulator of ribosome metabolism by corepressing MYC transcriptional activity. Lastly, Sirt6 is selectively downregulated in several human cancers, and expression levels of SIRT6 predict prognosis and tumor-free survival rates, highlighting SIRT6 as a critical modulator of cancer metabolism. Our studies reveal SIRT6 to be a potent tumor suppressor acting to suppress cancer metabolism.	[Zwaans, Bernadette M. M.; Greenson, Joel K.; Lombard, David B.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Lombard, David B.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [Sebastian, Carlos; Silberman, Dafne M.; Goren, Alon; Zhong, Lei; Ram, Oren; Toiber, Debra; Cosentino, Claudia; Giacosa, Sofia; Bernstein, Bradley E.; Mostoslavsky, Raul] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Goren, Alon; Ram, Oren; Bernstein, Bradley E.; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Gymrek, Melissa; Bernstein, Bradley E.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Gymrek, Melissa] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Goren, Alon; Ram, Oren; Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Goren, Alon; Ram, Oren; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Goren, Alon; Ram, Oren; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Goren, Alon; Ram, Oren; Truelove, Jessica; Guimaraes, Alexander R.; Weissleder, Ralph; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02140 USA; [MacDonald, Alasdair I.; McGlynn, Liane; Maxwell, Fraser; Edwards, Joanne; Shiels, Paul G.] Univ Glasgow, MVLS, Inst Canc Sci, Glasgow G12 8QQ, Lanark, Scotland; [Guccione, Ernesto] Inst Mol & Cell Biol, Proteos 138673, Singapore; [Silberman, Dafne M.] CEFyBO UBA CONICET, Sch Med, Dept Human Biochem, Buenos Aires, DF, Argentina	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); University of Glasgow; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Lombard, DB (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	davidlom@umich.edu; rmostoslavsky@mgh.harvard.edu	Sebastian, Carlos/H-8014-2018; Cosentino, Claudia/AAF-1100-2019; Sebastian, Carlos/CAG-6271-2022; Edwards, Joanne/J-1903-2015	Sebastian, Carlos/0000-0001-6623-8028; Edwards, Joanne/0000-0002-7192-6906; Goren, Alon/0000-0001-5669-9357; Gymrek, Melissa/0000-0002-6086-3903; Lombard, David/0000-0002-4292-0185; /0000-0003-0828-4143; Shiels, Paul/0000-0002-7577-9843	NIH [GM093072-01, DK088190-01A1, GM101171]; Sidney Kimmel Cancer Research Foundation; Richard D. and Katherine M. O'Connor Research Fund of the University of Michigan Comprehensive Cancer Center; Nathan Shock Center [AG013283]; Pardee Foundation; Beatriu de Pinos Postdoctoral Fellowship (Generalitat de Catalunya); National Defense Science and Engineering Graduate Fellowship; Brain Power for Israel Foundation; Fondazione Umberto Veronesi; NHGRI Center of Excellence in Genome Science [P50HG006193]; NATIONAL CANCER INSTITUTE [R01CA175727] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K08EB012859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101171, R01GM093072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Cancer Research Foundation; Richard D. and Katherine M. O'Connor Research Fund of the University of Michigan Comprehensive Cancer Center; Nathan Shock Center; Pardee Foundation; Beatriu de Pinos Postdoctoral Fellowship (Generalitat de Catalunya)(Generalitat de Catalunya); National Defense Science and Engineering Graduate Fellowship; Brain Power for Israel Foundation; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); NHGRI Center of Excellence in Genome Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH awards GM093072-01 and DK088190-01A1 (R.M.) and GM101171 (D.B.L.), the Sidney Kimmel Cancer Research Foundation (R.M.), the Richard D. and Katherine M. O'Connor Research Fund of the University of Michigan Comprehensive Cancer Center (D.B.L.), the Nathan Shock Center (AG013283; D.B.L.), and the Pardee Foundation (D.B.L.). R.M. is a Howard Goodman Scholar and an MGH Research Scholar. D.B.L. is a New Scholar in Aging of the Ellison Medical Foundation. C.S. is the recipient of a Beatriu de Pinos Postdoctoral Fellowship (Generalitat de Catalunya). M.G. is supported by a National Defense Science and Engineering Graduate Fellowship. D.T. is the recipient of the Brain Power for Israel Foundation. C.C. is supported by a Fellowship from the Fondazione Umberto Veronesi. A.R. is supported by a P50HG006193 from the NHGRI Center of Excellence in Genome Science. D.B.L. would like to thank Dr. Chuxia Deng (NIDDK/NIH) for the floxed SIRT6 mouse strain. We thank Nabeel Bardeesy, Eric Fearon, Alexandros Tzatsos, Polina Paskaleva, Kevin Haigis, Agustina D'Urso, Marco Bezzi, and the Mostoslavsky and Lombard labs for technical advice, reagents, and helpful discussions. We thank the ENCODE Chromatin Project at the Broad Institute for data sharing. R.M. is a member of Sirtris scientific advisory board.	Anders M., 2011, MOL CARCINOG; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Fang YJ, 2011, CANCER LETT, V306, P10, DOI 10.1016/j.canlet.2011.02.019; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Martinez-Pastor B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00022; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; YAMAMOTO T, 1990, BIOCHEM BIOPH RES CO, V170, P223, DOI 10.1016/0006-291X(90)91263-R; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Younes M, 1996, CANCER RES, V56, P1164; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	44	482	503	0	151	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1185	1199		10.1016/j.cell.2012.10.047	http://dx.doi.org/10.1016/j.cell.2012.10.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217706	Green Accepted, Bronze			2022-12-24	WOS:000311999900010
J	Endres, NF; Das, R; Smith, AW; Arkhipov, A; Kovacs, E; Huang, YJ; Pelton, JG; Shan, YB; Shaw, DE; Wemmer, DE; Groves, JT; Kuriyan, J				Endres, Nicholas F.; Das, Rahul; Smith, Adam W.; Arkhipov, Anton; Kovacs, Erika; Huang, Yongjian; Pelton, Jeffrey G.; Shan, Yibing; Shaw, David E.; Wemmer, David E.; Groves, Jay T.; Kuriyan, John			Conformational Coupling across the Plasma Membrane in Activation of the EGF Receptor	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; NEGATIVE COOPERATIVITY; TRANSMEMBRANE DOMAIN; JUXTAMEMBRANE REGION; KINASE ACTIVATION; CRYSTAL-STRUCTURE; LIGAND; BINDING; MODEL; FLUORESCENCE	How the epidermal growth factor receptor (EGFR) activates is incompletely understood. The intracellular portion of the receptor is intrinsically active in solution, and to study its regulation, we measured autophosphorylation as a function of EGFR surface density in cells. Without EGF, intact EGFR escapes inhibition only at high surface densities. Although the transmembrane helix and the intracellular module together suffice for constitutive activity even at low densities, the intracellular module is inactivated when tethered on its own to the plasma membrane, and fluorescence cross-correlation shows that it fails to dimerize. NMR and functional data indicate that activation requires an N-terminal interaction between the transmembrane helices, which promotes an antiparallel interaction between juxtamembrane segments and release of inhibition by the membrane. We conclude that EGF binding removes steric constraints in the extracellular module, promoting activation through N-terminal association of the transmembrane helices.	[Endres, Nicholas F.; Das, Rahul; Kovacs, Erika; Huang, Yongjian; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Smith, Adam W.; Wemmer, David E.; Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Endres, Nicholas F.; Das, Rahul; Kovacs, Erika; Huang, Yongjian; Pelton, Jeffrey G.; Wemmer, David E.; Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Huang, Yongjian; Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Smith, Adam W.; Wemmer, David E.; Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Arkhipov, Anton; Shan, Yibing; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; D. E. Shaw Research; Columbia University	Groves, JT (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	jtgroves@lbl.gov; kuriyan@berkeley.edu	Huang, Yongjian/GPK-5986-2022; Das, Rahul/AAU-5123-2020; Arkhipov, Anton/AAE-7801-2020; Smith, Adam/B-7156-2016	Huang, Yongjian/0000-0002-1168-6111; Das, Rahul/0000-0001-7841-8229; Arkhipov, Anton/0000-0003-1106-8310; Smith, Adam/0000-0001-5216-9017	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; National Cancer Institute (NCI) [2-R01-CA096504- 06, U54 CA143836]; Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences of the U.S. Department of Energy [DE-AC02-05CH11231]; National Science Foundation [BBS 87-20134l]; National Institutes of Health [GM68933]; NATIONAL CANCER INSTITUTE [U54CA143836, R01CA096504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM068933] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences of the U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jeff Iwig, Brian Kelch, Meg Stratton, and Julie Zorn for feedback on the manuscript, Eliza Zhang for initial work on the immunofluorescence assay, and David King for mass spectrometry. N.F.E. was a Leukemia and Lymphoma Society Fellow. R.D. was supported by postdoctoral fellowships from the Natural Sciences and Engineering Research Council of Canada (2009-2011) and the Canadian Institutes of Health Research (2011-2012). Y.H. is a Howard Hughes Medical Institute International Student Research fellow. This work was supported by a grant from the National Cancer Institute (NCI) to J.K. (2-R01-CA096504- 06) and by award U54 CA143836 from NCI to J.T.G. Additional support for the fluorescence spectroscopy system was provided by the Director, Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences of the U.S. Department of Energy under contract no. DE-AC02-05CH11231. Grants from the National Science Foundation (BBS 87-20134l; 600 MHz NMR) and the National Institutes of Health (GM68933; 900 MHz) supported the NMR instrumentation. N.F.E., Y.H., E. K., and J.K. developed the cell-based assays for EGFR activity. A.W.S. and J.T.G. developed the live-cell spectroscopy and built the PIE-FCCS microscope. R.D. conducted the NMR experiments, with guidance from D.E.W. and J.G.P., A.A., Y.S., and D.E.S. helped couple the interpretation of experimental data and the molecular dynamics simulations. All authors were responsible for editing and writing the paper.	Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Becker W, 2005, REV FLUORESCENCE, V2, P77; Bocharov EV, 2008, J BIOL CHEM, V283, P6950, DOI 10.1074/jbc.M709202200; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; Choowongkomon K, 2005, J BIOL CHEM, V280, P24043, DOI 10.1074/jbc.M502698200; Clayton AHA, 2008, GROWTH FACTORS, V26, P316, DOI 10.1080/08977190802442187; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Galush WJ, 2008, BIOPHYS J, V95, P2512, DOI 10.1529/biophysj.108.131540; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Glover KJ, 2001, BIOPHYS J, V81, P2163, DOI 10.1016/S0006-3495(01)75864-X; HAIGLER H, 1978, P NATL ACAD SCI USA, V75, P3317, DOI 10.1073/pnas.75.7.3317; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kay Lewis E, 2011, J Magn Reson, V213, P423, DOI 10.1016/j.jmr.2011.09.004; Larson DR, 2005, J CELL BIOL, V171, P527, DOI 10.1083/jcb.200503110; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Lu CF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414391; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; Mineev KS, 2010, J MOL BIOL, V400, P231, DOI 10.1016/j.jmb.2010.05.016; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Reuther GW, 2000, METHOD ENZYMOL, V327, P331, DOI 10.1016/S0076-6879(00)27288-1; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Scheck RA, 2012, ACS CHEM BIOL, V7, P1367, DOI 10.1021/cb300216f; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SILVERMAN L, 1992, J CELL BIOL, V119, P415, DOI 10.1083/jcb.119.2.415; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; SOROKIN A, 1995, ONCOGENE, V11, P1531; STERNBERG MJE, 1989, NATURE, V339, P587, DOI 10.1038/339587a0; Stuart AC, 1999, J AM CHEM SOC, V121, P5346, DOI 10.1021/ja984172w; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Wood ER, 2008, P NATL ACAD SCI USA, V105, P2773, DOI 10.1073/pnas.0708281105; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhu HJ, 2003, GROWTH FACTORS, V21, P15, DOI 10.1080/0897719031000096424	51	335	341	3	168	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					543	556		10.1016/j.cell.2012.12.032	http://dx.doi.org/10.1016/j.cell.2012.12.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374349	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000314362800023
J	Santini, E; Huynh, TN; MacAskill, AF; Carter, AG; Pierre, P; Ruggero, D; Kaphzan, H; Klann, E				Santini, Emanuela; Huynh, Thu N.; MacAskill, Andrew F.; Carter, Adam G.; Pierre, Philippe; Ruggero, Davide; Kaphzan, Hanoch; Klann, Eric			Exaggerated translation causes synaptic and behavioural aberrations associated with autism	NATURE			English	Article							PROTEIN-SYNTHESIS; INHIBITION; MEMORY; MODEL; DYSFUNCTIONS	Autism spectrum disorders (ASDs) are an early onset, heterogeneous group of heritable neuropsychiatric disorders with symptoms that include deficits in social interaction skills, impaired communication abilities, and ritualistic-like repetitive behaviours(1,2). One of the hypotheses for a common molecular mechanism underlying ASDs is altered translational control resulting in exaggerated protein synthesis(3). Genetic variants in chromosome 4q, which contains theEIF4E locus, have been described in patients with autism(4,5). Importantly, a rare single nucleotide polymorphism has been identified in autism that is associated with increased promoter activity in the EIF4E gene(6). Here we show that genetically increasing the levels of eukaryotic translation initiation factor 4E (eIF4E) in mice(7) results in exaggerated cap-dependent translation and aberrant behaviours reminiscent of autism, including repetitive and perseverative behaviours and social interaction deficits. Moreover, these autistic-like behaviours are accompanied by synaptic pathophysiology in the medial prefrontal cortex, striatumand hippocampus. The autistic-like behaviours displayed by the eIF4E-transgenic mice are corrected by intracerebroventricular infusions of the cap-dependent translation inhibitor 4EGI-1. Our findings demonstrate a causal relationship between exaggerated cap-dependent translation, synaptic dysfunction and aberrant behaviours associated with autism.	[Santini, Emanuela; Huynh, Thu N.; MacAskill, Andrew F.; Carter, Adam G.; Kaphzan, Hanoch; Klann, Eric] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Pierre, Philippe] Aix Marseille Univ, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; [Pierre, Philippe] INSERM, U1104, F-13288 Marseille, France; [Pierre, Philippe] CNRS, URM 7280, F-13288 Marseille, France; [Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Sch Med, Dept Urol, San Francisco, CA 94143 USA	New York University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Klann, E (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	eklann@cns.nyu.edu	Huynh, Thu/I-5864-2014; MacAskill, Andrew/AFO-2061-2022	Huynh, Thu/0000-0002-7625-5101; MacAskill, Andrew/0000-0002-0196-3779; pierre, philippe/0000-0003-0863-8255	National Institutes of Health (NIH) [NS034007, NS047384, NS078718]; Department of Defense CDMRP [W81XWH-11-1-0389]; NIH [CA154916]; Wellcome Trust; NATIONAL CANCER INSTITUTE [R01CA154916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034007, R21NS078718, R01NS034007, R01NS047384] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense CDMRP(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank J. LeDoux and members of his laboratory for their technical support and suggestions. We would also like to thank D. St Clair and Z. Miedzybrodzka for their comments on the manuscript. This research was supported by National Institutes of Health (NIH) grants NS034007, NS047384 and NS078718, and Department of Defense CDMRP award W81XWH-11-1-0389 (E. K.), NIH grant CA154916 (D. R.) and the Wellcome Trust (A.F.M.).	Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Borgkvist A, 2006, MOL CELL NEUROSCI, V31, P293, DOI 10.1016/j.mcn.2005.09.018; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Chalifoux JR, 2010, NEURON, V66, P101, DOI 10.1016/j.neuron.2010.03.012; Chevere-Torres I, 2012, NEUROBIOL DIS, V45, P156, DOI 10.1016/j.nbd.2011.07.018; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dumitriu D, 2011, NAT PROTOC, V6, P1391, DOI 10.1038/nprot.2011.389; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Errico F, 2008, MOL CELL NEUROSCI, V37, P335, DOI 10.1016/j.mcn.2007.10.007; Fineberg NA, 2010, NEUROPSYCHOPHARMACOL, V35, P591, DOI 10.1038/npp.2009.185; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gingras AC, 2001, GENE DEV, V15, P2852; Hoeffer CA, 2011, P NATL ACAD SCI USA, V108, P3383, DOI 10.1073/pnas.1013063108; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Levitt P, 2009, J CLIN INVEST, V119, P747, DOI 10.1172/JCI37934; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Neves-Pereira M, 2009, J MED GENET, V46, P759, DOI 10.1136/jmg.2009.066852; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Qiu AQ, 2010, J AM ACAD CHILD PSY, V49, P539, DOI 10.1016/j.jaac.2010.02.012; Rapin I, 2008, PEDIATR CLIN N AM, V55, P1129, DOI 10.1016/j.pcl.2008.07.005; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009	38	253	257	1	85	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					411	U158		10.1038/nature11782	http://dx.doi.org/10.1038/nature11782			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23263185	Green Accepted, Green Submitted			2022-12-24	WOS:000313615900053
J	Kolev, NG; Ramey-Butler, K; Cross, GAM; Ullu, E; Tschudi, C				Kolev, Nikolay G.; Ramey-Butler, Kiantra; Cross, George A. M.; Ullu, Elisabetta; Tschudi, Christian			Developmental Progression to Infectivity in Trypanosoma brucei Triggered by an RNA-Binding Protein	SCIENCE			English	Article							TSETSE-FLY	Unraveling the intricate interactions between Trypanosoma brucei, the protozoan parasite causing African trypanosomiasis, and the tsetse (Glossina) vector remains a challenge. Metacyclic trypanosomes, which inhabit the tsetse salivary glands, transmit the disease and are produced through a complex differentiation and unknown program. By overexpressing a single RNA-binding protein, TbRBP6, in cultured noninfectious trypanosomes, we recapitulated the developmental stages that have been observed in tsetse, including the generation of infective metacyclic forms expressing the variant surface glycoprotein. Thus, events leading to acquisition of infectivity in the insect vector are now accessible to laboratory investigation, providing an opening for new intervention strategies.	[Ramey-Butler, Kiantra; Ullu, Elisabetta] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06536 USA; [Kolev, Nikolay G.; Tschudi, Christian] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06536 USA; [Cross, George A. M.] Rockefeller Univ, Mol Parasitol Lab, New York, NY 10065 USA; [Ullu, Elisabetta] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06536 USA	Yale University; Yale University; Rockefeller University; Yale University	Ullu, E (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06536 USA.	elisabetta.ullu@yale.edu; christian.tschudi@yale.edu	Cross, George A M/B-7444-2011	Cross, George A M/0000-0003-1374-6955; Butler, Kiantra/0000-0001-6635-8601	National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) [AI028798, AI043594, AI021729, AI076879]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043594, R21AI076879, R01AI028798, R01AI021729, R37AI028798, R37AI021729] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Savage and S. Aksoy for assistance with the infectivity assays, J. Bangs for providing the immunofluorescence protocol and advice, D. Engman for the antibody against calflagin, and M. Chaudhuri for the antibody against alternative oxidase. Supported by grants AI028798 (E. U.), AI043594 (C. T.), AI021729 (G. A. M. C.), and AI076879 (S. Aksoy) from the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or the NIH. The sequence data from this study have been submitted to the National Center for Biotechnology Information Sequence Read Archive under accession nos. SRP002243 and SRA059559.	Bruce D, 1909, P R SOC LOND B-CONTA, V81, P405, DOI 10.1098/rspb.1909.0041; Ginger ML, 2002, EUKARYOT CELL, V1, P1000, DOI 10.1128/EC.1.6.1000-1009.2002; Rotureau B, 2012, DEVELOPMENT, V139, P1842, DOI 10.1242/dev.072611; Sharma R, 2009, TRENDS PARASITOL, V25, P517, DOI 10.1016/j.pt.2009.08.001; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Wurst M, 2012, MOL MICROBIOL, V83, P1048, DOI 10.1111/j.1365-2958.2012.07988.x	6	126	127	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1352	1353		10.1126/science.1229641	http://dx.doi.org/10.1126/science.1229641			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224556	Green Accepted			2022-12-24	WOS:000311991200069
J	Markle, JGM; Frank, DN; Mortin-Toth, S; Robertson, CE; Feazel, LM; Rolle-Kampczyk, U; von Bergen, M; McCoy, KD; Macpherson, AJ; Danska, JS				Markle, Janet G. M.; Frank, Daniel N.; Mortin-Toth, Steven; Robertson, Charles E.; Feazel, Leah M.; Rolle-Kampczyk, Ulrike; von Bergen, Martin; McCoy, Kathy D.; Macpherson, Andrew J.; Danska, Jayne S.			Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity	SCIENCE			English	Article							DIABETES SUSCEPTIBILITY; NOD MOUSE; ASSOCIATION; PREVENTION; COOPERATE; TRENDS; MICE	Microbial exposures and sex hormones exert potent effects on autoimmune diseases, many of which are more prevalent in women. We demonstrate that early-life microbial exposures determine sex hormone levels and modify progression to autoimmunity in the nonobese diabetic (NOD) mouse model of type 1 diabetes (T1D). Colonization by commensal microbes elevated serum testosterone and protected NOD males from T1D. Transfer of gut microbiota from adult males to immature females altered the recipient's microbiota, resulting in elevated testosterone and metabolomic changes, reduced islet inflammation and autoantibody production, and robust T1D protection. These effects were dependent on androgen receptor activity. Thus, the commensal microbial community alters sex hormone levels and regulates autoimmune disease fate in individuals with high genetic risk.	[Markle, Janet G. M.; Mortin-Toth, Steven; Danska, Jayne S.] Hosp Sick Children, Res Inst, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Markle, Janet G. M.; Danska, Jayne S.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Frank, Daniel N.; Feazel, Leah M.] Univ Colorado, Div Infect Dis, Sch Med, Aurora, CO 80045 USA; [Robertson, Charles E.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Rolle-Kampczyk, Ulrike; von Bergen, Martin] Helmholtz Ctr Environm Res, Dept Metab, D-04318 Leipzig, Germany; [von Bergen, Martin] Helmholtz Ctr Environm Res, Dept Prote, D-04318 Leipzig, Germany; [von Bergen, Martin] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, DK-9000 Aalborg, Denmark; [McCoy, Kathy D.; Macpherson, Andrew J.] Univ Bern, Maurice Muller Labs, Univ Klin Viszerale Chirurg & Med, CH-3008 Bern, Switzerland; [Danska, Jayne S.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Aalborg University; University of Bern; University Hospital of Bern; University of Toronto	Danska, JS (corresponding author), Hosp Sick Children, Res Inst, Program Genet & Genome Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jayne.danska@sickkids.ca	Markle, Janet/X-1975-2019; von Bergen, Martin/D-7960-2011; McCoy, Kathy/ABD-5814-2021; Rolle-Kampczyk, Ulrike E./D-4786-2015	von Bergen, Martin/0000-0003-2732-2977; Rolle-Kampczyk, Ulrike E./0000-0002-7728-6284; Markle, Janet/0000-0003-2189-4368; ROBERTSON, CHARLES/0000-0002-4136-4121	Canadian Institutes of Health Research (CIHR) [64216]; Juvenile Diabetes Research Foundation (JDRF) [17-2011-520]; Genome Canada; JDRF [36-2008-926]; Genaxen Foundation; CIHR Banting and Best fellowship; NIH [R21HG005964]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005964] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Genome Canada(Genome Canada); JDRF(Juvenile Diabetes Research Foundation); Genaxen Foundation; CIHR Banting and Best fellowship(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank S. Bashir for assistance with metabolomic data analysis, C. Vogel Kotter for high-throughput sequencing, and E. Simpson and M. Palmert for helpful discussions. The 16S sequence data have been submitted to the National Center for Biotechnology Information short-read archive project, accession no. SRA064044. Flow cytometry was performed in the SickKids-University Health Network Flow Cytometry Facility with funds from the Ontario Institute for Cancer Research, McEwen Centre for Regenerative Medicine, Canada Foundation for Innovation, and SickKids Foundation. Roche 454 sequencing was performed at the Centre for Applied Genomics, Hospital for Sick Children. Illumina sequencing was performed at the University of Colorado School of Medicine. Supported by Canadian Institutes of Health Research (CIHR) grant 64216 and Juvenile Diabetes Research Foundation (JDRF) grant 17-2011-520 (J. S. D.), Genome Canada (administered by Ontario Genomics Institute) (J.S.D. and A. J. M.), JDRF grant 36-2008-926 and the Genaxen Foundation (A. J. M.), a CIHR Banting and Best fellowship (J. G. M. M.), and NIH grant R21HG005964 (D.N.F. and C. E. R.). J. G. M. M. and J. S. D. designed the study, analyzed data, and wrote the manuscript; J. G. M. M., D.N.F., S.M.-T., C. E. R., M. v. B., K. D. M., and A. J. M. performed experiments and analyzed data; L. M. F. and U.R.-K. performed experiments; and all authors contributed to manuscript editing.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chai JG, 2004, BLOOD, V103, P3951, DOI 10.1182/blood-2003-11-3763; Doran MF, 2002, ARTHRITIS RHEUM-US, V46, P625, DOI 10.1002/art.509; FOX HS, 1992, J EXP MED, V175, P1409, DOI 10.1084/jem.175.5.1409; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; HARADA M, 1990, DIABETES RES CLIN PR, V8, P85, DOI 10.1016/0168-8227(90)90017-N; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; Ivakine EA, 2005, J IMMUNOL, V174, P7129, DOI 10.4049/jimmunol.174.11.7129; Ivakine EA, 2006, DIABETES, V55, P3611, DOI 10.2337/db06-0758; Koal T, 2010, CURR MOL MED, V10, P216, DOI 10.2174/156652410790963312; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Leiter E., 1998, NOD MICE RELATED STR, V2; Makino S, 1981, Jikken Dobutsu, V30, P137; Makino S, 1980, Jikken Dobutsu, V29, P1; Miao DM, 2007, FRONT BIOSCI-LANDMRK, V12, P1889, DOI 10.2741/2195; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; QIN HY, 1993, J IMMUNOL, V150, P2072; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Scobie HM, 2006, PLOS PATHOG, V2, P949, DOI 10.1371/journal.ppat.0020111; Serreze DV, 2001, CURR DIRECT AUTOIMMU, V4, P31; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Wagner BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020296; WEINSHENKER BG, 1994, ANN NEUROL, V36, pS6, DOI 10.1002/ana.410360704; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	34	1144	1193	27	437	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1084	1088		10.1126/science.1233521	http://dx.doi.org/10.1126/science.1233521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23328391				2022-12-24	WOS:000315452000044
J	Placais, PY; Preat, T				Placais, Pierre-Yves; Preat, Thomas			To Favor Survival Under Food Shortage, the Brain Disables Costly Memory	SCIENCE			English	Article							LONG-TERM-MEMORY; CONSOLIDATED MEMORY; PROTEIN-SYNTHESIS; DOPAMINE NEURONS; DROSOPHILA; POTENTIATION; PLASTICITY; RESOURCES; RECEPTORS; PHASES	The brain regulates energy homeostasis in the organism. Under resource shortage, the brain takes priority over peripheral organs for energy supply. But can the brain also down-regulate its own consumption to favor survival? We show that the brain of Drosophila specifically disables the costly formation of aversive long-term memory (LTM) upon starvation, a physiological state required for appetitive LTM formation. At the neural circuit level, the slow oscillations normally triggered in two pairs of dopaminergic neurons to enable aversive LTM formation were abolished in starved flies. Transient artificial activation of these neurons during training restored LTM formation in starved flies but at the price of a reduced survival. LTM formation is thus subject to adaptive plasticity that helps survival under food shortage.	[Placais, Pierre-Yves; Preat, Thomas] Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 7637, Neurobiol Unit, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Preat, T (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 7637, Neurobiol Unit, 10 Rue Vauquelin, F-75005 Paris, France.	thomas.preat@espci.fr		Preat, Thomas/0000-0001-9976-1763	Region Ile-de-France; French Agence Nationale de la Recherche	Region Ile-de-France(Region Ile-de-France); French Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank G. Belliart-Guerin and V. Goguel for valuable discussion, E. Le Glou for assistance in handling the Trikinetics device, and members of the Genes and Dynamics of Memory Systems group for critical comments on the manuscript. The authors declare no conflict of interest. P.-Y.P. was supported by a postdoctoral fellowship from Region Ile-de-France. T. P. was supported by a grant from the French Agence Nationale de la Recherche.	Aso Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002768; Burke CJ, 2011, CURR BIOL, V21, P746, DOI 10.1016/j.cub.2011.03.032; Colomb J, 2009, GENES BRAIN BEHAV, V8, P407, DOI 10.1111/j.1601-183X.2009.00482.x; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Dorn LA, 2000, EVOLUTION, V54, P1982, DOI 10.1111/j.0014-3820.2000.tb01242.x; Fehm HL, 2006, PROG BRAIN RES, V153, P129, DOI 10.1016/S0079-6123(06)53007-9; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hirano Y, 2013, SCIENCE, V339, P443, DOI 10.1126/science.1227170; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Lagasse F, 2012, P ROY SOC B-BIOL SCI, V279, P4015, DOI 10.1098/rspb.2012.1457; Lee PT, 2011, P NATL ACAD SCI USA, V108, P13794, DOI 10.1073/pnas.1019483108; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Mallon EB, 2003, P ROY SOC B-BIOL SCI, V270, P2471, DOI 10.1098/rspb.2003.2456; Mery F, 2005, SCIENCE, V308, P1148, DOI 10.1126/science.1111331; Oltmanns KM, 2008, AM J PHYSIOL-REG I, V294, pR12, DOI 10.1152/ajpregu.00093.2007; PAVLIDES C, 1995, NEUROSCIENCE, V68, P387, DOI 10.1016/0306-4522(95)00151-8; Pavlides C, 1999, BRAIN RES, V851, P204, DOI 10.1016/S0006-8993(99)02188-5; Placais PY, 2012, NAT NEUROSCI, V15, P592, DOI 10.1038/nn.3055; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; Schwabe L, 2012, NEUROSCI BIOBEHAV R, V36, P1740, DOI 10.1016/j.neubiorev.2011.07.002; Shi WX, 2009, J NEURAL TRANSM-SUPP, P103, DOI 10.1007/978-3-211-92660-4_8; Shi WX, 2005, J NEUROPHYSIOL, V94, P3516, DOI 10.1152/jn.00317.2005; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Valadares CT, 2005, NUTR NEUROSCI, V8, P39, DOI 10.1080/10284150500047302; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015	34	96	96	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					440	442		10.1126/science.1226018	http://dx.doi.org/10.1126/science.1226018			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349289				2022-12-24	WOS:000313960700041
J	Hansen, BB; Grotan, V; Aanes, R; Saether, BE; Stien, A; Fuglei, E; Ims, RA; Yoccoz, NG; Pedersen, AO				Hansen, Brage B.; Grotan, Vidar; Aanes, Ronny; Saether, Bernt-Erik; Stien, Audun; Fuglei, Eva; Ims, Rolf A.; Yoccoz, Nigel G.; Pedersen, Ashild O.			Climate Events Synchronize the Dynamics of a Resident Vertebrate Community in the High Arctic	SCIENCE			English	Article							POPULATION-DYNAMICS; SPATIAL SYNCHRONY; LEMMING CYCLES; SNOW EVENTS; REINDEER; SVALBARD; GREENLAND; RESPONSES; IMPACT; RAIN	Recently accumulated evidence has documented a climate impact on the demography and dynamics of single species, yet the impact at the community level is poorly understood. Here, we show that in Svalbard in the high Arctic, extreme weather events synchronize population fluctuations across an entire community of resident vertebrate herbivores and cause lagged correlations with the secondary consumer, the arctic fox. This synchronization is mainly driven by heavy rain on snow that encapsulates the vegetation in ice and blocks winter forage availability for herbivores. Thus, indirect and bottom-up climate forcing drives the population dynamics across all overwintering vertebrates. Icing is predicted to become more frequent in the circumpolar Arctic and may therefore strongly affect terrestrial ecosystem characteristics.	[Hansen, Brage B.; Grotan, Vidar; Aanes, Ronny; Saether, Bernt-Erik] Norwegian Univ Sci & Technol, Dept Biol, Ctr Conservat Biol, NO-7491 Trondheim, Norway; [Aanes, Ronny; Fuglei, Eva; Pedersen, Ashild O.] Norwegian Polar Res Inst, Fram Ctr, NO-9296 Tromso, Norway; [Stien, Audun] Norwegian Inst Nat Res, Fram Ctr, NO-9296 Tromso, Norway; [Ims, Rolf A.; Yoccoz, Nigel G.] Univ Tromso, Dept Arctic & Marine Biol, NO-9037 Tromso, Norway	Norwegian University of Science & Technology (NTNU); Norwegian Polar Institute; Norwegian Institute Nature Research; UiT The Arctic University of Tromso	Hansen, BB (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, Ctr Conservat Biol, NO-7491 Trondheim, Norway.	brage.b.hansen@ntnu.no	Grøtan, Vidar/A-4056-2008; Grøtan, Vidar/O-9453-2019; Yoccoz, Nigel/C-8561-2014; Hansen, Brage Bremset/B-9942-2008	Grøtan, Vidar/0000-0003-1222-0724; Grøtan, Vidar/0000-0003-1222-0724; Yoccoz, Nigel/0000-0003-2192-1039; Hansen, Brage Bremset/0000-0001-8763-4361; Stien, Audun/0000-0001-8046-7337	Norwegian Polar Institute; University of Tromso; Norwegian Institute for Nature Research (ALV); Norwegian Research Council; Governor of Svalbard; French Polar Institute; NORKLIMA [178561/S30, 216051]; European Research Council [ERC-2010-AdG 268562]; Centre for Conservation Biology (Norwegian University of Science and Technology); Nature Research, Norwegian Research Council (NORKLIMA)	Norwegian Polar Institute; University of Tromso; Norwegian Institute for Nature Research (ALV); Norwegian Research Council(Research Council of NorwayEuropean Commission); Governor of Svalbard; French Polar Institute; NORKLIMA; European Research Council(European Research Council (ERC)European Commission); Centre for Conservation Biology (Norwegian University of Science and Technology); Nature Research, Norwegian Research Council (NORKLIMA)	Data collection was financed by the Norwegian Polar Institute, University of Tromso, Norwegian Institute for Nature Research, Norwegian Research Council (ALV and NORKLIMA grants), Governor of Svalbard, and French Polar Institute. This study was financed by NORKLIMA (grants 178561/S30 and 216051), the European Research Council (ERC-2010-AdG 268562), and Centre for Conservation Biology (Norwegian University of Science and Technology). We thank the Norwegian Meteorological Institute (weather data), Governor of Svalbard (ptarmigan data), and Erik Ropstad (ptarmigan photo). Data are presented (table S8) in supplementary materials. Author contributions: A. S., R. A. I., N.G.Y., and E. F. collected vole data. R. A. collected reindeer data. E. F. collected fox data. E. F. and A.O.P. controlled ptarmigan data. R. A., B. B. H., and B. E. S. initiated the study. V. G. analyzed data and wrote Materials and Methods. B. B. H. wrote the manuscript. All authors contributed on later manuscript versions.	[Anonymous], 2011, SNOW WAT IC PERM ARC; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Eide NE, 2012, J ANIM ECOL, V81, P640, DOI 10.1111/j.1365-2656.2011.01936.x; Engen S, 2005, J ANIM ECOL, V74, P601, DOI 10.1111/j.1365-2656.2005.00942.x; FORCHHAMMER M, 1993, ECOGRAPHY, V16, P299, DOI 10.1111/j.1600-0587.1993.tb00219.x; Fuglei E, 2003, POLAR BIOL, V26, P93, DOI 10.1007/s00300-002-0458-8; Gilg O, 2009, GLOBAL CHANGE BIOL, V15, P2634, DOI 10.1111/j.1365-2486.2009.01927.x; Hansen BB, 2011, ECOLOGY, V92, P1917, DOI 10.1890/11-0095.1; Heino M, 1997, P ROY SOC B-BIOL SCI, V264, P481, DOI 10.1098/rspb.1997.0069; Ims RA, 2000, NATURE, V408, P194, DOI 10.1038/35041562; Ims RA, 2005, BIOSCIENCE, V55, P311, DOI 10.1641/0006-3568(2005)055[0311:TICITE]2.0.CO;2; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Myers JH, 1998, ECOLOGY, V79, P1111, DOI 10.1890/0012-9658(1998)079[1111:SIOOFL]2.0.CO;2; Post E, 2004, P NATL ACAD SCI USA, V101, P9286, DOI 10.1073/pnas.0305029101; Post E, 2002, NATURE, V420, P168, DOI 10.1038/nature01064; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Putkonen J, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016326; Rennert KJ, 2009, J CLIMATE, V22, P2302, DOI 10.1175/2008JCLI2117.1; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Saether BE, 2007, J ANIM ECOL, V76, P315, DOI 10.1111/j.1365-2656.2006.01195.x; Schmidt NM, 2012, P ROY SOC B-BIOL SCI, V279, P4417, DOI 10.1098/rspb.2012.1490; Solberg EJ, 2001, ECOGRAPHY, V24, P441, DOI 10.1034/j.1600-0587.2001.d01-200.x; STEEN JB, 1985, ORNIS SCAND, V16, P191, DOI 10.2307/3676630; Stien A, 2012, BIOL LETTERS, V8, P1002, DOI 10.1098/rsbl.2012.0764; van der Wal R, 2009, PERSPECT PLANT ECOL, V11, P231, DOI 10.1016/j.ppees.2009.03.003; Vik JO, 2004, NATURE, V427, P697, DOI 10.1038/427697a; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Yoccoz Nigel G., 1999, Ecological Bulletins, V47, P137	31	172	172	5	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					313	315		10.1126/science.1226766	http://dx.doi.org/10.1126/science.1226766			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329044	Green Submitted, Green Accepted			2022-12-24	WOS:000313622000042
J	Mukhopadhyay, S; Wen, XH; Ratti, N; Loktev, A; Rangell, L; Scales, SJ; Jackson, PK				Mukhopadhyay, Saikat; Wen, Xiaohui; Ratti, Navneet; Loktev, Alexander; Rangell, Linda; Scales, Suzie J.; Jackson, Peter K.			The Ciliary G-Protein-Coupled Receptor Gpr161 Negatively Regulates the Sonic Hedgehog Pathway via cAMP Signaling	CELL			English	Article							IFT-A COMPLEX; INTRAFLAGELLAR TRANSPORT; PRIMARY CILIUM; IDENTIFICATION; SUPPRESSOR; MUTANTS; TULP3; SHH; LOCALIZATION; TRANSDUCTION	The primary cilium is required for Sonic hedgehog (Shh) signaling in vertebrates. In contrast to mutants affecting ciliary assembly, mutations in the intraflagellar transport complex A (IFT-A) paradoxically cause increased Shh signaling. We previously showed that the IFT-A complex, in addition to its canonical role in retrograde IFT, binds to the tubby-like protein, Tulp3, and recruits it to cilia. Here, we describe a conserved vertebrate G-protein-coupled receptor, Gpr161, which localizes to primary cilia in a Tulp3/IFT-A-dependent manner. Complete loss of Gpr161 in mouse causes midgestation lethality and increased Shh signaling in the neural tube, phenocopying Tulp3/IFT-A mutants. Constitutive Gpr161 activity increases cAMP levels and represses Shh signaling by determining the processing of Gli3 to its repressor form. Conversely, Shh signaling directs Gpr161 to be internalized from cilia, preventing its activity. Thus, Gpr161 defines a morphogenetic pathway coupling protein kinase A activation to Shh signaling during neural tube development.	[Mukhopadhyay, Saikat; Loktev, Alexander; Jackson, Peter K.] Genentech Inc, Dept Res Oncol, San Francisco, CA 94080 USA; [Wen, Xiaohui; Scales, Suzie J.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Ratti, Navneet; Rangell, Linda] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Mukhopadhyay, S (corresponding author), UT SW Med Ctr, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	saikat.mukhopadhyay@utsouthwestern.edu; pjackson@gene.com	Scales, Suzie J./H-4507-2019	Scales, Suzie J./0000-0003-2544-0283; Jackson, Peter/0000-0002-1742-2539; Mukhopadhyay, Saikat/0000-0003-4790-3090				Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bananis E, 2004, MOL BIOL CELL, V15, P3688, DOI 10.1091/mbc.E04-04-0278; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; BRAY P, 1986, P NATL ACAD SCI USA, V83, P8893, DOI 10.1073/pnas.83.23.8893; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Damaj BB, 1996, FASEB J, V10, P1426, DOI 10.1096/fasebj.10.12.8903513; Degorce Francois, 2009, Curr Chem Genomics, V3, P22, DOI 10.2174/1875397300903010022; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Greasley PJ, 2001, J BIOL CHEM, V276, P46485, DOI 10.1074/jbc.M105791200; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Leung T, 2008, DEV BIOL, V323, P31, DOI 10.1016/j.ydbio.2008.08.001; Liem KF, 2012, J CELL BIOL, V197, P789, DOI 10.1083/jcb.201110049; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Matteson PG, 2008, P NATL ACAD SCI USA, V105, P2088, DOI 10.1073/pnas.0705657105; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Norman RX, 2009, HUM MOL GENET, V18, P1740, DOI 10.1093/hmg/ddp113; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Patterson VL, 2009, HUM MOL GENET, V18, P1719, DOI 10.1093/hmg/ddp075; Pazour GJ, 2008, CURR TOP DEV BIOL, V85, P115, DOI 10.1016/S0070-2153(08)00805-3; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Shimamura K, 1995, DEVELOPMENT, V121, P3923; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Tuson M, 2011, DEVELOPMENT, V138, P4921, DOI 10.1242/dev.070805; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; WILSON DB, 1986, J NEUROPATH EXP NEUR, V45, P43, DOI 10.1097/00005072-198601000-00004; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	45	285	294	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					210	223		10.1016/j.cell.2012.12.026	http://dx.doi.org/10.1016/j.cell.2012.12.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332756	Bronze			2022-12-24	WOS:000313719800018
J	Fu, WQ; O'Connor, TD; Jun, G; Kang, HM; Abecasis, G; Leal, SM; Gabriel, S; Altshuler, D; Shendure, J; Nickerson, DA; Bamshad, MJ; Akey, JM				Fu, Wenqing; O'Connor, Timothy D.; Jun, Goo; Kang, Hyun Min; Abecasis, Goncalo; Leal, Suzanne M.; Gabriel, Stacey; Altshuler, David; Shendure, Jay; Nickerson, Deborah A.; Bamshad, Michael J.; Akey, Joshua M.		NHLBI Exome Sequencing Project	Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants	NATURE			English	Article							POPULATION-GROWTH; RARE; MUTATIONS; DISEASE; GENE; EVOLUTION; HISTORY; EXCESS; AGE	Establishing the age of each mutation segregating in contemporary human populations is important to fully understand our evolutionary history(1,2) and will help to facilitate the development of new approaches for disease-gene discovery(3). Large-scale surveys of human genetic variation have reported signatures of recent explosive population growth(4-6), notable for an excess of rare genetic variants, suggesting that many mutations arose recently. To more quantitatively assess the distribution of mutation ages, we resequenced 15,336 genes in 6,515 individuals of European American and African American ancestry and inferred the age of 1,146,401 autosomal single nucleotide variants (SNVs). We estimate that approximately 73% of all protein-coding SNVs and approximately 86% of SNVs predicted to be deleterious arose in the past 5,000-10,000 years. The average age of deleterious SNVs varied significantly across molecular pathways, and disease genes contained a significantly higher proportion of recently arisen deleterious SNVs than other genes. Furthermore, European Americans had an excess of deleterious variants in essential and Mendelian disease genes compared to African Americans, consistent with weaker purifying selection due to the Out-of-Africa dispersal. Our results better delimit the historical details of human protein-coding variation, show the profound effect of recent human history on the burden of deleterious SNVs segregating in contemporary populations, and provide important practical information that can be used to prioritize variants in disease-gene discovery.	[Fu, Wenqing; O'Connor, Timothy D.; Shendure, Jay; Nickerson, Deborah A.; Bamshad, Michael J.; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Jun, Goo; Kang, Hyun Min; Abecasis, Goncalo] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gabriel, Stacey; Altshuler, David] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Baylor College of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Washington; University of Washington Seattle	Fu, WQ (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	wqfu@u.washington.edu; akeyj@u.washington.edu	Singleton, Andrew B/C-3010-2009; de Bakker, Paul IW/B-8730-2009; Jun, Goo/F-1941-2017; Jun, Goo/M-5235-2016; Abecasis, Goncalo R/B-7840-2010; Altshuler, David M/A-4476-2009; Shendure, Jay/AAU-3684-2021	de Bakker, Paul IW/0000-0001-7735-7858; Jun, Goo/0000-0003-0891-0204; Jun, Goo/0000-0003-0891-0204; Altshuler, David M/0000-0002-7250-4107; Shendure, Jay/0000-0002-1516-1865; Bustamante, Carlos D./0000-0002-4187-7920; Quinlan, Aaron/0000-0003-1756-0859; Ballantyne, Christie/0000-0002-6432-1730; Turner, Emily/0000-0001-9040-9229; Abecasis, Goncalo/0000-0003-1509-1825; Akey, Joshua/0000-0002-4411-1330; Seshadri, Sudha/0000-0001-6135-2622; Caan, Bette/0000-0002-5803-310X; O'Connor, Timothy/0000-0002-0276-1896	National Heart, Lung and Blood Institute (NHLBI); NHLBI [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924, RC2 HL-102925, RC2 HL-102926]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102923, RC2HL102926, RC2HL102924, RC2HL102925, RC2HL103010] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006513] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge the support of the National Heart, Lung and Blood Institute (NHLBI), the contributions of the research institutions that participated in this study, the study investigators, field staff and study participants who created this resource for biomedical research, and the Population Genetics Project Team of the NHLBI. We thank J. Wilson and R. Do for critical feedback on the manuscript. Funding for the GO (Grand Opportunity) Exome Sequencing Project was provided by NHLBI grants RC2 HL-103010 (Heart GO), RC2 HL-102923 (Lung GO) and RC2 HL-102924 (WHISP). The exome sequencing was was supported by NHLBI grants RC2 HL-102925 (Broad GO) and RC2 HL-102926 (Seattle GO).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Griffiths R., 1998, COMMUN STAT STOCH MO, V14, P273, DOI [10.1080/15326349808807471, DOI 10.1080/15326349808807471]; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hawks J, 2007, P NATL ACAD SCI USA, V104, P20753, DOI 10.1073/pnas.0707650104; Jia EZ, 2009, MOL BIOL REP, V36, P245, DOI 10.1007/s11033-007-9173-4; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; KIMURA M, 1973, GENETICS, V75, P199; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Liao BY, 2006, MOL BIOL EVOL, V23, P2072, DOI 10.1093/molbev/msl076; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pyun JA, 2012, MATURITAS, V71, P402, DOI 10.1016/j.maturitas.2012.01.011; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Valdmanis PN, 2007, AM J HUM GENET, V80, P152, DOI 10.1086/510782	27	650	658	3	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2013	493	7431					216	220		10.1038/nature11690	http://dx.doi.org/10.1038/nature11690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23201682	Green Submitted, Green Accepted			2022-12-24	WOS:000313259600038
J	Li, ZY; Gadue, P; Chen, KF; Jiao, Y; Tuteja, G; Schug, J; Li, W; Kaestner, KH				Li, Zhaoyu; Gadue, Paul; Chen, Kaifu; Jiao, Yang; Tuteja, Geetu; Schug, Jonathan; Li, Wei; Kaestner, Klaus H.			Foxa2 and H2A.Z Mediate Nucleosome Depletion during Embryonic Stem Cell Differentiation	CELL			English	Article							TRANSCRIPTION FACTORS; DNA METHYLATION; HIGH-RESOLUTION; GENOME; ENDODERM; PLURIPOTENT; ENHANCER; GENES; LIVER; MAPS	Nucleosome occupancy is fundamental for establishing chromatin architecture. However, little is known about the relationship between nucleosome dynamics and initial cell lineage specification. Here, we determine the mechanisms that control global nucleosome dynamics during embryonic stem (ES) cell differentiation into endoderm. Both nucleosome depletion and de novo occupation occur during the differentiation process, with higher overall nucleosome density after differentiation. The variant histone H2A.Z and the winged helix transcription factor Foxa2 both act to regulate nucleosome depletion and gene activation, thus promoting ES cell differentiation, whereas DNA methylation promotes nucleosome occupation and suppresses gene expression. Nucleosome depletion during ES cell differentiation is dependent on Nap1l1-coupled SWI/SNF and INO80 chromatin remodeling complexes. Thus, both epigenetic and genetic regulators cooperate to control nucleosome dynamics during ES cell fate decisions.	[Li, Zhaoyu; Jiao, Yang; Tuteja, Geetu; Schug, Jonathan; Kaestner, Klaus H.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Li, Zhaoyu; Jiao, Yang; Tuteja, Geetu; Schug, Jonathan; Kaestner, Klaus H.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Gadue, Paul] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Chen, Kaifu; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Baylor College of Medicine	Kaestner, KH (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	kaestner@mail.med.upenn.edu		Li, Zhaoyu/0000-0002-1136-2758; Li, Wei/0000-0001-9931-5990	National Institute of Diabetes and Digestive and Kidney Diseases [P01-DK049210]; National Science and Engineering Research Council of Canada; Juvenile Diabetes Research Foundation; Cancer Prevention Research Institute of Texas [RP110471-C3]; NATIONAL CANCER INSTITUTE [R00CA168983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210, P30DK019525] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Shelley Berger for critical comments on the manuscript, and Alan Fox, Olga Smirnova, Matt Mansh, Aline Disimone, Karrie Brondell, Amber Riblett, and James LaRossa for excellent technical support. We thank Drs. Keji Zhao and Gangqing Hu (National Institutes of Health/National Heart, Lung, and Blood Institute) for helpful suggestions on computational analysis on our nucleosome data. We also thank Dr. Philip Streeter (Oregon) for kindly providing the ENDM1 (G10) antibody. This study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (P01-DK049210 to K.H.K.). Z.L. was supported by National Science and Engineering Research Council of Canada and Juvenile Diabetes Research Foundation postdoctoral fellowship awards. This study was partially supported by the Cancer Prevention Research Institute of Texas (RP110471-C3 to W.L.). Z.L. and K.H.K. designed the experiments and wrote the manuscript. Z.L. performed the majority of experiments and computational analysis. P.G. and Y.J. did a part of the ES cell culture and sorting. K.C., W.L., G.T., and J.S. contributed to the computational analysis. K.H.K. directed the whole study.	Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Gadue P, 2009, STEM CELLS, V27, P2103, DOI 10.1002/stem.147; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kiefer JC, 2007, DEV DYNAM, V236, P1144, DOI 10.1002/dvdy.21094; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li ZY, 2011, NAT STRUCT MOL BIOL, V18, P742, DOI 10.1038/nsmb.2060; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2002, MOL CELL BIOL, V22, P856, DOI 10.1128/MCB.22.3.856-865.2002; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Tuteja G, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp536; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228	29	148	151	0	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1608	1616		10.1016/j.cell.2012.11.018	http://dx.doi.org/10.1016/j.cell.2012.11.018			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260146	Bronze, Green Accepted			2022-12-24	WOS:000312890300023
J	Fang, WW; Wang, X; Bracht, JR; Nowacki, M; Landweber, LF				Fang, Wenwen; Wang, Xing; Bracht, John R.; Nowacki, Mariusz; Landweber, Laura F.			Piwi-Interacting RNAs Protect DNA against Loss during Oxytricha Genome Rearrangement	CELL			English	Article							PARAMECIUM-TETRAURELIA; TETRAHYMENA-THERMOPHILA; C. ELEGANS; LYSINE-9 METHYLATION; EPIGENETIC MEMORY; 3' TERMINI; PIRNAS; GERMLINE; ELIMINATION; GENE	Genome duality in ciliated protozoa offers a unique system to showcase their epigenome as a model of inheritance. In Oxytricha, the somatic genome is responsible for vegetative growth, whereas the germline contributes DNA to the next sexual generation. Somatic nuclear development removes all transposons and other so-called "junk'' DNA, which comprise similar to 95% of the germline. We demonstrate that Piwi-interacting small RNAs (piRNAs) from the maternal nucleus can specify genomic regions for retention in this process. Oxytricha piRNAs map primarily to the somatic genome, representing the similar to 5% of the germline that is retained. Furthermore, injection of synthetic piRNAs corresponding to normally deleted regions leads to their retention in later generations. Our findings highlight small RNAs as powerful transgenerational carriers of epigenetic information for genome programming.	[Wang, Xing; Bracht, John R.; Landweber, Laura F.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Fang, Wenwen] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Nowacki, Mariusz] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland	Princeton University; Princeton University; University of Bern	Landweber, LF (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	lfl@princeton.edu	Wang, Xing/B-3682-2018; Fang, Wenwen/B-8422-2016; Nowacki, Mariusz/E-4485-2011	Wang, Xing/0000-0001-9930-3287; Nowacki, Mariusz/0000-0003-4894-2905	NIH [GM59708]; NSF [0923810, 0900544]; DOD [W81XWH-10-1-0122]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059708, F32GM099462] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); DOD(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Perlman, B. Zee, and B. Garcia for mass spectrometry validation of the Otiwi1 antibody; J. Buckles, W. Wang, D. Storton, and L. Parsons for Illumina sequencing; L. Li and A. D. Goldman for assistance with phylogenetic analysis; X. Chen for searching the micronuclear genome assembly for junction-spanning piRNAs; A. Chen, K. Mochizuki, and M. Couvillion for sharing RNA IP protocols; E. Swart, J. Bloom, and P. Jiang for advice on computational analysis of deep-sequencing results; J. Postberg and J. Goodhouse for immunofluorescence advice; P. Andolfatto, J. Swan, J. Khurana, P. Schedl, and L. Beh for discussion or comments on the manuscript; and J. Wang for help with Oxytricha cell culture. We also thank three anonymous referees for valuable suggestions. This study was supported by NIH grant GM59708 and NSF grants 0923810 and 0900544 (to L.F.L.) and a DOD predoctoral fellowship W81XWH-10-1-0122 (to W.F.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Arnaiz O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002984; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bouhouche K, 2011, NUCLEIC ACIDS RES, V39, P4249, DOI 10.1093/nar/gkq1283; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chalker DL, 1996, MOL CELL BIOL, V16, P3658; Couvillion MT, 2009, GENE DEV, V23, P2016, DOI 10.1101/gad.1821209; Coyne RS, 2012, METHOD CELL BIOL, V109, P53, DOI 10.1016/B978-0-12-385967-9.00004-9; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; DUHARCOURT S, 1995, GENE DEV, V9, P2065, DOI 10.1101/gad.9.16.2065; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gan HY, 2011, RNA, V17, P1191, DOI 10.1261/rna.2648411; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lee SR, 2006, GENE DEV, V20, P28, DOI 10.1101/gad.1377006; Lepere G, 2008, GENE DEV, V22, P1501, DOI 10.1101/gad.473008; Lepere G, 2009, NUCLEIC ACIDS RES, V37, P903, DOI 10.1093/nar/gkn1018; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Liu YF, 2004, P NATL ACAD SCI USA, V101, P1679, DOI 10.1073/pnas.0305421101; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mollenbeck M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002330; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Nowacki M, 2009, SCIENCE, V324, P935, DOI 10.1126/science.1170023; Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Patzel V, 1999, NUCLEIC ACIDS RES, V27, P4328, DOI 10.1093/nar/27.22.4328; Prescott DM, 2000, NAT REV GENET, V1, P191, DOI 10.1038/35042057; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Schoeberl UE, 2012, GENE DEV, V26, P1729, DOI 10.1101/gad.196493.112; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Storici F, 2008, CURR OPIN MOL THER, V10, P224; Tian YA, 2011, P NATL ACAD SCI USA, V108, P903, DOI 10.1073/pnas.1017762108; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Witherspoon DJ, 1997, MOL BIOL EVOL, V14, P696, DOI 10.1093/oxfordjournals.molbev.a025809; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737; Zahler AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042371; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang HB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000219	71	99	100	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1243	1255		10.1016/j.cell.2012.10.045	http://dx.doi.org/10.1016/j.cell.2012.10.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217708	Green Accepted, Bronze			2022-12-24	WOS:000311999900014
J	Cong, L; Ran, FA; Cox, D; Lin, SL; Barretto, R; Habib, N; Hsu, PD; Wu, XB; Jiang, WY; Marraffini, LA; Zhang, F				Cong, Le; Ran, F. Ann; Cox, David; Lin, Shuailiang; Barretto, Robert; Habib, Naomi; Hsu, Patrick D.; Wu, Xuebing; Jiang, Wenyan; Marraffini, Luciano A.; Zhang, Feng			Multiplex Genome Engineering Using CRISPR/Cas Systems	SCIENCE			English	Article							STREPTOCOCCUS-THERMOPHILUS; IMMUNE-SYSTEM; TAL EFFECTORS; CAS SYSTEMS; SMALL RNAS; DNA; BACTERIA; ENDONUCLEASE; NUCLEASES; DEFENSE	Functional elucidation of causal genetic variants and elements requires precise genome editing technologies. The type II prokaryotic CRISPR (clustered regularly interspaced short palindromic repeats)/Cas adaptive immune system has been shown to facilitate RNA-guided site-specific DNA cleavage. We engineered two different type II CRISPR/Cas systems and demonstrate that Cas9 nucleases can be directed by short RNAs to induce precise cleavage at endogenous genomic loci in human and mouse cells. Cas9 can also be converted into a nicking enzyme to facilitate homology-directed repair with minimal mutagenic activity. Lastly, multiple guide sequences can be encoded into a single CRISPR array to enable simultaneous editing of several sites within the mammalian genome, demonstrating easy programmability and wide applicability of the RNA-guided nuclease technology.	[Cong, Le; Ran, F. Ann; Cox, David; Lin, Shuailiang; Habib, Naomi; Hsu, Patrick D.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Cong, Le; Ran, F. Ann; Cox, David; Lin, Shuailiang; Habib, Naomi; Hsu, Patrick D.; Zhang, Feng] MIT, Dept Biol Engn, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Cong, Le] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Cox, David] Harvard Univ, Sch Med, Harvard MIT Hlth Sci & Technol, Boston, MA 02115 USA; [Ran, F. Ann; Hsu, Patrick D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Lin, Shuailiang] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Barretto, Robert] Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Wu, Xuebing] MIT, Computat & Syst Biol Grad Program, Cambridge, MA 02139 USA; [Wu, Xuebing] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Jiang, Wenyan; Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, New York, NY 10065 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Tsinghua University; Columbia University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Rockefeller University	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	zhang@broadinstitute.org	Hsu, Patrick/ABD-5749-2021; Cong, Le/M-9981-2013; Habib, Naomi/AAA-8937-2020; Macrae, Rhiannon/AAX-1536-2020; Wu, Xuebing/C-9152-2013; Lin, Shuailiang/O-3272-2016	Cong, Le/0000-0003-4725-8714; Wu, Xuebing/0000-0003-0369-5269; Hsu, Patrick/0000-0002-9380-2648	Zhang lab; Medical Scientist Training Program; NIH [R01-GM34277, R01-CA133404]; NIH Director's New Innovator Award [DP2AI104556]; NIH Director's Pioneer Award [DP1MH100706]; Keck foundation; McKnight foundation; Gates foundation; Damon Runyon foundation; Searle Scholars foundation; Klingenstein foundation; Simons foundation; NATIONAL CANCER INSTITUTE [R01CA133404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI104556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM034277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073124] Funding Source: NIH RePORTER	Zhang lab; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck foundation(W.M. Keck Foundation); McKnight foundation; Gates foundation(Bill & Melinda Gates Foundation); Damon Runyon foundation; Searle Scholars foundation; Klingenstein foundation(Klingenstein Philanthropies); Simons foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the entire Zhang lab for their support and advice; P. A. Sharp for generous help with Northern blot analysis; C. Jennings, R. Desimone, and M. Kowalczyk for helpful comments; and X. Ye for help with confocal imaging. L. C. and X. W. are Howard Hughes Medical Institute International Student Research Fellows. D. C. is supported by the Medical Scientist Training Program. P. D. H. is a James Mills Pierce Fellow. X. W. is supported by NIH grants R01-GM34277 and R01-CA133404 to P. A. Sharp, X.W.'s thesis adviser. L. A. M. is supported by Searle Scholars, R. Allen, an Irma T. Hirschl Award, and a NIH Director's New Innovator Award (DP2AI104556). F.Z. is supported by a NIH Director's Pioneer Award (DP1MH100706); the Keck, McKnight, Gates, Damon Runyon, Searle Scholars, Klingenstein, and Simons foundations; R. Metcalfe; M. Boylan; and J. Pauley. The authors have no conflicting financial interests. A patent application has been filed relating to this work, and the authors plan on making the reagents widely available to the academic community through Addgene and to provide software tools via the Zhang lab Web site (www.genome-engineering.org).	Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/nmeth.1648, 10.1038/NMETH.1648]; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Magadan AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040913; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Wood A. J., 2011, WOOD SCI, V333, P307; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	29	9232	10694	363	8173	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					819	823		10.1126/science.1231143	http://dx.doi.org/10.1126/science.1231143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23287718	Green Submitted, Green Accepted			2022-12-24	WOS:000314874400049
J	Gerber, A; Esnault, C; Aubert, G; Treisman, R; Pralong, F; Schibler, U				Gerber, Alan; Esnault, Cyril; Aubert, Gregory; Treisman, Richard; Pralong, Francois; Schibler, Ueli			Blood-Borne Circadian Signal Stimulates Daily Oscillations in Actin Dynamics and SRF Activity	CELL			English	Article							SERUM RESPONSE FACTOR; NUCLEAR ACTIN; BINDING PROTEINS; TRANSCRIPTION; LIVER; GENE; RHYTHMS; TEMPERATURE; PHASE	In peripheral tissues circadian gene expression can be driven either by local oscillators or by cyclic systemic cues controlled by the master clock in the brain's suprachiasmatic nucleus. In the latter case, systemic signals can activate immediate early transcription factors (IETFs) and thereby control rhythmic transcription. In order to identify IETFs induced by diurnal blood-borne signals, we developed an unbiased experimental strategy, dubbed Synthetic TAndem Repeat PROMoter (STAR-PROM) screening. This technique relies on the observation that most transcription factor binding sites exist at a relatively high frequency in random DNA sequences. Using STAR-PROM we identified serum response factor (SRF) as an IETF responding to oscillating signaling proteins present in human and rodent sera. Our data suggest that in mouse liver SRF is regulated via dramatic diurnal changes of actin dynamics, leading to the rhythmic translocation of the SRF coactivator Myocardin-related transcription factor-B (MRTF-B) into the nucleus.	[Gerber, Alan; Schibler, Ueli] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Gerber, Alan; Schibler, Ueli] Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva, Switzerland; [Esnault, Cyril; Treisman, Richard] London Res Inst, London WC2A 3LY, England; [Aubert, Gregory; Pralong, Francois] Univ Hosp Lausanne CHUV, Serv Endocrinol Diabetol & Metab, Dept Med, CH-1011 Lausanne, Switzerland	University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Schibler, U (corresponding author), Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland.	ueli.schibler@unige.ch	Aubert, Gregory/S-7075-2019	Gerber, Alan/0000-0003-3909-3606; Esnault, Cyril/0000-0002-7358-8760; Treisman, Richard/0000-0002-9658-0067; Aubert, Gregory/0000-0002-5539-0224	Swiss National Science Foundation [SNF 31-113565, SNF 31-128656/1, SNF 310000-122094, SNF 320030-124886]; Swiss National Science Foundation (NCCR program grant Frontiers in Genetics); European Research Council [ERC-AdG 250117, ERC-Ad-G 268690]; State of Geneva; Louis Jeantet Foundation of Medicine; EMBO; Cancer Research UK; Cancer Research UK [15687] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation (NCCR program grant Frontiers in Genetics)(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); State of Geneva; Louis Jeantet Foundation of Medicine; EMBO(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	We would like to thank Pascal Gos for transcardial perfusion, Jean-Marc Matter for his help with tissue preparation, Nicolas Roggli for the artwork, and David Suter (Harvard University, Boston) for critical comments on the manuscript. Work in the laboratory of U.S. was supported by the Swiss National Science Foundation (SNF 31-113565, SNF 31-128656/1 and the NCCR program grant Frontiers in Genetics), the European Research Council (ERC-AdG 250117), the State of Geneva, and the Louis Jeantet Foundation of Medicine. C.E. was funded in part by a long-term fellowship from EMBO. Work in the laboratory of R.T. was supported by core funding from Cancer Research UK and the European Research Council (ERC-Ad-G 268690). Work in the laboratory of F. P. was supported by the Swiss National Science Foundation (SNF grants 310000-122094 and 320030-124886).	Bailey MJ, 2004, J BIOL CHEM, V279, P52247, DOI 10.1074/jbc.M405679200; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Cochran B H, 1993, NIDA Res Monogr, V125, P3; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; de Lanerolle P, 2011, NAT CELL BIOL, V13, P1282, DOI 10.1038/ncb2364; Diaz-Munoz Mauricio, 2010, Comp Hepatol, V9, P5, DOI 10.1186/1476-5926-9-5; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; FOX JEB, 1981, ANAL BIOCHEM, V117, P170, DOI 10.1016/0003-2697(81)90707-7; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; HAN TH, 1992, MOL CELL BIOL, V12, P4472, DOI 10.1128/MCB.12.10.4472; Hriscu M.L., 2004, J APPL BIOMED, V2, P199; KAST A, 1988, CHRONOBIOL INT, V5, P363, DOI 10.3109/07420528809067782; Kornmann B, 2007, COLD SPRING HARB SYM, V72, P319, DOI 10.1101/sqb.2007.72.041; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kotarsky K, 2001, ANAL BIOCHEM, V288, P209, DOI 10.1006/abio.2000.4898; Lange K, 2006, J CELL PHYSIOL, V209, P270, DOI 10.1002/jcp.20717; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; MADER S, 1993, P NATL ACAD SCI USA, V90, P5603, DOI 10.1073/pnas.90.12.5603; May RC, 2001, J CELL SCI, V114, P1061; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; SAMBROOK J, 2000, MOL CLONING LAB MANU; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Sukumaran S, 2011, J APPL PHYSIOL, V110, P1732, DOI 10.1152/japplphysiol.00079.2011; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; UCHIYAMA Y, 1990, J GASTROEN HEPATOL, V5, P321, DOI 10.1111/j.1440-1746.1990.tb01634.x; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Vujovic N, 2008, AM J PHYSIOL-REG I, V295, pR355, DOI 10.1152/ajpregu.00498.2007; Wang B, 2005, J CLIN MICROBIOL, V43, P2339, DOI 10.1128/JCM.43.5.2339-2344.2005; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	44	96	97	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					492	503		10.1016/j.cell.2012.12.027	http://dx.doi.org/10.1016/j.cell.2012.12.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374345	Bronze			2022-12-24	WOS:000314362800019
J	Chen, Q; Chen, YB; Bian, CJ; Fujiki, R; Yu, XC				Chen, Qiang; Chen, Yibin; Bian, Chunjing; Fujiki, Ryoji; Yu, Xiaochun			TET2 promotes histone O-GlcNAcylation during gene transcription	NATURE			English	Article							EMBRYONIC STEM-CELLS; GLCNAC TRANSFERASE; TETRATRICOPEPTIDE REPEATS; 5-HYDROXYMETHYLCYTOSINE; GENOME; 5-METHYLCYTOSINE; PROTEINS; NUCLEAR; DNA; DIFFERENTIATION	Ten eleven translocation (TET) enzymes, including TET1, TET2 and TET3, convert 5-methylcytosine to 5-hydroxymethylcytosine(1) and regulate gene transcription(2-5). However, the molecular mechanism by which TET family enzymes regulate gene transcription remains elusive(5,6). Using protein affinity purification, here we search for functional partners of TET proteins, and find that TET2 and TET3 associate with O-linked beta-N-acetylglucosamine (O-GlcNAc) transferase (OGT), an enzyme that by itself catalyses the addition of O-GlcNAc onto serine and threonine residues (O-GlcNAcylation) in vivo(7,8). TET2 directly interacts with OGT, which is important for the chromatin association of OGT in vivo. Although this specific interaction does not regulate the enzymatic activity of TET2, it facilitates OGT-dependent histone O-GlcNAcylation. Moreover, OGT associates with TET2 at transcription start sites. Downregulation of TET2 reduces the amount of histone 2B Ser 112 GlcNAc marks in vivo, which are associated with gene transcription regulation. Taken together, these results reveal a TET2-dependent O-GlcNAcylation of chromatin. The double epigenetic modifications on both DNA and histones by TET2 and OGT coordinate together for the regulation of gene transcription.	[Chen, Qiang; Chen, Yibin; Bian, Chunjing; Yu, Xiaochun] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Fujiki, Ryoji] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Fujiki, Ryoji] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Michigan System; University of Michigan; University of Tokyo; Japan Science & Technology Agency (JST)	Yu, XC (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, 1150 W Med Ctr Dr,5560A MSRBII, Ann Arbor, MI 48109 USA.	xiayu@med.umich.edu	chen, qiang/G-5031-2016; Chen, Yibin/L-3533-2014; Chen, Yibin/A-3019-2015	Chen, Yibin/0000-0003-1060-9373	National Institutes of Health [CA132755, CA130899]; University of Michigan Cancer Center; GI Peptide Research Center; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA132755, R01CA130899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Cancer Center(University of Michigan System); GI Peptide Research Center; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. Kuang for proofreading the manuscript and J. Hutchins for research support. This work was supported by the National Institutes of Health (CA132755 and CA130899 to X.Y.), the University of Michigan Cancer Center and GI Peptide Research Center. X.Y. is a recipient of the Era of Hope Scholar Award from the Department of Defense.	Borst P, 2008, ANNU REV MICROBIOL, V62, P235, DOI 10.1146/annurev.micro.62.081307.162750; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Robinson KA, 2007, AM J PHYSIOL-ENDOC M, V292, pE884, DOI 10.1152/ajpendo.00569.2006; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang Z, 2011, STEM CELLS DEV, V20, P259, DOI 10.1089/scd.2010.0072; Zhang SS, 2011, J BIOL CHEM, V286, P37483, DOI 10.1074/jbc.M111.284885	35	366	383	2	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2013	493	7433					561	+		10.1038/nature11742	http://dx.doi.org/10.1038/nature11742			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23222540	Green Accepted			2022-12-24	WOS:000313871400044
J	Spellberg, B; Bartlett, JG; Gilbert, DN				Spellberg, Brad; Bartlett, John G.; Gilbert, David N.			The Future of Antibiotics and Resistance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Spellberg, Brad] Harbor Univ Calif Angeles UCLA, Med Ctr, Div Gen Internal Med, Los Angeles Biomed Res Inst, Los Angeles, CA USA; [Spellberg, Brad] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Bartlett, John G.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; [Gilbert, David N.] Providence Portland Med Ctr, Dept Med Educ, Portland, OR USA; [Gilbert, David N.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Providence Portland Medical Center; Oregon Health & Science University	Spellberg, B (corresponding author), Harbor Univ Calif Angeles UCLA, Med Ctr, Div Gen Internal Med, Los Angeles Biomed Res Inst, Los Angeles, CA USA.				NIAID NIH HHS [R21 AI101750, R01 AI081719] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101750, R01AI081719] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Howell L., 2013, GLOBAL RISKS 2013; Lin L, 2012, MBIO, V3, DOI 10.1128/mBio.00312-12; Spellberg B, 2012, CLIN INFECT DIS, V55, P1031, DOI 10.1093/cid/cis688	5	387	407	4	88	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2013	368	4					299	302		10.1056/NEJMp1215093	http://dx.doi.org/10.1056/NEJMp1215093			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075KX	23343059	Green Accepted, Bronze			2022-12-24	WOS:000313885900002
J	Lin, CQ; Garruss, AS; Luo, ZJ; Guo, FL; Shilatifard, A				Lin, Chengqi; Garruss, Alexander S.; Luo, Zhuojuan; Guo, Fengli; Shilatifard, Ali			The RNA Pol II Elongation Factor EII3 Marks Enhancers in ES Cells and Primes Future Gene Activation	CELL			English	Article							EMBRYONIC STEM-CELLS; CIS-REGULATORY SIGNATURE; POLYMERASE-II; COMPLEX SEC; TRANSCRIPTION ELONGATION; CHROMATIN INTERACTIONS; GENOME; EXPRESSION; DROSOPHILA; COHESIN	Enhancers play a central role in precisely regulating the expression of developmentally regulated genes. However, the machineries required for enhancer-promoter communication have remained largely unknown. We have found that EII3, a member of the Ell (eleven-nineteen lysine-rich leukemia gene) family of RNA Pol II elongation factors, occupies enhancers in embryonic stem cells. EII3's association with enhancers is required for setting up proper Pol II occupancy at the promoter-proximal regions of developmentally regulated genes and for the recruitment of the super elongation complex ( SEC) to these loci following differentiation signals. Furthermore, EII3 binding to inactive or poised enhancers is essential for stem cell specification. We have also detected the presence of Pol II and EII3 in germ cell nuclei. These findings raise the possibility that transcription factors could prime gene expression by marking enhancers in ES cells or even as early as in the germ cell state.	[Lin, Chengqi; Garruss, Alexander S.; Luo, Zhuojuan; Guo, Fengli; Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Shilatifard, A (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	ash@stowers.org		Lin, Chengqi/0000-0002-2121-584X	Alex's Lemonade Stand Foundation; National Institute of Health [R01CA89455, R01CA150265]; NATIONAL CANCER INSTITUTE [R01CA089455, R01CA150265] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Dr. Edwin Smith for conversations and for critical reading of the manuscript. We also thank Boris Rubenstein for mathematical support and Michael Durnin, Stacy Marshall, and Ka Chun Lai for technical assistance. We are also thankful to Laura Shilatifard for editorial assistance. This work was performed to fulfill, in part, requirements for C.L.'s PhD. thesis research as a student registered with the Open University. Studies in this manuscript were supported, in part, by funds provided by the Alex's Lemonade Stand Foundation and from the National Institute of Health (R01CA89455 and R01CA150265 to A.S.).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Deng WL, 2010, CURR OPIN GENET DEV, V20, P548, DOI 10.1016/j.gde.2010.06.007; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Elmendorf BJ, 2001, J BIOL CHEM, V276, P23109, DOI 10.1074/jbc.M101445200; Engel N, 2004, NAT GENET, V36, P883, DOI 10.1038/ng1399; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Khoueiry P, 2010, CURR BIOL, V20, P792, DOI 10.1016/j.cub.2010.03.063; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Markstein M, 2002, CURR OPIN GENET DEV, V12, P601, DOI 10.1016/S0959-437X(02)00345-3; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller T, 2000, J BIOL CHEM, V275, P32052, DOI 10.1074/jbc.M005175200; Mishiro T, 2009, EMBO J, V28, P1234, DOI 10.1038/emboj.2009.81; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Newman JJ, 2010, COLD SH Q B, V75, P227, DOI 10.1101/sqb.2010.75.016; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Raschke EE, 1999, J IMMUNOL, V163, P4375; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Smith ER, 2011, MOL CELL, V44, P954, DOI 10.1016/j.molcel.2011.12.008; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056	55	74	76	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					144	156		10.1016/j.cell.2012.12.015	http://dx.doi.org/10.1016/j.cell.2012.12.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23273992	Green Accepted, Bronze			2022-12-24	WOS:000313719800013
J	Renata, H; Zhou, QH; Baran, PS				Renata, Hans; Zhou, Qianghui; Baran, Phil S.			Strategic Redox Relay Enables A Scalable Synthesis of Ouabagenin, A Bioactive Cardenolide	SCIENCE			English	Article							CROSS-COUPLING REACTIONS; STEROID GLYCOSIDES; NATURAL-PRODUCTS; BUFADIENOLIDES; OXIDATION; ALCOHOLS; OLEFINS; OUABAIN; OXYGEN	Here, we report on a scalable route to the polyhydroxylated steroid ouabagenin with an unusual take on the age-old practice of steroid semisynthesis. The incorporation of both redox and stereochemical relays during the design of this synthesis resulted in efficient access to more than 500 milligrams of a key precursor toward ouabagenin-and ultimately ouabagenin itself-and the discovery of innovative methods for carbon-hydrogen (C-H) and carbon-carbon activation and carbon-oxygen bond homolysis. Given the medicinal relevance of the cardenolides in the treatment of congestive heart failure, a variety of ouabagenin analogs could potentially be generated from the key intermediate as a means of addressing the narrow therapeutic index of these molecules. This synthesis also showcases an approach to bypass the historically challenging problem of selective C-H oxidation of saturated carbon centers in a controlled fashion.	[Renata, Hans; Zhou, Qianghui; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pbaran@scripps.edu	Zhou, Qianghui/D-8258-2016; Zhou, Qianghui/U-8879-2019	Zhou, Qianghui/0000-0002-8125-0380; Zhou, Qianghui/0000-0002-8125-0380	LEO Pharma; TEVA; NIH/NCI [CA134785]; Bristol-Myers Squibb; Shanghai Institute of Organic Chemistry; NATIONAL CANCER INSTITUTE [R01CA134785] Funding Source: NIH RePORTER	LEO Pharma(LEO Pharma); TEVA(Teva Pharmaceutical Industries); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bristol-Myers Squibb(Bristol-Myers Squibb); Shanghai Institute of Organic Chemistry; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support for this work was provided by LEO Pharma and an unrestricted grant from TEVA. Early studies were supported by the NIH/NCI (CA134785). Bristol-Myers Squibb supported a graduate fellowship to H. R., and the Shanghai Institute of Organic Chemistry supported a postdoctoral fellowship to Q.Z. We are grateful to A. Rheingold and C. E. Moore (University of California, San Diego) for x-ray crystallographic analysis and G. Siuzdak (the Scripps Research Institute) for mass spectrometry assistance. We thank J. Felding, H. Bladh, and R. Shenvi for valuable discussions. Metrical parameters for the structures of compounds 7 and 11' are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-909412 and 909413, respectively.	Anderson NG, 2012, ORG PROCESS RES DEV, V16, P852, DOI 10.1021/op200347k; Baran PS, 2007, NATURE, V446, P404, DOI 10.1038/nature05569; Barker TJ, 2012, J AM CHEM SOC, V134, P13588, DOI 10.1021/ja3063716; Barluenga J, 2004, CHEM-EUR J, V10, P4206, DOI 10.1002/chem.200400136; BARTON DHR, 1962, J CHEM SOC, P470, DOI 10.1039/jr9620000470; BARTON DHR, 1982, J CHEM SOC PERK T 1, P2085, DOI 10.1039/p19820002085; CHUNG SK, 1979, J ORG CHEM, V44, P1014, DOI 10.1021/jo01320a033; Corey E. J., 1989, LOGIC CHEM SYNTHESIS, P17; COREY EJ, 1959, J AM CHEM SOC, V81, P5209, DOI 10.1021/ja01528a046; Egner U, 1999, TETRAHEDRON, V55, P11267, DOI 10.1016/S0040-4020(99)00638-9; ERHARDT PW, 1987, J MED CHEM, V30, P231, DOI 10.1021/jm00385a001; Fortner KC, 2010, J AM CHEM SOC, V132, P275, DOI 10.1021/ja906996c; Furstner A, 2008, CHEM COMMUN, P2873, DOI 10.1039/b805299a; Hanson JR, 2005, NAT PROD REP, V22, P104, DOI 10.1039/b415086b; Heasley B, 2012, CHEM-EUR J, V18, P3092, DOI 10.1002/chem.201103733; Hollingworth GJ, 1996, J CHEM SOC PERK T 1, P1913, DOI 10.1039/p19960001913; HRYCKO S, 1988, J ORG CHEM, V53, P1515, DOI 10.1021/jo00242a032; IMHOF R, 1972, HELV CHIM ACTA, V55, P1151, DOI 10.1002/hlca.19720550410; ISAYAMA S, 1989, CHEM LETT, P1071, DOI 10.1246/cl.1989.1071; Ishihara Y, 2010, SYNLETT, P1733, DOI 10.1055/s-0030-1258123; Jana CK, 2011, ANGEW CHEM INT EDIT, V50, P8407, DOI 10.1002/anie.201101869; Kamano Y, 1998, BIOORGAN MED CHEM, V6, P1103, DOI 10.1016/S0968-0896(98)00067-4; Kawamura A, 1999, P NATL ACAD SCI USA, V96, P6654, DOI 10.1073/pnas.96.12.6654; Larock R. C., 1989, COMPREHENSIVE ORGANI, P505; MCDONALD CE, 1990, TETRAHEDRON LETT, V31, P6283, DOI 10.1016/S0040-4039(00)97043-6; Narayan S, 2005, ANGEW CHEM INT EDIT, V44, P3275, DOI 10.1002/anie.200462883; Newhouse T, 2009, CHEM SOC REV, V38, P3010, DOI 10.1039/b821200g; Ng D, 2004, ORG LETT, V6, P645, DOI 10.1021/ol0499250; Rousseau G, 2011, ANGEW CHEM INT EDIT, V50, P2450, DOI 10.1002/anie.201006139; Samojlowicz C, 2008, CHEM COMMUN, P6282, DOI 10.1039/b816567j; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; Shi J, 2011, J AM CHEM SOC, V133, P8014, DOI 10.1021/ja202103e; Szent-Gyorgyi A, 1953, CHEM PHYSL CONTRACTI, P86; TSCHESCHE R, 1972, PROC R SOC SER B-BIO, V180, P187, DOI 10.1098/rspb.1972.0014; VIJAYARAHAVAN B, 1990, TETRAHEDRON LETT, V31, P6223, DOI 10.1016/S0040-4039(00)97030-8; WEHRLI H, 1961, HELV CHIM ACTA, V44, P2162, DOI 10.1002/hlca.19610440745; WIESNER K, 1986, PURE APPL CHEM, V58, P799, DOI 10.1351/pac198658050799; Wietzerbin K, 2000, EUR J INORG CHEM, P1391; YEOM H, 1995, BIOCHEMISTRY-US, V34, P14733, DOI 10.1021/bi00045a014; YOSHII E, 1978, J ORG CHEM, V43, P3946, DOI 10.1021/jo00414a031; Zhang HX, 2008, ANGEW CHEM INT EDIT, V47, P1272, DOI 10.1002/anie.200704959	41	114	115	4	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					59	63		10.1126/science.1230631	http://dx.doi.org/10.1126/science.1230631			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288535	Green Accepted			2022-12-24	WOS:000312985800050
J	Srivastava, M; Nambiar, M; Sharma, S; Karki, SS; Goldsmith, G; Hegde, M; Kumar, S; Pandey, M; Singh, RK; Ray, P; Natarajan, R; Kelkar, M; De, A; Choudhary, B; Raghavan, SC				Srivastava, Mrinal; Nambiar, Mridula; Sharma, Sheetal; Karki, Subhas S.; Goldsmith, G.; Hegde, Mahesh; Kumar, Sujeet; Pandey, Monica; Singh, Ram K.; Ray, Pritha; Natarajan, Renuka; Kelkar, Madhura; De, Abhijit; Choudhary, Bibha; Raghavan, Sathees C.			An Inhibitor of Nonhomologous End-Joining Abrogates Double-Strand Break Repair and Impedes Cancer Progression	CELL			English	Article							DNA-LIGASE IV; EMBRYONIC LETHALITY; XRCC4-LIGASE IV; UP-REGULATION; CELL-LINES; PROTEINS; GENES; P53	DNA Ligase IV is responsible for sealing of double-strand breaks (DSBs) during nonhomologous end-joining (NHEJ). Inhibiting Ligase IV could result in amassing of DSBs, thereby serving as a strategy toward treatment of cancer. Here, we identify a molecule, SCR7 that inhibits joining of DSBs in cell-free repair system. SCR7 blocks Ligase IV-mediated joining by interfering with its DNA binding but not that of T4 DNA Ligase or Ligase I. SCR7 inhibits NHEJ in a Ligase IV-dependent manner within cells, and activates the intrinsic apoptotic pathway. More importantly, SCR7 impedes tumor progression in mouse models and when coadministered with DSB-inducing therapeutic modalities enhances their sensitivity significantly. This inhibitor to target NHEJ offers a strategy toward the treatment of cancer and improvement of existing regimens.	[Srivastava, Mrinal; Nambiar, Mridula; Sharma, Sheetal; Hegde, Mahesh; Pandey, Monica; Choudhary, Bibha; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Karki, Subhas S.; Kumar, Sujeet] KLE Univ, Coll Pharm, Dept Pharmaceut Chem, Bangalore 560010, Karnataka, India; [Goldsmith, G.; Natarajan, Renuka; Choudhary, Bibha] Inst Bioinformat & Appl Biotechnol, Bangalore 560100, Karnataka, India; [Singh, Ram K.; Ray, Pritha; Kelkar, Madhura; De, Abhijit] Adv Ctr Treatment Res & Educ Canc, Navi Mumbai 410210, India	Indian Institute of Science (IISC) - Bangalore; K.L.E. Academy of Higher Education & Research; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC)	Raghavan, SC (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	sathees@biochem.iisc.ernet.in	KUMAR, SUJEET/AAD-5081-2019; Srivastava, Mrinal/AAM-5013-2020; Hegde, MahesH/ABE-2057-2020; DE, ABHIJIT/AAR-5631-2021; karki, subhas s/AAH-6451-2020	KUMAR, SUJEET/0000-0002-0833-158X; Hegde, MahesH/0000-0002-7853-6281; DE, ABHIJIT/0000-0002-5818-0206; karki, subhas s/0000-0002-5599-3594; Singh, Ram Kumar/0000-0002-7654-1212	Indian Institute of Science, Bangalore; Leukemia Research Foundation, USA; CSIR; IISc; DBT (India)	Indian Institute of Science, Bangalore; Leukemia Research Foundation, USA; CSIR(Council of Scientific & Industrial Research (CSIR) - India); IISc; DBT (India)(Department of Biotechnology (DBT) India)	We are thankful to Prof. N. Yathindra for modeling and docking studies. We also thank P. Ajitkumar and B. Tharakan for suggestions; P. Kuppusamy for help; K.K. Chiruvella for reagents; and S.R. Ranganatha, D. Iyer, S. Javadekar, and members of SCR laboratory for critical reading of the manuscript. We thank Strides ARCOLAB Bangalore for Doxorubicin. Ligase IV/XRCC4 plasmid was a gift from M. Modesti (France). pETDuet-1 was from B. Gopal (India); Ligase I and Ligase III alpha/XRCC1 plasmids were from A. Tomkinson (USA) and K.W. Caldecott (UK), respectively. pREP-hLIGIV was from C. Campbell (USA), I-SceI vector from R. Scully (USA), and pcDNA3.1 RFP from Arun Kumar (India); pJS296 was gifted by J. Stark (USA). We thank V. Hegde for NMR (IISc). Animal, NMR, confocal, microtome and FACS facilities of IISc, and FACS facilities of C-CAMP, NCBS, are also acknowledged. We thank R. Malhotra for mouse imaging (ACTREC). A start-up grant from the Indian Institute of Science, Bangalore, and financial assistance from Leukemia Research Foundation, USA, for S.C.R. are acknowledged. Financial support from R. Varadarajan is also acknowledged. M.S. and M.P. are supported by CSIR, M.N. by IISc Research Associate fellowship, and S.S. by DBT (India).	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Chen X, 2008, CANCER RES, V68, P3169, DOI 10.1158/0008-5472.CAN-07-6636; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Gostissa M, 2011, ANNU REV IMMUNOL, V29, P319, DOI 10.1146/annurev-immunol-031210-101329; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Jayaram S, 2008, NUCLEIC ACIDS RES, V36, P5773, DOI 10.1093/nar/gkn552; Kumar TS, 2010, J BIOL CHEM, V285, P32657, DOI 10.1074/jbc.M110.140350; Kuschel B, 2002, HUM MOL GENET, V11, P1399, DOI 10.1093/hmg/11.12.1399; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P5813, DOI 10.1093/nar/gkr223; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pucci S, 2001, ONCOGENE, V20, P739, DOI 10.1038/sj.onc.1204148; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Sathees CR, 1999, MUTAT RES-DNA REPAIR, V433, P1, DOI 10.1016/S0921-8777(98)00055-X; Sharma S, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/389129; Sharma S, 2011, CELL MOL LIFE SCI, V68, P661, DOI 10.1007/s00018-010-0472-x; Shintani S, 2003, CANCER SCI, V94, P894, DOI 10.1111/j.1349-7006.2003.tb01372.x; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Sirzen F, 1999, EUR J CANCER, V35, P111, DOI 10.1016/S0959-8049(98)00289-5; Zapata JM, 1998, BREAST CANCER RES TR, V47, P129, DOI 10.1023/A:1005940832123; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	33	260	270	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1474	1487		10.1016/j.cell.2012.11.054	http://dx.doi.org/10.1016/j.cell.2012.11.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260137	Bronze			2022-12-24	WOS:000312890300013
J	O'Connor, TJ; Boyd, D; Dorer, MS; Isberg, RR				O'Connor, Tamara J.; Boyd, Dana; Dorer, Marion S.; Isberg, Ralph R.			Aggravating Genetic Interactions Allow a Solution to Redundancy in a Bacterial Pathogen	SCIENCE			English	Article							LEGIONELLA-PNEUMOPHILA GENOME; RAB GTPASE FUNCTION; ENDOPLASMIC-RETICULUM; IDENTIFICATION; MACROPHAGES; SYSTEM	Interactions between hosts and pathogens are complex, so understanding the events that govern these interactions requires the analysis of molecular mechanisms operating in both organisms. Many pathogens use multiple strategies to target a single event in the disease process, confounding the identification of the important determinants of virulence. We developed a genetic screening strategy called insertional mutagenesis and depletion (iMAD) that combines bacterial mutagenesis and RNA interference, to systematically dissect the interplay between a pathogen and its host. We used this technique to resolve the network of proteins secreted by the bacterium Legionella pneumophila to promote intracellular growth, a critical determinant of pathogenicity of this organism. This strategy is broadly applicable, allowing the dissection of any interface between two organisms involving numerous interactions.	[O'Connor, Tamara J.; Dorer, Marion S.; Isberg, Ralph R.] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA; [O'Connor, Tamara J.; Dorer, Marion S.; Isberg, Ralph R.] Tufts Univ, Sch Med, Dept Mol Microbiol & Microbiol, Boston, MA 02111 USA; [Boyd, Dana] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Tufts University; Tufts University; Harvard University; Harvard Medical School	Isberg, RR (corresponding author), Tufts Univ, Sch Med, Howard Hughes Med Inst, 150 Harrison Ave, Boston, MA 02111 USA.	ralph.isberg@tufts.edu			Howard Hughes Medical Institute; Natalie V. Zucker Fellowship; NIH [GMO41883]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041883] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Natalie V. Zucker Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Rubin and C. Sassetti for helpful advice regarding the TraSH protocol, plasmids, and equipment use; J. Vogel for plasmids; K. Bodi, TUCF genomics core facility, and A. Ensminger for scientific advice with genome sequencing protocols and analyses; and A. Camilli for equipment use. We thank D. Daigle, K. Davis, E. Haenssler, A. Hempstead, D. DeJesus, S. Mohammadi, and E. Creasey for reviewing the manuscript. This work was supported by the Howard Hughes Medical Institute (T.J.O. and M. S. D.), a Natalie V. Zucker Fellowship (T.J.O.), and NIH grant GMO41883 (D. B.). R. R. I. is an investigator of the Howard Hughes Medical Institute.	Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; BRAND BC, 1994, MOL MICROBIOL, V14, P797, DOI 10.1111/j.1365-2958.1994.tb01316.x; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Creasey EA, 2012, P NATL ACAD SCI USA, V109, P3481, DOI 10.1073/pnas.1121286109; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kvitko BH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000388; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Monnat J, 2000, MOL BIOL CELL, V11, P3469, DOI 10.1091/mbc.11.10.3469; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Nguyen TMN, 2006, J INFECT DIS, V193, P102, DOI 10.1086/498575; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Robinson CG, 2006, CELL MICROBIOL, V8, P793, DOI 10.1111/j.1462-5822.2005.00666.x; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Swanson MS, 1996, INFECT IMMUN, V64, P2585, DOI 10.1128/IAI.64.7.2585-2594.1996; Tilney LG, 2001, J CELL SCI, V114, P4637; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	27	86	86	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1440	1444		10.1126/science.1229556	http://dx.doi.org/10.1126/science.1229556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239729	Green Accepted			2022-12-24	WOS:000312250800040
J	Mali, P; Yang, LH; Esvelt, KM; Aach, J; Guell, M; DiCarlo, JE; Norville, JE; Church, GM				Mali, Prashant; Yang, Luhan; Esvelt, Kevin M.; Aach, John; Guell, Marc; DiCarlo, James E.; Norville, Julie E.; Church, George M.			RNA-Guided Human Genome Engineering via Cas9	SCIENCE			English	Article							ZINC-FINGER NUCLEASES; SYNTHETIC BIOLOGY; MAMMALIAN-CELLS; GENE CORRECTION; IN-VIVO; SYSTEMS; CLEAVAGE; BACTERIA; IMMUNITY; SPECIFICITIES	Bacteria and archaea have evolved adaptive immune defenses, termed clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems, that use short RNA to direct degradation of foreign nucleic acids. Here, we engineer the type II bacterial CRISPR system to function with custom guide RNA (gRNA) in human cells. For the endogenous AAVS1 locus, we obtained targeting rates of 10 to 25% in 293T cells, 13 to 8% in K562 cells, and 2 to 4% in induced pluripotent stem cells. We show that this process relies on CRISPR components; is sequence-specific; and, upon simultaneous introduction of multiple gRNAs, can effect multiplex editing of target loci. We also compute a genome-wide resource of similar to 190 K unique gRNAs targeting similar to 40.5% of human exons. Our results establish an RNA-guided editing tool for facile, robust, and multiplexable human genome engineering.	[Mali, Prashant; Yang, Luhan; Aach, John; Guell, Marc; Norville, Julie E.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Esvelt, Kevin M.; Church, George M.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA; [Yang, Luhan] Harvard Univ, Sch Med, Biol & Biomed Sci Program, Boston, MA 02115 USA; [DiCarlo, James E.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Boston University	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	gchurch@genetics.med.harvard.edu	Wilson, Matthew H/K-3193-2013; DiCarlo, James/AAJ-1579-2021; Güell, Marc/J-2970-2017; Güell, Marc/AAB-3054-2021	DiCarlo, James/0000-0003-4728-3186; Güell, Marc/0000-0003-4000-7912; Güell, Marc/0000-0003-4000-7912; church, george/0000-0001-6232-9969; Esvelt, Kevin/0000-0001-8797-3945; Norville, Julie/0000-0001-9205-8936	NIH [P50 HG005550]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by NIH grant P50 HG005550. We thank S. Kosuri for advice on the oligonucleotide pool designs and synthesis. G. M. C. and P. M. have filed a patent based on the findings of this study.	Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; King NMP, 2008, MOL THER, V16, P432, DOI 10.1038/mt.2008.13; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Lee JH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000718; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; REBAR EJ, 1994, SCIENCE, V263, P671, DOI 10.1126/science.8303274; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	28	5957	7002	115	3821	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					823	826		10.1126/science.1232033	http://dx.doi.org/10.1126/science.1232033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23287722	Green Accepted			2022-12-24	WOS:000314874400050
J	Sun, LJ; Wu, JX; Du, FH; Chen, X; Chen, ZJJ				Sun, Lijun; Wu, Jiaxi; Du, Fenghe; Chen, Xiang; Chen, Zhijian J.			Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway	SCIENCE			English	Article							INTRACELLULAR DNA; INNATE; IDENTIFICATION; IMMUNITY; RANGE; GENE; RNA	The presence of DNA in the cytoplasm of mammalian cells is a danger signal that triggers host immune responses such as the production of type I interferons. Cytosolic DNA induces interferons through the production of cyclic guanosine monophosphate-adenosine monophosphate (cyclic GMP-AMP, or cGAMP), which binds to and activates the adaptor protein STING. Through biochemical fractionation and quantitative mass spectrometry, we identified a cGAMP synthase (cGAS), which belongs to the nucleotidyltransferase family. Overexpression of cGAS activated the transcription factor IRF3 and induced interferon-beta in a STING-dependent manner. Knockdown of cGAS inhibited IRF3 activation and interferon-b induction by DNA transfection or DNA virus infection. cGAS bound to DNA in the cytoplasm and catalyzed cGAMP synthesis. These results indicate that cGAS is a cytosolic DNA sensor that induces interferons by producing the second messenger cGAMP.	[Sun, Lijun; Wu, Jiaxi; Du, Fenghe; Chen, Xiang; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Sun, Lijun; Du, Fenghe; Chen, Xiang; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Wu, Jiaxi/K-3322-2016; Chen, Zhijian/C-6039-2012	Wu, Jiaxi/0000-0002-6976-4784; Chen, Zhijian/0000-0002-8475-8251	NIH [AI-093967]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. Li for helpful discussion on bioinformatics analyses. The GenBank accession numbers for human and mouse cGAS sequences are KC294566 and KC294567, respectively. Supported by NIH grant AI-093967. Z.J.C. is an investigator of Howard Hughes Medical Institute.	Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; CHOW KL, 1995, DEVELOPMENT, V121, P3615; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; O'Neill LAJ, 2009, CELL, V138, P428, DOI 10.1016/j.cell.2009.07.021; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Rigby RE, 2008, BIOESSAYS, V30, P833, DOI 10.1002/bies.20808; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yao YH, 2013, AUTOIMMUN REV, V12, P558, DOI 10.1016/j.autrev.2012.10.006; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	21	2351	2471	62	669	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					786	791		10.1126/science.1232458	http://dx.doi.org/10.1126/science.1232458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23258413	Green Accepted			2022-12-24	WOS:000314874400039
J	Picotti, P; Clement-Ziza, M; Lam, H; Campbell, DS; Schmidt, A; Deutsch, EW; Rost, H; Sun, Z; Rinner, O; Reiter, L; Shen, Q; Michaelson, JJ; Frei, A; Alberti, S; Kusebauch, U; Wollscheid, B; Moritz, RL; Beyer, A; Aebersold, R				Picotti, Paola; Clement-Ziza, Mathieu; Lam, Henry; Campbell, David S.; Schmidt, Alexander; Deutsch, Eric W.; Roest, Hannes; Sun, Zhi; Rinner, Oliver; Reiter, Lukas; Shen, Qin; Michaelson, Jacob J.; Frei, Andreas; Alberti, Simon; Kusebauch, Ulrike; Wollscheid, Bernd; Moritz, Robert L.; Beyer, Andreas; Aebersold, Ruedi			A complete mass-spectrometric map of the yeast proteome applied to quantitative trait analysis	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PEPTIDE IDENTIFICATION; BUDDING YEAST; EXPRESSION; PREDICTION; LIBRARIES; PROTEINS; SEQUENCE; TANDEM; ASSAYS	Experience from different fields of life sciences suggests that accessible, complete reference maps of the components of the system under study are highly beneficial research tools. Examples of such maps include libraries of the spectroscopic properties of molecules, or databases of drug structures in analytical or forensic chemistry. Such maps, and methods to navigate them, constitute reliable assays to probe any sample for the presence and amount of molecules contained in the map. So far, attempts to generate such maps for any proteome have failed to reach complete proteome coverage(1-3). Here we use a strategy based on high-throughput peptide synthesis and mass spectrometry to generate an almost complete reference map (97% of the genome-predicted proteins) of the Saccharomyces cerevisiae proteome. We generated two versions of this mass-spectrometric map, one supporting discovery-driven (shotgun)(3,4) and the other supporting hypothesis-driven (targeted)(5,6) proteomic measurements. Together, the two versions of the map constitute a complete set of proteomic assays to support most studies performed with contemporary proteomic technologies. To show the utility of the maps, we applied them to a protein quantitative trait locus (QTL) analysis(7), which requires precise measurement of the same set of peptides over a large number of samples. Protein measurements over 78 S. cerevisiae strains revealed a complex relationship between independent genetic loci, influencing the levels of related proteins. Our results suggest that selective pressure favours the acquisition of sets of polymorphisms that adapt protein levels but also maintain the stoichiometry of functionally related pathway members.	[Picotti, Paola; Roest, Hannes; Rinner, Oliver; Reiter, Lukas; Shen, Qin; Frei, Andreas; Wollscheid, Bernd; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Picotti, Paola] ETH, Inst Biochem, Dept Biol, CH-8093 Zurich, Switzerland; [Clement-Ziza, Mathieu; Michaelson, Jacob J.; Beyer, Andreas] Tech Univ Dresden, Ctr Biotechnol, D-01069 Dresden, Germany; [Lam, Henry] Hong Kong Univ Sci & Technol, Dept Chem & Biomol Engn, Hong Kong, Hong Kong, Peoples R China; [Lam, Henry] Hong Kong Univ Sci & Technol, Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Campbell, David S.; Deutsch, Eric W.; Sun, Zhi; Kusebauch, Ulrike; Moritz, Robert L.] Inst Syst Biol, Seattle, WA 98103 USA; [Schmidt, Alexander] Univ Basel, Prote Core Facil Biozentrum, CH-4056 Basel, Switzerland; [Rinner, Oliver; Reiter, Lukas] Biognosys AG, CH-8093 Zurich, Switzerland; [Shen, Qin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China; [Alberti, Simon] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Aebersold, Ruedi] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technische Universitat Dresden; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Institute for Systems Biology (ISB); University of Basel; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; University of Zurich	Aebersold, R (corresponding author), ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland.	paola.picotti@bc.biol.ethz.ch; andreas.beyer@biotec.tu-dresden.de; aebersold@imsb.biol.ethz.ch	Moritz, Robert L/B-9222-2011; Röst, Hannes/L-2056-2019; Clément-Ziza, Mathieu/J-4146-2012; Deutsch, Eric/AAF-5912-2020; Wollscheid, Bernd/E-8909-2010; Alberti, Simon/ABB-8277-2021; Röst, Hannes L/E-9564-2013; Lam, Henry/D-8629-2011; Beyer, Andreas/A-3352-2009; Beyer, Andreas/AAQ-5519-2020; Alberti, Simon/B-2822-2017	Röst, Hannes/0000-0003-0990-7488; Clément-Ziza, Mathieu/0000-0003-2763-249X; Wollscheid, Bernd/0000-0002-3923-1610; Röst, Hannes L/0000-0003-0990-7488; Lam, Henry/0000-0001-7928-0364; Beyer, Andreas/0000-0002-3891-2123; Beyer, Andreas/0000-0002-3891-2123; Michaelson, Jacob/0000-0001-9713-0992; Alberti, Simon/0000-0003-4017-6505; Deutsch, Eric/0000-0001-8732-0928	ETH Zurich; Swiss National Science Foundation [3100A0-107679]; National Heart, Lung and Blood Institute, National Institutes of Health [N01-HV-28179]; National Science Foundation MRI [0923536]; Luxembourg Centre for Systems Biomedicine; University of Luxembourg; SystemsX.ch; Swiss initiative for systems biology; Foerderungsprofessur grant from the Swiss National Science Foundation [PP00P3_133670]; European Union Seventh Framework Program Reintegration grant [FP7-PEOPLE-2010-RG-277147]; Promedica Stiftung [2-70669-11]; University Grant Council of the Hong Kong Special Administrative Region Government, China [HKUST DAG08/09.EG02]; Klaus Tschira Foundation; European Union FP7 HEALTH grant [HEALTH-F4-2008-223539]; European Research Council [ERC-2008-AdG 233226]; SystemsX.ch, the Swiss Initiative for Systems Biolod; Div Of Biological Infrastructure [0923536] Funding Source: National Science Foundation; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028179] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation MRI(National Science Foundation (NSF)); Luxembourg Centre for Systems Biomedicine; University of Luxembourg; SystemsX.ch; Swiss initiative for systems biology; Foerderungsprofessur grant from the Swiss National Science Foundation; European Union Seventh Framework Program Reintegration grant; Promedica Stiftung; University Grant Council of the Hong Kong Special Administrative Region Government, China; Klaus Tschira Foundation; European Union FP7 HEALTH grant; European Research Council(European Research Council (ERC)European Commission); SystemsX.ch, the Swiss Initiative for Systems Biolod; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project has been funded in part by ETH Zurich, the Swiss National Science Foundation (3100A0-107679), the National Heart, Lung and Blood Institute, National Institutes of Health (N01-HV-28179), the National Science Foundation MRI (grant 0923536); the Luxembourg Centre for Systems Biomedicine and the University of Luxembourg, and by SystemsX.ch, the Swiss initiative for systems biology. PP. is supported by a Foerderungsprofessur grant from the Swiss National Science Foundation (PP00P3_133670), by a European Union Seventh Framework Program Reintegration grant (FP7-PEOPLE-2010-RG-277147) and by a Promedica Stiftung (2-70669-11), H. L is supported by the University Grant Council of the Hong Kong Special Administrative Region Government, China (HKUST DAG08/09.EG02). A.B. is supported by the Klaus Tschira Foundation and by a European Union FP7 HEALTH grant (HEALTH-F4-2008-223539). R.A. is supported by the European Research Council (ERC-2008-AdG 233226) and by SystemsX.ch, the Swiss Initiative for Systems Biolod.	Ackermann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040916; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Ahrens CH, 2010, NAT REV MOL CELL BIO, V11, P789, DOI 10.1038/nrm2973; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Colon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016099; Craig R, 2006, J PROTEOME RES, V5, P1843, DOI 10.1021/pr0602085; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; de Smidt O, 2012, FEMS YEAST RES, V12, P33, DOI 10.1111/j.1567-1364.2011.00760.x; Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56; Deutsch EW, 2010, METHODS MOL BIOL, V604, P285, DOI 10.1007/978-1-60761-444-9_19; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Fraser HB, 2010, P NATL ACAD SCI USA, V107, P2977, DOI 10.1073/pnas.0912245107; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Krokhin OV, 2006, ANAL CHEM, V78, P7785, DOI 10.1021/ac060777w; Lam H, 2008, NAT METHODS, V5, P873, DOI 10.1038/NMETH.1254; Lam H, 2010, METHODS MOL BIOL, V604, P95, DOI 10.1007/978-1-60761-444-9_7; Lange V, 2008, MOL CELL PROTEOMICS, V7, P1489, DOI 10.1074/mcp.M800032-MCP200; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Michaelson JJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-502; Picotti P, 2008, NAT METHODS, V5, P913, DOI 10.1038/nmeth1108-913; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Reiter L, 2011, NAT METHODS, V8, P430, DOI [10.1038/NMETH.1584, 10.1038/nmeth.1584]; Rost H, 2012, MOL CELL PROTEOMICS, V11, P540, DOI 10.1074/mcp.M111.013045; Taussig M. J., 2007, NATURE METHODS, V4, p[13, 187]; YOUNG ET, 1985, MOL CELL BIOL, V5, P3024, DOI 10.1128/MCB.5.11.3024; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	30	212	218	5	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					266	270		10.1038/nature11835	http://dx.doi.org/10.1038/nature11835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23334424	Green Accepted			2022-12-24	WOS:000315137700046
J	Rao, S; Chun, C; Fan, JQ; Kofron, JM; Yang, MB; Hegde, RS; Ferrara, N; Copenhagen, DR; Lang, RA				Rao, Sujata; Chun, Christina; Fan, Jieqing; Kofron, J. Matthew; Yang, Michael B.; Hegde, Rashmi S.; Ferrara, Napoleone; Copenhagen, David R.; Lang, Richard A.			A direct and melanopsin-dependent fetal light response regulates mouse eye development	NATURE			English	Article							VEGF; APOPTOSIS; VESSEL; OPSIN; CELLS	Vascular patterning is critical for organ function. In the eye, there is simultaneous regression of embryonic hyaloid vasculature(1) (important to clear the optical path) and formation of the retinal vasculature (important for the high metabolic demands of retinal neurons). These events occur postnatally in the mouse. Here we have identified a light-response pathway that regulates both processes. We show that when mice are mutated in the gene (Opn4) for the atypical opsin melanopsin(3-5), or are dark-reared from late gestation, the hyaloid vessels are persistent at 8 days post-partum and the retinal vasculature overgrows. We provide evidence that these vascular anomalies are explained by a light-response pathway that suppresses retinal neuron number, limits hypoxia and, as a consequence, holds local expression of vascular endothelial growth factor (VEGFA) in check. We also show that the light response for this pathway occurs in late gestation at about embryonic day 16 and requires the photopigment in the fetus and not the mother. Measurements show that visceral cavity photon flux is probably sufficient to activate melanopsin-expressing retinal ganglion cells in the mouse fetus. These data thus show that light the stimulus for function of the mature eye is also critical in preparing the eye for vision by regulating retinal neuron number and initiating a series of events that ultimately pattern the ocular blood vessels.	[Rao, Sujata; Fan, Jieqing; Yang, Michael B.; Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Ophthalmol, Abrahamson Pediat Eye Inst, Visual Syst Grp, Cincinnati, OH 45229 USA; [Chun, Christina; Copenhagen, David R.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94158 USA; [Chun, Christina; Copenhagen, David R.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Kofron, J. Matthew; Hegde, Rashmi S.; Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Yang, Michael B.; Lang, Richard A.] Univ Cincinnati, Coll Med, Dept Ophthalmol, Cincinnati, OH 45229 USA; [Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA	Cincinnati Children's Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Roche Holding; Genentech	Lang, RA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Ophthalmol, Abrahamson Pediat Eye Inst, Visual Syst Grp, Cincinnati, OH 45229 USA.	cope@phy.ucsf.edu; richard.lang@cchmc.org		Lang, Richard/0000-0002-5212-254X; Kofron, Matthew/0000-0001-6427-4148	NIH [AR-47363]; Abrahamson Pediatric Eye Institute of CCHMC; That Man May See at UCSF; Research to Prevent Blindness; March of Dimes; NATIONAL EYE INSTITUTE [R01EY021636, R01EY023179, R01EY022917, R01EY014648, R01EY001869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047363] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abrahamson Pediatric Eye Institute of CCHMC; That Man May See at UCSF; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); March of Dimes(March of Dimes); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Bredl, P. Speeg and M. Sarangdhar for technical assistance, A. Delwig and N. Brown for advice. We acknowledge the assistance of the Research Flow Cytometry Core in the Division of Rheumatology at CCHMC, supported in part by NIH AR-47363. This work was supported by the NIH (R.A.L, D.R.C., J.M.K and R.S.H.) with additional funding from the Abrahamson Pediatric Eye Institute of CCHMC, That Man May See at UCSF, Research to Prevent Blindness (D.R.C.) and March of Dimes (D.R.C.).	ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Edwards MM, 2012, EXP EYE RES, V96, P147, DOI 10.1016/j.exer.2011.12.005; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Kurihara T, 2010, DEVELOPMENT, V137, P1563, DOI 10.1242/dev.049015; Lange C, 2011, NEUROBIOL DIS, V41, P119, DOI 10.1016/j.nbd.2010.08.028; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Meeson AP, 1999, DEVELOPMENT, V126, P1407; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Tarttelin EE, 2003, EXP EYE RES, V76, P393, DOI 10.1016/S0014-4835(02)00300-7; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Wong KY, 2012, J NEUROSCI, V32, P11478, DOI 10.1523/JNEUROSCI.1423-12.2012	25	123	127	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					243	246		10.1038/nature11823	http://dx.doi.org/10.1038/nature11823			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23334418	Green Accepted			2022-12-24	WOS:000315137700041
J	Hao, N; Budnik, BA; Gunawardena, J; O'Shea, EK				Hao, Nan; Budnik, Bogdan A.; Gunawardena, Jeremy; O'Shea, Erin K.			Tunable Signal Processing Through Modular Control of Transcription Factor Translocation	SCIENCE			English	Article							MAP KINASE PATHWAY; NUCLEAR-LOCALIZATION; PROTEIN-KINASE; GENE-REGULATION; STRESS; DYNAMICS; YEAST; PHOSPHORYLATION; SWITCH; P53	Signaling pathways can induce different dynamics of transcription factor (TF) activation. We explored how TFs process signaling inputs to generate diverse dynamic responses. The budding yeast general stress-responsive TF Msn2 acted as a tunable signal processor that could track, filter, or integrate signals in an input-dependent manner. This tunable signal processing appears to originate from dual regulation of both nuclear import and export by phosphorylation, as mutants with one form of regulation sustained only one signal-processing function. Versatile signal processing by Msn2 is crucial for generating distinct dynamic responses to different natural stresses. Our findings reveal how complex signal-processing functions are integrated into a single molecule and provide a guide for the design of TFs with "programmable" signal-processing functions.	[Hao, Nan; Budnik, Bogdan A.; O'Shea, Erin K.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Hao, Nan; O'Shea, Erin K.] Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Hao, Nan; O'Shea, Erin K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Gunawardena, Jeremy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard Medical School	O'Shea, EK (corresponding author), Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA.	erin_oshea@harvard.edu	Budnik, Bogdan/AGG-8824-2022; Budnik, Bogdan/AAH-9987-2019; Hao, Nan/O-3462-2016	Budnik, Bogdan/0000-0003-3622-2003; Hao, Nan/0000-0003-2857-4789	NIH [R01 GM081578]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081578] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Murray, P. Cluzel, S. Ramanathan, B. Stern, and M. Rust for comments on the manuscript and S. Mukherji, X. Zhou, A. S. Hansen, and other members of the O'Shea lab for helpful discussions. J.G. is supported by NIH R01 GM081578. E.K.O. is an Investigator of the Howard Hughes Medical Institute.	ADAMS JA, 1993, J BIOL CHEM, V268, P7747; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Batchelor E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.20; Behar M, 2010, CURR OPIN GENET DEV, V20, P684, DOI 10.1016/j.gde.2010.09.007; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chen XC, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-40; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Levy S, 2011, SCIENCE, V334, P1408, DOI 10.1126/science.1207154; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Locke JCW, 2011, SCIENCE, V334, P366, DOI 10.1126/science.1208144; Longo Diane M, 2010, Syst Synth Biol, V4, P15, DOI 10.1007/s11693-009-9044-5; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Shulga N, 1996, J CELL BIOL, V135, P329, DOI 10.1083/jcb.135.2.329; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Tudisca V, 2010, EUR J CELL BIOL, V89, P339, DOI 10.1016/j.ejcb.2009.08.005; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319	29	92	94	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					460	464		10.1126/science.1227299	http://dx.doi.org/10.1126/science.1227299			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349292	Green Accepted			2022-12-24	WOS:000313960700047
J	Morgan, JLW; Strumillo, J; Zimmer, J				Morgan, Jacob L. W.; Strumillo, Joanna; Zimmer, Jochen			Crystallographic snapshot of cellulose synthesis and membrane translocation	NATURE			English	Article							C-DI-GMP; ACETOBACTER-XYLINUM; STRUCTURAL BASIS; IN-VITRO; BIOSYNTHESIS; SYNTHASES; BINDING; SYSTEM; GLYCOSYLTRANSFERASES; MICROFIBRILS	Cellulose, the most abundant biological macromolecule, is an extracellular, linear polymer of glucose molecules. It represents an essential component of plant cell walls but is also found in algae and bacteria. In bacteria, cellulose production frequently correlates with the formation of biofilms, a sessile, multicellular growth form. Cellulose synthesis and transport across the inner bacterial membrane is mediated by a complex of the membrane-integrated catalytic BcsA subunit and the membrane-anchored, periplasmic BcsB protein. Here we present the crystal structure of a complex of BcsA and BcsB from Rhodobacter sphaeroides containing a translocating polysaccharide. The structure of the BcsA-BcsB translocation intermediate reveals the architecture of the cellulose synthase, demonstrates how BcsA forms a cellulose-conducting channel, and suggests a model for the coupling of cellulose synthesis and translocation in which the nascent polysaccharide is extended by one glucose molecule at a time.	[Morgan, Jacob L. W.; Strumillo, Joanna; Zimmer, Jochen] Univ Virginia, Dept Mol Physiol & Biol Phys, Ctr Membrane Biol, Charlottesville, VA 22908 USA; [Strumillo, Joanna] Univ Lodz, Fac Biol & Environm Protect, PL-90231 Lodz, Poland	University of Virginia; University of Lodz	Zimmer, J (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Ctr Membrane Biol, Charlottesville, VA 22908 USA.	jochen_zimmer@virginia.edu		Strumillo, Joanna/0000-0001-5478-2595; Zimmer, Jochen/0000-0002-8423-2882	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357, W-31-109-Eng-38]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; Department of Energy [DE-FG02-09ER-20097]; NIH [1R01GM101001]; University of Virginia; University of Virginia School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101001] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia; University of Virginia School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to G. Murshudov for advice on Refmac refinement and U. and Z. Derewenda for discussions. We thank L. Tamm, M. Wiener, A. Walling and T. Rapoport for critical comments on the manuscript. X-ray diffraction data were collected at GM/CA- and Southeast Regional-Collaborative Access Team beamlines at the Advanced Photon Source (APS), Argonne National Laboratory. Use of the APS was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, contract no. DE-AC02-06CH11357 and W-31-109-Eng-38. GM/CA at APS has been funded in whole or in part with funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Sciences (Y1-GM-1104). The University of Georgia CCRC is supported by the Department of Energy funded Center for Plant and Microbial Complex Carbohydrates (DE-FG02-09ER-20097). J.L.W.M. is partially supported by a Peach Fellowship, University of Virginia. J.Z. is support by NIH grant 1R01GM101001 and start-up funds from the University of Virginia School of Medicine.	ALONI Y, 1982, P NATL ACAD SCI-BIOL, V79, P6448, DOI 10.1073/pnas.79.21.6448; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Brown RM, 2004, J POLYM SCI POL CHEM, V42, P487, DOI 10.1002/pola.10877; BUREAU TE, 1987, P NATL ACAD SCI USA, V84, P6985, DOI 10.1073/pnas.84.20.6985; Burton B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000406; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carpita NC, 2011, PLANT PHYSIOL, V155, P171, DOI 10.1104/pp.110.163360; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Daras G, 2009, NEW PHYTOL, V184, P114, DOI 10.1111/j.1469-8137.2009.02960.x; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; DOWD MK, 1992, CARBOHYD RES, V233, P15, DOI 10.1016/S0008-6215(00)90917-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grimson MJ, 1996, J CELL SCI, V109, P3079; Harris DM, 2012, P NATL ACAD SCI USA, V109, P4098, DOI 10.1073/pnas.1200352109; Hu SQ, 2010, P NATL ACAD SCI USA, V107, P17957, DOI 10.1073/pnas.1000601107; Hubbard C, 2012, J MOL BIOL, V418, P21, DOI 10.1016/j.jmb.2012.01.053; Jahn CE, 2011, MICROBIOL-SGM, V157, P2733, DOI 10.1099/mic.0.051003-0; Kimura S, 1996, PROTOPLASMA, V194, P151, DOI 10.1007/BF01882023; Koyama M, 1997, P NATL ACAD SCI USA, V94, P9091, DOI 10.1073/pnas.94.17.9091; Kozmon S, 2006, J AM CHEM SOC, V128, P16921, DOI 10.1021/ja065944o; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Lai-Kee-Him J, 2002, J BIOL CHEM, V277, P36931, DOI 10.1074/jbc.M203530200; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; MATTHYSSE AG, 1995, J BACTERIOL, V177, P1076, DOI 10.1128/jb.177.4.1076-1081.1995; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Momany FA, 2011, CARBOHYD RES, V346, P619, DOI 10.1016/j.carres.2011.01.004; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PyMol, 2000, PYMOL MOL GRAPHICS S; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rapoport TA, 2008, FEBS J, V275, P4471, DOI 10.1111/j.1742-4658.2008.06588.x; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2002, RES MICROBIOL, V153, P205, DOI 10.1016/S0923-2508(02)01316-5; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; SAXENA IM, 1994, J BACTERIOL, V176, P5735, DOI 10.1128/JB.176.18.5735-5752.1994; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; STANDAL R, 1994, J BACTERIOL, V176, P665, DOI 10.1128/jb.176.3.665-672.1994; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545	50	363	371	28	415	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					181	U192		10.1038/nature11744	http://dx.doi.org/10.1038/nature11744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23222542	Green Accepted			2022-12-24	WOS:000313259600031
J	Plotnikov, SV; Pasapera, AM; Sabass, B; Waterman, CM				Plotnikov, Sergey V.; Pasapera, Ana M.; Sabass, Benedikt; Waterman, Clare M.			Force Fluctuations within Focal Adhesions Mediate ECM-Rigidity Sensing to Guide Directed Cell Migration	CELL			English	Article							PAXILLIN PHOSPHORYLATION; VINCULIN RECRUITMENT; MATRIX; KINASE; GROWTH; LAMELLIPODIA; CHEMOTAXIS; PHENOTYPE; DYNAMICS; ARP2/3	Cell migration toward areas of higher extracellular matrix (ECM) rigidity via a process called "durotaxis" is thought to contribute to development, immune response, and cancer metastasis. To understand how cells sample ECM rigidity to guide durotaxis, we characterized cell-generated forces on the nanoscale within single mature integrin-based focal adhesions (FAs). We found that individual FAs act autonomously, exhibiting either stable or dynamically fluctuating ("tugging") traction. We show that a FAK/phosphopaxillin/vinculin pathway is essential for high FA traction and to enable tugging FA traction over a broad range of ECM rigidities. We show that tugging FA traction is dispensable for FA maturation, chemotaxis, and haptotaxis but is critical to direct cell migration toward rigid ECM. We conclude that individual FAs dynamically sample rigidity by applying fluctuating pulling forces to the ECM to act as sensors to guide durotaxis, and that FAK/phosphopaxillin/vinculin signaling defines the rigidity range over which this dynamic sensing process operates.	[Plotnikov, Sergey V.; Pasapera, Ana M.; Waterman, Clare M.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20892 USA; [Sabass, Benedikt] Univ Stuttgart, Inst Theoret Phys, D-70550 Stuttgart, Germany	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Stuttgart	Waterman, CM (corresponding author), NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	watermancm@nhlbi.nih.gov	Sabass, Benedikt/N-1431-2017	Sabass, Benedikt/0000-0002-7769-8043; Plotnikov, Sergey/0000-0002-5561-8890; Waterman, Clare/0000-0001-6142-6775	Division of Intramural Research, National Heart Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005104] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Mary Beckerle for mouse embryonic fibroblasts, Michael Davidson for mApple paxillin, William Shin for support of the Waterman Lab microscopes, Sharon Campbell and Robert Fischer for helpful suggestions, and the NHLBI flow cytometry core facility. This research was supported by the Division of Intramural Research, National Heart Lung and Blood Institute.	Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Dumbauld DW, 2010, J CELL PHYSIOL, V223, P746, DOI 10.1002/jcp.22084; Dumbauld DW, 2010, BIOL CELL, V102, P203, DOI 10.1042/BC20090104; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fabry B, 2011, BIOPHYS J, V101, P2131, DOI 10.1016/j.bpj.2011.09.043; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; INGBER DE, 1989, CELL, V58, P803, DOI 10.1016/0092-8674(89)90928-8; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Koch D, 2012, BIOPHYS J, V102, P452, DOI 10.1016/j.bpj.2011.12.025; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Landau L.D., 1970, THEORY ELASTICITY; Mandeville JTH, 1997, J LEUKOCYTE BIOL, V61, P188, DOI 10.1002/jlb.61.2.188; Margadant F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001223; Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171; Nicolas A, 2004, P NATL ACAD SCI USA, V101, P12520, DOI 10.1073/pnas.0403539101; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Raz-Ben Aroush D, 2006, ADV MATER, V18, P1537, DOI 10.1002/adma.200600372; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Schneider IC, 2009, MOL BIOL CELL, V20, P3155, DOI 10.1091/mbc.E09-03-0219; Stricker J, 2011, BIOPHYS J, V100, P2883, DOI 10.1016/j.bpj.2011.05.023; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wolfenson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004304; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314	40	552	560	17	249	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1513	1527		10.1016/j.cell.2012.11.034	http://dx.doi.org/10.1016/j.cell.2012.11.034			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260139	Green Accepted, Bronze			2022-12-24	WOS:000312890300016
J	Polo, JM; Anderssen, E; Walsh, RM; Schwarz, BA; Nefzger, CM; Lim, SM; Borkent, M; Apostolou, E; Alaei, S; Cloutier, J; Bar-Nur, O; Cheloufi, S; Stadtfeld, M; Figueroa, ME; Robinton, D; Natesan, S; Melnick, A; Zhu, JF; Ramaswamy, S; Hochedlinger, K				Polo, Jose M.; Anderssen, Endre; Walsh, Ryan M.; Schwarz, Benjamin A.; Nefzger, Christian M.; Lim, Sue Mei; Borkent, Marti; Apostolou, Effie; Alaei, Sara; Cloutier, Jennifer; Bar-Nur, Ori; Cheloufi, Sihem; Stadtfeld, Matthias; Figueroa, Maria Eugenia; Robinton, Daisy; Natesan, Sridaran; Melnick, Ari; Zhu, Jinfang; Ramaswamy, Sridhar; Hochedlinger, Konrad			A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells	CELL			English	Article							PLURIPOTENT STEM-CELLS; MOUSE; EXPRESSION; FIBROBLASTS; INDUCTION; DISCOVERY	Factor-induced reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) is inefficient, complicating mechanistic studies. Here, we examined defined intermediate cell populations poised to becoming iPSCs by genome-wide analyses. We show that induced pluripotency elicits two transcriptional waves, which are driven by c-Myc/Klf4 (first wave) and Oct4/Sox2/Klf4 (second wave). Cells that become refractory to reprogramming activate the first but fail to initiate the second transcriptional wave and can be rescued by elevated expression of all four factors. The establishment of bivalent domains occurs gradually after the first wave, whereas changes in DNA methylation take place after the second wave when cells acquire stable pluripotency. This integrative analysis allowed us to identify genes that act as roadblocks during reprogramming and surface markers that further enrich for cells prone to forming iPSCs. Collectively, our data offer new mechanistic insights into the nature and sequence of molecular events inherent to cellular reprogramming.	[Polo, Jose M.; Anderssen, Endre; Walsh, Ryan M.; Schwarz, Benjamin A.; Borkent, Marti; Apostolou, Effie; Cloutier, Jennifer; Bar-Nur, Ori; Cheloufi, Sihem; Stadtfeld, Matthias; Robinton, Daisy; Ramaswamy, Sridhar; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Polo, Jose M.; Anderssen, Endre; Walsh, Ryan M.; Schwarz, Benjamin A.; Borkent, Marti; Apostolou, Effie; Cloutier, Jennifer; Bar-Nur, Ori; Cheloufi, Sihem; Stadtfeld, Matthias; Robinton, Daisy; Ramaswamy, Sridhar; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Polo, Jose M.; Anderssen, Endre; Walsh, Ryan M.; Schwarz, Benjamin A.; Borkent, Marti; Apostolou, Effie; Cloutier, Jennifer; Bar-Nur, Ori; Cheloufi, Sihem; Stadtfeld, Matthias; Robinton, Daisy; Ramaswamy, Sridhar; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Polo, Jose M.; Nefzger, Christian M.; Lim, Sue Mei; Alaei, Sara] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic 3800, Australia; [Polo, Jose M.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Anderssen, Endre; Ramaswamy, Sridhar] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Borkent, Marti] Erasmus MC, Dept Reprod & Dev, NL-3015 GE Rotterdam, Netherlands; [Figueroa, Maria Eugenia; Melnick, Ari] Weill Cornell Med Coll, Dept Med, Div Hematol Oncol, New York, NY 10065 USA; [Natesan, Sridaran] Sanofi Aventis, Cambridge, MA 02139 USA; [Zhu, Jinfang] NIAID, NIH, Bethesda, MD 20892 USA; [Hochedlinger, Konrad] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Hochedlinger, Konrad] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Monash University; Australian Regenerative Medicine Institute; Monash University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Erasmus University Rotterdam; Erasmus MC; Cornell University; Sanofi-Aventis; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University	Ramaswamy, S (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 185 Cambridge St, Boston, MA 02114 USA.	sridhar@mgh.harvard.edu; khochedlinger@helix.mgh.harvard.edu	Bar-Nur, Ori/GWQ-5917-2022; Zhu, Jinfang/B-7574-2012; Figueroa, Maria/AAE-8662-2019; Melnick, Ari/AAA-5763-2020; Apostolou, Effie/AAG-1559-2020	Zhu, Jinfang/0000-0002-0117-4745; Polo, Jose M/0000-0002-2531-778X; Lim, Sue Mei/0000-0001-8287-5756; Alaei, Sara/0000-0003-4897-6339; Cheloufi, Sihem/0000-0002-1726-4796; Nefzger, Christian/0000-0003-4631-5633; Cloutier, Jennifer/0000-0003-3462-0307; Figueroa, Maria Eugenia/0000-0003-4887-4981; Stadtfeld, Matthias/0000-0002-5852-9906	ECOR postdoctoral fellowship; Monash Larkins Program; NHMRC CDF; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, USA; NIH [DP2OD003266, R01HD058013]; HHMI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	ECOR postdoctoral fellowship; Monash Larkins Program; NHMRC CDF(National Health and Medical Research Council (NHMRC) of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, USA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Hochedlinger and Ramaswamy labs for helpful suggestions and critical reading of the manuscript. We thank Laura Prickett and Kat Folz-Donahue at the MGH/HSCI flow cytometry core and Flowcore Monash for expert cell sorting; Paul Lacaze, Danielle Evans, and Michelle Garred at Millenium Science for support with the Fluidigm experiments; and Lucy Dagostino from Lifetech Australia for help in miRNA assays. We are grateful to Ben Wittner for help with formatting and uploading genome-wide data. Support to J.M.P. was from an ECOR postdoctoral fellowship, Monash Larkins Program, and a NHMRC CDF. J.Z. was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, USA. K.H. was supported by the NIH (DP2OD003266 and R01HD058013). S.R. was supported by an HHMI Physican-Scientist Early Career Award.	Aranda-Orgilles B., 2012, CELL STEM CELL; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chang CQ, 2008, BIOINFORMATICS, V24, P1349, DOI 10.1093/bioinformatics/btn131; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Hansson J., 2012, CELL REP IN PRESS; Huo J.S., 2012, BIOCH BIOPHYS ACTA; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kudo T, 2004, MOL CELL BIOL, V24, P4221, DOI 10.1128/MCB.24.10.4221-4228.2004; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Subramanyam D, 2011, CURR OPIN GENET DEV, V21, P498, DOI 10.1016/j.gde.2011.04.011; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Yang CS, 2011, STEM CELLS, V29, P1528, DOI 10.1002/stem.717	26	599	614	8	192	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1617	1632		10.1016/j.cell.2012.11.039	http://dx.doi.org/10.1016/j.cell.2012.11.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260147	Green Accepted, Bronze			2022-12-24	WOS:000312890300024
J	Wang, YS; Rattner, A; Zhou, YL; Williams, J; Smallwood, PM; Nathans, J				Wang, Yanshu; Rattner, Amir; Zhou, Yulian; Williams, John; Smallwood, Philip M.; Nathans, Jeremy			Norrin/Frizzled4 Signaling in Retinal Vascular Development and Blood Brain Barrier Plasticity	CELL			English	Article							ENDOTHELIAL GROWTH-FACTOR; REDUNDANT ROLES; ANGIOGENESIS; MICE; FRIZZLED-4; DISEASE; NORRIN; VEGF; PERICYTES; SOX18	Norrin/Frizzled4 (Fz4) signaling activates the canonical Wnt pathway to control retinal vascular development. Using genetically engineered mice, we show that precocious Norrin production leads to premature retinal vascular invasion and delayed Norrin production leads to characteristic defects in intraretinal vascular architecture. In genetic mosaics, wildtype endothelial cells (ECs) instruct neighboring Fz4(-/-) ECs to produce an architecturally normal mosaic vasculature, a cell nonautonomous effect. However, over the ensuing weeks, Fz4(-/-) ECs are selectively eliminated from the mosaic vasculature, implying the existence of a quality control program that targets defective ECs. In the adult retina and cerebellum, gain or loss of Norrin/Fz4 signaling results in a cell-autonomous gain or loss, respectively, of blood retina barrier and blood brain barrier function, indicating an ongoing requirement for Frizzled signaling in barrier maintenance and substantial plasticity in mature CNS vascular structure.	[Wang, Yanshu; Rattner, Amir; Zhou, Yulian; Williams, John; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Wang, Yanshu; Williams, John; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Nathans, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	jnathans@jhmi.edu		Rattner, Amir/0000-0001-9542-6212; Nathans, Jeremy/0000-0001-8106-5460	National Eye Institute (NIH); HHMI; Johns Hopkins Brain Sciences Institute; Foundation Fighting Blindness; Ellison Medical Foundation; NATIONAL EYE INSTITUTE [R01EY018637] Funding Source: NIH RePORTER	National Eye Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); HHMI(Howard Hughes Medical Institute); Johns Hopkins Brain Sciences Institute; Foundation Fighting Blindness(European Commission); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Hugh Cahill, Hao Chang, Alex Kolodkin, Se-Jin Lee, Max Tischfield, and Xin Ye for advice and/or helpful comments on the manuscript. This work was supported by the National Eye Institute (NIH), HHMI, the Johns Hopkins Brain Sciences Institute, the Foundation Fighting Blindness, and the Ellison Medical Foundation.	Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Truong A, 2011, J MOL MED, V89, P343, DOI 10.1007/s00109-010-0709-z; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; de Boer AG, 2007, ANNU REV PHARMACOL, V47, P323, DOI 10.1146/annurev.pharmtox.47.120505.105237; Eichler AF, 2011, NAT REV CLIN ONCOL, V8, P344, DOI 10.1038/nrclinonc.2011.58; Fantin A, 2011, DEVELOPMENT, V138, P4185, DOI 10.1242/dev.070037; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Geretti E, 2008, ANGIOGENESIS, V11, P31, DOI 10.1007/s10456-008-9097-1; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Luhmann UFO, 2008, EUR J NEUROSCI, V27, P2619, DOI 10.1111/j.1460-9568.2008.06237.x; Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Paes KT, 2011, INVEST OPHTH VIS SCI, V52, P6452, DOI 10.1167/iovs.10-7146; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Pendeville H, 2008, DEV BIOL, V317, P405, DOI 10.1016/j.ydbio.2008.01.028; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Smallwood PM, 2007, J BIOL CHEM, V282, P4057, DOI 10.1074/jbc.M609618200; Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Strickland LA, 2005, J PATHOL, V206, P466, DOI 10.1002/path.1805; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Wang YS, 2001, J NEUROSCI, V21, P4761, DOI 10.1523/JNEUROSCI.21-13-04761.2001; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2011, GENE EXPR PATTERNS, V11, P151, DOI 10.1016/j.gep.2010.10.007; Ye X, 2010, TRENDS MOL MED, V16, P417, DOI 10.1016/j.molmed.2010.07.003; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047	40	226	236	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1332	1344		10.1016/j.cell.2012.10.042	http://dx.doi.org/10.1016/j.cell.2012.10.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217714	Green Accepted, Bronze			2022-12-24	WOS:000311999900021
J	Zala, D; Hinckelmann, MV; Yu, H; da Cunha, MML; Liot, G; Cordelieres, FP; Marco, S; Saudou, F				Zala, Diana; Hinckelmann, Maria-Victoria; Yu, Hua; da Cunha, Marcel Menezes Lyra; Liot, Geraldine; Cordelieres, Fabrice P.; Marco, Sergio; Saudou, Frederic			Vesicular Glycolysis Provides On-Board Energy for Fast Axonal Transport	CELL			English	Article							CULTURED HIPPOCAMPAL-NEURONS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PROTEOMIC ANALYSIS; ENZYME-ACTIVITY; MICROTUBULES; PROTEINS; KINESIN; DISEASE; DYNEIN; BRAIN	Fast axonal transport (FAT) requires consistent energy over long distances to fuel the molecular motors that transport vesicles. We demonstrate that glycolysis provides ATP for the FAT of vesicles. Although inhibiting ATP production from mitochondria did not affect vesicles motility, pharmacological or genetic inhibition of the glycolytic enzyme GAPDH reduced transport in cultured neurons and in Drosophila larvae. GAPDH localizes on vesicles via a huntingtin-dependent mechanism and is transported on fast-moving vesicles within axons. Purified motile vesicles showed GAPDH enzymatic activity and produced ATP. Finally, we show that vesicular GAPDH is necessary and sufficient to provide on-board energy for fast vesicular transport. Although detaching GAPDH from vesicles reduced transport, targeting GAPDH to vesicles was sufficient to promote FAT in GAPDH deficient neurons. This specifically localized glycolytic machinery may supply constant energy, independent of mitochondria, for the processive movement of vesicles over long distances in axons.	[Zala, Diana; Hinckelmann, Maria-Victoria; Yu, Hua; da Cunha, Marcel Menezes Lyra; Liot, Geraldine; Cordelieres, Fabrice P.; Marco, Sergio; Saudou, Frederic] Inst Curie, F-91405 Orsay, France; [Zala, Diana; Hinckelmann, Maria-Victoria; Yu, Hua; Liot, Geraldine; Saudou, Frederic] CNRS, UMR3306, F-91405 Orsay, France; [Zala, Diana; Hinckelmann, Maria-Victoria; Yu, Hua; Liot, Geraldine; Saudou, Frederic] INSERM, U1005, F-91405 Orsay, France; [da Cunha, Marcel Menezes Lyra; Marco, Sergio] INSERM, U759, F-91405 Orsay, France; [Cordelieres, Fabrice P.] Inst Curie, IBiSA Cell & Tissue Imaging Facil, F-91405 Orsay, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Saudou, F (corresponding author), Inst Curie, F-91405 Orsay, France.	frederic.saudou@curie.fr	marco garrido, sergio/F-5876-2013; marco, SERGIO/E-4875-2017; Zala, Diana/R-8196-2019; ZALA, Diana/L-4651-2017; Cordelières, Fabrice P/G-3574-2017; SAUDOU, Frédéric/L-3454-2014; Cunha, Marcel/J-3929-2014	Zala, Diana/0000-0002-0052-8011; ZALA, Diana/0000-0002-0052-8011; Cordelières, Fabrice P/0000-0002-5383-5816; SAUDOU, Frédéric/0000-0001-6107-1046; Liot, Geraldine/0000-0002-4784-7693	Agence Nationale pour la Recherche [ANR-08-MNP-039]; Association pour la Recherche sur le Cancer [ARC 4950]; Fondation pour la Recherche Medicale (FRM, equipe labellisee); CNRS; INSERM; Institut Curie; Association Huntington France; CHDI Foundation Inc.; Fondation Pierre-Gilles de Gennes pour la Recherche	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation pour la Recherche Medicale (FRM, equipe labellisee); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Curie; Association Huntington France; CHDI Foundation Inc.; Fondation Pierre-Gilles de Gennes pour la Recherche	We thank S. Humbert for support and discussions; E. Brouillet, A. Echard, A. Gautreau, F. Mochel, F. Perez, and, members of the Saudou and Humbert labs for helpful comments and/or reading of the manuscript; P. Pla, Y. Elipot, S. Bertho, C. Benstaali, and C. Lemercier for help with experiments; M. Chao, J.L. Dreyer, E.L. Holzbaur, M.A. Silverman, M.-L. Parmentier, M. Piel, A. Sawa, T. Schwarz, H. Yano, and G. Yellen for reagents and/or discussions. This work was supported by grants from Agence Nationale pour la Recherche (ANR-08-MNP-039, F.S.), Association pour la Recherche sur le Cancer (ARC 4950, F.S.), Fondation pour la Recherche Medicale (FRM, equipe labellisee) (F.S.), CNRS, INSERM, and the Institut Curie (F.S.). For fellowship support we thank: Association Huntington France (M.-V.H.), Institut Curie (D.Z.), CHDI Foundation Inc. (D.Z., G.L.), and Fondation Pierre-Gilles de Gennes pour la Recherche (D.Z., G.L.). F.C. and H.Y. are CNRS engineers and F.S. is an INSERM investigator. The authors declare no competing financial interests.	Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Bae Y, 2006, P NATL ACAD SCI USA, V103, P3405, DOI 10.1073/pnas.0511316103; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; Burre J, 2007, J NEUROCHEM, V101, P1448, DOI 10.1111/j.1471-4159.2007.04453.x; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Culver BP, 2012, J BIOL CHEM, V287, P21599, DOI 10.1074/jbc.M112.359307; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; DURRIEU C, 1987, ARCH BIOCHEM BIOPHYS, V252, P32, DOI 10.1016/0003-9861(87)90005-1; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; HUITOREL P, 1985, EUR J BIOCHEM, V150, P265, DOI 10.1111/j.1432-1033.1985.tb09016.x; Ikemoto A, 2003, J BIOL CHEM, V278, P5929, DOI 10.1074/jbc.M211617200; Kaasik A, 2007, J BIOL CHEM, V282, P32821, DOI 10.1074/jbc.M702295200; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kwinter DM, 2009, NEUROSCIENCE, V162, P1001, DOI 10.1016/j.neuroscience.2009.05.038; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Ratovitski T, 2012, CELL CYCLE, V11, P2006, DOI 10.4161/cc.20423; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Salinas S, 2008, CURR OPIN CELL BIOL, V20, P445, DOI 10.1016/j.ceb.2008.04.002; Schmidt Maike M, 2009, Front Neuroenergetics, V1, P1, DOI 10.3389/neuro.14.001.2009; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Tisdale EJ, 2002, J BIOL CHEM, V277, P3334, DOI 10.1074/jbc.M109744200; Tisdale EJ, 2004, J BIOL CHEM, V279, P54046, DOI 10.1074/jbc.M409472200; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Yang JY, 2005, BIOCHEMISTRY-US, V44, P11903, DOI 10.1021/bi0508082	39	310	311	0	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					479	491		10.1016/j.cell.2012.12.029	http://dx.doi.org/10.1016/j.cell.2012.12.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374344	Bronze			2022-12-24	WOS:000314362800018
J	Weber, JN; Peterson, BK; Hoekstra, HE				Weber, Jesse N.; Peterson, Brant K.; Hoekstra, Hopi E.			Discrete genetic modules are responsible for complex burrow evolution in Peromyscus mice	NATURE			English	Article							GENOME-WIDE ASSOCIATION; ARCHITECTURE; RELATEDNESS	Relative to morphological traits, we know little about how genetics influence the evolution of complex behavioural differences in nature(1). It is unclear how the environment influences natural variation in heritable behaviour(2), and whether complex behavioural differences evolve through few genetic changes, each affecting many aspects of behaviour, or through the accumulation of several genetic changes that, when combined, give rise to behavioural complexity(3). Here we show that in nature, oldfield mice (Pero-myscus polionotus) build complex burrows with long entrance and escape tunnels, and that burrow length is consistent across populations, although burrow depth varies with soil composition. This burrow architecture is in contrast with the small, simple burrows of its sister species, deer mice (P. maniculatus). When investigated under laboratory conditions, both species recapitulate their natural burrowing behaviour. Genetic crosses between the two species reveal that the derived burrows of oldfield mice are dominant and evolved through the addition of multiple genetic changes. In burrows built by first-generation backcross mice, entrancetunnel length and the presence of an escape tunnel can be uncoupled, suggesting that these traits are modular. Quantitative trait locus analysis also indicates that tunnel length segregates as a complex trait, affected by at least three independent genetic regions, whereas the presence of an escape tunnel is associated with only a single locus. Together, these results suggest that complex behaviours-in this case, a classic 'extended phenotype'(4)-can evolve through multiple genetic changes each affecting distinct behaviour modules.	[Weber, Jesse N.; Peterson, Brant K.; Hoekstra, Hopi E.] Museum Comparat Zool, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Peterson, Brant K.; Hoekstra, Hopi E.] Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA		Hoekstra, HE (corresponding author), Museum Comparat Zool, Dept Organism & Evolutionary Biol, 26 Oxford St, Cambridge, MA 02138 USA.	hoekstra@oeb.harvard.edu	Weber, Jesse N/I-8685-2019; Hoekstra, Hopi E/I-6690-2012	Weber, Jesse N/0000-0003-4839-6684; Hoekstra, Hopi E/0000-0003-1431-1769; Peterson, Brant/0000-0002-0433-3035	Chapman Funds for Vertebrate Locomotion; National Science Foundation [IOS-0910164]; Arnold and Mabel Beckman Young Investigator Award	Chapman Funds for Vertebrate Locomotion; National Science Foundation(National Science Foundation (NSF)); Arnold and Mabel Beckman Young Investigator Award	We thank D. Brimmer, A. Chiu, A. Goldberg, J. Hopwood, W. Tong, S. Wolff and the Hoekstra laboratory for assistance with behavioural assays and animal husbandry; D. Haig, B. Olveczky, N. E. Pierce and J. Sanes for helpful discussions; and Harvard's Office of Animal Resources, particularly J. Rocca and M. O'Donnell. We also thank R. Barrett, A. Bendesky, H. Fisher, E. Kay, H. Metz and W. Tong for comments on the manuscript. This research was funded by Chapman Funds for Vertebrate Locomotion to J. N. W., National Science Foundation grant (IOS-0910164) to J. N. W. and H. E. H., and an Arnold and Mabel Beckman Young Investigator Award to H.E.H.	Baker RH., 1968, BIOL PEROMYSCUS RODE; Beavis W. D, 1998, MOL DISSECTION COMPL, P431; Bendesky A, 2011, NAT REV GENET, V12, P809, DOI 10.1038/nrg3065; Boake CRB, 2002, AM NAT, V160, pS143, DOI 10.1086/342902; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cheng R, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-66; Cheng RY, 2010, GENETICS, V185, P1033, DOI 10.1534/genetics.110.116863; Dawkins R., 1982, pi; DAWSON WD, 1988, BEHAV GENET, V18, P371, DOI 10.1007/BF01260937; Doerge RW, 1996, HEREDITY, V76, P459, DOI 10.1038/hdy.1996.68; FELTHAUSER M, 1983, J WILDLIFE MANAGE, V47, P555, DOI 10.2307/3808536; Fitzpatrick MJ, 2005, TRENDS ECOL EVOL, V20, P96, DOI 10.1016/j.tree.2004.11.017; Hansell M, 2005, OXF ANIMAL BIOL SER; Hayne D. W., 1936, Journal of Mammalogy, V17, P420; Houtcooper W. C., 1971, P INDIANA ACAD SCI, V81, P348; Huxley J. S., 1914, P ZOOL SOC LOND, V35, P253; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; LORENZ KZ, 1958, SCI AM, V199, P67, DOI 10.1038/scientificamerican1258-67; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Mallarino R, 2011, P NATL ACAD SCI USA, V108, P4057, DOI 10.1073/pnas.1011480108; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rand A. L., 1942, BULL AMER MUS NAT HIST, V80, P1; SCHWARTZ CW, 1981, WILD MAMMALS MISSOUR; Sen S., 2006, R QTLDESIGN INBRED L; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; SUMNER F. B., 1929, JOUR MAMMALOGY, V10, P213, DOI 10.2307/1373928; Tan K.H., 2005, SOIL SAMPLING PREPAR, Vsecond, DOI [10.1201/9781482274769, DOI 10.1201/9781482274769]; Weber JN, 2009, ANIM BEHAV, V77, P603, DOI 10.1016/j.anbehav.2008.10.031; West-Eberhard Mary Jane, 2003, pi; WOLFE JL, 1977, BIOL BEHAV, V2, P343; Wright S, 1935, GENETICS, V20, P0084; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018	34	151	155	12	307	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					402	U145		10.1038/nature11816	http://dx.doi.org/10.1038/nature11816			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23325221				2022-12-24	WOS:000313615900051
J	Shimazu, T; Hirschey, MD; Newman, J; He, WJ; Shirakawa, K; Le Moan, N; Grueter, CA; Lim, H; Saunders, LR; Stevens, RD; Newgard, CB; Farese, RV; de Cabo, R; Ulrich, S; Akassoglou, K; Verdin, E				Shimazu, Tadahiro; Hirschey, Matthew D.; Newman, John; He, Wenjuan; Shirakawa, Kotaro; Le Moan, Natacha; Grueter, Carrie A.; Lim, Hyungwook; Saunders, Laura R.; Stevens, Robert D.; Newgard, Christopher B.; Farese, Robert V., Jr.; de Cabo, Rafael; Ulrich, Scott; Akassoglou, Katerina; Verdin, Eric			Suppression of Oxidative Stress by beta-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor	SCIENCE			English	Article							KETONE-BODIES; METABOLISM; EXPRESSION; CELLS	Concentrations of acetyl-coenzyme A and nicotinamide adenine dinucleotide (NAD(+)) affect histone acetylation and thereby couple cellular metabolic status and transcriptional regulation. We report that the ketone body D-beta-hydroxybutyrate (beta OHB) is an endogenous and specific inhibitor of class I histone deacetylases (HDACs). Administration of exogenous beta OHB, or fasting or calorie restriction, two conditions associated with increased beta OHB abundance, all increased global histone acetylation in mouse tissues. Inhibition of HDAC by beta OHB was correlated with global changes in transcription, including that of the genes encoding oxidative stress resistance factors FOXO3A and MT2. Treatment of cells with beta OHB increased histone acetylation at the Foxo3a and Mt2 promoters, and both genes were activated by selective depletion of HDAC1 and HDAC2. Consistent with increased FOXO3A and MT2 activity, treatment of mice with beta OHB conferred substantial protection against oxidative stress.	[Shimazu, Tadahiro; Hirschey, Matthew D.; Newman, John; He, Wenjuan; Shirakawa, Kotaro; Lim, Hyungwook; Saunders, Laura R.; Verdin, Eric] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Shimazu, Tadahiro; Hirschey, Matthew D.; Newman, John; He, Wenjuan; Shirakawa, Kotaro; Lim, Hyungwook; Saunders, Laura R.; Farese, Robert V., Jr.; Verdin, Eric] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Le Moan, Natacha; Akassoglou, Katerina] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Grueter, Carrie A.; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Grueter, Carrie A.; Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Stevens, Robert D.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; [Stevens, Robert D.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27704 USA; [Stevens, Robert D.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Canc Biol & Med, Durham, NC 27704 USA; [de Cabo, Rafael] NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA; [Ulrich, Scott] Ithaca Coll, Dept Chem, Ithaca, NY 14850 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Verdin, E (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA.	everdin@gladstone.ucsf.edu	Newman, John C/L-8112-2013; de Cabo, Rafael/E-7996-2010; Verdin, Eric/AAB-7999-2019; de Cabo, Rafael Carlos/J-5230-2016; SHIMAZU, Tadahiro/ABC-3950-2020; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael/0000-0003-2830-5693; de Cabo, Rafael Carlos/0000-0003-2830-5693; Akassoglou, Katerina/0000-0002-2632-1465; Grueter, Carrie/0000-0002-1913-2527; de Cabo, Rafael/0000-0002-3354-2442; Hirschey, Matthew/0000-0003-4541-5376; Verdin, Eric/0000-0003-3703-3183	Gladstone Institutes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056084, P30DK063720, P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000368, ZIAAG000361, ZIAAG000363, T32AG000212] Funding Source: NIH RePORTER	Gladstone Institutes(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Carroll for graphics, G. Howard and S. Ordway for editorial assistance, V. Fonseca for administrative assistance, and A. Brunet (Stanford University) for reagents. Supported by funds from the Gladstone Institutes.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; CAHILL GF, 1966, J CLIN INVEST, V45, P1751, DOI 10.1172/JCI105481; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; Kawai K, 2000, CHEM RES TOXICOL, V13, P1275, DOI 10.1021/tx000119l; Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x; KOESLAG JH, 1980, J PHYSIOL-LONDON, V301, P79, DOI 10.1113/jphysiol.1980.sp013190; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Ladurner AG, 2006, MOL CELL, V24, P1, DOI 10.1016/j.molcel.2006.09.002; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; North BJ, 2005, METHODS, V36, P338, DOI 10.1016/j.ymeth.2005.03.004; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; OWEN OE, 1973, J CLIN INVEST, V52, P2606, DOI 10.1172/JCI107453; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; VanLint C, 1996, GENE EXPRESSION, V5, P245; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097	22	926	959	11	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					211	214		10.1126/science.1227166	http://dx.doi.org/10.1126/science.1227166			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23223453	Green Accepted			2022-12-24	WOS:000313328200046
J	Luga, V; Zhang, L; Viloria-Petit, AM; Ogunjimi, AA; Inanlou, MR; Chiu, E; Buchanan, M; Hosein, AN; Basik, M; Wrana, JL				Luga, Valbona; Zhang, Liang; Viloria-Petit, Alicia M.; Ogunjimi, Abiodun A.; Inanlou, Mohammad R.; Chiu, Elaine; Buchanan, Marguerite; Hosein, Abdel Nasser; Basik, Mark; Wrana, Jeffrey L.			Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration	CELL			English	Article							TUMOR INVASION; POLARITY; METASTASIS; DEGRADATION; PROGRESSION; PLASTICITY; SECRETION; MOTILITY; RHOA	Stroma in the tumor microenvironment plays a critical role in cancer progression, but how it promotes metastasis is poorly understood. Exosomes are small vesicles secreted by many cell types and enable a potent mode of intercellular communication. Here, we report that fibroblast-secreted exosomes promote breast cancer cell (BCC) protrusive activity and motility via Wnt-planar cell polarity (PCP) signaling. We show that exosome-stimulated BCC protrusions display mutually exclusive localization of the core PCP complexes, Fzd-Dvl and Vangl-Pk. In orthotopic mouse models of breast cancer, coinjection of BCCs with fibroblasts dramatically enhances metastasis that is dependent on PCP signaling in BCCs and the exosome component, Cd81 in fibroblasts. Moreover, we demonstrate that trafficking in BCCs promotes tethering of autocrine Wnt11 to fibroblast-derived exosomes. This work reveals an intercellular communication pathway whereby fibroblast exosomes mobilize autocrine Wnt-PCP signaling to drive BCC invasive behavior.	[Luga, Valbona; Zhang, Liang; Ogunjimi, Abiodun A.; Inanlou, Mohammad R.; Chiu, Elaine; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Luga, Valbona; Wrana, Jeffrey L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Viloria-Petit, Alicia M.] Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Buchanan, Marguerite; Hosein, Abdel Nasser; Basik, Mark] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3S 1Y7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Guelph; Lady Davis Institute; McGill University	Wrana, JL (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	wrana@lunenfeld.ca	Wrana, Jeffrey/F-8857-2013	Hosein, Abdel/0000-0003-1567-6700; ZHANG, Liang/0000-0003-3100-8593	CIHR [MOP14339]; Terry Fox Research Institute; Krembil Foundation	CIHR(Canadian Institutes of Health Research (CIHR)); Terry Fox Research Institute; Krembil Foundation	We thank Eduardo Aguiar for assistance with cloning, Katherine Huang and Payman Tehrani for help with data analysis, Douglas Holmyard for technical support with EM, Brett Larsen and Cunjie Zhang for assistance with proteomic studies, and members of the J.L.W. lab for discussion. We thank Drs. Liliana Attisano, Rod Bremner, and Helen McNeill for critical review of the manuscript. This work was supported by funds from CIHR (to J.L.W. grant MOP14339), a Terry Fox Research Institute group grant, and the Krembil Foundation. J.L.W. is the Mary Janigan Chair in Experimental Therapeutics.	Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Finak G, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1608; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Gray RS, 2011, DEV CELL, V21, P120, DOI 10.1016/j.devcel.2011.06.011; Gros J, 2009, NATURE, V457, P589, DOI 10.1038/nature07564; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Hosein AN, 2010, CANCER RES, V70, P5770, DOI 10.1158/0008-5472.CAN-10-0673; Jessen JR, 2009, ZEBRAFISH, V6, P21, DOI 10.1089/zeb.2008.0571; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; SANFORD KK, 1956, CANCER RES, V16, P162; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Taylor DD, 2011, SEMIN IMMUNOPATHOL, V33, P441, DOI 10.1007/s00281-010-0234-8; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Viloria-Petit AM, 2009, P NATL ACAD SCI USA, V106, P14028, DOI 10.1073/pnas.0906796106; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	30	907	945	12	271	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1542	1556		10.1016/j.cell.2012.11.024	http://dx.doi.org/10.1016/j.cell.2012.11.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260141	Bronze			2022-12-24	WOS:000312890300018
J	Huang, XD; McGann, JC; Liu, BY; Hannoush, RN; Lill, JR; Pham, V; Newton, K; Kakunda, M; Liu, JF; Yu, C; Hymowitz, SG; Hongo, JA; Wynshaw-Boris, A; Polakis, P; Harland, RM; Dixit, VM				Huang, XiaoDong; McGann, James C.; Liu, Bob Y.; Hannoush, Rami N.; Lill, Jennie R.; Pham, Victoria; Newton, Kim; Kakunda, Michael; Liu, Jinfeng; Yu, Christine; Hymowitz, Sarah G.; Hongo, Jo-Anne; Wynshaw-Boris, Anthony; Polakis, Paul; Harland, Richard M.; Dixit, Vishva M.			Phosphorylation of Dishevelled by Protein Kinase RIPK4 Regulates Wnt Signaling	SCIENCE			English	Article							BETA-CATENIN; MUTATIONS; FORM	Receptor-interacting protein kinase 4 (RIPK4) is required for epidermal differentiation and is mutated in Bartsocas-Papas syndrome. RIPK4 binds to protein kinase C, but its signaling mechanisms are largely unknown. Ectopic RIPK4, but not catalytically inactive or Bartsocas-Papas RIPK4 mutants, induced accumulation of cytosolic beta-catenin and a transcriptional program similar to that caused by Wnt3a. In Xenopus embryos, Ripk4 synergized with coexpressed Xwnt8, whereas Ripk4 morpholinos or catalytic inactive Ripk4 antagonized Wnt signaling. RIPK4 interacted constitutively with the adaptor protein DVL2 and, after Wnt3a stimulation, with the co-receptor LRP6. Phosphorylation of DVL2 by RIPK4 favored canonical Wnt signaling. Wnt-dependent growth of xenografted human tumor cells was suppressed by RIPK4 knockdown, suggesting that RIPK4 overexpression may contribute to the growth of certain tumor types.	[Huang, XiaoDong; Newton, Kim; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Huang, XiaoDong; Kakunda, Michael] Genentech Inc, Dept Mol Diagnost & Canc Cell Biol, San Francisco, CA 94080 USA; [McGann, James C.; Harland, Richard M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [McGann, James C.; Harland, Richard M.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Liu, Bob Y.; Polakis, Paul] Genentech Inc, Dept Canc Targets, San Francisco, CA 94080 USA; [Hannoush, Rami N.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Lill, Jennie R.; Pham, Victoria] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Liu, Jinfeng] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Yu, Christine; Hymowitz, Sarah G.] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Hongo, Jo-Anne] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Wynshaw-Boris, Anthony] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Wynshaw-Boris, Anthony] Univ Calif San Francisco, Sch Med, Inst Human Genet, San Francisco, CA 94143 USA	Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; McGann, James/0000-0003-0895-0994; Liu, Jinfeng/0000-0002-0343-8222	NIGMS NIH HHS [R01 GM042341] Funding Source: Medline; NINDS NIH HHS [R01 NS073159] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073159] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Holland PM, 2002, CURR BIOL, V12, P1424, DOI 10.1016/S0960-9822(02)01075-8; Kalay E, 2012, AM J HUM GENET, V90, P76, DOI 10.1016/j.ajhg.2011.11.014; Kitaeva MN, 1997, CANCER RES, V57, P4478; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Mitchell K, 2012, AM J HUM GENET, V90, P69, DOI 10.1016/j.ajhg.2011.11.013; Montross WT, 2000, J CELL SCI, V113, P1759; Polakis P, 2000, GENE DEV, V14, P1837; Satoh K, 2004, P NATL ACAD SCI USA, V101, P8017, DOI 10.1073/pnas.0401733101; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	13	74	81	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1441	1445		10.1126/science.1232253	http://dx.doi.org/10.1126/science.1232253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23371553	Green Accepted			2022-12-24	WOS:000316740700045
J	Meyer, RE; Kim, S; Obeso, D; Straight, PD; Winey, M; Dawson, DS				Meyer, Regis E.; Kim, Seoyoung; Obeso, David; Straight, Paul D.; Winey, Mark; Dawson, Dean S.			Mps1 and Ipl1/Aurora B Act Sequentially to Correctly Orient Chromosomes on the Meiotic Spindle of Budding Yeast	SCIENCE			English	Article							CHECKPOINT; MEIOSIS; PHOSPHORYLATION; KINETOCHORES; INTERPHASE; TELOMERES	The conserved kinases Mps1 and Ipl1/Aurora B are critical for enabling chromosomes to attach to microtubules so that partner chromosomes will be segregated correctly from each other, but the precise roles of these kinases have been unclear. We imaged live yeast cells to elucidate the stages of chromosome-microtubule interactions and their regulation by Ipl1 and Mps1 through meiosis I. Ipl1 was found to release kinetochore-microtubule (kMT) associations after meiotic entry, liberating chromosomes to begin homologous pairing. Surprisingly, most chromosome pairs began their spindle interactions with incorrect kMT attachments. Ipl1 released these improper connections, whereas Mps1 triggered the formation of new force-generating microtubule attachments. This microtubule release and reattachment cycle could prevent catastrophic chromosome segregation errors in meiosis.	[Meyer, Regis E.; Kim, Seoyoung; Obeso, David; Dawson, Dean S.] Oklahoma Med Res Fdn, Dept Cell Cycle & Canc Biol, Oklahoma City, OK 73104 USA; [Kim, Seoyoung; Obeso, David; Dawson, Dean S.] Univ Oklahoma, Dept Cell Biol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Straight, Paul D.; Winey, Mark] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Colorado System; University of Colorado Boulder	Dawson, DS (corresponding author), Oklahoma Med Res Fdn, Dept Cell Cycle & Canc Biol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	dawsond@omrf.org		Straight, Paul/0000-0003-2460-8240; Meyer, Regis E/0000-0003-1530-4763	NIH [GM-07135, GM087377]; March of Dimes Birth Defects Foundation [FY98.409/FY99.617]; NSF [0950005]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087377, R01GM051312, T32GM007135] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Birth Defects Foundation(March of Dimes); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Jaspersen for critically reading the manuscript; K. Benjamin, S. Biggins, M. Dresser, M. Knop, K. Nasmyth, and A. Straight for providing strains and reagents; and current and past laboratory members for reagents and discussions of our work. P. D. S. was supported in part by NIH training grant GM-07135. This work was supported by March of Dimes Birth Defects Foundation grant FY98.409/FY99.617 to M. W. and NSF grant 0950005 and NIH grant GM087377 to D. D. Data used in this paper are available in the supplementary materials.	Araki Y, 2010, J CELL BIOL, V189, P41, DOI 10.1083/jcb.200910027; Bock LJ, 2012, NAT CELL BIOL, V14, P614, DOI 10.1038/ncb2495; Colombo R, 2010, CANCER RES, V70, P10255, DOI 10.1158/0008-5472.CAN-10-2101; Cowan CR, 2001, PLANT PHYSIOL, V125, P532, DOI 10.1104/pp.125.2.532; Hached K, 2011, DEVELOPMENT, V138, P2261, DOI 10.1242/dev.061317; Hayashi A, 1998, GENES CELLS, V3, P587, DOI 10.1046/j.1365-2443.1998.00215.x; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; Jin QW, 1998, J CELL BIOL, V141, P21, DOI 10.1083/jcb.141.1.21; Kemmler S, 2009, EMBO J, V28, P1099, DOI 10.1038/emboj.2009.62; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Lan WJ, 2010, J CELL BIOL, V190, P21, DOI 10.1083/jcb.201006080; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Maure JF, 2011, CURR BIOL, V21, P207, DOI 10.1016/j.cub.2010.12.050; Maure JF, 2007, CURR BIOL, V17, P2175, DOI 10.1016/j.cub.2007.11.032; Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Shimogawa MM, 2006, CURR BIOL, V16, P1489, DOI 10.1016/j.cub.2006.06.063; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; Tanaka TU, 2010, EMBO J, V29, P4070, DOI 10.1038/emboj.2010.294; Winey M, 2005, MOL BIOL CELL, V16, P1178, DOI 10.1091/mbc.E04-09-0765	24	45	45	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1071	1074		10.1126/science.1232518	http://dx.doi.org/10.1126/science.1232518			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23371552	Green Accepted			2022-12-24	WOS:000315452000040
J	Solovei, I; Wang, AS; Thanisch, K; Schmidt, CS; Krebs, S; Zwerger, M; Cohen, TV; Devys, D; Foisner, R; Peichl, L; Herrmann, H; Blum, H; Engelkamp, D; Stewart, CL; Leonhardt, H; Joffe, B				Solovei, Irina; Wang, Audrey S.; Thanisch, Katharina; Schmidt, Christine S.; Krebs, Stefan; Zwerger, Monika; Cohen, Tatiana V.; Devys, Didier; Foisner, Roland; Peichl, Leo; Herrmann, Harald; Blum, Helmut; Engelkamp, Dieter; Stewart, Colin L.; Leonhardt, Heinrich; Joffe, Boris			LBR and Lamin A/C Sequentially Tether Peripheral Heterochromatin and Inversely Regulate Differentiation	CELL			English	Article							B RECEPTOR; NUCLEAR-ENVELOPE; CHROMATIN-STRUCTURE; EMERIN; EXPRESSION; CELLS; PROLIFERATION; MATURATION; INTEGRITY; MEMBRANE	Eukaryotic cells have a layer of heterochromatin at the nuclear periphery. To investigate mechanisms regulating chromatin distribution, we analyzed heterochromatin organization in different tissues and species, including mice with mutations in the lamin B receptor (Lbr) and lamin A (Lmna) genes that encode nuclear envelope (NE) proteins. We identified LBR- and lamin-A/C-dependent mechanisms tethering heterochromatin to the NE. The two tethers are sequentially used during cellular differentiation and development: first the LBR -and then the lamin-A/C-dependent tether. The absence of both LBR and lamin A/C leads to loss of peripheral heterochromatin and an inverted architecture with heterochromatin localizing to the nuclear interior. Myoblast transcriptome analyses indicated that selective disruption of the LBR- or lamin-A-dependent heterochromatin tethers have opposite effects on muscle gene expression, either increasing or decreasing, respectively. These results show how changes in NE composition contribute to regulating heterochromatin positioning, gene expression, and cellular differentiation during development.	[Solovei, Irina; Thanisch, Katharina; Schmidt, Christine S.; Leonhardt, Heinrich; Joffe, Boris] Univ Munich, Dept Biol 2, CIPSM, D-82152 Martinsried, Germany; [Wang, Audrey S.; Stewart, Colin L.] Inst Med Biol, Singapore 138648, Singapore; [Wang, Audrey S.; Stewart, Colin L.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Krebs, Stefan; Blum, Helmut] Univ Munich, Lab Funct Genome Anal LAFUGA, Gene Ctr Munich, D-81377 Munich, Germany; [Zwerger, Monika; Herrmann, Harald] German Canc Res Ctr DKFC, Dept Mol Genet, D-69120 Heidelberg, Germany; [Cohen, Tatiana V.] Childrens Natl Med Ctr, Ctr Genet Med, Washington, DC 20010 USA; [Devys, Didier] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, UMR 7104,INSERM,U964, F-67404 Illkirch Graffenstaden, France; [Foisner, Roland] Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Peichl, Leo] Max Planck Inst Brain Res, D-60528 Frankfurt, Germany; [Engelkamp, Dieter] Univ Erlangen Nurnberg, Transgen Serv Facil, BTE, Franz Penzoldt Ctr, D-91058 Erlangen, Germany	University of Munich; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore; University of Munich; Children's National Health System; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Max Planck Society; University of Erlangen Nuremberg	Stewart, CL (corresponding author), Inst Med Biol, 8A Biomed Grove, Singapore 138648, Singapore.	colin.stewart@imb.a-star.edu.sg; h.leonhardt@lmu.de; boris.joffe@lmu.de	Solovei, Irina/K-1191-2014; Leonhardt, Heinrich/B-2791-2014; Foisner, Roland/AAD-1833-2019	Foisner, Roland/0000-0003-4734-4647; Devys, Didier/0000-0001-9655-3512; Wang, Audrey/0000-0001-5077-3456; Solovei, Irina/0000-0002-6813-7279; Peichl, Leo/0000-0002-8141-0911	DFG [SO1054/1, HE1853, SFB/TR5, JO903/1]; German-Israeli-Foundation for Scientific Research and Development [111/2007]; International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); BMBF (German agriculture network Phaenomics) [0315536F]; Austrian Science Research Fund [FWF P22403-B12]; Singapore Biomedical Research Council; Singapore Agency for Science, Technology, and Research (A*STAR); Austrian Science Fund (FWF) [P 22043] Funding Source: researchfish	DFG(German Research Foundation (DFG)); German-Israeli-Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); BMBF (German agriculture network Phaenomics)(Federal Ministry of Education & Research (BMBF)); Austrian Science Research Fund(Austrian Science Fund (FWF)); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore Agency for Science, Technology, and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to Stephen Young and Loren Fong (University of California, Los Angeles) for tissue samples of lamin-C-only mice, Yixian Zheng (Carnegie Institution for Science, Baltimore) for Lmnb1/Lmnb2 double-knockout tissue samples, Anand Swaroop (National Eye Institute, Bethesda) for NRL-L-plasmid, and Barbara Knowles (Institute of Medical Biology, Singapore) for Zp3-Cre mice. We gratefully acknowledge the support by the DFG (SO1054/1 to IS, HE1853 to HH, SFB/TR5 to HL, and JO903/1 to BJ); by the German-Israeli-Foundation for Scientific Research and Development (111/2007 to HH); by the International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS) to C.S.S. and K.T.; by BMBF (German agriculture network Phaenomics, 0315536F to H.B.); by Austrian Science Research Fund (FWF P22403-B12 to R.F.); and by the Singapore Biomedical Research Council and the Singapore Agency for Science, Technology, and Research (A*STAR) to C.L.S. and A.W.	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Barkan R, 2012, MOL BIOL CELL, V23, P543, DOI 10.1091/mbc.E11-06-0505; Bertrand AT, 2012, HUM MOL GENET, V21, P1037, DOI 10.1093/hmg/ddr534; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Brachner A, 2011, BIOCHEM SOC T, V39, P1735, DOI 10.1042/BST20110724; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Coffinier C, 2011, MOL BIOL CELL, V22, P4683, DOI 10.1091/mbc.E11-06-0504; Cohen TV, 2008, HUM MOL GENET, V17, P2921, DOI 10.1093/hmg/ddn191; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Demmerle J, 2012, J BIOL CHEM, V287, P22080, DOI 10.1074/jbc.M111.325308; Deniaud E, 2009, CURR OPIN GENET DEV, V19, P187, DOI 10.1016/j.gde.2009.01.005; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; Hirano Y, 2012, J BIOL CHEM, V287, P42654, DOI 10.1074/jbc.M112.397950; Huber MD, 2009, MOL CELL BIOL, V29, P5718, DOI 10.1128/MCB.00270-09; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Kizilyaprak C, 2011, NUCLEUS-AUSTIN, V2, P444, DOI 10.4161/nucl.2.5.17843; Kubben N, 2012, CHROMOSOMA, V121, P447, DOI 10.1007/s00412-012-0376-7; Kubben N, 2011, NUCLEUS-PHILA, V2, P195, DOI 10.4161/nucl.2.3.15731; Makatsori D, 2004, J BIOL CHEM, V279, P25567, DOI 10.1074/jbc.M313606200; Mattout A, 2011, CURR BIOL, V21, P1603, DOI 10.1016/j.cub.2011.08.030; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Olins AL, 2010, NUCLEUS-PHILA, V1, P53, DOI 10.4161/nucl.1.1.10515; Ozawa R, 2006, AM J PATHOL, V168, P907, DOI 10.2353/ajpath.2006.050564; Park YE, 2009, NEUROMUSCULAR DISORD, V19, P29, DOI 10.1016/j.nmd.2008.09.018; Rapaport DH, 2004, J COMP NEUROL, V474, P304, DOI 10.1002/cne.20134; ROBER RA, 1990, J CELL SCI, V95, P587; Shultz LD, 2003, HUM MOL GENET, V12, P61, DOI 10.1093/hmg/ddg003; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Tifft KE, 2009, J CELL SCI, V122, P3780, DOI 10.1242/jcs.048397; Towbin BD, 2010, COLD SH Q B, V75, P555, DOI 10.1101/sqb.2010.75.041; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Verhagen AM, 2012, J IMMUNOL, V188, P122, DOI 10.4049/jimmunol.1100942; Yang SH, 2011, HUM MOL GENET, V20, P3537, DOI 10.1093/hmg/ddr266; Yao J, 2011, GENE DEV, V25, P569, DOI 10.1101/gad.2021411; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	41	503	511	3	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 31	2013	152	3					584	598		10.1016/j.cell.2013.01.009	http://dx.doi.org/10.1016/j.cell.2013.01.009			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374351	Bronze			2022-12-24	WOS:000314362800026
J	Bumbarger, DJ; Riebesell, M; Rodelsperger, C; Sommer, RJ				Bumbarger, Daniel J.; Riebesell, Metta; Roedelsperger, Christian; Sommer, Ralf J.			System-wide Rewiring Underlies Behavioral Differences in Predatory and Bacterial-Feeding Nematodes	CELL			English	Article							CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; PRISTIONCHUS-PACIFICUS; NEURAL CIRCUIT; PHARYNX; RECONSTRUCTION; INTERNEURONS; SENSITIVITY; CENTRALITY; PHYSIOLOGY	The relationship between neural circuit function and patterns of synaptic connectivity is poorly understood, in part due to a lack of comparative data for larger complete systems. We compare system-wide maps of synaptic connectivity generated from serial transmission electron microscopy for the pharyngeal nervous systems of two nematodes with divergent feeding behavior: the microbivore Caenorhabditis elegans and the predatory nematode Pristionchus pacificus. We uncover a massive rewiring in a complex system of identified neurons, all of which are homologous based on neurite anatomy and cell body position. Comparative graph theoretical analysis reveals a striking pattern of neuronal wiring with increased connectional complexity in the anterior pharynx correlating with tooth-like denticles, a morphological feature in the mouth of P. pacificus. We apply focused centrality methods to identify neurons I1 and I2 as candidates for regulating predatory feeding and predict substantial divergence in the function of pharyngeal glands.	[Bumbarger, Daniel J.; Riebesell, Metta; Roedelsperger, Christian; Sommer, Ralf J.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, D-72076 Tubingen, Germany	Max Planck Society	Sommer, RJ (corresponding author), Max Planck Inst Dev Biol, Dept Evolutionary Biol, Spemannstr 37, D-72076 Tubingen, Germany.	ralf.sommer@tuebingen.mpg.de			Max-Planck Society	Max-Planck Society(Max Planck SocietyFoundation CELLEX)	This work was funded by the Max-Planck Society. We are grateful for the technical advice of H. Schwarz and M. Flotenmeyer on electron microscopy. D. Hall and S. Emmons provided valuable insight into C. elegans anatomy and synaptic connectivity. A. Cardona's support and response to feedback in developing TrakEM2 has been very important in accelerating our progress. Methodology benefited from discussions with K. Borgwardt and others. We thank T. Ott, B. Eberhart, J. Nordt, J. Neuner, D. Kazempour, and A. Seitz for assistance in 3D segmentation of the data.	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Altun ZF, 2009, DEV DYNAM, V238, P1936, DOI 10.1002/dvdy.22025; Anderson JR, 2011, J MICROSC-OXFORD, V241, P13, DOI 10.1111/j.1365-2818.20.10.03402.x; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; Baldwin JG, 2004, NEMATOLOGY, V6, P623, DOI 10.1163/1568541042843559; Baltzley MJ, 2010, J COMP PHYSIOL A, V196, P181, DOI 10.1007/s00359-010-0503-y; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Bento G, 2010, NATURE, V466, P494, DOI 10.1038/nature09164; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Brownlee D, 2000, ADV PARASIT, V45, P109, DOI 10.1016/S0065-308X(00)45004-9; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chiang JTA, 2006, J EXP BIOL, V209, P1859, DOI 10.1242/jeb.02165; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Costa LD, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00006; De Carlos JA, 2007, BRAIN RES REV, V55, P8, DOI 10.1016/j.brainresrev.2007.03.010; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Denk W, 2012, NAT REV NEUROSCI, V13, P351, DOI 10.1038/nrn3169; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Eisenberg E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.138701; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Franks Christopher J., 2006, Invertebrate Neuroscience, V6, P105, DOI 10.1007/s10158-006-0023-1; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; HALL DH, 1991, J NEUROSCI, V11, P1; HALL DH, 1987, ANN NY ACAD SCI, V494, P215, DOI 10.1111/j.1749-6632.1987.tb29527.x; Harris G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021897; Hayworth K., 2006, MICROSCOPY MICROA S2, V12, P86, DOI [10.1017/s1431927606066268, DOI 10.1017/S1431927606066268]; Hendricks M, 2012, NATURE, V487, P99, DOI 10.1038/nature11081; Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006; Hong RL, 2006, BIOESSAYS, V28, P651, DOI 10.1002/bies.20404; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Jurrus E., 2012, NEUROINFORMATICS; Kanzaki N, 2012, ZOOL SCI, V29, P403, DOI 10.2108/zsj.29.403; Katsuki T, 2011, DEV NEUROBIOL, V71, P458, DOI 10.1002/dneu.20859; Keane J, 2003, GENETICS, V164, P153; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Light S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-159; Lu J, 2009, PLOS BIOL, V7, P265, DOI 10.1371/journal.pbio.1000032; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newcomb JM, 2009, P R SOC B, V276, P99, DOI 10.1098/rspb.2008.0683; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Page L, 1999, PAGERANK CITATION RA, DOI DOI 10.1109/IISWC.2012.6402911; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Rae R, 2008, J EXP BIOL, V211, P1927, DOI 10.1242/jeb.014944; Rivard L, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-22; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Saideman SR, 2007, J NEUROSCI, V27, P6664, DOI 10.1523/JNEUROSCI.0315-07.2007; Sakurai A, 2011, CURR BIOL, V21, P1036, DOI 10.1016/j.cub.2011.04.040; Schlager B, 2009, GENESIS, V47, P300, DOI 10.1002/dvg.20499; Seung S., 2012, CONNECTOME BRAINS WI; SHAW SR, 1989, VISUAL NEUROSCI, V3, P405, DOI 10.1017/S0952523800005903; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sommer Ralf J, 2006, WormBook, P1; Sommer RJ, 2006, DEVELOPMENT, V133, P2451, DOI 10.1242/dev.02425; Sporns O., 2010, NETWORKS BRAIN; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Suthram S, 2005, NATURE, V438, P108, DOI 10.1038/nature04135; Tahseen Q, 2004, NEMATOLOGY, V6, P49, DOI 10.1163/156854104323072919; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; von Lieven AF, 2003, ZOOLOGY, V106, P183, DOI 10.1078/0944-2006-00115; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	75	93	94	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					109	119		10.1016/j.cell.2012.12.013	http://dx.doi.org/10.1016/j.cell.2012.12.013			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332749	Bronze			2022-12-24	WOS:000313719800010
J	Stroud, H; Greenberg, MVC; Feng, SH; Bernatavichute, YV; Jacobsen, SE				Stroud, Hume; Greenberg, Maxim V. C.; Feng, Suhua; Bernatavichute, Yana V.; Jacobsen, Steven E.			Comprehensive Analysis of Silencing Mutants Reveals Complex Regulation of the Arabidopsis Methylome	CELL			English	Article							NOVO DNA METHYLATION; LOCUS-SPECIFIC CONTROL; RNA-POLYMERASES IV; TRANSPOSABLE ELEMENTS; THALIANA; GENES; CHROMATIN; GENOME; METHYLTRANSFERASE; HETEROCHROMATIN	Cytosine methylation is involved in various biological processes such as silencing of transposable elements (TEs) and imprinting. Multiple pathways regulate DNA methylation in different sequence contexts, but the factors that regulate DNA methylation at a given site in the genome largely remain unknown. Here we have surveyed the methylomes of a comprehensive list of 86 Arabidopsis gene silencing mutants by generating single-nucleotide resolution maps of DNA methylation. We find that DNA methylation is site specifically regulated by different factors. Furthermore, we have identified additional regulators of DNA methylation. These data and analyses will serve as a comprehensive community resource for further understanding the control of DNA methylation patterning.	[Stroud, Hume; Greenberg, Maxim V. C.; Feng, Suhua; Bernatavichute, Yana V.; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu	Stroud, Hume/ABF-1325-2021	Greenberg, Maxim/0000-0001-9935-8763	NIH [GM60398]; NSF [0701745, 1121245]; Fred Eiserling and Judith Lengyel Graduate Doctorate Fellowship; US Public Health Service National Research Service Award [GM07104]; UCLA Dissertation Year Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060398, R37GM060398] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Fred Eiserling and Judith Lengyel Graduate Doctorate Fellowship; US Public Health Service National Research Service Award(United States Department of Health & Human ServicesUnited States Public Health Service); UCLA Dissertation Year Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Akhavan for Illumina sequencing; S. Cokus, W. Yan, and M. Pellegrini for help with the UCSC browser; X. Zhang for MNase protocols; and H. Vaucheret, X. Chen, C. Dean, M. Matzke, R. Amasino, X. Zhong, and L. Johnson for seeds. Sequencing was performed at the UCLA BSCRC Bio-Sequencing Core Facility. This work was supported by NIH grant GM60398 and NSF grants 0701745 and 1121245. H.S. was supported by a Fred Eiserling and Judith Lengyel Graduate Doctorate Fellowship. M.V.C.G. was supported by US Public Health Service National Research Service Award GM07104 and a UCLA Dissertation Year Fellowship. S.F. is a Special Fellow of the Leukemia and Lymphoma Society. S.E.J. is an investigator of the Howard Hughes Medical Institute.	Aufsatz W, 2002, EMBO J, V21, P6832, DOI 10.1093/emboj/cdf663; Baurle I, 2007, SCIENCE, V318, P109, DOI 10.1126/science.1146565; Baumbusch LO, 2001, NUCLEIC ACIDS RES, V29, P4319, DOI 10.1093/nar/29.21.4319; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Berr A, 2010, PLANT CELL, V22, P3232, DOI 10.1105/tpc.110.079962; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Earley KW, 2010, GENE DEV, V24, P1119, DOI 10.1101/gad.1914110; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Feng SH, 2011, METHODS MOL BIOL, V733, P223, DOI 10.1007/978-1-61779-089-8_16; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Greenberg MVC, 2011, EPIGENETICS-US, V6, P344, DOI 10.4161/epi.6.3.14242; Gu XF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002366; Guo L, 2010, P NATL ACAD SCI USA, V107, P18557, DOI 10.1073/pnas.1010478107; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; He XJ, 2009, GENE DEV, V23, P318, DOI 10.1101/gad.1765209; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu XC, 2012, PLANT PHYSIOL, V158, P119, DOI 10.1104/pp.111.184275; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Miura A, 2009, EMBO J, V28, P1078, DOI 10.1038/emboj.2009.59; Onodera Y, 2008, GENETICS, V180, P207, DOI 10.1534/genetics.108.090621; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pontvianne F, 2010, ADV BOT RES, V53, P1, DOI 10.1016/S0065-2296(10)53001-5; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Schonrock N, 2006, J BIOL CHEM, V281, P9560, DOI 10.1074/jbc.M513426200; Schotta G, 2003, GENETICA, V117, P149, DOI 10.1023/A:1022923508198; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; To TK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002055; Tran RK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r90; Voinnet O, 2008, TRENDS PLANT SCI, V13, P317, DOI 10.1016/j.tplants.2008.05.004; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Weinhofer I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001152; Woo HR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000156; Xu L, 2008, MOL CELL BIOL, V28, P1348, DOI 10.1128/MCB.01607-07; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62; Zheng BL, 2009, GENE DEV, V23, P2850, DOI 10.1101/gad.1868009; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zhong XH, 2012, NAT STRUCT MOL BIOL, V19, P870, DOI 10.1038/nsmb.2354	53	553	564	7	147	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					352	364		10.1016/j.cell.2012.10.054	http://dx.doi.org/10.1016/j.cell.2012.10.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23313553	Green Accepted, Bronze			2022-12-24	WOS:000313719800029
J	Holt, B; Lessard, JP; Borregaard, MK; Fritz, SA; Araujo, MB; Dimitrov, D; Fabre, PH; Graham, CH; Graves, GR; Jonsson, KA; Nogues-Bravo, D; Wang, ZH; Whittaker, RJ; Fjeldsa, J; Rahbek, C				Holt, Ben G.; Lessard, Jean-Philippe; Borregaard, Michael K.; Fritz, Susanne A.; Araujo, Miguel B.; Dimitrov, Dimitar; Fabre, Pierre-Henri; Graham, Catherine H.; Graves, Gary R.; Jonsson, Knud A.; Nogues-Bravo, David; Wang, Zhiheng; Whittaker, Robert J.; Fjeldsa, Jon; Rahbek, Carsten			An Update of Wallace's Zoogeographic Regions of the World	SCIENCE			English	Article							GLOBAL PATTERNS; CLIMATE-CHANGE; DISTRIBUTIONS; CONSERVATION; DIVERSITY; VELOCITY; ENDEMISM	Modern attempts to produce biogeographic maps focus on the distribution of species, and the maps are typically drawn without phylogenetic considerations. Here, we generate a global map of zoogeographic regions by combining data on the distributions and phylogenetic relationships of 21,037 species of amphibians, birds, and mammals. We identify 20 distinct zoogeographic regions, which are grouped into 11 larger realms. We document the lack of support for several regions previously defined based on distributional data and show that spatial turnover in the phylogenetic composition of vertebrate assemblages is higher in the Southern than in the Northern Hemisphere. We further show that the integration of phylogenetic information provides valuable insight on historical relationships among regions, permitting the identification of evolutionarily unique regions of the world.	[Holt, Ben G.; Lessard, Jean-Philippe; Borregaard, Michael K.; Fritz, Susanne A.; Araujo, Miguel B.; Graves, Gary R.; Nogues-Bravo, David; Wang, Zhiheng; Whittaker, Robert J.; Rahbek, Carsten] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Dept Biol, DK-2100 Copenhagen O, Denmark; [Fritz, Susanne A.] Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Fritz, Susanne A.] Senckenberg Gesell Nat Forsch, D-60325 Frankfurt, Germany; [Araujo, Miguel B.] CSIC, Dept Biogeog & Global Change, Natl Museum Nat Sci, Madrid 28006, Spain; [Araujo, Miguel B.] Univ Evora, Ctr Invest Biodiversidade & Recursos Genet, P-7000 Evora, Portugal; [Dimitrov, Dimitar; Fabre, Pierre-Henri; Jonsson, Knud A.; Fjeldsa, Jon] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Nat Hist Museum Denmark, DK-2100 Copenhagen O, Denmark; [Graham, Catherine H.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Graves, Gary R.] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20013 USA; [Whittaker, Robert J.] Univ Oxford, Biodivers Res Grp, Sch Geog & Environm, Ctr Environm, Oxford OX1 3QY, England	University of Copenhagen; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN); Consejo Superior de Investigaciones Cientificas (CSIC); University of Evora; University of Copenhagen; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Oxford	Lessard, JP (corresponding author), Univ Copenhagen, Ctr Macroecol Evolut & Climate, Dept Biol, DK-2100 Copenhagen O, Denmark.	jplessard@bio.ku.dk	Borregaard, Michael/B-8442-2008; Whittaker, Robert J/H-1548-2015; Graham, Catherine/AAN-1237-2020; Dimitrov, Dimitar/A-9563-2009; Wang, Zhiheng/G-1750-2010; Graham, Catherine/A-9560-2011; Fjeldså, Jon/A-9699-2013; Rahbek, Carsten/D-9372-2013; Graves, Gary R/P-1003-2017; Jønsson, Knud/GMW-5310-2022; Rahbek, Carsten/L-1129-2013; Fritz, Susanne/M-9872-2014; Araújo, Miguel B/B-6117-2008; Jonsson, Knud A/F-6902-2012	Borregaard, Michael/0000-0002-8146-8435; Whittaker, Robert J/0000-0001-7775-3383; Graham, Catherine/0000-0001-9267-7948; Dimitrov, Dimitar/0000-0001-5830-5702; Wang, Zhiheng/0000-0003-0808-7780; Graham, Catherine/0000-0001-9267-7948; Fjeldså, Jon/0000-0003-0790-3600; Graves, Gary R/0000-0003-1406-5246; Jønsson, Knud/0000-0002-1875-9504; Rahbek, Carsten/0000-0003-4585-0300; Fritz, Susanne/0000-0002-4085-636X; Araújo, Miguel B/0000-0002-5107-7265; Holt, Ben G./0000-0003-0831-9684; Nogues-Bravo, David/0000-0002-4060-0153; Pierre-Henri, Fabre/0000-0002-3414-5625	Danish National Research Foundation; Marie Curie Actions under the Seventh Framework Programme [PIEF-GA-2009-252888]; Spanish Research Council (CSIC)	Danish National Research Foundation(Danmarks Grundforskningsfond); Marie Curie Actions under the Seventh Framework Programme; Spanish Research Council (CSIC)	We thank the Danish National Research Foundation for its support of the Center for Macroecology, Evolution, and Climate. B.G.H. also thanks the Marie Curie Actions under the Seventh Framework Programme (PIEF-GA-2009-252888). M.B.A. also thanks the Spanish Research Council (CSIC) for support, and S.A.F. thanks the Landes-Offensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz program of Hesse's Ministry of Higher Education, Research, and the Arts. We thank L. Hansen for help with data and reference compilations. We thank the International Union for Conservation of Nature and Natural Resources for making the amphibian and mammal range data available. Data are archived at http://macroecology.ku.dk/resources/wallace.	Allen JRM, 2010, QUATERNARY SCI REV, V29, P2604, DOI 10.1016/j.quascirev.2010.05.031; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Cracraft J, 2001, P ROY SOC B-BIOL SCI, V268, P459, DOI 10.1098/rspb.2000.1368; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Fjeldsa J, 1999, ECOGRAPHY, V22, P63, DOI 10.1111/j.1600-0587.1999.tb00455.x; Fritz SA, 2012, J BIOGEOGR, V39, P1373, DOI 10.1111/j.1365-2699.2012.02757.x; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Ladle R. J., 2011, CONSERVATION BIOGEOG, DOI 10.1002/9781444390001; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; MANTEL N, 1967, CANCER RES, V27, P209; Mayr E, 1944, Q REV BIOL, V19, P1, DOI 10.1086/394684; Munguia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034420; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Proches S, 2012, BIOSCIENCE, V62, P260, DOI 10.1525/bio.2012.62.3.7; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Sclater P. L., 1858, J P LINNEAN SOC ZOOL, V2, P130, DOI [10.1111/j.1096-3642, DOI 10.1111/J.1096-3642.1858.TB02549.X]; Udvardy MDF, 1975, 18 INT UN CONS NAT; Upchurch P, 2008, TRENDS ECOL EVOL, V23, P229, DOI 10.1016/j.tree.2007.11.006; Wallace A. R, 1894, GEOGRAPHICAL J; Weber M, 1902, INDOAUSTRALISCHE ARC; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; [No title captured]	26	789	845	17	616	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					74	78		10.1126/science.1228282	http://dx.doi.org/10.1126/science.1228282			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23258408				2022-12-24	WOS:000312985800054
J	Deweerdt, S				Deweerdt, Sarah			COMPARATIVE BIOLOGY Looking for a master switch	NATURE			English	Editorial Material							FIBROBLASTS; RESISTANT											Austad SN, 2010, J COMP PATHOL, V141, pS10, DOI 10.1016/j.jcpa.2009.10.024; Edrey YH, 2012, AGING CELL, V11, P213, DOI 10.1111/j.1474-9726.2011.00772.x; Harper JM, 2007, AGING CELL, V6, P1, DOI 10.1111/j.1474-9726.2006.00255.x; Harper JM, 2011, J EXP BIOL, V214, P1902, DOI 10.1242/jeb.054643; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Soltow QA, 2010, INTEGR COMP BIOL, V50, P844, DOI 10.1093/icb/icq094	6	18	19	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					S10	S11		10.1038/492S10a	http://dx.doi.org/10.1038/492S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222666	Bronze			2022-12-24	WOS:000311893400006
J	Wu, D; Hu, Q; Yan, Z; Chen, W; Yan, CY; Huang, X; Zhang, J; Yang, PY; Deng, HT; Wang, JW; Deng, XW; Shi, YG				Wu, Di; Hu, Qi; Yan, Zhen; Chen, Wen; Yan, Chuangye; Huang, Xi; Zhang, Jing; Yang, Panyu; Deng, Haiteng; Wang, Jiawei; Deng, XingWang; Shi, Yigong			Structural basis of ultraviolet-B perception by UVR8	NATURE			English	Article							CATION-PI INTERACTIONS; PLANT PHOTORECEPTOR DOMAIN; BLUE; CRYPTOCHROMES; PHYTOCHROME; REGULATOR; SOFTWARE; REVEALS	The Arabidopsis thaliana protein UVR8 is a photoreceptor for ultraviolet-B. Upon ultraviolet-B irradiation, UVR8 undergoes an immediate switch from homodimer to monomer, which triggers a signalling pathway for ultraviolet protection. The mechanism by which UVR8 senses ultraviolet-B remains largely unknown. Here we report the crystal structure of UVR8 at 1.8 angstrom resolution, revealing a symmetric homodimer of seven-bladed beta-propeller that is devoid of any external cofactor as the chromophore. Arginine residues that stabilize the homodimeric interface, principally Arg 286 and Arg 338, make elaborate intramolecular cation-pi interactions with surrounding tryptophan amino acids. Two of these tryptophans, Trp 285 and Trp 233, collectively serve as the ultraviolet-B chromophore. Our structural and biochemical analyses identify the molecular mechanism for UVR8-mediated ultraviolet-B perception, in which ultraviolet-B radiation results in destabilization of the intramolecular cation-pi interactions, causing disruption of the critical intermolecular hydrogen bonds mediated by Arg 286 and Arg 338 and subsequent dissociation of the UVR8 homodimer.	[Wu, Di; Hu, Qi; Yan, Zhen; Zhang, Jing; Deng, Haiteng; Shi, Yigong] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Wu, Di; Hu, Qi; Yan, Zhen; Yan, Chuangye; Zhang, Jing; Deng, Haiteng; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Chen, Wen; Huang, Xi; Yang, Panyu; Deng, XingWang] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Yan, Chuangye; Wang, Jiawei] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Huang, Xi; Yang, Panyu; Deng, XingWang] Peking Univ, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Tsinghua University; Tsinghua University; Peking University; Tsinghua University; Peking University	Shi, YG (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010; Deng, Xing Wang/ABF-4107-2020; Yan, Chuangye/AAJ-5832-2021	Wang, Jiawei/0000-0001-9893-8539; Jan, Yuh Nung/0000-0003-1367-6299; He, Ye/0000-0002-3936-4958; Yan, Chuangye/0000-0001-9338-8048; Yan, Zhen/0000-0002-1999-8451; Jan, Lily/0000-0003-3938-8498; Deng, Haiteng/0000-0001-9496-1280; Yan, Zhiqiang/0000-0003-4714-2076; Shi, Yigong/0000-0003-2030-168X	Ministry of Science and Technology [2009CB918801, 2012CB910900]; National Natural Science Foundation; Beijing Municipal Commission of Education; Beijing Municipal Commission of Science; Beijing Municipal Commission of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047850] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Beijing Municipal Commission of Science; Beijing Municipal Commission of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. He and S. Huang at SSRF, and K. Hasegawa and T. Kumasaka at the SPring-8 beamline BL41XU, for assistance. This work was supported by funds from the Ministry of Science and Technology (grant no. 2009CB918801 to Y.S., and 2012CB910900 to X.W.D.), the National Natural Science Foundation, and the Beijing Municipal Commissions of Education and Science and Technology.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Brown BA, 2005, P NATL ACAD SCI USA, V102, P18225, DOI 10.1073/pnas.0507187102; Brown BA, 2008, PLANT PHYSIOL, V146, P576, DOI 10.1104/pp.107.108456; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2012, SCIENCE, V335, P1492, DOI 10.1126/science.1218091; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dougherty DA, 2007, J NUTR, V137, p1504S, DOI 10.1093/jn/137.6.1504S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falciatore A, 2005, CURR TOP DEV BIOL, V68, P317, DOI 10.1016/S0070-2153(05)68011-8; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; Gallivan JP, 2000, J AM CHEM SOC, V122, P870, DOI 10.1021/ja991755c; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kaiserli E, 2007, PLANT CELL, V19, P2662, DOI 10.1105/tpc.107.053330; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kliebenstein DJ, 2002, PLANT PHYSIOL, V130, P234, DOI 10.1104/pp.005041; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sinnokrot MO, 2002, J AM CHEM SOC, V124, P10887, DOI 10.1021/ja025896h; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; van der Linden AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000503; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; YU HT, 1992, J AM CHEM SOC, V114, P8449, DOI 10.1021/ja00048a015	40	321	369	11	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					214	U96		10.1038/nature10931	http://dx.doi.org/10.1038/nature10931			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	23222543				2022-12-24	WOS:000303149900029
